PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dimitrova, N; Chen, YCM; Spector, DL; de Lange, T				Dimitrova, Nadya; Chen, Yi-Chun M.; Spector, David L.; de Lange, Titia			53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility	NATURE			English	Article							DNA-DAMAGE; PROTEIN 53BP1; MDC1; TRF2; ATM; BINDING; PROTECTION; DYNAMICS; MEDIATOR; LENGTH	Double- strand breaks activate the ataxia telangiectasia mutated ( ATM) kinase, which promotes the accumulation of DNA damage factors in the chromatin surrounding the break. The functional significance of the resulting DNA damage foci is poorly understood. Here we show that 53BP1 ( also known as TRP53BP1), a component of DNA damage foci, changes the dynamic behaviour of chromatin to promote DNA repair. We used conditional deletion of the shelterin component TRF2 ( also known as TERF2) from mouse cells ( TRF2(fl/-)) to deprotect telomeres, which, like doublestrand breaks, activate the ATM kinase, accumulate 53BP1 and are processed by non- homologous end joining (NHEJ)(1,2). Deletion of TRF2 from 53BP1- deficient cells established that NHEJ of dysfunctional telomeres is strongly dependent on the binding of 53BP1 to damaged chromosome ends. To address the mechanism by which 53BP1 promotes NHEJ, we used time- lapse microscopy to measure telomere dynamics before and after their deprotection. Imaging showed that deprotected telomeres are more mobile and sample larger territories within the nucleus. This change in chromatin dynamics was dependent on 53BP1 and ATM but did not require a functional NHEJ pathway. We propose that the binding of 53BP1 near DNA breaks changes the dynamic behaviour of the local chromatin, thereby facilitating NHEJ repair reactions that involve distant sites, including joining of dysfunctional telomeres and AID ( also known as AICDA)- induced breaks in immunoglobulin class- switch recombination.	[Dimitrova, Nadya; de Lange, Titia] Rockefeller Univ, New York, NY 10065 USA; [Chen, Yi-Chun M.; Spector, David L.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Rockefeller University; Cold Spring Harbor Laboratory	de Lange, T (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	NIH [GM049046]; NIH Director's Pioneer Award [OD000379, EY18244, GM42694]; HHMI pre-doctoral fellowship; NATIONAL EYE INSTITUTE [PN2EY018244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049046, R01GM042694, R37GM049046] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000379] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI pre-doctoral fellowship(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to J. Chen for his gift of 53BP1- and MDC1-deficient mice. We thank D. White for expert mouse husbandry. We thank the Bio- Imaging Facilities at Cold Spring Harbor Laboratory and at The Rockefeller University. J. Petrini is thanked for his gift of NBS1 antibody, A. Sfeir for providing the TRF1 antibody and A. Konishi for the BP1- 2 construct. M. Dimitrov is thanked for mathematical advice on data analysis, and S. Jaramillo and Y. Fu for Matlab programming. Members of the de Lange laboratory are thanked for comments on the manuscript. This work was supported by a grant from the NIH (GM049046) and by the NIH Director's Pioneer Award (OD000379) to T. d. L., and grants from the NIH to D. L. S. (EY18244 and GM42694). N. D. was supported by an HHMI pre-doctoral fellowship.	Abney JR, 1997, J CELL BIOL, V137, P1459, DOI 10.1083/jcb.137.7.1459; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Dimitrova N, 2006, GENE DEV, V20, P3238, DOI 10.1101/gad.1496606; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Fernandez-Capetillo O, 2003, J CELL BIOL, V163, P15, DOI 10.1083/jcb.200305124; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Kao GD, 2003, J CELL BIOL, V160, P1017, DOI 10.1083/jcb.200209065; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Molenaar C, 2003, EMBO J, V22, P6631, DOI 10.1093/emboj/cdg633; Reina-San-Martin B, 2007, EUR J IMMUNOL, V37, P235, DOI 10.1002/eji.200636789; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	31	421	428	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					524	U51		10.1038/nature07433	http://dx.doi.org/10.1038/nature07433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18931659	Green Accepted			2022-12-28	WOS:000261170500043
J	Ennis, S; Jomary, C; Mullins, R; Cree, A; Chen, XL; MacLeod, A; Jones, S; Collins, A; Stone, E; Lotery, A				Ennis, Sarah; Jomary, Catherine; Mullins, Robert; Cree, Angela; Chen, Xaoli; MacLeod, Alex; Jones, Stephen; Collins, Andrew; Stone, Edwin; Lotery, Andrew			Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study	LANCET			English	Article							COMPLEMENT FACTOR-H; RANIBIZUMAB; RISK; POLYMORPHISM; METAANALYSIS; BEVACIZUMAB; MECHANISMS; INHIBITOR; COMPONENT; DISEASE	Background Age-related macular degeneration is the most prevalent form of visual impairment and blindness in developed countries. Genetic studies have made advancements in establishing the molecular cause of this disease, identifying mutations in the complement factor H (CFH) gene and a locus on chromosome 10 encompassing the HTRA1/LOC387715/ARMS2 genes. Variants in complement 3 (C3) and an HLA locus containing both factor B and C2 genes have also been implicated. We aimed to identify further genetic risk factors for this disease. Methods We used a case-control study design in a UK sample of patients with age-related macular degeneration (n=479) and controls (n=479) and undertook a low-density screen of 32 genes using 93 single nucleotide polymorphisms (SNPs). Genes were selected as candidates on the basis of potential functional relevance to age-related macular degeneration. Significant initial findings were confirmed by replication in an independent US cohort of 248 unrelated patients with disease and 252 controls, and by high-density genotyping around association signals. Findings The SNP variant rs2511989, located within intron six of the SERPING1 gene, showed highly significant genotypic association with age-related macular degeneration (uncorrected p=4.0x10(-5), corrected p=0.00372). We detected no evidence for association between disease and the other 31 candidate genes. The odds ratio for age-related macular degeneration in rs251.1989 G/A heterozygotes compared with wild type G/G homozygotes was 0 . 63 (95% CI 0 . 47-0 . 84). A similar comparison of the A/A homozygotes with the wild type yielded an odds ratio of 0 . 44 (0.31-0 . 64). We replicated the observed genotypic association in a US cohort (p=0.008). Furthermore, a secondary high-density genotyping study across the SERPING1 gene region identified five additional S N P variants similarly associated with age-related macular degeneration (rs2244169, rs2511990, rs2509897, rs1005510, and rs2511988). Interpretation Genetic variation in SERPING1 significantly alters susceptibility to age-related macular degeneration. SERPING1 encodes the C1 inhibitor, which has a crucial role in inhibition of complement component 1 (C1) and might implicate the classic pathway of complement activation in this disease. Funding Macula Vision Research Foundation, the Macular Disease Society, the Wellcome Trust, Brian Mercer Trust, the American Health Assistance Foundation, National institutes of Health, the Howard Hughes Medical Institute.	[Jomary, Catherine; Cree, Angela; Chen, Xaoli; Lotery, Andrew] Southampton Gen Hosp, Clin Neurosci Div, Southampton SO16 6YD, Hants, England; [MacLeod, Alex; Lotery, Andrew] Southampton Gen Hosp, Southampton Eye Unit, Southampton SO16 6YD, Hants, England; [Ennis, Sarah; Collins, Andrew] Southampton Gen Hosp, Div Human Genet, Genet Epidemiol & Bioinformat Grp, Southampton SO16 6YD, Hants, England; [Mullins, Robert; Stone, Edwin] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Jones, Stephen] Kings Coll London, Rayne Inst, St Thomas Hosp, London WC2R 2LS, England; [Stone, Edwin] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Southampton; University of Southampton; University of Southampton; University of Iowa; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Howard Hughes Medical Institute	Lotery, A (corresponding author), Southampton Gen Hosp, Clin Neurosci Div, Mailpoint 806, Southampton SO16 6YD, Hants, England.	a.j.lotery@southampton.ac.uk	Jomary, Catherine/A-2854-2011; Collins, Andrew/A-6595-2010; Collins, Andrew/S-2196-2019; Mullins, Robert F/I-6717-2013	Collins, Andrew/0000-0001-7108-0771; Collins, Andrew/0000-0001-7108-0771; Lotery, Andrew/0000-0001-5541-4305; Mullins, Robert/0000-0002-5006-0891; Stone, Edwin M./0000-0003-3343-4414; Cree, Angela/0000-0002-1987-8900	Macula Vision Research Foundation (MVRF); Macular Disease Society; Wellcome Trust; Brian Mercer Trust; American Health Assistance Foundation; N I H [EY-017451, EY-016822]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY017451, R01EY016822] Funding Source: NIH RePORTER	Macula Vision Research Foundation (MVRF); Macular Disease Society; Wellcome Trust(Wellcome TrustEuropean Commission); Brian Mercer Trust; American Health Assistance Foundation; N I H(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	For the UK studies. this research was supported by the Macula Vision Research Foundation (MVRF), the Macular Disease Society, the Wellcome Trust, Brian Mercer Trust, and the American Health Assistance Foundation. Aspects of the US-based study were Funded by the MVRF (RM), N I H grants EY-017451 (RM) and EY-016822 (B). and the Howard Hughes Medical Institute (ES). We thank Helen Griffiths, Elizabeth Faidley. Benjamin Roos, and Jessica Skeie for providing laboratory assistance; The Southampton WTCRF muses for help with sample collection; Lee Murphy and Angie Fawkes at the Edinburgh WTCRF: Jane Collier at KBioscience: and all study participants for agreeing to contribute to this research.	Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668; Bonastre J, 2002, Eur J Health Econ, V3, P94, DOI 10.1007/s10198-002-0104-y; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; BUFFONE GJ, 1985, CLIN CHEM, V31, P164; Cicardi M, 1996, NEW ENGL J MED, V334, P1666, DOI 10.1056/NEJM199606203342510; DAVIS AE, 1992, NAT GENET, V1, P354, DOI 10.1038/ng0892-354; DAVIS AE, 1986, P NATL ACAD SCI USA, V83, P3161, DOI 10.1073/pnas.83.10.3161; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lotery A, 2007, HUM GENET, V122, P219, DOI 10.1007/s00439-007-0406-3; Lotery A, 2007, BRIT J OPHTHALMOL, V91, P1303, DOI 10.1136/bjo.2007.116939; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mullins RF, 2006, MOL VIS, V12, P224; Raftery J, 2007, BRIT J OPHTHALMOL, V91, P1244, DOI 10.1136/bjo.2007.116616; Raftery JP, 2007, BRIT MED J, V334, P381, DOI 10.1136/bmj.39128.708565.3A; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Steemers FJ, 2005, PHARMACOGENOMICS, V6, P777, DOI 10.2217/14622416.6.7.777; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	30	129	132	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 22	2008	372	9652					1828	1834		10.1016/S0140-6736(08)61348-3	http://dx.doi.org/10.1016/S0140-6736(08)61348-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	18842294	Green Accepted			2022-12-28	WOS:000261112000025
J	Aliu, E; Anderhub, H; Antonelli, LA; Antoranz, P; Backes, M; Baixeras, C; Barrio, JA; Bartko, H; Bastieri, D; Becker, JK; Bednarek, W; Berger, K; Bernardini, E; Bigongiari, C; Biland, A; Bock, RK; Bonnoli, G; Bordas, P; Bosch-Ramon, V; Bretz, T; Britvitch, I; Camara, M; Carmona, E; Chilingarian, A; Commichau, S; Contreras, JL; Cortina, J; Costado, MT; Covino, S; Curtef, V; Dazzi, F; De Angelis, A; del Pozo, EDC; de los Reyes, R; De Lotto, B; De Maria, M; De Sabata, F; Mendez, CD; Dominguez, A; Dorner, D; Doro, M; Elsasser, D; Errando, M; Fagiolini, M; Ferenc, D; Fernandez, E; Firpo, R; Fonseca, MV; Font, L; Galante, N; Lopez, RJG; Garczarczyk, M; Gaug, M; Goebel, F; Hadasch, D; Hayashida, M; Herrero, A; Hohne, D; Hose, J; Hsu, CC; Huber, S; Jogler, T; Kranich, D; La Barbera, A; Laille, A; Leonardo, E; Lindfors, E; Lombardi, S; Longo, F; Lopez, M; Lorenz, E; Majumdar, P; Maneva, G; Mankuzhiyil, N; Mannheim, K; Maraschi, L; Mariotti, M; Martinez, M; Mazin, D; Meucci, M; Meyer, M; Miranda, JM; Mirzoyan, R; Moles, M; Moralejo, A; Nieto, D; Nilsson, K; Ninkovic, J; Otte, N; Oya, I; Paoletti, R; Paredes, JM; Pasanen, M; Pascoli, D; Pauss, F; Pegna, RG; Perez-Torres, MA; Persic, M; Peruzzo, L; Piccioli, A; Prada, F; Prandini, E; Puchades, N; Raymers, A; Rhode, W; Ribo, M; Rico, J; Rissi, M; Robert, A; Rugamer, S; Saggion, A; Saito, TY; Salvati, M; Sanchez-Conde, M; Sartori, P; Satalecka, K; Scalzotto, V; Scapin, V; Schweizer, T; Shayduk, M; Shinozaki, K; Shore, SN; Sidro, N; Sierpowska-Bartosik, A; Sillanpaa, A; Sobczynska, D; Spanier, F; Stamerra, A; Stark, LS; Takalo, L; Tavecchio, F; Temnikov, P; Tescaro, D; Teshima, M; Tluczykont, M; Torres, DF; Turini, N; Vankov, H; Venturini, A; Vitale, V; Wagner, RM; Wittek, W; Zabalza, V; Zandanel, F; Zanin, R; Zapatero, J; de Jager, OC; Wilhelmi, ED				Aliu, E.; Anderhub, H.; Antonelli, L. A.; Antoranz, P.; Backes, M.; Baixeras, C.; Barrio, J. A.; Bartko, H.; Bastieri, D.; Becker, J. K.; Bednarek, W.; Berger, K.; Bernardini, E.; Bigongiari, C.; Biland, A.; Bock, R. K.; Bonnoli, G.; Bordas, P.; Bosch-Ramon, V.; Bretz, T.; Britvitch, I.; Camara, M.; Carmona, E.; Chilingarian, A.; Commichau, S.; Contreras, J. L.; Cortina, J.; Costado, M. T.; Covino, S.; Curtef, V.; Dazzi, F.; De Angelis, A.; De Cea del Pozo, E.; de los Reyes, R.; De Lotto, B.; De Maria, M.; De Sabata, F.; Delgado Mendez, C.; Dominguez, A.; Dorner, D.; Doro, M.; Elsasser, D.; Errando, M.; Fagiolini, M.; Ferenc, D.; Fernandez, E.; Firpo, R.; Fonseca, M. V.; Font, L.; Galante, N.; Garcia Lopez, R. J.; Garczarczyk, M.; Gaug, M.; Goebel, F.; Hadasch, D.; Hayashida, M.; Herrero, A.; Hohne, D.; Hose, J.; Hsu, C. C.; Huber, S.; Jogler, T.; Kranich, D.; La Barbera, A.; Laille, A.; Leonardo, E.; Lindfors, E.; Lombardi, S.; Longo, F.; Lopez, M.; Lorenz, E.; Majumdar, P.; Maneva, G.; Mankuzhiyil, N.; Mannheim, K.; Maraschi, L.; Mariotti, M.; Martinez, M.; Mazin, D.; Meucci, M.; Meyer, M.; Miranda, J. M.; Mirzoyan, R.; Moles, M.; Moralejo, A.; Nieto, D.; Nilsson, K.; Ninkovic, J.; Otte, N.; Oya, I.; Paoletti, R.; Paredes, J. M.; Pasanen, M.; Pascoli, D.; Pauss, F.; Pegna, R. G.; Perez-Torres, M. A.; Persic, M.; Peruzzo, L.; Piccioli, A.; Prada, F.; Prandini, E.; Puchades, N.; Raymers, A.; Rhode, W.; Ribo, M.; Rico, J.; Rissi, M.; Robert, A.; Rugamer, S.; Saggion, A.; Saito, T. Y.; Salvati, M.; Sanchez-Conde, M.; Sartori, P.; Satalecka, K.; Scalzotto, V.; Scapin, V.; Schweizer, T.; Shayduk, M.; Shinozaki, K.; Shore, S. N.; Sidro, N.; Sierpowska-Bartosik, A.; Sillanpaa, A.; Sobczynska, D.; Spanier, F.; Stamerra, A.; Stark, L. S.; Takalo, L.; Tavecchio, F.; Temnikov, P.; Tescaro, D.; Teshima, M.; Tluczykont, M.; Torres, D. F.; Turini, N.; Vankov, H.; Venturini, A.; Vitale, V.; Wagner, R. M.; Wittek, W.; Zabalza, V.; Zandanel, F.; Zanin, R.; Zapatero, J.; de Jager, O. C.; Wilhelmi, E. de Ona		MAGIC Collaboration	Observation of Pulsed gamma-Rays Above 25 GeV from the Crab Pulsar with MAGIC	SCIENCE			English	Article							OUTER MAGNETOSPHERE; SLOT GAPS; EMISSION; RADIATION; TEV; TELESCOPE; SEARCH; ACCELERATION; NEBULA	One fundamental question about pulsars concerns the mechanism of their pulsed electromagnetic emission. Measuring the high- end region of a pulsar's spectrum would shed light on this question. By developing a new electronic trigger, we lowered the threshold of the Major Atmospheric gamma-ray Imaging Cherenkov (MAGIC) telescope to 25 giga-electron volts. In this configuration, we detected pulsed gamma-rays from the Crab pulsar that were greater than 25 giga-electron volts, revealing a relatively high cutoff energy in the phase- averaged spectrum. This indicates that the emission occurs far out in the magnetosphere, hence excluding the polar- cap scenario as a possible explanation of our measurement. The high cutoff energy also challenges the slot- gap scenario.	[Bastieri, D.; Bigongiari, C.; Bock, R. K.; Dazzi, F.; Doro, M.; Lombardi, S.; Lopez, M.; Mariotti, M.; Pascoli, D.; Peruzzo, L.; Prandini, E.; Saggion, A.; Sartori, P.; Scalzotto, V.; Venturini, A.] Univ Padua, I-35131 Padua, Italy; [Bastieri, D.; Bigongiari, C.; Bock, R. K.; Dazzi, F.; Doro, M.; Lombardi, S.; Lopez, M.; Mariotti, M.; Pascoli, D.; Peruzzo, L.; Prandini, E.; Saggion, A.; Sartori, P.; Scalzotto, V.; Venturini, A.] Ist Nazl Fis Nucl, I-35131 Padua, Italy; [Aliu, E.; Baixeras, C.; Cortina, J.; Errando, M.; Fernandez, E.; Firpo, R.; Font, L.; Martinez, M.; Mazin, D.; Moralejo, A.; Puchades, N.; Rico, J.; Robert, A.; Sidro, N.; Tescaro, D.; Zanin, R.; Wilhelmi, E. de Ona] Univ Autonoma Barcelona, Inst Fis Altes Energies, E-08193 Barcelona, Spain; [Anderhub, H.; Biland, A.; Britvitch, I.; Commichau, S.; Kranich, D.; Lorenz, E.; Pauss, F.; Rissi, M.; Stark, L. S.] ETH, CH-8093 Zurich, Switzerland; [Antonelli, L. A.; Covino, S.; La Barbera, A.; Maraschi, L.; Salvati, M.; Tavecchio, F.] INAF, I-00136 Rome, Italy; [Antoranz, P.; Barrio, J. A.; Camara, M.; Contreras, J. L.; de los Reyes, R.; Fonseca, M. V.; Miranda, J. M.; Nieto, D.; Oya, I.] Univ Complutense, E-28040 Madrid, Spain; [Backes, M.; Becker, J. K.; Curtef, V.; Hadasch, D.; Rhode, W.; Zapatero, J.] Tech Univ Dortmund, D-44221 Dortmund, Germany; [Bartko, H.; Bock, R. K.; Carmona, E.; Galante, N.; Garczarczyk, M.; Goebel, F.; Hayashida, M.; Hose, J.; Hsu, C. C.; Jogler, T.; Lorenz, E.; Majumdar, P.; Mirzoyan, R.; Ninkovic, J.; Otte, N.; Saito, T. Y.; Schweizer, T.; Shayduk, M.; Shinozaki, K.; Teshima, M.; Wagner, R. M.; Wittek, W.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Bednarek, W.; Sobczynska, D.] Univ Lodz, PL-90236 Lodz, Poland; [Berger, K.; Bretz, T.; Dorner, D.; Elsasser, D.; Hohne, D.; Huber, S.; Mannheim, K.; Meyer, M.; Rugamer, S.; Spanier, F.] Univ Wurzburg, D-97074 Wurzburg, Germany; [Bernardini, E.; Satalecka, K.; Tluczykont, M.] Deutsch Elekt Synchrotron, D-15738 Zeuthen, Germany; [Bonnoli, G.; Fagiolini, M.; Leonardo, E.; Meucci, M.; Paoletti, R.; Pegna, R. G.; Piccioli, A.; Stamerra, A.; Turini, N.] Univ Siena, I-53100 Siena, Italy; [Bonnoli, G.; Fagiolini, M.; Leonardo, E.; Meucci, M.; Paoletti, R.; Pegna, R. G.; Piccioli, A.; Stamerra, A.; Turini, N.] Ist Nazl Fis Nucl, I-53100 Siena, Italy; [Bordas, P.; Bosch-Ramon, V.; Paredes, J. M.; Ribo, M.; Zabalza, V.] Univ Barcelona, ICC, Inst Etud Espacials Catalunya IEEC, E-08028 Barcelona, Spain; [Chilingarian, A.; Raymers, A.] Yerevan Phys Inst, AM-375036 Yerevan, Armenia; [Costado, M. T.; Delgado Mendez, C.; Garcia Lopez, R. J.; Gaug, M.; Herrero, A.] Inst Astrofis Canarias, E-38200 San Cristobal la Laguna, Spain; [Costado, M. T.; Garcia Lopez, R. J.; Herrero, A.] Univ La Laguna, Dept Astrophys, E-38206 Tenerife, Spain; [De Angelis, A.; De Lotto, B.; De Maria, M.; De Sabata, F.; Longo, F.; Mankuzhiyil, N.; Scapin, V.; Vitale, V.] Univ Udine, I-33100 Udine, Italy; [De Angelis, A.; De Lotto, B.; De Maria, M.; De Sabata, F.; Longo, F.; Mankuzhiyil, N.; Scapin, V.; Vitale, V.] INFN Triest, I-33100 Udine, Italy; [De Cea del Pozo, E.; Sierpowska-Bartosik, A.; Torres, D. F.] CSIC, IEEC, E-08193 Bellaterra, Spain; [Dominguez, A.; Moles, M.; Perez-Torres, M. A.; Prada, F.; Sanchez-Conde, M.; Zandanel, F.] CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; [Ferenc, D.; Laille, A.] Univ Calif Davis, Davis, CA 95616 USA; [Lindfors, E.; Nilsson, K.; Pasanen, M.; Sillanpaa, A.; Takalo, L.] Turku Univ, Tuorla Observ, FI-21500 Piikkio, Finland; [Maneva, G.; Temnikov, P.; Vankov, H.] Inst Nucl Energy Res, BG-1784 Sofia, Bulgaria; [Otte, N.] Humboldt Univ, D-12489 Berlin, Germany; [Persic, M.] Osserv Astron Trieste, INAF, I-34143 Trieste, Italy; [Persic, M.] Ist Nazl Fis Nucl, I-34143 Trieste, Italy; [Rico, J.; Torres, D. F.] Inst Catalana Recerca & Estud Avancats, E-08010 Barcelona, Spain; [Shore, S. N.] Univ Pisa, I-56126 Pisa, Italy; [Shore, S. N.] Ist Nazl Fis Nucl, I-56126 Pisa, Italy; [de Jager, O. C.] NW Univ, Unit Space Phys, ZA-2520 Potchefstroom, South Africa	University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Institute for High Energy Physics (IFAE); Swiss Federal Institutes of Technology Domain; ETH Zurich; Istituto Nazionale Astrofisica (INAF); Complutense University of Madrid; Dortmund University of Technology; Max Planck Society; University of Lodz; University of Wurzburg; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Siena; Istituto Nazionale di Fisica Nucleare (INFN); Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona; Yerevan Physics Institute; Instituto de Astrofisica de Canarias; Universidad de la Laguna; University of Udine; Consejo Superior de Investigaciones Cientificas (CSIC); Institut d'Estudis Espacials de Catalunya (IEEC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); University of California System; University of California Davis; University of Turku; Bulgarian Academy of Sciences; Humboldt University of Berlin; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale di Fisica Nucleare (INFN); ICREA; University of Pisa; Istituto Nazionale di Fisica Nucleare (INFN); North West University - South Africa	Lopez, M (corresponding author), Univ Padua, I-35131 Padua, Italy.	marcos.lopezmoya@pd.infn.it; nepomake@scipp.ucsc.edu; Michael.Rissi@phys.ethz.ch; tschweiz@mppmu.mpg.de; shayduk@mppmu.mpg.de	Covino, Stefano/AAQ-5188-2021; Otte, Adam Nepomuk/L-4638-2019; Doro, Michele/F-9458-2012; Tjus, Julia/G-8145-2012; Fernandez, Enrique/L-5387-2014; Coma, Pol Bordas/AAA-2332-2020; Chilingarian, Ashot/B-1901-2014; Backes, Michael/N-5126-2016; Delgado, Carlos/K-7587-2014; Olaizola, Abelardo Moralejo/M-2916-2014; Mazin, Daniel/N-8038-2016; Torres, Diego F./AAF-7931-2019; Rodríguez, Manel Martínez/C-2539-2017; Costado, M. Teresa/ABB-2702-2020; González, María Victoria Fonseca/E-8093-2019; Ninkovic, Jelena/G-5005-2012; López-Moya, Marcos/L-2304-2014; Bernardini, Elisa/AAA-4810-2020; Font, Lluís/L-4197-2014; Miranda, Jose Miguel/F-2913-2013; Bastieri, Denis/AAC-5917-2020; Cortina, Juan/C-2783-2017; Rico, Javier/K-8004-2014; Antoranz, Pedro/H-5095-2015; CAMARA, Mamadou Bailo/F-5785-2019; Mannheim, Karl/F-6705-2012; Gaug, Markus/L-2340-2014; Bosch-Ramon, Valenti/E-5274-2016; Miranda, Jose/HCI-6099-2022; Ribó, Marc/B-3579-2015; Fernández, Ester/K-9734-2014; Barrio, Juan A/L-3227-2014; Temnikov, Petar P./L-6999-2016; Bretz, Thomas/AAK-8726-2020; Torres, Diego F/ABD-7940-2020; De Angelis, Alessandro/B-5372-2009; Hadasch, Daniela/N-7819-2016; Dominguez, Alberto/J-4429-2016; de Ona Wilhelmi, Emma/U-5587-2017; Torres, Diego F./O-9422-2016; Satalecka, Konstancja/AAT-1309-2020; Herrero, Artemio/H-7312-2015; Nieto, Daniel/J-7250-2015; Gonzalez, María Victoria Fonseca MV Fonseca/I-2004-2015; Maneva, Galina M/L-7120-2016; González, Jose Luis Contreras/K-7255-2014; ZANIN, Roberta/B-2316-2018; Lombardi, Saverio/Q-2818-2018	Covino, Stefano/0000-0001-9078-5507; Otte, Adam Nepomuk/0000-0002-5955-6383; Doro, Michele/0000-0001-9104-3214; Tjus, Julia/0000-0002-1748-7367; Fernandez, Enrique/0000-0002-6405-9488; Coma, Pol Bordas/0000-0002-0266-8536; Chilingarian, Ashot/0000-0002-2018-9715; Backes, Michael/0000-0002-9326-6400; Delgado, Carlos/0000-0002-7014-4101; Olaizola, Abelardo Moralejo/0000-0002-1344-9080; Mazin, Daniel/0000-0002-2010-4005; Torres, Diego F./0000-0002-1522-9065; Rodríguez, Manel Martínez/0000-0002-9763-9155; Costado, M. Teresa/0000-0002-2672-4061; González, María Victoria Fonseca/0000-0003-2235-0725; López-Moya, Marcos/0000-0002-8791-7908; Bernardini, Elisa/0000-0003-3108-1141; Font, Lluís/0000-0003-2109-5961; Miranda, Jose Miguel/0000-0002-1472-9690; Bastieri, Denis/0000-0002-6954-8862; Cortina, Juan/0000-0003-4576-0452; Rico, Javier/0000-0003-4137-1134; Antoranz, Pedro/0000-0002-3015-3601; Gaug, Markus/0000-0001-8442-7877; Bosch-Ramon, Valenti/0000-0002-6043-5079; Ribó, Marc/0000-0002-9931-4557; Barrio, Juan A/0000-0002-0965-0259; Temnikov, Petar P./0000-0002-9559-3384; Bretz, Thomas/0000-0002-3800-5531; Hadasch, Daniela/0000-0001-8663-6461; Dominguez, Alberto/0000-0002-3433-4610; de Ona Wilhelmi, Emma/0000-0002-5401-0744; Torres, Diego F./0000-0002-1522-9065; Satalecka, Konstancja/0000-0002-7669-266X; Nieto, Daniel/0000-0003-3343-0755; Gonzalez, María Victoria Fonseca MV Fonseca/0000-0003-2235-0725; Maneva, Galina M/0000-0002-5959-4179; González, Jose Luis Contreras/0000-0001-7282-2394; Prandini, Elisa/0000-0003-4502-9053; leonardo, elvira/0000-0003-0271-7673; Bednarek, Wlodek/0000-0003-0605-108X; ZANIN, Roberta/0000-0001-6320-1801; Lombardi, Saverio/0000-0002-6336-865X; Turini, Nicola/0000-0002-9395-5230; Oya, Igor/0000-0002-3881-9324; LA BARBERA, ANTONINO/0000-0002-5880-8913; Persic, Massimo/0000-0003-1853-4900; Hsu, Ching-Cheng/0000-0001-9406-2023; De Angelis, Alessandro/0000-0002-3288-2517; Sanchez-Conde, Miguel/0000-0002-3849-9164; Stamerra, Antonio/0000-0002-9430-5264; Sobczynska, Dorota/0000-0003-4973-7903; De Lotto, Barbara/0000-0003-3624-4480; Ninkovic, Jelena/0000-0003-1523-3635; Bonnoli, Giacomo/0000-0003-2464-9077; Bigongiari, Ciro/0000-0003-3293-8522; Spanier, Felix/0000-0001-6802-4744; Dazzi, Francesco/0000-0001-5409-6544; Puchades, Neus/0000-0001-7816-8119; Paredes, Josep M./0000-0002-1566-9044; de los Reyes Lopez, Raquel/0000-0003-0485-9552	German Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie; Max-Planck-Gesellschaft; Italian INFN and INAF; Swiss Schweizerische Nationalfonds; Spanish Ministerio de Ciencia e Innovacion; ETH [TH 34/043]; Polish Ministertwo Nauki i Szkolnictwa Wyzszego [N N203 390834]; Young Investigators Program of the Helmholtz Gemeinschaft; ICREA Funding Source: Custom	German Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie(Federal Ministry of Education & Research (BMBF)); Max-Planck-Gesellschaft(Max Planck Society); Italian INFN and INAF(Istituto Nazionale Astrofisica (INAF)); Swiss Schweizerische Nationalfonds(Swiss National Science Foundation (SNSF)); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); ETH(ETH Zurich); Polish Ministertwo Nauki i Szkolnictwa Wyzszego; Young Investigators Program of the Helmholtz Gemeinschaft; ICREA(ICREA)	We thank the electronics division at the Max-Planck-Insitut, Munich, for their work in developing and producing the analog sum trigger system, especially O. Reimann, R. Maier, S. Tran, and T. Dettlaff. We also thank L. Stodolsky for comments. We acknowledge the Instituto de Astrofisica for providing all infrastructure on the Roque de los Muchachos in La Palma. The support of the German Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie and Max-Planck-Gesellschaft, the Italian INFN and INAF, the Swiss Schweizerische Nationalfonds, and Spanish Ministerio de Ciencia e Innovacion is acknowledged. This work was also supported by ETH research grant TH 34/043, by the Polish Ministertwo Nauki i Szkolnictwa Wyzszego grant N N203 390834, and by the Young Investigators Program of the Helmholtz Gemeinschaft.	Aharonian F, 2007, ASTRON ASTROPHYS, V466, P543, DOI 10.1051/0004-6361:20066737; Aharonian F, 2004, ASTROPHYS J, V614, P897, DOI 10.1086/423931; Albert J, 2008, ASTROPHYS J, V674, P1037, DOI 10.1086/525270; ARONS J, 1979, ASTROPHYS J, V231, P854, DOI 10.1086/157250; Baring MG, 2004, ADV SPACE RES-SERIES, V33, P552, DOI 10.1016/j.asr.2003.08.020; Chadwick PM, 1998, ASTROPART PHYS, V9, P131, DOI 10.1016/S0927-6505(98)00017-6; CHENG KS, 1986, ASTROPHYS J, V300, P500, DOI 10.1086/163829; DAUGHERTY JK, 1982, ASTROPHYS J, V252, P337, DOI 10.1086/159561; de Naurois M, 2002, ASTROPHYS J, V566, P343, DOI 10.1086/337991; EDWARDS PG, 1994, ASTRON ASTROPHYS, V291, P468; GOLDREICH P, 1969, ASTROPHYS J, V157, P869, DOI 10.1086/150119; HARDING AK, COMMUNICATION; Harding AK, 2008, ASTROPHYS J, V680, P1378, DOI 10.1086/588037; Kuiper L, 2001, ASTRON ASTROPHYS, V378, P918, DOI 10.1051/0004-6361:20011256; Lessard RW, 2000, ASTROPHYS J, V531, P942, DOI 10.1086/308495; Lucarelli F, 2008, NUCL INSTRUM METH A, V589, P415, DOI 10.1016/j.nima.2008.03.007; LYNE AG, 1993, MON NOT R ASTRON SOC, V265, P1003, DOI 10.1093/mnras/265.4.1003; Muslimov AG, 2004, ASTROPHYS J, V606, P1143, DOI 10.1086/383079; OTTE AN, 2007, THESIS TU MUNICH; Romani RW, 1996, ASTROPHYS J, V470, P469, DOI 10.1086/177878; RUDERMAN MA, 1975, ASTROPHYS J, V196, P51, DOI 10.1086/153393; Tang APS, 2008, ASTROPHYS J, V676, P562, DOI 10.1086/527029	22	170	173	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1221	1224		10.1126/science.1164718	http://dx.doi.org/10.1126/science.1164718			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	18927358	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000261033400034
J	Athale, CA; Dinarina, A; Mora-Coral, M; Pugieux, C; Nedelec, F; Karsenti, E				Athale, Chaitanya A.; Dinarina, Ana; Mora-Coral, Maria; Pugieux, Celine; Nedelec, Francois; Karsenti, Eric			Regulation of Microtubule Dynamics by Reaction Cascades Around Chromosomes	SCIENCE			English	Article							XENOPUS EGG EXTRACTS; MITOTIC-SPINDLE; GRADIENT; EFFICIENT; CHROMATIN; SYSTEMS; GTPASES; CELLS	During spindle assembly, chromosomes generate gradients of microtubule stabilization through a reaction- diffusion process, but how this is achieved is not well understood. We measured the spatial distribution of microtubule aster asymmetry around chromosomes by incubating centrosomes and micropatterned chromatin patches in frog egg extracts. We then screened for microtubule stabilization gradient shapes that would generate such spatial distributions with the use of computer simulations. Only a long- range, sharply decaying microtubule stabilization gradient could generate aster asymmetries fitting the experimental data. We propose a reaction- diffusion model that combines the chromosome generated Ran- guanosine triphosphate- Importin reaction network to a secondary phosphorylation network as a potential mechanism for the generation of such gradients.	[Athale, Chaitanya A.; Dinarina, Ana; Mora-Coral, Maria; Pugieux, Celine; Nedelec, Francois; Karsenti, Eric] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Karsenti, E (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, Heidelberg, Germany.	karsenti@embl.de	Nedelec, Francois J/H-3317-2011; Athale, Chaitanya/G-8883-2011; Nedelec, Francois/AAC-1673-2019	Nedelec, Francois J/0000-0002-8141-5288; Athale, Chaitanya/0000-0002-9506-2153; Nedelec, Francois/0000-0002-8141-5288	Modeling and Simulation the Bioscience (BIOMS); Spanish ministry of education; European Union Specific Targeted Research Project BioMics; Human Frontier Science Program [RGY85]	Modeling and Simulation the Bioscience (BIOMS); Spanish ministry of education(Spanish Government); European Union Specific Targeted Research Project BioMics(European Commission); Human Frontier Science Program(Human Frontier Science Program)	We thank D. Foethke for inputs about the Cytosim code, M. Caudron and R. Carazo-Salas for sharing data, M. Loose for help in the initial set up of chromatin bead patterns, and the EMBL Advanced Light Microscopy Facility for invaluable help with microscopy. We acknowledge the center for Modeling and Simulation the Bioscience (BIOMS) for funding F.N. and C.A.A., the Spanish ministry of education for funding M.M.-C., European Union Specific Targeted Research Project BioMics for funding A.D., and support from Human Frontier Science Program grant RGY85.	Bastiaens P, 2006, TRENDS CELL BIOL, V16, P125, DOI 10.1016/j.tcb.2006.01.005; Carazo-Salas RE, 2003, CURR BIOL, V13, P1728, DOI 10.1016/j.cub.2003.09.006; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Dogterom M, 1996, J CELL BIOL, V133, P125, DOI 10.1083/jcb.133.1.125; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; Howard M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208103; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Melen GJ, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100036; STADTMAN ER, 1977, P NATL ACAD SCI USA, V74, P2761, DOI 10.1073/pnas.74.7.2761; Stelling J, 2009, J MATH BIOL, V58, P35, DOI 10.1007/s00285-008-0162-6; Van Albada SB, 2007, PLOS COMPUT BIOL, V3, P1925, DOI 10.1371/journal.pcbi.0030195; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Yokoyama H, 2008, J CELL BIOL, V180, P867, DOI 10.1083/jcb.200706189	25	62	62	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1243	1247		10.1126/science.1161820	http://dx.doi.org/10.1126/science.1161820			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	18948504				2022-12-28	WOS:000261033400041
J	McAlonan, K; Cavanaugh, J; Wurtz, RH				McAlonan, Kerry; Cavanaugh, James; Wurtz, Robert H.			Guarding the gateway to cortex with attention in visual thalamus	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; RETICULAR NUCLEUS; MACAQUE MONKEY; ORGANIZATION; NEURONS; GALAGO; SECTOR; MODULATION; PROJECTION; RESPONSES	The massive visual input from the eye to the brain requires selective processing of some visual information at the expense of other information, a process referred to as visual attention. Increases in the responses of visual neurons with attention have been extensively studied along the visual processing streams in monkey cerebral cortex, from primary visual areas to parietal and frontal cortex(1-4). Here we show, by recording neurons in attending macaque monkeys ( Macaca mulatta), that attention modulates visual signals before they even reach cortex by increasing responses of both magnocellular and parvocellular neurons in the first relay between retina and cortex, the lateral geniculate nucleus ( LGN). At the same time, attention decreases neuronal responses in the adjacent thalamic reticular nucleus ( TRN). Crick(5) argued for such modulation of the LGN by observing that it is inhibited by the TRN, and suggested that " the thalamus is the gateway to the cortex, the reticular complex might be described as the guardian of the gateway'', a reciprocal relationship we now show to be more than just hypothesis. The reciprocal modulation in LGN and TRN appears only during the initial visual response, but the modulation of LGN reappears later in the response, suggesting separate early and late sources of attentional modulation in LGN.	[McAlonan, Kerry; Cavanaugh, James; Wurtz, Robert H.] NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	McAlonan, K (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	km@nei.nih.gov			National Eye Institute; NATIONAL EYE INSTITUTE [Z01EY000109] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the intramural research program of the National Eye Institute. We are grateful for the assistance of J. McClurkin, A. Nichols, M. Smith, T. Ruffner and G. Tansey.	Briggs F, 2007, J NEUROSCI, V27, P5431, DOI 10.1523/JNEUROSCI.1035-07.2007; Casagrande VA, 2005, PROG BRAIN RES, V149, P11, DOI 10.1016/S0079-6123(05)49002-0; CONLEY M, 1990, EUR J NEUROSCI, V2, P211, DOI 10.1111/j.1460-9568.1990.tb00414.x; CRABTREE JW, 1989, EUR J NEUROSCI, V1, P94, DOI 10.1111/j.1460-9568.1989.tb00777.x; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fitzgibbon T, 2007, VISUAL NEUROSCI, V24, P857, DOI 10.1017/S0952523807070770; HARTING JK, 1991, J COMP NEUROL, V310, P411, DOI 10.1002/cne.903100310; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Jones E. G., 2007, THALAMUS, P1270; JONES EG, 1975, J COMP NEUROL, V162, P285, DOI 10.1002/cne.901620302; Kim U, 1997, SCIENCE, V278, P130, DOI 10.1126/science.278.5335.130; Kolmac CI, 1998, J COMP NEUROL, V396, P531; LUND JS, 1975, J COMP NEUROL, V164, P287, DOI 10.1002/cne.901640303; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; McAdams CJ, 2005, J NEUROSCI, V25, P11023, DOI 10.1523/JNEUROSCI.2904-05.2005; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; MONTERO VM, 1977, BRAIN RES, V138, P407, DOI 10.1016/0006-8993(77)90681-3; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Roberts M, 2007, NAT NEUROSCI, V10, P1483, DOI 10.1038/nn1967; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Sillito AM, 2006, TRENDS NEUROSCI, V29, P307, DOI 10.1016/j.tins.2006.05.001; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; Uhlrich DJ, 2003, J COMP NEUROL, V458, P128, DOI 10.1002/cne.10568; WILSON JR, 1995, ANAT REC, V242, P566, DOI 10.1002/ar.1092420413	30	335	337	3	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					391	U56		10.1038/nature07382	http://dx.doi.org/10.1038/nature07382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	18849967	Green Accepted			2022-12-28	WOS:000261039600044
J	Gavathiotis, E; Suzuki, M; Davis, ML; Pitter, K; Bird, GH; Katz, SG; Tu, HC; Kim, H; Cheng, EHY; Tjandra, N; Walensky, LD				Gavathiotis, Evripidis; Suzuki, Motoshi; Davis, Marguerite L.; Pitter, Kenneth; Bird, Gregory H.; Katz, Samuel G.; Tu, Ho-Chou; Kim, Hyungjin; Cheng, Emily H. -Y.; Tjandra, Nico; Walensky, Loren D.			BAX activation is initiated at a novel interaction site	NATURE			English	Article							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; STABILIZED ALPHA-HELICES; BCL-X-L; BH3-ONLY PROTEINS; CELL-DEATH; INTRACELLULAR-LOCALIZATION; PROAPOPTOTIC ACTIVITY; BH3 DOMAINS; APOPTOSIS; FAMILY	BAX is a pro- apoptotic protein of the BCL- 2 family that is stationed in the cytosol until activated by a diversity of stress stimuli to induce cell death. Anti- apoptotic proteins such as BCL- 2 counteract BAX- mediated cell death. Although an interaction site that confers survival functionality has been defined for anti- apoptotic proteins, an activation site has not been identified for BAX, rendering its explicit trigger mechanism unknown. We previously developed stabilized alpha- helix of BCL- 2 domains ( SAHBs) that directly initiate BAX- mediated mitochondrial apoptosis. Here we demonstrate by NMR analysis that BIM SAHB binds BAX at an interaction site that is distinct from the canonical binding groove characterized for anti- apoptotic proteins. The specificity of the human BIM- SAHB - BAX interaction is highlighted by point mutagenesis that disrupts functional activity, confirming that BAX activation is initiated at this novel structural location. Thus, we have now defined a BAX interaction site for direct activation, establishing a new target for therapeutic modulation of apoptosis.	[Suzuki, Motoshi; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Tu, Ho-Chou; Kim, Hyungjin; Cheng, Emily H. -Y.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Tu, Ho-Chou; Kim, Hyungjin; Cheng, Emily H. -Y.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Gavathiotis, Evripidis; Davis, Marguerite L.; Pitter, Kenneth; Bird, Gregory H.; Katz, Samuel G.; Walensky, Loren D.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Gavathiotis, Evripidis; Suzuki, Motoshi; Davis, Marguerite L.; Pitter, Kenneth; Bird, Gregory H.; Walensky, Loren D.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA; [Gavathiotis, Evripidis; Davis, Marguerite L.; Pitter, Kenneth; Bird, Gregory H.; Katz, Samuel G.; Walensky, Loren D.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Gavathiotis, Evripidis; Davis, Marguerite L.; Pitter, Kenneth; Bird, Gregory H.; Katz, Samuel G.; Walensky, Loren D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Washington University (WUSTL); Washington University (WUSTL); Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Tjandra, N (corresponding author), NHLBI, Lab Mol Biophys, NIH, Bldg 10, Bethesda, MD 20892 USA.	tjandran@nhlbi.nih.gov; loren_walensky@dfci.harvard.edu		Pitter, Kenneth/0000-0002-9450-313X; Suzuki, Motoshi/0000-0002-4346-7677; Gavathiotis, Evripidis/0000-0001-6319-8331	National Cancer Institute [5P01CA92625, 5RO1CA50239, 5RO1CA125562]; Burroughs Wellcome Fund Career Award; Culpeper Scholarship in Medical Science; American Society of Hematology Junior Faculty Scholar Award; William Lawrence Children's Foundation; Intramural Research Program of the National Heart, Lung and Blood Institute; Searle Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001048] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); Culpeper Scholarship in Medical Science; American Society of Hematology Junior Faculty Scholar Award; William Lawrence Children's Foundation; Intramural Research Program of the National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Searle Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank E. Smith for editorial and graphics assistance, W. Beavers for amino acid analyses, A. Perry for technical assistance, C. Turner and A. Bielecki of the MIT/Harvard Center for Magnetic Resonance for NMR technical advice, and R. Youle for feedback on the manuscript. We acknowledge the indelible contributions of the late S.J. Korsmeyer, who inspired this work. L.D.W. is supported by National Cancer Institute (NCI) grant 5P01CA92625, a Burroughs Wellcome Fund Career Award in the Biomedical Sciences, a Culpeper Scholarship in Medical Science from the Goldman Philanthropic Partnerships, an American Society of Hematology Junior Faculty Scholar Award, and a grant from the William Lawrence Children's Foundation. This research was also supported by NCI grant 5RO1CA50239. N.T. is supported by the Intramural Research Program of the National Heart, Lung and Blood Institute, NIH. E.H.-Y.C. is supported by the Searle Scholars Program and NCI grant 5RO1CA125562.	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Bird GH, 2008, METHOD ENZYMOL, V446, P369, DOI 10.1016/S0076-6879(08)01622-4; Cartron PF, 2002, FEBS LETT, V512, P95, DOI 10.1016/S0014-5793(02)02227-5; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen D, 2004, P NATL ACAD SCI USA, V101, P1235, DOI 10.1073/pnas.0308050100; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nie C, 2008, J BIOL CHEM, V283, P15359, DOI 10.1074/jbc.M800847200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; OLTVAI ZN, 1993, CELL, V74, P619; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Pitter K, 2008, METHOD ENZYMOL, V446, P387, DOI 10.1016/S0076-6879(08)01623-6; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schinzel A, 2004, J CELL BIOL, V164, P1021, DOI 10.1083/jcb.200309013; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200	50	534	574	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1076	U6		10.1038/nature07396	http://dx.doi.org/10.1038/nature07396			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948948	Green Accepted			2022-12-28	WOS:000260252600037
J	Hamilton, EE; Kay, SA				Hamilton, Elizabeth E.; Kay, Steve A.			SnapShot: Circadian Clock Proteins	CELL			English	Editorial Material									[Hamilton, Elizabeth E.; Kay, Steve A.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hamilton, EE (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.		Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878				Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Brunner M, 2008, MOL MICROBIOL, V68, P255, DOI 10.1111/j.1365-2958.2008.06148.x; Gardner MJ, 2006, BIOCHEM J, V397, P15, DOI 10.1042/BJ20060484; Hardin PE, 2006, CURR OPIN NEUROBIOL, V16, P686, DOI 10.1016/j.conb.2006.09.001; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Mas P, 2008, TRENDS CELL BIOL, V18, P273, DOI 10.1016/j.tcb.2008.03.005; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030	10	20	21	2	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					368	U16	368.e1	10.1016/j.cell.2008.09.042	http://dx.doi.org/10.1016/j.cell.2008.09.042			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957209	Bronze			2022-12-28	WOS:000260130400027
J	Sugarman, J; Siegel, AW				Sugarman, Jeremy; Siegel, Andrew W.			When embryonic stem cell lines fail to meet consent standards	SCIENCE			English	Editorial Material									[Sugarman, Jeremy; Siegel, Andrew W.] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA	Johns Hopkins University	Sugarman, J (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA.	jsugarm1@jhmi.edu		Sugarman, Jeremy/0000-0001-7022-8332				BAKER M, 2008, N NEWS          0728; *COMM GUID EMBR ST, 2005, GUID HUMAN EMBR STEM; *HUM EMBR STEM CEL, 2007, AM NAT AC GUID HUM E; *ISSCR, 2006, GUID COND HUM EMBR S; KELLER J, 2008, CHRON HIGHER ED 0728; Lyerly AD, 2007, SCIENCE, V317, P46, DOI 10.1126/science.1145067; National Bioethics Advisory Committee, 1999, RES INV HUM BIOL MAT, V1; National Institute of Health, 1994, REP HUM EMBR RES PAN; *NIH, 2000, FED REGISTER, V65, P51976; Streiffer R, 2008, HASTINGS CENT REP, V38, P40; Sugarman J, 2008, CELL STEM CELL, V3, P238, DOI 10.1016/j.stem.2008.08.012; WEISS R, 2008, ETHICALLY CHALLENGED	12	11	11	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2008	322	5900					379	379		10.1126/science.1164441	http://dx.doi.org/10.1126/science.1164441			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927375				2022-12-28	WOS:000260094500025
J	Janoueix-Lerosey, I; Lequin, D; Brugieres, L; Ribeiro, A; de Pontual, L; Combaret, V; Raynal, V; Puisieux, A; Schleiermacher, G; Pierron, G; Valteau-Couanet, D; Frebourg, T; Michon, J; Lyonnet, S; Amiel, J; Delattre, O				Janoueix-Lerosey, Isabelle; Lequin, Delphine; Brugieres, Laurence; Ribeiro, Agnes; de Pontual, Loic; Combaret, Valerie; Raynal, Virginie; Puisieux, Alain; Schleiermacher, Gudrun; Pierron, Gaelle; Valteau-Couanet, Dominique; Frebourg, Thierry; Michon, Jean; Lyonnet, Stanislas; Amiel, Jeanne; Delattre, Olivier			Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma	NATURE			English	Article							ANAPLASTIC LYMPHOMA KINASE; GENE; IDENTIFICATION; NPM; INHIBITOR; PROTEIN; FUSION; FLT3	Neuroblastoma, a tumour derived from the peripheral sympathetic nervous system, is one of the most frequent solid tumours in childhood(1,2). It usually occurs sporadically but familial cases are observed, with a subset of cases occurring in association with congenital malformations of the neural crest being linked to germline mutations of the PHOX2B gene(1-4). Here we conducted genome-wide comparative genomic hybridization analysis on a large series of neuroblastomas. Copy number increase at the locus encoding the anaplastic lymphoma kinase (ALK)(5) tyrosine kinase receptor was observed recurrently. One particularly informative case presented a high- level gene amplification that was strictly limited to ALK, indicating that this gene may contribute on its own to neuroblastoma development. Through subsequent direct sequencing of cell lines and primary tumour DNAs we identified somatic mutations of the ALK kinase domain that mainly clustered in two hotspots. Germline mutations were observed in two neuroblastoma families, indicating that ALK is a neuroblastoma predisposition gene. Mutated ALK proteins were overexpressed, hyperphosphorylated and showed constitutive kinase activity. The knockdown of ALK expression in ALK- mutated cells, but also in cell lines overexpressing a wild- type ALK, led to a marked decrease of cell proliferation. Altogether, these data identify ALK as a critical player in neuroblastomadevelopment that may hence represent a very attractive therapeutic target in this disease that is still frequently fatal with current treatments(6,7).	[Janoueix-Lerosey, Isabelle; Lequin, Delphine; Raynal, Virginie; Schleiermacher, Gudrun; Delattre, Olivier] Inst Curie, Ctr Rech, F-94805 Villejuif, France; [Janoueix-Lerosey, Isabelle; Lequin, Delphine; Raynal, Virginie; Schleiermacher, Gudrun; Delattre, Olivier] INSERM, U830, F-94805 Villejuif, France; [Brugieres, Laurence; Valteau-Couanet, Dominique] Inst Gustave Roussy, Dept Pediat, F-94805 Villejuif, France; [Ribeiro, Agnes; Pierron, Gaelle; Delattre, Olivier] Inst Curie, Unite Genet Somat, F-75248 Paris, France; [de Pontual, Loic; Lyonnet, Stanislas; Amiel, Jeanne] Univ Paris 05, Dept Genet, Fac Med, F-75743 Paris 15, France; [de Pontual, Loic; Lyonnet, Stanislas; Amiel, Jeanne] Hop Necker Enfants Malad, INSERM, U781, F-75743 Paris 15, France; [Combaret, Valerie; Puisieux, Alain] Ctr Leon Berard, FNCLCC, Lab Rech Translat, F-69008 Lyon, France; [Puisieux, Alain] INSERM, U590, F-69008 Lyon, France; [Puisieux, Alain] Univ Lyon 1, Inst Sci Pharmaceut & Biol, F-69008 Lyon, France; [Schleiermacher, Gudrun; Michon, Jean] Inst Curie, Dept Pediat, F-75248 Paris, France; [Frebourg, Thierry] CHU Rouen, Serv Genet, F-76183 Rouen, France; [Frebourg, Thierry] Fac Med Pharm, INSERM, U614, F-76183 Rouen, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Centre Leon Berard; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm)	Delattre, O (corresponding author), Inst Curie, Ctr Rech, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	olivier.delattre@curie.fr	Schleiermacher, Gudrun/AAN-4711-2021; Frebourg, Thierry/AAK-8390-2020; Janoueix-Lerosey, Isabelle/G-1758-2018; amiel, jeanne/AGX-1124-2022; amiel, jeanne/H-3501-2017; Lyonnet, Stanislas/H-5483-2017	Schleiermacher, Gudrun/0000-0002-0133-5879; Janoueix-Lerosey, Isabelle/0000-0003-0434-3003; amiel, jeanne/0000-0001-5973-4728; Lyonnet, Stanislas/0000-0001-5426-9417; delattre, olivier/0000-0002-8730-2276; DE PONTUAL, LOIC/0000-0002-3123-0453; PUISIEUX, Alain/0000-0002-9938-3798; Frebourg, Thierry/0000-0003-0399-4007	Agence Nationale pour la Recherche; Institut National du Cancer, the Ligue Nationale contre le Cancer (Equipe labellisee and CIT project); APAESIC; Association Hubert Gouin; Comite de l'Ain of the Ligue Nationale contre le Cancer	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut National du Cancer, the Ligue Nationale contre le Cancer (Equipe labellisee and CIT project)(Institut National du Cancer (INCA) France); APAESIC; Association Hubert Gouin; Comite de l'Ain of the Ligue Nationale contre le Cancer	We are grateful to F. Moreau-Gachelin, I. Gallais, D. Surdez, F. Tirode, A. Fix, F. Bourdeaut, A. Almeida, C. Lucchesi, S. Roman Roman, B. Bressac, J. Benard and G. Vassal for their critical help. We thank C. Decraene, D. Gentien and B. Albaud from the translational department of Institut Curie for profiling the paediatric tumours, and P. Rosa and E. Barillot for the development of bioinformatic tools. We thank M. Lathrop and the Centre National de Genotypage for the Affymetrix 100K SNP analysis and A. Chompret for collecting families. This work was supported by grants from the Agence Nationale pour la Recherche, the Institut National du Cancer, the Ligue Nationale contre le Cancer (Equipe labellisee and CIT project), the APAESIC ( Association des Parents et des Amis des Enfants Soignes a l'Institut Curie), the Association Hubert Gouin, les amis de Claire, Les Bagouz a Manon and Enfance et Sante. A. P. and V. C. are supported by the Comite de l'Ain of the Ligue Nationale contre le Cancer.	Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Chiarle R, 2008, NAT MED, V14, P676, DOI 10.1038/nm1769; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Fix A, 2008, GENE CHROMOSOME CANC, V47, P819, DOI 10.1002/gcc.20583; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Fujimoto J, 1996, P NATL ACAD SCI USA, V93, P4181, DOI 10.1073/pnas.93.9.4181; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Griffin CA, 1999, CANCER RES, V59, P2776; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Lamant L, 2000, AM J PATHOL, V156, P1711, DOI 10.1016/S0002-9440(10)65042-0; Li RS, 2008, MED RES REV, V28, P372, DOI 10.1002/med.20109; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; Miyake I, 2002, ONCOGENE, V21, P5823, DOI 10.1038/sj.onc.1205735; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Osajima-Hakomori Y, 2005, AM J PATHOL, V167, P213, DOI 10.1016/S0002-9440(10)62966-5; Renneville A, 2008, LEUKEMIA, V22, P915, DOI 10.1038/leu.2008.19; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; SCHWAB M, 1984, NATURE, V308, P288, DOI 10.1038/308288a0; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Tonini GP, 2003, CANCER LETT, V197, P41, DOI 10.1016/S0304-3835(03)00080-6; Trochet D, 2004, AM J HUM GENET, V74, P761, DOI 10.1086/383253; Vincent-Salomon A, 2008, NAT GENET, V40, P809, DOI 10.1038/ng0708-809a; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	27	634	666	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					967	U51		10.1038/nature07398	http://dx.doi.org/10.1038/nature07398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923523				2022-12-28	WOS:000260038300050
J	Jenkins, HE; Aylward, RB; Gasasira, A; Donnelly, CA; Abanida, EA; Koleosho-Adelekan, T; Grassly, NC				Jenkins, Helen E.; Aylward, R. Bruce; Gasasira, Alex; Donnelly, Christl A.; Abanida, Emmanuel A.; Koleosho-Adelekan, Titi; Grassly, Nicholas C.			Effectiveness of immunization against paralytic poliomyelitis in Nigeria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL POLIOVIRUS VACCINE; ACUTE FLACCID PARALYSIS; IMMUNOGENICITY; SURVEILLANCE; ERADICATION; BRAZIL; INDIA; RISK	Background: The number of cases of paralytic poliomyelitis has declined in Nigeria since the introduction of newly licensed monovalent oral poliovirus vaccines and new techniques of vaccine delivery. Understanding the relative contribution of these vaccines and the improved coverage to the decline in incident cases is essential for future planning. Methods: We estimated the field efficacies of monovalent type 1 oral poliovirus vaccine and trivalent oral poliovirus vaccine, using the reported number of doses received by people with poliomyelitis and by matched controls as identified in Nigeria's national surveillance database, in which 27,379 cases of acute flaccid paralysis were recorded between 2001 and 2007. Our estimates of vaccine coverage and vaccine-induced immunity were based on the number of doses received by children listed in the database who had paralysis that was not caused by poliovirus. Results: The estimated efficacies per dose of monovalent type 1 oral poliovirus vaccine and trivalent oral poliovirus vaccine against type 1 paralytic poliomyelitis were 67% (95% confidence interval [CI], 39 to 82) and 16% (95% CI, 10 to 21), respectively, and the estimated efficacy per dose of trivalent oral poliovirus vaccine against type 3 paralytic poliomyelitis was 18% (95% CI, 9 to 26). In the northwestern region of Nigeria, which reported the majority of cases during the study period, coverage with at least one dose of vaccine increased from 59 to 78%. Between 2005 and 2007, vaccine-induced immunity levels among children under the age of 5 years more than doubled, to 56%. Conclusions: The higher efficacy of monovalent type 1 oral poliovirus vaccine (four times as effective as trivalent oral poliovirus vaccine) and the moderate gains in coverage dramatically increased vaccine-induced immunity against serotype 1 in northern Nigeria. Further increases in coverage in Nigerian states with infected populations are required to achieve the levels of vaccine-induced immunity associated with the sustained elimination achieved in other parts of the country.	[Jenkins, Helen E.; Donnelly, Christl A.; Grassly, Nicholas C.] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modeling, Dept Infect Dis Epidemiol, Fac Med, London W2 1PG, England; [Aylward, R. Bruce] WHO, Global Polio Eradicat Initiat, CH-1211 Geneva, Switzerland; [Gasasira, Alex] WHO Nigeria, Abuja, Nigeria; [Abanida, Emmanuel A.; Koleosho-Adelekan, Titi] Natl Primary Hlth Care Dev Agcy, Abuja, Nigeria	Imperial College London; World Health Organization	Jenkins, HE (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modeling, Dept Infect Dis Epidemiol, Fac Med, St Marys Campus,Norfolk Pl, London W2 1PG, England.	h.jenkins@imperial.ac.uk	Grassly, Nicholas C/C-6381-2008	Grassly, Nicholas C/0000-0001-6067-4507; Jenkins, Helen/0000-0003-4749-1591; Donnelly, Christl/0000-0002-0195-2463	MRC [G0600719] Funding Source: UKRI; Medical Research Council [G0600719B] Funding Source: researchfish; Medical Research Council [G0600719] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDRUS JK, 1995, B WORLD HEALTH ORGAN, V73, P33; Caceres VM, 2001, CLIN INFECT DIS, V33, P531, DOI 10.1086/321905; CIRNE MD, 1995, J INFECT DIS, V171, P1097, DOI 10.1093/infdis/171.5.1097; *FED REP NIG NAT P, 2006, NAT IMM COV SURV 200; *FED REP NIG NAT P, 2007, LEG NOT PUBL 2006 CE; *FED REP NIG NAT P, 2003, DEM HLTH SURV NIG 20; Gary HE, 1997, J INFECT DIS, V175, pS135, DOI 10.1093/infdis/175.Supplement_1.S135; Grassly NC, 2007, LANCET, V369, P1790; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Kohler KA, 2002, B WORLD HEALTH ORGAN, V80, P210; Marx A, 2000, EPIDEMIOL REV, V22, P298, DOI 10.1093/oxfordjournals.epirev.a018041; Pallansch MA, 2006, NEW ENGL J MED, V355, P2508, DOI 10.1056/NEJMp068200; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Posey DL, 1997, J INFECT DIS, V175, pS258, DOI 10.1093/infdis/175.Supplement_1.S258; *WHO, 2004, GLOB POL ER IN PROGR; 1999, MMWR MORB MORTAL WKL, V48, P312; 2007, MMWR MORB MORTAL WKL, V56, P996	17	43	47	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2008	359	16					1666	U111		10.1056/NEJMoa0803259	http://dx.doi.org/10.1056/NEJMoa0803259			33	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360EY	18923171				2022-12-28	WOS:000260041400005
J	Donovan, CA				Donovan, Cory A.			Babies having babies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												coryadonovan@gmail.com							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2008	300	15					1739	1740		10.1001/jama.300.15.1739	http://dx.doi.org/10.1001/jama.300.15.1739			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QA	18854523				2022-12-28	WOS:000260002000001
J	Cresko, WA				Cresko, William A.			Armor development and fitness	SCIENCE			English	Editorial Material							GENETIC-BASIS; EVOLUTION; POPULATIONS; STICKLEBACK		[Cresko, William A.] Univ Oregon, Dept Biol, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA	University of Oregon	Cresko, WA (corresponding author), Univ Oregon, Dept Biol, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA.	wcresko@uoregon.edu	Cresko, William/H-4010-2014	Cresko, William/0000-0002-3496-8074	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM079486] Funding Source: NIH RePORTER; NIGMS NIH HHS [R24GM79486] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barrett RDH, 2008, SCIENCE, V322, P255, DOI 10.1126/science.1159978; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Bell M.A., 1994, EVOLUTIONARY BIOL TH; Bell MA, 2004, EVOLUTION, V58, P814; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; Fisher R.A., 1930, GENETICAL THEORY NAT; GILES N, 1983, J ZOOL, V199, P535; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Wright S, 1984, EVOLUTION GENETICS P, V1	15	9	9	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					204	206		10.1126/science.1165663	http://dx.doi.org/10.1126/science.1165663			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845737	Green Submitted			2022-12-28	WOS:000259902300028
J	Holman, CM				Holman, Christopher M.			Trends in human gene patent litigation	SCIENCE			English	Editorial Material									[Holman, Christopher M.] Univ Missouri, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Holman, CM (corresponding author), Univ Missouri, Kansas City, MO 64110 USA.	holmancm@umkc.edu						Barton JH, 2006, NAT BIOTECHNOL, V24, P939, DOI 10.1038/nbt0806-939; Caulfield T, 2006, NAT BIOTECHNOL, V24, P1091, DOI 10.1038/nbt0906-1091; Cho MK, 2003, J MOL DIAGN, V5, P3, DOI 10.1016/S1525-1578(10)60444-8; Crichton M, 2007, NY TIMES, pA23; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; HOLMAN CM, 2007, UMKC L REV, V76, P295; Hopkins MM, 2007, NAT BIOTECHNOL, V25, P185, DOI 10.1038/nbt0207-185; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; Lemley MA, 2005, J ECON PERSPECT, V19, P75, DOI 10.1257/0895330054048650; Pressman L, 2006, NAT BIOTECHNOL, V24, P31, DOI 10.1038/nbt0106-31; Walsh JP, 2005, SCIENCE, V309, P2002, DOI 10.1126/science.1115813; Williams-Jones Bryn, 2002, Health Law J, V10, P123	12	25	25	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					198	199		10.1126/science.1160687	http://dx.doi.org/10.1126/science.1160687			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	358FK	18845733				2022-12-28	WOS:000259902300024
J	Hou, XG; Siveter, DJ; Aldridge, RJ; Siveter, DJ				Hou, Xian-Guang; Siveter, Derek J.; Aldridge, Richard J.; Siveter, David J.			Collective behavior in an early Cambrian arthropod	SCIENCE			English	Article									[Hou, Xian-Guang] Yunnan Univ, Yunnan Key Lab Paleobiol, Kunming 650091, Peoples R China; [Siveter, Derek J.] Univ Oxford, Univ Museum, Oxford, England; [Siveter, Derek J.] Univ Oxford, Dept Earth Sci, Oxford, England; [Aldridge, Richard J.; Siveter, David J.] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England	Yunnan University; University of Oxford; University of Oxford; University of Leicester	Hou, XG (corresponding author), Yunnan Univ, Yunnan Key Lab Paleobiol, Kunming 650091, Peoples R China.	xghou@ynu.edu.cn			National Natural Foundation [40730211]; 973 Program of China [2006CB806400]; Science and Technology Department of Yunnan [2005D0002Z]; Royal Society	National Natural Foundation(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); Science and Technology Department of Yunnan; Royal Society(Royal Society of London)	Thanks to National Natural Foundation (40730211) and 973 Program of China (2006CB806400); Science and Technology Department of Yunnan (2005D0002Z); the Royal Society; and G. Boxshall, S. de Grave, G. McGavin, and A. Parker for discussion.	BONE Q, 1998, BIOL PELAGIC TUNICAT, P5; CHATTERTON BDE, 2008, ADV TRILOBITE RES CU, V9, P73; HERRNKIN.W, 1969, SCIENCE, V164, P1425, DOI 10.1126/science.164.3886.1425; Holldobler B., 1990, pi; SCOBLE M. J., 1992, LEPIDOPTERA FORM FUN; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733	6	25	31	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					224	224		10.1126/science.1162794	http://dx.doi.org/10.1126/science.1162794			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845748				2022-12-28	WOS:000259902300038
J	Sander, PM; Clauss, M				Sander, P. Martin; Clauss, Marcus			Sauropod gigantism	SCIENCE			English	Editorial Material							GROWTH-RATES; EVOLUTION; PHYSIOLOGY; HISTOLOGY; DINOSAURS		[Sander, P. Martin] Univ Bonn, Div Paleontol, Steinmann Inst, D-53115 Bonn, Germany; [Clauss, Marcus] Univ Zurich, Vetsuisse Fac, Clin Zoo Anim Exot Pets & Wildlife, CH-8057 Zurich, Switzerland	University of Bonn; University of Zurich	Sander, PM (corresponding author), Univ Bonn, Div Paleontol, Steinmann Inst, D-53115 Bonn, Germany.	martin.sander@uni-bonn.de; mclauss@vetclinics.uzh.ch	Clauss, Marcus/A-4710-2008; Clauss, Marcus/GRR-7996-2022; Clauss, Marcus/M-8702-2019	Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207				Berner RA, 2007, SCIENCE, V316, P557, DOI 10.1126/science.1140273; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Christian Andreas, 2007, Fossil Record, V10, P38; Clauss M, 2007, COMP BIOCHEM PHYS A, V148, P249, DOI 10.1016/j.cbpa.2007.05.024; Cooper LN, 2008, P ROY SOC B-BIOL SCI, V275, P2609, DOI 10.1098/rspb.2008.0912; DUNHAM AE, 1989, GEOL S AM S, V238, P1; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Farlow J.O., 1990, P43; Gaudin Timothy J., 2006, P1; Gillooly JF, 2006, PLOS BIOL, V4, P1467, DOI 10.1371/journal.pbio.0040248; Hone DWE, 2005, J EVOLUTION BIOL, V18, P587, DOI 10.1111/j.1420-9101.2004.00870.x; Hummel J, 2008, EVOL ECOL RES, V10, P925; Hummel J, 2008, P ROY SOC B-BIOL SCI, V275, P1015, DOI 10.1098/rspb.2007.1728; JANIS CM, 1991, ANN ZOOL FENN, V28, P201; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; PERRY SF, J EXP ZOOL A; Sander PM, 2008, PALAEONTOGR ABT A, V284, P69; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; Senter P, 2007, J ZOOL, V271, P45, DOI 10.1111/j.1469-7998.2006.00197.x; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2; Wings O, 2007, P ROY SOC B-BIOL SCI, V274, P635, DOI 10.1098/rspb.2006.3763	24	79	79	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					200	201		10.1126/science.1160904	http://dx.doi.org/10.1126/science.1160904			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845734				2022-12-28	WOS:000259902300025
J	Sexton, AC; Metcalfe, SA				Sexton, Adrienne C.; Metcalfe, Sylvia A.			Disclosing genetic research results after death of pediatric patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DUTY		[Sexton, Adrienne C.; Metcalfe, Sylvia A.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Sexton, Adrienne C.] Royal Childrens Hosp, Genet Hlth Serv Victoria, Parkville, Vic 3052, Australia; [Sexton, Adrienne C.; Metcalfe, Sylvia A.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne	Metcalfe, SA (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, 10th Floor,Flemington Rd, Parkville, Vic 3052, Australia.	sylvia.metcalfe@mcri.edu.au	Metcalfe, Sylvia A/B-5303-2014	Sexton, Adrienne/0000-0001-8749-1639				Bookman EB, 2006, AM J MED GENET A, V140A, P1033, DOI 10.1002/ajmg.a.31195; Chugh SS, 2004, J AM COLL CARDIOL, V43, P1625, DOI 10.1016/j.jacc.2003.11.052; Fitzpatrick JL, 1999, AM J HUM GENET, V64, P852, DOI 10.1086/302293; Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395; Knoppers BM, 2006, EUR J HUM GENET, V14, P1170, DOI 10.1038/sj.ejhg.5201690; Leonard H, 2005, LANCET, V366, P1584, DOI 10.1016/S0140-6736(05)67631-3; Lucassen A, 2006, J MED ETHICS, V32, P690, DOI 10.1136/jme.2005.013631; Ormondroyd E, 2007, J Genet Couns, V16, P527, DOI 10.1007/s10897-007-9088-1; Parker M., 2003, ETHICAL ISSUES GENET; Quaid KA, 2004, GENET TEST, V8, P347, DOI 10.1089/gte.2004.8.347; Sexton A C, 2008, J Genet Couns, V17, P261, DOI 10.1007/s10897-007-9145-9; Skinner JR, 2004, J PAEDIATR CHILD H, V40, P651, DOI 10.1111/j.1440-1754.2004.00498.x; Underwood JCE, 2006, HISTOPATHOLOGY, V49, P221, DOI 10.1111/j.1365-2559.2006.02418.x	13	12	12	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2008	300	14					1693	1695		10.1001/jama.300.14.1693	http://dx.doi.org/10.1001/jama.300.14.1693			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356YF	18840844				2022-12-28	WOS:000259812800032
J	Leong, KG; Wang, BE; Johnson, L; Gao, WQ				Leong, Kevin G.; Wang, Bu-Er; Johnson, Leisa; Gao, Wei-Qiang			Generation of a prostate from a single adult stem cell	NATURE			English	Article							PROXIMAL REGION; MOUSE PROSTATE; C-KIT; MURINE PROSTATE; MARKER; EXPRESSION; IDENTIFICATION; REGENERATION; CANCER; TISSUE	The existence of prostate stem cells ( PSCs) was first postulated from the observation that normal prostate regeneration can occur after repeated cycles of androgen deprivation and replacement in rodents(1). Given the critical role of PSCs in maintaining prostate tissue integrity and their potential involvement in prostate tumorigenesis(2), it is important to define specific markers for normal PSCs. Several cell- surface markers have been reported to identify candidate PSCs, including stem cell antigen-1 ( Sca-1, also known as Ly6a), CD133 (Prom1) and CD44 ( refs 3-10). However, many non- PSCs in the mouse prostate also express these markers and thus identification of a more defined PSC population remains elusive. Here we identify CD117 ( c- kit, stem cell factor receptor) as a new marker of a rare adult mouse PSC population, and demonstrate that a single stem cell defined by the phenotype Lin(-) Sca-1(+)CD133(+)CD44(+)CD117(+) can generate a prostate after transplantation in vivo. CD117 expression is predominantly localized to the region of the mouse prostate proximal to the urethra and is upregulated after castration- induced prostate involution - two characteristics consistent with that of a PSC marker. CD117(+) PSCs can generate functional, secretion- producing prostates when transplanted in vivo. Moreover, CD117(+) PSCs have long- term self-renewal capacity, as evidenced by serial isolation and transplantation in vivo. Our data establish that single cells in the adult mouse prostate with multipotent, self- renewal capacity are defined by a Lin(-)Sca-1(+) CD133(+) CD44(+) CD117(+) phenotype.	[Leong, Kevin G.; Wang, Bu-Er; Johnson, Leisa; Gao, Wei-Qiang] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Gao, WQ (corresponding author), Genentech Inc, Dept Mol Biol, 1 DNA Way, San Francisco, CA 94080 USA.	gao@gene.com	Thomson, Axel/A-7893-2013; Gao, Wei/GXH-0380-2022		Genentech Laboratory Animal Resources	Genentech Laboratory Animal Resources	We thank J. Cupp, L. Gilmour and W. Tombo for FACS support, X.-D. Wang, R. Soriano and Z. Modrusan for microarray services, I. Kasman, L. Komuves and J. Eastham- Anderson for microscopy assistance, B. D. Tarlow for assistance with laser- capture microdissection and PCR- based genotyping, Genentech Laboratory Animal Resources for support services, L. Blocher and J. Simko for human clinical prostate specimens, and F. J. de Sauvage for valuable discussion, input and supervision of the project.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; Bonkhoff H, 1996, PROSTATE, V28, P98; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Collins AT, 2001, J CELL SCI, V114, P3865; CUNHA GR, 1978, J EXP ZOOL, V205, P181, DOI 10.1002/jez.1402050203; Heissig B, 2003, THROMB HAEMOSTASIS, V90, P570, DOI 10.1160/TH03-03-0188; ISAACS JT, 1987, CONTROL CELL PROLIFE, V2, P85; Johnson MA, 2000, PROSTATE, V43, P255, DOI 10.1002/1097-0045(20000601)43:4<255::AID-PROS4>3.0.CO;2-M; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; LEV S, 1994, CRIT REV ONCOGENESIS, V5, P141, DOI 10.1615/CritRevOncog.v5.i2-3.30; Liu AY, 1997, P NATL ACAD SCI USA, V94, P10705, DOI 10.1073/pnas.94.20.10705; Moss KG, 2003, J PHARMACOL EXP THER, V307, P476, DOI 10.1124/jpet.103.052530; Perez-Losada J, 2002, BLOOD, V100, P1274, DOI 10.1182/blood.V100.4.1274.h81602001274_1274_1286; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Salm SN, 2005, J CELL BIOL, V170, P81, DOI 10.1083/jcb.200412015; Schmelz M, 2005, EUR J CELL BIOL, V84, P341, DOI 10.1016/j.ejcb.2004.12.019; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shen MM, 2003, DEV DYNAM, V228, P767, DOI 10.1002/dvdy.10397; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; SUGIMURA Y, 1986, BIOL REPROD, V34, P961, DOI 10.1095/biolreprod34.5.961; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; Tsujimura A, 2007, J UROLOGY, V178, P686, DOI 10.1016/j.juro.2007.03.092; Wang GM, 2007, PROSTATE, V67, P968, DOI 10.1002/pros.20582; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100	30	319	340	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					804	808		10.1038/nature07427	http://dx.doi.org/10.1038/nature07427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18946470				2022-12-28	WOS:000261559900052
J	Beaglehole, R; Bonita, R				Beaglehole, Robert; Bonita, Ruth			Global public health: a scorecard	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; CHRONIC DISEASES 1; IMPROVING HEALTH; PREVENTION; MORTALITY; COSTS; EDUCATION; PRIORITY; TOBACCO; BURDEN	Global health is attracting an unprecedented level of interest. In this paper, we summarise recent trends and identify the unfinished and new agendas in global public health. We propose a global public health scorecard as a simple way to assess progress and suggest actions by public health practitioners and their organisations for improving the effectiveness of public health. Although we find many recent positive developments in global health, the potential for global cooperation and progress is still largely untapped. Compared with other components of development, health improvement should easily foster global cooperation; strong advocacy and political will are keys to continuing progress. We view global public health as a barometer of more general development. Our responses to the current health challenges are at the forefront of the global struggle for survival.	[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand	University of Auckland	Beaglehole, R (corresponding author), 42 Albert Rd, N Shore City 0624, New Zealand.	r.beaglehole@auckland.ac.nz						Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; [Anonymous], 2008, WORLD HLTH STAT 2008; [Anonymous], 2007, LANCET SERIES GLOBAL; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Beaglehole R, 2004, LANCET, V363, P2084, DOI 10.1016/S0140-6736(04)16461-1; Beaglehole R, 1998, LANCET, V351, P590, DOI 10.1016/S0140-6736(97)09494-4; Beaglehole R, 2003, HUM RESOUR HEALTH, V1, P4, DOI DOI 10.1186/1478-4491-1-4; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; BONITA R, 2007, GLOBALIZATION HLTH; Campbell M, 2007, SCIENCE, V315, P1501, DOI 10.1126/science.1140057; Chen LC, 2006, LANCET, V367, P1800, DOI 10.1016/S0140-6736(06)68783-7; Chisholm D, 2007, BRIT J PSYCHIAT, V191, P528, DOI 10.1192/bjp.bp.107.038463; Cochrane A. L, 1972, PUBLIC HEALTH, DOI DOI 10.1016/S0033-3506(73)80082-4; CSDH, 2008, CLOS GAP GEN HLTH EQ; Donaldson L, 2007, LANCET, V369, P857, DOI 10.1016/S0140-6736(07)60327-4; Ebrahim S, 2008, INT J EPIDEMIOL, V37, P225, DOI 10.1093/ije/dyn016; *EXT EV TEAM PUBL, 2001, ENH PUBL HLTH DEV CO; Frieden TR, 2007, LANCET, V369, P1758, DOI 10.1016/S0140-6736(07)60782-X; Fuster V, 2005, LANCET, V366, P1512, DOI 10.1016/S0140-6736(05)67610-6; *GOYAK FRAM ACT GL, 2008, REP G8 HLTH EXP GROU; Haines A, 2007, LANCET, V370, P1264, DOI 10.1016/S0140-6736(07)61257-4; HORTON R, GLOBAL PUBLIC HLTH; Horton R, 2008, LANCET, V371, P1217, DOI 10.1016/S0140-6736(08)60533-4; Horton R, 2007, LANCET, V369, P806, DOI 10.1016/S0140-6736(07)60378-X; IJsselmuiden C, 2007, B WORLD HEALTH ORGAN, V85, P914, DOI 10.2471/BLT.07.045526; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 SCI; JAMSION DT, 2006, DIS CONTROL PRIORITI; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; MacDonald R, 2008, LANCET, V372, P99, DOI 10.1016/S0140-6736(08)61004-1; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; MATHERS CD, GLOBAL PUBL IN PRESS; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McCurry J, 2008, LANCET, V372, P191, DOI 10.1016/S0140-6736(08)61054-5; MCKEE M, GLOBAL PUBL IN PRESS; Mckee M, 2007, INT J EPIDEMIOL, V36, P269, DOI 10.1093/ije/dym002; McMichael AJ, 2008, BRIT MED J, V336, P191, DOI 10.1136/bmj.39392.473727.AD; Murray CJL, 2008, LANCET, V371, P1191, DOI 10.1016/S0140-6736(08)60526-7; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Murray CJI, PLOS MED, V3, pe260; *NUFF COUNC BIOETH, 2007, PUBL HLTH ETH ISS; Reich MR, 2008, LANCET, V371, P865, DOI 10.1016/S0140-6736(08)60384-0; Sachs J., 2005, END POVERTY CAN WE M; Sadana R, 2007, B WORLD HEALTH ORGAN, V85, P902, DOI 10.2471/BLT.07.049247; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Silberschmidt G, 2008, LANCET, V371, P1483, DOI 10.1016/S0140-6736(08)60634-0; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; STUCKLER D, LANCET IN PRESS; Stuckler D, 2008, LANCET, V372, P95, DOI 10.1016/S0140-6736(08)61013-2; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; *UN ENV PROGR, 2007, GLOB ENV OUTL 2007; *UNAIDS WHO, 2007, AIDS EP UPD DEC 2007; United Nations, MILL DEV GOALS REP; United Nations. Department of Economic and Social Affairs. Population Division, 2007, WORLD POP PROSP 2006; *WHO, HLTH MILL DEV GOALS; WHO, 2007, EV BUS STRENGTH HLTH; *WHO, 2008, UPD GLOB BURD DIS 20; Woodward D, 2008, LANCET, V372, P186, DOI 10.1016/S0140-6736(08)61051-X; World Health Organization, 2004, EST US DED TAX HLTH; *WORLD TRAD ORG, LAM WARNS PROT AM FI; 2008, LANCET, V372, P345; 2008, LANCET, V371, P2145; 2008, LANCET, V372, P178; [No title captured]; 2006, LANCET, V367, P1549; 2007, LANCET, V370, P801; 2008, LANCET, V372, P346	68	130	134	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2008	372	9654					1988	1996		10.1016/S0140-6736(08)61558-5	http://dx.doi.org/10.1016/S0140-6736(08)61558-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380NE	18945485				2022-12-28	WOS:000261471600025
J	Greenhalgh, T; Stramer, K; Bratan, T; Byrne, E; Mohammad, Y; Russell, J				Greenhalgh, Trisha; Stramer, Katja; Bratan, Tanja; Byrne, Emma; Mohammad, Yara; Russell, Jill			Introduction of shared electronic records: multi-site case study using diffusion of innovation theory	BRITISH MEDICAL JOURNAL			English	Article							CONSENT MECHANISMS; HEALTH RECORD; CARE; ORGANIZATIONS; TECHNOLOGY; SYSTEMS	Objective To explore the introduction of a centrally stored, shared electronic patient record ( the summary care record ( SCR)) in England and draw wider lessons about the implementation of large scale information technology projects in health care. Design Multi- site, mixed method case study applying utilisation focused evaluation. Setting Four early adopter sites for the SCR in England- three in urban areas of relative socioeconomic deprivation and the fourth in a relatively affluent rural area. Data sources and analysis Data included 250 staff interviews, 1500 hours of ethnographic observation, interviews and focus groups with 170 patients and carers, 2500 pages of correspondence and documentary evidence, and incorporation of relevant surveys and statistics produced by others. These were analysed by using a thematic approach drawing on ( and extending) a theoretical model of complex change developed in a previous systematic review. Main findings The mixed fortunes of the SCR programme in its first year were largely explained by eight interacting influences. The first was the SCR's material properties ( especially technical immaturity and lack of interoperability) and attributes ( especially the extent to which potential adopters believed the benefits outweighed the risks). The second was adopters' concerns ( especially about workload and the ethicality of sharing "confidential" information on an implied consent model). The third influence was interpersonal influence ( for example, opinion leaders, champions, facilitators), and the fourth was organisational antecedents for innovation ( for example past experience with information technology projects, leadership and management capacity, effective data capture systems, slack resources). The fifth was organisational readiness for the SCR ( for example, innovation- system fit, tension for change, power balances between supporters and opponents, baseline data quality). The sixth was the implementation process ( including the nature of the change model and the extent to which new routines associated with the SCR aligned with existing organisational routines). The seventh influence was the nature and quality of links between different parts of the system, and the final one was the wider environment especially the political context of the programme). Conclusion Shared electronic records are not plug- in technologies. They are complex innovations that must be accepted by individual patients and staff and also embedded in organisational and inter- organisational routines. This process is heavily influenced at the micro-level by the material properties of the technology, individuals' attitudes and concerns, and interpersonal influence; at the meso- level by organisational antecedents, readiness, and operational aspects of implementation; and at the macro- level by institutional and socio- political forces. A case study approach and multi- level theoretical analysis can illuminate how contextual factors shape, enable, and constrain new, technology supported models of patient care.	[Greenhalgh, Trisha; Stramer, Katja; Bratan, Tanja; Byrne, Emma; Mohammad, Yara; Russell, Jill] UCL, Res Dept Primary Care & Populat Hlth, London N19 5LW, England	University of London; University College London	Greenhalgh, T (corresponding author), UCL, Res Dept Primary Care & Populat Hlth, Highgate Hill, London N19 5LW, England.	p.greenhalgh@pcps.ucl.ac.uk	Greiver, Michelle/N-8764-2015; Greenhalgh, Trisha/B-1825-2015	Greiver, Michelle/0000-0001-8957-0285; Greenhalgh, Trisha/0000-0003-2369-8088; Mohammad, Yara/0000-0002-2309-9117	Department of Health; Connecting for Health Evaluation Programme [CFHEP/002]	Department of Health; Connecting for Health Evaluation Programme	This study was funded by a research grant from the Department of Health through the Connecting for Health Evaluation Programme (CFHEP/002); the CFHEP is organised through Richard Lilford's team at the University of Birmingham.	AARTS J, 2004, MEDINFO, V999, P1002; Baird G, 2008, BRIT J GEN PRACT, V58, P131, DOI 10.3399/bjgp08X277131; Berg M, 2001, INT J MED INFORM, V64, P143, DOI 10.1016/S1386-5056(01)00200-3; BRENNAN S, 2005, NHS IT PROJECT; *BRIT COMP SOC HLT, 2006, WAY FORW NHS HLTH IN; Coiera E, 2004, J AM MED INFORM ASSN, V11, P129, DOI 10.1197/jamia.M1480; DAMANPOUR F, 1991, ACAD MANAGE J, V34, P555, DOI 10.2307/256406; Department of Health, 2002, DEL 21 CENT IT SUPP; EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Greenhalgh T., 2008, SUMMARY CARE RECORD; GREENHALGH T, IN PRESS BMJ; Greenhalgh T, 2008, BMJ-BRIT MED J, V336, P1290, DOI 10.1136/bmj.a114; Gustafson DH, 2003, HEALTH SERV RES, V38, P751, DOI 10.1111/1475-6773.00143; Hanseth O, 2007, RISK, COMPLEXITY AND ICT, P1; HEEKS R, 2000, HEALTHCARE INFORMATI; HOFFMARCHER MM, 2007, 30 ORG EC COOP DEV; *HOUS COMM COMM PU, 2007, DEP HLTH NAT PROGR I; *HOUS COMM HLTH CO, 2007, EL PAT REC; Institute of Medicine, 2003, CROSS QUAL CHASM NEW; Keen J, 2006, BRIT MED J, V333, P3, DOI 10.1136/bmj.38889.569201.DE; Kluge EHW, 2007, INT J MED INFORM, V76, P402, DOI 10.1016/j.ijmedinf.2006.09.003; Markham SK, 1998, J PROD INNOVAT MANAG, V15, P490, DOI 10.1111/1540-5885.1560490; *NAT AUD OFF, 2006, DEP HLTH NAT PROGR I; *NHS CONF, 2004, 105 NHS CONF; Orlikowski WJ, 2006, J APPL BEHAV SCI, V42, P127, DOI 10.1177/0021886305285130; ORLIKOWSKI WJ, 1995, ORGAN SCI, V6, P423, DOI 10.1287/orsc.6.4.423; Patton MQ., 1997, UTILIZATION FOCUSED; Pettigrew A, 1992, SHAPING STRATEGIC CH; Rogers, 2003, DIFFUSION INNOVATION; Sanderson H, 2004, BRIT MED J, V328, P875, DOI 10.1136/bmj.328.7444.875; SCOTT T, 2007, IMPLEMENTING ELECT M; Van de Ven A.H., 1999, INNOVATION JOURNEY; Win KT, 2007, J MED SYST, V31, P91, DOI 10.1007/s10916-006-9030-3; Zahra SA, 2002, ACAD MANAGE REV, V27, P185, DOI 10.2307/4134351	35	118	119	0	54	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 1	2008	337								a1786	10.1136/bmj.a1786	http://dx.doi.org/10.1136/bmj.a1786			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	368AM	18948344	Green Published, hybrid			2022-12-28	WOS:000260593700030
J	Ganzini, L; Goy, ER; Dobscha, SK				Ganzini, Linda; Goy, Elizabeth R.; Dobscha, Steven K.			Prevalence of depression and anxiety in patients requesting physicians' aid in dying: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article							MENTAL STATUS QUESTIONNAIRE; REDUCING SUICIDAL IDEATION; TERMINALLY-ILL PATIENTS; PRIMARY-CARE PATIENTS; ASSISTED SUICIDE; HASTENED DEATH; OLDER PATIENTS; CANCER; HOPELESSNESS; DESIRE	Objective To determine the prevalence of depression and anxiety in terminally ill patients pursuing aid in dying from physicians. Design Cross sectional survey. Setting State of Oregon, USA. Participants 58 Oregonians, most terminally ill with cancer or amyotrophic lateral sclerosis, who had either requested aid in dying from a physician or contacted an aid in dying advocacy organisation. Main outcome measures Diagnosis of depression or anxiety according to the hospital anxiety and depression scale and the structured clinical interview for the Diagnostic and Statistical Manual of Mental Disorders. Results 15 study participants met "caseness" criteria for depression, and 13 met criteria for anxiety. 42 patients died by the end of the study; 18 received a prescription fora lethal drug under the Death with Dignity Act, and nine died by lethal ingestion. 15 participants who received a prescription for a lethal drug did not meet criteria for depression; three did. All three depressed participants died by legal ingestion within two months of the research interview. Conclusion Although most terminally ill Oregonians who receive aid in dying do not have depressive disorders, the current practice of the Death with Dignity Act may fail to protect some patients whose choices are influenced by depression from receiving a prescription for a lethal drug.	[Ganzini, Linda; Goy, Elizabeth R.; Dobscha, Steven K.] Portland VA Med Ctr, Columbia Ctr Study Chron Comorbid Mental & Phys D, Hlth Serv Res & Dev, Portland, OR 97239 USA; [Ganzini, Linda; Goy, Elizabeth R.; Dobscha, Steven K.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University	Ganzini, L (corresponding author), Portland VA Med Ctr, Columbia Ctr Study Chron Comorbid Mental & Phys D, Hlth Serv Res & Dev, POB 1034, Portland, OR 97239 USA.	Linda.Ganzini@va.gov			Northwest Health Foundation	Northwest Health Foundation	Northwest Health Foundation. The funding source had no role in any aspect of the study or this paper.	Appelbaum P.S., 2001, MACARTHUR COMPETENCE; BECK AT, 1990, AM J PSYCHIAT, V147, P190; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Blank K, 2001, J AM GERIATR SOC, V49, P153, DOI 10.1046/j.1532-5415.2001.49036.x; Breitbart W, 2000, JAMA-J AM MED ASSOC, V284, P2907, DOI 10.1001/jama.284.22.2907; Bruce ML, 2004, JAMA-J AM MED ASSOC, V291, P1081, DOI 10.1001/jama.291.9.1081; Carlson B, 2005, J PALLIAT MED, V8, P1160, DOI 10.1089/jpm.2005.8.1160; CHOCHINOV HM, 1994, AM J PSYCHIAT, V151, P537; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; Conwell Y, 2000, J AM GERIATR SOC, V48, P23, DOI 10.1111/j.1532-5415.2000.tb03024.x; Conwell Y, 2002, BIOL PSYCHIAT, V52, P193, DOI 10.1016/S0006-3223(02)01347-1; Emanuel EJ, 2005, J CLIN ONCOL, V23, P6456, DOI 10.1200/JCO.2005.06.001; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V284, P2460, DOI 10.1001/jama.284.19.2460; First M.B., 1997, USERS GUIDE STRUCTUR; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ganzini L, 1999, NEUROLOGY, V52, P1434, DOI 10.1212/WNL.52.7.1434; Ganzini L, 2006, J CLIN ETHIC, V17, P27; Ganzini L, 1996, AM J PSYCHIAT, V153, P1469; Ganzini L, 2000, AM J PSYCHIAT, V157, P595, DOI 10.1176/appi.ajp.157.4.595; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Ganzini L, 2002, NEW ENGL J MED, V347, P582, DOI 10.1056/NEJMsa020562; Ganzini L, 2008, J GEN INTERN MED, V23, P154, DOI 10.1007/s11606-007-0476-x; Henriksson MM, 1995, J AFFECT DISORDERS, V36, P11, DOI 10.1016/0165-0327(95)00047-X; Hotopf M, 2002, PALLIATIVE MED, V16, P81, DOI 10.1191/02169216302pm507oa; MINKOFF K, 1973, AM J PSYCHIAT, V130, P455; Passik SD, 1998, J CLIN ONCOL, V16, P1594, DOI 10.1200/JCO.1998.16.4.1594; PEREZSTABLE EJ, 1990, ARCH INTERN MED, V150, P1083, DOI 10.1001/archinte.150.5.1083; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Rosenfeld B, 2006, PSYCHOSOMATICS, V47, P504, DOI 10.1176/appi.psy.47.6.504; Simon G E, 1995, Arch Fam Med, V4, P99, DOI 10.1001/archfami.4.2.99; SMYER MA, 1979, J AM GERIATR SOC, V27, P263, DOI 10.1111/j.1532-5415.1979.tb06128.x; Tolle SW, 2004, J CLIN ETHIC, V15, P111; Unutzer J, 2006, J AM GERIATR SOC, V54, P1550, DOI 10.1111/j.1532-5415.2006.00882.x; Werth JL, 2004, BEHAV SCI LAW, V22, P627, DOI 10.1002/bsl.616; Wilson KG, 2007, HEALTH PSYCHOL, V26, P314, DOI 10.1037/0278-6133.26.3.314; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; 2007, COMPASSION CHOICES O	37	87	88	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a1682	10.1136/bmj.a1682	http://dx.doi.org/10.1136/bmj.a1682			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	363WS	18842645	Green Published, hybrid			2022-12-28	WOS:000260298800034
J	Pronovost, P; Berenholtz, S; Needham, D				Pronovost, Peter; Berenholtz, Sean; Needham, Dale			Translating evidence into practice: a model for large scale knowledge translation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE ORGANIZATIONS; BLOOD-STREAM INFECTIONS; GUIDELINES; QUALITY; PERFORMANCE; SAFETY; UNIT		[Pronovost, Peter; Berenholtz, Sean] Johns Hopkins Qual & Safety Res Grp, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21231 USA; [Needham, Dale] Div Pulm & Crit Care Med, Baltimore, MD 21287 USA	Johns Hopkins University	Pronovost, P (corresponding author), Johns Hopkins Qual & Safety Res Grp, Dept Anesthesiol & Crit Care Med, 1909 Thames St, Baltimore, MD 21231 USA.	ppronovo@jhmi.edu						Berenholtz SM, 2004, CRIT CARE MED, V32, P2014, DOI 10.1097/01.CCM.0000142399.70913.2F; Bradley EH, 2005, MED CARE, V43, P282, DOI 10.1097/00005650-200503000-00011; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol R, 1998, BRIT MED J, V317, P858, DOI 10.1136/bmj.317.7162.858; Hofer TP, 2002, ANN INTERN MED, V137, P327, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00008; Lenfant C, 2003, NEW ENGL J MED, V349, P868, DOI 10.1056/NEJMsa035507; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2004, BRIT MED J, V328, P343, DOI 10.1136/bmj.328.7435.343; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2007, JAMA-J AM MED ASSOC, V298, P2063, DOI 10.1001/jama.298.17.2063; Pronovost PJ, 2006, HEALTH SERV RES, V41, P1599, DOI 10.1111/j.1475-6773.2006.00567.x; Pronovost PJ, 2004, LANCET, V363, P1061, DOI 10.1016/S0140-6736(04)15843-1; PRONOVOST PJ, 2005, J PATIENT SAF, V1, P33; Rabe-Hesketh S.S.A., 2005, MULTILEVEL LONGITUDI; Schouten LMT, 2008, BMJ-BRIT MED J, V336, P1491, DOI 10.1136/bmj.39570.749884.BE; Sinuff T, 2007, CRIT CARE MED, V35, P2083, DOI 10.1097/01.ccm.0000281446.15342.74; Wenzel RP, 2006, NEW ENGL J MED, V355, P2781, DOI 10.1056/NEJMe068230	19	313	313	1	41	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2008	337	7676							a1714	10.1136/bmj.a1714	http://dx.doi.org/10.1136/bmj.a1714			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	363WS	18838424				2022-12-28	WOS:000260298800031
J	Rasmussen, B; Fletcher, IR; Brocks, JJ; Kilburn, MR				Rasmussen, Birger; Fletcher, Ian R.; Brocks, Jochen J.; Kilburn, Matt R.			Reassessing the first appearance of eukaryotes and cyanobacteria	NATURE			English	Article							ISOTOPIC RATIO MEASUREMENTS; PROTEROZOIC MCARTHUR BASIN; MOUNT BRUCE SUPERGROUP; GREAT OXIDATION EVENT; ATMOSPHERIC OXYGEN; MOLECULAR FOSSILS; WESTERN-AUSTRALIA; NORTHERN AUSTRALIA; PETROLEUM GEOLOGY; FLUID INCLUSIONS	The evolution of oxygenic photosynthesis had a profound impact on the Earth's surface chemistry, leading to a sharp rise in atmospheric oxygen between 2.45 and 2.32 billion years (Gyr) ago(1,2) and the onset of extreme ice ages(3). The oldest widely accepted evidence for oxygenic photosynthesis has come from hydrocarbons extracted from similar to 2.7-Gyr-old shales in the Pilbara Craton, Australia, which contain traces of biomarkers ( molecular fossils) indicative of eukaryotes and suggestive of oxygen- producing cyanobacteria(4-7). The soluble hydrocarbons were interpreted to be indigenous and syngenetic despite metamorphic alteration and extreme enrichment ( 10-20 parts per thousand) of (13)C relative to bulk sedimentary organic matter(5,8). Here we present micrometre-scale, in situ (13)C/(12)C measurements of pyrobitumen ( thermally altered petroleum) and kerogen from these metamorphosed shales, including samples that originally yielded biomarkers. Our results show that both kerogen and pyrobitumen are strongly depleted in (13)C, indicating that indigenous petroleum is 10-20 parts per thousand lighter than the extracted hydrocarbons(5). These results are inconsistent with an indigenous origin for the biomarkers. Whatever their origin, the biomarkers must have entered the rock after peak metamorphism 2.2 Gyr ago(9) and thus do not provide evidence for the existence of eukaryotes and cyanobacteria in the Archaeaneon. The oldest fossil evidence for eukaryotes and cyanobacteria therefore reverts to 1.78-1.68 Gyr ago and similar to 2.15 Gyr ago(10,11), respectively. Our results eliminate the evidence for oxygenic photosynthesis similar to 2.7 Gyr ago and exclude previous biomarker evidence for a long delay (similar to 300 million years) between the appearance of oxygen- producing cyanobacteria and the rise in atmospheric oxygen 2.45-2.32 Gyr ago(1).	[Rasmussen, Birger; Fletcher, Ian R.] Curtin Univ Technol, Dept Appl Geol, Bentley, WA 6102, Australia; [Brocks, Jochen J.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Brocks, Jochen J.] Australian Natl Univ, Ctr Macroevolut & Macroecol, Canberra, ACT 0200, Australia; [Kilburn, Matt R.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Nedlands, WA 6009, Australia	Curtin University; Australian National University; Australian National University; University of Western Australia	Rasmussen, B (corresponding author), Curtin Univ Technol, Dept Appl Geol, Kent St, Bentley, WA 6102, Australia.	B.Rasmussen@curtin.edu.au	Brocks, Jochen/E-3920-2012; Kilburn, Matthew R/C-4515-2011	Brocks, Jochen/0000-0002-8430-8744; Kilburn, Matthew R/0000-0002-1858-8485; Rasmussen, Birger/0000-0002-2745-0904	Australian Microscopy and Microanalysis Research Facility at the Centre for Microscopy, Characterisation and Analysis; University of Western Australia; University, State and Commonwealth Governments	Australian Microscopy and Microanalysis Research Facility at the Centre for Microscopy, Characterisation and Analysis; University of Western Australia; University, State and Commonwealth Governments	We thank S. Bengtson, G.A. Logan, J.R. Muhling, S. Revets and S. Sheppard for discussion and comments; and A.C. Cook for organic reflectivity measurements. We acknowledge the facilities of the Australian Microscopy and Microanalysis Research Facility at the Centre for Microscopy, Characterisation and Analysis, University of Western Australia, a facility funded by the University, State and Commonwealth Governments.	Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; [Anonymous], 1995, PETROLEUM GEOCHEMIST; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Brocks JJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4321, DOI 10.1016/S0016-7037(03)00209-6; Brocks JJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4289, DOI 10.1016/S0016-7037(03)00208-4; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Brocks JJ, 2008, GEOCHIM COSMOCHIM AC, V72, P871, DOI 10.1016/j.gca.2007.11.028; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; CRICK IH, 1988, AAPG BULL, V72, P1495; Des Marais DJ, 2001, REV MINERAL GEOCHEM, V43, P555, DOI 10.2138/gsrmg.43.1.555; Dutkiewicz A, 2006, GEOLOGY, V34, P437, DOI 10.1130/G22360.1; FLETCHER IR, INT J MASS IN PRESS; George SC, 2008, GEOCHIM COSMOCHIM AC, V72, P844, DOI 10.1016/j.gca.2007.11.021; Goldblatt C, 2006, NATURE, V443, P683, DOI 10.1038/nature05169; Hayes J. M., 1983, EARTHS EARLIEST BIOS, P93; HAYES JM, 1994, EARLY LIFE EARTH, P220; Hillion F, 2008, GEOCHIM COSMOCHIM AC, V72, pA377; Hinrichs KU, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000286; HOEFS J, 2004, STABLE ISOTOPE GEOCH, P158; HOFMANN HJ, 1976, J PALEONTOL, V50, P1040; Knoll AH, 2006, PHILOS T R SOC B, V361, P1023, DOI 10.1098/rstb.2006.1843; Konhauser KO, 2002, GEOLOGY, V30, P1079, DOI 10.1130/0091-7613(2002)030<1079:CBHFTP>2.0.CO;2; Kopp RE, 2005, P NATL ACAD SCI USA, V102, P11131, DOI 10.1073/pnas.0504878102; Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058; Rasmussen B, 2005, GEOLOGY, V33, P773, DOI 10.1130/G21666.1; Rasmussen B, 2005, GEOLOGY, V33, P497, DOI 10.1130/G21316.1; Rasmussen B, 2007, EARTH PLANET SC LETT, V258, P249, DOI 10.1016/j.epsl.2007.03.033; Sherman LS, 2007, ORG GEOCHEM, V38, P1987, DOI 10.1016/j.orggeochem.2007.08.012; Slodzian G, 2004, APPL SURF SCI, V231, P874, DOI 10.1016/j.apsusc.2004.03.155; Slodzian G, 2001, EUR PHYS J-APPL PHYS, V14, P199, DOI 10.1051/epjap:2001160; SMITH RE, 1982, J PETROL, V23, P75, DOI 10.1093/petrology/23.1.75; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; SUMMONS RE, 1988, GEOCHIM COSMOCHIM AC, V52, P1747, DOI 10.1016/0016-7037(88)90001-4	33	360	380	2	221	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1101	U9		10.1038/nature07381	http://dx.doi.org/10.1038/nature07381			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948954				2022-12-28	WOS:000260252600043
J	Christian, WM; Spittal, PM				Christian, Wayne M.; Spittal, Patricia M.			The Cedar Project: acknowledging the pain of our children	LANCET			English	Editorial Material							YOUNG ABORIGINAL PEOPLE; 2 CANADIAN CITIES; DRUGS		[Christian, Wayne M.] Splats Secwepemc Nation, Cedar Project Partnership, Enderby, BC V0E 1V0, Canada; [Spittal, Patricia M.] Univ British Columbia, Dept Hlth Care & Epidemiol, Dept Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Christian, WM (corresponding author), Splats Secwepemc Nation, Cedar Project Partnership, Enderby, BC V0E 1V0, Canada.	chief_wmchristian@spallumcheen.org						Furniss E., 1995, VICTIMS BENEVOLENCE; HARPER S, 2008, PM OFFERS FULL APOLO; HYLTON JH, 2006, ABORIGINAL SEXUAL OF; *IND NO AFF CAN, 2006, CAN POS UN DRAFT DEC; Pearce ME, 2008, SOC SCI MED, V66, P2185, DOI 10.1016/j.socscimed.2008.03.034; ROSS R, 2008, TELLING TRUTHS SEEKI; *ROYAL COMM AB PEO, 1996, REP ROYAL COMM AB PE, V1, P367; Spittal PM, 2007, INT J CIRCUMPOL HEAL, V66, P226, DOI 10.3402/ijch.v66i3.18259; Walters KL, 2002, AM J PUBLIC HEALTH, V92, P520, DOI 10.2105/AJPH.92.4.520	9	16	16	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP-OCT	2008	372	9644					1132	1133		10.1016/S0140-6736(08)61460-9	http://dx.doi.org/10.1016/S0140-6736(08)61460-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	355UN	18926262				2022-12-28	WOS:000259734700009
J	Holland, MD; Hastings, A				Holland, Matthew D.; Hastings, Alan			Strong effect of dispersal network structure on ecological dynamics	NATURE			English	Article							PERSISTENCE; SYNCHRONIZATION; LANDSCAPES; PREDATORS; CORRIDORS; STABILITY	A central question in ecology with great importance for management, conservation and biological control is how changing connectivity affects the persistence and dynamics of interacting species. Researchers in many disciplines have used large systems of coupled oscillators to model the behaviour of a diverse array of fluctuating systems in nature(1-4). In the well- studied regime of weak coupling, synchronization is favoured by increases in coupling strength and large- scale network structures ( for example 'small worlds') that produce short cuts and clustering(5-9). Here we show that, by contrast, randomizing the structure of dispersal networks in a model of predators and prey tends to favour asynchrony and prolonged transient dynamics, with resulting effects on the amplitudes of population fluctuations. Our results focus on synchronization and dynamics of clusters in models, and on time-scales, more appropriate for ecology, namely smaller systems with strong interactions outside the weak- coupling regime, rather than the better- studied cases of large, weakly coupled systems. In these smaller systems, the dynamics of transients and the effects of changes in connectivity can be well understood using a set of methods including numerical reconstructions of phase dynamics, examinations of cluster formation and the consideration of important aspects of cyclic dynamics, such as amplitude.	[Holland, Matthew D.; Hastings, Alan] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of California System; University of California Davis	Holland, MD (corresponding author), Univ Calif Davis, Dept Environm Sci & Policy, 1 Shields Ave, Davis, CA 95616 USA.	mdholland@ucdavis.edu	Hastings, Alan/O-6864-2019	Hastings, Alan/0000-0002-0717-8026	Quantitative Environmental and Integrative Biology; National Science Foundation	Quantitative Environmental and Integrative Biology; National Science Foundation(National Science Foundation (NSF))	We thank M. Holyoak for comments on an earlier version of the manuscript and D. Wysham for discussions. M. D. H. was funded by a Quantitative Environmental and Integrative Biology grant to A. H. and M. Holyoak from the National Science Foundation.	Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Cohen S. D., 1996, Computers in Physics, V10, P138; Comins HN, 1996, J THEOR BIOL, V183, P19, DOI 10.1006/jtbi.1996.0197; Crooks K. R., 2006, CONNECTIVITY CONSERV; CROWLEY PH, 1981, AM NAT, V118, P673, DOI 10.1086/283861; Ellner SP, 2001, NATURE, V412, P538, DOI 10.1038/35087580; Fortuna MA, 2006, P ROY SOC B-BIOL SCI, V273, P1429, DOI 10.1098/rspb.2005.3448; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; HASSELL MP, 1974, J ANIM ECOL, V43, P567, DOI 10.2307/3384; Hastings A, 2001, ECOL LETT, V4, P215, DOI 10.1046/j.1461-0248.2001.00220.x; Hilty J. A., 2006, CORRIDOR ECOLOGY SCI; Holyoak M, 2000, AM NAT, V156, P378, DOI 10.1086/303395; Hong H, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026139; Hudgens BR, 2003, AM NAT, V161, P808, DOI 10.1086/374343; Jansen VAA, 2001, THEOR POPUL BIOL, V59, P119, DOI 10.1006/tpbi.2000.1506; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; MATTHEWS PC, 1991, PHYSICA D, V52, P293, DOI 10.1016/0167-2789(91)90129-W; McIntire EJB, 2007, J APPL ECOL, V44, P725, DOI 10.1111/j.1365-2664.2007.01326.x; Murdoch W.W., 2013, CONSUMER RESOURCE DY; Nishikawa T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.014101; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Smith SW, 1997, SCI ENG GUIDE DIGITA; Tewksbury JJ, 2002, P NATL ACAD SCI USA, V99, P12923, DOI 10.1073/pnas.202242699; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; WATTS D, 1999, SMALL WORLDS; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3	30	136	139	1	97	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					792	U76		10.1038/nature07395	http://dx.doi.org/10.1038/nature07395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18931656				2022-12-28	WOS:000261559900049
J	Kappos, L; Gold, R; Miller, DH; MacManus, DG; Havrdova, E; Limmroth, V; Polman, CH; Schmierer, K; Yousry, TA; Yang, MH; Eraksoy, M; Meluzinova, E; Rektor, I; Dawson, KT; Sandrock, AW; O'Neill, GN				Kappos, Ludwig; Gold, Ralf; Miller, David H.; MacManus, David G.; Havrdova, Eva; Limmroth, Volker; Polman, Chris H.; Schmierer, Klaus; Yousry, Tarek A.; Yang, Minhua; Eraksoy, Mefkure; Meluzinova, Eva; Rektor, Ivan; Dawson, Katherine T.; Sandrock, Alfred W.; O'Neill, Gilmore N.		BG-12 Phase IIb Study Investigator	Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study	LANCET			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; RESONANCE-IMAGING FINDINGS; TRANSCRIPTION FACTOR NRF2; OXIDATIVE STRESS; DISEASE PROGRESSION; CONTROLLED TRIAL; ACID ESTERS; CELLS; ACTIVATION; DISABILITY	Background Oral fumarate (BG00012) might have dual anti-inflammatory and neuroprotective effects. Our aim was to assess the efficacy and safety of BG00012 in patients with relapsing-remitting multiple sclerosis. Methods 257 patients, aged 18-55 years, with relapsing-remitting multiple sclerosis were randomly assigned to receive 120 mg once daily (n=64), 120 mg three times daily (n=64), or 240 mg three times daily (n=64) BG00012, or placebo (n=65) for 24 weeks. During an extension period of 24 weeks for safety assessment, patients treated with placebo received BG00012 240 mg three times daily. The primary endpoint was total number of new gadolinium enhancing (GdE) lesions on brain MRI scans at weeks 12, 16, 20, and 24. Additional endpoints included cumulative number of new GAE lesions (weeks 4-24), new or enlarging T2-hyperintense lesions, new T1-hypointense lesions at week 24, and annualised relapse rate. Analysis was done on the efficacy-evaluable population. Safety and tolerability were also assessed. This study is registered with ClinicalTrials.gov, number NCT00168701. Findings Treatment with BG00012 240 mg three times daily reduced by 69% the mean total number of new GdE lesions from week 12 to 24 compared with placebo (1 . 4 vs 4.5, p<0 . 0001). It also reduced number of new or enlarging T2-hyperintense (p=0 . 0006) and new T1-hypointense (p=0.014) lesions compared with placebo. BG00012 reduced annualised relapse rate by 32% (0.44 vs 0 . 65 for placebo; p=0 . 272). Adverse events more common in patients given BG00012 than in those given placebo included abdominal pain, flushing, and hot flush. Dose-related adverse events in patients on BG00012 were headache, fatigue, and feeling hot. Interpretation The anti-inflammatory effects and favourable safety profile of BG00012 warrant further long-term phase III studies in large patient groups. Funding Biogen Idec, Inc.	[Kappos, Ludwig] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Gold, Ralf] Ruhr Univ Bochum, St Josef Hosp, Univ Clin Bochum, D-4630 Bochum, Germany; [Miller, David H.; MacManus, David G.; Schmierer, Klaus; Yousry, Tarek A.] UCL, Inst Neurol, London, England; [Havrdova, Eva] Gen Teaching Hosp, Prague, Czech Republic; [Limmroth, Volker] City Hosp Cologne, Cologne, Germany; [Polman, Chris H.] VU Med Ctr, Amsterdam, Netherlands; [Yang, Minhua; Dawson, Katherine T.; Sandrock, Alfred W.; O'Neill, Gilmore N.] Biogen Idec, Cambridge, MA USA; [Eraksoy, Mefkure] Univ Istanbul, Istanbul, Turkey; [Meluzinova, Eva] Charles Univ Prague, Sch Med 2, Motol Hosp, Prague, Czech Republic; [Rektor, Ivan] Masaryk Univ, Brno, Czech Republic	University of Basel; Ruhr University Bochum; University of London; University College London; General University Hospital Prague; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Biogen; Charles University Prague; Masaryk University Brno	Kappos, L (corresponding author), Univ Basel Hosp, Dept Biomed, Petersgraben 4, CH-4031 Basel, Switzerland.	lkappos@uhbs.ch	Rektor, Ivan IR/G-9480-2014; Havrdova, Eva Kubala/P-4892-2017; Schmierer, Klaus/W-3253-2019; Skoromets, Alexander/I-7569-2013; Eraksoy, Mefkure/AAE-4872-2020; Macedo, Ana/L-9912-2018; Horakova, Dana/O-3598-2017; Karrenbauer, Virginija Danylaite/C-4812-2017	Havrdova, Eva Kubala/0000-0002-9543-4359; Macedo, Ana/0000-0002-6978-8989; Horakova, Dana/0000-0003-1915-0036; Altintas, Ayse/0000-0002-8524-5087; MacManus, David/0000-0002-0902-977X; Brundin, Lou/0000-0003-4408-7817; Karrenbauer, Virginija Danylaite/0000-0002-7166-8951; Lycke, Jan/0000-0002-7891-8466	Biogen Idec Inc	Biogen Idec Inc(Biogen)	The authors acknowledge the contributions of J Licata and M Hasson (Scientific Connexions, Newtown, PA, USA) for editorial assistance in preparing this manuscript for submission. Their work was Funded by Biogen Idec Inc.	ALTMEYER PJ, 1994, J AM ACAD DERMATOL, V30, P977, DOI 10.1016/S0190-9622(94)70121-0; BARNES J, 1997, NEW ENGL J MED, V336, P1066; BO L, 1994, ANN NEUROL, V36, P778, DOI 10.1002/ana.410360515; Bruck W, 1997, ANN NEUROL, V42, P783, DOI 10.1002/ana.410420515; Calabrese V, 2005, J NEUROSCI RES, V79, P509, DOI 10.1002/jnr.20386; Chen XL, 2006, AM J PHYSIOL-HEART C, V290, pH1862, DOI 10.1152/ajpheart.00651.2005; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Hubbs AF, 2007, AM J PATHOL, V170, P2068, DOI 10.2353/ajpath.2007.060898; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kappos L, 1999, LANCET, V353, P964, DOI 10.1016/S0140-6736(98)03053-0; KAPPOS L, 2003, INTERACTIVE TRAINING; KATZ D, 1993, ANN NEUROL, V34, P661, DOI 10.1002/ana.410340507; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LANGEMANN H, 1992, EUR NEUROL, V32, P248, DOI 10.1159/000116835; LEVINE SM, 1992, MED HYPOTHESES, V39, P271, DOI 10.1016/0306-9877(92)90121-R; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; Liu YR, 2003, J NEUROIMMUNOL, V139, P27, DOI 10.1016/S0165-5728(03)00132-2; Loewe R, 2001, J INVEST DERMATOL, V117, P1363, DOI 10.1046/j.0022-202x.2001.01576.x; Lukashev M, 2007, MULT SCLER, V13, pS149; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; O'Connor P, 2005, MULT SCLER J, V11, P568, DOI 10.1191/1352458505ms1205oa; Richert ND, 2006, NEUROLOGY, V66, P551, DOI 10.1212/01.wnl.0000197982.78063.06; Satoh T, 2006, P NATL ACAD SCI USA, V103, P768, DOI 10.1073/pnas.0505723102; Schilling S, 2006, CLIN EXP IMMUNOL, V145, P101, DOI 10.1111/j.1365-2249.2006.03094.x; Schimrigk S, 2006, EUR J NEUROL, V13, P604, DOI 10.1111/j.1468-1331.2006.01292.x; Sormani MP, 2001, NEUROLOGY, V57, P1883, DOI 10.1212/WNL.57.10.1883; van der Goes A, 1998, J NEUROIMMUNOL, V92, P67, DOI 10.1016/S0165-5728(98)00175-1; van Walderveen MAA, 1999, ANN NEUROL, V46, P79, DOI 10.1002/1531-8249(199907)46:1<79::AID-ANA12>3.3.CO;2-0; Vargas MR, 2005, J BIOL CHEM, V280, P25571, DOI 10.1074/jbc.M501920200; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wierinckx A, 2005, J NEUROIMMUNOL, V166, P132, DOI 10.1016/j.jneuroim.2005.05.013; Zagorski T, 1991, Neurol Neurochir Pol, V25, P725; Zhao C, 2008, J NEUROL SCI, V265, P12, DOI 10.1016/j.jns.2007.05.008	36	386	419	2	45	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 25	2008	372	9648					1463	1472		10.1016/S0140-6736(08)61619-0	http://dx.doi.org/10.1016/S0140-6736(08)61619-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370ZJ	18970976				2022-12-28	WOS:000260801300023
J	Duncan, EM; Muratore-Schroeder, TL; Cook, RG; Garcia, BA; Shabanowitz, J; Hunt, DF; Allis, CD				Duncan, Elizabeth M.; Muratore-Schroeder, Tara L.; Cook, Richard G.; Garcia, Benjamin A.; Shabanowitz, Jeffrey; Hunt, Donald F.; Allis, C. David			Cathepsin L Proteolytically Processes Histone H3 During Mouse Embryonic Stem Cell Differentiation	CELL			English	Article							CYSTEINE PROTEINASES; NUCLEAR-LOCALIZATION; CHROMATIN; METHYLATION; INHIBITOR; MARKS; HETEROCHROMATIN; IDENTIFICATION; PLURIPOTENCY; PROTEOLYSIS	Chromatin undergoes developmentally-regulated structural and chemical changes as cells differentiate, which subsequently lead to differences in cellular function by altering patterns of gene expression. To gain insight into chromatin alterations that occur during mammalian differentiation, we turned to a mouse embryonic stem cell (ESC) model. Here we show that histone H3 is proteolytically cleaved at its N-terminus during ESC differentiation. We map the sites of H3 cleavage and identify Cathepsin L as a protease responsible for proteolytically processing the N-terminal H3 tail. In addition, our data suggest that H3 cleavage may be regulated by covalent modifications present on the histone tail itself. Our studies underscore the intriguing possibility that histone proteolysis, brought about by Cathepsin L and potentially other family members, plays a role in development and differentiation that was not previously recognized.	[Muratore-Schroeder, Tara L.; Garcia, Benjamin A.; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Duncan, Elizabeth M.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol, New York, NY 10065 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22904 USA; [Cook, Richard G.] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	University of Virginia; Rockefeller University; University of Virginia; Baylor College of Medicine	Hunt, DF (corresponding author), Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA.	dfh@virginia.edu; alliscd@rockefeller.edu	Duncan, Elizabeth/AAJ-3351-2020; Hunt, Donald F/I-6936-2012	Hunt, Donald F/0000-0003-2815-6368; Duncan, Elizabeth/0000-0003-2003-6417	Rockefeller University; Starr Foundation; National Institutes of Health [GM37537, GM53512]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037537, R01GM049351, R37GM053512, R01GM053512] Funding Source: NIH RePORTER	Rockefeller University; Starr Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Wysocka, T. Swigut, A. Ruthenburg, D. Shechter, L, Banaszynski, and B. Ueberheide for their advice on biochemical and ESC methods, and J. Wysocka and D. Shechter for their critical reading of the manuscript. Peptides were synthesized at the proteomics facilities at RU and Tufts. E. M. D. is an Anderson Cancer Center fellow (The Rockefeller University). This work was funded by institutional support from The Rockefeller University and grants from the Tri-Institutional Stem Cell Initiative (funded by the Starr Foundation) and National Institutes of Health Grants GM37537 (to D.F.H.) and GM53512 (to C.D.A.).	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ALLIS CD, 1980, CELL, V20, P55; Anand R, 2007, J BIOL CHEM, V282, P35425, DOI 10.1074/jbc.R700027200; Arney KL, 2004, J CELL SCI, V117, P4355, DOI 10.1242/jcs.01390; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bannister AJ, 2004, METHOD ENZYMOL, V376, P269; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Barrett AJ, 2003, HDB PROTEOLYTIC ENZY; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bulynko YA, 2006, MOL CELL BIOL, V26, P4172, DOI 10.1128/MCB.00135-06; Coon JJ, 2005, P NATL ACAD SCI USA, V102, P9463, DOI 10.1073/pnas.0503189102; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FALK MM, 1990, J VIROL, V64, P748, DOI 10.1128/JVI.64.2.748-756.1990; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Gan Q, 2007, STEM CELLS, V25, P2, DOI 10.1634/stemcells.2006-0383; Giadrossi S, 2007, CURR OPIN GENET DEV, V17, P132, DOI 10.1016/j.gde.2007.02.012; Goulet B, 2004, CELL CYCLE, V3, P986; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Hiwasa T, 1996, CANCER LETT, V99, P87, DOI 10.1016/0304-3835(95)04041-2; Ishidoh K, 1998, BIOCHEM BIOPH RES CO, V252, P202, DOI 10.1006/bbrc.1998.9613; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Loyola A, 2007, TRENDS BIOCHEM SCI, V32, P425, DOI 10.1016/j.tibs.2007.08.004; MASON RW, 1989, BIOCHEM J, V257, P125, DOI 10.1042/bj2570125; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Morin V, 2008, J CELL PHYSIOL, V216, P790, DOI 10.1002/jcp.21459; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Riccio M, 2001, EXP CELL RES, V262, P84, DOI 10.1006/excr.2000.5085; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Taverna SD, 2007, P NATL ACAD SCI USA, V104, P2086, DOI 10.1073/pnas.0610993104; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Vogel JL, 2006, P NATL ACAD SCI USA, V103, P6817, DOI 10.1073/pnas.0602109103; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028	45	252	261	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					284	294		10.1016/j.cell.2008.09.055	http://dx.doi.org/10.1016/j.cell.2008.09.055			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957203	Bronze, Green Accepted			2022-12-28	WOS:000260130400018
J	Hall, MA; Schneider, CE				Hall, Mark A.; Schneider, Carl E.			The professional ethics of billing and collections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hall, Mark A.] Wake Forest Univ, Sch Law, Winston Salem, NC 27109 USA; [Schneider, Carl E.] Univ Michigan, Ann Arbor, MI 48109 USA	Wake Forest University; University of Michigan System; University of Michigan	Hall, MA (corresponding author), Med Ctr Blvd,Worrell Prof Bldg,Room 3314, Winston Salem, NC 27105 USA.	mhall@wfubmc.edu		Hall, Mark A./0000-0001-6277-144X				American Medical Association, 2008, COD MED ETH CURR OP; Asplin BR, 2005, JAMA-J AM MED ASSOC, V294, P1248, DOI 10.1001/jama.294.10.1248; Baker R., 1999, AM MED ETHICS REVOLU; BROWN M, 2002, MED ECON, V79, P67; BROWN M, 2002, MED ECON, V79, P68; Brown Michael D, 2002, Med Econ, V79, P67; CABOT H, 1935, DOCTORS BILL; CATHELL DW, 1882, PHYS HIMSELF GRADUAT; Cunningham Peter J, 2006, Track Rep, P1; Fabre J, 1997, BRIT MED J, V315, P1669, DOI 10.1136/bmj.315.7123.1669; Hajny Tom, 2003, J Med Pract Manage, V19, P32; Hall MA, 2008, MICH LAW REV, V106, P643; Hing Esther, 2006, Adv Data, P1; Snyder L, 2005, ANN INTERN MED, V142, P560, DOI 10.7326/0003-4819-142-7-200504050-00014; Terry Ken, 2008, Med Econ, V85, P26; Terry Ken, 2008, Med Econ, V85, P18; [No title captured]	17	4	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2008	300	15					1806	1808		10.1001/jama.300.15.1806	http://dx.doi.org/10.1001/jama.300.15.1806			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QA	18854542	Green Published			2022-12-28	WOS:000260002000032
J	Gozar, A; Logvenov, G; Kourkoutis, LF; Bollinger, AT; Giannuzzi, LA; Muller, DA; Bozovic, I				Gozar, A.; Logvenov, G.; Kourkoutis, L. Fitting; Bollinger, A. T.; Giannuzzi, L. A.; Muller, D. A.; Bozovic, I.			High-temperature interface superconductivity between metallic and insulating copper oxides	NATURE			English	Article							CRITICAL CURRENT-DENSITY	The realization of high- transition- temperature ( high- T-c) superconductivity confined to nanometre- sized interfaces has been a long- standing goal because of potential applications(1,2) and the opportunity to study quantum phenomena in reduced dimensions(3,4). This has been, however, a challenging target: in conventional metals, the high electron density restricts interface effects ( such as carrier depletion or accumulation) to a region much narrower than the coherence length, which is the scale necessary for superconductivity to occur. By contrast, in copper oxides the carrier density is low whereas T-c is high and the coherence length very short, which provides an opportunity - but at a price: the interface must be atomically perfect. Here we report superconductivity in bilayers consisting of an insulator ( La2CuO4) and a metal ( La1.55Sr0.45CuO4), neither of which is superconducting in isolation. In these bilayers, T-c is either similar to 15 K or similar to 30 K, depending on the layering sequence. This highly robust phenomenon is confined within 2 - 3nm of the interface. If such a bilayer is exposed to ozone, T-c exceeds 50 K, and this enhanced superconductivity is also shown to originate from an interface layer about 1 - 2 unit cells thick. Enhancement of T-c in bilayer systems was observed previously(5) but the essential role of the interface was not recognized at the time.	[Gozar, A.; Logvenov, G.; Bollinger, A. T.; Bozovic, I.] Brookhaven Natl Lab, Upton, NY 11973 USA; [Kourkoutis, L. Fitting; Muller, D. A.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Giannuzzi, L. A.] FEI Co, Hillsboro, OR 97124 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Cornell University; Thermo Fisher Scientific; FEI Company	Bozovic, I (corresponding author), Brookhaven Natl Lab, Upton, NY 11973 USA.	bozovic@bnl.gov	Muller, David/A-7745-2010; Kourkoutis, Lena/B-4229-2010	Muller, David/0000-0003-4129-0473; Kourkoutis, Lena/0000-0002-1303-1362	US DOE; ONR EMMA MURI; Cornell Center for Materials Research; Applied Materials	US DOE(United States Department of Energy (DOE)); ONR EMMA MURI(MURI); Cornell Center for Materials Research; Applied Materials	The work at BNL was supported by US DOE. L. F. K. and D. A. M. acknowledge support under the ONR EMMA MURI and by the Cornell Center for Materials Research. L. F. K. acknowledges financial support by Applied Materials.	Ahn CH, 1999, SCIENCE, V284, P1152, DOI 10.1126/science.284.5417.1152; Ahn CH, 2003, NATURE, V424, P1015, DOI 10.1038/nature01878; BEREZINSKII VL, 1972, SOV PHYS JETP-USSR, V34, P610; Bozovic I, 2003, NATURE, V422, P873, DOI 10.1038/nature01544; Bozovic I, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.107001; BOZOVIC I, 1994, PHYSICA C, V235, P178, DOI 10.1016/0921-4534(94)91342-0; Bozovic I, 2001, IEEE T APPL SUPERCON, V11, P2686, DOI 10.1109/77.919617; CHEN CT, 1991, PHYS REV LETT, V66, P104, DOI 10.1103/PhysRevLett.66.104; CLAASSEN JH, 1991, REV SCI INSTRUM, V62, P996, DOI 10.1063/1.1141991; CLEM JR, 1992, PHYS REV B, V46, P14662, DOI 10.1103/PhysRevB.46.14662; DEVRIES JWC, 1989, PHYSICA C, V157, P406, DOI 10.1016/0921-4534(89)90264-5; Fogel NY, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.161306; Fujita K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.097006; GINZBURG VL, 1964, PHYS LETT, V13, P101, DOI 10.1016/0031-9163(64)90672-9; Gozar A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.201402; HEBARD AF, 1980, PHYS REV LETT, V44, P291, DOI 10.1103/PhysRevLett.44.291; Ino A, 1997, PHYS REV LETT, V79, P2101, DOI 10.1103/PhysRevLett.79.2101; JENSEN HJ, 1991, PHYS REV LETT, V66, P1630, DOI 10.1103/PhysRevLett.66.1630; Kastner MA, 1998, REV MOD PHYS, V70, P897, DOI 10.1103/RevModPhys.70.897; Kivelson SA, 2002, PHYSICA B, V318, P61, DOI 10.1016/S0921-4526(02)00775-5; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; Locquet JP, 1998, NATURE, V394, P453, DOI 10.1038/28810; Reyren N, 2007, SCIENCE, V317, P1196, DOI 10.1126/science.1146006; ROMBERG H, 1990, PHYS REV B, V42, P8768, DOI 10.1103/PhysRevB.42.8768; SEGUCHI Y, 1992, J PHYS SOC JPN, V61, P1875, DOI 10.1143/JPSJ.61.1875; SMADICI S, 2008, HOLE DELOCALIZATION	27	388	399	3	288	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2008	455	7214					782	785		10.1038/nature07293	http://dx.doi.org/10.1038/nature07293			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18843365	Green Submitted			2022-12-28	WOS:000259854900043
J	Tashkin, DP; Celli, B; Senn, S; Burkhart, D; Kesten, S; Menjoge, S; Decramer, M				Tashkin, Donald P.; Celli, Bartolome; Senn, Stephen; Burkhart, Deborah; Kesten, Steven; Menjoge, Shailendra; Decramer, Marc		UPLIFT Study Investigators	A 4-year trial of tiotropium in chronic obstructive pulmonary disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INHALED ANTICHOLINERGIC BRONCHODILATOR; ONCE-DAILY TIOTROPIUM; HEALTH OUTCOMES; COPD; DECLINE; EXACERBATIONS; ISOLDE	Background: Previous studies showing that tiotropium improves multiple end points in patients with chronic obstructive pulmonary disease (COPD) led us to examine the long-term effects of tiotropium therapy. Methods: In this randomized, double-blind trial, we compared 4 years of therapy with either tiotropium or placebo in patients with COPD who were permitted to use all respiratory medications except inhaled anticholinergic drugs. The patients were at least 40 years of age, with a forced expiratory volume in 1 second (FEV1) of 70% or less after bronchodilation and a ratio of FEV1 to forced vital capacity (FVC) of 70% or less. Coprimary end points were the rate of decline in the mean FEV1 before and after bronchodilation beginning on day 30. Secondary end points included measures of FVC, changes in response on St. George's Respiratory Questionnaire (SGRQ), exacerbations of COPD, and mortality. Results: Of a total of 5993 patients (mean age, 65+/-8 years) with a mean FEV1 of 1.32+/-0.44 liters after bronchodilation (48% of predicted value), we randomly assigned 2987 to the tiotropium group and 3006 to the placebo group. Mean absolute improvements in FEV1 in the tiotropium group were maintained throughout the trial (ranging from 87 to 103 ml before bronchodilation and from 47 to 65 ml after bronchodilation), as compared with the placebo group (P<0.001). After day 30, the differences between the two groups in the rate of decline in the mean FEV1 before and after bronchodilation were not significant. The mean absolute total score on the SGRQ was improved (lower) in the tiotropium group, as compared with the placebo group, at each time point throughout the 4-year period (ranging from 2.3 to 3.3 units, P<0.001). At 4 years and 30 days, tiotropium was associated with a reduction in the risks of exacerbations, related hospitalizations, and respiratory failure. Conclusions: In patients with COPD, therapy with tiotropium was associated with improvements in lung function, quality of life, and exacerbations during a 4-year period but did not significantly reduce the rate of decline in FEV1. (ClinicalTrials.gov number, NCT00144339.).	[Tashkin, Donald P.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Celli, Bartolome] Caritas St Elizabeths Med Ctr, Boston, MA USA; [Senn, Stephen] Univ Glasgow, Glasgow, Lanark, Scotland; [Burkhart, Deborah; Kesten, Steven; Menjoge, Shailendra] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Decramer, Marc] Katholieke Univ Leuven, Louvain, Belgium	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; St. Elizabeth's Medical Center; University of Glasgow; Boehringer Ingelheim; KU Leuven	Tashkin, DP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	dtashkin@mednet.ucla.edu	Cukier, Alberto/C-6101-2012; Senn, Stephen J/A-8101-2008; Senn, Stephen/B-2903-2013	Cukier, Alberto/0000-0002-7217-9498; Senn, Stephen/0000-0002-7558-8473; PAPI, ALBERTO/0000-0002-6924-4500; Rodriguez Gonzalez-Moro, Jose Miguel/0000-0002-8446-3373; Kesten, Steven/0000-0002-5522-7910; burghuber, otto/0000-0002-8419-621X; Jose L, Izquierdo Alonso/0000-0002-1671-2243; Epton, Michael/0000-0003-4644-366X; Costello, Richard/0000-0003-1179-6692; Driesen, Peter/0000-0002-8509-8750; Pothirat, Chaicharn/0000-0003-0616-7066; Peters, Matthew/0000-0002-9649-8741; Kuschner, Ware/0000-0002-9732-1366; Chlumsky, Jan/0000-0002-8975-5842	Boehringer Ingelheim and Pfizer; AstraZeneca; Dey Laboratories; Schering; Almirall; GlaxoSmithKline; Ivax; MediciNova; Nabi Biopharmaceuticals; Novartis; Pfizer; Sepracor; Forrest; Bayer; Chiesi; Eisai; INOT; Servier; Takeda; Amgen; Alcon; Unilever	Boehringer Ingelheim and Pfizer(Boehringer Ingelheim); AstraZeneca(AstraZeneca); Dey Laboratories; Schering; Almirall(Almirall); GlaxoSmithKline(GlaxoSmithKline); Ivax; MediciNova; Nabi Biopharmaceuticals; Novartis(Novartis); Pfizer(Pfizer); Sepracor; Forrest; Bayer(Bayer AG); Chiesi(Chiesi Pharmaceuticals Inc); Eisai(Eisai Co Ltd); INOT; Servier(Servier); Takeda(Takeda Pharmaceutical Company Ltd); Amgen(Amgen); Alcon(Novartis); Unilever(Unilever)	Supported by Boehringer Ingelheim and Pfizer.; Dr. Tashkin reports receiving consulting fees from AstraZeneca, Boehringer Ingelheim, Dey Laboratories, and Schering, lecture fees from AstraZeneca, Boehringer Ingelheim, and Dey Laboratories, and grant support from Almirall, AstraZeneca, Boehringer Ingelheim, Dey Laboratories, GlaxoSmithKline, Ivax, MediciNova, Nabi Biopharmaceuticals, Novartis, Pfizer, and Sepracor; Dr. Celli, receiving consulting fees from Almirall, AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline, lecture fees from Almirall, AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline, and grant support from Boehringer Ingelheim, Forrest, and GlaxoSmithKline; Dr. Senn, receiving consulting fees from Bayer, Boehringer Ingelheim, Chiesi, Eisai, GlaxoSmithKline, INOT, Novartis, Pfizer, Servier, and Takeda, lecture fees from Amgen, Alcon, and Unilever, and grant support from Boehringer Ingelheim, Chiesi, GlaxoSmithKline, and Novartis, having an equity interest in Novartis, and serving as an expert witness for GlaxoSmithKline; Ms. Burkhart, Dr. Kesten, and Dr. Menjoge, being employees of Boehringer Ingelheim; and Dr. Decramer, receiving consulting fees from Boehringer Ingelheim, Pfizer, GlaxoSmithKline, and Nycomed, lecture fees from Boehringer Ingelheim and Pfizer, and grant support from AstraZeneca. No other potential conflict of interest relevant to this article was reported.; We thank the UPLIFT trial team and clinical monitors; Dr. Dacheng Liu and Dr. Inge Leimer of Boehringer Ingelheim for their statistical support; Terry Keyser (funded by Boehringer Ingelheim) for editorial and technical support in the preparation of this manuscript; and Dr. Romain Pauwels, who contributed to the design of the study and was a key member of the UPLIFT Joint Advisory Committee before his death in 2005.	Altose MD, 2000, NEW ENGL J MED, V343, P1902; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Anzueto A, 2005, PULM PHARMACOL THER, V18, P75, DOI 10.1016/j.pupt.2004.10.003; Brusasco V, 2003, THORAX, V58, P399, DOI 10.1136/thorax.58.5.399; Brusasco V, 2005, THORAX, V60, P105; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley PMA, 2003, CHEST, V124, P1350, DOI 10.1378/chest.124.4.1350; Casaburi R, 2002, EUR RESPIR J, V19, P217, DOI 10.1183/09031936.02.00269802; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Decramer M, 2005, LANCET, V366, P984; Decramer M, 2005, LANCET, V365, P1552, DOI 10.1016/S0140-6736(05)66456-2; Decramer Marc, 2004, COPD, V1, P303, DOI 10.1081/COPD-200026934; Global Initiative for Chronic Obstructive Lung Disease, 2001, GLOB STRAT DIAGN MAN; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Kesten S, 2007, EUR RESPIR J, V30, P898, DOI 10.1183/09031936.00104606; Kesten S, 2006, CHEST, V130, P1695, DOI 10.1378/chest.130.6.1695; Maltais F, 2005, CHEST, V128, P1168, DOI 10.1378/chest.128.3.1168; Niewoehner DE, 2005, ANN INTERN MED, V143, P317, DOI 10.7326/0003-4819-143-5-200509060-00007; O'Donnell DE, 2004, EUR RESPIR J, V23, P832, DOI 10.1183/09031936.04.00116004; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; QUANJER PH, 1983, B EUR PHYSIOPATH RES, V19, P1; Soriano JB, 2007, CHEST, V131, P682, DOI 10.1378/chest.06-1696; Suissa S, 2006, AM J RESP CRIT CARE, V173, P842, DOI 10.1164/rccm.200508-1338PP; Tashkin DP, 2008, EUR RESPIR J, V31, P742, DOI 10.1183/09031936.00129607; Vincken W, 2002, EUR RESPIR J, V19, P209, DOI 10.1183/09031936.02.00238702	27	1609	1695	0	105	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2008	359	15					1543	1554		10.1056/NEJMoa0805800	http://dx.doi.org/10.1056/NEJMoa0805800			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FS	18836213				2022-12-28	WOS:000259903100003
J	Henkind, SJ; Sinnett, JC				Henkind, Steven J.; Sinnett, J. Christopher			Patient care, square-rigger sailing, and safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TEAMWORK		[Henkind, Steven J.] CCI Grp, Larchmont, NY 10538 USA; [Sinnett, J. Christopher] US Coast Guard, US Coast Guard Barque Eagle, New London, CT USA		Henkind, SJ (corresponding author), CCI Grp, 7 S Ridge Rd, Larchmont, NY 10538 USA.	sjh37@verizon.net						Auerbach AD, 2007, NEW ENGL J MED, V357, P608, DOI 10.1056/NEJMsb070738; Baker DP, 2005, JT COMM J QUAL PATIE, V31, P185, DOI 10.1016/S1553-7250(05)31025-7; Gawande Atul, 2007, New Yorker, P86; Grogan EL, 2004, J AM COLL SURGEONS, V199, P843, DOI 10.1016/j.jamcollsurg.2004.08.021; *HLTH SAF EX, 1996, PUBL OTO; *JCAHO, 2006, JT PERSPECTIVES PATI, V6, P9; Kohn L.T., 2000, TO ERR IS HUMAN BUIL; Morey JC, 2002, HEALTH SERV RES, V37, P1553, DOI 10.1111/1475-6773.01104; National Institute for Occupational Safety and Health, 2004, NIOSH PUBL, V2004-146; Okie S, 2007, NEW ENGL J MED, V356, P2665, DOI 10.1056/NEJMp078085; Petersen L A, 1998, Jt Comm J Qual Improv, V24, P77; Pizzi L, 2001, AHRQ PUBLICATION; Salas E, 2001, HUM FACTORS, V43, P641, DOI 10.1518/001872001775870386; *US COAST GUARD, 1998, USCG PUBL; Winters BD, 2006, JAMA-J AM MED ASSOC, V296, P1645, DOI 10.1001/jama.296.13.1645	15	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2008	300	14					1691	1693		10.1001/jama.300.14.1691	http://dx.doi.org/10.1001/jama.300.14.1691			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	356YF	18840843				2022-12-28	WOS:000259812800031
J	Eckart, RE; Field, ME; Hruczkowski, TW; Forman, DE; Dorbala, S; Di Carli, MF; Albert, CE; Malsel, WH; Epstein, LM; Stevenson, WG				Eckart, Robert E.; Field, Michael E.; Hruczkowski, Tomasz W.; Forman, Daniel E.; Dorbala, Sharmila; Di Carli, Marcelo F.; Albert, Christine E.; Malsel, William H.; Epstein, Laurence M.; Stevenson, William G.			Association of electrocardiographic morphology of exercise-induced ventricular arrhythmia with mortality	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; OUTFLOW TRACT TACHYCARDIA; PROGNOSTIC VALUE; BRUGADA-SYNDROME; 12-LEAD ELECTROCARDIOGRAM; FRAGMENTED-QRS; HEART; PREDICTOR; ORIGIN; SCORE	Background: The prognostic importance of exercise-induced ventricular arrhythmia (EIVA) may be confounded by the presence of lower-risk idiopathic right ventricular outflow tract arrhythmias with left bundle-branch block (LBBB) morphology. Objective: To determine whether right bundle-branch block (RBBB)-morphology EIVA was associated with increased mortality. Design: Retrospective cohort. Setting: Academic medical center. Patients: 585 unique patients with EIVA and 2340 patients without EIVA, matched by age, sex, and risk factor, who were referred for exercise testing in an academic medical center. Measurements: Deaths and ischemia and infarction found on perfusion scan. Results: During a mean follow-up of 24 months (SD, 13), 31 deaths occurred in the EIVA group compared with 43 deaths in the group without EIVA (5.3% vs. 1.8%; P < 0.001). Worse survival in patients with RBBB-morphology or multiple-morphology EIVA (6.9%) than in patients without EIVA caused this difference. Patients with LBBB-morphology EIVAs had a mortality rate (2.5%) similar to that of patients without EIVA (P = 0.93, log-rank test). Among patients without known atherosclerotic coronary artery disease, any RBBB-morphology EIVA was associated with death (hazard ratio, 2.73 [95% CI, 1.78 to 4.13]; P < 0.001), but LBBB-morphology EIVA was not (hazard ratio, 0.82 [CI, 0.18 to 2.04]; P = 0.72). Limitations: Not all LBBB-morphology EIVA can be dismissed, and not all RBBB-morphology EIVA is high risk. Further evaluation of patients for structural heart disease was clinically driven, not protocol-driven. Conclusion: Right bundle-branch block-or multiple-morphology EIVA is associated with increased mortality. Inclusion of patients with isolated LBBB-morphology EIVA, which often is idiopathic, may contribute to differences in the prognostic importance of EIVA in previous studies.	[Eckart, Robert E.] Brooke Army Med Ctr, Arrhythmia Serv ATTN MCHE MDC, San Antonio, TX 78234 USA; Brigham & Womens Hosp, Boston Vet Adm Med Ctr, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Univ Alberta, Edmonton, AB, Canada	San Antonio Military Medical Center; United States Department of Defense; United States Army; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; University of Alberta	Eckart, RE (corresponding author), Brooke Army Med Ctr, Arrhythmia Serv ATTN MCHE MDC, 3851 Roger Brooke Dr, San Antonio, TX 78234 USA.	robert.eckart@us.army.mil	Epstein, Laurence/AAQ-7571-2021; Epstein, Laurence/ABB-1592-2020	Epstein, Laurence/0000-0001-5410-0291; Albert, Christine/0000-0002-2081-1121	Medtronic; Boston Scientific; Biosense Webster	Medtronic(Medtronic); Boston Scientific(Boston Scientific); Biosense Webster	Honoraria: L. M. Epstein (Medtronic, Boston Scientific, St. Jude). Grants received: L. M. Epstein (Medtronic, Boston Scientific, Biosense Webster).	Bala R, 2007, HEART RHYTHM, V4, P366, DOI 10.1016/j.hrthm.2006.11.012; CALIFF RM, 1983, J AM COLL CARDIOL, V2, P1060, DOI 10.1016/S0735-1097(83)80330-1; Cerqueira MD, 2002, J NUCL CARDIOL, V9, P240, DOI 10.1067/mnc.2002.123122; Coronel R, 2005, CIRCULATION, V112, P2769, DOI 10.1161/CIRCULATIONAHA.105.532614; Das MK, 2006, CIRCULATION, V113, P2495, DOI 10.1161/CIRCULATIONAHA.105.595892; Das MK, 2007, HEART RHYTHM, V4, P1385, DOI 10.1016/j.hrthm.2007.06.024; Dixit S, 2003, J CARDIOVASC ELECTR, V14, P1, DOI 10.1046/j.1540-8167.2003.02404.x; FLEG JL, 1984, AM J CARDIOL, V54, P762, DOI 10.1016/S0002-9149(84)80204-0; Frolkis JP, 2003, NEW ENGL J MED, V348, P781, DOI 10.1056/NEJMoa022353; GOY JJ, 1990, PACE, V13, P1142, DOI 10.1111/j.1540-8159.1990.tb02172.x; Hayashi M, 2008, J AM COLL CARDIOL, V51, P1162, DOI 10.1016/j.jacc.2007.11.050; Iwai S, 2006, J CARDIOVASC ELECTR, V17, P1052, DOI 10.1111/j.1540-8167.2006.00539.x; JADONATH RL, 1995, AM HEART J, V130, P1107, DOI 10.1016/0002-8703(95)90215-5; Josephson ME, 2005, HEART RHYTHM, V2, P443, DOI 10.1016/j.hrthm.2004.12.014; Jouven X, 2000, NEW ENGL J MED, V343, P826, DOI 10.1056/NEJM200009213431201; Kang XP, 2006, J AM COLL CARDIOL, V47, P1418, DOI 10.1016/j.jacc.2005.11.062; Kim RJ, 2007, J AM COLL CARDIOL, V49, P2035, DOI 10.1016/j.jacc.2007.01.085; Kwok JMF, 1999, JAMA-J AM MED ASSOC, V282, P1047, DOI 10.1001/jama.282.11.1047; Marchlinski FE, 2000, AM HEART J, V139, P1009, DOI 10.1067/mhj.2000.106164; MARIEB MA, 1990, AM J CARDIOL, V66, P172, DOI 10.1016/0002-9149(90)90583-M; MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204; MONT L, 1991, AM J CARDIOL, V68, P897, DOI 10.1016/0002-9149(91)90405-A; Morita H, 2003, J CARDIOVASC ELECTR, V14, P373, DOI 10.1046/j.1540-8167.2003.02365.x; Morshedi-Meibodi A, 2004, CIRCULATION, V109, P2417, DOI 10.1161/01.CIR.0000129762.41889.41; Nasir K, 2004, CIRCULATION, V110, P1527, DOI 10.1161/01.CIR.0000142293.60725.18; Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392; O'Neill JO, 2004, J AM COLL CARDIOL, V44, P820, DOI 10.1016/j.jacc.2004.02.063; OHARA GE, 1992, AM J CARDIOL, V70, P875, DOI 10.1016/0002-9149(92)90730-M; Ohkubo K, 2007, CIRC J, V71, P1258, DOI 10.1253/circj.71.1258; Tanner H, 2005, J AM COLL CARDIOL, V45, P418, DOI 10.1016/j.jacc.2004.10.037; Zweytick B, 2004, EUROPACE, V6, P123, DOI 10.1016/j.eupc.2003.11.010	31	21	23	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2008	149	7					451	W82		10.7326/0003-4819-149-7-200810070-00005	http://dx.doi.org/10.7326/0003-4819-149-7-200810070-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QY	18838725				2022-12-28	WOS:000260004400002
J	Verhovsek, M; Douketis, JD; Yi, QL; Shrivastava, S; Tait, RC; Baglin, T; Poli, D; Lim, W				Verhovsek, Madeleine; Douketis, James D.; Yi, Qilong; Shrivastava, Sanjay; Tait, R. Campbell; Baglin, Trevor; Poli, Daniela; Lim, Wendy			Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; ORAL ANTICOAGULANT; 1ST EPISODE; PLASMA COAGULATION; PULMONARY-EMBOLISM; BLOOD-COAGULATION; RISK-FACTORS; DOUBLE-BLIND; WITHDRAWAL; ACTIVATION	Background: The optimal duration of anticoagulation for a first episode of unprovoked venous thromboembolism (VTE) is uncertain. Methods for predicting risk for recurrence may identify lowrisk patients who are less likely to benefit from prolonged anticoagulation. Purpose: To synthesize evidence evaluating the value of D-dimer as a predictor of recurrent disease in patients who have stopped anticoagulant therapy after a first unprovoked VTE. Data Sources: The MEDLINE, EMBASE, CINAHL, and Cochrane databases were searched until March 2008 without language restrictions. The strategy was supplemented with manual review of reference lists and contact with content experts. Study Selection: Randomized, controlled trials or prospective cohort studies that measured D-dimer after anticoagulant therapy in patients who received at least 3 months of anticoagulant treatment of unprovoked VTE. Data Extraction: Two authors independently reviewed articles and extracted data. Data Synthesis: Seven studies, totaling 1888 patients with a first unprovoked VTE, were eligible for analysis. During 4500 personyears of follow up, annual rates of recurrent VTE differed statistically significantly: 8.9% (95% CI, 5.8% to 11.9%) in patients with positive D-dimer results and 3.5% (CI, 2.7% to 4.3%) in patients with negative D-dimer results. Limitation: The duration of anticoagulation, timing of D-dimer testing, and D-dimer assay varied across studies. Conclusion: In patients who have completed at least 3 months of anticoagulation for a first episode of unprovoked VTE and after approximately 2 years of follow-up, a negative D-dimer result was associated with a 3.5% annual risk for recurrent disease, whereas a positive D-dimer result was associated with an 8.9% annual risk for recurrence. These rates should inform decisions about the balance of risks and benefits of prolonging anticoagulation.	[Douketis, James D.] St Josephs Hosp, Hamilton, ON L8N 4A6, Canada; McMaster Univ, Hamilton, ON, Canada; Univ Ottawa, Community Med, Ottawa, ON K1N 6N5, Canada; Brigham & Womens Hosp, Harvard Vanguard Med Associates, Boston, MA 02115 USA; Royal Infirm, Glasgow G31 2ER, Lanark, Scotland; Addenbrookes Hosp, Cambridge, England; Univ Careggi, Azienda Osped, Ctr Riferimento Reg Trombosi, Florence, Italy	McGill University; McMaster University; McMaster University; University of Ottawa; Harvard University; Brigham & Women's Hospital; Harvard Vanguard Medical Associates; Royal Infirmary of Edinburgh; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Florence; Azienda Ospedaliero Universitaria Careggi	Douketis, JD (corresponding author), St Josephs Hosp, Room F-544,50 Charlton Ave E, Hamilton, ON L8N 4A6, Canada.	jdouket@mcmaster.ca	Tait, Campbell/AFQ-8204-2022; Tait, Robert/AAC-6541-2022; Douketis, James/AAO-5659-2021	Tait, Campbell/0000-0003-4842-6783; Tait, Robert/0000-0003-4842-6783; Verhovsek, Madeleine/0000-0002-5022-9765				Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Aguilar C, 2005, BRIT J HAEMATOL, V130, P803, DOI 10.1111/j.1365-2141.2005.05686.x; Andreescu ACM, 2002, THROMB HAEMOSTASIS, V87, P47, DOI 10.1055/s-0037-1612942; Arcelus JI, 2003, J VASC SURG, V38, P916, DOI 10.1016/S0741-5214(03)00789-4; Baglin T, 2008, J THROMB HAEMOST, V6, P577, DOI 10.1111/j.1538-7836.2008.02889.x; Baglin T, 2007, J THROMB HAEMOST, V5, P2336, DOI 10.1111/j.1538-7836.2007.02771.x; Baglin T, 2004, J THROMB HAEMOST, V2, P2152, DOI 10.1111/j.1538-7836.2004.01050.x; Baglin T, 2003, LANCET, V362, P523, DOI 10.1016/S0140-6736(03)14111-6; Beyth RJ, 1998, AM J MED, V105, P91, DOI 10.1016/S0002-9343(98)00198-3; Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; Christiansen SC, 2005, JAMA-J AM MED ASSOC, V293, P2352, DOI 10.1001/jama.293.19.2352; Cosmi B, 2005, THROMB HAEMOSTASIS, V94, P969; Cosmi B, 2005, HAEMATOLOGICA, V90, P713; Cushman M, 2003, BLOOD, V101, P1243, DOI 10.1182/blood-2002-05-1416; de Groot M R, 2000, Clin Lab, V46, P575; de Raucourt E, 2000, BLOOD COAGUL FIBRIN, V11, P249; Eichinger S, 2003, JAMA-J AM MED ASSOC, V290, P1071, DOI 10.1001/jama.290.8.1071; Fattorini A, 2002, THROMB HAEMOSTASIS, V88, P162; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Ho WK, 2006, ARCH INTERN MED, V166, P729, DOI 10.1001/archinte.166.7.729; Hoibraaten E, 2001, THROMB HAEMOSTASIS, V85, P775; Hoke M, 2004, THROMB HAEMOSTASIS, V91, P935, DOI 10.1160/TH03-11-0719; Kearon C, 2007, J THROMB HAEMOST, V5, P2330, DOI 10.1111/j.1538-7836.2007.02761.x; Kevorkian JP, 1998, LANCET, V351, P571, DOI 10.1016/S0140-6736(05)78559-7; Kovacs MJ, 2007, J THROMB HAEMOST, V5, P1650, DOI 10.1111/j.1538-7836.2007.02613.x; Krieger E, 2004, J VASC SURG, V40, P644, DOI 10.1016/j.jvs.2004.07.004; Kuruvilla J, 2003, THROMB HAEMOSTASIS, V89, P284, DOI 10.1055/s-0037-1613444; Kyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959; Legnani C, 2006, BRIT J HAEMATOL, V134, P227, DOI 10.1111/j.1365-2141.2006.06130.x; Mcrae S, 2006, LANCET, V368, P371, DOI 10.1016/S0140-6736(06)69110-1; Meissner MH, 2000, J VASC SURG, V32, P870, DOI 10.1067/mva.2000.110359; Ombandza-Moussa E, 2003, INT ANGIOL, V22, P364; Ombandza-Moussa E, 2001, ANN BIOL CLIN-PARIS, V59, P579; Palareti G, 1998, Minerva Cardioangiol, V46, P374; Palareti G, 2005, J THROMB HAEMOST, V3, P955, DOI 10.1111/j.1538-7836.2005.01330.x; PALARETI G, 1994, THROMB HAEMOSTASIS, V72, P222; Palareti G, 2003, CIRCULATION, V108, P313, DOI 10.1161/01.CIR.0000079162.69615.0F; Palareti G, 2002, THROMB HAEMOSTASIS, V87, P7; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Poli D, 2008, J THROMB HAEMOST, V6, P708, DOI 10.1111/j.1538-7836.2008.02900.x; Poli D, 2005, TRANSPLANTATION, V80, P789, DOI 10.1097/01.TP.0000174168.00730.B4; Prandoni P, 2002, ANN INTERN MED, V137, P955, DOI 10.7326/0003-4819-137-12-200212170-00008; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Romero JMC, 2004, MED CLIN-BARCELONA, V123, P635, DOI 10.1016/S0025-7753(04)74624-2; Sallah S, 2004, CLIN CANCER RES, V10, P7238, DOI 10.1158/1078-0432.CCR-04-0445; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Shrivastava S, 2006, J THROMB HAEMOST, V4, P1208, DOI 10.1111/j.1538-7836.2006.01935.x; SIE P, 1994, THROMB HAEMOSTASIS, V72, P161; Snow V, 2007, ANN INTERN MED, V146, P204, DOI 10.7326/0003-4819-146-3-200702060-00149; Stain M, 2005, J THROMB HAEMOST, V3, P2671, DOI 10.1111/j.1538-7836.2005.01648.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tait R, 2007, J THROMB HAEMOST, V5, P060; Tardy B, 1997, BRIT J HAEMATOL, V96, P174, DOI 10.1046/j.1365-2141.1997.8752506.x; Wells G., 2000, NEWCASTLEOTTAWA SCAL; Young L, 2005, J THROMB HAEMOST S1, V3, P365	56	194	208	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2008	149	7					481	W94		10.7326/0003-4819-149-7-200810070-00008	http://dx.doi.org/10.7326/0003-4819-149-7-200810070-00008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QY	18838728				2022-12-28	WOS:000260004400005
J	Wu, XY; Kodama, A; Fuchs, E				Wu, Xiaoyang; Kodama, Atsuko; Fuchs, Elaine			ACF7 regulates cytoskeletal-focal adhesion dynamics and migration and has ATPase activity	CELL			English	Article							MICROTUBULE PLUS-END; LINKING FACTOR MACF; CELL-MIGRATION; STRESS FIBERS; MOTILE CELLS; ACTIN; KINASE; PROTEINS; PROMOTES; SPECTRAPLAKINS	Coordinated interactions between microtubule (MT) and actin cytoskeletons are involved in many polarized cellular processes. Spectraplakins are enormous (>500 kDa) proteins able to bind both MTs and actin filaments (F-actin) directly. To elucidate the physiological significance and functions of mammalian spectraplakin ACF7, we've conditionally targeted it in skin epidermis. Intriguingly, ACF7 deficiency compromises the targeting of microtubules along F-actin to focal adhesions (FAs), stabilizes FA-actin networks, and impairs epidermal migration. Exploring underlying mechanisms, we show that ACF7's binding domains for F-actin, MTs, and MT plus-end proteins are not sufficient to rescue the defects in FA-cytoskeletal dynamics and migration functions of ACF7 null keratinocytes. We've uncovered an intrinsic actin-regulated ATPase domain in ACF7 and demonstrate that it is both functional and essential for these roles. Our findings provide insight into the functions of this important cytoskeletal crosslinking protein in regulating dynamic interactions between MTs and F-actin to sustain directional cell movement.	[Wu, Xiaoyang; Kodama, Atsuko; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Wu, Xiaoyang; Kodama, Atsuko; Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016		National Institutes of Health [R01-AR27883]; American Association for Cancer Research; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for Cancer Research; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to Markus Schober, Mirna Perez-Moreno, Ellen Ezratty, and Michael Hack for discussion and helpful comments and to Ellen Wong, Maria Nikolova, June Racelis, Alison North, and Shivaprasad Bhuvanendran for their technical advice and assistance. We also thank William Earnshaw at University of Edinburgh for sharing reagents. The animal studies were performed with expert assistance from Lisa Polak and Nicole Stokes and were carried out in the Animal Lovers Against Animal Cruelty (ALAAC)-accredited LARC animal research facility at the Rockefeller University. This work was supported by a grant R01-AR27883 from the National Institutes of Health. E.F. is an investigator of the Howard Hughes Medical Institute. X.W. was an Anna D. Barker Fellow in Basic Cancer Research funded by the American Association for Cancer Research and is currently a postdoctoral fellow of the Jane Coffin Childs Memorial Fund for Medical Research.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Bernier G, 2000, DEV DYNAM, V219, P216, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1041>3.0.CO;2-O; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Bosher JM, 2003, J CELL BIOL, V161, P757, DOI 10.1083/jcb.200302151; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; Endlich N, 2007, CELL MOTIL CYTOSKEL, V64, P966, DOI 10.1002/cm.20237; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Fuchs E, 1999, CELL, V98, P547, DOI 10.1016/S0092-8674(00)80041-0; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Gupton SL, 2002, CURR BIOL, V12, P1891, DOI 10.1016/S0960-9822(02)01276-9; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kodama A, 2004, J CELL BIOL, V167, P203, DOI 10.1083/jcb.200408047; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Kogan Ilana, 2002, Methods Mol Med, V70, P143; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; Kusch J, 2003, TRENDS CELL BIOL, V13, P562, DOI 10.1016/j.tcb.2003.09.008; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Liu BP, 1998, CELL ADHES COMMUN, V5, P249, DOI 10.3109/15419069809040295; MIKHAILOV AV, 1995, CELL MOTIL CYTOSKEL, V32, P173, DOI 10.1002/cm.970320303; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Palazzo Alexander F, 2002, Sci STKE, V2002, ppe31, DOI 10.1126/stke.2002.139.pe31; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Roper K, 2002, J CELL SCI, V115, P4215, DOI 10.1242/jcs.00157; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Subramanian A, 2003, CURR BIOL, V13, P1086, DOI 10.1016/S0960-9822(03)00416-0; Sun DM, 2001, J CELL SCI, V114, P161; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wu XF, 2006, TRENDS CELL BIOL, V16, P135, DOI 10.1016/j.tcb.2006.01.004; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200; Yang YM, 1999, CELL, V98, P229, DOI 10.1016/S0092-8674(00)81017-X; Yarm F, 2001, CURR OPIN MICROBIOL, V4, P696, DOI 10.1016/S1369-5274(01)00271-5; Yvon AMC, 2000, J CELL BIOL, V151, P1003, DOI 10.1083/jcb.151.5.1003	56	211	223	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 3	2008	135	1					137	148		10.1016/j.cell.2008.07.045	http://dx.doi.org/10.1016/j.cell.2008.07.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854161	Bronze, Green Accepted			2022-12-28	WOS:000259728100015
J	Yang, L; Hotamisligil, GS				Yang, Ling; Hotamisligil, Gokhan S.			Stressing the brain, fattening the body	CELL			English	Editorial Material							INFLAMMATION	Obesity is characterized by chronic activation of inflammatory pathways in peripheral tissues. In this issue, Zhang et al. (2008) demonstrate that inflammation also occurs in the central nervous system where it disrupts activity of the hypothalamus leading to resistance to leptin that is mediated by activation of IKK and the endoplasmic reticulum stress response.	[Yang, Ling; Hotamisligil, Gokhan S.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Yang, Ling/C-8000-2011	Yang, Ling/0000-0002-3105-3063				Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; HOSOI T, 2008, MOL PHARM       0828; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]	7	21	22	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					20	22		10.1016/j.cell.2008.09.030	http://dx.doi.org/10.1016/j.cell.2008.09.030			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854151	Bronze			2022-12-28	WOS:000259728100005
J	Medzhitov, R; Littman, D				Medzhitov, Ruslan; Littman, Dan			HIV immunology needs a new direction	NATURE			English	Editorial Material									[Medzhitov, Ruslan] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Littman, Dan] NYU, New York, NY 10016 USA	Yale University; New York University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, 300 Cedar St, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu; dan.littman@med.nyu.edu						Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012	3	21	23	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2008	455	7213					591	591		10.1038/455591a	http://dx.doi.org/10.1038/455591a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833256				2022-12-28	WOS:000259639700022
J	Bhat, SB				Bhat, Suneel B.			Ethical coherency when medical students work abroad	LANCET			English	Editorial Material									[Bhat, Suneel B.] Caladrius Inst, Columbia, MD 21044 USA; [Bhat, Suneel B.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Bhat, SB (corresponding author), Caladrius Inst, Columbia, MD 21044 USA.	suneel.bhat@caladrius.org						*ASS AM MED SCH, 2007, MED SCH GRAD QUEST A; Beauchamp TL, 2009, PRINCIPLES BIOMEDICA; Bhat SB, 2006, J MED ETHICS, V32, P535, DOI 10.1136/jme.2005.013516; Shapiro HT, 2001, NEW ENGL J MED, V345, P139, DOI 10.1056/NEJM200107123450212	4	15	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP-OCT	2008	372	9644					1133	1134		10.1016/S0140-6736(08)61461-0	http://dx.doi.org/10.1016/S0140-6736(08)61461-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	355UN	18926263				2022-12-28	WOS:000259734700010
J	Moritz, CT; Perlmutter, SI; Fetz, EE				Moritz, Chet T.; Perlmutter, Steve I.; Fetz, Eberhard E.			Direct control of paralysed muscles by cortical neurons	NATURE			English	Article							MOTOR CORTEX CELLS; INTRASPINAL MICROSTIMULATION; ARM MUSCLES; MOVEMENT; COMPUTER; MONKEYS; NEUROPROSTHESIS; STIMULATION; PROSTHESIS; PLASTICITY	A potential treatment for paralysis resulting from spinal cord injury is to route control signals from the brain around the injury by artificial connections. Such signals could then control electrical stimulation of muscles, thereby restoring volitional movement to paralysed limbs(1-3). In previously separate experiments, activity of motor cortex neurons related to actual or imagined movements has been used to control computer cursors and robotic arms(4-10), and paralysed muscles have been activated by functional electrical stimulation(11-13). Here we show that Macaca nemestrina monkeys can directly control stimulation of muscles using the activity of neurons in the motor cortex, thereby restoring goal-directed movements to a transiently paralysed arm. Moreover, neurons could control functional stimulation equally well regardless of any previous association to movement, a finding that considerably expands the source of control signals for brain- machine interfaces. Monkeys learned to use these artificial connections from cortical cells to muscles to generate bidirectional wrist torques, and controlled multiple neuron - muscle pairs simultaneously. Such direct transforms from cortical activity to muscle stimulation could be implemented by autonomous electronic circuitry, creating a relatively natural neuroprosthesis. These results are the first demonstration that direct artificial connections between cortical cells and muscles can compensate for interrupted physiological pathways and restore volitional control of movement to paralysed limbs.	[Moritz, Chet T.; Perlmutter, Steve I.; Fetz, Eberhard E.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Moritz, Chet T.; Perlmutter, Steve I.; Fetz, Eberhard E.] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Moritz, CT (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	ctmoritz@u.washington.edu		Perlmutter, Steve/0000-0002-1149-4152	National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS051013, R01NS040867, R37NS012542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Shupe for programming assistance, C. Kent and L. Miller for advice on nerve block, C. Kirby, A. Price and K. McElwain for animal care, and A. Jackson, Y. Nishimura and A. Richardson for comments on the manuscript. This work was supported by grants from the National Institutes of Health.	Batschelet E, 1981, CIRCULAR STAT BIOL; BRINKMAN C, 1983, SCIENCE, V220, P438, DOI 10.1126/science.6836289; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Fagg AH, 2007, J NEUROSCI, V27, P11842, DOI 10.1523/JNEUROSCI.3516-07.2007; Fetz EE, 2007, J PHYSIOL-LONDON, V579, P571, DOI 10.1113/jphysiol.2006.127142; FETZ EE, 1973, J NEUROPHYSIOL, V36, P179, DOI 10.1152/jn.1973.36.2.179; FETZ EE, 1975, EXP BRAIN RES, V23, P217; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Jackson A, 2007, J NEUROPHYSIOL, V98, P3109, DOI 10.1152/jn.00569.2007; Jackson A, 2007, J NEUROPHYSIOL, V97, P360, DOI 10.1152/jn.00710.2006; Jackson A, 2006, IEEE T NEUR SYS REH, V14, P187, DOI 10.1109/TNSRE.2006.875547; Jackson A, 2006, NATURE, V444, P56, DOI 10.1038/nature05226; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Kuiken TA, 2004, PROSTHET ORTHOT INT, V28, P245; Lauer RT, 1999, NEUROREPORT, V10, P1767, DOI 10.1097/00001756-199906030-00026; Lemay MA, 2004, J NEUROPHYSIOL, V91, P502, DOI 10.1152/jn.00235.2003; LOEB GE, 1985, J NEUROPHYSIOL, V54, P565, DOI 10.1152/jn.1985.54.3.565; Mavoori J, 2005, J NEUROSCI METH, V148, P71, DOI 10.1016/j.jneumeth.2005.04.017; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Mushahwar VK, 2002, IEEE T NEUR SYS REH, V10, P68, DOI 10.1109/TNSRE.2002.1021588; NANNINI N, 1991, IEEE T BIO-MED ENG, V38, P769, DOI 10.1109/10.83589; Nudo RJ, 1996, J NEUROSCI, V16, P785; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Stein RB, 2002, ARCH ITAL BIOL, V140, P273; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; Tresch MC, 1999, EXP BRAIN RES, V129, P401, DOI 10.1007/s002210050908; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; WOOLSEY CN, 1950, RES PUBL ASSOC RES N, V30, P238	33	392	409	3	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2008	456	7222					639	U63		10.1038/nature07418	http://dx.doi.org/10.1038/nature07418			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18923392	Green Accepted			2022-12-28	WOS:000261340000041
J	Ludvigsson, J; Faresjo, M; Hjorth, M; Axelsson, S; Cheramy, M; Pihl, M; Vaarala, O; Forsander, G; Ivarsson, S; Johansson, C; Lindh, A; Nilsson, NO; Aman, J; Ortqvist, E; Zerhouni, P; Casas, R				Ludvigsson, Johnny; Faresjo, Maria; Hjorth, Maria; Axelsson, Stina; Cheramy, Mikael; Pihl, Mikael; Vaarala, Outi; Forsander, Gun; Ivarsson, Sten; Johansson, Calle; Lindh, Agne; Nilsson, Nils-Osten; Aman, Jan; Ortqvist, Eva; Zerhouni, Peter; Casas, Rosaura			GAD treatment and insulin secretion in recent-onset type 1 diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA-CELL FUNCTION; PROTEIN PEPTIDE DIAPEP277; DOUBLE-BLIND; C-PEPTIDE; CHILDREN; IMMUNOMODULATION; NICOTINAMIDE; RESPONSES; TRIAL	Background: The 65-kD isoform of glutamic acid decarboxylase (GAD) is a major autoantigen in patients with type 1 diabetes mellitus. This trial assessed the ability of alum-formulated GAD (GAD-alum) to reverse recent-onset type 1 diabetes in patients 10 to 18 years of age. Methods: We randomly assigned 70 patients with type 1 diabetes who had fasting C-peptide levels above 0.1 nmol per liter (0.3 ng per milliliter) and GAD autoantibodies, recruited within 18 months after receiving the diagnosis of diabetes, to receive subcutaneous injections of 20 microg of GAD-alum (35 patients) or placebo (alum alone, 35 patients) on study days 1 and 30. At day 1 and months 3, 9, 15, 21, and 30, patients underwent a mixed-meal tolerance test to stimulate residual insulin secretion (measured as the C-peptide level). The effect of GAD-alum on the immune system was also studied. Results: Insulin secretion gradually decreased in both study groups. The study treatment had no significant effect on change in fasting C-peptide level after 15 months (the primary end point). Fasting C-peptide levels declined from baseline levels significantly less over 30 months in the GAD-alum group than in the placebo group (-0.21 vs. -0.27 nmol per liter [-0.62 vs. -0.81 ng per milliliter], P=0.045), as did stimulated secretion measured as the area under the curve (-0.72 vs. -1.02 nmol per liter per 2 hours [-2.20 vs. -3.08 ng per milliliter per 2 hours], P=0.04). No protective effect was seen in patients treated 6 months or more after receiving the diagnosis. Adverse events appeared to be mild and similar in frequency between the two groups. The GAD-alum treatment induced a GAD-specific immune response. Conclusions: GAD-alum may contribute to the preservation of residual insulin secretion in patients with recent-onset type 1 diabetes, although it did not change the insulin requirement. (ClinicalTrials.gov number, NCT00435981.).	[Ludvigsson, Johnny; Faresjo, Maria; Hjorth, Maria; Axelsson, Stina; Cheramy, Mikael; Pihl, Mikael; Vaarala, Outi; Casas, Rosaura] Linkoping Univ, Div Pediat, Dept Clin & Expt Med, Fac Hlth Sci, SE-58185 Linkoping, Sweden; [Forsander, Gun] Queen Silvia Childrens Hosp, Gothenburg, Sweden; [Ivarsson, Sten] Malmo Univ Hosp, Malmo, Sweden; [Johansson, Calle] Reg Ryhov Hosp, Jonkoping, Sweden; [Lindh, Agne] So Alvsborg Hosp, Boras, Sweden; [Nilsson, Nils-Osten] Halmstad Cty Hosp, Halmstad, Sweden; [Aman, Jan] Orebro Univ Hosp, Orebro, Sweden; [Ortqvist, Eva] Karolinska Univ Hosp, Astrid Lindgrens Childrens Hosp, Stockholm, Sweden; [Zerhouni, Peter] Diamyd Med, Stockholm, Sweden; [Vaarala, Outi] Natl Publ Hlth Inst, Helsinki, Finland	Linkoping University; Queen Silvia Children's Hospital; Lund University; Skane University Hospital; Orebro University; Karolinska Institutet; Karolinska University Hospital; Finland National Institute for Health & Welfare	Ludvigsson, J (corresponding author), Linkoping Univ, Div Pediat, Dept Clin & Expt Med, Fac Hlth Sci, SE-58185 Linkoping, Sweden.	johnny.ludvigsson@lio.se	Faresjö, Maria/AAW-7985-2021; Ludvigsson, Johnny/AAI-2051-2020	Ludvigsson, Johnny/0000-0003-1695-5234	Diamyd Medical; Swedish Child Diabetes Foundation (Barndiabetesfonden); NovoNordisk; Medtronic	Diamyd Medical; Swedish Child Diabetes Foundation (Barndiabetesfonden); NovoNordisk(Novo Nordisk); Medtronic(Medtronic)	Supported by grants from Diamyd Medical and the Swedish Child Diabetes Foundation (Barndiabetesfonden). Dr. Ludvigsson reports receiving grant support from Diamyd Medical for the mechanistic studies and from NovoNordisk for studies on insulin analogues; and Dr. Ortqvist, lecture fees from Medtronic. Mr. Zerhouni reports being an employee of Diamyd Medical and holding stock options in the company. No other potential conflict of interest relevant to this article was reported.; We thank Lena Berglert, Gosia Smolinska, and Ingela Johansson for their skillful laboratory work; Prof. Ake Lernmark for determination of HLA types and classification of HLA risk groups; Profs. Mark Atkinson, Daniel Kaufman, Ake Lernmark, and David Leslie for their valuable input on a draft of the manuscript; Prof. Lernmark for supplying the pEx9 vector; and John Robertson for oversight of the manufacture of the study medication.	Agardh CD, 2005, J DIABETES COMPLICAT, V19, P238, DOI 10.1016/j.jdiacomp.2004.12.003; ALTMAN DG, 1990, LANCET, V335, P149, DOI 10.1016/0140-6736(90)90014-V; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; BAEKKESKOV S, 1982, NATURE, V298, P167, DOI 10.1038/298167a0; BOJESTIG M, 1994, NEW ENGL J MED, V330, P15, DOI 10.1056/NEJM199401063300103; BOJESTIG M, 1994, NEW ENGL J MED, V330, P584; CHASE HP, 1990, DIABETOLOGIA, V33, P444, DOI 10.1007/BF00404097; Coutant R, 1998, DIABETOLOGIA, V41, P1040, DOI 10.1007/s001250051028; DANEMAN D, 1987, CLIN INVEST MED, V10, P484; DUPRE J, 1988, DIABETES CARE, V11, P37; EISENBARTH GS, 1985, DIABETES RES CLIN EX, V2, P271; Genuth S, 2001, J PEDIATR-US, V139, P804, DOI 10.1067/mpd.2001.118887; Graham J, 2002, DIABETES, V51, P1346, DOI 10.2337/diabetes.51.5.1346; GREENBAUM CJ, 2008, DIABETES CARE   0715; Harrison LC, 2005, HUM VACCINES, V1, P143, DOI 10.4161/hv.1.4.1923; Herold KC, 2005, DIABETES, V54, P1763, DOI 10.2337/diabetes.54.6.1763; Jasinski J M, 2005, Clin Dev Immunol, V12, P181, DOI 10.1080/17402520500078204; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Larsson HE, 2005, DIABETOLOGIA, V48, P1484, DOI 10.1007/s00125-005-1813-4; Lazar L, 2007, DIABETES-METAB RES, V23, P286, DOI 10.1002/dmrr.711; Lernmark A, 2005, TRENDS IMMUNOL, V26, P608, DOI 10.1016/j.it.2005.08.015; LUDVIGSSON J, 1983, BRIT MED J, V286, P176, DOI 10.1136/bmj.286.6360.176; Ludvigsson J, 2001, DIABETES-METAB RES, V17, P131, DOI 10.1002/dmrr.176; Ludvigsson J, 2001, ARCH DIS CHILD, V85, P149, DOI 10.1136/adc.85.2.149; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; POZZILLI P, 1995, DIABETOLOGIA, V38, P848, DOI 10.1007/s001250050362; Raz I, 2001, LANCET, V358, P1749, DOI 10.1016/S0140-6736(01)06801-5; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Steele C, 2004, DIABETES, V53, P426, DOI 10.2337/diabetes.53.2.426; Steffes MW, 2003, DIABETES CARE, V26, P832, DOI 10.2337/diacare.26.3.832; Tian JD, 1996, NAT MED, V2, P1348, DOI 10.1038/nm1296-1348; Tisch R, 1998, DIABETES, V47, P894, DOI 10.2337/diabetes.47.6.894; Wahren J, 2000, AM J PHYSIOL-ENDOC M, V278, pE759, DOI 10.1152/ajpendo.2000.278.5.E759	33	358	383	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2008	359	18					1909	1920		10.1056/NEJMoa0804328	http://dx.doi.org/10.1056/NEJMoa0804328			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366BL	18843118	Bronze			2022-12-28	WOS:000260454500007
J	Watts, J				Watts, Jonathan			Chen Zhu: from barefoot doctor to China's Minister of Health Profile	LANCET			English	Biographical-Item												llamalad@gmail.com							0	10	11	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2008	372	9648					1455	1455		10.1016/S0140-6736(08)61561-5	http://dx.doi.org/10.1016/S0140-6736(08)61561-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370ZJ	18930519	Green Published, Bronze			2022-12-28	WOS:000260801300012
J	Loeffler, JS; Halperin, EC				Loeffler, Jay S.; Halperin, Edward C.			Selling a medical school's name - Ethical and practical dilemmas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Loeffler, Jay S.] Harvard Univ, Sch Med, Dept Radiat Oncol, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Halperin, Edward C.] Univ Louisville, Sch Med, Louisville, KY 40292 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Louisville	Loeffler, JS (corresponding author), Harvard Univ, Sch Med, Dept Radiat Oncol, Massachusetts Gen Hosp, 100 Blossom St,Cox 347, Boston, MA 02114 USA.	jloeffler@partners.org						DANIELS C, MAN WHO CHANGED MED; ELLIOTT S, CORPORATE DONATION R; HOUK R, 1989, JOHNSON CITY PR 0621, P8; HOUK R, 1989, JOHNSON CITY PR 0621, P1; KOCIENIEWSKI D, 2004, NY TIMES        0817, pB6; LAYTON MJ, MED SCH BERGEN SCAND; SCHMIDT S, WELLMARK RESCINDS 15; SMOTHERS R, 2004, NY TIMES        0704, P1; TOSTO P, 2007, PIONEER PRESS   1123, pA1; 1991, KINGSPORT TIMES 1004, pA8	10	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2008	300	16					1937	1938		10.1001/jama.300.16.1937	http://dx.doi.org/10.1001/jama.300.16.1937			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362UR	18940984				2022-12-28	WOS:000260223100027
J	Palmer, K; Nairn, M				Palmer, K.; Nairn, M.		Guideline Dev Grp	Guidelines - Management of acute gastrointestinal blood loss: summary of SIGN guidelines	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nairn, M.] Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland; [Palmer, K.] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Nairn, M (corresponding author), Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland.	moray.nairn@nhs.net		Houston, Graeme/0000-0002-9786-7975; Nairn, Moray/0000-0001-6474-4410				Rockall TA, 1996, GUT, V38, P316, DOI 10.1136/gut.38.3.316; *ST ELS NHS TRUST, 2007, UK COMP AUD UPP GAST	2	12	14	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 18	2008	337	7675							a1832	10.1136/bmj.a1832	http://dx.doi.org/10.1136/bmj.a1832			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360YE	18849311				2022-12-28	WOS:000260093900039
J	Coller, HA; Kruglyak, L				Coller, Hilary A.; Kruglyak, Leonid			It's the sequence, stupid!	SCIENCE			English	Editorial Material							CARRYING HUMAN-CHROMOSOME-21; HUMAN GENOME; TRANSCRIPTION; CODE		[Coller, Hilary A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Kruglyak, Leonid] Princeton Univ, Howard Hughes Med Inst, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University; Howard Hughes Medical Institute; Princeton University; Princeton University	Coller, HA (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hcoller@princeton.edu; leonid@genomics.princeton.edu			NIGMS NIH HHS [R01 GM081686, R01 GM086465] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081686, R01GM086465] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Wang QF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r1; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	13	6	6	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					380	381		10.1126/science.1165664	http://dx.doi.org/10.1126/science.1165664			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927376	Green Accepted			2022-12-28	WOS:000260094500026
J	Stice, E; Spoor, S; Bohon, C; Small, DM				Stice, E.; Spoor, S.; Bohon, C.; Small, D. M.			Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele	SCIENCE			English	Article							DOPAMINE-RECEPTOR GENE; BINDING CHARACTERISTICS; HEALTHY-VOLUNTEERS; ZUCKER RATS; REWARD; POLYMORPHISMS; REINFORCEMENT; ASSOCIATION; EXPRESSION; PREDICTION	The dorsal striatum plays a role in consummatory food reward, and striatal dopamine receptors are reduced in obese individuals, relative to lean individuals, which suggests that the striatum and dopaminergic signaling in the striatum may contribute to the development of obesity. Thus, we tested whether striatal activation in response to food intake is related to current and future increases in body mass and whether these relations are moderated by the presence of the A1 allele of the TaqIA restriction fragment length polymorphism, which is associated with dopamine D2 receptor (DRD2) gene binding in the striatum and compromised striatal dopamine signaling. Cross- sectional and prospective data from two functional magnetic resonance imaging studies support these hypotheses, which implies that individuals may overeat to compensate for a hypofunctioning dorsal striatum, particularly those with genetic polymorphisms thought to attenuate dopamine signaling in this region.	[Stice, E.; Spoor, S.; Bohon, C.] Oregon Res Inst, Eugene, OR 97403 USA; [Stice, E.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Bohon, C.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Small, D. M.] John B Pierce Fdn Lab, New Haven, CT 06519 USA; [Small, D. M.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA	Oregon Research Institute; University of Texas System; University of Texas Austin; University of Oregon; Yale University; The John B Pierce Laboratory, Inc; Yale University	Stice, E (corresponding author), Oregon Res Inst, 1715 Franklin Blvd, Eugene, OR 97403 USA.	estice@ori.org	Kauk, Rachel C/H-3622-2012	Bohon, Cara/0000-0001-9978-3727; Small, Dana/0000-0001-7363-1100	NIMH NIH HHS [F31 MH081588-01A2, F31 MH081588, R01 MH064560-05, R01 MH064560] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064560, F31MH081588] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bello NT, 2002, NEUROREPORT, V13, P1575, DOI 10.1097/00001756-200208270-00017; Blum K, 1996, PHARMACOGENETICS, V6, P297, DOI 10.1097/00008571-199608000-00003; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Comings DE, 2000, PROG BRAIN RES, V126, P325; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; de Leon J, 2007, J CLIN PSYCHOPHARM, V27, P22, DOI 10.1097/JCP.0b013e31802e513a; Epstein LH, 2007, BEHAV NEUROSCI, V121, P877, DOI 10.1037/0735-7044.121.5.877; Fetissov SO, 2002, AM J PHYSIOL-REG I, V283, pR905, DOI 10.1152/ajpregu.00092.2002; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Kelley AE, 2003, EUR J NEUROSCI, V18, P2592, DOI 10.1046/j.1460-9568.2003.02991.x; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Laruelle M, 1998, MOL PSYCHIATR, V3, P261, DOI 10.1038/sj.mp.4000343; Leddy JJ, 2004, OBES RES, V12, P224, DOI 10.1038/oby.2004.29; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; NOBLE EP, 1991, ARCH GEN PSYCHIAT, V48, P648; Orosco M, 1996, APPETITE, V26, P1, DOI 10.1006/appe.1996.0001; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Small DM, 2008, NEURON, V57, P786, DOI 10.1016/j.neuron.2008.01.021; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Spitz MR, 2000, NUTR RES, V20, P371, DOI 10.1016/S0271-5317(00)00130-5; Szczypka MS, 2001, NEURON, V30, P819, DOI 10.1016/S0896-6273(01)00319-1; Tataranni PA, 2001, DIABETES, V50, P901, DOI 10.2337/diabetes.50.4.901; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Tupala E, 2003, NEUROIMAGE, V19, P145, DOI 10.1016/S1053-8119(03)00060-0; Volkow ND, 2002, BEHAV PHARMACOL, V13, P355, DOI 10.1097/00008877-200209000-00008; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Wang Gene-Jack, 2002, Expert Opin Ther Targets, V6, P601, DOI 10.1517/14728222.6.5.601; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6	33	602	614	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					449	452		10.1126/science.1161550	http://dx.doi.org/10.1126/science.1161550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927395	Green Accepted			2022-12-28	WOS:000260094500049
J	Simmons, C; Farrar, J				Simmons, Cameron; Farrar, Jeremy			Insights into inflammation and influenza	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							H5N1 INFECTION		[Simmons, Cameron; Farrar, Jeremy] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam	University of Oxford	Simmons, C (corresponding author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam.		Simmons, Cameron P/ABA-3896-2021; Farrar, Jeremy J./HGA-7610-2022	Simmons, Cameron P/0000-0002-9039-7392; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust [079864] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Lee SMY, 2008, J INFECT DIS, V198, P525, DOI 10.1086/590499; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	5	37	40	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2008	359	15					1621	1623		10.1056/NEJMcibr0805865	http://dx.doi.org/10.1056/NEJMcibr0805865			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FS	18843127	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000259903100015
J	Mandal, PK; Kazazian, HH				Mandal, Prabhat K.; Kazazian, Haig H., Jr.			SnapShot: Vertebrate transposons	CELL			English	Editorial Material							GENOME; ELEMENTS		[Mandal, Prabhat K.; Kazazian, Haig H., Jr.] Hosp Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Mandal, PK (corresponding author), Hosp Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.							Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Gentles AJ, 2007, GENOME RES, V17, P992, DOI 10.1101/gr.6070707; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Volff JN, 2003, TRENDS GENET, V19, P674, DOI 10.1016/j.tig.2003.10.006; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wicker T, 2005, GENOME RES, V15, P126, DOI 10.1101/gr.2438005	8	54	56	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 3	2008	135	1							192.e1	10.1016/j.cell.2008.09.028	http://dx.doi.org/10.1016/j.cell.2008.09.028			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854165	Bronze			2022-12-28	WOS:000259728100021
J	Williams, RS; Moncalian, G; Williams, JS; Yamada, Y; Limbo, O; Shin, DS; Groocock, LM; Cahill, D; Hitomi, C; Guenther, G; Moiani, D; Carney, JP; Russell, P; Tainer, JA				Williams, R. Scott; Moncalian, Gabriel; Williams, Jessica S.; Yamada, Yoshiki; Limbo, Oliver; Shin, David S.; Groocock, Lynda M.; Cahill, Dana; Hitomi, Chiharu; Guenther, Grant; Moiani, Davide; Carney, James P.; Russell, Paul; Tainer, John A.			Mre11 dimers coordinate DNA end bridging and nuclease processing in double-strand-break repair	CELL			English	Article							TELANGIECTASIA-LIKE DISORDER; SACCHAROMYCES-CEREVISIAE MRE11; STRUCTURAL BASIS; DAMAGE RESPONSE; PROTEIN COMPLEX; ATM ACTIVATION; REPLICATION; RECOMBINATION; BINDING; RAD50	Mre11 forms the core of the multifunctional Mre11-Rad50-Nbs1 (MRN) complex that detects DNA double-strand breaks (DSBs), activates the ATM checkpoint kinase, and initiates homologous recombination (HR) repair of DSBs. To define the roles of Mre11 in both DNA bridging and nucleolytic processing during initiation of DSB repair, we combined small-angle X-ray scattering (SAXS) and crystal structures of Pyrococcus furiosus Mre11 dimers bound to DNA with mutational analyses of fission yeast Mre11. The Mre11 dimer adopts a four-lobed U-shaped structure that is critical for proper MRN complex assembly and for binding and aligning DNA ends. Further, mutations blocking Mre11 endonuclease activity impair cell survival after DSB induction without compromising MRN complex assembly or Mre11-dependant recruitment of Ctp1, an HR factor, to DSBs. These results show how Mre11 dimerization and nuclease activities initiate repair of DSBs and collapsed replication forks, as well as provide a molecular foundation for understanding cancer-causing Mre11 mutations in ataxia telangiectasia-like disorder (ATLD).	[Williams, R. Scott; Moncalian, Gabriel; Williams, Jessica S.; Yamada, Yoshiki; Limbo, Oliver; Shin, David S.; Groocock, Lynda M.; Hitomi, Chiharu; Guenther, Grant; Moiani, Davide; Russell, Paul; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Russell, Paul] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Williams, R. Scott; Moncalian, Gabriel; Shin, David S.; Hitomi, Chiharu; Moiani, Davide; Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Cahill, Dana; Carney, James P.] Univ Maryland, Sch Med, Radiat Oncol Res Lab, Dept Radiat Oncol, Baltimore, MD 21201 USA; [Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Dept Mol Biol, Berkeley, CA 94720 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University System of Maryland; University of Maryland Baltimore; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Russell, P (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,MB4, La Jolla, CA 92037 USA.	prussell@scripps.edu; jat@scripps.edu	Tainer, John/GWQ-4878-2022; Classen, Scott/AAY-8176-2020; Moncalian, Gabriel/K-3493-2014; moiani, davide/AAX-6790-2021; Williams, R Scott/A-6059-2015	Tainer, John/0000-0003-1659-2429; Moncalian, Gabriel/0000-0002-3007-6490; Williams, R Scott/0000-0002-4610-8397; Limbo, Oliver/0000-0003-1686-1414	Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; Skaggs Institute for Chemical Biology; Uehara Memorial Foundation; National Cancer Institute [CA117638, CA92584, CA77325]; U.S. Department of Energy programs IDAT; MAGGIE [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA077325, R01CA117638] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Skaggs Institute for Chemical Biology; Uehara Memorial Foundation(Uehara Memorial Foundation); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Energy programs IDAT(United States Department of Energy (DOE)); MAGGIE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R.S.W. is supported by the Canadian Institutes of Health Research, the Alberta Heritage Foundation for Medical Research, and the Skaggs Institute for Chemical Biology fellowships. Y.Y. is supported by a Uehara Memorial Foundation fellowship. Work on the Mre11 complex in the authors' laboratories is supported in part by National Cancer Institute grants CA117638, CA92584, and CA77325. Lawrence Berkeley National Laboratory efforts are supported in part by U.S. Department of Energy programs IDAT (for Integrating crystallography and X-ray scattering) and MAGGIE (for defining Pyrococus complexes) under contract number DE-AC02-05CH11231. We thank Scott Classen, Michal Hammel, Greg Hura, and Susan Tsutakawa for assistance with SAXS and X-ray data collection at the Advanced Light Source SIBYLS beamline and Brian Chapados for discussions and comments.	Bressan DA, 1998, GENETICS, V150, P591; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chahwan C, 2003, MOL CELL BIOL, V23, P6564, DOI 10.1128/MCB.23.18.6564-6573.2003; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Fernet M, 2005, HUM MOL GENET, V14, P307, DOI 10.1093/hmg/ddi027; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Krogh BO, 2005, GENETICS, V171, P1561, DOI 10.1534/genetics.105.049478; Lee JH, 2003, J BIOL CHEM, V278, P45171, DOI 10.1074/jbc.M308705200; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Manolis KG, 2001, EMBO J, V20, P210, DOI 10.1093/emboj/20.1.210; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Moreau S, 2001, GENETICS, V159, P1423; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2000, P NATL ACAD SCI USA, V97, P6409, DOI 10.1073/pnas.110144297; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rattray AJ, 2001, GENETICS, V158, P109; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Tomita K, 2003, MOL CELL BIOL, V23, P5186, DOI 10.1128/MCB.23.15.5186-5197.2003; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Wen Q, 2008, MOL BIOL CELL, V19, P1693, DOI 10.1091/mbc.E07-09-0975; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005	41	359	363	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					97	109		10.1016/j.cell.2008.08.017	http://dx.doi.org/10.1016/j.cell.2008.08.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854158	Green Accepted, Bronze			2022-12-28	WOS:000259728100012
J	Seehausen, O; Terai, Y; Magalhaes, IS; Carleton, KL; Mrosso, HDJ; Miyagi, R; van der Sluijs, I; Schneider, MV; Maan, ME; Tachida, H; Imai, H; Okada, N				Seehausen, Ole; Terai, Yohey; Magalhaes, Isabel S.; Carleton, Karen L.; Mrosso, Hillary D. J.; Miyagi, Ryutaro; van der Sluijs, Inke; Schneider, Maria V.; Maan, Martine E.; Tachida, Hidenori; Imai, Hiroo; Okada, Norihiro			Speciation through sensory drive in cichlid fish	NATURE			English	Article							LAKE VICTORIA CICHLIDS; TUNING SPECTRAL SENSITIVITY; OPSIN GENE-EXPRESSION; SEXUAL SELECTION; REPRODUCTIVE ISOLATION; MOLECULAR EVOLUTION; COLOR-VISION; DIVERGENT SELECTION; ADAPTIVE DIVERGENCE; NATURAL-SELECTION	Theoretically, divergent selection on sensory systems can cause speciation through sensory drive. However, empirical evidence is rare and incomplete. Here we demonstrate sensory drive speciation within island populations of cichlid fish. We identify the ecological and molecular basis of divergent evolution in the cichlid visual system, demonstrate associated divergence in male colouration and female preferences, and show subsequent differentiation at neutral loci, indicating reproductive isolation. Evidence is replicated in several pairs of sympatric populations and species. Variation in the slope of the environmental gradients explains variation in the progress towards speciation: speciation occurs on all but the steepest gradients. This is the most complete demonstration so far of speciation through sensory drive without geographical isolation. Our results also provide a mechanistic explanation for the collapse of cichlid fish species diversity during the anthropogenic eutrophication of Lake Victoria.	[Seehausen, Ole; Magalhaes, Isabel S.] Univ Bern, Inst Zool, CH-3012 Bern, Switzerland; [Seehausen, Ole; Magalhaes, Isabel S.; Schneider, Maria V.] Ctr Ecol Evolut & Biogeochem, Dept Fish Ecol & Evolut, Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-6047 Kastanienbaum, Switzerland; [Terai, Yohey; Miyagi, Ryutaro; Okada, Norihiro] Tokyo Inst Technol, Midori Ku, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Carleton, Karen L.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Mrosso, Hillary D. J.] Mwanza Ctr, Tanzania Fisheries Res Inst, Mwanza, Tanzania; [van der Sluijs, Inke; Maan, Martine E.] Leiden Univ, Dept Anim Ecol, Inst Biol, NL-2300 RA Leiden, Netherlands; [Tachida, Hidenori] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8108560, Japan; [Imai, Hiroo] Kyoto Univ, Dept Cellular & Mol Biol, Primate Res Inst, Kyoto 4848506, Japan	University of Bern; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Tokyo Institute of Technology; University System of Maryland; University of Maryland College Park; Leiden University; Leiden University - Excl LUMC; Kyushu University; Kyoto University	Seehausen, O (corresponding author), Univ Bern, Inst Zool, Baltzerstr 6, CH-3012 Bern, Switzerland.	ole.seehausen@aqua.unibe.ch; nokada@bio.titech.ac.jp	TATSUTA, HARUKI/F-2997-2010; Schneider, Maria Victoria/E-6317-2010; Seehausen, Ole/C-8272-2011; Maan, Martine/B-5444-2008	Seehausen, Ole/0000-0001-6598-1434; Maan, Martine/0000-0003-1113-8067; Okada, Norihiro/0000-0002-3655-8060; Schneider, Maria Victoria/0000-0002-7114-2060; Santos Magalhaes, Isabel/0000-0003-2391-3577; Mrosso, Hillary Deogratias John/0000-0003-1924-7268; Carleton, Karen/0000-0001-6306-5643; Imai, Hiroo/0000-0003-0729-0322	Swiss National Science Foundation [3100A0-106573]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We acknowledge the Tanzania Commission for Science & Technology for research permissions, the Tanzania Fisheries Research Institute, and its Muranza Centre director E. F. B. Katunzi, for hospitality and logistical support; M. Kayeba, M. Haluna, S. Mwaiko, M. Haesler and E. Burgerhout for help with data and fish collection; H. Araki, L. Excoffier, L. Harmon, B. Ibelings, I. Keller, T. Kocher, P. Nosil, M. Pierotti, D. Schluter, A. Sivasundar and O. Svensson for comments on the manuscript; and M. Kawata, J. J. M. van Alphen, K. Young, R. Stelkens and E. Bezault for discussion. This work was supported by Swiss National Science Foundation project 3100A0-106573 (to O.S.), and by the Ministry of Education, Culture, Sports, Science and Technology of Japan (to N.O.).	ASENJO AB, 1994, NEURON, V12, P1131, DOI 10.1016/0896-6273(94)90320-4; Belkhir K.P.B., 1996, GENETIX VERSION 4 05; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Carleton KL, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-22; Carleton KL, 2005, MOL ECOL, V14, P4341, DOI 10.1111/j.1365-294X.2005.02735.x; Carleton KL, 2001, MOL BIOL EVOL, V18, P1540, DOI 10.1093/oxfordjournals.molbev.a003940; Chunco AJ, 2007, EVOLUTION, V61, P2504, DOI 10.1111/j.1558-5646.2007.00213.x; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; ENDLER JA, 1973, SCIENCE, V179, P243, DOI 10.1126/science.179.4070.243; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gavrilets S, 2004, FITNESS LANDSCAPES O; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; Haesler MP, 2005, P ROY SOC B-BIOL SCI, V272, P237, DOI 10.1098/rspb.2004.2946; HUDSON RR, 1987, GENETICS, V116, P153; Kawata M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-99; Leimar O, 2008, EVOLUTION, V62, P807, DOI 10.1111/j.1558-5646.2008.00334.x; Levring T., 1956, OIKOS, V7, P98; Maan ME, 2006, AM NAT, V167, P947, DOI 10.1086/503532; Maan ME, 2004, P ROY SOC B-BIOL SCI, V271, P2445, DOI 10.1098/rspb.2004.2911; McDonald JH, 1998, MOL BIOL EVOL, V15, P377, DOI 10.1093/oxfordjournals.molbev.a025934; Nosil P, 2004, EVOLUTION, V58, P102, DOI 10.1111/j.0014-3820.2004.tb01577.x; Nosil P, 2003, P ROY SOC B-BIOL SCI, V270, P1911, DOI 10.1098/rspb.2003.2457; Nosil P, 2005, EVOLUTION, V59, P705; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Okullo W, 2007, APPL OPTICS, V46, P8553, DOI 10.1364/AO.46.008553; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parry JWL, 2005, CURR BIOL, V15, P1734, DOI 10.1016/j.cub.2005.08.010; Rasanen K, 2008, ECOL LETT, V11, P624, DOI 10.1111/j.1461-0248.2008.01176.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SCHLUTER D, 1995, AM NAT, V146, P292, DOI 10.1086/285799; SCHLUTER D, 1993, P ROY SOC B-BIOL SCI, V253, P117, DOI 10.1098/rspb.1993.0089; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 1998, BEHAV ECOL SOCIOBIOL, V42, P1, DOI 10.1007/s002650050405; Seehausen O., 1996, LAKE VICTORIA ROCK C; Shichida Yoshinori, 1999, P23; Smit SA, 1997, NETH J ZOOL, V47, P9; Spady TC, 2005, MOL BIOL EVOL, V22, P1412, DOI 10.1093/molbev/msi137; Stelkens RB, 2008, PHILOS T R SOC B, V363, P2861, DOI 10.1098/rstb.2008.0049; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Terai Y, 2002, P NATL ACAD SCI USA, V99, P15501, DOI 10.1073/pnas.232561099; Terai Y, 2006, PLOS BIOL, V4, P2244, DOI 10.1371/journal.pbio.0040433; van der Sluijs I, 2008, BEHAV ECOL, V19, P177, DOI 10.1093/beheco/arm120; VANDERMEER HJ, 1995, ENVIRON BIOL FISH, V44, P115, DOI 10.1007/BF00005910; Venables WN., 2002, MODERN APPL STAT S; Yokoyama S, 2000, GENE, V259, P17, DOI 10.1016/S0378-1119(00)00435-2	49	765	781	3	492	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2008	455	7213					620	U23		10.1038/nature07285	http://dx.doi.org/10.1038/nature07285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833272				2022-12-28	WOS:000259639700037
J	Tang, C; Louis, JM; Aniana, A; Suh, JY; Clore, GM				Tang, Chun; Louis, John M.; Aniana, Annie; Suh, Jeong-Yong; Clore, G. Marius			Visualizing transient events in amino-terminal autoprocessing of HIV-1 protease	NATURE			English	Article							ENCOUNTER COMPLEXES; NMR; BINDING; KINETICS; ENHANCEMENT; PRECURSOR; DYNAMICS; CLEAVAGE; ASSOCIATION; INHIBITORS	HIV- 1 protease processes the Gag and Gag- Pol polyproteins into mature structural and functional proteins, including itself, and is therefore indispensable for viral maturation(1,2). The mature protease is active only as a dimer(3-5) with each subunit contributing catalytic residues(6). The full- length transframe region protease precursor appears to be monomeric yet undergoes maturation via intramolecular cleavage of a putative precursor dimer(5,7-11), concomitant with the appearance of mature- like catalytic activity(7,9). How such intramolecular cleavage can occur when the amino and carboxy termini of the mature protease are part of an intersubunit beta-sheet located distal from the active site is unclear. Here we visualize the early events in N- terminal autoprocessing using an inactive mini- precursor with a four- residue N- terminal extension that mimics the transframe region protease precursor(5,12). Using paramagnetic relaxation enhancement, a technique that is exquisitely sensitive to the presence of minor species(13-16), we show that the mini- precursor forms highly transient, lowly populated (3-5%) dimeric encounter complexes that involve the mature dimer interface but occupy a wide range of subunit orientations relative to the mature dimer. Furthermore, the occupancy of the mature dimer configuration constitutes a very small fraction of the self- associated species ( accounting for the very low enzymatic activity of the protease precursor), and the N- terminal extension makes transient intra- and intersubunit contacts with the substrate binding site and is therefore available for autocleavage when the correct dimer orientation is sampled within the encounter complex ensemble.	[Tang, Chun; Louis, John M.; Aniana, Annie; Suh, Jeong-Yong; Clore, G. Marius] NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Clore, GM (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bldg 5, Bethesda, MD 20892 USA.	mariusc@mail.nih.gov	Clore, G. Marius/A-3511-2008; Clore, G Marius/L-2546-2018	Clore, G. Marius/0000-0003-3809-1027; Clore, G Marius/0000-0003-3809-1027; Tang, Chun/0000-0001-6477-6500; Louis, John M/0000-0002-0052-1899	Intramural Program of the NIH; NIDDK; AIDS Targeted Antiviral program	Intramural Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AIDS Targeted Antiviral program	We thank R. Ishima for providing initial backbone assignments for the <SUP>SFNF</SUP>PR(D25N) protease construct; C. Schwieters for many discussions; Y. Sheng for help with the CS-Rosetta calculations; Y. Kim for providing the code for structure clustering and d.r.m.s. calculations; and J. Sayer for MALDI measurements. This work was supported by funds from the Intramural Program of the NIH, NIDDK and the AIDS Targeted Antiviral program of the Office of the Director of the NIH (to G.M.C.).	ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Cherry E, 1998, J MOL BIOL, V284, P43, DOI 10.1006/jmbi.1998.1968; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; Clore GM, 2002, J AM CHEM SOC, V124, P2866, DOI 10.1021/ja017712p; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; CLORE GM, 1991, ANNU REV BIOPHYS BIO, V20, P29, DOI 10.1146/annurev.biophys.20.1.29; CO E, 1994, BIOCHEMISTRY-US, V33, P1248, DOI 10.1021/bi00171a027; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Ishima R, 2003, J BIOL CHEM, V278, P43311, DOI 10.1074/jbc.M307549200; Ishima R, 2007, J BIOL CHEM, V282, P17190, DOI 10.1074/jbc.M701304200; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Katoh E, 2003, PROTEIN SCI, V12, P1376, DOI 10.1110/ps.0300703; Kim YC, 2008, P NATL ACAD SCI USA, V105, P12855, DOI 10.1073/pnas.0802460105; Kuszewski J, 1999, J AM CHEM SOC, V121, P2337, DOI 10.1021/ja9843730; Louis J M, 2000, Adv Pharmacol, V49, P111; LOUIS JM, 1994, P NATL ACAD SCI USA, V91, P7970, DOI 10.1073/pnas.91.17.7970; Louis JM, 1999, NAT STRUCT BIOL, V6, P868; Louis JM, 1999, J BIOL CHEM, V274, P23437, DOI 10.1074/jbc.274.33.23437; Louis JM, 2007, ADV PHARMACOL, V55, P261, DOI 10.1016/S1054-3589(07)55008-8; Ludwig C, 2008, J VIROL, V82, P4573, DOI 10.1128/JVI.02353-07; Mahalingam B, 2004, EUR J BIOCHEM, V271, P1516, DOI 10.1111/j.1432-1033.2004.04060.x; MILLER M, 1989, SCIENCE, V246, P1149, DOI 10.1126/science.2686029; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2002, J BIOMOL NMR, V23, P221, DOI 10.1023/A:1019875223132; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; SPINELLI S, 1991, BIOCHIMIE, V73, P1391, DOI 10.1016/0300-9084(91)90169-2; Tang C, 2008, J AM CHEM SOC, V130, P4048, DOI 10.1021/ja710493m; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Tessmer U, 1998, J VIROL, V72, P3459, DOI 10.1128/JVI.72.4.3459-3463.1998; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WLODAWER A, 1993, ANNU REV BIOCHEM, V62, P543, DOI 10.1146/annurev.bi.62.070193.002551; Wlodawer A, 1998, ANNU REV BIOPH BIOM, V27, P249, DOI 10.1146/annurev.biophys.27.1.249; Wondrak EM, 1996, BIOCHEMISTRY-US, V35, P12957, DOI 10.1021/bi960984y; Wondrak EM, 1996, J BIOL CHEM, V271, P4477, DOI 10.1074/jbc.271.8.4477	40	101	103	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					693	U92		10.1038/nature07342	http://dx.doi.org/10.1038/nature07342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833280	Green Accepted			2022-12-28	WOS:000259639700053
J	Blehert, DS; Hicks, AC; Behr, M; Meteyer, CU; Berlowski-Zier, BM; Buckles, EL; Coleman, JTH; Darling, SR; Gargas, A; Niver, R; Okoniewski, JC; Rudd, RJ; Stone, WB				Blehert, David S.; Hicks, Alan C.; Behr, Melissa; Meteyer, Carol U.; Berlowski-Zier, Brenda M.; Buckles, Elizabeth L.; Coleman, Jeremy T. H.; Darling, Scott R.; Gargas, Andrea; Niver, Robyn; Okoniewski, Joseph C.; Rudd, Robert J.; Stone, Ward B.			Bat White-Nose Syndrome: An Emerging Fungal Pathogen?	SCIENCE			English	Article									[Blehert, David S.; Meteyer, Carol U.; Berlowski-Zier, Brenda M.] US Geol Survey, Natl Wildlife Hlth Res Ctr, Madison, WI 53711 USA; [Hicks, Alan C.; Okoniewski, Joseph C.; Stone, Ward B.] New York Dept Environm Conservat, Albany, NY 12233 USA; [Behr, Melissa; Rudd, Robert J.] New York State Dept Hlth, Albany, NY 12201 USA; [Buckles, Elizabeth L.] Cornell Univ, Ithaca, NY 14853 USA; [Coleman, Jeremy T. H.; Niver, Robyn] US Fish & Wildlife Serv, Cortland, NY 13045 USA; [Darling, Scott R.] Vermont Fish & Wildlife Dept, Rutland, VT 05701 USA; [Gargas, Andrea] Symbiol Ltd Liabil Corp, Middleton, WI 53562 USA	United States Department of the Interior; United States Geological Survey; State University of New York (SUNY) System; Cornell University; United States Department of the Interior; US Fish & Wildlife Service	Blehert, DS (corresponding author), US Geol Survey, Natl Wildlife Hlth Res Ctr, 6006 Schroeder Rd, Madison, WI 53711 USA.	dblehert@usgs.gov	Gargas, Andrea/T-1028-2016	Gargas, Andrea/0000-0002-6586-047X; Blehert, David/0000-0002-1065-9760; Berlowski-Zier, Brenda/0000-0002-7922-8352; Coleman, Jeremy/0000-0002-2762-947X				[Anonymous], [No title captured]; Duncan SM, 2008, ANTARCT SCI, V20, P463, DOI 10.1017/S0954102008001314; Marshall WA, 1998, MICROBIAL ECOL, V36, P212, DOI 10.1007/s002489900108; Rice AV, 2006, MYCOLOGIA, V98, P307, DOI 10.3852/mycologia.98.2.307; SIGLER L, 1976, Mycotaxon, V4, P349; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5	6	632	666	6	520	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2009	323	5911					227	227		10.1126/science.1163874	http://dx.doi.org/10.1126/science.1163874			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	18974316				2022-12-28	WOS:000262290600030
J	Cheng, J; Turkel, N; Hemati, N; Fuller, MT; Hunt, AJ; Yamashita, YM				Cheng, Jun; Turkel, Nezaket; Hemati, Nahid; Fuller, Margaret T.; Hunt, Alan J.; Yamashita, Yukiko M.			Centrosome misorientation reduces stem cell division during ageing	NATURE			English	Article							SELF-RENEWAL; DROSOPHILA SPERMATOGENESIS; GERMLINE; NICHE; MELANOGASTER; ORIENTATION; CANCER	Asymmetric division of adult stem cells generates one self- renewing stem cell and one differentiating cell, thereby maintaining tissue homeostasis. A decline in stem cell function has been proposed to contribute to tissue ageing, although the underlying mechanism is poorly understood. Here we show that changes in the stem cell orientation with respect to the niche during ageing contribute to the decline in spermatogenesis in the male germ line of Drosophila. Throughout the cell cycle, centrosomes in germline stem cells ( GSCs) are oriented within their niche and this ensures asymmetric division. We found that GSCs containing misoriented centrosomes accumulate with age and that these GSCs are arrested or delayed in the cell cycle. The cell cycle arrest is transient, and GSCs appear to re- enter the cell cycle on correction of centrosome orientation. On the basis of these findings, we propose that cell cycle arrest associated with centrosome misorientation functions as a mechanism to ensure asymmetric stem cell division, and that the inability of stem cells to maintain correct orientation during ageing contributes to the decline in spermatogenesis. We also show that some of the misoriented GSCs probably originate from dedifferentiation of spermatogonia.	[Turkel, Nezaket; Hemati, Nahid; Yamashita, Yukiko M.] Univ Michigan, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Cheng, Jun; Hunt, Alan J.] Univ Michigan, Dept Biomed Engn, Ctr Ultrafast Opt Sci, Ann Arbor, MI 48109 USA; [Yamashita, Yukiko M.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Fuller, Margaret T.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Fuller, Margaret T.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University; Stanford University	Yamashita, YM (corresponding author), Univ Michigan, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA.	yukikomy@umich.edu		Fuller, Margaret T/0000-0002-3804-4987; Turkel, Nezaket/0000-0002-4480-7282; Yamashita, Yukiko/0000-0001-5541-0216	University of Michigan; March of Dimes Basil O'Conner Starter Scholar Research Award; Searle Scholar Program; NIH [P01 DK53074, R01GM072006]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072006, R01GM086481, R01GM080501] Funding Source: NIH RePORTER	University of Michigan(University of Michigan System); March of Dimes Basil O'Conner Starter Scholar Research Award(March of Dimes); Searle Scholar Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Gonzalez, D. McKearin, N. Rusan, M. Peifer and the Bloomington Stock Center for fly stocks; R. Lehmann, C. Field and the Developmental Studies Hybridoma Bank for antibodies; M. Kiel and D. Nakada for help with X-ray irradiation; and S. Morrison and T. Mahowald for comments on the manuscript. This research was supported by a University of Michigan start-up fund, March of Dimes Basil O'Conner Starter Scholar Research Award and the Searle Scholar Program (to Y.M.Y.), and NIH grants P01 DK53074 (to M.T.F.) and R01GM072006 (to A.J.H.).	Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; DING D, 1993, P NATL ACAD SCI USA, V90, P2512, DOI 10.1073/pnas.90.6.2512; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Fuller Margaret T., 1993, P71; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021; Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; Serrano M, 2007, NAT REV MOL CELL BIO, V8, P715, DOI 10.1038/nrm2242; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910	27	229	238	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					599	U40		10.1038/nature07386	http://dx.doi.org/10.1038/nature07386			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18923395	Green Accepted, Green Published			2022-12-28	WOS:000261340000032
J	Difilippantonio, S; Gapud, E; Wong, N; Huang, CY; Mahowald, G; Chen, HT; Kruhlak, MJ; Callen, E; Livak, F; Nussenzweig, MC; Sleckman, BP; Nussenzweig, A				Difilippantonio, Simone; Gapud, Eric; Wong, Nancy; Huang, Ching-Yu; Mahowald, Grace; Chen, Hua Tang; Kruhlak, Michael J.; Callen, Elsa; Livak, Ferenc; Nussenzweig, Michel C.; Sleckman, Barry P.; Nussenzweig, Andre			53BP1 facilitates long-range DNA end-joining during V(D)J recombination	NATURE			English	Article							SWITCH REGION RECOMBINATION; GENOMIC INSTABILITY; CHROMOSOME BREAKS; IN-VIVO; DAMAGE; ATM; H2AX; P53; METHYLATION; PREVENTS	Variable, diversity and joining (V(D)J) recombination and class-switch recombination use overlapping but distinct non- homologous end joining pathways to repair DNA double- strand- break intermediates. 53BP1 is a DNA- damage- response protein that is rapidly recruited to sites of chromosomal double- strand breaks, where it seems to function in a subset of ataxia telangiectasia mutated ( ATM) kinase-, H2A histone family member X ( H2AX, also known as H2AFX)- and mediator of DNA damage checkpoint 1 (MDC1)- dependent events(1,2). A 53BP1- dependent end- joining pathway has been described that is dispensable for V( D) J recombination but essential for class- switch recombination(3,4). Here we report a previously unrecognized defect in the joining phase of V( D) J recombination in 53BP1- deficient lymphocytes that is distinct from that found in classical non- homologous- end- joining-, H2ax-, Mdc1- and Atm- deficient mice. Absence of 53BP1 leads to impairment of distal V - DJ joining with extensive degradation of unrepaired coding ends and episomal signal joint reintegration at V( D) J junctions. This results in apoptosis, loss of T- cell receptor a locus integrity and lymphopenia. Further impairment of the apoptotic checkpoint causes propagation of lymphocytes that have antigen receptor breaks. These data suggest a more general role for 53BP1 in maintaining genomic stability during long- range joining of DNA breaks.	[Difilippantonio, Simone; Wong, Nancy; Chen, Hua Tang; Kruhlak, Michael J.; Callen, Elsa; Nussenzweig, Andre] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Gapud, Eric; Huang, Ching-Yu; Mahowald, Grace; Sleckman, Barry P.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Livak, Ferenc] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; [Nussenzweig, Michel C.] Howard Hughes Med Inst, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL); University System of Maryland; University of Maryland Baltimore; Rockefeller University; Howard Hughes Medical Institute	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Huang, Ching-Yu/E-3981-2010; Nussenzweig, Michel/AAE-7292-2019	Huang, Ching-yu/0000-0002-5758-281X; Mahowald, Grace/0000-0003-4541-4920	NIH [R01AI074953]; Cancer Research Institute; Intramural Research Program; National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZICBC010915, ZICBC009255, ZIABC010283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074953] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Intramural Research Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to M. McAuliffe and co-workers for developing the three- dimensional- FISH measurement algorithm; D.G. Schatz and J. Haber for discussions; A. Wynshaw-Boris for Atm<SUP>-/-</SUP> mice and J. Chen for 53BP1<SUP>-/-</SUP> and Mdc1<SUP>-/-</SUP> mice; D. Venzon for help with statistical analysis; and numbers of the A. Nussenzweig laboratory (J. Daniel and A. Celeste) for comments on the manuscript. B.P.S. is supported by NIH grant R01AI074953. E.G. is supported by pre-doctoral fellowship from the Cancer Research Institute. M.C.N. is a HHMI investigator. A.N. is supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	Adams MM, 2005, CELL CYCLE, V4, P1854, DOI 10.4161/cc.4.12.2282; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Curry JD, 2005, NAT IMMUNOL, V6, P1272, DOI 10.1038/ni1270; Difilippantonio S, 2007, J EXP MED, V204, P1003, DOI 10.1084/jem.20070319; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Huang CY, 2007, J IMMUNOL, V179, P449, DOI 10.4049/jimmunol.179.1.449; Huang CY, 2007, J EXP MED, V204, P1371, DOI 10.1084/jem.20061460; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jones JM, 2002, EMBO J, V21, P4162, DOI 10.1093/emboj/cdf394; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Matei IR, 2007, BLOOD, V109, P1887, DOI 10.1182/blood-2006-05-020917; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Reina-San-Martin B, 2007, EUR J IMMUNOL, V37, P235, DOI 10.1002/eji.200636789; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Talukder SR, 2004, NUCLEIC ACIDS RES, V32, P4539, DOI 10.1093/nar/gkh778; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021	30	228	231	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					529	U57		10.1038/nature07476	http://dx.doi.org/10.1038/nature07476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18931658	Green Accepted			2022-12-28	WOS:000261170500044
J	Collins, N; Crossley, K; Beller, E; Darnell, R; McPoil, T; Vicenzino, B				Collins, Natalie; Crossley, Kay; Beller, Elaine; Darnell, Ross; McPoil, Thomas; Vicenzino, Bill			Foot orthoses and physiotherapy in the treatment of patellofemoral pain syndrome: randomised clinical trial	BRITISH MEDICAL JOURNAL			English	Article							ANTERIOR KNEE PAIN; LOWER-LIMB KINEMATICS; INJURIES; ORTHOTICS; MANAGEMENT; DISORDERS; SPORT; THERAPY	Objective To compare the clinical efficacy of foot orthoses in the management of patellofemoral pain syndrome with flat inserts or physiotherapy, and to investigate the effectiveness of foot orthoses plus physiotherapy. Design Prospective, single blind, randomised clinical trial. Setting Single centre trial within a community setting in Brisbane, Australia. Participants 179 participants ( 100 women) aged 18 to 40 years, with a clinical diagnosis of patellofemoral pain syndrome of greater than six weeks' duration, who had no previous treatment with foot orthoses or physiotherapy in the preceding 12 months. Interventions Six weeks of physiotherapist intervention with off the shelf foot orthoses, flat inserts, multimodal physiotherapy ( patellofemoral joint mobilisation, patellar taping, quadriceps muscle retraining, and education), or foot orthoses plus physiotherapy. Main outcome measures Global improvement, severity of usual and worst pain over the preceding week, anterior knee pain scale, and functional index questionnaire measured at 6, 12, and 52 weeks. Results Foot orthoses produced improvementbeyond that of flat inserts in the short term, notably at six weeks ( relative risk reduction 0.66, 99% confidence interval 0.05 to 1.17; NNT 4 ( 99% confidence interval 2 to 51). No significant differences were found between foot orthoses and physiotherapy, or between physiotherapy and physiotherapy plus orthoses. All groups showed clinically meaningful improvements in primary outcomes over 52 weeks. Conclusion While foot orthoses are superior to flat inserts according to participants' overall perception, they are similar to physiotherapy and do not improve outcomes when added to physiotherapy in the short term management of patellofemoral pain. Given the long term improvement observed in all treatment groups, general practitioners may seek to hasten recovery by prescribing prefabricated orthoses. Trial registration Australian Clinical Trials Registry ACTRN012605000463673 and ClinicalTrials. gov NCT00118521.	[Collins, Natalie; Darnell, Ross; Vicenzino, Bill] Univ Queensland, Sch Hlth & Rehab Sci, Brisbane, Qld 4072, Australia; [Crossley, Kay] Univ Melbourne, Melbourne Sch Engn, Melbourne, Vic, Australia; [Beller, Elaine] Univ Queensland, Sch Populat Hlth, Queensland Clin Trials Ctr, Brisbane, Qld 4072, Australia; [McPoil, Thomas] No Arizona Univ, Gait Res Lab, Dept Phys Therapies, Flagstaff, AZ 86011 USA	University of Queensland; University of Melbourne; University of Queensland; Northern Arizona University	Vicenzino, B (corresponding author), Univ Queensland, Sch Hlth & Rehab Sci, Brisbane, Qld 4072, Australia.	b.vicenzino@uq.edu.au	Darnell, Ross/B-3823-2009; Beller, Elaine/E-1615-2013; Vicenzino, Bill/A-8492-2011; Collins, Natalie/M-4034-2015	Darnell, Ross/0000-0002-7973-6322; Beller, Elaine/0000-0002-3241-2611; Vicenzino, Bill/0000-0003-0253-5933; Crossley, Kay/0000-0001-5892-129X; Collins, Natalie/0000-0001-9950-0192	National Health and Medical Research Council of Australia [301037]; National Health and Medical Research Council of Australia public health scholarship [No 351663]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia public health scholarship(National Health and Medical Research Council (NHMRC) of Australia)	This trial was funded primarily by the National Health and Medical Research Council of Australia (primary health care project grant No 301037). NC was the recipient of a National Health and Medical Research Council of Australia public health scholarship (No 351663). Vasyli International donated the foot orthoses and flat inserts. The work of the authors was independent of the funders.	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; *AM COLL FOOT ANKL, 2004, PRESCR CUST FOOT ORT; Arroll B, 1997, AM J SPORT MED, V25, P207, DOI 10.1177/036354659702500212; *AUSTR POD COUNC, 1998, CLIN GUID ORTH THER; Australian Acute Musculoskeletal Pain Guidelines Group, 2003, EV BAS MAN AC MUSC P; Ballas MT, 1997, AM FAM PHYSICIAN, V55, P2473; Baquie P, 1997, CLIN J SPORT MED, V7, P28, DOI 10.1097/00042752-199701000-00006; Bizzini M, 2003, J ORTHOP SPORT PHYS, V33, P4, DOI 10.2519/jospt.2003.33.1.4; Brosseau L, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003375; CHESWORTH B M, 1989, Journal of Orthopaedic and Sports Physical Therapy, V10, P302; Clark DI, 2000, ANN RHEUM DIS, V59, P700, DOI 10.1136/ard.59.9.700; Clement D B, 1981, Phys Sportsmed, V9, P47, DOI 10.1080/00913847.1981.11711077; Collins N, 2007, FOOT ANKLE INT, V28, P396, DOI 10.3113/FAI.2007.0396; CORNWALL MW, 1992, J AM PODIAT MED ASSN, V82, P371, DOI 10.7547/87507315-82-7-371; Crossley K, 2002, AM J SPORT MED, V30, P857, DOI 10.1177/03635465020300061701; Crossley K, 2001, CLIN J SPORT MED, V11, P103, DOI 10.1097/00042752-200104000-00007; Crossley KM, 2004, ARCH PHYS MED REHAB, V85, P815, DOI 10.1016/S0003-9993(03)00613-0; DEHAVEN KE, 1986, AM J SPORT MED, V14, P218, DOI 10.1177/036354658601400307; Devereaux M D, 1984, Br J Sports Med, V18, P18; DHONDT NE, 2002, COCHRANE DB SYST REV; ENG JJ, 1993, PHYS THER, V73, P62, DOI 10.1093/ptj/73.2.62; ENG JJ, 1994, PHYS THER, V74, P836, DOI 10.1093/ptj/74.9.836; Eng JJ, 1993, PHYS THER, V73, P68, DOI DOI 10.1093/PTJ/73.2.62; Harrison EL, 1999, PHYSIOTHER CAN, V51, P93; Heintjes EM, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003472, DOI 10.1002/14651858.CD003472]; KOGLER GF, 1995, CLIN BIOMECH, V10, P245, DOI 10.1016/0268-0033(95)99802-9; Kogler GF, 1996, CLIN BIOMECH, V11, P243, DOI 10.1016/0268-0033(96)00019-8; KUJALA UM, 1993, ARTHROSCOPY, V9, P159, DOI 10.1016/S0749-8063(05)80366-4; MATHESON GO, 1989, MED SCI SPORT EXER, V21, P379; McConnell J, 2002, CLIN SPORT MED, V21, P363, DOI 10.1016/S0278-5919(02)00027-3; MCCULLOCH MU, 1993, J ORTHOP SPORT PHYS, V17, P2, DOI 10.2519/jospt.1993.17.1.2; MCPOIL TG, 1995, J ORTHOP SPORT PHYS, V21, P381, DOI 10.2519/jospt.1995.21.6.381; Nigg BM, 1999, MED SCI SPORT EXER, V31, pS421, DOI 10.1097/00005768-199907001-00003; Nimon G, 1998, J PEDIATR ORTHOPED, V18, P118, DOI 10.1097/00004694-199801000-00021; NOVICK A, 1990, Journal of Orthopaedic and Sports Physical Therapy, V11, P301; Powers CM, 2002, FOOT ANKLE INT, V23, P634, DOI 10.1177/107110070202300709; Roush MB, 2000, CLIN J SPORT MED, V10, P22, DOI 10.1097/00042752-200001000-00005; Salaffi F, 2004, EUR J PAIN, V8, P283, DOI 10.1016/j.ejpain.2003.09.004; Subotnick Steven I, 1975, Phys Sportsmed, V3, P75, DOI 10.1080/00913847.1975.11948130; Taunton JE, 2002, BRIT J SPORT MED, V36, P95, DOI 10.1136/bjsm.36.2.95; van Middelkoop M, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-36; Vicenzino B, 2010, BRIT J SPORT MED, V44, P862, DOI 10.1136/bjsm.2008.052613; Vicenzino B, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-27; WIENEROGILVIE S, 2004, BR J PODIATRY, V7, P43; Witvrouw E, 2000, AM J SPORT MED, V28, P687, DOI 10.1177/03635465000280051201; Witvrouw E, 2000, AM J SPORT MED, V28, P480, DOI 10.1177/03635465000280040701	46	140	141	3	28	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 1	2008	337								a1735	10.1136/bmj.a1735	http://dx.doi.org/10.1136/bmj.a1735			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368AM	18952682	Bronze, Green Published			2022-12-28	WOS:000260593700028
J	Soles, CL; Ding, YF				Soles, Christopher L.; Ding, Yifu			MATERIALS SCIENCE Nanoscale Polymer Processing	SCIENCE			English	Editorial Material							NANOIMPRINT LITHOGRAPHY; FILMS		[Soles, Christopher L.] NIST, Div Polymers, Gaithersburg, MD 20899 USA; [Ding, Yifu] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder	Soles, CL (corresponding author), NIST, Div Polymers, Gaithersburg, MD 20899 USA.	csoles@nist.gov	Ding, Yifu/A-8200-2019; Ding, Yifu/GQR-1312-2022	/0000-0001-7779-7781; Soles, Christopher/0000-0002-1963-6039				Ahn SH, 2008, ADV MATER, V20, P2044, DOI 10.1002/adma.200702650; [Anonymous], 1980, VISCOELASTIC PROPERT; Brown HR, 1996, MACROMOLECULES, V29, P798, DOI 10.1021/ma951123k; Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85; De Gennes P.-G., 1979, SCALING CONCEPTS POL; DIMARZIO EA, 1965, J CHEM PHYS, V42, P2101, DOI 10.1063/1.1696251; Ding YF, 2007, ADV MATER, V19, P1377, DOI 10.1002/adma.200601998; FETTERS LJ, 1994, MACROMOLECULES, V27, P4639, DOI 10.1021/ma00095a001; GREEN MS, 1946, J CHEM PHYS, V14, P80, DOI 10.1063/1.1724109; HU HW, 1992, SCIENCE, V258, P1339, DOI 10.1126/science.258.5086.1339; Jones RL, 1999, NATURE, V400, P146, DOI 10.1038/22017; O'Connell PA, 2005, SCIENCE, V307, P1760, DOI 10.1126/science.1105658; Rowland HD, 2008, SCIENCE, V322, P720, DOI 10.1126/science.1157945; SI L, 2005, PHYS REV LETT, V94, P4	14	30	33	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					689	690		10.1126/science.1165174	http://dx.doi.org/10.1126/science.1165174			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974338				2022-12-28	WOS:000260605200031
J	Bell, CL; Watson, B; Waring, WS				Bell, Claire L.; Watson, Bruce; Waring, W. Stephen			Drug point - Acute psychosis caused by co-amoxiclav	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bell, Claire L.; Waring, W. Stephen] Royal Infirm Edinburgh NHS Trust, Scottish Poisons Informat Bur, Edinburgh EH16 4SA, Midlothian, Scotland; [Watson, Bruce] Royal Infirm Edinburgh NHS Trust, Dept Pharm, Edinburgh EH16 4SA, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Waring, WS (corresponding author), Royal Infirm Edinburgh NHS Trust, Scottish Poisons Informat Bur, Edinburgh EH16 4SA, Midlothian, Scotland.	s.waring@ed.ac.uk		Waring, William Stephen/0000-0001-6442-4548				MACKNIN ML, 1987, PEDIATR INFECT DIS J, V6, P873, DOI 10.1097/00006454-198709000-00024; *MED HEALTHC PROD, DRUG AN PRINTS DAT S; Sweetman S. C., 2007, MARTINDALE COMPLETE	3	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a2117	10.1136/bmj.a2117	http://dx.doi.org/10.1136/bmj.a2117			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18945734				2022-12-28	WOS:000260298800041
J	McColl, K				McColl, Karen			Robinson's crusade	BRITISH MEDICAL JOURNAL			English	Editorial Material												karen@karenmccoll.co.uk						MCKINLEY B, MIGRATION 21 CENTURY; *UN, 2008, SECR GEN CONCL REM H; *WHO, 2006, 301 WHO; *WHO, 2008, WHO COD PRACT INT RE	4	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a2065	10.1136/bmj.a2065	http://dx.doi.org/10.1136/bmj.a2065			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18940843				2022-12-28	WOS:000260298800029
J	Sorensen, PS; Sellebjerg, F				Sorensen, Per Soelberg; Sellebjerg, Finn			Oral fumarate for relapsing-remitting multiple sclerosis	LANCET			English	Editorial Material							ACID ESTERS; NRF2		[Sorensen, Per Soelberg; Sellebjerg, Finn] Rigshosp, Danish Multiple Sclerosis Res Ctr, Dept Neurol, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Sorensen, PS (corresponding author), Rigshosp, Danish Multiple Sclerosis Res Ctr, Dept Neurol, DK-2100 Copenhagen, Denmark.	pss@rh.dk		Sorensen, Per Soelberg/0000-0002-2818-3780; Sellebjerg, Finn/0000-0002-1333-9623				Comi G, 2008, LANCET, V371, P2085, DOI 10.1016/S0140-6736(08)60918-6; Gerdes S, 2007, BRIT J DERMATOL, V156, P838, DOI 10.1111/j.1365-2133.2007.07779.x; Hubbs AF, 2007, AM J PATHOL, V170, P2068, DOI 10.2353/ajpath.2007.060898; Kappos L, 2008, LANCET, V372, P1463, DOI 10.1016/S0140-6736(08)61619-0; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Lukashev M, 2007, MULT SCLER, V13, pS149; *NAT MULT SCLER SO, 2008, CLIN TRIALS MULT SCL; O'Connor PW, 2006, NEUROLOGY, V66, P894, DOI 10.1212/01.wnl.0000203121.04509.31; Ormerod AD, 2004, BRIT J DERMATOL, V150, P630, DOI 10.1111/j.0007-0963.2004.05903.x; Schilling S, 2006, CLIN EXP IMMUNOL, V145, P101, DOI 10.1111/j.1365-2249.2006.03094.x; Schimrigk S, 2006, EUR J NEUROL, V13, P604, DOI 10.1111/j.1468-1331.2006.01292.x; Wingerchuk DM, 2008, SEMIN NEUROL, V28, P56, DOI 10.1055/s-2007-1019128	12	6	15	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2008	372	9648					1447	1448		10.1016/S0140-6736(08)61605-0	http://dx.doi.org/10.1016/S0140-6736(08)61605-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370ZJ	18970966				2022-12-28	WOS:000260801300008
J	Delaney, EK; Baguley, S				Delaney, Elizabeth K.; Baguley, Steve			Genital warts	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Delaney, Elizabeth K.] Univ Aberdeen, Dept Gen Practice & Primary Care, Foresterhill Hlth Ctr, Aberdeen AB25 2AY, Scotland; [Baguley, Steve] Woolmanhill Hosp, Dept Genitourinary Med, Aberdeen AB25 1LD, Scotland	University of Aberdeen; University of Aberdeen	Delaney, EK (corresponding author), Univ Aberdeen, Dept Gen Practice & Primary Care, Foresterhill Hlth Ctr, Aberdeen AB25 2AY, Scotland.	liz.delaney@abdn.ac.uk	Griffiths, Malcolm/C-5918-2009	Griffiths, Malcolm/0000-0001-6910-2249				BAGULEY S, 2006, KEY TOPICS SEXUAL HL; MAW R, UK NATL GUIDELINE MA; *PAT UK, AN WARTS; *RCGP SEX DRUGS HI, 2006, SEX TRANSM INF PRIM	4	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 17	2008	337								a1171	10.1136/bmj.a1171	http://dx.doi.org/10.1136/bmj.a1171			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374FI	18930970				2022-12-28	WOS:000261028200001
J	Johnson, AP; Cleaves, HJ; Dworkin, JP; Glavin, DP; Lazcano, A; Bada, JL				Johnson, Adam P.; Cleaves, H. James; Dworkin, Jason P.; Glavin, Daniel P.; Lazcano, Antonio; Bada, Jeffrey L.			The Miller volcanic spark discharge experiment	SCIENCE			English	Article							AMINO-ACIDS		[Bada, Jeffrey L.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Johnson, Adam P.] Indiana Univ, Interdisciplinary Biochem Program, Bloomington, IN 47401 USA; [Cleaves, H. James] Carnegie Inst Washington, Washington, DC 20015 USA; [Dworkin, Jason P.; Glavin, Daniel P.] NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA; [Lazcano, Antonio] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City 04510, DF, Mexico	University of California System; University of California San Diego; Scripps Institution of Oceanography; Indiana University System; Indiana University Bloomington; Carnegie Institution for Science; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Universidad Nacional Autonoma de Mexico	Bada, JL (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	jbada@ucsd.edu	Glavin, Daniel P/D-6194-2012; Dworkin, Jason P./C-9417-2012	Glavin, Daniel P/0000-0001-7779-7765; Dworkin, Jason P./0000-0002-3961-8997; Cleaves, Henderson/0000-0003-4101-0654; Lazcano, Antonio/0000-0001-7365-8557				HILL RD, 1991, ORIGINS LIFE EVOL B, V22, P277; Lazcano A, 2003, ORIGINS LIFE EVOL B, V33, P235, DOI 10.1023/A:1024807125069; Leman L, 2004, SCIENCE, V306, P283, DOI 10.1126/science.1102722; McNutt SR, 2000, J VOLCANOL GEOTH RES, V102, P45, DOI 10.1016/S0377-0273(00)00181-5; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; MILLER SL, 1955, J AM CHEM SOC, V77, P2351, DOI 10.1021/ja01614a001; RING D, 1984, ORIGINS LIFE EVOL B, V15, P7, DOI 10.1007/BF01809389; RING D, 1972, P NATL ACAD SCI USA, V69, P765, DOI 10.1073/pnas.69.3.765	8	212	221	5	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					404	404		10.1126/science.1161527	http://dx.doi.org/10.1126/science.1161527			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927386				2022-12-28	WOS:000260094500036
J	Lee, J; Natarajan, M; Nashine, VC; Socolich, M; Vo, T; Russ, WP; Benkovic, SJ; Ranganathan, R				Lee, Jeeyeon; Natarajan, Madhusudan; Nashine, Vishal C.; Socolich, Michael; Vo, Tina; Russ, William P.; Benkovic, Stephen J.; Ranganathan, Rama			Surface sites for engineering allosteric control in proteins	SCIENCE			English	Article							COLI DIHYDROFOLATE-REDUCTASE; PHOTOACTIVE YELLOW PROTEIN; BLUE-LIGHT RECEPTOR; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; ENZYME CATALYSIS; STRUCTURAL BASIS; FUNCTIONAL-ROLE; AVENA-SATIVA; PHOTOTROPIN	Statistical analyses of protein families reveal networks of coevolving amino acids that functionally link distantly positioned functional surfaces. Such linkages suggest a concept for engineering allosteric control into proteins: The intramolecular networks of two proteins could be joined across their surface sites such that the activity of one protein might control the activity of the other. We tested this idea by creating PAS-DHFR, a designed chimeric protein that connects a light-sensing signaling domain from a plant member of the Per/Arnt/Sim (PAS) family of proteins with Escherichia coli dihydrofolate reductase (DHFR). With no optimization, PAS-DHFR exhibited light-dependent catalytic activity that depended on the site of connection and on known signaling mechanisms in both proteins. PAS-DHFR serves as a proof of concept for engineering regulatory activities into proteins through interface design at conserved allosteric sites.	[Natarajan, Madhusudan; Socolich, Michael; Vo, Tina; Russ, William P.; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Natarajan, Madhusudan; Socolich, Michael; Vo, Tina; Russ, William P.; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Lee, Jeeyeon; Nashine, Vishal C.; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Ranganathan, R (corresponding author), Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu		Socolich, Michael/0000-0002-0702-1061; Natarajan, Madhusudan/0000-0003-1607-2917	Robert A. Welch foundation; Defense Advanced Research Projects Agency; NATIONAL EYE INSTITUTE [R01EY018720] Funding Source: NIH RePORTER	Robert A. Welch foundation(The Welch Foundation); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank members of the Ranganathan and Benkovic labs for discussions, M. Rosen and K. H. Gardner for discussions and sharing of unpublished data and materials, and J. Wang for solvent accessibility calculations. Supported by the Robert A. Welch foundation (R.R.) and a grant from the Defense Advanced Research Projects Agency (R.R. and S.J.B.).	Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Brudler R, 2006, J MOL BIOL, V363, P148, DOI 10.1016/j.jmb.2006.07.078; Cameron CE, 1997, BIOCHEMISTRY-US, V36, P15792, DOI 10.1021/bi9716231; CHEN JT, 1987, BIOCHEMISTRY-US, V26, P4093, DOI 10.1021/bi00387a053; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Cusanovich MA, 2003, BIOCHEMISTRY-US, V42, P4759, DOI 10.1021/bi020690e; EPSTEIN DM, 1995, BIOCHEMISTRY-US, V34, P11037, DOI 10.1021/bi00035a009; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; Ferguson AD, 2007, P NATL ACAD SCI USA, V104, P513, DOI 10.1073/pnas.0609887104; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Rajagopalan PTR, 2002, CHEM REC, V2, P24, DOI 10.1002/tcr.10009; RICHARDS FM, 1993, Q REV BIOPHYS, V26, P423, DOI 10.1017/S0033583500002845; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Salomon M, 2001, P NATL ACAD SCI USA, V98, P12357, DOI 10.1073/pnas.221455298; Saraf MC, 2004, P NATL ACAD SCI USA, V101, P4142, DOI 10.1073/pnas.0400065101; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Yao XL, 2008, NAT CHEM BIOL, V4, P491, DOI 10.1038/nchembio.99	34	260	262	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					438	442		10.1126/science.1159052	http://dx.doi.org/10.1126/science.1159052			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927392	Green Accepted			2022-12-28	WOS:000260094500046
J	Lewis, J				Lewis, Julian			From signals to patterns: Space, time, and mathematics in developmental biology	SCIENCE			English	Review							SOMITE SEGMENTATION CLOCK; AUXIN-TRANSPORT; MORPHOGEN GRADIENT; GENE-EXPRESSION; ZEBRAFISH; PHYLLOTAXIS; BOUNDARIES; MODEL; SOMITOGENESIS; ARABIDOPSIS		[Lewis, Julian] Canc Res UK London Res Inst, Vertebrate Dev Lab, London WC2A 3PX, England	Cancer Research UK	Lewis, J (corresponding author), Canc Res UK London Res Inst, Vertebrate Dev Lab, London WC2A 3PX, England.		Lewis, Julian H/E-8733-2010		Cancer Research UK	Cancer Research UK(Cancer Research UK)	I thank N. Barkai, B. Reversade, R. Collins, A. Hanisch, C. Kuhlemeier, and an anonymous referee for comments and Cancer Research UK for funding.	Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Berleth T, 2007, TRENDS PLANT SCI, V12, P151, DOI 10.1016/j.tplants.2007.03.005; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; COOKE J, 1981, NATURE, V290, P775, DOI 10.1038/290775a0; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Giudicelli F, 2007, PLOS BIOL, V5, P1309, DOI 10.1371/journal.pbio.0050150; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Henry CA, 2002, DEVELOPMENT, V129, P3693; Holley SA, 2007, DEV DYNAM, V236, P1422, DOI 10.1002/dvdy.21162; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Meinhardt H., 1982, MODELS BIOL PATTERN; Oates AC, 2002, DEVELOPMENT, V129, P2929; OZBUDAK EM, 2008, IN PRESS CURR OPIN G; Ozbudak EM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040015; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Riedel-Kruse IH, 2007, SCIENCE, V317, P1911, DOI 10.1126/science.1142538; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Spemann H., 1938, EMBRYONIC DEV INDUCT; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wolpert L, 2007, PRINCIPLES DEV	36	132	136	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					399	403		10.1126/science.1166154	http://dx.doi.org/10.1126/science.1166154			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927385				2022-12-28	WOS:000260094500035
J	Raleigh, VS; Cooper, J; Bremner, SA; Scobie, S				Raleigh, Veena S.; Cooper, Jeremy; Bremner, Stephen A.; Scobie, Sarah			Patient safety indicators for England from hospital administrative data: case-control analysis and comparison with US data	BRITISH MEDICAL JOURNAL			English	Article							ADVERSE EVENTS; HEALTH-CARE; REVIEWER; QUALITY	Objective To assess the feasibility of deriving patient safety indicators for England from routine hospital data and whether they can indicate adverse outcomes for patients. Design Nine patient safety indicators developed by the United States Agency for Healthcare Research and Quality ( AHRQ) were derived using hospital episode statistics for England for 2003- 4, 2004- 5, and 2005- 6. A case- control analysis was undertaken to compare length of stay and mortality between cases ( patients experiencing the particular safety event measured by an indicator) and controls matched for age, sex, health resource group ( standard groupings of clinically similar treatments that use similar levels of healthcare resource), main specialty, and trust. Comparisons were undertaken with US data. Setting All NHS trusts in England. Participants Inpatients in NHS trusts. Results There was fair consistency in national rates for the nine indicators across three years. For all but one indicator, hospital stays were longer in cases than in matched controls (range 0.2- 17.1 days, P< 0.001). Mortality in cases was also higher than in controls ( 5.7-27.1%, P< 0.001), except for the obstetric trauma indicators. Excess length of stay and mortality in cases was greatest for postoperative hip fracture and sepsis. England's rates were lower than US rates for these indicators. Increased length of stay in cases was generally greater in England than in the US. Excess mortality was also higher in England than in the US, except for the obstetric trauma indicators where there were few deaths in both countries. Differences between England and the US in excess length of stay and mortality were most marked for postoperative hip fracture. Conclusions Hospital administrative data provide a potentially useful low burden, low cost source of information on safety events. Indicators can be derived with English data and show that cases have poorer outcomes than matched controls. These data therefore have potential for monitoring safety events. Further validation, for example, of individual cases, is needed and levels of event recording need to improve. Differences between England and the US might reflect differences in the depth of event coding and in health systems and patterns of healthcare provision.	[Raleigh, Veena S.; Cooper, Jeremy; Bremner, Stephen A.] Healthcare Commiss, London EC1Y 8TG, England; [Raleigh, Veena S.] Univ Surrey, Surrey GU2 7WG, England; [Scobie, Sarah] Natl Patient Safety Agcy, London W1T 5HD, England	University of Surrey	Raleigh, VS (corresponding author), Healthcare Commiss, London EC1Y 8TG, England.	raleigh@healthcarecommission.org.uk	Bremner, Stephen/R-4038-2016	Bremner, Stephen/0000-0003-0790-7070	Health and Social Care Information Centre	Health and Social Care Information Centre	The Healthcare Commission received a small grant from the Health and Social Care Information Centre to support the initial recoding work.	BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; *BRIST ROYAL INF I, 2001, LEARN BRIST REP PUBL, pCH21; Darzi A., 2008, HIGH QUALITY CARE AL; *DEP HHS AG HEALTH, 2007, AHRQ QUAL IND GUID P; Department of Health, 2007, PAYM RES GUID 2008 0; Foster, 2004, BMJ-BRIT MED J, V329, P369, DOI 10.1136/bmj.329.7462.369; Hayward RA, 2001, JAMA-J AM MED ASSOC, V286, P415, DOI 10.1001/jama.286.4.415; McDonald KM, 2002, AHRQ PUBLICATION, V02-0038; Millar J, 2004, OECD HLTH TECHNICAL; National Audit Office, 2005, SAF PLAC PAT LEARN I; Polancich S, 2006, AM J MED QUAL, V21, P262, DOI 10.1177/1062860606288244; Runciman WB, 2000, INT J QUAL HEALTH C, V12, P379, DOI 10.1093/intqhc/12.5.379; Sari A, 2006, BMJ-BRIT MED J, V334, P79; Serden L, 2003, HEALTH POLICY, V65, P101, DOI 10.1016/S0168-8510(02)00208-7; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; Vincent C, 2005, PATIENT SAFETY; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	18	44	44	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 17	2008	337								a1702	10.1136/bmj.a1702	http://dx.doi.org/10.1136/bmj.a1702			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374FI	18930971	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000261028200002
J	Ahmed, S; Rienstra, M; Crijns, HJGM; Links, TP; Wiesfeld, ACP; Hillege, HL; Bosker, HA; Lok, DJA; Van Veldhuisen, DJ; Van Gelder, IC				Ahmed, Sheba; Rienstra, Michiel; Crijns, Harry J. G. M.; Links, Thera P.; Wiesfeld, Ans C. P.; Hillege, Hans L.; Bosker, Hans A.; Lok, Dirk J. A.; Van Veldhuisen, Dirk J.; Van Gelder, Isabelle C.		CONVERT Investigators	Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Conference on Late Breaking Clinical Trials held at the Heart-Rhythm-Society	MAY 13, 2007	Denver, CO	Heart Rhythm Soc			ELECTRICAL CARDIOVERSION RACE; LOW-DOSE AMIODARONE; QUALITY-OF-LIFE; RHYTHM-CONTROL; MYOCARDIAL-INFARCTION; SERIAL CARDIOVERSION; EFFICACY; SAFETY; TOXICITY; ABLATION	Context Amiodarone effectively suppresses atrial fibrillation but causes many adverse events. Objective To compare major events in patients randomized to receive episodic amiodarone treatment with those who received continuous amiodarone treatment while still aiming to prevent atrial fibrillation. Design, Setting, and Participants A randomized trial of 209 ambulatory patients with recurrent symptomatic persistent atrial fibrillation, conducted from December 2002 through March 2007 at 7 Dutch medical centers. Intervention Patients were randomly assigned to receive either episodic or continuous amiodarone treatment after electrical cardioversion following amiodarone loading. Episodic amiodarone treatment was discontinued after a month of sinus rhythm and reinitiated if atrial fibrillation relapsed ( 1 month peri - electrical cardioversion). In the continuous treatment group amiodarone was maintained throughout. Main Outcome Measures The primary end point was a composite of amiodarone and underlying heart disease - related major events. The secondary end points were all- cause mortality and cardiovascular hospitalizations. Results After a median follow- up of 2.1 years ( range, 0.4- 2.5 years), 51 ( 48%) of those receiving episodic treatment vs 64( 62%) receiving continuous treatment had sinus rhythm ( P=. 05). There were 85 atrial fibrillation recurrences ( 80%) amongthe episodic treatment group vs 56 ( 54%) in the continuous treatment group ( P <. 001). No significant difference existed in the incidence of the primary composite end point between each group ( 37[35%] episodic vs 34 [ 33%] continuous; incidence rate difference, 0.2; 95% confidence interval [ CI], - 10.2 to 10.6). However, there were nonstatistically significant differences in the incidence of amiodarone- related major events ( 20 [ 19%] episodic vs 25 [ 24%] continuous; incidence rate difference, - 2.0; 95% CI, - 8.7 to 4.6) and underlying heart disease - related major events ( 17[ 16%] episodic vs9[ 9%] continuous; incidence rate difference, 3.6; 95% CI, - 1.6 to 8.7). All- cause mortality and cardiovascular hospitalizations were higheramong those receiving episodic treatment ( 56 [ 53%] vs 35 [ 34%], P=. 02). Conclusions In this study population, there was no difference in the composite of amiodarone and cardiac major adverse events between groups. However, patients receiving episodic treatment had a significantly increased rate of atrial fibrillation recurrence and a significantly higher rate of all- cause mortality and cardiovascular hospitalizations. Trial Registration clinicaltrials. gov Identifier: NCT00392431.	[Ahmed, Sheba; Rienstra, Michiel; Wiesfeld, Ans C. P.; Van Veldhuisen, Dirk J.; Van Gelder, Isabelle C.] Univ Groningen, Dept Cardiol, Thoraxctr, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Links, Thera P.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9700 RB Groningen, Netherlands; [Hillege, Hans L.] Univ Groningen, Univ Med Ctr Groningen, Trial Coordinat Ctr, NL-9700 RB Groningen, Netherlands; [Van Gelder, Isabelle C.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Crijns, Harry J. G. M.] Maastricht Univ Med Ctr, Dept Cardiol, Maastricht, Netherlands; [Bosker, Hans A.] Rijnstate Hosp, Dept Cardiol, Arnhem, Netherlands; [Lok, Dirk J. A.] Deventer Hosp, Dept Cardiol, Deventer, Netherlands	University of Groningen; University of Groningen; University of Groningen; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Maastricht University; Maastricht University Medical Centre (MUMC); Rijnstate Hospital; Deventer Hospital	Van Gelder, IC (corresponding author), Univ Groningen, Dept Cardiol, Thoraxctr, Univ Med Ctr Groningen, POB 30-001, NL-9700 RB Groningen, Netherlands.	I.C.van.Gelder@thorax.umcg.nl	van Veldhuisen, Dirk Jan/E-8967-2014	Rienstra, Michiel/0000-0002-2581-070X; tuininga, ype/0000-0002-7861-8623				Cairns JA, 1997, LANCET, V349, P675, DOI 10.1016/S0140-6736(96)08171-8; Calkins H, 2007, HEART RHYTHM, V4, P816, DOI 10.1016/j.hrthm.2007.04.005; Cappato R, 2005, CIRCULATION, V111, P1100, DOI 10.1161/01.CIR.0000157153.30978.67; Carlsson J, 2003, J AM COLL CARDIOL, V41, P1690, DOI 10.1016/S0735-1097(03)00332-2; Connolly SJ, 1999, CIRCULATION, V100, P2025, DOI 10.1161/01.CIR.100.19.2025; Essebag V, 2004, PACE, V27, P1519, DOI 10.1111/j.1540-8159.2004.00670.x; Fuster V, 2006, EUR HEART J, V27, P1979, DOI 10.1093/eurheartj/ehl176; GREENBERG ML, 1987, J AM COLL CARDIOL, V9, P1148, DOI 10.1016/S0735-1097(87)80320-0; GREENE HL, 1989, PROG CARDIOVASC DIS, V31, P319, DOI 10.1016/0033-0620(89)90029-7; Haffajee C.I, 1987, CLIN CARDIOL, V10, P16; Hagens VE, 2005, AM HEART J, V149, P1106, DOI 10.1016/j.ahj.2004.11.030; Hagens VE, 2004, J AM COLL CARDIOL, V43, P241, DOI 10.1016/j.jacc.2003.08.037; Hemels MEW, 2006, J AM COLL CARDIOL, V48, P1001, DOI 10.1016/j.jacc.2006.05.043; Hohnloser SH, 2000, LANCET, V356, P1789, DOI 10.1016/S0140-6736(00)03230-X; HOLT DW, 1983, AM HEART J, V106, P840, DOI 10.1016/0002-8703(83)90006-6; Julian DG, 1997, LANCET, V349, P667, DOI 10.1016/S0140-6736(96)09145-3; KERIN NZ, 1989, J CLIN PHARMACOL, V29, P418, DOI 10.1002/j.1552-4604.1989.tb03354.x; Lafuente-Lafuente C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005049.pub2; Levy S, 1999, CIRCULATION, V99, P3028, DOI 10.1161/01.CIR.99.23.3028; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; Singh BN, 2005, NEW ENGL J MED, V352, P1861, DOI 10.1056/NEJMoa041705; Singh SN, 2006, J AM COLL CARDIOL, V48, P721, DOI 10.1016/j.jacc.2006.03.051; Tieleman RG, 1997, AM J CARDIOL, V79, P53, DOI 10.1016/S0002-9149(96)00675-3; TRIP MD, 1991, AM J MED, V91, P507, DOI 10.1016/0002-9343(91)90187-3; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; VanGelder IC, 1996, ARCH INTERN MED, V156, P2585, DOI 10.1001/archinte.156.22.2585; Vassallo P, 2007, JAMA-J AM MED ASSOC, V298, P1312, DOI 10.1001/jama.298.11.1312; Vorperian VR, 1997, J AM COLL CARDIOL, V30, P791, DOI 10.1016/S0735-1097(97)00220-9; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Zimetbaum P, 2007, NEW ENGL J MED, V356, P935, DOI 10.1056/NEJMct065916	30	62	63	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2008	300	15					1784	1792		10.1001/jama.300.15.1784	http://dx.doi.org/10.1001/jama.300.15.1784			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	359QA	18854540				2022-12-28	WOS:000260002000030
J	Deng, XZ; Yin, XL; Allan, R; Lu, DD; Maurer, CW; Haimovitz-Friedman, A; Fuks, Z; Shaham, S; Kolesnick, R				Deng, Xinzhu; Yin, Xianglei; Allan, Richard; Lu, Diane D.; Maurer, Carine W.; Haimovitz-Friedman, Adriana; Fuks, Zvi; Shaham, Shai; Kolesnick, Richard			Ceramide biogenesis is required for radiation-induced apoptosis in the germ line of C-elegans	SCIENCE			English	Article							PROGRAMMED CELL-DEATH; DNA-DAMAGE CHECKPOINT; CAENORHABDITIS-ELEGANS; EGL-1; MEMBRANE; CED-4; COMPLEX	Ceramide engagement in apoptotic pathways has been a topic of controversy. To address this controversy, we tested loss- of- function (lf) mutants of conserved genes of sphingolipid metabolism in Caenorhabditis elegans. Although somatic ( developmental) apoptosis was unaffected, ionizing radiation- induced apoptosis of germ cells was obliterated upon inactivation of ceramide synthase and restored upon microinjection of long- chain natural ceramide. Radiation- induced increase in the concentration of ceramide localized to mitochondria and was required for BH3- domain protein EGL-1-mediated displacement of CED-4 ( an APAF-1-like protein) from the CED-9 ( a Bcl-2 family member)/CED- 4 complex, an obligate step in activation of the CED-3 caspase. These studies define CEP-1 ( the worm homolog of the tumor suppressor p53)-mediated accumulation of EGL- 1 and ceramide synthase-mediated generation of ceramide through parallel pathways that integrate at mitochondrial membranes to regulate stress-induced apoptosis.	[Deng, Xinzhu; Yin, Xianglei; Allan, Richard; Lu, Diane D.; Kolesnick, Richard] Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA; [Maurer, Carine W.; Shaham, Shai] Rockefeller Univ, Lab Dev Genet, New York, NY 10021 USA; [Haimovitz-Friedman, Adriana; Fuks, Zvi] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University; Memorial Sloan Kettering Cancer Center	Kolesnick, R (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, 1275 York Ave, New York, NY 10021 USA.	r-kolesnick@ski.mskcc.org		Maurer, Carine/0000-0002-7892-7127	 [CA85704];  [CA105125-03];  [2R01HD42680-06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042680] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA105125, R01CA085704] Funding Source: NIH RePORTER	; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Caenorhabitis Genetics Center and National BioResource Project-Japan for the strains provided; H. R. Horwitz for the anti-CED-4 antibody; Y. Gruenbaum for the anti-Ce-lamin-antibody; M.O. Hengartner for the strain opls219; and S. Davidor, D. Chau, H. Lee, J. Mesicek, and the Molecular Cytology and Genomics Core Laboratory of MSKCC for the technical assistance. This work was supported by grants CA85704 (R.K.), CA105125-03 (A.H.-F.), and 2R01HD42680-06 (S.S.).	Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; De Vos K, 1998, J BIOL CHEM, V273, P9673, DOI 10.1074/jbc.273.16.9673; del Peso L, 2000, J BIOL CHEM, V275, P27205; Deng XZ, 2004, NAT GENET, V36, P906, DOI 10.1038/ng1396; DUERR JS, 2007, WORM BOOK; Fairlie WD, 2006, CELL DEATH DIFFER, V13, P426, DOI 10.1038/sj.cdd.4401762; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Geeraert L, 1997, BIOCHEM J, V327, P125, DOI 10.1042/bj3270125; Goni FM, 2006, BBA-BIOMEMBRANES, V1758, P1902, DOI 10.1016/j.bbamem.2006.09.011; Gulbins E, 2006, AM J PHYSIOL-REG I, V290, pR11, DOI 10.1152/ajpregu.00416.2005; Hofmann ER, 2002, CURR BIOL, V12, P1908, DOI 10.1016/S0960-9822(02)01262-9; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P374, DOI 10.1016/S0968-0004(98)01289-4; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; RIEZMAN H, COMMUNICATION; Schumacher B, 2005, CELL DEATH DIFFER, V12, P153, DOI 10.1038/sj.cdd.4401539; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Yan NG, 2004, MOL CELL, V15, P999, DOI 10.1016/j.molcel.2004.08.022; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030	21	136	161	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2008	322	5898					110	115		10.1126/science.1158111	http://dx.doi.org/10.1126/science.1158111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832646	Green Accepted			2022-12-28	WOS:000259680200049
J	Abdo, AA; Ackermann, M; Atwood, WB; Baldini, L; Ballet, J; Barbiellini, G; Baring, MG; Bastieri, D; Baughman, BM; Bechtol, K; Bellazzini, R; Berenji, B; Blandford, RD; Bloom, ED; Bogaert, G; Bonamente, E; Borgland, AW; Bregeon, J; Brez, A; Brigida, M; Bruel, P; Burnett, TH; Caliandro, GA; Cameron, RA; Caraveo, PA; Carlson, P; Casandjian, JM; Cecchi, C; Charles, E; Chekhtman, A; Cheung, CC; Chiang, J; Ciprini, S; Claus, R; Cohen-Tanugi, J; Cominsky, LR; Conrad, J; Cutini, S; Davis, DS; Dermer, CD; de Angelis, A; de Palma, F; Digel, SW; Dormody, M; Silva, EDE; Drell, PS; Dubois, R; Dumora, D; Edmonds, Y; Farnier, C; Focke, WB; Fukazawa, Y; Funk, S; Fusco, P; Gargano, F; Gasparrini, D; Gehrels, N; Germani, S; Giebels, B; Giglietto, N; Giordano, F; Glanzman, T; Godfrey, G; Grenier, IA; Grondin, MH; Grove, JE; Guillemot, L; Guiriec, S; Harding, AK; Hartman, RC; Hays, E; Hughes, RE; Johannesson, G; Johnson, AS; Johnson, RP; Johnson, TJ; Johnson, WN; Kamae, T; Kanai, Y; Kanbach, G; Katagiri, H; Kawai, N; Kerr, M; Kishishita, T; Kiziltan, B; Knodlseder, J; Kocian, ML; Komin, N; Kuehn, F; Kuss, M; Latronico, L; Lemoine-Goumard, M; Longo, F; Lonjou, V; Loparco, F; Lott, B; Lovellette, MN; Lubrano, P; Makeev, A; Marelli, M; Mazziotta, MN; McEnery, JE; McGlynn, S; Meurer, C; Michelson, PF; Mineo, T; Mitthumsiri, W; Mizuno, T; Moiseev, AA; Monte, C; Monzani, ME; Morselli, A; Moskalenko, IV; Murgia, S; Nakamori, T; Nolan, PL; Nuss, E; Ohno, M; Ohsugi, T; Okumura, A; Omodei, N; Orlando, E; Ormes, JF; Ozaki, M; Paneque, D; Panetta, JH; Parent, D; Pelassa, V; Pepe, M; Pesce-Rollins, M; Piano, G; Pieri, L; Piron, F; Porter, TA; Raino, S; Rando, R; Ray, PS; Razzano, M; Reimer, A; Reimer, O; Reposeur, T; Ritz, S; Rochester, LS; Rodriguez, AY; Romani, RW; Roth, M; Ryde, F; Sadrozinski, HFW; Sanchez, D; Sander, A; Parkinson, PMS; Schalk, TL; Sellerholm, A; Sgro, C; Siskind, EJ; Smith, DA; Smith, PD; Spandre, G; Spinelli, P; Starck, JL; Strickman, MS; Suson, DJ; Tajima, H; Takahashi, H; Takahashi, T; Tanaka, T; Thayer, JB; Thayer, JG; Thompson, DJ; Thorsett, SE; Tibaldo, L; Torres, DF; Tosti, G; Tramacere, A; Usher, TL; Van Etten, A; Vilchez, N; Vitale, V; Wang, P; Watters, K; Winer, BL; Wood, KS; Yasuda, H; Ylinen, T; Ziegler, M				Abdo, A. A.; Ackermann, M.; Atwood, W. B.; Baldini, L.; Ballet, J.; Barbiellini, G.; Baring, M. G.; Bastieri, D.; Baughman, B. M.; Bechtol, K.; Bellazzini, R.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Bogaert, G.; Bonamente, E.; Borgland, A. W.; Bregeon, J.; Brez, A.; Brigida, M.; Bruel, P.; Burnett, T. H.; Caliandro, G. A.; Cameron, R. A.; Caraveo, P. A.; Carlson, P.; Casandjian, J. M.; Cecchi, C.; Charles, E.; Chekhtman, A.; Cheung, C. C.; Chiang, J.; Ciprini, S.; Claus, R.; Cohen-Tanugi, J.; Cominsky, L. R.; Conrad, J.; Cutini, S.; Davis, D. S.; Dermer, C. D.; de Angelis, A.; de Palma, F.; Digel, S. W.; Dormody, M.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Dumora, D.; Edmonds, Y.; Farnier, C.; Focke, W. B.; Fukazawa, Y.; Funk, S.; Fusco, P.; Gargano, F.; Gasparrini, D.; Gehrels, N.; Germani, S.; Giebels, B.; Giglietto, N.; Giordano, F.; Glanzman, T.; Godfrey, G.; Grenier, I. A.; Grondin, M. -H.; Grove, J. E.; Guillemot, L.; Guiriec, S.; Harding, A. K.; Hartman, R. C.; Hays, E.; Hughes, R. E.; Johannesson, G.; Johnson, A. S.; Johnson, R. P.; Johnson, T. J.; Johnson, W. N.; Kamae, T.; Kanai, Y.; Kanbach, G.; Katagiri, H.; Kawai, N.; Kerr, M.; Kishishita, T.; Kiziltan, B.; Knodlseder, J.; Kocian, M. L.; Komin, N.; Kuehn, F.; Kuss, M.; Latronico, L.; Lemoine-Goumard, M.; Longo, F.; Lonjou, V.; Loparco, F.; Lott, B.; Lovellette, M. N.; Lubrano, P.; Makeev, A.; Marelli, M.; Mazziotta, M. N.; McEnery, J. E.; McGlynn, S.; Meurer, C.; Michelson, P. F.; Mineo, T.; Mitthumsiri, W.; Mizuno, T.; Moiseev, A. A.; Monte, C.; Monzani, M. E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Nakamori, T.; Nolan, P. L.; Nuss, E.; Ohno, M.; Ohsugi, T.; Okumura, A.; Omodei, N.; Orlando, E.; Ormes, J. F.; Ozaki, M.; Paneque, D.; Panetta, J. H.; Parent, D.; Pelassa, V.; Pepe, M.; Pesce-Rollins, M.; Piano, G.; Pieri, L.; Piron, F.; Porter, T. A.; Raino, S.; Rando, R.; Ray, P. S.; Razzano, M.; Reimer, A.; Reimer, O.; Reposeur, T.; Ritz, S.; Rochester, L. S.; Rodriguez, A. Y.; Romani, R. W.; Roth, M.; Ryde, F.; Sadrozinski, H. F. -W.; Sanchez, D.; Sander, A.; Parkinson, P. M. Saz; Schalk, T. L.; Sellerholm, A.; Sgro, C.; Siskind, E. J.; Smith, D. A.; Smith, P. D.; Spandre, G.; Spinelli, P.; Starck, J. -L.; Strickman, M. S.; Suson, D. J.; Tajima, H.; Takahashi, H.; Takahashi, T.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Thompson, D. J.; Thorsett, S. E.; Tibaldo, L.; Torres, D. F.; Tosti, G.; Tramacere, A.; Usher, T. L.; Van Etten, A.; Vilchez, N.; Vitale, V.; Wang, P.; Watters, K.; Winer, B. L.; Wood, K. S.; Yasuda, H.; Ylinen, T.; Ziegler, M.			The Fermi Gamma-Ray Space Telescope Discovers the Pulsar in the Young Galactic Supernova Remnant CTA 1	SCIENCE			English	Article							X-RAY; EMISSION; RADIO; RADIATION	Energetic young pulsars and expanding blast waves [ supernova remnants (SNRs)] are the most visible remains after massive stars, ending their lives, explode in core-collapse supernovae. The Fermi Gamma- Ray Space Telescope has unveiled a radio quiet pulsar located near the center of the compact synchrotron nebula inside the supernova remnant CTA 1. The pulsar, discovered through its gamma- ray pulsations, has a period of 316.86 milliseconds and a period derivative of 3.614 x 10(-13) seconds per second. Its characteristic age of 10(4) years is comparable to that estimated for the SNR. We speculate that most unidentified Galactic gamma- ray sources associated with star- forming regions and SNRs are such young pulsars.	[Kanbach, G.; Orlando, E.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Kawai, N.] RIKEN, Inst Phys & Chem Res, Cosm Radiat Lab, Wako, Saitama 3510198, Japan; [Kishishita, T.; Ohno, M.; Ozaki, M.; Takahashi, T.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Kiziltan, B.] Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA; [Knodlseder, J.; Vilchez, N.] UPS, CNRS, Ctr Etud Spatiale Rayonnements, F-31028 Toulouse 4, France; [Mineo, T.] Ist Astrofis Spaziale & Fis Cosmica Palermo, I-90146 Palermo, Italy; [Moiseev, A. A.] NASA, Goddard Space Flight Ctr, Ctr Res & Explorat Space Sci & Technol, Greenbelt, MD 20771 USA; [Morselli, A.; Piano, G.; Vitale, V.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Morselli, A.; Piano, G.; Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Okumura, A.] Univ Tokyo, Dept Phys, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Ormes, J. F.] Univ Denver, Dept Phys & Astron, Denver, CO 80208 USA; [Rodriguez, A. Y.; Torres, D. F.] CSIC, Inst Ciencies Espai, Inst Estud Espacials Catalunya, Barcelona 08193, Spain; [Siskind, E. J.] NYCB Real Time Comp Inc, Lattingtown, NY 11560 USA; [Suson, D. J.] Purdue Univ Calumet, Dept Chem & Phys, Hammond, IN 46323 USA; [Torres, D. F.] Inst Catalana Recerca & Estud Avancats, Barcelona, Spain; [Tramacere, A.] Consorzio Interuniv Fis Spaziale, I-10133 Turin, Italy; [Ylinen, T.] Univ Kalmar, Sch Pure & Appl Nat Sci, SE-39182 Kalmar, Sweden; [Abdo, A. A.] Natl Acad Sci, Natl Res Council, Washington, DC 20001 USA; [Abdo, A. A.; Chekhtman, A.; Davis, D. S.; Dermer, C. D.; Grove, J. E.; Johnson, W. N.; Lovellette, M. N.; Ray, P. S.; Strickman, M. S.; Wood, K. S.] USN, Res Lab, Div Space Sci, Washington, DC 20375 USA; [Ackermann, M.; Bechtol, K.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Edmonds, Y.; Focke, W. B.; Funk, S.; Glanzman, T.; Godfrey, G.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Kocian, M. L.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Paneque, D.; Panetta, J. H.; Reimer, A.; Reimer, O.; Rochester, L. S.; Romani, R. W.; Tajima, H.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Tramacere, A.; Usher, T. L.; Van Etten, A.; Wang, P.; Watters, K.] Stanford Univ, WW Hansen Expt Phys Lab, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA; [Ackermann, M.; Bechtol, K.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Edmonds, Y.; Focke, W. B.; Funk, S.; Glanzman, T.; Godfrey, G.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Kocian, M. L.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Paneque, D.; Panetta, J. H.; Reimer, A.; Reimer, O.; Rochester, L. S.; Romani, R. W.; Tajima, H.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Tramacere, A.; Usher, T. L.; Van Etten, A.; Wang, P.; Watters, K.] Stanford Univ, Stanford Linear Accelerator Ctr, Stanford, CA 94305 USA; [Atwood, W. B.; Dormody, M.; Johnson, R. P.; Porter, T. A.; Sadrozinski, H. F. -W.; Parkinson, P. M. Saz; Schalk, T. L.; Thorsett, S. E.; Ziegler, M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Dept Phys, Santa Cruz, CA 95064 USA; [Atwood, W. B.; Dormody, M.; Johnson, R. P.; Porter, T. A.; Sadrozinski, H. F. -W.; Parkinson, P. M. Saz; Schalk, T. L.; Thorsett, S. E.; Ziegler, M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Dept Astron, Santa Cruz, CA 95064 USA; [Baldini, L.; Bellazzini, R.; Bregeon, J.; Brez, A.; Kuss, M.; Latronico, L.; Omodei, N.; Pesce-Rollins, M.; Razzano, M.; Sgro, C.; Spandre, G.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Ballet, J.; Casandjian, J. M.; Grenier, I. A.; Komin, N.; Starck, J. -L.] Univ Paris Diderot, Serv Astrophys, Lab Astrophys Interact Multiechelles, CEA Saclay,CNRS, F-91191 Gif Sur Yvette, France; [Barbiellini, G.; Longo, F.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.] Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; [Baring, M. G.] Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA; [Bastieri, D.; Pieri, L.; Rando, R.; Tibaldo, L.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Bastieri, D.; Rando, R.; Tibaldo, L.] Univ Padua, Dipartimento Fis G Galilei, I-35131 Padua, Italy; [Baughman, B. M.; Hughes, R. E.; Kuehn, F.; Sander, A.; Smith, P. D.; Winer, B. L.] Ohio State Univ, Dept Phys, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; [Bogaert, G.; Bruel, P.; Giebels, B.; Sanchez, D.] Ecole Polytech, CNRS, Lab Leprince Ringuet, CNRS,IN2P3, F-91128 Palaiseau, France; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; [Brigida, M.; Caliandro, G. A.; de Palma, F.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Univ Politecn Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; Caliandro, G. A.; de Palma, F.; Fusco, P.; Gargano, F.; Giglietto, N.; Giordano, F.; Loparco, F.; Mazziotta, M. N.; Monte, C.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Burnett, T. H.; Kerr, M.; Roth, M.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Caraveo, P. A.; Marelli, M.] Ist Astrofis Spaziale & Fis Cosmica, Ist Nazl Astrofis, I-20133 Milan, Italy; [Carlson, P.; Conrad, J.; McGlynn, S.; Ryde, F.; Ylinen, T.] AlbaNova, Dept Phys, Royal Inst Technol Kungliga Tekn Hogskolan, SE-10691 Stockholm, Sweden; [Chekhtman, A.; Makeev, A.] George Mason Univ, Fairfax, VA 22030 USA; [Cheung, C. C.; Gehrels, N.; Harding, A. K.; Hartman, R. C.; Hays, E.; Johnson, T. J.; McEnery, J. E.; Ritz, S.; Thompson, D. J.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Cohen-Tanugi, J.; Farnier, C.; Guiriec, S.; Komin, N.; Nuss, E.; Pelassa, V.; Piron, F.] Univ Montpellier 2, Lab Phys Theor & Astroparticules, CNRS IN2P3, Montpellier, France; [Cominsky, L. R.] Sonoma State Univ, Dept Phys & Astron, Rohnert Pk, CA 94928 USA; [Conrad, J.; Meurer, C.; Sellerholm, A.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Cutini, S.; Gasparrini, D.] Agcy Spaziale Italiana Sci Data Ctr, I-00044 Frascati, Italy; [Davis, D. S.] Univ Maryland Baltimore Cty, Ctr Space Sci & Technol, Baltimore, MD 21250 USA; [de Angelis, A.] Univ Udine, Dipartimento Fis, I-33100 Udine, Italy; [de Angelis, A.] Ist Nazl Fis Nucl, Sez Trieste, Grp Coll Udine, I-33100 Udine, Italy; [Dumora, D.; Grondin, M. -H.; Guillemot, L.; Lemoine-Goumard, M.; Lonjou, V.; Lott, B.; Parent, D.; Reposeur, T.; Smith, D. A.] CEN Bordeaux Gradignan, CNRS, IN2P3, UMR 5797, F-33175 Gradignan, France; [Brez, A.; Dumora, D.; Grondin, M. -H.; Guillemot, L.; Lemoine-Goumard, M.; Lonjou, V.; Lott, B.; Parent, D.; Reposeur, T.; Smith, D. A.] Univ Bordeaux 1, CEN Bordeaux Gradignan, UMR 5797, F-33175 Gradignan, France; [Fukazawa, Y.; Katagiri, H.; Mizuno, T.; Ohsugi, T.; Takahashi, H.; Yasuda, H.] Hiroshima Univ, Dept Phys Sci, Higashihiroshima 7398526, Japan; [Fukazawa, Y.; Katagiri, H.; Mizuno, T.; Ohsugi, T.; Takahashi, H.; Yasuda, H.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Higashihiroshima 7398526, Japan; [Gehrels, N.; Johnson, T. J.; Ritz, S.] Univ Maryland, College Pk, MD 20742 USA; [Kanai, Y.; Kawai, N.; Nakamori, T.] Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528551, Japan	Max Planck Society; RIKEN; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of California System; University of California Santa Cruz; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Istituto Nazionale Astrofisica (INAF); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Istituto Nazionale di Fisica Nucleare (INFN); University of Rome Tor Vergata; University of Tokyo; University of Denver; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona; Purdue University System; Purdue University; ICREA; Linnaeus University; University of Kalmar; National Academies of Sciences, Engineering & Medicine; United States Department of Defense; United States Navy; Naval Research Laboratory; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Istituto Nazionale di Fisica Nucleare (INFN); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Rice University; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; University System of Ohio; Ohio State University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; Politecnico di Bari; Istituto Nazionale di Fisica Nucleare (INFN); University of Washington; University of Washington Seattle; Istituto Nazionale Astrofisica (INAF); George Mason University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; California State University System; Sonoma State University; Stockholm University; University System of Maryland; University of Maryland Baltimore County; University of Udine; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; Hiroshima University; Hiroshima University; University System of Maryland; University of Maryland College Park; Tokyo Institute of Technology	Kanbach, G (corresponding author), Max Planck Inst Extraterr Phys, Giessenbachstr, D-85748 Garching, Germany.	gok@mpe.mpg.de; kent.wood@nrl.navy.mil; ziegler@scipp.ucsc.edu	Giglietto, Nicola/Y-2425-2019; Hays, Elizabeth/D-3257-2012; Gargano, Fabio/AAD-5121-2021; Baldini, Luca/E-5396-2012; tramacere, andrea/B-9424-2012; Rando, Riccardo/M-7179-2013; Bastieri, Denis/AAC-5917-2020; Tosti, Gino/E-9976-2013; Ozaki, Masanobu/K-1165-2013; Gargano, Fabio/O-8934-2015; Bogaert, Gilles/GZA-8066-2022; Torres, Diego F/ABD-7940-2020; Jóhannesson, Guðlaugur/O-8741-2015; Okumura, Akira/I-2468-2014; Parkinson, Pablo Miguel Saz/I-7980-2013; Cutini, Sara/ABB-1787-2020; Takahashi, Hiromitsu H/T-2713-2017; Rando, Riccardo/O-1302-2019; giglietto, nicola/I-8951-2012; Jóhannesson, Guðlaugur/ABC-7216-2020; De Angelis, Alessandro/B-5372-2009; Thompson, David J/D-2939-2012; Reimer, Olaf/A-3117-2013; Loparco, Francesco/O-8847-2015; Morselli, Aldo/G-6769-2011; Torres, Diego F./O-9422-2016; Funk, Stefan/B-7629-2015; Reimer, Anita/K-5822-2015; Moskalenko, Igor V/A-1301-2007; Caraveo, Patrizia/AAL-5708-2020; McEnery, Julie E/D-6612-2012; Harding, Alice K/D-3160-2012; Gehrels, Neil/D-2971-2012; Tajima, Hiroyasu/I-6228-2014; Funk, Stefan/AAI-1568-2021; Starck, Jean-Luc/D-9467-2011; Torres, Diego F./AAF-7931-2019; Mazziotta, Mario N/O-8867-2015; Gasparrini, Dario/X-6699-2019; Orlando, Elena/R-5594-2016; Fukazawa, Yasushi/G-2081-2017; Johnson, Neil/G-3309-2014; lubrano, pasquale/F-7269-2012; Kuss, Michael W/H-8959-2012; Nolan, Patrick L/A-5582-2009; Sgrò, Carmelo/K-3395-2016; cohen-tanugi, Johann/ABB-1481-2021; Komin, Nukri/J-6781-2015	Giglietto, Nicola/0000-0002-9021-2888; Gargano, Fabio/0000-0002-5055-6395; tramacere, andrea/0000-0002-8186-3793; Bastieri, Denis/0000-0002-6954-8862; Gargano, Fabio/0000-0002-5055-6395; Bogaert, Gilles/0000-0003-2507-3866; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Okumura, Akira/0000-0002-3055-7964; Cutini, Sara/0000-0002-1271-2924; Takahashi, Hiromitsu H/0000-0001-6314-5897; Rando, Riccardo/0000-0001-6992-818X; giglietto, nicola/0000-0002-9021-2888; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Thompson, David J/0000-0001-5217-9135; Reimer, Olaf/0000-0001-6953-1385; Loparco, Francesco/0000-0002-1173-5673; Morselli, Aldo/0000-0002-7704-9553; Torres, Diego F./0000-0002-1522-9065; Funk, Stefan/0000-0002-2012-0080; Reimer, Anita/0000-0001-8604-7077; Moskalenko, Igor V/0000-0001-6141-458X; Caraveo, Patrizia/0000-0003-2478-8018; Tajima, Hiroyasu/0000-0002-1721-7252; Funk, Stefan/0000-0002-2012-0080; Starck, Jean-Luc/0000-0003-2177-7794; Torres, Diego F./0000-0002-1522-9065; Mazziotta, Mario N/0000-0001-9325-4672; Gasparrini, Dario/0000-0002-5064-9495; Orlando, Elena/0000-0001-6406-9910; Fukazawa, Yasushi/0000-0002-0921-8837; lubrano, pasquale/0000-0003-0221-4806; cohen-tanugi, Johann/0000-0001-9022-4232; Sadrozinski, Hartmut/0000-0003-0019-5410; Porter, Troy/0000-0002-2621-4440; de Palma, Francesco/0000-0001-5898-2834; Ciprini, Stefano/0000-0002-0712-2479; Komin, Nukri/0000-0003-3280-0582; Kiziltan, Bulent/0000-0002-7109-6391; Tibaldo, Luigi/0000-0001-7523-570X; Pepe, Monica/0000-0001-5624-4010; Baldini, Luca/0000-0002-9785-7726; Cameron, Robert/0000-0003-0942-2747; Spandre, Gloria/0000-0003-0802-3453; Piano, Giovanni/0000-0002-9332-5319; Monzani, Maria Elena/0000-0002-8254-5308; Casandjian, Jean-Marc/0000-0003-1404-0524; Omodei, Nicola/0000-0002-5448-7577; SPINELLI, Paolo/0000-0001-6688-8864; Fusco, Piergiorgio/0000-0002-9383-2425; Thorsett, Stephen/0000-0002-2025-9613; Johnson, Tyrel/0000-0002-2771-472X; Murgia, Simona/0000-0003-0516-9422; Tanaka, Takaaki/0000-0002-4383-0368; Grenier, Isabelle/0000-0003-3274-674X; Ray, Paul/0000-0002-5297-5278; SANCHEZ, David/0000-0002-7210-4496; Cecchi, Claudia/0000-0002-2192-8233; Pesce-Rollins, Melissa/0000-0003-1790-8018; Berenji, Bijan/0000-0002-4551-772X; Cheung, Chi (Teddy)/0000-0002-4377-0174; Sgro', Carmelo/0000-0001-5676-6214; Mineo, Teresa/0000-0002-4931-8445; De Angelis, Alessandro/0000-0002-3288-2517; Kerr, Matthew/0000-0002-0893-4073; Ackermann, Markus/0000-0001-8952-588X; Charles, Eric/0000-0002-3925-7802; Katagiri, Hideaki/0000-0003-2347-8819; RAZZANO, MASSIMILIANO/0000-0003-4825-1629	NASA; U. S. Department of Energy in the United States; Commissariat l'Energie Atomique; Centre National de la Recherche Scientifique/Institut National de Physique Nuclaire et de Physique des Particules in France; Agenzia Spaziale Italiana; Istituto Nazionale di Fisica Nucleare in Italy; Ministry of Education, Culture, Sports, Science and Technology, the High Energy Accelerator Research Organization,; JAXA in Japan; K.A. Wallenberg Foundation; Swedish National Space Board in Sweden; ICREA Funding Source: Custom	NASA(National Aeronautics & Space Administration (NASA)); U. S. Department of Energy in the United States(United States Department of Energy (DOE)); Commissariat l'Energie Atomique(French Atomic Energy Commission); Centre National de la Recherche Scientifique/Institut National de Physique Nuclaire et de Physique des Particules in France(Centre National de la Recherche Scientifique (CNRS)); Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI)); Istituto Nazionale di Fisica Nucleare in Italy(Istituto Nazionale di Fisica Nucleare (INFN)); Ministry of Education, Culture, Sports, Science and Technology, the High Energy Accelerator Research Organization,(High Energy Accelerator Research Organization (KEK)); JAXA in Japan; K.A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish National Space Board in Sweden; ICREA(ICREA)	The Fermi LAT Collaboration acknowledges the generous support of a number of agencies and institutes, including NASA and the U. S. Department of Energy in the United States; the Commissariat l'Energie Atomique and the Centre National de la Recherche Scientifique/Institut National de Physique Nuclaire et de Physique des Particules in France; the Agenzia Spaziale Italiana and the Istituto Nazionale di Fisica Nucleare in Italy; the Ministry of Education, Culture, Sports, Science and Technology, the High Energy Accelerator Research Organization, and JAXA in Japan, and the K.A. Wallenberg Foundation and the Swedish National Space Board in Sweden.	Atwood WB, 2006, ASTROPHYS J, V652, pL49, DOI 10.1086/510018; Baring MG, 2004, ADV SPACE RES-SERIES, V33, P552, DOI 10.1016/j.asr.2003.08.020; Brazier KTS, 1998, MON NOT R ASTRON SOC, V295, P819, DOI 10.1046/j.1365-8711.1998.01263.x; CASWELL JL, 1967, MON NOT R ASTRON SOC, V136, P11, DOI 10.1093/mnras/136.1.11; GOLD T, 1969, NATURE, V221, P25, DOI 10.1038/221025a0; Halpern JP, 2004, ASTROPHYS J, V612, P398, DOI 10.1086/422409; Harding AK, 2008, ASTROPHYS J, V680, P1378, DOI 10.1086/588037; HARRIS DE, 1960, PUBL ASTRON SOC PAC, V72, P237, DOI 10.1086/127521; HARRIS DE, 1962, ASTROPHYS J, V135, P661, DOI 10.1086/147310; Hartman RC, 1999, ASTROPHYS J SUPPL S, V123, P79, DOI 10.1086/313231; Hobbs GB, 2006, MON NOT R ASTRON SOC, V369, P655, DOI 10.1111/j.1365-2966.2006.10302.x; KANBACH G, 1996, A AS, V120, P461; Mavromatakis F, 2000, ASTRON ASTROPHYS, V353, P371; MICHELSON PF, 2007, P 1 GLAST S AM I PHY; PINEAULT S, 1993, ASTRON J, V105, P1060, DOI 10.1086/116493; Pineault S, 1997, ASTRON ASTROPHYS, V324, P1152; Ransom S.M., 2001, THESIS HARVARD U; ROMANI RW, 1995, ASTROPHYS J, V438, P314, DOI 10.1086/175076; Romani RW, 1996, ASTROPHYS J, V470, P469, DOI 10.1086/177878; SEWARD FD, 1995, ASTROPHYS J, V453, P284, DOI 10.1086/176388; SIEBER W, 1979, ASTRON ASTROPHYS, V74, P361; SIEBER W, 1981, ASTRON ASTROPHYS, V103, P393; Slane P, 2004, ASTROPHYS J, V601, P1045, DOI 10.1086/380498; Slane P, 1997, ASTROPHYS J, V485, P221, DOI 10.1086/304416; SMITH DA, ASTRON ASTRO IN PRES; STURNER SJ, 1996, A AS, V120, P445; Thompson DJ, 1996, ASTROPHYS J, V465, P385, DOI 10.1086/177427	28	87	88	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1218	1221		10.1126/science.1165572	http://dx.doi.org/10.1126/science.1165572			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	18927355	Green Submitted			2022-12-28	WOS:000261033400033
J	Bowler, C; Allen, AE; Badger, JH; Grimwood, J; Jabbari, K; Kuo, A; Maheswari, U; Martens, C; Maumus, F; Otillar, RP; Rayko, E; Salamov, A; Vandepoele, K; Beszteri, B; Gruber, A; Heijde, M; Katinka, M; Mock, T; Valentin, K; Verret, F; Berges, JA; Brownlee, C; Cadoret, JP; Chiovitti, A; Choi, CJ; Coesel, S; De Martino, A; Detter, JC; Durkin, C; Falciatore, A; Fournet, J; Haruta, M; Huysman, MJJ; Jenkins, BD; Jiroutova, K; Jorgensen, RE; Joubert, Y; Kaplan, A; Kroger, N; Kroth, PG; La Roche, J; Lindquist, E; Lommer, M; Martin-Jezequel, V; Lopez, PJ; Lucas, S; Mangogna, M; McGinnis, K; Medlin, LK; Montsant, A; Oudot-Le Secq, MP; Napoli, C; Obornik, M; Parker, MS; Petit, JL; Porcel, BM; Poulsen, N; Robison, M; Rychlewski, L; Rynearson, TA; Schmutz, J; Shapiro, H; Siaut, M; Stanley, M; Sussman, MR; Taylor, AR; Vardi, A; von Dassow, P; Vyverman, W; Willis, A; Wyrwicz, LS; Rokhsar, DS; Weissenbach, J; Armbrust, EV; Green, BR; Van De Peer, Y; Grigoriev, IV				Bowler, Chris; Allen, Andrew E.; Badger, Jonathan H.; Grimwood, Jane; Jabbari, Kamel; Kuo, Alan; Maheswari, Uma; Martens, Cindy; Maumus, Florian; Otillar, Robert P.; Rayko, Edda; Salamov, Asaf; Vandepoele, Klaas; Beszteri, Bank; Gruber, Ansgar; Heijde, Marc; Katinka, Michael; Mock, Thomas; Valentin, Klaus; Verret, Frederic; Berges, John A.; Brownlee, Colin; Cadoret, Jean-Paul; Chiovitti, Anthony; Choi, Chang Jae; Coesel, Sacha; De Martino, Alessandra; Detter, J. Chris; Durkin, Colleen; Falciatore, Angela; Fournet, Jerome; Haruta, Miyoshi; Huysman, Marie J. J.; Jenkins, Bethany D.; Jiroutova, Katerina; Jorgensen, Richard E.; Joubert, Yolaine; Kaplan, Aaron; Kroger, Nils; Kroth, Peter G.; La Roche, Julie; Lindquist, Erica; Lommer, Markus; Martin-Jezequel, Veronique; Lopez, Pascal J.; Lucas, Susan; Mangogna, Manuela; McGinnis, Karen; Medlin, Linda K.; Montsant, Anton; Oudot-Le Secq, Marie-Pierre; Napoli, Carolyn; Obornik, Miroslav; Parker, Micaela Schnitzler; Petit, Jean-Louis; Porcel, Betina M.; Poulsen, Nicole; Robison, Matthew; Rychlewski, Leszek; Rynearson, Tatiana A.; Schmutz, Jeremy; Shapiro, Harris; Siaut, Magali; Stanley, Michele; Sussman, Michael R.; Taylor, Alison R.; Vardi, Assaf; von Dassow, Peter; Vyverman, Wim; Willis, Anusuya; Wyrwicz, Lucjan S.; Rokhsar, Daniel S.; Weissenbach, Jean; Armbrust, E. Virginia; Green, Beverley R.; Van de Peer, Yves; Grigoriev, Igor V.			The Phaeodactylum genome reveals the evolutionary history of diatom genomes	NATURE			English	Article							RECIPROCAL GENE LOSS; THALASSIOSIRA-PSEUDONANA; BACILLARIOPHYCEAE; METABOLISM; MECHANISMS; COMPONENTS; BACTERIA; YEASTS	Diatoms are photosynthetic secondary endosymbionts found throughout marine and freshwater environments, and are believed to be responsible for around one- fifth of the primary productivity on Earth(1,2). The genome sequence of the marine centric diatom Thalassiosira pseudonana was recently reported, revealing a wealth of information about diatom biology(3-5). Here we report the complete genome sequence of the pennate diatom Phaeodactylum tricornutum and compare it with that of T. pseudonana to clarify evolutionary origins, functional significance and ubiquity of these features throughout diatoms. In spite of the fact that the pennate and centric lineages have only been diverging for 90 million years, their genome structures are dramatically different and a substantial fraction of genes (similar to 40%) are not shared by these representatives of the two lineages. Analysis of molecular divergence compared with yeasts and metazoans reveals rapid rates of gene diversification in diatoms. Contributing factors include selective gene family expansions, differential losses and gains of genes and introns, and differential mobilization of transposable elements. Most significantly, we document the presence of hundreds of genes from bacteria. More than 300 of these gene transfers are found in both diatoms, attesting to their ancient origins, and many are likely to provide novel possibilities for metabolite management and for perception of environmental signals. These findings go a long way towards explaining the incredible diversity and success of the diatoms in contemporary oceans.	[Bowler, Chris; Allen, Andrew E.; Jabbari, Kamel; Maheswari, Uma; Maumus, Florian; Rayko, Edda; Heijde, Marc; De Martino, Alessandra; Lopez, Pascal J.; Montsant, Anton; Vardi, Assaf] Ecole Normale Super, CNRS, Dept Biol, UMR8186, F-75005 Paris, France; [Bowler, Chris; Coesel, Sacha; Falciatore, Angela; Mangogna, Manuela; Montsant, Anton; Siaut, Magali] Stn Zool A Dohrn, I-80121 Naples, Italy; [Allen, Andrew E.; Badger, Jonathan H.] J Craig Venter Inst, San Diego, CA 92121 USA; [Grimwood, Jane; Schmutz, Jeremy] Stanford Human Genome Ctr, Joint Genome Inst Stanford, Palo Alto, CA 94304 USA; [Kuo, Alan; Otillar, Robert P.; Salamov, Asaf; Detter, J. Chris; Lindquist, Erica; Lucas, Susan; Shapiro, Harris; Rokhsar, Daniel S.; Grigoriev, Igor V.] Joint Genome Inst, Walnut Creek, CA 94598 USA; [Martens, Cindy; Vandepoele, Klaas; Huysman, Marie J. J.; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Beszteri, Bank; Valentin, Klaus; Medlin, Linda K.] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Gruber, Ansgar; Kroth, Peter G.] Univ Konstanz, Fachbereich Biol, D-78457 Constance, Germany; [Katinka, Michael; Petit, Jean-Louis; Porcel, Betina M.; Weissenbach, Jean] CNRS, CEA Inst Genom, UMR 8030, F-91057 Evry, France; [Mock, Thomas; Durkin, Colleen; Parker, Micaela Schnitzler; Armbrust, E. Virginia] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Verret, Frederic; Brownlee, Colin; Medlin, Linda K.; Taylor, Alison R.] Marine Biol Assoc United Kingdom Lab, Plymouth PL1 2PB, Devon, England; [Berges, John A.; Choi, Chang Jae] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Cadoret, Jean-Paul] IFREMER, PBA, F-44311 Nantes 03, France; [Chiovitti, Anthony; Willis, Anusuya] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia; [Fournet, Jerome; Joubert, Yolaine; Martin-Jezequel, Veronique] Univ Nantes, Lab Mer Mol Sante, Fac Tech Sci, EA 2160, F-44322 Nantes 3, France; [Haruta, Miyoshi; Robison, Matthew; Sussman, Michael R.] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53706 USA; [Huysman, Marie J. J.; Vyverman, Wim] Univ Ghent, Lab Protistol & Aquat Ecol, B-9000 Ghent, Belgium; [Jenkins, Bethany D.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA; [Jenkins, Bethany D.] Univ Rhode Isl, Grad Sch Oceanog, Kingston, RI 02881 USA; [Jiroutova, Katerina; Obornik, Miroslav] Acad Sci Czech Republic, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Jiroutova, Katerina; Obornik, Miroslav] Univ S Bohemia, Fac Sci, CR-37005 Ceske Budejovice, Czech Republic; [Jorgensen, Richard E.; McGinnis, Karen; Napoli, Carolyn] Univ Arizona, Bio5 Inst, Tucson, AZ 85719 USA; [Jorgensen, Richard E.; McGinnis, Karen; Napoli, Carolyn] Univ Arizona, Dept Plant Sci, Tucson, AZ 85719 USA; [Kaplan, Aaron] Hebrew Univ Jerusalem, Dept Plant & Environm Sci, IL-91904 Jerusalem, Israel; [Kroger, Nils] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Kroger, Nils] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; [Kroger, Nils] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [La Roche, Julie; Lommer, Markus] Leibniz Inst Marine Sci, D-24105 Kiel, Germany; [Oudot-Le Secq, Marie-Pierre; Green, Beverley R.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Poulsen, Nicole] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Rychlewski, Leszek; Wyrwicz, Lucjan S.] BioInfoBank Inst, PL-60744 Poznan, Poland; [Rynearson, Tatiana A.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Stanley, Michele] Dunstaffnage Marine Res Lab, Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland; [Taylor, Alison R.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28403 USA; [Vardi, Assaf] Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Grp, New Brunswick, NJ 08901 USA; [von Dassow, Peter] CNRS, Biol Stn, UMR7144, F-29682 Roscoff, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Stazione Zoologica Anton Dohrn di Napoli; J. Craig Venter Institute; Stanford University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Flanders Institute for Biotechnology (VIB); Ghent University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Konstanz; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; University of Washington; University of Washington Seattle; Marine Biological Association United Kingdom; University of Wisconsin System; University of Wisconsin Milwaukee; Ifremer; University of Melbourne; Nantes Universite; University of Wisconsin System; University of Wisconsin Madison; Ghent University; University of Rhode Island; University of Rhode Island; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Arizona; University of Arizona; Hebrew University of Jerusalem; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of British Columbia; University System of Georgia; Georgia Institute of Technology; University of Rhode Island; UHI Millennium Institute; University of North Carolina; University of North Carolina Wilmington; Rutgers State University New Brunswick; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Bowler, C (corresponding author), Ecole Normale Super, CNRS, Dept Biol, UMR8186, 46 Rue Ulm, F-75005 Paris, France.	cbowler@biologie.ens.fr	Allen, Andrew E/C-4896-2012; Stanley, Michele S/D-5859-2013; Kroth, Peter G/A-9728-2008; Vandepoele, Klaas/E-7514-2010; Falciatore, Angela/Q-6161-2018; Kaplan, Aaron/GLN-5655-2022; Valentin, Klaus/G-5862-2014; Heijde, Marc/O-8958-2014; Wilis, Anusuya/AAV-6917-2020; Willis, Anusuya/B-6712-2013; Bowler, Chris/AAC-6256-2019; Obornik, Miroslav/G-9350-2014; Van de Peer, Yves/D-4388-2009; Coesel, Sacha/AAX-5588-2021; Green, Beverley R./AAJ-5199-2021; Dasseville, Renaat/B-3561-2010; Beszteri, Bank M/D-1961-2010; Schmutz, Jeremy/N-3173-2013; von Dassow, Peter/A-5399-2012; Berges, John A/D-9520-2012; Maumus, Florian/O-5426-2016; Mock, Thomas/A-3127-2008; Gruber, Ansgar/B-9587-2008; Grimwood, Jane/ABD-5737-2021; medlin, linda k/G-4820-2010; LaRoche, Julie/A-1109-2010; Van de Peer, Yves/AAE-7666-2019; Wyrwicz, Lucjan/ABD-6558-2021; Lopez, Pascal Jean/A-7427-2011; Lopez, Pascal Jean/P-5813-2019	Allen, Andrew E/0000-0001-5911-6081; Kroth, Peter G/0000-0003-4734-8955; Vandepoele, Klaas/0000-0003-4790-2725; Valentin, Klaus/0000-0001-7401-9423; Wilis, Anusuya/0000-0003-0829-7446; Van de Peer, Yves/0000-0003-4327-3730; Coesel, Sacha/0000-0001-9422-8388; Green, Beverley R./0000-0002-4021-9387; Beszteri, Bank M/0000-0002-6852-1588; Schmutz, Jeremy/0000-0001-8062-9172; Berges, John A/0000-0002-3124-4783; Maumus, Florian/0000-0001-7325-0527; Mock, Thomas/0000-0001-9604-0362; Gruber, Ansgar/0000-0002-5876-4391; Van de Peer, Yves/0000-0003-4327-3730; Wyrwicz, Lucjan/0000-0003-0808-6892; Lopez, Pascal Jean/0000-0002-9914-4252; Porcel, Betina/0000-0003-0169-5302; LaRoche, Julie/0000-0003-4809-6411; Parker, Micaela/0000-0003-1007-4612; martin-jezequel, veronique/0000-0002-6633-1334; heijde, marc/0000-0002-8109-8999; Falciatore, Angela/0000-0003-3318-9578; von Dassow, Peter/0000-0002-1858-1953; Choi, Chang Jae/0000-0002-0831-7470; Verret, Frederic/0000-0002-8175-7325; Bowler, Chris/0000-0003-3835-6187; Cadoret, Jean-Paul/0000-0001-7542-5474; Petit, Jean-Louis/0000-0002-8566-0571; Stanley, Michele/0000-0002-2348-3231; Fournet, jerome/0000-0001-8595-9971; Poulsen, Nicole/0000-0002-4533-8860; Shunmugam, Uma/0000-0001-7007-9234; Grigoriev, Igor/0000-0002-3136-8903; Kaplan, Aaron/0000-0002-0815-5731; Vardi, Assaf/0000-0002-7079-0234	EU-funded FP6 Diatomics [LSHG-CT-2004-512035]; EU-FP6 Marine Genomics Network of Excellence [GOCE-CT-2004-505403]; ATIP 'Blanche'; CNRS (France); Agence Nationale de la Recherche (France); NERC [mba010002, dml010007] Funding Source: UKRI; Natural Environment Research Council [mba010002, dml010007] Funding Source: researchfish	EU-funded FP6 Diatomics(European Commission); EU-FP6 Marine Genomics Network of Excellence(European Commission); ATIP 'Blanche'; CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Diatom genome sequencing at the JGI (USA) was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory, under contract no. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under contract no. DE-AC52-07NA27344 and Los Alamos National Laboratory under contract no. DE-AC02-06NA25396. P. tricornutum ESTs were generated at Genoscope (France). Funding for this work was also obtained from the EU-funded FP6 Diatomics project (LSHG-CT-2004-512035), the EU-FP6 Marine Genomics Network of Excellence (GOCE-CT-2004-505403), an ATIP 'Blanche' grant from the CNRS (France) and the Agence Nationale de la Recherche (France). We are grateful to M. Muffato and H.-R. Crollius for the analysis reported in Supplementary Fig. 3a.	Allen AE, 2006, CURR OPIN PLANT BIOL, V9, P264, DOI 10.1016/j.pbi.2006.03.013; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bhattacharya D, 2007, BIOESSAYS, V29, P1239, DOI 10.1002/bies.20671; Carpenter EJ, 2000, J PHYCOL, V36, P540, DOI 10.1046/j.1529-8817.2000.99163.x; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kooistra Wiebe H. C. F., 2007, P207; Kroger N, 2007, CURR OPIN CHEM BIOL, V11, P662, DOI 10.1016/j.cbpa.2007.10.009; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Martens C, 2008, P NATL ACAD SCI USA, V105, P3427, DOI 10.1073/pnas.0712248105; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Montsant A, 2007, J PHYCOL, V43, P585, DOI 10.1111/j.1529-8817.2007.00342.x; Oudot-Le Secq MP, 2007, MOL GENET GENOMICS, V277, P427, DOI 10.1007/s00438-006-0199-4; Purcell EB, 2007, P NATL ACAD SCI USA, V104, P18241, DOI 10.1073/pnas.0705887104; Roy SW, 2007, MOL BIOL EVOL, V24, P1447, DOI 10.1093/molbev/msm048; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Schmid AMM, 2003, J PHYCOL, V39, P122, DOI 10.1046/j.1529-8817.2003.02084.x; Semon M, 2007, TRENDS GENET, V23, P108, DOI 10.1016/j.tig.2007.01.003; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; Sumper M, 2008, CHEMBIOCHEM, V9, P1187, DOI 10.1002/cbic.200700764; Swartz TE, 2007, SCIENCE, V317, P1090, DOI 10.1126/science.1144306; Takahashi F, 2007, P NATL ACAD SCI USA, V104, P19625, DOI 10.1073/pnas.0707692104; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Zehr JP, 2000, TRENDS MICROBIOL, V8, P68, DOI 10.1016/S0966-842X(99)01670-4	30	1153	1239	19	435	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2008	456	7219					239	244		10.1038/nature07410	http://dx.doi.org/10.1038/nature07410			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	18923393	Green Published, hybrid			2022-12-28	WOS:000261039300040
J	Calonge, N; Petitti, DB; DeWitt, TG; Dietrich, AJ; Gregory, KD; Harris, R; Isham, G; LeFevre, ML; Leipzig, RM; Loveland-Cherry, C; Marion, LN; Melnyk, B; Moyer, VA; Ockene, JK; Sawaya, GF; Yawn, BP				Calonge, Ned; Petitti, Diana B.; DeWitt, Thomas G.; Dietrich, Allen J.; Gregory, Kimberly D.; Harris, Russell; Isham, George; LeFevre, Michael L.; Leipzig, Roseanne M.; Loveland-Cherry, Carol; Marion, Lucy N.; Melnyk, Bernadette; Moyer, Virginia A.; Ockene, Judith K.; Sawaya, George F.; Yawn, Barbara P.		US Preventive Serv Task Force	Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							VIRTUAL DISSECTION; TESTS; COLONOSCOPY; NATION; TRENDS; IMPACT; RISK	Description: Update of the 2002 U. S. Preventive Services Task Force (USPSTF) recommendation statement on screening for colorectal cancer. Methods: To update its recommendation, the USPSTF commissioned 2 studies: 1) a targeted systematic evidence review on 4 selected questions relating to test characteristics and benefits and harms of screening technologies, and 2) a decision analytic modeling analysis using population modeling techniques to compare the expected health outcomes and resource requirements of available screening modalities when used in a programmatic way over time. Recommendations: The USPSTF recommends screening for colorectal cancer using fecal occult blood testing, sigmoidoscopy, or colonoscopy in adults, beginning at age 50 years and continuing until age 75 years. The risks and benefits of these screening methods vary. (A recommendation) The USPSTF recommends against routine screening for colorectal cancer in adults 76 to 85 years of age. There may be considerations that support colorectal cancer screening in an individual patient. (C recommendation) The USPSTF recommends against screening for colorectal cancer in adults older than age 85 years. (D recommendation) The USPSTF concludes that the evidence is insufficient to assess the benefits and harms of computed tomographic colonography and fecal DNA testing as screening modalities for colorectal cancer. (I statement)	[Calonge, Ned] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Petitti, Diana B.] Univ So Calif, Keck Sch Med, Sierra Madre, CA USA; [DeWitt, Thomas G.] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Dietrich, Allen J.] Dartmouth Med Sch, Hanover, NH USA; [Gregory, Kimberly D.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Harris, Russell] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Isham, George] HealthPartners Inc, Minneapolis, MN USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, Columbia, MO USA; [Leipzig, Roseanne M.] Mt Sinai Sch Med, New York, NY USA; [Loveland-Cherry, Carol] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Marion, Lucy N.] Med Coll Georgia, Sch Nursing, Augusta, GA 30912 USA; [Melnyk, Bernadette] Arizona State Univ, Coll Nursing & Healthcare Innovat, Phoenix, AZ USA; [Moyer, Virginia A.] Univ Texas Hlth Sci Ctr, Houston, TX USA; [Ockene, Judith K.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Sawaya, George F.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Yawn, Barbara P.] Olmsted Med Ctr, Rochester, MN USA	Colorado Department of Public Health & Environment; University of Southern California; Cincinnati Children's Hospital Medical Center; Dartmouth College; Cedars Sinai Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Missouri System; University of Missouri Columbia; Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan; University System of Georgia; Augusta University; Arizona State University; Arizona State University-Downtown Phoenix; University of Texas System; University of Texas Health Science Center Houston; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; Olmsted Medical Center	Calonge, N (corresponding author), Colorado Dept Publ Hlth & Environm, Denver, CO USA.		Melnyk, Bernadette J/E-9868-2013; Harper, Diane M./I-2180-2014	Harper, Diane M./0000-0001-7648-883X	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The U. S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	*AM CANC SOC, 2005, COL CANC FACTS FIG; American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V110, P1199; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; Burch JA, 2007, J MED SCREEN, V14, P132, DOI 10.1258/096914107782066220; Canadian Task Force on Preventive Health Care, 2001, CMAJ, V165, P206; *COL CANC STUD GRO, 2004, NEW ENGL J MED, V351, P2704; Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation Board on Radiation Effects Research Division on Earth and Life Studies National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; Espey DK, 2007, CANCER-AM CANCER SOC, V110, P2119, DOI 10.1002/cncr.23044; Haug U, 2005, INT J CANCER, V117, P169, DOI 10.1002/ijc.21016; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Itoh M, 1996, J Med Screen, V3, P66; Johnson CD, 2007, AM J ROENTGENOL, V189, P672, DOI 10.2214/AJR.07.2354; Kim DH, 2008, CURR PROBL DIAGN RAD, V37, P165, DOI 10.1067/j.cpradiol.2007.10.004; Kim SH, 2007, RADIOLOGY, V244, P852, DOI 10.1148/radiol.2443060934; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Maciosek MV, 2006, AM J PREV MED, V31, P80, DOI 10.1016/j.amepre.2006.03.009; Petrone TJ, 1996, HEALTH PHYS, V70, P488, DOI 10.1097/00004032-199604000-00005; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Pignone M, 2002, ANN INTERN MED, V137, P96, DOI 10.7326/0003-4819-137-2-200207160-00007; Regueiro C, 2006, GASTROENTEROLOGY, V131, P1287, DOI 10.1053/j.gastro.2006.08.017; Ries LAG, 2007, SEER CANC STAT REV 1; US Cancer Statistics Working Group, 2007, US CANC STAT 2004 IN; Whitlock EP, 2008, AHRQ PUBLICATION, V08-E014; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Winawer Sidney J., 1999, American Journal of Medicine, V106, p3S, DOI 10.1016/S0002-9343(98)00338-6; Young GP, 2007, DIGESTION, V76, P26, DOI 10.1159/000108391; Zauber A, 2008, AHRQ PUBLICATION; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	30	1153	1172	0	51	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2008	149	9					627	+		10.7326/0003-4819-149-9-200811040-00243	http://dx.doi.org/10.7326/0003-4819-149-9-200811040-00243			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367XK	18838716	Green Submitted			2022-12-28	WOS:000260585700004
J	Zauber, AG; Lansdorp-Vogelaar, I; Knudsen, AB; Wilschut, J; van Ballegooijen, M; Kuntz, KM				Zauber, Ann G.; Lansdorp-Vogelaar, Iris; Knudsen, Amy B.; Wilschut, Janneke; van Ballegooijen, Marjolein; Kuntz, Karen M.			Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							LARGE-INTESTINE; LARGE-BOWEL; CLINICAL GUIDELINES; COST-EFFECTIVENESS; POLYPS; SURVEILLANCE; COLONOSCOPY; MORTALITY; PREVALENCE; CAPACITY	Background: The U. S. Preventive Services Task Force requested a decision analysis to inform their update of recommendations for colorectal cancer screening. Objective: To assess life-years gained and colonoscopy requirements for colorectal cancer screening strategies and identify a set of recommendable screening strategies. Design: Decision analysis using 2 colorectal cancer microsimulation models from the Cancer Intervention and Surveillance Modeling Network. Data Sources: Derived from the literature. Target Population: U. S. average-risk 40-year-old population. Perspective: Societal. Time Horizon: Lifetime. Interventions: Fecal occult blood tests (FOBTs), flexible sigmoidoscopy, or colonoscopy screening beginning at age 40, 50, or 60 years and stopping at age 75 or 85 years, with screening intervals of 1, 2, or 3 years for FOBT and 5, 10, or 20 years for sigmoidoscopy and colonoscopy. Outcome Measures: Number of life-years gained compared with no screening and number of colonoscopies and noncolonoscopy tests required. Results of Base-Case Analysis: Beginning screening at age 50 years was consistently better than at age 60. Decreasing the stop age from 85 to 75 years decreased life-years gained by 1% to 4%, whereas colonoscopy use decreased by 4% to 15%. Assuming equally high adherence, 4 strategies provided similar life-years gained: colonoscopy every 10 years, annual Hemoccult SENSA (Beckman Coulter, Fullerton, California) testing or fecal immunochemical testing, and sigmoidoscopy every 5 years with midinterval Hemoccult SENSA testing. Annual Hemoccult II and flexible sigmoidoscopy every 5 years alone were less effective. Results of Sensitivity Analysis: The results were most sensitive to beginning screening at age 40 years. Limitation: The stop age for screening was based only on chronologic age. Conclusion: The findings support colorectal cancer screening with the following: colonoscopy every 10 years, annual screening with a sensitive FOBT, or flexible sigmoidoscopy every 5 years with a midinterval sensitive FOBT from age 50 to 75 years.	[Zauber, Ann G.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; Erasmus MC, Rotterdam, Netherlands; Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Minnesota, Minneapolis, MN USA	Memorial Sloan Kettering Cancer Center; Erasmus University Rotterdam; Erasmus MC; Harvard University; Massachusetts General Hospital; University of Minnesota System; University of Minnesota Twin Cities	Zauber, AG (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 307 E 63rd St, New York, NY 10065 USA.	zaubera@mskcc.org		Wilschut, Janneke/0000-0002-4921-227X	National Cancer Institute [U01-CA-088204, U01-CA-097426, U01-CA-115953]; Agency for Healthcare Research and Quality [HHSP233200700350P, HHSP233200700210P, HHSP233200700196P]; NATIONAL CANCER INSTITUTE [U01CA097426, U01CA115953, U01CA088204, P30CA008748] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute (U01-CA-088204, U01-CA-097426, and U01-CA-115953) and the Agency for Healthcare Research and Quality (HHSP233200700350P, HHSP233200700210P, and HHSP233200700196P).	*AM CANC SOC, CANC FACTS FIG 2008; Arias Elizabeth, 2006, Natl Vital Stat Rep, V54, P1; ARMINSKI T. C., 1964, DIS COLON RECTUM, V7, P249, DOI 10.1007/BF02630528; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; Blatt LJ., 1961, DIS COLON RECTUM, V4, P277; BOMBI JA, 1988, CANCER-AM CANCER SOC, V61, P1472, DOI 10.1002/1097-0142(19880401)61:7<1472::AID-CNCR2820610734>3.0.CO;2-E; Breslow RA, 2008, AM J PREV MED, V35, pS14, DOI 10.1016/j.amepre.2008.04.005; Brown ML, 2003, AM J MED, V115, P129, DOI 10.1016/S0002-9343(03)00297-3; CHAPMAN I, 1963, ANN SURG, V157, P223, DOI 10.1097/00000658-196302000-00007; CLARK JC, 1985, INT J CANCER, V36, P179, DOI 10.1002/ijc.2910360209; Espey DK, 2007, CANCER-AM CANCER SOC, V110, P2119, DOI 10.1002/cncr.23044; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; JASS JR, 1992, GUT, V33, P1508, DOI 10.1136/gut.33.11.1508; JOHANNSEN LGK, 1989, SCAND J GASTROENTERO, V24, P799, DOI 10.3109/00365528909089217; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Loeve F, 1999, COMPUT BIOMED RES, V32, P13, DOI 10.1006/cbmr.1998.1498; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Mark DH, 2002, JAMA-J AM MED ASSOC, V287, P2428, DOI 10.1001/jama.287.18.2428; Mysliwiec PA, 2004, ANN INTERN MED, V141, P264, DOI 10.7326/0003-4819-141-4-200408170-00006; Rex DK, 2006, AM J GASTROENTEROL, V101, P873, DOI 10.1111/j.1572-0241.2006.00673.x; RICKERT RR, 1979, CANCER-AM CANCER SOC, V43, P1847, DOI 10.1002/1097-0142(197905)43:5<1847::AID-CNCR2820430538>3.0.CO;2-L; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1661, DOI 10.1053/j.gastro.2004.09.052; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT DAT INC SE; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Vogelaar I, 2006, CANCER-AM CANCER SOC, V107, P1624, DOI 10.1002/cncr.22115; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 2006, CA-CANCER J CLIN, V56, P143, DOI 10.3322/canjclin.56.3.143; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; ZAUBER AG, COST EFFECTIVENESS D	38	448	451	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2008	149	9					659	+		10.7326/0003-4819-149-9-200811040-00244	http://dx.doi.org/10.7326/0003-4819-149-9-200811040-00244			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367XK	18838717	Green Accepted			2022-12-28	WOS:000260585700006
J	Astrup, A; Madsbad, S; Breum, L; Jensen, TJ; Kroustrup, JP; Larsen, TM				Astrup, Arne; Madsbad, Sten; Breum, Leif; Jensen, Thomas J.; Kroustrup, Jens Peter; Larsen, Thomas Meinert			Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							WEIGHT-LOSS; PHYSICAL-ACTIVITY; SIBUTRAMINE; METAANALYSIS; OVERWEIGHT; REPRODUCIBILITY; RIMONABANT; MORTALITY; RESPONSES; VALIDITY	Background Weight-loss drugs produce an additional mean weight loss of only 3-5 kg above that of diet arid placebo over 6 months, and more effective pharmacotherapy of obesity is needed. We assessed the efficacy and safety of tesofensine-an inhibitor of the presynaptic uptake of noradrenaline, dopamine, and serotonin-in patients with obesity. Methods We undertook a phase II, randomised, double-blind, placebo-co n trolled trial in five Danish obesity management centres. After a 2 week run-in phase, 203 obese patients (body-mass index 30-<= 40 kg/m(2)) were prescribed an energy restricted diet and randomly assigned with a list of randomisation numbers to treatment with tesofensine 0 . 25 mg (n=52), 0.5 mg (n=50), or 1 . 0 mg (n=49), or placebo (n=52) once daily for 24 weeks. The primary outcome was percentage change in bodyweight. Analysis was by modified intention to treat (all randomised patients with measurement after at least one dose of study drug or placebo). The study is registered with ClinicalTrials.gov, number NCT00394667. Findings 161 (79%) participants completed the study. After 24 weeks, the mean weight loss produced by diet and placebo was 2.0% (SE 0. 60). Tesofensine 0 . 25 mg, 0. 5 ing, and 1. 0 mg and diet induced a mean weight loss of 4.5% (0 . 87), 9.2% (0.91), and 10 . 6% (0-84), respectively, greater than diet and placebo (p<0. 0001). The most common adverse events caused by tesofensine were dry mouth, nausea, constipation, hard stools, diarrhoea, and insomnia. After 24 weeks, tesofensine 0 . 25 mg and 0 . 5 mg showed no significant increases in systolic or diastolic blood pressure compared with placebo, whereas heart rate was increased by 7.4 beats per min in the tesofensine 0. 5 mg group (p = 0. 0001). Interpretation Our results suggest that tesofensine 0 . 5 mg might have the potential to produce a weight loss twice that of currently approved drugs. However, these findings of efficacy and safety need confirmation in phase III trials. Funding Neurosearch A/S, Denmark.	[Astrup, Arne; Larsen, Thomas Meinert] Univ Copenhagen, Dept Human Nutr, Fac Life Sci, DK-1958 Frederiksberg, Denmark; [Madsbad, Sten] Univ Copenhagen, Dept Endocrinol, DK-1958 Frederiksberg, Denmark; [Breum, Leif] Koge Hosp, Dept Med, Koge, Denmark; [Jensen, Thomas J.] Cyncron Clin Res Unit, Copenhagen, Denmark; [Kroustrup, Jens Peter] Aalborg Hosp, Dept Endocrinol, Aalborg, Denmark	University of Copenhagen; University of Copenhagen; Aalborg University; Aalborg University Hospital	Astrup, A (corresponding author), Univ Copenhagen, Dept Human Nutr, Fac Life Sci, Rolighedsvej 30, DK-1958 Frederiksberg, Denmark.	ast@life.ku.dk	Astrup, Arne/B-1407-2015; Meinert Larsen, Thomas/D-4818-2015	Astrup, Arne/0000-0001-8968-8996; Madsbad, Sten/0000-0002-5017-1815; Meinert Larsen, Thomas/0000-0001-7621-3131	EU [EC-FP6, LHM-CT-2003-503041]; Center for Pharmacogenomics, University of Copenhagen, Denmark	EU(European Commission); Center for Pharmacogenomics, University of Copenhagen, Denmark	Neurosearch A/S, Denmark was the main sponsor of this study. Additional funding for the research was provided by EU grant EC-FP6 (contract number: LHM-CT-2003-503041) and by the Center for Pharmacogenomics, University of Copenhagen, Denmark.	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Astrup A, 2005, LANCET, V366, P368, DOI 10.1016/S0140-6736(05)67017-1; Astrup A, 2008, OBESITY, V16, P1363, DOI 10.1038/oby.2008.56; Ayyad C, 2000, Obes Rev, V1, P113, DOI 10.1046/j.1467-789x.2000.00019.x; Buffenstein R, 2000, PHYSIOL BEHAV, V68, P439, DOI 10.1016/S0031-9384(99)00222-X; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Hansen DL, 1998, AM J CLIN NUTR, V68, P1180, DOI 10.1093/ajcn/68.6.1180; Hansen DL, 1999, INT J OBESITY, V23, P1016, DOI 10.1038/sj.ijo.0801059; James WPT, 2000, LANCET, V356, P2119, DOI 10.1016/S0140-6736(00)03491-7; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kolotkin RL, 2001, OBES RES, V9, P102, DOI 10.1038/oby.2001.13; Li ZP, 2005, ANN INTERN MED, V142, P532, DOI 10.7326/0003-4819-142-7-200504050-00012; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; Pols MA, 1997, INT J EPIDEMIOL, V26, pS181, DOI 10.1093/ije/26.suppl_1.S181; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Torp-Pedersen C, 2007, EUR HEART J, V28, P2915, DOI 10.1093/eurheartj/ehm217; Van Gaal L, 2008, DIABETES CARE, V31, pS229, DOI 10.2337/dc08-s258; WHO Consultation on Obesity : Geneva Switzerland World Health Organization. Division of Noncommunicable Diseases & World Health Organization. Programme of Nutrition Family and Reproductive Health, 1997, OB PREV MAN GLOB EP; Wilkes Scott, 2008, Int J Chron Obstruct Pulmon Dis, V3, P45	22	133	144	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2008	372	9653					1906	1913		10.1016/S0140-6736(08)61525-1	http://dx.doi.org/10.1016/S0140-6736(08)61525-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	379IA	18950853				2022-12-28	WOS:000261388700025
J	DeVoe, JE; Tillotson, C; Wallace, LS				DeVoe, Jennifer E.; Tillotson, Carrie; Wallace, Lorraine S.			Uninsured children and adolescents with insured parents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-INSURANCE COVERAGE; UNITED-STATES; ELIGIBLE CHILDREN; PREVENTIVE CARE; MEDICAID; ACCESS; SCHIP; ELIGIBILITY; RETENTION; FAMILIES	Context Millions of US children and adolescents lack health insurance coverage. Efforts to expand their insurance often focus on extending public coverage to uninsured parents. Less is known about the uninsured whose parents already have coverage. Objective To identify predictors of uninsurance among US children and adolescents with insured parents. Design and Setting Cross-sectional and full-year analyses of pooled 2002-2005 data from the nationally representative Medical Expenditure Panel Survey (MEPS). Participants Children and adolescents younger than 19 years in 4 yearly MEPS files with positive full-year weights who had at least 1 parent residing in the same household. There were 39 588 in the unweighted cross-sectional analysis and 39 710 in the unweighted full-year analysis. Main Outcome Measure Prevalence of uninsurance among children and adolescents with at least 1 insured parent; predictors of uninsurance among children with at least 1 insured parent. Results In the cross-sectional study population, 1380 of 39 588 children and adolescents were uninsured with at least 1 insured parent (weighted prevalence, 3.3%; 95% confidence interval [CI], 3.0%-3.6%). In multivariate analyses of children and adolescents with at least 1 insured parent, those uninsured were more likely Hispanic (odds ratio [OR], 1.58; 95% CI, 1.23-2.03) than white, non-Hispanic; low income (OR, 2.02; 95% CI, 1.42-2.88) and middle income (OR, 1.48; 95% CI, 1.09-2.03) than high income; from single-parent homes (OR, 1.99; 95% CI, 1.59-2.49) than from homes with 2 married parents; and living with parents who had less than a high school education (OR, 1.44; 95% CI, 1.10-1.89) than those with at least 1 parent who had completed high school. Those whose parents had public coverage were less likely to be uninsured (OR, 0.64; 95% CI, 0.43-0.96) than were those whose parents reported private health insurance. These predictors remained significant in full-year analyses. Similar patterns of vulnerability were also found among a subset of uninsured children with privately covered parents. Conclusions Among all US children, more than 3% were uninsured with at least 1 insured parent. Predictors of such uninsurance included having low and middle income. Having a parent covered by only public insurance was associated with better children's coverage rates.	[DeVoe, Jennifer E.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97239 USA; [Tillotson, Carrie] Oregon Hlth & Sci Univ, Biostat & Design Program, Oregon Clin & Translat Res Inst, Portland, OR 97239 USA; [Wallace, Lorraine S.] Univ Tennessee, Grad Sch Med, Dept Family Med, Knoxville, TN USA	Oregon Health & Science University; Oregon Health & Science University; University of Tennessee System; University of Tennessee Health Science Center	DeVoe, JE (corresponding author), Oregon Hlth & Sci Univ, Dept Family Med, 3181 Sam Jackson Park Rd,Mailcode FM, Portland, OR 97239 USA.	devoej@ohsu.edu			Agency for Healthcare Research and Quality (AHRQ) [1 K08 HS16181]; National Center for Research Resources (NCRR) [UL1 RR024140 01]; National Institutes of Health (NIH); NIH Roadmap for Medical Research; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS016181] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Dr DeVoe's time on this project was supported by grant 1 K08 HS16181 from the Agency for Healthcare Research and Quality (AHRQ). Ms Tillotson is employed by the Biostatistics Shared Resource of Oregon Health and Science University and by the Oregon Clinical and Translational Research Institute (OCTRI) and is supported by grant UL1 RR024140 01 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research.	Aday L A, 1974, Health Serv Res, V9, P208; *AG HEALTHC RES QU, MED EXP PAN SURV IND; *AG HEALTHC RES QU, 2006, HC089 MEPS AG HEALTH; Artiga Samantha, 2007, FAMILY COVERAGE SCHI; Bernard DM, 2006, MED CARE, V44, P12; Cohen JW, 1996, INQUIRY-J HEALTH CAR, V33, P373; Cohen SB., 1997, PUBLICATION AGENCY H, V97-0027; Cooper PF, 1997, HEALTH AFFAIR, V16, P142, DOI 10.1377/hlthaff.16.6.142; *CTR MED MED SERV, SCHIP EV ENR YEAR; Davidoff A, 2003, INQUIRY-J HEALTH CAR, V40, P254, DOI 10.5034/inquiryjrnl_40.3.254; DeVoe JE, 2008, MED CARE, V46, P3, DOI 10.1097/MLR.0b013e31815b97ac; Dubay L, 2003, HEALTH SERV RES, V38, P1283, DOI 10.1111/1475-6773.00177; DUBAY L, 2001, COVERING PARENTS MED; DUBAY LC, 2004, HEALTH AFFAIR, V23, P235; Dubay L, 2007, HEALTH AFFAIR, V26, pW22, DOI 10.1377/hlthaff.26.1.w22; Fairbrother G, 2004, HEALTH AFFAIR, V23, P237, DOI 10.1377/hlthaff.23.1.237; Fairbrother GL, 2007, HEALTH AFFAIR, V26, P520, DOI 10.1377/hlthaff.26.2.520; Gadomski A, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e1; Gilmer T, 2005, MED CARE RES REV, V62, P56, DOI 10.1177/1077558704271723; *GRAH CTR 1 PAG, 2005, AM FAM PHYSICIAN, V72, P1989; Gresenz CR, 2006, PEDIATRICS, V117, pE509, DOI 10.1542/peds.2005-0733; Guendelman S, 2005, MED CARE, V43, P68; Guendelman S, 2004, HEALTH AFFAIR, V23, P235, DOI 10.1377/hlthaff.23.2.235; Hadley J, 2003, MED CARE RES REV, V60, p3S, DOI 10.1177/1077558703254101; Hakim RB, 2001, PEDIATRICS, V108, P90, DOI 10.1542/peds.108.1.90; Hanson KL, 1998, INQUIRY-J HEALTH CAR, V35, P294; Hudson JL, 2007, HEALTH AFFAIR, V26, pW618, DOI 10.1377/hlthaff.26.5.w618; Institute of Medicine, 2002, HLTH INS IS FAM MATT; *KAIS COMM MED UN, HLTH COV LOW INC CHI; *KAIS COMM MED UN, CHILDR HLTH WHY INS; Kronebusch K, 2004, HEALTH AFFAIR, V23, P233, DOI 10.1377/hlthaff.23.3.233; KU L, 2000, IMPORTANCE FAMILY BA; Ku L., 2006, COVERAGE PARENTS HEL; Ku L., 2007, COLLATERAL DAMAGE CH; Ku L, 2008, HEALTH AFFAIR, V27, pW318, DOI 10.1377/hlthaff.27.4.w318; Luo XM, 2003, PEDIATRICS, V112, P314, DOI 10.1542/peds.112.2.314; Olson LM, 2005, NEW ENGL J MED, V353, P382, DOI 10.1056/NEJMsa043878; Perry M, 2007, ENROLLING CHILDREN M; ROSS DC, RESUMING PATH HLTH C; Satchell M, 2005, PEDIATRICS, V116, P1155, DOI 10.1542/peds.2004-2403; Sommers AS, 2007, HEALTH AFFAIR, V26, pW598, DOI 10.1377/hlthaff.26.5.w598; Sommers BD, 2005, HEALTH SERV RES, V40, P59, DOI 10.1111/j.1475-6773.2005.00342.x; Sommers BD, 2007, HEALTH AFFAIR, V26, pW560, DOI 10.1377/hlthaff.26.5.w560; Sommers BD, 2006, J HEALTH ECON, V25, P1154, DOI 10.1016/j.jhealeco.2006.04.003; Stevens GD, 2006, PEDIATRICS, V117, pE751, DOI 10.1542/peds.2005-1558; Tang SFS, 2003, PEDIATRICS, V112, pE168, DOI 10.1542/peds.112.2.e168; Vistnes JP, 2008, HEALTH AFFAIR, V27, P44, DOI 10.1377/hlthaff.27.1.44; WEINICK RM, 1997, AHCPR PUBLICATION; Zuvekas SH, 1999, HEALTH SERV RES, V34, P271	49	20	20	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2008	300	16					1904	1913		10.1001/jama.2008.516	http://dx.doi.org/10.1001/jama.2008.516			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	362UR	18940977	Green Accepted, Bronze			2022-12-28	WOS:000260223100020
J	Raj, A; van Oudenaarden, A				Raj, Arjun; van Oudenaarden, Alexander			Nature, Nurture, or Chance: Stochastic Gene Expression and Its Consequences	CELL			English	Review							POSITIVE-FEEDBACK LOOP; TO-CELL VARIATION; SINGLE-CELL; MESSENGER-RNA; TRANSCRIPTIONAL REGULATION; FLUCTUATING ENVIRONMENTS; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; CIRCADIAN CLOCK; PHENOTYPIC DIVERSITY		[Raj, Arjun; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019	Raj, Arjun/0000-0002-2915-6960	National Science Foundation (NSF) [PHY-0548484]; National Institutes of Health [R01-GM068957, R01-GM077183]; NSF Fellowship [DMS-0603392]; Burroughs Wellcome Fund Career Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068957, R01GM077183] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Fellowship(National Science Foundation (NSF)); Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank M. Laub, I. Golding, J. Collins, and J. Gore for many helpful comments on the manuscript. A.v.O was supported by National Science Foundation (NSF) grant PHY-0548484 and National Institutes of Health grants R01-GM068957 and R01-GM077183. A. R. is supported by NSF Fellowship DMS-0603392 and a Burroughs Wellcome Fund Career Award at the Scientific Interface.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Arkin A, 1998, GENETICS, V149, P1633; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Batada NN, 2007, NAT GENET, V39, P945, DOI 10.1038/ng2071; Beach DL, 1999, CURR BIOL, V9, P569, DOI 10.1016/S0960-9822(99)80260-7; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; de Krom M, 2002, MOL CELL, V9, P1319, DOI 10.1016/S1097-2765(02)00558-0; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Forger DB, 2005, P NATL ACAD SCI USA, V102, P321, DOI 10.1073/pnas.0408465102; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; Karmakar R, 2004, PHYS BIOL, V1, P197, DOI 10.1088/1478-3967/1/4/001; Kaufmann BB, 2007, PLOS BIOL, V5, P1973, DOI 10.1371/journal.pbio.0050239; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; KO MSH, 1990, EMBO J, V9, P2835, DOI 10.1002/j.1460-2075.1990.tb07472.x; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mettetal JT, 2006, P NATL ACAD SCI USA, V103, P7304, DOI 10.1073/pnas.0509874103; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; NESTER EW, 1963, J BACTERIOL, V86, P785, DOI 10.1128/JB.86.4.785-796.1963; Newlands S, 1998, GENE DEV, V12, P2748, DOI 10.1101/gad.12.17.2748; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Paulsson J, 2000, PHYS REV LETT, V84, P5447, DOI 10.1103/PhysRevLett.84.5447; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; PTASHNE M, 2007, CURR BIOL, V17, P33; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; ROSS IL, 1994, IMMUNOL CELL BIOL, V72, P177, DOI 10.1038/icb.1994.26; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; Shahrezaei V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.31; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Takasuka N, 1998, ENDOCRINOLOGY, V139, P1361, DOI 10.1210/en.139.3.1361; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Tsuboi A, 1999, J NEUROSCI, V19, P8409; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281; Voss TC, 2006, MOL ENDOCRINOL, V20, P2641, DOI 10.1210/me.2006-0091; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116; Weinberger LS, 2007, PLOS BIOL, V5, P67, DOI 10.1371/journal.pbio.0050009; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; WHITE MRH, 1995, J CELL SCI, V108, P441; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; YARCHUK O, 1992, J MOL BIOL, V226, P581, DOI 10.1016/0022-2836(92)90617-S; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	104	1608	1635	4	300	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					216	226		10.1016/j.cell.2008.09.050	http://dx.doi.org/10.1016/j.cell.2008.09.050			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957198	Green Accepted, Bronze			2022-12-28	WOS:000260130400012
J	Ray, LB				Ray, L. Bryan			Getting your loops straight - Introduction	SCIENCE			English	Editorial Material																			0	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					389	389		10.1126/science.322.5900.389	http://dx.doi.org/10.1126/science.322.5900.389			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927382				2022-12-28	WOS:000260094500032
J	Rondon, AG; Proudfoot, NJ				Rondon, Ana G.; Proudfoot, Nick J.			Nuclear Roadblocks for mRNA export	CELL			English	Editorial Material							TRANSCRIPTION; COMPLEX		[Rondon, Ana G.; Proudfoot, Nick J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Proudfoot, NJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	nicholas.proudfoot@path.ox.ac.uk	Rondon, Ana G/C-2102-2017	Proudfoot, Nicholas/0000-0001-8646-3222; , Ana/0000-0002-9481-1255				Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Saguez C, 2008, MOL CELL, V31, P91, DOI 10.1016/j.molcel.2008.04.030; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Vinciguerra P, 2004, CURR OPIN CELL BIOL, V16, P285, DOI 10.1016/j.ceb.2004.03.013	7	4	4	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 17	2008	135	2					207	208		10.1016/j.cell.2008.09.053	http://dx.doi.org/10.1016/j.cell.2008.09.053			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957194	Bronze			2022-12-28	WOS:000260130400008
J	Shalaev, VM				Shalaev, Vladimir M.			Transforming light	SCIENCE			English	Editorial Material							MAXWELLS EQUATIONS; OPTICAL HYPERLENS; DIFFRACTION; CLOAKING; FORM		[Shalaev, Vladimir M.] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA; [Shalaev, Vladimir M.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Shalaev, VM (corresponding author), Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA.	shalaev@ecn.purdue.edu	Shalaev, Vladimir M./B-9331-2019	Shalaev, Vladimir M./0000-0001-8976-1102				Cai WS, 2007, NAT PHOTONICS, V1, P224, DOI 10.1038/nphoton.2007.28; CHEW WC, 1994, MICROW OPT TECHN LET, V7, P599, DOI 10.1002/mop.4650071304; DOLIN LS, 1961, IZV VYSSH UCHEBN ZAV, V4, P964; Jacob Z, 2006, OPT EXPRESS, V14, P8247, DOI 10.1364/OE.14.008247; Kildishev AV, 2008, OPT LETT, V33, P43, DOI 10.1364/OL.33.000043; Kildishev AV, 2007, OPT LETT, V32, P3432, DOI 10.1364/OL.32.003432; LAX M, 1976, PHYS REV B, V13, P1777, DOI 10.1103/PhysRevB.13.1777; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Liu ZW, 2007, SCIENCE, V315, P1686, DOI 10.1126/science.1137368; Milton GW, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/10/248; Narimanov EE, 2007, NATURE, V447, P266, DOI 10.1038/447266a; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Post E. G., 1962, FORMAL STRUCTURE ELE; Salandrino A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075103; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Smolyaninov II, 2007, SCIENCE, V315, P1699, DOI 10.1126/science.1138746; Tamm I., 1924, J RUSS PHYS CHEM SOC, V56, P248; Ward AJ, 1996, J MOD OPTIC, V43, P773, DOI 10.1080/09500349608232782; [No title captured]	19	219	222	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					384	386		10.1126/science.1166079	http://dx.doi.org/10.1126/science.1166079			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927379				2022-12-28	WOS:000260094500029
J	El-Sayed, N; El-Gamal, Y; Abbassy, AA; Seoud, I; Salama, M; Kandeel, A; Hossny, E; Shawky, A; Abou Hussein, H; Pallansch, MA; van der Avoort, HGAM; Burton, AH; Sreevatsava, M; Malankar, P; Wahdan, MH; Sutter, RW				El-Sayed, Nasr; El-Gamal, Yehia; Abbassy, Ahmed-Amr; Seoud, Iman; Salama, Maha; Kandeel, Amr; Hossny, Elham; Shawky, Ahmed; Abou Hussein, Heba; Pallansch, Mark A.; van der Avoort, Harrie G. A. M.; Burton, Anthony H.; Sreevatsava, Meghana; Malankar, Pradeep; Wahdan, Mohamed H.; Sutter, Roland W.			Monovalent type 1 oral poliovirus vaccine in newborns	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEROCONVERSION RATES; POLIOMYELITIS; LIVE; IMMUNOGENICITY; IMMUNIZATION; DIARRHEA; CHILDREN; INFANTS; TROPICS; BRAZIL	Background: In 1988, the World Health Assembly resolved to eradicate poliomyelitis. Although substantial progress toward this goal has been made, eradication remains elusive. In 2004, the World Health Organization called for the development of a potentially more immunogenic monovalent type 1 oral poliovirus vaccine. Methods: We conducted a trial in Egypt to compare the immunogenicity of a newly licensed monovalent type 1 oral poliovirus vaccine with that of a trivalent oral poliovirus vaccine. Subjects were randomly assigned to receive one dose of monovalent type 1 oral poliovirus vaccine or trivalent oral poliovirus vaccine at birth. Thirty days after birth, a single challenge dose of monovalent type 1 oral poliovirus vaccine was administered in all subjects. Shedding of serotype 1 poliovirus was assessed through day 60. Results: A total of 530 subjects were enrolled, and 421 fulfilled the study requirements. Thirty days after the study vaccines were administered, the rate of seroconversion to type 1 poliovirus was 55.4% in the monovalent-vaccine group, as compared with 32.1% in the trivalent-vaccine group (P<0.001). Among those with a high reciprocal titer of maternally derived antibodies against type 1 poliovirus (>64), 46.0% of the subjects in the monovalent-vaccine group underwent seroconversion, as compared with 21.3% in the trivalent-vaccine group (P<0.001). Seven days after administration of the challenge dose of monovalent type 1 vaccine, a significantly lower proportion of subjects in the monovalent-vaccine group than in the trivalent-vaccine group excreted type 1 poliovirus (25.9% vs. 41.5%, P=0.001). None of the serious adverse events reported were attributed to the trial interventions. Conclusions: When given at birth, monovalent type 1 oral poliovirus vaccine is superior to trivalent oral poliovirus vaccine in inducing humoral antibodies against type 1 poliovirus, overcoming high preexisting levels of maternally derived antibodies, and increasing the resistance to excretion of type 1 poliovirus after administration of a challenge dose. (Current Controlled Trials number, ISRCTN76316509.).	[Burton, Anthony H.; Sreevatsava, Meghana; Malankar, Pradeep; Sutter, Roland W.] WHO, Polio Eradicat Dept, CH-1211 Geneva 27, Switzerland; [El-Sayed, Nasr; Kandeel, Amr] Minist Hlth & Populat, Cairo, Egypt; [El-Gamal, Yehia; Hossny, Elham] Ain Shams Univ, Cairo, Egypt; [Abbassy, Ahmed-Amr; Shawky, Ahmed] Univ Alexandria, Alexandria, Egypt; [Seoud, Iman; Abou Hussein, Heba] Cairo Univ, Kasr El Aini Hosp, Cairo, Egypt; [Salama, Maha; Wahdan, Mohamed H.] WHO, Eastern Mediterranean Reg Off, Cairo, Egypt; [Pallansch, Mark A.] Ctr Dis Control & Prevent, Atlanta, GA USA; [van der Avoort, Harrie G. A. M.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	World Health Organization; Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization; Centers for Disease Control & Prevention - USA; Netherlands National Institute for Public Health & the Environment	Sutter, RW (corresponding author), WHO, Polio Eradicat Dept, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	sutterr@who.int		Hossny, Elham/0000-0001-6876-6318; El-Gamal, Yehia/0000-0002-8177-4520	Gates Foundation [37460]; WHO	Gates Foundation(Bill & Melinda Gates Foundation); WHO(World Health Organization)	Supported by grants from the Gates Foundation (37460) and the WHO.	ALBRECHT P, 1983, J BIOL STAND, V11, P91, DOI 10.1016/S0092-1157(83)80031-6; [Anonymous], 2001, MMWR-MORBID MORTAL W, V50, P249; BERNKOPF H, 1957, AM J TROP MED HYG, V6, P697, DOI 10.4269/ajtmh.1957.6.697; BIJERK H, 1979, DEV BIOL STAND, V43, P195; Caceres VM, 2001, CLIN INFECT DIS, V33, P531, DOI 10.1086/321905; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P222; CHOPRA K, 1989, J TROP PEDIATRICS, V35, P19, DOI 10.1093/tropej/35.1.19; CIRNE MD, 1995, J INFECT DIS, V171, P1097, DOI 10.1093/infdis/171.5.1097; Conover William Jay, 1998, PRACTICAL NONPARAMET, V350; COX HR, SCI PUBLICATION, V44; DOMOK I, 1974, B WORLD HEALTH ORGAN, V51, P333; Efron B., 1994, MONOGRAPHS STAT APPL; *EXP PROGR IMM, 1996, WHOEPIGEN9503REV1; *EXP PROGR IMM, 1997, WHOEPILHIS9701; Grassly NC, 2007, LANCET, V369, P1790; HORWITZ A, 1961, POLIOMYELITIS, P221; John T J, 1972, Indian Pediatr, V9, P252; JOHN TJ, 1972, AM J EPIDEMIOL, V96, P263, DOI 10.1093/oxfordjournals.aje.a121457; LASCH EE, 1984, REV INFECT DIS, V6, pS467; MCBEAN AM, 1988, AM J EPIDEMIOL, V128, P615, DOI 10.1093/oxfordjournals.aje.a115009; Myaux JA, 1996, PEDIATR INFECT DIS J, V15, P204, DOI 10.1097/00006454-199603000-00006; PAL SR, 1966, INDIAN J MED RES, V54, P507; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Posey DL, 1997, J INFECT DIS, V175, pS258, DOI 10.1093/infdis/175.Supplement_1.S258; *R DEV COR TEAM, 2006, R LANG ENV COMP; ROBERTSON H. E., 1962, CANADIAN JOUR PUBL HEALTH, V53, P179; SABIN AB, 1960, JAMA-J AM MED ASSOC, V173, P1521, DOI 10.1001/jama.1960.03020320001001; *SAS I, 1989, SAS STAT US GUID VER, V1; SCHOUB BD, 1988, J INFECT DIS, V157, P836, DOI 10.1093/infdis/157.4.836; SMORODINTSEV AA, SCI PUBLICATION, V44; SUTTER RW, 1993, INT J EPIDEMIOL, V22, P936, DOI 10.1093/ije/22.5.936; SWARTZ TA, 1972, J HYG-CAMBRIDGE, V70, P719, DOI 10.1017/S0022172400022567; VERLINDE JD, SCI PUBLICATION, V44; VOROSHILOVA MK, 1961, POLIOMYELITIS, P296; *WHO, 2004, WKLY EPIDEMIOL REC, V79, P401; *WHO, 2004, IMM VACC BIOL POL LA; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P165; World Health Assembly, 1988, GLOB ER POL YEAR 200	38	57	60	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2008	359	16					1655	1665		10.1056/NEJMoa0800390	http://dx.doi.org/10.1056/NEJMoa0800390			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360EY	18923170				2022-12-28	WOS:000260041400004
J	Simpson, JA; Lobo, DN				Simpson, J. Alastair; Lobo, Dileep N.			A man who got "bladdered"	LANCET			English	Editorial Material									[Simpson, J. Alastair; Lobo, Dileep N.] Univ Nottingham Hosp, Queens Med Ctr, Div Gastrointestinal Surg, Wolfston Digest Dis Ctr, Nottingham NG7 2UH, England	University of Nottingham	Lobo, DN (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Div Gastrointestinal Surg, Wolfston Digest Dis Ctr, E Floor,West Block, Nottingham NG7 2UH, England.	Dileep.Lobo@nottingham.ac.uk	Lobo, Dileep/AAC-6207-2020	Lobo, Dileep/0000-0003-1187-5796					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1334	1334		10.1016/S0140-6736(08)61553-6	http://dx.doi.org/10.1016/S0140-6736(08)61553-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18929904	Bronze			2022-12-28	WOS:000260060500032
J	Burlini, L; Di Toro, G				Burlini, Luigi; Di Toro, Giulio			Volcanic symphony in the lab	SCIENCE			English	Editorial Material									[Burlini, Luigi] ETH, Inst Geol, CH-8092 Zurich, Switzerland; [Di Toro, Giulio] Univ Padua, Dipartimento Geosci, I-35137 Padua, Italy	ETH Zurich; University of Padua	Burlini, L (corresponding author), ETH, Inst Geol, CH-8092 Zurich, Switzerland.	luigi.burlini@erdw.ethz.ch; giulio.ditoro@unipd.it						AKI K, 2002, QUANITATIVE SEISMOLO; Benson PM, 2008, SCIENCE, V322, P249, DOI 10.1126/science.1161927; Burlini L, 2007, GEOLOGY, V35, P183, DOI 10.1130/G23195A.1; Chouet B, 2003, PURE APPL GEOPHYS, V160, P739, DOI 10.1007/PL00012556; Fortin J, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003854; LOCKNER D, 1993, INT J ROCK MECH MIN, V30, P883, DOI 10.1016/0148-9062(93)90041-B; MAGI K, 2007, EXPT ROCK MECH; McNutt S. R., 2000, ENCY VOLCANOES, V1st, P1015; OBERT L, 1945, 3803 US BUR; Paterson M.S., 2005, EXPT ROCK DEFORMATIO; SCHOLZ CH, 1968, B SEISMOL SOC AM, V58, P399	12	14	14	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					207	208		10.1126/science.1164545	http://dx.doi.org/10.1126/science.1164545			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845739				2022-12-28	WOS:000259902300030
J	Elsworth, D; Mattioli, G; Taron, J; Voight, B; Herd, R				Elsworth, Derek; Mattioli, Glen; Taron, Joshua; Voight, Barry; Herd, Richard			Implications of magma transfer between multiple reservoirs on eruption cycling	SCIENCE			English	Article							SOUFRIERE HILLS VOLCANO; WEST-INDIES; DECEMBER 1997; MONTSERRAT	Volcanic eruptions are episodic despite being supplied by melt at a nearly constant rate. We used histories of magma efflux and surface deformation to geodetically image magma transfer within the deep crustal plumbing of the Soufriere Hills volcano on Montserrat, West Indies. For three cycles of effusion followed by discrete pauses, supply of the system from the deep crust and mantle was continuous. During periods of reinitiated high surface efflux, magma rose quickly and synchronously from a deflating mid-crustal reservoir (at about 12 kilometers) augmented from depth. During repose, the lower reservoir refilled from the deep supply, with only minor discharge transiting the upper chamber to surface. These observations are consistent with a model involving the continuous supply of magma from the deep crust and mantle into a voluminous and compliant mid-crustal reservoir, episodically valved below a shallow reservoir (at about 6 kilometers).	[Elsworth, Derek; Taron, Joshua; Voight, Barry] Penn State Univ, Coll Earth & Mineral Sci, University Pk, PA 16802 USA; [Elsworth, Derek; Taron, Joshua; Voight, Barry] Univ Western Australia, Inst Adv Studies, Perth, WA 6009, Australia; [Mattioli, Glen] Univ Arkansas, Dept Geosci, Fayetteville, AR 72701 USA; [Herd, Richard] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Western Australia; University of Arkansas System; University of Arkansas Fayetteville; University of East Anglia	Elsworth, D (corresponding author), Penn State Univ, Coll Earth & Mineral Sci, University Pk, PA 16802 USA.	elsworth@psu.edu	Mattioli, Glen/AAC-3410-2020; Elsworth, Derek/D-2844-2015; Mattioli, Glen S/C-6619-2011	Mattioli, Glen/0000-0002-9117-7471; Elsworth, Derek/0000-0002-4942-1151; Taron, Joshua/0000-0003-2719-3917	NSF [NSF-CMS-9908590, NSF-CD-0607691, NSF-CD-0507334, NSF-CD-0607782, NSF-IF-0523097, NSF-IF-0732728]	NSF(National Science Foundation (NSF))	We thank M. Strutt, G. Ryan, and P. Williams of the Montserrat Volcano Observatory and W. Johnston for maintenance of the cGPS network on the SHV. This work is a result of partial support from NSF under awards NSF-CMS-9908590, NSF-CD-0607691, NSF-CD-0507334, and NSF-CD-0607782. The Caribbean Andesitic Lava Island Precision Seismo-geodetic Observatory (CALIPSO) Facility was supported by grants NSF-IF-0523097 and NSF-IF-0732728, and this support is gratefully acknowledged. The conclusions reported here are those of the authors.	Annen C, 2006, J PETROL, V47, P505, DOI 10.1093/petrology/egi084; Aspinall WP, 1998, GEOPHYS RES LETT, V25, P3397, DOI 10.1029/98GL00858; Barclay J, 1998, GEOPHYS RES LETT, V25, P3437, DOI 10.1029/98GL00856; Devine JD, 2003, J PETROL, V44, P1375, DOI 10.1093/petrology/44.8.1375; DRUITT TH, 2002, MEMOIR GEOLOGICAL SO, V21; Mattioli GS, 1998, GEOPHYS RES LETT, V25, P3417, DOI 10.1029/98GL00931; MATTIOLI GS, 2003, SEISMOL RES LETT, V74, P230; Murphy MD, 2000, J PETROL, V41, P21, DOI 10.1093/petrology/41.1.21; NORTON G, 2002, MEMOIR GEOLOGICAL SO, V21; Sparks RSJ, 1998, GEOPHYS RES LETT, V25, P3421, DOI 10.1029/98GL00639; Voight B, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024870; Voight B, 1999, SCIENCE, V283, P1138, DOI 10.1126/science.283.5405.1138; Young SR, 1998, GEOPHYS RES LETT, V25, P3389, DOI 10.1029/98GL01405	13	84	85	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					246	248		10.1126/science.1161297	http://dx.doi.org/10.1126/science.1161297			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845752				2022-12-28	WOS:000259902300044
J	Wing, K; Onishi, Y; Prieto-Martin, P; Yamaguchi, T; Miyara, M; Fehervari, Z; Nomura, T; Sakaguchi, S				Wing, Kajsa; Onishi, Yasushi; Prieto-Martin, Paz; Yamaguchi, Tomoyuki; Miyara, Makoto; Fehervari, Zoltan; Nomura, Takashi; Sakaguchi, Shimon			CTLA-4 control over Foxp3(+) regulatory T cell function	SCIENCE			English	Article							DENDRITIC CELLS; COSTIMULATORY MOLECULES; TARGET GENES; ANTIGEN 4; AUTOIMMUNITY; BLOCKADE; CD25(+); INFLAMMATION; TOLERANCE; IMMUNITY	Naturally occurring Foxp3(+)CD4(+) regulatory T cells (Tregs) are essential for maintaining immunological self-tolerance and immune homeostasis. Here, we show that a specific deficiency of cytotoxic T lymphocyte antigen 4 (CTLA-4) in Tregs results in spontaneous development of systemic lymphoproliferation, fatal T cell-mediated autoimmune disease, and hyperproduction of immunoglobulin E in mice, and it also produces potent tumor immunity. Treg-specific CTLA-4 deficiency impairs in vivo and in vitro suppressive function of Tregs - in particular, Treg-mediated down-regulation of CD80 and CD86 expression on dendritic cells. Thus, natural Tregs may critically require CTLA-4 to suppress immune responses by affecting the potency of antigen-presenting cells to activate other T cells.	[Wing, Kajsa; Onishi, Yasushi; Prieto-Martin, Paz; Yamaguchi, Tomoyuki; Miyara, Makoto; Fehervari, Zoltan; Nomura, Takashi; Sakaguchi, Shimon] Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Onishi, Yasushi] Tohoku Univ, Grad Sch Med, Dept Rheumatol & Haematol, Sendai, Miyagi 9808574, Japan; [Sakaguchi, Shimon] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Sakaguchi, Shimon] Osaka Univ, Expt Immunol Lab, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	Kyoto University; Tohoku University; Japan Science & Technology Agency (JST); Osaka University	Sakaguchi, S (corresponding author), Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto 6068507, Japan.	shimon@frontier.kyoto-u.ac.jp	Miyara, Makoto/P-4491-2017; Sakaguchi, Shimon/C-9535-2009	Miyara, Makoto/0000-0001-8743-8846; Wing, Kajsa/0000-0001-7744-4847	Ministry of Education, Sports and Culture of Japan, Japan Science and Technology Agency [Grants-in-Aid]; Japan Society for the Promotion of Science; Astra-Zeneca, Loughborough, UK	Ministry of Education, Sports and Culture of Japan, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astra-Zeneca, Loughborough, UK(AstraZeneca)	We thank M. Ono for discussion and R. Ishii and M. Matsushita for technical assistance. This work was supported by Grants-in-Aid from the Ministry of Education, Sports and Culture of Japan, Japan Science and Technology Agency. Z.F. was a Japan Society for the Promotion of Science fellow, and K. W. was granted a fellowship by Astra-Zeneca, Loughborough, UK.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; DiPaolo RJ, 2007, J IMMUNOL, V179, P4685, DOI 10.4049/jimmunol.179.7.4685; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Oderup C, 2006, IMMUNOLOGY, V118, P240, DOI 10.1111/j.1365-2567.2006.02362.x; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Ono M, 2006, J IMMUNOL, V176, P4748, DOI 10.4049/jimmunol.176.8.4748; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Shimizu J, 1999, J IMMUNOL, V163, P5211; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yamazaki S, 2006, IMMUNOL REV, V212, P314, DOI 10.1111/j.0105-2896.2006.00422.x; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	25	2029	2141	5	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					271	275		10.1126/science.1160062	http://dx.doi.org/10.1126/science.1160062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845758				2022-12-28	WOS:000259902300052
J	Batistatou, A; Charalabopoulos, K				Batistatou, Anna; Charalabopoulos, Konstantinos			The picture of Oscar X - An image of the future	NATURE			English	Editorial Material									[Batistatou, Anna; Charalabopoulos, Konstantinos] Univ Ioannina, Sch Med, GR-45110 Ioannina, Greece	University of Ioannina	Batistatou, A (corresponding author), Univ Ioannina, Sch Med, GR-45110 Ioannina, Greece.								0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 9	2008	455	7214					834	834		10.1038/455834a	http://dx.doi.org/10.1038/455834a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18843370	Bronze			2022-12-28	WOS:000259854900055
J	Houghton, J				Houghton, John			Meetings that changed the world: Madrid 1995: Diagnosing climate change	NATURE			English	Editorial Material												john.houghton@jri.org.uk							0	6	7	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 9	2008	455	7214					737	738		10.1038/455737a	http://dx.doi.org/10.1038/455737a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18843350	Bronze			2022-12-28	WOS:000259854900028
J	Cisse, B; Caton, ML; Lehner, M; Maeda, T; Scheu, S; Locksley, R; Holmberg, D; Zweier, C; den Hollander, NS; Kant, SG; Holter, W; Rauch, A; Zhuang, YA; Reizis, B				Cisse, Babacar; Caton, Michele L.; Lehner, Manfred; Maeda, Takahiro; Scheu, Stefanie; Locksley, Richard; Holmberg, Dan; Zweier, Christiane; den Hollander, Nicolette S.; Kant, Sarina G.; Holter, Wolfgang; Rauch, Anita; Zhuang, Yuan; Reizis, Boris			Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development	CELL			English	Article							T-LYMPHOCYTE DEVELOPMENT; PITT-HOPKINS-SYNDROME; I INTERFERON; AUTOIMMUNE-DISEASES; BONE-MARROW; E2A; PROGENITORS; ACTIVATION; PROTEINS; RECEPTOR	Plasmacytoid dendritic cells (PDCs) represent a unique immune cell type specialized in type I interferon (IFN) secretion in response to viral nucleic acids. The molecular control of PDC lineage specification has been poorly understood. We report that basic helix-loop-helix transcription factor (E protein) E2-2/Tcf4 is preferentially expressed in murine and human PDCs. Constitutive or inducible deletion of murine E2-2 blocked the development of PDCs but not of other lineages and abolished IFN response to unmethylated DNA. Moreover, E2-2 haploinsufficiency in mice and in human Pitt-Hopkins syndrome patients was associated with aberrant expression profile and impaired IFN response of the PDC. E2-2 directly activated multiple PDC-enriched genes, including transcription factors involved in PDC development (SpiB, Irf8) and function (Irf7). These results identify E2-2 as a specific transcriptional regulator of the PDC lineage in mice and humans and reveal a key function of E proteins in the innate immune system.	[Cisse, Babacar; Caton, Michele L.; Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA; [Lehner, Manfred; Holter, Wolfgang] Univ Erlangen Nurnberg, Childrens Univ Hosp, Dept Hematol & Oncol, D-91054 Erlangen, Germany; [Maeda, Takahiro] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8538691, Japan; [Scheu, Stefanie; Locksley, Richard] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med & Microbiol Immunol, San Francisco, CA 94143 USA; [Scheu, Stefanie] Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany; [Scheu, Stefanie] Univ Dusseldorf, Hosp Hyg, D-40225 Dusseldorf, Germany; [Holmberg, Dan] Umea Univ, Dept Med Biosci, S-90187 Umea, Sweden; [Zweier, Christiane; Rauch, Anita] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Human Genet, D-91054 Erlangen, Germany; [den Hollander, Nicolette S.; Kant, Sarina G.] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2300 RC Leiden, Netherlands; [Zhuang, Yuan] Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA	Columbia University; University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Nagasaki University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Umea University; University of Erlangen Nuremberg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Duke University	Reizis, B (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA.	bvr2101@columbia.edu	Scheu, Stefanie/H-3670-2019; Zweier, Christiane/F-2202-2015; Rauch, Anita/C-5568-2014; Kant, Sarina/F-8596-2010	Scheu, Stefanie/0000-0002-9707-8191; Zweier, Christiane/0000-0001-8002-2020; Rauch, Anita/0000-0003-2930-3163; zhuang, yuan/0000-0002-2964-3654; Lehner, Manfred/0000-0002-5776-4218; Reizis, Boris/0000-0003-1140-7853	National Institutes of Health (NIH) [AI072571]; Sandler Program for Asthma Research; American Society of Hematology Junior Faculty Scholar; NIH [AI007525, HD055165, GM007367, AI080184, AI078869]; Paul and Daisy Soros Fellowship for New Americans; Deutsche Forschungsgemeinschaft; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD055165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI085439, R01AI072571, F31AI080184, P01AI078869, F31AI066459, T32AI007525, R37AI026918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Program for Asthma Research; American Society of Hematology Junior Faculty Scholar; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul and Daisy Soros Fellowship for New Americans; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Flora, H. Zoghbi, E. Mercer, C. Murre, and T. Ludwig for animals and reagents, B. Jones for help with E2a/HEB strain analysis, B. Kee for communicating data prior to publication, all members of the Reizis lab for helpful discussions, and J. Galan for invaluable help with expression analysis and ChIP. This work was supported by National Institutes of Health (NIH) grant AI072571, the Sandler Program for Asthma Research award, and the American Society of Hematology Junior Faculty Scholar award (B.R.), NIH training grants AI007525 and HD055165 (M.L.C.), NIH training grant GM007367, NIH fellowship AI080184, and the Paul and Daisy Soros Fellowship for New Americans (B.C.), Deutsche Forschungsgemeinschaft (A.R.), and the Howard Hughes Medical Institute and NIH grant AI078869 (R.L.).	Amiel J, 2007, AM J HUM GENET, V80, P988, DOI 10.1086/515582; Asselin-Paturel C, 2005, J EXP MED, V202, P461, DOI 10.1084/jem.20051395; BAIN G, 1993, MOL CELL BIOL, V13, P3522, DOI 10.1128/MCB.13.6.3522; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barchet W, 2005, SEMIN IMMUNOL, V17, P253, DOI 10.1016/j.smim.2005.05.008; Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; Bergqvist I, 2000, EUR J IMMUNOL, V30, P2857, DOI 10.1002/1521-4141(200010)30:10<2857::AID-IMMU2857>3.0.CO;2-G; Cao W, 2007, CURR OPIN IMMUNOL, V19, P24, DOI 10.1016/j.coi.2006.11.004; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013; Flora A, 2007, P NATL ACAD SCI USA, V104, P15382, DOI 10.1073/pnas.0707456104; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Harman BC, 2006, BLOOD, V108, P878, DOI 10.1182/blood-2005-11-4545; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Jones ME, 2007, IMMUNITY, V27, P860, DOI 10.1016/j.immuni.2007.10.014; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Lazorchak A, 2005, TRENDS IMMUNOL, V26, P334, DOI 10.1016/j.it.2005.03.011; Maeda T, 2005, INT J HEMATOL, V81, P148, DOI 10.1532/IJH97.04116; Meyers JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000458; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; Quong MW, 2004, J EXP MED, V199, P1101, DOI 10.1084/jem.20031180; Quong MW, 1999, EMBO J, V18, P6307, DOI 10.1093/emboj/18.22.6307; Reizis B, 2001, J EXP MED, V194, P979, DOI 10.1084/jem.194.7.979; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schotte R, 2004, J EXP MED, V200, P1503, DOI 10.1084/jem.20041231; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Wikstrom I, 2006, J IMMUNOL, V177, P6723, DOI 10.4049/jimmunol.177.10.6723; Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; Zweier C, 2007, AM J HUM GENET, V80, P994, DOI 10.1086/515583	44	458	469	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					37	48		10.1016/j.cell.2008.09.016	http://dx.doi.org/10.1016/j.cell.2008.09.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854153	Green Accepted, Bronze			2022-12-28	WOS:000259728100007
J	Paux, E; Sourdille, P; Salse, J; Saintenac, C; Choulet, F; Leroy, P; Korol, A; Michalak, M; Kianian, S; Spielmeyer, W; Lagudah, E; Somers, D; Kilian, A; Alaux, M; Vautrin, S; Berges, H; Eversole, K; Appels, R; Safar, J; Simkova, H; Dolezel, J; Bernard, M; Feuillet, C				Paux, Etienne; Sourdille, Pierre; Salse, Jerome; Saintenac, Cyrille; Choulet, Frederic; Leroy, Philippe; Korol, Abraham; Michalak, Monika; Kianian, Shahryar; Spielmeyer, Wolfgang; Lagudah, Evans; Somers, Daryl; Kilian, Andrzej; Alaux, Michael; Vautrin, Sonia; Berges, Helene; Eversole, Kellye; Appels, Rudi; Safar, Jan; Simkova, Hana; Dolezel, Jaroslav; Bernard, Michel; Feuillet, Catherine			A physical map of the 1-gigabase bread wheat chromosome 3B	SCIENCE			English	Article							RUST RESISTANCE GENE; HEXAPLOID WHEAT; RICE; GENOMES; SR2	As the staple food for 35% of the world's population, wheat is one of the most important crop species. To date, sequence- based tools to accelerate wheat improvement are lacking. As part of the international effort to sequence the 17- billion- base- pair hexaploid bread wheat genome ( 2n = 6x = 42 chromosomes), we constructed a bacterial artificial chromosome ( BAC)based integrated physical map of the largest chromosome, 3B, that alone is 995 megabases. A chromosome- specific BAC library was used to assemble 82% of the chromosome into 1036 contigs that were anchored with 1443 molecular markers, providing a major resource for genetic and genomic studies. This physical map establishes a template for the remaining wheat chromosomes and demonstrates the feasibility of constructing physical maps in large, complex, polyploid genomes with a chromosome- based approach.	[Paux, Etienne; Sourdille, Pierre; Salse, Jerome; Saintenac, Cyrille; Choulet, Frederic; Leroy, Philippe; Bernard, Michel; Feuillet, Catherine] Univ Blaise Pascal, INRA, UMR 1095, Clermont Ferrand, France; [Korol, Abraham] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Michalak, Monika; Kianian, Shahryar] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; [Spielmeyer, Wolfgang; Lagudah, Evans] CSIRO, Canberra, ACT, Australia; [Somers, Daryl] Agr & Agri Food Canada, Cereal Res Ctr, Winnipeg, MB, Canada; [Kilian, Andrzej] Divers Arrays Technol, Canberra, ACT, Australia; [Alaux, Michael] INRA, Unite Rech Genom Info, F-78026 Versailles, France; [Vautrin, Sonia; Berges, Helene] INRA, Ctr Natl Ressources Genom Vegetales, F-31931 Toulouse, France; [Eversole, Kellye] Eversole Assoc, Int Wheat Genome Sequencing Consortium, Bethesda, MD USA; [Appels, Rudi] Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia; [Safar, Jan; Simkova, Hana; Dolezel, Jaroslav] Inst Expt Bot, Lab Mol Cytogenet & Cytometry, Olomouc, Czech Republic	Centre National de la Recherche Scientifique (CNRS); INRAE; Universite Clermont Auvergne (UCA); University of Haifa; North Dakota State University Fargo; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Agriculture & Agri Food Canada; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Murdoch University; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Paux, E (corresponding author), Univ Blaise Pascal, INRA, UMR 1095, Clermont Ferrand, France.		Sourdille, Pierre/CAF-2780-2022; Simkova, Hana/F-7734-2014; Spielmeyer, Wolfgang/M-3254-2018; Safar, Jan/G-1038-2014; Lagudah, Evans/A-2007-2010; Dolezel, Jaroslav/B-7716-2008; Eversole, Kellye/AAN-6141-2020	Simkova, Hana/0000-0003-4159-7619; Spielmeyer, Wolfgang/0000-0002-5115-7820; Lagudah, Evans/0000-0002-6234-1789; Dolezel, Jaroslav/0000-0002-6263-0492; Eversole, Kellye/0000-0002-8784-4913; Sourdille, Pierre/0000-0002-1027-2224; BERGES, Helene/0000-0002-5492-1062; Paux, Etienne/0000-0002-3094-7129; Alaux, Michael/0000-0001-9356-4072; Choulet, Frederic/0000-0003-1788-7288; Kilian, Andrzej/0000-0002-2730-7462	Agence Nationale de la Recherche [ANR-05-BLANC-0258-01]; INRA	Agence Nationale de la Recherche(French National Research Agency (ANR)); INRA	We thank D. Boyer, K. Paux, and members of the GENTYANE platform for technical assistance; M. Ganal (Trait Genetics), P. Jack (RAGT), and F. Azanza (Syngenta) for providing SSR markers and genotyping data; the support of F. Legeai and D. Steinbach from Unit, de Recherche en Genomique-Info in establishing the Gbrowse display of the integrated physical map; A. Kumar (Choudhury Charan Singh University Meerut), O. Riera-Lizarazu (Oregon State University), and Y. Gu (U. S. Department of Agriculture- Agricultural Research Service) for significant contributions to the RH mapping work; and F. Quetier ( gence Nationale de la Recherche) for support and discussions. Supported by the Agence Nationale de la Recherche (grant ANR-05-BLANC-0258-01) and the INRA.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Chen MS, 2002, PLANT CELL, V14, P537, DOI 10.1105/tpc.010485; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Cone KC, 2002, PLANT PHYSIOL, V130, P1598, DOI 10.1104/pp.012245; Dilbirligi M, 2004, GENETICS, V166, P461, DOI 10.1534/genetics.166.1.461; Dolezel J, 2004, CHROMOSOME RES, V12, P77, DOI 10.1023/B:CHRO.0000009293.15189.e5; Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x; Endo TR, 1996, J HERED, V87, P295, DOI 10.1093/oxfordjournals.jhered.a023003; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; Gojobori T, 2007, GENOME RES, V17, P175, DOI 10.1101/gr.5509507; Hossain KG, 2004, GENETICS, V168, P415, DOI 10.1534/genetics.103.022590; Klein PE, 2000, GENOME RES, V10, P789, DOI 10.1101/gr.10.6.789; Kota R, 2006, THEOR APPL GENET, V112, P492, DOI 10.1007/s00122-005-0151-8; La Rota Mauricio, 2004, Functional & Integrative Genomics, V4, P34, DOI 10.1007/s10142-003-0098-2; Liu Sixin, 2006, Functional & Integrative Genomics, V6, P83, DOI 10.1007/s10142-005-0007-y; Luo MC, 2003, GENOMICS, V82, P378, DOI 10.1016/S0888-7543(03)00128-9; McNeil MD, 2008, MOL BREEDING, V22, P15, DOI 10.1007/s11032-007-9152-4; Munkvold JD, 2004, GENETICS, V168, P639, DOI 10.1534/genetics.104.034819; Paux E, 2006, PLANT J, V48, P463, DOI 10.1111/j.1365-313X.2006.02891.x; Safar J, 2004, PLANT J, V39, P960, DOI 10.1111/j.1365-313X.2004.02179.x; Warren RL, 2006, GENOME RES, V16, P768, DOI 10.1101/gr.5090606; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Wollenweber B, 2005, CURR OPIN PLANT BIOL, V8, P337, DOI 10.1016/j.pbi.2005.03.001	23	301	325	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2008	322	5898					101	104		10.1126/science.1161847	http://dx.doi.org/10.1126/science.1161847			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832645				2022-12-28	WOS:000259680200047
J	Gordon, GRJ; Choi, HB; Rungta, RL; Ellis-Davies, GCR; MacVicar, BA				Gordon, Grant R. J.; Choi, Hyun B.; Rungta, Ravi L.; Ellis-Davies, Graham C. R.; MacVicar, Brian A.			Brain metabolism dictates the polarity of astrocyte control over arterioles	NATURE			English	Article							CEREBRAL-BLOOD-FLOW; PROSTAGLANDIN TRANSPORTER PGT; RAT HIPPOCAMPAL SLICES; ACTIVATED HUMAN BRAIN; NEURONAL-ACTIVITY; OXIDATIVE-METABOLISM; IN-VIVO; EXTRACELLULAR LACTATE; SENSORY STIMULATION; CORTICAL ASTROCYTES	Calcium signalling in astrocytes couples changes in neural activity to alterations in cerebral blood flow by eliciting vasoconstriction or vasodilation of arterioles. However, the mechanism for how these opposite astrocyte influences provide appropriate changes in vessel tone within an environment that has dynamic metabolic requirements remains unclear. Here we show that the ability of astrocytes to induce vasodilations over vasoconstrictions relies on the metabolic state of the rat brain tissue. When oxygen availability is lowered and astrocyte calcium concentration is elevated, astrocyte glycolysis and lactate release are maximized. External lactate attenuates transporter- mediated uptake from the extracellular space of prostaglandin E(2), leading to accumulation and subsequent vasodilation. In conditions of low oxygen concentration extracellular adenosine also increases, which blocks astrocyte- mediated constriction, facilitating dilation. These data reveal the role of metabolic substrates in regulating brain blood flow and provide a mechanism for differential astrocyte control over cerebrovascular diameter during different states of brain activation.	[Gordon, Grant R. J.; Choi, Hyun B.; Rungta, Ravi L.; MacVicar, Brian A.] Univ British Columbia, Dept Psychiat, Brain Res Ctr, Vancouver, BC T2N 2B5, Canada; [Ellis-Davies, Graham C. R.] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA	University of British Columbia; Drexel University	MacVicar, BA (corresponding author), Univ British Columbia, Dept Psychiat, Brain Res Ctr, Vancouver, BC T2N 2B5, Canada.	bmacvicar@brain.ubc.ca	MacVicar, Brian/AAI-7729-2020; MacVicar, Brian/P-1553-2015	MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623; Rungta, Ravi/0000-0003-3505-2743	Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; Natural Science and Engineering Council of Canada; Wilms Foundation; Heart and Stroke Foundation of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Wilms Foundation; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Murphy, T. Phillips and Y. Tian Wang for reading an earlier version of the manuscript. T34 was a gift from V.L. Schuster and Y. Chi. This work was supported by an operating grant from the Canadian Institutes of Health Research. B.A.M. is a Canada Research Chair and a Michael Smith Foundation for Health Research (MSFHR) Distinguished Scholar. G.R.J.G. is supported by fellowships from the Alberta Heritage Foundation for Medical Research, MSFHR and the Natural Science and Engineering Council of Canada. H. B. C. is supported by postdoctoral fellowships from Wilms Foundation and the Heart and Stroke Foundation of Canada.	Ances BM, 2001, NEUROSCI LETT, V306, P106, DOI 10.1016/S0304-3940(01)01868-7; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Brust TB, 2006, J NEUROSCI, V26, P12427, DOI 10.1523/JNEUROSCI.4052-06.2006; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Chaigneau E, 2007, J NEUROSCI, V27, P6452, DOI 10.1523/JNEUROSCI.3141-06.2007; Chan BS, 1998, J BIOL CHEM, V273, P6689, DOI 10.1074/jbc.273.12.6689; Chan BS, 2002, AM J PHYSIOL-RENAL, V282, pF1097, DOI 10.1152/ajprenal.00151.2001; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Chi YL, 2006, J PHARMACOL EXP THER, V316, P1346, DOI 10.1124/jpet.105.091975; Chuquet J, 2007, J NEUROSCI, V27, P4036, DOI 10.1523/JNEUROSCI.0721-07.2007; D'Agostino DP, 2007, J NEUROPHYSIOL, V98, P1030, DOI 10.1152/jn.01003.2006; DENK W, 1994, P NATL ACAD SCI USA, V91, P6629, DOI 10.1073/pnas.91.14.6629; Devor A, 2005, P NATL ACAD SCI USA, V102, P3822, DOI 10.1073/pnas.0407789102; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Filosa JA, 2004, CIRC RES, V95, pE73, DOI 10.1161/01.RES.0000148636.60732.2e; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Frenguelli BG, 2003, J NEUROCHEM, V86, P1506, DOI 10.1046/j.1471-4159.2003.01957.x; Hein TW, 2006, INVEST OPHTH VIS SCI, V47, P693, DOI 10.1167/iovs.05-1224; Hu YB, 1997, J NEUROCHEM, V69, P1484; Ido Y, 2004, P NATL ACAD SCI USA, V101, P653, DOI 10.1073/pnas.0307458100; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; KLAIDMAN LK, 1995, ANAL BIOCHEM, V228, P312, DOI 10.1006/abio.1995.1356; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Malonek D, 1997, P NATL ACAD SCI USA, V94, P14826, DOI 10.1073/pnas.94.26.14826; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Mintun MA, 2004, P NATL ACAD SCI USA, V101, P659, DOI 10.1073/pnas.0307457100; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Murphy K, 2003, MOL PHARMACOL, V64, P640, DOI 10.1124/mol.64.3.640; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Offenhauser N, 2005, J PHYSIOL-LONDON, V565, P279, DOI 10.1113/jphysiol.2005.082776; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Ryu JK, 2003, NEUROBIOL DIS, V12, P121, DOI 10.1016/S0969-9961(03)00002-0; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Simard M, 2003, J NEUROSCI, V23, P9254; SORG O, 1991, BRAIN RES, V563, P227, DOI 10.1016/0006-8993(91)91538-C; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; Vishwasrao HD, 2005, J BIOL CHEM, V280, P25119, DOI 10.1074/jbc.M502475200; Vlassenko AG, 2006, P NATL ACAD SCI USA, V103, P1964, DOI 10.1073/pnas.0510632103; Wender R, 2000, J NEUROSCI, V20, P6804, DOI 10.1523/JNEUROSCI.20-18-06804.2000; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Yamanishi S, 2006, AM J PHYSIOL-HEART C, V290, pH925, DOI 10.1152/ajpheart.01012.2005; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	49	511	522	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					745	U45		10.1038/nature07525	http://dx.doi.org/10.1038/nature07525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18971930	Green Accepted			2022-12-28	WOS:000261559900039
J	Byres, E; Paton, AW; Paton, JC; Lofling, JC; Smith, DF; Wilce, MCJ; Talbot, UM; Chong, DC; Yu, H; Huang, SS; Chen, X; Varki, NM; Varki, A; Rossjohn, J; Beddoe, T				Byres, Emma; Paton, Adrienne W.; Paton, James C.; Lofling, Jonas C.; Smith, David F.; Wilce, Matthew C. J.; Talbot, Ursula M.; Chong, Damien C.; Yu, Hai; Huang, Shengshu; Chen, Xi; Varki, Nissi M.; Varki, Ajit; Rossjohn, Jamie; Beddoe, Travis			Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin	NATURE			English	Article							SUBTILASE CYTOTOXIN; CHOLERA-TOXIN; AB(5) TOXIN; MODEL; MICE; TARGETS; BINDING; POTENT; SITE	AB(5) toxins comprise an A subunit that corrupts essential eukaryotic cell functions, and pentameric B subunits that direct targetcell uptake after binding surface glycans. Subtilase cytotoxin (SubAB) is an AB5 toxin secreted by Shiga toxigenic Escherichia coli (STEC)(1), which causes serious gastrointestinal disease in humans(2). SubAB causes haemolytic uraemic syndrome- like pathology in mice(3) through SubA- mediated cleavage of BiP/GRP78, an essential endoplasmic reticulum chaperone(4). Here we show that SubB has a strong preference for glycans terminating in the sialic acid N- glycolylneuraminic acid (Neu5Gc), a monosaccharide not synthesized in humans. Structures of SubB - Neu5Gc complexes revealed the basis for this specificity, and mutagenesis of key SubB residues abrogated in vitro glycan recognition, cell binding and cytotoxicity. SubAB specificity for Neu5Gc was confirmed using mouse tissues with a human- like deficiency of Neu5Gc and human cell lines fed with Neu5Gc. Despite lack of Neu5Gc biosynthesis in humans, assimilation of dietary Neu5Gc creates high- affinity receptors on human gut epithelia and kidney vasculature. This, and the lack of Neu5Gc- containing body fluid competitors in humans, confers susceptibility to the gastrointestinal and systemic toxicities of SubAB. Ironically, foods rich in Neu5Gc are the most common source of STEC contamination. Thus a bacterial toxin's receptor is generated by metabolic incorporation of an exogenous factor derived from food.	[Lofling, Jonas C.; Varki, Nissi M.; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Byres, Emma; Wilce, Matthew C. J.; Rossjohn, Jamie; Beddoe, Travis] Monash Univ, Prot Crystallog Unit, Clayton, Vic 3800, Australia; [Byres, Emma; Wilce, Matthew C. J.; Rossjohn, Jamie; Beddoe, Travis] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Paton, Adrienne W.; Paton, James C.; Talbot, Ursula M.; Chong, Damien C.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Smith, David F.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Yu, Hai; Huang, Shengshu; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California San Diego; Monash University; Monash University; University of Adelaide; Emory University; University of California System; University of California Davis	Varki, A (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu; jamie.rossjohn@med.monash.edu.au; travis.beddoe@med.monash.edu.au	Beddoe, Travis/F-3415-2014; Rossjohn, Jamie/F-9032-2013; Chen, Xi/H-1811-2018; Paton, James C/A-9920-2008	Beddoe, Travis/0000-0003-4550-2277; Rossjohn, Jamie/0000-0002-2020-7522; Chen, Xi/0000-0002-3160-614X; 	Program Grant from the National Health; Medical Research Council of Australia; NHMRC Project Grant; National Institute of General Medical Sciences to the Consortium for Functional Glycomics; National Institutes of Health [RO1]; ARC Centre of Excellence in Structural and Functional Microbial Genomics; Australian Research Council Federation Fellowship; NHMRC Career Development Award; NHMRC Australia Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068715] Funding Source: NIH RePORTER	Program Grant from the National Health; Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Project Grant(National Health and Medical Research Council (NHMRC) of Australia); National Institute of General Medical Sciences to the Consortium for Functional Glycomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARC Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); Australian Research Council Federation Fellowship(Australian Research Council); NHMRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the staff at the General Medicine and Cancer Institutes Collaborative Access Team Advanced Photon Source, Chicago, for assistance with data collection. This research was supported by a Program Grant from the National Health and Medical Research Council of Australia (NHMRC; to A.W.P. and J.C.P.), an NHMRC Project Grant (to T.B. and A.W.P.), a grant from the National Institute of General Medical Sciences to the Consortium for Functional Glycomics, RO1 grants from the National Institutes of Health (to A.W.P., J.C.P., J.R., X.C. and A.V.) and from the ARC Centre of Excellence in Structural and Functional Microbial Genomics (to J.R.). J.R. is supported by an Australian Research Council Federation Fellowship; T.B. by an NHMRC Career Development Award; J. C. P. by an NHMRC Australia Fellowship. We also thank C.J. Gregg for assistance with in vivo experiments and with collection of data, and L. Wiggleton for technical assistance with tissue sectioning and staining.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chong DC, 2008, CELL MICROBIOL, V10, P795, DOI 10.1111/j.1462-5822.2007.01085.x; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS PR, 1997, P CCP4 STUD WEEK REC, P97; Gagneux P, 2001, AM J PHYS ANTHROPOL, V115, P99, DOI 10.1002/ajpa.1061; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB, P26; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Merritt EA, 1997, PROTEIN SCI, V6, P1516, DOI 10.1002/pro.5560060716; MERRITT EA, 1994, MOL MICROBIOL, V13, P745, DOI 10.1111/j.1365-2958.1994.tb00467.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Neu U, 2008, P NATL ACAD SCI USA, V105, P5219, DOI 10.1073/pnas.0710301105; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; PERRAKIS A, 1997, ACTA CRYSTALLOGR D, V30, P551; Sandvig K, 2002, ANNU REV CELL DEV BI, V18, P1, DOI 10.1146/annurev.cellbio.18.011502.142107; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; STEIN PE, 1994, NAT STRUCT BIOL, V1, P591, DOI 10.1038/nsb0994-591; Talbot UM, 2005, INFECT IMMUN, V73, P4432, DOI 10.1128/IAI.73.7.4432-4436.2005; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Varki A, 2009, GLYCOCONJUGATE J, V26, P231, DOI 10.1007/s10719-008-9183-z; Wang H, 2007, J INFECT DIS, V196, P1093, DOI 10.1086/521364; Yahiro K, 2006, MOL MICROBIOL, V62, P480, DOI 10.1111/j.1365-2958.2006.05379.x	30	170	174	3	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2008	456	7222					648	U75		10.1038/nature07428	http://dx.doi.org/10.1038/nature07428			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18971931	Green Accepted			2022-12-28	WOS:000261340000043
J	Wang, LD; Utzinger, J; Zhou, XN				Wang, Longde; Utzinger, Juerg; Zhou, Xiao-Nong			Schistosomiasis control: experiences and lessons from China	LANCET			English	Editorial Material							METAANALYSIS		[Zhou, Xiao-Nong] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai 200025, Peoples R China; [Wang, Longde] Minist Hlth, Beijing, Peoples R China; [Utzinger, Juerg] Swiss Trop Inst, Dept Publ Hlth & Epidemiol, CH-4002 Basel, Switzerland	Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; University of Basel; Swiss Tropical & Public Health Institute	Zhou, XN (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai 200025, Peoples R China.	ipdzhouxn@sh163.net						BIAN Y, 2004, INT J HLTH PLANN S1, V19, P79; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Guo JG, 2005, ACTA TROP, V96, P177, DOI 10.1016/j.actatropica.2005.07.012; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Liang S, 2006, B WORLD HEALTH ORGAN, V84, P139, DOI 10.2471/BLT.05.025031; Poon LLM, 2004, LANCET INFECT DIS, V4, P663, DOI 10.1016/S1473-3099(04)01172-7; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Utzinger J, 2005, ACTA TROP, V96, P69, DOI 10.1016/j.actatropica.2005.08.004; WANG LD, 2008, N ENGL J ME IN PRESS; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005	12	167	209	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2008	372	9652					1793	1795		10.1016/S0140-6736(08)61358-6	http://dx.doi.org/10.1016/S0140-6736(08)61358-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	18930529	Green Published, Bronze			2022-12-28	WOS:000261112000009
J	Cadwell, K; Liu, JY; Brown, SL; Miyoshi, H; Loh, J; Lennerz, JK; Kishi, C; Kc, W; Carrero, JA; Hunt, S; Stone, CD; Brunt, EM; Xavier, RJ; Sleckman, BP; Li, E; Mizushima, N; Stappenbeck, TS; Virgin, HW				Cadwell, Ken; Liu, John Y.; Brown, Sarah L.; Miyoshi, Hiroyuki; Loh, Joy; Lennerz, Jochen K.; Kishi, Chieko; Kc, Wumesh; Carrero, Javier A.; Hunt, Steven; Stone, Christian D.; Brunt, Elizabeth M.; Xavier, Ramnik J.; Sleckman, Barry P.; Li, Ellen; Mizushima, Noboru; Stappenbeck, Thaddeus S.; Virgin, Herbert W.			A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells	NATURE			English	Article							GENOME-WIDE ASSOCIATION; MESENTERIC ADIPOSE-TISSUE; SUSCEPTIBILITY LOCI; CROHN-DISEASE; PROTEIN; PATHOGENESIS; EXPRESSION; MEMBRANE; COMPLEX	Susceptibility to Crohn's disease, a complex inflammatory disease involving the small intestine, is controlled by over 30 loci(1). One Crohn's disease risk allele is in ATG16L1, a gene homologous to the essential yeast autophagy gene ATG16 ( ref. 2). It is not known how ATG16L1 or autophagy contributes to intestinal biology or Crohn's disease pathogenesis. To address these questions, we generated and characterized mice that are hypomorphic for ATG16L1 protein expression, and validated conclusions on the basis of studies in these mice by analysing intestinal tissues that we collected from Crohn's disease patients carrying the Crohn's disease risk allele of ATG16L1. Here we show that ATG16L1 is a bona fide autophagy protein. Within the ileal epithelium, both ATG16L1 and a second essential autophagy protein ATG5 are selectively important for the biology of the Paneth cell, a specialized epithelial cell that functions in part by secretion of granule contents containing antimicrobial peptides and other proteins that alter the intestinal environment(3). ATG16L1- andATG5- deficient Paneth cells exhibited notable abnormalities in the granule exocytosis pathway. In addition, transcriptional analysis revealed an unexpected gain of function specific to ATG16L1- deficient Paneth cells including increased expression of genes involved in peroxisome proliferator- activated receptor ( PPAR) signalling and lipid metabolism, of acute phase reactants and of two adipocytokines, leptin and adiponectin, known to directly influence intestinal injury responses. Importantly, Crohn's disease patients homozygous for the ATG16L1 Crohn's disease risk allele displayed Paneth cell granule abnormalities similar to those observed in autophagy- protein- deficient mice and expressed increased levels of leptin protein. Thus, ATG16L1, and probably the process of autophagy, have a role within the intestinal epithelium of mice and Crohn's disease patients by selective effects on the cell biology and specialized regulatory properties of Paneth cells.	[Cadwell, Ken; Liu, John Y.; Brown, Sarah L.; Miyoshi, Hiroyuki; Loh, Joy; Lennerz, Jochen K.; Kc, Wumesh; Carrero, Javier A.; Brunt, Elizabeth M.; Sleckman, Barry P.; Stappenbeck, Thaddeus S.; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Hunt, Steven] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Stone, Christian D.; Li, Ellen] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Virgin, Herbert W.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Kishi, Chieko; Mizushima, Noboru] Tokyo Med & Dent Univ, Grad Sch, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Kishi, Chieko; Mizushima, Noboru] Tokyo Med & Dent Univ, Fac Med, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	stappenb@wustl.edu; virgin@wustl.edu	Mizushima, Noboru/C-3635-2009	Mizushima, Noboru/0000-0002-6258-6444; Cadwell, Ken/0000-0002-5860-0661; Virgin, Herbert/0000-0001-8580-7628; Miyoshi, Hiroyuki/0000-0001-7400-0714	Broad Foundation; NIH [T32 AR07279, R01 AI062832, AI062773, DK43351]; Lallage Feazel Wall Fellowship [DRG-1972-08]; Damon Runyon Cancer Research Foundation; Pew Foundation; Washington University Digestive Diseases Research Core Center [P30 DK52574]; Barnes Jewish Foundation; Johnson and Johnson Translational Seed Award; Crohn's Colitis Foundation of America; Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Toray Science Foundation;  [U54 AI057160 Project 6]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062773, U54AI057160, R01AI062832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK052574, P30DK040561] Funding Source: NIH RePORTER	Broad Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lallage Feazel Wall Fellowship; Damon Runyon Cancer Research Foundation; Pew Foundation; Washington University Digestive Diseases Research Core Center; Barnes Jewish Foundation; Johnson and Johnson Translational Seed Award(Johnson & JohnsonJohnson & Johnson USA); Crohn's Colitis Foundation of America; Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Toray Science Foundation(Toray Industries, Inc.); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Abe for technical assistance with fluorescence microscopy, V. Cavalli for microscope use, J. Eisenberg and A. Ng for help with bioinformatics analysis, A. J. Ouellette for technical advice, and I. Mysorekar and J. Mills for help with antibodies. This research was supported by grant U54 AI057160 Project 6 and the Broad Foundation (K.C., J. Loh and H.W.V.), training grant NIH T32 AR07279 (K.C.), the Lallage Feazel Wall Fellowship DRG-1972-08 (K.C.) from the Damon Runyon Cancer Research Foundation; the Pew Foundation (J. Liu, S.L.B., H.M., W.K. and T.S.S.); the Washington University Digestive Diseases Research Core Center P30 DK52574, Barnes Jewish Foundation, Johnson and Johnson Translational Seed Award, and the Crohn's Colitis Foundation of America (E.L., S.H. and C.S.); grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Toray Science Foundation (C.K. and N.M.); NIH R01 AI062832 (J.A.C.); and NIH AI062773 and DK43351 (R.J.X.).	Barbier M, 2003, GASTROEN CLIN BIOL, V27, P987; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; DVORAK AM, 1980, HUM PATHOL, V11, P561; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Ouellette AJ, 2006, CURR TOP MICROBIOL, V306, P1; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Stappenbeck TS, 2003, P NATL ACAD SCI USA, V100, P1004, DOI 10.1073/pnas.242735899; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yamamoto K, 2005, GUT, V54, P789, DOI 10.1136/gut.2004.046516	29	1093	1130	4	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					259	U62		10.1038/nature07416	http://dx.doi.org/10.1038/nature07416			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	18849966	Green Accepted			2022-12-28	WOS:000261039300044
J	Liu, Y; Dentin, R; Chen, D; Hedrick, S; Ravnskjaer, K; Schenk, S; Milne, J; Meyers, DJ; Cole, P; Yates, J; Olefsky, J; Guarente, L; Montminy, M				Liu, Yi; Dentin, Renaud; Chen, Danica; Hedrick, Susan; Ravnskjaer, Kim; Schenk, Simon; Milne, Jill; Meyers, David J.; Cole, Phil; Yates, John, III; Olefsky, Jerrold; Guarente, Leonard; Montminy, Marc			A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange	NATURE			English	Article							TRANSCRIPTION FACTOR FOXO1; GLUCOSE-HOMEOSTASIS; CATALYTIC SUBUNIT; GENE-EXPRESSION; FACTOR FKHR; GLUCOSE-6-PHOSPHATASE; SIRT1; P300; METABOLISM; STARVATION	During early fasting, increases in skeletal muscle proteolysis liberate free amino acids for hepatic gluconeogenesis in response to pancreatic glucagon. Hepatic glucose output diminishes during the late protein- sparing phase of fasting, when ketone body production by the liver supplies compensatory fuel for glucose- dependent tissues(1-4). Glucagon stimulates the gluconeogenic program by triggering the dephosphorylation and nuclear translocation of the CREB regulated transcription coactivator 2 ( CRTC2; also known as TORC2), while parallel decreases in insulin signalling augment gluconeogenic gene expression through the dephosphorylation and nuclear shuttling of forkhead box O1 (FOXO1)(5-7). Here we show that a fasting- inducible switch, consisting of the histone acetyltransferase p300 and the nutrient- sensing deacetylase sirtuin 1 ( SIRT1), maintains energy balance in mice through the sequential induction of CRTC2 and FOXO1. After glucagon induction, CRTC2 stimulated gluconeogenic gene expression by an association with p300, which we show here is also activated by dephosphorylation at Ser 89 during fasting. In turn, p300 increased hepatic CRTC2 activity by acetylating it at Lys 628, a site that also targets CRTC2 for degradation after its ubiquitination by the E3 ligase constitutive photomorphogenic protein (COP1)(8). Glucagon effects were attenuated during late fasting, when CRTC2 was downregulated owing to SIRT1- mediated deacetylation and when FOXO1 supported expression of the gluconeogenic program. Disrupting SIRT1 activity, by liver- specific knockout of the Sirt1 gene or by administration of a SIRT1 antagonist, increased CRTC2 activity and glucose output, whereas exposure to SIRT1 agonists reduced them. In view of the reciprocal activation of FOXO1 and its coactivator peroxisome proliferator- activated receptor-gamma coactivator-1 alpha (PGC-1 alpha, encoded by Ppargc1 alpha) by SIRT1 activators(9-12), our results illustrate how the exchange of two gluconeogenic regulators during fasting maintains energy balance.	[Liu, Yi; Dentin, Renaud; Hedrick, Susan; Ravnskjaer, Kim; Montminy, Marc] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Chen, Danica; Guarente, Leonard] MIT, Dept Biol, Cambridge, MA 02139 USA; [Schenk, Simon; Olefsky, Jerrold] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Milne, Jill] Sirtris Pharmaceut Inc, Cambridge, MA 02139 USA; [Meyers, David J.; Cole, Phil] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Yates, John, III] Scripps Res Inst, La Jolla, CA 92037 USA	Salk Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; Johns Hopkins University; Scripps Research Institute	Montminy, M (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	Montminy@salk.edu	dentin, Renaud/P-4939-2017; Dentin, Renaud/AAV-5818-2020	dentin, Renaud/0000-0003-0988-4458; Dentin, Renaud/0000-0003-0988-4458; Schenk, Simon/0000-0002-8224-3203	National Institutes of Health; Clayton Medical Research Foundation, Inc; Hillblom Foundation; Kieckhefer Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037828] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Medical Research Foundation, Inc; Hillblom Foundation; Kieckhefer Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Kahn for the gift of phospho-specific p300 antiserum and L. Vera for technical assistance. We also thank R. Shaw and M. Mihaylova for sharing results on p300 phosphorylation. This work was supported by grants from the National Institutes of Health, the Clayton Medical Research Foundation, Inc., the Hillblom Foundation (to Y.L.), and the Kieckhefer Foundation.	Ayala JE, 1999, DIABETES, V48, P1885, DOI 10.2337/diabetes.48.9.1885; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Barthel A, 2001, BIOCHEM BIOPH RES CO, V285, P897, DOI 10.1006/bbrc.2001.5261; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; FERRE P, 1978, AM J PHYSIOL, V234, pE129, DOI 10.1152/ajpendo.1978.234.2.E129; Freiman RN, 2003, CELL, V112, P11, DOI 10.1016/S0092-8674(02)01278-3; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Gan LX, 2005, BIOCHEM BIOPH RES CO, V337, P1092, DOI 10.1016/j.bbrc.2005.09.169; GOODMAN MN, 1980, AM J PHYSIOL, V239, pE277; GOODMAN MN, 1981, AM J PHYSIOL, V241, pE321, DOI 10.1152/ajpendo.1981.241.4.E321; Guidez F, 2005, MOL CELL BIOL, V25, P5552, DOI 10.1128/MCB.25.13.5552-5566.2005; Hornbuckle LA, 2004, AM J PHYSIOL-ENDOC M, V286, pE795, DOI 10.1152/ajpendo.00455.2003; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; MARLISS EB, 1970, J CLIN INVEST, V49, P2256, DOI 10.1172/JCI106445; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schmoll D, 1999, BIOCHEM J, V338, P457, DOI 10.1042/0264-6021:3380457; Yang WB, 2001, J BIOL CHEM, V276, P38341, DOI 10.1074/jbc.C100316200; Yuan LW, 2000, J BIOL CHEM, V275, P40946, DOI 10.1074/jbc.M007832200; Zheng YJ, 2005, J AM CHEM SOC, V127, P17182, DOI 10.1021/ja0558544	30	406	430	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					269	U74		10.1038/nature07349	http://dx.doi.org/10.1038/nature07349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	18849969	Green Accepted			2022-12-28	WOS:000261039300046
J	Hoshida, Y; Villanueva, A; Kobayashi, M; Peix, J; Chiang, DY; Camargo, A; Gupta, S; Moore, J; Wrobel, MJ; Lerner, J; Reich, M; Chan, JA; Glickman, JN; Ikeda, K; Hashimoto, M; Watanabe, G; Daidone, MG; Roayaie, S; Schwartz, M; Thung, S; Salvesen, HB; Gabriel, S; Mazzaferro, V; Bruix, J; Friedman, SL; Kumada, H; Llovet, JM; Golub, TR				Hoshida, Yujin; Villanueva, Augusto; Kobayashi, Masahiro; Peix, Judit; Chiang, Derek Y.; Camargo, Amy; Gupta, Supriya; Moore, Jamie; Wrobel, Matthew J.; Lerner, Jim; Reich, Michael; Chan, Jennifer A.; Glickman, Jonathan N.; Ikeda, Kenji; Hashimoto, Masaji; Watanabe, Goro; Daidone, Maria G.; Roayaie, Sasan; Schwartz, Myron; Thung, Swan; Salvesen, Helga B.; Gabriel, Stacey; Mazzaferro, Vincenzo; Bruix, Jordi; Friedman, Scott L.; Kumada, Hiromitsu; Llovet, Josep M.; Golub, Todd R.			Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED-TRIAL; LIVER-CANCER; RECURRENCE; RESECTION; INTERFERON; PREVENTION; MANAGEMENT; TUMOR; RISK	Background: It is a challenge to identify patients who, after undergoing potentially curative treatment for hepatocellular carcinoma, are at greatest risk for recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predictors of outcome in patients with hepatocellular carcinoma has been the lack of a means to carry out genomewide expression profiling of fixed, as opposed to frozen, tissue. Methods: We aimed to demonstrate the feasibility of gene-expression profiling of more than 6000 human genes in formalin-fixed, paraffin-embedded tissues. We applied the method to tissues from 307 patients with hepatocellular carcinoma, from four series of patients, to discover and validate a gene-expression signature associated with survival. Results: The expression-profiling method for formalin-fixed, paraffin-embedded tissue was highly effective: samples from 90% of the patients yielded data of high quality, including samples that had been archived for more than 24 years. Gene-expression profiles of tumor tissue failed to yield a significant association with survival. In contrast, profiles of the surrounding nontumoral liver tissue were highly correlated with survival in a training set of tissue samples from 82 Japanese patients, and the signature was validated in tissues from an independent group of 225 patients from the United States and Europe (P=0.04). Conclusions: We have demonstrated the feasibility of genomewide expression profiling of formalin-fixed, paraffin-embedded tissues and have shown that a reproducible gene-expression signature correlated with survival is present in liver tissue adjacent to the tumor in patients with hepatocellular carcinoma.	[Hoshida, Yujin; Chiang, Derek Y.; Camargo, Amy; Gupta, Supriya; Moore, Jamie; Wrobel, Matthew J.; Lerner, Jim; Reich, Michael; Chan, Jennifer A.; Gabriel, Stacey; Golub, Todd R.] MIT, Broad Inst, Canc Program, Cambridge, MA 02142 USA; [Hoshida, Yujin; Chiang, Derek Y.; Camargo, Amy; Gupta, Supriya; Moore, Jamie; Wrobel, Matthew J.; Lerner, Jim; Reich, Michael; Chan, Jennifer A.; Gabriel, Stacey; Golub, Todd R.] Harvard Univ, Cambridge, MA 02142 USA; [Golub, Todd R.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Hoshida, Yujin; Chiang, Derek Y.; Golub, Todd R.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Glickman, Jonathan N.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA; [Villanueva, Augusto; Peix, Judit; Roayaie, Sasan; Schwartz, Myron; Thung, Swan; Friedman, Scott L.; Llovet, Josep M.] Mt Sinai Sch Med, Mt Sinai Liver Canc Program, Div Liver Dis, New York, NY 10029 USA; [Kobayashi, Masahiro; Ikeda, Kenji; Hashimoto, Masaji; Watanabe, Goro; Kumada, Hiromitsu] Toranomon Gen Hosp, Tokyo, Japan; [Daidone, Maria G.; Mazzaferro, Vincenzo] Natl Canc Inst, I-20133 Milan, Italy; [Salvesen, Helga B.] Univ Bergen, Haukeland Univ Hosp, Bergen, Norway; [Bruix, Jordi; Llovet, Josep M.] Hosp Clin Barcelona, Ctr Invest Red Enfermedades Hepat & Digest, Inst Invest Biomed August Pi & Sunyer, Barcelona Clin Liver Canc Grp, Barcelona, Spain; [Llovet, Josep M.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Icahn School of Medicine at Mount Sinai; Toranomon Hospital; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Bergen; Haukeland University Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ICREA	Golub, TR (corresponding author), MIT, Broad Inst, Canc Program, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	josep.llovet@mssm.edu; golub@broad.mit.edu	Llovet, Josep M/ABB-6264-2021; Llovet, Josep M/D-4340-2014; Daidone, Maria Grazia/E-9232-2017; Hoshida, Yujin/R-7513-2019; Chiang, Derek/L-6452-2019; Mazzaferro, Vincenzo/C-2726-2017; salvesen, Helga B/C-1187-2017; Augusto, Villanueva/F-9378-2012; Mazzaferro, Vincenzo/AAL-4707-2020	Llovet, Josep M/0000-0003-0547-2667; Llovet, Josep M/0000-0003-0547-2667; Daidone, Maria Grazia/0000-0002-4786-1321; Mazzaferro, Vincenzo/0000-0002-4013-8085; salvesen, Helga B/0000-0002-4438-8831; Augusto, Villanueva/0000-0003-3585-3727; Chiang, Derek/0000-0002-1131-6065; Reich, Michael/0000-0003-4735-5514; Bruix, Jordi/0000-0002-9826-0753	National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK076986-01]; National Cancer Institute [5U54 CA112962-03]; Samuel Waxman Cancer Research Foundation; Spanish National Health Institute [SAF2007-61898]; Institucio Catalana de Recerca i Estudis Avancats; Centro de Investigaciones en Red de Enfermedades Hepaticas y Digestivas; Fund for Health of Spain of the Institute of Health Carlos III [PI05-0150]; National Institutes of Health [DK37340]; Italian Association for Cancer Research; Norwegian Cancer Society; Harald Andersens grant; Charles A. King Trust fellowship; Fundacion Pedro Barri, de la Maza; Sheila Sherlock Fellowship; National Cancer Center Fellowship; ICREA Funding Source: Custom; NATIONAL CANCER INSTITUTE [U54CA112962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076986, R01DK037340] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Samuel Waxman Cancer Research Foundation; Spanish National Health Institute(Spanish Government); Institucio Catalana de Recerca i Estudis Avancats(ICREA); Centro de Investigaciones en Red de Enfermedades Hepaticas y Digestivas; Fund for Health of Spain of the Institute of Health Carlos III(Instituto de Salud Carlos III); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Norwegian Cancer Society(Norwegian Cancer Society); Harald Andersens grant; Charles A. King Trust fellowship; Fundacion Pedro Barri, de la Maza; Sheila Sherlock Fellowship; National Cancer Center Fellowship; ICREA(ICREA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK076986-01, to Dr. Llovet), the National Cancer Institute (5U54 CA112962-03, to Dr. Golub), the Samuel Waxman Cancer Research Foundation (to Dr. Llovet), the Spanish National Health Institute (SAF2007-61898, to Dr. Llovet), Institucio Catalana de Recerca i Estudis Avancats (to Dr. Llovet), Centro de Investigaciones en Red de Enfermedades Hepaticas y Digestivas (to Drs. Llovet and Bruix), the Fund for Health of Spain of the Institute of Health Carlos III (PI05-0150, to Dr. Bruix), the National Institutes of Health (DK37340, to Dr. Friedman), the Italian Association for Cancer Research (to Dr. Mazzaferro), Helse Vest and Norwegian Cancer Society, Harald Andersens grant (to Dr. Salvesen), the Charles A. King Trust fellowship (to Dr. Hoshida), and Fundacion Pedro Barri, de la Maza, the Sheila Sherlock Fellowship, and the National Cancer Center Fellowship (all to Dr. Villanueva).	Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Coudry RA, 2007, J MOL DIAGN, V9, P70, DOI 10.2353/jmoldx.2007.060004; Fan JB, 2004, GENOME RES, V14, P878, DOI 10.1101/gr.2167504; Habel LA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1412; Ikeda K, 2000, HEPATOLOGY, V32, P228, DOI 10.1053/jhep.2000.9409; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Lau WY, 1999, LANCET, V353, P797, DOI 10.1016/S0140-6736(98)06475-7; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Mazzaferro V, 2006, HEPATOLOGY, V44, P1543, DOI 10.1002/hep.21415; Muto Y, 1996, NEW ENGL J MED, V334, P1561, DOI 10.1056/NEJM199606133342402; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takayama T, 2000, LANCET, V356, P1690; Takayama T, 2000, LANCET, V356, P802, DOI 10.1016/S0140-6736(00)02654-4; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843	22	960	996	1	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					1995	2004		10.1056/NEJMoa0804525	http://dx.doi.org/10.1056/NEJMoa0804525			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368OW	18923165	Green Accepted			2022-12-28	WOS:000260632700004
J	Vecchi, GA; Swanson, KL; Soden, BJ				Vecchi, Gabriel A.; Swanson, Kyle L.; Soden, Brian J.			CLIMATE CHANGE Whither Hurricane Activity?	SCIENCE			English	Editorial Material							FREQUENCY		[Vecchi, Gabriel A.] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA; [Swanson, Kyle L.] Univ Wisconsin, Dept Math Sci, Atmospher Sci Grp, Milwaukee, WI 53201 USA; [Soden, Brian J.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Wisconsin System; University of Wisconsin Milwaukee; University of Miami	Vecchi, GA (corresponding author), NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA.	gabriel.a.vecchi@noaa.gov	Soden, Brian/ABC-3659-2021; Vecchi, Gabriel/A-2413-2008	Vecchi, Gabriel/0000-0002-5085-224X; Soden, Brian/0000-0001-9693-8236				Bengtsson L, 2007, TELLUS A, V59, P539, DOI 10.1111/j.1600-0870.2007.00251.x; Emanuel K, 2008, B AM METEOROL SOC, V89, P347, DOI 10.1175/BAMS-89-3-347; Emanuel K, 2007, J CLIMATE, V20, P5497, DOI 10.1175/2007JCLI1571.1; Hoyos CD, 2006, SCIENCE, V312, P94, DOI 10.1126/science.1123560; Knutson TR, 2006, J CLIMATE, V19, P1624, DOI 10.1175/JCLI3709.1; Knutson TR, 2008, NAT GEOSCI, V1, P359, DOI 10.1038/ngeo202; Latif M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027969; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; MMS, 2021, CLIMATE RODRIGUES IS; Oouchi K, 2006, J METEOROL SOC JPN, V84, P259, DOI 10.2151/jmsj.84.259; Santer BD, 2006, P NATL ACAD SCI USA, V103, P13905, DOI 10.1073/pnas.0602861103; Swanson KL, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001844; Vecchi GA, 2007, NATURE, V450, P1066, DOI 10.1038/nature06423; Vimont DJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029683; Zhang R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026267	15	147	149	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					687	689		10.1126/science.1164396	http://dx.doi.org/10.1126/science.1164396			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974337				2022-12-28	WOS:000260605200030
J	Adashi, EY; West, DM				Adashi, Eli Y.; West, Darrell M.			Election 2008: The candidates' positions: Reproductive freedom and the next president	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Adashi, Eli Y.] Brown Univ, Providence, RI 02912 USA; [West, Darrell M.] Brookings Inst, Washington, DC 20036 USA	Brown University; Brookings Institution	Adashi, EY (corresponding author), Brown Univ, Providence, RI 02912 USA.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2008	359	18					1867	1869		10.1056/NEJMp0805263	http://dx.doi.org/10.1056/NEJMp0805263			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366BL	18971488	Bronze			2022-12-28	WOS:000260454500002
J	Giezen, TJ; Mantel-Teeuwisse, AK; Straus, SMJM; Schellekens, H; Leufkens, HGM; Egberts, ACG				Giezen, Thijs J.; Mantel-Teeuwisse, Aukje K.; Straus, Sabine M. J. M.; Schellekens, Huub; Leufkens, Hubert G. M.; Egberts, Antoine C. G.			Safety-related regulatory actions for biologicals approved in the United States and the European Union	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK; INFECTIONS; BIOPHARMACEUTICALS; PHARMACOVIGILANCE; IMMUNOGENICITY	Context Biologicals are a relatively new class of medicines that carry specific risks (eg, immunogenicity). However, limited information is available on the nature and timing of safety problems with their use that were identified after approval. Objective To determine the nature, frequency, and timing of safety-related regulatory actions for biologicals following approval in the United States and/or the European Union. Design and Setting Follow-up of a group of biologicals approved in the United States and/or European Union between January 1995 and June 2007. Vaccines, allergenic products, and products for further manufacture and transfusion purposes were excluded. Main Outcome Measures Nature, frequency, and timing of safety-related regulatory actions defined as (1) dear healthcare professional letters (United States) and direct healthcare professional communications (European Union), (2) black box warnings (United States), and (3) safety-related marketing withdrawals (United States and European Union) issued between January 1995 and June 2008. Results A total of 174 biologicals were approved (136 in the United States and 105 in the European Union, of which 67 were approved in both regions). Eighty-two safety-related regulatory actions (46 dear healthcare professional letters, 17 direct healthcare professional communications, 19 black box warnings, and no withdrawals) were issued for 41 of the 174 different biologicals (23.6%). The probability of a first safety-related regulatory action, derived from Kaplan-Meier analyses, was 14% (95% confidence interval [CI], 9%-19%) 3 years after approval and 29% (95% CI, 20%-37%) 10 years after approval. Biologicals first in class to obtain approval had a higher risk for a first safety-related regulatory action compared with later approved products in that class (12.0/1000 vs 2.9/1000 months, respectively; hazard ratio, 3.7 [95% CI, 1.5- 9.5]). Warnings mostly concerned the classes general disorders and administration site conditions, infections and infestations, immune system disorders and neoplasms benign, malignant, and unspecified. Conclusions The nature of safety problems identified after approval for biologicals is often related to the immunomodulatory effect (infections). Because the biologicals first to be approved in a class were more likely to be subjected to regulatory action, close monitoring is recommended.	[Giezen, Thijs J.; Mantel-Teeuwisse, Aukje K.; Leufkens, Hubert G. M.; Egberts, Antoine C. G.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Pharmacotherapy, NL-3508 TB Utrecht, Netherlands; [Schellekens, Huub] Univ Utrecht, Div Pharmaceut, NL-3508 TB Utrecht, Netherlands; [Schellekens, Huub] Univ Utrecht, Dept Innovat Sci, NL-3508 TB Utrecht, Netherlands; [Egberts, Antoine C. G.] Univ Med Ctr Utrecht, Dept Clin Pharm, Utrecht, Netherlands; [Giezen, Thijs J.; Mantel-Teeuwisse, Aukje K.; Straus, Sabine M. J. M.; Leufkens, Hubert G. M.] Med Evaluat Board, The Hague, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center	Mantel-Teeuwisse, AK (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Pharmacotherapy, POB 80082, NL-3508 TB Utrecht, Netherlands.	A.K.Mantel@uu.nl	Egberts, Toine/K-4579-2019; Mantel-Teeuwisse, Aukje/I-8902-2016; Egberts, Toine/A-6625-2012	Egberts, Toine/0000-0003-1758-7779; Egberts, Toine/0000-0003-1758-7779	GlaxoSmithKline; Organon; Merck; Novo Nordisk; Roche; Merck-Serono	GlaxoSmithKline(GlaxoSmithKline); Organon; Merck(Merck & Company); Novo Nordisk(Novo Nordisk); Roche(Roche Holding); Merck-Serono(Merck & Company)	The department employing Drs Giezen, Mantel-Teeuwisse, Leufkens, and Egberts has received unrestricted research grants from GlaxoSmithKline, Organon, Merck, and Novo Nordisk for the conduct of pharmacoepidemiological research. Dr Schellekens reported receiving research grants from Organon, Roche, and Merck-Serono. Dr Straus did not report any financial disclosures.	Aggarwal S, 2007, NAT BIOTECHNOL, V25, P1097, DOI 10.1038/nbt1007-1097; Aksamit AJ, 2006, NEUROLOGIST, V12, P293, DOI 10.1097/01.nrl.0000250948.04681.96; BAKKE OM, 1995, CLIN PHARMACOL THER, V58, P108, DOI 10.1016/0009-9236(95)90078-0; Baumann A, 2006, CURR DRUG METAB, V7, P15, DOI 10.2174/138920006774832604; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Botsios C, 2005, AUTOIMMUN REV, V4, P162, DOI 10.1016/j.autrev.2004.09.001; Brennan FR, 2004, MOL BIOTECHNOL, V27, P59, DOI 10.1385/MB:27:1:59; Brune K, 2007, RHEUMATOLOGY, V46, P911, DOI 10.1093/rheumatology/kem070; Crommelin DJA, 2003, INT J PHARMACEUT, V266, P3, DOI 10.1016/S0378-5173(03)00376-4; *EUR COMM, 2007, VOL 9A RUL GOV MED P; Frank RG, 2007, NEW ENGL J MED, V357, P841, DOI 10.1056/NEJMp078095; Hamilton CD, 2004, CURR OPIN RHEUMATOL, V16, P393, DOI 10.1097/01.bor.0000127594.92432.7c; Hartford CG, 2006, DRUG SAFETY, V29, P657, DOI 10.2165/00002018-200629080-00003; Kessler M, 2006, NEPHROL DIAL TRANSPL, V21, P9, DOI 10.1093/ndt/gfl476; Kromminga A, 2005, ANN NY ACAD SCI, V1050, P257, DOI 10.1196/annals.1313.027; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; Meyboom RHB, 1996, CLIN DRUG INVEST, V12, P207, DOI 10.2165/00044011-199612040-00006; Nieminen O, 2005, EUR J PHARM BIOPHARM, V60, P319, DOI 10.1016/j.ejpb.2005.01.013; Ryff JC, 2002, TRENDS PHARMACOL SCI, V23, P254, DOI 10.1016/S0165-6147(02)02024-2; Schellekens H, 2005, NEPHROL DIAL TRANSPL, V20, P31, DOI 10.1093/ndt/gfh1085; Schellekens H, 2005, BEST PRACT RES CL HA, V18, P473, DOI 10.1016/j.beha.2005.01.016; Schellekens H, 2002, TRENDS PHARMACOL SCI, V23, P119, DOI 10.1016/S0165-6147(00)01967-2; SCHELLEKENS H, 2001, MED BIOTECHNOLOGIE; Schellekens H, 2006, NAT BIOTECHNOL, V24, P613, DOI 10.1038/nbt0606-613; Schneeweiss S, 2007, CLIN PHARMACOL THER, V82, P143, DOI 10.1038/sj.clpt.6100249; Shankar G, 2007, NAT BIOTECHNOL, V25, P555, DOI 10.1038/nbt1303; Sims J, 2001, TOXICOL LETT, V120, P59, DOI 10.1016/S0378-4274(01)00310-1; Stricker BHC, 2004, BRIT MED J, V329, P44, DOI 10.1136/bmj.329.7456.44; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Temple RJ, 2002, JAMA-J AM MED ASSOC, V287, P2273, DOI 10.1001/jama.287.17.2273; *US FDA, 2007, DRUG SAF INF FDAS CO; Vonberg RP, 2007, J HOSP INFECT, V65, P15, DOI 10.1016/j.jhin.2006.09.018; Walsh G, 2006, NAT BIOTECHNOL, V24, P769, DOI 10.1038/nbt0706-769; Winthrop KL, 2006, NAT CLIN PRACT RHEUM, V2, P602, DOI 10.1038/ncprheum0336	34	172	178	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2008	300	16					1887	1896		10.1001/jama.300.16.1887	http://dx.doi.org/10.1001/jama.300.16.1887			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362UR	18940975				2022-12-28	WOS:000260223100018
J	Colombo, P				Colombo, Paolo			In praise of pores	SCIENCE			English	Editorial Material							CERAMICS		[Colombo, Paolo] Univ Padua, Dipartimento Ingn Meccan Settore Mat, I-35131 Padua, Italy; [Colombo, Paolo] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA	University of Padua; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Colombo, P (corresponding author), Univ Padua, Dipartimento Ingn Meccan Settore Mat, I-35131 Padua, Italy.	paolo.colombo@unipd.it						Colombo P, 2008, J EUR CERAM SOC, V28, P1389, DOI 10.1016/j.jeurceramsoc.2007.12.002; Deville S, 2008, ADV ENG MATER, V10, P155, DOI 10.1002/adem.200700270; Gibson L.J., 1988, CELLULAR SOLIDS STRU, DOI [10.1017/CBO9781139878326, DOI 10.1017/CBO9781139878326]; Gogotsi Y, 2003, NAT MATER, V2, P591, DOI 10.1038/nmat957; Greil P, 2001, J EUR CERAM SOC, V21, P105, DOI 10.1016/S0955-2219(00)00179-5; Hunks WJ, 2005, J MATER CHEM, V15, P3716, DOI 10.1039/b504511h; Lewis JA, 2006, ADV FUNCT MATER, V16, P2193, DOI 10.1002/adfm.200600434; Nangrejo M, 2008, PHARM DEV TECHNOL, V13, P425, DOI [10.1080/10837450802247929, 10.1080/10837450802247929 ]; Oh S., 2006, AM J BIOCH BIOTECHNO, V2, P49, DOI [10.3844/ajbbsp.2006.49.562, DOI 10.3844/AJBBSP.2006.49.56]; Perkowitz S., 2000, UNIVERSAL FOAM CAPPU; Polarz S, 2002, J NANOSCI NANOTECHNO, V2, P581, DOI 10.1166/jnn.2002.151; Pyzik AJ, 2005, INT J APPL CERAM TEC, V2, P440, DOI 10.1111/j.1744-7402.2005.02045.x; Scheffler M, 2005, CELLULAR CERAMICS: STRUCTURE, MANUFACTURING, PROPERTIES AND APPLICATIONS, P1, DOI 10.1002/3527606696; Studart AR, 2006, J AM CERAM SOC, V89, P1771, DOI 10.1111/j.1551-2916.2006.01044.x; Twigg MV, 2007, IND ENG CHEM RES, V46, P4166, DOI 10.1021/ie061122o	15	122	126	0	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2008	322	5900					381	383		10.1126/science.1162962	http://dx.doi.org/10.1126/science.1162962			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927377				2022-12-28	WOS:000260094500027
J	Chen, YY; Takita, J; Choi, YL; Kato, M; Ohira, M; Sanada, M; Wang, LL; Soda, M; Kikuchi, A; Igarashi, T; Nakagawara, A; Hayashi, Y; Mano, H; Ogawa, S				Chen, Yuyan; Takita, Junko; Choi, Young Lim; Kato, Motohiro; Ohira, Miki; Sanada, Masashi; Wang, Lili; Soda, Manabu; Kikuchi, Akira; Igarashi, Takashi; Nakagawara, Akira; Hayashi, Yasuhide; Mano, Hiroyuki; Ogawa, Seishi			Oncogenic mutations of ALK kinase in neuroblastoma	NATURE			English	Article							ANAPLASTIC LYMPHOMA KINASE; CASPASE-8 GENE; LUNG-CANCER; PROTEIN; FUSION; SYSTEM; ARRAYS; DNA	Neuroblastoma in advanced stages is one of the most intractable paediatric cancers, even with recent therapeutic advances(1). Neuroblastoma harbours a variety of genetic changes, including a high frequency of MYCN amplification, loss of heterozygosity at 1p36 and 11q, and gain of genetic material from 17q, all of which have been implicated in the pathogenesis of neuroblastoma(2-5). However, the scarcity of reliable molecular targets has hampered the development of effective therapeutic agents targeting neuroblastoma. Here we show that the anaplastic lymphoma kinase (ALK), originally identified as a fusion kinase in a subtype of non- Hodgkin's lymphoma (NPM-ALK)(6-8) and more recently in adenocarcinoma of lung (EML4-ALK)(9,10), is also a frequent target of genetic alteration in advanced neuroblastoma. According to our genome- wide scans of genetic lesions in 215 primary neuroblastoma samples using high- density single- nucleotide polymorphism genotyping microarrays(11-14), the ALK locus, centromeric to the MYCN locus, was identified as a recurrent target of copy number gain and gene amplification. Furthermore, DNA sequencing of ALK revealed eight novel missense mutations in 13 out of 215 (6.1%) fresh tumours and 8 out of 24 ( 33%) neuroblastoma- derived cell lines. All but one mutation in the primary samples ( 12 out of 13) were found in stages 3 - 4 of the disease and were harboured in the kinase domain. The mutated kinases were autophosphorylated and displayed increased kinase activity compared with the wild- type kinase. They were able to transform NIH3T3 fibroblasts as shown by their colony formation ability in soft agar and their capacity to form tumours in nude mice. Furthermore, we demonstrate that downregulation of ALK through RNA interference suppresses proliferation of neuroblastoma cells harbouring mutated ALK. We anticipate that our findings will provide new insights into the pathogenesis of advanced neuroblastoma and that ALK- specific kinase inhibitors might improve its clinical outcome.	[Takita, Junko; Choi, Young Lim; Sanada, Masashi; Wang, Lili; Ogawa, Seishi] Univ Tokyo, Cell Therapy & Transplantat Med, Tokyo 1138655, Japan; [Chen, Yuyan; Takita, Junko; Kato, Motohiro; Igarashi, Takashi] Univ Tokyo, Dept Pediat, Tokyo 1138655, Japan; [Chen, Yuyan; Takita, Junko; Kato, Motohiro; Sanada, Masashi; Wang, Lili; Ogawa, Seishi] Univ Tokyo, Canc Genom Project, Grad Sch Med, Tokyo 1138655, Japan; [Choi, Young Lim; Soda, Manabu; Mano, Hiroyuki] Jichi Med Univ, Div Funct Genom, Toguchi 3290498, Japan; [Ohira, Miki; Nakagawara, Akira] Chiba Canc Ctr, Res Inst, Div Biochem, Chiba 2608717, Japan; [Sanada, Masashi; Wang, Lili; Mano, Hiroyuki; Ogawa, Seishi] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Kikuchi, Akira] Saitama Childrens Med Ctr, Div Hematol Oncol, Saitama 3398551, Japan; [Hayashi, Yasuhide] Gunma Childrens Med Ctr, Shibukawa 3778577, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Jichi Medical University; Chiba Cancer Center; Japan Science & Technology Agency (JST); Saitama Children's Medical Center; Gunma Children's Medical Centre	Ogawa, S (corresponding author), Univ Tokyo, Cell Therapy & Transplantat Med, Tokyo 1138655, Japan.	hayashiy-tky@umin.ac.jp; sogawa-tky@umin.net	wang, lili/HDL-7210-2022; Chen, Yuyan/V-7279-2019; Ogawa, Seishi/AAE-7088-2019	Chen, Yuyan/0000-0002-2894-1430; Kato, Motohiro/0000-0001-5145-1774	Core Research for Evolutional Science and Technology; Japan Science and Technology Agency; Ministry of Health, Labor and Welfare of Japan	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	We thank H. P. Koeffler for critically reading and editing the manuscript. We also thank M. Matsumura, Y. Ogino, S. Ichimura, S. Sohma, E. Matsui, Y. Yin, N. Hoshino and Y. Nakamura for their technical assistance. This work was supported by the Core Research for Evolutional Science and Technology, Japan Science and Technology Agency and by a Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan for the third-term Comprehensive 10-year Strategy for Cancer Control.	Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Bown N, 1999, NEW ENGL J MED, V340, P1954, DOI 10.1056/NEJM199906243402504; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Donella-Deana A, 2005, BIOCHEMISTRY-US, V44, P8533, DOI 10.1021/bi0472954; Donohoe E, 2005, METH MOLEC MED, V108, P173; Fujimoto J, 1996, P NATL ACAD SCI USA, V93, P4181, DOI 10.1073/pnas.93.9.4181; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hu JJ, 2003, MOL CELL, V12, P1379, DOI 10.1016/S1097-2765(03)00487-8; Kawamata N, 2008, BLOOD, V111, P776, DOI 10.1182/blood-2007-05-088310; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Maris JM, 2000, J CLIN ONCOL, V18, P1888, DOI 10.1200/JCO.2000.18.9.1888; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Osajima-Hakomori Y, 2005, AM J PATHOL, V167, P213, DOI 10.1016/S0002-9440(10)62966-5; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; SHIOTA M, 1995, BLOOD, V86, P1954, DOI 10.1182/blood.V86.5.1954.bloodjournal8651954; SMITH EI, 1989, J PEDIATR SURG, V24, P386, DOI 10.1016/S0022-3468(89)80277-5; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; TAKITA J, 1995, ONCOGENE, V11, P1829; Takita J, 2001, ONCOGENE, V20, P4424, DOI 10.1038/sj.onc.1204521; Takita J, 2000, MED PEDIATR ONCOL, V35, P541, DOI 10.1002/1096-911X(20001201)35:6<541::AID-MPO9>3.0.CO;2-T; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809	26	655	694	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					971	U56		10.1038/nature07399	http://dx.doi.org/10.1038/nature07399			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923524				2022-12-28	WOS:000260038300051
J	Neschis, DG; Scalea, TM; Flinn, WR; Griffith, BP				Neschis, David G.; Scalea, Thomas M.; Flinn, William R.; Griffith, Bartley P.			Current concepts: Blunt aortic injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CHEST COMPUTED-TOMOGRAPHY; TRAUMATIC RUPTURE; THORACIC AORTA; OPEN REPAIR; HELICAL CT; MANAGEMENT; MECHANISMS; RISK; PARAPLEGIA; EXPERIENCE		[Neschis, David G.; Flinn, William R.] Univ Maryland, Med Ctr, Div Vasc Surg, Sch Med, Baltimore, MD 21201 USA; [Griffith, Bartley P.] Univ Maryland, Sch Med, Div Cardiac Surg, Baltimore, MD 21201 USA; [Scalea, Thomas M.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Scalea, Thomas M.] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Neschis, DG (corresponding author), Univ Maryland, Med Ctr, Div Vasc Surg, Sch Med, 22 S Greene St,Rm N4W66, Baltimore, MD 21201 USA.	dneschis@smail.umaryland.edu			W.L. Gore and Associates	W.L. Gore and Associates	Dr. Neschis reports receiving grant support from W.L. Gore and Associates. No other potential conflict of interest relevant to this article was reported.	Amabile P, 2004, J VASC SURG, V40, P873, DOI 10.1016/j.jvs.2004.08.053; Attar S, 1999, ANN THORAC SURG, V67, P959, DOI 10.1016/S0003-4975(99)00174-5; Cardarelli MG, 2002, ANN SURG, V236, P465, DOI 10.1097/00000658-200210000-00009; COHEN AM, 1992, AM J ROENTGENOL, V159, P271, DOI 10.2214/ajr.159.2.1632338; Demetriades D, 1998, ARCH SURG-CHICAGO, V133, P1084, DOI 10.1001/archsurg.133.10.1084; Ellis JD, 2007, CAN ASSOC RADIOL J, V58, P22; Exadaktylos Aristomenis K, 2005, Cardiovasc J S Afr, V16, P162; Fabian TC, 1998, ANN SURG, V227, P666, DOI 10.1097/00000658-199805000-00007; Fabian TC, 1997, J TRAUMA, V42, P374, DOI 10.1097/00005373-199703000-00003; Galli R, 1998, ANN THORAC SURG, V65, P461, DOI 10.1016/S0003-4975(97)01302-7; Gammie JS, 1998, ANN THORAC SURG, V66, P1295, DOI 10.1016/S0003-4975(98)00778-4; Gavant ML, 1999, RADIOL CLIN N AM, V37, P553, DOI 10.1016/S0033-8389(05)70111-1; Gavelli G, 2002, EUR RADIOL, V12, P1273, DOI 10.1007/s00330-002-1439-6; GREENDYKE RM, 1966, J AMER MED ASSOC, V195, P527, DOI 10.1001/jama.195.7.527; Hochheiser GM, 2002, ARCH SURG-CHICAGO, V137, P434, DOI 10.1001/archsurg.137.4.434; Horton TG, 2000, J TRAUMA, V48, P1008, DOI 10.1097/00005373-200006000-00003; Idu MM, 2005, J ENDOVASC THER, V12, P503, DOI 10.1583/04-1515R.1; Jahromi AS, 2001, J VASC SURG, V34, P1029, DOI 10.1067/mva.2001.120036; Kasirajan K, 2003, ANN VASC SURG, V17, P589, DOI 10.1007/s10016-003-0066-2; KIPFER B, 1994, EUR J CARDIO-THORAC, V8, P30, DOI 10.1016/1010-7940(94)90129-5; KODALI S, 1991, CIRCULATION, V84, P40; Malhotra AK, 2001, J TRAUMA, V51, P1042, DOI 10.1097/00005373-200112000-00003; Melton SM, 2004, J TRAUMA, V56, P243, DOI 10.1097/01.TA.0000111751.84052.24; Michaels AJ, 1996, J TRAUMA, V41, P105, DOI 10.1097/00005373-199607000-00016; MIRVIS SE, 1987, RADIOLOGY, V163, P487, DOI 10.1148/radiology.163.2.3562831; Moore EE, 2004, ANN SURG, V240, P38, DOI 10.1097/01.sla.0000129355.74638.00; Neschis DG, 2007, J VASC SURG, V45, P487, DOI 10.1016/j.jvs.2006.11.038; Nikolic S, 2006, AM J FOREN MED PATH, V27, P292, DOI 10.1097/01.paf.0000248756.73053.82; Ott MC, 2004, J TRAUMA, V56, P565, DOI 10.1097/01.TA.0000114061.69699.A3; PARMLEY LF, 1958, CIRCULATION, V17, P1086, DOI 10.1161/01.CIR.17.6.1086; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; PATE JW, 1995, WORLD J SURG, V19, P119, DOI 10.1007/BF00316994; Plurad D, 2007, J TRAUMA, V62, P631, DOI 10.1097/TA.0b013e31802bf009; Razzouk AJ, 2000, ARCH SURG-CHICAGO, V135, P913, DOI 10.1001/archsurg.135.8.913; Richens D, 2002, EUR J CARDIO-THORAC, V21, P288, DOI 10.1016/S1010-7940(01)01095-8; RIZOLI SB, 1994, ANN THORAC SURG, V58, P1404, DOI 10.1016/0003-4975(94)91923-2; Rousseau H, 2005, J THORAC CARDIOV SUR, V129, P1050, DOI 10.1016/j.jtcvs.2004.12.023; Schulman CI, 2007, J TRAUMA, V62, P664, DOI 10.1097/TA.0b013e318031b58c; SEVITT S, 1977, BRIT J SURG, V64, P166, DOI 10.1002/bjs.1800640305; SMITH RS, 1986, AM J SURG, V152, P660, DOI 10.1016/0002-9610(86)90444-7; Stemper BD, 2007, J TRAUMA, V62, P1171, DOI 10.1097/TA.0b013e31804d4950; Ungar TC, 2006, J TRAUMA, V61, P1150, DOI 10.1097/01.ta.0000239357.68782.30; Volodos N L, 1991, Vasa Suppl, V33, P93; VONOPPELL UO, 1994, ANN THORAC SURG, V58, P585, DOI 10.1016/0003-4975(94)92270-5; WOODRING J H, 1990, Journal of Emergency Medicine, V8, P467	45	155	168	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2008	359	16					1708	1716		10.1056/NEJMra0706159	http://dx.doi.org/10.1056/NEJMra0706159			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360EY	18923173				2022-12-28	WOS:000260041400009
J	Whitelaw, A				Whitelaw, Andrew			Collapse of GMC hearing into research misconduct	LANCET			English	Editorial Material							NEGATIVE EXTRATHORACIC PRESSURE; FAILURE; TRIAL		[Whitelaw, Andrew] Univ Bristol, Dept Clin Sci, Bristol BS10 5NB, Avon, England	University of Bristol	Whitelaw, A (corresponding author), Univ Bristol, Dept Clin Sci, Bristol BS10 5NB, Avon, England.	andrew.whitelaw@bris.ac.uk						Azzopardi D, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-17; Chalmers I, 2001, BRIT MED J, V323, P280, DOI 10.1136/bmj.323.7307.280; Farthing M, 2000, BRIT MED J, V321, P1485, DOI 10.1136/bmj.321.7275.1485; *GEN MED COUNC, 2008, FITN PRACT PAN; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Hey E, 2006, PEDIATRICS, V117, P2244, DOI 10.1542/peds.2006-0819; Hey E, 2002, ARCH DIS CHILD, V86, P1, DOI 10.1136/adc.86.1.1; Jenny C, 2007, PEDIATRICS, V119, P797, DOI 10.1542/peds.2006-2472; Samuels MP, 1996, PEDIATRICS, V98, P1154; Stenson BJ, 2004, ARCH DIS CHILD-FETAL, V89, pF321, DOI 10.1136/adc.2002.021931; Telford K, 2006, LANCET, V367, P1080, DOI 10.1016/S0140-6736(06)68475-4	11	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1283	1284		10.1016/S0140-6736(08)61532-9	http://dx.doi.org/10.1016/S0140-6736(08)61532-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18929890				2022-12-28	WOS:000260060500009
J	Cordeiro, PG				Cordeiro, Peter G.			Breast reconstruction after surgery for breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SKIN-SPARING MASTECTOMY; QUALITY-OF-LIFE; SALINE-FILLED IMPLANTS; TRAM FLAP; PATIENT SATISFACTION; LOCAL RECURRENCE; IMMEDIATE RECONSTRUCTION; PSYCHOLOGICAL IMPACT; CONSERVING SURGERY; 12-YEAR EXPERIENCE		[Cordeiro, Peter G.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Cordeiro, Peter G.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Cordeiro, PG (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave,Rm MRI1007B, New York, NY 10021 USA.				National Endowment for Plastic Surgery of the Plastic Surgery Education Foundation; Canfield Imaging; Ethicon; Integra; LifeCell; Medicis Aesthetics; Mentor; Stryker; Allergan	National Endowment for Plastic Surgery of the Plastic Surgery Education Foundation; Canfield Imaging; Ethicon; Integra; LifeCell; Medicis Aesthetics; Mentor(Canadian Institutes of Health Research (CIHR)); Stryker; Allergan(AbbVieAllergan)	Dr. Cordeiro reports receiving grant support from the National Endowment for Plastic Surgery of the Plastic Surgery Education Foundation, which receives funding from several corporate partners including Canfield Imaging, Ethicon, Integra, LifeCell, Medicis Aesthetics, Mentor, Stryker, and Allergan. No other potential conflict of interest relevant to this article was reported.	Al-Ghazal SK, 2000, EUR J CANCER, V36, P1938, DOI 10.1016/S0959-8049(00)00197-0; Al-Ghazal SK, 2000, EUR J SURG ONCOL, V26, P17, DOI 10.1053/ejso.1999.0733; Alderman AK, 2002, PLAST RECONSTR SURG, V109, P2265, DOI 10.1097/00006534-200206000-00015; Alderman AK, 2007, J AM COLL SURGEONS, V204, P7, DOI 10.1016/j.jamcollsurg.2006.09.022; Allen RJ, 1998, CLIN PLAST SURG, V25, P293; *AM CANC SOC, 2007, CANC FACTS FIG 2007; *AM SOC PLAST SURG, 2006 REC SURG PROC; *AM SOC PLAST SURG, 2007 REC SURG PROC; *AM SOC PLAST SURG, 1994 BREAST SURG STA; *AM SOC PLAST SURG, BREAST REC; Ascherman JA, 2006, PLAST RECONSTR SURG, V117, P359, DOI 10.1097/01.prs.0000201478.64877.87; Barlow WE, 2001, J NATL CANCER I, V93, P447, DOI 10.1093/jnci/93.6.447; Bassiouny Mahmoud M, 2005, J Egypt Natl Canc Inst, V17, P231; Blondeel PN, 1997, BRIT J PLAST SURG, V50, P315, DOI 10.1016/S0007-1226(97)90539-7; Blondeel PN, 1997, BRIT J PLAST SURG, V50, P322, DOI 10.1016/S0007-1226(97)90540-3; BOYD JB, 1984, PLAST RECONSTR SURG, V73, P1, DOI 10.1097/00006534-198401000-00001; Brown SL, 2001, J RHEUMATOL, V28, P996; Cordeiro PG, 2006, PLAST RECONSTR SURG, V118, P825, DOI 10.1097/01.prs.0000232362.82402.e8; Cordeiro PG, 2006, PLAST RECONSTR SURG, V118, P832, DOI 10.1097/01.prs.0000232397.14818.0e; Cordeiro PG, 2004, PLAST RECONSTR SURG, V113, P877, DOI 10.1097/01.PRS.0000105689.84930.E5; DEAN C, 1983, LANCET, V1, P459; Deapen D, 2000, PLAST RECONSTR SURG, V105, P535, DOI 10.1097/00006534-200002000-00009; Deapen DM, 1997, PLAST RECONSTR SURG, V99, P1346, DOI 10.1097/00006534-199704001-00022; Delay E, 1998, PLAST RECONSTR SURG, V102, P1461, DOI 10.1097/00006534-199810000-00020; Elder EE, 2005, BREAST, V14, P201, DOI 10.1016/j.breast.2004.10.008; EVANS GRD, 1995, PLAST RECONSTR SURG, V96, P1111, DOI 10.1097/00006534-199510000-00016; Feller A M, 2002, Handchir Mikrochir Plast Chir, V34, P257, DOI 10.1055/s-2002-36293; Fujino T, 1981, Int Adv Surg Oncol, V4, P127; Garvey PB, 2006, PLAST RECONSTR SURG, V117, P1711, DOI 10.1097/01.prs.0000210679.77449.7d; Gaubitz M, 2002, RHEUMATOLOGY, V41, P129, DOI 10.1093/rheumatology/41.2.129; Guerra AB, 2004, ANN PLAS SURG, V53, P305, DOI 10.1097/01.sap.0000128619.83670.e1; Harcourt DM, 2003, PLAST RECONSTR SURG, V111, P1060, DOI 10.1097/01.PRS.0000046249.33122.76; Haywood RM, 2003, BRIT J PLAST SURG, V56, P689, DOI 10.1016/S0007-1226(03)00206-6; Holm C, 2007, J PLAST RECONSTR AES, V60, P946, DOI 10.1016/j.bjps.2005.12.066; Howard MA, 2006, PLAST RECONSTR SURG, V117, P1381, DOI 10.1097/01.prs.0000208116.86765.4a; Huang CJ, 2006, PLAST RECONSTR SURG, V118, P1079, DOI 10.1097/01.prs.0000220527.35442.44; Hultman C Scott, 2002, Breast Dis, V16, P65; Jakesz R, 2003, ANN SURG, V237, P556, DOI 10.1097/00000658-200304000-00018; Karlson EW, 1999, AM J MED, V106, P11, DOI 10.1016/S0002-9343(98)00358-1; Kroll SS, 1996, PLAST RECONSTR SURG, V97, P364, DOI 10.1097/00006534-199602000-00014; Langstein HN, 2003, PLAST RECONSTR SURG, V111, P712, DOI 10.1097/01.PRS.0000041441.42563.95; Lantz PM, 2005, HEALTH SERV RES, V40, P745, DOI 10.1111/j.1475-6773.2005.00383.x; Marin-Gutzke M, 2005, ANN PLAS SURG, V54, P356, DOI 10.1097/01.sap.0000151462.83283.0b; McCarthy CM, 2008, PLAST RECONSTR SURG, V121, P381, DOI 10.1097/01.prs.0000298316.74743.dd; Meretoja TJ, 2007, EJSO-EUR J SURG ONC, V33, P1142, DOI 10.1016/j.ejso.2007.03.022; Metcalfe KA, 2004, PLAST RECONSTR SURG, V114, P360, DOI 10.1097/01.PRS.0000131877.52740.0E; Molenaar S, 2004, BRIT J CANCER, V90, P2123, DOI 10.1038/sj.bjc.6601835; Munhoz AM, 2007, BREAST J, V13, P470, DOI 10.1111/j.1524-4741.2007.00467.x; Murphy RX, 2003, ANN PLAS SURG, V50, P333, DOI 10.1097/01.SAP.0000041488.88950.A2; Nahabedian MY, 2005, ANN PLAS SURG, V54, P124, DOI 10.1097/01.sap.0000147174.31409.3a; Nano MT, 2005, ANZ J SURG, V75, P940, DOI 10.1111/j.1445-2197.2005.03517.x; *NAT COMPR CANC NE, BREAST CANC NCCN CLI; Nold RJ, 2000, AM J SURG, V180, P413, DOI 10.1016/S0002-9610(00)00501-8; Parker PA, 2007, ANN SURG ONCOL, V14, P3078, DOI 10.1245/s10434-007-9413-9; Rinker BD, 2007, PLAST RECONSTR SURG, V119, P2001, DOI 10.1097/01.prs.0000260583.61020.ad; Roth RS, 2007, PLAST RECONSTR SURG, V119, P2008, DOI 10.1097/01.prs.0000260584.09371.99; Roth RS, 2005, PLAST RECONSTR SURG, V116, P993, DOI 10.1097/01.prs.0000178395.19992.ca; Rowland, 2001, JNCI-J NATL CANCER I, V93, P68; Rowland JH, 2000, J NATL CANCER I, V92, P1422, DOI 10.1093/jnci/92.17.1422; SANCHEZGUERRERO J, 1995, NEW ENGL J MED, V332, P1666, DOI 10.1056/NEJM199506223322502; Saulis AS, 2007, PLAST RECONSTR SURG, V119, P1669, DOI 10.1097/01.prs.0000258827.21635.84; Serletti JM, 2006, J SURG ONCOL, V94, P532, DOI 10.1002/jso.20492; Shaw WW, 1998, CLIN PLAST SURG, V25, P267; Sheehan J, 2007, PSYCHO-ONCOLOGY, V16, P342, DOI 10.1002/pon.1067; Spear SL, 2000, PLAST RECONSTR SURG, V105, P930, DOI 10.1097/00006534-200003000-00016; Spear SL, 2003, PLAST RECONSTR SURG, V112, P101, DOI 10.1097/01.PRS.0000066007.06371.47; Spiegel AJ, 2007, PLAST RECONSTR SURG, V120, P1450, DOI 10.1097/01.prs.0000270282.92038.3f; Suominen S, 1996, ANN PLAS SURG, V36, P629, DOI 10.1097/00000637-199606000-00012; Tachi Masahiro, 2005, Int J Clin Oncol, V10, P289, DOI 10.1007/s10147-005-0527-4; Temple WJ, 2006, J CLIN ONCOL, V24, P3367, DOI 10.1200/JCO.2005.02.7771; Tran NV, 2001, PLAST RECONSTR SURG, V108, P78, DOI 10.1097/00006534-200107000-00013; Vandeweyer E, 2003, ACTA CHIR BELG, V103, P98; Vandeweyer E, 2001, PLAST RECONSTR SURG, V107, P1409, DOI 10.1097/00006534-200105000-00013; Vaughan A, 2007, AM J SURG, V194, P438, DOI 10.1016/j.amjsurg.2007.06.011; Vega SJ, 2006, ANN PLAS SURG, V56, P487, DOI 10.1097/01.sap.0000205236.88313.10	75	246	260	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2008	359	15					1590	1601		10.1056/NEJMct0802899	http://dx.doi.org/10.1056/NEJMct0802899			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FS	18843123				2022-12-28	WOS:000259903100007
J	Baker, BK; Ombaka, E				Baker, Brook K.; Ombaka, Eva			The danger of in-kind drug donations to the Global Fund	LANCET			English	Editorial Material							PHARMACEUTICAL-INDUSTRY; GENERIC ENTRY		[Baker, Brook K.] Hlth GAP NE Univ, Program Human Rights & Global Econ, Sch Law, Boston, MA 02115 USA	Northeastern University	Baker, BK (corresponding author), Hlth GAP NE Univ, Program Human Rights & Global Econ, Sch Law, 400 Huntington Ave, Boston, MA 02115 USA.	B.Baker@neu.edu						[Anonymous], PROTECTION DATA SUBM; [Anonymous], 2001, WHO GLOB STRAT CONT; [Anonymous], 2006, USE FLEXIBILITIES TR; Autier P., 2002, DRUG DONATIONS POSTE, P1; Bae JP, 1997, HEALTH SERV RES, V32, P87; BAKER B, 2004, DFID             AUG; Caines K., 2004, IMPACT PUBLIC PRIVAT; Caines K., 2004, GLOBAL HLTH PARTNERS; CHIEN C, 2007, PLOS ONE         MAR; Competition Bureau of Canada, 2007, CAN GEN DRUG SECT ST; Congressional Budgetary Office, 1998, INCR COMP GEN DRUGS; DALEN DM, 2006, HLTH EC RES PROG; Frank RG, 1997, J ECON MANAGE STRAT, V6, P75, DOI 10.1162/105864097567039; Frank RG, 2007, NEW ENGL J MED, V357, P1993, DOI 10.1056/NEJMp078193; *GLOB FUND FIGHT A, 2007, TUB MAL SUMM GLOB FU; Guilloux Allain, 2001, HIDDEN PRICE TAGS DI; Haas JS, 2005, ANN INTERN MED, V142, P891, DOI 10.7326/0003-4819-142-11-200506070-00006; HECHMANN R, 2007, J HUMANITARIAN ASST; Henry D, 2002, LANCET, V360, P1590, DOI 10.1016/S0140-6736(02)11527-3; Hudson J., 2000, INT REV LAW ECON, V24, P103; KAHN T, 2006, BUS DAY         0207; KIMANI D, 2006, NATIONMEDIA     0123; LEWISLETTINGTON R, 2004, DFID             SEP; MANGWIRO C, 2007, REUTERS ALERT N 0529; Medicens Sans Frontieres, 2007, UNT WEB PRIC RED PRI; MORENOTORRES I, 2007, GENERIC ENTRY REGULA; Morton FMS, 1999, RAND J ECON, V30, P421, DOI 10.2307/2556056; Oyediran ABOO, 2002, B WORLD HEALTH ORGAN, V80, P817; Perez-Casas C, 2001, TROP MED INT HEALTH, V6, P960, DOI 10.1046/j.1365-3156.2001.00801.x; RATANAWIFITRASI.S, 2002, EFFECTIVE DRUG REGIS; Reiffen D, 2005, REV ECON STAT, V87, P37, DOI 10.1162/0034653053327694; Reiffen David, 2005, BRANDED GENERICS STR; Rudholm N, 2001, REV IND ORGAN, V19, P351, DOI 10.1023/A:1011868404205; Saha A, 2006, INT J ECON BUS, V13, P15, DOI 10.1080/13571510500519905; Shretta R, 2001, HEALTH POLICY PLANN, V16, P161, DOI 10.1093/heapol/16.2.161; Thomas M.J.W., 2003, HUMAN FACTORS AEROSP, V3, P25; THORPE P, 2001, STUDY IMPLEMENTATION; *WHO, 2007, ANT THER HIV INF AD; *WHO, 2007, SUMM REP GLOB PRIC R; *WHO, 2000, 1 YEAR EXP INT GUID; *WORLD COMM ADV BO, 2005, M IND GEN DRUGS IND; World Health Organisation, 2007, PRIOR 2 LIN ANT DRUG; World Health Organization, 2006, MEAS TRANSP MED REG; World Health Organization, 1999, GUID DRUG DON; 2007, PLUS NEWS       1010	45	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2009	373	9670					1218	1221		10.1016/S0140-6736(08)61487-7	http://dx.doi.org/10.1016/S0140-6736(08)61487-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429SO	18848353				2022-12-28	WOS:000264940600036
J	Holden, LG; Prochnow, C; Chang, YP; Bransteitter, R; Chelico, L; Sen, U; Stevens, RC; Goodman, MF; Chen, XJS				Holden, Lauren G.; Prochnow, Courtney; Chang, Y. Paul; Bransteitter, Ronda; Chelico, Linda; Sen, Udayaditya; Stevens, Raymond C.; Goodman, Myron F.; Chen, Xiaojiang S.			Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications	NATURE			English	Article							DNA DEAMINASE DOMAIN; RESTRICTION; MODEL	The APOBEC family members are involved in diverse biological functions. APOBEC3G restricts the replication of human immunodeficiency virus (HIV), hepatitis B virus and retroelements by cytidine deamination on single- stranded DNA or by RNA binding(1-4). Here we report the high- resolution crystal structure of the carboxy- terminal deaminase domain of APOBEC3G (APOBEC3G-CD2) purified from Escherichia coli. The APOBEC3G-CD2 structure has a five- stranded beta- sheet core that is common to all known deaminase structures and closely resembles the structure of another APOBEC protein, APOBEC2 ( ref. 5). A comparison of APOBEC3G-CD2 with other deaminase structures shows a structural conservation of the active- site loops that are directly involved in substrate binding. In the X- ray structure, these APOBEC3G active- site loops form a continuous 'substrate groove' around the active centre. The orientation of this putative substrate groove differs markedly ( by 90 degrees) from the groove predicted by the NMR structure(6). We have introduced mutations around the groove, and have identified residues involved in substrate specificity, single- stranded DNA binding and deaminase activity. These results provide a basis for understanding the underlying mechanisms of substrate specificity for the APOBEC family.	[Holden, Lauren G.; Prochnow, Courtney; Chang, Y. Paul; Bransteitter, Ronda; Chelico, Linda; Sen, Udayaditya; Goodman, Myron F.; Chen, Xiaojiang S.] Univ So Calif, Los Angeles, CA 90089 USA; [Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of Southern California; Scripps Research Institute	Chen, XJS (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	xiaojiang.chen@usc.edu	Stevens, Raymond/K-7272-2015	Stevens, Raymond/0000-0002-4522-8725; Sen, Udayaditya/0000-0001-5742-2907; Chelico, Linda/0000-0003-4673-8978; Holden, Lauren/0000-0001-8014-4503	CBM; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087986] Funding Source: NIH RePORTER	CBM; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Berkeley Laboratory's Advanced Light Source (ALS) BL8.2.1 and Advanced Photon Source 19ID in Argonne National Laboratory for assistance in data collection, and M. Klein and other members of the X.S.C. laboratory for help and discussion. This work is supported in part by CBM graduate training grants to L.G.H. and Y.P.C., and by National Institutes of Health grants to M.F.G. and X.S.C.	Bertram JG, 2004, J BIOL CHEM, V279, P33047, DOI 10.1074/jbc.C400265200; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Chung SJ, 2005, J MED CHEM, V48, P658, DOI 10.1021/jm0496279; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; DeLano W.L, PYMOL MOL GRAPHICS S; Goodman Myron F, 2007, Adv Immunol, V94, P127, DOI 10.1016/S0065-2776(06)94005-X; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678	15	182	205	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					121	U13		10.1038/nature07357	http://dx.doi.org/10.1038/nature07357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18849968	Green Accepted			2022-12-28	WOS:000260674000053
J	Portner, HO; Farrell, AP				Poertner, Hans O.; Farrell, Anthony P.			ECOLOGY Physiology and Climate Change	SCIENCE			English	Editorial Material							THERMAL TOLERANCE; TEMPERATURE; SALMON; OCEAN; SHIFTS; HEAT; COD		[Poertner, Hans O.] Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany; [Farrell, Anthony P.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Farrell, Anthony P.] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC V6T 1Z4, Canada	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of British Columbia; University of British Columbia	Portner, HO (corresponding author), Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany.	hans.poertner@awi.de	Pörtner, Hans-O./K-9429-2016	Pörtner, Hans-O./0000-0001-6535-6575				Brander K, 2003, ICES MARINE SCI S, V219, P261; BRETT JR, 1971, AM ZOOL, V11, P99; Dahle R, 2003, COMP BIOCHEM PHYS A, V136, P641, DOI 10.1016/S1095-6433(03)00215-0; Fangue NA, 2006, J EXP BIOL, V209, P2859, DOI 10.1242/jeb.02260; Farrell AP, 2008, PHYSIOL BIOCHEM ZOOL, V81, P697, DOI 10.1086/592057; Goniea TM, 2006, T AM FISH SOC, V135, P408, DOI 10.1577/T04-113.1; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Helaouet P, 2007, MAR ECOL PROG SER, V345, P147, DOI 10.3354/meps06775; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pinkhaus O, 2007, FRESHWATER BIOL, V52, P1537, DOI 10.1111/j.1365-2427.2007.01786.x; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2006, DEEP-SEA RES PT II, V53, P1071, DOI 10.1016/j.dsr2.2006.02.015; Portner HO, 2008, CLIM RES, V37, P253, DOI 10.3354/cr00766; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002561; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; Takasuka A, 2008, MAR ECOL PROG SER, V360, P211, DOI 10.3354/meps07407; Takasuka A, 2007, CAN J FISH AQUAT SCI, V64, P768, DOI 10.1139/F07-052; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Wiltshire KH, 2004, HELGOLAND MAR RES, V58, P269, DOI 10.1007/s10152-004-0196-0; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151	23	6396	6509	67	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					690	692		10.1126/science.1163156	http://dx.doi.org/10.1126/science.1163156			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974339				2022-12-28	WOS:000260605200032
J	Rohr, JR; Schotthoefer, AM; Raffel, TR; Carrick, HJ; Halstead, N; Hoverman, JT; Johnson, CM; Johnson, LB; Lieske, C; Piwoni, MD; Schoff, PK; Beasley, VR				Rohr, Jason R.; Schotthoefer, Anna M.; Raffel, Thomas R.; Carrick, Hunter J.; Halstead, Neal; Hoverman, Jason T.; Johnson, Catherine M.; Johnson, Lucinda B.; Lieske, Camilla; Piwoni, Marvin D.; Schoff, Patrick K.; Beasley, Val R.			Agrochemicals increase trematode infections in a declining amphibian species	NATURE			English	Article							FROGS RANA-PIPIENS; LIMB DEVELOPMENT; ATRAZINE; EXPOSURE; SURVIVAL; SURVIVORSHIP; DEFORMITIES; HERBICIDE; DISEASE; STAGE	Global amphibian declines have often been attributed to disease(1,2), but ignorance of the relative importance and mode of action of potential drivers of infection has made it difficult to develop effective remediation. In a field study, here we show that the widely used herbicide, atrazine, was the best predictor ( out of more than 240 plausible candidates) of the abundance of larval trematodes ( parasitic flatworms) in the declining northern leopard frog Rana pipiens. The effects of atrazine were consistent across trematode taxa. The combination of atrazine and phosphate - principal agrochemicals in global corn and sorghum production - accounted for 74% of the variation in the abundance of these often debilitating larval trematodes ( atrazine alone accounted for 51%). Analysis of field data supported a causal mechanism whereby both agrochemicals increase exposure and susceptibility to larval trematodes by augmenting snail intermediate hosts and suppressing amphibian immunity. A mesocosm experiment demonstrated that, relative to control tanks, atrazine tanks had immunosuppressed tadpoles, had significantly more attached algae and snails, and had tadpoles with elevated trematode loads, further supporting a causal relationship between atrazine and elevated trematode infections in amphibians. These results raise concerns about the role of atrazine and phosphate in amphibian declines, and illustrate the value of quantifying the relative importance of several possible drivers of disease risk while determining the mechanisms by which they facilitate disease emergence.	[Rohr, Jason R.; Raffel, Thomas R.; Halstead, Neal] Univ S Florida, Dept Biol, Tampa, FL 33620 USA; [Rohr, Jason R.; Raffel, Thomas R.] Penn State Univ, Penn State Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Schotthoefer, Anna M.; Lieske, Camilla; Beasley, Val R.] Univ Illinois, Coll Vet Med, Urbana, IL 61802 USA; [Carrick, Hunter J.] Penn State Univ, Sch Forest Resources, University Pk, PA 16802 USA; [Hoverman, Jason T.] Univ Tennessee, Dept Forest Wildlife & Fisheries, Knoxville, TN 37996 USA; [Johnson, Catherine M.; Johnson, Lucinda B.; Schoff, Patrick K.] Univ Minnesota, Nat Resources Res Inst, Duluth, MN 55811 USA; [Piwoni, Marvin D.] Illinois Waste Management & Res Ctr, Champaign, IL 61820 USA	State University System of Florida; University of South Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Illinois System; University of Illinois Urbana-Champaign; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Tennessee System; University of Tennessee Knoxville; University of Minnesota System; University of Minnesota Duluth	Rohr, JR (corresponding author), Univ S Florida, Dept Biol, Tampa, FL 33620 USA.	jasonrohr@gmail.com	Hoverman, Jason T/D-1756-2013; Rohr, Jason R./AAJ-5856-2021; Hoverman, Jason/AGR-0056-2022	Hoverman, Jason T/0000-0002-4002-2728; Hoverman, Jason/0000-0002-4002-2728; Johnson, Catherine/0000-0003-3241-9394; Johnson, Catherine/0000-0003-3133-9616	National Science Foundation [DEB-0809487]; US Department of Agriculture [NRI 2008-00622, NRI 2008-01785]; US Environmental Protection Agency STAR [R825867, R833835]	National Science Foundation(National Science Foundation (NSF)); US Department of Agriculture(United States Department of Agriculture (USDA)); US Environmental Protection Agency STAR(United States Environmental Protection Agency)	We thank J. Murphy, A. Antolin, K. Beckman, R. Cole, A. Koehler, C. Hall, T. Hollenhorst and J. Romansic for collection and compilation of field, parasitological or land cover data; R. Cole, M. Martin, M. Mescher, J. Romansic, J. Runyon and the O. Bjornstad, C. De Moraes, E. Holmes, P. Hudson, B. Grenfell and M. Poss laboratories for comments and suggestions on this work; and J. Grace for reviewing sections of the paper on structural equation modelling. We also thank the USGS National Wildlife Health Center for laboratory space and support. Funds came from National Science Foundation (DEB-0809487) and US Department of Agriculture (NRI 2008-00622 and 2008-01785) grants to J.R.R., and US Environmental Protection Agency STAR grants to V. R. B. (R825867) and J.R.R. and T.R.R (R833835). This work does not necessarily reflect the views of these agencies.	Agius C, 2003, J FISH DIS, V26, P499, DOI 10.1046/j.1365-2761.2003.00485.x; [Anonymous], 2004, PESTICIDE IND SALES; BEASLEY VR, 2003, STATUS CONSERVATION, P153; BROCK TCM, 2000, 088 ALT GREEN WORLD; Brodkin MA, 2007, ENVIRON TOXICOL CHEM, V26, P80, DOI 10.1897/05-469.1; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Davidson C, 2001, ECOL APPL, V11, P464, DOI 10.1890/1051-0761(2001)011[0464:DOTCRL]2.0.CO;2; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Dezfuli BS, 2007, J PARASITOL, V93, P1416, DOI 10.1645/GE-1214.1; Forson D, 2006, ENVIRON TOXICOL CHEM, V25, P168, DOI 10.1897/05-260R.1; Gammon DW., 2001, ATRAZINE RISK CHARAC; Grace J.B., 2006, STRUCT EQ MOD NAT; Hayes TB, 2002, P NATL ACAD SCI USA, V99, P5476, DOI 10.1073/pnas.082121499; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Johnson PTJ, 2007, P NATL ACAD SCI USA, V104, P15781, DOI 10.1073/pnas.0707763104; Johnson PTJ, 1999, SCIENCE, V284, P802, DOI 10.1126/science.284.5415.802; Johnson PTJ, 2003, TRENDS PARASITOL, V19, P332, DOI 10.1016/S1471-4922(03)00148-X; Kiesecker JM, 2002, P NATL ACAD SCI USA, V99, P9900, DOI 10.1073/pnas.152098899; Lafferty KD, 2002, CONSERV BIOL, V16, P593, DOI 10.1046/j.1523-1739.2002.00446.x; Reyes JL, 2007, PARASITE IMMUNOL, V29, P609, DOI 10.1111/j.1365-3024.2007.00973.x; Rohr JR, 2006, TRENDS ECOL EVOL, V21, P606, DOI 10.1016/j.tree.2006.07.002; Rohr JR, 2006, ENVIRON HEALTH PERSP, V114, P46, DOI 10.1289/ehp.8405; Rohr JR, 2005, ECOL APPL, V15, P1135, DOI 10.1890/03-5353; ROHR JR, ECOL APPL IN PRESS; Rorabaugh JC, 2005, AMPHIBIAN DECLINES C; Schotthoefer AM, 2003, CAN J ZOOL, V81, P1144, DOI [10.1139/z03-099, 10.1139/Z03-099]; Schotthoefer AM, 2003, J PARASITOL, V89, P475, DOI 10.1645/0022-3395(2003)089[0475:ROTSTL]2.0.CO;2; Skelly David K., 2006, P153; Storrs SI, 2004, ENVIRON HEALTH PERSP, V112, P1054, DOI 10.1289/ehp.6821; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538	30	324	333	4	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2008	455	7217					1235	U50		10.1038/nature07281	http://dx.doi.org/10.1038/nature07281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18972018				2022-12-28	WOS:000260462100043
J	Yamasaki, M; Li, W; Johnson, DJD; Huntington, JA				Yamasaki, Masayuki; Li, Wei; Johnson, Daniel J. D.; Huntington, James A.			Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization	NATURE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; REACTIVE-CENTER LOOP; HUMAN ALPHA(1)-ANTITRYPSIN; MECHANISM; SERPINOPATHIES; DENATURATION; ANTITHROMBIN; DEFICIENCY; PEPTIDES; DEMENTIA	Repeating intermolecular protein association by means of beta-sheet expansion is the mechanism underlying a multitude of diseases including Alzheimer's, Huntington's and Parkinson's and the prion encephalopathies(1). A family of proteins, known as the serpins, also forms large stable multimers by ordered beta-sheet linkages leading to intracellular accretion and disease(2). These 'serpinopathies' include early- onset dementia caused by mutations in neuroserpin, liver cirrhosis and emphysema caused by mutations in alpha(1)- antitrypsin (alpha(1)AT), and thrombosis caused by mutations in antithrombin(3). Serpin structure and function are quite well understood, and the family has therefore become a model system for understanding the beta-sheet expansion disorders collectively known as the conformational diseases(4). To develop strategies to prevent and reverse these disorders, it is necessary to determine the structural basis of the intermolecular linkage and of the pathogenic monomeric state. Here we report the crystallographic structure of a stable serpin dimer which reveals a domain swap of more than 50 residues, including two long antiparallel beta-strands inserting in the centre of the principal b-sheet of the neighbouring monomer. This structure explains the extreme stability of serpin polymers, the molecular basis of their rapid propagation, and provides critical new insights into the structural changes which initiate irreversible beta-sheet expansion.	[Yamasaki, Masayuki; Li, Wei; Johnson, Daniel J. D.; Huntington, James A.] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Cambridge	Huntington, JA (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	jah52@cam.ac.uk			National Institutes of Health (USA); Uehara Memorial Foundation Japan	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation Japan(Uehara Memorial Foundation)	We thank R. Carrell, D. Crowther and D. Lomas for their comments on the manuscript. We are also grateful to J. Lowe for access to the robotic crystallisation facility in the MRC-LMB, and to M. Weldon for N- terminal sequencing. This work was supported by the National Institutes of Health ( USA) and the Uehara Memorial Foundation (Japan, to M.Y.), and J.A.H. is a senior MRC non- clinical fellow. Data were collected at beamlines I02 and I04 at the Diamond Light Source and we acknowledge the support of L. Duke, G. Evans, R. Flaig, J. Sandy and T. Sorensen.	Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Corral J, 2004, J THROMB HAEMOST, V2, P931, DOI 10.1111/j.1538-7836.2004.00749.x; Crowther DC, 2003, BIOCHEMISTRY-US, V42, P2355, DOI 10.1021/bi0259305; Dafforn TR, 1999, J BIOL CHEM, V274, P9548, DOI 10.1074/jbc.274.14.9548; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; DeLano W.L, PYMOL MOL GRAPHICS S; Devlin GL, 2002, J MOL BIOL, V324, P859, DOI 10.1016/S0022-2836(02)01088-4; Egelund R, 2001, J BIOL CHEM, V276, P13077, DOI 10.1074/jbc.M009024200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Im H, 2000, PROTEIN SCI, V9, P1497, DOI 10.1110/ps.9.8.1497; James EL, 1998, ARCH BIOCHEM BIOPHYS, V356, P296, DOI 10.1006/abbi.1998.0751; James EL, 1999, J BIOL CHEM, V274, P9482, DOI 10.1074/jbc.274.14.9482; Jung CH, 2004, PROTEIN SCI, V13, P694, DOI 10.1110/ps.03356604; Kim DY, 1996, BIOCHEM BIOPH RES CO, V226, P378, DOI 10.1006/bbrc.1996.1364; Kjoller L, 1996, EUR J BIOCHEM, V241, P38, DOI 10.1111/j.1432-1033.1996.0038t.x; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; Lomas DA, 2005, BIOCHEM SOC T, V33, P321, DOI 10.1042/BST0330321; Lomas DA, 2004, FRONT BIOSCI-LANDMRK, V9, P2873, DOI 10.2741/1444; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Pearce MC, 2007, FEBS J, V274, P3622, DOI 10.1111/j.1742-4658.2007.05897.x; Pedersen KE, 2003, BIOCHEM J, V372, P747, DOI 10.1042/BJ20021868; SHARP HL, 1969, J LAB CLIN MED, V73, P934; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Stock D, 2005, PROG BIOPHYS MOL BIO, V88, P311, DOI 10.1016/j.pbiomolbio.2004.07.009; Tew DJ, 2001, J MOL BIOL, V313, P1161, DOI 10.1006/jmbi.2001.5104; YU MH, 1995, NAT STRUCT BIOL, V2, P363, DOI 10.1038/nsb0595-363; Zhou A, 2008, J MOL BIOL, V375, P36, DOI 10.1016/j.jmb.2007.10.055; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	39	197	198	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2008	455	7217					1255	U65		10.1038/nature07394	http://dx.doi.org/10.1038/nature07394			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18923394				2022-12-28	WOS:000260462100048
J	Chan, EYY; Griffiths, SM; Chan, CW				Chan, E. Y. Y.; Griffiths, S. M.; Chan, C. W.			Public-health risks of melamine in milk products	LANCET			English	Editorial Material									[Chan, E. Y. Y.; Griffiths, S. M.] Chinese Univ Hong Kong, Sch Publ Hlth, Fac Med, Hong Kong, Peoples R China; [Chan, C. W.] Int Pediat Assoc, Hong Kong, Peoples R China	Chinese University of Hong Kong	Chan, EYY (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth, Fac Med, Hong Kong, Peoples R China.	emily.chan@cuhk.edu.hk	Chan, Emily Ying Yang/H-6849-2017	Chan, Emily Ying Yang/0000-0002-8854-5093				*CDCP, 2008, MEL CHIN MAN INF FOR; Chen K., 2007, PUBLIC HLTH SECURITY, P169; CHEN S, 2008, S CHINA MORNING 0922, pA4; *CTR FOOD SAF, FREQ ASK QUEST; FAN LW, 2007, PUBLIC HLTH LAW SURV, P332; *FOOD STAND AG, 2008, CHIN MILK ADV; GRIFFITHS S, 2008, S CHINA MORNING 1001, pA10; Parry J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1802; World Health Organization, 2008, MEL CYAN AC TOX PREL; XIAOFENG G, 2008, CHINA DAILY HON 1010, P3; 2008, CHINA DAILY     0916	11	179	190	4	49	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 25	2008	372	9648					1444	1445		10.1016/S0140-6736(08)61604-9	http://dx.doi.org/10.1016/S0140-6736(08)61604-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	370ZJ	18970965	Green Published, Bronze			2022-12-28	WOS:000260801300006
J	Chapman, GA				Chapman, Gary A.			Astronomy - Aspects of our Sun	SCIENCE			English	Editorial Material							SOLAR OBLATENESS; PHOTOSPHERIC FACULAE; GENERAL-RELATIVITY		[Chapman, Gary A.] Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA	California State University System; California State University Northridge	Chapman, GA (corresponding author), Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA.	gary.chapman@csun.edu						ANDERSON JD, 1975, ASTROPHYS J, V200, P221, DOI 10.1086/153779; BRANS C, 1961, PHYS REV, V124, P925, DOI 10.1103/PhysRev.124.925; CHAPMAN GA, 1973, ASTROPHYS J, V183, P1005, DOI 10.1086/152287; CHAPMAN GA, 1972, ASTROPHYS J, V175, P819, DOI 10.1086/151601; DICKE RH, 1974, ASTROPHYS J, V190, P187, DOI 10.1086/152863; DICKE RH, 1972, ASTROPHYS J, V175, P831, DOI 10.1086/151602; DICKE RH, 1967, PHYS REV LETT, V18, P313, DOI 10.1103/PhysRevLett.18.313; Fivian MD, 2008, SCIENCE, V322, P560, DOI 10.1126/science.1160863; HILL HA, 1975, ASTROPHYS J, V200, P471, DOI 10.1086/153813; LIBBRECHT KG, 1985, ASTROPHYS J, V299, P1047, DOI 10.1086/163772; Misner C.W., 1973, GRAVITATION; Shapiro SS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.121101; Thuillier G, 2006, ADV SPACE RES, V38, P1792, DOI 10.1016/j.asr.2006.04.034; WILL CM, 1990, SCIENCE, V250, P770, DOI 10.1126/science.250.4982.770; Woodard MF, 2003, SOL PHYS, V212, P51, DOI 10.1023/A:1022952206013	15	2	2	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					535	536		10.1126/science.1163101	http://dx.doi.org/10.1126/science.1163101			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948526				2022-12-28	WOS:000260299100024
J	Lee, HH; Elia, N; Ghirlando, R; Lippincott-Schwartz, J; Hurley, JH				Lee, Hyung Ho; Elia, Natalie; Ghirlando, Rodolfo; Lippincott-Schwartz, Jennifer; Hurley, James H.			Midbody targeting of the ESCRT machinery by a noncanonical coiled coil in CEP55	SCIENCE			English	Article							LATE DOMAINS; CYTOKINESIS; PROTEIN; HIV-1; ALIX; REQUIREMENTS; RECRUITMENT; RELEASE; PATHWAY; TSG101	The ESCRT (endosomal sorting complex required for transport) machinery is required for the scission of membrane necks in processes including the budding of HIV-1 and cytokinesis. An essential step in cytokinesis is recruitment of the ESCRT-I complex and the ESCRT-associated protein ALIX to the midbody (the structure that tethers two daughter cells) by the protein CEP55. Biochemical experiments show that peptides from ALIX and the ESCRT-I subunit TSG101 compete for binding to the ESCRT- and ALIX-binding region (EABR) of CEP55. We solved the crystal structure of EABR bound to an ALIX peptide at a resolution of 2.0 angstroms. The structure shows that EABR forms an aberrant dimeric parallel coiled coil. Bulky and charged residues at the interface of the two central heptad repeats create asymmetry and a single binding site for an ALIX or TSG101 peptide. Both ALIX and ESCRT-i are required for cytokinesis, which suggests that multiple CEP55 dimers are required for function.	[Lee, Hyung Ho; Ghirlando, Rodolfo; Hurley, James H.] NIDDKD, Mol Biol Lab, Bethesda, MD 20892 USA; [Elia, Natalie; Lippincott-Schwartz, Jennifer] NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Ghirlando, Rodolfo/A-8880-2009		U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NIH intramural suppor; NIDDK; NICHD; IATAP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036125] Funding Source: NIH RePORTER	U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NIH intramural suppor(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); IATAP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank B. Beach for generating DNA constructs, E. Freed and K. Kutsche for providing DNAs, T. Alber for discussions, and the staff of SER-CAT for user support at the Advanced Photon Source (APS). Use of the APS was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract W-31-109-Eng-38. Supported by NIH intramural support, NIDDK (J.H.H.), NICHD (J.L.), and IATAP (J.H.H. and J.L.). Crystallographic coordinates have been deposited in the RCSB Protein Data Bank with accession number 3E1R.	Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Kostelansky MS, 2007, CELL, V129, P485, DOI 10.1016/j.cell.2007.03.016; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Martinez-Garay I, 2006, GENOMICS, V87, P243, DOI 10.1016/j.ygeno.2005.11.006; McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Munshi UM, 2007, J BIOL CHEM, V282, P3847, DOI 10.1074/jbc.M607489200; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Pineda-Molina E, 2006, TRAFFIC, V7, P1007, DOI 10.1111/j.1600-0854.2006.00440.x; Pornillos O, 2002, NAT STRUCT BIOL, V9, P812, DOI 10.1038/nsb856; Prekeris R, 2008, J CELL SCI, V121, P1569, DOI 10.1242/jcs.018770; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Zhai Q, 2008, NAT STRUCT MOL BIOL, V15, P43, DOI 10.1038/nsmb1319; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	26	189	195	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					576	580		10.1126/science.1162042	http://dx.doi.org/10.1126/science.1162042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948538	Green Accepted			2022-12-28	WOS:000260299100040
J	McCain, JS				McCain, John S.			Making access to quality and affordable health care a reality for every American	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2008	300	16					1925	1926						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362UR	18940979				2022-12-28	WOS:000260223100022
J	Newton, MF; Keirns, CC; Cunningham, R; Hayward, RA; Stanley, R				Newton, Manya F.; Keirns, Carla C.; Cunningham, Rebecca; Hayward, Rodney A.; Stanley, Rachel			Uninsured adults presenting to US emergency departments - Assumptions vs data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HEALTH-CARE UTILIZATION; NEW-YORK-CITY; SAFETY-NET; HOSPITAL EMERGENCY; INSURANCE STATUS; QUALITATIVE RESEARCH; AMBULATORY-CARE; UNITED-STATES; SOCIOECONOMIC-STATUS; ETHNIC DISPARITIES	Context Emergency departments (EDs) are experiencing increased patient volumes and serve as a source of care of last resort for uninsured patients. Common assumptions about the effect of uninsured patients on the ED often drive policy solutions. Objective To compare common unsupported statements about uninsured patients presenting to the ED with the best available evidence on the topic. Data Sources OVID search of MEDLINE and MEDLINE in-process citations from 1950 through September 19, 2008, using the terms (Emergency Medical Services OR Emergency Service, Hospital OR emergency department.mp OR emergency medicine.mp OR Emergency Medicine) AND (uninsured.mp OR medically uninsured OR uncompensated care OR indigent.mp OR uncompensated care.mp OR medical indigency). Study Selection Of 526 articles identified, 127 (24%) met inclusion/exclusion criteria. Articles were included if they focused on the medical and surgical care of adult (aged 18 to <65 years) uninsured patients in emergency settings. Excluded articles involved pediatric or geriatric populations, psychiatric and dental illnesses, and non patient care issues. Data Extraction Statements about uninsured patients presenting for emergency care that appeared without citation or that were not based on data provided in the articles were identified using a qualitative descriptive approach based in grounded theory. Each assumption was then addressed separately in searches for supporting data in national data sets, administrative data, and peer-reviewed literature. Results Among the 127 identified articles, 53 had at least 1 assumption about uninsured ED patients, with a mean of 3 assumptions per article. Common assumptions supported by the evidence include assumptions that increasing numbers of uninsured patients present to the ED and that uninsured patients lack access to primary care. Available data support the statement that care in the ED is more expensive than office-based care when appropriate, but this is true for all ED users, insured and uninsured. Available data do not support assumptions that uninsured patients are a primary cause of ED overcrowding, present with less acute conditions than insured patients, or seek ED care primarily for convenience. Conclusion Some common assumptions regarding uninsured patients and their use of the ED are not well supported by current data.	[Newton, Manya F.; Keirns, Carla C.; Hayward, Rodney A.] Univ Michigan, Robert Wood Johnson Clin Scholars Program, Sch Med, Ann Arbor, MI 48109 USA; [Newton, Manya F.; Cunningham, Rebecca; Stanley, Rachel] Univ Michigan, Med Ctr, Dept Emergency Med, Ann Arbor, MI USA; [Newton, Manya F.; Keirns, Carla C.; Hayward, Rodney A.] Univ Michigan, Med Ctr, Div Gen Med, Dept Internal Med, Ann Arbor, MI USA; [Newton, Manya F.; Cunningham, Rebecca; Stanley, Rachel] Hurley Med Ctr, Dept Emergency Med, Flint, MI USA; [Newton, Manya F.; Cunningham, Rebecca; Hayward, Rodney A.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Keirns, Carla C.; Hayward, Rodney A.] Ann Arbor VA Hlth Syst, Vet Affairs HSR&D Ctr Excellence, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Newton, MF (corresponding author), Univ Michigan, Robert Wood Johnson Clin Scholars Program, Sch Med, 1150 W Med Ctr Dr,6312 Med Sci Bldg 1, Ann Arbor, MI 48109 USA.	manyan@umich.edu	Keirns, Carla/AAT-9384-2020		Robert Wood Johnson Clinical Scholars Program	Robert Wood Johnson Clinical Scholars Program(Robert Wood Johnson Foundation (RWJF))	This study was supported by the Robert Wood Johnson Clinical Scholars Program.	ALLISON EJ, 1991, ANN EMERG MED, V20, P820; *AM COLL EM PHYS, 1987, ANN EMERG MED, V16, P1302; [Anonymous], ORAL HLTH AM REPORT; Archdeacon MT, 2007, J BONE JOINT SURG AM, V89A, P2625, DOI 10.2106/JBJS.F.01499; Asplin BR, 2004, ANN EMERG MED, V43, P174, DOI 10.1016/j.annemergmed.2003.12.001; Asplin BR, 2003, ANN EMERG MED, V41, P477, DOI 10.1067/mem.2003.112; Asplin BR, 2001, ACAD EMERG MED, V8, P1075, DOI 10.1111/j.1553-2712.2001.tb01118.x; Baker DW, 2000, ARCH INTERN MED, V160, P1269, DOI 10.1001/archinte.160.9.1269; Baker DW, 1996, ANN EMERG MED, V28, P677, DOI 10.1016/S0196-0644(96)70093-8; BAKER DW, 1994, JAMA-J AM MED ASSOC, V271, P1909, DOI 10.1001/jama.271.24.1909; Bamezai A, 2005, ANN EMERG MED, V45, P483, DOI 10.1016/j.annemergmed.2004.08.029; Barber JW, 2000, PEDIATRICS, V105, P819, DOI 10.1542/peds.105.4.819; Barnhart JM, 2005, J URBAN HEALTH, V82, P207, DOI 10.1093/jurban/jti045; Barry CA, 1999, QUAL HEALTH RES, V9, P26, DOI 10.1177/104973299129121677; Bebber RJ, 2005, HEALTH CARE MANAG, V24, P159, DOI 10.1097/00126450-200504000-00009; Begley CE, 2006, J HEALTH CARE POOR U, V17, P610, DOI 10.1353/hpu.2006.0098; Bennett KJ, 2007, J RURAL HEALTH, V23, P258, DOI 10.1111/j.1748-0361.2007.00099.x; Bernstein SL, 2006, EMERG MED CLIN N AM, V24, P821, DOI 10.1016/j.emc.2006.06.013; Billings J, 2000, Issue Brief (Commonw Fund), P1; BILLINGS J, 1993, HEALTH AFFAIR, V12, P162, DOI 10.1377/hlthaff.12.1.162; Bitterman RA, 2002, ANN EMERG MED, V40, P470, DOI 10.1067/mem.2002.128799; Blanchard JC, 2003, ACAD EMERG MED, V10, P1289, DOI 10.1197/S1069-6563(03)00501-3; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; Bond TK, 1999, NURS ECON, V17, P207; Bradbury R C, 2001, Health Serv Manage Res, V14, P203, DOI 10.1258/0951484011912708; Braitberg G, 2007, MED J AUSTRALIA, V187, P624, DOI 10.5694/j.1326-5377.2007.tb01448.x; Brewster L R, 2001, Issue Brief Cent Stud Health Syst Change, P1; Brim Carla, 2008, Nurse Res, V15, P72; Brooks JR, 2006, CAN MED ASSOC J, V175, P464, DOI 10.1503/cmaj.060983; Burt Catharine W, 2004, Vital Health Stat 13, P1; Burt R.S., 2005, BROKERAGE CLOSURE IN; Carpenter D, 2001, HOSP HEALTH NETWORK, V75, P44; Cetta MG, 2000, ANN EMERG MED, V36, P243, DOI 10.1067/mem.2000.109911; Committee on Consequences of Uninsurance, 2002, CAR COV TOO LITTL TO; Crabtree BF, 1992, DOING QUALITATIVE RE; CROSS LA, 1992, ANN EMERG MED, V21, P1266, DOI 10.1016/S0196-0644(05)81760-3; Cunningham Peter, 2003, Issue Brief Cent Stud Health Syst Change, P1; Cunningham Peter J, 2006, Track Rep, P1; Cunningham PJ, 2006, HEALTH AFFAIR, V25, pW324, DOI 10.1377/hlthaff.25.w324; Cunningham PJ, 1995, MED CARE RES REV, V52, P453, DOI 10.1177/107755879505200402; CUNNINGHAM PJ, 2002, TRACK REP, V6, P1; Davidson RA, 2003, J COMMUN HEALTH, V28, P59, DOI 10.1023/A:1021333222164; Davison SP, 2004, PLAST RECONSTR SURG, V114, P453, DOI 10.1097/01.PRS.0000131885.65308.2B; Derlet RW, 2001, ACAD EMERG MED, V8, P151, DOI 10.1111/j.1553-2712.2001.tb01280.x; Derlet RW, 2002, ANN EMERG MED, V39, P430, DOI 10.1067/mem.2002.122707; DeVoe JE, 2003, AM J PUBLIC HEALTH, V93, P786, DOI 10.2105/AJPH.93.5.786; Doty Michelle M, 2005, Issue Brief (Commonw Fund), P1; Doyle JJ, 2005, REV ECON STAT, V87, P256, DOI 10.1162/0034653053970348; Eastaugh Steven R, 2002, Hosp Top, V80, P7; Fatovich DM, 2002, BMJ-BRIT MED J, V324, P958, DOI 10.1136/bmj.324.7343.958; Felland Laurie E, 2004, Issue Brief Cent Stud Health Syst Change, P1; Felt-Lisk S, 2002, HEALTH AFFAIR, V21, P277, DOI 10.1377/hlthaff.21.5.277; Ferris TG, 2002, J GEN INTERN MED, V17, P905, DOI 10.1046/j.1525-1497.2002.20230.x; Fields WW, 2001, ACAD EMERG MED, V8, P1064, DOI 10.1111/j.1553-2712.2001.tb01116.x; FIELDS WW, 2004, HLTH AFF MILLWO 0324, DOI DOI 10.1377/HLTHAFF.W4.143; Fogle Crystelle C, 2008, J Public Health Manag Pract, V14, pe17, DOI 10.1097/01.PHH.0000316496.78282.47; FOX M, 2007, SURVEY FINDS US HOSP; Fryer George E Jr, 2003, Ann Fam Med, V1, P81, DOI 10.1370/afm.52; Gerbner G., 2002, MEDIA EFFECTS ADV TH, V2nd; Glauser J, 2001, ACAD EMERG MED, V8, P1101, DOI 10.1111/j.1553-2712.2001.tb01123.x; Glick DF, 1997, NURS ECON, V15, P42; Gordon JA, 2001, ACAD EMERG MED, V8, P1024, DOI 10.1111/j.1553-2712.2001.tb01110.x; GREENE J, 1990, MOD HEALTHCARE, V20, P6; GRUMBACH K, 1993, AM J PUBLIC HEALTH, V83, P372, DOI 10.2105/AJPH.83.3.372; Hall AG, 2008, J HEALTH CARE POOR U, V19, P625, DOI 10.1353/hpu.0.0011; Hargraves J Lee, 2004, Track Rep, P1; Hazlett SB, 2004, ACAD EMERG MED, V11, P193, DOI 10.1197/j.aem.2003.09.014; HIMMELSTEIN DU, 1995, AM J PUBLIC HEALTH, V85, P341, DOI 10.2105/AJPH.85.3.341; Hock MOE, 2005, J PUBLIC HEALTH POL, V26, P269, DOI 10.1057/palgrave.jphp.3200028; Hodges J, 2004, HOSP HEALTH NETWORK, V78, P22; Hoekstra James, 2004, Emerg Med Australas, V16, P183, DOI 10.1111/j.1742-6723.2004.00600.x; Hong R, 2007, J EMERG MED, V32, P149, DOI 10.1016/j.jemermed.2006.05.042; Horwitz SM, 2005, ACAD EMERG MED, V12, P647, DOI 10.1197/j.aem.2005.02.015; Hsia RY, 2008, ANN EMERG MED, V51, P265, DOI 10.1016/j.annemergmed.2007.08.009; HUMBET JM, 2002, MENTAL ILLNESS PUBLI; Hwang U, 2007, J AM GERIATR SOC, V55, P1873, DOI 10.1111/j.1532-5415.2007.01400.x; *I MED, 2006, EM MED SERV CROSSR, V2; *I MED, 2006, HOSP BAS EM CAR BREA, V1; Institute of Medicine, 2007, HOSP BAS EM CAR BREA, DOI [10.17226/11621, DOI 10.17226/11621]; Irvin CB, 2003, ACAD EMERG MED, V10, P1271, DOI 10.1197/S1069-6563(03)00498-6; Irvin CB, 2003, ANN EMERG MED, V42, P571, DOI 10.1067/S0196-0644(03)00413-X; Iserson KV, 1996, AM J EMERG MED, V14, P1, DOI 10.1016/S0735-6757(96)90001-7; Johnson WG, 2004, PEDIATRICS, V113, P483, DOI 10.1542/peds.113.3.483; Kaplan SA, 2006, J HEALTH CARE POOR U, V17, P116, DOI 10.1353/hpu.2006.0026; Katz HP, 2008, J GEN INTERN MED, V23, P517, DOI 10.1007/s11606-007-0491-y; Kellermann AL, 2003, MED CARE, V41, P195, DOI 10.1097/00005650-200302000-00001; Kellermann AL, 2002, ANN EMERG MED, V40, P644, DOI 10.1067/mem.2002.129724; Kellermann AL, 2000, ANN EMERG MED, V35, P83, DOI 10.1016/S0196-0644(00)70110-7; Kellermann AL, 2006, NEW ENGL J MED, V355, P1300, DOI 10.1056/NEJMp068194; Kennedy J, 2004, ANN EMERG MED, V43, P567, DOI 10.1016/j.annemergmed.2003.10.012; Khaliq AA, 2006, HEALTH SERV MANAG RE, V19, P13, DOI 10.1258/095148406775322034; Knapp JF, 2004, PEDIATRICS, V114, P878; Knopp RK, 2000, ANN EMERG MED, V35, P295, DOI 10.1016/S0196-0644(00)70084-9; KOSKA MT, 1989, HOSPITALS, V63, P70; KOSKA MT, 1989, HOSPITALS, V63, P68; KOSKA MT, 1989, HOSPITALS, V63, P66; Koziol-McLain J, 2000, J Emerg Nurs, V26, P554, DOI 10.1067/men.2000.110904; Krome R, 1997, ANN EMERG MED, V30, P689, DOI 10.1016/S0196-0644(97)70088-X; Kushel MB, 2001, JAMA-J AM MED ASSOC, V285, P200, DOI 10.1001/jama.285.2.200; Lee KH, 2006, HEALTH CARE MANAG, V25, P155, DOI 10.1097/00126450-200604000-00008; Lee Tiana Mayere, 2004, Ann Health Law, V13, P145; Lowe RA, 2006, AM J EMERG MED, V24, P33, DOI 10.1016/j.ajem.2005.06.009; LOWE RA, 1991, ANN EMERG MED, V20, P790, DOI 10.1016/S0196-0644(05)80844-3; Lucas RH, 1998, ANN EMERG MED, V32, P563, DOI 10.1016/S0196-0644(98)70033-2; Lynn S G, 1991, Health PAC Bull, V21, P5; Mann J, 1995, Adv Health Econ Health Serv Res, V15, P49; Markovitz BP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-14; May Jessica H, 2004, Issue Brief Cent Stud Health Syst Change, P1; McCaig L F, 2001, Adv Data, P1; MCCAIG LF, 2006, ADV DATA, V372, P1; McCaig Linda F, 2004, Adv Data, P1; McCaig Linda F, 2003, Adv Data, P1; MCCANN J, 1983, EMERG DEP NEWS, V5, P5; MCCANN J, 1983, EMERG DEP NEWS, V5, P9; McLaughlin CG, 2003, HEALTH AFFAIR, V22, P143, DOI 10.1377/hlthaff.22.6.143; Mehrotra A, 2008, ANN INTERN MED, V148, P915, DOI 10.7326/0003-4819-148-12-200806170-00004; Memel S L, 1989, Healthc Exec, V4, P29; Meng YY, 2006, ANN ALLERG ASTHMA IM, V96, P291, DOI 10.1016/S1081-1206(10)61238-0; Miles M., 2013, QUALITATIVE DATA ANA; Mistry RD, 2005, PEDIATRICS, V115, pE147, DOI 10.1542/peds.2004-1798; MITCHELL TA, 1992, ANN EMERG MED, V21, P1208, DOI 10.1016/S0196-0644(05)81748-2; Mohanty SA, 2005, AM J PUBLIC HEALTH, V95, P1431, DOI 10.2105/AJPH.2004.044602; MUMIK M, 2006, FAM MED, V38, P185; Murray M, 2003, JAMA-J AM MED ASSOC, V289, P1035, DOI 10.1001/jama.289.8.1035; Murray M, 2003, JAMA-J AM MED ASSOC, V289, P1042, DOI 10.1001/jama.289.8.1042; Nathens AB, 2001, J TRAUMA, V50, P776, DOI 10.1097/00005373-200105000-00002; Nawar Eric W, 2007, Adv Data, P1; Newacheck PW, 2005, ARCH PEDIAT ADOL MED, V159, P10, DOI 10.1001/archpedi.159.1.10; NICHOLS L, 2004, MYTHS UNINSURED, P1; Nordberg M, 1985, Emerg Med Serv, V14, P25; Nordberg M, 1990, Emerg Med Serv, V19, P35; NORDBERG M, 1990, EMERG MED SERV, V19, P35; NORDBERG M, 1990, EMERG MED SERV, V19, P40; Northam S, 1996, PUBLIC HEALTH NURS, V13, P353, DOI 10.1111/j.1525-1446.1996.tb00261.x; O'Connell PA, 2003, J GEN INTERN MED, V18, P230, DOI 10.1046/j.1525-1497.2003.30117.x; OLSON EJ, 1994, STANFORD LAW REV, V46, P449, DOI 10.2307/1229189; Oster A, 2003, MED CARE, V41, P198, DOI 10.1097/00005650-200302000-00002; Oxford Centre for Evidence-based Medicine (CEBM), LEV EV; Pearson DA, 2007, ANN EMERG MED, V50, P646, DOI 10.1016/j.annemergmed.2007.07.015; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Pezzin LE, 2003, ACAD EMERG MED, V10, P1228, DOI 10.1197/S1069-6563(03)00493-7; Pisarek W, 2003, EUR J EMERG MED, V10, P314, DOI 10.1097/00063110-200312000-00014; Prinz TS, 2003, J URBAN HEALTH, V80, P635, DOI 10.1093/jurban/jtg070; Proudlove NC, 2003, EMERG MED J, V20, P149, DOI 10.1136/emj.20.2.149; RHOADES JA, 2006, LONG TERM UNINSURED; Richardson LD, 2002, ANN EMERG MED, V40, P388, DOI 10.1067/mem.2002.128012; Richardson LD, 2001, ACAD EMERG MED, V8, P1030, DOI 10.1111/j.1553-2712.2001.tb01111.x; Rivara FP, 2006, J TRAUMA, V61, P949, DOI 10.1097/01.ta.0000219936.72483.6a; Rodriguez JL, 2005, J TRAUMA, V59, P1, DOI 10.1097/01.TA.0000171454.91359.D8; Rosner D, 2006, CAL MILBANK BOOK HEA, V15, P1; Ruane J. M., 2008, 2 THOUGHTS SEEING CO; Rubin Marcie A., 1995, Journal of Emergency Medicine, V13, P839, DOI 10.1016/0736-4679(95)02013-6; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2004, QUAL HEALTH RES, V14, P1366, DOI 10.1177/1049732304269672; Sandelowski M, 2003, QUAL HEALTH RES, V13, P781, DOI 10.1177/1049732303013006003; Santos-Eggimann B, 2002, BRIT MED J, V324, P1186, DOI 10.1136/bmj.324.7347.1186; Sarver JH, 2002, ACAD EMERG MED, V9, P916, DOI 10.1197/aemj.9.9.916; SAVER BG, 1993, AM J PUBLIC HEALTH, V83, P1583, DOI 10.2105/AJPH.83.11.1583; Schull MJ, 2007, ANN EMERG MED, V49, P257, DOI 10.1016/j.annemergmed.2006.06.027; Scott M, 2005, HOSP HEALTH NETWORK, V79, P25; Seifert RW, 2006, HEALTH AFFAIR, V25, pW89, DOI 10.1377/hlthaff.25.w89; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Selassie AW, 2003, ACAD EMERG MED, V10, P1260, DOI 10.1197/S1069-6563(03)00497-4; SHESSER R, 1991, ANN EMERG MED, V20, P743, DOI 10.1016/S0196-0644(05)80835-2; SHI L, 2004, VULNERABLE POPULATIO; Showstack J, 2003, ANN INTERN MED, V138, P268, DOI 10.7326/0003-4819-138-3-200302040-00036; SIEGEL B, 2004, HLTH AFF MILLWO 0324, DOI DOI 10.1377/HLTHAFF.W4.146; SILBERNER J, 2006, UNINSURED PATIENTS F; Smith-Campbell B, 2005, J NURS SCHOLARSHIP, V37, P80, DOI 10.1111/j.1547-5069.2005.00011.x; Solberg LI, 2003, ANN EMERG MED, V42, P824, DOI 10.1016/S0196-0644(03)00816-3; Steiner JF, 2002, AM J MANAG CARE, V8, P653; Strauss AL., 1987, QUALITATIVE ANAL SOC, Vxv, P319; Svenson JE, 2001, AM J EMERG MED, V19, P19, DOI 10.1053/ajem.2001.18041; Taylor EF, 2006, HEALTH AFFAIR, V25, pW173, DOI 10.1377/hlthaff.25.w173; TAYLOR J, 2006, NHPF ISSUE BRIEF, P1; TAYLOR M, 1999, MOD HEALTHCARE, V29, P36; TAYLOR M, 1999, MOD HEALTHCARE, V29, P38; Trzeciak S, 2003, EMERG MED J, V20, P402, DOI 10.1136/emj.20.5.402; Twanmoh Joseph R, 2006, Manag Care, V15, P54; Tyrance PH, 1996, AM J PUBLIC HEALTH, V86, P1527, DOI 10.2105/AJPH.86.11.1527; U.S. General Accounting Office, 2000, OR HLTH DENT DIS IS; *US GEN ACC OFF, 2003, HIGHW INFR STAK VIEW, P1; Uzych L, 1996, J Emerg Med, V14, P381, DOI 10.1016/0736-4679(96)00039-X; Waldrop RD, 2000, AM J EMERG MED, V18, P687, DOI 10.1053/ajem.2000.7333; Walker AF, 2002, CAN MED ASSOC J, V166, P465; Washington DL, 2002, ANN INTERN MED, V137, P707, DOI 10.7326/0003-4819-137-9-200211050-00005; Weber EJ, 2005, ANN EMERG MED, V45, P4, DOI 10.1016/j.annemergmed.2004.06.023; Weber EJ, 2008, ANN EMERG MED, V52, P108, DOI 10.1016/j.annemergmed.2008.01.327; Weiner SJ, 2006, J URBAN HEALTH, V83, P244, DOI 10.1007/s11524-005-9018-1; Weissman JS, 2003, INQUIRY-J HEALTH CAR, V40, P84, DOI 10.5034/inquiryjrnl_40.1.84; Wetta-Hall Ruth, 2005, Emerg Nurse, V13, P12; White FA, 2007, J EMERG MED, V32, P159, DOI 10.1016/j.jemermed.2006.05.043; Young D, 2007, AM J HEALTH-SYST PH, V64, P1674, DOI 10.2146/news070073; Young GP, 1996, JAMA-J AM MED ASSOC, V276, P460, DOI 10.1001/jama.276.6.460; Zuckerman S, 2004, MED CARE, V42, P176, DOI 10.1097/01.mlr.0000108747.51198.41; 2004, HOSP CASE MANAG, V12, P113; 2008, NY TIMES        0119, pA18; 2000, ED MANAG, V12, P102; 2000, ED MANAG, V12, P103; 2005, LA EMERGENCY ROOMS F	200	133	133	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2008	300	16					1914	1924		10.1001/jama.300.16.1914	http://dx.doi.org/10.1001/jama.300.16.1914			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	362UR	18940978				2022-12-28	WOS:000260223100021
J	Aiga, H				Aiga, Hirotsugu			How many people are really hungry?	LANCET			English	Editorial Material									[Aiga, Hirotsugu] Japan Int Cooperat Agcy, Dept Human Dev, Shibuya Ku, Tokyo 1518558, Japan; [Aiga, Hirotsugu] UN World Food Programme, Program Design & Support Div, Rome, Italy; [Aiga, Hirotsugu] George Washington Univ, Dept Global Hlth, Washington, DC USA; [Aiga, Hirotsugu] Univ Tokyo, Dept Hlth Policy & Planning, Tokyo, Japan	George Washington University; University of Tokyo	Aiga, H (corresponding author), Japan Int Cooperat Agcy, Dept Human Dev, Shibuya Ku, Tokyo 1518558, Japan.	aiga.hirotsugu@jica.go.jp						Aiga H, 2006, HUMANITARIAN EXCHANG, V36, P36; *FOOD AGR ORG UN, 2003, FAO METH MEAS FOOD D, P2; *FOOD AGR ORG UN, 2006, STAT FOOD INS WORLD, P32; *FOOD AGR ORG UN, 2008, HIGH LEV C WORLD FOO; Food And Agriculture Organisation Of The United Nations-FAO, 1996, ROM DECL WORLD FOOD; LANJOUW JO, 2000, DEMYSTIFYING POVERTY, P4; *MIN FOR AFF JAP, G8 LEAD STAT GLOB FO; STIGLITZ JE, 2003, GLOBALIZATION ITS DI; SVEDBERG P, 1999, POVERTY UNDERNUTRITI, P298; UNICEF, 1990, STRAT IMPR NUTR CHIL, P18; 2008, ECONOMIST       0605, P61; 2007, GOAL 1 ERADICATE EXT	12	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 18	2008	372	9647					1367	1369		10.1016/S0140-6736(08)61568-8	http://dx.doi.org/10.1016/S0140-6736(08)61568-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362WP	18940453				2022-12-28	WOS:000260228200007
J	Donaldson, C; Bate, A; Brambleby, P; Waldner, H				Donaldson, Cam; Bate, Angela; Brambleby, Peter; Waldner, Howard			Moving forward on rationing - An economic view	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Donaldson, Cam; Bate, Angela] Univ Newcastle, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England; [Brambleby, Peter] N Yorkshire & York Primary Care Trust, Harrogate HG2 8RE, England; [Waldner, Howard] Vancouver Isl Hlth Author, Vancouver, BC, Canada	Newcastle University - UK; Vancouver Island Health Authority	Donaldson, C (corresponding author), Univ Newcastle, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England.	cam.donaldson@ncl.ac.uk	Bate, Angela/AAR-1027-2020	Bate, Angela/0000-0001-5277-4188; Donaldson, Cam/0000-0003-4670-5340	Economic and Social Research Council [ES/G007470/1, RES-451-25-4087] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10086] Funding Source: researchfish; ESRC [ES/G007470/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		DONALDSON C, 2006, EC HLTH CARE FINANCI; DONALDSON C, 2008, NATL HLTH EXECUT JAN, P22; DONALDSON C, 2008, BRIT MED J, V337, P578; Gibson Jennifer, 2006, J Health Serv Res Policy, V11, P32, DOI 10.1258/135581906775094280; Healthcare Commission, 2008, IS TREATM WORK PROGR; Maynard A, 1996, NEW ENGL J MED, V334, P604, DOI 10.1056/NEJM199602293340918; Mitton C, 2003, SOC SCI MED, V57, P1653, DOI 10.1016/S0277-9536(02)00549-X; Mitton C, 2001, J Health Serv Res Policy, V6, P239, DOI 10.1258/1355819011927558; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224	9	12	12	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 18	2008	337	7675							a1872	10.1136/bmj.a1872	http://dx.doi.org/10.1136/bmj.a1872			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	360YE	18845596				2022-12-28	WOS:000260093900032
J	Karimi, M; Cohan, N; Bagheri, MH; Lotfi, M; Omidvari, S; Geramizadeh, B				Karimi, Mehran; Cohan, Nader; Bagheri, Mohamad Hadi; Lotfi, Mehrzad; Omidvari, Shapour; Geramizadeh, Bita			A lump on the head	LANCET			English	Editorial Material							EXTRAMEDULLARY HEMATOPOIESIS; THALASSEMIA-INTERMEDIA		[Geramizadeh, Bita] Shiraz Univ Med Sci, Organ Transplant Res Ctr, Shiraz, Iran; [Geramizadeh, Bita] Shiraz Univ Med Sci, Dept Pathol, Shiraz, Iran; [Karimi, Mehran] Nemazee Hosp, Haematol Res Ctr, Shiraz, Iran; [Bagheri, Mohamad Hadi; Lotfi, Mehrzad] Nemazee Hosp, Dept Radiol, Shiraz, Iran; [Omidvari, Shapour] Nemazee Hosp, Dept Radiotherapy, Shiraz, Iran	Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science	Karimi, M (corresponding author), Shiraz Univ Med Sci, Haematol Res Ctr, Shiraz, Iran.	Karimim@sums.ac.ir	Karimi, Mehran/P-3530-2017; Omidvari, Shapour/M-9992-2018; Lotfi, Mehrzad/V-3194-2017; Omidvari, Shapour/GLR-8070-2022; Geramizadeh, Bita/AAA-9497-2021; Cohan, Nader/P-3613-2017	Karimi, Mehran/0000-0001-8555-1001; Omidvari, Shapour/0000-0003-3656-9891; Lotfi, Mehrzad/0000-0001-5192-4930; Omidvari, Shapour/0000-0003-3656-9891; Geramizadeh, Bita/0000-0002-4867-5686; Cohan, Nader/0000-0003-2464-8445				Chiam QLL, 2007, AUSTRALAS RADIOL, V51, P168, DOI 10.1111/j.1440-1673.2007.01689.x; Gibbins J, 2005, CLIN LAB HAEMATOL, V27, P391, DOI 10.1111/j.1365-2257.2005.00724.x; Jabr FI, 2006, AM J HEMATOL, V81, P151, DOI 10.1002/ajh.20478; Shinder R, 2008, OPHTHAL PLAST RECONS, V24, P48, DOI 10.1097/IOP.0b013e31815c9366; Turgut B, 2003, CLIN LAB HAEMATOL, V25, P409, DOI 10.1046/j.0141-9854.2003.00546.x	5	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 18	2008	372	9647					1436	1436		10.1016/S0140-6736(08)61590-1	http://dx.doi.org/10.1016/S0140-6736(08)61590-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362WP	18940467				2022-12-28	WOS:000260228200030
J	Kerse, N; Peri, K; Robinson, E; Wilkinson, T; von Randow, M; Kiata, L; Parsons, J; Latham, N; Parsons, M; Willingale, J; Brown, P; Arroll, B				Kerse, Ngaire; Peri, Kathy; Robinson, Elizabeth; Wilkinson, Tim; von Randow, Martin; Kiata, Liz; Parsons, John; Latham, Nancy; Parsons, Matthew; Willingale, Jane; Brown, Paul; Arroll, Bruce			Does a functional activity programme improve function, quality of life, and falls for residents in long term care? Cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FRAIL OLDER-PEOPLE; NURSING-HOME; NUTRITIONAL SUPPLEMENTATION; PHYSICAL-ACTIVITY; ELDERLY PERSONS; HEALTH-STATUS; PREVENTION; EXERCISE; MOBILITY; INTERVENTIONS	Objective To assess the effectiveness of an activity programme in improving function, quality of life, and falls in older people in residential care. Design Cluster randomised controlled trial with one year follow-up. Setting 41 low level dependency residential care homes in New Zealand. Participants 682 people aged 65 years or over. Interventions 330 residents were offered a goal setting and individualised activities of daily living activity programme by a gerontology nurse, reinforced by usual healthcare assistants; 352 residents received social visits. Main outcome measures Function (late life function and disability instruments, elderly mobility scale, FICSIT-4 balance test, timed up and go test), quality of life (life satisfaction index, EuroQol), and falls (time to fall over 12 months). Secondary outcomes were depressive symptoms and hospital admissions. Results 473 (70%) participants completed the trial. The programme had no impact overall. However, in contrast to residents with impaired cognition (no differences between intervention and control group), those with normal cognition in the intervention group may have maintained overall function (late life function and disability instrument total function, P=0.024) and lower limb function (late life function and disability instrument basic lower extremity, P=0.015). In residents with cognitive impairment, the likelihood of depression increased in the intervention group. No other outcomes differed between groups. Conclusion A programme of functional rehabilitation had minimal impact for elderly people in residential care with normal cognition but was not beneficial for those with poor cognition. Trial registration Australian Clinical Trials Register ACTRN12605000667617.	[Kerse, Ngaire; Kiata, Liz; Willingale, Jane; Brown, Paul; Arroll, Bruce] Univ Auckland, Dept Gen Practice & Primary Hlth Care, Sch Populat Hlth, Auckland 1001, New Zealand; [Peri, Kathy; Parsons, John; Parsons, Matthew] Univ Auckland, Sch Nursing, Auckland 1001, New Zealand; [Robinson, Elizabeth] Univ Auckland, Dept Epidemiol & Biostat, Sch Populat Hlth, Auckland 1001, New Zealand; [Wilkinson, Tim] Univ Otago, Christchurch, New Zealand; [von Randow, Martin] Univ Auckland, Dept Sociol, Auckland 1001, New Zealand; [Latham, Nancy] Boston Univ, Sch Publ Hlth, Hlth & Disabil Res Unit, Boston, MA USA; Univ Auckland, Auckland 1001, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Otago; University of Auckland; Boston University; University of Auckland	Kerse, N (corresponding author), Univ Auckland, Dept Gen Practice & Primary Hlth Care, Sch Populat Hlth, Private Bag 92019, Auckland 1001, New Zealand.	n.kerse@auckland.ac.nz	Parsons, John/AAA-3842-2020; Latham, Nancy/K-3405-2012; Kerse, Ngaire/AFF-8119-2022; Wilkinson, Tim J/C-5515-2008	Parsons, John/0000-0003-0867-8564; Wilkinson, Tim J/0000-0002-4080-4164; Latham, Nancy/0000-0002-8516-0016; Parsons, Matthew/0000-0003-2004-1347	New Zealand Health Research Council; Accident Compensation Corporation	New Zealand Health Research Council(Health Research Council of New Zealand); Accident Compensation Corporation	New Zealand Health Research Council and Accident Compensation Corporation. The funders had no involvement in the research design or conduct or in interpretation of results.	Altman DG, 1996, BRIT MED J, V313, P570; Becker C, 2003, J AM GERIATR SOC, V51, P306, DOI 10.1046/j.1532-5415.2003.51103.x; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; BROWN AB, 1990, J APPL PHYSIOL, V69, P1725, DOI 10.1152/jappl.1990.69.5.1725; BUCHNER DM, 1993, J AM GERIATR SOC, V41, P297, DOI 10.1111/j.1532-5415.1993.tb06708.x; BUCHNER DM, 1992, ANNU REV PUBL HEALTH, V13, P469, DOI 10.1146/annurev.publhealth.13.1.469; DiPietro L, 2001, J GERONTOL A-BIOL, V56, P13, DOI 10.1093/gerona/56.suppl_2.13; Ebrahim S, 1997, AGE AGEING, V26, P253, DOI 10.1093/ageing/26.4.253; Elley CR, 2005, AUST NZ J PUBL HEAL, V29, P461, DOI 10.1111/j.1467-842X.2005.tb00227.x; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; FIATARONE MA, 1993, J AM GERIATR SOC, V41, P333, DOI 10.1111/j.1532-5415.1993.tb06714.x; FOLMAN Y, 1994, ARCH PHYS MED REHAB, V75, P454, DOI 10.1016/0003-9993(94)90171-6; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; GUYATT GH, 1993, JAMA-J AM MED ASSOC, V270, P2598, DOI 10.1001/jama.270.21.2598; Hill KD, 1996, ARCH PHYS MED REHAB, V77, P1025, DOI 10.1016/S0003-9993(96)90063-5; HODGKINSON HM, 1972, AGE AGEING, V1, P233; Kerse N, 2004, J AM GERIATR SOC, V52, P524, DOI 10.1111/j.1532-5415.2004.52157.x; KING AH, 2001, PRIMARY HLTH CARE ST, P23; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Latham NK, 2003, J AM GERIATR SOC, V51, P291, DOI 10.1046/j.1532-5415.2003.51101.x; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; MCMURDO MET, 1994, ARCH PHYS MED REHAB, V75, P600; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM494, DOI 10.1093/gerona/54.10.M494; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; Norton R, 1999, AGE AGEING, V28, P135, DOI 10.1093/ageing/28.2.135; Peri K, 2008, J AM MED DIR ASSOC, V9, P253, DOI 10.1016/j.jamda.2007.11.008; Peri K, 2008, AGE AGEING, V37, P57, DOI 10.1093/ageing/afm135; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rejeski WJ, 2001, J GERONTOL A-BIOL, V56, P23, DOI 10.1093/gerona/56.suppl_2.23; Reuben DB, 2002, MED CARE, V40, P416, DOI 10.1097/00005650-200205000-00007; Rubenstein LZ, 1996, CLIN GERIATR MED, V12, P881; Sayers SP, 2004, J AM GERIATR SOC, V52, P1554, DOI 10.1111/j.1532-5415.2004.52422.x; Simons LA, 1996, AUST NZ J MED, V26, P40, DOI 10.1111/j.1445-5994.1996.tb02905.x; Singh MAF, 2002, J GERONTOL A-BIOL, V57, pM262, DOI 10.1093/gerona/57.5.M262; SMITH R, 1994, PHYSIOTHERAPY, V80, P745; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Westhoff MH, 2000, J AGING PHYS ACTIV, V8, P325, DOI 10.1123/japa.8.4.325; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	38	94	95	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2008	337	7675							a1445	10.1136/bmj.a1445	http://dx.doi.org/10.1136/bmj.a1445			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	360YE	18845605	hybrid, Green Published			2022-12-28	WOS:000260093900035
J	Schott, GD				Schott, G. D.			The art of medicine - Piero della Francesca's projections and neuroimaging today	LANCET			English	Editorial Material									[Schott, G. D.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Schott, GD (corresponding author), Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	geoffrey.schott@uclh.nhs.uk						ANDERSEN K, 1992, AMPHORA FESTSCHRIFT, P1; EVANS R, 1995, PROJECTIVE CAST ARCH, P147; FIELD JV, 2004, P DELLAFRANCESCA MAT, P164; KEMP M, 1990, SCI ART OPTICAL THEM, P27; SMEDLEY G, 1996, ATT CONV INT STUD AR, P385	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 18	2008	372	9647					1378	1379		10.1016/S0140-6736(08)61576-7	http://dx.doi.org/10.1016/S0140-6736(08)61576-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	362WP	18946913				2022-12-28	WOS:000260228200013
J	Petit, JM; Kavelaars, JJ; Gladman, BJ; Margot, JL; Nicholson, PD; Jones, RL; Parker, JW; Ashby, MLN; Bagatin, AC; Benavidez, P; Coffey, J; Rousselot, P; Mousis, O; Taylor, PA				Petit, J. -M.; Kavelaars, J. J.; Gladman, B. J.; Margot, J. L.; Nicholson, P. D.; Jones, R. L.; Parker, J. Wm.; Ashby, M. L. N.; Campo Bagatin, A.; Benavidez, P.; Coffey, J.; Rousselot, P.; Mousis, O.; Taylor, P. A.			The extreme Kuiper Belt binary 2001 QW(322)	SCIENCE			English	Article							ENCOUNTERS	The study of binary Kuiper Belt objects helps to probe the dynamic conditions present during planet formation in the solar system. We report on the mutual-orbit determination of 2001 QW(322), a Kuiper Belt binary with a very large separation whose properties challenge binary-formation and -evolution theories. Six years of tracking indicate that the binary's mutual-orbit period is approximate to 25 to 30 years, that the orbit pole is retrograde and inclined 50 degrees to 62 degrees from the ecliptic plane, and, most surprisingly, that the mutual orbital eccentricity is <0.4. The semimajor axis of 105,000 to 135,000 kilometers is 10 times that of other near-equal-mass binaries. Because this weakly bound binary is prone to orbital disruption by interlopers, its lifetime in its present state is probably less than 1 billion years.	[Petit, J. -M.; Rousselot, P.; Mousis, O.] Univ Franche Comte, Observ Besancon, F-25010 Besancon, France; [Kavelaars, J. J.] Natl Res Council Canada, Herzberg Inst Astrophys, Victoria, BC V9E 2E7, Canada; [Petit, J. -M.; Gladman, B. J.; Coffey, J.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Margot, J. L.; Nicholson, P. D.; Taylor, P. A.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Jones, R. L.] Univ Washington, Dept Astron, Seattle, WA 98195 USA; [Parker, J. Wm.] SW Res Inst, Boulder, CO 80302 USA; [Ashby, M. L. N.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Campo Bagatin, A.; Benavidez, P.] Univ Alicante, Escuela Politecn Super, E-03080 Alicante, Spain	Universite de Franche-Comte; National Research Council Canada; University of British Columbia; Cornell University; University of Washington; University of Washington Seattle; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Universitat d'Alacant	Petit, JM (corresponding author), Univ Franche Comte, Observ Besancon, F-25010 Besancon, France.	petit@obs-besancon.fr	Margot, Jean-Luc/A-6154-2012; Bagatin, Adriano Campo/L-2809-2014; Mousis, Olivier/X-2712-2019	Margot, Jean-Luc/0000-0001-9798-1797; Bagatin, Adriano Campo/0000-0001-9840-2216; Kavelaars, JJ/0000-0001-7032-5255; Taylor, Patrick/0000-0002-2493-943X; Benavidez, Paula/0000-0001-6569-0223	NASA/Planetary Astronomy Program [NNG04GI29G, NNX07AK68G]; Ministerio de Educacion y Ciencia (Spain) [AYA2005-07808-C03-03]; Canadian Space Agency	NASA/Planetary Astronomy Program(National Aeronautics & Space Administration (NASA)); Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Canadian Space Agency(Canadian Space Agency)	This work was partially supported by NASA/Planetary Astronomy Program grant NNG04GI29G. A.C.B. also acknowledges support from Ministerio de Educacion y Ciencia (Spain), National project n. AYA2005-07808-C03-03. J.L.M. was partially supported by grant NNX07AK68G from the NASA Planetary Astronomy program. This research used the facilities of the Canadian Astronomy Data Centre operated by the National Research Council of Canada with the support of the Canadian Space Agency. The Canada-France-Hawaii Telescope is operated by the National Research Council of Canada, the Institut National des Sciences de l'Univers of the Centre National de la Recherche Scientifique of France, and the University of Hawaii. Observations at Palomar Observatory are carried out under a collaborative agreement between Cornell University and the California Institute of Technology. Observations made with European Southern Observatory Telescopes at the La Silla or Paranal Observatories under program IDs 069.C-0460, 071.C-0497, 072.C-0542, 074.C-0379, 075.C-0251, and 380.C-0791. The Gemini Observatory is operated by the Association of Universities for Research in Astronomy, under a cooperative agreement with NSF on behalf of the Gemini partnership: NSF (US), the Science and Technology Facilities Council (UK), the National Research Council (Canada), Comision Nacional de Investigacion Cientifica y Tecnologica (Chile), the Australian Research Council (Australia), Ministerio da Ciencia e Tecnologia (Brazil), and Secretaria de Ciencia y Technologia (Argentina). Observations were obtained at the WIYN Observatory, a joint facility of the University of Wisconsin-Madison, Indiana University, Yale University, and the National Optical Astronomy Observatories; the William Herschel Telescope, at Roque de los Muchachos Observatory (La Palma, Canary Islands, Spain), operated by the Instituto de Astrofisica de Canarias; and the MMT Observatory, a joint facility of the Smithsonian Institution and the University of Arizona.	Astakhov SA, 2005, MON NOT R ASTRON SOC, V360, P401, DOI 10.1111/j.1365-2966.2005.09072.x; BURNS J, 2002, MINOR PLANET ELECT C, V30, P1; Funato Y, 2004, NATURE, V427, P518, DOI 10.1038/nature02323; Gladman B., 2008, SOLAR SYSTEM NEPTUNE, P43; Gulbis AAS, 2006, ICARUS, V183, P168, DOI 10.1016/j.icarus.2006.01.021; Hainaut OR, 2002, ASTRON ASTROPHYS, V389, P641, DOI 10.1051/0004-6361:20020431; KAVELAARS JJ, 2001, IAU CIRC, V7749, P1; Margot J. L, 2005, BAAS, V37, P737; Merline W.J., 2000, BAAS, V32, P1017; Merline W.J., 2002, ASTEROIDS, VIII, P289; Nesvorny D, 2003, ASTRON J, V126, P398, DOI 10.1086/375461; Noll K. S., 2008, SOLAR SYSTEM NEPTUNE, P345; Petit JM, 2004, ICARUS, V168, P409, DOI 10.1016/j.icarus.2003.12.013; SPENCER JR, 2006, B AM ASTRON SOC, V38, P546; Stansberry JA, 2006, ASTROPHYS J, V643, P556, DOI 10.1086/502674; Weidenschilling SJ, 2002, ICARUS, V160, P212, DOI 10.1006/icar.2002.6952	17	33	33	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					432	434		10.1126/science.1163148	http://dx.doi.org/10.1126/science.1163148			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927391	Green Submitted			2022-12-28	WOS:000260094500044
J	Zimmer, J; Nam, YS; Rapoport, TA				Zimmer, Jochen; Nam, Yunsun; Rapoport, Tom A.			Structure of a complex of the ATPase SecA and the protein-translocation channel	NATURE			English	Article							SIGNAL-SEQUENCE RECOGNITION; X-RAY-STRUCTURE; ESCHERICHIA-COLI; MEMBRANE-PROTEIN; DIMERIC SECA; DENSITY-MODIFICATION; CRYSTAL-STRUCTURES; SECYEG; MEDIATE; EXPORT	Most proteins are secreted from bacteria by the interaction of the cytoplasmic SecA ATPase with a membrane channel, formed by the heterotrimeric SecY complex. Here we report the crystal structure of SecA bound to the SecY complex, with a maximum resolution of 4.5 angstrorm ( A), obtained for components from Thermotoga maritima. One copy of SecA in an intermediate state of ATP hydrolysis is bound to one molecule of the SecY complex. Both partners undergo important conformational changes on interaction. The polypeptide- cross- linking domain of SecA makes a large conformational change that could capture the translocation substrate in a 'clamp'. Polypeptide movement through the SecY channel could be achieved by the motion of a 'two-helix finger' of SecA inside the cytoplasmic funnel of SecY, and by the coordinated tightening and widening of SecA's clamp above the SecY pore. SecA binding generates a 'window' at the lateral gate of the SecY channel and it displaces the plug domain, preparing the channel for signal sequence binding and channel opening.	[Zimmer, Jochen; Nam, Yunsun; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Zimmer, Jochen; Nam, Yunsun; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu		Zimmer, Jochen/0000-0002-8423-2882; Nam, Yunsun/0000-0002-7939-8626	National Institutes of Health; Damon Runyon Cancer Research Foundation [DRG-#1953-07]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation	We thank B. van den Berg and P. Bendapudi for initial experiments with the B. subtilis SecA and T. maritima SecY complex, G. Skiniotis for electron microscopy analysis, W. Li for his help with data processing, the staff at Advanced Photon Source beamlines ID- 19 and 24ID and at Brookhaven National Laboratory beamline X29, and the SB Grid consortium at Harvard Medical School. We thank A. Brunger and S. Harrison for comments, and A. Brunger, B. van den Berg, W. Li, A. Osborne and S. Schulman for critical reading of the manuscript. The work was supported by a National Institutes of Health grant. T. A. R. is an HHMI investigator. Y.N. is supported by the Damon Runyon Cancer Research Foundation (DRG-#1953-07).	AKIMARU J, 1991, P NATL ACAD SCI USA, V88, P6545, DOI 10.1073/pnas.88.15.6545; Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bostina M, 2005, J MOL BIOL, V352, P1035, DOI 10.1016/j.jmb.2005.08.005; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen B, 2005, STRUCTURE, V13, P197, DOI 10.1016/j.str.2004.12.004; Chiba K, 2002, J BACTERIOL, V184, P2243, DOI 10.1128/JB.184.8.2243-2250.2002; Cooper DB, 2008, J MOL BIOL, V382, P74, DOI 10.1016/j.jmb.2008.06.049; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; de Keyzer J, 2005, J BIOL CHEM, V280, P35255, DOI 10.1074/jbc.M506157200; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; DeLano W.L, PYMOL MOL GRAPHICS S; DEVRIJE T, 1988, NATURE, V334, P173, DOI 10.1038/334173a0; Duong F, 1998, EMBO J, V17, P696, DOI 10.1093/emboj/17.3.696; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; JAROSIK GP, 1991, J BACTERIOL, V173, P860, DOI 10.1128/jb.173.2.860-868.1991; Jilaveanu LB, 2005, P NATL ACAD SCI USA, V102, P7511, DOI 10.1073/pnas.0502774102; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karamanou S, 1999, MOL MICROBIOL, V34, P1133, DOI 10.1046/j.1365-2958.1999.01686.x; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mitra K, 2006, NAT STRUCT MOL BIOL, V13, P957, DOI 10.1038/nsmb1166; Mori H, 2002, J BIOL CHEM, V277, P48550, DOI 10.1074/jbc.M204436200; Mori H, 2001, P NATL ACAD SCI USA, V98, P5128, DOI 10.1073/pnas.081617398; Mori H, 2006, J BIOL CHEM, V281, P36249, DOI 10.1074/jbc.M606906200; Neumann-Haefelin C, 2000, EMBO J, V19, P6419, DOI 10.1093/emboj/19.23.6419; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; Or E, 2005, J BIOL CHEM, V280, P9097, DOI 10.1074/jbc.M413947200; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Prinz WA, 1996, EMBO J, V15, P5209, DOI 10.1002/j.1460-2075.1996.tb00906.x; Qi HY, 1999, J BIOL CHEM, V274, P8993, DOI 10.1074/jbc.274.13.8993; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Satoh Y, 2003, BIOCHEMISTRY-US, V42, P7434, DOI 10.1021/bi034331a; SHIBA K, 1984, EMBO J, V3, P631, DOI 10.1002/j.1460-2075.1984.tb01859.x; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Zhou JH, 2003, NAT STRUCT BIOL, V10, P942, DOI 10.1038/nsb980; Zimmer J, 2006, J MOL BIOL, V364, P259, DOI 10.1016/j.jmb.2006.08.044	62	343	355	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					936	U32		10.1038/nature07335	http://dx.doi.org/10.1038/nature07335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923516	Green Accepted			2022-12-28	WOS:000260038300043
J	Takizawa, T; Meaburn, KJ; Misteli, T				Takizawa, Takumi; Meaburn, Karen J.; Misteli, Tom			The meaning of gene positioning	CELL			English	Article							NUCLEAR LAMINA; TRANSCRIPTIONAL REGULATION; DROSOPHILA-MELANOGASTER; CHROMOSOME TERRITORIES; SPATIAL-ORGANIZATION; GENOME FUNCTION; LOCUS; REORGANIZATION; EXPRESSION; LOCALIZATION	There is no doubt that genomes are organized nonrandomly in the nucleus of higher eukaryotes. But what is the functional relevance of this nonrandomness? In this Essay, we explore the biological meaning of spatial gene positioning by examining the functional link between the activity of a gene and its radial position in the nucleus.	[Takizawa, Takumi; Meaburn, Karen J.; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov	Meaburn, Karen/J-2482-2019; Takizawa, Takumi/AAH-4996-2020	Meaburn, Karen/0000-0002-1327-5957; Takizawa, Takumi/0000-0003-2169-0787	Intramural NIH HHS [Z01 BC010309-09] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Brown CR, 2007, CURR OPIN GENET DEV, V17, P100, DOI 10.1016/j.gde.2007.02.005; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Brown JM, 2006, J CELL BIOL, V172, P177, DOI 10.1083/jcb.200507073; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Cremer T, 2006, EUR J HISTOCHEM, V50, P161; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Erwin JA, 2008, CURR OPIN CELL BIOL, V20, P349, DOI 10.1016/j.ceb.2008.04.007; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gilbert DM, 2001, J CELL BIOL, V152, pF11, DOI 10.1083/jcb.152.2.F11; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hewitt SL, 2004, EUR J IMMUNOL, V34, P3604, DOI 10.1002/eji.200425469; HOCHSTRASSER M, 1986, J CELL BIOL, V102, P112, DOI 10.1083/jcb.102.1.112; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kosak ST, 2007, PLOS BIOL, V5, P2602, DOI 10.1371/journal.pbio.0050309; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lawrence JB, 2008, J CELL BIOL, V182, P1035, DOI 10.1083/jcb.200808121; Meaburn KJ, 2008, J CELL BIOL, V180, P39, DOI 10.1083/jcb.200708204; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Misteli T, 2004, CELL, V119, P153, DOI 10.1016/j.cell.2004.09.035; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Murmann AE, 2005, EXP CELL RES, V311, P14, DOI 10.1016/j.yexcr.2005.07.020; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Takizawa T, 2008, GENE DEV, V22, P489, DOI 10.1101/gad.1634608; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107; [No title captured]	38	170	174	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					9	13		10.1016/j.cell.2008.09.026	http://dx.doi.org/10.1016/j.cell.2008.09.026			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854147	Green Accepted, Bronze			2022-12-28	WOS:000259728100001
J	Pflamm-Altenburg, J; Kroupa, P				Pflamm-Altenburg, Jan; Kroupa, Pavel			Clustered star formation as a natural explanation for the H alpha cut-off in disk galaxies	NATURE			English	Article							INITIAL MASS FUNCTION; EXTREME OUTER DISK; SPIRAL GALAXIES; FORMATION RATES; GALACTIC DISKS; FORMATION LAW; GAS; REGIONS; CONTINUUM; DENSITY	The rate of star formation in a galaxy is often determined by the observation of emission in the H alpha line, which is related to the presence of short- lived massive stars. Disk galaxies show a strong cut- off in H alpha radiation at a certain galactocentric distance, which has led to the conclusion that star formation is suppressed in the outer regions of disk galaxies. This is seemingly in contradiction to recent observations(1) in the ultraviolet which imply that disk galaxies have star formation beyond the H alpha cut- off, and that the star-formation-rate surface density is linearly related to the underlying gas surface density, which is a shallower relationship than that derived from H alpha luminosities(2). In a galaxy- wide formulation, the clustered nature of star formation has recently led to the insight that the total galactic H alpha luminosity is nonlinearly related to the galaxy- wide star formation rate(3). Here we show that a local formulation of the concept of clustered star formation naturally leads to a steeper radial decrease in the H alpha surface luminosity than in the star-formation-rate surface density, in quantitative agreement with the observations, and that the observed H alpha cut- off arises naturally.	[Pflamm-Altenburg, Jan; Kroupa, Pavel] Univ Bonn, Argelander Inst Astron, D-53121 Bonn, Germany	University of Bonn	Pflamm-Altenburg, J (corresponding author), Univ Bonn, Argelander Inst Astron, D-53121 Bonn, Germany.	jpflamm@astro.uni-bonn.de	Kroupa, Pavel/H-5190-2012	Kroupa, Pavel/0000-0002-7301-3377				Boissier S, 2007, ASTROPHYS J SUPPL S, V173, P524, DOI 10.1086/516642; COWIE LL, 1981, ASTROPHYS J, V245, P66, DOI 10.1086/158786; Crosthwaite LP, 2007, ASTRON J, V134, P1827, DOI 10.1086/521645; Elmegreen BG, 2006, ASTROPHYS J, V636, P712, DOI 10.1086/498082; Ferguson AMN, 1996, ASTRON J, V111, P2265, DOI 10.1086/117961; Hoversten EA, 2008, ASTROPHYS J, V675, P163, DOI 10.1086/524095; Hunter DA, 2001, ASTROPHYS J, V556, P773, DOI 10.1086/321611; KENNEY JDP, 1989, ASTROPHYS J, V344, P171, DOI 10.1086/167787; Kennicutt RC, 1998, ASTROPHYS J, V498, P541, DOI 10.1086/305588; KENNICUTT RC, 1989, ASTROPHYS J, V344, P685, DOI 10.1086/167834; KENNICUTT RC, 1994, ASTROPHYS J, V435, P22, DOI 10.1086/174790; Kennicutt RC, 2007, ASTROPHYS J, V671, P333, DOI 10.1086/522300; Koppen J, 2007, MON NOT R ASTRON SOC, V375, P673, DOI 10.1111/j.1365-2966.2006.11328.x; Kroupa P, 2001, MON NOT R ASTRON SOC, V322, P231, DOI 10.1046/j.1365-8711.2001.04022.x; Kroupa P, 2002, SCIENCE, V295, P82, DOI 10.1126/science.1067524; Krumholz MR, 2008, NATURE, V451, P1082, DOI 10.1038/nature06620; Lada CJ, 2003, ANNU REV ASTRON ASTR, V41, P57, DOI 10.1146/annurev.astro.41.011802.094844; Lelievre M, 2000, ASTRON J, V120, P1306, DOI 10.1086/301537; Martin CL, 2001, ASTROPHYS J, V555, P301, DOI 10.1086/321452; Pflamm-Altenburg J, 2007, ASTROPHYS J, V671, P1550, DOI 10.1086/523033; Schuster KF, 2007, ASTRON ASTROPHYS, V461, P143, DOI 10.1051/0004-6361:20065579; Thilker DA, 2005, ASTROPHYS J, V619, pL79, DOI 10.1086/425251; TOOMRE A, 1964, ASTROPHYS J, V139, P1217, DOI 10.1086/147861; VANBEVEREN D, 1983, ASTRON ASTROPHYS, V124, P71; Weidner C, 2004, MON NOT R ASTRON SOC, V348, P187, DOI 10.1111/j.1365-2966.2004.07340.x; Weidner C, 2005, ASTROPHYS J, V625, P754, DOI 10.1086/429867; Weidner C, 2004, MON NOT R ASTRON SOC, V350, P1503, DOI 10.1111/j.1365-2966.2004.07758.x; Wong T, 2002, ASTROPHYS J, V569, P157, DOI 10.1086/339287; Zaritsky D, 2007, ASTRON J, V134, P135, DOI 10.1086/518238; Zasov AV, 2006, ASTRON REP+, V50, P874, DOI 10.1134/S1063772906110023	30	65	65	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					641	643		10.1038/nature07266	http://dx.doi.org/10.1038/nature07266			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833274	Green Submitted			2022-12-28	WOS:000259639700041
J	Wolfe, AM; Jorgenson, RA; Robishaw, T; Heiles, C; Prochaska, JX				Wolfe, Arthur M.; Jorgenson, Regina A.; Robishaw, Timothy; Heiles, Carl; Prochaska, Jason X.			An 84-mu G magnetic field in a galaxy at redshift z=0.692	NATURE			English	Article							LY-ALPHA SYSTEMS; ABSORPTION-LINE; STAR-FORMATION; 3C 286; ABSORBERS; ORIGIN	The magnetic field pervading our Galaxy is a crucial constituent of the interstellar medium: it mediates the dynamics of interstellar clouds, the energy density of cosmic rays, and the formation of stars(1). The field associated with ionized interstellar gas has been determined through observations of pulsars in our Galaxy. Radiofrequency measurements of pulse dispersion and the rotation of the plane of linear polarization, that is, Faraday rotation, yield an average value for the magnetic field of B approximate to 3 mu G (ref. 2). The possible detection of Faraday rotation of linearly polarized photons emitted by high-redshift quasars(3) suggests similar magnetic fields are present in foreground galaxies with redshifts z > 1. As Faraday rotation alone, however, determines neither the magnitude nor the redshift of the magnetic field, the strength of galactic magnetic fields at redshifts z. 0 remains uncertain. Here we report a measurement of a magnetic field of B approximate to 84 mu G in a galaxy at z = 0.692, using the same Zeeman- splitting technique that revealed an average value of B = 6 mu G in the neutral interstellar gas of our Galaxy(4). This is unexpected, as the leading theory of magnetic field generation, the mean- field dynamo model, predicts large- scale magnetic fields to be weaker in the past rather than stronger(5).	[Wolfe, Arthur M.; Jorgenson, Regina A.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Wolfe, Arthur M.; Jorgenson, Regina A.] Univ Calif San Diego, Ctr Astrophys & Space Sci, La Jolla, CA 92093 USA; [Robishaw, Timothy; Heiles, Carl] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Prochaska, Jason X.] UCO Lick Observ, San Jose, CA USA; [Prochaska, Jason X.] Univ Calif Santa Cruz, Santa Cruz, CA 95464 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Berkeley; University of California System; University of California Santa Cruz	Wolfe, AM (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	awolfe@ucsd.edu	Jorgenson, Regina/ABC-6248-2020; Robishaw, Timothy/B-2654-2014	Robishaw, Timothy/0000-0002-4217-5138	US National Science Foundation	US National Science Foundation(National Science Foundation (NSF))	We wish to thank F. H. Shu for suggesting the merger model and H.-W. Chen for providing us with her reanalysed images of 3C 286. We also thank F. H. Shu, E. Gawiser and A. Lazarian for comments and the US National Science Foundation for financial support. The GBT is one of the facilities of the National Radio Astronomy Observatory, which is a center of the National Science Foundation operated under cooperative agreement by Associated Observatories, Inc. A.M.W., R.A.J. and J.X.P. are Visiting Astronomers at the W. M. Keck Telescope. The Keck Observatory is a joint facility of the University of California, the California Institute of Technology and the National Aeronautics and Space Administration.	BAYM G, 1981, LECT QUANTUM MECH, pCH1; Beck R, 2005, LECT NOTES PHYS, V664, P41, DOI 10.1007/3540313966_3; Bernet ML, 2008, NATURE, V454, P302, DOI 10.1038/nature07105; Boisse P, 1998, ASTRON ASTROPHYS, V333, P841; BROWN RL, 1973, ASTROPHYS J, V184, pL7, DOI 10.1086/181276; DAVIS MM, 1978, ASTROPHYS J, V219, P1, DOI 10.1086/155748; Han JL, 2006, ASTROPHYS J, V642, P868, DOI 10.1086/501444; Heiles C, 2004, ASTROPHYS J SUPPL S, V151, P271, DOI 10.1086/381753; Heiles C, 2001, PUBL ASTRON SOC PAC, V113, P1243, DOI 10.1086/323291; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Kronberg PP, 2008, ASTROPHYS J, V676, P70, DOI 10.1086/527281; LeBrun V, 1997, ASTRON ASTROPHYS, V321, P733; Lotz JM, 2008, ASTROPHYS J, V672, P177, DOI 10.1086/523659; MCKEE CF, 1977, ASTROPHYS J, V218, P148, DOI 10.1086/155667; Meiring JD, 2006, MON NOT R ASTRON SOC, V370, P43, DOI 10.1111/j.1365-2966.2006.10500.x; Morganti R, 2006, MON NOT R ASTRON SOC, V371, P157, DOI 10.1111/j.1365-2966.2006.10681.x; Morganti R, 2004, NEW ASTRON REV, V48, P1195, DOI 10.1016/j.newar.2004.09.022; PARKER EN, 1970, ASTROPHYS J, V160, P383, DOI 10.1086/150442; Rees MJ, 2006, ASTRON NACHR, V327, P395, DOI 10.1002/asna.200610540; Savage BD, 1996, ANNU REV ASTRON ASTR, V34, P279, DOI 10.1146/annurev.astro.34.1.279; STEIDEL CC, 1994, ASTRON J, V108, P2046, DOI 10.1086/117217; WOLFE AM, 1976, ASTROPHYS J, V208, pL47, DOI 10.1086/182230; Wolfe AM, 2005, ANNU REV ASTRON ASTR, V43, P861, DOI 10.1146/annurev.astro.42.053102.133950; Wolfe AM, 2003, ASTROPHYS J, V593, P215, DOI 10.1086/376520; Wolfe AM, 2006, ASTROPHYS J, V652, P981, DOI 10.1086/507574	25	55	55	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2008	455	7213					638	640		10.1038/nature07264	http://dx.doi.org/10.1038/nature07264			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833273	Green Submitted			2022-12-28	WOS:000259639700040
J	Kaiser, TE; Intine, RV; Dundr, M				Kaiser, Trish E.; Intine, Robert V.; Dundr, Miroslav			De Novo Formation of a Subnuclear Body	SCIENCE			English	Article							CAJAL BODIES; IN-VIVO; SMN; PROTEIN; ORGANIZATION; RNA; EXPRESSION; ORGANELLES; DYNAMICS; GENOME	The mammalian cell nucleus contains structurally stable functional compartments. We show here that one of them, the Cajal body ( CB), can be formed de novo. Immobilization on chromatin of both CB structural components, such as coilin, and functional components of the CB, such as the SMN complex, spliceosomal small nuclear ribonucleoproteins ( RNPs), small nucleolar RNPs, and small Cajal body- specific RNPs, is sufficient for the formation of a morphologically normal and apparently functional CB. Biogenesis of the CB does not follow a hierarchical assembly pathway and exhibits hallmarks of a self- organizing structure.	[Kaiser, Trish E.; Intine, Robert V.; Dundr, Miroslav] Rosalind Franklin Univ Med & Sci, Dept Cell Biol, N Chicago, IL 60064 USA; [Intine, Robert V.] Rosalind Franklin Univ Med & Sci, Dr William M Scholl Coll Podiat Med, N Chicago, IL 60064 USA	Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science	Dundr, M (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Cell Biol, N Chicago, IL 60064 USA.	mirek.dundr@rosalindfranklin.edu			Schweppe Career Development Award (the Schweppe Foundation); Rosalind Franklin University of Medicine and Science	Schweppe Career Development Award (the Schweppe Foundation); Rosalind Franklin University of Medicine and Science	We thank A. Belmont, E. Bertrand, J. Gall, M. Hastings, P. Hemmerich, T. Kiss, I. Lemm, R. Luhrmann, G. Matera, T. Meier, T. Misteli, S. Sharma, E. Soutoglou, C. Verheggen, and P. Young for reagents; S. Shevtsov for technical assistance; and T. Misteli for helpful suggestions and critical reading of the manuscript. This research was supported by Schweppe Career Development Award (the Schweppe Foundation) to M.D. and by startup funds from the Rosalind Franklin University of Medicine and Science to M. D.	Belmont AS, 1999, METHOD CELL BIOL, V58, P203; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Carrero G, 2006, J THEOR BIOL, V239, P298, DOI 10.1016/j.jtbi.2005.07.019; Dundr M, 2004, J CELL BIOL, V164, P831, DOI 10.1083/jcb.200311121; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Isaac C, 1998, J CELL BIOL, V142, P319, DOI 10.1083/jcb.142.2.319; Kumaran RI, 2008, CELL, V132, P929, DOI 10.1016/j.cell.2008.03.004; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Matera AG, 2006, CURR OPIN CELL BIOL, V18, P317, DOI 10.1016/j.ceb.2006.03.005; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Misteli T, 2008, HISTOCHEM CELL BIOL, V129, P5, DOI 10.1007/s00418-007-0355-x; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Morse R, 2007, HUM MOL GENET, V16, P2349, DOI 10.1093/hmg/ddm192; Mouaikel J, 2002, MOL CELL, V9, P891, DOI 10.1016/S1097-2765(02)00484-7; Querido E, 2008, METHOD CELL BIOL, V85, P273; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; Sleeman JE, 2003, J CELL SCI, V116, P2039, DOI 10.1242/jcs.00400; Sleeman JE, 2001, J CELL SCI, V114, P4407; Stanek D, 2008, MOL BIOL CELL, V19, P2534, DOI 10.1091/mbc.E07-12-1259; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083	25	184	184	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1713	1717		10.1126/science.1165216	http://dx.doi.org/10.1126/science.1165216			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	18948503				2022-12-28	WOS:000261608300051
J	Brohawn, SG; Leksa, NC; Spear, ED; Rajashankar, KR; Schwartz, TU				Brohawn, Stephen G.; Leksa, Nina C.; Spear, Eric D.; Rajashankar, Kanagalaghatta R.; Schwartz, Thomas U.			Structural Evidence for Common Ancestry of the Nuclear Pore Complex and Vesicle Coats	SCIENCE			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; CRYOELECTRON TOMOGRAPHY; MOLECULAR ARCHITECTURE; CELL-CYCLE; NUCLEOPORINS; ORGANIZATION; FOLD; EVOLUTION; MEMBRANE; PROTEINS	Nuclear pore complexes ( NPCs) facilitate nucleocytoplasmic transport. These massive assemblies comprise an eightfold symmetric scaffold of architectural proteins and central- channel phenylalanine- glycine- repeat proteins forming the transport barrier. We determined the nucleoporin 85 (Nup85).Seh1 structure, a module in the heptameric Nup84 complex, at 3.5 angstroms resolution. Structural, biochemical, and genetic analyses position the Nup84 complex in two peripheral NPC rings. We establish a conserved tripartite element, the ancestral coatomer element ACE1, that reoccurs in several nucleoporins and vesicle coat proteins, providing structural evidence of coevolution from a common ancestor. We identified interactions that define the organization of the Nup84 complex on the basis of comparison with vesicle coats and confirmed the sites by mutagenesis. We propose that the NPC scaffold, like vesicle coats, is composed of polygons with vertices and edges forming a membrane- proximal lattice that provides docking sites for additional nucleoporins.	[Brohawn, Stephen G.; Leksa, Nina C.; Spear, Eric D.; Schwartz, Thomas U.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Rajashankar, Kanagalaghatta R.] Argonne Natl Lab, NE Collaborat Access Team, Argonne, IL 60439 USA	Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Argonne National Laboratory	Schwartz, TU (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tus@mit.edu	Schwartz, Thomas/K-9029-2017; Schwartz, Thomas/ABA-1770-2021	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512; Brohawn, Stephen/0000-0001-6768-3406	NIH [GM77537]; Pew Scholar Award; Koch Fellowship Award; Vertex Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077537, P50GM068762] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar Award; Koch Fellowship Award; Vertex Scholarship(Vertex Pharmaceuticals); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank staff at beamlines 24-ID-C/-E at Argonne National Laboratory and X6A at National Synchrotron Light Source for excellent assistance with data collection, R. Sauer and T. Baker for critically reading the manuscript, G. Wink for contributions, members of the Schwartz laboratory for discussions, and the Biophysical Instrumentation Facility for the Study of Complex Macromolecular Systems (NSF-0070319 and NIH GM68762) for providing instrumentation. Supported by NIH grant GM77537 ( T. U. S.), a Pew Scholar Award ( T. U. S.), a Koch Fellowship Award ( S. G. B.), and a Vertex Scholarship ( S. G. B.). Coordinates and structure factors of the Nup85.Seh1 crystal structure have been deposited in the Protein Data Bank ( PDB) with accession code 3EWE.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Berke IC, 2004, J CELL BIOL, V167, P591, DOI 10.1083/jcb.200408109; Boehmer T, 2008, MOL CELL, V30, P721, DOI 10.1016/j.molcel.2008.04.022; Chaudhuri I, 2008, PROTEINS, V71, P795, DOI 10.1002/prot.21764; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Drummond SP, 2006, CAN J PHYSIOL PHARM, V84, P423, DOI 10.1139/Y05-148; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Hinshaw JE, 2003, J STRUCT BIOL, V141, P259, DOI 10.1016/S1047-8477(02)00626-3; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; Jeudy S, 2007, J BIOL CHEM, V282, P34904, DOI 10.1074/jbc.M705479200; Lusk CP, 2002, J CELL BIOL, V159, P267, DOI 10.1083/jcb.200203079; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Marelli M, 1998, J CELL BIOL, V143, P1813, DOI 10.1083/jcb.143.7.1813; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Schrader N, 2008, MOL CELL, V29, P46, DOI 10.1016/j.molcel.2007.10.022; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Zabel U, 1996, J CELL BIOL, V133, P1141, DOI 10.1083/jcb.133.6.1141	38	154	158	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2008	322	5906					1369	1373		10.1126/science.1165886	http://dx.doi.org/10.1126/science.1165886			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	18974315	Green Accepted			2022-12-28	WOS:000261170600036
J	Belch, J; MacCuish, A; Campbell, I; Cobbe, S; Taylor, R; Prescott, R; Lee, R; Bancroft, J; MacEwan, S; Shepherd, J; Macfarlane, P; Morris, A; Jung, R; Kelly, C; Connacher, A; Peden, N; Jamieson, A; Matthews, D; Leese, G; McKnight, J; O'Brien, I; Semple, C; Petrie, J; Gordon, D; Pringle, S; MacWalter, R				Belch, Jill; MacCuish, Angus; Campbell, Iain; Cobbe, Stuart; Taylor, Roy; Prescott, Robin; Lee, Robert; Bancroft, Jean; MacEwan, Shirley; Shepherd, James; Macfarlane, Peter; Morris, Andrew; Jung, Roland; Kelly, Christopher; Connacher, Alan; Peden, Norman; Jamieson, Andrew; Matthews, David; Leese, Graeme; McKnight, John; O'Brien, Iain; Semple, Colin; Petrie, John; Gordon, Derek; Pringle, Stuart; MacWalter, Ron		Prevent Progression Arterial Dis &; Diabet Registry Grp; Royal Coll Phys Edinburgh	The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR EVENTS; SECONDARY PREVENTION; METAANALYSIS; RISK; ASSOCIATION; SAFETY	Objective To determine whether aspirin and antioxidant therapy, combined or alone, are more effective than placebo in reducing the development of cardiovascular events in patients with diabetes mellitus and asymptomatic peripheral arterial disease. Design Multicentre, randomised, double blind, 2 x 2 factorial, placebo controlled trial. Setting 16 hospital centres in Scotland, supported by 188 primary care groups. Participants 1276 adults aged 40 or more with type 1 or type 2 diabetes and an ankle brachial pressure index of 0.99 or less but no symptomatic cardiovascular disease. Interventions Daily, 100 mg aspirin tablet plus antioxidant capsule ( n= 320), aspirin tablet plus placebo capsule ( n= 318), placebo tablet plus antioxidant capsule ( n= 320), or placebo tablet plus placebo capsule ( n= 318). Main outcome measures Two hierarchical composite primary end points of death from coronary heart disease or stroke, non- fatal myocardial infarction or stroke, or amputation above the ankle for critical limb ischaemia; and death from coronary heart disease or stroke. Results Noevidence was found of any interaction between aspirin and antioxidant. Overall, 116 of 638 primary events occurred in the aspirin groups compared with 117 of 638 in the no aspirin groups ( 18.2% v 18.3%): hazard ratio 0.98 ( 95% confidence interval 0.76 to 1.26). Forty three deaths from coronary heart disease or stroke occurred in the aspirin groups compared with 35 in the no aspirin groups ( 6.7% v 5.5%): 1.23 ( 0.79 to 1.93). Among the antioxidant groups 117 of 640 ( 18.3%) primary events occurred compared with 116 of 636 ( 18.2%) in the no antioxidant groups ( 1.03, 0.79 to 1.33). Forty two ( 6.6%) deaths from coronary heart disease or stroke occurred in the antioxidant groups compared with 36 ( 5.7%) in the no antioxidant groups ( 1.21, 0.78 to 1.89). Conclusion This trial does not provide evidence to support the use of aspirin or antioxidants in primary prevention of cardiovascular events and mortality in the population with diabetes studied. Trial registration Current Controlled Trials ISRCTN53295293.	[Belch, Jill; Bancroft, Jean; MacEwan, Shirley; MacWalter, Ron] Univ Dundee, Ninewells Hosp & Med Sch, Cardiovasc Res Inst, Dundee DD1 9SY, Scotland; [MacCuish, Angus] Glasgow Royal Infirm, Ctr Diabet, Glasgow G4 0SF, Lanark, Scotland; [Campbell, Iain] Royal Victoria Hosp, Dept Med, Kirkcaldy, Scotland; [Cobbe, Stuart] Univ Glasgow, Cardiovasc Res Ctr, British Heart Fdn Glasgow, Glasgow, Lanark, Scotland; [Taylor, Roy] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Shepherd, James] Glasgow Royal Infirm, Dept Biochem, Glasgow G4 0SF, Lanark, Scotland; [Macfarlane, Peter] Glasgow Royal Infirm, Dept Med Cardiol, Glasgow G4 0SF, Lanark, Scotland; [Prescott, Robin; Lee, Robert] Univ Edinburgh, Med Stat Unit, Edinburgh, Midlothian, Scotland; [Morris, Andrew; Jung, Roland; Petrie, John] Univ Dundee, Ninewells Hosp & Med Sch, Diabet Res Ctr, Dundee DD1 9SY, Scotland; [Kelly, Christopher] Stirling Royal Infirm, Ctr Diabet, Stirling, Scotland; [Peden, Norman] Falkirk & Dist Royal Infirm, Ctr Diabet, Falkirk, Scotland; [Jamieson, Andrew] Queen Margaret Hosp, Ctr Diabet, Dunfermline, Fife, Scotland; [Matthews, David] Monklands Hosp, Ctr Diabet, Airdrie, Scotland; [Leese, Graeme; McKnight, John] Western Gen Hosp, Metab Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [O'Brien, Iain] Wishaw Gen Hosp, Wishaw, Scotland; [Semple, Colin] So Gen Hosp NHS Trust, Glasgow, Lanark, Scotland; [Gordon, Derek] Stobhill NHS Trust, Med Unit B, Glasgow, Lanark, Scotland; [Pringle, Stuart] Univ Dundee, Ninewells Hosp & Med Sch, Dept Cardiol, Dundee DD1 9SY, Scotland	University of Dundee; University of Glasgow; University of Glasgow; Newcastle University - UK; University of Glasgow; University of Glasgow; University of Edinburgh; University of Dundee; Monklands Hospital; University of Edinburgh; University of Dundee	Belch, J (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Cardiovasc Res Inst, Dundee DD1 9SY, Scotland.	J.J.F.Belch@dundee.ac.uk	Belch, Jill/AAE-9189-2019; Gray, Stuart/L-2489-2017	Belch, Jill/0000-0001-8280-6689; Gray, Stuart/0000-0001-8969-9636; Murray, Gordon/0000-0001-9866-4734; Fox, Keith/0000-0002-0140-2752	Medical Research Council [G9534799]; MRC [G9534799] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council grant number G9534799. All researchers were independent of the funder.	Abraira C, 1997, ARCH INTERN MED, V157, P181, DOI 10.1001/archinte.157.2.181; *ACC AHA, 2006, GUID MAN PAT PER ART; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; BELCH JJF, 1989, FREE RADICAL BIO MED, V6, P375, DOI 10.1016/0891-5849(89)90082-8; Belch JJF, 2003, ARCH INTERN MED, V163, P884, DOI 10.1001/archinte.163.8.884; Buse JB, 2007, DIABETES CARE, V30, P162, DOI 10.2337/dc07-9917; Cochrane W.G., 1957, EXPT DESIGNS; Colwell John A, 2003, Diabetes Care, V26 Suppl 1, pS87; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Cull CA, 2004, DIABETIC MED, V21, P1368, DOI 10.1111/j.1464-5491.2004.01328.x; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Diabet Control Complications Trial DCCT Res Grp, 1995, AM J CARDIOL, V75, P894; Elhadd TA, 1999, PRACT DIABETES INT, V16, P163, DOI DOI 10.1002/PDI.1960160605; FAULKNER G, 1988, BRIT MED J, V297, P1311, DOI 10.1136/bmj.297.6659.1311; FOWKES FGR, 1991, INT J EPIDEMIOL, V20, P384, DOI 10.1093/ije/20.2.384; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Howard BV, 2006, DIABETES CARE, V29, P391, DOI 10.2337/diacare.29.02.06.dc05-1299; JENNINGS PE, 1992, METABOLISM, V41, P36, DOI 10.1016/0026-0495(92)90093-P; LAGARDE M, 1980, THROMB RES, V19, P823, DOI 10.1016/0049-3848(80)90010-9; LANAS A, 1992, GASTROENTEROLOGY, V103, P862, DOI 10.1016/0016-5085(92)90018-T; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; Lowe GDO, 2001, HEART, V85, P245, DOI 10.1136/heart.85.3.245; MacDonald TM, 1997, BMJ-BRIT MED J, V315, P1333, DOI 10.1136/bmj.315.7119.1333; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Piechowski-Jozwiak Bartlomiej, 2005, Cerebrovasc Dis, V20 Suppl 1, P15, DOI 10.1159/000088233; Sacco M, 2003, DIABETES CARE, V26, P3264, DOI 10.2337/diacare.26.12.3264; SALONEN JT, 1989, ANN MED, V21, P59, DOI 10.3109/07853898909149183; Sanmuganathan PS, 2001, HEART, V85, P265, DOI 10.1136/heart.85.3.265; Scottish Intercollegiate Guidelines Network, 2006, DIAGN MAN PER ART DI; Scottish Intercollegiate Guidelines Network, 2007, RISK EST PREV CARD D; SIVENIUS J, 1992, STROKE, V23, P851, DOI 10.1161/01.STR.23.6.851; TASC Working Group, 2000, EUR J VASC ENDOVASC, V19, pS1; Tierney S, 2000, BRIT MED J, V320, P1262, DOI 10.1136/bmj.320.7244.1262; *US FDA, 2007, GOOD CLIN PRACT REG; Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988	37	520	552	1	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2008	337								a1840	10.1136/bmj.a1840	http://dx.doi.org/10.1136/bmj.a1840			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368AM	18927173	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000260593700027
J	Reynolds-Wooding, A				Reynolds-Wooding, Abigail			A patient's journey - Common variable immunodeficiency	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Stanley.notoes@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2008	337	7676							a1855	10.1136/bmj.a1855	http://dx.doi.org/10.1136/bmj.a1855			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18930972				2022-12-28	WOS:000260298800040
J	De Smet, I; Vassileva, V; De Rybel, B; Levesque, MP; Grunewald, W; Van Damme, D; Van Noorden, G; Naudts, M; Van Isterdael, G; De Clercq, R; Wang, JY; Meuli, N; Vanneste, S; Friml, J; Hilson, P; Jurgens, G; Ingram, GC; Inze, D; Benfey, PN; Beeckman, T				De Smet, Ive; Vassileva, Valya; De Rybel, Bert; Levesque, Mitchell P.; Grunewald, Wim; Van Damme, Daniel; Van Noorden, Giel; Naudts, Mirande; Van Isterdael, Gert; De Clercq, Rebecca; Wang, Jean Y.; Meuli, Nicholas; Vanneste, Steffen; Friml, Jiri; Hilson, Pierre; Juergens, Gerd; Ingram, Gwyneth C.; Inze, Dirk; Benfey, Philip N.; Beeckman, Tom			Receptor-like kinase ACR4 restricts formative cell divisions in the Arabidopsis root	SCIENCE			English	Article							GENE; DIFFERENTIATION; INITIATION; EPIDERMIS; THALIANA; MERISTEM	During the development of multicellular organisms, organogenesis and pattern formation depend on formative divisions to specify and maintain pools of stem cells. In higher plants, these activities are essential to shape the final root architecture because the functioning of root apical meristems and the de novo formation of lateral roots entirely rely on it. We used transcript profiling on sorted pericycle cells undergoing lateral root initiation to identify the receptor-like kinase ACR4 of Arabidopsis as a key factor both in promoting formative cell divisions in the pericycle and in constraining the number of these divisions once organogenesis has been started. In the root tip meristem, ACR4 shows a similar action by controlling cell proliferation activity in the columella cell lineage. Thus, ACR4 function reveals a common mechanism of formative cell division control in the main root tip meristem and during lateral root initiation.	[De Smet, Ive; Vassileva, Valya; De Rybel, Bert; Grunewald, Wim; Van Damme, Daniel; Van Noorden, Giel; Naudts, Mirande; Van Isterdael, Gert; De Clercq, Rebecca; Vanneste, Steffen; Friml, Jiri; Hilson, Pierre; Inze, Dirk; Beeckman, Tom] Univ Ghent VIB, Flanders Inst Biotechnol, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [De Smet, Ive; Vassileva, Valya; De Rybel, Bert; Grunewald, Wim; Van Damme, Daniel; Van Noorden, Giel; Naudts, Mirande; Van Isterdael, Gert; De Clercq, Rebecca; Vanneste, Steffen; Friml, Jiri; Hilson, Pierre; Inze, Dirk; Beeckman, Tom] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Levesque, Mitchell P.; Wang, Jean Y.; Benfey, Philip N.] Duke Univ, Dept Biol, Ctr Syst Biol, Durham, NC 27708 USA; [Levesque, Mitchell P.; Wang, Jean Y.; Benfey, Philip N.] Duke Univ, Inst Genome Sci & Policy, Ctr Syst Biol, Durham, NC 27708 USA; [De Smet, Ive; Juergens, Gerd] Univ Tubingen, Ctr Plant Mol Biol ZMBP, D-72076 Tubingen, Germany; [Meuli, Nicholas; Ingram, Gwyneth C.] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh EH9 3JR, Midlothian, Scotland	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Duke University; Duke University; Eberhard Karls University of Tubingen; University of Edinburgh	Beeckman, T (corresponding author), Univ Ghent VIB, Flanders Inst Biotechnol, Dept Plant Syst Biol, B-9052 Ghent, Belgium.	tom.beeckman@psb.ugent.be	De Smet, Ive/E-6086-2011; van damme, daniel/ABA-1397-2020; Friml, Jiri/D-9511-2012; Beeckman, Tom/ABI-1703-2020; Inzé, Dirk/AAW-6381-2021; Grunewald, Wim/C-6521-2008; Vanneste, Steffen/K-8353-2013; van damme, daniel/F-6139-2014; De Smet, Ive/A-6583-2011; Beeckman, Tom/ABA-1164-2020	De Smet, Ive/0000-0003-4607-8893; van damme, daniel/0000-0002-9385-4851; Friml, Jiri/0000-0002-8302-7596; Beeckman, Tom/0000-0001-8656-2060; Inzé, Dirk/0000-0002-3217-8407; Vanneste, Steffen/0000-0002-9948-9672; van damme, daniel/0000-0002-9385-4851; De Smet, Ive/0000-0003-4607-8893; De Rybel, Bert/0000-0002-9551-042X; Van Isterdael, Gert/0000-0001-6626-1316; Vassileva, Valya/0000-0002-9055-8002; Ingram, Gwyneth/0000-0002-1425-9545	Interuniversity Poles of Attraction Prograin-Belgian Science Policy [P5/13]; U.S. National Science Foundation Arabidopsis 2010 program; non-European Union researchers from the Belgian Science Policy; European Molecular Biology Organization [ALTF 108-2006, ALTF 142-2007]; Institute for the Promotion of innovation by Science and Technology in Flanders; Bijzonder Onderzoeksfonds van de Universitert Gent; Gatsby Charitable Foundation; Research Foundation of Flanders	Interuniversity Poles of Attraction Prograin-Belgian Science Policy; U.S. National Science Foundation Arabidopsis 2010 program(National Science Foundation (NSF)); non-European Union researchers from the Belgian Science Policy; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Institute for the Promotion of innovation by Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Bijzonder Onderzoeksfonds van de Universitert Gent; Gatsby Charitable Foundation; Research Foundation of Flanders(FWO)	We thank B. Scheres, K. Theres, P. Springer, H. Fukaki, and Nottingharn Arabidopsis Stock Centre for providing seeds. This work was funded by grants from the Interuniversity Poles of Attraction Prograin-Belgian Science Policy (P5/13); grants from the U.S. National Science Foundation Arabidopsis 2010 program to P.N.B.; a fellowship for non-European Union researchers from the Belgian Science Policy (BELSPO) to V.V.; long-term fellowships from the European Molecular Biology Organization ALTF 108-2006 to I.D.S. and ALTF 142-2007 to S.V.; predoctoral fellowships from the Institute for the Promotion of innovation by Science and Technology in Flanders to I.D.S. and S.V., from the Bijzonder Onderzoeksfonds van de Universitert Gent to B.D.R., and from the Gatsby Charitable Foundation to N.M.; a travel grant of the Research Foundation of Flanders to I.D.S.; and a postdoctoral fellowship of the Research Foundation of Flanders to D.V.D. We are. grateful to R. Gross-Hardt, U. Voss, S. Lau, and two anonymous referees for critical comments and suggestions on the manuscript.	Becraft PW, 2001, PLANT PHYSIOL, V127, P486, DOI 10.1104/pp.010299; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Cao XY, 2005, PLANTA, V220, P645, DOI 10.1007/s00425-004-1378-3; Caussinus Emmanuel, 2007, Prog Mol Subcell Biol, V45, P205; Clevers H, 2005, NAT GENET, V37, P1027, DOI 10.1038/ng1005-1027; De Smet I, 2007, DEVELOPMENT, V134, P681, DOI 10.1242/dev.02753; Dinneny JR, 2008, CELL, V132, P553, DOI 10.1016/j.cell.2008.02.001; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Fukaki H, 2007, INT REV CYTOL, V256, P111, DOI 10.1016/S0074-7696(07)56004-3; Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926; Gifford ML, 2003, DEVELOPMENT, V130, P4249, DOI 10.1242/dev.00634; Heidstra Renze, 2007, V45, P1; Himanen K, 2002, PLANT CELL, V14, P2339, DOI 10.1105/tpc.004960; Kwak SH, 2005, SCIENCE, V307, P1111, DOI 10.1126/science.1105373; Kwak SH, 2007, DEV BIOL, V302, P118, DOI 10.1016/j.ydbio.2006.09.009; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Tanaka H, 2007, DEVELOPMENT, V134, P1643, DOI 10.1242/dev.003533; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Vanneste S, 2005, PLANT CELL, V17, P3035, DOI 10.1105/tpc.105.035493; WOLPERT L, 1988, J CELL SCI, P1	21	267	272	6	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					594	597		10.1126/science.1160158	http://dx.doi.org/10.1126/science.1160158			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948541				2022-12-28	WOS:000260299100045
J	Mercer, SW; Lean, MEJ				Mercer, S. W.; Lean, M. E. J.			Request for slimming tablets	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mercer, S. W.] Univ Glasgow, Fac Med, Div Community Based Sci, Glasgow G12 9LX, Lanark, Scotland; [Lean, M. E. J.] Univ Glasgow, Fac Med, Div Dev Med, Glasgow G12 9LX, Lanark, Scotland	University of Glasgow; University of Glasgow	Mercer, SW (corresponding author), Univ Glasgow, Fac Med, Div Community Based Sci, Glasgow G12 9LX, Lanark, Scotland.	s.mercer@clinmed.gla.ac.uk		Mercer, Stewart William/0000-0002-1703-3664					0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 24	2008	337								a1287	10.1136/bmj.a1287	http://dx.doi.org/10.1136/bmj.a1287			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374FQ	18952680				2022-12-28	WOS:000261029000004
J	Sessions, SY; Lee, PR				Sessions, Samuel Y.; Lee, Philip R.			Using tax reform to drive health care reform - Putting the horse before the cart	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNIVERSAL COVERAGE		[Sessions, Samuel Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Lee, Philip R.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco	Sessions, SY (corresponding author), Harbor UCLA Med Ctr, Dept Psychiat & Biobehav Sci, Box 497,1000 W Carson St, Torrance, CA 90509 USA.	ssessions@mednet.ucla.edu						Aaron HJ, 2003, NEW ENGL J MED, V349, P801, DOI 10.1056/NEJMe030091; BARR DA, 2007, INTRO US HLTH POLICY; BIMBAUM JH, 1987, SHOWDOWN GUCCI GULCH; Cebul Randall D., 2008, 14212 NAT BUR EC RES; Emanuel EJ, 2005, NEW ENGL J MED, V352, P1255, DOI 10.1056/NEJMsb041704; Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P1057, DOI 10.1001/jama.299.9.1057; GRAETZ MJ, 2008, 100 MILLION UNNECESS, P96; GROSS D, 2006, NY TIMES        1203; *JOINT COMM TAX, 2008, TAX EXP HLTH CAR; Oberlander J, 2008, NEW ENGL J MED, V359, P781, DOI 10.1056/NEJMp0804659; RELMAN AS, 2007, 2 OPINION RESCUING A; Sessions SY, 2008, J HEALTH POLIT POLIC, V33, P155, DOI 10.1215/03616878-2007-052; Skocpol T., 1997, BOOMERANG HLTH CARE; SLEMROD J, 2004, TAXING OURSELVES CIT	14	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2008	300	16					1929	1931		10.1001/jama.2008.512	http://dx.doi.org/10.1001/jama.2008.512			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362UR	18940981				2022-12-28	WOS:000260223100024
J	Simonneau, G; Rubin, LJ; Galie, N; Barst, RJ; Fleming, TR; Frost, AE; Engel, PJ; Kramer, MR; Burgess, G; Collings, L; Cossons, N; Sitbon, O; Badesch, DB				Simonneau, Gerald; Rubin, Lewis J.; Galie, Nazzareno; Barst, Robyn J.; Fleming, Thomas R.; Frost, Adaani E.; Engel, Peter J.; Kramer, Mordechai R.; Burgess, Gary; Collings, Lorraine; Cossons, Nandini; Sitbon, Olivier; Badesch, David B.		PACES Study Grp	Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							COMBINATION THERAPY; INHALED ILOPROST; ORAL SILDENAFIL; BOSENTAN; TREPROSTINIL; PROSTACYCLIN; SURVIVAL; EFFICACY; SAFETY	Background: Oral sildenafil and intravenous epoprostenol have independently been shown to be effective in patients with pulmonary arterial hypertension. Objective: To investigate the effect of adding oral sildenafil to long-term intravenous epoprostenol in patients with pulmonary arterial hypertension. Design: A 16-week, double-blind, placebo-controlled, parallel-group study. Setting: Multinational study at 41 centers in 11 countries from 3 July 2003 to 27 January 2006. Patients: 267 patients with pulmonary arterial hypertension ( idiopathic, associated anorexigen use or connective tissue disease, or corrected congenital heart disease) who were receiving long-term intravenous epoprostenol therapy. Intervention: Patients were randomly assigned to receive placebo or sildenafil, 20 mg three times daily, titrated to 40 mg and 80 mg three times daily, as tolerated, at 4-week intervals. Of 265 patients who received treatment, 256 ( 97%) patients ( 123 in the placebo group and 133 in the sildenafil group) completed the study. Measurements: Change from baseline in exercise capacity measured by 6-minute walk distance ( primary end point) and hemodynamic measurements, time to clinical worsening, and Borg dyspnea score ( secondary end points). Results: A placebo-adjusted increase of 28.8 meters ( 95% CI, 13.9 to 43.8 meters) in the 6-minute walk distance occurred in patients in the sildenafil group; these improvements were most prominent among patients with baseline distances of 325 meters or more. Relative to epoprostenol monotherapy, addition of sildenafil resulted in a greater change in mean pulmonary arterial pressure by -3.8 mm Hg ( CI, -5.6 to -2.1 mm Hg); cardiac output by 0.9 L/min (CI, 0.5 to 1.2 L/min); and longer time to clinical worsening, with a smaller proportion of patients experiencing a worsening event in the sildenafil group (0.062) than in the placebo group (0.195) by week 16 (P = 0.002). Health-related quality of life also improved in patients who received combined therapy compared with those who received epoprostenol monotherapy. There was no effect on the Borg dyspnea score. Of the side effects generally associated with sildenafil treatment, the most commonly reported in the placebo and sildenafil groups, respectively, were headache (34% and 57%; difference, 23 percentage points [CI, 12 to 35 percentage points]), dyspepsia (2% and 16%; difference, 13 percentage points [CI, 7 to 20 percentage points]), pain in extremity (18% and 25%; difference, 8 percentage points [CI, -2 to 18 percentage points]), and nausea (18% and 25%; difference, 8 percentage points [CI, -2 to 18 percentage points]). Limitations: The study excluded patients with pulmonary arterial hypertension associated with other causes. There was an imbalance in missing data between groups, with 8 placebo recipients having no postbaseline walk assessment compared with 1 sildenafil recipient. These patients were excluded from the analysis. Conclusion: In some patients with pulmonary arterial hypertension, the addition of sildenafil to long-term intravenous epoprostenol therapy improves exercise capacity, hemodynamic measurements, time to clinical worsening, and quality of life, but not Borg dyspnea score. Increased rates of headache and dyspepsia occurred with the addition of sildenafil.	[Simonneau, Gerald] Univ Paris Sud, Hop Antoine Beclere, Serv Pneumol, F-92140 Clamart, France; Univ Calif San Diego, La Jolla, CA 92093 USA; Univ Bologna, Inst Cardiol, Bologna, Italy; Columbia Univ, New York, NY USA; Univ Washington, Seattle, WA 98195 USA; Baylor Coll Med, Houston, TX 77030 USA; Lindner Clin Trial Ctr, Ohio Heart & Vasc Center, Cincinnati, OH USA; Rabin Med Ctr, Petah Tiqwa, Israel; Pfizer Ltd, Pfizer Global Res & Dev, Sandwich CT13 9NJ, Kent, England; Univ Colorado, Hlth Sci Ctr, Denver, CO USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California San Diego; University of Bologna; Columbia University; University of Washington; University of Washington Seattle; Baylor College of Medicine; Rabin Medical Center; Pfizer; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Simonneau, G (corresponding author), Univ Paris Sud, Hop Antoine Beclere, Serv Pneumol, 157 Rue Porte de Trivaux, F-92140 Clamart, France.	gerald.simonneau@abc.ap-hop-paris.fr	Sitbon, Olivier/I-3623-2019; Simonneau, Gerald/ABE-6614-2020; Galie, Nazzareno/F-7004-2014	Sitbon, Olivier/0000-0002-1942-1951; Galie, Nazzareno/0000-0003-4271-8670	Pfizer, Sandwich, United Kingdom	Pfizer, Sandwich, United Kingdom(Pfizer)	Grant Support: By Pfizer, Sandwich, United Kingdom.	Archer SL, 2006, CURR OPIN CARDIOL, V21, P385; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; Channick RN, 2006, J AM COLL CARDIOL, V48, P1433, DOI 10.1016/j.jacc.2006.05.070; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488; Galie N, 2004, J AM COLL CARDIOL, V43, p81S, DOI 10.1016/j.jacc.2004.02.038; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Ghofrani HA, 2002, ANN INTERN MED, V136, P515, DOI 10.7326/0003-4819-136-7-200204020-00008; Ghofrani HA, 2003, J AM COLL CARDIOL, V42, P158, DOI 10.1016/S0735-1097(03)00555-2; Gomberg-Maitland M, 2005, AM J CARDIOL, V96, P1334, DOI 10.1016/j.amjcard.2005.06.083; Halank M, 2006, WIEN KLIN WOCHENSCHR, V118, P54, DOI 10.1007/s00508-005-0507-8; Hoeper MM, 2004, EUR RESPIR J, V24, P1007, DOI 10.1183/09031936.04.00051104; Hoeper MM, 2005, EUR RESPIR J, V26, P858, DOI 10.1183/09031936.05.00075305; Humbert M, 2004, EUR RESPIR J, V24, P353, DOI 10.1183/09031936.04.00028404; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Ikeda D, 2005, J CARDIOVASC PHARM, V45, P286, DOI 10.1097/01.fjc.0000155386.49103.ce; Kawut SM, 2005, AM J CARDIOL, V95, P199, DOI 10.1016/j.amjcard.2004.09.006; Klepetko W, 2004, J AM COLL CARDIOL, V43, p73S, DOI 10.1016/j.jacc.2004.02.039; Lee SH, 2005, J INTERN MED, V258, P199, DOI 10.1111/j.1365-2796.2005.01542.x; Liu C, 2006, RESP MED, V100, P765, DOI 10.1016/j.rmed.2006.01.021; McLaughlin VV, 2006, AM J RESP CRIT CARE, V174, P1257, DOI 10.1164/rccm.200603-358OC; McLaughlin VV, 2006, CIRCULATION, V114, P1417, DOI 10.1161/CIRCULATIONAHA.104.503540; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; Nagaya Noritoshi, 2004, Am J Cardiovasc Drugs, V4, P75, DOI 10.2165/00129784-200404020-00002; O'Callaghan D, 2007, CLIN CHEST MED, V28, P169, DOI 10.1016/j.ccm.2006.11.011; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Stiebellehner L, 2003, CHEST, V123, P1293, DOI 10.1378/chest.123.4.1293; VANE JR, 1995, AM J CARDIOL, V75, pA3, DOI 10.1016/S0002-9149(99)80377-4; Verbeke G, 2000, LINEAR MIXED MODELS; Ware J.E., 2000, SF 36 HLTH SURVEY MA; Wharton J, 2005, AM J RESP CRIT CARE, V172, P105, DOI 10.1164/rccm.200411-1587OC; Wilkens H, 2001, CIRCULATION, V104, P1218, DOI 10.1161/hc3601.096826	34	480	504	1	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2008	149	8					521	W102		10.7326/0003-4819-149-8-200810210-00004	http://dx.doi.org/10.7326/0003-4819-149-8-200810210-00004			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367XJ	18936500				2022-12-28	WOS:000260585600001
J	Li, F; Huarte, M; Zaratiegui, M; Vaughn, MW; Shi, Y; Martienssen, R; Cande, WZ				Li, Fei; Huarte, Maite; Zaratiegui, Mikel; Vaughn, Matthew W.; Shi, Yang; Martienssen, Rob; Cande, W. Zacheus			Lid2 Is Required for Coordinating H3K4 and H3K9 Methylation of Heterochromatin and Euchromatin	CELL			English	Article							HISTONE LYSINE METHYLATION; CHROMATIN-BINDING; RNA INTERFERENCE; FISSION; GENE; INTERACT; PROTEINS; RITS	In most eukaryotes, histone methylation patterns regulate chromatin architecture and function: methylation of histone H3 lysine-9 (H3K9) demarcates heterochromatin, whereas H3K4 methylation demarcates euchromatin. We show here that the S. pombe JmjC-domain protein Lid2 is a trimethyl H3K4 demethylase responsible for H3K4 hypomethylation in heterochromatin. Lid2 interacts with the histone lysine-9 methyltransferase, Clr4, through the Dos1/Clr8-Rik1 complex, which also functions in the RNA interference pathway. Disruption of the JmjC domain alone results in severe heterochromatin defects and depletion of siRNA, whereas overexpressing Lid2 enhances heterochromatin silencing. The physical and functional link between H3K4 demethylation and H3K9 methylation suggests that the two reactions act in a coordinated manner. Surprisingly, crossregulation of H3K4 and H3K9 methylation in euchromatin also requires Lid2. We suggest that Lid2 enzymatic activity in euchromatin is regulated through a dynamic interplay with other histone-modification enzymes. Our findings provide mechanistic insight into the coordination of H3K4 and H3K9 methylation.	[Li, Fei; Cande, W. Zacheus] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Huarte, Maite; Shi, Yang] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Zaratiegui, Mikel; Vaughn, Matthew W.; Martienssen, Rob] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of California System; University of California Berkeley; Harvard University; Harvard Medical School; Cold Spring Harbor Laboratory	Li, F (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	feili@nature.berkeley.edu; zcande@berkeley.edu	Hu, Ruogu/B-2203-2008; Huarte, Maite/J-6903-2014	Huarte, Maite/0000-0003-3753-6493; Li, Fei/0000-0002-1206-9684; Vaughn, Matthew/0000-0002-1384-4283; Zaratiegui, Mikel/0000-0002-0342-0268	National Institutes of Health [RO1GM076396, NCI118487]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067992, R01GM076396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Zac Cande laboratory, especially Xie Tang, for kind help and valuable discussions; Michael Myers and the Cold Spring Harbor Laboratory mass spectrometry facility for the mass spectrometry analysis; Erin Osborne for critical reading of the manuscript; and Amikam Cohen, Stephen Kearsey, Jun-ichi Nakayama, and Mitsuhiro Yanagida for kindly providing strains. This work was supported by grants from the National Institutes of Health (RO1GM076396 to W. Z. C. and R. M., and NCI118487 to Y. S.).	Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Eissenberg JC, 2007, NAT STRUCT MOL BIOL, V14, P344, DOI 10.1038/nsmb1217; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Huarte M, 2007, J BIOL CHEM, V282, P21662, DOI 10.1074/jbc.M703897200; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Lachner M, 2004, COLD SPRING HARB SYM, V69, P209, DOI 10.1101/sqb.2004.69.209; Lan F, 2007, MOL CELL, V26, P89, DOI 10.1016/j.molcel.2007.02.023; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lee N, 2007, NAT STRUCT MOL BIOL, V14, P341, DOI 10.1038/nsmb1216; Li F, 2005, CURR BIOL, V15, P1448, DOI 10.1016/j.cub.2005.07.021; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2002, P NATL ACAD SCI USA, V99, P16438, DOI 10.1073/pnas.182436399; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Roesch A, 2005, MODERN PATHOL, V18, P1249, DOI 10.1038/modpathol.3800413; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Singh G, 2008, YEAST, V25, P117, DOI 10.1002/yea.1569; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thon G, 2005, GENETICS, V171, P1583, DOI 10.1534/genetics.105.048298; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016	34	108	109	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					272	283		10.1016/j.cell.2008.08.036	http://dx.doi.org/10.1016/j.cell.2008.08.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957202	Green Accepted, Bronze			2022-12-28	WOS:000260130400017
J	Saifee, NH; Zheng, N				Saifee, Nabiha Huq; Zheng, Ning			A Ubiquitin-like Protein Unleashes Ubiquitin Ligases	CELL			English	Editorial Material							COMPLEX		[Saifee, Nabiha Huq; Zheng, Ning] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Zheng, Ning] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Zheng, N (corresponding author), Univ Washington, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	nzheng@u.washington.edu		Zheng, Ning/0000-0002-1039-1581; Huq Saifee, Nabiha/0000-0003-1646-9201				Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	10	6	7	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 17	2008	135	2					209	211		10.1016/j.cell.2008.09.049	http://dx.doi.org/10.1016/j.cell.2008.09.049			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957195	Bronze			2022-12-28	WOS:000260130400009
J	Huang, TTK; Glass, TA				Huang, Terry T. -K.; Glass, Thomas A.			Transforming research strategies for understanding and preventing obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH		[Huang, Terry T. -K.] NICHHD, Obes Res Strateg Core, NIH, Bethesda, MD 20892 USA; [Glass, Thomas A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Huang, TTK (corresponding author), NICHHD, Obes Res Strateg Core, NIH, 6100 Execut Blvd,4B11, Bethesda, MD 20892 USA.	huangter@mail.nih.gov		Glass, Thomas/0000-0003-4399-612X; Huang, Terry/0000-0001-5544-5187				Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; BRATTEBO G, 1990, SCAND J SOC MED, V18, P225, DOI 10.1177/140349489001800312; Cole SW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r189; Drewnowski A, 2007, SOC SCI MED, V65, P2458, DOI 10.1016/j.socscimed.2007.07.001; Fichtenberg CM, 2000, NEW ENGL J MED, V343, P1772, DOI 10.1056/NEJM200012143432406; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; World Health Organization, SOC DET HLTH; 2003, PROGR GROCER    0813	15	104	104	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2008	300	15					1811	1813		10.1001/jama.300.15.1811	http://dx.doi.org/10.1001/jama.300.15.1811			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QA	18854544				2022-12-28	WOS:000260002000034
J	Gould, PL				Gould, P. L.			Cold molecules beat the shakes	SCIENCE			English	Editorial Material							PHOTOASSOCIATION; TEMPERATURES		[Gould, P. L.] Univ Connecticut, Dept Phys, Storrs, CT 06269 USA	University of Connecticut	Gould, PL (corresponding author), Univ Connecticut, Dept Phys, Storrs, CT 06269 USA.	phillip.gould@uconn.edu						Bahns JT, 1996, J CHEM PHYS, V104, P9689, DOI 10.1063/1.471731; Bethlem HL, 1999, PHYS REV LETT, V83, P1558, DOI 10.1103/PhysRevLett.83.1558; Danzl JG, 2008, SCIENCE, V321, P1062, DOI 10.1126/science.1159909; DEMILLE D, 2002, PHYS REV LETT, V88; Jones KM, 2006, REV MOD PHYS, V78, P483, DOI 10.1103/RevModPhys.78.483; Kohler T, 2006, REV MOD PHYS, V78, P1311, DOI 10.1103/RevModPhys.78.1311; Lahaye T, 2007, NATURE, V448, P672, DOI 10.1038/nature06036; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; Nikolov AN, 2000, PHYS REV LETT, V84, P246, DOI 10.1103/PhysRevLett.84.246; Sage JM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.203001; Viteau M, 2008, SCIENCE, V321, P232, DOI 10.1126/science.1159496; Weinstein JD, 1998, NATURE, V395, P148, DOI 10.1038/25949	12	5	5	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					203	204		10.1126/science.1164990	http://dx.doi.org/10.1126/science.1164990			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845736				2022-12-28	WOS:000259902300027
J	Schipper, J; Chanson, JS; Chiozza, F; Cox, NA; Hoffmann, M; Katariya, V; Lamoreux, J; Rodrigues, ASL; Stuart, SN; Temple, HJ; Baillie, J; Boitani, L; Lacher, TE; Mittermeier, RA; Smith, AT; Absolon, D; Aguiar, JM; Amori, G; Bakkour, N; Baldi, R; Berridge, RJ; Bielby, J; Black, PA; Blanc, JJ; Brooks, TM; Burton, JA; Butynski, TM; Catullo, G; Chapman, R; Cokeliss, Z; Collen, B; Conroy, J; Cooke, JG; da Fonseca, GAB; Derocher, AE; Dublin, HT; Duckworth, JW; Emmons, L; Emslie, RH; Festa-Bianchet, M; Foster, M; Foster, S; Garshelis, DL; Gates, C; Gimenez-Dixon, M; Gonzalez, S; Gonzalez-Maya, JF; Good, TC; Hammerson, G; Hammond, PS; Happold, D; Happold, M; Hare, J; Harris, RB; Hawkins, CE; Haywood, M; Heaney, LR; Hedges, S; Helgen, KM; Hilton-Taylor, C; Hussain, SA; Ishii, N; Jefferson, TA; Jenkins, RKB; Johnston, CH; Keith, M; Kingdon, J; Knox, DH; Kovacs, KM; Langhammer, P; Leus, K; Lewison, R; Lichtenstein, G; Lowry, LF; Macavoy, Z; Mace, GM; Mallon, DP; Masi, M; McKnight, MW; Medellin, RA; Medici, P; Mills, G; Moehlman, PD; Molur, S; Mora, A; Nowell, K; Oates, JF; Olech, W; Oliver, WRL; Oprea, M; Patterson, BD; Perrin, WF; Polidoro, BA; Pollock, C; Powel, A; Protas, Y; Racey, P; Ragle, J; Ramani, P; Rathbun, G; Reeves, RR; Reilly, SB; Reynolds, JE; Rondinini, C; Rosell-Ambal, RG; Rulli, M; Rylands, AB; Savini, S; Schank, CJ; Sechrest, W; Self-Sullivan, C; Shoemaker, A; Sillero-Zubiri, C; De Silva, N; Smith, DE; Srinivasulu, C; Stephenson, PJ; van Strien, N; Talukdar, BK; Taylor, BL; Timmins, R; Tirira, DG; Tognelli, MF; Tsytsulina, K; Veiga, LM; Vie, JC; Williamson, EA; Wyatt, SA; Xie, Y; Young, BE				Schipper, Jan; Chanson, Janice S.; Chiozza, Federica; Cox, Neil A.; Hoffmann, Michael; Katariya, Vineet; Lamoreux, John; Rodrigues, Ana S. L.; Stuart, Simon N.; Temple, Helen J.; Baillie, Jonathan; Boitani, Luigi; Lacher, Thomas E., Jr.; Mittermeier, Russell A.; Smith, Andrew T.; Absolon, Daniel; Aguiar, John M.; Amori, Giovanni; Bakkour, Noura; Baldi, Ricardo; Berridge, Richard J.; Bielby, Jon; Black, Patricia Ann; Blanc, J. Julian; Brooks, Thomas M.; Burton, James A.; Butynski, Thomas M.; Catullo, Gianluca; Chapman, Roselle; Cokeliss, Zoe; Collen, Ben; Conroy, Jim; Cooke, Justin G.; da Fonseca, Gustavo A. B.; Derocher, Andrew E.; Dublin, Holly T.; Duckworth, J. W.; Emmons, Louise; Emslie, Richard H.; Festa-Bianchet, Marco; Foster, Matt; Foster, Sabrina; Garshelis, David L.; Gates, Cormack; Gimenez-Dixon, Mariano; Gonzalez, Susana; Gonzalez-Maya, Jose Fernando; Good, Tatjana C.; Hammerson, Geoffrey; Hammond, Philip S.; Happold, David; Happold, Meredith; Hare, John; Harris, Richard B.; Hawkins, Clare E.; Haywood, Mandy; Heaney, Lawrence R.; Hedges, Simon; Helgen, Kristofer M.; Hilton-Taylor, Craig; Hussain, Syed Ainul; Ishii, Nobuo; Jefferson, Thomas A.; Jenkins, Richard K. B.; Johnston, Charlotte H.; Keith, Mark; Kingdon, Jonathan; Knox, David H.; Kovacs, Kit M.; Langhammer, Penny; Leus, Kristin; Lewison, Rebecca; Lichtenstein, Gabriela; Lowry, Lloyd F.; Macavoy, Zoe; Mace, Georgina M.; Mallon, David P.; Masi, Monica; McKnight, Meghan W.; Medellin, Rodrigo A.; Medici, Patricia; Mills, Gus; Moehlman, Patricia D.; Molur, Sanjay; Mora, Arturo; Nowell, Kristin; Oates, John F.; Olech, Wanda; Oliver, William R. L.; Oprea, Monik; Patterson, Bruce D.; Perrin, William F.; Polidoro, Beth A.; Pollock, Caroline; Powel, Abigail; Protas, Yelizaveta; Racey, Paul; Ragle, Jim; Ramani, Pavithra; Rathbun, Galen; Reeves, Randall R.; Reilly, Stephen B.; Reynolds, John E., III; Rondinini, Carlo; Rosell-Ambal, Ruth Grace; Rulli, Monica; Rylands, Anthony B.; Savini, Simona; Schank, Cody J.; Sechrest, Wes; Self-Sullivan, Caryn; Shoemaker, Alan; Sillero-Zubiri, Claudio; De Silva, Naamal; Smith, David E.; Srinivasulu, Chelmala; Stephenson, Peter J.; van Strien, Nico; Talukdar, Bibhab Kumar; Taylor, Barbara L.; Timmins, Rob; Tirira, Diego G.; Tognelli, Marcelo F.; Tsytsulina, Katerina; Veiga, Liza M.; Vie, Jean-Christophe; Williamson, Elizabeth A.; Wyatt, Sarah A.; Xie, Yan; Young, Bruce E.			The status of the world's land and marine mammals: Diversity, threat, and knowledge	SCIENCE			English	Article							GLOBAL DISTRIBUTION; EXTINCTION RISK; RANGE SIZE; RED LIST; CONSERVATION; PATTERNS	Knowledge of mammalian diversity is still surprisingly disparate, both regionally and taxonomically. Here, we present a comprehensive assessment of the conservation status and distribution of the world's mammals. Data, compiled by 1700+ experts, cover all 5487 species, including marine mammals. Global macroecological patterns are very different for land and marine species but suggest common mechanisms driving diversity and endemism across systems. Compared with land species, threat levels are higher among marine mammals, driven by different processes (accidental mortality and pollution, rather than habitat loss), and are spatially distinct (peaking in northern oceans, rather than in Southeast Asia). Marine mammals are also disproportionately poorly known. These data are made freely available to support further scientific developments and conservation action.	[Schipper, Jan; Chanson, Janice S.; Cox, Neil A.; Hoffmann, Michael; Katariya, Vineet; Lamoreux, John; Stuart, Simon N.; Polidoro, Beth A.; Ragle, Jim] IUCN, Species Programme, CH-1196 Gland, Switzerland; [Schipper, Jan; Chanson, Janice S.; Cox, Neil A.; Hoffmann, Michael; Stuart, Simon N.; Lacher, Thomas E., Jr.; Mittermeier, Russell A.; Aguiar, John M.; Bakkour, Noura; Brooks, Thomas M.; Foster, Matt; Rylands, Anthony B.; De Silva, Naamal; Wyatt, Sarah A.] Conservat Int, Ctr Appl Biodivers Sci, Arlington, VA 22202 USA; [Chiozza, Federica; Boitani, Luigi; Rondinini, Carlo] Univ Roma La Sapienza, Dept Anim & Human Biol, I-00185 Rome, Italy; [Lamoreux, John; Lacher, Thomas E., Jr.; Aguiar, John M.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Rodrigues, Ana S. L.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Temple, Helen J.; Hilton-Taylor, Craig; Pollock, Caroline] IUCN, Species Programme, Cambridge CB3 0DL, England; [Baillie, Jonathan; Bielby, Jon; Cokeliss, Zoe; Collen, Ben] Zool Soc London, Inst Zool, London NW1 4RY, England; [Smith, Andrew T.; Johnston, Charlotte H.; Langhammer, Penny] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Amori, Giovanni] CNR, Inst Ecosyst Studies, I-00161 Rome, Italy; [Bakkour, Noura] Columbia Univ, Sch Int & Publ Affairs, Dept Environm Sci & Policy, New York, NY 10027 USA; [Baldi, Ricardo] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagonico, RA-9120 Puerto Madryn, Argentina; [Baldi, Ricardo] Wildlife Conservat Soc, Patagonian & Andean Steppe Program, RA-9120 Puerto Madryn, Argentina; [Berridge, Richard J.] Mantella Conservat Org, London SE16 7TS, England; [Bielby, Jon; Macavoy, Zoe; Mace, Georgina M.] Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; [Black, Patricia Ann] Fac Ciencias Nat, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Black, Patricia Ann] Inst Miguel Lillo, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Blanc, J. Julian] MIKE, CITES, Nairobi 00100, Kenya; [Brooks, Thomas M.] Univ Philippines, World Agroforestry Ctr ICRAF, Los Banos 4031, Philippines; [Brooks, Thomas M.] Univ Tasmania, Hobart, Tas 7001, Australia; [Burton, James A.] Earthwatch Inst Europe, Oxford OX2 7DE, England; [Burton, James A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH25 9RG, Midlothian, Scotland; [Butynski, Thomas M.] Eastern Africa Primate Divers & Conservat Program, Nanyuki 10400, Kenya; [Butynski, Thomas M.] Drexel Univ, Dept Biosci & Biotechnol, Philadelphia, PA 19104 USA; [Catullo, Gianluca; Masi, Monica; Rulli, Monica; Savini, Simona] Ist Ecol Applicata, I-00162 Rome, Italy; [Conroy, Jim] Celt Environm Ltd, Banchory AB31 4JG, Kincardine, Scotland; [Cooke, Justin G.] Ctr Ecosyst Management Studies, D-79297 Winden, Germany; [da Fonseca, Gustavo A. B.] Global Environm Facil, Washington, DC 20433 USA; [da Fonseca, Gustavo A. B.] Univ Fed Minas Gerais, Dept Zool, BR-31270901 Belo Horizonte, MG, Brazil; [Derocher, Andrew E.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Dublin, Holly T.] Ctr Biodivers Conservat, S African Natl Biodivers Inst, IUCN Species Survival Commiss, ZA-7735 Cape Town, South Africa; [Duckworth, J. W.] Wildlife Conservat Soc, Asia Programs, Bronx, NY 10460 USA; [Emmons, Louise; Helgen, Kristofer M.; Oprea, Monik] Smithsonian Inst, Dept Vertebrate Zool, Div Mammals, Washington, DC 20013 USA; [Emslie, Richard H.] African Rhino Specialist Grp, IUCN SSC Species Survival Commiss, ZA-3245 Hilton, South Africa; [Festa-Bianchet, Marco] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Foster, Sabrina; Ramani, Pavithra; Schank, Cody J.; Sechrest, Wes; Smith, David E.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; [Garshelis, David L.] Minnesota Dept Nat Resources, Grand Rapids, MN 55744 USA; [Gates, Cormack] Univ Calgary, Dept Environm Sci, Calgary, AB T2N 1N4, Canada; [Gonzalez, Susana] IIBCE, Fac Ciencias, Montevideo 11600, Uruguay; [Gonzalez-Maya, Jose Fernando] ProCAT Int, Las Alturas, Coto Brus, Costa Rica; [Good, Tatjana C.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Hammerson, Geoffrey; Young, Bruce E.] NatureServ, Arlington, VA 22209 USA; [Hammond, Philip S.] Univ St Andrews, Sea Mammal Res Unit, Gatty Marine Lab, St Andrews KY16 8LB, Fife, Scotland; [Happold, David; Happold, Meredith] Australian Natl Univ, Canberra, ACT 0200, Australia; [Hare, John] Wild Camel Protect Fdn, Sch Farm, Benenden TN17 4EU, Kent, England; [Harris, Richard B.] Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Hawkins, Clare E.] Dept Primary Ind & Water, Threatened Species Sect, Hobart, Tas 7001, Australia; [Hawkins, Clare E.] Univ Tasmania, Sch Zool, Hobart, Tas 7001, Australia; [Haywood, Mandy] Univ Otago, Ctr Sci Commun, Dunedin 9054, New Zealand; [Heaney, Lawrence R.; Patterson, Bruce D.] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; [Hussain, Syed Ainul] Wildlife Inst India, Dehra Dun 248001, Uttar Pradesh, India; [Ishii, Nobuo] Tokyo Womans Christian Univ, Suginami Ku, Tokyo 1678585, Japan; [Jefferson, Thomas A.; Perrin, William F.; Reilly, Stephen B.; Taylor, Barbara L.] Natl Ocean & Atmospher Adm Fisheries, SW Fisheries Sci Ctr, La Jolla, CA 92037 USA; [Jenkins, Richard K. B.; Racey, Paul] Univ Aberdeen, Sch Biol Sci, Aberdeen AB24 2TZ, Scotland; [Jenkins, Richard K. B.] Madagasikara Voakajy, Antananarivo, Madagascar; [Keith, Mark] Univ Witwatersrand, ZA-2050 Johannesburg, South Africa; [Kingdon, Jonathan] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Knox, David H.] Conservat Int, ZA-7735 Claremont, South Africa; [Kovacs, Kit M.] Norwegian Polar Res Inst, N-9296 Tromso, Norway; [Kovacs, Kit M.] Univ Ctr Svalbard, N-9171 Longyearbyen, Norway; [Leus, Kristin] Copenhagen Zoo & Conservat Breeding Specialist Gr, Reg Off Europe, B-2170 Merksem, Belgium; [Lewison, Rebecca] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Lichtenstein, Gabriela] Inst Nacl Antropol & Pensamiento Latinoamer, RA-1378 Buenos Aires, DF, Argentina; [Lowry, Lloyd F.] Univ Alaska, Sch Fisheries & Ocean Sci, Fairbanks, AK 99701 USA; [Mallon, David P.] Manchester Metropolitan Univ, Dept Biol Sci, Manchester M1 5GD, Lancs, England; [Medellin, Rodrigo A.] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Medici, Patricia] Inst Pesquisas Ecol, Inst Ecol Res, Lowland Tapir Conservat Initiat, BR-12960000 Sao Paulo, Brazil; [Medici, Patricia] Univ Kent, DICE, Canterbury CT2 7NZ, Kent, England; [Mills, Gus] Tony & Lisette Lewis Fdn, ZA-2196 Sandton, South Africa; [Moehlman, Patricia D.] Wildlife Trust Alliance, Beijing 100011, Peoples R China; [Molur, Sanjay] Zoo Outreach Org, Coimbatore 641004, Tamil Nadu, India; [Molur, Sanjay] Wildlife Informat & Liaison Dev Soc, Coimbatore 641004, Tamil Nadu, India; [Mora, Arturo] IUCN S Amer Reg Off, Species Unit, Quito, Pichincha, Ecuador; [Nowell, Kristin] Cat Act Treasury, Cape Neddick 03902, ME USA; [Oates, John F.] CUNY, CUNY Hunter Coll, Dept Anthropol, New York, NY 10065 USA; [Olech, Wanda] Warsaw Univ Life Sci, PL-02787 Warsaw, Poland; [Oliver, William R. L.] Fauna & Flora Int, Philippine Biodivers Conservat Programme, Manila 1004, Philippines; [Powel, Abigail] Victoria Univ Wellington, Wellington 6140, New Zealand; [Protas, Yelizaveta] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Rathbun, Galen] Calif Acad Sci, Dept Ornithol & Mammal, Cambria, CA 93428 USA; [Reeves, Randall R.] Okapi Wildlife Assoc, Quebec City, PQ J0P 1H0, Canada; [Reynolds, John E., III] Mote Marine Lab, Sarasota, FL 34236 USA; [Rosell-Ambal, Ruth Grace] CI Philippines, Quezon City 1101, Philippines; [Self-Sullivan, Caryn] Sirenian Int, Fredericksburg, VA 22401 USA; [Shoemaker, Alan] IUCN Tapir Specialist Grp, Columbia, SC 29210 USA; [Sillero-Zubiri, Claudio] Univ Oxford, Wildlife Conservat Res Unit, Dept Zool, Tubney OX13 5QL, England; [Srinivasulu, Chelmala] Osmania Univ, Dept Zool, Univ Coll Sci, Hyderabad 500007, Andhra Pradesh, India; [Stephenson, Peter J.] WWF Int, CH-1196 Gland, Switzerland; [van Strien, Nico] White Oak Conservat Ctr, Int Rhino Fdn, Yulee, FL 32097 USA; [Talukdar, Bibhab Kumar] Aaranyak, Guwhati 781028, Assam, India; [Tirira, Diego G.] Fdn Mamiferos & Conservac, Quito, Ecuador; [Tognelli, Marcelo F.] Ctr Sci & Technol Mendoza, CONICET, IADIZA Argentinean Arid Res Inst, RA-5500 Mendoza, Argentina; [Tognelli, Marcelo F.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Tsytsulina, Katerina] Russian Bat Res Grp, St Petersburg 195196, Russia; [Veiga, Liza M.] Museu Paraense Emilio Goeldi, Dept Zool, Belem, Para, Brazil; [Williamson, Elizabeth A.] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Xie, Yan] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China	Conservation International; Sapienza University Rome; Texas A&M University System; Texas A&M University College Station; University of Cambridge; Zoological Society of London; Arizona State University; Arizona State University-Tempe	Schipper, J (corresponding author), IUCN, Species Programme, 28 Rue Mauverney, CH-1196 Gland, Switzerland.	jan.schipper@iucn.org	González-Maya, José F./B-6913-2011; Self-Sullivan, Caryn/H-2605-2012; Derocher, Andrew/J-4469-2012; González, Susana/AAC-7053-2021; Rodrigues, Ana/GYQ-6273-2022; Jenkins, Richard KB/A-4567-2012; Williamson, Elizabeth/E-4727-2016; Gonzalez, Susana A/F-1300-2017; Helgen, Kristofer M./AAB-8348-2019; Keith, Mark/G-7234-2011; Tirira, Diego G./E-3617-2018; Hoffmann, Michael/E-6419-2010; Veiga, Liza/C-6667-2009; Oprea, Monik/E-6204-2010; Rodrigues, Ana S.L./A-5914-2009; Patterson, Bruce D/O-5068-2019; Williamson, Elizabeth/N-8958-2019; Keith, Mark/Q-1527-2018; Schipper, Jan/N-5266-2015; Stephenson, PJ/AAC-3081-2021; Williamson, Elizabeth/B-9090-2011; Olech, Wanda/AAB-5072-2022; Mace, Georgina M/I-3072-2016; Rondinini, Carlo/E-9027-2011; Bielby, Jon/D-5051-2011; Collen, Ben/D-5055-2011; Collen, Ben/F-2543-2016; Keith, Mark/A-2458-2015; Tognelli, Marcelo/L-3958-2019; Srinivasulu, Chelmala/AAU-2204-2020	González-Maya, José F./0000-0002-8942-5157; Self-Sullivan, Caryn/0000-0003-0785-3682; Derocher, Andrew/0000-0002-1104-7774; González, Susana/0000-0001-6470-6182; Williamson, Elizabeth/0000-0001-6848-9154; Helgen, Kristofer M./0000-0002-8776-4040; Tirira, Diego G./0000-0002-5344-6175; Hoffmann, Michael/0000-0003-4785-2254; Rodrigues, Ana S.L./0000-0003-4775-0127; Patterson, Bruce D/0000-0002-2249-7260; Williamson, Elizabeth/0000-0001-6848-9154; Keith, Mark/0000-0001-7179-9989; Schipper, Jan/0000-0002-8338-7874; Olech, Wanda/0000-0002-6166-3954; Mace, Georgina M/0000-0001-8965-5211; Collen, Ben/0000-0003-2564-4243; Keith, Mark/0000-0001-6690-2718; Tognelli, Marcelo/0000-0002-9761-4505; Srinivasulu, Chelmala/0000-0003-4331-8580; Hammond, Philip/0000-0002-2381-8302; Festa-Bianchet, Marco/0000-0002-2352-3379; Brooks, Thomas/0000-0001-8159-3116; Molur, Sanjay/0000-0001-8230-518X; Haywood, Mandy/0000-0002-5012-6926; Hawkins, Clare/0000-0002-1909-2545; Ragle, James/0000-0002-5829-3745; STEPHENSON, PJ/0000-0002-0087-466X; Blanc, Julian/0000-0003-4331-5339; Bielby, Jon/0000-0003-4586-0429; Rondinini, Carlo/0000-0002-6617-018X	Natural Environment Research Council [cpb010001, smru10001] Funding Source: researchfish; NERC [cpb010001] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; BRYANT PJ, 1995, J MAMMAL, V76, P857, DOI 10.2307/1382754; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; Davies RG, 2007, P ROY SOC B-BIOL SCI, V274, P1189, DOI 10.1098/rspb.2006.0061; Davies TJ, 2008, P NATL ACAD SCI USA, V105, P11556, DOI 10.1073/pnas.0801917105; ENTWISTLE AC, 2000, PRIORITIES CONSERVAT, P119; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hawkins BA, 2006, GLOBAL ECOL BIOGEOGR, V15, P461, DOI 10.1111/j.1466-822x.2006.00243.x; Hildebrand J, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P101; Hoffmann M, 2008, NATURE, V454, P159, DOI 10.1038/454159a; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; *IUCN, 1996, 1996 IUCN RED LIST T; MCLEOD B, 2008, ARCTIC, P1; Morrison JC, 2007, J MAMMAL, V88, P1363, DOI 10.1644/06-MAMM-A-124R2.1; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Reeder DeeAnn M., 2007, Occasional Papers Museum of Texas Tech University, V269, P1; REEVES RR, 1978, ATLANTIC WALRUS ODOB; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; SECHREST WW, 2003, THESIS U VIRGINIA CH; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stora J, 2004, MAR MAMMAL SCI, V20, P115, DOI 10.1111/j.1748-7692.2004.tb01143.x; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Turney CSM, 2008, P NATL ACAD SCI USA, V105, P12150, DOI 10.1073/pnas.0801360105; Turvey ST, 2007, BIOL LETTERS, V3, P193, DOI 10.1098/rsbl.2006.0585; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292	34	999	1052	16	639	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					225	230		10.1126/science.1165115	http://dx.doi.org/10.1126/science.1165115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845749	Green Accepted			2022-12-28	WOS:000259902300039
J	Reznik, D; Sangiovanni, G; Gunnarsson, O; Devereaux, TP				Reznik, D.; Sangiovanni, G.; Gunnarsson, O.; Devereaux, T. P.			Photoemission kinks and phonons in cuprates	NATURE			English	Letter							COPPER-OXIDE SUPERCONDUCTORS		[Reznik, D.] Forschungszentrum Karlsruhe, Inst Festkorperphys, D-76021 Karlsruhe, Germany; [Sangiovanni, G.] Max Planck Inst Festkorperforsch, D-70506 Stuttgart, Germany; [Gunnarsson, O.; Devereaux, T. P.] Stanford Univ, Dept Photon Sci, Stanford Linear Accelerator Ctr, Menlo Pk, CA 94025 USA	Helmholtz Association; Karlsruhe Institute of Technology; Max Planck Society; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Reznik, D (corresponding author), Forschungszentrum Karlsruhe, Inst Festkorperphys, POB 3640, D-76021 Karlsruhe, Germany.	reznik@llb.saclay.cea.fr	Sangiovanni, Giorgio/L-5893-2013; Gunnarsson, Olle/B-4011-2012	Sangiovanni, Giorgio/0000-0003-2218-2901; 				Bohnen KP, 2003, EUROPHYS LETT, V64, P104, DOI 10.1209/epl/i2003-00143-x; Giustino F, 2008, NATURE, V452, P975, DOI 10.1038/nature06874; Heid R, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.137001; Horsch P, 2005, PHYSICA B, V359, P620, DOI 10.1016/j.physb.2005.01.170; IWASAWA H, 2008, ISOTOPIC FINGERPRINT; Pintschovius L, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.174514; Pintschovius L, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.214506; Reznik D, 2007, J LOW TEMP PHYS, V147, P353, DOI 10.1007/s10909-007-9318-9; Reznik D, 2006, NATURE, V440, P1170, DOI 10.1038/nature04704; Rosch O, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.224518; Uchiyama H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.197005; Zhou XJ, 2003, NATURE, V423, P398, DOI 10.1038/423398a	12	61	61	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2008	455	7213					E6	E7		10.1038/nature07364	http://dx.doi.org/10.1038/nature07364			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833217	Green Submitted			2022-12-28	WOS:000259639700056
J	Weyand, S; Shimamura, T; Yajima, S; Suzuki, S; Mirza, O; Krusong, K; Carpenter, EP; Rutherford, NG; Hadden, JM; O'Reilly, J; Ma, P; Saidijam, M; Patching, SG; Hope, RJ; Norbertczak, HT; Roach, PCJ; Iwata, S; Henderson, PJF; Cameron, AD				Weyand, Simone; Shimamura, Tatsuro; Yajima, Shunsuke; Suzuki, Shun'ichi; Mirza, Osman; Krusong, Kuakarun; Carpenter, Elisabeth P.; Rutherford, Nicholas G.; Hadden, Jonathan M.; O'Reilly, John; Ma, Pikyee; Saidijam, Massoud; Patching, Simon G.; Hope, Ryan J.; Norbertczak, Halina T.; Roach, Peter C. J.; Iwata, So; Henderson, Peter J. F.; Cameron, Alexander D.			Structure and Molecular Mechanism of a Nucleobase-Cation-Symport-1 Family Transporter	SCIENCE			English	Article							PURINE-CYTOSINE PERMEASE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; NEUROTRANSMITTER TRANSPORTERS; FUNCTIONAL-ANALYSIS; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; BINDING-SITE; PROTEINS; REVEALS	The nucleobase- cation- symport- 1 ( NCS1) transporters are essential components of salvage pathways for nucleobases and related metabolites. Here, we report the 2.85- angstrom resolution structure of the NCS1 benzyl- hydantoin transporter, Mhp1, from Microbacterium liquefaciens. Mhp1 contains 12 transmembrane helices, 10 of which are arranged in two inverted repeats of five helices. The structures of the outward- facing open and substrate- bound occluded conformations were solved, showing how the outward- facing cavity closes upon binding of substrate. Comparisons with the leucine transporter LeuT(Aa) and the galactose transporter vSGLT reveal that the outwardand inward- facing cavities are symmetrically arranged on opposite sides of the membrane. The reciprocal opening and closing of these cavities is synchronized by the inverted repeat helices 3 and 8, providing the structural basis of the alternating access model for membrane transport.	[Weyand, Simone; Carpenter, Elisabeth P.; Iwata, So; Cameron, Alexander D.] Diamond Light Source Ltd, Membrane Prot Lab, Didcot OX11 0DE, Oxon, England; [Weyand, Simone; Shimamura, Tatsuro; Yajima, Shunsuke; Mirza, Osman; Krusong, Kuakarun; Carpenter, Elisabeth P.; Iwata, So; Cameron, Alexander D.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Membrane Prot Crystallog Grp, London SW7 2AZ, England; [Shimamura, Tatsuro; Iwata, So] Japan Sci & Technol Agcy, Human Receptor Crystallog Project, ERATO, Sakyo Ku, Kyoto 6068501, Japan; [Suzuki, Shun'ichi; Rutherford, Nicholas G.; Hadden, Jonathan M.; O'Reilly, John; Ma, Pikyee; Saidijam, Massoud; Patching, Simon G.; Hope, Ryan J.; Norbertczak, Halina T.; Roach, Peter C. J.; Henderson, Peter J. F.] Univ Leeds, Astbury Ctr Struct Mol Biol, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [Saidijam, Massoud] Hamedan Univ Med Sci, Sch Med, Hamadan, Iran; [Iwata, So] RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Diamond Light Source; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Imperial College London; Japan Science & Technology Agency (JST); University of Leeds; RIKEN	Iwata, S (corresponding author), Diamond Light Source Ltd, Membrane Prot Lab, Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England.	s.iwata@imperial.ac.uk; p.j.f.henderson@leeds.ac.uk	Patching, Simon G./Z-3906-2019; Ma, Pikyee/B-8282-2012; Cameron, Alexander/L-7288-2013; Saidijam, Massoud/G-2646-2017; Henderson, Peter JF/Q-1907-2018	Patching, Simon G./0000-0001-6132-5317; Ma, Pikyee/0000-0003-4080-2908; Saidijam, Massoud/0000-0001-8910-556X; Henderson, Peter/0000-0002-9187-0938; Cameron, Alexander/0000-0001-8776-3518; Carpenter, Liz/0000-0001-9138-2937; Mirza, Osman Asghar/0000-0001-9435-0690	Biotechnology and Biological Sciences Research Council [B17935, BB/C51725]; Ajinomoto Incorporated; European Membrane Protein consortium [LSHG-CT-2004-504601]; Membrane Protein Structure Initiative [BBS/B/14418]; Wellcome Trust [062164/Z/00/Z]; Leverhulme Trust; European Molecular Biology Organization long-term fellowship; Biotechnology and Biological Sciences Research Council [BB/C51725X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ajinomoto Incorporated; European Membrane Protein consortium; Membrane Protein Structure Initiative; Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded primarily by the Biotechnology and Biological Sciences Research Council (grant nos. B17935 and BB/C51725), with important contributions from Ajinomoto Incorporated, the European Membrane Protein consortium (grant no. LSHG-CT-2004-504601), the Membrane Protein Structure Initiative (grant no. BBS/B/14418), and the Wellcome Trust (grant no. 062164/Z/00/Z). We wish to thank the Membrane Protein Laboratory (MPL) at the Diamond Light Source Limited for use of the MPL facilities. J. Abramson kindly provided us with the coordinates of vSGLT before their release from the Protein Data Bank (PDB). We are also grateful to S. Phillips, S. Baldwin, P. Gilmartin, S. Radford, D. Drew, M. Jormakka, K. Watanabe, and M. Iwata for support or advice. The Japan Society for the Promotion of Science provided personal funding to S.Y. and the Leverhulme Trust to P.J.F.H. S.W. was a recipient of a European Molecular Biology Organization long-term fellowship. The coordinates and the structure factors for Mhp1 without substrate and the hydantoin complex have been deposited in the PDB (entries 2JLN and 2JLO, respectively).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BLOCH JC, 1992, MOL MICROBIOL, V6, P2989, DOI 10.1111/j.1365-2958.1992.tb01757.x; Bowie JU, 2006, NAT STRUCT MOL BIOL, V13, P94, DOI 10.1038/nsmb0206-94; BRETHES D, 1992, EUR J BIOCHEM, V204, P699, DOI 10.1111/j.1432-1033.1992.tb16684.x; CHEVALLIER MR, 1975, J BACTERIOL, V122, P629, DOI 10.1128/JB.122.2.629-641.1975; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Ferreira T, 1997, J BIOL CHEM, V272, P9697; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; HENDERSON PJF, 1994, ANTON LEEUW INT J G, V65, P349, DOI 10.1007/BF00872218; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Loo DDF, 2006, J GEN PHYSIOL, V128, P701, DOI 10.1085/jgp.200609643; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mirza O, 2006, EMBO J, V25, P1177, DOI 10.1038/sj.emboj.7601028; Pantazopoulou A, 2007, FEMS MICROBIOL REV, V31, P657, DOI 10.1111/j.1574-6976.2007.00083.x; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Suzuki S, 2006, J BACTERIOL, V188, P3329, DOI 10.1128/JB.188.9.3329-3336.2006; TANFORD C, 1983, P NATL ACAD SCI-BIOL, V80, P3701, DOI 10.1073/pnas.80.12.3701; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Turk E, 2000, J BIOL CHEM, V275, P25711, DOI 10.1074/jbc.M003127200; Wilson TH, 2001, BBA-BIOENERGETICS, V1505, P121, DOI 10.1016/S0005-2728(00)00282-6; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	36	289	291	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					709	713		10.1126/science.1164440	http://dx.doi.org/10.1126/science.1164440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18927357	Green Accepted			2022-12-28	WOS:000260605200039
J	Aaron, HJ				Aaron, Henry J.			Waste, we know you are out there	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Cutler DM, 2006, NEW ENGL J MED, V355, P920, DOI 10.1056/NEJMsa054744; *TUFTS MED CTR CTR, COST EFF AN REG; [No title captured]	3	22	22	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2008	359	18					1865	1867		10.1056/NEJMp0807204	http://dx.doi.org/10.1056/NEJMp0807204			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366BL	18971487				2022-12-28	WOS:000260454500001
J	Morris, BH; Oh, W; Tyson, JE; Stevenson, DK; Phelps, DL; O'Shea, TM; McDavid, GE; Perritt, RL; Van Meurs, KP; Vohr, BR; Grisby, C; Yao, Q; Pedroza, C; Das, A; Poole, WK; Carlo, WA; Duara, S; Laptook, AR; Salhab, WA; Shankaran, S; Poindexter, BB; Fanaroff, AA; Walsh, MC; Rasmussen, MR; Stoll, BJ; Cotten, CM; Donovan, EF; Ehrenkranz, RA; Guillet, R; Higgins, RD				Morris, Brenda H.; Oh, William; Tyson, Jon E.; Stevenson, David K.; Phelps, Dale L.; O'Shea, T. Michael; McDavid, Georgia E.; Perritt, Rebecca L.; Van Meurs, Krisa P.; Vohr, Betty R.; Grisby, Cathy; Yao, Qing; Pedroza, Claudia; Das, Abhik; Poole, W. Kenneth; Carlo, Waldemar A.; Duara, Shahnaz; Laptook, Abbot R.; Salhab, Walid A.; Shankaran, Seetha; Poindexter, Brenda B.; Fanaroff, Avroy A.; Walsh, Michele C.; Rasmussen, Maynard R.; Stoll, Barbara J.; Cotten, C. Michael; Donovan, Edward F.; Ehrenkranz, Richard A.; Guillet, Ronnie; Higgins, Rosemary D.		NICHD Neonatal Res Network	Aggressive vs. conservative phototherapy for infants with extremely low birth weight	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BAYESIAN SUBSET ANALYSIS; PEAK SERUM BILIRUBIN; CLINICAL-TRIALS; NEONATAL HYPERBILIRUBINEMIA; NEURODEVELOPMENTAL OUTCOMES; INTRACRANIAL HEMORRHAGE; PRETERM INFANTS; AGE; KERNICTERUS; CHILDREN	Background: It is unclear whether aggressive phototherapy to prevent neurotoxic effects of bilirubin benefits or harms infants with extremely low birth weight (1000 g or less). Methods: We randomly assigned 1974 infants with extremely low birth weight at 12 to 36 hours of age to undergo either aggressive or conservative phototherapy. The primary outcome was a composite of death or neurodevelopmental impairment determined for 91% of the infants by investigators who were unaware of the treatment assignments. Results: Aggressive phototherapy, as compared with conservative phototherapy, significantly reduced the mean peak serum bilirubin level (7.0 vs. 9.8 mg per deciliter [120 vs. 168 micromol per liter], P<0.01) but not the rate of the primary outcome (52% vs. 55%; relative risk, 0.94; 95% confidence interval [CI], 0.87 to 1.02; P=0.15). Aggressive phototherapy did reduce rates of neurodevelopmental impairment (26%, vs. 30% for conservative phototherapy; relative risk, 0.86; 95% CI, 0.74 to 0.99). Rates of death in the aggressive-phototherapy and conservative-phototherapy groups were 24% and 23%, respectively (relative risk, 1.05; 95% CI, 0.90 to 1.22). In preplanned subgroup analyses, the rates of death were 13% with aggressive phototherapy and 14% with conservative phototherapy for infants with a birth weight of 751 to 1000 g and 39% and 34%, respectively (relative risk, 1.13; 95% CI, 0.96 to 1.34), for infants with a birth weight of 501 to 750 g. Conclusions: Aggressive phototherapy did not significantly reduce the rate of death or neurodevelopmental impairment. The rate of neurodevelopmental impairment alone was significantly reduced with aggressive phototherapy. This reduction may be offset by an increase in mortality among infants weighing 501 to 750 g at birth. (ClinicalTrials.gov number, NCT00114543.).	[Morris, Brenda H.; Tyson, Jon E.; McDavid, Georgia E.] Univ Texas Houston, Sch Med, Dept Pediat, Houston, TX 77030 USA; [Oh, William; Vohr, Betty R.; Laptook, Abbot R.] Brown Univ, Women & Infants Hosp, Providence, RI 02912 USA; [Stevenson, David K.; Van Meurs, Krisa P.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Phelps, Dale L.; Guillet, Ronnie] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [O'Shea, T. Michael] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; [Perritt, Rebecca L.; Yao, Qing; Poole, W. Kenneth] RTI Int, Res Triangle Pk, NC USA; [Grisby, Cathy; Donovan, Edward F.] Univ Cincinnati, Cincinnati, OH USA; [Pedroza, Claudia] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Carlo, Waldemar A.] Univ Alabama, Birmingham, AL USA; [Duara, Shahnaz] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Salhab, Walid A.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Shankaran, Seetha] Wayne State Univ, Detroit, MI USA; [Poindexter, Brenda B.] Indiana Univ, James Whitcomb Riley Hosp Children, Indianapolis, IN 46204 USA; [Fanaroff, Avroy A.; Walsh, Michele C.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Rasmussen, Maynard R.] Univ Calif San Diego, Sharp Mary Birch Hosp Women, San Diego, CA 92103 USA; [Stoll, Barbara J.] Emory Univ, Atlanta, GA 30322 USA; [Cotten, C. Michael] Duke Univ, Durham, NC USA; [Ehrenkranz, Richard A.] Yale Univ, Sch Med, New Haven, CT USA; [Higgins, Rosemary D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA	University of Texas System; University of Texas Health Science Center Houston; Brown University; Women & Infants Hospital Rhode Island; Stanford University; University of Rochester; Wake Forest University; Research Triangle Institute	Tyson, JE (corresponding author), Univ Texas Houston, Sch Med, Dept Pediat, 6431 Fannin,MSB 3-226, Houston, TX 77030 USA.	jon.e.tyson@uth.tmc.edu	Das, Abhik/AAF-1883-2020	Das, Abhik/0000-0003-2722-0479; Pedroza, Claudia/0000-0003-4235-1282; Hintz, Susan/0000-0001-7023-4433	National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Natus; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD021364, U10HD027880, U10HD027853, U10HD021373, U10HD027871, U10HD034216, U10HD021385, U10HD027904, U10HD040492, U10HD027856, U10HD027851, U10HD040461, U10HD040689] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD040521, U10HD040498, U10HD021397, U01HD036790] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148, UL1RR024128, M01RR008084, KL2RR024149, M01RR006022, M01RR016587, M01RR007122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Natus(National University of Singapore); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by grants from the National Institutes of Health and from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, which provided overall oversight for study conduct. All data analyses and interpretation were done independently of the funding agency. Natus Medical loaned light-emitting diode phototherapy lights to each center. These lights were used at the discretion of the attending neonatologist in treating infants in either treatment group. The lights were returned to Natus Medical or purchased at a prorated price after the study. Natus Medical played no role in the study design, data collection, data analysis, or manuscript preparation or revision.; Dr. Fanaroff reports receiving consulting fees, and Dr. Guillet grant support, from Natus. No other potential conflict of interest relevant to this article was reported.; We thank our medical and nursing colleagues and the infants and their parents.	Ahlfors CE, 2000, J PEDIATR-US, V137, P540, DOI 10.1067/mpd.2000.108566; BAYLEY N, 1993, BAYLEY SCALES INFANT, V2; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; BOGGS TR, 1967, J PEDIATR-US, V71, P553, DOI 10.1016/S0022-3476(67)80107-0; BRATLID D, 1990, CLIN PERINATOL, V17, P449, DOI 10.1016/S0095-5108(18)30578-5; BROPHY JM, 1995, JAMA-J AM MED ASSOC, V273, P871, DOI 10.1001/jama.273.11.871; BROWN AK, 1985, PEDIATRICS, V75, P393; CASHORE WJ, 1990, CLIN PERINATOL, V17, P437, DOI 10.1016/S0095-5108(18)30577-3; DeMets DL, 1999, LANCET, V354, P1983, DOI 10.1016/S0140-6736(99)03464-9; DIXON DO, 1994, BIOMETRICS, V50, P322; DIXON DO, 1991, BIOMETRICS, V47, P871, DOI 10.2307/2532645; GOPINATHAN V, 1994, FEBS LETT, V349, P197, DOI 10.1016/0014-5793(94)00666-0; GRAZIANI LJ, 1992, PEDIATRICS, V89, P229; Hack M, 2000, ARCH PEDIAT ADOL MED, V154, P725, DOI 10.1001/archpedi.154.7.725; Hintz SR, 1999, PEDIATR RES, V45, P54, DOI 10.1203/00006450-199901000-00009; JADAD AR, 2007, RANDOMIZED CONTROLLE, P13; Lilford RJ, 1995, BMJ-BRIT MED J, V311, P1621, DOI 10.1136/bmj.311.7020.1621; LIPSITZ PJ, 1985, PEDIATRICS, V75, P422; LUCEY JF, 1982, PEDIATRICS, V69, P381; Maisels MJ, 2001, CARE HIGH RISK NEONA, P324; Oh W, 2003, PEDIATRICS, V112, P773, DOI 10.1542/peds.112.4.773; OSHEA TM, 1992, PEDIATRICS, V90, P888; Oxman A, 2002, USERS GUIDES INTERAC; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; R Development Core Team, 2007, R LANG ENV STAT COMP; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; SCHEIDT PC, 1990, PEDIATRICS, V85, P455; SCHEIDT PC, 1977, J PEDIATR-US, V91, P292, DOI 10.1016/S0022-3476(77)80835-4; Simon R, 2002, STAT MED, V21, P2909, DOI 10.1002/sim.1295; SIMON RM, 1995, RECENT ADV CLIN TRIA, P155; SINCLAIR JC, 1992, EFFECTIVE CARE NEWBO, P532; SISSON TRC, 1987, FASEB J, V46, P1883; Spiegelhalter DJ, 1999, BRIT MED J, V319, P508, DOI 10.1136/bmj.319.7208.508; TOZZI E, 1989, BIOL NEONATE, V56, P204; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; VANDEBOR M, 1989, PEDIATRICS, V83, P915; Vohr BR, 2005, PEDIATRICS, V116, P635, DOI 10.1542/peds.2004-2247; Vreman HJ, 2004, SEMIN PERINATOL, V28, P326, DOI 10.1053/j.semperi.2004.09.003; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; WATCHKO JF, 1992, PEDIATRICS, V90, P707; Wong RJ, 2007, NEOREVIEWS, V8, pe77, DOI DOI 10.1542/NEO.8-2-E77; Yeo KL, 1998, PEDIATRICS, V102, P1426, DOI 10.1542/peds.102.6.1426	42	147	152	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2008	359	18					1885	1896		10.1056/NEJMoa0803024	http://dx.doi.org/10.1056/NEJMoa0803024			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366BL	18971491	Green Accepted			2022-12-28	WOS:000260454500005
J	Provan, D; Chapel, HM; Sewell, WAC; O'Shaughnessy, D				Provan, Drew; Chapel, Helen M.; Sewell, W. A. Carrock; O'Shaughnessy, Denise		UK Immunoblobulin Expert Working G	Guidelines - Prescribing intravenous immunoglobulin: summary of Department of Health guidelines	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Provan, Drew] Royal London Hosp, Dept Haematol, Barts & London NHS Trust, London E1 2ES, England; [Chapel, Helen M.] Univ Oxford, Nuffield Dept Med, Oxford OX3 9DU, England; [Chapel, Helen M.] Oxford Radcliffe Hosp NHS Trust, Oxford OX3 9DU, England; [Sewell, W. A. Carrock] Scunthorpe Gen Hosp, N Lincolnshire & Goole NHS Trust, Scunthorpe DN15 7BH, N Lincs, England; [O'Shaughnessy, Denise] Dept Hlth, Blood Policy Unit, London SE13 6LH, England	Barts Health NHS Trust; Royal London Hospital; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Provan, D (corresponding author), Royal London Hosp, Dept Haematol, Barts & London NHS Trust, London E1 2ES, England.	a.provan@virgin.net	Provan, Drew/AAF-2766-2021	Provan, Drew/0000-0002-5110-8455	Department of Health Funding Source: Medline	Department of Health		[Anonymous], 2008, DEM MAN PLAN IMM US; Boulis A, 2002, J HEALTH POLIT POLIC, V27, P977, DOI 10.1215/03616878-27-6-977; Darabi K, 2006, TRANSFUSION, V46, P741, DOI 10.1111/j.1537-2995.2006.00792.x; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Pendergrast JM, 2005, VOX SANG, V89, P150, DOI 10.1111/j.1423-0410.2005.00670.x; Provan D., 2008, IVIG GUIDELINE DEV G, V2nd; *US DEP HHS, 1993, AHCPR PUBL, V1	7	15	16	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a1831	10.1136/bmj.a1831	http://dx.doi.org/10.1136/bmj.a1831			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18936060				2022-12-28	WOS:000260298800038
J	Durniak, KJ; Bailey, S; Steitz, TA				Durniak, Kimberly J.; Bailey, Scott; Steitz, Thomas A.			The structure of a transcribing T7 RNA polymerase in transition from initiation to elongation	SCIENCE			English	Article							MAJOR CONFORMATIONAL-CHANGES; TRANSCRIPTION INITIATION; ANGSTROM RESOLUTION; PROMOTER CLEARANCE; COMPLEX; RELEASE; T7-RNA-POLYMERASE; BACTERIOPHAGE-T7; HOLOENZYME; MECHANISM	Structural studies of the T7 bacteriophage DNA-dependent RNA polymerase (T7 RNAP) have shown that the conformation of the amino-terminal domain changes substantially between the initiation and elongation phases of transcription, but how this transition is achieved remains unclear. We report crystal structures of T7 RNAP bound to promoter DNA containing either a 7- or an 8-nucleotide (nt) RNA transcript that illuminate intermediate states along the transition pathway. The amino-terminal domain comprises the C-helix subdomain and the promoter binding domain (PBD), which consists of two segments separated by subdomain H. The structures of the intermediate complex reveal that the PBD and the bound promoter rotate by -45 degrees upon synthesis of an 8-nt RNA transcript. This allows the promoter contacts to be maintained while the active site is expanded to accommodate a growing heteroduplex. The C-helix subdomain moves modestly toward its elongation conformation, whereas subdomain H remains in its initiation- rather than its elongation-phase location, more than 70 angstroms away.	[Durniak, Kimberly J.; Bailey, Scott; Steitz, Thomas A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Bailey, Scott; Steitz, Thomas A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	thomas.steitz@yale.edu	Steitz, Thomas A./C-6559-2009	Durniak, Kimberly/0000-0002-4114-7135	NIH [GM57510]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057510] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Advanced Photon Source beamline 24-ID and at the. National. Synchrotron Light Source beamline X25. We also thank T. Jorgensen for help with the supplemental movie and the staff of the Center for Structural Biology core facility at Yale University. This work was Supported by NIH grant GM57510 (to T.A.S.). The coordinates have been deposited in the Research Collaboratory for Structural Bioinformatics Protein Data Bank with accession numbers 3E2E and 3E3J for the 7- and 8-nt RNA intermediate complex structures, respectively.	Bandwar RP, 2007, J BIOL CHEM, V282, P22879, DOI 10.1074/jbc.M702589200; Bandwar RP, 2006, J MOL BIOL, V360, P466, DOI 10.1016/j.jmb.2006.05.029; Brieba LG, 2001, EMBO J, V20, P6826, DOI 10.1093/emboj/20.23.6826; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; CHEETHAM GMT, 1988, SCIENCE, V27, P3966; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Guillerez J, 2005, P NATL ACAD SCI USA, V102, P5958, DOI 10.1073/pnas.0407141102; Guo Q, 2005, J MOL BIOL, V353, P256, DOI 10.1016/j.jmb.2005.08.016; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; He B, 1997, J MOL BIOL, V265, P275, DOI 10.1006/jmbi.1996.0741; Huang JB, 2000, J MOL BIOL, V303, P347, DOI 10.1006/jmbi.2000.4150; IKEDA RA, 1987, J BIOL CHEM, V262, P3790; IKEDA RA, 1986, P NATL ACAD SCI USA, V83, P3614, DOI 10.1073/pnas.83.11.3614; Ma KY, 2005, P NATL ACAD SCI USA, V102, P17612, DOI 10.1073/pnas.0508865102; Ma KY, 2002, J BIOL CHEM, V277, P43206, DOI 10.1074/jbc.M206658200; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; Mentesana PE, 2000, J MOL BIOL, V302, P1049, DOI 10.1006/jmbi.2000.4114; Mukherjee S, 2002, CELL, V110, P81, DOI 10.1016/S0092-8674(02)00815-2; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Pal M, 2003, P NATL ACAD SCI USA, V100, P5700, DOI 10.1073/pnas.1037057100; Place C, 1999, BIOCHEMISTRY-US, V38, P4948, DOI 10.1021/bi982689e; Steitz TA, 2004, CURR OPIN STRUC BIOL, V14, P4, DOI 10.1016/j.sbi.2004.01.006; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Tang GQ, 2008, MOL CELL, V30, P567, DOI 10.1016/j.molcel.2008.04.003; Temiakov D, 2000, P NATL ACAD SCI USA, V97, P14109, DOI 10.1073/pnas.250473197; Theis K, 2004, BIOCHEMISTRY-US, V43, P12709, DOI 10.1021/bi0486987; Turingan RS, 2007, BIOCHEMISTRY-US, V46, P6165, DOI 10.1021/bi700058b; Turingan RS, 2007, BIOCHEMISTRY-US, V46, P1714, DOI 10.1021/bi061905d; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	32	75	85	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					553	557		10.1126/science.1163433	http://dx.doi.org/10.1126/science.1163433			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948533	Green Accepted			2022-12-28	WOS:000260299100033
J	Wheeler, AR				Wheeler, Aaron R.			Chemistry - Putting electrowetting to work	SCIENCE			English	Editorial Material							DIGITAL MICROFLUIDICS; ACTUATION; DROPLETS; ASSAYS		[Wheeler, Aaron R.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada	University of Toronto	Wheeler, AR (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.	awheeler@chem.utoronto.ca	Wheeler, Aaron/J-2287-2017	Wheeler, Aaron/0000-0001-5230-7475				Abdelgawad M, 2008, LAB CHIP, V8, P672, DOI 10.1039/b801516c; Abdelgawad M, 2009, ADV MATER, V21, P920, DOI 10.1002/adma.200802244; Barbulovic-Nad I, 2008, LAB CHIP, V8, P519, DOI 10.1039/b717759c; Berge B, 2000, EUR PHYS J E, V3, P159, DOI 10.1007/s101890070029; Chang YH, 2006, BIOMED MICRODEVICES, V8, P215, DOI 10.1007/s10544-006-8171-y; Chatterjee D, 2006, LAB CHIP, V6, P199, DOI 10.1039/b515566e; Chiou PY, 2008, J MICROELECTROMECH S, V17, P133, DOI 10.1109/JMEMS.2007.904336; Fan SK, 2008, LAB CHIP, V8, P1325, DOI 10.1039/b803204a; Fouillet Y, 2008, MICROFLUID NANOFLUID, V4, P159, DOI 10.1007/s10404-007-0164-5; Hou L., 2007, APPL PHYS LETT, V90; Huebner A, 2008, LAB CHIP, V8, P1244, DOI 10.1039/b806405a; Lee J, 2002, SENSOR ACTUAT A-PHYS, V95, P259, DOI 10.1016/S0924-4247(01)00734-8; Li XM, 2007, CHEM SOC REV, V36, P1350, DOI 10.1039/b602486f; Liu YJ, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/4/045017; Luk VN, 2008, LANGMUIR, V24, P6382, DOI 10.1021/la7039509; Miller EM, 2008, ANAL CHEM, V80, P1614, DOI 10.1021/ac702269d; Pollack MG, 2000, APPL PHYS LETT, V77, P1725, DOI 10.1063/1.1308534	17	236	272	6	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					539	540		10.1126/science.1165719	http://dx.doi.org/10.1126/science.1165719			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948529				2022-12-28	WOS:000260299100027
J	Yang, GD; Wu, LY; Jiang, B; Yang, W; Qi, JS; Cao, K; Meng, QH; Mustafa, AK; Mu, WT; Zhang, SM; Snyder, SH; Wang, R				Yang, Guangdong; Wu, Lingyun; Jiang, Bo; Yang, Wei; Qi, Jiansong; Cao, Kun; Meng, Qinghe; Mustafa, Asif K.; Mu, Weitong; Zhang, Shengming; Snyder, Solomon H.; Wang, Rui			H2S as a physiologic vasorelaxant: Hypertension in mice with deletion of cystathionine gamma-lyase	SCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; HYDROGEN-SULFIDE GENERATION; KNOCKOUT MICE; RAT; INHIBITION; RELAXATION; CALMODULIN; MODULATION; LACKING; GENE	Studies of nitric oxide over the past two decades have highlighted the fundamental importance of gaseous signaling molecules in biology and medicine. The physiological role of other gases such as carbon monoxide and hydrogen sulfide (H2S) is now receiving increasing attention. Here we show that H2S is physiologically generated by cystathionine gamma-lyase (CSE) and that genetic deletion of this enzyme in mice markedly reduces H2S levels in the serum, heart, aorta, and other tissues, Mutant mice lacking CSE display pronounced hypertension and diminished endothelium-dependent vasorelaxation. CSE is physiologically activated by calcium-calmodulin, which is a mechanism for H2S formation in response to vascular activation. These findings provide direct evidence that H2S is a physiologic vasodilator and regulator of blood pressure.	[Wu, Lingyun] Univ Saskatchewan, Dept Pharmacol, Saskatoon, SK S7N 5E5, Canada; [Yang, Guangdong; Jiang, Bo; Yang, Wei; Qi, Jiansong; Cao, Kun; Wang, Rui] Univ Saskatchewan, Dept Physiol, Saskatoon, SK S7N 5E5, Canada; [Meng, Qinghe] Univ Saskatchewan, Dept Pathol, Saskatoon, SK S7N 5E5, Canada; [Mustafa, Asif K.; Mu, Weitong; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Mustafa, Asif K.; Mu, Weitong; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Mustafa, Asif K.; Mu, Weitong; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Yang, Guangdong; Zhang, Shengming; Wang, Rui] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Mu, Weitong] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Lakehead University; Johns Hopkins University	Wu, LY (corresponding author), Univ Saskatchewan, Dept Pharmacol, Saskatoon, SK S7N 5E5, Canada.	lily.wu@usask.ca; ssnyder@jhmi.edu; rwang@lakeheadu.ca	Yang, Guangdong/G-4129-2011; Wang, Rui/C-7824-2012	Wang, Rui/0000-0003-3825-3620	U.S. Public Health Service [MH18501]; Research Scientist Award [DA00074]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000074] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Research Scientist Award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank C. Watkins for experimental and conceptual assistance. Supported by U.S. Public Health Service grant MH18501 and Research Scientist Award DA00074 to S.H.S., and operating grants of Canadian Institutes of Health Research to L.W. and R.W.	Boehning D, 2004, J BIOL CHEM, V279, P30927, DOI 10.1074/jbc.C400222200; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Brandes RP, 2000, P NATL ACAD SCI USA, V97, P9747, DOI 10.1073/pnas.97.17.9747; Cheng YQ, 2004, AM J PHYSIOL-HEART C, V287, pH2316, DOI 10.1152/ajpheart.00331.2004; Cooke CLM, 2003, CARDIOVASC RES, V60, P635, DOI 10.1016/j.cardiores.2003.08.011; Feletou M, 2007, ANN MED, V39, P495, DOI 10.1080/07853890701491000; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; HEINONEN K, 1973, BIOCHEM J, V136, P1011, DOI 10.1042/bj1361011; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Ignarro LJ, 1999, BIOSCIENCE REP, V19, P51, DOI 10.1023/A:1020150124721; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Iwata C, 2007, LIFE SCI, V80, P873, DOI 10.1016/j.lfs.2006.11.012; Kimura H, 2002, MOL NEUROBIOL, V26, P13, DOI 10.1385/MN:26:1:013; Lake-Bruse KD, 1999, AM J PHYSIOL-HEART C, V277, pH770, DOI 10.1152/ajpheart.1999.277.2.H770; McCully KS, 1996, NAT MED, V2, P386, DOI 10.1038/nm0496-386; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Mok YYP, 2004, BRIT J PHARMACOL, V143, P881, DOI 10.1038/sj.bjp.0706014; Ndisang JF, 2004, J HYPERTENS, V22, P1057, DOI 10.1097/00004872-200406000-00002; Searcy DG, 1998, J EXP ZOOL, V282, P310, DOI 10.1002/(SICI)1097-010X(19981015)282:3<310::AID-JEZ4>3.0.CO;2-P; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Wang J, 2003, HUM GENET, V112, P404, DOI 10.1007/s00439-003-0906-8; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Yang GD, 2004, J BIOL CHEM, V279, P49199, DOI 10.1074/jbc.M408997200; Zhao WM, 2003, CAN J PHYSIOL PHARM, V81, P848, DOI 10.1139/Y03-077; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhong GZ, 2003, J HYPERTENS, V21, P1879, DOI 10.1097/00004872-200310000-00015; ZLOTKIN SH, 1982, PEDIATR RES, V16, P65	28	1819	1929	9	306	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					587	590		10.1126/science.1162667	http://dx.doi.org/10.1126/science.1162667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948540	Green Accepted			2022-12-28	WOS:000260299100043
J	Davis, K				Davis, Karen			Slowing the growth of health care costs - Learning from international experience	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Davis, Karen] Commonwealth Fund, New York, NY 10021 USA	Commonwealth Fund	Davis, K (corresponding author), Commonwealth Fund, New York, NY 10021 USA.							*AM COLL PHYS, 2008, ANN INTERN MED, V148, P635; [Anonymous], 2008, ANN INTERN MED, V148, P55, DOI 10.7326/0003-4819-148-1-200801010-00196; Nolte E, 2008, HEALTH AFFAIR, V27, P58, DOI 10.1377/hlthaff.27.1.58; Orszag PR, 2007, NEW ENGL J MED, V357, P1885, DOI 10.1056/NEJMp078191; Schoen C, 2007, BENDING CURVE OPTION; Schoen C, 2007, HEALTH AFFAIR, V26, pW717, DOI 10.1377/hlthaff.26.6.w717	6	38	38	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2008	359	17					1751	1755		10.1056/NEJMp0805261	http://dx.doi.org/10.1056/NEJMp0805261			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	363DJ	18946060	Bronze			2022-12-28	WOS:000260245800002
J	Fontanarosa, PB; Rennie, D; DeAngelis, CD				Fontanarosa, Phil B.; Rennie, Drummond; DeAngelis, Catherine D.			Health of the nation 2008 and beyond	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												phil.fontanarosa@jama-archives.org						DeVoe JE, 2008, JAMA-J AM MED ASSOC, V300, P1904, DOI 10.1001/jama.2008.516; Emanuel E, 2008, JAMA-J AM MED ASSOC, V300, P1931, DOI 10.1001/jama.2008.536; Fontanarosa PB, 2008, JAMA-J AM MED ASSOC, V299, P576, DOI 10.1001/jama.299.5.576; Fontanarosa PB, 2007, JAMA-J AM MED ASSOC, V297, P1128, DOI 10.1001/jama.297.10.1128; Loeffler JS, 2008, JAMA-J AM MED ASSOC, V300, P1937, DOI 10.1001/jama.300.16.1937; McCain JS, 2008, JAMA-J AM MED ASSOC, V300, P1925, DOI 10.1001/jama.2008.514; Mehta RH, 2008, JAMA-J AM MED ASSOC, V300, P1897, DOI 10.1001/jama.300.16.1897; Newton MF, 2008, JAMA-J AM MED ASSOC, V300, P1914, DOI 10.1001/jama.300.16.1914; Obama B, 2008, JAMA-J AM MED ASSOC, V300, P1927, DOI 10.1001/jama.2008.515; Ross JS, 2008, JAMA-J AM MED ASSOC, V300, P1934, DOI 10.1001/jama.300.16.1934; SCHOEN C, 2008, HLTH AFF, V27, pW289; Sessions SY, 2008, JAMA-J AM MED ASSOC, V300, P1929, DOI 10.1001/jama.2008.512; Voelker R, 2008, JAMA-J AM MED ASSOC, V300, P1869, DOI 10.1001/jama.300.16.1869	13	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2008	300	16					1941	1942		10.1001/jama.2008.509	http://dx.doi.org/10.1001/jama.2008.509			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362UR	18940986				2022-12-28	WOS:000260223100029
J	Calonge, N; Petitti, DB; DeWitt, TG; Dietrich, A; Gregory, KD; Harris, R; Isham, G; LeFevre, ML; Leipzig, R; Loveland-Cherry, C; Marion, LN; Moyer, VA; Ockene, JK; Sawaya, GF; Yawn, BP				Calonge, Ned; Petitti, Diana B.; DeWitt, Thomas G.; Dietrich, Allen; Gregory, Kimberly D.; Harris, Russell; Isham, George; LeFevre, Michael L.; Leipzig, Rosanne; Loveland-Cherry, Carol; Marion, Lucy N.; Moyer, Virginia A.; Ockene, Judith K.; Sawaya, George F.; Yawn, Barbara P.		US Preventive Serv Task Force	Primary Care Interventions to Promote Breastfeeding: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article								Description: Update of a 2003 U. S. Preventive Services Task Force (USPSTF) recommendation on counseling to promote breastfeeding. Methods: The USPSTF evaluated the results of a systematic review, conducted by the Tufts-New England Medical Center Evidence-based Practice Center, of literature published since January 2007 on primary care-initiated, -conducted, or -referable activities to promote and support breastfeeding. Recommendation: The USPSTF recommends interventions during pregnancy and after birth to promote and support breastfeeding ( Grade B recommendation).	[Calonge, Ned] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Petitti, Diana B.] Univ So Calif, Keck Sch Med, Sierra Madre, CA USA; [DeWitt, Thomas G.] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Dietrich, Allen] Dartmouth Med Sch, Lebanon, NH USA; [Gregory, Kimberly D.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Harris, Russell] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Isham, George] HealthPartners, Minneapolis, MN USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, Columbia, MO USA; [Leipzig, Rosanne] Mt Sinai Sch Med, New York, NY USA; [Loveland-Cherry, Carol] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Marion, Lucy N.] Med Coll Georgia, Sch Nursing, Augusta, GA 30912 USA; [Moyer, Virginia A.] Univ Texas Hlth Sci Ctr, Houston, TX USA; [Ockene, Judith K.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Sawaya, George F.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Yawn, Barbara P.] Olmsted Med Ctr, Rochester, MN USA	Colorado Department of Public Health & Environment; University of Southern California; Cincinnati Children's Hospital Medical Center; Dartmouth College; Cedars Sinai Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Missouri System; University of Missouri Columbia; Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan; University System of Georgia; Augusta University; University of Texas System; University of Texas Health Science Center Houston; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; Olmsted Medical Center	Calonge, N (corresponding author), Colorado Dept Publ Hlth & Environm, Denver, CO USA.				Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Financial Support: The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	American Academy of Pediatrics American College of Obstetricians and Gynecologists March of Dimes Birth Defects Foundation, 2007, GUID PER CAR, V6th; *CDCP, 2007, BREASTF PRACT RES NA; Chung M, 2008, ANN INTERN MED, V149, P565, DOI 10.7326/0003-4819-149-8-200810210-00009; *DEP HLTH HUM SERV, 2007, BREASTF BEST BAB BES; Guise Jeanne-Marie, 2003, Ann Fam Med, V1, P70, DOI 10.1370/afm.56; Ip Stanley, 2007, Evid Rep Technol Assess (Full Rep), P1; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; LEAWOOD KS, 2007, BREASTFEEDING POSITI; LEAWOOD KS, 2007, BREASTFEEDING POLICY; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2	11	45	48	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2008	149	8					560	107		10.7326/0003-4819-149-8-200810210-00008	http://dx.doi.org/10.7326/0003-4819-149-8-200810210-00008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367XJ	18936503				2022-12-28	WOS:000260585600005
J	Berger, SP				Berger, S. Paul			Brain science and addiction	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; EXPOSURE THERAPY; D-CYCLOSERINE; DISORDER		[Berger, S. Paul] Dept Vet Affairs Med Ctr, Portland, OR 97239 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Berger, SP (corresponding author), Dept Vet Affairs Med Ctr, Portland, OR 97239 USA.	bergerp@ohsu.edu						Academy of Medical Sciences, 2008, BRAIN SCI ADD DRUGS; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; BENDER E, 2003, PSYCHIAT NEWS, V38, P12; Berger SP, 2007, NATURE, V449, P972, DOI 10.1038/449972a; Davis M, 2002, EUR J NEUROSCI, V16, P395, DOI 10.1046/j.1460-9568.2002.02138.x; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P544, DOI 10.1016/j.biopsych.2007.11.011; Krystal JH, 2001, NEW ENGL J MED, V345, P1734, DOI 10.1056/NEJMoa011127; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Pucci E, 2007, COCHRANE DB SYST REV, V1; Wilhelm S, 2008, AM J PSYCHIAT, V165, P335, DOI 10.1176/appi.ajp.2007.07050776	10	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1280	1281		10.1016/S0140-6736(08)61530-5	http://dx.doi.org/10.1016/S0140-6736(08)61530-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18929888				2022-12-28	WOS:000260060500007
J	Buis, J; Wu, YP; Deng, YB; Leddon, J; Westfield, G; Eckersdorff, M; Sekiguchi, JM; Chang, S; Ferguson, DO				Buis, Jeffrey; Wu, Yipin; Deng, Yibin; Leddon, Jennifer; Westfield, Gerwin; Eckersdorff, Mark; Sekiguchi, JoAnn M.; Chang, Sandy; Ferguson, David O.			Mre11 nuclease activity has essential roles in DNA repair and genomic stability distinct from ATM activation	CELL			English	Article							DOUBLE-STRAND BREAKS; END-JOINING PATHWAY; SACCHAROMYCES-CEREVISIAE; V(D)J RECOMBINATION; LIGASE IV; MEIOTIC RECOMBINATION; EMBRYONIC LETHALITY; DAMAGE RESPONSES; HUMAN TELOMERES; COMPLEX	The Mre11/Rad50/NBS1 (MRN) complex maintains genomic stability by bridging DNA ends and initiating DNA damage signaling through activation of the ATM kinase. Mre11 possesses DNA nuclease activities that are highly conserved in evolution but play unknown roles in mammals. To define the functions of Mre11, we engineered targeted mouse alleles that either abrogate nuclease activities or inactivate the entire MRN complex. Mre11 nuclease deficiency causes a striking array of phenotypes indistinguishable from the absence of MRN, including early embryonic lethality and dramatic genomic instability. We identify a crucial role for the nuclease activities in homology-directed double-strand-break repair and a contributing role in activating the ATR kinase. However, the nuclease activities are not required to activate ATM after DNA damage or telomere deprotection. Therefore, nucleolytic processing by Mre11 is an essential function of fundamental importance in DNA repair, distinct from MRN control of ATM signaling.	[Buis, Jeffrey; Wu, Yipin; Leddon, Jennifer; Eckersdorff, Mark; Ferguson, David O.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Deng, Yibin; Chang, Sandy] Univ Texas Houston, MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Deng, Yibin; Chang, Sandy] Univ Texas Houston, MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Westfield, Gerwin; Sekiguchi, JoAnn M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Westfield, Gerwin; Sekiguchi, JoAnn M.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ferguson, DO (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	daviferg@umich.edu		Deng, Yibin/0000-0001-5711-3565; Westfield, Gerwin/0000-0001-9634-2336; Sekiguchi, JoAnn/0000-0002-7178-4258	National Institutes of Health (NIH) [HL079118]; Sidney Kimmel Cancer Research Foundation; University of Michigan Cancer Center [5-P30-CA46592]; Munn Endowment; Cure foundations, the Michael Kadoorie Cancer Genetics Research Program; NIH [AG028888, CA129037, AI063058]; Pew Foundation Scholars Award;  [K08 HL067580];  [1K01CA124461-01]; NATIONAL CANCER INSTITUTE [T32CA009676, R01CA129037, P30CA016672, K01CA124461, P30CA046592] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079118, K08HL067580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028888] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sidney Kimmel Cancer Research Foundation; University of Michigan Cancer Center(University of Michigan System); Munn Endowment; Cure foundations, the Michael Kadoorie Cancer Genetics Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Foundation Scholars Award; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support for this work to D.O.F. was provided by the National Institutes of Health (NIH) (HL079118), Sidney Kimmel Cancer Research Foundation, University of Michigan Cancer Center Support Grant 5-P30-CA46592, and Munn Endowment, and by K08 HL067580 under initial mentorship of Frederick W. Alt. D.O.F. thanks John Moran, Tom Wilson, Mats Ljungman, Chris Canman, and Tobias Else for advice on the manuscript and experiments. S.C. acknowledges M.D. Anderson Cancer Center's Molecular Cytogenetics Core (CA016672) and support from the Welch, Elsa U. Pardee, and Abraham and Phyllis Katz, and Susan G. Komen for the Cure foundations, the Michael Kadoorie Cancer Genetics Research Program, and the NIH (AG028888, CA129037). Y.D. supported by 1K01CA124461-01. J.M.S. is supported by NIH AI063058 and Pew Foundation Scholars Award.	Arthur LM, 2004, NUCLEIC ACIDS RES, V32, P1886, DOI 10.1093/nar/gkh343; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Boisvert FM, 2005, GENE DEV, V19, P671, DOI 10.1101/gad.1279805; Bressan DA, 1998, GENETICS, V150, P591; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Difilippantonio S, 2007, CELL CYCLE, V6, P2366, DOI 10.4161/cc.6.19.4758; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Krogh BO, 2005, GENETICS, V171, P1561, DOI 10.1534/genetics.105.049478; Lambert S, 2007, DNA REPAIR, V6, P1042, DOI 10.1016/j.dnarep.2007.02.024; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Morales M, 2005, GENE DEV, V19, P3043, DOI 10.1101/gad.1373705; Moreau S, 1999, MOL CELL BIOL, V19, P556; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Petermann E, 2006, CELL CYCLE, V5, P2203, DOI 10.4161/cc.5.19.3256; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Rooney S, 2003, J EXP MED, V197, P553, DOI 10.1084/jem.20021891; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2005, MOL CELL, V19, P724, DOI 10.1016/j.molcel.2005.07.006; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Xiao YH, 1997, NUCLEIC ACIDS RES, V25, P2985, DOI 10.1093/nar/25.15.2985; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Zhong H, 2005, HUM MOL GENET, V14, P2685, DOI 10.1093/hmg/ddi302; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	52	239	244	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					85	96		10.1016/j.cell.2008.08.015	http://dx.doi.org/10.1016/j.cell.2008.08.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854157	Green Accepted, Bronze			2022-12-28	WOS:000259728100011
J	Wakeham, B				Wakeham, Bill			UK physics gets a health check	NATURE			English	Editorial Material									[Wakeham, Bill] Univ Southampton, Southampton SO17 1BJ, Hants, England	University of Southampton	Wakeham, B (corresponding author), Univ Southampton, Univ Rd, Southampton SO17 1BJ, Hants, England.	vice-chancellor@soton.ac.uk							0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					592	592		10.1038/455592a	http://dx.doi.org/10.1038/455592a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833257				2022-12-28	WOS:000259639700023
J	Klaver, CCW; Bergen, AAB				Klaver, Caroline C. W.; Bergen, Arthur A. B.			The SERPING1 gene and age-related macular degeneration	LANCET			English	Editorial Material							SUSCEPTIBILITY		[Klaver, Caroline C. W.] Erasmus MC, Dept Ophthalmol, NL-3000 CA Rotterdam, Netherlands; [Klaver, Caroline C. W.] Erasmus MC, Dept Epidemiol & Biostat, NL-3000 CA Rotterdam, Netherlands; [Bergen, Arthur A. B.] Netherlands Inst Neurosci, Dept Ophthalmogenet, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Klaver, CCW (corresponding author), Erasmus MC, Dept Ophthalmol, NL-3000 CA Rotterdam, Netherlands.	carolineklaver@yahoo.com	Klaver, Caroline C.W./A-2013-2016	Bergen, Arthur/0000-0002-6333-9576; Klaver, Caroline/0000-0002-2355-5258				Conley YP, 2006, HUM MOL GENET, V15, P3206, DOI 10.1093/hmg/ddl396; Duponchel Christiane, 2006, Hum Mutat, V27, P295, DOI 10.1002/humu.9414; Emonts M, 2007, FEMS IMMUNOL MED MIC, V50, P330, DOI 10.1111/j.1574-695X.2007.00250.x; ENNIS S, 2008, LANCET          1007, DOI DOI 10.1016/S0140-6736(08)61348-3; Gosswein T, 2008, CYTOGENET GENOME RES, V121, P181, DOI 10.1159/000138883; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212; Thakkinstian A, 2006, AM J EPIDEMIOL, V164, P813, DOI 10.1093/aje/kwj279; van Soest SS, 2007, MOL VIS, V13, P1608; *WASH SCH MED, SNPSEEK RETR AN FUNC; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618	14	4	4	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2008	372	9652					1788	1789		10.1016/S0140-6736(08)61349-5	http://dx.doi.org/10.1016/S0140-6736(08)61349-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	18842295				2022-12-28	WOS:000261112000006
J	Keller, PJ; Schmidt, AD; Wittbrodt, J; Stelzer, EHK				Keller, Philipp J.; Schmidt, Annette D.; Wittbrodt, Joachim; Stelzer, Ernst H. K.			Reconstruction of Zebrafish Early Embryonic Development by Scanned Light Sheet Microscopy	SCIENCE			English	Article							CELL MOVEMENTS; GASTRULATION; EXTENSION; POLARITY; LINEAGE; ONSET	A long- standing goal of biology is to map the behavior of all cells during vertebrate embryogenesis. We developed digital scanned laser light sheet fluorescence microscopy and recorded nuclei localization and movement in entire wild- type and mutant zebrafish embryos over the first 24 hours of development. Multiview in vivo imaging at 1.5 billion voxels per minute provides "digital embryos," that is, comprehensive databases of cell positions, divisions, and migratory tracks. Our analysis of global cell division patterns reveals a maternally defined initial morphodynamic symmetry break, which identifies the embryonic body axis. We further derive a model of germ layer formation and show that the mesendoderm forms from one- third of the embryo's cells in a single event. Our digital embryos, with 55 million nucleus entries, are provided as a resource.	[Keller, Philipp J.; Wittbrodt, Joachim; Stelzer, Ernst H. K.] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Keller, Philipp J.; Schmidt, Annette D.; Wittbrodt, Joachim] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Wittbrodt, Joachim] Heidelberg Univ, Inst Zool, Dept Dev Physiol, INF 230, D-69120 Heidelberg, Germany; [Wittbrodt, Joachim] KIT, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology	Keller, PJ (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	keller@embl.de; wittbrod@embl.de	Stelzer, Ernst H K/A-7648-2011; Wittbrodt, Joachim/D-4735-2014; Keller, Philipp J/F-2343-2010	Stelzer, Ernst H K/0000-0003-1545-0736; Wittbrodt, Joachim/0000-0001-8550-7377; Keller, Philipp/0000-0003-2896-4920	Studienstiftung des deutschen Volkes; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology;  [EU-FP6-STREP Plurigenes];  [DFG SFB-488]	Studienstiftung des deutschen Volkes; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology; ; 	We thank U. Liebel, M. Alef, and M. Wahlers for excellent KIT/EMBL computer cluster support; the EMBL mechanical workshop for custom hardware; A. Riedinger and G. Ritter for custom electronics; F. Harle and A. Riedinger for custom microscope operating software; W. Dilling for technical drawings; M. Knop, K. Brown, K. Khairy, J. Martinez, D. Gilmour, and C.-P. Heisenberg for critical manuscript comments; L. Centanin for immunostained medaka embryos; C.- P. Heisenberg for MZoep mutants; S. Terjung for Leica SP5 support; G. Giese for Zeiss LSM 510 NLO support. Financial support: EU-FP6-STREP Plurigenes, DFG SFB-488 (J.W.); Studienstiftung des deutschen Volkes (P.J.K.); Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, HBIGS (A.D.S.). Contributions: P.J.K. outlined the digital embryo project, designed and built the DSLM, recorded the microscopy data, developed the image processing pipeline, performed the reconstructions and drafted the manuscript. A.D.S. developed the biological methods, performed the biological preparations, contributed to project planning and participated in the writing of the manuscript. E.H.K.S. outlined the DSLM development, cosupervised the project, and participated in manuscript preparation. P.J.K., A.D.S., and J.W. analyzed the digital embryos. J.W. guided the biological research, cosupervised the project, and participated in the writing of the manuscript.	Adams RJ, 2004, GASTRULATION CELLS E, P305; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Concha ML, 1998, DEVELOPMENT, V125, P983; Dougan ST, 2003, DEVELOPMENT, V130, P1837, DOI 10.1242/dev.00400; Ellingsen S, 2005, DEVELOPMENT, V132, P3799, DOI 10.1242/dev.01951; England SJ, 2006, DEVELOPMENT, V133, P4613, DOI 10.1242/dev.02678; Gilbert SF, 2006, DEV BIOL; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Heisenberg CP, 2002, SEMIN CELL DEV BIOL, V13, P471, DOI 10.1016/S1084952102001003; Hirose Y, 2004, DEVELOPMENT, V131, P2553, DOI 10.1242/dev.01140; HISAOKA KENICHI KENNETH, 1958, J MORPH, V102, P311, DOI 10.1002/jmor.1051020205; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; KANE D, 2002, PATTERN FORMATION ZE; KANE DA, 1993, DEVELOPMENT, V119, P447; Kane DA, 1996, DEVELOPMENT, V123, P47; Keller PJ, 2007, NAT METHODS, V4, P843, DOI 10.1038/NMETH1087; Keller PJ, 2006, CURR OPIN CELL BIOL, V18, P117, DOI 10.1016/j.ceb.2005.12.012; Lemaire P, 2006, SCIENCE, V312, P1145, DOI 10.1126/science.1128784; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Pezeron G, 2008, CURR BIOL, V18, P276, DOI 10.1016/j.cub.2008.01.028; Rembold M, 2006, SCIENCE, V313, P1130, DOI 10.1126/science.1127144; Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3; SCHMITZ B, 1994, ROUX ARCH DEV BIOL, V203, P374, DOI 10.1007/BF00188685; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Sepich Diane S., 2004, V294, P211; Sepich DS, 2005, DEV DYNAM, V234, P279, DOI 10.1002/dvdy.20507; SHIH J, 1995, DEVELOPMENT, V121, P2755; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Trinkaus J. P., 1984, CELLS ORGANS FORCES; Tsien R. Y., 2006, HDB BIOL CONFOCAL MI, V3rd, P338, DOI [10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2_16]; WARGA RM, 1990, DEVELOPMENT, V108, P569; Warga RM, 1998, DEV BIOL, V203, P116, DOI 10.1006/dbio.1998.9022; Wolpert L, 2007, PRINCIPLES DEV	40	1019	1055	20	373	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1065	1069		10.1126/science.1162493	http://dx.doi.org/10.1126/science.1162493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	18845710				2022-12-28	WOS:000260867700028
J	Helms, CM; Polgreen, PM; Isaacs, D; Leask, J				Helms, Charles M.; Polgreen, Philip M.; Isaacs, David; Leask, Julie			Should influenza immunisation be mandatory for healthcare workers?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Helms, Charles M.; Polgreen, Philip M.] Univ Iowa, Carver Coll Med, Dept Internal Med, Div Infect Dis, Iowa City, IA 52242 USA; [Isaacs, David] Childrens Hosp Westmead, Dept Infect Dis, Westmead, NSW 2145, Australia; [Leask, Julie] Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance, Westmead, NSW 2145, Australia; [Leask, Julie] Univ Sydney, Sydney, NSW 2006, Australia	University of Iowa; University of Sydney; University of Sydney; University of Sydney	Helms, CM (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, Div Infect Dis, 200 Hawkins Dr, Iowa City, IA 52242 USA.	Charles-helms@uiowa.edu; davidi@chw.edu.au	Leask, Julie/ABE-2077-2020	Leask, Julie/0000-0001-5095-1443; Polgreen, Philip/0000-0002-0630-5898					0	33	33	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 1	2008	337								a2142	10.1136/bmj.a2142	http://dx.doi.org/10.1136/bmj.a2142			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	368AM	18957466				2022-12-28	WOS:000260593700025
J	Hedges, LM; Brownlie, JC; O'Neill, SL; Johnson, KN				Hedges, Lauren M.; Brownlie, Jeremy C.; O'Neill, Scott L.; Johnson, Karyn N.			Wolbachia and Virus Protection in Insects	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER		[Hedges, Lauren M.; Brownlie, Jeremy C.; O'Neill, Scott L.; Johnson, Karyn N.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia	University of Queensland	Johnson, KN (corresponding author), Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia.	karynj@uq.edu.au	O'Neill, Scott/R-9560-2019; Johnson, Karyn N/B-7980-2008; O'Neill, Scott L/B-3568-2009	O'Neill, Scott/0000-0002-4131-3615; Johnson, Karyn N/0000-0001-8647-8985; O'Neill, Scott L/0000-0002-4131-3615; Brownlie, Jeremy/0000-0003-0161-2204	University of Queensland; Australian Research Council; Foundation for the National Institutes of Health; Grand Challenges in Global Health Initiative	University of Queensland(University of Queensland); Australian Research Council(Australian Research Council); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grand Challenges in Global Health Initiative	We thank M. Riegler for advice and E. McGraw and F. Pringle for critical reading of the manuscript. This work was supported by funding from The University of Queensland, Australian Research Council, and the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative.	Brun G., 1980, Genetics and Biology of Drosophila, V2d, P625; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; Hoffmann AA, 1998, GENETICS, V148, P221; Johnson KN, 1998, J GEN VIROL, V79, P191, DOI 10.1099/0022-1317-79-1-191; ONeill SL, 1997, INFLUENTIAL PASSENGE; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694	7	793	840	4	225	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					702	702		10.1126/science.1162418	http://dx.doi.org/10.1126/science.1162418			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974344				2022-12-28	WOS:000260605200037
J	Lopatto, D; Alvarez, C; Barnard, D; Chandrasekaran, C; Chung, HM; Du, C; Eckdahl, T; Goodman, AL; Hauser, C; Jones, CJ; Kopp, OR; Kuleck, GA; McNeil, G; Morris, R; Myka, JL; Nagengast, A; Overvoorde, PJ; Poet, JL; Reed, K; Regisford, G; Revie, D; Rosenwald, A; Saville, K; Shaw, M; Skuse, GR; Smith, C; Smith, M; Spratt, M; Stamm, J; Thompson, JS; Wilson, BA; Witkowski, C; Youngblom, J; Leung, W; Shaffer, CD; Buhler, J; Mardis, E; Elgin, SCR				Lopatto, D.; Alvarez, C.; Barnard, D.; Chandrasekaran, C.; Chung, H. -M.; Du, C.; Eckdahl, T.; Goodman, A. L.; Hauser, C.; Jones, C. J.; Kopp, O. R.; Kuleck, G. A.; McNeil, G.; Morris, R.; Myka, J. L.; Nagengast, A.; Overvoorde, P. J.; Poet, J. L.; Reed, K.; Regisford, G.; Revie, D.; Rosenwald, A.; Saville, K.; Shaw, M.; Skuse, G. R.; Smith, C.; Smith, M.; Spratt, M.; Stamm, J.; Thompson, J. S.; Wilson, B. A.; Witkowski, C.; Youngblom, J.; Leung, W.; Shaffer, C. D.; Buhler, J.; Mardis, E.; Elgin, S. C. R.			UNDERGRADUATE RESEARCH Genomics Education Partnership	SCIENCE			English	Editorial Material							DOT CHROMOSOME; DROSOPHILA		[Lopatto, D.] Grinnell Coll, Grinnell, IA 50112 USA; [Alvarez, C.] Longwood Univ, Farmville, VA USA; [Barnard, D.] Worcester State Coll, Worcester, MA USA; [Chandrasekaran, C.] Texas Wesleyan Univ, Ft Worth, TX USA; [Chung, H. -M.] Univ W Florida, Pensacola, FL 32514 USA; [Du, C.] Montclair State Univ, Montclair, NJ USA; [Eckdahl, T.; Poet, J. L.] Missouri Western State Univ, St Joseph, MO USA; [Goodman, A. L.] Calif Polytech State Univ San Luis Obispo, San Luis Obispo, CA 93407 USA; [Hauser, C.] St Edwards Univ, Austin, TX 78704 USA; [Jones, C. J.] Moravian Coll, Bethlehem, PA USA; [Kopp, O. R.] Utah Valley Univ, Orem, UT USA; [Kuleck, G. A.] Loyola Marymount Univ, Los Angeles, CA 90045 USA; [McNeil, G.] CUNY York Coll, Jamaica, NY 11451 USA; [Morris, R.; Nagengast, A.] Widener Univ, Chester, PA 19013 USA; [Myka, J. L.] Galen Coll Nursing, Cincinnati, OH USA; [Overvoorde, P. J.] Macalester Coll, St Paul, MN 55105 USA; [Reed, K.] Austin Coll, Sherman, TX 75090 USA; [Regisford, G.] Prairie View A&M Univ, Prairie View, TX USA; [Revie, D.] Calif Lutheran Univ, Thousand Oaks, CA USA; [Rosenwald, A.] Georgetown Univ, Washington, DC USA; [Saville, K.] Albion Coll, Albion, MI 49224 USA; [Shaw, M.] New Mexico Highlands Univ, Las Vegas, NM USA; [Skuse, G. R.] Rochester Inst Technol, Rochester, NY 14623 USA; [Smith, C.] San Francisco State Univ, San Francisco, CA 94132 USA; [Smith, M.] N Carolina Agr & Tech State Univ, Greensboro, NC USA; [Spratt, M.] William Woods Univ, Fulton, MO USA; [Stamm, J.] Univ Evansville, Evansville, IN USA; [Thompson, J. S.] Denison Univ, Granville, OH 43023 USA; [Wilson, B. A.] Jackson State Univ, Jackson, MS USA; [Witkowski, C.] Missouri State Univ, Springfield, MO USA; [Youngblom, J.] Calif State Univ Stanislaus, Turlock, CA 95382 USA; [Leung, W.; Shaffer, C. D.; Buhler, J.; Mardis, E.; Elgin, S. C. R.] Washington Univ, St Louis, MO USA	Longwood University; Massachusetts System of Public Higher Education; Worcester State University; State University System of Florida; University of West Florida; Montclair State University; California State University System; California Polytechnic State University San Luis Obispo; Utah System of Higher Education; Utah Valley University; Loyola Marymount University; City University of New York (CUNY) System; York College NY (CUNY); Widener University; Macalester College; Texas A&M University System; Prairie View A&M University; California Lutheran University; Georgetown University; Albion College; Rochester Institute of Technology; California State University System; San Francisco State University; University of North Carolina; North Carolina A&T State University; William Woods University; University of Evansville; Denison University; Jackson State University; Missouri State University; California State University System; California State University Stanislaus; Washington University (WUSTL)	Lopatto, D (corresponding author), Grinnell Coll, Grinnell, IA 50112 USA.	lopatto@grinnell.edu; selgin@biology.wustl.edu	Thompson, Jeff/HGB-3965-2022; Mardis, Elaine/W-2202-2019; Jones, Christopher J/B-5466-2009	Thompson, Jeff/0000-0002-9281-2596; Jones, Christopher J/0000-0001-5031-3839; Elgin, Sarah C. R./0000-0002-5176-2510	Howard Hughes Medical Institute [52005790] Funding Source: Medline; NIGMS NIH HHS [R01 GM031532-15A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031532] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blanton, 2008, CREATING EFFECTIVE U, P33; Campbell A Malcolm, 2007, CBE Life Sci Educ, V6, P109, DOI 10.1187/cbe.06-10-0196; Denofrio LA, 2007, SCIENCE, V318, P1872, DOI 10.1126/science.1150788; Lopatto D., 2008, CREATING EFFECTIVE U, P112; Lopatto David, 2007, CBE Life Sci Educ, V6, P297, DOI 10.1187/cbe.07-06-0039; Riddle NC, 2006, CHROMOSOME RES, V14, P405, DOI 10.1007/s10577-006-1061-6; Russell S. H, 2008, CREATING EFFECTIVE R, P53; Seymour E, 2004, SCI EDUC, V88, P493, DOI 10.1002/sce.10131; Slawson EE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r15; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340	10	115	116	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					684	685		10.1126/science.1165351	http://dx.doi.org/10.1126/science.1165351			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974335	Green Accepted			2022-12-28	WOS:000260605200028
J	McCauley, E; Nelson, WA; Nisbet, RM				McCauley, Edward; Nelson, William A.; Nisbet, Roger M.			Small-amplitude cycles emerge from stage-structured interactions in Daphnia-algal systems	NATURE			English	Article							PREY; POPULATION; DYNAMICS; MODEL; ENVIRONMENTS; ZOOPLANKTON; MECHANISMS; PLANKTON	A long-standing issue in ecology is reconciling the apparent stability of many populations with robust predictions of large-amplitude population cycles from general theory on consumer resource interactions(1). Even when consumers are decoupled from dynamic resources, large- amplitude cycles can theoretically emerge from delayed feedback processes found in many consumers(2,3). Here we show that resource- dependent mortality and a dynamic developmental delay in consumers produces a new type of small- amplitude cycle that coexists with large- amplitude fluctuations in coupled consumer - resource systems. A distinctive characteristic of the small- amplitude cycles is slow juvenile development for consumers, leading to a developmental delay that is longer than the cycle period. By contrast, the period exceeds the delay in large-amplitude cycles. These theoretical predictions may explain previous empirical results on coexisting attractors found in Daphnia algal systems(4,5). To test this, we used bioassay experiments that measure the growth rates of individuals in populations exhibiting each type of cycle. The results were consistent with predictions. Together, the new theory and experiments establish that two very general features of consumers - a resource- dependent juvenile stage duration and resource- dependent mortality - combine to produce small- amplitude resource - consumer cycles. This phenomenon may contribute to the prevalence of small- amplitude fluctuations in many other consumer - resource populations(6,7).	[McCauley, Edward] Univ Calgary, Dept Biol Sci, Ecol & Evolut Grp, Calgary, AB T2N 1N4, Canada; [Nelson, William A.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Nisbet, Roger M.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of Calgary; Queens University - Canada; University of California System; University of California Santa Barbara	McCauley, E (corresponding author), Univ Calgary, Dept Biol Sci, Ecol & Evolut Grp, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	mccauley@ucalgary.ca	Nelson, William A/D-1405-2013; Nisbet, Roger M/B-6951-2014		NSERC ( Discovery Grants and Accelerator Award); Canada Foundation for Innovation; Canada Research Chairs Program; Alberta Ingenuity; US National Science Foundation [DEB- 0717259]	NSERC ( Discovery Grants and Accelerator Award)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs Program(Canada Research Chairs); Alberta Ingenuity; US National Science Foundation(National Science Foundation (NSF))	We acknowledge feedback from A. de Roos, J. Fox, J. Casas, L. Persson and C. Briggs. A. Potapov provided advice on the bifurcation analysis. Experiments and theoretical analysis were supported by NSERC (Discovery Grants and Accelerator Award), Canada Foundation for Innovation, and the Canada Research Chairs Program to E. M. W. A. N. acknowledges support from Alberta Ingenuity. R. M. N. acknowledges support from the US National Science Foundation (Grant DEB- 0717259).	Abrams PA, 2002, THEOR POPUL BIOL, V62, P281, DOI 10.1006/tpbi.2002.1614; Benton TG, 2006, P R SOC B, V273, P1173, DOI 10.1098/rspb.2006.3495; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Claessen D, 2004, P ROY SOC B-BIOL SCI, V271, P333, DOI 10.1098/rspb.2003.2555; de Roos AM, 2003, THEOR POPUL BIOL, V63, P1, DOI 10.1016/S0040-5809(02)00009-6; Dennis B, 2001, ECOL MONOGR, V71, P277, DOI 10.1890/0012-9615(2001)071[0277:ECACDI]2.0.CO;2; DEROOS AM, 1990, J MATH BIOL, V28, P609, DOI 10.1007/BF00160229; GROVER JP, 1994, AM NAT, V143, P258, DOI 10.1086/285603; HASTINGS A, 1982, THEOR POPUL BIOL, V21, P44, DOI 10.1016/0040-5809(82)90005-3; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; KRETZSCHMAR M, 1993, THEOR POPUL BIOL, V44, P32, DOI 10.1006/tpbi.1993.1017; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; MCCAULEY E, 1987, AM NAT, V129, P97, DOI 10.1086/284624; McCauley E, 1996, ECOL MONOGR, V66, P479, DOI 10.2307/2963491; MCCAULEY E, 1990, NATURE, V343, P455, DOI 10.1038/343455a0; Medvinsky AB, 2004, CR BIOL, V327, P277, DOI 10.1016/j.crvi.2003.11.013; Murdoch W.W., 2013, CONSUMER RESOURCE DY; MURDOCH WW, 1985, NATURE, V316, P628, DOI 10.1038/316628a0; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; Murdoch WW, 2002, NATURE, V417, P541, DOI 10.1038/417541a; Nelson WA, 2007, EVOL ECOL, V21, P499, DOI 10.1007/s10682-006-9131-y; Nisbet RM, 2004, ECOLOGY, V85, P3132, DOI 10.1890/03-0429; Persson L, 2007, SCIENCE, V316, P1743, DOI 10.1126/science.1141412; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	24	59	61	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2008	455	7217					1240	1243		10.1038/nature07220	http://dx.doi.org/10.1038/nature07220			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18972019				2022-12-28	WOS:000260462100044
J	Chen, Z				Chen, Zhu			Biomedical science and technology in China	LANCET			English	Editorial Material									[Chen, Zhu] Minist Hlth, Beijing 100044, Peoples R China; [Chen, Zhu] Rui Jin Hosp, Shanghai, Peoples R China		Chen, Z (corresponding author), Minist Hlth, Beijing 100044, Peoples R China.	zchen@stn.sh.cn						Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Chen Z, 2007, PHILOS T R SOC B, V362, P947, DOI 10.1098/rstb.2007.2025; Deng Xiaoping, 1993, SELECTED WORKS XP DE, V3, P274; *E FOR SCI TECHN, 2004, 53 E FOR SCI TECHN; Guo J, 2006, SCIENCE, V314, P1232, DOI 10.1126/science.314.5803.1232; He JF, 2004, SCIENCE, V303, P1666, DOI 10.1126/science.1092002; Hu J., 2007, 17 CPC C; *HUM PROT ORG, HUM LIV PROT PROJ; JIANG Z, 2006, SELECTED WORKS ZM JI, P425; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; *STAT COUNC, 2006, PEOPL REP CHIN GUID; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130	15	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 25	2008	372	9648					1441	1443		10.1016/S0140-6736(08)61352-5	http://dx.doi.org/10.1016/S0140-6736(08)61352-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370ZJ	18930525	Green Published, Bronze			2022-12-28	WOS:000260801300005
J	Cheng, MH				Cheng, Margaret Harris			Han Qide: a medical and political leader in China Profile	LANCET			English	Biographical-Item												mharris@netvigator.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2008	372	9648					1456	1456		10.1016/S0140-6736(08)61562-7	http://dx.doi.org/10.1016/S0140-6736(08)61562-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370ZJ	18930532				2022-12-28	WOS:000260801300013
J	Dillner, J; Rebolj, M; Birembaut, P; Petry, KU; Szarewski, A; Munk, C; de Sanjose, S; Naucler, P; Lloveras, B; Kjaer, S; Cuzick, J; van Ballegooijen, M; Clavel, C; Iftner, T				Dillner, Joalim; Rebolj, Matejka; Birembaut, Philippe; Petry, Karl-Ulrich; Szarewski, Anne; Munk, Christian; de Sanjose, Silvia; Naucler, Pontus; Lloveras, Belen; Kjaer, Susanne; Cuzick, Jack; van Ballegooijen, Marjolein; Clavel, Christine; Iftner, Thomas			Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; LIQUID-BASED CYTOLOGY; FOLLOW-UP; HPV; WOMEN; POPULATION; RISK; DNA; RECRUITMENT; PERSISTENCE	Objective To obtain large scale and generalisable data on the long term predictive value of cytology and human papillomavirus (HPV) testing for development of cervical intraepithelial neoplasia grade 3 or cancer (CIN3+). Design Multinational cohort study with joint database analysis. Setting Seven primary HPV screening studies in six European countries. Participants 24 295 women attending cervical screening enrolled into HPV screening trials who had at least one cervical cytology or histopathology examination during follow-up. Main outcome measure Longterm cumulative incidence of CIN3+. Results The cumulative incidence rate of CIN3+ after six years was considerably lower among women negative for HPV at baseline (0.27%, 95% confidence interval 0.12% to 0.45%) than among women with negative results on cytology (0.97%, 0.53% to 1.34%)). By comparison, the cumulative incidence rate for women with negative cytology results at the most commonly recommended screening interval in Europe (three years) was 0.51% (0.23% to 0.77%). The cumulative incidence rate among women with negative cytology results who were positive for HPV increased continuously overtime, reaching 10% at six years, whereas the rate among women with positive cytology results who were negative for HPV remained below 3%. Conclusions A consistently low six year cumulative incidence rate of CIN3+ among women negative for HPV suggests that cervical screening strategies in which women are screened for HPV every six years are safe and effective.	[Dillner, Joalim; Naucler, Pontus] Lund Univ, Univ Hosp MAS, S-20502 Malmo, Sweden; [Rebolj, Matejka; van Ballegooijen, Marjolein] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Birembaut, Philippe; Clavel, Christine] CHU Reims, Serv Anat Pathol, INSERM, UMR S903,Lab Pol Bouin, Reims, France; [Petry, Karl-Ulrich] Teaching Hosp Wolfsburg, Dept Obstet & Gynaecol, Wolfsburg, Germany; [Szarewski, Anne; Cuzick, Jack] Canc Res UK, Wolfson Inst Prevent Med, London, England; [Munk, Christian; Kjaer, Susanne] Danish Canc Soc, Inst Canc Epidemiol, DK-2100 Copenhagen, Denmark; [de Sanjose, Silvia; Lloveras, Belen] Hosp Duran i Reynals, Catalan Inst Oncol, Barcelona, Spain; [Kjaer, Susanne] Copenhagen Univ Hosp, Gynecol Clin, Rigshosp, Copenhagen, Denmark; [Iftner, Thomas] Univ Tubingen Hosp, Sect Expt Virol, Inst Med Virol, Tubingen, Germany	Lund University; Skane University Hospital; Erasmus University Rotterdam; Erasmus MC; CHU de Reims; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Reims Champagne-Ardenne; Cancer Research UK; University of London; Queen Mary University London; Danish Cancer Society; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Rigshospitalet; University of Copenhagen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Dillner, J (corresponding author), Lund Univ, Univ Hosp MAS, S-20502 Malmo, Sweden.	joakim.dillner@med.lu.se	BIREMBAUT, Philippe/P-5210-2016; de Sanjosé Llongueras, Silvia/H-6339-2014; Iftner, Thomas/ABF-9029-2020	Rebolj, Matejka/0000-0001-9597-645X; Kjaer, Susanne/0000-0002-8347-1398	European Union Biomed 5 [QLG4-CT2000-01238]; Digene; Spanish Ministry of Health [99/1207]; CIBER [SP 06-0073]; Swedish Cancer Society; Europe against Cancer; ARC; Region Champagne-Ardenne; Canceropole Grand Est	European Union Biomed 5(European Commission); Digene; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); CIBER; Swedish Cancer Society(Swedish Cancer Society); Europe against Cancer; ARC(Australian Research Council); Region Champagne-Ardenne(Region Grand-Est); Canceropole Grand Est(Region Grand-Est)	European Union Biomed 5 contract HPV-based cervical cancer screening (QLG4-CT2000-01238). Digene provided the HPV Kits (Tiibingen). Digene and the Spanish Ministry of Health funded the Spanish study (grant Nos 99/1207 and CIBER SP 06-0073); Swedish Cancer Society and Europe against Cancer funded the Swedish study; and ARC (Association de Recherche contre le Cancer), the Region Champagne-Ardenne, and Canceropole Grand Est funded the French study.	[Anonymous], 1997, S PLUS 4 GUID STAT; Anttila A, 2004, BRIT J CANCER, V91, P935, DOI 10.1038/sj.bjc.6602069; Arbyn M, 2006, VACCINE, V24, P78, DOI 10.1016/j.vaccine.2006.05.117; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P677, DOI 10.1158/1055-9965.EPI-04-0569; Bray F, 2002, EUR J CANCER, V38, P99, DOI 10.1016/S0959-8049(01)00350-1; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Bulkmans NWJ, 2005, BRIT J CANCER, V92, P1800, DOI 10.1038/sj.bjc.6602541; Clavel C, 2001, BRIT J CANCER, V84, P1616, DOI 10.1054/bjoc.2001.1845; Crawley M.J., 1993, GLIM ECOLOGISTS; Cuzick J, 2008, INT J CANCER, V122, P2294, DOI 10.1002/ijc.23339; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; De Sanjose S, 2003, SEX TRANSM DIS, V30, P788, DOI 10.1097/01.OLQ.0000080177.82204.E0; Efron B., 1993, INTRO BOOSTRAP; Elfgren K, 2005, AM J OBSTET GYNECOL, V193, P650, DOI 10.1016/j.ajog.2005.01.056; Franco Eduardo L, 2003, J Natl Cancer Inst Monogr, P89; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Hoyer H, 2005, INT J CANCER, V116, P136, DOI 10.1002/ijc.20955; Kitchener HC, 2006, BRIT J CANCER, V95, P56, DOI 10.1038/sj.bjc.6603210; Kjaer SK, 2016, BMJ-BRIT MED J, V353, DOI [10.1136/bmj.325.7364.572, 10.1136/bmj.i2820]; Kotaniemi-Talonen L, 2005, BRIT J CANCER, V93, P862, DOI 10.1038/sj.bjc.6602799; Kulmala SM, 2004, J CLIN MICROBIOL, V42, P2470, DOI 10.1128/JCM.42.6.2470-2475.2004; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Petry KU, 2003, BRIT J CANCER, V88, P1570, DOI 10.1038/sj.bjc.6600918; Pretorius Robert G, 2006, J Low Genit Tract Dis, V10, P5, DOI 10.1097/01.lgt.0000192694.85549.3d; Ronco G, 2006, JNCI-J NATL CANCER I, V98, P765, DOI 10.1093/jnci/djj209; Ronco G, 2006, LANCET ONCOL, V7, P547, DOI 10.1016/S1470-2045(06)70731-8; Schilthuizen Menno, 2003, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V14, P9; Sherman ME, 2003, JNCI-J NATL CANCER I, V95, P46, DOI 10.1093/jnci/95.1.46; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Venturoli S, 2002, J CLIN VIROL, V25, P177, DOI 10.1016/S1386-6532(02)00007-0; Vergouwe Yvonne, 2002, Semin Urol Oncol, V20, P96, DOI 10.1053/suro.2002.32521; Wahlstrom C, 2007, J MED VIROL, V79, P1169, DOI 10.1002/jmv.20898	33	432	448	1	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a1754	10.1136/bmj.a1754	http://dx.doi.org/10.1136/bmj.a1754			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18852164	hybrid, Green Published			2022-12-28	WOS:000260298800033
J	Yang, GH; Zhong, NS				Yang, Gong-huan; Zhong, Nan-shan			Effect on health from smoking and use of solid fuel in China	LANCET			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; RISK		[Zhong, Nan-shan] Guangzhou Med Coll, State Key Lab Resp Dis, Guangzhou 510120, Peoples R China; [Yang, Gong-huan] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Chinese Center for Disease Control & Prevention	Zhong, NS (corresponding author), Guangzhou Med Coll, State Key Lab Resp Dis, Guangzhou 510120, Peoples R China.	nanshan@vip.163.com						Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; CJ Murray, 1996, GLOBAL BURDEN DIS CO, VI; Kraft Robert, LANCET, V379, P1013, DOI [10.1016/S0140-6736(11)61345-7, DOI 10.1016/S0140-6736(11)61345-7]; Liu SM, 2007, THORAX, V62, P889, DOI 10.1136/thx.2006.061457; *MIN HLTH CHIN, 2007, STAT STAT B HLTH CAR; Wang Jun, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P837; Yang, 2005, DEATHS THEIR RISK FA; Yin P, 2007, LANCET, V370, P751, DOI 10.1016/S0140-6736(07)61378-6; Zheng JP, 2008, LANCET, V371, P2013, DOI 10.1016/S0140-6736(08)60869-7; Zhong N, 2007, AM J RESP CRIT CARE, V176, P753, DOI 10.1164/rccm.200612-1749OC	10	13	14	1	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 25	2008	372	9648					1445	1446		10.1016/S0140-6736(08)61346-X	http://dx.doi.org/10.1016/S0140-6736(08)61346-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	370ZJ	18835639				2022-12-28	WOS:000260801300007
J	Mylotte, DM; O'Regan, A				Mylotte, Darren M.; O'Regan, Anthony			What lies beneath?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mylotte, Darren M.; O'Regan, Anthony] Univ Coll Hosp Galway, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	Mylotte, DM (corresponding author), Univ Coll Hosp Galway, Galway, Ireland.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2008	359	17					1822	1822		10.1056/NEJMicm064533	http://dx.doi.org/10.1056/NEJMicm064533			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363DJ	18946067				2022-12-28	WOS:000260245800009
J	Zhang, FC; Zhou, ZH; Xu, X; Wang, XL; Sullivan, C				Zhang, Fucheng; Zhou, Zhonghe; Xu, Xing; Wang, Xiaolin; Sullivan, Corwin			A bizarre Jurassic maniraptoran from China with elongate ribbon-like feathers	NATURE			English	Article							BIRD; DINOSAUR; THEROPOD; ORIGIN	Recent coelurosaurian discoveries have greatly enriched our knowledge of the transition from dinosaurs to birds, but all reported taxa close to this transition are from relatively well known coelurosaurian groups(1-3). Here we report a new basal avialan, Epidexipteryx hui gen. et sp. nov., from the Middle to Late Jurassic of Inner Mongolia, China. This new species is characterized by an unexpected combination of characters seen in several different theropod groups, particularly the Oviraptorosauria. Phylogenetic analysis shows it to be the sister taxon to Epidendrosaurus(4,5), forming a new clade at the base of Avialae(6). Epidexipteryx also possesses two pairs of elongate ribbon- like tail feathers, and its limbs lack contour feathers for flight. This finding shows that a member of the avialan lineage experimented with integumentary ornamentation as early as the Middle to Late Jurassic, and provides further evidence relating to this aspect of the transition from non- avian theropods to birds.	[Zhang, Fucheng; Zhou, Zhonghe; Xu, Xing; Wang, Xiaolin; Sullivan, Corwin] Chinese Acad Sci, Lab Evolutionary Systemat Vertebrates, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Zhang, FC (corresponding author), Chinese Acad Sci, Lab Evolutionary Systemat Vertebrates, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	zhangfucheng@ivpp.ac.cn	Sullivan, Corwin/D-4563-2009	Sullivan, Corwin/0000-0002-5488-6797	National Natural Science Foundation of China; Chinese Academy of Sciences; Major Basic Research Projects of the Ministry of Science and Technology, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Major Basic Research Projects of the Ministry of Science and Technology, China	We thank F. Jin for discussion, Y. Li for specimen preparation, W. Gao for photography, and J. Choiniere for the use of his laptop computer. This research was funded by the National Natural Science Foundation of China, the Chinese Academy of Sciences, and Major Basic Research Projects of the Ministry of Science and Technology, China.	ANDERSSON M, 1982, NATURE, V299, P818, DOI 10.1038/299818a0; [陈文 Chen Wen], 2004, [地质通报, Geological Bulletin of China], V23, P1165; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Czerkas Stephen A., 2002, Dinosaur Museum Journal, V1, P63; Gao KQ, 2006, ACTA GEOL SIN-ENGL, V80, P42; Gill F. B., 1995, ORNITHOLOGY; He HY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020792; Hou LH, 1999, CHINESE SCI BULL, V44, P834, DOI 10.1007/BF02885031; Kirkland JI, 2005, NATURE, V435, P84, DOI 10.1038/nature03468; Liu YX, 2006, ACTA GEOL SIN-ENGL, V80, P733; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Padian K, 2004, DINOSAURIA, 2ND EDITION, P210; Prum RO, 2002, Q REV BIOL, V77, P261, DOI 10.1086/341993; Sampson SD, 2001, NATURE, V409, P504, DOI 10.1038/35054046; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; WEISHAMPEL DB, 2004, DINOSAUNIA; Xing X, 2006, GEOL J, V41, P419, DOI 10.1002/gj.1044; Xu X, 2006, NATURE, V440, P287, DOI 10.1038/440287a; Xu X, 2002, NATURE, V419, P291, DOI 10.1038/nature00966; Xu Xing, 2006, P627; Zhang FC, 2002, NATURWISSENSCHAFTEN, V89, P394, DOI 10.1007/s00114-002-0353-8; Zhang FC, 2000, SCIENCE, V290, P1955, DOI 10.1126/science.290.5498.1955; ZHANG FC, 2003, JEHOL BIOTA EMERGENC, P129; Zhang FC, 2008, SCI CHINA SER D, V51, P625, DOI 10.1007/s11430-008-0050-3; Zhang Fucheng, 2006, P611; Zheng XT, 2007, ACTA GEOL SIN-ENGL, V81, P703; Zhou ZH, 2003, CAN J EARTH SCI, V40, P731, DOI 10.1139/E03-011; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	30	160	184	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2008	455	7216					1105	1108		10.1038/nature07447	http://dx.doi.org/10.1038/nature07447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948955				2022-12-28	WOS:000260252600044
J	Emanuel, E; Wyden, R				Emanuel, Ezekiel; Wyden, Ron			A new federal-state partnership in health care - Real power for states	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Emanuel, Ezekiel] NIH, Dept Clin Bioeth, NIH Clin Ctr, Dept Bioeth, Bethesda, MD 20892 USA; [Wyden, Ron] US Senate, Washington, DC 20510 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Emanuel, E (corresponding author), NIH, Dept Clin Bioeth, NIH Clin Ctr, Dept Bioeth, 10 Ctr Dr,Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	eemanuel@cc.nih.gov						APPLEBY J, 2008, USA TODAY       0630; AUERBACH D, 2007, CBOS HLTH INSURANCE, V1; *BOARDS TRUST, 2008, FED HOSP INS FED SUP; BUTLER S, 2007, WASHINGTON POST 0513; Butler Stuart M., 2007, EVOLVING TRADITIONAL; Catlin A, 2008, HEALTH AFFAIR, V27, P14, DOI 10.1377/hlthaff.27.1.14; KLEIN E, WASHINGTON MONTHLY; MCKETHAN A, 2008, WHAT PUBLIC EMPLOYEE; *OFF GOV STAT CAL, 2007, GOV HLTH CAR PROP; *OR HLTH SCI U CTR, DRUG EFF REV PROJ; PIERRON W, 2008, 314 EMPL BEN RES I; STEINHAUER J, 2008, NY TIMES        0701; TURNBULL N, 2007, WHATS NEXT UNCOMPENS	13	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2008	300	16					1931	1934		10.1001/jama.2008.536	http://dx.doi.org/10.1001/jama.2008.536			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362UR	18940982				2022-12-28	WOS:000260223100025
J	Esposito, K; Ciotola, M; Maiorino, MI; Gualdiero, R; Schisano, B; Ceriello, A; Beneduce, F; Feola, G; Giugliano, D				Esposito, Katherine; Ciotola, Miryam; Maiorino, Maria Ida; Gualdiero, Roberto; Schisano, Bruno; Ceriello, Antonio; Beneduce, Flora; Feola, Giovanni; Giugliano, Dario			Addition of Neutral Protamine Lispro Insulin or Insulin Glargine to Oral Type 2 Diabetes Regimens for Patients with Suboptimal Glycemic Control A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							TO-TARGET TRIAL; BASAL INSULIN; NPH INSULIN; CONSENSUS STATEMENT; INITIATING INSULIN; THERAPY; MANAGEMENT; SULFONYLUREA; METFORMIN; MELLITUS	Background: Injection of long-acting insulin at bedtime is a common therapeutic approach for patients with type 2 diabetes that is poorly controlled with oral regimens. Neutral protamine lispro (NPL) insulin has demonstrated better glycemic control and similar incidence of hypoglycemic events than that of neutral protamine Hagedorn insulin. Objective: To compare the clinical efficacy and safety of bedtime NPL insulin or insulin glargine in patients with type 2 diabetes who had suboptimal glycemic control while receiving stable doses of metformin and sulfonylurea. Design: Open-label, randomized trial. Setting: Teaching hospital (Azienda Ospedaliera Universitaria, Second University of Naples), Naples, Italy. Patients: 116 adults receiving stable doses of metformin plus sulfonylurea for longer than 90 days with hemoglobin A(1c) ( HbA(1c)) levels of 7.5% to 10% and fasting plasma glucose levels of 6.7 mmol/L or greater (>= 120 mg/dL). Intervention: 10 IU of NPL insulin or insulin glargine injected subcutaneously at bedtime with weekly dose titrations to target fasting glucose levels less than 5.6 mmol/L (< 100 mg/dL) in addition to stable oral regimens. Patients receiving nighttime sulfonylurea before the study were switched to metformin. Measurements: The primary outcome was change in HbA(1c) levels from baseline to week 36. Secondary outcomes were HbA(1c) levels less than 7%, self-reported hypoglycemic episodes, insulin dose, self-monitored glucose level, and body weight. Twenty patients in each group had continuous glucose monitoring for 3 consecutive days before adding insulin and at week 36. Results: Improvement in HbA(1c) levels was similar in both groups ( 1.83% and 1.89% for NPL and glargine, respectively). The difference between the groups was 0.06 percentage point ( 95% CI, -0.1 to 0.15 percentage points). Secondary outcomes did not differ between groups. Hemoglobin A(1c) levels less than 7% occurred in 62% of patients receiving NPL and 64% of patients receiving glargine ( difference, 2.0 percentage points [ CI, -1.1 to 5.0 percentage points]). Fasting plasma glucose levels less than 5.6 mmol/L (< 100 mg/dL) occurred in 40% of patients receiving NPL and 41% of patients receiving glargine ( difference, 1.0 percentage point [ CI, -0.9 to 3.0 percentage points]). Any hypoglycemic event occurred in 74% of patients receiving NPL and 67% of patients receiving glargine ( difference, 7 percentage points [ CI, -5 to 13 percentage points]). Continuous glucose level monitoring in the patients who had this measurement did not differ statistically. Limitation: The study was not blinded, had limited power to detect differences in hypoglycemic events, and did not obtain continuous glucose level monitoring for all patients. Conclusion: Similar glycemic control occurred with the addition of NPL or glargine insulin to oral regimens in patients with poorly controlled type 2 diabetes. Hypoglycemia was similar in the 2 groups, but sample size limited the ability to make a definite safety assessment.	[Giugliano, Dario] Univ Naples 2, Policlin, Div Metab Dis, I-80031 Naples, Italy; Azienda Sanit Locale Napoli 5, Naples, Italy; Warwick Med Sch, Coventry, W Midlands, England	Universita della Campania Vanvitelli; University of Warwick	Giugliano, D (corresponding author), Univ Naples 2, Policlin, Div Metab Dis, Piazza L Miraglia, I-80031 Naples, Italy.	dario.giugliano@unina2.it	Esposito, Katherine/AHE-2564-2022; Maiorino, Maria Ida/AHE-9986-2022	Esposito, Katherine/0000-0002-3652-5154; Maiorino, Maria Ida/0000-0003-4659-7546; Ceriello, Antonio/0000-0001-8122-3203; Giugliano, Dario/0000-0002-9377-873X	Second University of Naples	Second University of Naples	Grant Support: In part by the Second University of Naples.	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Amer Diabet Associat, 2008, DIABETES CARE, V31, pS61, DOI 10.2337/dc08-S061; Bretzel RG, 2008, LANCET, V371, P1073, DOI 10.1016/S0140-6736(08)60485-7; Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9; Fritsche A, 2003, ANN INTERN MED, V138, P952, DOI 10.7326/0003-4819-138-12-200306170-00006; Goldberg RB, 2008, NEW ENGL J MED, V358, P293, DOI 10.1056/NEJMclde0708469; Halperin Florencia, 2008, N Engl J Med, V358, pe8, DOI 10.1056/NEJMclde0801078; Hermansen K, 2006, DIABETES CARE, V29, P1269, DOI 10.2337/dc05-1365; HOLMAN RR, 1987, DIABETIC MED, V4, P457, DOI 10.1111/j.1464-5491.1987.tb00909.x; Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392; International Diabetes Federation, 2005, GLOB GUID TYP 2 DIAB; Janka HU, 2007, J AM GERIATR SOC, V55, P182, DOI 10.1111/j.1532-5415.2007.01043.x; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Koro CE, 2004, DIABETES CARE, V27, P17, DOI 10.2337/diacare.27.1.17; Lepore M, 2000, DIABETES, V49, P2142, DOI 10.2337/diabetes.49.12.2142; Maran A, 2002, DIABETES CARE, V25, P347, DOI 10.2337/diacare.25.2.347; McMahon GT, 2007, NEW ENGL J MED, V357, P1759, DOI 10.1056/NEJMe078196; McNally PG, 2007, DIABETES CARE, V30, P1044, DOI 10.2337/dc06-1328; Nathan DM, 2008, DIABETES CARE, V31, P173, DOI [10.2337/dc08-9016, 10.2337/dc08-0545]; Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912; Nyback-Nakell A, 2007, DIABETIC MED, V24, P1424, DOI 10.1111/j.1464-5491.2007.02286.x; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Raskin P, 2005, DIABETES CARE, V28, P260, DOI 10.2337/diacare.28.2.260; Riddle MC, 2008, DIABETES CARE, V31, pS125, DOI 10.2337/dc08-s231; Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080; Roach P, 2002, CLIN PHARMACOKINET, V41, P1043, DOI 10.2165/00003088-200241130-00003; Roach P, 2001, INT J CLIN PRACT, V55, P177; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; STRATTON I, 2003, BMJ-BRIT MED J, V321, P405; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Yki-Jarvinen H, 2006, DIABETOLOGIA, V49, P442, DOI 10.1007/s00125-005-0132-0; Yki-Jarvinen H, 1999, ANN INTERN MED, V130, P389, DOI 10.7326/0003-4819-130-5-199903020-00002; Yki-Jarvinen H, 2000, DIABETES CARE, V23, P1130, DOI 10.2337/diacare.23.8.1130; Yki-Jarvinen H, 2001, DIABETES CARE, V24, P758, DOI 10.2337/diacare.24.4.758; STATEMENT ADA RELATE	36	41	41	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2008	149	8					531	103		10.7326/0003-4819-149-8-200810210-00005	http://dx.doi.org/10.7326/0003-4819-149-8-200810210-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367XJ	18936501				2022-12-28	WOS:000260585600002
J	Rawaf, S; De Maeseneer, J; Starfield, B				Rawaf, Salman; De Maeseneer, Jan; Starfield, Barbara			From Alma-Ata to Almaty: a new start for primary health care	LANCET			English	Editorial Material									[Rawaf, Salman] Wandsworth Teaching PCT, WHO Collaborat Ctr, London SW19 3RU, England; [De Maeseneer, Jan] Univ Ghent, European Forum Primary Care, B-9000 Ghent, Belgium; [Starfield, Barbara] Johns Hopkins Univ, Baltimore, MD USA	Ghent University; Johns Hopkins University	Rawaf, S (corresponding author), Wandsworth Teaching PCT, WHO Collaborat Ctr, London SW19 3RU, England.	srawaf@sgul.ac.uk		Rawaf, Salman/0000-0001-7191-2355				ANNEMANS L, 2008, COMP COST QUAL 2 FIN; Bindman AB, 2007, BMJ-BRIT MED J, V334, P1261, DOI 10.1136/bmj.39203.658970.55; BROWN A, 2001, INTEGRATING VERTICAL; Chan M, 2008, LANCET, V372, P865, DOI 10.1016/S0140-6736(08)61372-0; De Maeseneer J, PRIMARY HLTH CARE ST; De Maeseneer J, 2008, BRIT MED J, V336, P518, DOI 10.1136/bmj.39496.444271.80; Mash R, 2008, S AFR FAM PRACT, V50, P60, DOI 10.1080/20786204.2008.10873720; *MIN SAL BRAS, 2006, EV MEJ CAL ESTR FA B; *NAT AUD OFF, 2005, PAT CHOIC POINT GP R; PEREIRAGRAY D, 2006, DOZEN FACTS GEN PRAC; Pongsupap Y., 2007, INTRO HUMAN DIMENSIO; Rhyne R, 1998, COMMUNITY ORIENTED P; Starfield B, 2008, J EPIDEMIOL COMMUN H, V62, P580, DOI 10.1136/jech.2007.071027; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; *SULT OM, 2006, 2 PRIM HLTH CAR REV; WHO, 2008, CLOS GAP GEN HLTH EQ; WHO, 2008, MAX POS SYN HLTH SYS; *WHO UNICEF, 1978, DECL ALM AT INT C PR	18	53	55	4	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2008	372	9647					1365	1367		10.1016/S0140-6736(08)61524-X	http://dx.doi.org/10.1016/S0140-6736(08)61524-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362WP	18922572				2022-12-28	WOS:000260228200006
J	Lin, GA; Dudley, RA; Lucas, FL; Malenka, DJ; Vittinghoff, E; Redberg, RF				Lin, Grace A.; Dudley, R. Adams; Lucas, F. L.; Malenka, David J.; Vittinghoff, Eric; Redberg, Rita F.			Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; CONTROLLED CLINICAL-TRIAL; 3 THERAPEUTIC STRATEGIES; OPTIMAL MEDICAL THERAPY; ARTERY-DISEASE; UNITED-STATES; MASS-II; ANGINA-PECTORIS; HEART-DISEASE; RITA-2 TRIAL	Context Guidelines call for documenting ischemia in patients with stable coronary artery disease prior to elective percutaneous coronary intervention ( PCI). Objective To determine the frequency and predictors of stress testing prior to elective PCI in a Medicare population. Design, Setting, and Patients Retrospective, observational cohort study using claims data from a 20% random sample of 2004 Medicare fee- for- service beneficiaries aged 65 years or older who had an elective PCI ( N= 23 887). Main Outcome Measures Percentage of patients who underwent stress testing within 90 days prior to elective PCI; variation in stress testing prior to PCI across 306 hospital referral regions; patient, physician, and hospital characteristics that predicted the appropriate use of stress testing prior to elective PCI. Results In the United States, 44.5% ( n= 10 629) of patients underwent stress testing within the 90 days prior to elective PCI. There was wide regional variation among the hospital referral regions with stress test rates ranging from 22.1% to 70.6% ( national mean, 44.5%; interquartile range, 39.0%- 50.9%). Female sex ( adjusted odds ratio [ AOR], 0.91; 95% confidence interval [ CI], 0.86- 0.97), age of 85 years or older ( AOR, 0.83; 95% CI, 0.72- 0.95), a history of congestive heart failure ( AOR, 0.85; 95% CI, 0.79- 0.92), and prior cardiac catheterization ( AOR, 0.45; 95% CI, 0.38- 0.54) were associated with a decreased likelihood of prior stress testing. A history of chest pain ( AOR, 1.28; 95% CI, 1.09- 1.54) and black race ( AOR, 1.26; 95% CI, 1.09- 1.46) increased the likelihood of stress testing prior to PCI. Patients treated by physicians performing 150 or more PCIs per year were less likely to have stress testing prior to PCI ( AOR, 0.84; 95% CI, 0.77- 0.93). No hospital characteristics were associated with receipt of stress testing. Conclusion The majority of Medicare patients with stable coronary artery disease do not have documentation of ischemia by noninvasive testing prior to elective PCI.	[Redberg, Rita F.] Univ Calif San Francisco, Sch Med, Div Cardiol, San Francisco, CA 94143 USA; [Lin, Grace A.] Univ Calif San Francisco, Sch Med, Div Gen Internal Med, San Francisco, CA 94143 USA; [Vittinghoff, Eric] Univ Calif San Francisco, Sch Med, Div Epidemiol & Biostat, San Francisco, CA 94143 USA; [Dudley, R. Adams] Univ Calif San Francisco, Sch Med, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Lucas, F. L.] Maine Med Ctr, Ctr Outcomes Res & Evaluat, Portland, OR USA; [Malenka, David J.] Dartmouth Hitchcock Med Ctr, Div Cardiol, Lebanon, NH 03766 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Dartmouth College	Redberg, RF (corresponding author), Univ Calif San Francisco, Sch Med, Div Cardiol, 505 Parnassus Ave,Ste M-1180, San Francisco, CA 94143 USA.	redberg@medicine.ucsf.edu			Blue Shield of California Foundation; Robert Wood Johnson Foundation	Blue Shield of California Foundation; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This study was funded by the Blue Shield of California Foundation. A portion of Dr Dudley's work was supported by an Investigator Award in Health Policy from the Robert Wood Johnson Foundation.	Anderson HV, 2005, CIRCULATION, V112, P2786, DOI 10.1161/CIRCULATIONAHA.105.553727; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bucher HC, 2000, BMJ-BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Campione Joanne R, 2005, Am J Geriatr Pharmacother, V3, P229, DOI 10.1016/j.amjopharm.2005.12.001; Favarato ME, 2007, INT J CARDIOL, V116, P364, DOI 10.1016/j.ijcard.2006.06.001; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Folland ED, 1997, J AM COLL CARDIOL, V29, P1505, DOI 10.1016/S0735-1097(97)00097-1; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Hannan EL, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-35; Henderson RA, 2003, J AM COLL CARDIOL, V42, P1161, DOI 10.1016/S0735-1097(03)00951-3; HLATKY MA, 1984, AM J MED, V77, P64, DOI 10.1016/0002-9343(84)90437-6; Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065; Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; Kwok Y, 1999, AM J CARDIOL, V83, P660, DOI 10.1016/S0002-9149(98)00963-1; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Larsen K, 2000, BIOMETRICS, V56, P909, DOI 10.1111/j.0006-341X.2000.00909.x; Lee CH, 2008, ARCH INTERN MED, V168, P291, DOI 10.1001/archinternmed.2007.78; Lin GA, 2007, ARCH INTERN MED, V167, P1604, DOI 10.1001/archinte.167.15.1604; Lucas F L, 1999, Eff Clin Pract, V2, P71; Lucas FL, 2006, CIRCULATION, V113, P374, DOI 10.1161/CIRCULATIONAHA.105.560433; Lucas FL, 2007, AM HEART J, V154, P502, DOI 10.1016/j.ahj.2007.04.044; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Nallamothu BK, 2007, JAMA-J AM MED ASSOC, V297, P962, DOI 10.1001/jama.297.9.962; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Pfisterer M, 2003, JAMA-J AM MED ASSOC, V289, P1117, DOI 10.1001/jama.289.9.1117; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202; Pocock SJ, 2000, J AM COLL CARDIOL, V35, P907, DOI 10.1016/S0735-1097(99)00637-3; Poses RM, 2002, CHEST, V122, P122, DOI 10.1378/chest.122.1.122; Rogers AM, 2007, AM HEART J, V154, P461, DOI 10.1016/j.ahj.2007.05.003; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Shaw LJ, 2008, J NUCL CARDIOL, V15, P762, DOI 10.1007/BF03007357; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Shaw LJ, 1999, J AM COLL CARDIOL, V33, P661, DOI 10.1016/S0735-1097(98)00606-8; SHAW LJ, 1994, ANN INTERN MED, V120, P559, DOI 10.7326/0003-4819-120-7-199404010-00005; Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220; Spertus JA, 2004, CIRCULATION, V110, P3789, DOI 10.1161/01.CIR.0000150392.70749.C7; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; STRAUSS WE, 1995, CIRCULATION, V92, P1710, DOI 10.1161/01.CIR.92.7.1710; TOBIN JN, 1987, ANN INTERN MED, V107, P19, DOI 10.7326/0003-4819-107-1-19; TOPOL EJ, 1993, CIRCULATION, V87, P1489, DOI 10.1161/01.CIR.87.5.1489; Wennberg D, 1997, J Health Serv Res Policy, V2, P75; Wennberg DE, 1996, JAMA-J AM MED ASSOC, V275, P1161, DOI 10.1001/jama.275.15.1161; Wennberg DE, 1997, J GEN INTERN MED, V12, P172; Wennberg J. E., 1996, DARTMOUTH ATLAS HLTH; Zellweger MJ, 2003, J AM COLL CARDIOL, V42, P33, DOI 10.1016/S0735-1097(03)00557-6	50	185	188	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2008	300	15					1765	1773		10.1001/jama.300.15.1765	http://dx.doi.org/10.1001/jama.300.15.1765			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QA	18854538	Bronze			2022-12-28	WOS:000260002000028
J	Ludwig, DS; Nestle, M				Ludwig, David S.; Nestle, Marion			Can the food industry play a constructive role in the obesity epidemic?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INSULIN		[Ludwig, David S.] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Nestle, Marion] NYU, Dept Nutr Food Studies & Publ Hlth, New York, NY USA	Harvard University; Boston Children's Hospital; New York University	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544				*AM DIET ASS, AM DIET ASS WELC COC; *COC COL CO, CORP RESP ACT LIF; HABER GB, 1977, LANCET, V2, P679; *KRAFT, HLTH WELLN; Lesser LI, 2007, PLOS MED, V4, P41, DOI 10.1371/journal.pmed.0040005; Lewin A, 2006, J PUBLIC HEALTH POL, V27, P327, DOI 10.1057/palgrave.jphp.3200098; *MCD CORP, BAL ACT LIF 2006 WOR; *PEPSICO, PEPSICO JOINS AM YMC; *PEPSICO, HLTH WELLN PEPSICOS; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; SARGENT G, AM PROSPECT BERMANS; Simon M., 2006, LOYOLA LOS ANGELES L, V39, P169; WOOTAN MG, STUDY SHOWS PROGR GE	13	151	152	0	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2008	300	15					1808	1811		10.1001/jama.300.15.1808	http://dx.doi.org/10.1001/jama.300.15.1808			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QA	18854543				2022-12-28	WOS:000260002000033
J	Montori, VM; Guyatt, GH				Montori, Victor M.; Guyatt, Gordon H.			Progress in evidence-based medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							USERS GUIDES		[Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hlth Sci Ctr, Clin Adv Res & Informat Translat CLARITY Res Grp, Hamilton, ON L8N 3Z5, Canada; [Guyatt, Gordon H.] McMaster Univ, Fac Hlth Sci, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Montori, Victor M.] Mayo Clin, Knowledge & Encounter Res Unit, Dept Med, Rochester, MN USA; [Montori, Victor M.] Mayo Clin, Dept Hlth Sci Res, Coll Med, Rochester, MN USA	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; McMaster University; Mayo Clinic; Mayo Clinic	Guyatt, GH (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hlth Sci Ctr, Clin Adv Res & Informat Translat CLARITY Res Grp, Room 2C12, Hamilton, ON L8N 3Z5, Canada.	guyatt@mcmaster.ca		Montori, Victor/0000-0003-0595-2898				Accreditation Council for Graduate Medical Education, COMM PROGR REQ; Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Avorn J, 2007, NEW ENGL J MED, V357, P2219, DOI 10.1056/NEJMp0706892; Eddy DM, 2005, HEALTH AFFAIR, V24, P9, DOI 10.1377/hlthaff.24.1.9; GUYAT GH, 1993, JAMA-J AM MED ASSOC, V270, P2096, DOI 10.1001/jama.270.17.2096; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Guyatt G, 2008, JAMA EVIDENCE USERS; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; Guyatt GH., 1991, ACP J CLUB, V114, pA; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; MONTORI V, 2007, HARVARD HLTH POLICY, P145; Montori VM, 2004, J GEN INTERN MED, V19, P1240, DOI 10.1111/j.1525-1497.2004.41001.x; Wilczynski Nancy L, 2005, BMC Med Inform Decis Mak, V5, P20, DOI 10.1186/1472-6947-5-20	14	164	170	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2008	300	15					1814	1816		10.1001/jama.300.15.1814	http://dx.doi.org/10.1001/jama.300.15.1814			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QA	18854545	Bronze			2022-12-28	WOS:000260002000035
J	Benson, PM; Vinciguerra, S; Meredith, PG; Young, RP				Benson, Philip M.; Vinciguerra, Sergio; Meredith, Philip G.; Young, R. Paul			Laboratory simulation of volcano seismicity	SCIENCE			English	Article							MAGMA ASCENT; EARTHQUAKES; CALDERA; SIGNALS; ISLAND; SLIP	The physical processes generating seismicity within volcanic edifices are highly complex and not fully understood. We report results from a laboratory experiment in which basalt from Mount Etna volcano (Italy) was deformed and fractured. The experiment was monitored with an array of transducers around the sample to permit full-waveform capture, location, and analysis of microseismic events. Rapid post-failure decompression of the water-filled pore volume and damage zone triggered many low-frequency events, analogous to volcanic long-period seismicity. The low frequencies were associated with pore fluid decompression and were located in the damage zone in the fractured sample; these events exhibited a weak component of shear (double-couple) slip, consistent with fluid-driven events occurring beneath active volcanoes.	[Benson, Philip M.; Meredith, Philip G.] UCL, Rock & Ice Phys Lab, Dept Earth Sci, London WC1E 6BT, England; [Benson, Philip M.; Young, R. Paul] Univ Toronto, Lassonde Inst, Toronto, ON M5S 3E3, Canada; [Vinciguerra, Sergio] Ist Nazl Geofis & Vulcanol, Sez Roma 1, I-00143 Rome, Italy	University of London; University College London; University of Toronto; Istituto Nazionale Geofisica e Vulcanologia (INGV)	Benson, PM (corresponding author), UCL, Rock & Ice Phys Lab, Dept Earth Sci, Gower St, London WC1E 6BT, England.	p.benson@ucl.ac.uk		Young, R. Paul/0000-0002-6285-9879; Benson, Philip/0000-0003-2120-3280; Meredith, Philip/0000-0003-2193-5342	6th European Community Framework program [MOIF-CT-2005-020167]; Sviluppo Nuove Tecnologie per la Protezione e Difesa del Territorio dai Rischi Naturali [FIRB-MIUR]; Canadian Foundation for Innovation; NERC [NE/D012910/1] Funding Source: UKRI; Natural Environment Research Council [NE/D012910/1] Funding Source: researchfish	6th European Community Framework program(European Commission); Sviluppo Nuove Tecnologie per la Protezione e Difesa del Territorio dai Rischi Naturali; Canadian Foundation for Innovation(Canada Foundation for Innovation); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a Marie-Curie International Fellowship within the 6th European Community Framework program (contract MOIF-CT-2005-020167 to P.M.B.), project FIRB-MIUR (Sviluppo Nuove Tecnologie per la Protezione e Difesa del Territorio dai Rischi Naturali) to S.V.; and a Canadian Foundation for Innovation award to R.P.Y. The authors thank L. Malagnini and J. Neuberg for fruitful discussions, A. Cavallo for FESEM technical support at the HT-HP laboratory (INGV Rome), and two anonymous reviewers for comments that greatly helped to improve this manuscript.	Aki K., 2002, QUANTITATIVE SEISMOL, Vsecond; Benson PM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028721; BENSON PM, 2007, 29 COURS INT SCH GEO; Burlini L, 2007, GEOLOGY, V35, P183, DOI 10.1130/G23195A.1; Chouet B, 2003, PURE APPL GEOPHYS, V160, P739, DOI 10.1007/PL00012556; Chouet BA, 1996, NATURE, V380, P309, DOI 10.1038/380309a0; Collins DS, 2002, PURE APPL GEOPHYS, V159, P197, DOI 10.1007/PL00001251; Foulger GR, 2004, J VOLCANOL GEOTH RES, V132, P45, DOI 10.1016/s0377-0273(03)00420-7; HATTON CG, 1994, NATURE, V367, P160, DOI 10.1038/367160a0; Ito Y, 2007, SCIENCE, V315, P503, DOI 10.1126/science.1134454; James MR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003718; James MR, 2004, J VOLCANOL GEOTH RES, V129, P61, DOI 10.1016/S0377-0273(03)00232-4; JULIAN BR, 1994, J GEOPHYS RES-SOL EA, V99, P11859, DOI 10.1029/93JB03129; Kilburn CRJ, 2003, J VOLCANOL GEOTH RES, V125, P271, DOI 10.1016/S0377-0273(03)00117-3; Kumagai H, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001704; Kumagai H, 2001, SCIENCE, V293, P687, DOI 10.1126/science.1062136; LOCKNER DA, 1991, NATURE, V350, P39, DOI 10.1038/350039a0; MAIN I, 1992, NATURE, V357, P27, DOI 10.1038/357027a0; McNutt S.R., 1996, MONITORING MITIGATIO, P99, DOI [DOI 10.1007/978-3-642-80087-0_3, 10.1007/978-3-642-80087-0]; Miller SA, 2004, NATURE, V427, P724, DOI 10.1038/nature02251; Neuberg JW, 2006, J VOLCANOL GEOTH RES, V153, P37, DOI 10.1016/j.jvolgeores.2005.08.008; Patane D, 2003, SCIENCE, V299, P2061, DOI 10.1126/science.1080653; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Rowe CA, 1998, GEOPHYS RES LETT, V25, P2297, DOI 10.1029/98GL01622; Scandone R, 2007, EARTH PLANET SC LETT, V253, P513, DOI 10.1016/j.epsl.2006.11.016; Stanchits S, 2006, PURE APPL GEOPHYS, V163, P974, DOI 10.1007/s00024-006-0059-5; Tuffen H, 2005, B VOLCANOL, V67, P370, DOI 10.1007/s00445-004-0383-5; Voight B, 1999, SCIENCE, V283, P1138, DOI 10.1126/science.283.5405.1138	28	121	131	4	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					249	252		10.1126/science.1161927	http://dx.doi.org/10.1126/science.1161927			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845753	Green Submitted			2022-12-28	WOS:000259902300045
J	Qu, LT; Dai, LM; Stone, M; Xia, ZH; Wang, ZL				Qu, Liangti; Dai, Liming; Stone, Morley; Xia, Zhenhai; Wang, Zhong Lin			Carbon nanotube arrays with strong shear binding-on and easy normal lifting-off	SCIENCE			English	Article							GECKO FOOT-HAIR; DRY ADHESIVES; MECHANICS; FRICTION; BIOLOGY; GROWTH; FORCE	The ability of gecko lizards to adhere to a vertical solid surface comes from their remarkable feet with aligned microscopic elastic hairs. By using carbon nanotube arrays that are dominated by a straight body segment but with curly entangled top, we have created gecko-foot-mimetic dry adhesives that show macroscopic adhesive forces of similar to 100 newtons per square centimeter, almost 10 times that of a gecko foot, and a much stronger shear adhesion force than the normal adhesion force, to ensure strong binding along the shear direction and easy lifting in the normal direction. This anisotropic force distribution is due to the shear-induced alignments of the curly segments of the nanotubes. The mimetic adhesives can be alternatively binding-on and lifting-off over various substrates for simulating the walking of a living gecko.	[Qu, Liangti; Dai, Liming] Univ Dayton, Dept Chem & Mat Engn, Sch Engn, Dayton, OH 45469 USA; [Stone, Morley] USAF, Res Lab, Human Effectiveness Directorate, AFRL RH, Wright Patterson AFB, OH 45433 USA; [Xia, Zhenhai] Univ Akron, Dept Mech Engn, Akron, OH 44325 USA; [Wang, Zhong Lin] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA	University of Dayton; United States Department of Defense; United States Air Force; US Air Force Research Laboratory; University System of Ohio; University of Akron; University System of Georgia; Georgia Institute of Technology	Dai, LM (corresponding author), Univ Dayton, Dept Chem & Mat Engn, Sch Engn, 300 Coll Pk, Dayton, OH 45469 USA.	ldai@udayton.edu; zlwang@gatech.edu	Dai, Liming/AAV-4376-2020; Wang, Zhong Lin/E-2176-2011; wang, jie/GRS-0942-2022	Dai, Liming/0000-0001-7536-160X; Wang, Zhong Lin/0000-0002-5530-0380; Xia, Zhenhai/0000-0002-0881-2906	AFRL/Air Force Office of Scientific Research; NSF [CMS-0609077]	AFRL/Air Force Office of Scientific Research(United States Department of DefenseUS Air Force Research LaboratoryAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF))	L.D., Z.L.W., and M.S. thank AFRL/Air Force Office of Scientific Research for financial support. L.D. also thanks T. Yamada, S. Sangwook, A. Roy, J. Baur, and T. Benson-Tolle for useful discussions as well as financial support from NSF (grant CMS-0609077).	Akita S, 2002, JPN J APPL PHYS 1, V41, P4242, DOI 10.1143/JJAP.41.4242; Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Dickrell PL, 2005, TRIBOL LETT, V18, P59, DOI 10.1007/s11249-004-1752-0; Gao HJ, 2005, MECH MATER, V37, P275, DOI 10.1016/j.mechmat.2004.03.008; Gao HJ, 2004, P NATL ACAD SCI USA, V101, P7851, DOI 10.1073/pnas.0400757101; Ge L, 2007, P NATL ACAD SCI USA, V104, P10792, DOI 10.1073/pnas.0703505104; Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917; Huang SM, 2002, J PHYS CHEM B, V106, P3543, DOI 10.1021/jp014047y; Huang SM, 1999, J PHYS CHEM B, V103, P4223, DOI 10.1021/jp990342v; Irschick DJ, 1996, BIOL J LINN SOC, V59, P21, DOI 10.1111/j.1095-8312.1996.tb01451.x; Jin MHC, 2006, CARBON NANOTECHNOLOGY: RECENT DEVELOPMENTS IN CHEMISTRY, PHYSICS, MATERIALS SCIENCE AND DEVICE APPLICATIONS, P611, DOI 10.1016/B978-044451855-2/50020-6; Kinoshita H, 2004, APPL PHYS LETT, V85, P2780, DOI 10.1063/1.1804254; Leckband D, 2001, Q REV BIOPHYS, V34, P105, DOI 10.1017/S0033583501003687; Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968; Lee J, 2008, J R SOC INTERFACE, V5, P835, DOI 10.1098/rsif.2007.1308; Lu XK, 1999, APPL PHYS LETT, V75, P193, DOI 10.1063/1.124316; Majidi CS, 2005, J APPL PHYS, V98, DOI 10.1063/1.2128697; Qu L, 2007, ADV MATER, V19, P3844, DOI 10.1002/adma.200700023; Qu L, 2007, J MATER CHEM, V17, P3401, DOI 10.1039/b703046k; Sitti M, 2003, J ADHES SCI TECHNOL, V17, P1055, DOI 10.1163/156856103322113788; Tian Y, 2006, P NATL ACAD SCI USA, V103, P19320, DOI 10.1073/pnas.0608841103; Yao H, 2006, J MECH PHYS SOLIDS, V54, P1120, DOI 10.1016/j.jmps.2006.01.002; Yu MF, 2001, PHYS REV LETT, V86, P87, DOI 10.1103/PhysRevLett.86.87; Yurdumakan B, 2005, CHEM COMMUN, P3799, DOI 10.1039/b506047h; Zhang XB, 2006, ADV MATER, V18, P1505, DOI 10.1002/adma.200502528; Zhao Y, 2006, J VAC SCI TECHNOL B, V24, P331, DOI 10.1116/1.2163891	27	580	645	13	601	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					238	242		10.1126/science.1159503	http://dx.doi.org/10.1126/science.1159503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845750				2022-12-28	WOS:000259902300042
J	Qi, H; Cannons, JL; Klauschen, F; Schwartzberg, PL; Germain, RN				Qi, Hai; Cannons, Jennifer L.; Klauschen, Frederick; Schwartzberg, Pamela L.; Germain, Ronald N.			SAP-controlled T-B cell interactions underlie germinal centre formation	NATURE			English	Article							LINKED LYMPHOPROLIFERATIVE-DISEASE; HUMORAL IMMUNITY; DENDRITIC CELLS; IN-VIVO; LYMPH-NODES; CYTOKINE REGULATION; ANTIBODY-RESPONSES; GENE-PRODUCT; ACTIVATION; INFECTION	Generation of long- term antibody- mediated immunity depends on the germinal centre reaction, which requires cooperation between antigen- specific T and B lymphocytes. In human X- linked lymphoproliferative disease and its gene- targeted mouse model, loss- of- function mutations in signalling lymphocyte activation molecule- associated protein ( SAP, encoded by SH2D1a) cause a profound defect in germinal centre formation by an as yet unknown mechanism. Here, using two- photon intravital imaging, we show that SAP deficiency selectively impairs the ability of CD4(+) T cells to stably interact with cognate B cells but not antigen- presenting dendritic cells. This selective defect results in a failure of antigen- specific B cells to receive adequate levels of contact- dependent T- cell help to expand normally, despite Sap(-/-) T cells exhibiting the known characteristics of otherwise competent helper T cells. Furthermore, the lack of stable interactions with B cells renders Sap(-/-) T cells unable to be efficiently recruited to and retained in a nascent germinal centre to sustain the germinal centre reaction. These results offer an explanation for the germinal centre defect due to SAP deficiency and provide new insights into the bi- directional communication between cognate T and B cells in vivo.	[Qi, Hai; Klauschen, Frederick; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Cannons, Jennifer L.; Schwartzberg, Pamela L.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pams@nhgri.nih.gov; rgermain@niaid.nih.gov	Qi, Hai/A-3955-2009; Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019; Klauschen, Frederick/C-5637-2015	Klauschen, Frederick/0000-0002-9131-2389; Qi, Hai/0000-0001-5475-3989	National Institute of Allergy and Infectious Disease; National Human Genome Research Institute; National Institutes of Health, USA.; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health, USA.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	H. Q. is in debt to Y. Hong for support, encouragement and inspiration. This work was funded by the intramural research programs of the National Institute of Allergy and Infectious Disease and National Human Genome Research Institute, National Institutes of Health, USA.	ABBAS AK, 1985, J IMMUNOL, V135, P1661; Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Andoh A, 2000, IMMUNOL LETT, V73, P35, DOI 10.1016/S0165-2478(00)00202-9; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Cannons JL, 2006, J EXP MED, V203, P1551, DOI 10.1084/jem.20052097; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Celli S, 2007, IMMUNITY, V27, P625, DOI 10.1016/j.immuni.2007.08.018; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; COICO RF, 1983, J IMMUNOL, V131, P2254; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Crotty S, 2006, BLOOD, V108, P3085, DOI 10.1182/blood-2006-04-018929; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Davidson D, 2004, IMMUNITY, V21, P707, DOI 10.1016/j.immuni.2004.10.005; de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Garcia Z, 2007, P NATL ACAD SCI USA, V104, P4553, DOI 10.1073/pnas.0610019104; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; GRIERSON HL, 1991, AM J MED GENET, V40, P294, DOI 10.1002/ajmg.1320400309; Hron JD, 2004, J EXP MED, V200, P261, DOI 10.1084/jem.20040526; Huang AYC, 2004, IMMUNITY, V21, P331, DOI 10.1016/S1074-7613(04)00235-3; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; KELSOE G, 1993, CURR OPIN IMMUNOL, V5, P418, DOI 10.1016/0952-7915(93)90062-W; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Ma CS, 2005, J CLIN INVEST, V115, P1049, DOI 10.1172/JCI23139; MacLennan ICM, 1997, IMMUNOL REV, V156, P53, DOI 10.1111/j.1600-065X.1997.tb00958.x; McCausland MM, 2007, J IMMUNOL, V178, P817, DOI 10.4049/jimmunol.178.2.817; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; MITCHISON N A, 1971, European Journal of Immunology, V1, P18, DOI 10.1002/eji.1830010104; Morra M, 2005, P NATL ACAD SCI USA, V102, P4819, DOI 10.1073/pnas.0408681102; Moser B, 2002, TRENDS IMMUNOL, V23, P250, DOI 10.1016/S1471-4906(02)02218-4; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; PURTILO D T, 1975, Lancet, V1, P935; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Raff M C, 1970, Nature, V226, P1257, DOI 10.1038/2261257a0; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713	44	468	489	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2008	455	7214					764	U2		10.1038/nature07345	http://dx.doi.org/10.1038/nature07345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18843362	Green Accepted			2022-12-28	WOS:000259854900039
J	Calonge, N; Petitti, DB; DeWitt, TG; Dietrich, AJ; Gordis, L; Gregory, KD; Harris, R; Isham, G; Leipzig, R; LeFevre, ML; Loveland-Cherry, C; Marion, LN; Moyer, VA; Ockene, JK; Sawaya, GF; Yawn, BP				Calonge, Ned; Petitti, Diana B.; DeWitt, Thomas G.; Dietrich, Allen J.; Gordis, Leon; Gregory, Kimberly D.; Harris, Russell; Isham, George; Leipzig, Rosanne; LeFevre, Michael L.; Loveland-Cherry, Carol; Marion, Lucy N.; Moyer, Virginia A.; Ockene, Judith K.; Sawaya, George F.; Yawn, Barbara P.		US Preventive Serv Task Force	Behavioral counseling to prevent sexually transmitted infections: U.S. Preventive Services Task Force recommendation statement	ANNALS OF INTERNAL MEDICINE			English	Article							RISK	Description: New U. S. Preventive Services Task Force (USPSTF) recommendations about behavioral counseling of adolescents and adults to prevent sexually transmitted infections (STIs). Methods: The USPSTF reviewed the evidence on the benefits and harms of counseling. The review included studies evaluating behavioral counseling interventions conducted in primary settings, those judged feasible in primary care, and those to which patients might be referred from primary care. Recommendations: The USPSTF recommends high-intensity behavioral counseling for all sexually active adolescents and for adults at increased risk for STIs. ( B recommendation) Current evidence is insufficient to assess the balance of benefits and harms of behavioral counseling to prevent STIs in non-sexually active adolescents and in adults not at increased risk for STIs. (I statement).	[Calonge, Ned] USPSTF, Colorado Dept Publ Hlth & Environm, Denver, CO USA; USPSTF, Agcy Healthcare Res & Qual, Rockville, MD USA; [Petitti, Diana B.] Univ So Calif, USPSTF, Keck Sch Med, Sierra Madre, CA USA; [DeWitt, Thomas G.] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Dietrich, Allen J.] Dartmouth Med Sch, Hanover, NH USA; [Gordis, Leon] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Gregory, Kimberly D.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Harris, Russell] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Isham, George] HealthPartners Inc, Minneapolis, MN USA; [Leipzig, Rosanne] Mt Sinai Sch Med, New York, NY USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, Columbia, MO USA; [Loveland-Cherry, Carol] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Marion, Lucy N.] Med Coll Georgia, Augusta, GA 30912 USA; [Moyer, Virginia A.] Univ Texas Hlth Sci Ctr, Houston, TX USA; [Ockene, Judith K.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Sawaya, George F.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Yawn, Barbara P.] Olmsted Med Ctr, Rochester, MN USA	Colorado Department of Public Health & Environment; Agency for Healthcare Research & Quality; University of Southern California; Cincinnati Children's Hospital Medical Center; Dartmouth College; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cedars Sinai Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Icahn School of Medicine at Mount Sinai; University of Missouri System; University of Missouri Columbia; University of Michigan System; University of Michigan; University System of Georgia; Augusta University; University of Texas System; University of Texas Health Science Center Houston; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; Olmsted Medical Center	Calonge, N (corresponding author), USPSTF, Colorado Dept Publ Hlth & Environm, Denver, CO USA.				USPSTF; Agency for Healthcare Research and Quality	USPSTF; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The U. S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	ACOG Committee on Gynecologic Practice, 2006, Obstet Gynecol, V108, P1615; *AM AC FAM PHYS, 2007, REC CLIN PREV SERV; *AM MED ASS, 2007, ED COND US; *AM MED ASS, 1997, GAPS MONOGRAPH, V16, P5; American College of Obstetricians and Gynecologists Committee on Adolescent Health Care, 2004, Obstet Gynecol, V104, P891; DANIELSON R, 1990, FAM PLANN PERSPECT, V22, P115, DOI 10.2307/2135642; Jemmott JB, 2005, ARCH PEDIAT ADOL MED, V159, P440, DOI 10.1001/archpedi.159.5.440; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Lin JS, 2008, ANN INTERN MED, V149, P497, DOI 10.7326/0003-4819-149-7-200810070-00011; PICKERING LK, 2006, RED BOOK 2006 REPORT; WENGER NS, 1992, ANN INTERN MED, V117, P905, DOI 10.7326/0003-4819-117-11-905	11	32	35	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2008	149	7					491	W95		10.7326/0003-4819-149-7-200810070-00016	http://dx.doi.org/10.7326/0003-4819-149-7-200810070-00016			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QY	18838729				2022-12-28	WOS:000260004400006
J	Lin, JS; Whitlock, E; O'Connor, E; Bauer, V				Lin, Jennifer S.; Whitlock, Evelyn; O'Connor, Elizabeth; Bauer, Vance			Behavioral counseling to prevent sexually transmitted infections: A systematic review for the U.S. Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; RISK REDUCTION INTERVENTIONS; AFRICAN-AMERICAN; HIV-RISK; ADOLESCENT GIRLS; MINORITY WOMEN; MANAGED CARE; DISEASE; EFFICACY; ADULTS	Background: Despite advances in prevention and treatment, sexually transmitted infections (STIs) remain an important cause of morbidity and mortality in the United States. Purpose: To systematically review the evidence for behavioral counseling interventions to prevent STIs in adolescents and adults (nonpregnant and pregnant). Data Sources: English-language articles in MEDLINE, PsycINFO, the Centers for Disease Control and Prevention's Prevention Synthesis Research Project database, and Cochrane databases (1988 through December 2007), supplemented with expert recommendations and the bibliographies of previous systematic reviews. Study Selection: Reviewers included 21 articles representing 15 fair-or good-quality randomized, controlled trials that evaluated behavioral counseling interventions feasible in primary care and 1 fair-quality and 1 good-quality controlled trial with study samples representative of primary care populations in English-speaking countries. Comparative effectiveness trials that did not include a true control group were excluded. Data Extraction: Investigators abstracted, critically appraised, and synthesized 21 articles that met inclusion criteria. Data Synthesis: Most evidence suggests a modest reduction in STIs at 12 months among high-risk adults receiving multiple intervention sessions and among sexually active adolescents. Evidence also suggested that these interventions increase adherence to treatment recommendations for women in STI clinics and general contraceptive use in male adolescents and decrease nonsexual risky behavior and pregnancy in sexually active female adolescents. No evidence of substantial behavioral or biological harms for risk reduction counseling was found. Limitation: Significant clinical heterogeneity in study populations, interventions, and measurement of outcomes limited the reviewers' ability to meta-analyze trial results and to suggest important intervention components. Conclusion: Good-quality evidence suggests that behavioral counseling interventions with multiple sessions conducted in STI clinics and primary care effectively reduces STI incidence in "at-risk" adult and adolescent populations. Additional trial evidence is needed for both lower-intensity behavioral counseling interventions and lowerrisk patient populations.	[Lin, Jennifer S.] Kaiser Permanente NW, Ctr Hlth Res, Portland, OR 97227 USA	Kaiser Permanente	Lin, JS (corresponding author), Kaiser Permanente NW, Ctr Hlth Res, 3800 N Interstate Ave, Portland, OR 97227 USA.	jennifer.s.lin@kpchr.org			Agency for Healthcare Research and Quality, Rockville, Maryland [290-02-0024]; Oregon Clinical and Translational Research Institute [UL1 RR024140]; National Center for Research Resources; National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality, Rockville, Maryland(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Oregon Clinical and Translational Research Institute; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was conducted by the Oregon Evidencebased Practice Center under contract to the Agency for Healthcare Research and Quality, Rockville, Maryland (contract no. 290-02-0024, task order 1). It was also supported by the Oregon Clinical and Translational Research Institute (grant no. UL1 RR024140) from the National Center for Research Resources, National Institutes of Health.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], [No title captured]; Boekeloo BO, 1999, PEDIATRICS, V103, P107, DOI 10.1542/peds.103.1.107; Bolu OO, 2004, SEX TRANSM DIS, V31, P469, DOI 10.1097/01.olq.0000135987.12346.f2; Boyer CB, 1997, AIDS, V11, P359, DOI 10.1097/00002030-199703110-00014; Carey MP, 2004, J CONSULT CLIN PSYCH, V72, P252, DOI 10.1037/0022-006X.72.2.252; Chou R, 2005, ANN INTERN MED, V143, P55, DOI 10.7326/0003-4819-143-1-200507050-00010; Coyle S L, 1998, Public Health Rep, V113 Suppl 1, P19; DANIELSON R, 1990, FAM PLANN PERSPECT, V22, P115, DOI 10.2307/2135642; DiClemente RJ, 2004, JAMA-J AM MED ASSOC, V292, P171, DOI 10.1001/jama.292.2.171; Ehrhardt AA, 2002, AIDS CARE, V14, P147, DOI 10.1080/09540120220104677; Fairbrother G, 2005, J ADOLESCENT HEALTH, V37, P467, DOI 10.1016/j.jadohealth.2004.11.001; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Harris RP., 2001, US PREVENTIVE SERVIC; Henderson Z, 2005, INFECT DIS CLIN N AM, V19, P491, DOI 10.1016/j.idc.2005.03.003; Herbst JH, 2007, AM J PREV MED, V32, pS38, DOI 10.1016/j.amepre.2006.12.006; Jemmott JB, 2005, ARCH PEDIAT ADOL MED, V159, P440, DOI 10.1001/archpedi.159.5.440; Jemmott LS, 2007, AM J PUBLIC HEALTH, V97, P1034, DOI 10.2105/AJPH.2003.020271; JOHNSON WD, 2005, INTERVENTIONS MODIFY; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Meyers DS, 2007, ANN INTERN MED, V147, P135, DOI 10.7326/0003-4819-147-2-200707170-00173; Millstein SG, 1996, J ADOLESCENT HEALTH, V19, P249, DOI 10.1016/S1054-139X(96)00092-4; Petersen R, 2007, PERSPECT SEX REPRO H, V39, P21, DOI 10.1363/3902107; Proude EM, 2004, FAM PRACT, V21, P537, DOI 10.1093/fampra/cmh510; Scholes D, 2003, AIDS, V17, P1547, DOI 10.1097/00002030-200307040-00016; Shain RN, 1999, NEW ENGL J MED, V340, P93, DOI 10.1056/NEJM199901143400203; Shain RN, 2004, SEX TRANSM DIS, V31, P401, DOI 10.1097/01.olq.0000135301.97350.84; Smoak ND, 2006, JAIDS-J ACQ IMM DEF, V41, P374, DOI 10.1097/01.qai.0000185575.36591.fc; Underhill K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005421.pub2; US Preventive Serv Task Force, 2005, ANN INTERN MED, V143, P32, DOI 10.7326/0003-4819-143-1-200507050-00008; US Preventive Services Task Force, 2007, ANN INTERN MED, V147, P128, DOI 10.7326/0003-4819-147-2-200707170-00172; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x; WENGER NS, 1992, ANN INTERN MED, V117, P905, DOI 10.7326/0003-4819-117-11-905; Zenilman JM, 2005, INFECT DIS CLIN N AM, V19, P541, DOI 10.1016/j.idc.2005.04.002	34	63	66	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2008	149	7					497	W99		10.7326/0003-4819-149-7-200810070-00011	http://dx.doi.org/10.7326/0003-4819-149-7-200810070-00011			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	359QY	18838730				2022-12-28	WOS:000260004400007
J	Li, Y; Van Hooser, SD; Mazurek, M; White, LE; Fitzpatrick, D				Li, Ye; Van Hooser, Stephen D.; Mazurek, Mark; White, Leonard E.; Fitzpatrick, David			Experience with moving visual stimuli drives the early development of cortical direction selectivity	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; OCULAR DOMINANCE COLUMNS; RECEPTIVE-FIELDS; ORIENTATION MAPS; IN-VIVO; CORTEX; CAT; ORGANIZATION; KITTENS; SENSITIVITY	The onset of vision occurs when neural circuits in the visual cortex are immature, lacking both the full complement of connections(1,2) and the response selectivity that defines functional maturity(3,4). Direction- selective responses are particularly vulnerable to the effects of early visual deprivation, but it remains unclear how stimulus- driven neural activity guides the emergence of cortical direction selectivity. Here we report observations from a motion training protocol that allowed us to monitor the impact of experience on the development of direction- selective responses in visually naive ferrets. Using intrinsic signal imaging techniques, we found that training with a single axis of motion induced the rapid emergence of direction columns that were confined to cortical regions preferentially activated by the training stimulus. Using two- photon calcium imaging techniques, we found that single neurons in visually naive animals exhibited weak directional biases and lacked the strong local coherence in the spatial organization of direction preference that was evident in mature animals. Training with a moving stimulus, but not with a flashed stimulus, strengthened the direction- selective responses of individual neurons and preferentially reversed the direction biases of neurons that deviated from their neighbours. Both effects contributed to an increase in local coherence. We conclude that early experience with moving visual stimuli drives the rapid emergence of direction-selective responses in the visual cortex.	[Li, Ye; Van Hooser, Stephen D.; Mazurek, Mark; White, Leonard E.; Fitzpatrick, David] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA; [White, Leonard E.] Duke Univ, Sch Med, Dept Community & Family Med, Doctor Phys Therapy Div, Durham, NC 27710 USA; [Fitzpatrick, David] Duke Univ, Duke Inst Brain Sci, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Fitzpatrick, D (corresponding author), Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA.	fitzpat@neuro.duke.edu		Van Hooser, Stephen/0000-0002-1112-5832	Whitehall Foundation; US National Institutes of Health; NATIONAL EYE INSTITUTE [R01EY011488, P30EY005722, F32EY018064] Funding Source: NIH RePORTER	Whitehall Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank P. Kara, T. Mrsic-Flogel and A. Kerlin for help with two- photon imaging techniques, T. Tucker and J. Heiner for technical assistance and M. Christensson and the members of the Fitzpatrick lab for comments on the manuscript. This work was supported by grants from the Whitehall Foundation to L.E.W. and the US National Institutes of Health to D.F. and S.D.V.H.	Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; BOURGEOIS JP, 1993, J NEUROSCI, V13, P2801; Cai DQ, 1997, J NEUROPHYSIOL, V78, P1045, DOI 10.1152/jn.1997.78.2.1045; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; DAW NW, 1978, SCIENCE, V199, P565, DOI 10.1126/science.622560; Durack JC, 1996, CEREB CORTEX, V6, P178, DOI 10.1093/cercor/6.2.178; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Kawasaki H, 2004, J NEUROSCI, V24, P9962, DOI 10.1523/JNEUROSCI.2165-04.2004; Krug K, 2001, J NEUROPHYSIOL, V85, P1436, DOI 10.1152/jn.2001.85.4.1436; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; Shmuel A, 1996, J NEUROSCI, V16, P6945; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tanaka S, 2006, NEUROIMAGE, V30, P462, DOI 10.1016/j.neuroimage.2005.09.056; Tavazoie SF, 2000, NAT NEUROSCI, V3, P608, DOI 10.1038/75786; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Yao HS, 2007, NAT NEUROSCI, V10, P772, DOI 10.1038/nn1895; ZHOU YF, 1995, J NEUROSCI, V15, P689	30	129	131	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					952	956		10.1038/nature07417	http://dx.doi.org/10.1038/nature07417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	18946471	Green Accepted			2022-12-28	WOS:000261768300046
J	Hu, SL; Tang, SL; Liu, YL; Zhao, YX; Escobar, ML; de Ferranti, D				Hu, Shanlian; Tang, Shenglan; Liu, Yuanli; Zhao, Yuxin; Escobar, Maria-Luisa; de Ferranti, David			Health System Reform in China 6 Reform of how health care is paid for in China: challenges and opportunities	LANCET			English	Article							UNIVERSAL COVERAGE; LESSONS; MEXICO	China's current strategy to improve how health services are paid for is headed in the right direction, but much more remains to be done. The problems to be resolved, reflecting the setbacks of recent decades, are substantial: high levels of out-of-pocket payments and cost escalation, stalled progress in providing adequate health insurance for all, widespread inefficiencies in health facilities, uneven quality, extensive inequality, and perverse incentives for hospitals and doctors. China's leadership is taking bold steps to accelerate improvement, including increasing government spending on health and committing to reaching 100% insurance coverage by 2010. China's efforts are part of a worldwide transformation in the financing of health care that will dominate global health in the 21st century. The prospects that China will complete this transformation successfully in the next two decades are good, although success is not guaranteed. The real test, as other countries have experienced, will come when tougher reforms have to be introduced.	[Escobar, Maria-Luisa; de Ferranti, David] Brookings Inst, Washington, DC 20036 USA; [Hu, Shanlian] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Tang, Shenglan] WHO, Beijing Off, Beijing, Peoples R China; [Tang, Shenglan] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Liu, Yuanli] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Zhao, Yuxin] Minist Hlth, Natl Econ Inst, Beijing, Peoples R China	Brookings Institution; Fudan University; Nokia Corporation; Pfizer; World Health Organization; Liverpool School of Tropical Medicine; University of Liverpool; Harvard University; Harvard T.H. Chan School of Public Health	de Ferranti, D (corresponding author), Brookings Inst, Washington, DC 20036 USA.	david@deferranti.org	Tang, Shenglan/AAO-7403-2020					Baron G., 2007, CUENTAS SALUD COLOMB; Bleich SN, 2007, BMJ-BRIT MED J, V335, P875, DOI 10.1136/bmj.39350.617616.BE; *BUR POL STRAT, THAIL MACR HLTH FRAM; Chen Z., 2008, QUI SHI, V1, P35; *CHIN MIN HLTH, CHIN HLTH STAT YB 20; *CHIN NAT HLTH EC, 2004, CHIN NAT HLTH ACC RE; China National Health Development Research Center, 2020, CHIN NAT HLTH ACC RE; DOLLAR D, 2007, 2453 WORLD BANK; ESCOBAR ML, 2003, UNIVERAL HLTH INSURA; Fan M., 2008, WASH POST, P7; FLOREZ CE, 2006, INEQUIDADES SALUD CO; FLOREZ CE, 2007, FINANCIAL PROTECTION; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; GIEDIEN U, 2005, OPCIONES TRANSFORMAC; GIEDION D, IMPACT HLTH IN PRESS; GIEDION U, 2005, OPCIONES TRANSFORMAC; Gottret P, 2008, GOOD PRACTICES HLTH; Gottret P. E., 2006, HLTH FINANCING REVIS; Hughes D, 2007, HEALTH AFFAIR, V26, P999, DOI 10.1377/hlthaff.26.4.999; KNAUL F, 2007, CATASTROPHIC IMPOVER; Knaul FM, 2005, HEALTH AFFAIR, V24, P1467, DOI 10.1377/hlthaff.24.6.1467; KUTZIN J, 2002, EUROPEAN OBSERVATORY, P92; Liu Y, 2002, PEOPLES REPUBLIC CHI; LIU Y, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61362-8; Martineau T, 2004, INT J HEALTH PLAN M, V19, P101, DOI 10.1002/hpm.748; MENG Q, 2005, 33233 WORLD BANK; *MIN HLTH HLTH STA, 2008, P NAT HLTH C 2008, P96; *MIN HLTH PRC, 2004, AN REP NAT HLTH SERV; *MIN HLTH PRC, 2007, CHIN HLTH STAT YB 20; Mossialos E., 2004, EURO OBSERVER, V6, P1; Nitayarumphong S., 1998, ACHIEVING UNIVERSAL, P258; Pannarunothai S, 2000, HEALTH POLICY PLANN, V15, P303, DOI 10.1093/heapol/15.3.303; SCOTT J, 2006, INCIDENCE ANAL SEGUR; *STAT COUNC, 2000, DEC EST URB EMPL BAS, P759; TANG S, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61364-1; *THAIL MIN PUBL HL, THAIL HLTH PROF 2001; Towse A, 2004, BRIT MED J, V328, P103, DOI 10.1136/bmj.328.7431.103; URIBE A, 2006, INFORME CUATRIENIO H; UWE ER, 2000, J ECON PERSPECT, V14, P71; Wagstaff A, 2007, 4150 WORLD BANK; Wagstaff Adam, 2005, HLTH SYSTEMS E ASIA; World Bank, 2005, PUBL EXP ROL GOV CHI; *WORLD BANK, 2004, TAK STOCK CHIN RUR H; *WORLD BANK, 2005, CHIN HLTH SECT WHY R; WU Y, 2007, 2007 NAT CMS C BEIJ, P381; WU Y, 2008, NAT HLTH C BEIJ JAN; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu Liu, 2008, THESIS U LIVERPOOL, P1; Yip W, 2008, HEALTH AFFAIR, V27, P460, DOI 10.1377/hlthaff.27.2.460; Yu D., 2005, CHINESE HLTH EC, V24, P5; ZHAO Y, 2007, CHINESE HLTH EC, V26, P10; ZHAO Y, 2005, 34529 WORLD BANK; Zhao Y, 2008, HLTH EC J, V27, P5	55	312	318	2	122	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2008	372	9652					1846	1853		10.1016/S0140-6736(08)61368-9	http://dx.doi.org/10.1016/S0140-6736(08)61368-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	375KG	18930520				2022-12-28	WOS:000261112000027
J	Fang, J; Kaufman, J				Fang, Jing; Kaufman, Joan			Reproductive health in China: improve the means to the end	LANCET			English	Editorial Material									[Fang, Jing] Kunming Med Coll, Inst Hlth & Dev Studies, Kunming 650031, Peoples R China; [Kaufman, Joan] Brandeis Univ, Heller Sch, Waltham, MA 02254 USA	Kunming Medical University; Brandeis University	Fang, J (corresponding author), Kunming Med Coll, Inst Hlth & Dev Studies, Kunming 650031, Peoples R China.	fangjing07@126.com						Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; *CHIN POP DEV RES, 2004, CHIN UNFPA REPR HLTH; *CTR YOUTH RES, 2008, CHINA YOUTH DAI 0117; FANG J, 2004, HLTH POLICY PLANN S1, V19, P40; Gu BC, 2007, POPUL DEV REV, V33, P129, DOI 10.1111/j.1728-4457.2007.00161.x; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Kaufman J, 2006, STUD FAMILY PLANN, V37, P17, DOI 10.1111/j.1728-4465.2006.00080.x; Kaufman J, 2002, REPROD HEALTH MATTER, V10, P108, DOI 10.1016/S0968-8080(02)00090-3; Kaufman J, 1999, STUD FAMILY PLANN, V30, P112, DOI 10.1111/j.1728-4465.1999.00112.x; KAUFMAN J, 1992, INT FAM PLAN PERSPEC, V18, P1; LI SZ, 2001, RES PRACTICE GENDER; LIU YG, 2007, P GLOB FOR HLTH RES; MENG QY, 2000, INT C CHIN RUR HLTH, P67; *UNFPA, 1994, INT C POP DEV SUMM P; YU JJ, 2006, XINHUA DAILY TE 1117; 2007, XINHUA NEWS AGE 0605	16	21	21	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1619	1620		10.1016/S0140-6736(08)61356-2	http://dx.doi.org/10.1016/S0140-6736(08)61356-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18930522				2022-12-28	WOS:000260899900010
J	Okita, K; Nakagawa, M; Hong, HJ; Ichisaka, T; Yamanaka, S				Okita, Keisuke; Nakagawa, Masato; Hong, Hyenjong; Ichisaka, Tomoko; Yamanaka, Shinya			Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors	SCIENCE			English	Article							FIBROBLASTS; EXPRESSION; EFFICIENT; MYC	Induced pluripotent stem ( iPS) cells have been generated from mouse and human somatic cells by introducing Oct3/4 and Sox2 with either Klf4 and c-Myc or Nanog and Lin28 using retroviruses or lentiviruses. Patient- specific iPS cells could be useful in drug discovery and regenerative medicine. However, viral integration into the host genome increases the risk of tumorigenicity. Here, we report the generation of mouse iPS cells without viral vectors. Repeated transfection of two expression plasmids, one containing the complementary DNAs ( cDNAs) of Oct3/4, Sox2, and Klf4 and the other containing the c- Myc cDNA, into mouse embryonic fibroblasts resulted in iPS cells without evidence of plasmid integration, which produced teratomas when transplanted into mice and contributed to adult chimeras. The production of virus-free iPS cells, albeit from embryonic fibroblasts, addresses a critical safety concern for potential use of iPS cells in regenerative medicine.	[Okita, Keisuke; Nakagawa, Masato; Ichisaka, Tomoko; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Inst Integrated Cell Mat Sci, Kyoto 6068507, Japan; [Nakagawa, Masato; Hong, Hyenjong; Yamanaka, Shinya] Kyoto Univ, Dept Stem Cell Biol, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Ichisaka, Tomoko; Yamanaka, Shinya] Japan Sci & Technol Agcy, Yamanaka iPS Cell Project, Kawaguchi, Saitama 3320012, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); University of California System; University of California San Francisco; The J David Gladstone Institutes	Yamanaka, S (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Inst Integrated Cell Mat Sci, Kyoto 6068507, Japan.	yamanaka@frontier.kyoto-u.ac.jp		Okita, Keisuke/0000-0001-5806-1090				Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Hasegawa K, 2007, STEM CELLS, V25, P1707, DOI 10.1634/stemcells.2006-0813; Hsiao EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002532; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	19	1439	1737	5	581	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					949	953		10.1126/science.1164270	http://dx.doi.org/10.1126/science.1164270			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18845712				2022-12-28	WOS:000260674100049
J	Wang, RT; Henderson, GE				Wang, Ruotao; Henderson, Gail E.			Medical research ethics in China	LANCET			English	Editorial Material									[Wang, Ruotao] Chinese Ctr Dis Control & Prevent, Beijing 100050, Peoples R China; [Henderson, Gail E.] Univ N Carolina, Chapel Hill, NC USA	Chinese Center for Disease Control & Prevention; University of North Carolina; University of North Carolina Chapel Hill	Wang, RT (corresponding author), Chinese Ctr Dis Control & Prevent, Beijing 100050, Peoples R China.	rtwang@chinaaids.cn			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI050410, P30 AI050410-10, P30 AI050410-099008] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209; Cyranoski D, 2005, NATURE, V435, P138, DOI 10.1038/435138a; Fan RP, 1997, BIOETHICS, V11, P309, DOI 10.1111/1467-8519.00070; Fan RP, 2006, THEOR MED BIOETH, V27, P541, DOI 10.1007/s11017-006-9023-8; KING N. M. P, 1999, REGULATIONS ETHICS H; Lynoe N, 2004, SCAND J PUBLIC HEALT, V32, P472, DOI 10.1080/14034940410029432; Macklin Ruth, 1999, Account Res, V7, P59, DOI 10.1080/08989629908573942; *MIN HLTH PEOPL RE, 2007, REG ETH REV BIOM RES; Nie JB, 2000, KENNEDY INST ETHIC J, V10, P239, DOI 10.1353/ken.2000.0020; QIU RZ, 2003, INTRO BIOETHICS; Sleeboom M, 2005, NEW GENET SOC, V24, P57, DOI 10.1080/14636770500037776; Walker Rebecca L., 2007, WORKING VIRTUE VIRTU; Wang H, 2004, J CLIN ETHIC, V15, P61	13	11	12	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2008	372	9653					1867	1868		10.1016/S0140-6736(08)61353-7	http://dx.doi.org/10.1016/S0140-6736(08)61353-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	379IA	18930538	Green Accepted			2022-12-28	WOS:000261388700009
J	Gerberding, JL; Romero, JM; Ferraro, MJ; Pisculli, M; Rosenberg, ES; Heller, HM; Atkins, EH				Gerberding, Julie L.; Romero, Javier M.; Ferraro, Mary Jane; Pisculli, Mary; Rosenberg, Eric S.; Heller, Howard M.; Atkins, Elisha H.			A woman with neck pain and fever - Laboratory-acquired infection with B. melitensis, with cervical spinal osteomyelitis and epidural abscess	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BRUCELLOSIS		[Gerberding, Julie L.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Romero, Javier M.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Ferraro, Mary Jane] Massachusetts Gen Hosp, Clin Microbiol Lab, Boston, MA 02114 USA; [Ferraro, Mary Jane] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Romero, Javier M.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Ferraro, Mary Jane] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Centers for Disease Control & Prevention - USA; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Gerberding, JL (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.			Romero, Javier/0000-0001-5749-3000	General Electric	General Electric(General Electric)	Dr. Romero reports receiving research grant support from General Electric. No other potential conflict of interest relevant to this article was reported.	Araj GF, 2005, CLIN DIAGN LAB IMMUN, V12, P1334, DOI 10.1128/CDLI.12.11.1334-1335.2005; Bouza E, 2005, J HOSP INFECT, V61, P80, DOI 10.1016/j.jhin.2005.02.018; Darouiche RO, 2006, NEW ENGL J MED, V355, P2012, DOI 10.1056/NEJMra055111; Griffith J., 2008, Morbidity and Mortality Weekly Report, V57, P39; Hunt DL, 2000, BIOL SAFETY PRINCIPL, P35; HUYNH LY, 2008, FRONTIERS RES, V1, P47; Kamani I, 2004, CLIN RADIOL, V59, P881, DOI 10.1016/j.crad.2004.03.023; SHARIF HS, 1990, RADIOLOGY, V177, P101, DOI 10.1148/radiology.177.1.2399306; Solera J, 1999, CLIN INFECT DIS, V29, P1440, DOI 10.1086/313524; Ugarriza LF, 2005, BRIT J NEUROSURG, V19, P235, DOI 10.1080/02688690500204949; 2008, MMWR MORB MORTAL WKL, V57, P603	11	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2008	359	18					1942	1949		10.1056/NEJMcpc0806980	http://dx.doi.org/10.1056/NEJMcpc0806980			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366BL	18971496				2022-12-28	WOS:000260454500011
J	Keown, P; Mercer, G; Scott, J				Keown, Patrick; Mercer, Gavin; Scott, Jan			Retrospective analysis of hospital episode statistics, involuntary admissions under the Mental Health Act 1983, and number of psychiatric beds in England 1996-2006	BRITISH MEDICAL JOURNAL			English	Article							CARE; REINSTITUTIONALISATION	Objective To analyse the number of voluntary and involuntary (detentions under the Mental Health Act 1983) admissions for mental disorders between 1996 and 2006 in England. Design Retrospective analysis. Setting England. Main outcome measures Number of voluntary and involuntary admissions for mental disorders in England's health service, number of involuntary admissions to private beds, and number of NHS beds for patients with mental disorders or learning disabilities. Results Admissions for mental disorders in the NHS in England peaked in 1998 and then started to fall. Reductions in admissions were confined to patients with depression, learning disabilities, or dementia. Admissions for schizophrenic and manic disorders did not change whereas those for drug and alcohol problems increased. The number of NHS psychiatric beds decreased by 29%. The total number of involuntary admissions per annum increased by 20%, with a threefold increase in the likelihood of admission to a private facility. Patients admitted involuntarily occupied 23% of NHS psychiatric beds in 1996 but 36% in 2006. Conclusions Psychiatric inpatient care changed considerably in the decade from 1996 to 2006, with more involuntary admissions to fewer NHS beds. The case mix has shifted further towards psychotic and substance misuse disorders, which has changed the milieu of inpatient wards. Increasing proportions of involuntary patients were admitted to private facilities.	[Keown, Patrick; Mercer, Gavin] NHS Ctr, E Community Mental Hlth Team, Newcastle Upon Tyne NE6 1SG, Tyne & Wear, England; [Scott, Jan] Royal Victoria Infirm, Univ Dept Psychiat, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK	Keown, P (corresponding author), NHS Ctr, E Community Mental Hlth Team, Molineux St, Newcastle Upon Tyne NE6 1SG, Tyne & Wear, England.	p.j.keown@newcastle.ac.uk	Scott, Jan/F-2966-2010	Scott, Jan/0000-0002-7203-8601				Craig TK, 2004, BMJ-BRIT MED J, V329, P1067, DOI 10.1136/bmj.38246.594873.7C; Davidge M., 1993, SURVEY ENGLISH MENTA; *DEP HLTH, 2006, BED AV OCC; Glover G, 2006, BRIT J PSYCHIAT, V189, P441, DOI 10.1192/bjp.bp.105.020362; *INF CTR, 2007, INP FORM DET HOSP ME; JOHNSON S, 2005, BRIT MED J, V331, P4; Priebe S, 2005, BMJ-BRIT MED J, V330, P123, DOI 10.1136/bmj.38296.611215.AE; Priebe S, 2003, BRIT MED J, V326, P175, DOI 10.1136/bmj.326.7382.175; Wall S, 1999, BRIT MED J, V318, P1520, DOI 10.1136/bmj.318.7197.1520	9	48	48	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a1837	10.1136/bmj.a1837	http://dx.doi.org/10.1136/bmj.a1837			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18845592	Green Published, hybrid			2022-12-28	WOS:000260298800035
J	Boyer, P				Boyer, Pascal			Religion: Bound to believe?	NATURE			English	Editorial Material									[Boyer, Pascal] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Boyer, Pascal] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Boyer, P (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	pboyer@wustl.edu							0	102	104	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1038	1039		10.1038/4551038a	http://dx.doi.org/10.1038/4551038a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	363FG	18948934	Bronze			2022-12-28	WOS:000260252600019
J	Galiana, G; Branca, RT; Jenista, ER; Warren, WS				Galiana, Gigi; Branca, Rosa T.; Jenista, Elizabeth R.; Warren, S. Warren			Accurate temperature imaging based on intermolecular coherences in magnetic resonance	SCIENCE			English	Article							PROTON CHEMICAL-SHIFT; SOLUTION NMR; INHOMOGENEOUS FIELDS; QUANTUM COHERENCES; HIGH-RESOLUTION; HYPERTHERMIA; WATER; SPECTROSCOPY; THERMOMETRY; LIPOSOMES	Conventional magnetic resonance methods that provide interior temperature profiles, which find use in clinical applications such as hyperthermic therapy, can develop inaccuracies caused by the inherently inhomogeneous magnetic field within tissues or by probe dynamics, and work poorly in important applications such as fatty tissues. We present a magnetic resonance method that is suitable for imaging temperature in a wide range of environments. It uses the inherently sharp resonances of intermolecular zero-quantum coherences, in this case flipping up a water spin while flipping down a nearby fat spin. We show that this method can rapidly and accurately assign temperatures in vivo on an absolute scale.	[Galiana, Gigi; Branca, Rosa T.; Jenista, Elizabeth R.; Warren, S. Warren] Duke Univ, Ctr Mol & Biomol Imaging, Durham, NC 27708 USA; [Galiana, Gigi] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Duke University; Princeton University	Warren, WS (corresponding author), Duke Univ, Ctr Mol & Biomol Imaging, Durham, NC 27708 USA.	warren.warren@duke.edu		Branca, Rosa Tamara/0000-0002-6871-1824	NIH [EB2122, EB5979]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002122, F31EB005979] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by NIH grants EB2122 and EB5979. We thank M. Dewhirst for useful discussions.	Boss A, 2005, J MAGN RESON IMAGING, V22, P813, DOI 10.1002/jmri.20438; Chen Z, 2004, J AM CHEM SOC, V126, P446, DOI 10.1021/ja036491f; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; De Senneville BD, 2005, INT J HYPERTHER, V21, P515, DOI 10.1080/02656730500133785; Dewhirst MW, 2005, INT J HYPERTHER, V21, P779, DOI 10.1080/02656730500271668; Faber C, 2003, J MAGN RESON, V161, P265, DOI 10.1016/S1090-7807(03)00006-5; Gaber MH, 1996, INT J RADIAT ONCOL, V36, P1177, DOI 10.1016/S0360-3016(96)00389-6; Galiana G, 2005, J AM CHEM SOC, V127, P17574, DOI 10.1021/ja054463m; Gellermann J, 2005, INT J HYPERTHER, V21, P497, DOI 10.1080/02656730500070102; HE QH, 1993, J CHEM PHYS, V98, P6779, DOI 10.1063/1.464770; Hehr T, 2003, ONKOLOGIE, V26, P295, DOI 10.1159/000071628; Hekmatyar SK, 2005, MAGN RESON MED, V53, P294, DOI 10.1002/mrm.20345; HINDMAN JC, 1966, J CHEM PHYS, V44, P4582, DOI 10.1063/1.1726676; ISHIHARA Y, 1995, MAGNET RESON MED, V34, P814, DOI 10.1002/mrm.1910340606; Jones EL, 2005, J CLIN ONCOL, V23, P3079, DOI 10.1200/JCO.2005.05.520; Kong G, 2000, CANCER RES, V60, P4440; Kuroda K, 2000, MAGNET RESON MED, V43, P220, DOI 10.1002/(SICI)1522-2594(200002)43:2<220::AID-MRM8>3.0.CO;2-9; Lee S, 1996, J CHEM PHYS, V105, P874, DOI 10.1063/1.471968; Lin YY, 2000, PHYS REV LETT, V85, P3732, DOI 10.1103/PhysRevLett.85.3732; Lin YY, 2000, SCIENCE, V290, P118, DOI 10.1126/science.290.5489.118; McDannold N, 2004, RADIOLOGY, V230, P743, DOI 10.1148/radiol.2303021713; Needham D, 2000, CANCER RES, V60, P1197; Peters RD, 1999, MAGNET RESON MED, V41, P909, DOI 10.1002/(SICI)1522-2594(199905)41:5<909::AID-MRM9>3.0.CO;2-N; Raaphorst GP, 1990, INTRO PRACTICAL ASPE, P10; Rieke V, 2004, MAGNET RESON MED, V51, P1223, DOI 10.1002/mrm.20090; van der Zee J, 2002, ANN ONCOL, V13, P1173, DOI 10.1093/annonc/mdf280; Vathyam S, 1996, SCIENCE, V272, P92, DOI 10.1126/science.272.5258.92; WARREN WS, 1993, SCIENCE, V262, P2005, DOI 10.1126/science.8266096; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5; YATVIN MB, 1978, SCIENCE, V202, P1290, DOI 10.1126/science.364652; [No title captured]; [No title captured]	32	54	56	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					421	424		10.1126/science.1163242	http://dx.doi.org/10.1126/science.1163242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927389	Green Accepted, Green Submitted			2022-12-28	WOS:000260094500041
J	Erlandson, KJ; Miller, SBM; Nam, Y; Osborne, AR; Zimmer, J; Rapoport, TA				Erlandson, Karl J.; Miller, Stephanie B. M.; Nam, Yunsun; Osborne, Andrew R.; Zimmer, Jochen; Rapoport, Tom A.			A role for the two-helix finger of the SecA ATPase in protein translocation	NATURE			English	Article							ESCHERICHIA-COLI; PORE RESIDUES; CHANNEL; MEMBRANE; COMPLEX; MEDIATE; RECOGNITION; PROTEOLYSIS; HYDROLYSIS; PEPTIDASE	An important step in the biosynthesis of many proteins is their partial or complete translocation across the plasma membrane in prokaryotes or the endoplasmic reticulum membrane in eukaryotes(1). In bacteria, secretory proteins are generally translocated after completion of their synthesis by the interaction of the cytoplasmic ATPase SecA and a protein- conducting channel formed by the SecY complex(2). How SecA moves substrates through the SecY channel is unclear. However, a recent structure of a SecA - SecY complex raises the possibility that the polypeptide chain is moved by a two- helix finger domain of SecA that is inserted into the cytoplasmic opening of the SecY channel(3). Here we have used disulphide- bridge cross-linking to show that the loop at the tip of the two- helix finger of Escherichia coli SecA interacts with a polypeptide chain right at the entrance into the SecY pore. Mutagenesis demonstrates that a tyrosine in the loop is particularly important for translocation, but can be replaced by some other bulky, hydrophobic residues. We propose that the two- helix finger of SecA moves a polypeptide chain into the SecY channel with the tyrosine providing the major contact with the substrate, a mechanism analogous to that suggested for hexameric, protein- translocating ATPases.	[Erlandson, Karl J.; Miller, Stephanie B. M.; Nam, Yunsun; Osborne, Andrew R.; Zimmer, Jochen; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Erlandson, Karl J.; Miller, Stephanie B. M.; Nam, Yunsun; Osborne, Andrew R.; Zimmer, Jochen; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu		Zimmer, Jochen/0000-0002-8423-2882; Nam, Yunsun/0000-0002-7939-8626	NIH; Damon Runyon Cancer Research Foundation [DRG 1953-07]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. DeLaBarre and B. Burton for critical reading of the manuscript, and R. Sauer, T. Baker and A. Horwich for discussion. The work was supported by an NIH grant. T.A.R. is a HHMI investigator. Y.N. was supported by the Damon Runyon Cancer Research Foundation (DRG 1953-07)	Bensing BA, 2005, MOL MICROBIOL, V58, P1468, DOI 10.1111/j.1365-2958.2005.04919.x; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Collinson I, 2001, EMBO J, V20, P2462, DOI 10.1093/emboj/20.10.2462; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Erlandson KJ, 2008, J BIOL CHEM, V283, P15709, DOI 10.1074/jbc.M710356200; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; JAROSIK GP, 1991, J BACTERIOL, V173, P860, DOI 10.1128/jb.173.2.860-868.1991; Karamanou S, 1999, MOL MICROBIOL, V34, P1133, DOI 10.1046/j.1365-2958.1999.01686.x; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Matlack KES, 1997, SCIENCE, V277, P938, DOI 10.1126/science.277.5328.938; MATSUYAMA S, 1990, J BIOL CHEM, V265, P8760; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Park EY, 2005, J BIOL CHEM, V280, P22892, DOI 10.1074/jbc.M500035200; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vrontou E, 2004, J BIOL CHEM, V279, P22490, DOI 10.1074/jbc.M401008200; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200	27	105	107	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					984	U67		10.1038/nature07439	http://dx.doi.org/10.1038/nature07439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923526	Green Accepted, Green Submitted			2022-12-28	WOS:000260038300054
J	Walsh, M; Spurling, G				Walsh, Maie; Spurling, Geoffrey			Aspirin in type 2 diabetes: is there any evidence base?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LOW-DOSE ASPIRIN; CARDIOVASCULAR EVENTS; PRIMARY PREVENTION; RANDOMIZED TRIALS; METAANALYSIS; MELLITUS; DISEASE		[Spurling, Geoffrey] Univ Queensland, Royal Brisbane Hosp, Discipline Gen Practice, Brisbane, Qld 4072, Australia; [Walsh, Maie] Univ Queensland, Royal Brisbane Hosp, Herston, Qld 4029, Australia	Royal Brisbane & Women's Hospital; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland	Spurling, G (corresponding author), Univ Queensland, Royal Brisbane Hosp, Discipline Gen Practice, Brisbane, Qld 4072, Australia.	g.spurling@uq.edu.au	Spurling, Geoffrey K/F-1783-2010	Spurling, Geoffrey K/0000-0002-3525-4663				Ajjan R, 2008, DIABETOLOGIA, V51, P385, DOI 10.1007/s00125-007-0898-3; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; BUSE J, 1997, DIABETES CARE, V20, P1767; De Berardis G, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-21; FERRIS FL, 1992, JAMA-J AM MED ASSOC, V268, P1292; Halushka MK, 2002, CIRCULATION, V105, P1620, DOI 10.1161/01.CIR.0000015422.86569.52; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; *MACR DIS EXP WORK, 2001, PREV DET MACR DIS TY; McQuaid KR, 2006, AM J MED, V119, P624, DOI 10.1016/j.amjmed.2005.10.039; RYDEN L, EUR HEART J, V28, P88; Sacco M, 2003, DIABETES CARE, V26, P3264, DOI 10.2337/diacare.26.12.3264; Sanmuganathan PS, 2001, HEART, V85, P265, DOI 10.1136/heart.85.3.265	14	4	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2008	337								a1902	10.1136/bmj.a1902	http://dx.doi.org/10.1136/bmj.a1902			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374FF	18927174				2022-12-28	WOS:000261027900002
J	Lupardus, PJ; Shen, A; Bogyo, M; Garcia, KC				Lupardus, Patrick J.; Shen, Aimee; Bogyo, Matthew; Garcia, K. Christopher			Small molecule-induced allosteric activation of the Vibrio cholerae RTX cysteine protease domain	SCIENCE			English	Article							CLOSTRIDIUM-DIFFICILE TOXIN; BACTERIAL; CLEAVAGE; DEPENDS; MICE	Vibrio cholerae RTX (repeats in toxin) is an actin-disrupting toxin that is autoprocessed by an internal cysteine protease domain (CPD). The RTX CPD is efficiently activated by the eukaryote-specific small molecule inositol hexakisphosphate (InsP(6)), and we present the 2.1 angstrom structure of the RTX CPD in complex with InsP(6). InsP(6) binds to a conserved basic cleft that is distant from the protease active site. Biochemical and kinetic analyses of CPD mutants indicate that InsP(6) binding induces an allosteric switch that leads to the autoprocessing and intracellular release of toxin-effector domains.	[Shen, Aimee; Bogyo, Matthew] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Lupardus, Patrick J.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Lupardus, Patrick J.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Bogyo, M (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	mbogyo@stanford.edu; kcgarcia@stanford.edu		Shen, Aimee/0000-0002-9786-5742; Bogyo, Matthew/0000-0003-3753-4412	Damon Runyon Cancer Research Foundation; NIH Keck Foundation; Howard Hughes Medical Institute; Burroughs Wellcome Foundation; Searle Scholars Program; NIH National Technology Center for Networks and Pathways [U54RR020843]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; NIH Keck Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Searle Scholars Program; NIH National Technology Center for Networks and Pathways(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank S. Juo for assistance with data collection and structure determination, E.D. Sandoval for assistance with kinetic analyses and helpful discussion, M. Blokech and G. Schoolnik for help with V. cholerae strain construction, and A. Guzzetta for intact mass analysis of SeMet-labeled CPD. P.J.L. is a Damon Runyon Fellow, supported by the Damon Runyon Cancer Research Foundation. K.C.G. is supported by the NIH Keck Foundation and the Howard Hughes Medical Institute. M.B. is supported by the Burroughs Wellcome Foundation, the Searle Scholars Program, and the NIH National Technology Center for Networks and Pathways (grant U54RR020843). P.J.L, A.S., M.B., and K.C.G. are listed as inventors on a patent application related to use of the V. cholerae RTX CPD for biotechnical applications. Coordinates and structure factors have been deposited in the Protein Data Bank (www.rcsb.org) under accession number 3EEB.	Cordero CL, 2007, J CLIN MICROBIOL, V45, P2289, DOI 10.1128/JCM.00349-07; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; GORDON VM, 1994, INFECT IMMUN, V62, P333, DOI 10.1128/IAI.62.2.333-340.1994; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Olivier V, 2007, INFECT IMMUN, V75, P5043, DOI 10.1128/IAI.00508-07; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Satchell KJF, 2007, INFECT IMMUN, V75, P5079, DOI 10.1128/IAI.00525-07; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700	13	95	96	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					265	268		10.1126/science.1162403	http://dx.doi.org/10.1126/science.1162403			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845756	Green Accepted			2022-12-28	WOS:000259902300050
J	Tang, JW; Settles, GS				Tang, J. W.; Settles, G. S.			Coughing and aerosols	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Settles, Gary S/D-5260-2009						0	52	52	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2008	359	15					E19	E19		10.1056/NEJMicm072576	http://dx.doi.org/10.1056/NEJMicm072576			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FS	18843121				2022-12-28	WOS:000259903100010
J	Jacobsen, SJ; Cheetham, TC; Haque, R; Shi, JM; Loo, RK				Jacobsen, Steven J.; Cheetham, T. Craig; Haque, Reina; Shi, Jiaxiao M.; Loo, Ronald K.			Association between 5-alpha reductase inhibition and risk of hip fracture	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; BENIGN PROSTATIC HYPERPLASIA; FINASTERIDE; MEN; TESTOSTERONE	Context For more than 15 years, 5-alpha reductase inhibitors, which block the conversion of testosterone to dihydrotestosterone, have been used in the treatment of benign prostatic hyperplasia ( BPH). Short- term studies show no effects of these agents on bone metabolism, but long- term data are not available. Objective To assess the association between use of 5-alpha reductase inhibitors ( eg, finasteride) for BPH and occurrence of hip fracture. Design, Setting, and Patients Population- based case- control study using data from Kaiser Permanente Southern California, a managed care organization with more than 3 million members. Case patients included 7076 men 45 years and older with incident hip fracture from 1997- 2006. Control patients were 7076 men without incident hip fracture, optimally matched at a 1: 1 ratio to case patients on age and medical center. Electronic information on pharmaceutical use was used to identify use of finasteride from 1991 forward. Results Overall, 2547 ( 36%) and 2488 ( 35%) case and control patients, respectively, had a diagnosis of BPH ( P=. 30), and 109 ( 1.5%) and 141 ( 2.0%) of case and control patients, respectively, had been exposed to finasteride prior to the index date ( matched odds ratio, 0.77; 95% confidence interval, 0.59- 1.00; P=. 04). There was no suggestion of a dose- response relationship between exposure to 5- alpha reductase inhibitors when the exposure was stratified into tertiles of total exposure ( P=. 12). By contrast, there was a slightly higher prevalence of alpha-blocker use in case vs control patients ( 32% vs 30%, respectively; P=. 04). Conclusions Exposure to 5-alpha reductase inhibitors was not associated with increased risk of hip fracture. The reduction in risk observed with exposure to 5-alpha reductase inhibitors and the modest increase in risk associated with exposure to alpha-blockers require replication and warrant further investigation.	[Jacobsen, Steven J.; Haque, Reina; Shi, Jiaxiao M.] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Cheetham, T. Craig] Kaiser Permanente So Calif, Pharm Analyt Serv, Downey, CA USA; [Loo, Ronald K.] Kaiser Permanente So Calif, Dept Urol, Bellflower Med Ctr, Bellfower, CA USA	Kaiser Permanente; Kaiser Permanente; Kaiser Permanente	Jacobsen, SJ (corresponding author), Kaiser Permanente So Calif, Dept Res & Evaluat, 100 S Robles Ave,2nd Floor, Pasadena, CA 91101 USA.	steven.j.jacobsen@kp.org		Jacobsen, Steven/0000-0002-8174-8533	Kaiser Foundation Community Benefit; Southern California Permanente Medical Group	Kaiser Foundation Community Benefit; Southern California Permanente Medical Group	This study was supported through the Kaiser Foundation Community Benefit fund and the Southern California Permanente Medical Group.	Amory JK, 2004, J CLIN ENDOCR METAB, V89, P503, DOI 10.1210/jc.2003-031110; Andriole G, 2004, J UROLOGY, V172, P1399, DOI 10.1097/01.ju.0000139539.94828.29; AUA Practise Guidelines Committee, 2003, J UROLOGY, V170, P530, DOI 10.1097/01.ju.0000078083.38675.79; Bergstralh EJ, 1996, EPIDEMIOLOGY, V7, P331; CastroMagana M, 1996, J ANDROL, V17, P516; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clayman Ralph V, 2005, J Urol, V173, P1200; COLVARD DS, 1989, P NATL ACAD SCI USA, V86, P854, DOI 10.1073/pnas.86.3.854; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Djavan B, 1999, EUR UROL, V36, P1, DOI 10.1159/000019919; Issa S, 2002, J CLIN ENDOCR METAB, V87, P5401, DOI 10.1210/jc.2001-011902; JACOBSEN SJ, 1995, ARCH INTERN MED, V155, P477, DOI 10.1001/archinte.155.5.477; JACOBSEN SJ, 1990, AM J PUBLIC HEALTH, V80, P871, DOI 10.2105/AJPH.80.7.871; Khosla S, 2002, J CLIN ENDOCR METAB, V87, P1443, DOI 10.1210/jc.87.4.1443; Khosla S, 2001, J CLIN ENDOCR METAB, V86, P3555, DOI 10.1210/jc.86.8.3555; Matsumoto AM, 2002, J UROLOGY, V167, P2105, DOI 10.1016/S0022-5347(05)65095-1; Orwoll E, 2006, ARCH INTERN MED, V166, P2124, DOI 10.1001/archinte.166.19.2124; SANDLER RB, 1987, CALCIFIED TISSUE INT, V41, P65; Sobel V, 2006, J CLIN ENDOCR METAB, V91, P3017, DOI 10.1210/jc.2005-2809; Somjen D, 2007, J STEROID BIOCHEM, V107, P238, DOI 10.1016/j.jsbmb.2007.03.048; Tollin SR, 1996, J CLIN ENDOCR METAB, V81, P1031, DOI 10.1210/jc.81.3.1031; Wei JT, 2005, J UROLOGY, V173, P1256, DOI 10.1097/01.ju.0000155709.37840.fe	22	31	31	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2008	300	14					1660	1664		10.1001/jama.300.14.1660	http://dx.doi.org/10.1001/jama.300.14.1660			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356YF	18840839	Bronze			2022-12-28	WOS:000259812800027
J	Liu, OW; Chun, CD; Chow, ED; Chen, CB; Madhani, HD; Noble, SM				Liu, Oliver W.; Chun, Cheryl D.; Chow, Eric D.; Chen, Changbin; Madhani, Hiten D.; Noble, Suzanne M.			Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans	CELL			English	Article							SIGNATURE-TAGGED MUTAGENESIS; HUMAN-IMMUNODEFICIENCY-VIRUS; UDP-GLUCOSE DEHYDROGENASE; CENTRAL-NERVOUS-SYSTEM; INSERTIONAL MUTAGENESIS; YEAST; CELL; GENOME; ENZYME; STRESS	The fungus Cryptococcus neoformans is a leading cause of mortality and morbidity among HIV-infected individuals. We utilized the completed genome sequence and optimized methods for homologous DNA replacement using high-velocity particle bombardment to engineer 1201 gene knockout mutants. We screened this resource in vivo for proliferation in murine lung tissue and in vitro for three well-recognized virulence attributes-polysaccharide capsule formation, melanization, and growth at body temperature. We identified dozens of previously uncharacterized genes that affect these known attributes as well as 40 infectivity mutants without obvious defects in these traits. The latter mutants affect predicted regulatory factors, secreted proteins, and immune-related factors, and represent powerful tools for elucidating novel virulence mechanisms. In particular, we describe a GATA family transcription factor that inhibits phagocytosis by murine macrophages independently of the capsule, indicating a previously unknown mechanism of innate immune modulation.	[Liu, Oliver W.; Chun, Cheryl D.; Chow, Eric D.; Chen, Changbin; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Noble, Suzanne M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Noble, Suzanne M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 600 16th St,GH-N372C, San Francisco, CA 94158 USA.	hitenmadhani@gmail.com		Noble, Suzanne/0000-0001-9855-8448; Madhani, Hiten/0000-0001-7400-6657	Herb and Marion Sandler Foundation; NIAID [R01AI065519]; Howard Hughes Medical Institute (HHMI); Host Defense Training Program [T32AI060537]; National Science Foundation; Department of Biochemistry and Biophysics Boyer Postdoctoral Fellowship; Stewart Family Trust; HHMI Postdoctoral Fellowship for Physicians; Burroughs-Wellcome Fund Career Development Award; NIH [K08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060537, R01AI065519] Funding Source: NIH RePORTER	Herb and Marion Sandler Foundation; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Host Defense Training Program; National Science Foundation(National Science Foundation (NSF)); Department of Biochemistry and Biophysics Boyer Postdoctoral Fellowship; Stewart Family Trust; HHMI Postdoctoral Fellowship for Physicians(Howard Hughes Medical Institute); Burroughs-Wellcome Fund Career Development Award(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to J. Lodge, C. Hull, J. Heitman, T. Kozel, and G. Cox for strains, reagents, training, and assistance with protocols, to S. O'Brien for assistance with bioinformatics, and to J. Cox and J. Brown for helpful discussion and comments on the manuscript. This work was supported by an Opportunity Grant from the Herb and Marion Sandler Foundation to H.D.M. and a grant from the NIAID (R01AI065519) to H.D.M. O.W.L. was supported by a Howard Hughes Medical Institute (HHMI) Predoctoral Fellowship and by the NIAID-sponsored UCSF Microbial Pathogenesis and Host Defense Training Program (T32AI060537). C.D.C. was supported by a National Science Foundation Predoctoral Fellowship. C.C. was supported by a Department of Biochemistry and Biophysics Boyer Postdoctoral Fellowship and a grant from the Stewart Family Trust. S.M.N. was supported by a HHMI Postdoctoral Fellowship for Physicians, a Burroughs-Wellcome Fund Career Development Award, and an NIH K08 award. O.W.L. and E.D.C. generated and profiled the deletion library. O.W.L. and C.C. reconstructed and retested deletion strains. C.C. constructed the overexpression strain and performed microarray experiments. C.D.C. and O.W.L. constructed double mutant strains and performed macrophage phagocytosis experiments. S.M.N. developed protocols for the STM assay, and provided reagents, training, and guidance. Strain requests should be addressed to H.D.M.	Akhter S, 2003, INFECT IMMUN, V71, P5794, DOI 10.1128/IAI.71.10.5794-5802.2003; Alspaugh JA, 2002, EUKARYOT CELL, V1, P75, DOI 10.1128/EC.1.1.75-84.2002; Bader GD, 2003, TRENDS CELL BIOL, V13, P344, DOI 10.1016/S0962-8924(03)00127-2; Bahn YS, 2005, MOL BIOL CELL, V16, P2285, DOI 10.1091/mbc.E04-11-0987; Bekondi C, 2006, INT J INFECT DIS, V10, P387, DOI 10.1016/j.ijid.2005.07.004; Belay T, 1997, INFECT IMMUN, V65, P718, DOI 10.1128/IAI.65.2.718-728.1997; Bicanic T, 2005, BRIT MED BULL, V72, P99, DOI 10.1093/bmb/ldh043; Chang YC, 2007, MOL MICROBIOL, V64, P614, DOI 10.1111/j.1365-2958.2007.05676.x; Chow ED, 2007, CURR GENET, V52, P137, DOI 10.1007/s00294-007-0147-9; Chun CD, 2007, PLOS PATHOG, V3, P225, DOI 10.1371/journal.ppat.0030022; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Cox GM, 2001, MOL MICROBIOL, V39, P166, DOI 10.1046/j.1365-2958.2001.02236.x; Cramer KL, 2006, EUKARYOT CELL, V5, P1147, DOI 10.1128/EC.00145-06; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; de Jesus-Berrios M, 2003, CURR BIOL, V13, P1963, DOI 10.1016/j.cub.2003.10.029; Del Poeta M, 2004, EUKARYOT CELL, V3, P1067, DOI 10.1128/EC.3.5.1067-1075.2004; Fiscella M, 2003, NAT BIOTECHNOL, V21, P302, DOI 10.1038/nbt797; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Fujimoto D, 2002, PHYSIOL MOL PLANT P, V61, P77, DOI 10.1006/pmpp.2002.0418; Griffith CL, 2004, J BIOL CHEM, V279, P51669, DOI 10.1074/jbc.M408889200; Hull CM, 2004, INFECT IMMUN, V72, P3643, DOI 10.1128/IAI.72.6.3643-3645.2004; Idnurm A, 2004, EUKARYOT CELL, V3, P420, DOI 10.1128/EC.3.2.420-429.2004; Idnurm A, 2007, EUKARYOT CELL, V6, P60, DOI 10.1128/EC.00214-06; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Jung WH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040045; KOZEL TR, 1976, INFECT IMMUN, V14, P62, DOI 10.1128/IAI.14.1.62-67.1976; Liu OW, 2007, EUKARYOT CELL, V6, P630, DOI 10.1128/EC.00398-06; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Monari C, 2006, FEMS YEAST RES, V6, P537, DOI 10.1111/j.1567-1364.2006.00072.x; Moyrand F, 2004, EUKARYOT CELL, V3, P1601, DOI 10.1128/EC.3.6.1601-1608.2004; Moyrand F, 2004, EUKARYOT CELL, V3, P1513, DOI 10.1128/EC.3.6.1513-1524.2004; Nelson RT, 2001, GENETICS, V157, P935; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Noverr MC, 2004, INFECT IMMUN, V72, P1693, DOI 10.1128/IAI.72.3.1693-1699.2004; Okabayashi K, 2007, MYCOPATHOLOGIA, V163, P1, DOI 10.1007/s11046-006-0083-0; Olszewski MA, 2004, AM J PATHOL, V164, P1761, DOI 10.1016/S0002-9440(10)63734-0; Saenz HL, 2005, CURR OPIN MICROBIOL, V8, P612, DOI 10.1016/j.mib.2005.08.013; Shea JM, 2006, INFECT IMMUN, V74, P5977, DOI 10.1128/IAI.00768-06; Siafakas AR, 2007, J BIOL CHEM, V282, P37508, DOI 10.1074/jbc.M707913200; Vaishnav VV, 1998, CARBOHYD RES, V306, P315, DOI 10.1016/S0008-6215(97)10058-1; Wang P, 2004, EUKARYOT CELL, V3, P1028, DOI 10.1128/EC.3.4.1028-1035.2004; Warnock DW, 2006, MED MYCOL, V44, P697, DOI 10.1080/13693780601009493	46	308	316	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					174	188		10.1016/j.cell.2008.07.046	http://dx.doi.org/10.1016/j.cell.2008.07.046			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854164	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000259728100018
J	Barouch, DH				Barouch, Dan H.			Challenges in the development of an HIV-1 vaccine	NATURE			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL RESPONSES; RETROVIRUSES HTLV-III; PLASMID DNA VACCINE; SIMIAN IMMUNODEFICIENCY; IMMUNE-RESPONSES; DISEASE PROGRESSION; VIRAL LOAD; IMMUNOGENICITY EVALUATION; MONOCLONAL-ANTIBODIES	The development of a safe and effective human immunodeficiency virus (HIV)-1 vaccine is a critically important global health priority. Despite recent advances in our understanding of HIV-1 pathogenesis and immunology, however, major scientific obstacles remain. Prototype HIV-1 vaccine candidates aimed at eliciting humoral and cellular immune responses have so far failed to protect against HIV- 1 infection or to reduce viral loads after infection in clinical efficacy studies. A renewed and coordinated commitment to basic discovery research, preclinical studies and clinical trials will therefore be required to overcome the hurdles currently facing the field. Here I review key challenges and future prospects in the quest to develop a prophylactic HIV- 1 vaccine.	[Barouch, Dan H.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Barouch, DH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Barouch, Dan/Y-3918-2019		National Institutes of Health; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066924, R01AI058727, U19AI066305, U19AI078526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The author would like to thank R. Dolin, N. Letvin, J. Mascola and J. McElrath for critically reviewing this manuscript. The author acknowledges support from the National Institutes of Health and the Bill & Melinda Gates Foundation.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Baba TW, 1999, NAT MED, V5, P194, DOI 10.1038/5557; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; BABA TW, 1995, SCIENCE, V267, P1820, DOI 10.1126/science.7892606; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; BAROUCH DH, 2008, KEYST S HIV VACC BAN, P60; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chong SY, 2007, VACCINE, V25, P4967, DOI 10.1016/j.vaccine.2006.11.070; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Farina SF, 2001, J VIROL, V75, P11603, DOI 10.1128/JVI.75.23.11603-11613.2001; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Fauci AS, 2008, NATURE, V453, P289, DOI 10.1038/453289a; FAUCI AS, 2008, NIAID WILL NOT MOVE; FAUCI AS, 2007, RELEASE NEW DATA HVT; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Fitzgerald JC, 2003, J IMMUNOL, V170, P1416, DOI 10.4049/jimmunol.170.3.1416; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liu JY, 2008, J VIROL, V82, P5643, DOI 10.1128/JVI.02564-07; Liu JY, 2008, J VIROL, V82, P4844, DOI 10.1128/JVI.02616-07; Luckay A, 2007, J VIROL, V81, P5257, DOI 10.1128/JVI.00055-07; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; Montefiori D, 2007, PLOS MED, V4, P1867, DOI 10.1371/journal.pmed.0040348; MOORE JP, 1995, J VIROL, V69, P101, DOI 10.1128/JVI.69.1.101-109.1995; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; MURPHEYCORB M, 1989, SCIENCE, V246, P1293, DOI 10.1126/science.2555923; Musey L, 1997, NEW ENGL J MED, V337, P1267, DOI 10.1056/NEJM199710303371803; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; SARNGADHARAN MG, 1984, SCIENCE, V224, P506, DOI 10.1126/science.6324345; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; SCHUPBACH J, 1984, SCIENCE, V224, P503, DOI 10.1126/science.6200937; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shiver JW, 2004, ANNU REV MED, V55, P355, DOI 10.1146/annurev.med.55.091902.104344; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Thorner AR, 2006, J CLIN MICROBIOL, V44, P3781, DOI 10.1128/JCM.01249-06; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Walker BD, 2001, NAT IMMUNOL, V2, P473, DOI 10.1038/88656; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Weaver EA, 2006, J VIROL, V80, P6745, DOI 10.1128/JVI.02484-05; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Wyand MS, 1996, J VIROL, V70, P3724, DOI 10.1128/JVI.70.6.3724-3733.1996; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zhang ZQ, 2002, J VIROL, V76, P12845, DOI 10.1128/JVI.76.24.12845-12854.2002; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	92	257	356	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					613	619		10.1038/nature07352	http://dx.doi.org/10.1038/nature07352			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833271	Green Accepted, Bronze			2022-12-28	WOS:000259639700036
J	Conrad, S; Renninger, M; Hennenlotter, J; Wiesner, T; Just, L; Bonin, M; Aicher, W; Buhring, HJ; Mattheus, U; Mack, A; Wagner, HJ; Minger, S; Matzkies, M; Reppel, M; Hescheler, J; Sievert, KD; Stenzl, A; Skutella, T				Conrad, Sabine; Renninger, Markus; Hennenlotter, Joerg; Wiesner, Tina; Just, Lothar; Bonin, Michael; Aicher, Wilhelm; Buehring, Hans-Joerg; Mattheus, Ulrich; Mack, Andreas; Wagner, Hans-Joachim; Minger, Stephen; Matzkies, Matthias; Reppel, Michael; Hescheler, Juergen; Sievert, Karl-Dietrich; Stenzl, Arnulf; Skutella, Thomas			RETRACTED: Generation of pluripotent stem cells from adult human testis (Retracted article. See vol. 512, pg. 338, 2014)	NATURE			English	Article; Retracted Publication							PRIMORDIAL GERM-CELLS; IN-VITRO; DIFFERENTIATION; FIBROBLASTS; CULTURE; CARDIOMYOCYTES; DERIVATION; MARKERS	Human primordial germ cells and mouse neonatal and adult germline stem cells are pluripotent and show similar properties to embryonic stem cells. Here we report the successful establishment of human adult germline stem cells derived from spermatogonial cells of adult human testis. Cellular and molecular characterization of these cells revealed many similarities to human embryonic stem cells, and the germline stem cells produced teratomas after transplantation into immunodeficient mice. The human adult germline stem cells differentiated into various types of somatic cells of all three germ layers when grown under conditions used to induce the differentiation of human embryonic stem cells. We conclude that the generation of human adult germline stem cells from testicular biopsies may provide simple and non- controversial access to individual cell- based therapy without the ethical and immunological problems associated with human embryonic stem cells.	[Conrad, Sabine; Wiesner, Tina; Just, Lothar; Skutella, Thomas] Inst Anat, Dept Expt Embryol, D-72074 Tubingen, Germany; [Mattheus, Ulrich; Mack, Andreas; Wagner, Hans-Joachim] Inst Anat, Dept Cellular Neurobiol, D-72074 Tubingen, Germany; [Renninger, Markus; Hennenlotter, Joerg; Sievert, Karl-Dietrich; Stenzl, Arnulf] Univ Clin Tubingen, Dept Urol, D-72076 Tubingen, Germany; [Bonin, Michael] Univ Clin Tubingen, Inst Anthropol & Human Genet, Microarray Facil, D-72076 Tubingen, Germany; [Aicher, Wilhelm] Univ Clin Tubingen, ZMF Res Labs, D-72072 Tubingen, Germany; [Aicher, Wilhelm; Skutella, Thomas] Ctr Regenerat Biol & Med ZRM, D-72076 Tubingen, Germany; [Buehring, Hans-Joerg] Univ Clin Tubingen, Dept Internal Med 2, D-72076 Tubingen, Germany; [Minger, Stephen] Kings Coll London, Stem Cell Biol Lab, Wolfson Ctr Age Related Dis, London SE1 1UL, England; [Matzkies, Matthias; Reppel, Michael; Hescheler, Juergen] Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of London; King's College London; University of Cologne	Skutella, T (corresponding author), Inst Anat, Dept Expt Embryol, Osterbergstr 3, D-72074 Tubingen, Germany.	Thomas.Skutella@regmed.uni-tuebingen.de		Aicher, Wilhelm K/0000-0003-2210-6773	Department of Urology; Institute of Anatomy; ZRM (University Clinic Tubingen)	Department of Urology; Institute of Anatomy; ZRM (University Clinic Tubingen)	We thank S. Singer, U. Mau-Holzmann and O. Riess for karyotyping the human adult GSCs obtained from the patients' biopsies; M. Schenk for providing support with ELISA; D. Blaurock for proofreading the manuscript; K. Kohler for discussion and encouragement; and P. Bauer for conducting the microsatellite analysis. Financial support for this research was provided by the Department of Urology, Institute of Anatomy and ZRM (University Clinic Tubingen).	Alexander D, 2002, BIOL CHEM, V383, P1845, DOI 10.1515/BC.2002.208; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bielby RC, 2004, TISSUE ENG, V10, P1518, DOI 10.1089/ten.2004.10.1518; Blyszczuk P, 2004, INT J DEV BIOL, V48, P1095, DOI 10.1387/ijdb.041904pb; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; de Rooij DG, 2006, P NATL ACAD SCI USA, V103, P7939, DOI 10.1073/pnas.0602432103; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hamra FK, 2004, DEV BIOL, V269, P393, DOI 10.1016/j.ydbio.2004.01.027; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2007, BIOL REPROD, V76, P55, DOI 10.1095/biolreprod.106.055863; Kehat I, 2003, METHOD ENZYMOL, V365, P461; Kubota H, 2006, NAT CLIN PRACT ENDOC, V2, P99, DOI 10.1038/ncpendmet0098; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; MALTSEV VA, 1993, MECH DEVELOP, V44, P41, DOI 10.1016/0925-4773(93)90015-P; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Ringe J, 2003, MED KLIN, V98, P35; Schatten G, 2005, NAT METHODS, V2, P455, DOI 10.1038/nmeth0605-455; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Segev H, 2004, STEM CELLS, V22, P265, DOI 10.1634/stemcells.22-3-265; Shamblott MJ, 2001, P NATL ACAD SCI USA, V98, P113, DOI 10.1073/pnas.021537998; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; STEVENS LC, 1984, CELL DIFFER DEV, V15, P69, DOI 10.1016/0045-6039(84)90054-X; Stukenborg JB, 2008, J ANDROL, V29, P312, DOI 10.2164/jandrol.107.002857; Turnpenny L, 2006, STEM CELLS, V24, P212, DOI 10.1634/stemcells.2005-0255; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; WITTWER CT, 1989, NUCLEIC ACIDS RES, V17, P4353, DOI 10.1093/nar/17.11.4353; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	37	364	416	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					344	U25		10.1038/nature07404	http://dx.doi.org/10.1038/nature07404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	18849962				2022-12-28	WOS:000261039600034
J	Liang, HL; Nien, CY; Liu, HY; Metzstein, MM; Kirov, N; Rushlow, C				Liang, Hsiao-Lan; Nien, Chung-Yi; Liu, Hsiao-Yun; Metzstein, Mark M.; Kirov, Nikolai; Rushlow, Christine			The zinc-finger protein Zelda is a key activator of the early zygotic genome in Drosophila	NATURE			English	Article							POLARIZED MEMBRANE GROWTH; REPRESSION; BINDING; CELLULARIZATION; INSERTIONS; TRANSITION; REGULATOR; CLEAVAGE; ENCODES; TARGETS	In all animals, the initial events of embryogenesis are controlled by maternal gene products that are deposited into the developing oocyte. At some point after fertilization, control of embryogenesis is transferred to the zygotic genome in a process called the maternal- to-zygotic transition. During this time, many maternal RNAs are degraded and transcription of zygotic RNAs ensues(1). There is a long-standing question as to which factors regulate these events. The recent findings that microRNAs(2,3) and Smaug(4) mediate maternal transcript degradation have shed new light on this aspect of the problem. However, the transcription factor(s) that activate the zygotic genomeremain elusive. The discovery that many of the early transcribed genes in Drosophila share a cis- regulatory heptamer motif, CAGGTAG and related sequences(5,6), collectively referred to as TAGteam sites(5) raised the possibility that a dedicated transcription factor could interact with these sites to activate transcription. Here we report that the zinc- finger protein Zelda ( Zld; Zinc- finger early Drosophila activator) binds specifically to these sites and is capable of activating transcription in transient transfection assays. Mutant embryos lacking zld are defective in cellular blastoderm formation, and fail to activate many genes essential for cellularization, sex determination and pattern formation. Global expression profiling confirmed that Zld has an important role in the activation of the early zygotic genome and suggests that Zld may also regulate maternal RNA degradation during the maternal- to- zygotic transition.	[Liang, Hsiao-Lan; Nien, Chung-Yi; Liu, Hsiao-Yun; Kirov, Nikolai; Rushlow, Christine] NYU, Dept Biol, New York, NY 10003 USA; [Metzstein, Mark M.] Univ Utah, Inst Human Genet, Salt Lake City, UT 84112 USA	New York University; Utah System of Higher Education; University of Utah	Rushlow, C (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.	chris.rushlow@nyu.edu			National Institutes of Health [GM63024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the following people for gifts of RNA probes, plasmids, antibodies and fly stocks: J. Erickson, R. Lehmann, R. Cinalli, R. Martinho, C. Navarro, J. Treisman and L. Pick. We thank J. Rhee and A. Chung for help with isolating and characterizing zld null mutants, and S. Fu for help locating TAGteam sites in Zelda target genes. We are grateful to M. Siegel and K. Birnbaum for help with the microarray analysis, and C. Desplan, P. Struffi, S. Small and R. Lehmann for critical reading of the manuscript. This work was supported by a grant from the National Institutes of Health (GM63024).	Biemar F, 2005, P NATL ACAD SCI USA, V102, P15907, DOI 10.1073/pnas.0507817102; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; Bushati N, 2008, CURR BIOL, V18, P501, DOI 10.1016/j.cub.2008.02.081; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Chou TB, 1996, GENETICS, V144, P1673; De Renzis S, 2007, PLOS BIOL, V5, P1036, DOI 10.1371/journal.pbio.0050117; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gross SP, 2003, CURR BIOL, V13, P1660, DOI 10.1016/j.cub.2003.08.032; Grosshans J, 2003, DEV CELL, V5, P285, DOI 10.1016/S1534-5807(03)00208-9; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; JIANG J, 1992, EMBO J, V11, P3147, DOI 10.1002/j.1460-2075.1992.tb05387.x; Kirkpatrick H, 2001, J BIOL CHEM, V276, P18216, DOI 10.1074/jbc.M101365200; KIROV N, 1993, EMBO J, V12, P3193, DOI 10.1002/j.1460-2075.1993.tb05988.x; Lecuit T, 2002, DEV CELL, V2, P425, DOI 10.1016/S1534-5807(02)00141-7; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Pilot F, 2006, DEVELOPMENT, V133, P711, DOI 10.1242/dev.02251; Robinson DN, 1997, DEVELOPMENT, V124, P1405; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; SCHWEISGUTH F, 1990, GENE DEV, V4, P922, DOI 10.1101/gad.4.6.922; SIMPSON L, 1990, DEVELOPMENT, V110, P851; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; Staudt N, 2006, MOL BIOL CELL, V17, P2356, DOI 10.1091/mbc.E05-11-1056; Stein JA, 2002, DEVELOPMENT, V129, P3925; Tadros W, 2007, DEV CELL, V12, P143, DOI 10.1016/j.devcel.2006.10.005; ten Bosch JR, 2006, DEVELOPMENT, V133, P1967, DOI 10.1242/dev.02373; Yu Y, 1997, NATURE, V385, P552, DOI 10.1038/385552a0	28	312	318	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					400	U67		10.1038/nature07388	http://dx.doi.org/10.1038/nature07388			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	18931655	Green Accepted			2022-12-28	WOS:000261039600046
J	O'Connell, DRH				O'Connell, Daniel R. H.			GEOPHYSICS Assessing Ground Shaking	SCIENCE			English	Editorial Material							EARTHQUAKE; BEHAVIOR; MOTION		[O'Connell, Daniel R. H.] William Lettis & Assoc Inc, Golden, CO 80401 USA		O'Connell, DRH (corresponding author), William Lettis & Assoc Inc, Golden, CO 80401 USA.	oconnell@lettis.com						Aoi S, 2008, SCIENCE, V322, P727, DOI 10.1126/science.1163113; BERESNEV IA, 1995, B SEISMOL SOC AM, V85, P496; Beresnev IA, 2002, B SEISMOL SOC AM, V92, P3152, DOI 10.1785/0120020009; Bonilla LF, 2005, B SEISMOL SOC AM, V95, P2373, DOI 10.1785/0120040128; COCHRANE ES, 2008, SCEC ANN M P ABS, V18, P85; Crouse CB, 2003, B SEISMOL SOC AM, V93, P546, DOI 10.1785/0120020107; Field EH, 1998, J GEOPHYS RES-SOL EA, V103, P26869, DOI 10.1029/98JB02235; Frankel AD, 1999, SCIENCE, V283, P2032, DOI 10.1126/science.283.5410.2032; FUJIWARA H, 2005, TECHNICAL NOTE NATL, V264, P91; Hanks TC, 2005, NATO SCI S SS IV EAR, V58, P55; Hardin B., 1972, JSOIL MECH FOUND DIV, V98, P667, DOI [10.1061/JSFEAQ.0001760, DOI 10.1061/JSFEAQ.0001760]; Hardin B. O., 1972, J SOIL MECH FDN DIV, V98, P603, DOI DOI 10.1016/0022-4898(73)90212-7; Hartzell S, 2002, B SEISMOL SOC AM, V92, P831, DOI 10.1785/0120010114; Hartzell S, 2005, B SEISMOL SOC AM, V95, P614, DOI 10.1785/0120040136; Howell D, 1999, PHYS REV LETT, V82, P5241, DOI 10.1103/PhysRevLett.82.5241; Iai S, 1995, SOILS FOUND, V35, P115; O'Connell DRH, 1999, SCIENCE, V283, P2045, DOI 10.1126/science.283.5410.2045; SEED HB, 1970, B SEISMOL SOC AM, V60, P125; VUCETIC M, 1990, CAN GEOTECH J, V27, P29, DOI 10.1139/t90-004; WEICHERT DH, 1986, B SEISMOL SOC AM, V76, P1473; 2008, EARTHQUAKE SPECTRA, V24, P1	21	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					686	687		10.1126/science.1166149	http://dx.doi.org/10.1126/science.1166149			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974336				2022-12-28	WOS:000260605200029
J	Fuchs, VR				Fuchs, Victor R.			Three "inconvenient truths" about health care.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fuchs, Victor R.] Stanford Univ, Stanford, CA 94305 USA	Stanford University	Fuchs, VR (corresponding author), Stanford Univ, Stanford, CA 94305 USA.							Congressional Budget Office, 2022, PRESCR DRUGS SPEND U; *COUNC EC ADV, 2007, STAT TABL REL INC EM; Gruber J, 2000, HANDB ECON, V17, P645; Pauly MV, 2005, HEALTH AFFAIR, V24, P1523, DOI 10.1377/hlthaff.24.6.1523; RIVLIN AM, 2007, PERSPECTIVES LONG RU, P4	5	20	20	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2008	359	17					1749	1751		10.1056/NEJMp0807432	http://dx.doi.org/10.1056/NEJMp0807432			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	363DJ	18946059	Bronze			2022-12-28	WOS:000260245800001
J	Obama, B				Obama, Barack			Affordable health care for all Americans - The Obama-Biden plan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	17	17	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2008	300	16					1927	1928						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362UR	18940980				2022-12-28	WOS:000260223100023
J	Shapiro, E; Gil, B				Shapiro, Ehud; Gil, Binyamin			RNA computing in a living cell	SCIENCE			English	Editorial Material							COMPUTATION		[Shapiro, Ehud] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Shapiro, Ehud; Gil, Binyamin] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Shapiro, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	ehud.shapiro@weizmann.ac.il						ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Benenson Y, 2001, NATURE, V414, P430, DOI 10.1038/35106533; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; BENENSON Y, 2004, DEKKER ENCY NANOSCIE, P2043; BENNETT CH, 1982, INT J THEOR PHYS, V21, P905, DOI 10.1007/BF02084158; Breaker RR, 2002, CURR OPIN BIOTECH, V13, P31, DOI 10.1016/S0958-1669(02)00281-1; Mao CD, 2000, NATURE, V407, P493, DOI 10.1038/35035038; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Simmel FC, 2007, NANOMEDICINE-UK, V2, P817, DOI 10.2217/17435889.2.6.817; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Suess B, 2008, RNA BIOL, V5, P24, DOI 10.4161/rna.5.1.5955; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998	15	25	32	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2008	322	5900					387	388		10.1126/science.1165665	http://dx.doi.org/10.1126/science.1165665			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927381				2022-12-28	WOS:000260094500031
J	Vlaminck, V; Bailleul, M				Vlaminck, Vincent; Bailleul, Matthieu			Current-induced spin-wave Doppler shift	SCIENCE			English	Article								Spin transfer appears to be a promising tool for improving spintronics devices. Experiments that quantitatively access the magnitude of the spin transfer are required for a fundamental understanding of this phenomenon. By inductively measuring spin waves propagating along a permalloy strip subjected to a large electrical current, we observed a current-induced spin wave Doppler shift that we relate to the adiabatic spin transfer torque. Because spin waves provide a well-defined system for performing spin transfer, we anticipate that they could be used as an accurate probe of spin-polarized transport in various itinerant ferromagnets.	[Vlaminck, Vincent; Bailleul, Matthieu] Univ Strasbourg, Inst Phys & Chim Mat Strasbourg, CNRS, UMR 7504, F-67034 Strasbourg 2, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Vlaminck, V (corresponding author), Univ Strasbourg, Inst Phys & Chim Mat Strasbourg, CNRS, UMR 7504, 23 Rue Loess, F-67034 Strasbourg 2, France.		Bailleul, Matthieu/U-3590-2018	Bailleul, Matthieu/0000-0001-9975-7705; Vlaminck, Vincent/0000-0001-7291-6227	Agence Nationale de la Recherche "spectrospin"; Region Alsace	Agence Nationale de la Recherche "spectrospin"(French National Research Agency (ANR)); Region Alsace(Region Grand-Est)	We thank J. Grollier and C. Deranlot (UMR CNRS/Thales) for providing the permalloy films, H. Hurdequint for advice, A. Carvalho for assistance with e-beam lithography, A. Boulard for the fabrication of the measurement set-up, and K. Hajjia for measurements on unprocessed films. Support from the staff of the Consortium de Nanosciences et de Nanotechnologies de Strasbourg nanofabrication facilities and financial support from Agence Nationale de la Recherche "spectrospin" and from Region Alsace are gratefully acknowledged.	Bailleul M, 2003, APPL PHYS LETT, V83, P972, DOI 10.1063/1.1597745; Banhart J, 1997, PHYS REV B, V56, P10165, DOI 10.1103/PhysRevB.56.10165; Bass J, 1999, J MAGN MAGN MATER, V200, P274, DOI 10.1016/S0304-8853(99)00316-9; Bazaliy YB, 1998, PHYS REV B, V57, pR3213, DOI 10.1103/PhysRevB.57.R3213; Beach GSD, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.057203; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Campbell I. A., 1982, Ferromagnetic materials. A handbook on the properties of magnetically ordered substances. Vol.3, P747, DOI 10.1016/S1567-2719(82)03012-1; Fernandez-Rossier J, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.174412; Gill T. P., 1965, DOPPLER EFFECT INTRO; HIRST LL, 1966, PHYS REV, V141, P503, DOI 10.1103/PhysRev.141.503; Hurdequint H, 2002, J MAGN MAGN MATER, V242, P521, DOI 10.1016/S0304-8853(01)01091-5; LEDERER P, 1966, PHYS REV, V148, P542, DOI 10.1103/PhysRev.148.542; MAYADAS AF, 1974, J APPL PHYS, V45, P2780, DOI 10.1063/1.1663668; Mijnarends PE, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.075106; Myers EB, 1999, SCIENCE, V285, P867, DOI 10.1126/science.285.5429.867; RIPPARD WH, 2007, HDB MAGNETISM ADV MA, V2, P1167; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Stancil DD, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.060404; STANCIL DD, 1993, THEORY MAGNETOSTATIC; Stiles MD, 2006, TOP APPL PHYS, V101, P225; Thiaville A, 2005, EUROPHYS LETT, V69, P990, DOI 10.1209/epl/i2004-10452-6; Thomas L, 2007, HDB MAGNETISM ADV MA, V2, P942; Tsoi M, 2000, NATURE, V406, P46, DOI 10.1038/35017512; Xiao J, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.054428; Zhang S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.127204	27	256	259	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2008	322	5900					410	413		10.1126/science.1162843	http://dx.doi.org/10.1126/science.1162843			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927387	Green Submitted			2022-12-28	WOS:000260094500038
J	Downs, JP; Daeschler, EB; Jenkins, FA; Shubin, NH				Downs, Jason P.; Daeschler, Edward B.; Jenkins, Farish A., Jr.; Shubin, Neil H.			The cranial endoskeleton of Tiktaalik roseae	NATURE			English	Article							EARLIEST-KNOWN TETRAPOD; EARLY EVOLUTION; DEVONIAN FISH; BRAINCASE; STAPES; AUSTRALIA; ORIGIN; EAR	Among themorphological changes that occurred during the 'fish- to- tetrapod' transition was a marked reorganization of the cranial endoskeleton. Details of this transition, including the sequence of character acquisition, have not been evident from the fossil record. Here we describe the braincase, palatoquadrate and branchial skeleton of Tiktaalik roseae, the Late Devonian sarcopterygian fish most closely related to tetrapods. Although retaining a primitive configuration in many respects, the cranial endoskeleton of T. roseae shares derived features with tetrapods such as a large basal articulation and a flat, horizontally oriented entopterygoid. Other features in T. roseae, like the short, straight hyomandibula, show morphology intermediate between the condition observed in more primitive fish and that observed in tetrapods. The combination of characters in T. roseae helps to resolve the relative timing of modifications in the cranial endoskeleton. The sequence of modifications suggests changes in head mobility and intracranial kinesis that have ramifications for the origin of vertebrate terrestriality.	[Downs, Jason P.; Daeschler, Edward B.] Acad Nat Sci Philadelphia, Philadelphia, PA 19103 USA; [Jenkins, Farish A., Jr.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Jenkins, Farish A., Jr.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Shubin, Neil H.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Shubin, Neil H.] Field Museum Nat Hist, Chicago, IL 60605 USA	Drexel University; Harvard University; Harvard University; University of Chicago; Field Museum of Natural History (Chicago)	Downs, JP (corresponding author), Acad Nat Sci Philadelphia, 1900 Benjamin Franklin Pkwy, Philadelphia, PA 19103 USA.	downs@ansp.org; nshubin@uchicago.edu			Polar Continental Shelf Project; Canadian Museum of Nature; Academy of Natural Sciences of Philadelphia; Putnam Expeditionary Fund (Harvard University); University of Chicago; National Science Foundation; National Geographic Society Committee for Research and Exploration	Polar Continental Shelf Project(Natural Resources Canada); Canadian Museum of Nature; Academy of Natural Sciences of Philadelphia; Putnam Expeditionary Fund (Harvard University); University of Chicago(University of Chicago); National Science Foundation(National Science Foundation (NSF)); National Geographic Society Committee for Research and Exploration(National Geographic Society)	The illustrations are the work of K. Monoyios. Specimen preparation was performed by C.F. Mullison. This research was made possible by permits from the Nunavut Ministry of Culture, Languages, Elders and Youth, the Grise Fiord Hamlet and HTA, with logistical support from the Polar Continental Shelf Project and collections support from the Canadian Museum of Nature. M. Brazeau improved interpretation of P. rhombolepis and offered input. Assistance in the field (1999-2006) was provided by W. Amaral, B. Atagootak, J. Conrad, M. Davis, S. Gatesy, A. Gillis, B. Kilbourne, S. Madsen, K. Middleton, J. Miller, K. Monoyios, C. Schaff, M. Shapiro, R. Shearman and C. Sullivan. This research was supported by an anonymous donor, the Academy of Natural Sciences of Philadelphia, the Putnam Expeditionary Fund (Harvard University), the University of Chicago, the National Science Foundation, and the National Geographic Society Committee for Research and Exploration.	Ahlberg PE, 1998, NATURE, V395, P792, DOI 10.1038/27421; Ahlberg PE, 1996, NATURE, V381, P61, DOI 10.1038/381061a0; Ahlberg PE, 2008, NATURE, V453, P1199, DOI 10.1038/nature06991; Brazeau MD, 2006, NATURE, V439, P318, DOI 10.1038/nature04196; Carroll R. L., 1980, TERRESTRIAL ENV ORIG, P293; Clack J.A., 1994, Meddelelser om Gronland Geoscience, V31, P1; Clack JA, 1998, ZOOL J LINN SOC-LOND, V122, P61, DOI 10.1006/zjls.1997.0114; CLACK JA, 1994, NATURE, V369, P392, DOI 10.1038/369392a0; Clack JA, 2002, J NEUROBIOL, V53, P251, DOI 10.1002/neu.10129; CLACK JA, 1989, NATURE, V342, P425, DOI 10.1038/342425a0; CLACK JA, 1996, EVOLUTIONARY BIOL HE, P405; Clack Jennifer A., 2000, Amphibian Biology, V4, P979; COATES MI, 1991, NATURE, V352, P234, DOI 10.1038/352234a0; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Fox Richard C., 1995, Memoirs of the Queensland Museum, V38, P97; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Johanson Z, 2003, PALAEONTOLOGY, V46, P271, DOI 10.1111/1475-4983.00298; Johanson Z, 1997, T ROY SOC EDIN-EARTH, V88, P39, DOI 10.1017/S0263593300002303; Lebedev Oleg A., 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P287; Long J.A., 1997, Records of the Western Australian Museum Supplement, V53, P1; Long JA, 2006, NATURE, V444, P199, DOI 10.1038/nature05243; ROMER ALFRED S., 1937, BULL MUS COMP ZOOL, V82, P1; Romer AS, 1941, J MORPHOL, V69, P141, DOI 10.1002/jmor.1050690106; Schultze Hans-Peter, 1996, P316; SCHULTZE HP, 1985, PALAEONTOLOGY, V28, P292; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; SMITHSON TR, 1982, ZOOL J LINN SOC-LOND, V74, P93, DOI 10.1111/j.1096-3642.1982.tb01142.x; Thomson K. S., 1965, Proceedings of the Linnean Society of London, V176, P181; THOMSON KEITH STEWART, 1967, J LINN SOC LONDON ZOOL, V46, P223; Vorobyeva E., 1991, P68; VOROBYEVA EI, 1980, ZOOL J LINN SOC-LOND, V70, P191, DOI 10.1111/j.1096-3642.1980.tb00851.x	31	43	46	3	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					925	929		10.1038/nature07189	http://dx.doi.org/10.1038/nature07189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923515				2022-12-28	WOS:000260038300041
J	George, RE; Sanda, T; Hanna, M; Frohling, S; Luther, W; Zhang, JM; Ahn, Y; Zhou, WJ; London, WB; McGrady, P; Xue, LQ; Zozulya, S; Gregor, VE; Webb, TR; Gray, NS; Gilliland, DG; Diller, L; Greulich, H; Morris, SW; Meyerson, M; Look, AT				George, Rani E.; Sanda, Takaomi; Hanna, Megan; Frohling, Stefan; Luther, William, II; Zhang, Jianming; Ahn, Yebin; Zhou, Wenjun; London, Wendy B.; McGrady, Patrick; Xue, Liquan; Zozulya, Sergey; Gregor, Vlad E.; Webb, Thomas R.; Gray, Nathanael S.; Gilliland, D. Gary; Diller, Lisa; Greulich, Heidi; Morris, Stephan W.; Meyerson, Matthew; Look, A. Thomas			Activating mutations in ALK provide a therapeutic target in neuroblastoma	NATURE			English	Article							ANAPLASTIC LYMPHOMA KINASE; HIGH-RISK NEUROBLASTOMA; EML4-ALK FUSION GENE; CELL LUNG-CANCER; GEFITINIB; IDENTIFICATION; INHIBITOR; TRANSPLANTATION; TRANSFORMATION; PLEIOTROPHIN	Neuroblastoma, an embryonal tumour of the peripheral sympathetic nervous system, accounts for approximately 15% of all deaths due to childhood cancer(1). High- risk neuroblastomas are rapidly progressive; even with intensive myeloablative chemotherapy, relapse is common and almost uniformly fatal(2,3). Here we report the detection of previously unknown mutations in the ALK gene, which encodes a receptor tyrosine kinase, in 8% of primary neuroblastomas. Five non- synonymous sequence variations were identified in the kinase domain of ALK, of which three were somatic and two were germ line. The most frequent mutation, F1174L, was also identified in three different neuroblastoma cell lines. ALK complementary DNAs encoding the F1174L and R1275Q variants, but not the wild- type ALK cDNA, transformed interleukin-3-dependent murine haematopoietic Ba/F3 cells to cytokine-independent growth. Ba/F3 cells expressing these mutations were sensitive to the small- molecule inhibitor of ALK, TAE684 (ref. 4). Furthermore, two human neuroblastoma cell lines harbouring the F1174L mutation were also sensitive to the inhibitor. Cytotoxicity was associated with increased amounts of apoptosis as measured by TdT-mediated dUTP nick end labelling ( TUNEL). Short hairpin RNA (shRNA)- mediated knockdown of ALK expression in neuroblastoma cell lines with the F1174L mutation also resulted in apoptosis and impaired cell proliferation. Thus, activating alleles of the ALK receptor tyrosine kinase are present in primary neuroblastoma tumours and in established neuroblastoma cell lines, and confer sensitivity to ALK inhibition with small molecules, providing a molecular rationale for targeted therapy of this disease.	[George, Rani E.; Sanda, Takaomi; Luther, William, II; Ahn, Yebin; Diller, Lisa; Look, A. Thomas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Hanna, Megan; Greulich, Heidi; Meyerson, Matthew] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hanna, Megan; Greulich, Heidi; Meyerson, Matthew] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Zhang, Jianming; Zhou, Wenjun; Gray, Nathanael S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Hanna, Megan; Greulich, Heidi; Meyerson, Matthew] Harvard & MIT, Broad Inst, Cambridge, MA 02142 USA; [Frohling, Stefan; Gilliland, D. Gary] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [London, Wendy B.; McGrady, Patrick] Univ Florida, Childrens Oncol Grp Stat & Data Ctr, Gainesville, FL 32601 USA; [Xue, Liquan; Morris, Stephan W.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Xue, Liquan; Morris, Stephan W.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; [Webb, Thomas R.] St Jude Childrens Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Zozulya, Sergey; Gregor, Vlad E.] ChemBridge Res Labs Inc, San Diego, CA 92127 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Children's Oncology Group (COG); State University System of Florida; University of Florida; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Look, AT (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	matthew_meyerson@dfci.harvard.edu; thomas_look@dfci.harvard.edu	London, Wendy/ABD-4624-2021; London, Wendy Beth/ABA-8948-2021; Zozulya, Sergey A/F-2986-2015; Meyerson, Matthew L/E-7123-2012; George, Rani/AAG-7635-2019; Webb, Thomas/J-4511-2013	London, Wendy Beth/0000-0003-3571-6538; Zozulya, Sergey A/0000-0002-1179-2993; Zhang, Jianming/0000-0001-6326-3906	National Institutes of Health; Friends for Life Neuroblastoma Fund; Children's Oncology Group; Alex's Lemonade Stand Foundation; NCI [CA69129]; Cancer Center Core [CA21765]; American Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA069129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS047983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friends for Life Neuroblastoma Fund; Children's Oncology Group; Alex's Lemonade Stand Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Core; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Elechko and L. Moreau for technical assistance, A. Azarova for help with cell culture and cell growth assays, Q. Jiang and X. Cui for assistance during ALK small-molecule inhibitor development, and A. Kung for Ba/F3 cells and retroviral vectors. Weacknowledge the Children's Oncology Group for provision of neuroblastoma tumour and matched normal DNAs, and tumour touch prep slides. We thank J. Maris for neuroblastoma cell lines. We thank Abbott Molecular International for the Vysis LSI ALK Dual Color, Break Apart Rearrangement Probe. This work was supported by grants from the National Institutes of Health (R.E.G.), the Friends for Life Neuroblastoma Fund (R.E.G.), the Children's Oncology Group (R.E.G.), Alex's Lemonade Stand Foundation (M.H. and M.M.), NCI CA69129 (L.X. and S.W.M.), Cancer Center Core grant CA21765 (T.R.W., L.X. and S.W.M.), the American Lebanese Syrian Associated Charities and St. Jude Children's Research Hospital (T.R.W., L.X. and S.W.M.).	Calvet L, 2006, ONCOGENE, V25, P3150, DOI 10.1038/sj.onc.1209348; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; George RE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000255; George RE, 2006, J CLIN ONCOL, V24, P2891, DOI 10.1200/JCO.2006.05.6986; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Jiang JR, 2005, CANCER RES, V65, P8968, DOI 10.1158/0008-5472.CAN-05-1829; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Lamant L, 2000, AM J PATHOL, V156, P1711, DOI 10.1016/S0002-9440(10)65042-0; Li RS, 2008, MED RES REV, V28, P372, DOI 10.1002/med.20109; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; Miyake I, 2002, ONCOGENE, V21, P5823, DOI 10.1038/sj.onc.1205735; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; NAKAGAWARA A, 1995, CANCER RES, V55, P1792; *NCI, 2005, SURV EP END RES DAT; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Osajima-Hakomori Y, 2005, AM J PATHOL, V167, P213, DOI 10.1016/S0002-9440(10)62966-5; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946	27	632	673	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					975	978		10.1038/nature07397	http://dx.doi.org/10.1038/nature07397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923525	Green Accepted			2022-12-28	WOS:000260038300052
J	Balasubramanian, G; Chan, IY; Kolesov, R; Al-Hmoud, M; Tisler, J; Shin, C; Kim, C; Wojcik, A; Hemmer, PR; Krueger, A; Hanke, T; Leitenstorfer, A; Bratschitsch, R; Jelezko, F; Wrachtrup, J				Balasubramanian, Gopalakrishnan; Chan, I. Y.; Kolesov, Roman; Al-Hmoud, Mohannad; Tisler, Julia; Shin, Chang; Kim, Changdong; Wojcik, Aleksander; Hemmer, Philip R.; Krueger, Anke; Hanke, Tobias; Leitenstorfer, Alfred; Bratschitsch, Rudolf; Jelezko, Fedor; Wrachtrup, Joerg			Nanoscale imaging magnetometry with diamond spins under ambient conditions	NATURE			English	Article							MAGNETIC-RESONANCE; SINGLE SPIN; OPTICAL MICROSCOPY; COHERENT DYNAMICS; RESOLUTION; CENTERS	Magnetic resonance imaging and optical microscopy are key technologies in the life sciences. For microbiological studies, especially of the inner workings of single cells, optical microscopy is normally used because it easily achieves resolution close to the optical wavelength. But in conventional microscopy, diffraction limits the resolution to about half the wavelength. Recently, it was shown that this limit can be partly overcome by nonlinear imaging techniques(1,2), but there is still a barrier to reaching the molecular scale. In contrast, in magnetic resonance imaging the spatial resolution is not determined by diffraction; rather, it is limited by magnetic field sensitivity, and so can in principle go well below the optical wavelength. The sensitivity of magnetic resonance imaging has recently been improved enough to image single cells(3,4), and magnetic resonance force microscopy(5) has succeeded in detecting single electrons(6) and small nuclear spin ensembles(7). However, this technique currently requires cryogenic temperatures, which limit most potential biological applications(8). Alternatively, single-electron spin states can be detected optically(9,10), even at room temperature in some systems(11-14). Here we show how magneto- optical spin detection can be used to determine the location of a spin associated with a single nitrogen- vacancy centre in diamond with nanometre resolution under ambient conditions. By placing these nitrogen- vacancy spins in functionalized diamond nanocrystals, biologically specific magnetofluorescent spin markers can be produced. Significantly, we show that this nanometre- scale resolution can be achieved without any probes located closer than typical cell dimensions. Furthermore, we demonstrate the use of a single diamond spin as a scanning probe magnetometer to map nanoscale magnetic field variations. The potential impact of single- spin imaging at room temperature is far- reaching. It could lead to the capability to probe biologically relevant spins in living cells.	[Balasubramanian, Gopalakrishnan; Kolesov, Roman; Al-Hmoud, Mohannad; Tisler, Julia; Jelezko, Fedor; Wrachtrup, Joerg] Univ Stuttgart, Inst Phys 3, D-70550 Stuttgart, Germany; [Chan, I. Y.] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; [Shin, Chang; Kim, Changdong; Wojcik, Aleksander; Hemmer, Philip R.] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA; [Krueger, Anke] Univ Kiel, Otto Diels Inst Organ Chem, D-24098 Kiel, Germany; [Hanke, Tobias; Leitenstorfer, Alfred; Bratschitsch, Rudolf] Univ Konstanz, D-78457 Constance, Germany; [Hanke, Tobias; Leitenstorfer, Alfred; Bratschitsch, Rudolf] Ctr Appl Photon, D-78457 Constance, Germany	University of Stuttgart; Brandeis University; Texas A&M University System; Texas A&M University College Station; University of Kiel; University of Konstanz	Jelezko, F (corresponding author), Univ Stuttgart, Inst Phys 3, D-70550 Stuttgart, Germany.	f.jelezko@physik.uni-stuttgart.de	Bratschitsch, Rudolf/C-9027-2009; Balasubramanian, Gopalakrishnan/AAZ-5187-2020; Leitenstorfer, Alfred/B-9561-2015; Al-Hmoud, Mohannad/B-6586-2014; Hanke, Tobias/AAK-7263-2020	Bratschitsch, Rudolf/0000-0002-2368-2548; Balasubramanian, Gopalakrishnan/0000-0002-3839-3837; Leitenstorfer, Alfred/0000-0002-9847-257X; Al-Hmoud, Mohannad/0000-0002-8997-5319	EU (QAP, EQUIND, NANO4DRUGS, NEDQIT); DFG (SFB/TR21 and FOR730); Landesstiftung BW	EU (QAP, EQUIND, NANO4DRUGS, NEDQIT); DFG (SFB/TR21 and FOR730)(German Research Foundation (DFG)); Landesstiftung BW	We thank M. D. Lukin for drawing our attention to advanced echo-based techniques, and R. Kamella for technical assistance. This work was supported by the EU (QAP, EQUIND, NANO4DRUGS, NEDQIT), DFG (SFB/TR21 and FOR730) and Landesstiftung BW.	AGUAYO JB, 1986, NATURE, V322, P190, DOI 10.1038/322190a0; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Chernobrod BM, 2005, J APPL PHYS, V97, DOI 10.1063/1.1829373; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; Ciobanu L, 2002, J MAGN RESON, V158, P178, DOI 10.1016/S1090-7807(02)00071-X; Epstein RJ, 2005, NAT PHYS, V1, P94, DOI 10.1038/nphys141; Fu CC, 2007, P NATL ACAD SCI USA, V104, P727, DOI 10.1073/pnas.0605409104; Gaebel T, 2006, NAT PHYS, V2, P408, DOI 10.1038/nphys318; Glover P, 2002, REP PROG PHYS, V65, P1489, DOI 10.1088/0034-4885/65/10/203; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; Hanson R, 2008, SCIENCE, V320, P352, DOI 10.1126/science.1155400; KOHLER J, 1993, NATURE, V363, P242, DOI 10.1038/363242a0; Kuhn S, 2001, J MICROSC-OXFORD, V202, P2, DOI 10.1046/j.1365-2818.2001.00829.x; Liu KK, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/32/325102; Mamin HJ, 2007, NAT NANOTECHNOL, V2, P301, DOI 10.1038/nnano.2007.105; Neugart F, 2007, NANO LETT, V7, P3588, DOI 10.1021/nl0716303; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; RUGAR D, 1992, NATURE, V360, P563, DOI 10.1038/360563a0; TAYLOR JM, 2008, IN PRESS NATURE PHYS; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; WRACHTRUP J, 1993, NATURE, V363, P244, DOI 10.1038/363244a0	21	1306	1380	29	548	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2008	455	7213					648	U46		10.1038/nature07278	http://dx.doi.org/10.1038/nature07278			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833276	Green Published			2022-12-28	WOS:000259639700043
J	Abdulla, S; Sagara, I; Borrmann, S; D'Alessandro, U; Gonzalez, R; Hamel, M; Ogutu, B; Martensson, A; Lyimo, J; Maiga, H; Sasi, P; Nahum, A; Bassat, Q; Juma, E; Otieno, L; Bjorkman, A; Beck, HP; Andriano, K; Cousin, M; Lefevre, G; Ubben, D; Premji, Z				Abdulla, Salim; Sagara, Issaka; Borrmann, Steffen; D'Alessandro, Umberto; Gonzalez, Raquel; Hamel, Mary; Ogutu, Bernhards; Martensson, Andreas; Lyimo, John; Maiga, Hamma; Sasi, Philip; Nahum, Alain; Bassat, Quique; Juma, Elizabeth; Otieno, Lucas; Bjorkman, Anders; Beck, Hans Peter; Andriano, Kim; Cousin, Marc; Lefevre, Gilbert; Ubben, David; Premji, Zulfikarali			Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial	LANCET			English	Article							PLASMODIUM-FALCIPARUM MALARIA; PLUS SULFADOXINE-PYRIMETHAMINE; INDIVIDUAL PATIENT DATA; 6-DOSE REGIMEN; COMBINATION THERAPY; ANTIMALARIAL-DRUGS; POOLED ANALYSIS; AMODIAQUINE; ARTESUNATE; UGANDA	Background Combination treatments, preferably containing an artemisinin derivative, are recommended to improve efficacy and prevent Plasmodium falciparum drug resistance. Our aim was to show non-inferiority of a new dispersible formulation of artemether-lumefantrine to the conventional crushed tablet in the treatment of young children with Uncomplicated malaria. Methods We did a randomised non-inferiority study on children weighing 5-35 kg with uncomplicated P falciparum malaria in Benin, Kenya, Mali, Mozambique, and Tanzania. The primary outcome measure was PCR-corrected 28-day parasitological cure rate. We aimed to show non-inferiority (with a margin of -5%) of dispersible versus crushed tablet. We constructed an asymptotic one-sided 97.5% Cl on the difference in cure rates. A computer-generated randomisation list was kept centrally and investigators were unaware of the study medication administered. We used a modified intention-to-treat analysis. This trial is registered with ClinicalTrials.gov, number NCT00386763. Findings 899 children aged 12 years or younger were randomly assigned to either dispersible (n=447) or crushed tablets (n=452). More than 85% of patients in each treatment group completed the study. 812 children qualified for the modified intention-to-treat analysis (n=403 vs n=409). The PCR-corrected day-28 cure rate was 97.8% (95% Cl 96.3-99.2) in the group on dispersible formulation and 98.5% (97.4-99.7) in the group on crushed formulation. The lower bound of the one-sided 97 . 5% C1 was -2.7%. The most common drug-related adverse event was vomiting (n=33 [7%] and n=42 [9%], respectively). No signs of ototoxicity or relevant cardiotoxicity were seen. Interpretation A six-dose regimen of artemether-lumefantrine with the new dispersible formulation is as efficacious as the currently used crushed tablet in infants and children, and has a similar safety profile. Funding Novartis Pharma, Basel, Switzerland, and Medicines for Malaria Venture (MMV), Geneva, Switzerland.	[Abdulla, Salim; Lyimo, John] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Sagara, Issaka; Maiga, Hamma] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Borrmann, Steffen; Sasi, Philip] Kenya Govt Med Res Ctr, Kilifi, Kenya; [Borrmann, Steffen] Heidelberg Univ, Heidelberg, Germany; [D'Alessandro, Umberto] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [D'Alessandro, Umberto; Nahum, Alain] Ctr Rech Entomol Cotonou, Cotonou, Benin; [Gonzalez, Raquel; Bassat, Quique] Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain; [Gonzalez, Raquel; Bassat, Quique] Manhica Hlth Res Ctr CISM, Manhica, Mozambique; [Hamel, Mary; Juma, Elizabeth] Kenya Govt Med Res Ctr, Malaria Branch, Ctr Dis Control & Prevent, Kisumu, Kenya; [Ogutu, Bernhards; Otieno, Lucas] Kenya Govt Med Res Ctr, Walter Reed Project, Kisumu, Kenya; [Martensson, Andreas; Bjorkman, Anders] Karolinska Univ Hosp, Stockholm, Sweden; [Martensson, Andreas; Bjorkman, Anders] Karolinska Inst, Zanzibar Malaria Res Unit, Zanzibar, Tanzania; [Martensson, Andreas] Kullbergska Hosp, Katrineholm, Sweden; [Beck, Hans Peter] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Cousin, Marc; Lefevre, Gilbert] Novartis, Basel, Switzerland; [Ubben, David] Med Malaria Venture, Geneva, Switzerland; [Premji, Zulfikarali] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania	Ifakara Health Institute; University of Bamako; Kenya Medical Research Institute; Ruprecht Karls University Heidelberg; Institute of Tropical Medicine (ITM); Entomological Research Center of Cotonou (CREC); ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Centro de Investigacao em Saude de Manhica; Kenya Medical Research Institute; Kenya Medical Research Institute; Karolinska Institutet; Karolinska University Hospital; University of Basel; Swiss Tropical & Public Health Institute	Abdulla, S (corresponding author), Ifakara Hlth Inst, 360 Kiko Ave,POB 78373, Dar Es Salaam, Tanzania.	sabdulla@ihi.or.tz	Borrmann, Steffen/G-1838-2013; Gonzalez, Raquel/J-3604-2017; D'Alessandro, Umberto/D-3457-2015; Bassat, Quique/P-2341-2016	Borrmann, Steffen/0000-0001-9189-4393; Gonzalez, Raquel/0000-0001-5487-801X; D'Alessandro, Umberto/0000-0001-6341-5009; Bassat, Quique/0000-0003-0875-7596; Beck, Hans-Peter/0000-0001-8326-4834	German Research Foundation Junior Group [SFB 544, A7]	German Research Foundation Junior Group(German Research Foundation (DFG))	We thank the study population and local staff, without whom the present Study would riot have been possible. The local staff consisted of: C Membi, A Mohammed, A Abdallah (Ifakara Health Institute, Dar es Salaam, Tanzania); E G Rotllant, H Makame (Zanzibar Malaria Research Unit of the Karolinska Institute, Tanzania); M Bashraheil, P K Klouwenberg, A Sabin (Kenya Medical Research Institute, Kifili, Kenya); DAhounou, D Bonou, A Massougbodji, M Bancole, T Hounhouedo, C Agbowai (Centre de Recherche Entomologique de Cotonou, Cotonou, Benin): C Menendez (CRESIB. Barcelona Centre for International Health Research); S Machevo, M Renom, I Mandomando (Manhica;a Health Research Centre, Manhica, Mozambique); V Owira. M Polhemus, N Otsyula (Walter Reed Project and Kenya Medical Research Institute, Kisumu, Kenya); A Djimde, O B Traore, M Tekete, Z I Traore, N Diallo, S Dama, N Ouologuem, O Doumbo (Malaria Research and Training Centre, University of Bamako, Bamako, Mali); IA Coovadia (Novartis, South Africa): P lbarra de Palacios, A C Marrast (Novartis Pharma, Switzerland); N Mulure (Novartis, Kenya); O Nwaiwu (Novartis, Nigeria). We also thank P Kremsner and K Dietz front the University of Tubingen (German),) for their participation in the data monitoring board. Statistical analysis was carried out by DATAMAP GmbH (Freiburg, Germany). We. acknowledge the dedicated work of M Wibberg, T Widmayer, and J Lilienthal. Drafting of the manuscript was done by E A Mueller (3P Consulting, Bad Krozingen, Germany). Novartis Pharma sponsored this trial as part of the clinical development programme for the new paediatric formulation investigated. The trial was cosponsored by Medicines for Malaria Venture (MMV). S Borrmann is funded by a German Research Foundation junior Group grant (SFB 544, A7).	[Anonymous], 2003, ASS MON ANT DRUG EFF; Ashley EA, 2005, CURR OPIN INFECT DIS, V18, P531, DOI 10.1097/01.qco.0000186848.46417.6c; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BREWER TG, 1994, T ROY SOC TROP MED H, V88, P33, DOI 10.1016/0035-9203(94)90469-3; Chanda P, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-21; Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210; Falade C, 2005, T ROY SOC TROP MED H, V99, P459, DOI 10.1016/j.trstmh.2004.09.013; Felger Ingrid, 2002, Methods Mol Med, V72, P117, DOI 10.1385/1-59259-271-6:117; Fogg C, 2004, AM J TROP MED HYG, V71, P525, DOI 10.4269/ajtmh.2004.71.525; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Hutagalung R, 2006, AM J TROP MED HYG, V74, P211, DOI 10.4269/ajtmh.2006.74.211; Koram KA, 2005, ACTA TROP, V95, P194, DOI 10.1016/j.actatropica.2005.06.018; Makanga M, 2006, AM J TROP MED HYG, V74, P991, DOI 10.4269/ajtmh.2006.74.991; Martensson A, 2005, CLIN INFECT DIS, V41, P1079, DOI 10.1086/444460; Mueller EA, 2006, ACTA TROP, V100, P41, DOI 10.1016/j.actatropica.2006.09.007; Muheki C, 2004, TROP MED INT HEALTH, V9, P959, DOI 10.1111/j.1365-3156.2004.01292.x; Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3; Neuenschwander Beat, 2004, J Biopharm Stat, V14, P1005, DOI 10.1081/BIP-200035478; Piola P, 2005, LANCET, V365, P1467, DOI 10.1016/S0140-6736(05)66416-1; Price R, 1999, AM J TROP MED HYG, V60, P547, DOI 10.4269/ajtmh.1999.60.547; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Taylor WRJ, 2004, DRUG SAFETY, V27, P25, DOI 10.2165/00002018-200427010-00003; Toovey S, 2004, T ROY SOC TROP MED H, V98, P261, DOI 10.1016/j.trstmh.2003.11.001; Traebert Martin, 2005, Expert Opin Drug Saf, V4, P421, DOI 10.1517/14740338.4.3.421; White NJ, 2007, LANCET INFECT DIS, V7, P549, DOI 10.1016/S1473-3099(07)70187-1; WHO, 2005, SUSC PLASM FALC ANT; WHO, 2006, GUID TREATM MAL; *WHO, 2000, WHOCDSRBM200133; *WHO, 2006, GLOB AMDP DAT AFRO; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; Yeung S, 2004, AM J TROP MED HYG, V71, P179, DOI 10.4269/ajtmh.2004.71.179; Zongo I, 2007, LANCET, V369, P491, DOI 10.1016/S0140-6736(07)60236-0	34	96	97	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2008	372	9652					1819	1827		10.1016/S0140-6736(08)61492-0	http://dx.doi.org/10.1016/S0140-6736(08)61492-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	18926569				2022-12-28	WOS:000261112000024
J	Lourenco, T; Pickard, R; Vale, L; Grant, A; Fraser, C; MacLennan, G; N'Dow, J				Lourenco, Tania; Pickard, Robert; Vale, Luke; Grant, Adrian; Fraser, Cynthia; MacLennan, Graeme; N'Dow, James		Benign Prostatic Enlargement Team	Minimally invasive treatments for benign prostatic enlargement: systematic review of randomised controlled trials	BRITISH MEDICAL JOURNAL			English	Article							HYPERPLASIA; QUALITY	Objective To compare the effectiveness and risk profile of minimally invasive interventions against the current standard of transurethral resection of the prostate. Design Systematic review and meta-analysis of randomised controlled trials. Data sources Electronic and paper records up to March 2006. Review methods We searched forall relevant randomised controlled trials. Two reviewers independently extracted data and assessed quality. Meta-analyses of prespecified outcomes were performed with fixed and random effects models and reported using relative risks or weighted mean difference. Results 3794 abstracts were identified; 22 randomised controlled trials met the inclusion criteria. These provided data on 2434 participants. The studies evaluated were of moderate to poor quality with small sample sizes. Minimally invasive interventions were less effective than transurethral resection of the prostate in terms of improvement in symptom scores and increase in urine flow rate, with most comparisons showing significance despite wide confidence intervals. Rates of reoperation were significantly higher for minimally invasive treatments. The risk profile of minimally invasive interventions was better than that of transurethral resection, with fewer adverse events. The results, however, showed significant heterogeneity. Conclusion Which minimally invasive intervention is the most promising remains unclear. Their place in the management of benign prostate enlargement will continue to remain controversial until well designed and well reported randomised controlled trials following CONSORT guidelines prove they are superior and more cost effective than drug treatment, or that strategies of sequential surgical treatments are preferred by patients and are more cost effective than the more invasive but more effective tissue ablative interventions such as transurethral resection.	[N'Dow, James] Univ Aberdeen, Acad Urol Unit, Inst Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland; [Lourenco, Tania; Vale, Luke; Grant, Adrian; Fraser, Cynthia; MacLennan, Graeme] Univ Aberdeen, Hlth Serv Res Unit, Inst Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland; [Pickard, Robert] Univ Newcastle, Dept Urol, Sch Surg & Reprod Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Vale, Luke] Univ Aberdeen, Hlth Econ Res Unit, Inst Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen; Newcastle University - UK; University of Aberdeen	N'Dow, J (corresponding author), Univ Aberdeen, Acad Urol Unit, Inst Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland.	j.ndow@abdn.ac.uk		Vale, Luke/0000-0001-8574-8429; MacLennan, Graeme/0000-0002-1039-5646	Health Technology Assessment programme [04/38/03]; Chief Scientist Office of the Scottish Government Health Directorates; National Institute for Health Research [04/38/03] Funding Source: researchfish; Chief Scientist Office [HERU2, HERU1, HSRU1] Funding Source: researchfish	Health Technology Assessment programme(National Institute for Health Research (NIHR)); Chief Scientist Office of the Scottish Government Health Directorates; National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	Health Technology Assessment programme (project No 04/38/03). The health services research unit and the health economics research unit are core funded by the Chief Scientist Office of the Scottish Government Health Directorates.	ANSON K, 1995, UROLOGY, V46, P305, DOI 10.1016/S0090-4295(99)80211-8; BANTA HD, 1993, HEALTH POLICY, V23, P1, DOI 10.1016/0168-8510(93)90002-7; BARRY MJ, 1995, J UROLOGY, V154, P1770, DOI 10.1016/S0022-5347(01)66780-6; Bouza Carmen, 2006, BMC Urol, V6, P14, DOI 10.1186/1471-2490-6-14; Djavan B, 1999, J UROLOGY, V161, P139, DOI 10.1016/S0022-5347(01)62084-6; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Egger M., 2008, SYSTEMATIC REV HLTH, V2nd, DOI DOI 10.1002/9780470693926.CH12; HOFFMAN RM, 2007, COCHRANE DATABASE SY; MEBUST WK, 1989, J UROLOGY, V141, P243, DOI 10.1016/S0022-5347(17)40731-2; *U YORK CRD, 2001, 4 CRD U YORK; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0	11	50	52	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a1662	10.1136/bmj.a1662	http://dx.doi.org/10.1136/bmj.a1662			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18845591	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000260298800032
J	Tang, SL; Meng, QY; Chen, L; Bekedam, H; Evans, T; Whitehead, M				Tang, Shenglon; Meng, Qingyue; Chen, Lincoln; Bekedam, Henk; Evans, Tim; Whitehead, Margaret			Health System Reform in China 1 Tackling the challenges to health equity in China	LANCET			English	Article							RURAL CHINA; POOR COUNTRIES; TB SERVICES; MORTALITY; ACCESS	In terms of economic development, China is widely acclaimed as a miracle economy. Over a period of rapid economic growth, however, China's reputation for health has been slipping. In the 1970s China was a shining example of health development, but no longer. Government and public concerns about health equity have grown. China's health-equity challenges are truly daunting because of a vicious cycle of three synergistic factors: the social determinants of health have become more inequitable; imbalances in the roles of the market and government have developed; and concerns among the public have grown about fairness in health. With economic boom and growing government revenues, China is unlike other countries challenged by health inequities and can afford the necessary reforms so that economic development goes hand-in-hand with improved health equity. Reforms to improve health equity will receive immense popular support, governmental commitment, and interest from the public-health community worldwide.	[Whitehead, Margaret] Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England; [Tang, Shenglon] WHO, Beijing, Peoples R China; [Tang, Shenglon] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Meng, Qingyue] Shandong Univ, Jinan 250100, Peoples R China; [Chen, Lincoln] China Med Board, Cambridge, MA USA; [Bekedam, Henk] WHO, WPRO, Div Hlth Syst Dev, Manila, Philippines; [Evans, Tim] WHO, CH-1211 Geneva, Switzerland	University of Liverpool; World Health Organization; Liverpool School of Tropical Medicine; University of Liverpool; Shandong University; WHO Western Pacific Regional Office; World Health Organization; World Health Organization	Whitehead, M (corresponding author), Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England.	mmw@liverpool.ac.uk	Tang, Shenglan/AAO-7403-2020					ANAND S, 1993, J ECON PERSPECT, V7, P133, DOI 10.1257/jep.7.1.133; [Anonymous], 2007, Health Statistics Quarterly, P73; Banister J., 2004, Journal of Population Research, V21, P19; *BEIJ HLTH BUR, 2008, PIL PROJ MCH SERV MI; CALDWELL JC, 1986, POPUL DEV REV, V12, P171, DOI 10.2307/1973108; *CDCP, 2006, REP CHRON DIS CHIN; Chen C.M., 2004, 10 YEAR TRACKING NUT; CHEN Z, 2008, 17 CPC C NAT HLTH FO; CHEN Z, 2008, QIUSHI           JAN; *CHIN AC SOC SCI I, 2002, REP HOUS SURV 2002; *CHIN DEV RES FDN, 2005, HUM DEV REP 2005; Dollar D, 2007, 4253 WORLD BANK; FENG C, 2006, XINHUA NEWS AGEN OCT; FENG XS, 1995, SOC SCI MED, V41, P1111; Foster J., 1997, EC INEQUALITY; Gao J, 2001, HEALTH POLICY PLANN, V16, P302, DOI 10.1093/heapol/16.3.302; GU XY, 1995, HEALTH POLICY, V32, P181, DOI 10.1016/0168-8510(95)00735-B; HU S, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61368-9; HU X, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61360-4; Klasen S, 2002, POPUL DEV REV, V28, P285, DOI 10.1111/j.1728-4457.2002.00285.x; LIU Y, 2008, LANCET          1020, DOI DOI 10.1016/SO140-6736(08)61362-8; Liu YL, 1998, HEALTH POLICY, V44, P103, DOI 10.1016/S0168-8510(98)00010-4; Liu YL, 2003, J HEALTH POPUL NUTR, V21, P216; Liu YL, 1996, HEALTH POLICY, V38, P155, DOI 10.1016/0168-8510(96)00856-1; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; MARMOT M, 2004, STAT SYNDROME SOCIAL; Meng QY, 2004, INT J HEALTH PLAN M, V19, pS45, DOI 10.1002/hpm.774; *MIN HLTH, 2004, AN REP NAT HLTH SERV; *MIN HLTH, 2007, CHIN HLTH STAT YB 20; Ministry of Health, 2004, ANN HLTH STAT YB CHI; Ministry of Health, 2004, NAT HLTH SERV SURV 2; Ministry of Health, 1989, URB MED SERV STUD CH; MoH UNICEF WHO UNFPA, 2006, MAT CHILD SURV STRAT; National Bureau of Statistics, 2007, CHIN STAT YB; *POP CENS OFF, 2002, 2000 NAT POP CENS; Ravallion M, 2007, J DEV ECON, V82, P1, DOI 10.1016/j.jdeveco.2005.07.003; SEN A, 1992, WORLD DEV, V20, P1305, DOI 10.1016/0305-750X(92)90079-B; SEN A, 1989, WORLD DEV, V17, P769, DOI 10.1016/0305-750X(89)90001-6; Sen A, 2002, HEALTH ECON, V11, P659, DOI 10.1002/hec.762; Shen Ru-gang, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P223; State Statistics Bureau, 2006, CHIN STAT YB 2006; TANG YL, MORE 90 PEOPLE WERE; *UN DEV PROGR, 2008, 20078 UN DEV PROGR; *UN POP DIV, 2006, WORLD POP PROSP 2004; US Census Bureau, 2005, INT STAT POP PROJ; WANG L, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61365-3; WANG LD, 2007, PRINCIPLES GUIDE HLT; Whitehead M., 2007, CONCEPTS PRINCIPLE 1; *WHO, 2001, WORLD HLTH CHARTS 19; *WORLD BANK, 2005, CHIN HLTH SECT WHY R; XU L, 2008, THESIS U LIVERPOOL; Xu L, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-37; Zhang TH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-19; Zhu LP, 2006, CHIN J REPROD HLTH, V17, P271; [No title captured]	55	330	334	3	113	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2008	372	9648					1493	1501		10.1016/S0140-6736(08)61364-1	http://dx.doi.org/10.1016/S0140-6736(08)61364-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	370ZJ	18930531	Green Published, Bronze			2022-12-28	WOS:000260801300026
J	Edgerton, D				Edgerton, David			The charge of technology	NATURE			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Ctr Hist Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Edgerton, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Hist Sci Technol & Med, London SW7 2AZ, England.	d.edgerton@imperial.ac.uk	Edgerton, David e/E-9687-2012					ABRAMOVITZ M, 1956, AM ECON REV, V46, P5; Edgerton D, 1996, SCI TECHNOLOGY BRIT; National Science Board, 2008, SCI ENG IND	3	7	7	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1030	1031		10.1038/4551030a	http://dx.doi.org/10.1038/4551030a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	363FG	18948929				2022-12-28	WOS:000260252600015
J	Bloom, K				Bloom, Kerry			Kinetochores and Microtubules Wed without a Ring	CELL			English	Editorial Material							MOLECULAR ARCHITECTURE; ATTACHMENT SITE; MITOSIS; DRIVEN		Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Bloom, K (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	kerry_bloom@unc.edu	Bloom, Kerry/AAE-5336-2019	Bloom, Kerry/0000-0002-3457-004X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032238] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM032238-21, R01 GM032238] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Jun S, 2006, P NATL ACAD SCI USA, V103, P12388, DOI 10.1073/pnas.0605305103; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; NICKLAS RB, 1988, ANNU REV BIOPHYS BIO, V17, P431, DOI 10.1146/annurev.bb.17.060188.002243; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Yeh E, 2008, CURR BIOL, V18, P81, DOI 10.1016/j.cub.2007.12.019	9	0	0	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 17	2008	135	2					211	213		10.1016/j.cell.2008.10.001	http://dx.doi.org/10.1016/j.cell.2008.10.001			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957196	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000260130400010
J	Mukhopadhyay, J; Das, K; Ismail, S; Koppstein, D; Jang, MY; Hudson, B; Sarafianos, S; Tuske, S; Patel, J; Jansen, R; Irschik, H; Arnold, E; Ebright, RH				Mukhopadhyay, Jayanta; Das, Kalyan; Ismail, Sajida; Koppstein, David; Jang, Minyoung; Hudson, Brian; Sarafianos, Stefan; Tuske, Steven; Patel, Jay; Jansen, Rolf; Irschik, Herbert; Arnold, Eddy; Ebright, Richard H.			The RNA Polymerase "Switch Region" Is a Target for Inhibitors	CELL			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; MYXOPYRONIN-B ANALOGS; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; GLIDING BACTERIA; BINDING; HOLOENZYME; ANTIBIOTICS; ELONGATION; INITIATION	The alpha-pyrone antibiotic myxopyronin (Myx) inhibits bacterial RNA polymerase (RNAP). Here, through a combination of genetic, biochemical, and structural approaches, we show that Myx interacts with the RNAP "switch region''-the hinge that mediates opening and closing of the RNAP active center cleft-to prevent interaction of RNAP with promoter DNA. We define the contacts between Myx and RNAP and the effects of Myx on RNAP conformation and propose that Myx functions by interfering with opening of the RNAP active-center cleft during transcription initiation. We further show that the structurally related alpha-pyrone antibiotic corallopyronin (Cor) and the structurally unrelated macrocyclic-lactone antibiotic ripostatin (Rip) function analogously to Myx. The RNAP switch region is distant from targets of previously characterized RNAP inhibitors, and, correspondingly, Myx, Cor, and Rip do not exhibit crossresistance with previously characterized RNAP inhibitors. The RNAP switch region is an attractive target for identification of	[Das, Kalyan; Hudson, Brian; Sarafianos, Stefan; Tuske, Steven; Patel, Jay; Arnold, Eddy] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Mukhopadhyay, Jayanta; Ismail, Sajida; Koppstein, David; Jang, Minyoung; Ebright, Richard H.] Rutgers State Univ, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; [Mukhopadhyay, Jayanta; Ismail, Sajida; Koppstein, David; Jang, Minyoung; Ebright, Richard H.] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Mukhopadhyay, Jayanta; Das, Kalyan; Ismail, Sajida; Koppstein, David; Jang, Minyoung; Hudson, Brian; Sarafianos, Stefan; Tuske, Steven; Patel, Jay; Arnold, Eddy; Ebright, Richard H.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Jansen, Rolf; Irschik, Herbert] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	Rutgers State University New Brunswick; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Helmholtz Association; Helmholtz-Center for Infection Research	Arnold, E (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	arnold@cabm.rutgers.edu; ebright@mbcl.rutgers.edu	Das, Kalyan/O-9224-2019; Jansen, Rolf/C-1570-2011; Das, Kalyan/B-2967-2018; Ebright, Richard/O-3321-2019	Das, Kalyan/0000-0002-8897-324X; Jansen, Rolf/0000-0002-3592-4807; Das, Kalyan/0000-0002-8897-324X; Ebright, Richard/0000-0001-8915-7140; Sarafianos, Stefan G/0000-0002-5840-154X; Koppstein, David/0000-0002-8618-7237	NIH [AI072766, GM41376]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041376, R01GM041376] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Chakraborty, N. Connell, S. Darst, Y. Korlann, C. Self, Y. Sun, G. Olson, M. Talaue, D. Wang, X. Wang, A. Wasmuth, and S. Weiss for unpublished data and G. Hofle, M. Kalesse, and E. Sineva for discussion. This work was supported by NIH grant AI072766 to R. H. E. and E. A., NIH grant GM41376 to R. H. E., and a Howard Hughes Medical Investigatorship to R. H.	AUGUSTINIAK H, 1996, LIEBIGS ANN CHEM, V10, P1657; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Chopra I, 2007, CURR OPIN INVEST DR, V8, P600; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Darst SA, 2004, TRENDS BIOCHEM SCI, V29, P159, DOI 10.1016/j.tibs.2004.02.005; Daubendiek SL, 1997, NAT BIOTECHNOL, V15, P273, DOI 10.1038/nbt0397-273; Doundoulakis T, 2004, BIOORG MED CHEM LETT, V14, P5667, DOI 10.1016/j.bmcl.2004.08.045; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Guo Y, 1998, P NATL ACAD SCI USA, V95, P11655, DOI 10.1073/pnas.95.20.11655; Helmann JD, 1999, BIOCHEMISTRY-US, V38, P5959, DOI 10.1021/bi990206g; Hu T, 1998, J ORG CHEM, V63, P2401, DOI 10.1021/jo9721610; IRSCHIK H, 1995, J ANTIBIOT, V48, P787, DOI 10.7164/antibiotics.48.787; IRSCHIK H, 1983, J ANTIBIOT, V36, P1651, DOI 10.7164/antibiotics.36.1651; IRSCHIK H, 1985, J ANTIBIOT, V38, P145, DOI 10.7164/antibiotics.38.145; JANSEN R, 1985, LIEBIGS ANN CHEM, P822; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; KOHL W, 1983, LIEBIGS ANN CHEM, P1656; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lira R, 2007, BIOORG MED CHEM LETT, V17, P6797, DOI 10.1016/j.bmcl.2007.10.017; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Mukhopadhyay J, 2004, MOL CELL, V14, P739, DOI 10.1016/j.molcel.2004.06.010; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; O'Neill A, 2000, ANTIMICROB AGENTS CH, V44, P3163, DOI 10.1128/AAC.44.11.3163-3166.2000; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; Sluis-Cremer N, 2004, CURR HIV RES, V2, P323, DOI 10.2174/1570162043351093; TANTILLO C, 1994, J MOL BIOL, V243, P369, DOI 10.1006/jmbi.1994.1665; TRIPATARA A, 1993, J MOL BIOL, V233, P349, DOI 10.1006/jmbi.1993.1516; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Young BA, 2002, CELL, V109, P417, DOI 10.1016/S0092-8674(02)00752-3; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	38	178	197	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					295	307		10.1016/j.cell.2008.09.033	http://dx.doi.org/10.1016/j.cell.2008.09.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957204	Green Accepted, Bronze			2022-12-28	WOS:000260130400019
J	Kanaar, R; Wyman, C				Kanaar, Roland; Wyman, Claire			DNA repair by the MRN complex: Break it to make it	CELL			English	Editorial Material							MRE11 COMPLEX; RECOMBINATION; ENDS; HOOK	Genomic instability in ataxia telangiectasia-like disorder and Nijmegen breakage syndrome is due to disruption of the Mre11-Rad50-Nbs1 complex. Buis et al. (2008) and Williams et al. (2008) now reveal the importance of the nuclease activity of Mre11 for mammalian genome maintenance and present a molecular view of its active site.	[Kanaar, Roland; Wyman, Claire] Erasmus MC, Dept Cell Biol & Genet, Canc Genom Ctr, NL-3000 CA Rotterdam, Netherlands; [Kanaar, Roland; Wyman, Claire] Erasmus MC, Dept Radiat Oncol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC	Wyman, C (corresponding author), Erasmus MC, Dept Cell Biol & Genet, Canc Genom Ctr, POB 2040, NL-3000 CA Rotterdam, Netherlands.	c.wyman@erasmusmc.nl						de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Jazayeri A, 2008, EMBO J, V27, P1953, DOI 10.1038/emboj.2008.128; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Wiltzius JJW, 2005, NAT STRUCT MOL BIOL, V12, P403, DOI 10.1038/nsmb928; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451	8	27	28	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 3	2008	135	1					14	16		10.1016/j.cell.2008.09.027	http://dx.doi.org/10.1016/j.cell.2008.09.027			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854148	Bronze			2022-12-28	WOS:000259728100002
J	Marles-Wright, J; Grant, T; Delumeau, O; van Duinen, G; Firbank, SJ; Lewis, PJ; Murray, JW; Newman, JA; Quin, MB; Race, PR; Rohou, A; Tichelaar, W; van Heel, M; Lewis, RJ				Marles-Wright, Jon; Grant, Tim; Delumeau, Olivier; van Duinen, Gijs; Firbank, Susan J.; Lewis, Peter J.; Murray, James W.; Newman, Joseph A.; Quin, Maureen B.; Race, Paul R.; Rohou, Alexis; Tichelaar, Willem; van Heel, Marin; Lewis, Richard J.			Molecular architecture of the "stressosome," a signal integration and transduction hub	SCIENCE			English	Article							TRANSCRIPTION FACTOR SIGMA(B); BACILLUS-SUBTILIS; SERINE KINASE; PATHWAY; PROTEIN; COMPLEX; PHOSPHORYLATION; ACTIVATION; REGULATORS; RSBR	A commonly used strategy by microorganisms to survive multiple stresses involves a signal transduction cascade that increases the expression of stress- responsive genes. Stress signals can be integrated by a multiprotein signaling hub that responds to various signals to effect a single outcome. We obtained a medium- resolution cryo- electron microscopy reconstruction of the 1.8- megadalton "stressosome" from Bacillus subtilis. Fitting known crystal structures of components into this reconstruction gave a pseudoatomic structure, which had a virus capsid- like core with sensory extensions. We suggest that the different sensory extensions respond to different signals, whereas the conserved domains in the core integrate the varied signals. The architecture of the stressosome provides the potential for cooperativity, suggesting that the response could be tuned dependent on the magnitude of chemophysical insult.	[Grant, Tim; van Duinen, Gijs; Rohou, Alexis; Tichelaar, Willem; van Heel, Marin] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, London SW7 2AZ, England; [Marles-Wright, Jon; Delumeau, Olivier; Firbank, Susan J.; Murray, James W.; Newman, Joseph A.; Quin, Maureen B.; Race, Paul R.; Lewis, Richard J.] Univ Newcastle, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Lewis, Peter J.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	Imperial College London; Newcastle University - UK; University of Newcastle	van Heel, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, London SW7 2AZ, England.	m.vanheel@imperial.ac.uk; r.lewis@ncl.ac.uk		Grant, Tim/0000-0002-4855-8703; Marles-Wright, Jon/0000-0002-9156-3284; newman, Joseph/0000-0003-4488-0516; lewis, richard/0000-0003-2641-8643; Rohou, Alexis/0000-0002-3343-9621; Quin, Maureen/0000-0001-7193-639X; Murray, James/0000-0002-8897-0161	Biotechnology and Biological Sciences Research Council; Newcastle University; Australian Research Council; University of Newcastle (Australia); European Union NOE [LSHG-CT-2004-502828]; Dutch Ministry of Economic Affairs [BSIK 03036]; BBSRC; Glaxo Wellcome; SmithKline Beecham; BBSRC [BB/F001533/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D000521/1, BB/F001533/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newcastle University; Australian Research Council(Australian Research Council); University of Newcastle (Australia); European Union NOE(European Commission); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Glaxo Wellcome; SmithKline Beecham(GlaxoSmithKline); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council ( BBSRC), Newcastle University (UK), Australian Research Council, University of Newcastle (Australia) by grants from the European Union NOE, Contract LSHG-CT-2004-502828), and the Dutch Ministry of Economic Affairs ("Cyttron", BSIK 03036). The electron microscopes used for this work were purchased with financial support from the BBSRC, Glaxo Wellcome, and SmithKline Beecham. We are grateful to M. Schatz (Image Science, Berlin, Germany) for IMAGIC software support and to W. Haldenwang for strain BSK5. We thank R. Harris, H. Gilbert, M. Embley, and N. Robinson for advice and useful comments on the manuscript and E. Lowe for help with curve fitting. We are grateful for access to the Diamond synchrotron light source and its beamline scientists for help during data collection. Coordinates and structure factors for MtRsbS are deposited in the Protein Databank with the accession number 2VY9. Electron microscopy-derived molecular envelopes are deposited in the Electron Microscopy Database at the Macromolecular Structure Database Group with the following accession numbers:RsbR<INF>(146-274)</INF>: RsbS, 1558; RsbR: RsbS, 1555; and RsbR: RsbS: RsbT 1556.	Akbar S, 2001, J BACTERIOL, V183, P1329, DOI 10.1128/JB.183.4.1329-1338.2001; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; BENSON AK, 1993, J BACTERIOL, V175, P1929, DOI 10.1128/JB.175.7.1929-1935.1993; Beuron F, 1998, J STRUCT BIOL, V123, P248, DOI 10.1006/jsbi.1998.4039; BOYLAN SA, 1993, J BACTERIOL, V175, P7931, DOI 10.1128/JB.175.24.7931-7937.1993; Chen CC, 2004, J BACTERIOL, V186, P6830, DOI 10.1128/JB.186.20.6830-6836.2004; Chen CC, 2003, MOL MICROBIOL, V49, P1657, DOI 10.1046/j.1365-2958.2003.03663.x; Delumeau O, 2004, J BIOL CHEM, V279, P40927, DOI 10.1074/jbc.M405464200; Delumeau O, 2002, J BACTERIOL, V184, P5583, DOI 10.1128/JB.184.20.5583-5589.2002; Delumeau O, 2006, J BACTERIOL, V188, P7885, DOI 10.1128/JB.00892-06; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Dufour A, 1996, J BACTERIOL, V178, P3701, DOI 10.1128/jb.178.13.3701-9sigma.1996; Gaidenko TA, 1999, J MOL BIOL, V288, P29, DOI 10.1006/jmbi.1999.2665; Gaidenko TA, 2006, J BACTERIOL, V188, P6387, DOI 10.1128/JB.00691-06; Hardwick SW, 2007, J BIOL CHEM, V282, P11562, DOI 10.1074/jbc.M609733200; Kang CM, 1996, J BACTERIOL, V178, P3846, DOI 10.1128/jb.178.13.3846-3853.1996; Kang CM, 1998, MOL MICROBIOL, V30, P189, DOI 10.1046/j.1365-2958.1998.01052.x; Kim TJ, 2004, J BACTERIOL, V186, P6124, DOI 10.1128/jb.186.18.6124-6132.2004; Kim TJ, 2004, J MOL BIOL, V341, P135, DOI 10.1016/j.jmb.2004.05.043; Kuo S, 2004, MICROBIOL-SGM, V150, P4125, DOI 10.1099/mic.0.27421-0; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Masuda S, 2004, J MOL BIOL, V340, P941, DOI 10.1016/j.jmb.2004.05.040; Murray JW, 2005, P NATL ACAD SCI USA, V102, P17320, DOI 10.1073/pnas.0506599102; Pane-Farre J, 2005, J MOL MICROB BIOTECH, V9, P65, DOI 10.1159/000088837; Petersohn A, 2001, J BACTERIOL, V183, P5617, DOI 10.1128/JB.183.19.5617-5631.2001; Price CW, 2001, MOL MICROBIOL, V41, P757, DOI 10.1046/j.1365-2958.2001.02534.x; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Woodbury RL, 2004, J BACTERIOL, V186, P2789, DOI 10.1128/JB.186.9.2789-2797.2004; Zhang SY, 2003, J BACTERIOL, V185, P5714, DOI 10.1128/JB.185.19.5714-5721.2003	30	122	124	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2008	322	5898					92	96		10.1126/science.1159572	http://dx.doi.org/10.1126/science.1159572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832644				2022-12-28	WOS:000259680200045
J	Anand, S; Fan, VY; Zhang, JH; Zhang, LL; Ke, Y; Dong, Z; Chen, LC				Anand, Sudhir; Fan, Victoria Y.; Zhang, Junhua; Zhang, Lingling; Ke, Yang; Dong, Zhe; Chen, Lincoln C.			Health System Reform in China 5 4 China's human resources for health: quantity, quality, and distribution	LANCET			English	Article								in this paper, we analyse China's current health workforce in terms of quantity, quality, and distribution. Unlike most countries, China has more doctors than nurses-in 2005, there were 1.9 million licensed doctors and 1.4 million nurses. Doctor density in urban areas was more than twice that in rural areas, with nurse density showing more than a three-fold difference. Most of China's doctors (67.2%) and nurses (97.5%) have been educated up to only junior college or secondary school level. Since 1998 there has been a massive expansion of medical education, with an excess in the production of health workers over absorption into the health workforce. Inter-county inequality in the distribution of both doctors and nurses is very high, with most of this inequality accounted for by within-province inequalities (82% or more) rather than by between-province inequalities. Urban-rural disparities in doctor and nurse density account for about a third of overall inter-county inequality. These inequalities matter greatly with respect to health outcomes across counties, provinces, and strata in China; for instance, a cross-county multiple regression analysis using data from the 2000 census shows that the density of health workers is highly significant in explaining infant mortality.	[Anand, Sudhir] Univ Oxford, Dept Econ, Oxford, England; [Anand, Sudhir; Fan, Victoria Y.; Zhang, Lingling; Chen, Lincoln C.] Harvard Univ, Global Equ Initiat, Cambridge, MA 02138 USA; [Zhang, Junhua] Hlth Human Resources Dev Ctr, Beijing, Peoples R China; [Fan, Victoria Y.; Zhang, Lingling] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Ke, Yang; Dong, Zhe] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Chen, Lincoln C.] China Med Board, Cambridge, MA USA	University of Oxford; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Peking University	Anand, S (corresponding author), Univ Oxford St Catherines Coll, Oxford OX1 3UJ, England.	sudhir.anand@economics.ox.ac.uk	zhang, lingling/HDM-2189-2022; Fan, Victoria/AGG-4359-2022	Fan, Victoria/0000-0001-7755-9425				*ALL CHIN MARK RES, 2005, CHIN COUNTR BOUND 20; *ALL CHIN MARK RES, 2005, CHIN HIST 1990 COUNT; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; ANAND S, 1983, INEQUALITY POVERTY M, P303; Anand S, 2007, LANCET, V369, P1277, DOI 10.1016/S0140-6736(07)60599-6; [Anonymous], 2004, HUM RES HLTH OV CRIS; *DEP POP EMPL STAT, 1996, CHIN POP STAT YB 199, P350; *DEP POP EMPL STAT, 2005, CHIN POP STAT YB 200, P223; HAN J, 1995, ED STAT YB CHINA 199; HAN J, 1990, ED STAT YB CHINA 199; Han J., 2005, ED STAT YB CHINA 200; HAN J, 2000, ED STAT YB CHINA 200; *MIN HLTH, 2008, CHIN HLTH STAT YB 20, P335; *POL BUR CHIN MIN, 2006, CHIN COUNT CIT POP S; The Ministry of Health Department of Human Resources and Statistics Information Center, 2007, 2006 CHIN HUM RES HL; WANG D, 2007, WFME EX COUNC M FOR; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	17	215	224	13	101	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 15	2008	372	9651					1774	1781		10.1016/S0140-6736(08)61363-X	http://dx.doi.org/10.1016/S0140-6736(08)61363-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374XV	18930528				2022-12-28	WOS:000261077900027
J	Blendon, RJ; Altman, DE; Benson, JM; Brodie, M; Buhr, T; Deane, C; Buscho, S				Blendon, Robert J.; Altman, Drew E.; Benson, John M.; Brodie, Mollyann; Buhr, Tami; Deane, Claudia; Buscho, Sasha			Voters and Health Reform in the 2008 Presidential Election	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TELEPHONE SURVEY; NONRESPONSE; IMPACT; CARE		[Blendon, Robert J.; Benson, John M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Blendon, Robert J.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; [Altman, Drew E.; Brodie, Mollyann; Deane, Claudia; Buscho, Sasha] Kaiser Family Fdn, Menlo Pk, CA USA; [Buhr, Tami] Opin Dynam, Waltham, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Blendon, RJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,4th Fl, Boston, MA 02115 USA.	rblendon@hsph.harvard.edu						*AM ASS PUBL OP RE, 2006, FIN DISP CAS COD OUT; Blendon RJ, 2003, J HEALTH COMMUN, V8, P83, DOI 10.1080/10810730390224884; Blendon RJ, 2008, NEW ENGL J MED, V358, P414, DOI 10.1056/NEJMsr0708410; Blendon RJ, 2006, NEW ENGL J MED, V355, P1928, DOI 10.1056/NEJMsr066042; CALMES J, 2008, NY TIMES        0901, pA14; Curtin R, 2000, PUBLIC OPIN QUART, V64, P413, DOI 10.1086/318638; CUTLER DM, 2008, N ENGL J MED    1009; DANIEL WW, 1991, BIOSTATISTICS FDN AN, P225; *HARV SCH PUBL HLT, 2008, HARR INT POLL AM BEL; *HARV SCH PUBL HLT, 2008, RW JOHNS FDN POLL; JOHNSON H, 1996, SYSTEM AM WAY POLITI; *KAIS FAM FDN, 2008, HARV SCH PUBL HLTH P; Kaiser Family Foundation, 2008, KAIS HLTH TRACK POLL; Keeter S, 2000, PUBLIC OPIN QUART, V64, P125, DOI 10.1086/317759; KEETER S, 2008, IMPACT CELL ONLYS PU; Keeter S, 2007, PUBLIC OPIN QUART, V71, P772, DOI 10.1093/poq/nfm053; Keeter S, 2006, PUBLIC OPIN QUART, V70, P759, DOI 10.1093/poq/nfl035; Keeter Scott, 2008, CELL PHONES 2008 VOT; LANGER G, 2008, CELL ONLIES REPORT T; *ROP CTR PUBL OP R, 1992, VOT RES SURV NAT EL; *ROP CTR PUBL OP R, 2008, GALL POLL; *ROP CTR PUBL OP R, 2004, NAT EL POOL ED MED R; Traugott MW, 2001, PUBLIC OPIN QUART, V65, P389, DOI 10.1086/322850; VOSS DS, 1995, PUBLIC OPIN QUART, V59, P98, DOI 10.1086/269461; 2000, LOS ANGELES TIM 1107; 1996, LOS ANGELES TIM 1105	26	23	23	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					2050	2061		10.1056/NEJMsr0807717	http://dx.doi.org/10.1056/NEJMsr0807717			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	368OW	18974307				2022-12-28	WOS:000260632700014
J	Fitzharris, P; Hurst, M				Fitzharris, Penny; Hurst, Miriam			Commentary: Controversies in the Department of Health's clinical guidelines for immunoglobulin use	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Fitzharris, Penny; Hurst, Miriam] Auckland City Hosp, Auckland 1023, New Zealand	Auckland City Hospital	Fitzharris, P (corresponding author), Auckland City Hosp, Auckland 1023, New Zealand.	pennyf@adhb.govt.nz						[Anonymous], 2008, DEM MAN PLAN IMM US; *AS PAC IMM IMM EX, 2008, CONS REC US IMM REPL; Association of British Neurologists, 2005, GUID US INTR IMM NEU; National Blood Authority Australia, 2008, CRIT CLIN US INTR IM; Provan D., 2008, IVIG GUIDELINE DEV G, V2nd	5	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a1851	10.1136/bmj.a1851	http://dx.doi.org/10.1136/bmj.a1851			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18936061				2022-12-28	WOS:000260298800039
J	Kahn, CR				Kahn, C. Ronald			Medicine - Can we nip obesity in its vascular bud?	SCIENCE			English	Editorial Material							ADIPOSE-TISSUE; STEM-CELLS; NEURAL CREST; BROWN; FAT; ORIGIN; PREADIPOCYTES; ADIPOGENESIS; ADIPOCYTES		[Kahn, C. Ronald] Joslin Diabet Ctr, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.	Kahn, CR (corresponding author), Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228	NIDDK NIH HHS [R01 DK082659, P30 DK036836] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082659, P30DK036836] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Billon N, 2007, DEVELOPMENT, V134, P2283, DOI 10.1242/dev.002642; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cantile M, 2003, J CELL PHYSIOL, V194, P225, DOI 10.1002/jcp.10210; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Lin G, 2008, STEM CELLS DEV, V17, P1053, DOI 10.1089/scd.2008.0117; Moulin K, 2001, BIOCHEM J, V356, P659, DOI 10.1042/bj3560659; Muller SM, 2008, J IMMUNOL, V180, P5344, DOI 10.4049/jimmunol.180.8.5344; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sengenes C, 2005, J CELL PHYSIOL, V205, P114, DOI 10.1002/jcp.20381; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Tchkonia T, 2006, DIABETES, V55, P2571, DOI 10.2337/db06-0540; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	21	23	23	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					542	543		10.1126/science.1165667	http://dx.doi.org/10.1126/science.1165667			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948531	Green Accepted			2022-12-28	WOS:000260299100029
J	Norheim, OF				Norheim, Ole Frithjof			Clinical priority setting	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE; CARDIOVASCULAR-DISEASE; NICE; PREVENTION; GUIDELINES; EQUITY		[Norheim, Ole Frithjof] Haukeland Hosp, Dept Thorac Med, N-5020 Bergen, Norway	University of Bergen; Haukeland University Hospital	Norheim, OF (corresponding author), Haukeland Hosp, Dept Thorac Med, N-5020 Bergen, Norway.	ole.norheim@isf.uib.no	Norheim, Ole Frithjof/AAC-8771-2020	Norheim, Ole Frithjof/0000-0002-5748-5956				Anand S, 2002, J EPIDEMIOL COMMUN H, V56, P485, DOI 10.1136/jech.56.7.485; Anand S, 2001, CHALLENGING INEQUITI, P49; [Anonymous], 2007, JUST HLTH; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; Cappelen AW, 2005, J MED ETHICS, V31, P476, DOI 10.1136/jme.2004.010421; Cookson R, 2000, J MED ETHICS, V26, P323, DOI 10.1136/jme.26.5.323; DANIELS N, 1994, HASTINGS CENT REP, V24, P27, DOI 10.2307/3562841; Daniels N, 2002, SETTING LIMITS FAIRL; Daniels N, 1988, AM I MY PARENTS KEEP; DOLAN P, 2002, DISTRIBUTING HLTH CA; Graham I, 2007, EUR J CARDIOV PREV R, V14, pS1, DOI 10.1097/01.hjr.0000277983.23934.c9; Ham C., 2003, REASONABLE RATIONING; Harris J, 2005, J MED ETHICS, V31, P373, DOI 10.1136/jme.2005.012906; Holm S, 1998, BRIT MED J, V317, P1000, DOI 10.1136/bmj.317.7164.1000; KLEIN R, 1993, RATIONING HLTH CARE, P73; Klein RDP, 1996, MANAGING SCARCITY PR; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; NAYLOR CD, 1995, LANCET, V345, P840, DOI 10.1016/S0140-6736(95)92969-X; Norheim OF, 1999, BRIT MED J, V319, P1426, DOI 10.1136/bmj.319.7222.1426; NORHEIM OF, 1996, THESIS U OSLO OSLO; Pearson SD, 2005, JAMA-J AM MED ASSOC, V294, P2618, DOI 10.1001/jama.294.20.2618; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; Sackett D. L., 1997, EVIDENCE BASED MED P; Smith R, 2000, BRIT MED J, V321, P1363, DOI 10.1136/bmj.321.7273.1363; Ubel PA, 1997, ANN INTERN MED, V126, P74, DOI 10.7326/0003-4819-126-1-199701010-00010; Williams A, 1997, HEALTH ECON, V6, P117, DOI 10.1002/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-B	26	22	22	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2008	337	7675							a1846	10.1136/bmj.a1846	http://dx.doi.org/10.1136/bmj.a1846			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	360YE	18845594				2022-12-28	WOS:000260093900030
J	Zarate, YA; Hopkin, RJ				Zarate, Yuri A.; Hopkin, Robert J.			Lysosomal storage disease 3 - Fabry's disease	LANCET			English	Review							ENZYME-REPLACEMENT THERAPY; QUALITY-OF-LIFE; AGALSIDASE-BETA THERAPY; ALPHA-GALACTOSIDASE-A; OUTCOME SURVEY; CLINICAL-MANIFESTATIONS; NATURAL-HISTORY; X-INACTIVATION; CARDIAC INVOLVEMENT; CRYPTOGENIC STROKE	Fabry's disease is an X-linked lysosomal storage disorder caused by abnormalities in the GLA gene, which leads to a deficiency in alpha-galactosidase A. The consequent abnormal accumulation of glycosphingolipids results in several clinical signs and symptoms and substantial morbidity and mortality. This review covers all basic aspects of the disease such as epidemiology, pathophysiology, clinical presentation by systems, diagnosis, management, prevention, and repercussions on quality of life. With the development of enzyme replacement therapy in the past few years, early initiation of treatment is key for improvement in major affected organs with decreased cardiac mass and stabilisation of kidney function, and improvement in neuropathic pain, sweating, gastrointestinal symptoms, hearing loss, and pulmonary symptoms. However, treatment of individual symptoms in addition to enzyme replacement therapy seems to be needed for many patients, especially those who have had some degree of organ dysfunction. Additional data are needed to document long-term treatment outcomes.	[Zarate, Yuri A.; Hopkin, Robert J.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Human Genet,Dept Pediat, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Hopkin, RJ (corresponding author), Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Human Genet,Dept Pediat, 3333 Burnet Ave,MLC 4006, Cincinnati, OH 45229 USA.	rob.hopkin@cchmc.org		Zarate, Yuri/0000-0001-8235-6200; Hopkin, Robert/0000-0003-0770-5516				Alroy J, 2002, J AM SOC NEPHROL, V13, pS134, DOI 10.1097/01.ASN.0000016684.07368.75; Banikazemi M, 2005, MOL GENET METAB, V85, P255, DOI 10.1016/j.ymgme.2005.04.009; Banikazemi M, 2007, ANN INTERN MED, V146, P77, DOI 10.7326/0003-4819-146-2-200701160-00148; Beck M, 2005, ACTA PAEDIATR, V94, P5, DOI 10.1080/08035320510028003; Beck M, 2004, EUR J CLIN INVEST, V34, P838, DOI 10.1111/j.1365-2362.2004.01424.x; Beer M, 2006, AM J CARDIOL, V97, P1515, DOI 10.1016/j.amjcard.2005.11.087; Bodary PF, 2007, TRENDS CARDIOVAS MED, V17, P129, DOI 10.1016/j.tcm.2007.02.006; Branton M, 2002, J AM SOC NEPHROL, V13, pS139, DOI 10.1097/01.ASN.0000016683.73778.78; Breunig F, 2006, KIDNEY INT, V69, P1216, DOI 10.1038/sj.ki.5000208; Brouns R, 2007, CLIN NEUROL NEUROSUR, V109, P479, DOI 10.1016/j.clineuro.2007.03.008; Clarke JTR, 2007, ANN INTERN MED, V146, P425, DOI 10.7326/0003-4819-146-6-200703200-00007; Cleeland CS, 2002, ACTA PAEDIATR, V91, P43, DOI 10.1080/080352502762457914; Deegan PB, 2006, J MED GENET, V43, P347, DOI 10.1136/jmg.2005.036327; Desnick RJ, 2004, J PEDIATR-US, V144, pS20, DOI 10.1016/j.jpeds.2004.01.051; Desnick RJ, 2003, ANN INTERN MED, V138, P338, DOI 10.7326/0003-4819-138-4-200302180-00014; Dobrovolny R, 2005, J MOL MED, V83, P647, DOI 10.1007/s00109-005-0656-2; Elleder M, 1998, Cesk Patol, V34, P7; Eng CM, 2007, J INHERIT METAB DIS, V30, P184, DOI 10.1007/s10545-007-0521-2; Eng CM, 2006, GENET MED, V8, P539, DOI 10.1097/01.gim.0000237866.70357.c6; Eng CM, 2001, AM J HUM GENET, V68, P711, DOI 10.1086/318809; Fabry H, 2002, ACTA PAEDIATR, V91, P3, DOI 10.1080/080352502762457824; Faggiano A, 2006, J CLIN ENDOCR METAB, V91, P4319, DOI 10.1210/jc.2006-0858; Fellgiebel A, 2006, LANCET NEUROL, V5, P791, DOI 10.1016/S1474-4422(06)70548-8; Frustaci A, 2001, NEW ENGL J MED, V345, P25, DOI 10.1056/NEJM200107053450104; Frustaci A, 2007, CIRCULATION, V116, pE350, DOI 10.1161/CIRCULATIONAHA.107.723387; Germain DP, 2007, J AM SOC NEPHROL, V18, P1547, DOI 10.1681/ASN.2006080816; Germain Dominique P, 2002, BMC Med Genet, V3, P10, DOI 10.1186/1471-2350-3-10; Germain DP, 2005, CLIN GENET, V68, P93, DOI 10.1111/j.1399-0004.2005.00457.x; Ginsberg L, 2006, ACTA PAEDIATR, V95, P57, DOI 10.1080/08035320600618908; Gold KF, 2002, QUAL LIFE RES, V11, P317, DOI 10.1023/A:1015511908710; Guffon N, 2004, J INHERIT METAB DIS, V27, P221, DOI 10.1023/B:BOLI.0000028726.11177.8b; Hajioff D, 2006, EUR J CLIN INVEST, V36, P663, DOI 10.1111/j.1365-2362.2006.01701.x; Hegemann S, 2006, EUR J CLIN INVEST, V36, P654, DOI 10.1111/j.1365-2362.2006.01702.x; Hilz MJ, 2002, ACTA PAEDIATR, V91, P38, DOI 10.1080/080352502762457905; Hoffmann B, 2005, J MED GENET, V42, P247, DOI 10.1136/jmg.2004.025791; Hoffmann B, 2007, CLIN GASTROENTEROL H, V5, P1447, DOI 10.1016/j.cgh.2007.08.012; Hoffmann B, 2007, CLIN J PAIN, V23, P535, DOI 10.1097/AJP.0b013e318074c986; Hoigne P, 2006, INT J CARDIOL, V111, P413, DOI 10.1016/j.ijcard.2005.08.023; Hopkin RJ, 2003, GENET MED, V5, P144, DOI 10.1097/01.GIM.0000069509.57929.CD; Jardim L, 2004, J INHERIT METAB DIS, V27, P229, DOI 10.1023/B:BOLI.0000028794.04349.91; Jardim LB, 2006, ARQ NEURO-PSIQUIAT, V64, P711, DOI 10.1590/S0004-282X2006000500002; Kalliokoski RJ, 2006, J INHERIT METAB DIS, V29, P112, DOI 10.1007/s10545-006-0221-3; Kaneski CR, 2006, NEUROLOGY, V67, P2045, DOI 10.1212/01.wnl.0000247278.88077.09; Kararizou E, 2006, NEUROMUSCULAR DISORD, V16, P304, DOI 10.1016/j.nmd.2006.03.001; Keating GM, 2007, DRUGS, V67, P435, DOI 10.2165/00003495-200767030-00007; Keilmann A, 2003, ACTA PAEDIATR, V92, P31, DOI 10.1080/08035320310000438; Kim W, 2007, AM J MED GENET A, V143A, P377, DOI 10.1002/ajmg.a.31600; Kleinert J, 2006, AM J HYPERTENS, V19, P782, DOI 10.1016/j.amjhyper.2006.01.011; Kolodny EH, 2006, ACTA PAEDIATR, V95, P55, DOI 10.1080/08035320600619153; Kotanko P, 2004, J AM SOC NEPHROL, V15, P1323, DOI 10.1097/01.ASN.0000124671.61963.1E; Lidove O, 2007, INT J CLIN PRACT, V61, P293, DOI 10.1111/j.1742-1241.2006.01237.x; Lidove O, 2006, INT J CLIN PRACT, V60, P1053, DOI 10.1111/j.1742-1241.2006.01061.x; Linhart A, 2002, ACTA PAEDIATR, V91, P15, DOI 10.1080/080352502762457851; Linhart A, 2007, HEART, V93, P528, DOI 10.1136/hrt.2005.063818; Linhart A, 2007, EUR HEART J, V28, P1228, DOI 10.1093/eurheartj/ehm153; Linthorst GE, 2004, KIDNEY INT, V66, P1589, DOI 10.1111/j.1523-1755.2004.00924.x; Low M, 2007, INTERN MED J, V37, P436, DOI 10.1111/j.1445-5994.2007.01366.x; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; MacDermot KD, 2001, J MED GENET, V38, P769, DOI 10.1136/jmg.38.11.769; Maier EM, 2006, ACTA PAEDIATR, V95, P30, DOI 10.1080/08035320600618809; Mehta A, 2005, ACTA PAEDIATR, V94, P24, DOI 10.1080/08035320510028076; Mehta A, 2004, EUR J CLIN INVEST, V34, P236, DOI 10.1111/j.1365-2362.2004.01309.x; Miners AH, 2002, QUAL LIFE RES, V11, P127, DOI 10.1023/A:1015009210639; Moore DF, 2007, J NEUROL SCI, V257, P258, DOI 10.1016/j.jns.2007.01.053; Morrone A, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e103; Nguyen TT, 2005, CLIN EXP OPHTHALMOL, V33, P164, DOI 10.1111/j.1442-9071.2005.00990.x; Ohashi T, 2007, MOL GENET METAB, V92, P271, DOI 10.1016/j.ymgme.2007.06.013; Oliveira JP, 2007, CLIN THER, V29, pS15, DOI 10.1016/S0149-2918(07)80121-4; Orteu CH, 2007, BRIT J DERMATOL, V157, P331, DOI 10.1111/j.1365-2133.2007.08002.x; Papaxanthos-Roche A, 2007, FERTIL STERIL, V88, DOI 10.1016/j.fertnstert.2006.11.036; Pieroni M, 2006, J AM COLL CARDIOL, V47, P1663, DOI 10.1016/j.jacc.2005.11.070; Pieroni M, 2003, CIRCULATION, V107, P1978, DOI 10.1161/01.CIR.0000061952.27445.A0; Pisani A, 2005, AM J KIDNEY DIS, V46, P120, DOI 10.1053/j.ajkd.2005.03.016; Ramaswami U, 2007, ACTA PAEDIATR, V96, P122, DOI 10.1111/j.1651-2227.2007.00029.x; Ramaswami U, 2006, ACTA PAEDIATR, V95, P86, DOI 10.1080/08035250500275022; Ries M, 2003, EUR J PEDIATR, V162, P767, DOI 10.1007/s00431-003-1299-3; Ries M, 2005, PEDIATRICS, V115, pE344, DOI 10.1542/peds.2004-1678; Ries M, 2006, GENET MED, V8, P96, DOI 10.1097/01.gim.0000200950.25118.dd; Ries M, 2006, PEDIATRICS, V118, P924, DOI 10.1542/peds.2005-2895; Rolfs A, 2005, LANCET, V366, P1794, DOI 10.1016/S0140-6736(05)67635-0; Sadick Norman, 2007, Heart Lung Circ, V16, P200, DOI 10.1016/j.hlc.2007.03.007; Sakuraba H, 2006, J HUM GENET, V51, P180, DOI 10.1007/s10038-005-0342-9; Schaefer E, 2005, ACTA PAEDIATR, V94, P87, DOI 10.1080/08035320510031045; Schiffmann R, 2003, MUSCLE NERVE, V28, P703, DOI 10.1002/mus.10497; Schiffmann R, 2002, ACTA PAEDIATR, V91, P48, DOI 10.1080/080352502762457923; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schiffmann R, 2007, J AM SOC NEPHROL, V18, P1576, DOI 10.1681/ASN.2006111263; Schiffmann R, 2007, ANN INTERN MED, V146, P142, DOI 10.7326/0003-4819-146-2-200701160-00147; Schwarting A, 2006, CLIN NEPHROL, V66, P77; Seino Yoshihiko, 2005, Journal of Nippon Medical School, V72, P254, DOI 10.1272/jnms.72.254; Shah JS, 2005, ACTA PAEDIATR, V94, P11, DOI 10.1080/08035320510028058; Shin SH, 2007, BIOCHEM BIOPH RES CO, V359, P168, DOI 10.1016/j.bbrc.2007.05.082; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Spinelli L, 2004, CLIN GENET, V66, P158, DOI 10.1111/j.1399-0004.2004.00284.x; Street NJ, 2006, GENET MED, V8, P346, DOI 10.1097/01.gim.0000223545.63012.5a; Utsumi K, 1997, INTERNAL MED, V36, P327, DOI 10.2169/internalmedicine.36.327; Vedder AC, 2006, J INHERIT METAB DIS, V29, P106, DOI 10.1007/s10545-006-0196-0; Vedder AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000598; Wang RY, 2007, GENET MED, V9, P34, DOI 10.1097/GIM.0b013e31802d8321; Warnock DG, 2006, ADV CHRONIC KIDNEY D, V13, P138, DOI 10.1053/j.ackd.2006.01.013; Wilcox WR, 2008, MOL GENET METAB, V93, P112, DOI 10.1016/j.ymgme.2007.09.013; Yam GHF, 2006, AM J PHYSIOL-CELL PH, V290, pC1076, DOI 10.1152/ajpcell.00426.2005; Young E, 2005, ACTA PAEDIATR, V94, P51, DOI 10.1080/08035320510028111; Youngren JF, 2005, BREAST CANCER RES TR, V94, P37, DOI 10.1007/s10549-005-6939-z; ZARATE YA, 2007, CUR MED LIT LYSOSOMA, V7, P8	105	468	485	2	74	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2008	372	9647					1427	1435		10.1016/S0140-6736(08)61589-5	http://dx.doi.org/10.1016/S0140-6736(08)61589-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362WP	18940466				2022-12-28	WOS:000260228200029
J	McIntosh, JR; Grishchuk, EL; Morphew, MK; Efremov, AK; Zhudenkov, K; Volkov, VA; Cheeseman, IM; Desai, A; Mastronarde, DN; Ataullakhanov, FI				McIntosh, J. Richard; Grishchuk, Ekaterina L.; Morphew, Mary K.; Efremov, Artem K.; Zhudenkov, Kirill; Volkov, Vladimir A.; Cheeseman, Iain M.; Desai, Arshad; Mastronarde, David N.; Ataullakhanov, Fazly I.			Fibrils Connect Microtubule Tips with Kinetochores: A Mechanism to Couple Tubulin Dynamics to Chromosome Motion	CELL			English	Article							FISSION YEAST; IN-VITRO; MOLECULAR ARCHITECTURE; DISTINCT MECHANISMS; FORCE PRODUCTION; RING COMPLEX; DASH COMPLEX; DEPOLYMERIZATION; DAM1; ENDS	Kinetochores of mitotic chromosomes are coupled to spindle microtubules in ways that allow the energy from tubulin dynamics to drive chromosome motion. Most kinetochore-associated microtubule ends display curving "protofilaments,'' strands of tubulin dimers that bend away from the microtubule axis. Both a kinetochore "plate'' and an encircling, ring-shaped protein complex have been proposed to link protofilament bending to poleward chromosome motion. Here we show by electron tomography that slender fibrils connect curved protofilaments directly to the inner kinetochore. Fibril-protofilament associations correlate with a local straightening of the flared protofilaments. Theoretical analysis reveals that protofilament-fibril connections would be efficient couplers for chromosome motion, and experimental work on two very different kinetochore components suggests that filamentous proteins can couple shortening microtubules to cargo movements. These analyses define a ring-independent mechanism for harnessing microtubule dynamics directly to chromosome movement.	[McIntosh, J. Richard; Grishchuk, Ekaterina L.; Morphew, Mary K.; Efremov, Artem K.; Volkov, Vladimir A.; Mastronarde, David N.] Univ Colorado, Dept MCD Biol, Boulder, CO 80309 USA; [Grishchuk, Ekaterina L.] Inst Gen Pathol & Pathophysiol, Moscow 125315, Russia; [Efremov, Artem K.; Zhudenkov, Kirill; Volkov, Vladimir A.; Ataullakhanov, Fazly I.] Natl Res Ctr Hematol, Moscow 117513, Russia; [Cheeseman, Iain M.] MIT, Whitehead Inst, Cambridge, MA 02139 USA; [Desai, Arshad] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Desai, Arshad] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ataullakhanov, Fazly I.] Moscow MV Lomonosov State Univ, Dept Phys, Moscow 119899, Russia; [Ataullakhanov, Fazly I.] RAS, Ctr Theoret Problems Physicochem Pharmacol, Moscow 119991, Russia	University of Colorado System; University of Colorado Boulder; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Massachusetts Institute of Technology (MIT); Whitehead Institute; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Lomonosov Moscow State University; Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Russian Academy of Sciences	McIntosh, JR (corresponding author), Univ Colorado, Dept MCD Biol, Boulder, CO 80309 USA.	richard.mcintosh@colorado.edu	McIntosh, Richard/GLN-3533-2022; Volkov, Vladimir/N-8746-2013; Zhudenkov, Kirill/AGG-2014-2022; Ataullakhanov, Fazoil/J-8076-2012	Volkov, Vladimir/0000-0002-5407-3366; Efremov, Artem/0000-0002-1603-610X; Cheeseman, Iain/0000-0002-3829-5612; Zhudenkov, Kirill/0000-0003-2991-6189	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033787] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR000592, RR000592, P41 RR000592-35] Funding Source: Medline; NIGMS NIH HHS [R01 GM033787, GM033787, R01 GM033787-24] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Asbury CL, 2006, P NATL ACAD SCI USA, V103, P9873, DOI 10.1073/pnas.0602249103; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; COUE M, 1991, J CELL BIOL, V112, P1165, DOI 10.1083/jcb.112.6.1165; Davis TN, 2007, TRENDS CELL BIOL, V17, P377, DOI 10.1016/j.tcb.2007.08.001; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Dong YM, 2007, NAT CELL BIOL, V9, P516, DOI 10.1038/ncb1576; Efremov A, 2007, P NATL ACAD SCI USA, V104, P19017, DOI 10.1073/pnas.0709524104; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; Gachet Y, 2008, MOL BIOL CELL, V19, P1646, DOI 10.1091/mbc.E07-09-0910; Ganem NJ, 2006, CELL CYCLE, V5, P481, DOI 10.4161/cc.5.5.2519; Grishchuk EL, 2008, P NATL ACAD SCI USA, V105, P6918, DOI 10.1073/pnas.0801811105; Grishchuk EL, 2008, P NATL ACAD SCI USA, V105, P15423, DOI 10.1073/pnas.0807859105; Grishchuk EL, 2006, EMBO J, V25, P4888, DOI 10.1038/sj.emboj.7601353; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; Heermann D.W., 1990, COMPUTER SIMULATION; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; LOMBILLO VA, 1995, NATURE, V373, P161, DOI 10.1038/373161a0; LOMBILLO VA, 1995, J CELL BIOL, V128, P107, DOI 10.1083/jcb.128.1.107; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; McAinsh AD, 2006, EMBO J, V25, P4033, DOI 10.1038/sj.emboj.7601293; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Molodtsov MI, 2005, P NATL ACAD SCI USA, V102, P4353, DOI 10.1073/pnas.0501142102; Morphew MK, 2003, J MICROSC-OXFORD, V212, P21, DOI 10.1046/j.1365-2818.2003.01231.x; Morrison EE, 2007, CELL MOL LIFE SCI, V64, P307, DOI 10.1007/s00018-007-6360-3; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; O'Toole ET, 2003, J CELL BIOL, V163, P451, DOI 10.1083/jcb.200304035; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Sanchez-Perez I, 2005, EMBO J, V24, P2931, DOI 10.1038/sj.emboj.7600761; Schittenhelm RB, 2007, CHROMOSOMA, V116, P385, DOI 10.1007/s00412-007-0103-y; Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141; VandenBeldt KJ, 2006, CURR BIOL, V16, P1217, DOI 10.1016/j.cub.2006.04.046; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607	47	156	157	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 17	2008	135	2					322	333		10.1016/j.cell.2008.08.038	http://dx.doi.org/10.1016/j.cell.2008.08.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957206	Green Accepted, Bronze			2022-12-28	WOS:000260130400021
J	Villeneuve, AM				Villeneuve, Anne M.			Ensuring an exit strategy: RTeL1 Restricts Rogue Recombination	CELL			English	Editorial Material							BLOOMS-SYNDROME HELICASE; HOMOLOGOUS RECOMBINATION		[Villeneuve, Anne M.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Villeneuve, Anne M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Villeneuve, AM (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	villen@cmgm.stanford.edu						Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	9	3	3	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 17	2008	135	2					213	215		10.1016/j.cell.2008.10.003	http://dx.doi.org/10.1016/j.cell.2008.10.003			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957197	Bronze			2022-12-28	WOS:000260130400011
J	Patel, V; Garrison, P; Mari, JD; Minas, H; Prince, M; Saxena, S				Patel, Vikram; Garrison, Preston; Mari, Jair de Jesus; Minas, Harry; Prince, Martin; Saxena, Shekhar		Advisory Grp Movement Global Menta	The Lancet's Series on Global Mental Health: 1 year on	LANCET			English	Editorial Material							MIDDLE-INCOME COUNTRIES		[Patel, Vikram] Sangath Ctr, Porvorim 403521, Goa, India; [Patel, Vikram] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; [Garrison, Preston] World Federat Mental Hlth, Springfield, VA USA; [Mari, Jair de Jesus] Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil; [Minas, Harry] Univ Melbourne, Ctr Int Mental Hlth, Melbourne, Vic, Australia; [Prince, Martin] Inst Psychiat, Ctr Publ Mental Hlth, London, England; [Saxena, Shekhar] WHO, Dept Mental Hlth & Substance Abuse, CH-1211 Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; Universidade Federal de Sao Paulo (UNIFESP); University of Melbourne; University of London; King's College London; World Health Organization	Patel, V (corresponding author), Sangath Ctr, Porvorim 403521, Goa, India.	vikram.patel@lshtm.ac.uk	Wessely, Simon C/A-8713-2008; Thornicroft, Graham/B-4027-2010; Minas, Harry/O-8276-2019; Cohen, Alex/A-6974-2009; Adewuya, Abiodun/N-4997-2017; Minas, Harry/F-7718-2010; Prince, Martin J/A-9170-2010; Whiteford, Harvey A/A-4840-2009; Araya, Ricardo/S-3144-2019; de Jesus Mari, Jair/A-7309-2008	Thornicroft, Graham/0000-0003-0662-0879; Minas, Harry/0000-0003-1719-7367; Adewuya, Abiodun/0000-0002-7611-6953; Prince, Martin J/0000-0003-1379-7146; Whiteford, Harvey A/0000-0003-4667-6623; Araya, Ricardo/0000-0002-0420-5148; de Jesus Mari, Jair/0000-0002-5403-0112; Collins, Pamela Y./0000-0003-3956-448X; Patel, Vikram/0000-0003-1066-8584	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CHAN M, 4 GLOB M HEADS WHO C; Jacob KS, 2007, LANCET, V370, P1061, DOI 10.1016/S0140-6736(07)61241-0; *LANC GLOB MENT HL, 2008, LANCET, V380, P2352; PATEL V, GLOBAL MENTAL HLTH C; PATEL V, SCALING SERVICES PEO; Patel V, 2008, CURR OPIN PSYCHIATR, V21, P109, DOI 10.1097/YCO.0b013e3282f43c7f; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; SANGATH, LEADERSHIP MENTAL HL; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; STEFFENS M, EXPERTS HIGHLIGHT LA; WHO, 2008, MENT HLTH GAP ACT PR	13	55	56	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1354	1357		10.1016/S0140-6736(08)61556-1	http://dx.doi.org/10.1016/S0140-6736(08)61556-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	360MB	18929907	Green Accepted, Green Published			2022-12-28	WOS:000260060500035
J	Steinbock, B				Steinbock, Bonnie			Designer babies: choosing our children's genes	LANCET			English	Editorial Material									[Steinbock, Bonnie] SUNY Albany, Dept Philosophy, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany	Steinbock, B (corresponding author), SUNY Albany, Dept Philosophy, Albany, NY 12222 USA.	steinbock@albany.edu						Agar Nicholas, 2004, LIBERAL EUGENICS DEF; Glover J, 2006, CHOOSING CHILDREN GE; GREEN RM, 2007, BABIES DESIGN ETHNIC; MURRAY TH, 1996, WORTH CHILD; Sandel M., 2008, CASE PERFECTION ETHI	5	5	5	2	125	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1294	1295		10.1016/S0140-6736(08)61538-X	http://dx.doi.org/10.1016/S0140-6736(08)61538-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18946895	Green Published, Bronze			2022-12-28	WOS:000260060500013
J	Knickelbein, JE; Khanna, KM; Yee, MB; Baty, CJ; Kinchington, PR; Hendricks, RL				Knickelbein, Jared E.; Khanna, Kamal M.; Yee, Michael B.; Baty, Catherine J.; Kinchington, Paul R.; Hendricks, Robert L.			Noncytotoxic lytic granule-mediated CD8(+) T cell inhibition of HSV-1 reactivation from neuronal latency	SCIENCE			English	Article							HERPES-SIMPLEX-VIRUS; HUMAN TRIGEMINAL GANGLIA; GAMMA-INTERFERON; INSITU HYBRIDIZATION; TYPE-1 REACTIVATION; SENSORY GANGLIA; NERVOUS SYSTEMS; INFECTION; EXPRESSION; GRANZYME	Reactivation of herpes simplex virus type 1 (HSV-1) from neuronal latency is a common and potentially devastating cause of disease worldwide. CD8(+) T cells can completely inhibit HSV reactivation in mice, with interferon-gamma affording a portion of this protection. We found that CD8(+) T cell lytic granules are also required for the maintenance of neuronal latency both in vivo and in ex vivo ganglia cultures and that their directed release to the junction with neurons in latently infected ganglia did not induce neuronal apoptosis. Here, we describe a nonlethal mechanism of viral inactivation in which the lytic granule component, granzyme B, degrades the HSV-1 immediate early protein, ICP4, which is essential for further viral gene expression.	[Knickelbein, Jared E.; Khanna, Kamal M.; Yee, Michael B.; Kinchington, Paul R.; Hendricks, Robert L.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15213 USA; [Baty, Catherine J.] Univ Pittsburgh, Sch Med, Ctr Biol Imaging, Pittsburgh, PA 15213 USA; [Baty, Catherine J.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; [Kinchington, Paul R.; Hendricks, Robert L.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Hendricks, Robert L.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA; [Knickelbein, Jared E.] Univ Pittsburgh, Sch Med, Grad Program Immunol, Pittsburgh, PA 15213 USA; [Knickelbein, Jared E.] Univ Pittsburgh, Sch Med, Med Sci Training Program, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hendricks, RL (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15213 USA.	hendricksrr@upmc.edu	Yee, Michael/AAI-4164-2020	Yee, Michael/0000-0002-6296-7757	NIH [F30NS061471, R01EY05945, R01EY015291, P30EY08098]; Research to Prevent Blindness Medical Student Eye Research Fellowship; Eye and Ear Foundation of Pittsburgh; NATIONAL EYE INSTITUTE [P30EY008098, R01EY005945, R01EY015291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS061471] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Medical Student Eye Research Fellowship(Research to Prevent Blindness (RPB)); Eye and Ear Foundation of Pittsburgh; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Lathrop and J. Karlsson for assistance with microscopy and preparation of figures and N. Zurowski for assistance with flow cytometry. We have no conflicting financial interests. This work was supported by NIH grants F30NS061471 (J.E.K.), R01EY05945 (R.L.H.), R01EY015291 (P.R.K.), and P30EY08098 (R.L.H.); a Research to Prevent Blindness Medical Student Eye Research Fellowship (J.E.K.); and unrestricted grants from Research to Prevent Blindness and the Eye and Ear Foundation of Pittsburgh (R.L.H.).	Andrade F, 2007, EMBO J, V26, P2148, DOI 10.1038/sj.emboj.7601650; Backes C, 2005, NUCLEIC ACIDS RES, V33, pW208, DOI 10.1093/nar/gki433; CANTIN EM, 1995, J VIROL, V69, P4898, DOI 10.1128/JVI.69.8.4898-4905.1995; CROEN KD, 1987, NEW ENGL J MED, V317, P1427, DOI 10.1056/NEJM198712033172302; Decman V, 2005, J VIROL, V79, P10339, DOI 10.1128/JVI.79.16.10339-10347.2005; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; Derfuss T, 2007, BRAIN PATHOL, V17, P389, DOI 10.1111/j.1750-3639.2007.00088.x; Freeman ML, 2007, J IMMUNOL, V179, P322, DOI 10.4049/jimmunol.179.1.322; Hoshino Y, 2007, J VIROL, V81, P8157, DOI 10.1128/JVI.00474-07; Hufner K, 2006, J NEUROPATH EXP NEUR, V65, P1022, DOI 10.1097/01.jnen.0000235852.92963.bf; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Liu T, 1996, J VIROL, V70, P264, DOI 10.1128/JVI.70.1.264-271.1996; Liu T, 2001, J VIROL, V75, P11178, DOI 10.1128/JVI.75.22.11178-11184.2001; Mueller SN, 2003, J VIROL, V77, P2445, DOI 10.1128/JVI.77.4.2445-2451.2003; Pereira RA, 2000, J VIROL, V74, P1029, DOI 10.1128/JVI.74.2.1029-1032.2000; Perng GC, 2000, SCIENCE, V287, P1500, DOI 10.1126/science.287.5457.1500; Sheridan BS, 2007, EXPERT OPIN BIOL TH, V7, P1323, DOI 10.1517/14712598.7.9.1323; SIMMONS A, 1992, J EXP MED, V175, P1337, DOI 10.1084/jem.175.5.1337; STROOP WG, 1987, ACTA NEUROPATHOL, V74, P124, DOI 10.1007/BF00692842; Telford WG, 2002, CYTOMETRY, V47, P81, DOI 10.1002/cyto.10052; Theil D, 2003, AM J PATHOL, V163, P2179, DOI 10.1016/S0002-9440(10)63575-4; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Verjans GMGM, 2007, P NATL ACAD SCI USA, V104, P3496, DOI 10.1073/pnas.0610847104	25	251	257	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					268	271		10.1126/science.1164164	http://dx.doi.org/10.1126/science.1164164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845757	Green Accepted			2022-12-28	WOS:000259902300051
J	Baker, M				Baker, Monya			Being patient	NATURE			English	News Item							CARDIOMYOCYTES											Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Tabar V, 2008, NAT MED, V14, P379, DOI 10.1038/nm1732; van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001	4	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2008	455	7213					586	588		10.1038/455586a	http://dx.doi.org/10.1038/455586a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833248	Bronze			2022-12-28	WOS:000259639700014
J	Blow, N				Blow, Nathan			Biochemistry's new look	NATURE			English	Editorial Material							METABOLOMICS											May P, 2008, GENETICS, V179, P157, DOI 10.1534/genetics.108.088336; Northen TR, 2007, NATURE, V449, P1033, DOI 10.1038/nature06195; Styczynski MP, 2007, ANAL CHEM, V79, P966, DOI 10.1021/ac0614846; Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001	4	93	94	5	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					697	700		10.1038/455697a	http://dx.doi.org/10.1038/455697a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833281	Bronze			2022-12-28	WOS:000259639700054
J	Bochud, PY; Chien, JW; Marr, KA; Leisenring, WM; Upton, A; Janer, M; Rodrigues, SD; Li, S; Hansen, JA; Zhao, LP; Aderem, A; Boeckh, M				Bochud, Pierre-Yves; Chien, Jason W.; Marr, Kieren A.; Leisenring, Wendy M.; Upton, Arlo; Janer, Marta; Rodrigues, Stephanie D.; Li, Sarah; Hansen, John A.; Zhao, Lue Ping; Aderem, Alan; Boeckh, Michael			Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VERSUS-HOST-DISEASE; INTERLEUKIN-10 PROMOTER POLYMORPHISM; PULMONARY ASPERGILLOSIS; INVASIVE ASPERGILLOSIS; RECEPTOR-4 MUTATIONS; FUNGAL-INFECTIONS; RISK-FACTOR; TLR4; RECOGNITION; SUSCEPTIBILITY	Background: Toll-like receptors (TLRs) are essential components of the immune response to fungal pathogens. We examined the role of TLR polymorphisms in conferring a risk of invasive aspergillosis among recipients of allogeneic hematopoietic-cell transplants. Methods: We analyzed 20 single-nucleotide polymorphisms (SNPs) in the toll-like receptor 2 gene (TLR2), the toll-like receptor 3 gene (TLR3), the toll-like receptor 4 gene (TLR4), and the toll-like receptor 9 gene (TLR9) in a cohort of 336 recipients of hematopoietic-cell transplants and their unrelated donors. The risk of invasive aspergillosis was assessed with the use of multivariate Cox regression analysis. The analysis was replicated in a validation study involving 103 case patients and 263 matched controls who received hematopoietic-cell transplants from related and unrelated donors. Results: In the discovery study, two donor TLR4 haplotypes (S3 and S4) increased the risk of invasive aspergillosis (adjusted hazard ratio for S3, 2.20; 95% confidence interval [CI], 1.14 to 4.25; P=0.02; adjusted hazard ratio for S4, 6.16; 95% CI, 1.97 to 19.26; P=0.002). The haplotype S4 was present in carriers of two SNPs in strong linkage disequilibrium (1063 A/G [D299G] and 1363 C/T [T399I]) that influence TLR4 function. In the validation study, donor haplotype S4 also increased the risk of invasive aspergillosis (adjusted odds ratio, 2.49; 95% CI, 1.15 to 5.41; P=0.02); the association was present in unrelated recipients of hematopoietic-cell transplants (odds ratio, 5.00; 95% CI, 1.04 to 24.01; P=0.04) but not in related recipients (odds ratio, 2.29; 95% CI, 0.93 to 5.68; P=0.07). In the discovery study, seropositivity for cytomegalovirus (CMV) in donors or recipients, donor positivity for S4, or both, as compared with negative results for CMV and S4, were associated with an increase in the 3-year probability of invasive aspergillosis (12% vs. 1%, P=0.02) and death that was not related to relapse (35% vs. 22%, P=0.02). Conclusions: This study suggests an association between the donor TLR4 haplotype S4 and the risk of invasive aspergillosis among recipients of hematopoietic-cell transplants from unrelated donors.	[Bochud, Pierre-Yves; Marr, Kieren A.; Leisenring, Wendy M.; Upton, Arlo; Boeckh, Michael] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Program Infect Dis, Seattle, WA 98109 USA; [Bochud, Pierre-Yves; Janer, Marta; Rodrigues, Stephanie D.; Li, Sarah; Aderem, Alan] Fred Hutchinson Canc Res Ctr, Inst Syst Biol, Seattle, WA 98109 USA; [Hansen, John A.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Zhao, Lue Ping] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Chien, Jason W.; Marr, Kieren A.; Leisenring, Wendy M.; Hansen, John A.; Boeckh, Michael] Univ Washington, Dept Med, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Institute for Systems Biology (ISB); Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Boeckh, M (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Program Infect Dis, 1100 Fairview Ave N, Seattle, WA 98109 USA.	mboeckh@fhcrc.org	Bochud, Pierre-Yves/ABE-5979-2020; Boeckh, Michael/AAA-1607-2022	Bochud, Pierre-Yves/0000-0002-2208-4757	Swiss Foundation for Medical and Biological Grants [1121]; Swiss National Science Foundation [81LA- 65462]; Leenaards Foundation; U. S. National Institutes of Health [CA18029, CA15704, AI054523, AI051468, AI33484, HL87690, HL088201, HL69860]; National Center for Research Resources [RR03655]; Astellas; Pfizer; Enzon; Merck; NATIONAL CANCER INSTITUTE [P30CA015704, P01CA018029] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087690, K23HL069860, R01HL088201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI033484, U54AI054523, K24AI085118, R01AI051468] Funding Source: NIH RePORTER	Swiss Foundation for Medical and Biological Grants; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Leenaards Foundation; U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Astellas(Astellas Pharmaceuticals); Pfizer(Pfizer); Enzon; Merck(Merck & Company); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the Swiss Foundation for Medical and Biological Grants (1121), the Swiss National Science Foundation (81LA- 65462), and the Leenaards Foundation (to Dr. Bochud); and the U. S. National Institutes of Health (CA18029, CA15704, AI054523, AI051468, AI33484, HL87690, HL088201, and HL69860). Some of the results of this study were obtained with the use of SAGE software, which is supported by a grant from the National Center for Research Resources (RR03655). Dr. Marr reports receiving consulting fees from Astellas, Basilea, Enzon, Merck, Pfizer, and Schering-Plough, being a member of a data and safety monitoring board for a trial of antifungal prophylaxis for Schering-Plough, and receiving research support from Astellas, Pfizer, Enzon, and Merck; Dr. Boeckh, being a member of a data and safety monitoring board for a human immunodeficiency virus trial for Pfizer, receiving research support from Pfizer and Merck, and receiving consulting fees from Enzon; and Drs. Bochud, Boeckh, Chien, and Marr, having a pending application for a patent on TLR4 SNPs and haplotypes and the risk of aspergillosis. No other potential conflict of interest relevant to this article was reported. We thank Jeremy Smith, Ravinder K. Sandhu, Craig Silva, Christopher Davis, Peter Choe, and Sanam Hussain for assistance in data collection and handling; Jeffrey Stevens, Gary J. Olsem, Tera R. Matson, Terry Stevens- Ayers, Jennifer Gravley, and Kimberly Harrington for technical assistance; and Veronique Erard for critical review of an earlier version of the manuscript.	Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Bellocchio S, 2004, J IMMUNOL, V173, P7406, DOI 10.4049/jimmunol.173.12.7406; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bochud PY, 2007, LANCET INFECT DIS, V7, P531, DOI 10.1016/S1473-3099(07)70185-8; Bochud PY, 2007, AIDS, V21, P441, DOI 10.1097/QAD.0b013e328012b8ac; Braedel S, 2004, BRIT J HAEMATOL, V125, P392, DOI 10.1111/j.1365-2141.2004.04922.x; *CAS W RES U, 2005, SAGE STAT AN GEN EP; Erridge C, 2003, J EXP MED, V197, P1787, DOI 10.1084/jem.20022078; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; GUADERMAN WJ, QUANTO 1 1 COMPUTER; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; Kesh S, 2005, ANN NY ACAD SCI, V1062, P95, DOI 10.1196/annals.1358.012; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Lazarus R, 2003, GENOMICS, V81, P85, DOI 10.1016/S0888-7543(02)00022-8; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lin M, 2003, NEW ENGL J MED, V349, P2201, DOI 10.1056/NEJMoa022060; Lin MT, 2005, BLOOD, V106, P3995, DOI 10.1182/blood-2004-11-4338; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Mambula SS, 2002, J BIOL CHEM, V277, P39320, DOI 10.1074/jbc.M201683200; Marr KA, 2004, BLOOD, V103, P1527, DOI 10.1182/blood-2003-08-2644; Marr KA, 2002, CLIN INFECT DIS, V34, P909, DOI 10.1086/339202; Meier A, 2003, CELL MICROBIOL, V5, P561, DOI 10.1046/j.1462-5822.2003.00301.x; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Netea MG, 2003, J INFECT DIS, V188, P320, DOI 10.1086/376456; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Rezazadeh M, 2006, J INFECTION, V53, P206, DOI 10.1016/j.jinf.2005.10.018; Sainz J, 2007, HUM IMMUNOL, V68, P41, DOI 10.1016/j.humimm.2006.10.011; Sainz J, 2007, IMMUNOL LETT, V109, P76, DOI 10.1016/j.imlet.2007.01.005; Seo KW, 2005, BONE MARROW TRANSPL, V36, P1089, DOI 10.1038/sj.bmt.1705181; Shoham S, 2001, J IMMUNOL, V166, P4620, DOI 10.4049/jimmunol.166.7.4620; SULLIVAN KM, 1991, SEMIN HEMATOL, V28, P250; Tal G, 2004, J INFECT DIS, V189, P2057, DOI 10.1086/420830; Upton A, 2007, CLIN INFECT DIS, V44, P531, DOI 10.1086/510592; Vaid M, 2007, CLIN CHEM LAB MED, V45, P183, DOI 10.1515/CCLM.2007.033; Van der Graaf CAA, 2006, EUR CYTOKINE NETW, V17, P29; von Aulock S, 2003, J INFECT DIS, V188, P938, DOI 10.1086/378095; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003	44	344	355	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2008	359	17					1766	1777		10.1056/NEJMoa0802629	http://dx.doi.org/10.1056/NEJMoa0802629			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363DJ	18946062	Bronze, Green Accepted			2022-12-28	WOS:000260245800004
J	Ding, L; Getz, G; Wheeler, DA; Mardis, ER; McLellan, MD; Cibulskis, K; Sougnez, C; Greulich, H; Muzny, DM; Morgan, MB; Fulton, L; Fulton, RS; Zhang, QY; Wendl, MC; Lawrence, MS; Larson, DE; Chen, K; Dooling, DJ; Sabo, A; Hawes, AC; Shen, H; Jhangiani, SN; Lewis, LR; Hall, O; Zhu, YM; Mathew, T; Ren, YR; Yao, JQ; Scherer, SE; Clerc, K; Metcalf, GA; Ng, B; Milosavljevic, A; Gonzalez-Garay, ML; Osborne, JR; Meyer, R; Shi, XQ; Tang, YZ; Koboldt, DC; Lin, L; Abbott, R; Miner, TL; Pohl, C; Fewell, G; Haipek, C; Schmidt, H; Dunford-Shore, BH; Kraja, A; Crosby, SD; Sawyer, CS; Vickery, T; Sander, S; Robinson, J; Winckler, W; Baldwin, J; Chirieac, LR; Dutt, A; Fennell, T; Hanna, M; Johnson, BE; Onofrio, RC; Thomas, RK; Tonon, G; Weir, BA; Zhao, XJ; Ziaugra, L; Zody, MC; Giordano, T; Orringer, MB; Roth, JA; Spitz, MR; Wistuba, II; Ozenberger, B; Good, PJ; Chang, AC; Beer, DG; Watson, MA; Ladanyi, M; Broderick, S; Yoshizawa, A; Travis, WD; Pao, W; Province, MA; Weinstock, GM; Varmus, HE; Gabriel, SB; Lander, ES; Gibbs, RA; Meyerson, M; Wilson, RK				Ding, Li; Getz, Gad; Wheeler, David A.; Mardis, Elaine R.; McLellan, Michael D.; Cibulskis, Kristian; Sougnez, Carrie; Greulich, Heidi; Muzny, Donna M.; Morgan, Margaret B.; Fulton, Lucinda; Fulton, Robert S.; Zhang, Qunyuan; Wendl, Michael C.; Lawrence, Michael S.; Larson, David E.; Chen, Ken; Dooling, David J.; Sabo, Aniko; Hawes, Alicia C.; Shen, Hua; Jhangiani, Shalini N.; Lewis, Lora R.; Hall, Otis; Zhu, Yiming; Mathew, Tittu; Ren, Yanru; Yao, Jiqiang; Scherer, Steven E.; Clerc, Kerstin; Metcalf, Ginger A.; Ng, Brian; Milosavljevic, Aleksandar; Gonzalez-Garay, Manuel L.; Osborne, John R.; Meyer, Rick; Shi, Xiaoqi; Tang, Yuzhu; Koboldt, Daniel C.; Lin, Ling; Abbott, Rachel; Miner, Tracie L.; Pohl, Craig; Fewell, Ginger; Haipek, Carrie; Schmidt, Heather; Dunford-Shore, Brian H.; Kraja, Aldi; Crosby, Seth D.; Sawyer, Christopher S.; Vickery, Tammi; Sander, Sacha; Robinson, Jody; Winckler, Wendy; Baldwin, Jennifer; Chirieac, Lucian R.; Dutt, Amit; Fennell, Tim; Hanna, Megan; Johnson, Bruce E.; Onofrio, Robert C.; Thomas, Roman K.; Tonon, Giovanni; Weir, Barbara A.; Zhao, Xiaojun; Ziaugra, Liuda; Zody, Michael C.; Giordano, Thomas; Orringer, Mark B.; Roth, Jack A.; Spitz, Margaret R.; Wistuba, Ignacio I.; Ozenberger, Bradley; Good, Peter J.; Chang, Andrew C.; Beer, David G.; Watson, Mark A.; Ladanyi, Marc; Broderick, Stephen; Yoshizawa, Akihiko; Travis, William D.; Pao, William; Province, Michael A.; Weinstock, George M.; Varmus, Harold E.; Gabriel, Stacey B.; Lander, Eric S.; Gibbs, Richard A.; Meyerson, Matthew; Wilson, Richard K.			Somatic mutations affect key pathways in lung adenocarcinoma	NATURE			English	Article							HUMAN BREAST; MENDELIAN-INHERITANCE; HOMOZYGOUS DELETIONS; COLORECTAL CANCERS; EGFR MUTATIONS; TOBACCO-SMOKE; KRAS MUTATION; NEVER SMOKERS; RECEPTOR GENE; GEFITINIB	Determining the genetic basis of cancer requires comprehensive analyses of large collections of histopathologically well- classified primary tumours. Here we report the results of a collaborative study to discover somatic mutations in 188 human lung adenocarcinomas. DNA sequencing of 623 genes with known or potential relationships to cancer revealed more than 1,000 somatic mutations across the samples. Our analysis identified 26 genes that are mutated at significantly high frequencies and thus are probably involved in carcinogenesis. The frequently mutated genes include tyrosine kinases, among them the EGFR homologue ERBB4; multiple ephrin receptor genes, notably EPHA3; vascular endothelial growth factor receptor KDR; and NTRK genes. These data provide evidence of somatic mutations in primary lung adenocarcinoma for several tumour suppressor genes involved in other cancers - including NF1, APC, RB1 and ATM - and for sequence changes in PTPRD as well as the frequently deleted gene LRP1B. The observed mutational profiles correlate with clinical features, smoking status and DNA repair defects. These results are reinforced by data integration including single nucleotide polymorphism array and gene expression array. Our findings shed further light on several important signalling pathways involved in lung adenocarcinoma, and suggest new molecular targets for treatment.	[Ding, Li; Mardis, Elaine R.; McLellan, Michael D.; Fulton, Lucinda; Fulton, Robert S.; Wendl, Michael C.; Larson, David E.; Chen, Ken; Dooling, David J.; Osborne, John R.; Meyer, Rick; Shi, Xiaoqi; Tang, Yuzhu; Koboldt, Daniel C.; Lin, Ling; Abbott, Rachel; Miner, Tracie L.; Pohl, Craig; Fewell, Ginger; Haipek, Carrie; Schmidt, Heather; Dunford-Shore, Brian H.; Crosby, Seth D.; Sawyer, Christopher S.; Vickery, Tammi; Sander, Sacha; Robinson, Jody; Weinstock, George M.; Wilson, Richard K.] Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63108 USA; [Getz, Gad; Cibulskis, Kristian; Sougnez, Carrie; Greulich, Heidi; Lawrence, Michael S.; Winckler, Wendy; Baldwin, Jennifer; Dutt, Amit; Fennell, Tim; Hanna, Megan; Onofrio, Robert C.; Weir, Barbara A.; Zhao, Xiaojun; Ziaugra, Liuda; Zody, Michael C.; Gabriel, Stacey B.; Lander, Eric S.; Meyerson, Matthew] Broad Inst Harvard & MIT, Canc Program, Genome Biol Program, Cambridge, MA 02142 USA; [Wheeler, David A.; Muzny, Donna M.; Morgan, Margaret B.; Sabo, Aniko; Hawes, Alicia C.; Shen, Hua; Jhangiani, Shalini N.; Lewis, Lora R.; Hall, Otis; Zhu, Yiming; Mathew, Tittu; Ren, Yanru; Yao, Jiqiang; Scherer, Steven E.; Clerc, Kerstin; Metcalf, Ginger A.; Ng, Brian; Milosavljevic, Aleksandar; Gonzalez-Garay, Manuel L.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Greulich, Heidi; Winckler, Wendy; Dutt, Amit; Hanna, Megan; Johnson, Bruce E.; Tonon, Giovanni; Weir, Barbara A.; Zhao, Xiaojun; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Zhang, Qunyuan; Kraja, Aldi; Province, Michael A.] Washington Univ, Sch Med, Div Stat Genom, Dept Genet, St Louis, MO 63108 USA; [Chirieac, Lucian R.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Chirieac, Lucian R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Chirieac, Lucian R.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Thomas, Roman K.] Max Planck Soc, Max Planck Inst Neurol Res, Klaus Joachim Zulch Labs, D-50931 Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Fac Med, D-50931 Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol, D-50931 Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; [Giordano, Thomas] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Orringer, Mark B.; Chang, Andrew C.; Beer, David G.] Univ Michigan, Thorac Surg Sect, Dept Surg, Ann Arbor, MI 48109 USA; [Roth, Jack A.; Wistuba, Ignacio I.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Spitz, Margaret R.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Wistuba, Ignacio I.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Ozenberger, Bradley; Good, Peter J.] NHGRI, NIH, Bethesda, MD 20892 USA; [Watson, Mark A.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63108 USA; [Ladanyi, Marc; Broderick, Stephen; Yoshizawa, Akihiko; Travis, William D.; Pao, William] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Ladanyi, Marc; Broderick, Stephen; Yoshizawa, Akihiko; Travis, William D.; Pao, William] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Ladanyi, Marc; Broderick, Stephen; Yoshizawa, Akihiko; Travis, William D.; Pao, William] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Ladanyi, Marc; Broderick, Stephen; Yoshizawa, Akihiko; Travis, William D.; Pao, William] Mem Sloan Kettering Canc Ctr, Dept Computat Biol, New York, NY 10065 USA; [Ladanyi, Marc; Pao, William] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Varmus, Harold E.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA	Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Baylor College of Medicine; Harvard University; Dana-Farber Cancer Institute; Washington University (WUSTL); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Max Planck Society; University of Cologne; University of Cologne; University of Cologne; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Washington University (WUSTL); Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Wilson, RK (corresponding author), Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63108 USA.	matthew_meyerson@dfci.harvard.edu; rwilson@wustl.edu	Wilson, Richard K./AAF-4139-2019; Yoshizawa, Akihiko/AAM-9519-2020; Weinstock, George M/C-6314-2013; Wendl, Michael C/A-2741-2008; Chirieac, Lucian R./AAD-2030-2019; Meyerson, Matthew L/E-7123-2012; Tonon, Giovanni/J-9804-2018; Wheeler, David A/M-9740-2018; Ladanyi, Marc/AAG-8585-2019; Dutt, Amit/I-1911-2013; Cibulskis, Kristian/AAC-7380-2019; Chen, Ken/AAU-1432-2021; Lawrence, Michael/AAC-8202-2020; Mardis, Elaine/W-2202-2019; Chen, Ken/A-1074-2009	Wilson, Richard K./0000-0002-1992-1358; Weinstock, George M/0000-0002-2997-4592; Tonon, Giovanni/0000-0003-2973-5038; Wheeler, David A/0000-0002-9056-6299; Dutt, Amit/0000-0002-1119-4774; Chen, Ken/0000-0003-4013-5279; Giordano, Thomas/0000-0003-0641-8873; Chang, Andrew/0000-0001-9506-0425; Cibulskis, Kristian/0000-0003-1343-1582; Gonzalez-Garay, Manuel/0000-0003-3412-0353; MCLELLAN, MICHAEL/0000-0002-2703-8784; Larson, David/0000-0001-7934-5906	National Human Genome Research Institute; NATIONAL CANCER INSTITUTE [R01CA154365, U19CA084953, P50CA070907] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank A. Lash, M.F. Zakowski, M.G. Kris and V. Rusch for intellectual contributions, and many members of the Baylor Human Genome Sequencing Center, the Broad Institute of Harvard and MIT, and the Genome Center at Washington University for support. This work was funded by grants from the National Human Genome Research Institute to E.S.L., R.A.G. and R.K.W.	Ahrendt SA, 2003, J NATL CANCER I, V95, P961, DOI 10.1093/jnci/95.13.961; Beasley MB, 2005, SEMIN ROENTGENOL, V40, P90, DOI 10.1053/j.ro.2005.01.001; Burma S, 2004, DNA REPAIR, V3, P909, DOI 10.1016/j.dnarep.2004.03.021; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Chehab NH, 2000, GENE DEV, V14, P278; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Forgacs E, 1998, ONCOGENE, V17, P1557, DOI 10.1038/sj.onc.1202070; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; HOWLEY PM, 1991, COLD SPRING HARB SYM, V56, P149; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Juergens Rosalyn A, 2006, J Natl Compr Canc Netw, V4, P595; Kim JH, 2006, HUM MOL GENET, V15, P1181, DOI 10.1093/hmg/ddl033; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Koivunen JP, 2008, BRIT J CANCER, V99, P245, DOI 10.1038/sj.bjc.6604469; Le Calvez F, 2005, CANCER RES, V65, P5076, DOI 10.1158/0008-5472.CAN-05-0551; Liu CX, 2000, CANCER RES, V60, P1961; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti A, 2008, HUM MUTAT, V29, P609, DOI 10.1002/humu.20707; Marks JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000426; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Motoi N, 2008, AM J SURG PATHOL, V32A, P810, DOI 10.1097/PAS.0b013e31815cb162; Ohgaki H, 2004, CANCER LETT, V207, P197, DOI 10.1016/j.canlet.2003.10.020; Packenham JP, 1995, CLIN CANCER RES, V1, P687; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; RODENHUIS S, 1988, CANCER RES, V48, P5738; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sandsmark DK, 2007, CANCER RES, V67, P4790, DOI 10.1158/0008-5472.CAN-06-4470; Sasaki H, 2007, ONCOL REP, V18, P623; SELLERS TA, 1990, J NATL CANCER I, V82, P1272, DOI 10.1093/jnci/82.15.1272; Sellers TA, 1998, GENET EPIDEMIOL, V15, P251, DOI 10.1002/(SICI)1098-2272(1998)15:3<251::AID-GEPI4>3.0.CO;2-7; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sonoda I, 2004, CANCER RES, V64, P3741, DOI 10.1158/0008-5472.CAN-04-0172; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	50	2015	2106	7	245	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1069	1075		10.1038/nature07423	http://dx.doi.org/10.1038/nature07423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948947	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000260252600036
J	Khan, MN; Jais, P; Cummings, J; Di Biase, L; Sanders, P; Martin, DO; Kautzner, J; Hao, S; Themistoclakis, S; Fanelli, R; Potenza, D; Massaro, R; Wazni, O; Schweikert, R; Saliba, W; Wang, P; Al-Ahmad, A; Beheiry, S; Santarelli, P; Starling, RC; Dello Russo, A; Pelargonio, G; Brachmann, J; Schibgilla, V; Bonso, A; Casella, M; Raviele, A; Haissaguerre, M; Natale, A				Khan, Mohammed N.; Jais, Pierre; Cummings, Jennifer; Di Biase, Luigi; Sanders, Prashanthan; Martin, David O.; Kautzner, Josef; Hao, Steven; Themistoclakis, Sakis; Fanelli, Raffaele; Potenza, Domenico; Massaro, Raimondo; Wazni, Oussama; Schweikert, Robert; Saliba, Walid; Wang, Paul; Al-Ahmad, Amin; Beheiry, Salwa; Santarelli, Pietro; Starling, Randall C.; Dello Russo, Antonio; Pelargonio, Gemma; Brachmann, Johannes; Schibgilla, Volker; Bonso, Aldo; Casella, Michela; Raviele, Antonio; Haissaguerre, Michel; Natale, Andrea		PABA-CHF Investigators	Pulmonary-vein isolation for atrial fibrillation in patients with heart failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; CATHETER ABLATION; CARDIAC RESYNCHRONIZATION; ANTRUM ISOLATION; RHYTHM; OUTCOMES; TRIAL	Background: Pulmonary-vein isolation is increasingly being used to treat atrial fibrillation in patients with heart failure. Methods: In this prospective, multicenter clinical trial, we randomly assigned patients with symptomatic, drug-resistant atrial fibrillation, an ejection fraction of 40% or less, and New York Heart Association class II or III heart failure to undergo either pulmonary-vein isolation or atrioventricular-node ablation with biventricular pacing. All patients completed the Minnesota Living with Heart Failure questionnaire (scores range from 0 to 105, with a higher score indicating a worse quality of life) and underwent echocardiography and a 6-minute walk test (the composite primary end point). Over a 6-month period, patients were monitored for both symptomatic and asymptomatic episodes of atrial fibrillation. Results: In all, 41 patients underwent pulmonary-vein isolation, and 40 underwent atrioventricular-node ablation with biventricular pacing; none were lost to follow-up at 6 months. The composite primary end point favored the group that underwent pulmonary-vein isolation, with an improved questionnaire score at 6 months (60, vs. 82 in the group that underwent atrioventricular-node ablation with biventricular pacing; P<0.001), a longer 6-minute-walk distance (340 m vs. 297 m, P<0.001), and a higher ejection fraction (35% vs. 28%, P<0.001). In the group that underwent pulmonary-vein isolation, 88% of patients receiving antiarrhythmic drugs and 71% of those not receiving such drugs were free of atrial fibrillation at 6 months. In the group that underwent pulmonary-vein isolation, pulmonary-vein stenosis developed in two patients, pericardial effusion in one, and pulmonary edema in another; in the group that underwent atrioventricular-node ablation with biventricular pacing, lead dislodgment was found in one patient and pneumothorax in another. Conclusions: Pulmonary-vein isolation was superior to atrioventricular-node ablation with biventricular pacing in patients with heart failure who had drug-refractory atrial fibrillation. (ClinicalTrials.gov number, NCT00599976.).	[Khan, Mohammed N.] Cardiovasc Assoc, Elk Grove Village, IL 60007 USA; [Jais, Pierre; Haissaguerre, Michel] Hop Cardiol Haut Leveque, Bordeaux, France; [Cummings, Jennifer; Di Biase, Luigi; Martin, David O.; Wazni, Oussama; Schweikert, Robert; Saliba, Walid; Starling, Randall C.] Cleveland Clin, Cleveland, OH 44106 USA; [Di Biase, Luigi] Univ Foggia, Foggia, Italy; [Themistoclakis, Sakis; Bonso, Aldo; Casella, Michela; Raviele, Antonio] Umberto I Hosp, Mestre Venice, Italy; [Fanelli, Raffaele; Potenza, Domenico; Massaro, Raimondo] Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy; [Santarelli, Pietro] Catholic Univ, Campobasso, Italy; [Dello Russo, Antonio; Pelargonio, Gemma] Univ Cattolica Sacro Cuore, I-00168 Rome, Italy; [Sanders, Prashanthan] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Kautzner, Josef] Inst Clin & Expt Med, Prague, Czech Republic; [Hao, Steven; Beheiry, Salwa] Sutter Heart Ctr, San Francisco, CA USA; [Wang, Paul; Al-Ahmad, Amin; Natale, Andrea] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Brachmann, Johannes; Schibgilla, Volker] Klinikum Coburg, Coburg, Germany; [Natale, Andrea] St Davids Med Ctr, Texas Cardiac Arrhythmia Inst, Austin, TX USA; [Natale, Andrea] Case Western Reserve Univ, Cleveland, OH 44106 USA	CHU Bordeaux; Cleveland Clinic Foundation; University of Foggia; IRCCS Casa Sollievo Della Sofferenza; Catholic University of the Sacred Heart; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Royal Adelaide Hospital; Institute for Clinical & Experimental Medicine (IKEM); Stanford University; Klinikum Coburg; Saint David's Medical Center; Case Western Reserve University	Khan, MN (corresponding author), Cardiovasc Assoc, 701 Biesterfield Rd, Elk Grove Village, IL 60007 USA.	mnktx@yahoo.com	Casella, Michela/Y-9354-2019; Natale, Andrea/ABE-7273-2020; Brachmann, Johannes/AAD-1499-2021; Dello Russo, Antonio/AAB-5030-2022; Sanders, Prashanthan/D-7641-2013; Casella, Michela/HDN-5651-2022; Casella, Michela/F-6737-2018; Themistoclakis, Sakis/AAC-3385-2022	Casella, Michela/0000-0002-5322-1742; Dello Russo, Antonio/0000-0001-7737-421X; Sanders, Prashanthan/0000-0003-3803-8429; Casella, Michela/0000-0002-5322-1742; Di Biase, Luigi/0000-0001-6508-4047; Themistoclakis, Sakis/0000-0002-7998-7113	Ministry of Education, Youth, and Sports of the Czech Republic [257-2]; St. Jude Medical Educational Grant; Boston Scientific	Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); St. Jude Medical Educational Grant; Boston Scientific(Boston Scientific)	Supported by a grant (257-2) from the Ministry of Education, Youth, and Sports of the Czech Republic and by a St. Jude Medical Educational Grant. Dr. Khan reports receiving lecture fees from Boston Scientific; Dr. Jais, consulting fees from St. Jude Medical, Sorin Medical, and Biosense Webster; Dr. Cummings, consulting fees from St. Jude Medical and lecture fees from Boston Scientific, Medtronic, Corazon, Biosense Webster, and Siemens; Dr. Sanders, consulting fees from Medtronic and St. Jude Medical and lecture fees from St. Jude Medical, Biosense Webster, and Bard Electrophysiology; Dr. Kautzner, consulting and lecture fees from Boston Scientific, Biosense Webster, Medtronic, and St. Jude Medical; Dr. Wazni, lecture fees from St. Jude Medical; Dr. Schweikert, lecture fees from Medtronic, Biotronik, St. Jude Medical, Boston Scientific, Reliant Pharmaceuticals, Biosense Webster, and Siemens; and Dr. Saliba, lecture fees from Medtronic, Boston Scientific, and St. Jude Medical. Dr. Wang reports receiving consulting fees from Lifewatch, lecture fees from Boston Scientific, Medtronic, and St. Jude, and research support from Boston Scientific and having equity interest in Hansen Medical. Dr. Starling reports receiving consulting fees from Medtronic and BioControl and research support from Medtronic and having equity interest in Cardiomems. Dr. Haissaguerre reports receiving lecture fees from Biosense Webster and Bard Electrophysiology and research support from Boston Scientific. No other potential conflict of interest relevant to this article was reported.	Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Chen MS, 2004, J AM COLL CARDIOL, V43, P1004, DOI 10.1016/j.jacc.2003.09.056; Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11; Daoud EG, 1996, AM J CARDIOL, V78, P1433, DOI 10.1016/S0002-9149(97)89297-1; Doshi RN, 2005, J CARDIOVASC ELECTR, V16, P1160, DOI 10.1111/j.1540-8167.2005.50062.x; Gentlesk PJ, 2007, J CARDIOVASC ELECTR, V18, P9, DOI 10.1111/j.1540-8167.2006.00653.x; Haissaguerre M, 2000, CIRCULATION, V101, P1409, DOI 10.1161/01.CIR.101.12.1409; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hsu LF, 2004, NEW ENGL J MED, V351, P2373, DOI 10.1056/NEJMoa041018; Kanj M, 2007, HEART RHYTHM, V4, pS73, DOI 10.1016/j.hrthm.2006.12.036; Kanj MH, 2006, HEART RHYTHM, V3, P866, DOI 10.1016/j.hrthm.2006.02.1033; Natale A, 1996, AM J CARDIOL, V78, P1431, DOI 10.1016/S0002-9149(97)89296-X; Pappone C, 2003, J AM COLL CARDIOL, V42, P185, DOI 10.1016/S0735-1097(03)00577-1; Sanders P, 2004, HEART RHYTHM, V1, P176, DOI 10.1016/j.hrthm.2004.03.072; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; Wood MA, 2000, CIRCULATION, V101, P1138, DOI 10.1161/01.CIR.101.10.1138; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685	19	458	479	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2008	359	17					1778	1785		10.1056/NEJMoa0708234	http://dx.doi.org/10.1056/NEJMoa0708234			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363DJ	18946063				2022-12-28	WOS:000260245800005
J	Ross, JS; Detsky, AS				Ross, Joseph S.; Detsky, Allan S.			Comparison of the US and Canadian health care systems - A tale of 2 Mount Sinai's	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; COUNTRIES		[Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med & Hlth Policy, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Management, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Evaluat, Toronto, ON, Canada; [Ross, Joseph S.] Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY USA; [Ross, Joseph S.] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Ross, Joseph S.] James J Peters Vet Adm Med Ctr, HSR&D Res Enhancement Award Program, Bronx, NY USA; [Ross, Joseph S.] James J Peters Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Bronx, NY USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 427-600 Univ Ave, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca		Ross, Joseph/0000-0002-9218-3320				Anderson GF, 2005, HEALTH AFFAIR, V24, P903, DOI 10.1377/hlthaff.24.4.903; Aufses A.H., 2002, THIS HOUSE NOBLE DEE; Bodenheimer T, 2007, ANN INTERN MED, V146, P301, DOI 10.7326/0003-4819-146-4-200702200-00011; Davis K, 2007, MIRROR MIRROR WALL I; Detsky AS, 2007, JAMA-J AM MED ASSOC, V298, P799, DOI 10.1001/jama.298.7.799; Hussey PS, 2004, HEALTH AFFAIR, V23, P89, DOI 10.1377/hlthaff.23.3.89; Ko DT, 2007, CIRCULATION, V115, P196, DOI 10.1161/CIRCULATIONAHA.106.657601; Lasser KE, 2006, AM J PUBLIC HEALTH, V96, P1300, DOI 10.2105/AJPH.2004.059402; *ORG EC COOP DEV, 2007, OECD HLTH DAT 2007 S; SCHOEN C, 2005, HLTH AFF MILWOOD S; Schoen C, 2006, HEALTH AFFAIR, V25, pW555, DOI 10.1377/hlthaff.25.w555; Woolhandler S, 2003, NEW ENGL J MED, V349, P768, DOI 10.1056/NEJMsa022033; Woolhandler S, 2002, HEALTH AFFAIR, V21, P88, DOI 10.1377/hlthaff.21.4.88	13	6	6	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2008	300	16					1934	1936		10.1001/jama.300.16.1934	http://dx.doi.org/10.1001/jama.300.16.1934			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362UR	18940983				2022-12-28	WOS:000260223100026
J	Choi, PJ; Cai, L; Frieda, K; Xie, S				Choi, Paul J.; Cai, Long; Frieda, Kirsten; Xie, Sunney			A stochastic single-molecule event triggers phenotype switching of a bacterial cell	SCIENCE			English	Article							LAC REPRESSOR; ESCHERICHIA-COLI; GENE-EXPRESSION; OPERATOR COMPLEX; LEVEL; DYNAMICS; PROTEIN; OPERON; TRANSCRIPTION; BINDING	By monitoring fluorescently labeled lactose permease with single-molecule sensitivity, we investigated the molecular mechanism of how an Escherichia coli cell with the lac operon switches from one phenotype to another. At intermediate inducer concentrations, a population of genetically identical cells exhibits two phenotypes: induced cells with highly fluorescent membranes and uninduced cells with a small number of membrane-bound permeases. We found that this basal-level expression results from partial dissociation of the tetrameric lactose repressor from one of its operators on looped DNA. In contrast, infrequent events of complete dissociation of the repressor from DNA result in large bursts of permease expression that trigger induction of the lac operon. Hence, a stochastic single-molecule event determines a cell's phenotype.	[Choi, Paul J.; Cai, Long; Frieda, Kirsten; Xie, Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University	Xie, S (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu			NIH; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010244] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank G. Church, A. Miyawaki, and B. Wanner for bacterial strains and plasmids; J. Hearn for technical assistance; and J. Elf, N. Friedman, and G.W. Li for helpful discussions. This work was supported by the NIH Director's Pioneer Award. P.J.C. acknowledges the John and Fannie Hertz Foundation.	Arkin A, 1998, GENETICS, V149, P1633; Artyomov MN, 2007, P NATL ACAD SCI USA, V104, P18958, DOI 10.1073/pnas.0706110104; BARKLEY MD, 1975, BIOCHEMISTRY-US, V14, P1700, DOI 10.1021/bi00679a024; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; COHEN GN, 1957, BACTERIOL REV, V21, P169, DOI 10.1128/MMBR.21.3.169-194.1957; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; DUNAWAY M, 1980, J BIOL CHEM, V255, P115; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; Hornos JEM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051907; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KENNELL D, 1977, J MOL BIOL, V114, P1, DOI 10.1016/0022-2836(77)90279-0; KRAMER H, 1987, EMBO J, V6, P1481, DOI 10.1002/j.1460-2075.1987.tb02390.x; M_uller-Hill B., 1996, LAC OPERON SHORT HIS; Mettetal JT, 2006, P NATL ACAD SCI USA, V103, P7304, DOI 10.1073/pnas.0509874103; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Ptashne M, 2004, GENETIC SWITCH PHAGE; REVZIN A, 1977, BIOCHEMISTRY-US, V16, P4769, DOI 10.1021/bi00641a002; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Vilar JMG, 2003, J CELL BIOL, V161, P471, DOI 10.1083/jcb.200301125; Xie XS, 2008, ANNU REV BIOPHYS, V37, P417, DOI 10.1146/annurev.biophys.37.092607.174640; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	26	333	335	3	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					442	446		10.1126/science.1161427	http://dx.doi.org/10.1126/science.1161427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927393	Green Accepted, Green Submitted			2022-12-28	WOS:000260094500047
J	Rougemaille, M; Dieppois, G; Kisseleva-Romanova, E; Gudipati, RK; Lemoine, S; Blugeon, C; Boulay, J; Jensen, TH; Stutz, F; Devaux, F; Libri, D				Rougemaille, Mathieu; Dieppois, Guennaelle; Kisseleva-Romanova, Elena; Gudipati, Rajani Kanth; Lemoine, Sophie; Blugeon, Corinne; Boulay, Jocelyne; Jensen, Torben Heick; Stutz, Francoise; Devaux, Frederic; Libri, Domenico			THO/Sub2p Functions to Coordinate 3 '-End Processing with Gene-Nuclear Pore Association	CELL			English	Article							MESSENGER-RNA EXPORT; QUALITY-CONTROL; COTRANSCRIPTIONAL RECRUITMENT; TRANSCRIPTION ELONGATION; YEAST-CELLS; THO COMPLEX; MRNP; MEX67P; LOCALIZATION; SUB2P	During transcription, proteins assemble sequentially with nascent RNA to generate a messenger ribonucleoprotein particle (mRNP). The THO complex and its associated Sub2p helicase are functionally implicated in both transcription and mRNP biogenesis but their precise function remains elusive. We show here that THO/Sub2p mutation leads to the accumulation of a stalled intermediate in mRNP biogenesis that contains nuclear pore components and polyadenylation factors in association with chromatin. Microarray analyses of genomic loci that are aberrantly docked to the nuclear pore in mutants allowed the identification of approximately 400 novel validated target genes that require THO /Sub2p for efficient expression. Our data strongly suggests that the THO complex/Sub2p function is required to coordinate events leading to the acquisition of export competence at a step that follows commitment to 30-processing.	[Rougemaille, Mathieu; Kisseleva-Romanova, Elena; Gudipati, Rajani Kanth; Boulay, Jocelyne; Jensen, Torben Heick; Libri, Domenico] CNRS, Ctr Genet Mol, LEA Lab Nucl RNA Metab, UPR2167, F-91190 Gif Sur Yvette, France; [Dieppois, Guennaelle; Stutz, Francoise] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Lemoine, Sophie; Blugeon, Corinne; Devaux, Frederic] Ecole Normale Super, IFR36, F-75231 Paris, France; [Rougemaille, Mathieu; Gudipati, Rajani Kanth; Lemoine, Sophie; Blugeon, Corinne; Boulay, Jocelyne; Devaux, Frederic] Ecole Normale Super, CNRS, Genet Mol Lab, UMR8541, F-75006 Paris, France; [Rougemaille, Mathieu; Gudipati, Rajani Kanth; Boulay, Jocelyne; Jensen, Torben Heick; Libri, Domenico] Aarhus Univ, Dept Mol Biol, Ctr mRNP Biogenesis & Metab, DK-8000 Aarhus C, Denmark	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Geneva; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Aarhus University	Libri, D (corresponding author), CNRS, Ctr Genet Mol, LEA Lab Nucl RNA Metab, UPR2167, 1 Av Terrasse, F-91190 Gif Sur Yvette, France.	libri@cgm.cnrs-gif.fr	Jensen, Torben H/G-2954-2017; Stutz, Françoise C/N-4329-2017; DEVAUX, Frédéric/N-2288-2019	DEVAUX, Frédéric/0000-0002-0039-9096; Rougemaille, Mathieu/0000-0002-9675-3888; gudipati, Rajani Kanth/0000-0002-7364-9279				Abruzzi KC, 2006, EMBO J, V25, P4253, DOI 10.1038/sj.emboj.7601305; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Cui YJ, 2003, MOL CELL BIOL, V23, P7887, DOI 10.1128/MCB.23.21.7887-7901.2003; Daneholt B, 2001, P NATL ACAD SCI USA, V98, P7012, DOI 10.1073/pnas.111145498; Dieppois G, 2006, MOL CELL BIOL, V26, P7858, DOI 10.1128/MCB.00870-06; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gilbert W, 2004, MOL CELL, V13, P201, DOI 10.1016/S1097-2765(04)00030-9; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jensen TH, 2001, CURR BIOL, V11, P1711, DOI 10.1016/S0960-9822(01)00529-2; Jensen TH, 2004, MOL CELL, V16, P235, DOI 10.1016/j.molcel.2004.09.019; Jensen TH, 2003, MOL CELL, V11, P1129, DOI 10.1016/S1097-2765(03)00191-6; Jensen TH, 2001, MOL CELL, V7, P887, DOI 10.1016/S1097-2765(01)00232-5; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Koszul R, 2004, EMBO J, V23, P234, DOI 10.1038/sj.emboj.7600024; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; Lemoine S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-467; Libri D, 2001, GENE DEV, V15, P36, DOI 10.1101/gad.852101; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Luna R, 2005, MOL CELL, V18, P711, DOI 10.1016/j.molcel.2005.05.001; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Luthra R, 2007, J BIOL CHEM, V282, P3042, DOI 10.1074/jbc.M608741200; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mieczkowski PA, 2006, DNA REPAIR, V5, P1010, DOI 10.1016/j.dnarep.2006.05.027; Rehwinkel J, 2004, NAT STRUCT MOL BIOL, V11, P558, DOI 10.1038/nsmb759; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Rondon AG, 2003, J BIOL CHEM, V278, P39037, DOI 10.1074/jbc.M305718200; Rougemaille M, 2007, EMBO J, V26, P2317, DOI 10.1038/sj.emboj.7601669; Saguez C, 2008, MOL CELL, V31, P91, DOI 10.1016/j.molcel.2008.04.030; Santos-Rosa H, 1998, MOL CELL BIOL, V18, P6826, DOI 10.1128/MCB.18.11.6826; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; Schneiter R, 1999, MOL CELL BIOL, V19, P3415; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Thomsen R, 2003, RNA, V9, P1049, DOI 10.1261/rna.5170303; Voynov V, 2006, P NATL ACAD SCI USA, V103, P14423, DOI 10.1073/pnas.0606546103; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002	47	115	117	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					308	321		10.1016/j.cell.2008.08.005	http://dx.doi.org/10.1016/j.cell.2008.08.005			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957205	Bronze			2022-12-28	WOS:000260130400020
J	Frikh, R; Sedrati, O				Frikh, Rachid; Sedrati, Omar			Keratoacanthoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Frikh, Rachid; Sedrati, Omar] Mil Hosp Mohammed V, Rabat 10000, Morocco	Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat	Frikh, R (corresponding author), Mil Hosp Mohammed V, Rabat 10000, Morocco.			Frikh, Rachid/0000-0002-9676-5459					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2008	359	16					1717	1717		10.1056/NEJMicm073453	http://dx.doi.org/10.1056/NEJMicm073453			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360EY	18923174				2022-12-28	WOS:000260041400010
J	Ford, AC; Talley, NJ; van Zanten, SJOV; Vakil, NB; Simel, DL; Moayyedi, P				Ford, Alexander C.; Talley, Nicholas J.; van Zanten, Sander J. O. Veldhuyzen; Vakil, Nimish B.; Simel, David L.; Moayyedi, Paul			Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIFFERENT DIAGNOSTIC-CRITERIA; MANNINGS CRITERIA; PREVALENCE; ROME; CARE; QUESTIONNAIRE; DISORDERS; COMMUNITY; DISEASE; CANCER	Context Many individuals experience lower gastrointestinal tract symptoms, most commonly attributable to functional conditions. These individuals are frequently diagnosed with irritable bowel syndrome ( IBS) based on their symptoms; however, some may require additional testing or referral to specialists before this diagnosis is made. Objective To systematically review the literature of the accuracy of individual symptoms and combinations of findings in diagnosing IBS. Data Sources Search of MEDLINE and EMBASE ( up to June 2008) for prospective studies reporting on unselected cohorts of adult patients with lower gastrointestinal tract symptoms recorded before investigation. Study Selection Studies prospectively evaluating accuracy of individual symptoms or combinations of findings compared with results from investigations of the lower gastrointestinal tract. Data Extraction Two authors independently assessed studies and extracted data to estimate likelihood ratios ( LRs) of individual symptoms and combinations of findings in diagnosing IBS. Results Ten studies evaluating 2355 patients were identified, with a summary prevalence of IBS following investigation of 57%. Individual symptom items yielded positive LRs from 1.2 ( 95% confidence interval [ CI], 0.93- 1.6) for passage of mucus per rectum to 2.1 ( 95% CI, 1.4- 3.0) for looser stools at onset of abdominal pain and negative LRs from 0.29 ( 95% CI, 0.12- 0.72) for no lower abdominal pain to 0.88 ( 95% CI, 0.72- 1.1) for no passage of mucus per rectum in diagnosing IBS. The Manning criteria had a summary positive LR of 2.9 ( 95% CI, 1.3- 6.4) and a summary negative LR of 0.29 ( 95% CI, 0.12- 0.71). The Rome I criteria had a positive LR of 4.8 ( 95% CI, 3.6- 6.5) and a negative LR of 0.34 ( 95% CI, 0.29- 0.41). The Kruis scoring system provided a summary positive LR of 8.6 ( 95% CI, 2.9- 26.0) and a summary negative LR of 0.26 ( 95% CI, 0.17- 0.41). The Rome II and III criteria have not been studied. Conclusions Individual symptoms have limited accuracy for diagnosing IBS in patients referred with lower gastrointestinal tract symptoms. The accuracy of the Manning criteria and Kruis scoring system were only modest. Despite strong advocacy for use of the Rome criteria, only the Rome I classification has been validated. Future research should concentrate on validating existing diagnostic criteria or developing more accurate ways of predicting a diagnosis of IBS without the need for investigation of the lower gastrointestinal tract.	[Ford, Alexander C.; Moayyedi, Paul] McMaster Univ, Med Ctr, Div Gastroenterol, Hamilton, ON L8N 3Z5, Canada; [Talley, Nicholas J.] Mayo Clin, Dept Med, Jacksonville, FL 32224 USA; [van Zanten, Sander J. O. Veldhuyzen] Univ Alberta, Div Gastroenterol, Edmonton, AB, Canada; [Vakil, Nimish B.] Univ Wisconsin, Sch Med, Dept Med, Madison, WI USA; [Simel, David L.] Durham Vet Affairs Med Ctr, Dept Med, Durham, NC USA; [Simel, David L.] Duke Univ, Durham, NC USA	McMaster University; Mayo Clinic; University of Alberta; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Ford, AC (corresponding author), McMaster Univ, Med Ctr, Div Gastroenterol, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	alexf12399@yahoo.com	Ford, Alexander/K-5491-2012; Talley, Nicholas J/D-5399-2013; Moayyedi, Paul/M-6178-2014	Ford, Alexander/0000-0001-6371-4359; Talley, Nicholas J/0000-0003-2537-3092; Moayyedi, Paul/0000-0002-3616-9292				Agreus L, 2000, SCAND J GASTROENTERO, V35, P142; Amer College Gastroenterology Func, 2002, AM J GASTROENTEROL, V97, pS1; Aziz Q, 2000, J NEUROSCI, V20, P2657; Banerjee Rupa, 2005, Indian J Gastroenterol, V24, P164; BELLENTANI S, 1990, FAM PRACT, V7, P307, DOI 10.1093/fampra/7.4.307; Brown WH, 2003, J CLIN GASTROENTEROL, V36, P222, DOI 10.1097/00004836-200303000-00008; *COCHR COLL, 2007, COCHR METH GROUP SYS; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dogan UB, 1996, ACTA GASTRO-ENT BELG, V59, P225; Drossman D., 1990, GASTR INT, V3, P159; Drossman DA, 1999, GUT, V45, P1; Ford AC, 2008, GUT, V57, P1545, DOI 10.1136/gut.2008.159723; FRIGERIO G, 1992, DIGEST DIS SCI, V37, P164, DOI 10.1007/BF01308166; Golder M, 2003, LANCET, V361, P1945, DOI 10.1016/S0140-6736(03)13583-0; GROVER SA, 1993, JAMA-J AM MED ASSOC, V270, P2218, DOI 10.1001/jama.270.18.2218; Hammer J, 2004, GUT, V53, P666, DOI 10.1136/gut.2003.021857; Hammer J, 2008, J CLIN GASTROENTEROL, V42, P160, DOI 10.1097/MCG.0b013e3181574d48; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hillila MT, 2004, ALIMENT PHARM THERAP, V20, P339, DOI 10.1111/j.1365-2036.2004.02034.x; Howell S, 2004, AM J GASTROENTEROL, V99, P1572, DOI 10.1111/j.1572-0241.2004.40188.x; Hungin APS, 2003, ALIMENT PHARM THER, V17, P643, DOI 10.1046/j.1365-2036.2003.01456.x; Jeong Hyeok, 1993, Korean Journal of Internal Medicine (English Edition), V8, P34; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; JONES R, 1992, BRIT MED J, V304, P87, DOI 10.1136/bmj.304.6819.87; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Koloski NA, 2003, ALIMENT PHARM THER, V17, P841, DOI 10.1046/j.1365-2036.2003.01498.x; KRUIS W, 1984, GASTROENTEROLOGY, V87, P1; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; MANNING AP, 1978, BRIT MED J, V2, P653, DOI 10.1136/bmj.2.6138.653; MANOUSOS ON, 1967, BRIT MED J, V3, P762, DOI 10.1136/bmj.3.5568.762; Marshall JK, 2004, ALIMENT PHARM THER, V20, P1317, DOI 10.1111/j.1365-2036.2004.02284.x; May C, 2004, SOCIOL HEALTH ILL, V26, P135, DOI 10.1111/j.1467-9566.2004.00384.x; Mazumdar T N, 1988, Indian J Gastroenterol, V7, P101; MCKEE DP, 1993, DIGEST DIS SCI, V38, P1761, DOI 10.1007/BF01296097; Morini S, 2001, GASTROINTEST ENDOSC, V54, P175, DOI 10.1067/mge.2001.116565; Mouzas IA, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-8; Murff HJ, 2004, JAMA-J AM MED ASSOC, V292, P1480, DOI 10.1001/jama.292.12.1480; NAYLOR CD, 1994, JAMA-J AM MED ASSOC, V271, P1859, DOI 10.1001/jama.271.23.1859; Paterson WG, 1999, CAN MED ASSOC J, V161, P154; POYNARD T, 1992, EUR J GASTROEN HEPAT, V4, P747; Rao K P, 1993, J Assoc Physicians India, V41, P357; Rubin G, 2006, FAM PRACT, V23, P687, DOI 10.1093/fampra/cml050; Saito YA, 2000, AM J GASTROENTEROL, V95, P2816, DOI 10.1016/S0002-9270(00)01985-7; Scherer K, 2005, JAMA-J AM MED ASSOC, V293, P1906, DOI 10.1001/jama.293.15.1906; Simpson J, 2003, BRIT J SURG, V90, P899, DOI 10.1002/bjs.4277; SMITH RC, 1991, GASTROENTEROLOGY, V100, P591, DOI 10.1016/0016-5085(91)80002-Q; Sperber AD, 2005, NEUROGASTROENT MOTIL, V17, P207, DOI 10.1111/j.1365-2982.2005.00623.x; Spiller R, 2007, GUT, V56, P1770, DOI 10.1136/gut.2007.119446; TALLEY NJ, 1995, AM J EPIDEMIOL, V142, P76, DOI 10.1093/oxfordjournals.aje.a117548; TALLEY NJ, 1989, ANN INTERN MED, V111, P671, DOI 10.7326/0003-4819-111-8-671; Thompson WG, 1999, GUT, V45, P43; Thompson WG, 2002, DIGEST DIS SCI, V47, P225, DOI 10.1023/A:1013208713670; Thompson WG, 1997, EUR J GASTROEN HEPAT, V9, P689; Thompson WG, 2000, GUT, V46, P78, DOI 10.1136/gut.46.1.78; THOMPSON WG, 1982, DIGEST DIS SCI, V27, P605, DOI 10.1007/BF01297216; Tibble JA, 2002, GASTROENTEROLOGY, V123, P450, DOI 10.1053/gast.2002.34755; TRIMBLE KC, 1995, DIGEST DIS SCI, V40, P1607, DOI 10.1007/BF02212678; Wilson S, 2004, BRIT J GEN PRACT, V54, P495; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Woolthuis AHOK, 2004, SCAND J GASTROENTERO, V39, P17, DOI 10.1080/00855920410010942; Yawn BP, 2001, AM J MANAG CARE, V7, P585	61	78	81	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2008	300	15					1793	1805		10.1001/jama.300.15.1793	http://dx.doi.org/10.1001/jama.300.15.1793			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QA	18854541				2022-12-28	WOS:000260002000031
J	Escartin, J; Smith, DK; Cann, J; Schouten, H; Langmuir, CH; Escrig, S				Escartin, J.; Smith, D. K.; Cann, J.; Schouten, H.; Langmuir, C. H.; Escrig, S.			Central role of detachment faults in accretion of slow-spreading oceanic lithosphere	NATURE			English	Article							MID-ATLANTIC RIDGE; MICROEARTHQUAKE CHARACTERISTICS; HYDROTHERMAL FIELD; COMPLEXES; BENEATH; VALLEY; MODES	The formation of oceanic detachment faults is well established from inactive, corrugated fault planes exposed on sea floor formed along ridges spreading at less than 80 km Myr(-1) ( refs 1 - 4). These faults can accommodate extension for up to 1 - 3 Myr ( ref. 5), and are associated with one of the two contrasting modes of accretion operating along the northern Mid- Atlantic Ridge. The first mode is asymmetrical accretion involving an active detachment fault(6) along one ridge flank. The second mode is the well- known symmetrical accretion, dominated by magmatic processes with subsidiary high- angle faulting and the formation of abyssal hills on both flanks. Here we present an examination of similar to 2,500 km of the Mid- Atlantic Ridge between 12.5 and 35 degrees N, which reveals asymmetrical accretion along almost half of the ridge. Hydrothermal activity identified so far in the study region is closely associated with asymmetrical accretion, which also shows high levels of near-continuous hydroacoustically and teleseismically recorded seismicity. Increased seismicity is probably generated along detachment faults that accommodate a sizeable proportion of the total plate separation. In contrast, symmetrical segments have lower levels of seismicity, which occurs primarily at segment ends. Basalts erupted along asymmetrical segments have compositions that are consistent with crystallization at higher pressures than basalts from symmetrical segments, and with lower extents of partial melting of the mantle. Both seismic evidence and geochemical evidence indicate that the axial lithosphere is thicker and colder at asymmetrical sections of the ridge, either because associated hydrothermal circulation efficiently penetrates to greater depths or because the rising mantle is cooler. We suggest that much of the variability in sea- floor morphology, seismicity and basalt chemistry found along slow- spreading ridges can be thus attributed to the frequent involvement of detachment faults in oceanic lithospheric accretion.	[Escartin, J.] Inst Phys Globe, CNRS, Marine Geosci Grp, F-75252 Paris 05, France; [Smith, D. K.; Schouten, H.] Woods Hole Oceanog Inst, Geol & Geophys Dept, Woods Hole, MA 02543 USA; [Cann, J.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Langmuir, C. H.; Escrig, S.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Woods Hole Oceanographic Institution; University of Leeds; Harvard University	Escartin, J (corresponding author), Inst Phys Globe, CNRS, Marine Geosci Grp, 4 Pl Jussieu, F-75252 Paris 05, France.	escartin@ipgp.jussieu.fr	Escartin, Javier/B-3344-2008; ESCARTIN, Javier/A-1043-2010	ESCARTIN, Javier/0000-0002-3416-6856; Escrig, Stephane/0000-0002-7525-4000	CNRS; NSF; WHOI; Harvard University; University of Leeds; MIT	CNRS(Centre National de la Recherche Scientifique (CNRS)); NSF(National Science Foundation (NSF)); WHOI; Harvard University; University of Leeds; MIT	This work was carried out during a during a 16-month visit to Harvard University and MIT by J.E., and was supported by CNRS (J.E.), NSF (D.K. S., H.S., C.L. and S.E.), WHOI (J.E., D.K.S., H.S. and J.C.), Harvard University (J.E., C.L. and S. E.), University of Leeds (J.C.) and MIT (J.E.). We thank M. Cannat and J.P. Canales for discussions, and W.R. Buck and B. Ildefonse for reviews. This is IPGP contribution 2404.	Barclay AH, 2001, J GEOPHYS RES-SOL EA, V106, P2017, DOI 10.1029/2000JB900371; BATUEV BN, 1994, BRIDGE NEWSLETTER, V6, P6; Bel'tenev V., 2004, INTERRIDGE NEWS, V13, P5; BELTENEV V, 2005, INTERRIDGE NEWS, V14, P14; BELTENEV V, 2007, INTERRIDGE NEWS, V16, P1; Bohnenstiehl DR, 2002, TECTONOPHYSICS, V354, P49, DOI 10.1016/S0040-1951(02)00289-5; Boschi C, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001074; Boschi C, 2006, OFIOLITI, V31, P129; BOUGAULT H, 1988, EARTH PLANET SC LETT, V88, P27, DOI 10.1016/0012-821X(88)90043-X; Buck WR, 2005, NATURE, V434, P719, DOI 10.1038/nature03358; Canales JP, 2000, J GEOPHYS RES-SOL EA, V105, P28411, DOI 10.1029/2000JB900301; Cann JR, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000954; Cann JR, 1997, NATURE, V385, P329, DOI 10.1038/385329a0; Cannat M, 2006, GEOLOGY, V34, P605, DOI 10.1130/G22486.1; Carbotte S.M., 2004, EOS T AGU, V85, P553, DOI DOI 10.1029/2004E0510002; Davydov MP, 2007, DOKL EARTH SCI, V415, P954, DOI 10.1134/S1028334X07060281; deMartin BJ, 2007, GEOLOGY, V35, P711, DOI 10.1130/G23718A.1; DETRICK RS, 1986, GEOLOGY, V14, P1004; Escartin J, 1999, J GEOPHYS RES-SOL EA, V104, P10421, DOI 10.1029/1998JB900097; Fujiwara T, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000364; JAMES RH, 1995, GEOCHIM COSMOCHIM AC, V59, P651, DOI 10.1016/0016-7037(95)00003-I; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; KLEIN EM, 1989, J GEOPHYS RES-SOLID, V94, P4241, DOI 10.1029/JB094iB04p04241; KLINKHAMMER G, 1985, NATURE, V314, P727, DOI 10.1038/314727a0; KONG LSL, 1992, J GEOPHYS RES-SOL EA, V97, P1659, DOI 10.1029/91JB02566; LANGMUR CH, 2006, AGU GEOPHYS MONOGR S, V87; Lehnert K, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/1999GC000026; Lissenberg CJ, 2008, EARTH PLANET SC LETT, V271, P311, DOI 10.1016/j.epsl.2008.04.023; MACDONALD KC, 1977, GEOL SOC AM BULL, V88, P621, DOI 10.1130/0016-7606(1977)88<621:DSOTSO>2.0.CO;2; MCALISTER E, 1996, TECTONIC MAGMATIC HY, V118, P29; McCaig AM, 2007, GEOLOGY, V35, P935, DOI 10.1130/G23657A.1; Muller RD, 1997, J GEOPHYS RES-SOL EA, V102, P3211, DOI 10.1029/96JB01781; Okino K, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000793; RONA PA, 1986, NATURE, V321, P33, DOI 10.1038/321033a0; Smith BG, 1908, BIOL BULL-US, V15, P9, DOI 10.2307/1535560; Smith DK, 2006, NATURE, V442, P440, DOI 10.1038/nature04950; Smith DK, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001964; Smith DK, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013912; SU YJ, 2002, MID OCEAN RIDGE BASA; TOOMEY DR, 1985, J GEOPHYS RES-SOLID, V90, P5443, DOI 10.1029/JB090iB07p05443; Tucholke BE, 1998, J GEOPHYS RES-SOL EA, V103, P9857, DOI 10.1029/98JB00167; Tucholke BE, 2008, GEOLOGY, V36, P455, DOI 10.1130/G24639A.1; Wolfe CJ, 1995, J GEOPHYS RES-SOL EA, V100, P24449, DOI 10.1029/95JB02399	43	321	335	10	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2008	455	7214					790	U5		10.1038/nature07333	http://dx.doi.org/10.1038/nature07333			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18843367	Green Submitted			2022-12-28	WOS:000259854900045
J	Maze, JR; Stanwix, PL; Hodges, JS; Hong, S; Taylor, JM; Cappellaro, P; Jiang, L; Dutt, MVG; Togan, E; Zibrov, AS; Yacoby, A; Walsworth, RL; Lukin, MD				Maze, J. R.; Stanwix, P. L.; Hodges, J. S.; Hong, S.; Taylor, J. M.; Cappellaro, P.; Jiang, L.; Dutt, M. V. Gurudev; Togan, E.; Zibrov, A. S.; Yacoby, A.; Walsworth, R. L.; Lukin, M. D.			Nanoscale magnetic sensing with an individual electronic spin in diamond	NATURE			English	Article							COHERENT DYNAMICS; SINGLE; MAGNETOMETER; QUBITS	Detection of weak magnetic fields with nanoscale spatial resolution is an outstanding problem in the biological and physical sciences(1-5). For example, at a distance of 10 nm, the spin of a single electron produces a magnetic field of about 1 mu T, and the corresponding field from a single proton is a few nanoteslas. A sensor able to detect such magnetic fields with nanometre spatial resolution would enable powerful applications, ranging from the detection of magnetic resonance signals from individual electron or nuclear spins in complex biological molecules(5,6) to readout of classical or quantum bits of information encoded in an electron or nuclear spin memory(7). Here we experimentally demonstrate an approach to such nanoscale magnetic sensing, using coherent manipulation of an individual electronic spin qubit associated with a nitrogen- vacancy impurity in diamond at room temperature(8). Using an ultra- pure diamond sample, we achieve detection of 3 nT magnetic fields at kilohertz frequencies after 100 s of averaging. In addition, we demonstrate a sensitivity of 0.5 mu THz(-1/2) for a diamond nanocrystal with a diameter of 30 nm.	[Maze, J. R.; Hodges, J. S.; Hong, S.; Cappellaro, P.; Jiang, L.; Togan, E.; Zibrov, A. S.; Yacoby, A.; Walsworth, R. L.; Lukin, M. D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Stanwix, P. L.; Cappellaro, P.; Walsworth, R. L.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Hodges, J. S.] MIT, Dept Nucl Sci & Engn, Cambridge, MA 02139 USA; [Taylor, J. M.] MIT, Dept Phys, Cambridge, MA 02138 USA; [Dutt, M. V. Gurudev] Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA	Harvard University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	lukin@fas.harvard.edu	Stanwix, Paul L./H-5883-2014; Stanwix, Paul/A-5280-2009; Taylor, Jacob M/B-7826-2011; Cappellaro, Paola/B-1413-2010; Dutt, Gurudev/B-2889-2009; Hodges, Jonathan/G-1034-2010; Jiang, Liang/GVU-8654-2022; Zibrov, Alexander S/G-7419-2014; Jiang, Liang/A-9847-2008; Taylor, Jacob/O-1670-2019; Hong, Sungkun/D-3282-2014; Maze, Jeronimo/E-7422-2013	Stanwix, Paul L./0000-0002-7069-8569; Stanwix, Paul/0000-0002-7069-8569; Taylor, Jacob M/0000-0003-0493-5594; Cappellaro, Paola/0000-0003-3207-594X; Jiang, Liang/0000-0002-0000-9342; Jiang, Liang/0000-0002-0000-9342; Taylor, Jacob/0000-0003-0493-5594; Hong, Sungkun/0000-0003-0985-6641; Hodges, Jonathan/0000-0002-3487-6698; Maze, Jeronimo/0000-0003-0751-9182; Dutt, Gurudev/0000-0001-7426-9246	NSF; DARPA; Packard Foundation; Harvard CNS	NSF(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Packard Foundation(The David & Lucile Packard Foundation); Harvard CNS	We acknowledge A. Akimov, D. Budker, F. Jelezko, F. Koppens, A. Trifonov, P. Hemmer and J. Wratchtrup for many discussions and experimental assistance. This work was supported by the NSF, DARPA, the Packard Foundation and Harvard CNS.	Bending SJ, 1999, ADV PHYS, V48, P449, DOI 10.1080/000187399243437; Budker D., 2004, ATOMIC PHYS EXPLORAT; Budker D, 2007, NAT PHYS, V3, P227, DOI 10.1038/nphys566; Chang DE, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.053002; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; Cirac JI, 2000, NATURE, V404, P579, DOI 10.1038/35007021; DEGEN CL, 2008, SCANNING MAGNETIC FI; Gaebel T, 2006, NAT PHYS, V2, P408, DOI 10.1038/nphys318; Dutt MVG, 2007, SCIENCE, V316, P1312, DOI 10.1126/science.1139831; Hanson R, 2008, SCIENCE, V320, P352, DOI 10.1126/science.1155400; Hanson R, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.087601; Jelezko F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.130501; Jelezko F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076401; Jiang L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.073001; Kleiner R, 2004, P IEEE, V92, P1534, DOI 10.1109/JPROC.2004.833655; Kominis IK, 2003, NATURE, V422, P596, DOI 10.1038/nature01484; Ludlow AD, 2008, SCIENCE, V319, P1805, DOI 10.1126/science.1153341; Mamin HJ, 2007, NAT NANOTECHNOL, V2, P301, DOI 10.1038/nnano.2007.105; MAZE JR, 2008, ELECT SPIN DECOHEREN; OWSTON CN, 1967, J SCI INSTRUM, V44, P798, DOI 10.1088/0950-7671/44/9/441; Rabeau JR, 2007, NANO LETT, V7, P3433, DOI 10.1021/nl0719271; Rabeau JR, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2158700; RABI P, 2008, STRONG MAGNETIC COUP; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; TAYLOR J, 2008, IN PRESS NATURE; Treutlein P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.140403; Wrachtrup J, 2006, J PHYS-CONDENS MAT, V18, pS807, DOI 10.1088/0953-8984/18/21/S08	29	1293	1386	30	499	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2008	455	7213					644	U41		10.1038/nature07279	http://dx.doi.org/10.1038/nature07279			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833275				2022-12-28	WOS:000259639700042
J	Corkum, S; Cuervo, LG; Porras, A				Corkum, Sonya; Cuervo, Luis Gabriel; Porras, Analia		EVIPNET Amer Secretariat	EVIPNet Americas: informing policies with evidence	LANCET			English	Editorial Material									[Corkum, Sonya; Cuervo, Luis Gabriel; Porras, Analia; EVIPNET Amer Secretariat] WHO, Pan Amer Hlth Org, Washington, DC 20037 USA	Pan American Health Organization; World Health Organization	Corkum, S (corresponding author), WHO, Pan Amer Hlth Org, Washington, DC 20037 USA.	evipnet@paho.org	Cuervo, Luis Gabriel/A-9464-2009	Cuervo, Luis Gabriel/0000-0003-2732-5019; Porras, Analia/0000-0003-1831-4625				Chalmers I, 2005, EVID POLICY, V1, P227, DOI DOI 10.1332/1744264053730806; Hamid M, 2005, LANCET, V366, P1758, DOI 10.1016/S0140-6736(05)67709-4; Lavis JN, 2004, LANCET, V364, P1615, DOI 10.1016/S0140-6736(04)17317-0; Lavis John, 2005, J Health Serv Res Policy, V10 Suppl 1, P35, DOI 10.1258/1355819054308549; *MIN HLTH AM, 2007, HLTH AG AM 2008 2012; *MIN SUMM HLTH RES, 2004, MEX STAT HLTH RES KN; *PAN AM HLTH ORG, 2007, PROP STRAT PLAN 2008; The Commission on Health Research for Development, 1990, HLTH RES ESS LINK EQ; World Health Organization, 2004, WORLD REP KNOWL BETT; *WORLD HLTH ASS, 2005, MIN SUMM HLTH RES WH	10	18	19	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2008	372	9644					1130	1131						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	355UN	18926261				2022-12-28	WOS:000259734700008
J	Li, W; Zhou, XB; Lock, R; Patchkovskii, S; Stolow, A; Kapteyn, HC; Murnane, MM				Li, Wen; Zhou, Xibin; Lock, Robynne; Patchkovskii, Serguei; Stolow, Albert; Kapteyn, Henry C.; Murnane, Margaret M.			Time-Resolved Dynamics in N2O4 Probed Using High Harmonic Generation	SCIENCE			English	Article							PHOTOELECTRON-SPECTROSCOPY; DINITROGEN TETROXIDE; LASER FIELDS; RARE-GASES; DIFFRACTION; IONIZATION; RADIATION; MOLECULES	The attosecond time- scale electron- recollision process that underlies high harmonic generation has uncovered extremely rapid electronic dynamics in atoms and diatomics. We showed that high harmonic generation can reveal coupled electronic and nuclear dynamics in polyatomic molecules. By exciting large amplitude vibrations in dinitrogen tetraoxide, we showed that tunnel ionization accesses the ground state of the ion at the outer turning point of the vibration but populates the first excited state at the inner turning point. This state- switching mechanism is manifested as bursts of high harmonic light that is emitted mostly at the outer turning point. Theoretical calculations attribute the large modulation to suppressed emission from the first excited state of the ion. More broadly, these results show that high harmonic generation and strong- field ionization in polyatomic molecules undergoing bonding or configurational changes involve the participation of multiple molecular orbitals.	[Li, Wen; Zhou, Xibin; Lock, Robynne; Kapteyn, Henry C.; Murnane, Margaret M.] Univ Colorado, JILA, Boulder, CO 80309 USA; [Li, Wen; Zhou, Xibin; Lock, Robynne; Kapteyn, Henry C.; Murnane, Margaret M.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Li, Wen; Zhou, Xibin; Lock, Robynne; Kapteyn, Henry C.; Murnane, Margaret M.] Natl Inst Stand & Technol, Boulder, CO 80309 USA; [Patchkovskii, Serguei; Stolow, Albert] Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON K1A 0R6, Canada	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA; National Research Council Canada	Li, W (corresponding author), Univ Colorado, JILA, Boulder, CO 80309 USA.	wli@jila.colorado.edu	Kapteyn, Henry C/H-6559-2011; Stolow, Albert/AAN-5609-2020; Zhou, Xibin/B-5544-2009; Zhou, Xibin/C-1316-2011	Kapteyn, Henry C/0000-0001-8386-6317; Li, Wen/0000-0002-3721-4008	U. S. Department of Energy Office of Basic Energy Sciences; NSF Physics Frontier Centers	U. S. Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF Physics Frontier Centers(National Science Foundation (NSF))	The authors thank M. Ivanov and O. Smirnova for helpful discussions. They also gratefully acknowledge support for this work from the U. S. Department of Energy Office of Basic Energy Sciences and the NSF Physics Frontier Centers and the use of facilities from the NSF Engineering Research Center on EUV Science and Technology.	AMMOSOV MV, 1986, ZH EKSP TEOR FIZ+, V91, P2008; Baker S, 2006, SCIENCE, V312, P424, DOI 10.1126/science.1123904; Blanchet V, 1999, NATURE, V401, P52, DOI 10.1038/43410; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; FERRAY M, 1988, J PHYS B-AT MOL OPT, V21, pL31, DOI 10.1088/0953-4075/21/3/001; GAN TH, 1977, J CHEM SOC FARAD T 2, V73, P1459, DOI 10.1039/f29777301459; Gessner O, 2006, SCIENCE, V311, P219, DOI 10.1126/science.1120779; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; Kapteyn H, 2007, SCIENCE, V317, P775, DOI 10.1126/science.1143679; KULANDER KC, 1993, SUPER INTENSE LASER, V316, P95; KVICK A, 1982, J CHEM PHYS, V76, P3754, DOI 10.1063/1.443414; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; Lezius M, 2002, J CHEM PHYS, V117, P1575, DOI 10.1063/1.1487823; MAIRESSE Y, 2008, 11 INT C MULT PROC M, pFR62; MCPHERSON A, 1987, J OPT SOC AM B, V4, P595, DOI 10.1364/JOSAB.4.000595; Meckel M, 2008, SCIENCE, V320, P1478, DOI 10.1126/science.1157980; Patchkovskii S, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2711809; Santra R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.073906; SMIRNOVA O, 2008, 11 INT C MULT PROC M, P7; Smits M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.203402; Stolow A, 2004, CHEM REV, V104, P1719, DOI 10.1021/cr020683w; Stolow A, 2008, ADV CHEM PHYS, V139, P497, DOI 10.1002/9780470259498.ch6; Tong XM, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.033402; Wagner NL, 2006, P NATL ACAD SCI USA, V103, P13279, DOI 10.1073/pnas.0605178103; Walters ZB, 2007, J PHYS B-AT MOL OPT, V40, pF277, DOI 10.1088/0953-4075/40/18/F01; Zhou XB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.073902	26	277	278	5	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1207	1211		10.1126/science.1163077	http://dx.doi.org/10.1126/science.1163077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	18974317				2022-12-28	WOS:000261033400031
J	Xiao, SY; Kohrman, M				Xiao, Shuiyuan; Kohrman, Matthew			Anthropology in China's health promotion and tobacco	LANCET			English	Editorial Material									[Xiao, Shuiyuan] Cent S Univ, Sch Publ Hlth, Xiangya Med Sch, Changsha 410078, Hunan, Peoples R China; [Kohrman, Matthew] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA	Central South University; Stanford University	Xiao, SY (corresponding author), Cent S Univ, Sch Publ Hlth, Xiangya Med Sch, Changsha 410078, Hunan, Peoples R China.	xiaosy@gmail.com						Baer Hans, 2004, MED ANTHR WORLD SYST; BENEDICT C, 2008, ANN M AM HIST ASS WA; *CHIN ASS SMOK HLT, 2004, NEWSL CHIN SMOK HLTH, V62, P7; Frieden TR, 2007, LANCET, V369, P1758, DOI 10.1016/S0140-6736(07)60782-X; Hu TW, 2008, SER CONTEMP CHINA, V12, P189; Kohrman M, 2007, CHINA J, V58, P85, DOI 10.1086/tcj.58.20066308; LI XS, 1999, LAO PIAOZHENG; MACKAY J, 2006, TOBACCO ATLAS, P85; Peto R, 2004, TOBACCO PUBLIC HLTH, P281; RONG G, 2004, YANBIAO SHOUCANG YU	10	14	14	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 8	2008	372	9650					1617	1618		10.1016/S0140-6736(08)61361-6	http://dx.doi.org/10.1016/S0140-6736(08)61361-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18930530				2022-12-28	WOS:000260899900009
J	Bouzigon, E; Corda, E; Aschard, H; Dizier, MH; Boland, A; Bousquet, J; Chateigner, N; Gormand, F; Just, J; Le Moual, N; Scheinmann, P; Siroux, V; Vervloet, D; Zelenika, D; Pin, I; Kauffmann, F; Lathrop, M; Demenais, F				Bouzigon, Emmanuelle; Corda, Eve; Aschard, Hugues; Dizier, Marie-Helene; Boland, Anne; Bousquet, Jean; Chateigner, Nicolas; Gormand, Frederic; Just, Jocelyne; Le Moual, Nicole; Scheinmann, Pierre; Siroux, Valerie; Vervloet, Daniel; Zelenika, Diana; Pin, Isabelle; Kauffmann, Francine; Lathrop, Mark; Demenais, Florence			Effect of 17q21 Variants and Smoking Exposure in Early-Onset Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; CHILDHOOD ASTHMA; BRONCHIAL HYPERRESPONSIVENESS; ORMDL3 EXPRESSION; CHILDRENS HEALTH; LUNG-FUNCTION; GENE; ASSOCIATION; LIFE; POLYMORPHISM	Background: A genomewide association study has shown an association between variants at chromosome 17q21 and an increased risk of asthma. To elucidate the relationship between this locus and disease, we examined a large, family-based data set that included extensive phenotypic and environmental data from the Epidemiological Study on the Genetics and Environment of Asthma. Methods: We tested 36 single-nucleotide polymorphisms (SNPs) in the 17q21 region in 1511 subjects from 372 families for an association with asthma. We also tested for genetic heterogeneity according to the age at the onset of asthma and exposure to environmental tobacco smoke in early life. Results: Eleven SNPs were significantly associated with asthma (P<0.01), of which three (rs8069176, rs2305480, and rs4795400) were strongly associated (P<0.001). Ordered-subset regression analysis led us to select an onset at 4 years of age or younger to classify patients as having early-onset asthma. Association with early-onset asthma was highly significant (P<10(-5) for four SNPs), whereas no association was found with late-onset asthma. With respect to exposure to environmental tobacco smoke in early life, we observed a significant association with early-onset asthma only in exposed subjects (P<5 x 10(-5) for six SNPs). Under the best-fitting recessive model, homozygous status (GG) at the most strongly associated SNP (rs8069176) conferred an increase in risk by a factor of 2.9, as compared with other genotypes (AG and AA) in the group exposed to environmental tobacco smoke (P=2.8 x 10(-6); P=0.006 for the test for heterogeneity of the SNP effect on early-onset asthma between groups with tobacco exposure and those without such exposure). Conclusions: This study shows that the increased risk of asthma conferred by 17q21 genetic variants is restricted to early-onset asthma and that the risk is further increased by early-life exposure to environmental tobacco smoke. These findings provide a greater understanding of the functional role of the 17q21 variants in the pathophysiology of asthma.	[Bouzigon, Emmanuelle; Corda, Eve; Aschard, Hugues; Chateigner, Nicolas; Lathrop, Mark; Demenais, Florence] Fdn Jean Dausset, CEPH, INSERM, U794, F-75010 Paris, France; [Bouzigon, Emmanuelle; Aschard, Hugues; Chateigner, Nicolas; Demenais, Florence] Univ Evry, Evry, France; [Dizier, Marie-Helene] INSERM, U535, Villejuif, France; [Dizier, Marie-Helene; Le Moual, Nicole; Kauffmann, Francine] Univ Paris 11, Villejuif, France; [Boland, Anne; Zelenika, Diana; Lathrop, Mark] Ctr Natl Genotypage, CEA, Inst Genom, Evry, France; [Bousquet, Jean] Hop Arnaud de Villeneuve, Montpellier, France; [Gormand, Frederic] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France; [Just, Jocelyne] Hop Enfants Armand Trousseau, Paris, France; [Le Moual, Nicole; Kauffmann, Francine] INSERM, U780, Villejuif, France; [Scheinmann, Pierre] Hop Necker Enfants Malad, Paris, France; [Siroux, Valerie; Pin, Isabelle] INSERM, U823, Grenoble, France; [Vervloet, Daniel] Hop St Marguerite, Marseille, France; [Pin, Isabelle] CHU Grenoble, F-38043 Grenoble, France	Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Universite de Montpellier; CHU de Montpellier; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Demenais, F (corresponding author), Fdn Jean Dausset, CEPH, INSERM, U794, 27 Rue Juliette Dodu, F-75010 Paris, France.	demenais@inserm.fr	Le Moual, Nicole/GNP-5114-2022; siroux, valerie/N-1865-2013; Bouzigon, Emmanuelle/L-2766-2017; GORMAND, FREDERIC/I-1414-2017; PIN, Isabelle/N-3020-2013; Le Moual, Nicole/R-8976-2016; Dizier, Marie-Hélène/K-8463-2018; Demenais, Florence/G-3298-2013	Le Moual, Nicole/0000-0002-2723-5569; siroux, valerie/0000-0001-7329-7237; Bouzigon, Emmanuelle/0000-0001-5756-4286; Le Moual, Nicole/0000-0002-2723-5569; Dizier, Marie-Hélène/0000-0001-8460-7667; Demenais, Florence/0000-0001-8361-0936	INSERM; French Ministry of Higher Education and Research; University of Evry; French Agency for Environmental and Occupational Health Safety; Afsset-APR-SE-2004; French National Agency for Research [ANR 05-SEST-020-02/05-9-97, ANR 06-CEBS]; European Commission as part of the Global Allergy and Asthma European Network [FOOD-CT-2004-506378]; GABRIEL consortium; Glaxo SmithKline; Stallergenes; Allerbio; Astra Zeneca; UCB	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Ministry of Higher Education and Research; University of Evry; French Agency for Environmental and Occupational Health Safety; Afsset-APR-SE-2004; French National Agency for Research(French National Research Agency (ANR)); European Commission as part of the Global Allergy and Asthma European Network(European CommissionEuropean Commission Joint Research Centre); GABRIEL consortium; Glaxo SmithKline(GlaxoSmithKline); Stallergenes; Allerbio; Astra Zeneca(AstraZeneca); UCB(UCB Pharma SA)	Supported by INSERM, the French Ministry of Higher Education and Research, and the University of Evry and by grants from the French Agency for Environmental and Occupational Health Safety (Afsset-APR-SE-2004), the French National Agency for Research (ANR 05-SEST-020-02/05-9-97 and ANR 06-CEBS), and the European Commission as part of the Global Allergy and Asthma European Network (FOOD-CT-2004-506378) and the GABRIEL consortium (a multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community; HEALTH-LSH-2005-018996). Dr. Vervloet reports receiving lecture fees from Glaxo SmithKline, Stallergenes, and Allerbio and consulting fees from Astra Zeneca, GlaxoSmithKline, Allerbio, and UCB. No other potential conflict of interest relevant to this article was reported.	Barrett R, 2008, J MOTOR BEHAV, V40, P62, DOI 10.3200/JMBR.40.1.62-70; Choudhry S, 2005, AM J RESP CRIT CARE, V172, P173, DOI 10.1164/rccm.200409-1232OC; Colilla S, 2003, J ALLERGY CLIN IMMUN, V111, P840, DOI 10.1067/mai.2003.170; DiFranza JR, 2004, PEDIATRICS, V113, P1007; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dizier MH, 2007, EUR J HUM GENET, V15, P810, DOI 10.1038/sj.ejhg.5201830; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Hashimoto Shu, 2008, Allergol Int, V57, P21, DOI 10.2332/allergolint.R-07-156; Hirota T, 2008, J ALLERGY CLIN IMMUN, V121, P769, DOI 10.1016/j.jaci.2007.09.038; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Holgate ST, 2007, EUR RESPIR J, V29, P793, DOI 10.1183/09031936.00087506; Kabesch M, 2004, THORAX, V59, P569, DOI 10.1136/thx.2003.016667; Katoh M, 2003, INT J MOL MED, V12, P399; Kauffmann F, 1997, AM J RESP CRIT CARE, V156, pS123, DOI 10.1164/ajrccm.156.4.12tac9; Kurukulaaratchy RJ, 2004, PEDIATRICS, V113, P345, DOI 10.1542/peds.113.2.345; Kurukulaaratchy RJ, 2003, CLIN EXP ALLERGY, V33, P573, DOI 10.1046/j.1365-2222.2003.01657.x; Li MY, 2006, AM J HUM GENET, V78, P778, DOI 10.1086/503711; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Lowe LA, 2005, AM J RESP CRIT CARE, V171, P231, DOI 10.1164/rccm.200406-695OC; Madore AM, 2008, HUM GENET, V123, P93, DOI 10.1007/s00439-007-0444-x; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Meyers DA, 2005, J ALLERGY CLIN IMMUN, V115, P1169, DOI 10.1016/j.jaci.2005.01.070; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; Pattaro C, 2007, J CLIN EPIDEMIOL, V60, P704, DOI 10.1016/j.jclinepi.2006.10.010; Salam MT, 2004, ENVIRON HEALTH PERSP, V112, P760, DOI 10.1289/ehp.6662; Schmitt C, 2002, APOPTOSIS, V7, P277, DOI 10.1023/A:1015372322419; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Simpson A, 2005, AM J RESP CRIT CARE, V172, P55, DOI 10.1164/rccm.200412-1708OC; Siroux V, 2004, EUR J EPIDEMIOL, V19, P841, DOI 10.1023/B:EJEP.0000040528.89863.59; Stein Renato T, 2004, Paediatr Respir Rev, V5, P155, DOI 10.1016/j.prrv.2004.01.007; Tamura M, 2007, GENOMICS, V89, P618, DOI 10.1016/j.ygeno.2007.01.003; Tavendale R, 2008, J ALLERGY CLIN IMMUN, V121, P860, DOI 10.1016/j.jaci.2008.01.015; Toren K, 2006, J CLIN EPIDEMIOL, V59, P90, DOI 10.1016/j.jclinepi.2005.03.019; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Wang ZX, 2001, AM J RESP CRIT CARE, V163, P1404, DOI 10.1164/ajrccm.163.6.2001101; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Zeiger RS, 1999, J ALLERGY CLIN IMMUN, V103, P376, DOI 10.1016/S0091-6749(99)70460-4	38	275	285	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					1985	1994		10.1056/NEJMoa0806604	http://dx.doi.org/10.1056/NEJMoa0806604			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368OW	18923164				2022-12-28	WOS:000260632700003
J	Nash, DT; Nash, SD				Nash, David T.; Nash, Stephen D.			Ranolazine for chronic stable angina	LANCET			English	Article							LIFE-STYLE CHANGES; GENDER-DIFFERENCES; ANTIANGINAL AGENT; CORONARY; EFFICACY; PHARMACOKINETICS; POPULATION; IMPAIRMENT; AMLODIPINE; DILTIAZEM	Ranolazine is a new and unique antianginal drug that has been approved for the treatment of chronic stable angina pectoris. The drug is administered as a sustained-release formulation. Although the drug's mechanism of action has not been fully elucidated, current thinking is that ranolazine, a selective inhibitor of late sodium influx, attenuates the abnormalities of ventricular repolarisation and contractility associated with ischaemia. Three randomised trials have shown efficacy for ranolazine in increasing exercise testing or reducing anginal episodes or use of glyceryl trinitrate. Side-effects include dizziness, constipation, nausea, and the potential for prolongation of the QT interval. Ranolazine seems to be a safe addition to current traditional drugs for chronic stable angina, especially in aggressive multidrug regimens.	[Nash, David T.; Nash, Stephen D.] Syracuse Prevent Cardiol, Syracuse, NY 13202 USA		Nash, DT (corresponding author), Syracuse Prevent Cardiol, 600 E Genesee St, Syracuse, NY 13202 USA.	Davidtnash@aol.com						Abdallah H, 2005, J CLIN PHARMACOL, V45, P802, DOI 10.1177/0091270005276739; Belardinelli L, 2005, HEART RHYTHM, V2, pS16, DOI 10.1016/j.hrthm.2004.10.032; Belardinelli L, 2004, EUR HEART J SUPPL, V6, pI3, DOI 10.1093/eurheartj/6.suppl_i.i3; Bers DM, 2003, CARDIOVASC RES, V57, P897, DOI 10.1016/S0008-6363(02)00656-9; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Chaitman BR, 2004, J AM COLL CARDIOL, V43, P1375, DOI 10.1016/j.jacc.2003.11.045; Chaitman BR, 2004, JAMA-J AM MED ASSOC, V291, P309, DOI 10.1001/jama.291.3.309; *CV THER, 2006, RAN; *CV THER INC, 2006, RANEXATM RAN EXT REL; Daly C, 2006, CIRCULATION, V113, P490, DOI 10.1161/CIRCULATIONAHA.105.561647; Fraser H, 2006, J MOL CELL CARDIOL, V41, P1031, DOI 10.1016/j.yjmcc.2006.08.012; Hale SL, 2006, J PHARMACOL EXP THER, V318, P418, DOI 10.1124/jpet.106.103242; Heberden W, 1987, CLIN CARDIOL, V10, P211, DOI [10.1002/clc.4960100314, DOI 10.1002/CLC.4960100314]; HEMMINGWAY H, 2006, JAMA-J AM MED ASSOC, V295, P1401; Holubkov R, 2002, AM HEART J, V144, P826, DOI 10.1067/mhj.2002.125505; Jerling M, 2006, CLIN PHARMACOKINET, V45, P469, DOI 10.2165/00003088-200645050-00003; Jerling M, 2005, CLIN PHARMACOL THER, V78, P288, DOI 10.1016/j.clpt.2005.05.004; Jerling M, 2005, J CLIN PHARMACOL, V45, P422, DOI 10.1177/0091270004273992; Koren MJ, 2007, J AM COLL CARDIOL, V49, P1027, DOI 10.1016/j.jacc.2006.10.067; Loscalzo J, 2008, CIRCULATION, V117, P4, DOI 10.1161/CIRCULATIONAHA.107.755710; MacInnes A, 2003, CIRC RES, V93, pE26, DOI 10.1161/01.RES.0000086943.72932.71; MARK DB, 1987, ANN INTERN MED, V106, P793, DOI 10.7326/0003-4819-106-6-793; MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204; Morrow DA, 2007, JAMA-J AM MED ASSOC, V297, P1775, DOI 10.1001/jama.297.16.1775; Murphy E, 1999, CIRC RES, V84, P1469; Norris Colleen M, 2004, Health Qual Life Outcomes, V2, P21, DOI 10.1186/1477-7525-2-21; Ornish D, 1998, AM J CARDIOL, V82, p72T; ORNISH D, 1990, LANCET, V336, P129, DOI 10.1016/0140-6736(90)91656-U; Pepine CJ, 1999, AM J CARDIOL, V84, P46, DOI 10.1016/S0002-9149(99)00190-3; PEPINE CJ, 1994, AM J CARDIOL, V74, P226, DOI 10.1016/0002-9149(94)90361-1; Richardson J, 2003, DISABIL REHABIL, V25, P973, DOI 10.1080/0963828031000122294; Rosamond W, 2008, HEART DIS STROKE STA, pe53; Rousseau MF, 2005, AM J CARDIOL, V95, P311, DOI 10.1016/j.amjcard.2004.09.025; Scirica BM, 2007, CIRCULATION, V116, P1647, DOI 10.1161/CIRCULATIONAHA.107.724880; Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502; Song YJ, 2004, J CARDIOVASC PHARM, V44, P192, DOI 10.1097/00005344-200408000-00008; Stone PH, 2006, J AM COLL CARDIOL, V48, P566, DOI 10.1016/j.jacc.2006.05.044; Thomas EJ, 2000, BRIT MED J, V320, P741, DOI 10.1136/bmj.320.7237.741; Wenger NK, 2007, AM J CARDIOL, V99, P11, DOI 10.1016/j.amjcard.2006.07.052; Wenger NK, 2003, PROG CARDIOVASC DIS, V46, P199, DOI 10.1016/j.pcad.2003.08.003; Wu L, 2004, J PHARMACOL EXP THER, V310, P599, DOI 10.1124/jpet.104.066100; 2007, PHYS DESK REFERENCE, P1035	42	51	58	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2008	372	9646					1335	1341		10.1016/S0140-6736(08)61554-8	http://dx.doi.org/10.1016/S0140-6736(08)61554-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18929905				2022-12-28	WOS:000260060500033
J	van der Ploeg, AT; Reuser, AJJ				van der Ploeg, Ans T.; Reuser, Arnold J. J.			Lysosomal storage disease 2 - Pompe's disease	LANCET			English	Review							ACID-ALPHA-GLUCOSIDASE; ENZYME-REPLACEMENT THERAPY; GLYCOGENOSIS TYPE-II; DRIED BLOOD SPOTS; GENOTYPE-PHENOTYPE CORRELATION; DIRECT MULTIPLEX ASSAY; HIGH-LEVEL PRODUCTION; KNOCKOUT MOUSE MODEL; MALTASE DEFICIENCY; SKELETAL-MUSCLE	Pompe's disease, glycogen-storage disease type II, and acid maltase deficiency are alternative names for the same metabolic disorder. It is a pan-ethnic autosomal recessive trait characterised by acid alpha-glucosidase deficiency leading to lysosomal glycogen storage. Pompe's disease is also regarded as a muscular disorder, but the generalised storage of glycogen causes more than mobility and respiratory problems. The clinical spectrum is continuous and broad. First symptoms can present in infants, children, and adults. Cardiac hypertrophy is a key feature of classic infantile Pompe's disease. For a long time, there was no means to stop disease progression, but the approval of enzyme replacement therapy has substantially changed the prospects for patients. With this new development, the disease is now among the small but increasing number of lysosomal storage disorders, for which treatment has become a reality. This review is meant to raise general awareness, to present and discuss the latest insights in disease pathophysiology, and to draw attention to new developments about diagnosis and care. We also discuss the developments that led to the approval of enzyme replacement therapy with recombinant human alpha-glucosidase from Chinese hamster ovary cells (alglucosidase alfa) by the US Food and Drug Administration and European Medicines Agency in 2006, and review clinical practice.	[van der Ploeg, Ans T.] Sophia Childrens Univ Hosp, Erasmus MC, Univ Med Ctr, Dept Paediat,Div Metab Dis & Genet, NL-3015 GJ Rotterdam, Netherlands; [Reuser, Arnold J. J.] Erasmus MC, Dept Clin Genet, Univ Med Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC	van der Ploeg, AT (corresponding author), Sophia Childrens Univ Hosp, Erasmus MC, Univ Med Ctr, Dept Paediat,Div Metab Dis & Genet, Dr Molewaterpl 60, NL-3015 GJ Rotterdam, Netherlands.	a.vanderploeg@erasmusmc.nl						Amalfitano A, 1999, P NATL ACAD SCI USA, V96, P8861, DOI 10.1073/pnas.96.16.8861; Amalfitano A, 2001, GENET MED, V3, P132, DOI 10.1097/00125817-200103000-00008; [Anonymous], [No title captured]; Ansong AK, 2006, GENET MED, V8, P297, DOI 10.1097/01.gim.0000195896.04069.5f; ASHWELL G, 1974, ADV ENZYMOL RAMB, V41, P99; Ausems MGEM, 1999, EUR J HUM GENET, V7, P713, DOI 10.1038/sj.ejhg.5200367; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; BARTON NW, 1990, P NATL ACAD SCI USA, V87, P1913, DOI 10.1073/pnas.87.5.1913; BAUDHUIN P, 1964, LAB INVEST, V13, P1139; Becker JA, 1998, AM J HUM GENET, V62, P991, DOI 10.1086/301788; Bembi B, 2003, J INHERIT METAB DIS, V26, P675, DOI 10.1023/B:BOLI.0000005618.76542.ed; BESANCON AM, 1985, CLIN GENET, V27, P479; Bijvoet AGA, 1999, HUM MOL GENET, V8, P2145, DOI 10.1093/hmg/8.12.2145; Bijvoet AGA, 1998, HUM MOL GENET, V7, P1815, DOI 10.1093/hmg/7.11.1815; Bijvoet AGA, 1998, HUM MOL GENET, V7, P53, DOI 10.1093/hmg/7.1.53; Bijvoet AGA, 1999, J PATHOL, V189, P416, DOI 10.1002/(SICI)1096-9896(199911)189:3<416::AID-PATH445>3.0.CO;2-6; BOERKOEL CF, 1995, AM J HUM GENET, V56, P887; BRAUNSDORF WE, 1987, NEUROSURGERY, V21, P748, DOI 10.1227/00006123-198711000-00030; Case LE, 2007, PEDIATR RADIOL, V37, P437, DOI 10.1007/s00247-007-0428-y; Chamoles NA, 2004, CLIN CHIM ACTA, V347, P97, DOI 10.1016/j.cccn.2004.04.009; Cook AL, 2006, GENET MED, V8, P313, DOI 10.1097/01.gim.0000217786.79173.a8; Cresawn KO, 2005, HUM GENE THER, V16, P68, DOI 10.1089/hum.2005.16.68; Dagnino F, 2000, HUM HERED, V50, P331, DOI 10.1159/000022938; Drost MR, 2005, J BIOMECH, V38, P1035, DOI 10.1016/j.jbiomech.2004.05.040; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; ENGEL AG, 1973, NEUROLOGY, V23, P95, DOI 10.1212/WNL.23.1.95; ENGEL AG, 1970, NEUROLOGY, V20, P382; FRATANTONI JC, 1968, SCIENCE, V162, P570, DOI 10.1126/science.162.3853.570; Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807; Fukuda T, 2006, MOL THER, V14, P831, DOI 10.1016/j.ymthe.2006.08.009; Fukuda T, 2006, AUTOPHAGY, V2, P318, DOI 10.4161/auto.2984; Fuller M, 1995, EUR J BIOCHEM, V234, P903, DOI 10.1111/j.1432-1033.1995.903_a.x; Gelb MH, 2006, J INHERIT METAB DIS, V29, P397, DOI 10.1007/s10545-006-0265-4; GILLETTE PC, 1974, AM J DIS CHILD, V128, P622, DOI 10.1001/archpedi.1974.02110300032005; Grabowski GA, 2004, J PEDIATR-US, V144, pS15, DOI 10.1016/j.jpeds.2004.01.050; GRABOWSKI GA, 1995, ANN INTERN MED, V122, P33, DOI 10.7326/0003-4819-122-1-199501010-00005; Hagemans MLC, 2006, NEUROLOGY, V66, P581, DOI 10.1212/01.wnl.0000198776.53007.2c; Hagemans MLC, 2005, NEUROLOGY, V64, P2139, DOI 10.1212/01.WNL.0000165979.46537.56; Hagemans MLC, 2005, BRAIN, V128, P671, DOI 10.1093/brain/awh384; Harmatz P, 2004, J PEDIATR-US, V144, P574, DOI 10.1016/j.jpeds.2004.03.018; Harmatz P, 2006, J PEDIATR-US, V148, P533, DOI 10.1016/j.jpeds.2005.12.014; HASILIK A, 1980, J BIOL CHEM, V255, P4946; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HERMANS MMP, 1994, HUM MOL GENET, V3, P2213, DOI 10.1093/hmg/3.12.2213; Hermans MMP, 2004, HUM MUTAT, V23, P47, DOI 10.1002/humu.10286; HERS HG, 1963, BIOCHEM J, V86, P11, DOI 10.1042/bj0860011; Hesselink RP, 2006, MUSCLE NERVE, V33, P505, DOI 10.1002/mus.20482; Hesselink RP, 2002, MUSCLE NERVE, V25, P873, DOI 10.1002/mus.10125; Hirschhorn R, 2001, METABOLIC MOL BASES, P3389; HOEFSLOOT LH, 1988, EMBO J, V7, P1697, DOI 10.1002/j.1460-2075.1988.tb02998.x; Howell RR, 2006, GENET MED, V8, P289, DOI 10.1097/01.gim.0000204462.42910.b8; HUG G, 1967, J CELL BIOL, V35, pC1, DOI 10.1083/jcb.35.1.C1; HUIE ML, 1994, HUM MOL GENET, V3, P2231; HUIE ML, 1994, HUM MOL GENET, V3, P1081, DOI 10.1093/hmg/3.7.1081; Huie ML, 2002, AM J HUM GENET, V70, P1054, DOI 10.1086/339691; Hunley TE, 2004, PEDIATRICS, V114, pE532, DOI 10.1542/peds.2003-0988-L; Ing RJ, 2004, PEDIATR ANESTH, V14, P514, DOI 10.1111/j.1460-9592.2004.01242.x; Ioannou Y. A., 1996, American Journal of Human Genetics, V59, pA15; Jack RM, 2006, GENET MED, V8, P307, DOI 10.1097/01.gim.0000217785.19262.9e; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Kallwass H, 2007, MOL GENET METAB, V90, P449, DOI 10.1016/j.ymgme.2006.12.006; Kamphoven JHJ, 2004, NEUROBIOL DIS, V16, P14, DOI 10.1016/j.nbd.2003.12.018; KAPLAN A, 1977, P NATL ACAD SCI USA, V74, P2026, DOI 10.1073/pnas.74.5.2026; Kikuchi T, 1998, J CLIN INVEST, V101, P827, DOI 10.1172/JCI1722; Kishnani PS, 2007, NEUROLOGY, V68, P99, DOI 10.1212/01.wnl.0000251268.41188.04; Kishnani PS, 2006, J PEDIATR-US, V148, P671, DOI 10.1016/j.jpeds.2005.11.033; Kishnani PS, 2006, GENET MED, V8, P267, DOI 10.1097/01.gim.0000218152.87434.f3; Kishnani PS, 2006, J PEDIATR-US, V149, P89, DOI 10.1016/j.jpeds.2006.02.035; Klinge L, 2005, NEUROPEDIATRICS, V36, P6, DOI 10.1055/s-2005-837543; Klinge L, 2005, NEUROMUSCULAR DISORD, V15, P24, DOI 10.1016/j.nmd.2004.10.009; Kostera-Pruszczyk A, 2006, NEUROMUSCULAR DISORD, V16, P282, DOI 10.1016/j.nmd.2006.02.001; Kroos MA, 2007, NEUROLOGY, V68, P110, DOI 10.1212/01.wnl.0000252798.25690.76; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Laforet P, 2000, NEUROLOGY, V55, P1122, DOI 10.1212/WNL.55.8.1122; Li YJ, 2004, CLIN CHEM, V50, P1785, DOI 10.1373/clinchem.2004.035907; LIN CY, 1987, J INHERIT METAB DIS, V10, P11, DOI 10.1007/BF01799482; Lynch CM, 2005, J HISTOCHEM CYTOCHEM, V53, P63, DOI 10.1369/jhc.4A6365.2005; Mah C, 2007, MOL THER, V15, P501, DOI 10.1038/sj.mt.6300100; MAKOS M M, 1985, Neurology, V35, P193; Martiniuk F, 1998, AM J MED GENET, V79, P69, DOI 10.1002/(SICI)1096-8628(19980827)79:1<69::AID-AJMG16>3.0.CO;2-K; MARTINIUK F, 1986, P NATL ACAD SCI USA, V83, P9641, DOI 10.1073/pnas.83.24.9641; MATSUOKA Y, 1988, J NEUROL, V235, P371, DOI 10.1007/BF00314237; McVie-Wylie AJ, 2003, J GENE MED, V5, P399, DOI 10.1002/jgm.355; MEHLER M, 1977, NEUROLOGY, V27, P178, DOI 10.1212/WNL.27.2.178; Meikle PJ, 2006, MOL GENET METAB, V88, P307, DOI 10.1016/j.ymgme.2006.02.013; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Mellies U, 2005, NEUROLOGY, V64, P1465, DOI 10.1212/01.WNL.0000158682.85052.C0; Mellies U, 2001, NEUROLOGY, V57, P1290, DOI 10.1212/WNL.57.7.1290; Montalvo ALE, 2006, HUM MUTAT, V27, P999, DOI 10.1002/humu.20374; Muenzer J, 2002, ACTA PAEDIATR, V91, P98, DOI 10.1080/080352502762458012; Muenzer J, 2006, GENET MED, V8, P465, DOI 10.1097/01.gim.0000232477.37660.fb; Okumiya T, 2006, MOL GENET METAB, V88, P22, DOI 10.1016/j.ymgme.2005.10.016; Okumiya T, 2007, MOL GENET METAB, V90, P49, DOI 10.1016/j.ymgme.2006.09.010; Parenti G, 2007, MOL THER, V15, P508, DOI 10.1038/sj.mt.6300074; Pauly DF, 2001, HUM GENE THER, V12, P527, DOI 10.1089/104303401300042447; Pellegrini N, 2005, EUR RESPIR J, V26, P1024, DOI 10.1183/09031936.05.00020005; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; Raben N, 2005, MOL THER, V11, P48, DOI 10.1016/j.ymthe.2004.09.017; Raben N, 2003, MOL GENET METAB, V80, P159, DOI 10.1016/j.ymgme.2003.08.022; Raben N, 2002, MOL THER, V6, P601, DOI 10.1006/mthe.2002.0716; Raben N, 1998, J BIOL CHEM, V273, P19086, DOI 10.1074/jbc.273.30.19086; REUSER AJJ, 1978, AM J HUM GENET, V30, P132; REUSER AJJ, 1984, EXP CELL RES, V155, P178, DOI 10.1016/0014-4827(84)90779-1; REUSER AJJ, 1995, MUSCLE NERVE, pS61; REUSER AJJ, 1987, J CLIN INVEST, V79, P1689, DOI 10.1172/JCI113008; Sands MS, 2001, J BIOL CHEM, V276, P43160, DOI 10.1074/jbc.M107778200; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; SEIFERT BL, 1992, AM HEART J, V123, P239, DOI 10.1016/0002-8703(92)90779-U; Shieh JJ, 1998, HUM MUTAT, V11, P306, DOI 10.1002/(SICI)1098-1004(1998)11:4<306::AID-HUMU8>3.0.CO;2-S; Slonim AE, 2000, J PEDIATR-US, V137, P283, DOI 10.1067/mpd.2000.107112; Slonim AE, 2006, MUSCLE NERVE, V33, P571, DOI 10.1002/mus.20473; Slonim AE, 2007, MUSCLE NERVE, V35, P70, DOI 10.1002/mus.20665; Sly WS, 2006, P NATL ACAD SCI USA, V103, P15172, DOI 10.1073/pnas.0607053103; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Sun BD, 2006, MOL THER, V14, P822, DOI 10.1016/j.ymthe.2006.08.001; Talsma MD, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.4.e65; Thurberg BL, 2006, LAB INVEST, V86, P1208, DOI 10.1038/labinvest.3700484; Umapathysivam K, 2005, CLIN CHIM ACTA, V361, P191, DOI 10.1016/j.cccn.2005.05.025; Umapathysivam K, 2001, CLIN CHEM, V47, P1378; Van den Hout H, 2000, LANCET, V356, P397, DOI 10.1016/S0140-6736(00)02533-2; van den Hout HMP, 2003, PEDIATRICS, V112, P332, DOI 10.1542/peds.112.2.332; Van den Hout JMP, 2004, PEDIATRICS, V113, pE448, DOI 10.1542/peds.113.5.e448; Van Hove JLK, 1997, BIOCHEM MOL BIOL INT, V43, P613; VANDERKRAAN M, 1994, BIOCHEM BIOPH RES CO, V203, P1535, DOI 10.1006/bbrc.1994.2360; VANDERPLOEG AT, 1988, PEDIATR RES, V24, P90, DOI 10.1203/00006450-198807000-00021; VANDERPLOEG AT, 1991, J CLIN INVEST, V87, P513, DOI 10.1172/JCI115025; VANDERPLOEG AT, 1990, PEDIATR RES, V28, P344, DOI 10.1203/00006450-199010000-00009; VanHove JLK, 1996, P NATL ACAD SCI USA, V93, P65, DOI 10.1073/pnas.93.1.65; Winkel LPF, 2005, J NEUROL, V252, P875, DOI 10.1007/s00415-005-0922-9; Winkel LPF, 2004, ANN NEUROL, V55, P495, DOI 10.1002/ana.20019; Winkel LPF, 2003, MUSCLE NERVE, V27, P743, DOI 10.1002/mus.10381; WISSELAAR HA, 1993, J BIOL CHEM, V268, P2223; WOKKE JHJ, 1995, ANN NEUROL, V38, P450, DOI 10.1002/ana.410380316; Wraith JE, 2004, J PEDIATR-US, V144, P581, DOI 10.1016/j.jpeds.2004.01.046; Zhang HY, 2006, GENET MED, V8, P302, DOI 10.1097/01.gim.0000217781.66786.9b; Zhu YX, 2005, BIOCHEM J, V389, P619, DOI 10.1042/BJ20050364; Zhu YX, 2004, J BIOL CHEM, V279, P50336, DOI 10.1074/jbc.M409676200	137	461	484	2	100	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2008	372	9646					1342	1353		10.1016/S0140-6736(08)61555-X	http://dx.doi.org/10.1016/S0140-6736(08)61555-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18929906				2022-12-28	WOS:000260060500034
J	Colwell, RK; Brehm, G; Cardelus, CL; Gilman, AC; Longino, JT				Colwell, Robert K.; Brehm, Gunnar; Cardelus, Catherine L.; Gilman, Alex C.; Longino, John T.			Global warming, elevational range shifts, and lowland biotic attrition in the wet tropics	SCIENCE			English	Article							CLIMATE-CHANGE; SPECIES RICHNESS; FOREST; RESPONSES; BIODIVERSITY; PATTERNS; IMPACTS; GROWTH	Many studies suggest that global warming is driving species ranges poleward and toward higher elevations at temperate latitudes, but evidence for range shifts is scarce for the tropics, where the shallow latitudinal temperature gradient makes upslope shifts more likely than poleward shifts. Based on new data for plants and insects on an elevational transect in Costa Rica, we assess the potential for lowland biotic attrition, range-shift gaps, and mountaintop extinctions under projected warming. We conclude that tropical lowland biotas may face a level of net lowland biotic attrition without parallel at higher latitudes (where range shifts may be compensated for by species from lower latitudes) and that a high proportion of tropical species soon faces gaps between current and projected elevational ranges.	[Colwell, Robert K.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Brehm, Gunnar] Univ Jena, Inst Spezielle Zool, D-07743 Jena, Germany; [Brehm, Gunnar] Univ Jena, Evolutionsbiol Phyletischem Museum, D-07743 Jena, Germany; [Cardelus, Catherine L.] Colgate Univ, Dept Biol, Hamilton, NY 13346 USA; [Gilman, Alex C.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90950 USA; [Longino, John T.] Evergreen State Coll, Olympia, WA 98505 USA	University of Connecticut; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Colgate University; University of California System; University of California Los Angeles	Colwell, RK (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.	colwell@uconn.edu	Cardelus, Catherine/ABA-8409-2020; Colwell, Robert K/C-7276-2015; Brehm, Gunnar/D-5831-2013	Cardelus, Catherine/0000-0003-0526-7612; Brehm, Gunnar/0000-0002-7599-2847	Organization for Tropical Studies; Conservation International; University of Connecticut; U.S. NSF [DEB-0072702, DEB-0640015, DEB-0639979]; Research Fellowship and Dissertation Improvement Grant; Sigma Phi, Explorer's Club, and Steven Vavra Plant Systematics Fund; Deutsche Forschungsgemeinschaft [BR 2280/1-1]	Organization for Tropical Studies; Conservation International; University of Connecticut; U.S. NSF(National Science Foundation (NSF)); Research Fellowship and Dissertation Improvement Grant; Sigma Phi, Explorer's Club, and Steven Vavra Plant Systematics Fund; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by the Organization for Tropical Studies; the Tropical Ecology Assessment and Monitoring (TEAM) project of Conservation International; University of Connecticut (R.K.C. and C.L.C.); UCLA (A.C.G.); U.S. NSF (DEB-0072702: R.K.C., G.B., and J.T.L.; DEB-0640015: J.T.L.; DEB-0639979: R.K.C.; Research Fellowship and Dissertation Improvement Grant: C.L.C.); Sigma Phi, Explorer's Club, and Steven Vavra Plant Systematics Fund (A.C.G.); and the Deutsche Forschungsgemeinschaft (BR 2280/1-1: G.B.). We thank M. B. Bush, R.L. Chazdon, D.A. Clark, R.R. Dunn, K.M. Kuhn, C. Rahbek, T.F.L.V.B. Rangel, M. R. Silman, and our peer reviewers for comments.	Ackerly DD, 2000, BIOSCIENCE, V50, P979, DOI 10.1641/0006-3568(2000)050[0979:TEOPET]2.0.CO;2; [Anonymous], 1878, TROPICAL NATURE OTHE; Brehm G, 2007, GLOBAL ECOL BIOGEOGR, V16, P205, DOI 10.1111/j.1466-8238.2006.00281.x; Bush MB, 2008, PHILOS T R SOC B, V363, P1795, DOI 10.1098/rstb.2007.0014; Bush Mark B., 2005, P125; Bush MB, 2004, J QUATERNARY SCI, V19, P677, DOI 10.1002/jqs.883; Bush MB, 2002, GLOBAL ECOL BIOGEOGR, V11, P463, DOI 10.1046/j.1466-822X.2002.00305.x; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Cardelus CL, 2006, J ECOL, V94, P144, DOI 10.1111/j.1365-2745.2005.01052.x; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Cowling SA, 2004, PHILOS T R SOC B, V359, P539, DOI 10.1098/rstb.2003.1427; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dobzhansky T., 1950, American Scientist, V38, P209; Feeley KJ, 2007, ECOL LETT, V10, P461, DOI 10.1111/j.1461-0248.2007.01033.x; FIENLEY JR, 1998, CLIMATIC CHANGE, V39, P177; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; HANNAH L, 2007, TROPICAL RAINFOREST, P351; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Kluge J, 2006, GLOBAL ECOL BIOGEOGR, V15, P358, DOI 10.1111/j.1466-822x.2006.00223.x; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Mayle FE, 2004, PHILOS T R SOC B, V359, P499, DOI 10.1098/rstb.2003.1434; Miles L, 2004, GLOBAL ECOL BIOGEOGR, V13, P553, DOI 10.1111/j.1466-822X.2004.00105.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; PETERS RL, 1985, BIOSCIENCE, V35, P707, DOI 10.2307/1310052; Phillips O.L., 2007, TROPICAL RAINFOREST, P317; Pounds J. Alan, 2005, P70; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x	32	803	861	12	475	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					258	261		10.1126/science.1162547	http://dx.doi.org/10.1126/science.1162547			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845754				2022-12-28	WOS:000259902300048
J	Marshall, E				Marshall, Eliot			Lemons, oranges, and complexity	SCIENCE			English	Editorial Material																			0	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					209	209		10.1126/science.322.5899.209	http://dx.doi.org/10.1126/science.322.5899.209			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845740				2022-12-28	WOS:000259902300031
J	Weavers, H; Prieto-Sanchez, S; Grawe, F; Garcia-Lopez, A; Artero, R; Wilsch-Brauninger, M; Ruiz-Gomez, M; Skaer, H; Denholm, B				Weavers, Helen; Prieto-Sanchez, Silvia; Grawe, Ferdinand; Garcia-Lopez, Amparo; Artero, Ruben; Wilsch-Braeuninger, Michaela; Ruiz-Gomez, Mar; Skaer, Helen; Denholm, Barry			The insect nephrocyte is a podocyte-like cell with a filtration slit diaphragm	NATURE			English	Article							CONGENITAL NEPHROTIC SYNDROME; GLOMERULAR PROTEIN; NEPHRIN; DROSOPHILA; ORIGIN; CD2AP; BINDS	The nephron is the basic structural and functional unit of the vertebrate kidney. It is composed of a glomerulus, the site of ultrafiltration, and a renal tubule, along which the filtrate is modified. Although widely regarded as a vertebrate adaptation(1), 'nephronlike' features can be found in the excretory systems of many invertebrates, raising the possibility that components of the vertebrate excretory system were inherited from their invertebrate ancestors(2). Here we show that the insect nephrocyte has remarkable anatomical, molecular and functional similarity to the glomerular podocyte, a cell in the vertebrate kidney that forms the main size-selective barrier as blood is ultrafiltered to make urine. In particular, both cell types possess a specialized filtration diaphragm, known as the slit diaphragm in podocytes or the nephrocyte diaphragm in nephrocytes. We find that fly ( Drosophila melanogaster) orthologues of the major constituents of the slit diaphragm, including nephrin, NEPH1 ( also known as KIRREL), CD2AP, ZO-1 (TJP1) and podocin, are expressed in the nephrocyte and form a complex of interacting proteins that closely mirrors the vertebrate slit diaphragm complex. Furthermore, we find that the nephrocyte diaphragm is completely lost in flies lacking the orthologues of nephrin or NEPH1 - a phenotype resembling loss of the slit diaphragm in the absence of either nephrin ( as in human congenital nephrotic syndrome of the Finnish type, NPHS1) or NEPH1. These changes markedly impair filtration function in the nephrocyte. The similarities we describe between invertebrate nephrocytes and vertebrate podocytes provide evidence suggesting that the two cell types are evolutionarily related, and establish the nephrocyte as a simple model in which to study podocyte biology and podocyte- associated diseases.	[Weavers, Helen; Skaer, Helen; Denholm, Barry] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Prieto-Sanchez, Silvia; Ruiz-Gomez, Mar] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Grawe, Ferdinand] Univ Dusseldorf, Inst Genet, D-40225 Dusseldorf, Germany; [Garcia-Lopez, Amparo; Artero, Ruben] Univ Valencia, Dept Genet, E-46100 Valencia, Spain; [Wilsch-Braeuninger, Michaela] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	University of Cambridge; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Heinrich Heine University Dusseldorf; University of Valencia; Max Planck Society	Skaer, H (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	hs17@cam.ac.uk	Ruiz-Gómez, Mar/K-9266-2014; Artero, Ruben/K-6815-2014; Weavers, Helen/AGX-6323-2022	Ruiz-Gómez, Mar/0000-0002-9024-1400; Artero, Ruben/0000-0003-1596-047X; Prieto Sanchez, Silvia/0000-0001-7950-8162; Weavers, Helen/0000-0002-5383-6085; Grawe, Ferdi/0000-0001-6448-4989	Wellcome Trust [072441, 079221]; Deutsche Forschungsgemeinschaft SFB 590 [SFB 590]; ARC [1242]; MEC [BFU2007-62201]; Fundacion Ramon Areces; CBMSO; EC [LSHG-CT-2004-511978]; FPU	Wellcome Trust(Wellcome Trust); Deutsche Forschungsgemeinschaft SFB 590(German Research Foundation (DFG)); ARC(Australian Research Council); MEC(European Commission); Fundacion Ramon Areces; CBMSO; EC(European CommissionEuropean Commission Joint Research Centre); FPU(Spanish Government)	We thank F. Evers, Z. Cseresnyes, M. Guerra and E. Salvador for technical assistance, and S. Abmayr, L. Cooley, C. Doe, M. Affolter, K. Fischbach and K. Tryggvason for reagents. We thank V. Hartenstein, M. Inamdar, A. Woolf, I. Miguel- Aliaga, F. Evers, M. Landgraf and members of the Skaer laboratory for discussions, and E. Knust and W. B. Huttner for their support. This work was supported by Wellcome Trust grants awarded to H.S. (072441 and 079221; H.W., B.D. and H.S.); Deutsche Forschungsgemeinschaft SFB 590 awarded to E. Knust (F.G.) and ARC 1242 (H.W., B.D., H.S. and F.G.); an MEC grant awarded to M.R.-G. (BFU2007-62201; S.P.-S. and M.R.-G.); a Fundacion Ramon Areces grant to the CBMSO (M.R.-G.); EC grant LSHG-CT-2004-511978 to MYORES (M.R.-G.); and an FPU fellowship from the MEC awarded to A.G.-L.	Akilesh S, 2008, P NATL ACAD SCI USA, V105, P967, DOI 10.1073/pnas.0711515105; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; BERRIDGE MJ, 1972, TRANSPORTING EPITHEL, P11; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Crossley A.C., 1985, P487; Das D, 2008, CELL TISSUE RES, V331, P565, DOI 10.1007/s00441-007-0518-z; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Galletta BJ, 2004, MECH DEVELOP, V121, P1455, DOI 10.1016/j.mod.2004.08.001; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Huber TB, 2003, J BIOL CHEM, V278, P13417, DOI 10.1074/jbc.C200678200; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Khoshnoodi J, 2003, AM J PATHOL, V163, P2337, DOI 10.1016/S0002-9440(10)63590-0; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; KOWALEVSKY A, 1889, BIOL CENTRALBL, V9, P74; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Locke M, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P687; Nagel AC, 2002, DEV GENES EVOL, V212, P93, DOI 10.1007/s00427-002-0210-y; Patrakka J, 2000, KIDNEY INT, V58, P972, DOI 10.1046/j.1523-1755.2000.00254.x; RODEWALD R, 1974, J CELL BIOL, V60, P423, DOI 10.1083/jcb.60.2.423; RUGENDORFF A, 1994, ROUX ARCH DEV BIOL, V203, P266, DOI 10.1007/BF00360522; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; RUPPERT EE, 1994, AM ZOOL, V34, P542; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Smith H. W., 1953, FISH PHILOS; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; Wartiovaara J, 2004, J CLIN INVEST, V114, P1475, DOI 10.1172/JCI200422562	32	209	213	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					322	U5		10.1038/nature07526	http://dx.doi.org/10.1038/nature07526			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	18971929	Green Accepted, Green Submitted			2022-12-28	WOS:000262440900041
J	Bakir, M; Millington, KA; Soysal, A; Deeks, JJ; Efee, S; Aslan, Y; Dosanjh, DPS; Lalvani, A				Bakir, Mustafa; Millington, Kerry A.; Soysal, Ahmet; Deeks, Jonathan J.; Efee, Serpil; Aslan, Yasemin; Dosanjh, Davinder P. S.; Lalvani, Ajit			Prognostic Value of a T-Cell-Based, Interferon-gamma Biomarker in Children with Tuberculosis Contact	ANNALS OF INTERNAL MEDICINE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; LATENT TUBERCULOSIS; IFN-GAMMA; SKIN-TEST; CHILDHOOD TUBERCULOSIS; PREDICTIVE-VALUE; RAPID DETECTION; INFECTION; DIAGNOSIS; ENUMERATION	Background: Enzyme-linked immunospot (ELISpot) assay is an increasingly widely used, T-cell-based, interferon-gamma-release assay for diagnosing tuberculosis infection, but whether positive results are prognostic of active tuberculosis is not known. Objective: To determine whether ELISpot results predict the development of active tuberculosis among persons with recent tuberculosis exposure. Design: Longitudinal cohort study of children and adolescents with tuberculosis contact recruited from October 2002 to April 2004. Setting: Community-based contact investigations in Turkey. Patients: 908 children and adolescents with recent household tuberculosis exposure. Intervention: Enzyme-linked immunospot assay, incorporating early secretory antigenic target-6 and culture filtrate protein-10, and tuberculin skin test were done at baseline. Measurements: Incidence rates ratios of progression to active tuberculosis for contacts with positive tuberculin skin test and ELISpot results, and relative incidence rates comparing contacts with positive and negative test results. Results: Isoniazid preventive therapy was given to 688 (76%) contacts according to local guidelines. Fifteen contacts developed active tuberculosis over 1201 person-years of follow-up. Of 381 contacts with positive ELISpot results, 11 developed active tuberculosis over 536 person-years of follow-up ( incidence rate, 21 per 1000 person-years [95% CI, 10.2 to 36.7 per 1000 person-years]), a statistically significant 3- to 4-fold increased risk for progression relative to ELISpot-negative contacts. Of 550 contacts with positive tuberculin skin test results, 12 developed active tuberculosis over 722 person-years of follow-up ( incidence rate, 17 per 1000 person-years [CI, 8.6 to 29.0 per 1000 person-years]). Limitation: Only 3 of the 15 incident cases were confirmed by culture. Conclusion: Positive ELISpot results predict subsequent development of active tuberculosis in recent tuberculosis contacts. Although tuberculosis contacts with positive ELISpot results have an incidence rate of tuberculosis similar to that of contacts with positive tuberculin skin test results, ELISpot testing could allow more focused targeting of preventive therapy to fewer contacts.	[Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, TB Immunol Grp, Dept Resp Med, Natl Heart & Lung Inst, London W2 1PG, England; Marmara Univ, Sch Med, Istanbul, Turkey; Univ Birmingham, Birmingham, W Midlands, England	Imperial College London; Marmara University; University of Birmingham	Lalvani, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, TB Immunol Grp, Dept Resp Med, Natl Heart & Lung Inst, Norfolk Pl, London W2 1PG, England.	a.lalvani@imperial.ac.uk	Dosanjh, Davinder/ABD-8895-2021; ASLAN, YASEMİN/AAP-7409-2020; Deeks, Jon/AAV-5745-2020; Aslan, Yasemin/AAP-7713-2020	Dosanjh, Davinder/0000-0002-9169-5607; Deeks, Jon/0000-0002-8850-1971; Aslan, Yasemin/0000-0001-6292-2332; Lalvani, Ajit/0000-0002-2396-246X	Trust and the United Nations; (International) Children's Fund/United Nations Development Programme/World Bank/World Health Organization; UK Department of Health; Centre for Respiratory Infection, Imperial College London	Trust and the United Nations; (International) Children's Fund/United Nations Development Programme/World Bank/World Health Organization(World Health Organization); UK Department of Health; Centre for Respiratory Infection, Imperial College London	By the Wellcome Trust and the United Nations (International) Children's Fund/United Nations Development Programme/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases, a UK Department of Health Senior Fellowship in Evidence Synthesis (Dr. Deeks), and the Sir Halley Stewart Trust ( Dr. Dosanjh's PhD studentship). Dr. Lalvani is a Wellcome Senior Research Fellow in Clinical Science, and Dr. Millington was a Wellcome Trust Prize PhD student. Both are members of the Wellcome Trust-funded Centre for Respiratory Infection, Imperial College London.	Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; [Anonymous], 2000, AM J RESP CRIT CARE, V161, pS221; Barnes PF, 2004, AM J RESP CRIT CARE, V170, P5, DOI 10.1164/rccm.2404004; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; FEREBEE SH, 1962, AM REV RESPIR DIS, V85, P490; FINE PEM, 1994, LANCET, V344, P1245, DOI 10.1016/S0140-6736(94)90748-X; Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962; Fourth report to the Medical Research Council by its Tuberculosis Vaccines Clinical Trials Committee, 1972, B WHO, V46, P371; Hesseling AC, 2002, INT J TUBERC LUNG D, V6, P1038; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; HSU KHK, 1984, JAMA-J AM MED ASSOC, V251, P1283, DOI 10.1001/jama.251.10.1283; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; LALVANI A, 2008, EUR RESP J IN PRESS; Lalvani A, 2008, J INFECT DIS, V197, P941, DOI 10.1086/529049; Lalvani A, 2007, CURR OPIN INFECT DIS, V20, P264, DOI 10.1097/QCO.0b013e32813e3fd8; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Marais BJ, 2006, AM J RESP CRIT CARE, V173, P1078, DOI 10.1164/rccm.200511-1809SO; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; *NAT COLL CTR CHRO, 2006, TUB CLIN DIAGN MAN T; *NAT CTR HIV STD T, 2005, MMWR RECOMM REP, V54, P49; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Richeldi L, 2004, AM J RESP CRIT CARE, V170, P288, DOI 10.1164/rccm.200403-307OC; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; SCHAAF HS, 1995, PEDIATR INFECT DIS J, V14, P189, DOI 10.1097/00006454-199503000-00004; Schluger Neil W, 2003, Semin Respir Infect, V18, P241; Shams H, 2005, AM J RESP CRIT CARE, V172, P1161, DOI 10.1164/rccm.200505-748OC; Shieh FK, 2006, AM J RESP CRIT CARE, V174, P717, DOI 10.1164/rccm.200510-1667OC; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Starke JR, 2006, PEDIATR INFECT DIS J, V25, P941, DOI 10.1097/01.inf.0000239685.49999.d3; Sterling TR, 2006, NEW ENGL J MED, V355, P118, DOI 10.1056/NEJMp068015; Stout JE, 2008, AM J RESP CRIT CARE, V177, P1055, DOI 10.1164/rccm.200802-251ED; *TURK CUMH SAGL BA, 2003, TURK TUB KONTR BASV; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; *WHO, 2007, WHO PUBL; Zellweger JP, 2005, INT J TUBERC LUNG D, V9, P1242	50	127	138	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2008	149	11					777	W163		10.7326/0003-4819-149-11-200812020-00248	http://dx.doi.org/10.7326/0003-4819-149-11-200812020-00248			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	383AA	18936496	Green Accepted			2022-12-28	WOS:000261645300001
J	Lederle, FA; Larson, JC; Margolis, KL; Allison, MA; Freiberg, MS; Cochrane, BB; Graettinger, WF; Curb, JD				Lederle, Frank A.; Larson, Joseph C.; Margolis, Karen L.; Allison, Matthew A.; Freiberg, Matthew S.; Cochrane, Barbara B.; Graettinger, William F.; Curb, J. David			Abdominal aortic aneurysm events in the women's health initiative: cohort study	BRITISH MEDICAL JOURNAL			English	Article							PERIPHERAL ARTERIAL-DISEASE; CARDIOVASCULAR RISK-FACTORS; CLINICAL-TRIAL; PREVALENCE; THERAPY; SMOKING; MEN	Objective To assess the association between potential risk factors and subsequent clinically important abdominal aortic aneurysm events ( repairs and ruptures) in women. Design Large prospective observational cohort study with mean follow- up of 7.8 years. Setting 40 clinical centres across the United States. Participants 161 808 postmenopausal women aged 5079 enrolled in the women's health initiative. Main outcome measures Association of self reported or measured baseline variables with confirmed abdominal aortic aneurysm events assessed with multiple logistic regression. Results Events occurred in 184 women and were strongly associated with age and smoking. Ever smoking, current smoking, and amount smoked all contributed independent risk. Diabetes showed a negative association ( odds ratio 0.29, 95% confidence interval 0.13, 0.68), as did postmenopausal hormone therapy. Positive associations were also seen for height, hypertension, cholesterol lowering treatment, and coronary and peripheral artery disease. Conclusions Our findings confirm the strong positive associations of clinically important abdominal aortic aneurysm with age and smoking in women and the negative association with diabetes previously reported in men.	[Lederle, Frank A.] VA Med Ctr, Minneapolis, MN 55417 USA; [Larson, Joseph C.] Fred Hutchinson Canc Res Ctr, Womens Hlth Initiat Clin Coordinating Ctr, Seattle, WA 98109 USA; [Margolis, Karen L.] HealthPartners Res Fdn, Minneapolis, MN 55440 USA; [Allison, Matthew A.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Freiberg, Matthew S.] Univ Pittsburgh, Pittsburgh, PA 15215 USA; [Cochrane, Barbara B.] Univ Washington, Sch Nursing, Seattle, WA 98195 USA; [Graettinger, William F.] Univ Nevada, Sch Med, Reno, NV 89557 USA; [Curb, J. David] Univ Hawaii, Sch Med, Honolulu, HI 96813 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Fred Hutchinson Cancer Center; HealthPartners Institute for Education & Research; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Hawaii System	Lederle, FA (corresponding author), VA Med Ctr, Minneapolis, MN 55417 USA.	frank.lederle@va.gov		Margolis, Karen/0000-0003-1862-7402; Allison, Matthew/0000-0003-0777-8272; Caan, Bette/0000-0002-5803-310X	National Heart, Lung and Blood Institute; US Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH042116, N01WH032112, N01WH032111, N01WH032108, N01WH042122, N01WH042132, N01WH042126, N01WH032101, N01WH032100, N01WH032102, N01WH042111, N01WH042131, N01WH042109, N01WH042124, N01WH032115, N01WH042119, N01WH032122, N01WH042114, N01WH042121, N01WH022110, N01WH042112, N01WH042123, N01WH042130, N01WH032109, N01WH032105, N01WH042108, N01WH042125, N01WH032106, N01WH032119, N01WH042107, N01WH032118, N01WH032113, N01WH042129, N01WH042115, N01WH042120, N01WH042113, N01WH042110, N01WH042117, N01WH042118] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US Department of Health and Human Services; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The WHI program is funded by the National Heart, Lung and Blood Institute, US Department of Health and Human Services (contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221).	Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Cepeda MS, 2003, AM J EPIDEMIOL, V158, P280, DOI 10.1093/aje/kwg115; DeRubertis BG, 2007, J VASC SURG, V46, P630, DOI 10.1016/j.jvs.2007.06.024; Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314; Hsia J, 2004, CIRCULATION, V109, P620, DOI 10.1161/01.CIR.0000115309.63979.92; Hsia J, 2006, AM HEART J, V152, P170, DOI 10.1016/j.ahj.2005.09.005; Iribarren C, 2007, ANN EPIDEMIOL, V17, P669, DOI 10.1016/j.annepidem.2007.02.004; Kanagasabay R, 1996, J Med Screen, V3, P208; LAMORTE WW, 1995, J VASC SURG, V21, P422, DOI 10.1016/S0741-5214(95)70284-9; Lederle FA, 2000, ARCH INTERN MED, V160, P1425, DOI 10.1001/archinte.160.10.1425; Lederle FA, 2003, J VASC SURG, V38, P329, DOI 10.1016/S0741-5214(03)00136-8; Lederle FA, 2001, J VASC SURG, V34, P122, DOI 10.1067/mva.2001.115275; Lederle FA, 1997, ANN INTERN MED, V126, P441, DOI 10.7326/0003-4819-126-6-199703150-00004; McPhee JT, 2007, J VASC SURG, V45, P891, DOI 10.1016/j.jvs.2007.01.043; *NAT CTR HLTH STAT, 2008, CDC WONDER ON LIN DA; Norman PE, 2007, CIRCULATION, V115, P2865, DOI 10.1161/CIRCULATIONAHA.106.671859; Norman PE, 2007, CONNECT TISSUE RES, V48, P125, DOI 10.1080/03008200701331524; Pleumeekers HJCM, 1995, AM J EPIDEMIOL, V142, P1291, DOI 10.1093/oxfordjournals.aje.a117596; Prentice RL, 2005, AM J EPIDEMIOL, V162, P404, DOI 10.1093/aje/kwi223; Rodin MB, 2003, HYPERTENSION, V42, P61, DOI 10.1161/01.HYP.0000078829.02288.98; Singh K, 2001, AM J EPIDEMIOL, V154, P236, DOI 10.1093/aje/154.3.236; Weiss JS, 2006, EUR J VASC ENDOVASC, V31, P143, DOI 10.1016/j.ejvs.2005.08.015; Wong DR, 2007, AM J EPIDEMIOL, V165, P838, DOI 10.1093/aje/kwk063	23	59	60	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 1	2008	337								a1724	10.1136/bmj.a1724	http://dx.doi.org/10.1136/bmj.a1724			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368AM	18854591	Green Published, hybrid			2022-12-28	WOS:000260593700029
J	Liu, YL; Rao, KQ; Wu, J; Gakidou, E				Liu, Yuanli; Rao, Keqin; Wu, Jing; Gakidou, Emmanuela			Health System Reform in China 7 China's health system performance	LANCET			English	Article							TB SERVICES; CARE; IMPOVERISHMENT; EXPENDITURE	We created a comprehensive set of health-system performance measurements for China nationally and regionally, health-system coverage and catastrophic medical spending as major indicators. With respect to performance of health-care delivery, China has done well in provision of maternal and child health services, but poorly in addressing non-communicable diseases. For example, coverage of hospital delivery increased from 20% in 1993 to 62% in 2003 for women living in rural areas. However, effective coverage of hypertension treatment was only 12% for patients living in urban areas and 7% for those in rural areas in 2004. With respect to performance of health-care financing, 14% of urban and 16% of rural households incurred catastrophic medical expenditure in 2003. Furthermore, 15% of urban and 22% of rural residents had affordability difficulties when accessing health care. Although health-system coverage improved for both urban and rural areas from 1993 to 2003, affordability difficulties had worsened in rural areas. Additionally, substanfial inter-regional and intra-regional inequalities in health-system coverage and healthcare affordability measures exist. People with low income not only receive lower health-system coverage than those with high income, but also have an increased probability of either not seeking health care when ill or undergoing catastrophic medical spending. China's current health-system reform efforts need to be assessed for their effect performance indicators, for which substantial data gaps exist.	[Liu, Yuanli] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Rao, Keqin; Wu, Jing] Minist Hlth, Beijing, Peoples R China; [Gakidou, Emmanuela] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Harvard University; Harvard T.H. Chan School of Public Health; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Liu, YL (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	yuanliu@hsph.harvard.edu						Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Chen Z., 2008, QUI SHI, V1, P35; *CHIN MIN HLTH, 2007, CHIN HLTH STAT DIG; *CHIN SOC SCI AC, 2006, 2007 SOC DEV REP; DOLLAR D, 2007, 4253 WORLD BANK POL; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; GAO Q, 2007, CHINA DEV OBSERVATIO, V4, P44; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; HU S, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61368-9; LIU Y, 2006, HARVARD CHINA REV, V3, P14; Liu YL, 2004, B WORLD HEALTH ORGAN, V82, P532; Liu YL, 2003, J HEALTH POPUL NUTR, V21, P216; Liu YL, 2006, SOC SCI MED, V63, P2784, DOI 10.1016/j.socscimed.2006.06.019; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; MA K, 2007, MACROECONOMIC MANAGE, V1, P8; Meng QY, 2004, INT J HEALTH PLAN M, V19, pS45, DOI 10.1002/hpm.774; *MOH CTR HLTH STAT, 2004, AN REP NAT HLTH SERV; Murray C.J.L., 2003, HLTH SYSTEMS PERFORM; Roberts MJ., 2004, GETTING HLTH REFORM; Shengelia B., 2003, HLTH SYSTEMSPERFORMA, P221; TANG S, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61364-1; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Wagstaff A, 2007, J HEALTH ECON, V26, P505, DOI 10.1016/j.jhealeco.2006.10.006; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; WEN J, SUMM DAV DAL CHIN; WEN J, 2007, NAT URB RES BAS MED; *WORLD BANK, 2001, 5 WORLD BANK; World Health Organization, 2000, WORLD HLTH REP 2000; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Yip W, 2008, HEALTH AFFAIR, V27, P460, DOI 10.1377/hlthaff.27.2.460; Zhang TH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-19	34	135	141	8	76	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2008	372	9653					1914	1923		10.1016/S0140-6736(08)61362-8	http://dx.doi.org/10.1016/S0140-6736(08)61362-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	379IA	18930536				2022-12-28	WOS:000261388700026
J	Wieman, CE; Adams, WK; Perkins, KK				Wieman, Carl E.; Adams, Wendy K.; Perkins, Katherine K.			PHYSICS PhET: Simulations That Enhance Learning	SCIENCE			English	Editorial Material									[Adams, Wendy K.; Perkins, Katherine K.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Wieman, Carl E.] Univ British Columbia, Sci Educ Initiat, Vancouver, BC V6T 1Z3, Canada; [Wieman, Carl E.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z3, Canada	University of Colorado System; University of Colorado Boulder; University of British Columbia; University of British Columbia	Adams, WK (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.	wendy.adams@colorado.edu	Adams, Wendy K/I-7523-2012					Adams Wendy K., 2008, Journal of Interactive Learning Research, V19, P397; Adams Wendy K., 2008, Journal of Interactive Learning Research, V19, P551; Bransford JD., 2000, PEOPLE LEARN; Finkelstein ND, 2005, PHYS REV SPEC TOP-PH, V1, DOI 10.1103/PhysRevSTPER.1.010101; MALONE TW, 1981, COGNITIVE SCI, V5, P333, DOI 10.1016/S0364-0213(81)80017-1; McKagan SB, 2008, AM J PHYS, V76, P406, DOI 10.1119/1.2885199; Perkins K., 2006, PHYS TEACH, V44, P18	7	162	165	6	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					682	683		10.1126/science.1161948	http://dx.doi.org/10.1126/science.1161948			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974334	Green Submitted			2022-12-28	WOS:000260605200027
J	Hartzell, HC				Hartzell, H. Criss			Physiology - CaCl-ing channels get the last laugh	SCIENCE			English	Editorial Material							VOLUME		[Hartzell, H. Criss] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA	Emory University	Hartzell, HC (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.	criss.hartzell@emory.edu			NEI NIH HHS [R01 EY014852-08, R01 EY014852] Funding Source: Medline; NIGMS NIH HHS [R01 GM060448-08, R01 GM060448] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060448] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Espinosa I, 2008, AM J SURG PATHOL, V32, P210, DOI 10.1097/PAS.0b013e3181238cec; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Klausen TK, 2007, J CELL PHYSIOL, V210, P831, DOI 10.1002/jcp.20918; VILLAZ M, 1995, J PHYSIOL-LONDON, V488, P689, DOI 10.1113/jphysiol.1995.sp021000; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	6	15	15	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					534	535		10.1126/science.1165668	http://dx.doi.org/10.1126/science.1165668			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948525				2022-12-28	WOS:000260299100023
J	Tilburt, JC; Emanuel, EJ; Kaptchuk, TJ; Curlin, FA; Miller, FG				Tilburt, Jon C.; Emanuel, Ezekiel J.; Kaptchuk, Ted J.; Curlin, Farr A.; Miller, Franklin G.			Prescribing "placebo treatments": results of national survey of US internists and rheumatologists	BRITISH MEDICAL JOURNAL			English	Article							QUESTIONNAIRE SURVEY; POWERFUL PLACEBO; PHYSICIANS; ATTITUDES; ETHICS	Objective To describe the attitudes and behaviours regarding placebo treatments, defined as a treatment whose benefits derive from positive patient expectations and not from the physiological mechanism of the treatment itself. Design Cross sectional mailed survey. Setting Physicians' clinical practices. Participants 1200 practising internists and rheumatologists in the United States. Main outcome measures Investigators measured physicians' self reported behaviours and attitudes concerning the use of placebo treatments, including measures of whether they would use or had recommended a "placebo treatment," their ethical judgments about the practice, what they recommended as placebo treatments, and how they typically communicate with patients about the practice. Results 679 physicians ( 57%) responded to the survey. About half of the surveyed internists and rheumatologists reported prescribing placebo treatments on a regular basis ( 46- 58%, depending on how the question was phrased). Most physicians ( 399, 62%) believed the practice to be ethically permissible. Few reported using saline ( 18, 3%) or sugar pills ( 12, 2%) as placebo treatments, while large proportions reported using over the counter analgesics ( 267, 41%) and vitamins ( 243, 38%) as placebo treatments within the past year. A small but notable proportion of physicians reported using antibiotics ( 86, 13%) and sedatives ( 86, 13%) as placebo treatments during the same period. Furthermore, physicians who use placebo treatments most commonly describe them to patients as a potentially beneficial medicine or treatment not typically used for their condition ( 241, 68%); only rarely do they explicitly describe them as placebos ( 18, 5%). Conclusions Prescribing placebo treatments seems to be common and is viewed as ethically permissible among the surveyed US internists and rheumatologists. Vitamins and over the counter analgesics are the most commonly used treatments. Physicians might not be fully transparent with their patients about the use of placebos and might have mixed motivations for recommending such treatments.	[Tilburt, Jon C.; Emanuel, Ezekiel J.; Miller, Franklin G.] NIH, Dept Bioeth, Bethesda, MD 20892 USA; [Kaptchuk, Ted J.] Harvard Univ, Sch Med, Osher Inst, Boston, MA 02215 USA; [Curlin, Farr A.] Univ Chicago, Sect Internal Med, Chicago, IL 60637 USA; [Curlin, Farr A.] Univ Chicago, McClean Ctr Clin Med Eth, Chicago, IL 60637 USA	National Institutes of Health (NIH) - USA; Harvard University; Harvard Medical School; University of Chicago; University of Chicago	Tilburt, JC (corresponding author), NIH, Dept Bioeth, Bldg 10, Bethesda, MD 20892 USA.	tilburt.jon@mayo.edu			NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [K23AT002749] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT004095] Funding Source: NIH RePORTER; NCCIH NIH HHS [K23 AT002749, K24 AT004095] Funding Source: Medline	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		ABRAMOWITZ EW, 1948, NEW YORK STATE J MED, V48, P1927; *AM MED ASS, 2I06 CEJA AM MED ASS; American Association for Public Opinion Research, 2006, STAND DEF FIN DISP C, V4th; BEECHER HK, 1955, JAMA-J AM MED ASSOC, V159, P1602, DOI 10.1001/jama.1955.02960340022006; Berger JT, 1999, WESTERN J MED, V170, P93; BOK S, 1974, SCI AM, V231, P17, DOI 10.1038/scientificamerican1174-17; BRODY H, 1982, ANN INTERN MED, V97, P112, DOI 10.7326/0003-4819-97-1-112; Brody H., 1977, PLACEBOS PHILOS MED; BROWN WA, 1994, NEUROPSYCHOPHARMACOL, V10, P265, DOI 10.1038/npp.1994.53; Cabot R.C., 1903, AM MED, V5, P344; FINDLEY F, 1953, MED CLIN N AM, V37, P1821; GOODWIN JS, 1979, ANN INTERN MED, V91, P106, DOI 10.7326/0003-4819-91-1-106; GRAY G, 1981, GEN HOSP PSYCHIAT, V3, P199, DOI 10.1016/0163-8343(81)90002-5; Hrobjartsson A, 2003, EVAL HEALTH PROF, V26, P153, DOI 10.1177/0163278703026002002; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Jefferson T., 1898, WRITINGS T JEFFERSON, V9; Kaptchuk TJ, 1998, LANCET, V351, P1722, DOI 10.1016/S0140-6736(97)10111-8; LESLIE A, 1954, AM J MED, V16, P854, DOI 10.1016/0002-9343(54)90450-7; LYNOE N, 1993, SOC SCI MED, V36, P767, DOI 10.1016/0277-9536(93)90037-5; Miller FG, 2006, J CLIN EPIDEMIOL, V59, P331, DOI 10.1016/j.jclinepi.2005.12.001; Nitzan U, 2004, BMJ-BRIT MED J, V329, P944, DOI 10.1136/bmj.38236.646678.55; SCHWARTZ RK, 1989, SOC SCI MED, V28, P577, DOI 10.1016/0277-9536(89)90252-9; Shermon R, 2008, J GEN INTERN MED, V23, P7, DOI 10.1007/s11606-007-0332-z; SIMMONS B, 1978, J MED ETHICS, V4, P172, DOI 10.1136/jme.4.4.172; THOMSON RJ, 1982, NEW ZEAL MED J, V95, P492; Tuke DH., 1873, ILLUSTRATIONS INFLUE; 1946, NY J MED, V17, P722; 1954, LANCET, V2, P321; 1885, MED RECORD, V27, P576	29	166	170	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 23	2008	337								a1938	10.1136/bmj.a1938	http://dx.doi.org/10.1136/bmj.a1938			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	374FP	18948346	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000261028900001
J	Barber, LJ; Youds, JL; Ward, JD; McIlwraith, MJ; O'Neil, NJ; Petalcorin, MIR; Martin, JS; Collis, SJ; Cantor, SB; Auclair, M; Tissenbaum, H; West, SC; Rose, AM; Boulton, SJ				Barber, Louise J.; Youds, Jillian L.; Ward, Jordan D.; McIlwraith, Michael J.; O'Neil, Nigel J.; Petalcorin, Mark I. R.; Martin, Julie S.; Collis, Spencer J.; Cantor, Sharon B.; Auclair, Melissa; Tissenbaum, Heidi; West, Stephen C.; Rose, Ann M.; Boulton, Simon J.			RTEL1 Maintains Genomic Stability by Suppressing Homologous Recombination	CELL			English	Article							SACCHAROMYCES-CEREVISIAE SRS2; STRAND BREAK REPAIR; BOX DNA HELICASE; BLOOMS-SYNDROME HELICASE; CROSS-LINK REPAIR; CAENORHABDITIS-ELEGANS; C-ELEGANS; HYPER-RECOMBINATION; IONIZING-RADIATION; DAMAGE CHECKPOINT	Homologous recombination (HR) is an important conserved process for DNA repair and ensures maintenance of genome integrity. Inappropriate HR causes gross chromosomal rearrangements and tumorigenesis in mammals. In yeast, the Srs2 helicase eliminates inappropriate recombination events, but the functional equivalent of Srs2 in higher eukaryotes has been elusive. Here, we identify C. elegans RTEL-1 as a functional analog of Srs2 and describe its vertebrate counterpart, RTEL1, which is required for genome stability and tumor avoidance. We find that rtel-1 mutant worms and RTEL1-depleted human cells share characteristic phenotypes with yeast srs2 mutants: lethality upon deletion of the sgs1/BLM homolog, hyperrecombination, and DNA damage sensitivity. In vitro, purified human RTEL1 antagonizes HR by promoting the disassembly of D loop recombination intermediates in a reaction dependent upon ATP hydrolysis. We propose that loss of HR control after deregulation of RTEL1 may be a critical event that drives genome instability and cancer.	[Barber, Louise J.; Youds, Jillian L.; Ward, Jordan D.; Petalcorin, Mark I. R.; Martin, Julie S.; Collis, Spencer J.; Boulton, Simon J.] Canc Res UK, London Res Inst, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England; [Youds, Jillian L.; O'Neil, Nigel J.; Rose, Ann M.] Univ British Columbia, Fac Med, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada; [McIlwraith, Michael J.; West, Stephen C.] Canc Res UK, London Res Inst, Genet Recombinat Lab, S Mimms EN6 3LD, Herts, England; [Cantor, Sharon B.] Univ Massachusetts, Sch Med, Program Canc Biol, Worcester, MA 01605 USA; [Auclair, Melissa; Tissenbaum, Heidi] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Auclair, Melissa; Tissenbaum, Heidi] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Cancer Research UK; University of British Columbia; Cancer Research UK; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Boulton, SJ (corresponding author), Canc Res UK, London Res Inst, DNA Damage Response Lab, Clare Hall, S Mimms EN6 3LD, Herts, England.	simon.boulton@cancer.org.uk	O'Neil, Nigel/J-4012-2014; Barber, Louise J./L-8579-2019; Ward, Jordan/H-3444-2019; Ward, Jordan/C-1505-2008	O'Neil, Nigel/0000-0002-1992-6976; Barber, Louise J./0000-0001-9265-3516; Ward, Jordan/0000-0001-9870-8936; Ward, Jordan/0000-0001-9870-8936; Mcilwraith, Michael/0000-0003-1559-4369; Collis, Spencer/0000-0002-7874-1891; Petalcorin, Mark/0000-0001-8211-9440; West, Stephen/0000-0001-8848-9418	William Randolph Hearst Foundation; National Institutes of Health [AG25891]; Natural Sciences and Engineering Research Council; National Cancer Institute of Canada; Michael Smith Foundation; Louis-Jeantet Foundation; Cancer Research UK; NATIONAL INSTITUTE ON AGING [R01AG025891, R01AG031237] Funding Source: NIH RePORTER	William Randolph Hearst Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Michael Smith Foundation(Michael Smith Foundation for Health Research); Louis-Jeantet Foundation; Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We wish to thank Shohei Mitani (National Bioresource Project, Japan) and the C. elegans Knockout Consortium for providing nematode strains; Cancer Research UK Cell Services, Helen Bryant and Thomas Helleday for cells; Ian Hickson for BLM protein; and Helen Bryant, Thomas Helleday, and Janet Cronshaw for plasmids. H. A. T. is funded by the William Randolph Hearst Foundation; H. A. T. and M. A. are also funded by a grant from the National Institutes of Health (AG25891); A. M. R. is funded by the Natural Sciences and Engineering Research Council; J.L.Y. was funded by National Cancer Institute of Canada and Michael Smith Foundation for Health Research; S. C. W. is supported by the Louis-Jeantet Foundation and is part of the EU DNA Repair Consortium; and the labs of S. C. W and S. J. B. receive funding from Cancer Research UK.	ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; AGUILERA A, 1988, GENETICS, V119, P779; Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Alpi A, 2003, CHROMOSOMA, V112, P6, DOI 10.1007/s00412-003-0237-5; ARTHUR HM, 1980, MOL GEN GENET, V180, P185, DOI 10.1007/BF00267368; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Bai C, 2000, P NATL ACAD SCI USA, V97, P1230, DOI 10.1073/pnas.97.3.1230; Baumann P, 1997, MUTAT RES-DNA REPAIR, V384, P65, DOI 10.1016/S0921-8777(97)00028-1; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Bierne H, 1997, MOL MICROBIOL, V26, P557, DOI 10.1046/j.1365-2958.1997.6011973.x; Birrell GW, 2002, P NATL ACAD SCI USA, V99, P8778, DOI 10.1073/pnas.132275199; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; BRENNER S, 1974, GENETICS, V77, P71; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/ng928, 10.1038/417405a]; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Chiolo I, 2007, MOL CELL BIOL, V27, P7439, DOI 10.1128/MCB.00963-07; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Collis SJ, 2006, DNA REPAIR, V5, P1398, DOI 10.1016/j.dnarep.2006.06.010; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; GERMAN J, 1995, DERMATOL CLIN, V13, P7, DOI 10.1016/S0733-8635(18)30101-3; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Jeong YS, 2003, DNA REPAIR, V2, P1309, DOI 10.1016/j.dnarep.2003.07.003; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kim J, 2002, J BIOL CHEM, V277, P24530, DOI 10.1074/jbc.M201612200; Klein H, 2001, GENETICS, V157, P557; Kohzaki M, 2007, MOL CELL BIOL, V27, P2812, DOI 10.1128/MCB.02043-06; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2004, J BIOL CHEM, V279, P23193, DOI 10.1074/jbc.M402586200; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; LAWRENCE CW, 1979, J BACTERIOL, V139, P866, DOI 10.1128/JB.139.3.866-876.1979; Lee SJ, 2004, DEVELOPMENT, V131, P2565, DOI 10.1242/dev.01136; Lee SK, 1999, SCIENCE, V286, P2339, DOI 10.1126/science.286.5448.2339; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Martin JS, 2005, MOL CELL BIOL, V25, P3127, DOI 10.1128/MCB.25.8.3127-3139.2005; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; Mohindra A, 2002, HUM MOL GENET, V11, P2189, DOI 10.1093/hmg/11.18.2189; MOREL P, 1993, NUCLEIC ACIDS RES, V21, P3205, DOI 10.1093/nar/21.14.3205; Morishita T, 2005, MOL CELL BIOL, V25, P8074, DOI 10.1128/MCB.25.18.8074-8083.2005; Osman F, 2005, MOL CELL BIOL, V25, P8084, DOI 10.1128/MCB.25.18.8084-8096.2005; PALLADINO F, 1992, GENETICS, V132, P23; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; RONG L, 1991, GENETICS, V127, P75; ROSE AM, 1979, GENETICS, V92, P409; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wang SW, 2001, NUCLEIC ACIDS RES, V29, P2963, DOI 10.1093/nar/29.14.2963; Weidhaas JB, 2006, P NATL ACAD SCI USA, V103, P9946, DOI 10.1073/pnas.0603791103; Wicky C, 2004, MOL CELL BIOL, V24, P5016, DOI 10.1128/MCB.24.11.5016-5027.2004; Youds JL, 2008, MOL CELL BIOL, V28, P1470, DOI 10.1128/MCB.01641-07; Youds JL, 2006, GENETICS, V173, P697, DOI 10.1534/genetics.106.056879; ZIEG J, 1978, J BACTERIOL, V134, P958, DOI 10.1128/JB.134.3.958-966.1978	66	268	279	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 17	2008	135	2					261	271		10.1016/j.cell.2008.08.016	http://dx.doi.org/10.1016/j.cell.2008.08.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957201	Green Accepted, Bronze			2022-12-28	WOS:000260130400016
J	Brandman, O; Meyer, T				Brandman, Onn; Meyer, Tobias			Feedback loops shape cellular signals in space and time	SCIENCE			English	Review							POSITIVE-FEEDBACK; INOSITOL TRISPHOSPHATE; ENDOPLASMIC-RETICULUM; CALCIUM SPIKING; OSCILLATIONS; CHEMOTAXIS; ACTIVATION; CELLS; ADAPTATION; INHIBITION		[Brandman, Onn] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Brandman, Onn] Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Meyer, Tobias] Stanford Univ, Med Ctr, Dept Chem & Syst Biol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; Stanford University	Brandman, O (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	Onn.Brandman@ucsf.edu; tobias1@stanford.edu		Meyer, Tobias/0000-0003-4339-3804	NIH [R01GM063702, R01GM030179, R01MH064801]; NATIONAL CANCER INSTITUTE [R33CA120732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030179, R01GM063702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064801] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Hammer, J. Ferrell, M. Covert, A. Salmeen, Y. Brandman, and P. Vitorino for helpful discussion and suggestions and NIH grants R01GM063702, R01GM030179, and R01MH064801 for funding the work.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Augustine G J, 1992, Curr Opin Neurobiol, V2, P302, DOI 10.1016/0959-4388(92)90119-6; Bautista DM, 2002, J PHYSIOL-LONDON, V541, P877, DOI 10.1113/jphysiol.2001.016154; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; CHANCE B, 1964, P NATL ACAD SCI USA, V51, P1244, DOI 10.1073/pnas.51.6.1244; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fivaz M, 2008, CURR BIOL, V18, P44, DOI 10.1016/j.cub.2007.11.051; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; HAROOTUNIAN AT, 1991, SCIENCE, V251, P75, DOI 10.1126/science.1986413; Iglesias PA, 2008, CURR OPIN CELL BIOL, V20, P35, DOI 10.1016/j.ceb.2007.11.011; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; JACOB R, 1988, NATURE, V335, P40, DOI 10.1038/335040a0; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lotka AJ, 1910, J PHYS CHEM-US, V14, P271, DOI 10.1021/j150111a004; Mak DOD, 1998, P NATL ACAD SCI USA, V95, P15821, DOI 10.1073/pnas.95.26.15821; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; MEYER T, 1991, ANNU REV BIOPHYS BIO, V20, P153, DOI 10.1146/annurev.bb.20.060191.001101; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; NICHOLLS D, 1982, BIOCHIM BIOPHYS ACTA, V683, P57, DOI 10.1016/0304-4173(82)90013-1; PARKER I, 1991, P ROY SOC B-BIOL SCI, V246, P269, DOI 10.1098/rspb.1991.0154; Pfluger E., 1877, PFLUGERS ARCH, V15, P57, DOI [10.1007/BF01628340, DOI 10.1007/BF01628340]; Politi A, 2006, BIOPHYS J, V90, P3120, DOI 10.1529/biophysj.105.072249; Prigogine I., 1961, THERMODYNAMICS IRREV; SAI J, IN PRESS J BIOL CHEM; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; UMBARGER HE, 1956, SCIENCE, V123, P848, DOI 10.1126/science.123.3202.848; WALKER JW, 1987, NATURE, V327, P249, DOI 10.1038/327249a0; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Wiener Norbert, 1948, CYBERNETICS CONTROL; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; ZIGMOND SH, 1979, J CELL BIOL, V82, P517, DOI 10.1083/jcb.82.2.517	48	313	317	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					390	395		10.1126/science.1160617	http://dx.doi.org/10.1126/science.1160617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927383	Green Accepted			2022-12-28	WOS:000260094500033
J	Gorostiza, P; Isacoff, EY				Gorostiza, Pau; Isacoff, Ehud Y.			Optical switches for remote and noninvasive control of cell signaling	SCIENCE			English	Review							ION CHANNELS; GLUTAMATE; CHANNELRHODOPSIN-2; MANIPULATION; ACTIVATION; RECEPTORS; TRIGGERS; AGONIST		[Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Biosci, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Phys Biosci, Berkeley, CA 94720 USA; [Gorostiza, Pau] Inst Catalana Recerca & Estud Avancats, Barcelona 08028, Spain; [Gorostiza, Pau] Inst Bioengn Catalunya, Barcelona 08028, Spain	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; ICREA; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 271 Life Sci Addit, Berkeley, CA 94720 USA.	ehud@berkeley.edu	isacoff, ehud/AAP-1459-2020; Gorostiza, Pau/Q-2544-2015	Gorostiza, Pau/0000-0002-7268-5577; Isacoff, Ehud Y./0000-0003-4775-9359	Human Frontier Science Program Organization; European Research Council; NIH Nanomedicine Development Center for the Optical Control of Biological Function [5PN2EY018241]; NATIONAL EYE INSTITUTE [PN2EY018241] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Human Frontier Science Program Organization(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); NIH Nanomedicine Development Center for the Optical Control of Biological Function(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); ICREA(ICREA)	P.G. is supported by the Human Frontier Science Program Organization through a Career Development Award and by the European Research Council through a Starting Grant. This work was supported by the NIH Nanomedicine Development Center for the Optical Control of Biological Function (grant 5PN2EY018241).	Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; BARTELS E, 1971, P NATL ACAD SCI USA, V68, P1820, DOI 10.1073/pnas.68.8.1820; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Blaustein RO, 2000, NAT STRUCT BIOL, V7, P309; Bose M, 2006, J AM CHEM SOC, V128, P388, DOI 10.1021/ja055467u; Chambers JJ, 2006, J NEUROPHYSIOL, V96, P2792, DOI 10.1152/jn.00318.2006; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Fortin DL, 2008, NAT METHODS, V5, P331, DOI [10.1038/NMETH.1187, 10.1038/nmeth.1187]; Goeldner M, 2005, DYNAMIC STUDIES IN BIOLOGY: PHOTOTRIGGERS, PHOTOSWITCHES AND CAGED BIOMOLECULES, P1, DOI 10.1002/3527605592; Gorostiza P, 2008, PHYSIOLOGY, V23, P238, DOI 10.1152/physiol.00018.2008; Gorostiza P, 2007, MOL BIOSYST, V3, P686, DOI 10.1039/b710287a; Gorostiza P, 2007, P NATL ACAD SCI USA, V104, P10865, DOI 10.1073/pnas.0701274104; Housley GD, 1998, HEARING RES, V119, P1, DOI 10.1016/S0378-5955(97)00206-2; Kocer A, 2005, SCIENCE, V309, P755, DOI 10.1126/science.1114760; LESTER HA, 1980, J GEN PHYSIOL, V75, P207, DOI 10.1085/jgp.75.2.207; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Lutz C, 2008, NAT METHODS, V5, P821, DOI 10.1038/NMETH.1241; Nagel G, 2005, BIOCHEM SOC T, V33, P863, DOI 10.1042/BST0330863; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shoham S, 2005, NAT METHODS, V2, P837, DOI 10.1038/nmeth793; SILMAN I, 1969, SCIENCE, V164, P1420, DOI 10.1126/science.164.3886.1420; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Tong YH, 2001, J GEN PHYSIOL, V117, P103, DOI 10.1085/jgp.117.2.103; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Volgraf M, 2007, J AM CHEM SOC, V129, P260, DOI 10.1021/ja067269o; Weijer CJ, 2003, SCIENCE, V300, P96, DOI 10.1126/science.1082830; Woolley GA, 2005, ACCOUNTS CHEM RES, V38, P486, DOI 10.1021/ar040091v; Yoshimura K, 2001, BIOPHYS J, V80, P2198, DOI 10.1016/S0006-3495(01)76192-9; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhao J, 2006, BIOCHEMISTRY-US, V45, P4915, DOI 10.1021/bi052082f	38	250	258	1	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2008	322	5900					395	399		10.1126/science.1166022	http://dx.doi.org/10.1126/science.1166022			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927384	Green Accepted			2022-12-28	WOS:000260094500034
J	Chou, IH; Chouard, T				Chou, I-han; Chouard, Tanguy			Neuropsychiatric disease	NATURE			English	Editorial Material																			0	7	7	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					889	889		10.1038/455889a	http://dx.doi.org/10.1038/455889a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923509	Bronze			2022-12-28	WOS:000260038300035
J	Svenning, JC; Condit, R				Svenning, Jens-Christian; Condit, Richard			Biodiversity in a warmer world	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; FOREST; EUROPE; DIVERSITY; EVOLUTION; ECOLOGY; IMPACT		[Svenning, Jens-Christian] Univ Aarhus, DK-8000 Aarhus C, Denmark; [Condit, Richard] Smithsonian Trop Res Inst, Global Forest Observ Network, Unit 0948, Miami, FL 34002 USA	Aarhus University; Smithsonian Institution; Smithsonian Tropical Research Institute	Svenning, JC (corresponding author), Univ Aarhus, Ny Munkegade 1540, DK-8000 Aarhus C, Denmark.	svenning@biology.au.dk; conditr@gmail.com	Svenning, Jens-Christian/C-8977-2012	Svenning, Jens-Christian/0000-0002-3415-0862				Bermingham E, 2001, SCIENCE, V293, P2214, DOI 10.1126/science.1065310; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Condit R, 1996, J TROP ECOL, V12, P231, DOI 10.1017/S0266467400009433; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Grinnell J., 1924, ANIMAL LIFE YOSEMITE; Huber M, 2008, SCIENCE, V321, P353, DOI 10.1126/science.1161170; Huntingford C, 2008, PHILOS T R SOC B, V363, P1857, DOI 10.1098/rstb.2007.0028; Jaramillo C, 2006, SCIENCE, V311, P1893, DOI 10.1126/science.1121380; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Moe AP, 2005, PALAEOGEOGR PALAEOCL, V221, P203, DOI 10.1016/j.palaeo.2005.02.012; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Mosbrugger V, 2005, P NATL ACAD SCI USA, V102, P14964, DOI 10.1073/pnas.0505267102; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Skov F, 2004, ECOGRAPHY, V27, P366, DOI 10.1111/j.0906-7590.2004.03823.x; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Svenning JC, 2008, ECOGRAPHY, V31, P316, DOI 10.1111/j.0906-7590.2008.05206.x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011	18	26	26	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					206	207		10.1126/science.1164542	http://dx.doi.org/10.1126/science.1164542			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845738				2022-12-28	WOS:000259902300029
J	Stathopulos, PB; Zheng, L; Li, GY; Plevin, MJ; Ikura, M				Stathopulos, Peter B.; Zheng, Le; Li, Guang-Yao; Plevin, Michael J.; Ikura, Mitsuhiko			Structural and mechanistic insights into STIM1-mediated initiation of store-operated calcium entry	CELL			English	Article							STROMAL INTERACTION MOLECULE-1; SAM DOMAIN; CA2+ ENTRY; CRAC CHANNELS; POINT MUTATIONS; I-CRAC; STIM1; PROTEIN; BINDING; ER	Stromal interaction molecule-1 (STIM1) activates store-operated Ca2+ entry (SOCE) in response to diminished luminal Ca2+ levels. Here, we present the atomic structure of the Ca2+-sensing region of STIM1 consisting of the EF-hand and sterile a motif (SAM) domains (EF-SAM). The canonical EF-hand is paired with a previously unidentified EF-hand. Together, the EF-hand pair mediates mutually indispensable hydrophobic interactions between the EF-hand and SAM domains. Structurally critical mutations in the canonical EF-hand, "hidden'' EF-hand, or SAM domain disrupt Ca2+ sensitivity in oligomerization via destabilization of the entire EF-SAM entity. In mammalian cells, EF-SAM destabilization mutations within full-length STIM1 induce punctae formation and activate SOCE independent of luminal Ca2+. We provide atomic resolution insight into the molecular basis for STIM1-mediated SOCE initiation and show that the folded/unfolded state of the Ca2+-sensing region of STIM is crucial to SOCE regulation.	[Stathopulos, Peter B.; Zheng, Le; Li, Guang-Yao; Plevin, Michael J.; Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 1L7, Canada; [Stathopulos, Peter B.; Zheng, Le; Li, Guang-Yao; Plevin, Michael J.; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Ikura, M (corresponding author), Univ Toronto, Ontario Canc Inst, Div Signaling Biol, Toronto Med Discovery Tower,MaRS Ctr,101 Coll St, Toronto, ON M5G 1L7, Canada.	mikura@uhnres.utoronto.ca		Stathopulos, Peter B./0000-0002-0536-6656; Plevin, Michael/0000-0003-2057-8291	Canadian Institutes of Health Research; Canadian Foundation for Innovation [800 MHz NMR]; Natural Sciences and Engineering Research Council of Canada; Ontario Cancer Institute Knudson	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Cancer Institute Knudson	We thank N. Ishiyama for his EM assistance, R.S. Lewis (Stanford University) for providing cherryFP-STIM1, and Bruker Biospin Corporation (Fremont, CA) for 900 MHz NMR time. This research was made possible through a Canadian Institutes of Health Research operating grant, a Canadian Foundation for Innovation grant for an 800 MHz NMR spectrometer, and Natural Sciences and Engineering Research Council of Canada and Ontario Cancer Institute Knudson fellowships (to P.B.S.). M.I. holds the Canada Research Chair in Cancer Structural Biology.	ARMSTRONG DJ, 1993, BIOCHEM BIOPH RES CO, V192, P1380, DOI 10.1006/bbrc.1993.1569; Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Cai XJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000609; Chen LH, 2007, CARCINOGENESIS, V28, P2328, DOI 10.1093/carcin/bgm173; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; IKURA M, 1985, BIOCHEMISTRY-US, V24, P4264, DOI 10.1021/bi00337a002; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; KASS GEN, 1990, J BIOL CHEM, V265, P17486; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; STAROVASNIK MA, 1992, PROTEIN SCI, V1, P245; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Strange K, 2007, CELL CALCIUM, V42, P193, DOI 10.1016/j.ceca.2007.02.007; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Williams RT, 2002, BBA-PROTEIN STRUCT M, V1596, P131, DOI 10.1016/S0167-4838(02)00211-X; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wojcik J, 1997, BIOCHEMISTRY-US, V36, P680, DOI 10.1021/bi961821c; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yan XH, 2006, J GEN PHYSIOL, V128, P443, DOI 10.1085/jgp.200609611; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	56	343	354	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					110	122		10.1016/j.cell.2008.08.006	http://dx.doi.org/10.1016/j.cell.2008.08.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854159	Bronze			2022-12-28	WOS:000259728100013
J	Tan, I; Yong, J; Dong, JM; Lim, L; Leung, T				Tan, Ivan; Yong, Jeffery; Dong, Jing Ming; Lim, Louis; Leung, Thomas			A tripartite complex containing MRCK modulates lamellar actomyosin retrograde flow	CELL			English	Article							CDC42-BINDING KINASE-ALPHA; FOCAL ADHESION DYNAMICS; RHO-DEPENDENT KINASE; MIGRATING CELLS; MYOSIN-II; ACTIN CYTOSKELETON; MAMMALIAN-CELLS; PROTRUSION; MOTILITY; CDC42	Actomyosin retrograde flow underlies the contraction essential for cell motility. Retrograde flow in both lamellipodia and lamella is required for membrane protrusion and for force generation by coupling to cell adhesion. We report that the Rac/Cdc42-binding kinase MRCK and myosin II-related MYO18A linked by the adaptor protein LRAP35a form a functional tripartite complex, which is responsible for the assembly of lamellar actomyosin bundles and of a subnuclear actomyosin network. LRAP35a binds independently to MYO18A and MRCK. This binding leads to MRCK activation and its phosphorylation of MYO18A, independently of ROK and MLCK. The MRCK complex moves in concert with the retrograde flow of actomyosin bundles, with MRCK being able to influence other flow components such as MYO2A. The promotion of persistent protrusive activity and inhibition of cell motility by the respective expression of wild-type and dominant-negative mutant components of the MRCK complex show it to be crucial to cell protrusion and migration.	[Tan, Ivan; Yong, Jeffery; Dong, Jing Ming; Lim, Louis; Leung, Thomas] Inst Mol & Cell Biol, GSK IMCB Grp, Singapore 138673, Singapore; [Yong, Jeffery; Leung, Thomas] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 119260, Singapore; [Lim, Louis] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 1PJ, England	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); GlaxoSmithKline; National University of Singapore; University of London; University College London	Leung, T (corresponding author), Inst Mol & Cell Biol, GSK IMCB Grp, 61 Biopolis Dr, Singapore 138673, Singapore.	mcbthoml@imcb.a-star.edu.sg			GSK (Singapore) Research Fund	GSK (Singapore) Research Fund(GlaxoSmithKline)	We thank Robin Philps for peptide sequencing and Ed Manser for valuable comments on the manuscript. This work was supported by the GSK (Singapore) Research Fund.	Basu R, 2007, CURR OPIN CELL BIOL, V19, P88, DOI 10.1016/j.ceb.2006.12.012; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Chen XQ, 1999, J BIOL CHEM, V274, P19901, DOI 10.1074/jbc.274.28.19901; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Groeger G, 2007, BIOCHEM J, V404, P23, DOI 10.1042/BJ20070146; Gupton SL, 2007, J CELL SCI, V120, P3475, DOI 10.1242/jcs.006049; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Isogawa Y, 2005, BIOCHEMISTRY-US, V44, P6190, DOI 10.1021/bi0475931; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Katoh K, 2001, J CELL BIOL, V153, P569, DOI 10.1083/jcb.153.3.569; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kolega J, 2003, MOL BIOL CELL, V14, P4745, DOI 10.1091/mbc.E03-04-0205; Kolega J, 2006, MOL BIOL CELL, V17, P4435, DOI 10.1091/mbc.E06-05-0431; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mori K, 2005, BIOCHEM BIOPH RES CO, V326, P491, DOI 10.1016/j.bbrc.2004.11.058; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Ng Y, 2004, J BIOL CHEM, V279, P34156, DOI 10.1074/jbc.M405252200; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sumi T, 2001, J BIOL CHEM, V276, P23092, DOI 10.1074/jbc.C100196200; Tan I, 2001, MOL CELL BIOL, V21, P2767, DOI 10.1128/MCB.21.8.2767-2778.2001; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yamashiro S, 2003, MOL BIOL CELL, V14, P1745, DOI 10.1091/mbc.E02-07-0427; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	37	94	108	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					123	136		10.1016/j.cell.2008.09.018	http://dx.doi.org/10.1016/j.cell.2008.09.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854160	Bronze			2022-12-28	WOS:000259728100014
J	Sridhar, D; Batniji, R				Sridhar, Devi; Batniji, Rajaie			Misfinancing global health: a case for transparency in disbursements and decision making	LANCET			English	Article							DISEASE-CONTROL; PRIORITIES; CHALLENGE; WORLD	To address the gap between health investments and financial flows worldwide, we identified the patterns in allocation of funds by the four largest donors-ie, the World Bank, Bill & Melinda Gates Foundation (BMGF), the US Government, and the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria-in 2005. We created a disbursement database with information gathered from the annual reports and budgets. Funding per death varied widely according to type of disease eg, US$1029.10 for HIV/AIDS to $3.21 for non-communicable diseases. The World Bank, US Government, and Global Fund provided more than 98% of their funds to service delivery, whereas BMGF gave most of its funds to research. BMGF grants in 2005 were given largely to private research organisations, universities, and civil societies in rich countries, whereas the US Government and Global Fund primarily disbursed grants to sub-Saharan Africa. Publicly available data for global health disbursements is incomplete and not standardised. Continued attention is needed to develop country ownership, particularly in planning and priority setting.	[Sridhar, Devi; Batniji, Rajaie] Univ Oxford, Dept Polit & Int Relat, Oxford, England	University of Oxford	Sridhar, D (corresponding author), Univ Oxford All Souls Coll, High St, Oxford OX1 4AL, England.	devi.sridhar@politics.ox.ac.uk						Barrett S, 2004, B WORLD HEALTH ORGAN, V82, P683; Birn AE, 2005, LANCET, V366, P514, DOI 10.1016/S0140-6736(05)66479-3; Chen L. C., 1999, GLOBAL PUBLIC GOODS; *CTR PUBL INT, DIV INT THIS DAT; *DFID, INT HLTH PARTN LAUNC; Eiseman E, 2005, CHALLENGES CREATING; Fidler David, 2007, GLOBAL HLTH GOVERNAN, V1, P1; *GLOB EC GOV, 2008, PREL REP HIGH LEV WO; *GLOB FUND, 2007, 2007 15 BOARD M GLOB; Gottret P. E., 2006, HLTH FINANCING REVIS; *I MED US COMM EV, 2007, PEPFAR IMPL PROGR PR; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; KATES J, 2006, INT ASS HIV AIDS DEV; Kates J, 2006, LANCET, V368, P187, DOI 10.1016/S0140-6736(06)69018-1; Lane C, 2007, HEALTH AFFAIR, V26, P935, DOI 10.1377/hlthaff.26.4.935; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; LEVINE R, 2007, FOLLOWING MONEY BETT; Lopez AD, 2006, DIS CONTROL PRIORITI; MacKellar L, 2005, POPUL DEV REV, V31, P293, DOI 10.1111/j.1728-4457.2005.00066.x; Michaud C., 2003, DEV ASSISTANCE HLTH; Murray CJL, 2008, LANCET, V371, P1191, DOI 10.1016/S0140-6736(08)60526-7; Murray CJL, 2007, LANCET, V370, P1018, DOI 10.1016/S0140-6736(07)61458-5; OECD, CRED REP SYST; OECD, PAR DECL AID EFF; *PEPFAR, 2005, EM PLAN AIDS REL FIS; SALAAMBLUTHER T, 2007, US INT HIV AIDS TUBE; Shakow A., 2006, GLOBAL FUND WORLD BA; Shiffman J, 2006, HEALTH POLICY PLANN, V21, P411, DOI 10.1093/heapol/czl028; Sridhar Devi, 2008, BATTLE HUNGER; *WHO, 2008, GLOBAL BURDEN DIS PR; Woods N, 2000, WORLD DEV, V28, P823, DOI 10.1016/S0305-750X(99)00156-4; World Bank, 2007, HEALTHY DEVELOPMENT: THE WORLD BANK STRATEGY FOR HEALTH, NUTRITION, AND POPULATION RESULTS, P1, DOI 10.1596/978-0-8213-7193-0; World Health Organisation, 2007, NAT HLTH ACC	33	131	132	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2008	372	9644					1185	1191		10.1016/S0140-6736(08)61485-3	http://dx.doi.org/10.1016/S0140-6736(08)61485-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	355UN	18926279	Green Submitted			2022-12-28	WOS:000259734700034
J	Baigent, C; Patrono, C				Baigent, Colin; Patrono, Carlo			Selective COX-2 inhibitors: where dowe go from here?	LANCET			English	Editorial Material							SAFETY; RISK		[Baigent, Colin] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Baigent, Colin] Univ Oxford, Epidemiol Studies Unit, Oxford OX3 7LF, England; [Patrono, Carlo] Univ Cattolica Sacro Cuore, Dept Pharmacol, Rome, Italy	University of Oxford; University of Oxford; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Baigent, C (corresponding author), Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England.	colin.baigent@ctsu.ox.ac.uk		Patrono, Carlo/0000-0002-6447-2424	MRC [MC_U137686849] Funding Source: UKRI; Medical Research Council [MC_U137686849] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		BARON JA, 2008, LANCET          1014, DOI DOI 10.1016/S0140-6736(08)61490-7; Bresalier RS, 2006, NEW ENGL J MED, V355, P221; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Furberg CD, 2006, NEW ENGL J MED, V355, P204; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Lagakos SW, 2006, NEW ENGL J MED, V355, P113, DOI 10.1056/NEJMp068137; Nissen SE, 2006, NEW ENGL J MED, V355, P203; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; Rostom A, 2007, CLIN GASTROENTEROL H, V5, P818, DOI 10.1016/j.cgh.2007.03.011; Solomon SD, 2008, CIRCULATION, V117, P2104, DOI 10.1161/CIRCULATIONAHA.108.764530	11	8	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2008	372	9651					1712	1713		10.1016/S0140-6736(08)61491-9	http://dx.doi.org/10.1016/S0140-6736(08)61491-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374XV	18922571				2022-12-28	WOS:000261077900006
J	Whitlock, EP; Lin, JS; Liles, E; Beil, TL; Fu, RW				Whitlock, Evelyn P.; Lin, Jennifer S.; Liles, Elizabeth; Beil, Tracy L.; Fu, Rongwei			Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							FECAL OCCULT-BLOOD; COMPUTED TOMOGRAPHIC COLONOGRAPHY; RANDOMIZED CONTROLLED-TRIAL; CT COLONOGRAPHY; AVERAGE-RISK; EXTRACOLONIC FINDINGS; FLEXIBLE SIGMOIDOSCOPY; VIRTUAL COLONOSCOPY; ASYMPTOMATIC ADULTS; UNITED-STATES	Background: In 2002, the U. S. Preventive Services Task Force (USPSTF) recommended colorectal cancer screening for adults 50 years of age or older but concluded that evidence was insufficient to prioritize among screening tests or evaluate newer tests, such as computed tomographic (CT) colonography. Purpose: To review evidence related to knowledge gaps identified by the 2002 recommendation and to consider community performance of screening endoscopy, including harms. Data Sources: MEDLINE, Cochrane Library, expert suggestions, and bibliographic reviews. Study Selection: Eligible studies reported performance of colorectal cancer screening tests or health outcomes in average-risk populations and were at least of fair quality according to design-specific USPSTF criteria, as determined by 2 reviewers. Data Extraction: Two reviewers verified extracted data. Data Synthesis: Four fecal immunochemical tests have superior sensitivity (range, 61% to 91%), and some have similar specificity (97% to 98%), to the Hemoccult II fecal occult blood test (Beckman Coulter, Fullerton, California). Tradeoffs between superior sensitivity and reduced specificity occur with high-sensitivity guaiac tests and fecal DNA, with other important uncertainties for fecal DNA. In settings with sufficient quality control, CT colonography is as sensitive as colonoscopy for large adenomas and colorectal cancer. Uncertainties remain for smaller polyps and frequency of colonoscopy referral. We did not find good estimates of community endoscopy accuracy; serious harms occur in 2.8 per 1000 screening colonoscopies and are 10-fold less common with flexible sigmoidoscopy. Limitation: The accuracy and harms of screening tests were reviewed after only a single application. Conclusion: Fecal tests with better sensitivity and similar specificity are reasonable substitutes for traditional fecal occult blood testing, although modeling may be needed to determine all tradeoffs. Computed tomographic colonography seems as likely as colonoscopy to detect lesions 10 mm or greater but may be less sensitive for smaller adenomas. Potential radiation-related harms, the effect of extracolonic findings, and the accuracy of test performance of CT colonography in community settings remain uncertain. Emphasis on quality standards is important for implementing any operator-dependent colorectal cancer screening test.	[Whitlock, Evelyn P.; Lin, Jennifer S.; Liles, Elizabeth; Beil, Tracy L.; Fu, Rongwei] Kaiser Permanente Ctr Hlth Res, Portland, OR USA	Kaiser Permanente	Whitlock, EP (corresponding author), Kaiser Permanente Ctr Hlth Res, Portland, OR USA.				Oregon Evidence-based Practice Center [HHSA-290-2007-10057-I-EPC3]	Oregon Evidence-based Practice Center	This study was conducted by the Oregon Evidence-based Practice Center under contract to the Agency for Healthcare Research and Quality (contract HHSA-290-2007-10057-I-EPC3, task order 3).	Allison JE, 2007, JNCI-J NATL CANCER I, V99, P1462, DOI 10.1093/jnci/djm150; Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304; *AM CANC SOC, 2008, COL CANC FACTS FIG S; Ananthakrishnan AN, 2007, ARCH INTERN MED, V167, P258, DOI 10.1001/archinte.167.3.258; Anderson JC, 2004, AM J GASTROENTEROL, V99, P472, DOI 10.1111/j.1572-0241.2004.04093.x; Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; Atkin WS, 1998, GUT, V42, P560, DOI 10.1136/gut.42.4.560; BARNES E, ACRIN TRIAL SHOWS VC; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; *BLUE CROSS BLUE S, FEC DNA AN COL CANC; *BLUE CROSS BLUE S, IMM VERS GUAIAC FEC; Bossuyt PM, 2006, BRIT MED J, V332, P1089, DOI 10.1136/bmj.332.7549.1089; Breen N, 2001, J NATL CANCER I, V93, P1704, DOI 10.1093/jnci/93.22.1704; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2005, GASTROENTEROLOGY, V129, P328, DOI 10.1053/j.gastro.2005.05.021; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Burke CA, 2006, AM J GASTROENTEROL, V101, P1329, DOI 10.1111/j.1572-0241.2006.00639.x; Burling D, 2007, CLIN RADIOL, V62, P424, DOI 10.1016/j.crad.2006.11.004; Burling D, 2006, EUR RADIOL, V16, P1737, DOI 10.1007/s00330-006-0189-2; Cheng TI, 2002, J FORMOS MED ASSOC, V101, P685; Chin M, 2005, AM J GASTROENTEROL, V100, P2771, DOI 10.1111/j.1572-0241.2005.00337.x; Chu K C, 1995, Arch Fam Med, V4, P849, DOI 10.1001/archfami.4.10.849; Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation Board on Radiation Effects Research Division on Earth and Life Studies National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Cooper GS, 1997, CANCER EPIDEM BIOMAR, V6, P283; Cotterill M, 2005, CAN FAM PHYSICIAN, V51, P1224; Cress RD, 2000, PREV MED, V31, P447, DOI 10.1006/pmed.2000.0730; *CTR MED MED SERV, 2008 CLIN DIAGN LAB; *CTR MED MED SERV, DEC MEM SCREEN DNA S; Edwards JT, 2004, RADIOLOGY, V230, P459, DOI 10.1148/radiol.2302021422; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Fletcher RH, 2008, ARCH INTERN MED, V168, P685, DOI 10.1001/archinte.168.7.685; Gondal G, 2003, SCAND J GASTROENTERO, V38, P635, DOI 10.1080/00365520310003002; GRASER A, 2006, RAD SOC N AM M 28 NO; Halligan S, 2007, EUR J RADIOL, V61, P400, DOI 10.1016/j.ejrad.2006.07.030; Hamza TH, 2008, J CLIN EPIDEMIOL, V61, P41, DOI 10.1016/j.jclinepi.2007.03.016; Hara AK, 2002, GASTROENTEROL CLIN N, V31, P1045, DOI 10.1016/S0889-8553(02)00060-2; Hara AK, 2000, RADIOLOGY, V215, P353, DOI 10.1148/radiology.215.2.r00ap33353; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hassan C, 2008, ARCH INTERN MED, V168, P696, DOI 10.1001/archinte.168.7.696; Haug U, 2007, CLIN CHEM, V53, P787, DOI 10.1373/clinchem.2006.078188; *HAYES, 2006, COMP TOM COL VIRT CO; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ibanez MB, 2004, GASTROINTEST ENDOSC, V59, P634; Ikeda Y, 2000, GASTROINTEST ENDOSC, V52, P358, DOI 10.1067/mge.2000.107908; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Imperiale TF, 2003, ANN INTERN MED, V139, P959, DOI 10.7326/0003-4819-139-12-200312160-00005; Itoh M, 1996, J Med Screen, V3, P66; Jackson-Thompson J, 2006, CANCER, V107, P1103, DOI 10.1002/cncr.22007; Jain Ankur, 2002, Hawaii Med J, V61, P118; Jensch S, 2006, EUR RADIOL, V16, P981, DOI 10.1007/s00330-005-0047-7; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Johnson CD, 2007, AM J ROENTGENOL, V189, P672, DOI 10.2214/AJR.07.2354; Joseph D. A., 2008, Morbidity and Mortality Weekly Report, V57, P253; Kewenter J, 1996, DIS COLON RECTUM, V39, P676, DOI 10.1007/BF02056949; Kim DH, 2007, ENDOSCOPY, V39, P545, DOI 10.1055/s-2007-966240; Kim DH, 2007, NEW ENGL J MED, V357, P1403, DOI 10.1056/NEJMoa070543; Kim SH, 2007, RADIOLOGY, V244, P852, DOI 10.1148/radiol.2443060934; Klabunde CN, 2003, PREV MED, V36, P352, DOI 10.1016/S0091-7435(02)00066-X; Ko CW, 2007, GASTROENTEROLOGY, V132, pA149; Ko CW, 2007, GASTROINTEST ENDOSC, V65, P648, DOI 10.1016/j.gie.2006.06.020; Korman LY, 2003, GASTROINTEST ENDOSC, V58, P554, DOI 10.1067/S0016-5107(03)01890-X; *LAB CORP AM, 2003, GUID CLIN US PREG PL; Launoy GD, 2005, INT J CANCER, V115, P493, DOI 10.1002/ijc.20921; Lee YC, 2006, J GASTROEN HEPATOL, V21, P1575, DOI 10.1111/j.1440-1746.2006.04145.x; Levi Z, 2007, ANN INTERN MED, V146, P244, DOI 10.7326/0003-4819-146-4-200702200-00003; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Levin TR, 2002, GASTROENTEROLOGY, V123, P1786, DOI 10.1053/gast.2002.37064; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Liedenbaum MH, 2008, EUR RADIOL, V18, P2222, DOI 10.1007/s00330-008-0994-x; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lord SJ, 2006, ANN INTERN MED, V144, P850, DOI 10.7326/0003-4819-144-11-200606060-00011; Macari M, 2000, AM J ROENTGENOL, V174, P1543, DOI 10.2214/ajr.174.6.1741543; Macari M, 2004, RADIOLOGY, V230, P629, DOI 10.1148/radiol.2303021624; Meissner HI, 2006, CANCER EPIDEM BIOMAR, V15, P389, DOI 10.1158/1055-9965.EPI-05-0678; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Mulhall BP, 2005, ANN INTERN MED, V142, P635, DOI 10.7326/0003-4819-142-8-200504190-00013; Nakama H, 1996, J Med Screen, V3, P63; Nakama H, 1999, HEPATO-GASTROENTEROL, V46, P228; Nelson DB, 2002, GASTROINTEST ENDOSC, V55, P307, DOI 10.1067/mge.2002.121883; Newcomer MK, 1999, J CLIN GASTROENTEROL, V29, P76, DOI 10.1097/00004836-199907000-00019; Pedersen BG, 2003, GUT, V52, P1744; Pickhardt PJ, 2008, RADIOLOGY, V249, P151, DOI 10.1148/radiol.2491072148; Pickhardt PJ, 2006, RADIOLOGY, V241, P417, DOI 10.1148/radiol.2412052007; Pickhardt PJ, 2007, DIS COLON RECTUM, V50, P56, DOI 10.1007/s10350-006-0806-9; Pickhardt PJ, 2006, RADIOLOGY, V239, P313, DOI 10.1148/radiol.2392052002; Pickhardt PJ, 2004, AM J ROENTGENOL, V183, P1343, DOI 10.2214/ajr.183.5.1831343; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Pignone M, 2002, ANN INTERN MED, V137, P96, DOI 10.7326/0003-4819-137-2-200207160-00007; POLLACK LA, 2006, PREVENTING CHRONIC D, V3; Ransohoff DF, 2004, JAMA-J AM MED ASSOC, V291, P1772, DOI 10.1001/jama.291.14.1772; Rathgaber SW, 2006, GASTROINTEST ENDOSC, V64, P556, DOI 10.1016/j.gie.2006.03.014; Rex DK, 2006, AM J GASTROENTEROL, V101, P873, DOI 10.1111/j.1572-0241.2006.00673.x; Rex DK, 1999, GASTROINTEST ENDOSC, V50, P309, DOI 10.1053/ge.1999.v50.97776; Rex DK, 2000, ENDOSCOPY, V32, P260, DOI 10.1055/s-2000-98; Robinson MHE, 1999, GUT, V45, P588, DOI 10.1136/gut.45.4.588; Schoen RE, 2003, JAMA-J AM MED ASSOC, V290, P41, DOI 10.1001/jama.290.1.41; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Schoenfeld P, 1999, GASTROENTEROLOGY, V117, P312, DOI 10.1053/gast.1999.0029900312; Schootman M, 2006, J EPIDEMIOL COMMUN H, V60, P202, DOI 10.1136/jech.2005.041020; Segnan N, 2002, J NATL CANCER I, V94, P1763; Smith RA, 2007, CA-CANCER J CLIN, V57, P90, DOI 10.3322/canjclin.57.2.90; SOARESWEISER K, 2007, DIAGNOSTIC ACCURACY; Sosna J, 2006, RADIOLOGY, V239, P457, DOI 10.1148/radiol.2392050287; *SURV EP END RES P, CONT SEER CANC STAT; Thiis-Evensen E, 1999, SCAND J GASTROENTERO, V34, P414; Troisi RJ, 1999, CANCER, V85, P1670, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1670::AID-CNCR5>3.0.CO;2-M; Turner RM, 2000, STAT MED, V19, P3417, DOI 10.1002/1097-0258(20001230)19:24<3417::AID-SIM614>3.0.CO;2-L; *US FDA, 2007, WARN LETT; *US PREV SERV TASK, 1996, CLIN GUID PREV SERV; *US PREV SERV TASK, 2007, POCK GUID CLIN PREV, P32; van Gelder RE, 2002, RADIOLOGY, V224, P25, DOI 10.1148/radiol.2241011126; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Viiala CH, 2007, MED J AUSTRALIA, V187, P274, DOI 10.5694/j.1326-5377.2007.tb01241.x; Wallace MB, 1999, AM J MED, V107, P214, DOI 10.1016/S0002-9343(99)00225-9; Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78; Weissfeld JL, 2005, JNCI-J NATL CANCER I, V97, P989, DOI 10.1093/jnci/dji175; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Whitlock EP, 2008, SCREENING COLORECTAL; Whitlock EP, 2008, ANN INTERN MED, V148, P776, DOI 10.7326/0003-4819-148-10-200805200-00010; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Woolf SH, 2004, NEW ENGL J MED, V351, P2755, DOI 10.1056/NEJMe048259; Yeazel MW, 2004, CANCER EPIDEM BIOMAR, V13, P654; Yeshwant SC, 2006, RADIOLOGY, V241, P802, DOI 10.1148/radiol.2413051534; Young BM, 2007, AM J ROENTGENOL, V188, P122, DOI 10.2214/AJR.05.1535; Zalis ME, 2005, RADIOLOGY, V236, P3, DOI 10.1148/radiol.2361041926; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	129	570	589	0	43	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2008	149	9					638	+		10.7326/0003-4819-149-9-200811040-00245	http://dx.doi.org/10.7326/0003-4819-149-9-200811040-00245			27	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367XK	18838718				2022-12-28	WOS:000260585700005
J	Zhang, DQ; Unschuld, PU				Zhang, Daqing; Unschuld, Paul U.			China's barefoot doctor: past, present, and future	LANCET			English	Editorial Material									[Zhang, Daqing] Peking Univ, Ctr Hist Med, Beijing 100191, Peoples R China; [Unschuld, Paul U.] Charite Univ Med Berlin, Horst Gortz Stiftungsinst Theorie Geschichte, D-13353 Berlin, Germany; [Unschuld, Paul U.] Charite Univ Med Berlin, Eth Chinesischer Lebenswissensch, D-13353 Berlin, Germany	Peking University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Zhang, DQ (corresponding author), Peking Univ, Ctr Hist Med, Beijing 100191, Peoples R China.	zhangdq@bjmu.edu.cn						CHEN HF, 1993, HIST CHINESE HEALTHC, P267; CUI YL, 1984, CHINESE ANN HLTH, P60; HUANG SZ, 1986, HLTH MODERN CHINA, P13; LAMPTON DM, 1977, POLITICS MED CHINA, P229; LI TA, 1934, CHIN MED J, V20, P1113; MAO ZD, 1970, LONG LIVE MAO ZD THO, P135; *MIN HLTH, 2005, CHIN ANN HLTH STAT, P54; Zhang Z, 1994, CHINESE RURAL HLTH S, V14, P4; ZHANG ZK, 2005, CHIN RURAL HLTH SERV, V25, P5; 1974, MAKE COOPERATIVE MED, V1; 1968, RED FLAG, V3, P20; 1965, HLTH NEWS       0814, P1	12	116	118	4	45	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2008	372	9653					1865	1867		10.1016/S0140-6736(08)61355-0	http://dx.doi.org/10.1016/S0140-6736(08)61355-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	379IA	18930539				2022-12-28	WOS:000261388700008
J	Chang, CW; Wang, TE; Shih, SC; Chang, WH; Chen, MJ				Chang, Ching-Wei; Wang, Tsang-En; Shih, Shou-Chuan; Chang, Wen-Hsiung; Chen, Ming-Jen			Shortness of breath, fever - and pain in both legs	LANCET			English	Editorial Material							GAS-GANGRENE; INFECTIONS		[Chang, Ching-Wei; Wang, Tsang-En; Shih, Shou-Chuan; Chang, Wen-Hsiung; Chen, Ming-Jen] Mackay Mem Hosp, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan; [Chang, Ching-Wei; Wang, Tsang-En; Shih, Shou-Chuan; Chang, Wen-Hsiung; Chen, Ming-Jen] Mackay Med Nursing & Management Coll, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management	Chen, MJ (corresponding author), Mackay Mem Hosp, Div Gastroenterol, Dept Internal Med, 92 Sec 2,Chungshan N Rd, Taipei, Taiwan.	mingjen.ch@msa.hinet.net	Wang, Tsang-En/GQH-7847-2022					BESSMAN AN, 1975, JAMA-J AM MED ASSOC, V233, P958, DOI 10.1001/jama.233.9.958; DARKE SG, 1977, BRIT J SURG, V64, P104, DOI 10.1002/bjs.1800640207; Lin JC, 2006, J CLIN ENDOCR METAB, V91, P3084, DOI 10.1210/jc.2005-2749; VANBEEK A, 1974, ARCH SURG-CHICAGO, V108, P552; Vinh DC, 2005, LANCET INFECT DIS, V5, P501, DOI 10.1016/S1473-3099(05)70191-2	5	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 25	2008	372	9648					1518	1518		10.1016/S0140-6736(08)61621-9	http://dx.doi.org/10.1016/S0140-6736(08)61621-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370ZJ	18970978				2022-12-28	WOS:000260801300028
J	Bonetta, L				Bonetta, Laura			Enhancing NIH Grant Peer Review: A Broader Perspective	CELL			English	Editorial Material																			0	9	9	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 17	2008	135	2					201	204		10.1016/j.cell.2008.09.051	http://dx.doi.org/10.1016/j.cell.2008.09.051			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957192	Bronze			2022-12-28	WOS:000260130400006
J	Hopkins, BB; Paull, TT				Hopkins, Ben B.; Paull, Tanya T.			The P-furiosus Mre11/Rad50 Complex Promotes 5 ' Strand Resection at a DNA Double-Strand Break	CELL			English	Article							HOMOLOGOUS RECOMBINATION; NUCLEASE ACTIVITIES; MRE11 COMPLEX; RECBCD ENZYME; SBCCD PROTEIN; REPAIR; RAD50; HELICASE; CHECKPOINT; BINDING	The Mre11/Rad50 complex has been implicated in the early steps of DNA double-strand break (DSB) repair through homologous recombination in several organisms. However, the enzymatic properties of this complex are incompatible with the generation of 30 single-stranded DNA for recombinase loading and strand exchange. In thermophilic archaea, the Mre11 and Rad50 genes cluster in an operon with genes encoding a helicase, HerA, and a 50 to 30 exonuclease, NurA, suggesting a common function. Here we show that purified Mre11 and Rad50 from Pyrococcus furiosus act cooperatively with HerA and NurA to resect the 50 strand at a DNA end under physiological conditions in vitro. The 30 single-stranded DNA generated by these enzymes can be utilized by the archaeal RecA homolog RadA to catalyze strand exchange. This work elucidates how the conserved Mre11/Rad50 complex promotes DNA end resection in archaea and may serve as a model for DSB processing in eukaryotes.	[Hopkins, Ben B.; Paull, Tanya T.] Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA; [Hopkins, Ben B.; Paull, Tanya T.] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [Hopkins, Ben B.; Paull, Tanya T.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Paull, TT (corresponding author), Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA.	tpaull@mail.utexas.edu		Paull, Tanya/0000-0002-2991-651X	NIH [R01 CA094008]; DOD; NATIONAL CANCER INSTITUTE [R01CA094008] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to J. Carney for the P. furiosus Mre11/Rad50 expression plasmid, to L. Symington for personal communication of unpublished results, and to members of the Paull lab for comments about this project. This work was supported by NIH grant R01 CA094008 and DOD predoctoral fellowship to B. B.	ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; Amundsen SK, 2007, GENE DEV, V21, P3296, DOI 10.1101/gad.1605807; Aravind L, 2001, GENOME RES, V11, P1365, DOI 10.1101/gr.181001; Arthur LM, 2004, NUCLEIC ACIDS RES, V32, P1886, DOI 10.1093/nar/gkh343; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Barlow JH, 2008, MOL CELL, V30, P73, DOI 10.1016/j.molcel.2008.01.016; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Connelly JC, 1999, NUCLEIC ACIDS RES, V27, P1039, DOI 10.1093/nar/27.4.1039; Connelly JC, 1997, J BIOL CHEM, V272, P19819, DOI 10.1074/jbc.272.32.19819; Constantinesco F, 2004, NUCLEIC ACIDS RES, V32, P1439, DOI 10.1093/nar/gkh283; Constantinesco F, 2002, EMBO REP, V3, P537, DOI 10.1093/embo-reports/kvf112; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Doherty AJ, 2001, FEBS LETT, V500, P186, DOI 10.1016/S0014-5793(01)02589-3; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Komori K, 2000, J BIOL CHEM, V275, P33791, DOI 10.1074/jbc.M004556200; Kondo N, 2008, EXTREMOPHILES, V12, P217, DOI 10.1007/s00792-007-0118-6; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Manzan A, 2004, EMBO REP, V5, P54, DOI 10.1038/sj.embor.7400037; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moncalian G, 2004, J MOL BIOL, V335, P937, DOI 10.1016/j.jmb.2003.11.026; Moreau S, 1999, MOL CELL BIOL, V19, P556; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Quaiser A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-25; Seitz EM, 2001, ADV APPL MICROBIOL, V50, P101, DOI 10.1016/S0065-2164(01)50005-2; Seitz EM, 1998, GENE DEV, V12, P1248, DOI 10.1101/gad.12.9.1248; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Smith GR, 2001, ANNU REV GENET, V35, P243, DOI 10.1146/annurev.genet.35.102401.090509; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Zhang ST, 2008, DNA REPAIR, V7, P380, DOI 10.1016/j.dnarep.2007.10.010; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111	49	125	129	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					250	260		10.1016/j.cell.2008.09.054	http://dx.doi.org/10.1016/j.cell.2008.09.054			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957200	Green Accepted, Bronze			2022-12-28	WOS:000260130400015
J	Tsukazaki, T; Mori, H; Fukai, S; Ishitani, R; Mori, T; Dohmae, N; Perederina, A; Sugita, Y; Vassylyev, DG; Ito, K; Nureki, O				Tsukazaki, Tomoya; Mori, Hiroyuki; Fukai, Shuya; Ishitani, Ryuichiro; Mori, Takaharu; Dohmae, Naoshi; Perederina, Anna; Sugita, Yuji; Vassylyev, Dmitry G.; Ito, Koreaki; Nureki, Osamu			Conformational transition of Sec machinery inferred from bacterial SecYE structures	NATURE			English	Article							TRANSLOCATION ATPASE SECA; PROTEIN-TRANSLOCATION; PREPROTEIN TRANSLOCATION; MEMBRANE; CHANNEL; COMPLEX; COMPONENTS; PARALLEL; DOMAIN; PHASE	Over 30% of proteins are secreted across or integrated into membranes. Their newly synthesized forms contain either cleavable signal sequences or non- cleavable membrane anchor sequences, which direct them to the evolutionarily conserved Sec translocon (SecYEG in prokaryotes and Sec61, comprising alpha-, gamma- and beta-subunits, in eukaryotes). The translocon then functions as a protein-conducting channel(1). These processes of protein localization occur either at or after translation. In bacteria, the SecA ATPase(2,3) drives post- translational translocation. The only high- resolution structure of a translocon available so far is that for SecYE beta from the archaeon Methanococcus jannaschii(4), which lacks SecA. Here we present the 3.2- A-resolution crystal structure of the SecYE translocon from a SecA- containing organism, Thermus thermophilus. The structure, solved as a complex with an anti- SecY Fab fragment, revealed a 'pre-open' state of SecYE, in which several transmembrane helices are shifted, as compared to the previous SecYEb structure(4), to create a hydrophobic crack open to the cytoplasm. Fab and SecA bind to a common site at the tip of the cytoplasmic domain of SecY. Molecular dynamics and disulphide mapping analyses suggest that the pre- open state might represent a SecYE conformational transition that is inducible by SecA binding. Moreover, we identified a SecA - SecYE interface that comprises SecA residues originally buried inside the protein, indicating that both the channel and the motor components of the Sec machinery undergo cooperative conformational changes on formation of the functional complex.	[Tsukazaki, Tomoya; Fukai, Shuya; Nureki, Osamu] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Midori Ku, Kanagawa 2268501, Japan; [Mori, Hiroyuki; Ito, Koreaki] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Div Struct Biol, Dept Basic Med Sci, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Dohmae, Naoshi] RIKEN, Biomol Characterizat Team, Wako, Saitama 3510198, Japan; [Dohmae, Naoshi] RIKEN, CREST JST, Wako, Saitama 3510198, Japan; [Perederina, Anna; Vassylyev, Dmitry G.] Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Perederina, Anna; Vassylyev, Dmitry G.] Univ Alabama Birmingham, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	Tokyo Institute of Technology; Kyoto University; University of Tokyo; RIKEN; Japan Science & Technology Agency (JST); RIKEN; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Nureki, O (corresponding author), Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Midori Ku, 4259 Nagatsuta Cho, Kanagawa 2268501, Japan.	Koreaki.Ito@ky5.ecs.kyoto-u.ac.jp; nureki@ims.u-tokyo.ac.jp	Dohmae, Naoshi/C-2040-2011; Vassylyev, Dmitry/A-9005-2008; Mori, Takaharu/AAH-1234-2021; Tsukazaki, Tomoya/N-2299-2019; Sugita, Yuji/L-6726-2014; Fukai, Shuya/X-4838-2018; NUREKI, OSAMU/G-4960-2014	Dohmae, Naoshi/0000-0002-5242-9410; Tsukazaki, Tomoya/0000-0002-6386-723X; Sugita, Yuji/0000-0001-9738-9216; Fukai, Shuya/0000-0002-1241-1443; Mori, Hiroyuki/0000-0002-0429-1269	SORST program; CREST; BIRD; Global COE Program (Center of Education and Research for Advanced Genome-Based Medicine); National Project on Protein Structural and Functional Analyses; NIH; MEXT; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [20247020] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074840, R01GM074252] Funding Source: NIH RePORTER	SORST program; CREST(Core Research for Evolutional Science and Technology (CREST)); BIRD; Global COE Program (Center of Education and Research for Advanced Genome-Based Medicine)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Inaba, Y. Akiyama and M. Hattori for useful suggestions about sample preparation and crystallization; T. Sakamoto and T. Saika for their assistance in the purification of T. thermophilus SecYE; K. Mochizuki, M. Sano, K. Yoshikaie, T. Adachi and Y. Echizen for technical support; and the beamline staff members at BL41XU of SPring- 8 ( Sayo, Japan) and NW12 of PF ( Tsukuba, Japan) for technical help during data collection. We also thank I. Artsimovitch for critically reading the manuscript. This work was supported by a SORST program grant from JST ( Japan Science and Technology) to O. N., by a CREST grant from JST to K. I. and N. D., by a BIRD grant from JST to H. M. and Y. S., by Global COE Program (Center of Education and Research for Advanced Genome-Based Medicine) and a grant for the National Project on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science and Technology ( MEXT) to O. N., by NIH grants to D. G. V., by grants from MEXT to H.M, S.F., R.I., K.I. and O.N., and by Mitsubishi Foundation grants to O.N.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L, PYMOL MOL GRAPHICS S; DOUVILLE K, 1995, J BIOL CHEM, V270, P20106, DOI 10.1074/jbc.270.34.20106; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Karamanou S, 1999, MOL MICROBIOL, V34, P1133, DOI 10.1046/j.1365-2958.1999.01686.x; Karamanou S, 2007, EMBO J, V26, P2904, DOI 10.1038/sj.emboj.7601721; Kida Y, 2007, J CELL BIOL, V179, P1441, DOI 10.1083/jcb.200707050; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Mori H, 2003, J BIOL CHEM, V278, P14257, DOI 10.1074/jbc.M300230200; Mori H, 2003, J BACTERIOL, V185, P405, DOI 10.1128/JB.185.2.405-412.2003; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Mori H, 2001, P NATL ACAD SCI USA, V98, P5128, DOI 10.1073/pnas.081617398; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rusch SL, 2007, BBA-BIOMEMBRANES, V1768, P5, DOI 10.1016/j.bbamem.2006.08.013; Shindo N, 1997, ANAL BIOCHEM, V249, P79, DOI 10.1006/abio.1997.2155; Sianidis G, 2001, EMBO J, V20, P961, DOI 10.1093/emboj/20.5.961; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2006, J MOL BIOL, V364, P248, DOI 10.1016/j.jmb.2006.09.061; Vassylyeva MN, 2006, ACTA CRYSTALLOGR F, V62, P909, DOI 10.1107/S1744309106030843; Veenendaal AKJ, 2001, J BIOL CHEM, V276, P32559, DOI 10.1074/jbc.M103912200; Vrontou E, 2004, BBA-MOL CELL RES, V1694, P67, DOI 10.1016/j.bbamcr.2004.06.003; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504	43	177	184	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					988	U72		10.1038/nature07421	http://dx.doi.org/10.1038/nature07421			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923527	Green Accepted			2022-12-28	WOS:000260038300055
J	Moritz, C; Patton, JL; Conroy, CJ; Parra, JL; White, GC; Beissinger, SR				Moritz, Craig; Patton, James L.; Conroy, Chris J.; Parra, Juan L.; White, Gary C.; Beissinger, Steven R.			Impact of a century of climate change on small-mammal communities in Yosemite National Park, USA	SCIENCE			English	Article							SPECIES RANGE; GREAT-BASIN; 20TH-CENTURY; RESPONSES; EXTINCTION; CALIFORNIA; SHIFT	We provide a century-scale view of small-mammal responses to global warming, without confounding effects of land-use change, by repeating Grinnell's early-20th century survey across a 3000-meter-elevation gradient that spans Yosemite National Park, California, USA. Using occupancy modeling to control for variation in detectability, we show substantial (similar to 500 meters on average) upward changes in elevational limits for half of 28 species monitored, consistent with the observed similar to 3 degrees C increase in minimum temperatures. Formerly low-elevation species expanded their ranges and high-elevation species contracted theirs, leading to changed community composition at mid- and high elevations. Elevational replacement among congeners changed because species' responses were idiosyncratic. Though some high-elevation species are threatened, protection of elevation gradients allows other species to respond via migration.	[Moritz, Craig; Patton, James L.; Conroy, Chris J.; Parra, Juan L.; Beissinger, Steven R.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Moritz, Craig; Patton, James L.; Parra, Juan L.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [White, Gary C.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Beissinger, Steven R.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Colorado State University; University of California System; University of California Berkeley	Moritz, C (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	craigm@berkeley.edu	White, Gary/CAG-1290-2022; Beissinger, Steven R/F-3809-2012		Yosemite Foundation; National Parks Service; NSF [DEB 0640859]	Yosemite Foundation; National Parks Service; NSF(National Science Foundation (NSF))	Supported by funding from the Yosemite Foundation, the National Parks Service, and NSF (DEB 0640859). Assistance was received from A. Chang, H. Shofi, K. Tsao, D. Yang, W. Monahan, R. Hijmans, and M. Koo. L. Chow (U.S. Geological Survey Yosemite) and S. Thompson (Yosemite National Park) stimulated and participated in the project. Comments from R. Colwell, M. Power, F. Hamer, and L. Shoo improved this manuscript.	Beever EA, 2003, J MAMMAL, V84, P37, DOI 10.1644/1545-1542(2003)084<0037:POAEAI>2.0.CO;2; Burns CE, 2003, P NATL ACAD SCI USA, V100, P11474, DOI 10.1073/pnas.1635115100; Chao A., 2005, ENCY STAT SCI; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Grayson DK, 2006, QUATERNARY SCI REV, V25, P2964, DOI 10.1016/j.quascirev.2006.03.004; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; Grinnell J., 1924, ANIMAL LIFE YOSEMITE; Grinnell Joseph, 1910, Popular Science Monthly, V77; Guarin A, 2005, FOREST ECOL MANAG, V218, P229, DOI 10.1016/j.foreco.2005.07.014; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hill JK, 2002, P ROY SOC B-BIOL SCI, V269, P2163, DOI 10.1098/rspb.2002.2134; Intergovernmental Panel on Climate Change { IPCC, 2007, GENEBRA SUICA; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; MacKenzie D.I., 2006, INFERRING PATTERNS D; Millar CI, 2004, ARCT ANTARCT ALP RES, V36, P181, DOI 10.1657/1523-0430(2004)036[0181:ROSCIT]2.0.CO;2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Rowe RJ, 2007, AM NAT, V170, P242, DOI 10.1086/518948; Rowe RJ, 2005, J BIOGEOGR, V32, P1883, DOI 10.1111/j.1365-2699.2005.01346.x; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x	28	720	757	9	438	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					261	264		10.1126/science.1163428	http://dx.doi.org/10.1126/science.1163428			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845755				2022-12-28	WOS:000259902300049
J	Pain, A; Bohme, U; Berry, AE; Mungall, K; Finn, RD; Jackson, AP; Mourier, T; Mistry, J; Pasini, EM; Aslett, MA; Balasubrammaniam, S; Borgwardt, K; Brooks, K; Carret, C; Carver, TJ; Cherevach, I; Chillingworth, T; Clark, TG; Galinski, MR; Hall, N; Harper, D; Harris, D; Hauser, H; Ivens, A; Janssen, CS; Keane, T; Larke, N; Lapp, S; Marti, M; Moule, S; Meyer, IM; Ormond, D; Peters, N; Sanders, M; Sanders, S; Sargeant, TJ; Simmonds, M; Smith, F; Squares, R; Thurston, S; Tivey, AR; Walker, D; White, B; Zuiderwijk, E; Churcher, C; Quail, MA; Cowman, AF; Turner, CMR; Rajandream, MA; Kocken, CHM; Thomas, AW; Newbold, CI; Barrell, BG; Berriman, M				Pain, A.; Bohme, U.; Berry, A. E.; Mungall, K.; Finn, R. D.; Jackson, A. P.; Mourier, T.; Mistry, J.; Pasini, E. M.; Aslett, M. A.; Balasubrammaniam, S.; Borgwardt, K.; Brooks, K.; Carret, C.; Carver, T. J.; Cherevach, I.; Chillingworth, T.; Clark, T. G.; Galinski, M. R.; Hall, N.; Harper, D.; Harris, D.; Hauser, H.; Ivens, A.; Janssen, C. S.; Keane, T.; Larke, N.; Lapp, S.; Marti, M.; Moule, S.; Meyer, I. M.; Ormond, D.; Peters, N.; Sanders, M.; Sanders, S.; Sargeant, T. J.; Simmonds, M.; Smith, F.; Squares, R.; Thurston, S.; Tivey, A. R.; Walker, D.; White, B.; Zuiderwijk, E.; Churcher, C.; Quail, M. A.; Cowman, A. F.; Turner, C. M. R.; Rajandream, M. A.; Kocken, C. H. M.; Thomas, A. W.; Newbold, C. I.; Barrell, B. G.; Berriman, M.			The genome of the simian and human malaria parasite Plasmodium knowlesi	NATURE			English	Article							ANTIGENIC VARIATION; VARIANT ANTIGEN; SEQUENCE; PROTEIN; EXPRESSION; VIRULENCE; SIGNAL; IDENTIFICATION; ERYTHROCYTES; INFECTIONS	Plasmodium knowlesi is an intracellular malaria parasite whose natural vertebrate host is Macaca fascicularis ( the 'kra' monkey); however, it is now increasingly recognized as a significant cause of human malaria, particularly in southeast Asia(1,2). Plasmodium knowlesi was the first malaria parasite species in which antigenic variation was demonstrated(3), and it has a close phylogenetic relationship to Plasmodium vivax(4), the second most important species of human malaria parasite ( reviewed in ref. 4). Despite their relatedness, there are important phenotypic differences between them, such as host blood cell preference, absence of a dormant liver stage or 'hypnozoite' in P. knowlesi, and length of the asexual cycle ( reviewed in ref. 4). Here we present an analysis of the P. knowlesi ( H strain, Pk1( A+) clone(5)) nuclear genome sequence. This is the first monkey malaria parasite genome to be described, and it provides an opportunity for comparison with the recently completed P. vivax genome(4) and other sequenced Plasmodium genomes(6-8). In contrast to other Plasmodium genomes, putative variant antigen families are dispersed throughout the genome and are associated with intrachromosomal telomere repeats. One of these families, the KIRs(9), contains sequences that collectively match over one- half of the host CD99 extracellular domain, which may represent an unusual form of molecular mimicry.	[Pain, A.; Bohme, U.; Berry, A. E.; Mungall, K.; Finn, R. D.; Jackson, A. P.; Mistry, J.; Aslett, M. A.; Balasubrammaniam, S.; Brooks, K.; Carret, C.; Carver, T. J.; Cherevach, I.; Chillingworth, T.; Clark, T. G.; Harper, D.; Harris, D.; Hauser, H.; Ivens, A.; Keane, T.; Larke, N.; Moule, S.; Ormond, D.; Peters, N.; Sanders, M.; Sanders, S.; Simmonds, M.; Smith, F.; Squares, R.; Thurston, S.; Tivey, A. R.; Walker, D.; White, B.; Zuiderwijk, E.; Churcher, C.; Quail, M. A.; Rajandream, M. A.; Newbold, C. I.; Barrell, B. G.; Berriman, M.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Mourier, T.] Univ Copenhagen, Dept Biol, Ancient DNA & Evolut Grp, DK-2100 Copenhagen, Denmark; [Pasini, E. M.; Kocken, C. H. M.; Thomas, A. W.] Biomed Primate Res Ctr, Dept Parasitol, NL-2280 GH Rijswijk, Netherlands; [Borgwardt, K.] Univ Cambridge, Dept Engn, Machine Learning Grp, Cambridge CB2 1PZ, England; [Clark, T. G.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 9BN, England; [Galinski, M. R.; Lapp, S.] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Hall, N.] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Janssen, C. S.; Turner, C. M. R.] Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8TA, Lanark, Scotland; [Marti, M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Meyer, I. M.] Univ British Columbia, UBC Bioinformat Ctr, Vancouver, BC V6T 1Z4, Canada; [Meyer, I. M.] Univ British Columbia, Dept Comp Sci, Vancouver, BC V6T 1Z4, Canada; [Meyer, I. M.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada; [Sargeant, T. J.; Cowman, A. F.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Sargeant, T. J.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Newbold, C. I.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	Wellcome Trust Sanger Institute; University of Copenhagen; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; Emory University; University of Liverpool; University of Glasgow; Harvard University; Harvard T.H. Chan School of Public Health; University of British Columbia; University of British Columbia; University of British Columbia; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; University of Oxford	Pain, A (corresponding author), Wellcome Trust Sanger Inst, Genome Campus, Hinxton CB10 1SA, Cambs, England.	ap2@sanger.ac.uk	Mourier, Tobias/C-1164-2015; Pain, Arnab/L-5766-2015; Clark, Taane G./AAM-2570-2020; Berriman, Matthew/A-7618-2011; Cowman, Alan F/C-7642-2013; Quail, michael/ABE-6131-2020; Hall, Neil/A-8717-2013	Mourier, Tobias/0000-0003-2727-1903; Pain, Arnab/0000-0002-1755-2819; Clark, Taane G./0000-0001-8985-9265; Berriman, Matthew/0000-0002-9581-0377; Cowman, Alan F/0000-0001-5145-9004; Hall, Neil/0000-0002-7995-3810; Ivens, Al/0000-0002-0112-3876; Hall, Neil/0000-0003-2808-0009; Berry, Andrew/0000-0001-5096-7701; Harper, David/0000-0002-8313-3516; Kocken, Clemens/0000-0002-4784-1734; Newbold, Chris/0000-0002-9274-3789; Borgwardt, Karsten/0000-0001-7221-2393; Mistry, Jaina/0000-0003-2479-5322; Finn, Robert/0000-0001-8626-2148; Bohme, Ulrike/0000-0002-0248-5924; Jackson, Andrew Paul/0000-0002-5704-8596; Sargeant, Tobias/0000-0002-0909-7182	Wellcome Trust; Netherlands Organization for Scientific Research; NIH; BioMalPar; Virimal contract	Wellcome Trust(Wellcome TrustEuropean Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BioMalPar; Virimal contract	We acknowledge the support of the Wellcome Trust Sanger Institute core sequencing and informatics groups. The study was funded by the Wellcome Trust through its support to the Pathogen Sequencing Unit at the Wellcome Trust Sanger Institute. We thank J. Barnwell for providing the Pk1( A1) clone of the H strain of the parasite for the generation of genomic DNA by A. Thomas. We thank A. Voorberg-vd Wel ( BPRC, Rijswijk) for technical assistance. We thank D. Fergusson for providing us with the electron micrograph image of the erythrocyte, used in Fig. 2. Part of this work was supported by the Netherlands Organization for Scientific Research, NIH, BioMalPar and the Virimal contract. This work is dedicated to the memory of Marie-Adele Rajandream.	Al-Khedery B, 1999, MOL CELL, V3, P131, DOI 10.1016/S1097-2765(00)80304-4; BARNWELL JW, 1983, INFECT IMMUN, V40, P985, DOI 10.1128/IAI.40.3.985-994.1983; Barry JD, 2005, BIOCHEM SOC T, V33, P986, DOI 10.1042/BST20050986; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berriman M, 2004, METH MOL B, V270, P17; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; BROWN KN, 1965, NATURE, V208, P1286, DOI 10.1038/2081286a0; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Galinski MR, 2004, MOL BIOCHEM PARASIT, V134, P17, DOI 10.1016/j.molbiopara.2003.09.013; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GOUNDIS D, 1988, NATURE, V335, P82, DOI 10.1038/335082a0; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; HALL R, 1992, MOL BIOCHEM PARASIT, V53, P105, DOI 10.1016/0166-6851(92)90012-9; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; HOWARD RJ, 1983, P NATL ACAD SCI-BIOL, V80, P4129, DOI 10.1073/pnas.80.13.4129; Janssen CS, 2004, NUCLEIC ACIDS RES, V32, P5712, DOI 10.1093/nar/gkh907; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MacDonald SM, 2001, P NATL ACAD SCI USA, V98, P10829, DOI 10.1073/pnas.201191498; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Meyer IM, 2004, NUCLEIC ACIDS RES, V32, P776, DOI 10.1093/nar/gkh211; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Nergadze SG, 2004, GENOME RES, V14, P1704, DOI 10.1101/gr.2778904; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Sonnhammer ELL, 1995, GENE, V167, pGC1, DOI 10.1016/0378-1119(95)00714-8; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; Werner EBE, 1998, MOL BIOCHEM PARASIT, V94, P185, DOI 10.1016/S0166-6851(98)00067-X; White NJ, 2008, CLIN INFECT DIS, V46, P172, DOI 10.1086/524889	39	279	304	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2008	455	7214					799	U7		10.1038/nature07306	http://dx.doi.org/10.1038/nature07306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18843368	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000259854900047
J	Stricker, J; Cookson, S; Bennett, MR; Mather, WH; Tsimring, LS; Hasty, J				Stricker, Jesse; Cookson, Scott; Bennett, Matthew R.; Mather, William H.; Tsimring, Lev S.; Hasty, Jeff			A fast, robust and tunable synthetic gene oscillator	NATURE			English	Article							ESCHERICHIA-COLI; TOGGLE SWITCH; EXPRESSION; NETWORKS; CIRCUITS; BIOLOGY; PROTEIN; CELLS	One defining goal of synthetic biology is the development of engineering- based approaches that enable the construction of gene- regulatory networks according to 'design specifications' generated from computational modelling(1-6). This approach provides a systematic framework for exploring how a given regulatory network generates a particular phenotypic behaviour. Several fundamental gene circuits have been developed using this approach, including toggle switches(7) and oscillators(8-10), and these have been applied in new contexts such as triggered biofilm development(11) and cellular population control(12). Here we describe an engineered genetic oscillator in Escherichia coli that is fast, robust and persistent, with tunable oscillatory periods as fast as 13 min. The oscillator was designed using a previously modelled network architecture comprising linked positive and negative feedback loops(1,13). Using a microfluidic platform tailored for single- cell microscopy, we precisely control environmental conditions and monitor oscillations in individual cells through multiple cycles. Experiments reveal remarkable robustness and persistence of oscillations in the designed circuit; almost every cell exhibited large- amplitude fluorescence oscillations throughout observation runs. The oscillatory period can be tuned by altering inducer levels, temperature and the media source. Computational modelling demonstrates that the key design principle for constructing a robust oscillator is a time delay in the negative feedback loop, which can mechanistically arise from the cascade of cellular processes involved in forming a functional transcription factor. The positive feedback loop increases the robustness of the oscillations and allows for greater tunability. Examination of our refined model suggested the existence of a simplified oscillator design without positive feedback, and we construct an oscillator strain confirming this computational prediction.	[Stricker, Jesse; Cookson, Scott; Bennett, Matthew R.; Mather, William H.; Hasty, Jeff] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Bennett, Matthew R.; Tsimring, Lev S.; Hasty, Jeff] Univ Calif San Diego, Inst Nonlinear Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hasty, J (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	hasty@bioeng.ucsd.edu	Bennett, Matthew/B-3700-2008	Bennett, Matthew/0000-0002-4975-8854; Tsimring, Lev/0000-0003-0709-3548	National Institutes of Health [GM69811-01]; US Department of Defense; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Bujard, C. Yang, and Z. Zhang for gifts of reagents, and D. Volfson and M. Simpson for discussions. This work was supported by grants from the National Institutes of Health (GM69811-01) and the US Department of Defense.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; BLISS RD, 1982, J THEOR BIOL, V97, P177, DOI 10.1016/0022-5193(82)90098-4; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Cookson S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100032; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gerland U, 2002, P NATL ACAD SCI USA, V99, P12015, DOI 10.1073/pnas.192693599; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hasty J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.148101; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Jaeger J, 2006, BIOESSAYS, V28, P1102, DOI 10.1002/bies.20494; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Lee SK, 2007, APPL ENVIRON MICROB, V73, P5711, DOI 10.1128/AEM.00791-07; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Rateitschak K, 2007, MATH BIOSCI, V205, P163, DOI 10.1016/j.mbs.2006.08.010; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Wang X, 2006, BIOPHYS J, V90, P1961, DOI 10.1529/biophysj.105.073874; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	30	773	808	8	296	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2008	456	7221					516	U39		10.1038/nature07389	http://dx.doi.org/10.1038/nature07389			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18971928	Green Accepted			2022-12-28	WOS:000261170500041
J	Saitoh, T; Fujita, N; Jang, MH; Uematsu, S; Yang, BG; Satoh, T; Omori, H; Noda, T; Yamamoto, N; Komatsu, M; Tanaka, K; Kawai, T; Tsujimura, T; Takeuchi, O; Yoshimori, T; Akira, S				Saitoh, Tatsuya; Fujita, Naonobu; Jang, Myoung Ho; Uematsu, Satoshi; Yang, Bo-Gie; Satoh, Takashi; Omori, Hiroko; Noda, Takeshi; Yamamoto, Naoki; Komatsu, Masaaki; Tanaka, Keiji; Kawai, Taro; Tsujimura, Tohru; Takeuchi, Osamu; Yoshimori, Tamotsu; Akira, Shizuo			Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1 beta production	NATURE			English	Article							GENOME-WIDE ASSOCIATION; IMMUNE ACTIVATION; CROHN-DISEASE; INNATE; MACROPHAGES; CELLS; INFLAMMASOME; RECOGNITION; RECEPTORS; MEMBRANE	Systems for protein degradation are essential for tight control of the inflammatory immune response(1,2). Autophagy, a bulk degradation system that delivers cytoplasmic constituents into autolysosomes, controls degradation of long- lived proteins, insoluble protein aggregates and invading microbes, and is suggested to be involved in the regulation of inflammation(3-5). However, the mechanism underlying the regulation of inflammatory response by autophagy is poorly understood. Here we show that Atg16L1 ( autophagy-related 16-like 1), which is implicated in Crohn's disease(6,7), regulates endotoxin- induced inflammasome activation in mice. Atg16L1- deficiency disrupts the recruitment of the Atg12-Atg5 conjugate to the isolation membrane, resulting in a loss of microtubule- associated protein 1 light chain 3 ( LC3) conjugation to phosphatidylethanolamine. Consequently, both autophagosome formation and degradation of long- lived proteins are severely impaired in Atg16L1- deficient cells. Following stimulation with lipopolysaccharide, a ligand for Toll- like receptor 4 ( refs 8, 9), Atg16L1- deficient macrophages produce high amounts of the inflammatory cytokines IL-1 beta and IL-18. In lipopolysaccharide-stimulated macrophages, Atg16L1- deficiency causes Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta ( TRIF)dependent activation of caspase- 1, leading to increased production of IL-1 beta. Mice lacking Atg16L1 in haematopoietic cells are highly susceptible to dextran sulphate sodium- induced acute colitis, which is alleviated by injection of anti-IL-1 beta and IL-18 antibodies, indicating the importance of Atg16L1 in the suppression of intestinal inflammation. These results demonstrate that Atg16L1 is an essential component of the autophagic machinery responsible for control of the endotoxin- induced inflammatory immune response.	[Saitoh, Tatsuya; Uematsu, Satoshi; Yang, Bo-Gie; Satoh, Takashi; Kawai, Taro; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan; [Jang, Myoung Ho] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Gastrointestinal Immunol, Suita, Osaka 5650871, Japan; [Saitoh, Tatsuya; Uematsu, Satoshi; Yang, Bo-Gie; Satoh, Takashi; Kawai, Taro; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan; [Fujita, Naonobu; Omori, Hiroko; Noda, Takeshi; Yoshimori, Tamotsu] Osaka Univ, Res Inst Microbial Dis, Dept Cellular Regulat, Suita, Osaka 5650871, Japan; [Yamamoto, Naoki] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan; [Komatsu, Masaaki; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan; [Komatsu, Masaaki] Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan; [Komatsu, Masaaki] Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Tsujimura, Tohru] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan; [Yoshimori, Tamotsu] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Osaka University; Osaka University; Osaka University; Osaka University; National Institute of Infectious Diseases (NIID); Tokyo Metropolitan Institute of Medical Science; Juntendo University; Japan Science & Technology Agency (JST); Hyogo College of Medicine; Japan Science & Technology Agency (JST)	Akira, S (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	akira@biken.osaka-u.ac.jp	Jang, Myoung Ho/D-1714-2009; Takeuchi, Osamu/AAG-9359-2019; surname, name s/A-2183-2010; Takeuchi, Osamu/D-6007-2011; Noda, Takeshi/B-7240-2008; Komatsu, Masaaki/B-8321-2011; Fujita, Naonobu/A-1218-2010; Akira, Shizuo/C-3134-2009	Jang, Myoung Ho/0000-0001-8909-4725; Takeuchi, Osamu/0000-0002-1260-6232; Noda, Takeshi/0000-0003-3581-7961; Komatsu, Masaaki/0000-0001-7672-7722; Kawai, Taro/0000-0001-7510-4662; Fujita, Naonobu/0000-0003-1914-8438; Yang, Bo-Gie/0000-0002-1538-8488	NIH [AI070167]; Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan.	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We are grateful to T. Kitamura, S. Yamaoka and N. Mizushima for providing materials. We thank K. J. Ishii, M. Yamamoto and members of the Laboratory of Host Defense for discussions; Y. Fujiwara, M. Shiokawa, R. Nakayama and N. Kitagaki for technical assistance; and M. Hashimoto and E. Kamada for secretarial assistance. This work was in part supported by grants from NIH (AI070167) and the Ministry of Health, Labour and Welfare of Japan, and by Grant-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hewinson J, 2008, J IMMUNOL, V180, P8410, DOI 10.4049/jimmunol.180.12.8410; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Ishikura T, 2003, J GASTROEN HEPATOL, V18, P960, DOI 10.1046/j.1440-1746.2003.03097.x; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	31	1536	1611	3	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					264	U68		10.1038/nature07383	http://dx.doi.org/10.1038/nature07383			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	18849965				2022-12-28	WOS:000261039300045
J	West, R; Townsend, J; Joossens, L; Arnott, D; Lewis, S				West, Robert; Townsend, Joy; Joossens, Luk; Arnott, Deborah; Lewis, Sarah			Why combating tobacco smuggling is a priority	BRITISH MEDICAL JOURNAL			English	Editorial Material							SMOKING PREVALENCE; CIGARETTE-SMOKING		[West, Robert] UCL, Dept Epidemiol & Publ Hlth, Canc Res UK Hlth Behav Res Ctr, London, England; [Townsend, Joy] UCL, London Sch Hyg & Trop Med, Publ & Environm Hlth Res Unit, London, England; [Joossens, Luk] Framework Convent Alliance, Brussels, Belgium; [Arnott, Deborah] Act Smoking & Hlth, London, England; [Lewis, Sarah] Univ Nottingham, Dept Epidemiol & Publ Hlth, Nottingham NG7 2RD, England	Cancer Research UK; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University College London; University of Nottingham	West, R (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Canc Res UK Hlth Behav Res Ctr, London, England.	robert.west@ucl.ac.uk	West, Robert/B-5414-2009; West, Robert/B-5414-2009	West, Robert/0000-0002-0291-5760; West, Robert/0000-0001-6398-0921	Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		*ACT SMOK HLTH, 2006, IMP SMOK FREE LEG IR; *ACT SMOK HLTH, 2008, SMOK KILLS; *CHIEF MED OFF, 2005, ANN REP CHIEF MED OF; Cullum P., 2004, DEMAND TOBACCO PRODU; Department of Health, 1999, SMOK KILLS WHIT PAP; Goddard E., 2007, SMOKING DRINKING ADU; *HM REV CUST, MEAS IND TAX LOSS 20; Jarvis MJ, 2003, ADDICTION, V98, P1569, DOI 10.1046/j.1360-0443.2003.00528.x; Joossens L, 2006, TOB CONTROL, V15, P247, DOI 10.1136/tc.2005.015347; National Statistics, 2008, HLTH SURV ENGL 2006; *OFF NAT STAT, 2007, DEATHS REL DRUG POIS; TOWNSEND J, 1994, BMJ-BRIT MED J, V309, P923, DOI 10.1136/bmj.309.6959.923; West R, 2007, CANCER EPIDEM BIOMAR, V16, P820, DOI 10.1158/1055-9965.EPI-06-0679; *WHO, 2007, EL PROT DEC FCTC COP	14	10	10	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 1	2008	337								a1933	10.1136/bmj.a1933	http://dx.doi.org/10.1136/bmj.a1933			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368AM	18845593				2022-12-28	WOS:000260593700026
J	White, MA; Eykelenboom, JK; Lopez-Vernaza, MA; Wilson, E; Leach, DRF				White, Martin A.; Eykelenboom, John K.; Lopez-Vernaza, Manuel A.; Wilson, Emily; Leach, David R. F.			Non-random segregation of sister chromosomes in Escherichia coli	NATURE			English	Article							SEPARATE CELL HALVES; IMMORTAL STRAND HYPOTHESIS; BACTERIAL CHROMOSOME; DNA-POLYMERASE; STEM-CELLS; REPLICATION; ORGANIZATION; REGION; ARMS; MREB	It has long been known that the 59 to 39 polarity of DNA synthesis results in both a leading and lagging strand at all replication forks(1). Until now, however, there has been no evidence that leading or lagging strands are spatially organized in any way within a cell. Here we show that chromosome segregation in Escherichia coli is not random but is driven in a manner that results in the leading and lagging strands being addressed to particular cellular destinations. These destinations are consistent with the known patterns of chromosome segregation(2,3). Our work demonstrates a new level of organization relating to the replication and segregation of the E. coli chromosome.	[White, Martin A.; Eykelenboom, John K.; Lopez-Vernaza, Manuel A.; Wilson, Emily; Leach, David R. F.] Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Leach, DRF (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	D.Leach@ed.ac.uk	Leach, David R/H-7159-2012	Leach, David R/0000-0003-4964-6913; Lopez Vernaza, Manuel Augusto/0000-0002-9542-7028; Eykelenboom, John/0000-0003-4115-9686; White, Martin/0000-0001-6482-8462	Medical Research Council; MRC [G0401313] Funding Source: UKRI; Medical Research Council [G0401313] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank D. Sherratt for the gifts of plasmids pWX6, pLau43 and pLau44. We also thank E. Darmon and J. Blackwood for reading the manuscript. This work was supported by the Medical Research Council.	CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Darmon E, 2007, J BACTERIOL, V189, P6686, DOI 10.1128/JB.00489-07; Eykelenboom JK, 2008, MOL CELL, V29, P644, DOI 10.1016/j.molcel.2007.12.020; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Karczmarek A, 2007, MOL MICROBIOL, V65, P51, DOI 10.1111/j.1365-2958.2007.05777.x; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kruse T, 2006, GENE DEV, V20, P113, DOI 10.1101/gad.366606; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Lew DJ, 2008, CELL, V133, P21, DOI 10.1016/j.cell.2008.03.016; MASON DJ, 1956, J BACTERIOL, V71, P474, DOI 10.1128/JB.71.4.474-479.1956; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; Niki H, 2000, GENE DEV, V14, P212; Pinder DJ, 1998, MOL MICROBIOL, V28, P719, DOI 10.1046/j.1365-2958.1998.00831.x; Possoz C, 2006, EMBO J, V25, P2596, DOI 10.1038/sj.emboj.7601155; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Rocha EPC, 2003, MOL MICROBIOL, V49, P895, DOI 10.1046/j.1365-2958.2003.03606.x; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; SKARSTAD K, 1993, J BACTERIOL, V175, P5505, DOI 10.1128/JB.175.17.5505-5509.1993; Thanbichler M, 2008, NAT REV MICROBIOL, V6, P28, DOI 10.1038/nrmicro1795; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wang XD, 2005, GENE DEV, V19, P2367, DOI 10.1101/gad.345305; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Woldringh CL, 2006, J STRUCT BIOL, V156, P273, DOI 10.1016/j.jsb.2006.04.013; Yamaichi Y, 2004, EMBO J, V23, P221, DOI 10.1038/sj.emboj.7600028	30	58	58	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2008	455	7217					1248	1250		10.1038/nature07282	http://dx.doi.org/10.1038/nature07282			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18972020				2022-12-28	WOS:000260462100046
J	Ashworth, M; Medina, J; Morgan, M				Ashworth, Mark; Medina, Jibby; Morgan, Myfanwy			Effect of social deprivation on blood pressure monitoring and control in England: a survey of data from the quality and outcomes framework	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; DISEASE; HYPERTENSION; CARE; UK; INTERVENTIONS; PREVALENCE; MANAGEMENT; TRENDS	Objective To determine levels of blood pressure monitoring and control in primary care and to determine the effect of social deprivation on these levels. Design Retrospective longitudinal survey, 2005 to 2007. Setting General practices in England. Participants Data obtained from 8515 practices ( 99.3% of all practices) in year 1, 8264 ( 98.3%) in year 2, and 8192 ( 97.8%) in year 3. Main outcome measures Blood pressure indicators and chronic disease prevalence estimates contained within the UK quality and outcomes framework; social deprivation scores for each practice, ethnicity data obtained from the 2001 national census; general practice characteristics. Results In 2005, 82.3% of adults ( n= 52.8 m) had an up to date blood pressure recording; by 2007, this proportion had risen to 88.3% ( n= 53.2 m). Initially, there was a 1.7% gap between mean blood pressure recording levels in practices located in the least deprived fifth of communities compared with the most deprived fifth, but, three years later, this gap had narrowed to 0.2%. Achievement of target blood pressure levels in 2005 for practices located in the least deprived communities ranged from 71.0% ( 95% CI 70.4% to 71.6%) for diabetes to 85.1% ( 84.7% to 85.6%) for coronary heart disease; practices in the most deprived communities achieved 68.9% ( 68.4% to 69.5%) and 81.8 % ( 81.3% to 82.3%) respectively. Three years later, target achievement in the least deprived practices had risen to 78.6% ( 78.1% to 79.1%) and 89.4% ( 89.1% to 89.7%) respectively. Target achievement in the most deprived practices rose similarly, to 79.2% ( 78.8% to 79.6%) and 88.4% ( 88.2% to 88.7%) respectively. Similar changes were observed for the achievement of blood pressure targets in hypertension, cerebrovascular disease, and chronic kidney disease. Conclusions Since the reporting of performance indicators for primary care and the incorporation of pay for performance in 2004, blood pressure monitoring and control have improved substantially. Improvements in achievement have been accompanied by the near disappearance of the achievement gap between least and most deprived areas.	[Ashworth, Mark] Kings Coll London, Dept Gen Practice & Primary Care, Div Hlth & Social Care Res, London SE11 6SP, England; [Medina, Jibby; Morgan, Myfanwy] Kings Coll London, Dept Publ Hlth Sci, Div Hlth & Social Care Res, London SE11 6SP, England	University of London; King's College London; University of London; King's College London	Ashworth, M (corresponding author), Kings Coll London, Dept Gen Practice & Primary Care, Div Hlth & Social Care Res, London SE11 6SP, England.	mark.ashworth@kcl.ac.uk		Ashworth, Mark/0000-0001-6514-9904; Morgan, Myfanwy/0000-0001-5532-8941	King's College Centre for Caribbean Health	King's College Centre for Caribbean Health	JM was supported by a grant from the King's College Centre for Caribbean Health.	Ashworth M, 2007, BRIT J GEN PRACT, V57, P441; Baker D, 2003, J EPIDEMIOL COMMUN H, V57, P417, DOI 10.1136/jech.57.6.417; Campbell SM, 2005, BMJ-BRIT MED J, V331, P1121, DOI 10.1136/bmj.38632.611123.AE; Cappuccio FP, 1997, HEART, V78, P555, DOI 10.1136/hrt.78.6.555; Chen R, 2003, J HUM HYPERTENS, V17, P751, DOI 10.1038/sj.jhh.1001612; *COMM LOC GOV, ENGL IND DEPR 2004 S; Connell P, 2005, BRIT J GEN PRACT, V55, P357; de Lusignan S, 2005, FAM PRACT, V22, P234, DOI 10.1093/fampra/cmi026; *DEP HLTH, 2008, VASC CHECKS WILL PRE; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; He FJ, 2003, J HUM HYPERTENS, V17, P455, DOI 10.1038/sj.jhh.1001581; Horsfield Pete, 2003, Inform Prim Care, V11, P137; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; *NAT STAT, BEG GUID UK GEOGR SU; Odell SM, 1997, BRIT J PSYCHIAT, V171, P537, DOI 10.1192/bjp.171.6.537; Primatesta P, 2006, J HYPERTENS, V24, P1187, DOI 10.1097/01.hjh.0000226210.95936.bc; SPROSTON K, 2003, HLTH SURVEY ENGLAND, V1; Strong M, 2006, J PUBLIC HEALTH, V28, P39, DOI 10.1093/pubmed/fdi065; Swales JD, 1999, J HYPERTENS, V17, pS15; *UK DEP HLTH, 2003, INV GEN PRACT NEW GM; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10	23	73	73	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2008	337								a2030	10.1136/bmj.a2030	http://dx.doi.org/10.1136/bmj.a2030			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375QT	18957697	hybrid, Green Published			2022-12-28	WOS:000261129100001
J	Parsons, J; Wand, Y				Parsons, Jeffrey; Wand, Yair			A question of class	NATURE			English	Editorial Material									[Parsons, Jeffrey] Mem Univ Newfoundland, St John, NF A1C 5S7, Canada; [Wand, Yair] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	Memorial University Newfoundland; University of British Columbia	Parsons, J (corresponding author), Mem Univ Newfoundland, St John, NF A1C 5S7, Canada.	jeffreyp@mun.ca; yair.wand@ubc.ca	Parsons, Jeffrey/AAF-3380-2020	Parsons, Jeffrey/0000-0002-4819-2801					0	22	22	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1040	1041		10.1038/4551040a	http://dx.doi.org/10.1038/4551040a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	363FG	18948935	Bronze			2022-12-28	WOS:000260252600020
J	Perrotta, S; Gallagher, PG; Mohandas, N				Perrotta, Silverio; Gallagher, Patrick G.; Mohandas, Narla			Hereditary spherocytosis	LANCET			English	Review							RED-CELL SKELETON; INCREASED OSMOTIC FRAGILITY; ANEMIA TYPE-II; BAND-3 DEFICIENCY; ANKYRIN GENE; SUBTOTAL SPLENECTOMY; SPECTRIN DEFICIENCY; FRAMESHIFT MUTATION; HEMOLYTIC-ANEMIA; MOLECULAR-BASIS	Hereditary spherocytosis is a common inherited disorder that is characterised by anaemia, jaundice, and splenomegaly. It is reported worldwide and is the most common inherited anaemia in individuals of northern European ancestry. Clinical severity is variable with most patients having a well-compensated haemolytic anaemia. Some individuals are asymptomatic, whereas others have severe haemolytic anaemia requiring erythrocyte transfusion. The primary lesion in hereditary spherocytosis is loss of membrane surface area, leading to reduced deformability due to defects in the membrane proteins ankyrin, band 3, beta spectrin, alpha spectrin, or protein 4.2. Many isolated mutations have been identified in the genes encoding these membrane proteins; common hereditary spherocytosis-associated mutations have not been identified. Abnormal spherocytes are trapped and destroyed in the spleen and this is the main cause of haemolysis in this disorder. Common complications are cholelithiasis, haemolytic episodes, and aplastic crises. Splenectomy is curative but should be undertaken only after careful assessment of the risks and benefits.	[Perrotta, Silverio] Univ Naples 2, Dipartimento Pediat, I-80138 Naples, Italy; [Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Mohandas, Narla] New York Blood Ctr, New York, NY 10021 USA	Universita della Campania Vanvitelli; Yale University; New York Blood Center	Perrotta, S (corresponding author), Univ Naples 2, Dipartimento Pediat, Via S Andrea Dame 4, I-80138 Naples, Italy.	silverio.perrotta@unina2.it		Perrotta, Silverio/0000-0001-6149-6845	Progetti di Rilevante Interesse Nazionale, Agenzia Italiana del Farmaco, and Regione Campania [LR 5/02, 2005, DK62039, HK65488, DK26263]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK026263, R01DK026263, R01DK062039] Funding Source: NIH RePORTER	Progetti di Rilevante Interesse Nazionale, Agenzia Italiana del Farmaco, and Regione Campania; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was partly provided by grants from Progetti di Rilevante Interesse Nazionale, Agenzia Italiana del Farmaco, and Regione Campania (LR 5/02, 2005) to SP, DK62039 and HK65488 to PGG, and DK26263 to NM.	AGRE P, 1982, NEW ENGL J MED, V306, P1155, DOI 10.1056/NEJM198205133061906; AGRE P, 1986, NEW ENGL J MED, V315, P1579, DOI 10.1056/NEJM198612183152504; Akar N, 2002, PEDIATR HEMAT ONCOL, V19, P569, DOI 10.1080/08880010290097431; Alloisio N, 1997, BLOOD, V90, P414; Alloisio N, 1996, BLOOD, V88, P1062; An XL, 2007, BLOOD, V109, P1284, DOI 10.1182/blood-2006-07-036954; Bader-Meunier B, 2001, BLOOD, V97, P399, DOI 10.1182/blood.V97.2.399; Balaguer EJ, 2006, J SURG RES, V134, P68, DOI 10.1016/j.jss.2006.02.053; BECKER PS, 1993, J CLIN INVEST, V92, P612, DOI 10.1172/JCI116628; Bellows CF, 2005, AM FAM PHYSICIAN, V72, P637; Berardi A, 2006, BIOL NEONATE, V90, P243, DOI 10.1159/000093668; Boguslawska DM, 2004, ANN HEMATOL, V83, P28, DOI 10.1007/s00277-003-0739-5; Bolton-Maggs PHB, 2004, BRIT J HAEMATOL, V126, P455, DOI 10.1111/j.1365-2141.2004.05052.x; BOUHASSIRA EE, 1992, BLOOD, V79, P1846; Bracher NA, 2001, BRIT J HAEMATOL, V113, P689, DOI 10.1046/j.1365-2141.2001.02800.x; Brown KE, 2000, BEST PRACT RES CL HA, V13, P245, DOI 10.1053/beha.1999.0071; Bruce LJ, 2005, NAT GENET, V37, P1258, DOI 10.1038/ng1656; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Bruce LJ, 2002, BLOOD, V100, P1878, DOI 10.1182/blood-2002-03-0706; Calhoun SK, 2001, PEDIATR RADIOL, V31, P879, DOI 10.1007/s002470100011; Cartron JP, 1999, BEST PRACT RES CL HA, V12, P655, DOI 10.1053/beha.1999.0047; Cartron JP, 2001, LANCET, pS57, DOI 10.1016/S0140-6736(01)07069-6; Castagnola E, 2003, EUR J HAEMATOL, V71, P319, DOI 10.1034/j.1600-0609.2003.00158.x; Caterino M, 2006, FEBS LETT, V580, P6527, DOI 10.1016/j.febslet.2006.10.070; Cavill I, 1996, BRIT MED J, V312, P430; CHASIS JA, 1988, J CLIN INVEST, V82, P617, DOI 10.1172/JCI113640; Cherif-Zahar B, 1998, BLOOD, V92, P2535, DOI 10.1182/blood.V92.7.2535.2535_2535_2540; CLARK MR, 1983, BLOOD, V61, P899, DOI 10.1182/blood.V61.5.899.899; Curro G, 2006, SURG ENDOSC, V20, P252, DOI 10.1007/s00464-005-0318-z; Cynober T, 1996, J LAB CLIN MED, V128, P259, DOI 10.1016/S0022-2143(96)90027-X; Da Costa L, 2001, BLOOD, V98, P2894, DOI 10.1182/blood.V98.10.2894; DACIE J, 1985, HAEMOLYTIC ANAEMIA, P134; Dacie JV, 1991, PRACTICAL HAEMATOLOG, P195; Danise P, 2001, CLIN LAB HAEMATOL, V23, P7, DOI 10.1046/j.1365-2257.2001.00354.x; Davies JM, 2002, CLIN MED, V2, P440, DOI 10.7861/clinmedicine.2-5-440; del Giudice EM, 2001, BRIT J HAEMATOL, V112, P42; del Giudice EM, 1999, BLOOD, V94, P2259, DOI 10.1182/blood.V94.7.2259.419k42_2259_2262; del Giudice EM, 1998, BRIT J HAEMATOL, V101, P251, DOI 10.1046/j.1365-2141.1998.00688.x; del Giudice EM, 1998, J PEDIATR-US, V132, P117; Delaunay J, 2004, BRIT J HAEMATOL, V127, P118, DOI 10.1111/j.1365-2141.2004.05160.x; Delaunay J, 2007, BLOOD REV, V21, P1, DOI 10.1016/j.blre.2006.03.005; delGiudice EM, 1997, HAEMATOLOGICA, V82, P332; DELGIUDICE EM, 1994, BRIT J HAEMATOL, V88, P52; Delhommeau F, 2000, BLOOD, V95, P393, DOI 10.1182/blood.V95.2.393; Dhermy D, 1997, BRIT J HAEMATOL, V98, P32, DOI 10.1046/j.1365-2141.1997.1893005.x; Dhermy D, 2000, CLIN LAB HAEMATOL, V22, P329, DOI 10.1046/j.1365-2257.2000.00319.x; Discher DE, 2001, CELL MOL BIOL LETT, V6, P593; Eber S, 2004, SEMIN HEMATOL, V41, P118, DOI 10.1053/j.seminhematol.2004.01.002; Eber SW, 1996, NAT GENET, V13, P214, DOI 10.1038/ng0696-214; EBER SW, 1992, ANN HEMATOL, V64, P88, DOI 10.1007/BF01715351; Eber SW, 1999, ANN HEMATOL, V78, P524, DOI 10.1007/s002770050550; EBER SW, 1990, J PEDIATR-US, V117, P409, DOI 10.1016/S0022-3476(05)81081-9; Edelman EJ, 2007, BLOOD, V109, P5491, DOI 10.1182/blood-2006-09-046573; Farah RA, 1997, J PEDIATR-US, V131, P41, DOI 10.1016/S0022-3476(97)70122-7; Gallagher P., 2003, HEMATOLOGY INFANCY C, P560; Gallagher P. G., 2005, HEMATOLOGY BASIC PRI, P669; Gallagher Patrick G, 2004, Curr Hematol Rep, V3, P85; Gallagher PG, 2005, BLOOD CELL MOL DIS, V35, P345, DOI 10.1016/j.bcmd.2005.08.008; Gallagher PG, 2005, HUM MOL GENET, V14, P2501, DOI 10.1093/hmg/ddi254; Gallagher PG, 2001, J BIOL CHEM, V276, P41683, DOI 10.1074/jbc.M105844200; GALLAGHER PG, 1995, J CLIN INVEST, V95, P1174, DOI 10.1172/JCI117766; Gallagher PG, 2000, BRIT J HAEMATOL, V111, P1190, DOI 10.1046/j.1365-2141.2000.02441.x; GALLAGHER PG, 2005, HEMATOLOGY BASIC PRI, P576; Giraldi S, 2003, PEDIATR DERMATOL, V20, P427, DOI 10.1046/j.1525-1470.2003.20512.x; GODAL HC, 1981, SCAND J HAEMATOL, V27, P30; Guarnone R, 1996, BRIT J HAEMATOL, V92, P150, DOI 10.1046/j.1365-2141.1996.00285.x; Hansen K, 2001, PEDIATR DEVEL PATHOL, V4, P105, DOI 10.1007/s100240010145; HANSPAL M, 1991, BLOOD, V77, P165; Hassoun H, 1997, BLOOD, V90, P398; Heimpel H, 2003, BLOOD, V102, P4576, DOI 10.1182/blood-2003-02-0613; Hery G, 2008, SURG ENDOSC, V22, P45, DOI 10.1007/s00464-007-9509-0; Huang CH, 2000, SEMIN HEMATOL, V37, P150, DOI 10.1016/S0037-1963(00)90040-4; Iolascon A, 1998, BLOOD, V91, P1093, DOI 10.1182/blood.V91.3.1093; Iolascon Achille, 2003, Rev Clin Exp Hematol, V7, P22; Jalbert F, 2005, J NEUROSURG-SPINE, V2, P491, DOI 10.3171/spi.2005.2.4.0491; Jardine DL, 2004, INTERN MED J, V34, P214, DOI 10.1111/j.1444-0903.2004.00580.x; Jarolim P, 1996, BLOOD, V88, P4366; JAROLIM P, 1994, J CLIN INVEST, V93, P121, DOI 10.1172/JCI116935; JAROLIM P, 1995, BLOOD, V85, P3278, DOI 10.1182/blood.V85.11.3278.bloodjournal85113278; JENSSON O, 1977, ACTA MED SCAND, V201, P187; Jugenburg M, 1999, J PEDIATR SURG, V34, P1064, DOI 10.1016/S0022-3468(99)90565-1; Kaplinsky C, 2006, PEDIATR BLOOD CANCER, V47, P740, DOI 10.1002/pbc.21014; Kedar PS, 2004, CLIN CHIM ACTA, V344, P221, DOI 10.1016/j.cccn.2004.02.021; Kerr R, 2000, CLIN LAB HAEMATOL, V22, P365, DOI 10.1046/j.1365-2257.2000.00338.x; Kimura F, 2003, AM J ROENTGENOL, V181, P1021, DOI 10.2214/ajr.181.4.1811021; King MJ, 2004, BRIT J HAEMATOL, V124, P106, DOI 10.1046/j.1365-2141.2003.04730.x; KORONES D, 1989, J PEDIATR-US, V114, P264, DOI 10.1016/S0022-3476(89)80794-2; Kutter Dolphe, 2002, Clin Lab, V48, P163; Lee JCM, 2001, BIOPHYS J, V81, P3178, DOI 10.1016/S0006-3495(01)75954-1; Lima PRM, 2005, EUR J HAEMATOL, V74, P396, DOI 10.1111/j.1600-0609.2004.00405.x; LUX SE, 1990, NATURE, V345, P736, DOI 10.1038/345736a0; MACKENZIE FA, 1962, LANCET, V1, P1102; MARTINEZCLIMENT JA, 1995, EUR J PEDIATR, V154, P753, DOI 10.1007/BF02276723; MCLANE NJ, 1984, AM J OPHTHALMOL, V97, P444, DOI 10.1016/S0002-9394(14)76127-6; MOHANDAS N, 1993, SEMIN HEMATOL, V30, P171; MOHANDAS N, 1986, BLOOD, V68, P506; Mohler PJ, 2005, FRONT BIOSCI, V10, P2832, DOI 10.2741/1739; MOTTA M, 1999, SURG LAPARO ENDO PER, V9, P203; Mouro-Chanteloup I, 2003, BLOOD, V101, P338, DOI 10.1182/blood-2002-04-1285; Nicolas V, 2003, J BIOL CHEM, V278, P25526, DOI 10.1074/jbc.M302816200; Ozcan R, 2003, BRIT J HAEMATOL, V122, P669, DOI 10.1046/j.1365-2141.2003.04479.x; PAJOR A, 1993, ARCH GYNECOL OBSTET, V253, P37, DOI 10.1007/BF02770632; PEKRUN A, 1993, ANN HEMATOL, V67, P89, DOI 10.1007/BF01788132; Perrotta S, 2005, BLOOD, V106, P4359, DOI 10.1182/blood-2005-07-2806; Perrotta S, 1999, HAEMATOLOGICA, V84, P660; Perrotta S, 1999, BLOOD, V93, P2131; Peters LL, 2004, BLOOD, V103, P3233, DOI 10.1182/blood-2003-08-2813; PINTO L, 1995, INT J PEDIAT HEM ONC, V2, P43; Premetis EVANGELOS, 1999, Hematology, V4, P361; Price VE, 2006, PEDIATR BLOOD CANCER, V46, P597, DOI 10.1002/pbc.20477; Reliene R, 2002, BLOOD, V100, P2208, DOI 10.1182/blood.V100.6.2208.h81802002208_2208_2215; Rescorla FJ, 2002, AM SURGEON, V68, P297; Rescorla FJ, 2007, ANN SURG, V246, P683, DOI 10.1097/SLA.0b013e318155abb9; Ribeiro ML, 2000, BLOOD, V96, P1602; Ricard MP, 2000, HAEMATOLOGICA, V85, P994; Ricard MP, 1996, CLIN LAB HAEMATOL, V18, P75, DOI 10.1046/j.1365-2257.1996.00157.x; Rice HE, 2003, ANN SURG, V237, P281, DOI 10.1097/00000658-200302000-00019; Saada V, 2006, PEDIATR HEMAT ONCOL, V23, P387, DOI 10.1080/08880010600646662; Sanchez-Lopez JY, 2003, BLOOD CELL MOL DIS, V31, P357, DOI 10.1016/S1079-9796(03)00207-9; Sandler A, 1999, J PEDIATR SURG, V34, P1077, DOI 10.1016/S0022-3468(99)90569-9; SAVVIDES P, 1993, BLOOD, V82, P2953; SCHILLING RF, 1995, ANN INTERN MED, V122, P187, DOI 10.7326/0003-4819-122-3-199502010-00005; Schilling RF, 1997, LANCET, V350, P1677, DOI 10.1016/S0140-6736(05)64276-6; Schilling RF, 2006, AM J HEMATOL, V81, P315, DOI 10.1002/ajh.20566; SCHROTER W, 1983, J PEDIATR-US, V103, P460, DOI 10.1016/S0022-3476(83)80428-4; Shatz DV, 2005, EXPERT REV VACCINES, V4, P27, DOI 10.1586/14760584.4.1.27; Stewart GW, 1996, BRIT J HAEMATOL, V93, P303, DOI 10.1046/j.1365-2141.1996.4881033.x; Stoehr GA, 2006, BRIT J HAEMATOL, V132, P791, DOI 10.1111/j.1365-2141.2005.05956.x; Stoehr GA, 2006, BRIT J HAEMATOL, V132, P788, DOI 10.1111/j.1365-2141.2005.05918.x; Stoya G, 2006, ACTA HAEMATOL-BASEL, V116, P186, DOI 10.1159/000094679; SUMMERFIELD GP, 1985, LANCET, V2, P1070; Tamary H, 2003, J PEDIAT HEMATOL ONC, V25, P952, DOI 10.1097/00043426-200312000-00009; Tanner MJA, 2002, CURR OPIN HEMATOL, V9, P133, DOI 10.1097/00062752-200203000-00009; Tchernia G, 2000, Hematol J, V1, P146, DOI 10.1038/sj.thj.6200022; TCHERNIA G, 1993, BLOOD, V81, P2014; Tewari M, 2006, J SURG ONCOL, V93, P629, DOI 10.1002/jso.20529; Toye AM, 2005, BLOOD, V105, P4088, DOI 10.1182/blood-2004-05-1895; Troendle SB, 2007, PEDIATR BLOOD CANCER, V49, P781, DOI 10.1002/pbc.21319; Ustun C, 2003, ACTA HAEMATOL-BASEL, V109, P46, DOI 10.1159/000067273; Van Dort HM, 2001, J BIOL CHEM, V276, P46968, DOI 10.1074/jbc.M107855200; Vasilescu C, 2006, SURG ENDOSC, V20, P748, DOI 10.1007/s00464-005-0429-6; Vermeulen S, 2002, AM J MED GENET, V108, P315, DOI 10.1002/ajmg.10295; Wandersee NJ, 2004, BLOOD, V103, P710, DOI 10.1182/blood-2003-02-0492; WHITFIELD CF, 1991, BLOOD, V78, P3043; Wichterle H, 1996, J CLIN INVEST, V98, P2300, DOI 10.1172/JCI119041; Wong EY, 2004, J BIOL CHEM, V279, P55024, DOI 10.1074/jbc.M408886200; Yawata Y, 2000, INT J HEMATOL, V71, P118	147	384	403	1	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2008	372	9647					1411	1426		10.1016/S0140-6736(08)61588-3	http://dx.doi.org/10.1016/S0140-6736(08)61588-3			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362WP	18940465				2022-12-28	WOS:000260228200028
J	Bakal, C; Linding, R; Llense, F; Heffern, E; Martin-Blanco, E; Pawson, T; Perrimon, N				Bakal, Chris; Linding, Rune; Llense, Flora; Heffern, Elleard; Martin-Blanco, Enrique; Pawson, Tony; Perrimon, Norbert			Phosphorylation networks regulating JNK activity in diverse genetic backgrounds	SCIENCE			English	Article							RECEPTOR TYROSINE KINASE; CELL POLARITY; DORSAL CLOSURE; DROSOPHILA; PATHWAY; PHOSPHATASE; MOVEMENT; INVASION; ENCODES; PROTEIN	Cellular signaling networks have evolved to enable swift and accurate responses, even in the face of genetic or environmental perturbation. Thus, genetic screens may not identify all the genes that regulate different biological processes. Moreover, although classical screening approaches have succeeded in providing parts lists of the essential components of signaling networks, they typically do not provide much insight into the hierarchical and functional relations that exist among these components. We describe a high-throughput screen in which we used RNA interference to systematically inhibit two genes simultaneously in 17,724 combinations to identify regulators of Drosophila JUN NH(2)-terminal kinase (JNK). Using both genetic and phosphoproteomics data, we then implemented an integrative network algorithm to construct a JNK phosphorylation network, which provides structural and mechanistic insights into the systems architecture of JNK signaling.	[Bakal, Chris; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA; [Bakal, Chris; Heffern, Elleard; Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02215 USA; [Linding, Rune] Inst Canc Res, Cellular & Mol Log Team, London SW3 6JB, England; [Llense, Flora; Martin-Blanco, Enrique] CSIC, Spanish Council Sci Res, Inst Biol Mol Barcelona, E-08028 Barcelona, Spain; [Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bakal, C (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02215 USA.	cbakal@receptor.med.harvard.edu	Pawson, Tony J/E-4578-2013; Martin-Blanco, Enrique/ABH-1280-2020	Martin-Blanco, Enrique/0000-0002-6926-910X; Perrimon, Norbert/0000-0001-7542-472X; Linding, Rune/0000-0003-0420-4839; Bakal, Chris/0000-0002-0413-6744	Genome Canada; Spanish Ministerio de Ciencia e Innovacion (BFU/Consolider 2007); European Union (FP6)	Genome Canada(Genome Canada); Spanish Ministerio de Ciencia e Innovacion (BFU/Consolider 2007)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union (FP6)(European Commission)	We are deeply indebted to the Drosophila RNAi Screening Center and to J. Aach, S. Lee, C. Jorgensen, B. Mathey-Prevot, and B. Bodenmiller. The NetworKIN and NetPhorest algorithms are available at http://networkin.info and http://NetPhorest.info, respectively. This work is supported by Genome Canada through the Ontario Genomics Institute, the Spanish Ministerio de Ciencia e Innovacion (BFU/Consolider 2007), and the European Union (FP6). C.B. is a Fellow of the Leukemia and Lymphoma Society. N.P. is an Investigator of the Howard Hughes Medical Institute.	AFFOLTER M, 1994, DEVELOPMENT, V120, P3105; Bodenmiller B, 2007, MOL BIOSYST, V3, P275, DOI 10.1039/b617545g; Chiariello M, 1998, ONCOGENE, V16, P2435, DOI 10.1038/sj.onc.1201778; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Felix MA, 2008, HEREDITY, V100, P132, DOI 10.1038/sj.hdy.6800915; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Massimi P, 2003, EXP CELL RES, V290, P265, DOI 10.1016/S0014-4827(03)00317-3; Murray MJ, 2006, DEVELOPMENT, V133, P3063, DOI 10.1242/dev.02467; Primo L, 2007, J CELL BIOL, V176, P1035, DOI 10.1083/jcb.200607053; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005	23	99	101	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					453	456		10.1126/science.1158739	http://dx.doi.org/10.1126/science.1158739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927396	Green Accepted			2022-12-28	WOS:000260094500050
J	Cheng, MH				Cheng, Margaret Harris			Nigeria struggles to contain poliomyelitis	LANCET			English	News Item																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1287	1290		10.1016/S0140-6736(08)61534-2	http://dx.doi.org/10.1016/S0140-6736(08)61534-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18946911	Bronze			2022-12-28	WOS:000260060500011
J	Chivian, D; Brodie, EL; Alm, EJ; Culley, DE; Dehal, PS; DeSantis, TZ; Gihring, TM; Lapidus, A; Lin, LH; Lowry, SR; Moser, DP; Richardson, PM; Southam, G; Wanger, G; Pratt, LM; Andersen, GL; Hazen, TC; Brockman, FJ; Arkin, AP; Onstott, TC				Chivian, Dylan; Brodie, Eoin L.; Alm, Eric J.; Culley, David E.; Dehal, Paramvir S.; DeSantis, Todd Z.; Gihring, Thomas M.; Lapidus, Alla; Lin, Li-Hung; Lowry, Stephen R.; Moser, Duane P.; Richardson, Paul M.; Southam, Gordon; Wanger, Greg; Pratt, Lisa M.; Andersen, Gary L.; Hazen, Terry C.; Brockman, Fred J.; Arkin, Adam P.; Onstott, Tullis C.			Environmental genomics reveals a single-species ecosystem deep within earth	SCIENCE			English	Article							COMMUNITY STRUCTURE; SOUTH-AFRICA; SUBSURFACE; DIVERSITY; PROKARYOTES; METABOLISM; BACTERIUM; WATER; SEA	DNA from low-biodiversity fracture water collected at 2.8-kilometer depth in a South African gold mine was sequenced and assembled into a single, complete genome. This bacterium, Candidatus Desulforudis audaxviator, composes > 99.9% of the microorganisms inhabiting the fluid phase of this particular fracture. Its genome indicates a motile, sporulating, sulfate-reducing, chemoautotrophic thermophile that can fix its own nitrogen and carbon by using machinery shared with archaea. Candidatus Desulforudis audaxviator is capable of an independent life-style well suited to long-term isolation from the photosphere deep within Earth's crust and offers an example of a natural ecosystem that appears to have its biological component entirely encoded within a single genome.	[Chivian, Dylan; Dehal, Paramvir S.; Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Chivian, Dylan; Brodie, Eoin L.; Alm, Eric J.; Dehal, Paramvir S.; DeSantis, Todd Z.; Andersen, Gary L.; Hazen, Terry C.; Arkin, Adam P.] Virtual Inst Microbial Stress & Survival, Berkeley, CA 94720 USA; [Brodie, Eoin L.; DeSantis, Todd Z.; Andersen, Gary L.; Hazen, Terry C.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Alm, Eric J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Alm, Eric J.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Culley, David E.] Pacific NW Natl Lab, Energy & Efficiency Technol Div, Richland, WA 99352 USA; [Gihring, Thomas M.] Florida State Univ, Dept Oceanog, Tallahassee, FL 32306 USA; [Lapidus, Alla; Lowry, Stephen R.; Richardson, Paul M.] US DOE, Joint Genom Inst, Genom Technol Program, Berkeley, CA 94598 USA; [Lin, Li-Hung] Natl Taiwan Univ, Dept Geosci, Taipei 106, Taiwan; [Moser, Duane P.] Desert Res Inst, Div Earth & Ecosyst Sci, Las Vegas, NV 89119 USA; [Southam, Gordon; Wanger, Greg] Univ Western Ontario, Dept Earth Sci, London, ON N6A 5B7, Canada; [Pratt, Lisa M.] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Pratt, Lisa M.; Hazen, Terry C.; Onstott, Tullis C.] NASA Astrobiol Inst, IPTAI, Bloomington, IN 47405 USA; [Brockman, Fred J.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Onstott, Tullis C.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Pacific Northwest National Laboratory; State University System of Florida; Florida State University; United States Department of Energy (DOE); National Taiwan University; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Western University (University of Western Ontario); Indiana University System; Indiana University Bloomington; National Aeronautics & Space Administration (NASA); United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of California System; University of California Berkeley; Princeton University	Chivian, D (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	DCChivian@lbl.gov	Arkin, Adam P/A-6751-2008; Lapidus, Alla L/I-4348-2013; Lin, Li-Hung/K-8091-2012; Andersen, Gary/G-2792-2015; Arkin, Adam/M-9941-2019; Hazen, Terry C/C-1076-2012; Brodie, Eoin L/A-7853-2008; Southam, Gordon/D-1983-2013	Arkin, Adam P/0000-0002-4999-2931; Lapidus, Alla L/0000-0003-0427-8731; Andersen, Gary/0000-0002-1618-9827; Arkin, Adam/0000-0002-4999-2931; Hazen, Terry C/0000-0002-2536-9993; Brodie, Eoin L/0000-0002-8453-8435; Southam, Gordon/0000-0002-8941-1249; Onstott, Tullis/0000-0002-2898-3374; Chivian, Dylan/0000-0001-8189-8729; Lin, Li-Hung/0000-0002-0985-1464	DOE, Office of Science, Office of Biological and Environmental Research, Genomics Program: GTL [DE-AC02-05CH11231]; NASA Astrobiology Institute [NNA01CC03A]; Howard Hughes Medical Institute	DOE, Office of Science, Office of Biological and Environmental Research, Genomics Program: GTL(United States Department of Energy (DOE)); NASA Astrobiology Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank J. Banfield and G. Tyson for helpful discussion; J. Bruckner and B. Baker for assistance with microscopy; F. Warnecke for advice on 16S fluorescent in situ hybridization; T. Kieft, G. Zane, and the MicrobesOnline team (M. Price, K. Keller, and K. Huang) for advice; and D. Kershaw and colleagues at the Mponeng mine and AngloGold Ashanti Limited, RSA. This work was part of the Virtual Institute for Microbial Stress and Survival (http://vimss.lbl.gov), supported by DOE, Office of Science, Office of Biological and Environmental Research, Genomics Program: GTL through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and DOE. This work was also supported by the NASA Astrobiology Institute through award NNA01CC03A to the IPTAI Team co-directed by L.M.P. and T.C.O. A.P.A. received support from the Howard Hughes Medical Institute. The genome sequence and 16S library sequences reported in this study have been deposited in GenBank under the accession numbers CP000860 and EU730965 to EU731008, respectively.	Alm EJ, 2005, GENOME RES, V15, P1015, DOI 10.1101/gr.3844805; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beja O, 2000, ENVIRON MICROBIOL, V2, P516, DOI 10.1046/j.1462-2920.2000.00133.x; Chapelle FH, 2002, NATURE, V415, P312, DOI 10.1038/415312a; Deutschbauer AM, 2006, CURR OPIN BIOTECH, V17, P229, DOI 10.1016/j.copbio.2006.04.003; Drake HL, 2004, RES MICROBIOL, V155, P868, DOI 10.1016/j.resmic.2004.10.001; Gihring TM, 2006, GEOMICROBIOL J, V23, P415, DOI 10.1080/01490450600875696; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Lefticariu L, 2006, GEOCHIM COSMOCHIM AC, V70, P4889, DOI 10.1016/j.gca.2006.07.026; Lin LH, 2006, SCIENCE, V314, P479, DOI 10.1126/science.1127376; Mehta MP, 2006, SCIENCE, V314, P1783, DOI 10.1126/science.1134772; Moser DP, 2005, APPL ENVIRON MICROB, V71, P8773, DOI 10.1128/AEM.71.12.8773-8783.2005; Moser DP, 2003, GEOMICROBIOL J, V20, P517, DOI 10.1080/713851170; Mussmann M, 2005, J BACTERIOL, V187, P7126, DOI 10.1128/JB.187.20.7126-7137.2005; Onstott TC, 2006, GEOMICROBIOL J, V23, P369, DOI 10.1080/01490450600875688; PHELPS TJ, 1994, MICROBIAL ECOL, V28, P335, DOI 10.1007/BF00662027; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wanger G, 2006, GEOMICROBIOL J, V23, P443, DOI 10.1080/01490450600875746; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065; Zverlov V, 2005, J BACTERIOL, V187, P2203, DOI 10.1128/JB.187.6.2203-2208.2005	26	306	320	6	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					275	278		10.1126/science.1155495	http://dx.doi.org/10.1126/science.1155495			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845759	Green Submitted			2022-12-28	WOS:000259902300053
J	Stanley, JC				Stanley, James C.			Saturday	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jstanley@umich.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2008	300	14					1629	1629		10.1001/jama.300.14.1629	http://dx.doi.org/10.1001/jama.300.14.1629			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356YF	18840825				2022-12-28	WOS:000259812800001
J	Wright, AA; Zhang, BH; Ray, A; Mack, JW; Trice, E; Balboni, T; Mitchell, SL; Jackson, VA; Block, SD; Maciejewski, PK; Prigerson, HG				Wright, Alexi A.; Zhang, Baohui; Ray, Alaka; Mack, Jennifer W.; Trice, Elizabeth; Balboni, Tracy; Mitchell, Susan L.; Jackson, Vicki A.; Block, Susan D.; Maciejewski, Paul K.; Prigerson, Holly G.			Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVANCED CANCER-PATIENTS; TREATMENT PREFERENCES; FAMILY CAREGIVERS; IMMINENT DEATH; SERIOUSLY ILL; BAD-NEWS; COMMUNICATION; PROGNOSIS; PHYSICIANS; ILLNESS	Context Talking about death can be difficult. Without evidence that end- of- life discussions improve patient outcomes, physicians must balance their desire to honor patient autonomy against a concern of inflicting psychological harm. Objective To determine whether end- of- life discussions with physicians are associated with fewer aggressive interventions. Design, Setting, and Participants A US multisite, prospective, longitudinal cohort study of patients with advanced cancer and their informal caregivers ( n= 332 dy-ads), September 2002- February 2008. Patients were followed up from enrollment to death, a median of 4.4 months later. Bereaved caregivers' psychiatric illness and quality of life was assessed a median of 6.5 months later. Main Outcome Measures Aggressive medical care ( eg, ventilation, resuscitation) and hospice in the final week of life. Secondary outcomes included patients' mental health and caregivers' bereavement adjustment. Results One hundred twenty- three of 332 ( 37.0%) patients reported having end-of-life discussions before baseline. Such discussions were not associated with higher rates of major depressive disorder ( 8.3% vs 5.8%; adjusted odds ratio [ OR], 1.33; 95% confidence interval [ CI], 0.54- 3.32), or more worry ( mean McGill score, 6.5 vs 7.0; P=. 19). After propensity- score weighted adjustment, end- of- life discussions were associated with lower rates of ventilation ( 1.6% vs 11.0%; adjusted OR, 0.26; 95% CI, 0.08- 0.83), resuscitation ( 0.8% vs 6.7%; adjusted OR, 0.16; 95% CI, 0.03- 0.80), ICU admission ( 4.1% vs 12.4%; adjusted OR, 0.35; 95% CI, 0.14- 0.90), and earlier hospice enrollment ( 65.6% vs 44.5%; adjusted OR, 1.65; 95% CI, 1.04- 2.63). In adjusted analyses, more aggressive medical care was associated with worse patient quality of life ( 6.4 vs 4.6; F= 3.61, P=. 01) and higher risk of major depressive disorder in bereaved caregivers ( adjusted OR, 3.37; 95% CI, 1.12- 10.13), whereas longer hospice stays were associated with better patient quality of life ( mean score, 5.6 vs 6.9; F= 3.70, P=. 01). Better patient quality of life was associated with better caregiver quality of life at follow- up (beta=. 20; P=. 001). Conclusions End- of- life discussions are associated with less aggressive medical care near death and earlier hospice referrals. Aggressive care is associated with worse patient quality of life and worse bereavement adjustment.	[Wright, Alexi A.; Trice, Elizabeth] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wright, Alexi A.; Zhang, Baohui; Ray, Alaka; Trice, Elizabeth; Balboni, Tracy; Block, Susan D.; Prigerson, Holly G.] Dana Farber Canc Inst, Ctr Psychooncol & Palliat Care Res, Boston, MA 02115 USA; [Mack, Jennifer W.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Outcomes & Policy Res, Boston, MA 02115 USA; [Ray, Alaka; Jackson, Vicki A.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Balboni, Tracy] Harvard Univ, Harvard Radiat Oncol Program, Boston, MA USA; [Jackson, Vicki A.; Block, Susan D.; Prigerson, Holly G.] Harvard Univ, Sch Med, Ctr Palliat Care, Boston, MA USA; [Mitchell, Susan L.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Block, Susan D.; Maciejewski, Paul K.; Prigerson, Holly G.] Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital	Wright, AA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 550 Shields Warren,44 Binney St, Boston, MA 02115 USA.	awright2@partners.org	Wright, Alexi/T-5793-2019; Prigerson, Holly/L-3800-2019; Prigerson, Holly/GWV-3283-2022; Balboni, Tracy/AAH-4490-2020	Prigerson, Holly/0000-0002-7075-4268; 	National Cancer Institute [CA 106370]; National Institute of Mental Health [MH63892]; National Cancer Institute's "Program in Cancer Outcomes Research Training" [CA 92044343]; Dana-Farber Cancer Institute's Friends Fellowship; NATIONAL CANCER INSTITUTE [T32CA009172, R01CA106370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG033640] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute's "Program in Cancer Outcomes Research Training"; Dana-Farber Cancer Institute's Friends Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants CA 106370 from the National Cancer Institute and MH63892 from the National Institute of Mental Health. Dr Wright was supported, in part, by grant CA 92044343, which is part of the National Cancer Institute's "Program in Cancer Outcomes Research Training" and by the Dana-Farber Cancer Institute's Friends Fellowship.	Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127; [Anonymous], 1999, DEATH FORETOLD PROPH; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Back Anthony L, 2003, Ann Intern Med, V138, P439; Baile WF, 2002, J CLIN ONCOL, V20, P2189, DOI 10.1200/JCO.2002.08.004; Balboni TA, 2007, J CLIN ONCOL, V25, P555, DOI 10.1200/JCO.2006.07.9046; CARALIS PV, 1993, J CLIN ETHIC, V4, P155; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cherlin E, 2005, J PALLIAT MED, V8, P1176, DOI 10.1089/jpm.2005.8.1176; Chu KC, 2007, J NATL MED ASSOC, V99, P1092; Cohen SR, 1997, PALLIATIVE MED, V11, P3; Crawley L, 2000, JAMA-J AM MED ASSOC, V284, P2518, DOI 10.1001/jama.284.19.2518; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; EIDINGER RN, 1984, CANCER, V53, P2736, DOI 10.1002/1097-0142(19840615)53:12<2736::AID-CNCR2820531233>3.0.CO;2-W; ENDICOTT J, 1984, CANCER, V53, P2243; First M.B., 2016, STRUCTURED CLIN INTE; Fried TR, 2003, J AM GERIATR SOC, V51, P1398, DOI 10.1046/j.1532-5415.2003.51457.x; Gessert Charles E., 2001, Ethnicity and Disease, V11, P97; Gordon EJ, 2003, BIOETHICS, V17, P142, DOI 10.1111/1467-8519.00330; Hagerty RG, 2004, J CLIN ONCOL, V22, P1721, DOI 10.1200/JCO.2004.04.095; Hagerty RG, 2005, J CLIN ONCOL, V23, P1278, DOI 10.1200/JCO.2005.11.138; Hancock K, 2007, PALLIATIVE MED, V21, P507, DOI 10.1177/0269216307080823; Harrington SE, 2008, JAMA-J AM MED ASSOC, V299, P2667, DOI 10.1001/jama.299.22.2667; Helft PR, 2005, J CLIN ONCOL, V23, P3146, DOI 10.1200/JCO.2005.07.003; Hofmann JC, 1997, ANN INTERN MED, V127, P1, DOI 10.7326/0003-4819-127-1-199707010-00001; KARNOFSKY DA, 1948, CANCER-AM CANCER SOC, V1, P634, DOI 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L; Kris AE, 2006, AM J GERIAT PSYCHIAT, V14, P264, DOI 10.1097/01.JGP.0000194642.86116.ce; Lamont E B, 2000, J Palliat Med, V3, P27, DOI 10.1089/jpm.2000.3.27; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Lehmann L, 2007, J CLIN ONCOL, V25; Leydon GM, 2000, BMJ-BRIT MED J, V320, P909, DOI 10.1136/bmj.320.7239.909; Maciejewski PK, 2007, JAMA-J AM MED ASSOC, V297, P716, DOI 10.1001/jama.297.7.716; Mack JW, 2008, CANCER-AM CANCER SOC, V112, P2509, DOI 10.1002/cncr.23476; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Meier DE, 2001, JAMA-J AM MED ASSOC, V286, P3007, DOI 10.1001/jama.286.23.3007; PRIGERSON HG, 1992, J HEALTH SOC BEHAV, V33, P378, DOI 10.2307/2137315; Ptacek JT, 2001, J BEHAV MED, V24, P205, DOI 10.1023/A:1010766732373; Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502; Ray A, 2006, J PALLIAT MED, V9, P1359, DOI 10.1089/jpm.2006.9.1359; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Selman L, 2007, HEART, V93, P963, DOI 10.1136/hrt.2006.106518; Siegel MD, 2008, CRIT CARE MED, V36, P1722, DOI 10.1097/CCM.0b013e318174da72; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Sullivan AM, 2007, J PALLIAT MED, V10, P882, DOI 10.1089/jpm.2007.0189; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; The AM, 2001, WESTERN J MED, V174, P247, DOI 10.1136/ewjm.174.4.247; Trice ED, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.6506; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630	49	1788	1796	7	156	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2008	300	14					1665	1673		10.1001/jama.300.14.1665	http://dx.doi.org/10.1001/jama.300.14.1665			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	356YF	18840840	Bronze, Green Accepted			2022-12-28	WOS:000259812800028
J	Zhang, XQ; Zhang, G; Zhang, H; Karin, M; Bai, H; Cai, DS				Zhang, Xiaoqing; Zhang, Guo; Zhang, Hai; Karin, Michael; Bai, Hua; Cai, Dongsheng			Hypothalamic IKK beta/NF-kappa B and ER stress link overnutrition to energy imbalance and obesity	CELL			English	Article							INDUCED INSULIN-RESISTANCE; ENHANCED LEPTIN SENSITIVITY; DIET-INDUCED OBESITY; FOOD-INTAKE; GLUCOSE-HOMEOSTASIS; BODY-WEIGHT; RECEPTOR; BRAIN; MICE; REPRODUCTION	Overnutrition is associated with chronic inflammation in metabolic tissues. Whether metabolic inflammation compromises the neural regulatory systems and therefore promotes overnutrition-associated diseases remains unexplored. Here we show that a mediator of metabolic inflammation, IKK beta/NF-kappa B, normally remains inactive although enriched in hypothalamic neurons. Overnutrition atypically activates hypothalamic IKK beta/NF-kappa B at least in part through elevated endoplasmic reticulum stress in the hypothalamus. While forced activation of hypothalamic IKK beta/NF-kappa B interrupts central insulin/leptin signaling and actions, site- or cell-specific suppression of IKK beta either broadly across the brain or locally within the mediobasal hypothalamus, or specifically in hypothalamic AGRP neurons significantly protects against obesity and glucose intolerance. The molecular mechanisms involved include regulation by IKK beta/NF-kappa B of SOCS3, a core inhibitor of insulin and leptin signaling. Our results show that the hypothalamic IKK beta/NF-kappa B program is a general neural mechanism for energy imbalance underlying obesity and suggest that suppressing hypothalamic IKK beta/NF-kappa B may represent a strategy to combat obesity and related diseases.	[Zhang, Xiaoqing; Zhang, Guo; Zhang, Hai; Bai, Hua; Cai, Dongsheng] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; [Zhang, Hai] Univ Wisconsin, Cellular & Mol Biol Grad Program, Madison, WI 53706 USA; [Karin, Michael] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Diego	Cai, DS (corresponding author), Univ Wisconsin, Dept Physiol, 1300 Univ Ave, Madison, WI 53706 USA.	dcai@physiology.wisc.edu	Zhang, Guo/Q-8513-2016; Zhang, Xiaoqing/O-3424-2017	Zhang, Xiaoqing/0000-0002-7405-1893; Zhang, Guo/0000-0003-0841-4710; Bai, Hua/0000-0002-0448-4052; Zhang, Guo/0000-0002-3880-6996	NIH [R56, R01 DK078750]; American Diabetes Association Junior Faculty Award [1-07-JF-09]; UW-Madison Start-up funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK078750, R01DK078750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Junior Faculty Award(American Diabetes Association); UW-Madison Start-up funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Barsh and A. Xu for AGRP-Cre mice; T. Blackwell for NGL mice; P. Mellon for GT1-7 cells; L. Rui for HEK 293-lepR cells; J. Seufert for SOCS3 cDNA; R. Bruick for SOCS3-pGL3; S. Albelda for Cre adenovirus; G. Francisco for synpasin promoter-controlled lentiviral vector; and S. Miyamoto for p65 antibody. We thank S. Shoelson, M. Hendrickson, A. Attie, D. Sun, C. Berridge, R. Weindruch, and Cai lab members for suggestions and technical assistance. This study was supported by NIH grants (R56 and R01 DK078750), American Diabetes Association Junior Faculty Award (1-07-JF-09), and UW-Madison Start-up funds (all to D. C.).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Elmquist JK, 2004, SCIENCE, V304, P63, DOI 10.1126/science.1096746; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Kievit P, 2006, CELL METAB, V4, P123, DOI 10.1016/j.cmet.2006.06.010; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lehrke M, 2004, NAT MED, V10, P126, DOI 10.1038/nm0204-126; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Wang JL, 2001, DIABETES, V50, P2786, DOI 10.2337/diabetes.50.12.2786; Woods SC, 2004, PHYSIOL BEHAV, V83, P573, DOI 10.1016/j.physbeh.2004.07.026; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	34	1001	1028	0	100	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 3	2008	135	1					61	73		10.1016/j.cell.2008.07.043	http://dx.doi.org/10.1016/j.cell.2008.07.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854155	Bronze, Green Accepted			2022-12-28	WOS:000259728100009
J	Baron, JA; Sandler, RS; Bresalier, RS; Lanas, A; Morton, DG; Riddell, R; Iverson, ER; DeMets, DL				Baron, John A.; Sandler, Robert S.; Bresalier, Robert S.; Lanas, Angel; Morton, Dion G.; Riddell, Robert; Iverson, Erik R.; DeMets, David L.			Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial	LANCET			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CYCLOOXYGENASE-2 INHIBITORS; RANDOMIZED-TRIAL; COX-2 INHIBITION; METAANALYSIS; RISK; COMPLICATIONS; PREVENTION; VALDECOXIB; PARECOXIB	Background Selective inhibition of cyclo-oxygenase-2 has been associated with an increased risk of cardiovascular events in several clinical trials. The Adenomatous Polyp Prevention on Vioxx (APPROVe) study assessed the effect of 3-year treatment with a cyclo-oxygenase-2 inhibitor, rofecoxib (25 mg), on recurrence of neoplastic polyps of the large bowel. We report the cardiovascular outcomes of a long-term follow-up of participants in the trial. Methods The APPROVe study is a multicentre, randomised, placebo-controlled, double-blind trial. 2587 patients with a history of colorectal adenomas were recruited at 108 centres worldwide during 2000 and 2001. Participants were followed for adverse events while on treatment and during the following 14 days. However, after early termination of treatment because of cardiovascular toxicity, we attempted to follow tip all randomised patients for at least 1 year after stopping study treatment. External committees blindly assessed potential serious cardiovascular events. The focus of the analysis was the combined incidence of non-fatal myocardial infarction, non-fatal stroke, and death from cardiovascular, haemorrhagic, and unknown causes (Antiplatelet Trialists' Collaboration [APTC] combined endpoint). We used Cox proportional hazards regression to calculate endpoint hazard ratios. The study is registered with ClinicalTrials.gov, number NCT0282386. Findings We obtained extended post-treatment cardiovascular follow-up data from 84% of participants, and extended mortality follow-up from 95%. In total, 59 individuals had an APTC endpoint in the rofecoxib group and 34 in the placebo group (hazard ratio 1. 79, 95% CI 1. 17-2-73; p=0.006). In the first year after cessation of treatment, there was a non-significant increase in the risks of APTC endpoints. The APTC hazard ratio did not substantially change over time. Interpretation Use of rofecoxib is associated with increased rates of APTC events. Study data are compatible with an early increase in risk that persists for one year after stopping treatment. Funding Merck Research Laboratories.	[Baron, John A.] Dartmouth Med Sch, Dept Med, Lebanon, NH 03756 USA; [Baron, John A.] Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH 03756 USA; [Sandler, Robert S.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Bresalier, Robert S.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Gastrointestinal Med & Nutr, Houston, TX 77030 USA; [Lanas, Angel] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Zaragoza, Spain; [Morton, Dion G.] Univ Birmingham, Dept Surg, Birmingham, W Midlands, England; [Riddell, Robert] Mt Sinai Hosp, Dept Pathol, Toronto, ON M5G 1X5, Canada; [Iverson, Erik R.; DeMets, David L.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53706 USA	Dartmouth College; Dartmouth College; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Birmingham; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Wisconsin System; University of Wisconsin Madison	Baron, JA (corresponding author), Dartmouth Med Sch, Dept Med, Suite 300,46 Centerra Pkwy, Lebanon, NH 03756 USA.	John.A.Baron@Dartmouth.edu	Riddell, Robert H/J-5557-2016	Bresalier, Robert/0000-0002-9740-281X	Merck Research Laboratories; APPROVe Trial Steering Committee; University of Wisconsin; Merck	Merck Research Laboratories(Merck & Company); APPROVe Trial Steering Committee; University of Wisconsin; Merck(Merck & Company)	APPROVe was funded by Merck Research Laboratories. JAB, RSB, RSS, RR, DGM, and AL received consulting fees as members of the APPROVe Trial Steering Committee. JAB is a consultant to Bayer and has received research funding from the company. DLD consults extensively with NIH, FDA, arid industry of clinical trials. In particular, he has obtained support for this analysis through a contract between the University of Wisconsin and Merck. ERI was supported by this same contract.	ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Aw TJ, 2005, ARCH INTERN MED, V165, P490, DOI 10.1001/archinte.165.5.IOI50013; Baron JA, 2003, PROG EXP TUMOR RES, V37, P1; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bresalier RS, 2006, NEW ENGL J MED, V355, P221; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Cannon CP, 2006, LANCET, V368, P1771, DOI 10.1016/S0140-6736(06)69666-9; Cryer B, 1998, AM J MED, V104, P413, DOI 10.1016/S0002-9343(98)00091-6; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Fletcher RH, 2014, CLIN EPIDEMIOLOGY ES, V5; Furberg CD, 2006, NEW ENGL J MED, V355, P204; Graham DJ, 2006, JAMA-J AM MED ASSOC, V296, P1653, DOI 10.1001/jama.296.13.jed60058; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Kerr DJ, 2007, NEW ENGL J MED, V357, P360, DOI 10.1056/NEJMoa071841; Konstam MA, 2001, CIRCULATION, V104, P2280, DOI 10.1161/hc4401.100078; Lagakos SW, 2006, NEW ENGL J MED, V355, P113, DOI 10.1056/NEJMp068137; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; Nissen SE, 2006, NEW ENGL J MED, V355, P203; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; Ott E, 2003, J THORAC CARDIOV SUR, V125, P1481, DOI 10.1016/S0022-5223(03)00125-9; Parzen MI, 1997, SCAND J STAT, V24, P309, DOI 10.1111/1467-9469.t01-1-00065; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1; Solomon SD, 2006, CIRCULATION, V114, P1028, DOI 10.1161/CIRCULATIONAHA.106.636746; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Weir MR, 2003, AM HEART J, V146, P591, DOI 10.1016/S0002-8703(03)00398-3; Zhang JJ, 2006, JAMA-J AM MED ASSOC, V296, P1619, DOI 10.1001/jama.296.13.jrv60015	31	158	167	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2008	372	9651					1756	1764		10.1016/S0140-6736(08)61490-7	http://dx.doi.org/10.1016/S0140-6736(08)61490-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374XV	18922570				2022-12-28	WOS:000261077900025
J	Wang, SY; Li, YH; Chi, GB; Xiao, SY; Ozanne-Smith, J; Stevenson, M; Phillips, MR				Wang, S. Y.; Li, Y. H.; Chi, G. B.; Xiao, S. Y.; Ozanne-Smith, J.; Stevenson, M.; Phillips, M. R.			Health System Reform in China 4 Injury-related fatalities in China: an under-recognised public-health problem	LANCET			English	Article							RISK-FACTORS; SUICIDE; MORTALITY	The May 2008 earthquake in Wenchuan drew attention to the important but largely unrecognised public-health problem of injury-related mortality and morbidity in China. Injuries account for more than 10% of all deaths and more than 30% of all potentially productive years of life lost due to premature mortality in China. Traffic-related injuries (mainly among cyclists and pedestrians), suicide, drowning, and falls account for 79% of all injury deaths. Rural injury death rates are double those of urban rates and male rates are double those of female rates. Despite an 81% increase in the traffic-related mortality from 1987 to 2006-associated with rapid motorisation-the overall injury mortality decreased by 17%, largely due to a surprising (and unexplained) 57% reduction in the suicide rate. Low-cost prevention measures that are most likely to produce large reductions in injury deaths include enforcement of laws for drinking and driving and for seat belt and helmet use, restriction of access to the most potent pesticides, and teaching children to swim. China needs to improve monitoring of fatal and non-fatal injuries, promote intersectoral collaboration, build institutional capacities, and, most importantly, mobilise community support and political will for investment in prevention.	[Phillips, M. R.] Beijing Hui Long Guan Hosp, WHO Coordinating Ctr Res & Training Suicide Preve, Beijing Suicide Res & Prevent Ctr, Beijing 100096, Peoples R China; [Wang, S. Y.; Chi, G. B.] Jinan Univ, Coll Med, Ctr Injury Prevent & Control, Guangzhou, Guangdong, Peoples R China; [Li, Y. H.] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Xiao, S. Y.] Cent S Univ, Sch Publ Hlth, Changsha, Hunan, Peoples R China; [Ozanne-Smith, J.] Monash Univ, Accident Res Ctr, Clayton, Vic 3800, Australia; [Ozanne-Smith, J.] Monash Univ, Dept Forens Med, Clayton, Vic 3800, Australia; [Stevenson, M.] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia; [Stevenson, M.] Peking Univ, Hlth Sci Ctr, George Inst China, Beijing 100871, Peoples R China; [Phillips, M. R.] Columbia Univ, Dept Psychiat, New York, NY USA; [Phillips, M. R.] Columbia Univ, Dept Epidemiol, New York, NY USA	Jinan University; Shanghai Center for Disease Control & Prevention; Central South University; Monash University; Monash University; University of Sydney; Peking University; Columbia University; Columbia University	Phillips, MR (corresponding author), Beijing Hui Long Guan Hosp, WHO Coordinating Ctr Res & Training Suicide Preve, Beijing Suicide Res & Prevent Ctr, Beijing 100096, Peoples R China.	phillipschina@yahoo.com	Phillips, Michael Robert/AAE-7585-2021; stevenson, mark/AAE-9706-2019	Phillips, Michael Robert/0000-0002-5973-2439; stevenson, mark/0000-0003-3166-5876				Banister J, 2004, POP STUD-J DEMOG, V58, P55, DOI 10.1080/0032472032000183753; BRENNER RA, ARCH PEDIAT IN PRESS; *CHIN IND RES MARK, 2008, AUT PARTS ACC MAN IN; *CHIN MIN HLTH, 2003, ANN REP CHIN HLTH ST; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Conner KR, 2007, AM J PUBLIC HEALTH, V97, P1842, DOI 10.2105/AJPH.2005.077420; Conner KR, 2005, PSYCHOL MED, V35, P1197, DOI 10.1017/S003329170500454X; *DIS PREV CONTR BU, 2007, REP INJ PREV CHIN; Dollar D, 2007, 4253 WORLD BANK; Eddleston M, 2008, LANCET, V371, P597, DOI 10.1016/S0140-6736(07)61202-1; Fahquist JN, 2006, ACCIDENT ANAL PREV, V38, P1113, DOI 10.1016/j.aap.2006.04.020; Gunnell D, 2007, INT J EPIDEMIOL, V36, P1235, DOI 10.1093/ije/dym164; JING RW, 2004, BEIJING INJURY SURVE; [李献云 Li Xianyun], 2005, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V31, P272; [李献云 Li Xianyun], 2003, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V29, P27; [刘娜 Liu Na], 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P746; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Mathers CD, 2003, GLOBAL BURDEN DIS 20; Moniruzzaman S, 2004, PUBLIC HEALTH, V118, P346, DOI 10.1016/j.puhe.2003.10.004; Murray C. J. L., 1996, GLOBAL BURDEN DIS; *NAT BUR STAT CHIN, 1996, B 1995 NAT 1 SAMPL S; *NAT BUR STAT CHIN, 2007, B 2005 NAT 1 SAMPL S; *NAT BUR STAT CHIN, 2006, B MAIN RES 2005 1 SA; National Bureau of Statistics of China, 1988, CHIN STAT YB; OZANNESMITH J, 2008, WORLD REPOR IN PRESS; Passmore J, 2006, Int J Inj Contr Saf Promot, V13, P187, DOI 10.1080/17457300500248444; Peden M., 2004, WORLD REPORT ROAD TR; PERREMENT M, 2006, DROWNING IS NUMBER 1; Phillips M. R., 2004, Morbidity and Mortality Weekly Report, V53, P481; Phillips MR, 2002, LANCET, V360, P1728, DOI 10.1016/S0140-6736(02)11681-3; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Phillips MR, 1998, CHINA J, V39, P1, DOI 10.2307/2667691; RAHMIN A, 2005, BANGLADESH HLTH INJU; Rao C, 2005, B WORLD HEALTH ORGAN, V83, P618; Routley V, 2007, INJURY PREV, V13, P388, DOI 10.1136/ip.2007.015701; Shi Qi-chang, 2005, Zhonghua Yufang Yixue Zazhi, V39, P229; STAINES C, CHILD EARLY ADOLESCE; *STAT COUNC INF OF, LAT DEV WENCH EARTHQ; STEVENSON M, INJ PREV IN PRESS; United Nations, 1996, PREV SUIC GUID FORM; WANG L, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61365-3; Wang Li-Jun, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P889; [王艳红 WANG Yanhong], 2007, [中华流行病学杂志, Chinese Journal of Epidemiology], V28, P195; Wasserman Danuta, 2016, SUICIDE UNNECESSARY; *WHO, 2008, WORLD HLTH STAT REP; WHO, 2006, SAF ACC PEST COMM IN; WHO, 2002, INJ CHARTB GRAPH OV; *WHO, HUM AN RAB; World Health Organization, INT STAT CLASS DIS R, V10th; World Health Organization, WHO MORT DAT; Yang GH, 2005, BIOMED ENVIRON SCI, V18, P379; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3; Yang L, 2007, INJURY PREV, V13, P178, DOI 10.1136/ip.2006.013409; ZHANG KL, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61357-4; Zhou Y, 2003, INJ PREV, V9, P124, DOI 10.1136/ip.9.2.124	55	202	274	2	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2008	372	9651					1765	1773		10.1016/S0140-6736(08)61367-7	http://dx.doi.org/10.1016/S0140-6736(08)61367-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	374XV	18930527				2022-12-28	WOS:000261077900026
J	Zacho, J; Tybjaerg-Hansen, A; Jensen, JS; Grande, P; Sillesen, H; Nordestgaard, BG				Zacho, Jeppe; Tybjaerg-Hansen, Anne; Jensen, Jan Skov; Grande, Peer; Sillesen, Henrik; Nordestgaard, Borge G.			Genetically elevated C-reactive protein and ischemic vascular disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; CRP GENE POLYMORPHISMS; MENDELIAN RANDOMIZATION; CARDIOVASCULAR EVENTS; SERUM CRP; NONFASTING TRIGLYCERIDES; MYOCARDIAL-INFARCTION; REGRESSION DILUTION; PROMOTER REGION	Background: Elevated levels of C-reactive protein (CRP) are associated with increased risks of ischemic heart disease and ischemic cerebrovascular disease. We tested whether this is a causal association. Methods: We studied 10,276 persons from a general population cohort, including 1786 in whom ischemic heart disease developed and 741 in whom ischemic cerebrovascular disease developed. We examined another 31,992 persons from a cross-sectional general population study, of whom 2521 had ischemic heart disease and 1483 had ischemic cerebrovascular disease. Finally, we compared 2238 patients with ischemic heart disease with 4474 control subjects and 612 patients with ischemic cerebrovascular disease with 1224 control subjects. We measured levels of high-sensitivity CRP and conducted genotyping for four CRP polymorphisms and two apolipoprotein E polymorphisms. Results: The risk of ischemic heart disease and ischemic cerebrovascular disease was increased by a factor of 1.6 and 1.3, respectively, in persons who had CRP levels above 3 mg per liter, as compared with persons who had CRP levels below 1 mg per liter. Genotype combinations of the four CRP polymorphisms were associated with an increase in CRP levels of up to 64%, resulting in a theoretically predicted increased risk of up to 32% for ischemic heart disease and up to 25% for ischemic cerebrovascular disease. However, these genotype combinations were not associated with an increased risk of ischemic vascular disease. In contrast, apolipoprotein E genotypes were associated with both elevated cholesterol levels and an increased risk of ischemic heart disease. Conclusions: Polymorphisms in the CRP gene are associated with marked increases in CRP levels and thus with a theoretically predicted increase in the risk of ischemic vascular disease. However, these polymorphisms are not in themselves associated with an increased risk of ischemic vascular disease.	[Zacho, Jeppe; Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Dept Clin Biochem,Herlev Hosp, DK-2730 Herlev, Denmark; [Zacho, Jeppe; Tybjaerg-Hansen, Anne; Jensen, Jan Skov; Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Copenhagen Gen Populat Study,Herlev Hosp, DK-2730 Herlev, Denmark; [Tybjaerg-Hansen, Anne] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Rigshosp,Dept Clin Biochem, DK-2730 Herlev, Denmark; [Grande, Peer] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Rigshosp,Dept Cardiol, DK-2730 Herlev, Denmark; [Sillesen, Henrik] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Rigshosp,Dept Vasc Surg, DK-2730 Herlev, Denmark; [Tybjaerg-Hansen, Anne; Jensen, Jan Skov; Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Copenhagen City Heart Study,Bispebjerg Hosp, DK-2730 Herlev, Denmark; [Jensen, Jan Skov] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Dept Cardiol,Gentofte Hosp, DK-2730 Herlev, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Nordestgaard, BG (corresponding author), Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Dept Clin Biochem,Herlev Hosp, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	brno@heh.regionh.dk	Nordestgaard, Borge Gronne/ABF-1310-2020; Sillesen, Henrik/ABB-5668-2020		Danish Heart Foundation; BG Medicine; AstraZeneca; Sanofi-Aventis; Merck; Pfizer; Boehringer Ingelheim	Danish Heart Foundation; BG Medicine; AstraZeneca(AstraZeneca); Sanofi-Aventis(Sanofi-Aventis); Merck(Merck & Company); Pfizer(Pfizer); Boehringer Ingelheim(Boehringer Ingelheim)	Supported by the Danish Heart Foundation. Dr. Nordestgaard reports receiving consulting fees from BG Medicine and AstraZeneca and lecture fees from AstraZeneca, Sanofi-Aventis, Merck, Pfizer, and Boehringer Ingelheim; Dr. Sillesen, consulting fees from Merck, Pfizer, BG Medicine, Boehringer Ingelheim, Sanofi-Aventis, and AstraZeneca; Dr. Grande, consulting fees from AstraZeneca; and Dr. Tybjaerg-Hansen, lecture fees from Pfizer and Sanofi-Aventis. No other potential conflict of interest relevant to this article was reported.; We thank Hanne Damm, Dorthe Uldall Andersen, and Dorthe Kjeldgaard Hansen for their assistance with the large-scale genotyping and the staff and participants of the Copenhagen City Heart Study, the Copenhagen General Population Study, the Copenhagen Ischemic Heart Disese Study, and the Copenhagen Carotid Stroke Study for their important contributions to our study.	AgerholmLarsen B, 1997, ANN INTERN MED, V127, P346, DOI 10.7326/0003-4819-127-5-199709010-00002; Balistreri CR, 2006, ANN NY ACAD SCI, V1067, P276, DOI 10.1196/annals.1354.036; Ballantyne CM, 2005, ARCH INTERN MED, V165, P2479, DOI 10.1001/archinte.165.21.2479; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Bis JC, 2008, ATHEROSCLEROSIS, V198, P166, DOI 10.1016/j.atherosclerosis.2007.09.031; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Everett BM, 2006, J AM COLL CARDIOL, V48, P2235, DOI 10.1016/j.jacc.2006.09.030; Flex A, 2004, STROKE, V35, P2270, DOI 10.1161/01.STR.0000140740.19421.fe; Frikke-Schmidt R, 2000, J AM COLL CARDIOL, V35, P1192, DOI 10.1016/S0735-1097(00)00520-9; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Kardys I, 2006, EUR HEART J, V27, P1331, DOI 10.1093/eurheartj/ehl018; Kathiresan S, 2006, CIRCULATION, V113, P1415, DOI 10.1161/CIRCULATIONAHA.105.591271; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Klein, 2003, SURVIVAL ANAL TECHNI, P295, DOI [10.1007/b97377, DOI 10.1007/B97377]; Kovacs A, 2005, ATHEROSCLEROSIS, V178, P193, DOI 10.1016/j.atherosclerosis.2004.08.018; Ladenvall C, 2006, STROKE, V37, P2018, DOI 10.1161/01.STR.0000231872.86071.68; Lange LA, 2006, JAMA-J AM MED ASSOC, V296, P2703, DOI 10.1001/jama.296.22.2703; Lowe Gordon D O, 2006, Curr Atheroscler Rep, V8, P421, DOI 10.1007/s11883-006-0040-x; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Miller DT, 2005, ANN HUM GENET, V69, P623, DOI 10.1111/j.1529-8817.2005.00210.x; Nitsch D, 2006, AM J EPIDEMIOL, V163, P397, DOI 10.1093/aje/kwj062; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Reitz C, 2007, STROKE, V38, P2356, DOI 10.1161/STROKEAHA.107.482661; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Sattar N, 2007, CIRCULATION, V115, P981, DOI 10.1161/CIRCULATIONAHA.106.643114; Schnohr P, 2002, EUR HEART J, V23, P620, DOI 10.1053/euhj.2001.2842; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Szalai AJ, 2005, J MOL MED, V83, P440, DOI 10.1007/s00109-005-0658-0; Szalai AJ, 2005, RHEUMATOLOGY, V44, P864, DOI 10.1093/rheumatology/keh613; Wang QW, 2006, AM J PHYSIOL-HEART C, V291, pH2752, DOI 10.1152/ajpheart.01164.2005; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zee RYL, 2002, ATHEROSCLEROSIS, V162, P217, DOI 10.1016/S0021-9150(01)00703-1	36	624	647	2	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2008	359	18					1897	1908		10.1056/NEJMoa0707402	http://dx.doi.org/10.1056/NEJMoa0707402			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366BL	18971492				2022-12-28	WOS:000260454500006
J	Hammond, P				Hammond, Phil			(Not) warts and all	BRITISH MEDICAL JOURNAL			English	Editorial Material												hamm82@msn.com						2008, SEXUALLY TRANSMITTED, V84, P251, DOI DOI 10.1136/STI.2008.032755	1	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a2186	10.1136/bmj.a2186	http://dx.doi.org/10.1136/bmj.a2186			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18948345				2022-12-28	WOS:000260298800050
J	Greaves, GN; Wilding, MC; Fearn, S; Langstaff, D; Kargl, F; Cox, S; Van, QV; Majerus, O; Benmore, CJ; Weber, R; Martin, CM; Hennet, L				Greaves, G. N.; Wilding, M. C.; Fearn, S.; Langstaff, D.; Kargl, F.; Cox, S.; Van, Q. Vu; Majerus, O.; Benmore, C. J.; Weber, R.; Martin, C. M.; Hennet, L.			Detection of first-order liquid/liquid phase transitions in yttrium oxide-aluminum oxide melts	SCIENCE			English	Article							LIQUID-PHASE; GLASS; SEPARATION; ICE	We combine small-angle x-ray scattering (SAXS) and wide-angle x-ray scattering (WAXS) with aerodynamic levitation techniques to study in situ phase transitions in the liquid state under contactless conditions. At very high temperatures, yttria-alumina melts show a first-order transition, previously inferred from phase separation in quenched glasses. We show how the transition coincides with a narrow and reversible maximum in SAXS indicative of liquid unmixing on the nanoscale, combined with an abrupt realignment in WAXS features related to reversible shifts in polyhedral packing on the atomic scale. We also observed a rotary action in the suspended supercooled drop driven by repetitive transitions (a polyamorphic rotor) from which the reversible changes in molar volume (1.2 +/- 0.2 cubic centimeters) and entropy (19 +/- 4 joules mole(-1) kelvin(-1)) can be estimated.	[Greaves, G. N.; Wilding, M. C.; Fearn, S.; Langstaff, D.; Kargl, F.; Cox, S.; Van, Q. Vu] Aberystwyth Univ, Ctr Adv Funct Mat & Devices, Inst Math & Phys, Aberystwyth SY23 3BZ, Dyfed, Wales; [Majerus, O.] Ecole Natl Super Chim Paris, F-75231 Paris, France; [Benmore, C. J.] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Weber, R.] Mat Dev, Arlington Hts, IL 60004 USA; [Martin, C. M.] STFC Daresbury Lab, Synchrotron Radiat Source, Warrington WA4 4AD, Cheshire, England; [Hennet, L.] CNRS CEMHTI, F-45071 Orleans 9, France	Aberystwyth University; UDICE-French Research Universities; PSL Research University Paris; Chimie ParisTech; United States Department of Energy (DOE); Argonne National Laboratory; STFC Daresbury Laboratory; Centre National de la Recherche Scientifique (CNRS)	Greaves, GN (corresponding author), Aberystwyth Univ, Ctr Adv Funct Mat & Devices, Inst Math & Phys, Aberystwyth SY23 3BZ, Dyfed, Wales.	gng@aber.ac.uk	HENNET, Louis/C-1711-2008; MAJERUS, Odile/AAQ-6866-2020; Langstaff, Dave/GXV-5852-2022; Cox, Simon/F-5280-2012	HENNET, Louis/0000-0002-2992-4800; MAJERUS, Odile/0000-0003-2811-8804; Cox, Simon/0000-0001-6129-3394; Kargl, Florian/0000-0001-9902-0420; Benmore, Chris/0000-0001-7007-7749; Wilding, Martin/0000-0002-0802-0423; Langstaff, Dave/0000-0002-2339-8205	Higher Education Funding Council in Wales; Centre for Advanced Functional Materials and Devices; EPSRC [EP/E026818/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E026818/1] Funding Source: researchfish	Higher Education Funding Council in Wales; Centre for Advanced Functional Materials and Devices; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank W. Bras, P. McMillan, and P. Poole for very Useful discussions; the Science Technology Facilities Council and staff at the Synchrotron Radiation Source for access to the SAXS/WAXS facilities on station 6.2; and the Advanced Photon Source for access to high-energy x-ray scattering facilities on 11-ID-C. We also acknowledge the support of the Higher Education Funding Council in Wales through the Centre for Advanced Functional Materials and Devices.	AASLAND S, 1994, NATURE, V369, P633, DOI 10.1038/369633a0; Bras W, 2005, J NON-CRYST SOLIDS, V351, P2178, DOI 10.1016/j.jnoncrysol.2005.06.006; Brazhkin VV, 1997, HIGH PRESSURE RES, V15, P267, DOI 10.1080/08957959708240477; Bridgeman P.W, 1949, PHYS HIGH PRESSURE; Cernik RJ, 2004, J SYNCHROTRON RADIAT, V11, P163, DOI 10.1107/S0909049503027870; Cristiglio V, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/41/415105; Debenedetti P. G., 1997, METASTABLE LIQUIDS; Di Cicco A, 2004, HIGH PRESSURE RES, V24, P93, DOI 10.1080/08957950410001661864; Finney JL, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.225503; Greaves GN, 2007, ADV PHYS, V56, P1, DOI 10.1080/00018730601147426; Greaves GN, 2005, SCIENCE, V308, P1299, DOI 10.1126/science.1109411; GRIMSDITCH M, 1984, PHYS REV LETT, V52, P2379, DOI 10.1103/PhysRevLett.52.2379; Katayama Y, 2004, SCIENCE, V306, P848, DOI 10.1126/science.1102735; Katayama Y, 2000, NATURE, V403, P170, DOI 10.1038/35003143; Koza MM, 2007, J APPL CRYSTALLOGR, V40, pS517, DOI 10.1107/S0021889807004992; Landron C, 2001, PHYS REV LETT, V86, P4839, DOI 10.1103/PhysRevLett.86.4839; McMillan PF, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/41/415101; Mcmillan PF, 2005, NAT MATER, V4, P680, DOI 10.1038/nmat1458; Mishima O, 2002, NATURE, V419, P599, DOI 10.1038/nature01106; MISHIMA O, 1984, NATURE, V310, P393, DOI 10.1038/310393a0; Nagashio K, 2002, J AM CERAM SOC, V85, P2353, DOI 10.1111/j.1151-2916.2002.tb00459.x; Nelmes RJ, 2006, NAT PHYS, V2, P414, DOI 10.1038/nphys313; Onuki A., 2004, PHASE TRANSITION DYN; PONYATOVSKY EG, 1992, MATER SCI REP, V8, P147, DOI 10.1016/0920-2307(92)90007-N; Poole PH, 1997, SCIENCE, V275, P322, DOI 10.1126/science.275.5298.322; POOLE PH, 1992, NATURE, V360, P324, DOI 10.1038/360324a0; RAPOPORT E, 1967, J CHEM PHYS, V46, P3279, DOI 10.1063/1.1841211; Sastry S, 2003, NAT MATER, V2, P739, DOI 10.1038/nmat994; Skinner LB, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/20/205103; Tangeman JA, 2007, J AM CERAM SOC, V90, P758, DOI 10.1111/j.1551-2916.2007.01489.x; Weber JKR, 2000, J AM CERAM SOC, V83, P1868, DOI 10.1111/j.1151-2916.2000.tb01483.x; Wilding MC, 2001, J NON-CRYST SOLIDS, V293, P357, DOI 10.1016/S0022-3093(01)00686-X	32	152	156	3	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					566	570		10.1126/science.1160766	http://dx.doi.org/10.1126/science.1160766			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948535	Green Submitted			2022-12-28	WOS:000260299100037
J	Kraft, NJB; Valencia, R; Ackerly, DD				Kraft, Nathan J. B.; Valencia, Renato; Ackerly, David D.			Functional traits and niche-based tree community assembly in an amazonian forest	SCIENCE			English	Article							DISTRIBUTIONS; STRATEGIES; HERBIVORES; MECHANISMS; DIVERSITY	It is debated whether species-level differences in ecological strategy, which play a key role in much of coexistence theory, are important in structuring highly diverse communities. We examined the co-occurrence patterns of over 1100 tree species in a 25-hectare Amazonian forest plot in relation to field-measured functional traits. Using a null model approach, we show that co-occurring trees are often less ecologically similar than a niche-free (neutral) model predicts. Furthermore, we find evidence for processes that simultaneously drive convergence and divergence in key aspects of plant strategy, suggesting that at least two distinct niche-based processes are occurring. Our results show that strategy differentiation among species contributes to the maintenance of diversity in one of the most diverse tropical forests in the world.	[Kraft, Nathan J. B.; Ackerly, David D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Valencia, Renato] Pontificia Univ Catolica Ecuador, Lab Ecol Plantas, Escuela Ciencias Biol, Quito, Ecuador	University of California System; University of California Berkeley; Pontificia Universidad Catolica del Ecuador	Kraft, NJB (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.		Ackerly, David/A-1247-2009; Kraft, Nathan J. B./A-2817-2012	Ackerly, David/0000-0002-1847-7398; Kraft, Nathan J. B./0000-0001-8867-7806; Valencia, Renato/0000-0001-9770-6568	Center for Tropical Forest Science; University of California, Berkeley; Department of Integrative Biology; NSF [DEB-614525, DEB-614055, DEB-614659]	Center for Tropical Forest Science(Smithsonian InstitutionSmithsonian Tropical Research Institute); University of California, Berkeley(University of California System); Department of Integrative Biology; NSF(National Science Foundation (NSF))	N.I.B.K. is grateful to A. Martin, L. Williams, P. Avia, and L. Dunn for field assistance and to A. Thompson, T. Aftandilians, and M. Piven for help with sample analysis. Leaf trait collection was supported by the Center for Tropical Forest Science and the University of California, Berkeley, Department of Integrative Biology. We benefited from interactions with R. Condit, W. Cornwell, P. Fine, S. Kembel, J. Lake, M. Metz, N. Swenson, and four anonymous reviewers. S. J. Wright and N. Gat-wood generously provided unpublished seed data front collection efforts supported by NSF grants DEB-614525, DEB-614055, and DEB-614659. R.V. thanks the government of Ecuador (Donaciones de Impuesto a la Rento 2004-2006), Pontificia Universidad Catolica del Ecuador, the Mellon Foundation, the Tapper Family Foundation, the Smithsonian Tropical Research Institute, and NSF (grants DEB-0090311 and DEB-9806828) for support of the forest census. This research was possible because of the kind permission of the Ministerio del Ambiente of Ecuador.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; CORNWELL WK, ECOL MONOGR IN PRESS, DOI DOI 10.1890/07-1134.A; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Falster DS, 2005, J ECOL, V93, P521, DOI 10.1111/j.0022-0477.2005.00992.x; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Hubbell Stephen P., 2001, V32, pi; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Stubbs WJ, 2004, J ECOL, V92, P557, DOI 10.1111/j.0022-0477.2004.00898.x; Turner I.M., 2001, CAM TROP B, DOI 10.1017/CBO9780511542206; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; Webb CO, 2006, ECOLOGY, V87, pS123, DOI 10.1890/0012-9658(2006)87[123:PSMSSA]2.0.CO;2; Weiher E., 1999, ECOLOGICAL ASSEMBLY, DOI DOI 10.1017/CBO9780511542237; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	27	773	854	24	650	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					580	582		10.1126/science.1160662	http://dx.doi.org/10.1126/science.1160662			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948539				2022-12-28	WOS:000260299100041
J	Goodyear, LJ				Goodyear, Laurie J.			The exercise pill - Too good to be true?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHRONIC ACTIVATION; GLYCOGEN; MUSCLE		[Goodyear, Laurie J.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Goodyear, Laurie J.] Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Goodyear, LJ (corresponding author), Joslin Diabet Ctr, Boston, MA 02215 USA.							Barre L, 2007, AM J PHYSIOL-ENDOC M, V292, pE802, DOI 10.1152/ajpendo.00369.2006; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; Leff T, 2003, BIOCHEM SOC T, V31, P224; Musi Nicolas, 2002, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V2, P119; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051	5	76	82	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2008	359	17					1842	1844		10.1056/NEJMcibr0806723	http://dx.doi.org/10.1056/NEJMcibr0806723			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363DJ	18946072				2022-12-28	WOS:000260245800015
J	Zheng, HW; Ying, HQ; Yan, HY; Kimmelman, AC; Hiller, DJ; Chen, AJ; Perry, SR; Tonon, G; Chu, GC; Ding, ZH; Stommel, JM; Dunn, KL; Wiedemeyer, R; You, MJJ; Brennan, C; Wang, YA; Ligon, KL; Wong, WH; Chin, L; DePinho, RA				Zheng, Hongwu; Ying, Haoqiang; Yan, Haiyan; Kimmelman, Alec C.; Hiller, David J.; Chen, An-Jou; Perry, Samuel R.; Tonon, Giovanni; Chu, Gerald C.; Ding, Zhihu; Stommel, Jayne M.; Dunn, Katherine L.; Wiedemeyer, Ruprecht; You, Mingjian J.; Brennan, Cameron; Wang, Y. Alan; Ligon, Keith L.; Wong, Wing H.; Chin, Lynda; DePinho, Ronald A.			p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation	NATURE			English	Article							CANCER STEM-CELLS; SELF-RENEWAL; INITIATING CELLS; C-MYC; TUMORS; GLIOBLASTOMA; EXPRESSION; RECEPTOR; PATHWAYS; BIOLOGY	Glioblastoma ( GBM) is a highly lethal brain tumour presenting as one of two subtypes with distinct clinical histories and molecular profiles. The primary GBM subtype presents acutely as a high-grade disease that typically harbours mutations in EGFR, PTEN and INK4A/ARF ( also known as CDKN2A), and the secondary GBM subtype evolves from the slow progression of a low- grade disease that classically possesses PDGF and TP53 events(1-3). Here we show that concomitant central nervous system (CNS)- specific deletion of p53 and Pten in the mouse CNS generates a penetrant acute- onset high- grade malignant glioma phenotype with notable clinical, pathological and molecular resemblance to primary GBM in humans. This genetic observation prompted TP53 and PTEN mutational analysis in human primary GBM, demonstrating unexpectedly frequent inactivating mutations of TP53 as well as the expected PTEN mutations. Integrated transcriptomic profiling, in silico promoter analysis and functional studies of murine neural stem cells ( NSCs) established that dual, but not singular, inactivation of p53 and Pten promotes an undifferentiated state with high renewal potential and drives increased Myc protein levels and its associated signature. Functional studies validated increased Myc activity as a potent contributor to the impaired differentiation and enhanced renewal of NSCs doubly null for p53 and Pten (p53(-/-) Pten(-/-)) as well as tumour neurospheres (TNSs) derived from this model. Myc also serves to maintain robust tumorigenic potential of p53(-/-) Pten(-/-) TNSs. These murine modelling studies, together with confirmatory transcriptomic/ promoter studies in human primary GBM, validate a pathogenetic role of a common tumour suppressor mutation profile in human primary GBM and establish Myc as an important target for cooperative actions of p53 and Pten in the regulation of normal and malignant stem/ progenitor cell differentiation, self- renewal and tumorigenic potential.	[Zheng, Hongwu; Ying, Haoqiang; Yan, Haiyan; Kimmelman, Alec C.; Chen, An-Jou; Perry, Samuel R.; Tonon, Giovanni; Chu, Gerald C.; Ding, Zhihu; Stommel, Jayne M.; Dunn, Katherine L.; Wiedemeyer, Ruprecht; You, Mingjian J.; Wang, Y. Alan; Ligon, Keith L.; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Perry, Samuel R.; Chu, Gerald C.; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Ctr Appl Canc Sci, Belfer Fdn Inst Innovat Canc Sci, Boston, MA 02115 USA; [Ligon, Keith L.] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Kimmelman, Alec C.] Harvard Univ, Sch Med, Harvard Radiat Oncol Program, Boston, MA 02115 USA; [Chu, Gerald C.; Ligon, Keith L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Ligon, Keith L.] Harvard Univ, Sch Med, Div Neuropathol, Boston, MA 02115 USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Hiller, David J.; Wong, Wing H.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Brennan, Cameron] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Brennan, Cameron] Weill Cornell Med Coll, Dept Neurosurg, New York, NY 10065 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Stanford University; Memorial Sloan Kettering Cancer Center; Cornell University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	DePinho, RA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu	Tonon, Giovanni/J-9804-2018; Brennan, Cameron/R-7082-2019; Ying, Haoqiang/AAK-4325-2020; Stommel, Jayne M/M-3439-2017	Tonon, Giovanni/0000-0003-2973-5038; Brennan, Cameron/0000-0003-4064-8891; Zheng, Hongwu/0000-0002-5823-4913; DePinho, Ronald/0000-0002-5625-577X	Helen Hay Whitney Foundation; Marsha Mae Moeslein Fellowship; American Brain Tumor Association; Leonard B. Holman Research Pathway Fellowship; Damon Runyon Cancer Research Foundation; Ruth L. Kirschstein National Research Service Award Fellowship; Mildred Scheel Fellowship (Deutsche Krebshilfe); Goldhirsh Foundation; NIH [U01 CA84313, RO1CA99041, 5P01CA95616]; Robert A. and Renee E. Belfer Foundation Institute for Innovative Cancer Science; NATIONAL CANCER INSTITUTE [R01CA099041, U01CA084313, P01CA095616] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; Marsha Mae Moeslein Fellowship; American Brain Tumor Association; Leonard B. Holman Research Pathway Fellowship; Damon Runyon Cancer Research Foundation; Ruth L. Kirschstein National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mildred Scheel Fellowship (Deutsche Krebshilfe)(Deutsche Krebshilfe); Goldhirsh Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. and Renee E. Belfer Foundation Institute for Innovative Cancer Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Berns for providing p53 L mice; S. Zhou and S. Jiang for mouse husbandry and care; R. T. Bronson for discussion on pathology analysis; K. Montgomery for discussion on sequencing; and Y.- H. Xiao, B. Feng and J. Zhang for bioinformatic help. H. Z. was supported by Helen Hay Whitney Foundation. H. Ying is a recipient of the Marsha Mae Moeslein Fellowship from the American Brain Tumor Association. A. C. K. is a recipient of the Leonard B. Holman Research Pathway Fellowship. Z. D. is supported by the Damon Runyon Cancer Research Foundation. J. M. S. is supported by a Ruth L. Kirschstein National Research Service Award Fellowship. R. W. is supported by a Mildred Scheel Fellowship ( Deutsche Krebshilfe). Grant support comes from the Goldhirsh Foundation (R.A.D.), and NIH grants U01 CA84313 (R.A.D.), RO1CA99041 ( L. C.) and 5P01CA95616 (R.A.D., L.C., W.H.W., C.B. and K.L.L.). R.A.D. is an American Cancer Society Research Professor supported by the Robert A. and Renee E. Belfer Foundation Institute for Innovative Cancer Science.	Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Fukushima T, 2006, J NEUROPATH EXP NEUR, V65, P12, DOI 10.1097/01.jnen.0000196132.66464.96; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kleihues P, 1999, Neuro Oncol, V1, P44, DOI 10.1093/neuonc/1.1.44; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; The WHO, 2020, CLASSIFICATION TUMOU; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004; Zhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	35	534	547	4	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1129	U13		10.1038/nature07443	http://dx.doi.org/10.1038/nature07443			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948956	Green Accepted, Green Submitted			2022-12-28	WOS:000260252600049
J	Keyhani, S; Kleinman, LC; Rothschild, M; Bernstein, JM; Anderson, R; Chassin, M				Keyhani, Salomeh; Kleinman, Lawrence C.; Rothschild, Michael; Bernstein, Joseph M.; Anderson, Rebecca; Chassin, Mark			Overuse of tympanostomy tubes in New York metropolitan area: evidence from five hospital cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OTITIS-MEDIA SURGERY; OF-LIFE OUTCOMES; DEVELOPMENTAL OUTCOMES; RISK-FACTORS; GLUE EAR; APPROPRIATENESS; INSERTION; CHILDREN; EFFUSION; EPIDEMIOLOGY	Objectives To compare tympanostomy tube insertion for children with otitis media in 2002 with the recommendations of two sets of expert guidelines. Design Retrospective cohort study. Setting New York metropolitan area practices associated with five diverse hospitals. Participants 682 of 1046 children who received tympanostomy tubes in the five hospitals for whom charts from the hospital, primary care physician, and otolaryngologist could be accessed. Results The mean age was 3.8 years. On average, children with acute otitis media had fewer than four infections in the year before surgery. Children with otitis media with effusion had less than 30 consecutive days of effusion at the time of surgery. Concordance with recommendations was very low: 30.3% (n=207) of all tympanostomies were concordant with the explicit criteria developed for this study and 7.5% (n=13) with the 1994 guideline from the American Academy of Pediatrics, American Academy of Family Medicine, and American Academy of Otolaryngology-Head and Neck Surgery. Children who had previously had tympanostomy tube surgery, who were having a concomitant procedure, or who had "at risk conditions" were more likely to be discordant. Conclusions A significant majority of tympanostomy tube insertions in the largest and most populous metropolitan area in the United States were inappropriate according to the explicit criteria and not recommended according to both guidelines. Regardless of whether current practice represents a substantial overuse of surgery or the guidelines are overly restrictive, the persistent discrepancy between guidelines and practice cannot be good for children or for people interested in improving their health care.	[Keyhani, Salomeh; Kleinman, Lawrence C.; Anderson, Rebecca] Mt Sinai Sch Med, Dept Hlth Policy, New York, NY 10029 USA; [Rothschild, Michael] Mt Sinai Sch Med, Dept Otolaryngol, New York, NY 10029 USA; [Rothschild, Michael] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Chassin, Mark] Joint Commiss, Oak Brook Terrace, IL USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Keyhani, S (corresponding author), Mt Sinai Sch Med, Dept Hlth Policy, 1 Gustave L Levy Pl,Box 1077, New York, NY 10029 USA.	Salomeh.Keyhani@mountsinai.org	Kleinman, Lawrence/AAS-6934-2021		AHRQ HHS [R01 HS 10302] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010302] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		BLACK N, 1995, J EPIDEMIOL COMMUN H, V49, P234, DOI 10.1136/jech.49.3.234; BLACK N, 1985, J ROY SOC MED, V78, P641, DOI 10.1177/014107688507800809; Black N, 2002, QUAL SAF HEALTH CARE, V11, P121, DOI 10.1136/qhc.11.2.121; Bluestone CD, 1998, PEDIATR INFECT DIS J, V17, P1090, DOI 10.1097/00006454-199811000-00040; Boston M, 2003, ARCH OTOLARYNGOL, V129, P293, DOI 10.1001/archotol.129.3.293; Brook R H, 1986, Int J Technol Assess Health Care, V2, P53; Byrns PJ, 1997, ARCH PEDIAT ADOL MED, V151, P407, DOI 10.1001/archpedi.1997.02170410081011; CASSELBRANT ML, 1985, LARYNGOSCOPE, V95, P428; Chow Y, 2007, INT J PEDIATR OTORHI, V71, P1543, DOI 10.1016/j.ijporl.2007.06.001; Coyte PC, 2001, JAMA-J AM MED ASSOC, V286, P2128, DOI 10.1001/jama.286.17.2128; CROTEAU N, 1990, AM J DIS CHILD, V144, P535, DOI 10.1001/archpedi.1990.02150290029019; DALY KA, 1991, OTOLARYNG CLIN N AM, V24, P775; HALL MJ, 1998, 300 NAT CTR HLTH STA; Halm EA, 2003, STROKE, V34, P1464, DOI 10.1161/01.STR.0000072514.79745.7D; Karevold G, 2007, INT J PEDIATR OTORHI, V71, P1035, DOI 10.1016/j.ijporl.2007.03.010; Karevold G, 2007, ACTA OTO-LARYNGOL, V127, P29, DOI 10.1080/00016480600606756; Keyhani S, 2008, PEDIATRICS, V121, pE24, DOI 10.1542/peds.2007-0623; KLEINMAN LC, 1994, JAMA-J AM MED ASSOC, V271, P1250, DOI 10.1001/jama.271.16.1250; Kleinman LC, 1997, JAMA-J AM MED ASSOC, V278, P497, DOI 10.1001/jama.278.6.497; Kogan MD, 2000, AM J PUBLIC HEALTH, V90, P245, DOI 10.2105/AJPH.90.2.245; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; MAW AR, 1994, CLIN OTOLARYNGOL, V19, P125, DOI 10.1111/j.1365-2273.1994.tb01195.x; Mehta R, 2008, J NUCL CARDIOL, V15, P337, DOI 10.1016/j.nuclcard.2007.10.010; O'Connor GT, 2008, J AM COLL CARDIOL, V51, P2323, DOI 10.1016/j.jacc.2008.01.067; Paradise JL, 2007, NEW ENGL J MED, V356, P248, DOI 10.1056/NEJMoa062980; Paradise JL, 1997, PEDIATRICS, V99, P318, DOI 10.1542/peds.99.3.318; Paradise JL, 2003, PEDIATR INFECT DIS J, V22, P309; Richards M, 2002, ARCH OTOLARYNGOL, V128, P776, DOI 10.1001/archotol.128.7.776; Rosenfeld RM, 2004, OTOLARYNG HEAD NECK, V130, pS95, DOI 10.1016/j.otohns.2004.02.002; Rosenfeld RM, 2004, PEDIATRICS, V113, P1412, DOI 10.1542/peds.113.5.1412; Rosenfeld RM, 2000, ARCH OTOLARYNGOL, V126, P585, DOI 10.1001/archotol.126.5.585; STOOL SE, 1994, AHCPR PUBLICATION; TEELE DW, 1980, ANN OTO RHINOL LARYN, V89, P5, DOI 10.1177/00034894800890S304; ZIELHUIS GA, 1990, INT J EPIDEMIOL, V19, P1037, DOI 10.1093/ije/19.4.1037	34	37	37	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2008	337	7675							a1607	10.1136/bmj.a1607	http://dx.doi.org/10.1136/bmj.a1607			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360YE	18835846	Green Published, hybrid			2022-12-28	WOS:000260093900037
J	Sharp, D				Sharp, David			Advances in conspiracy theory	LANCET			English	Editorial Material							AFRICAN-AMERICANS; BIRTH-CONTROL; HIV/AIDS; BELIEFS; HIV		[Sharp, David] The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							[Anonymous], 2005, LANCET, V365, P448, DOI 10.1016/S0140-6736(05)17875-1; Bird ST, 2005, J SOC ISSUES, V61, P109, DOI 10.1111/j.0022-4537.2005.00396.x; Bogart LM, 2006, J NATL MED ASSOC, V98, P1144; Clark A, 2008, AIDS PATIENT CARE ST, V22, P753, DOI 10.1089/apc.2007.0249; Douglas KM, 2008, J SOC PSYCHOL, V148, P210, DOI 10.3200/SOCP.148.2.210-222; Grzesiak-Feldman M, 2008, PSYCHOL REP, V102, P884, DOI 10.2466/PR0.102.3.884-886; Hutchinson AB, 2007, JAIDS-J ACQ IMM DEF, V45, P603, DOI 10.1097/QAI.0b013e3181151262; LEMAN P, PSYCHOL CONSPIRACY; Ross MW, 2006, JAIDS-J ACQ IMM DEF, V41, P342, DOI 10.1097/01.qai.0000209897.59384.52; 1980, GUARDIAN        0731	10	6	6	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 18	2008	372	9647					1371	1372		10.1016/S0140-6736(08)61570-6	http://dx.doi.org/10.1016/S0140-6736(08)61570-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362WP	18940455				2022-12-28	WOS:000260228200009
J	Mathew-Fenn, RS; Das, R; Harbury, PAB				Mathew-Fenn, Rebecca S.; Das, Rhiju; Harbury, Pehr A. B.			Remeasuring the double helix	SCIENCE			English	Article							PROTEIN-DNA COMPLEXES; OPTICAL TWEEZERS; NUCLEIC-ACIDS; STRANDED-DNA; SINGLE; DISTANCES; FLUCTUATIONS; TRANSITIONS; ELASTICITY; MICROSCOPY	DNA is thought to behave as a stiff elastic rod with respect to the ubiquitous mechanical deformations inherent to its biology. To test this model at short DNA lengths, we measured the mean and variance of end-to-end length for a series of DNA double helices in solution, using small-angle x-ray scattering interference between gold nanocrystal labels. In the absence of applied tension, DNA is at least one order of magnitude softer than measured by single-molecule stretching experiments. Further, the data rule out the conventional elastic rod model. The variance in end-to-end length follows a quadratic dependence on the number of base pairs rather than the expected linear dependence, indicating that DNA stretching is cooperative over more than two turns of the DNA double helix. Our observations support the idea of long-range allosteric communication through DNA structure.	[Mathew-Fenn, Rebecca S.; Harbury, Pehr A. B.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Mathew-Fenn, Rebecca S.; Das, Rhiju; Harbury, Pehr A. B.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Das, Rhiju] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Harbury, PAB (corresponding author), Stanford Univ, Biophys Program, Stanford, CA 94305 USA.	harbury@cmgm.stanford.edu		Das, Rhiju/0000-0001-7497-0972	NIH [GM068126-01, DP OD000429-01]; NSF; U.S. Department of Energy [W-31-109 Eng-438]; Stanford Synchrotron Radiation Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068126] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000429] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); Stanford Synchrotron Radiation Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C.J. Ackerson for discussions on nanocrystal synthesis; R.L. Baldwin, F.E. Boas, Z.D. Bryant, L.S. Churchman, A.R. Dunn, D.R. Halpin, D. Herschlag, W.L. Martin, B.H. Robinson, J.M. Schurr, A.L. Smith, R.M. Weisinger, and S.J. Wrenn for insights into DNA; Y. Bai, S. Doniach, K. Ito, J. Lipfert, I. S. Millett, S. Seifert, P. Thiyagarajan and H. Tsuruta for assistance and advice on x-ray scattering; T.D. Fenn for writing code that was used to calculate crystallographic dispersion values and for valuable discussions throughout this work; P.A. Walker for expert assistance with DNA synthesis; and P. Bradley and D. Baker for permitting use of unpublished code to prepare Fig. 4. Supported by NIH grants GM068126-01 and DP OD000429-01 (P.A.B.H.), an NIH training grant fellowship (R.S.F.), an NSF graduate fellowship (R.D.), and the U.S. Department of Energy (contract W-31-109 Eng-438 to the Advanced Photon Source, and support of Stanford Synchrotron Radiation Laboratory).	Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Cai Q, 2006, NUCLEIC ACIDS RES, V34, P4722, DOI 10.1093/nar/gkl546; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Cloutier TE, 2005, P NATL ACAD SCI USA, V102, P3645, DOI 10.1073/pnas.0409059102; Cloutier TE, 2004, MOL CELL, V14, P355, DOI 10.1016/S1097-2765(04)00210-2; DEPEW RE, 1975, P NATL ACAD SCI USA, V72, P4275, DOI 10.1073/pnas.72.11.4275; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Gore J, 2006, NATURE, V442, P836, DOI 10.1038/nature04974; GRIFFITH JD, 1978, SCIENCE, V201, P525, DOI 10.1126/science.663672; HARBURY PAB, 2008, PLOS 1, V3, pE3329; Hillisch A, 2001, CURR OPIN STRUC BIOL, V11, P201, DOI 10.1016/S0959-440X(00)00190-1; Kosikov KM, 1999, J MOL BIOL, V289, P1301, DOI 10.1006/jmbi.1999.2798; Laurence TA, 2005, P NATL ACAD SCI USA, V102, P17348, DOI 10.1073/pnas.0508584102; Liu YX, 2001, J BIOMOL STRUCT DYN, V18, P505, DOI 10.1080/07391102.2001.10506684; Morozov AV, 2005, NUCLEIC ACIDS RES, V33, P5781, DOI 10.1093/nar/gki875; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687; Sakata-Sogawa K, 1998, EUR BIOPHYS J BIOPHY, V27, P55, DOI 10.1007/s002490050110; Schurr JM, 2000, BIOPOLYMERS, V54, P561, DOI 10.1002/1097-0282(200012)54:7<561::AID-BIP80>3.0.CO;2-M; Schurr JM, 1997, BIOPOLYMERS, V44, P283, DOI 10.1002/(SICI)1097-0282(1997)44:3<283::AID-BIP7>3.0.CO;2-R; SHORE D, 1983, J MOL BIOL, V170, P983, DOI 10.1016/S0022-2836(83)80199-5; SHORE D, 1983, J MOL BIOL, V170, P957, DOI 10.1016/S0022-2836(83)80198-3; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Sonnichsen C, 2005, NAT BIOTECHNOL, V23, P741, DOI 10.1038/nbt1100; Ulyanov NB, 1995, METHOD ENZYMOL, V261, P90; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Zhu PZ, 2005, BIOPHYS J, V89, pL37, DOI 10.1529/biophysj.105.071027; ZIMMERMAN SB, 1979, J MOL BIOL, V135, P1023, DOI 10.1016/0022-2836(79)90526-6	31	167	168	4	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					446	449		10.1126/science.1158881	http://dx.doi.org/10.1126/science.1158881			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927394	Green Accepted			2022-12-28	WOS:000260094500048
J	Mezger, M; Schroder, H; Reichert, H; Schramm, S; Okasinski, JS; Schoder, S; Honkimaki, V; Deutsch, M; Ocko, BM; Ralston, J; Rohwerder, M; Stratmann, M; Dosch, H				Mezger, Markus; Schroder, Heiko; Reichert, Harald; Schramm, Sebastian; Okasinski, John S.; Schoder, Sebastian; Honkimaki, Veijo; Deutsch, Moshe; Ocko, Benjamin M.; Ralston, John; Rohwerder, Michael; Stratmann, Martin; Dosch, Helmut			Molecular layering of fluorinated ionic liquids at a charged sapphire (0001) surface	SCIENCE			English	Article							X-RAY; METAL; SOLVENTS; FILMS	Room-temperature ionic liquids (RTILs) are promising candidates for a broad range of "green" applications, for which their interaction with solid surfaces plays a crucial role. In this high-energy x-ray reflectivity study, the temperature-dependent structures of three ionic liquids with the tris(pentafluoroethyl) trifluorophosphate anion in contact with a charged sapphire substrate were investigated with submolecular resolution. All three RTILs show strong interfacial layering, starting with a cation layer at the substrate and decaying exponentially into the bulk liquid. The observed decay length and layering period point to an interfacial ordering mechanism, akin to the charge inversion effect, which is suggested to originate from strong correlations between the unscreened ions. The observed layering is expected to be a generic feature of RTILs at charged interfaces.	[Mezger, Markus; Schroder, Heiko; Reichert, Harald; Schramm, Sebastian; Okasinski, John S.; Schoder, Sebastian; Dosch, Helmut] Max Planck Inst Met Res, D-70569 Stuttgart, Germany; [Schoder, Sebastian; Honkimaki, Veijo] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Deutsch, Moshe] Bar Ilan Univ, Dept Phys, IL-52900 Ramat Gan, Israel; [Deutsch, Moshe] Bar Ilan Univ, Inst Nanotechnol & Adv Mat, IL-52900 Ramat Gan, Israel; [Ocko, Benjamin M.] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA; [Ralston, John] Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia; [Rohwerder, Michael; Stratmann, Martin] Max Planck Inst Eisenforsch GmbH, D-40237 Dusseldorf, Germany; [Dosch, Helmut] Univ Stuttgart, Inst Theoret & Angew Phys, D-70550 Stuttgart, Germany	Max Planck Society; European Synchrotron Radiation Facility (ESRF); Bar Ilan University; Bar Ilan University; United States Department of Energy (DOE); Brookhaven National Laboratory; University of South Australia; Max Planck Society; University of Stuttgart	Reichert, H (corresponding author), Max Planck Inst Met Res, D-70569 Stuttgart, Germany.	reichert@mf.mpg.de	Ralston, John/B-9248-2009; Mezger, Markus/D-6897-2014; Reichert, Harald/AAZ-9105-2021	Ralston, John/0000-0002-8271-3041; Mezger, Markus/0000-0001-9049-6983; Reichert, Harald/0000-0001-7730-6962; Schoder, Sebastian/0000-0002-9872-6146	German-Israeli Foundation for Scientific Research and Development [I 779-42.10/2003]; U.S.-Israel Binational Science Foundation (Jerusalem); Division of Materials Science of the U.S. Department of Energy [DE-AC02-98CH10886]; Australian Research Council Special Research Centre Scheme	German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); U.S.-Israel Binational Science Foundation (Jerusalem)(US-Israel Binational Science Foundation); Division of Materials Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Australian Research Council Special Research Centre Scheme(Australian Research Council)	This work was supported by the German-Israeli Foundation for Scientific Research and Development (no. I 779-42.10/2003), the U.S.-Israel Binational Science Foundation (Jerusalem), the Division of Materials Science of the U.S. Department of Energy under contract no. DE-AC02-98CH10886, and the Australian Research Council Special Research Centre Scheme.	Als-Nielsen J., 2001, ELEMENTS MODERN XRAY; Bach U, 1998, NATURE, V395, P583, DOI 10.1038/26936; Blanchard LA, 1999, NATURE, V399, P28, DOI 10.1038/19887; Borra EF, 2007, NATURE, V447, P979, DOI 10.1038/nature05909; Bowers J, 2004, LANGMUIR, V20, P309, DOI 10.1021/la035495v; Carmichael AJ, 2001, MOL PHYS, V99, P795, DOI 10.1080/00268970010012301; Chen YG, 2006, P NATL ACAD SCI USA, V103, P7560, DOI 10.1073/pnas.0600282103; Crowhurst L, 2004, J AM CHEM SOC, V126, P11549, DOI 10.1021/ja046757y; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Grosberg AY, 2002, REV MOD PHYS, V74, P329, DOI 10.1103/RevModPhys.74.329; Ha BY, 1997, PHYS REV LETT, V79, P1289, DOI 10.1103/PhysRevLett.79.1289; Ignat'ev NV, 2005, J FLUORINE CHEM, V126, P1150, DOI 10.1016/j.jfluchem.2005.04.017; INGBER L, 1993, MATH COMPUT MODEL, V18, P29, DOI 10.1016/0895-7177(93)90204-C; Krossing I, 2006, Z PHYS CHEM, V220, P1343, DOI 10.1524/zpch.2006.220.10.1343; Lynden-Bell RM, 2007, ACCOUNTS CHEM RES, V40, P1138, DOI 10.1021/ar700065s; MAGNUSSEN OM, 1995, PHYS REV LETT, V74, P4444, DOI 10.1103/PhysRevLett.74.4444; Mezger M, 2006, P NATL ACAD SCI USA, V103, P18401, DOI 10.1073/pnas.0608827103; Pinilla C, 2007, J PHYS CHEM B, V111, P4877, DOI 10.1021/jp067184+; Regan MJ, 1997, PHYS REV B, V55, P15874, DOI 10.1103/PhysRevB.55.15874; Reichert H, 2003, PHYSICA B, V336, P46, DOI 10.1016/S0921-4526(03)00268-0; Rogers RD, 2003, SCIENCE, V302, P792, DOI 10.1126/science.1090313; Santos CS, 2007, J PHYS CHEM C, V111, P7682, DOI 10.1021/jp0652751; Sha ML, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2898497; Shafir A, 2006, EUR PHYS J E, V19, P155, DOI 10.1140/epje/e2006-00018-3; Solutskin E, 2005, J AM CHEM SOC, V127, P7796, DOI 10.1021/ja0509679; Walden P., 1914, B ACAD IMPER SCI ST, V8, P405; Wang P, 2003, J AM CHEM SOC, V125, P1166, DOI 10.1021/ja029294+; Wasserscheid P, 2007, IONIC LIQUIDS SYNTHE; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Zhao HB, 2007, SCIENCE, V316, P1597, DOI 10.1126/science.1141199	30	540	542	5	335	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2008	322	5900					424	428		10.1126/science.1164502	http://dx.doi.org/10.1126/science.1164502			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927390				2022-12-28	WOS:000260094500042
J	Stewart, PM; Stears, A; Tomlinson, JW; Brown, MJ				Stewart, Paul M.; Stears, Anna; Tomlinson, Jeremy W.; Brown, Morris J.			Regulation-the real threat to clinical research	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ETHICS; MULTICENTER; TRIAL		[Stewart, Paul M.; Tomlinson, Jeremy W.; Brown, Morris J.] Univ Birmingham, Div Med Sci, Birmingham B15 2TT, W Midlands, England; [Stears, Anna; Brown, Morris J.] Addenbrookes Hosp, Cambridge CB2 2QQ, England	University of Birmingham; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Brown, MJ (corresponding author), Univ Birmingham, Div Med Sci, Birmingham B15 2TT, W Midlands, England.	m.j.brown@cai.cam.ac.uk		Tomlinson, Jeremy/0000-0002-3170-8533	British Heart Foundation Funding Source: Medline; Wellcome Trust Funding Source: Medline	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)		*CENTERWATCH, WHY PEOPL PART; Christie DRH, 2007, INTERN MED J, V37, P680, DOI 10.1111/j.1445-5994.2007.01451.x; Elwyn G, 2005, BRIT MED J, V330, P847, DOI 10.1136/bmj.330.7495.847; Hood SJ, 2007, CIRCULATION, V116, P268, DOI 10.1161/CIRCULATIONAHA.107.690396; Jamrozik K, 2004, BRIT MED J, V329, P286, DOI 10.1136/bmj.329.7460.286; Mitchell P, 2007, NAT BIOTECHNOL, V25, P485, DOI 10.1038/nbt0507-485; *NAT I HLTH RES, 2008, BUR BUST NIHR COORD; *OFF STRAT COORD H, 2008, BACKGR REV HLTH RES; Robinson L, 2007, BRIT MED J, V335, P6, DOI 10.1136/bmj.39201.508692.2C; Smith R, 2000, BRIT MED J, V321, P1041; Tomlinson JW, 2007, J CLIN ENDOCR METAB, V92, P857, DOI 10.1210/jc.2006-2325; Zillich AJ, 2006, HYPERTENSION, V48, P219, DOI 10.1161/01.HYP.0000231552.10054.aa; 2008, FINANCIAL TIMES 0626, P3	13	49	50	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2008	337								a1732	10.1136/bmj.a1732	http://dx.doi.org/10.1136/bmj.a1732			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374FF	18927171				2022-12-28	WOS:000261027900001
J	Dehghan, A; Kottgen, A; Yang, Q; Hwang, SJ; Kao, WHL; Rivadeneira, F; Boerwinkle, E; Levy, D; Hofman, A; Astor, BC; Benjamin, EJ; van Duijn, CM; Witteman, JC; Coresh, J; Fox, CS				Dehghan, Abbas; Kottgen, Anna; Yang, Qiong; Hwang, Shih Jen; Kao, W. H. Linda; Rivadeneira, Fernando; Boerwinkle, Eric; Levy, Daniel; Hofman, Albert; Astor, Brad C.; Benjamin, Emelia J.; van Duijn, Cornelia M.; Witteman, Jacqueline C.; Coresh, Josef; Fox, Caroline S.			Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study	LANCET			English	Article							PRACTICE RESEARCH DATABASE; ATHEROSCLEROSIS RISK; UNIFIED APPROACH; APICAL MEMBRANE; HEART-DISEASE; UNITED-STATES; SERUM URATE; FRAMINGHAM; DESIGN; HYPERURICEMIA	Background Hyperuricaemia, a highly heritable trait, is a key risk factor for gout. We aimed to identify novel genes associated with serum uric acid concentration and gout. Methods Genome-wide association studies were done for serum uric acid in 7699 participants in the Framingham cohort and in 4148 participants in the Rotterdam cohort. Genome-wide significant single nucleotide polymorphisms (SNPs) were replicated in white (n=11024) and black (n=3843) individuals who took part in the study of Atherosclerosis Risk in Communities (ARIC). The SNPs that reached genome-wide significant association with uric acid in either the Framingham cohort (p<5.0x10(-8)) or the Rotterdam cohort (p<1.0x10(-7)) were evaluated with gout. The results obtained in white participants were combined using meta-analysis. Findings Three loci in the Framingham cohort and two in the Rotterdam cohort showed genome-wide association with uric acid. Top SNPs in each locus were: missense rs16890979 in SLC2A9 (p=7.0x10(-168) and 2.9x10(-18) for white and black participants, respectively); missense rs2231142 in ABCG2 (p=2.5x10(-60) and 9.8x10(-4)), and rs17.65205 in SLC17A3 (p=3.3x10(-26) and 0.33). All SNPs were direction-consistent with gout in white participants: rs16890979 (OR 0.59 per T allele, 95% CI 0.52-0.68, p=7.0x10(-14)), rs2231.142 (1.74, 1.51-1.99, p=3.3x10(-15)), and rs1165205 (0.85, 0.77-0.94, p=0.002). In black participants of the ARIC study, rs2231142 was direction-consistent with gout (1.71, 1.06-2.77, p=0.028). An additive genetic risk score of high-risk alleles at the three loci showed graded associations with uric acid (272-351 mu mol/L in the Framingham cohort, 269-386 mu mol/L in the Rotterdam cohort, and 303-426 mu mol/L in white participants of the ARIC study) and gout (frequency 2-13% in the Framingham cohort, 2-8% in the Rotterdam cohort, and 1-18% in white participants in the ARIC study). Interpretation We identified three genetic loci associated with uric acid concentration and gout. A score based on genes with a putative role in renal urate handling showed a substantial risk for gout. Funding Netherlands Organisation for Scientific Research (NWO); the National Heart, Lung, and Blood Institute.	[Hwang, Shih Jen; Levy, Daniel; Fox, Caroline S.] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Hwang, Shih Jen; Levy, Daniel; Fox, Caroline S.] Ctr Populat Studies, Framingham, MA 01702 USA; [Hwang, Shih Jen; Levy, Daniel; Fox, Caroline S.] NHLBI, Bethesda, MD 20892 USA; [Dehghan, Abbas; Hofman, Albert; van Duijn, Cornelia M.; Witteman, Jacqueline C.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Rivadeneira, Fernando] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Kottgen, Anna; Kao, W. H. Linda; Astor, Brad C.; Coresh, Josef] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Kottgen, Anna; Kao, W. H. Linda; Astor, Brad C.; Coresh, Josef] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Yang, Qiong] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Benjamin, Emelia J.] Boston Univ, Dept Cardiol, Sch Med, Boston, MA 02215 USA; [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; [Fox, Caroline S.] Brigham & Womens Hosp, Div Endocrinol Hypertens & Diabet, Boston, MA 02115 USA; [Fox, Caroline S.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Johns Hopkins University; Johns Hopkins University; Boston University; Boston University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Fox, CS (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave Suite 2, Framingham, MA 01702 USA.	foxca@nhlbi.nih.gov	Dehghan, Abbas/ABE-7377-2020; Kottgen, Anna/D-2920-2012; Yang, Qiong/G-5438-2014; Rivadeneira, Fernando/O-5385-2015; Hwang, Shih-Jen/HGU-5826-2022; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Dehghan, Abbas/B-9896-2008; Benjamin, Emelia/E-7103-2011	Rivadeneira, Fernando/0000-0001-9435-9441; Levy, Daniel/0000-0003-1843-8724; Ballantyne, Christie/0000-0002-6432-1730; Dehghan, Abbas/0000-0001-6403-016X; Van Duijn, Cornelia/0000-0002-2374-9204; Benjamin, Emelia/0000-0003-4076-2336	Netherlands organisation for scientific research (NWO) [175.01.2005.011]; National Heart, Lung, and Blood Institute's Framingham heart study [NOI-HC-25195]; Affymetrix genotyping [N02-HL-6-4278]; National Heart, Lung, and Blood Institute [NO1-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, NO1-HC-55021, N01-HC-55022, R01DK076770-01]; National Centre for Research Resources; NIH Roadmap for Medical Research [UL1 RR 025005]; German research foundation fellowship; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195, N01HC055020, N01HC055019, N01HC055021, N01HC055018, N01HC055016, N01HC055015, N01HC055022] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL055018, R01HL064278, R42HL055018, R41HL055019, ZIAHL006001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076770] Funding Source: NIH RePORTER	Netherlands organisation for scientific research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Heart, Lung, and Blood Institute's Framingham heart study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Affymetrix genotyping; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Centre for Research Resources; NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German research foundation fellowship(German Research Foundation (DFG)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the staff and participants in the Framingham cohort study, the Rotterdam study, and the Atherosclerosis Risk in Communities study for their important contributions. We received funding from the Netherlands organisation for scientific research (NWO) (175.01.2005.011); the National Heart, Lung, and Blood Institute's Framingham heart study (NOI-HC-25195). Affymetrix genotyping was supported by contract N02-HL-6-4278. The Atherosclerosis Risk in Communities study was supported by the National Heart, Lung, and Blood Institute (contracts NO1-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, NO1-HC-55021, and N01-HC-55022, with ancillary funding by R01DK076770-01). The project was partly supported by the National Centre for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research (grant UL1 RR 025005). AK was supported by a German research foundation fellowship. We acknowledge the individual participating studies and investigators of the Cohorts for Heart and Aging Research in Genome Epidemiology (CHARGe Consortium).	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; CROWLEY LV, 1964, CLIN CHEM, V10, P838; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; ECKFELDT JH, 1994, ARCH PATHOL LAB MED, V118, P496; Eraly SA, 2008, PHYSIOL GENOMICS, V33, P180, DOI 10.1152/physiolgenomics.00207.2007; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Huls M, 2008, KIDNEY INT, V73, P220, DOI 10.1038/sj.ki.5002645; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Iribarren C, 1996, ANN EPIDEMIOL, V6, P331, DOI 10.1016/S1047-2797(96)00052-X; Ishibashi K., 2003, NEPHRON PHYSIOL, V94, P10; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Krishnan E, 2008, J RHEUMATOL, V35, P498; Kusuhara H, 2007, PFLUG ARCH EUR J PHY, V453, P735, DOI 10.1007/s00424-006-0134-x; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Mikuls TR, 2005, RHEUMATOLOGY, V44, P1038, DOI 10.1093/rheumatology/keh679; Mikuls TR, 2005, ANN RHEUM DIS, V64, P267, DOI 10.1136/ard.2004.024091; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Roddy E, 2007, NAT CLIN PRACT RHEUM, V3, P443, DOI 10.1038/ncprheum0556; Saag KG, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1907; SCHWARZER G, 2007, META PACKAGE 08 2; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Stark K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001948; Sundy John S, 2007, Curr Rheumatol Rep, V9, P258, DOI 10.1007/s11926-007-0041-y; Takenaka K, 2007, CANCER RES, V67, P6965, DOI 10.1158/0008-5472.CAN-06-4720; Taniguchi A, 2008, CURR OPIN RHEUMATOL, V20, P192, DOI 10.1097/BOR.0b013e3282f33f87; Terkeltaub R, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1909; TRIVEDI RC, 1978, CLIN CHEM, V24, P1908; Uchino H, 2000, BIOCHEM BIOPH RES CO, V270, P254, DOI 10.1006/bbrc.2000.2407; Underwood M, 2006, BMJ-BRIT MED J, V332, P1315, DOI 10.1136/bmj.332.7553.1315; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wu EQ, 2008, J MANAGE CARE PHARM, V14, P164, DOI 10.18553/jmcp.2008.14.2.164; Yang Q, 2005, METABOLISM, V54, P1435, DOI 10.1016/j.metabol.2005.05.007	47	512	554	3	70	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2008	372	9654					1953	1961		10.1016/S0140-6736(08)61343-4	http://dx.doi.org/10.1016/S0140-6736(08)61343-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380NE	18834626	Green Accepted			2022-12-28	WOS:000261471600022
J	Zhang, KL; Detels, R; Liao, SS; Cohen, M; Yu, DB				Zhang, Kong-Lai; Detels, Roger; Liao, Susu; Cohen, Myron; Yu, Dong-Bao			China's HIV/AIDS epidemic: continuing challenges	LANCET			English	Editorial Material							HIV		[Zhang, Kong-Lai] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100005, Peoples R China; [Detels, Roger] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA; [Cohen, Myron] Univ N Carolina, Chapel Hill, NC USA; [Liao, Susu] Peking Union Med Coll, Dept Epidemiol, Beijing 100021, Peoples R China; [Yu, Dong-Bao] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; University of California System; University of California Los Angeles; University of North Carolina; University of North Carolina Chapel Hill; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; World Health Organization	Zhang, KL (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100005, Peoples R China.	Konglai_Zhang@163.com						*CHIN STAT COUNC A, 2007, JOINT ASS HIV AIDS P; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Gill B, 2007, NEW ENGL J MED, V356, P1801, DOI 10.1056/NEJMp078010; Li L, 2007, INT J EPIDEMIOL, V36, P178, DOI 10.1093/ije/dyl256; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; *STAT COUNC AIDS W, 2004, JOINT ASS HIV AIDS P; UNAIDS, 2008, REP GLOB EP; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8	8	31	34	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 22	2008	372	9652					1791	1793		10.1016/S0140-6736(08)61357-4	http://dx.doi.org/10.1016/S0140-6736(08)61357-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	375KG	18930521				2022-12-28	WOS:000261112000008
J	Takeuchi, A; Reyes, N; Artigas, P; Gadsby, DC				Takeuchi, Ayako; Reyes, Nicolas; Artigas, Pablo; Gadsby, David C.			The ion pathway through the opened Na+,K+-ATPase pump	NATURE			English	Article							NA,K-ATPASE ALPHA-SUBUNIT; TRANSMEMBRANE SEGMENT M1; CALCIUM-PUMP; CRYSTAL-STRUCTURE; K+-ATPASE; BINDING; CYSTEINE; OCCLUSION; MECHANISM; TRANSPORT	P-type ATPases pump ions across membranes, generating steep electrochemical gradients that are essential for the function of all cells. Access to the ion-binding sites within the pumps alternates between the two sides of the membrane(1) to avoid the dissipation of the gradients that would occur during simultaneous access. In Na+,K+-ATPase pumps treated with the marine agent palytoxin, this strict alternation is disrupted and binding sites are sometimes simultaneously accessible from both sides of the membrane, transforming the pumps into ion channels (see, for example, refs 2, 3). Current recordings in these channels can monitor accessibility of introduced cysteine residues to water-soluble sulphydryl-specific reagents(4). We found previously(5) that Na+,K+ pump-channels open to the extracellular surface through a deep and wide vestibule that emanates from a narrower pathway between transmembrane helices 4 and 6 (TM4 and TM6). Here we report that cysteine scans from TM1 to TM6 reveal a single unbroken cation pathway that traverses palytoxin-bound Na+,K+ pump-channels from one side of the membrane to the other. This pathway comprises residues from TM1, TM2, TM4 and TM6, passes through ion-binding site II,and is probably conserved in structurally and evolutionarily related P-type pumps, such as sarcoplasmic- and endoplasmic-reticulum Ca2+-ATPases and H+,K+-ATPases.	[Takeuchi, Ayako; Reyes, Nicolas; Artigas, Pablo; Gadsby, David C.] Rockefeller Univ, Lab Cardiac Membrane Physiol, New York, NY 10065 USA	Rockefeller University	Gadsby, DC (corresponding author), Rockefeller Univ, Lab Cardiac Membrane Physiol, New York, NY 10065 USA.	gadsby@rockefeller.edu		Reyes, Nicolas/0000-0001-6618-8307	NIH; Vicente Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036783] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vicente Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank N. Fataliev for help with molecular biology, the late R. F. Rakowski for cDNAs encoding Xenopus alpha<INF>1</INF> and beta<INF>3</INF> Na<SUP>+</SUP>,K<SUP>+</SUP>-ATPase subunits, and P. Nissen, B. Vilsen and J. V. Moller for providing atomic coordinates before their publication. The work was supported by a grant from the NIH (to D. C. G.) and a fellowship from the Vicente Trust (to P. A.); N. R. is presently a Jane Coffin Fund Fellow. We dedicate this paper to the memory of our colleague R. F. Rakowski.	Artigas P, 2004, J GEN PHYSIOL, V123, P357, DOI 10.1085/jgp.200308964; Artigas P, 2003, P NATL ACAD SCI USA, V100, P501, DOI 10.1073/pnas.0135849100; Artigas P, 2006, P NATL ACAD SCI USA, V103, P12613, DOI 10.1073/pnas.0602720103; CANESSA CM, 1992, EMBO J, V11, P1681, DOI 10.1002/j.1460-2075.1992.tb05218.x; Einholm AP, 2007, J BIOL CHEM, V282, P23854, DOI 10.1074/jbc.M702259200; Einholm AP, 2005, P NATL ACAD SCI USA, V102, P11254, DOI 10.1073/pnas.0501201102; Guennoun S, 2000, FEBS LETT, V482, P144, DOI 10.1016/S0014-5793(00)02050-0; Guennoun S, 2002, FEBS LETT, V513, P277, DOI 10.1016/S0014-5793(02)02323-2; Harmel N, 2006, J GEN PHYSIOL, V128, P103, DOI 10.1085/jgp.200609505; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; Horisberger JD, 2004, J BIOL CHEM, V279, P29542, DOI 10.1074/jbc.M400585200; INESI G, 1987, J BIOL CHEM, V262, P16338; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Lauger P., 1991, ELECTROGENIC ION PUM; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nielsen JM, 1998, BIOCHEMISTRY-US, V37, P1961, DOI 10.1021/bi972524q; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Rakowski RF, 2007, J GEN PHYSIOL, V130, P41, DOI 10.1085/jgp.200709770; Reyes N, 2006, NATURE, V443, P470, DOI 10.1038/nature05129; Sakmann B., 1995, SINGLE CHANNEL RECOR; SCHEINERBOBIS G, 1994, MOL PHARMACOL, V45, P1132; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Zhang ZS, 2000, BIOCHEMISTRY-US, V39, P8758, DOI 10.1021/bi000185m	30	63	66	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					413	416		10.1038/nature07350	http://dx.doi.org/10.1038/nature07350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	18849964	Green Accepted			2022-12-28	WOS:000261039600049
J	Yang, GH; Kong, LZ; Zhao, WH; Wan, X; Zhai, Y; Chen, LC; Koplan, JP				Yang, Gonghuan; Kong, Lingzhi; Zhao, Wenhua; Wan, Xia; Zhai, Yi; Chen, Lincoln C.; Koplan, Jeffrey P.			Health System Reform in China 3 Emergence of chronic non-communicable diseases in China	LANCET			English	Article							VERBAL AUTOPSY PROCEDURES; OF-DEATH STATISTICS; VALIDATION; PREVALENCE; SMOKING	China has experienced an epidemiological transition shifting from the infectious to the chronic diseases in much shorter time than many other countries. The pace and spread of behavioural changes, including changing diets, decreased physical activity high rates of male smoking, and other high risk behaviours, has accelerated to an unprecedented degree. As a result, the burden of chronic diseases, preventable morbidity and mortality and associated health-care costs could now increase substantially. China already has 177 million adults with hypertension; furthermore, 303 million adults smoke, which is a third of the world's total number of smokers, and 530 million people in China are passively exposed to second-hand smoke. The prevalence of overweight people and obesity is increasing in Chinese adults and children, because of dietary changes and reduced physical activity. Emergence of chronic diseases presents special challenges for China's ongoing reform of health care, given the large numbers who require curative treatment and the narrow window of opportunity for timely prevention of disease.	[Yang, Gonghuan; Zhao, Wenhua; Zhai, Yi] Chinese Ctr Dis Control & Prevent, Beijing 100050, Peoples R China; [Kong, Lingzhi] Minist Hlth, Bur Dis Prevent & Control, Beijing, Peoples R China; [Yang, Gonghuan; Wan, Xia] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Yang, Gonghuan; Wan, Xia] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China; [Chen, Lincoln C.] China Med Board, Cambridge, MA USA; [Koplan, Jeffrey P.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA	Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Emory University	Yang, GH (corresponding author), Chinese Ctr Dis Control & Prevent, 27 Nan Wei Rd, Beijing 100050, Peoples R China.	yanggh@chinacdc.cn		Zhai, Yi/0000-0002-1779-6645				Banister J, 2004, POP STUD-J DEMOG, V58, P55, DOI 10.1080/0032472032000183753; Chen K, 2004, PIGM CELL RES, V17, P36, DOI 10.1046/j.1600-0749.2003.00106.x; *CHIN AC PREV MED, 1997, SER REP CHIN DIS SUR; *CHIN INT INF CTR, 2008, ISS PROM 3 SURV CAUS; Chinese Academy of Preventive Medicine, 1997, SMOK HLTH CHIN 1996; Chinese Nutrition Society, 2008, CHIN DIET GUID; Choo V, 2002, LANCET, V360, P235, DOI 10.1016/S0140-6736(02)09512-0; *COMM REV CHIN GUI, 2006, CHIN HYP GUID; GE KY, 1996, J HYGIENE RES S29, V25, P54; HU SL, 2003, CHIN HLTH EC MAG, V22, P18; HUA XL, 2006, CHINA TOBACCO HIST; HUANG R, 1995, MORTALITY DATA CHINA; HUANG XQ, 2008, CHINA TOBACCO, V3, P59; International Institute for Applied Systems Analysis, CHIN POP AG SEX 1950; Li J, 2000, CELL BIOL INT, V24, P9, DOI 10.1006/cbir.1999.0438; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; *MIN HLTH, 2005, ANN CHIN HLTH YB; *MIN HLTH CANC PRE, 1979, STUD CANC DEATH SURV; *MIN HLTH COMM NAT, 1987, 1984 NAT PREV SURV S; *MIN HLTH CTR HLTH, 2004, AN REP NAT HLTH SERV; *MIN HLTH DEP DIS, 2006, REP CHRON DIS CHIN; *MIN HLTH MIN PUBL, 1992, MED CERT DEATH STREN; Population Census Office under the State Council and Department of Population Social Science and Technology Statistics, 2002, TAB 2000 POP CENS PE; Population Census Office under the State Council Department of Population and Employment Statistics of National Bureau of Statistics, 1993, TAB 1990 POP CENS PE; PUSKA P, 1988, EURO REPORTS STUDIES, V106; Rao C, 2005, B WORLD HEALTH ORGAN, V83, P618; Rao C, 2007, INT J EPIDEMIOL, V36, P642, DOI 10.1093/ije/dym003; Setel PW, 2006, PLOS MED, V3, P1282, DOI 10.1371/journal.pmed.0030268; *STAT STAT BUR PEO, 1996, 1982 POP CENS CHIN; TANG S, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61364-1; UN Department of Economic and Social Affairs Population Division, 2006, WORLD POP PROSP 2006; Wang LD, 2005, COMPREHENSIVE REPORT; Wang LJ, 2007, J EPIDEMIOL COMMUN H, V61, P519, DOI 10.1136/jech.2005.043927; WANG WZ, 2002, CHIN J GERIATR CARDI, V4, P30; WENG XZ, 1987, CHINESE MED J-PEKING, V100, P886; WHO, 2008, REP GLOB TOB EP 2008; *WHO, 2002, PREV CHRON DIS VIT I; World Health Organization, 1986, 1 INT C HLTH PROM OT; World Health Organization, 1993, MORT GUID CERT RUL C, V2, P30; World Health Organization, 1997, OB PREV MAN GLOB EP; World Health Organization, 1983, WHOSMO834; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Wu Yang-feng, 2005, Zhonghua Yufang Yixue Zazhi, V39, P316; Xie Gaoqiang, 2008, Wei Sheng Yan Jiu, V37, P33; Yang, 2005, DEATHS THEIR RISK FA; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; YANG GH, 2004, TOBACCO SCI POLICY P, P215; YANG GH, 1992, J CHIN EPIDEMIOL, V13, P79; Yang GH, 2006, INT J EPIDEMIOL, V35, P741, DOI 10.1093/ije/dyi181; [杨功焕 Yang Gonghuan], 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P77; [No title captured]; 2007, PERIODIC REPORT IMPL	52	373	418	7	95	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1697	1705		10.1016/S0140-6736(08)61366-5	http://dx.doi.org/10.1016/S0140-6736(08)61366-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372KG	18930526				2022-12-28	WOS:000260899900034
J	Krukowski, ZH; Bruce, J				Krukowski, Zygmunt H.; Bruce, Julie			Commentary: Controversies in NICE guidance on surgical site infection	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bruce, Julie] Univ Aberdeen, Sect Populat Hlth, Aberdeen AB25 2ZD, Scotland; [Krukowski, Zygmunt H.] Aberdeen Royal Infirm, Ward 31, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen	Bruce, J (corresponding author), Univ Aberdeen, Sect Populat Hlth, Aberdeen AB25 2ZD, Scotland.	j.bruce@abdn.ac.uk	Bruce, Julie/G-7588-2014	Bruce, Julie/0000-0002-8462-7999	MRC [G106/1178] Funding Source: UKRI; Medical Research Council [G106/1178] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		CRUSE PJE, 1980, SURG CLIN N AM, V60, P27; *HLTH PROT AG, SURG SIT INF SURV EN; *HLTH PROT SCOTL, 2007, SURG SIT INF SURV SC; KRUKOWSKI ZH, 1988, BRIT J SURG, V75, P857, DOI 10.1002/bjs.1800750909; National Institute for Health and Clinical Excellence, 2008, SURG SIT INF; Taylor EW, 2004, BRIT J SURG, V91, P105, DOI 10.1002/bjs.4365	6	10	10	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 1	2008	337								a2120	10.1136/bmj.a2120	http://dx.doi.org/10.1136/bmj.a2120			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368AM	18957456				2022-12-28	WOS:000260593700033
J	Jha, AK; Orav, EJ; Zheng, J; Epstein, AM				Jha, Ashish K.; Orav, E. John; Zheng, Jie; Epstein, Arnold M.			Patients' perception of hospital care in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-CARE; HEALTH-CARE; TECHNICAL QUALITY; STAFFING LEVELS; MORTALITY; MEDICARE; SATISFACTION; PERFORMANCE; RESPONSES; OUTCOMES	Background: Patients' perceptions of their care, especially in the hospital setting, are not well known. Data from the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey provide a portrait of patients' experiences in U.S. hospitals. Methods: We assessed the performance of hospitals across multiple domains of patients' experiences. We examined whether key characteristics of hospitals that are thought to enhance patients' experiences (i.e., a high ratio of nurses to patient-days, for-profit status, and nonacademic status) were associated with a better experience for patients. We also examined whether a hospital's performance on the HCAHPS survey was related to its performance on indicators of the quality of clinical care. Results: We found moderately high levels of satisfaction with care (e.g., on average, 67.4% of a hospital's patients said that they would definitely recommend the hospital), with a high degree of correlation among the measures of patients' experiences (Cronbach's alpha, 0.94). As compared with hospitals in the bottom quartile of the ratio of nurses to patient-days, those in the top quartile had a somewhat better performance on the HCAHPS survey (e.g., 63.5% vs. 70.2% of patients responded that they "would definitely recommend'' the hospital; P<0.001). Hospitals with a high level of patient satisfaction provided clinical care that was somewhat higher in quality for all conditions examined. For example, those in the top quartile of HCAHPS ratings performed better than those in the bottom quartile with respect to the care that patients received for acute myocardial infarction (actions taken to provide appropriate care as a proportion of all opportunities for providing such actions, 95.8% vs. 93.1% in unadjusted analyses; P<0.001) and for pneumonia (90.5% vs. 88.6% in unadjusted analyses, P<0.001). Conclusions: This portrait of patients' experiences in U.S. hospitals offers insights into areas that need improvement, suggests that the same characteristics of hospitals that lead to high nurse-staffing levels may be associated with better experiences for patients, and offers evidence that hospitals can provide both a high quality of clinical care and a good experience for the patient.	[Jha, Ashish K.; Zheng, Jie; Epstein, Arnold M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Jha, Ashish K.; Orav, E. John; Epstein, Arnold M.] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; [Jha, Ashish K.] Boston Vet Affairs Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Jha, AK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	ajha@hsph.harvard.edu			Commonwealth Fund, New York; Robert Wood Johnson Foundation Faculty Scholar Program	Commonwealth Fund, New York; Robert Wood Johnson Foundation Faculty Scholar Program(Robert Wood Johnson Foundation (RWJF))	Supported by a grant from the Commonwealth Fund, New York, and in part by the Robert Wood Johnson Foundation Faculty Scholar Program (to Dr. Jha). No potential conflict of interest relevant to this article was reported.	Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Chang JT, 2006, ANN INTERN MED, V145, P635, DOI 10.7326/0003-4819-145-8-200610170-00020; Chang JT, 2006, ANN INTERN MED, V144, P665, DOI 10.7326/0003-4819-144-9-200605020-00010; Clark PA, 2007, J NURS CARE QUAL, V22, P119, DOI 10.1097/01.NCQ.0000263100.29181.e3; Corrigan J. M., 2001, CROSSING QUALITY CHA; *CTR MED MED SERV, 2008, MOD PAT MIX ADJ CAHP; Darby C, 2005, HEALTH SERV RES, V40, P1973, DOI 10.1111/j.1475-6773.2005.00490.x; de Vries H, 2005, HEALTH SERV RES, V40, P2120, DOI 10.1111/j.1475-6773.2005.00479.x; Elliott MN, 2005, HEALTH SERV RES, V40, P2096, DOI 10.1111/j.1475-6773.2005.00476.x; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Gandhi TK, 2002, MED CARE, V40, P155, DOI 10.1097/00005650-200202000-00010; Goldstein E, 2005, HEALTH SERV RES, V40, P1977, DOI 10.1111/j.1475-6773.2005.00477.x; Hall LM, 2003, MED CARE, V41, P1096; Hurst Keith, 2007, Nurs Stand, V21, P15; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Kahn CN, 2006, HEALTH AFFAIR, V25, P148, DOI 10.1377/hlthaff.25.1.148; Keller S, 2005, HEALTH SERV RES, V40, P2057, DOI 10.1111/j.1475-6773.2005.00478.x; Mark BA, 2004, HEALTH SERV RES, V39, P279, DOI 10.1111/j.1475-6773.2004.00228.x; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Needleman J, 2002, NEW ENGL J MED, V346, P1715, DOI 10.1056/NEJMsa012247; Numata Y, 2006, J ADV NURS, V55, P435, DOI 10.1111/j.1365-2648.2006.03941.x; O'Malley AJ, 2005, HEALTH SERV RES, V40, P2162, DOI 10.1111/j.1475-6773.2005.00470.x; O'Malley AJ, 2005, HEALTH SERV RES, V40, P2078, DOI 10.1111/j.1475-6773.2005.00471.x; Person SD, 2004, MED CARE, V42, P4, DOI 10.1097/01.mlr.0000102369.67404.b0; Phillips DM, 2000, JAMA-J AM MED ASSOC, V284, P428, DOI 10.1001/jama.284.4.428; Rao M, 2006, BMJ-BRIT MED J, V333, P19, DOI 10.1136/bmj.38874.499167.7C; Schneider EC, 2001, MED CARE, V39, P1313, DOI 10.1097/00005650-200112000-00007; Sovie MD, 2001, J NURS ADMIN, V31, P588, DOI 10.1097/00005110-200112000-00010; Tervo-Heikkinen T, 2008, J NURS CARE QUAL, V23, P58, DOI 10.1097/01.NCQ.0000303806.09242.37; Wennberg JE, 1998, DARTMOUTH ATLAS HLTH	32	607	617	4	83	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2008	359	18					1921	1931		10.1056/NEJMsa0804116	http://dx.doi.org/10.1056/NEJMsa0804116			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	366BL	18971493				2022-12-28	WOS:000260454500008
J	Bayne, EH; Portoso, M; Kagansky, A; Kos-Braun, IC; Urano, T; Ekwall, K; Alves, F; Rappsilber, J; Allshire, RC				Bayne, Elizabeth H.; Portoso, Manuela; Kagansky, Alexander; Kos-Braun, Isabelle C.; Urano, Takeshi; Ekwall, Karl; Alves, Flavia; Rappsilber, Juri; Allshire, Robin C.			Splicing factors facilitate RNAi-directed silencing in fission yeast	SCIENCE			English	Article							PRE-MESSENGER-RNA; SCHIZOSACCHAROMYCES-POMBE; CENTROMERE FUNCTION; HETEROCHROMATIN; MUTANTS; RITS; ESTABLISHMENT; TRANSCRIPTION; INTERFERENCE; CHROMATIN	Heterochromatin formation at fission yeast centromeres is directed by RNA interference (RNAi). Noncoding transcripts derived from centromeric repeats are processed into small interfering RNAs (siRNAs) that direct the RNA-induced transcriptional silencing (RITS) effector complex to engage centromer transcripts, resulting in recruitment of the histone H3 lysine 9 methyltransferase Clr4, and hence silencing. We have found that defects in specific splicing factors, but not splicing itself, affect the generation of centromeric siRNAs and consequently centromeric heterochromatin integrity. Moreover, splicing factors physically associate with Cid12, a component of the RNAi machinery, and with centromeric chromatin, consistent with a direct role in RNAi. We propose that spliceosomal complexes provide a platform for siRNA generation and hence facilitate effective centromere repeat silencing.	[Bayne, Elizabeth H.; Portoso, Manuela; Kagansky, Alexander; Kos-Braun, Isabelle C.; Alves, Flavia; Rappsilber, Juri; Allshire, Robin C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Bayne, Elizabeth H.; Portoso, Manuela; Kagansky, Alexander; Kos-Braun, Isabelle C.; Alves, Flavia; Rappsilber, Juri; Allshire, Robin C.] Univ Edinburgh, Inst Cell Biol, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Urano, Takeshi] Shimane Univ, Fac Med, Dept Biochem, Izumo, Shimane 6938501, Japan; [Ekwall, Karl] Univ Coll Sodertorn, Karolinska Inst, Dept Biosci & Med Nutr, S-14157 Huddinge, Sweden	University of Edinburgh; University of Edinburgh; Shimane University; Karolinska Institutet; Sodertorn University	Allshire, RC (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Sch Biol Sci, 6-34 Swann Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	robin.allshire@ed.ac.uk	Rappsilber, Juri/ABF-3328-2020; Kagansky, Alexander/B-3137-2011; Rappsilber, Juri/B-7265-2015; /C-3697-2019; Bayne, Elizabeth H/G-5411-2010	Kagansky, Alexander/0000-0002-6219-6892; Rappsilber, Juri/0000-0001-5999-1310; Bayne, Elizabeth H/0000-0001-8775-999X; Urano, Takeshi/0000-0003-3383-3554; Allshire, Robin/0000-0002-8005-3625; Kos-Braun, Isabelle/0000-0002-2380-5720; Ekwall, Karl/0000-0002-3029-4041	Epigenome Network of Excellence [EC-FP6/Contract/LSHG-CT2004-503433]; UK Medical Research Council [G0301153/ID:69173]; Wellcome Trust Prize Studentship [067844]; Marie Curie Excellence Grant [MEXT-CT-014171]; Wellcome Trust Principal Research Fellowship [065061/Z]; Medical Research Council [G0301153] Funding Source: researchfish; MRC [G0301153] Funding Source: UKRI	Epigenome Network of Excellence; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Prize Studentship(Wellcome Trust); Marie Curie Excellence Grant(European Commission); Wellcome Trust Principal Research Fellowship(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J. Beggs, E. S. Chin, A. Pidoux, F. Simmer, I. Stancheva, and D. Tollervey for comments; N. Kaufer, D. Moazed, and T. Tani for materials; and the Allshire lab for support. Supported by Epigenome Network of Excellence (EC-FP6/Contract/LSHG-CT2004-503433), of which R.C.A. and K.E. are members (E.B.); UK Medical Research Council grant G0301153/ID:69173 (A.K.); Wellcome Trust Prize Studentship 067844 (M.P.); Marie Curie Excellence Grant MEXT-CT-014171 from the European Commission (I.R.); and Wellcome Trust Principal Research Fellowship grant 065061/Z (R.C.A.).	Bartels C, 2002, EMBO REP, V3, P875, DOI 10.1093/embo-reports/kvf172; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Ekwall K, 1999, GENETICS, V153, P1153; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Goymer P, 2007, NAT REV MOL CELL BIO, V8, P597, DOI 10.1038/nrm2225; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Habara Y, 2001, RNA, V7, P671, DOI 10.1017/S1355838201001200; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; LOCKHART SR, 1994, MOL CELL BIOL, V14, P3623, DOI 10.1128/MCB.14.6.3623; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Potashkin J, 1998, CURR GENET, V34, P153, DOI 10.1007/s002940050381; ROSENBERG GH, 1991, MOL GEN GENET, V226, P305, DOI 10.1007/BF00273617; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Urushiyama S, 1996, MOL GEN GENET, V253, P118, DOI 10.1007/s004380050304; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; VOLPE TA, 2002, SCIENCE, V297, P18533, DOI DOI 10.1112/SCIENCE.1074973	25	99	98	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					602	606		10.1126/science.1164029	http://dx.doi.org/10.1126/science.1164029			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948543	Green Accepted			2022-12-28	WOS:000260299100047
J	Schwander, T; Keller, L				Schwander, Tanja; Keller, Laurent			Genetic compatibility affects queen and worker caste determination	SCIENCE			English	Article									[Schwander, Tanja; Keller, Laurent] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland	University of Lausanne	Schwander, T (corresponding author), Simon Fraser Univ, Dept Biol Sci, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	tanja.schwander@gmail.com	keller, laurent/AAI-7175-2020	keller, laurent/0000-0002-5046-9953; Schwander, Tanja/0000-0003-1945-5374	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank C. Campbell for help in the field; F. Dessimoz and C. Ohayon for ant care and laboratory work; B.J. Crespi, P. Chnste, M. Chapunsat, and D. Queler for comments; and K. Parker and D. Arbuthnott for help with English. Supported by the Swiss National Science Foundation.	Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508	4	42	42	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					552	552		10.1126/science.1162590	http://dx.doi.org/10.1126/science.1162590			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948532	Green Submitted			2022-12-28	WOS:000260299100032
J	Pincock, S				Pincock, Stephen			Profile - Francoise Barre-Sinoussi: shares Nobel Prize for discovery of HIV	LANCET			English	Biographical-Item												stephen.pincock@journalist.co.uk		Pincock, Stephen/0000-0003-1655-2902					0	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 18	2008	372	9647					1377	1377		10.1016/S0140-6736(08)61575-5	http://dx.doi.org/10.1016/S0140-6736(08)61575-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362WP	18940456	Bronze			2022-12-28	WOS:000260228200012
J	Silberstein, SD				Silberstein, Stephen D.			Recent developments in migraine	LANCET			English	Editorial Material							DOUBLE-BLIND; CONTROLLED-TRIAL; RISK; INTERVENTION; CGRP		[Silberstein, Stephen D.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA	Jefferson University	Silberstein, SD (corresponding author), Thomas Jefferson Univ, Philadelphia, PA 19107 USA.	stephen.silberstein@jefferson.edu						Ayata C, 2006, ANN NEUROL, V59, P652, DOI 10.1002/ana.20778; Diener HC, 2007, LANCET NEUROL, V6, P1054, DOI 10.1016/S1474-4422(07)70272-7; Doods H, 2007, TRENDS PHARMACOL SCI, V28, P580, DOI 10.1016/j.tips.2007.10.005; Dowson A, 2008, CIRCULATION, V117, P1397, DOI 10.1161/CIRCULATIONAHA.107.727271; Ho TW, 2008, NEUROLOGY, V70, P1304, DOI 10.1212/01.WNL.0000286940.29755.61; HO TW, 2008, HEADACHE S1, V48, P7; Kurth T, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a636; Kurth T, 2007, ARCH INTERN MED, V167, P795, DOI 10.1001/archinte.167.8.795; Lipton RB, 2005, HEADACHE, V45, P792; MATCHAR DB, 2008, HEADACHE        0610, DOI DOI 10.1111/J.1526-4610.2007.01148.X; Scher AI, 2005, NEUROLOGY, V64, P614, DOI 10.1212/01.WNL.0000151857.43225.49; Schoonman GG, 2008, BRAIN, V131, P2192, DOI 10.1093/brain/awn094; Silberstein S, 2008, NEUROLOGY, V70, P548, DOI 10.1212/01.wnl.0000297551.27191.70; Silberstein SD, 2008, NEUROLOGY, V71, P114, DOI 10.1212/01.wnl.0000316800.22949.20; Silberstein SD, 2004, LANCET, V363, P381, DOI 10.1016/S0140-6736(04)15440-8; Vanmolkot Kaate R J, 2007, Hum Mutat, V28, P522, DOI 10.1002/humu.9486	16	5	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2008	372	9647					1369	1371		10.1016/S0140-6736(08)61569-X	http://dx.doi.org/10.1016/S0140-6736(08)61569-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362WP	18940454				2022-12-28	WOS:000260228200008
J	Win, MN; Smolke, CD				Win, Maung Nyan; Smolke, Christina D.			Higher-order cellular information processing with synthetic RNA devices	SCIENCE			English	Article							GENE-EXPRESSION; ALLOSTERIC RIBOZYMES; MAMMALIAN-CELLS; RIBOSWITCHES; BINDING	The engineering of biological systems is anticipated to provide effective solutions to challenges that include energy and food production, environmental quality, and health and medicine. Our ability to transmit information to and from living systems, and to process and act on information inside cells, is critical to advancing the scale and complexity at which we can engineer, manipulate, and probe biological systems. We developed a general approach for assembling RNA devices that can execute higher-order cellular information processing operations from standard components. The engineered devices can function as logic gates (AND, NOR, NAND, or OR gates) and signal filters, and exhibit cooperativity. RNA devices process and transmit molecular inputs to targeted protein outputs, linking computation to gene expression and thus the potential to control cellular function.	[Win, Maung Nyan; Smolke, Christina D.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Smolke, CD (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd,MC 210-41, Pasadena, CA 91125 USA.	smolke@cheme.caltech.edu			Center for Biological Circuit Design at the California Institute of Technology; Arnold and Mabel Beckman Foundation; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM074767, R01GM086663] Funding Source: NIH RePORTER	Center for Biological Circuit Design at the California Institute of Technology; Arnold and Mabel Beckman Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Chen, J. Liang, and D. Endy for critical reading of the manuscript and A. Babiskin for pRzS. This work was supported by the Center for Biological Circuit Design at the California Institute of Technology, the Arnold and Mabel Beckman Foundation, and the NIH. The authors declare competing financial interests in the form of a pending patent application.	Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Breaker RR, 2002, CURR OPIN BIOTECH, V13, P31, DOI 10.1016/S0958-1669(02)00281-1; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; Kramer BP, 2004, BIOTECHNOL BIOENG, V87, P478, DOI 10.1002/bit.20142; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Mathews DH, 2006, CURR OPIN STRUC BIOL, V16, P270, DOI 10.1016/j.sbi.2006.05.010; NELSON DL, 2005, LEHNINGER PRINCIPLES, P167; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Penchovsky R, 2005, NAT BIOTECHNOL, V23, P1424, DOI 10.1038/nbt1155; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Robertson MP, 1999, NAT BIOTECHNOL, V17, P62, DOI 10.1038/5236; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Sudarsan N, 2006, SCIENCE, V314, P300, DOI 10.1126/science.1130716; Suess B, 2008, RNA BIOL, V5, P24, DOI 10.4161/rna.5.1.5955; Welz R, 2007, RNA, V13, P573, DOI 10.1261/rna.407707; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Woodside MT, 2006, P NATL ACAD SCI USA, V103, P6190, DOI 10.1073/pnas.0511048103	25	402	435	3	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					456	460		10.1126/science.1160311	http://dx.doi.org/10.1126/science.1160311			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927397	Green Accepted			2022-12-28	WOS:000260094500051
J	Hassan, M				Hassan, Mohamed			Beijing 1987: China's coming-out party	NATURE			English	Editorial Material									[Hassan, Mohamed] TWAS, Acad Sci Dev World, Trieste, Italy		Hassan, M (corresponding author), TWAS, Acad Sci Dev World, Trieste, Italy.	mhassan@twas.org	Hassan, Mohamed/AEY-5600-2022; Hassan, Mohamed M./GQH-8348-2022	Hassan, Mohamed/0000-0003-1612-107X; Hassan, Mohamed M./0000-0003-1612-107X					0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2008	455	7213					598	599		10.1038/455598a	http://dx.doi.org/10.1038/455598a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833263	Bronze			2022-12-28	WOS:000259639700028
J	Andersson, MI; Hughes, J; Gordon, FH; Ijaz, S; Donati, M				Andersson, Monique I.; Hughes, Jon; Gordon, Fiona H.; Ijaz, Samreen; Donati, Matthew			Of pigs and pregnancy	LANCET			English	Editorial Material							HEPATITIS-E VIRUS; ENGLAND		[Andersson, Monique I.; Donati, Matthew] HPA Reg Lab, Bristol BS2 8EL, Avon, England; [Hughes, Jon] St Michaels Hosp, Bristol, Avon, England; [Gordon, Fiona H.] Bristol Royal Infirm & Gen Hosp, Bristol, Avon, England; [Ijaz, Samreen] Hlth Protect Agcy, Blood Borne Viruses Unit, London, England	Bristol Royal Infirmary; Health Protection Agency	Andersson, MI (corresponding author), HPA Reg Lab, Myrtle Rd, Bristol BS2 8EL, Avon, England.	monique.andersson@uhbristol.nhs.uk		Ijaz, Samreen/0000-0001-6658-3542				Dalton HR, 2007, J VIRAL HEPATITIS, V14, P304, DOI 10.1111/j.1365-2893.2006.00800.x; Herremans M, 2007, J VIRAL HEPATITIS, V14, P140, DOI 10.1111/j.1365-2893.2006.00786.x; Ijaz S, 2005, J INFECT DIS, V192, P1166, DOI 10.1086/444396; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Patra S, 2007, ANN INTERN MED, V147, P28, DOI 10.7326/0003-4819-147-1-200707030-00005	5	21	22	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP-OCT	2008	372	9644					1192	1192		10.1016/S0140-6736(08)61486-5	http://dx.doi.org/10.1016/S0140-6736(08)61486-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	355UN	18926280				2022-12-28	WOS:000259734700035
J	Sumbre, G; Muto, A; Baier, H; Poo, MM				Sumbre, German; Muto, Akira; Baier, Herwig; Poo, Mu-ming			Entrained rhythmic activities of neuronal ensembles as perceptual memory of time interval	NATURE			English	Article							EVENT-RELATED POTENTIALS; IN-VIVO; PREFRONTAL CORTEX; LARVAL ZEBRAFISH; OPTIC TECTUM; PSYCHOPHYSICS; NETWORKS; PROTEIN; MACAQUE; RETINA	The ability to process temporal information is fundamental to sensory perception, cognitive processing and motor behaviour of all living organisms, from amoebae to humans(1-4). Neural circuit mechanisms based on neuronal and synaptic properties have been shown to process temporal information over the range of tens of microseconds to hundreds of milliseconds(5-7). How neural circuits process temporal information in the range of seconds to minutes is much less understood. Studies of working memory in monkeys and rats have shown that neurons in the prefrontal cortex(8-10), the parietal cortex(9,11) and the thalamus(12) exhibit ramping activities that linearly correlate with the lapse of time until the end of a specific time interval of several seconds that the animal is trained to memorize. Many organisms can also memorize the time interval of rhythmic sensory stimuli in the timescale of seconds and can coordinate motor behaviour accordingly, for example, by keeping the rhythm after exposure to the beat of music. Here we report a form of rhythmic activity among specific neuronal ensembles in the zebrafish optic tectum, which retains the memory of the time interval ( in the order of seconds) of repetitive sensory stimuli for a duration of up to similar to 20 s. After repetitive visual conditioning stimulation ( CS) of zebrafish larvae, we observed rhythmic post-CS activities among specific tectal neuronal ensembles, with a regular interval that closely matched the CS. Visuomotor behaviour of the zebrafish larvae also showed regular post- CS repetitions at the entrained time interval that correlated with rhythmic neuronal ensemble activities in the tectum. Thus, rhythmic activities among specific neuronal ensembles may act as an adjustable 'metronome' for time intervals in the order of seconds, and serve as a mechanism for the short- term perceptual memory of rhythmic sensory experience.	[Sumbre, German; Poo, Mu-ming] Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; [Muto, Akira; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco	Poo, MM (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	mpoo@berkeley.edu	Sumbre, German/K-7538-2017; Muto, Akira/E-2580-2015	Sumbre, German/0000-0003-4436-6840; Muto, Akira/0000-0003-4276-1775	US National Institutes of Health; NATIONAL EYE INSTITUTE [R01EY012406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053358] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Kampff, F. Engert, Y. Fu and S. Smith for their help with two- photon microscopy, C. Niell for advice on the zebrafish preparation, N. Farchi, Y. Loewenstein, B. Hochner, G. de Polavieja and A. Noe for comments on the manuscript, and A. Arrenberg, B. Barak, V. Yoon, R. Chen and J. Sumbre for their technical help. This work was supported by the US National Institutes of Health.	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Brustein E, 2003, PFLUG ARCH EUR J PHY, V446, P766, DOI 10.1007/s00424-003-1138-4; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; BULLOCK TH, 1994, ELECTROEN CLIN NEURO, V91, P42, DOI 10.1016/0013-4694(94)90017-5; BULLOCK TH, 1993, J COMP PHYSIOL A, V172, P501, DOI 10.1007/BF00213532; BULLOCK TH, 1990, J NEUROPHYSIOL, V64, P903, DOI 10.1152/jn.1990.64.3.903; BULLOCK TH, 1990, J EXP ZOOL, V256, P142; Buonomano DV, 2007, NAT CHEM BIOL, V3, P594, DOI 10.1038/nchembio1007-594; Buonomano DV, 2003, P NATL ACAD SCI USA, V100, P4897, DOI 10.1073/pnas.0736909100; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Easter SS, 1996, DEV BIOL, V180, P646; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; Komura Y, 2001, NATURE, V412, P546, DOI 10.1038/35087595; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lister JA, 1999, DEVELOPMENT, V126, P3757; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; MEEK J, 1983, BRAIN RES, V287, P247; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; O'Malley DM, 2004, METHOD CELL BIOL, V76, P261; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Quintana J, 1999, CEREB CORTEX, V9, P213, DOI 10.1093/cercor/9.3.213; Rainer G, 1999, J NEUROSCI, V19, P5493; Ramdya P, 2006, J NEUROSCI METH, V157, P230, DOI 10.1016/j.jneumeth.2006.04.021; Ritter DA, 2001, J NEUROSCI, V21, P8956, DOI 10.1523/JNEUROSCI.21-22-08956.2001; Saigusa T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018101; Sato T, 2007, J NEUROSCI, V27, P5271, DOI 10.1523/JNEUROSCI.0883-07.2007; Schwartz G, 2007, NAT NEUROSCI, V10, P552, DOI 10.1038/nn1887; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; VANEGAS H, 1983, BRAIN RES REV, V6, P117, DOI 10.1016/0165-0173(83)90036-X; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874	38	108	109	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					102	U6		10.1038/nature07351	http://dx.doi.org/10.1038/nature07351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18923391	Green Accepted			2022-12-28	WOS:000260674000049
J	Wang, LD; Wang, Y; Jin, SG; Wu, ZY; Chin, DP; Koplan, JP; Wilson, ME				Wang, Longde; Wang, Yu; Jin, Shuigao; Wu, Zunyou; Chin, Daniel P.; Koplan, Jeffrey P.; Wilson, Mary Elizabeth			Health system reform in China 2 Emergence and control of infectious diseases in China	LANCET			English	Article							STREPTOCOCCUS-SUIS; AVIAN INFLUENZA; SARS; BATS; CORONAVIRUSES; TRANSMISSION; OUTBREAK; VIRUS	Infectious diseases remain the major causes of morbidity and mortality in China despite substantial progress in their control. China is a major contributor to the worldwide infectious disease burden because of its population size. The association of China with the rest of the world through travel and trade means that events in the country can affect distant populations. The ecological interaction of people with animals in China favours the emergence of new microbial threats. The public-health system has to be prepared to deal with the challenges of newly emerging infectious diseases and at the same time try to control existing diseases. To address the microbial threats, such as severe acute respiratory syndrome, the government has committed substantial resources to the implementation of new strategies, including the development of a real-time monitoring system as part of the infectious-disease surveillance. This strategy can serve as a model for worldwide surveillance and response to threats from infectious diseases.	[Wang, Yu; Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing 100050, Peoples R China; [Wang, Longde] Minist Hlth, Beijing, Peoples R China; [Jin, Shuigao] Chinese Ctr Dis Control & Prevent, Natl Ctr Publ Hlth Surveillance & Informat Serv, Beijing 100050, Peoples R China; [Chin, Daniel P.] Bill & Melinda Gates Fdn China Off, Beijing, Peoples R China; [Koplan, Jeffrey P.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA; [Wilson, Mary Elizabeth] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Emory University; Harvard University; Harvard T.H. Chan School of Public Health	Wu, ZY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, 27 Nanwei Rd, Beijing 100050, Peoples R China.	wuzy@263.net			FOGARTY INTERNATIONAL CENTER [U2RTW006918] Funding Source: NIH RePORTER; FIC NIH HHS [U2R TW06918, U2R TW006918-05, U2R TW006918-04, U2R TW006918] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Cavanagh D, 2005, AVIAN PATHOL, V34, P439, DOI 10.1080/03079450500367682; Chen SL, 2007, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2007/11/010; Chen XS, 2000, SEX TRANSM DIS, V27, P138, DOI 10.1097/00007435-200003000-00003; *CHIN CTR DIS CONT, NAT DAT NOT DIS CHIN; *CHIN MIN HLTH, 2006, NOT DIS CHIN 2005; *CHIN MIN HLTH, 2005, NOT DIS CHIN 2005; *CHIN MIN HLTH, 2007, NOT DIS CHIN 2006; *CHIN MIN HLTH, 2007, CHIN ANN HLTH STAT 2; Cook IG, 2004, HEALTH POLICY, V67, P329, DOI 10.1016/j.healthpol.2003.07.005; Cui J, 2007, EMERG INFECT DIS, V13, P1526, DOI 10.3201/eid1310.070448; Feng Ping, 2007, Sichuan Da Xue Xue Bao Yi Xue Ban, V38, P874; Gil VE, 1996, SOC SCI MED, V42, P141, DOI 10.1016/0277-9536(95)00064-X; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Hai W., 2004, ASIAN ECON PAP, V3, P57, DOI [10.1162/1535351041747905, DOI 10.1162/1535351041747905]; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Hampton T, 2005, JAMA-J AM MED ASSOC, V294, P2291, DOI 10.1001/jama.294.18.2291; Ho G, 2006, NURS INQ, V13, P2, DOI 10.1111/j.1440-1800.2006.00301.x; Hon CC, 2008, J VIROL, V82, P1819, DOI 10.1128/JVI.01926-07; Lam WK, 2003, RESPIROLOGY, V8, pS2, DOI 10.1046/j.1440-1843.2003.00516.x; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Lim W, 2006, ANN ACAD MED SINGAP, V35, P354; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Matsui S, 2005, WATER SCI TECHNOL, V51, P91, DOI 10.2166/wst.2005.0234; Mcfee RB, 2007, DM-DIS MON, V53, P343, DOI 10.1016/j.disamonth.2007.05.005; *NAT TECHN STEER G, 2002, CHIN J TUBERC RESP D, V25, P3; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Normile D, 2005, SCIENCE, V309, P1308; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Poland GA, 2007, VACCINE, V25, P3057, DOI 10.1016/j.vaccine.2007.01.050; RANDS G, 1989, J ROY SOC HEALTH, V109, P79, DOI 10.1177/146642408910900302; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Shao C, 1996, Chin Med Sci J, V11, P252; Shaw K, 2006, PUBLIC HEALTH, V120, P8, DOI 10.1016/j.puhe.2005.10.002; *STAT COUNC AIDS W, 2007, UN THEM GROUP AIDS C; TANG S, 2008, LANCET          1020, DOI DOI 10.1016/SO140-6736(08)6134-1; Tang SL, 2005, HEALTH POLICY, V72, P93, DOI 10.1016/j.healthpol.2004.06.009; United Nations Commission on Human Security, 2007, HUM DEV REP 2007 200; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; WANG L, 2008, LANCET          1020, DOI DOI 10.1016/SO140-6736(08)61358-6; Wang LF, 2007, CURR TOP MICROBIOL, V315, P325; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Watts J, 2004, LANCET, V363, P1370, DOI 10.1016/S0140-6736(04)16087-X; WHO, 2021, CUM NUMB CONF HUM CA; Ye CY, 2008, EMERG INFECT DIS, V14, P787, DOI 10.3201/eid1405.070437; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang FJ, 2006, CHINESE MED J-PEKING, V119, P1999, DOI 10.1097/00029330-200612010-00010; ZHANG K, 2008, LANCET          1020, DOI DOI 10.1016/SO140-6736(08)61357-4; Zhang XB, 1996, ARS COMBINATORIA, V42, P3; ZHENG LQ, 2007, HLTH NEWS BEIJI 0608; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	51	262	292	7	68	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2008	372	9649					1598	1605		10.1016/S0140-6736(08)61365-3	http://dx.doi.org/10.1016/S0140-6736(08)61365-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367ZG	18930534	Green Published, Bronze			2022-12-28	WOS:000260590500034
J	Rosenfield, A; Charo, RA; Chavkin, W				Rosenfield, Allan; Charo, R. Alta; Chavkin, Wendy			Election 2008: Opinion and analysis: Moving forward on reproductive health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenfield, Allan; Chavkin, Wendy] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Rosenfield, Allan; Chavkin, Wendy] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Charo, R. Alta] Univ Wisconsin, Madison, WI USA	Columbia University; Columbia University; University of Wisconsin System; University of Wisconsin Madison				Charo, Robin Alta/0000-0003-3710-1043				Bianchi SM., 2005, WORK FAMILY HLTH WEL; *GUTTM I, 2007, STRONG EV FAV COMPR; Rosenbaum S., 2008, WOMENS HLTH HLTH CAR; *US HR, 2003, POL SCI BUSH ADM; *WHO, 2006, POL BRIEF INT SEX RE	5	10	10	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2008	359	18					1869	1871		10.1056/NEJMp0806807	http://dx.doi.org/10.1056/NEJMp0806807			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366BL	18971489				2022-12-28	WOS:000260454500003
J	Compston, A; Coles, A				Compston, Alastair; Coles, Alasdair			Multiple sclerosis	LANCET			English	Review							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; STEM-CELL TRANSPLANTATION; DOUBLE-BLIND; INTERFERON BETA-1B; GLATIRAMER ACETATE; NEUROMYELITIS-OPTICA; IN-VITRO; DIAGNOSTIC-CRITERIA; RECURRENCE RISKS; AXONAL DAMAGE	Multiple sclerosis is primarily an inflammatory disorder of the brain and spinal cord in which focal lymphocytic infiltration leads to damage of myelin and axons. Initially, inflammation is transient and remyelination occurs but is not durable. Hence, the early course of disease is characterised by episodes of neurological dysfunction that usually recover. However, over time the pathological changes become dominated by widespread microglial activation associated with extensive and chronic neurodegeneration, the clinical correlate of which is progressive accumulation of disability. Paraclinical investigations show abnormalities that indicate the distribution of inflammatory lesions and axonal loss (MRI); interference of conduction in previously myelinated pathways (evoked electrophysiological potentials); and intrathecal synthesis of oligoclonal antibody (examination by lumbar puncture of the cerebrospinal fluid). Multiple sclerosis is triggered by environmental factors in individuals with complex genetic-risk profiles. Licensed disease modifying agents reduce the frequency of new episodes but do not reverse fixed deficits and have questionable effects on the long-term accumulation of disability and disease progression. We anticipate that future studies in multiple sclerosis will provide a new taxonomy on the basis of mechanisms rather than clinical empiricism, and so inform strategies for improved treatment at all stages of the disease.	[Compston, Alastair; Coles, Alasdair] Univ Cambridge, Addenbrookes Hosp, Sch Clin, Dept Clin Neurosci, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Coles, A (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin, Dept Clin Neurosci, Hills Rd, Cambridge CB2 2QQ, England.	ajc1020@medschl.cam.ac.uk		Coles, Alasdair/0000-0003-4738-0760				Achiron A, 2004, CLIN IMMUNOL, V113, P155, DOI 10.1016/j.clim.2004.06.004; ALPEROVITCH A, 1992, ANN NEUROL, V32, P724; ALTER M, 1962, ARCH NEUROL-CHICAGO, V7, P253, DOI 10.1001/archneur.1962.04210040005001; ANDERSEN O, 1993, J NEUROL, V240, P417, DOI 10.1007/BF00867354; Anderson JM, 2008, BRAIN, V131, P1736, DOI 10.1093/brain/awn119; Barbellion W. N. P., 1919, J DISAPPOINTED MAN; Barbellion W. N. P., 1920, LAST DIARY; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Belogurov AA, 2008, J IMMUNOL, V180, P1258, DOI 10.4049/jimmunol.180.2.1258; Bielekova B, 2004, P NATL ACAD SCI USA, V101, P8705, DOI 10.1073/pnas.0402653101; Black JA, 2006, BRAIN, V129, P3196, DOI 10.1093/brain/awl216; Breij ECW, 2008, ANN NEUROL, V63, P16, DOI 10.1002/ana.21311; Broadley SA, 2000, BRAIN, V123, P1102, DOI 10.1093/brain/123.6.1102; Bronnum-Hansen H, 2004, BRAIN, V127, P844, DOI 10.1093/brain/awh104; BROPHY P, 1987, BAROQUE N ROLL, P1; Buljevac D, 2002, BRAIN, V125, P952, DOI 10.1093/brain/awf098; Cabre P, 2005, BRAIN, V128, P2899, DOI 10.1093/brain/awh624; *CAMMS223 TRIAL IN, 2008, NEW ENGL J MED, V359, P30; Carswell R., 1838, PATHOLOGICAL ANATOMY; Carton H, 1997, J NEUROL NEUROSUR PS, V62, P329, DOI 10.1136/jnnp.62.4.329; Chandran S, 2008, PHILOS T R SOC B, V363, P171, DOI 10.1098/rstb.2006.2019; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Cohen JA, 2007, NEUROLOGY, V68, P939, DOI 10.1212/01.wnl.0000257109.61671.06; Cohen JA, 2002, NEUROLOGY, V59, P679, DOI 10.1212/WNL.59.5.679; Coles AJ, 2006, J NEUROL, V253, P98, DOI 10.1007/s00415-005-0934-5; Coles AJ, 1999, LANCET, V354, P1691, DOI 10.1016/S0140-6736(99)02429-0; Coman I, 2006, BRAIN, V129, P3186, DOI 10.1093/brain/awl144; Comi G, 2008, J NEUROL, V255, P10; Comi G, 2008, LANCET, V371, P2085, DOI 10.1016/S0140-6736(08)60918-6; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Compston A, 2004, CLIN MED, V4, P346, DOI 10.7861/clinmedicine.4-4-346; COMPSTON DAS, 1976, LANCET, V2, P1261; COMPSTON DAS, 2005, MCALPINES MULTIPLE S, P1; Confavreux C, 2006, BRAIN, V129, P595, DOI 10.1093/brain/awh714; Confavreux C, 2001, NEW ENGL J MED, V344, P319, DOI 10.1056/NEJM200102013440501; Correale J, 2007, ANN NEUROL, V61, P97, DOI 10.1002/ana.21067; Davie CA, 1995, BRAIN, V118, P1583, DOI 10.1093/brain/118.6.1583; Dawson JW, 1916, EDINBURGH MED J, V17, DOI [10.1007/978-3-319-02735-7, DOI 10.1007/978-3-319-02735-7]; Dean G, 2008, NEUROLOGY, V70, P101, DOI 10.1212/01.wnl.0000284598.98525.d7; DEAN G, 1971, BMJ-BRIT MED J, V3, P725, DOI 10.1136/bmj.3.5777.725; DETELS R, 1977, AM J EPIDEMIOL, V105, P303, DOI 10.1093/oxfordjournals.aje.a112387; DUQUETTE P, 1995, NEUROLOGY, V45, P1277; Durelli L, 2002, LANCET, V359, P1453, DOI 10.1016/S0140-6736(02)08430-1; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Dyment DA, 2006, J NEUROL NEUROSUR PS, V77, P258, DOI 10.1136/jnnp.2005.063008; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Ebers GC, 2000, ANN NEUROL, V48, P927, DOI 10.1002/1531-8249(200012)48:6<927::AID-ANA14>3.3.CO;2-6; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Edan G, 1997, J NEUROL NEUROSUR PS, V62, P112, DOI 10.1136/jnnp.62.2.112; Eikelenboom MJ, 2003, NEUROLOGY, V60, P219, DOI 10.1212/01.WNL.0000041496.58127.E3; ELIAN M, 1990, J NEUROL NEUROSUR PS, V53, P906, DOI 10.1136/jnnp.53.10.906; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Filippi M, 2008, J NEUROL, V255, P9; Filippi M, 2003, BRAIN, V126, P433, DOI 10.1093/brain/awg038; Filippini G, 2003, LANCET, V361, P545, DOI 10.1016/S0140-6736(03)12512-3; FIRTH D, 1984, CASE A DESTE; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Francis G, 2001, NEUROLOGY, V56, P1628; *GAME COLL GROUP, 2006, J NEUROIMMUNOL, V179, P108; Golde S, 2002, J NEUROCHEM, V82, P269, DOI 10.1046/j.1471-4159.2002.00973.x; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hammond SR, 2000, BRAIN, V123, P968, DOI 10.1093/brain/123.5.968; HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979; Hartung HP, 2002, LANCET, V360, P2018, DOI 10.1016/S0140-6736(02)12023-X; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Hensiek AE, 2007, NEUROLOGY, V68, P376, DOI 10.1212/01.wnl.0000252822.53506.46; Hernan MA, 2005, BRAIN, V128, P1461, DOI 10.1093/brain/awh471; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; Kappos L, 2008, LANCET, V372, P1463, DOI 10.1016/S0140-6736(08)61619-0; Kappos L, 2007, LANCET, V370, P389, DOI 10.1016/S0140-6736(07)61194-5; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Keegan M, 2005, LANCET, V366, P579, DOI 10.1016/S0140-6736(05)67102-4; Keegan M, 2002, NEUROLOGY, V58, P143, DOI 10.1212/WNL.58.1.143; KELLARWOOD H, 1994, ANN NEUROL, V36, P109, DOI 10.1002/ana.410360121; King J, 2001, NEUROLOGY, V56, P1496; Kinkel RP, 2006, NEUROLOGY, V66, P678; Kira J, 1999, J NEUROL SCI, V166, P53, DOI 10.1016/S0022-510X(99)00115-X; Kremenchutzky M, 2006, BRAIN, V129, P584, DOI 10.1093/brain/awh721; Kuhle J, 2007, NEW ENGL J MED, V356, P371, DOI 10.1056/NEJMoa063602; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; KURTZKE JF, 1975, ACTA NEUROL SCAND, V51, P110; KURTZKE JF, 1993, CLIN MICROBIOL REV, V6, P382, DOI 10.1128/CMR.6.4.382-427.1993; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Le Page E, 2008, J NEUROL NEUROSUR PS, V79, P52, DOI 10.1136/jnnp.2007.124958; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Levin LI, 2003, JAMA-J AM MED ASSOC, V289, P1533, DOI 10.1001/jama.289.12.1533; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 1996, BRAIN PATHOL, V6, P259, DOI 10.1111/j.1750-3639.1996.tb00854.x; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; MAGLIOZZI R, 2007, J EXP MED, V204, P2899; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Mahad D, 2008, BRAIN, V131, P1722, DOI 10.1093/brain/awn105; Marrie RA, 2004, LANCET NEUROL, V3, P709, DOI 10.1016/S1474-4422(04)00933-0; MARROSU MG, 1992, NEUROLOGY, V42, P883, DOI 10.1212/WNL.42.4.883; MARTYN CN, 1993, J NEUROL NEUROSUR PS, V56, P167, DOI 10.1136/jnnp.56.2.167; Mathey EK, 2007, J EXP MED, V204, P2363, DOI 10.1084/jem.20071053; Matsuoka T, 2007, BRAIN, V130, P1206, DOI 10.1093/brain/awm027; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Metz I, 2007, BRAIN, V130, P1254, DOI 10.1093/brain/awl370; Mikaeloff Y, 2007, BRAIN, V130, P2589, DOI 10.1093/brain/awm198; Miller DH, 1999, ANN NEUROL, V46, P850, DOI 10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q; Miller DM, 2000, MULT SCLER, V6, P267, DOI 10.1191/135245800678827770; MINDEN SL, 1990, ARCH NEUROL-CHICAGO, V47, P98, DOI 10.1001/archneur.1990.00530010124031; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; MUMFORD CJ, 1994, NEUROLOGY, V44, P11, DOI 10.1212/WNL.44.1.11; Munari LM, 2004, LANCET NEUROL, V3, P641, DOI 10.1016/S1474-4422(04)00899-3; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Panitch H, 2004, NEUROLOGY, V63, P1788; Panitch H, 2002, NEUROLOGY, V59, P1496, DOI 10.1212/01.WNL.0000034080.43681.DA; PANITCH HS, 1987, LANCET, V1, P893; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Ramagopalan SV, 2007, PLOS GENET, V3, P1607, DOI 10.1371/journal.pgen.0030150; Ramagopolan SV, 2007, LANCET NEUROL, V6, P604, DOI 10.1016/S1474-4422(07)70132-1; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Renoux C, 2007, NEW ENGL J MED, V356, P2603, DOI 10.1056/NEJMoa067597; RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319; Ristori G, 2006, ANN NEUROL, V59, P27, DOI 10.1002/ana.20683; Robertson NP, 1996, BRAIN, V119, P449, DOI 10.1093/brain/119.2.449; Robertson NP, 1997, LANCET, V349, P1587, DOI 10.1016/S0140-6736(96)07317-5; Robertson NP, 1996, NEUROLOGY, V47, P347, DOI 10.1212/WNL.47.2.347; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Saccardi R, 2006, MULT SCLER, V12, P814, DOI 10.1177/1352458506071301; SADOVNICK AD, 1988, NEUROLOGY, V38, P990, DOI 10.1212/WNL.38.6.990; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Sawcer S, 2008, LANCET NEUROL, V7, P567, DOI 10.1016/S1474-4422(08)70122-4; Schmied M, 2003, CLIN IMMUNOL, V106, P163, DOI 10.1016/S1521-6616(03)00020-2; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Smith KJ, 2006, BRAIN, V129, P3147, DOI 10.1093/brain/awl323; SMITH KJ, 1981, BRAIN, V104, P383, DOI 10.1093/brain/104.2.383; Smith KJ, 2001, ANN NEUROL, V49, P470; Sorensen PS, 2003, LANCET, V362, P1184, DOI 10.1016/S0140-6736(03)14541-2; Stadelmann C, 2005, BRAIN, V128, P979, DOI 10.1093/brain/awh457; TERASAKI PI, 1976, SCIENCE, V193, P1245, DOI 10.1126/science.1085490; Tienari PJ, 1998, J NEUROIMMUNOL, V81, P158, DOI 10.1016/S0165-5728(97)00171-9; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; *US FDA, 2008, NAT MARK TYS INF; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Vukusic S, 2004, BRAIN, V127, P1353, DOI 10.1093/brain/awh152; Weinshenker BG, 1999, ANN NEUROL, V46, P878, DOI 10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q; Wilkins A, 2001, GLIA, V36, P48, DOI 10.1002/glia.1094; Wilkins A, 2005, J NEUROCHEM, V92, P1487, DOI 10.1111/j.1471-4159.2004.02981.x; Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100; Williams A, 2007, BRAIN, V130, P2554, DOI 10.1093/brain/awm202; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Wolinsky JS, 2007, ANN NEUROL, V61, P14, DOI 10.1002/ana.21079; Wolswijk G, 1998, PROG BRAIN RES, V117, P233; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yeo TW, 2007, ANN NEUROL, V61, P228, DOI 10.1002/ana.21063; YOUL BD, 1991, BRAIN, V114, P2437, DOI 10.1093/brain/114.6.2437; YUDKIN PL, 1991, LANCET, V338, P1051, DOI 10.1016/0140-6736(91)91909-E; ZAJICEK JP, 1992, BRAIN, V115, P1611, DOI 10.1093/brain/115.6.1611; Zeis T, 2008, BRAIN, V131, P288, DOI 10.1093/brain/awm291	174	3370	3465	26	885	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2008	372	9648					1502	1517		10.1016/S0140-6736(08)61620-7	http://dx.doi.org/10.1016/S0140-6736(08)61620-7			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370ZJ	18970977				2022-12-28	WOS:000260801300027
J	Hawkes, N				Hawkes, Nigel			NHS dentistry: a service with teeth	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a2043	10.1136/bmj.a2043	http://dx.doi.org/10.1136/bmj.a2043			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18940838				2022-12-28	WOS:000260298800030
J	Kipping, RR; Jago, R; Lawlor, DA				Kipping, Ruth R.; Jago, Russell; Lawlor, Debbie A.			Obesity in children. Part 2: Prevention and management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CHILDHOOD OBESITY; INTERVENTIONS; ADOLESCENTS; METAANALYSIS; OVERWEIGHT; PROGRAMS; OUTCOMES; RISK		[Kipping, Ruth R.; Lawlor, Debbie A.] Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England; [Jago, Russell] Univ Bristol, Dept Exercise Nutr & Hlth Sci, Bristol BS8 1TP, Avon, England; [Lawlor, Debbie A.] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Bristol BS8 2BN, Avon, England	University of Bristol; University of Bristol; University of Bristol	Kipping, RR (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England.	ruth.kipping@bristol.ac.uk	Jago, Russell/ABD-6271-2021	Jago, Russell/0000-0002-3394-0176; Lawlor, Debbie A/0000-0002-6793-2262; Kipping, Ruth/0000-0002-5446-8077				Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; Curioni C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006162.pub2; DeMattia L, 2007, OBES REV, V8, P69, DOI 10.1111/j.1467-789X.2006.00259.x; Department of Health, 2008, HLTH WEIGHT HLTH LIV; Foresight (Program) & Great Britain, 2007, TACKL OB FUT CHOIC P; Freemark M, 2007, DIABETES CARE, V30, P395, DOI 10.2337/dc06-1569; Gately PJ, 2005, PEDIATRICS, V116, P73, DOI 10.1542/peds.2004-0397; Hoddinott P, 2008, BMJ-BRIT MED J, V336, P881, DOI 10.1136/bmj.39521.566296.BE; Kipping RR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1824; Lawson ML, 2006, J PEDIATR SURG, V41, P137, DOI 10.1016/j.jpedsurg.2005.10.017; National Health and Medical Research Council, 2003, CLIN PRACT GUID MAN; *NIH CLIN EXC, QUICK REF GUID 2 NHS; Padwal RS, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004094.pub2, DOI 10.1002/14651858.CD004094.PUB2]; PETTITT DJ, 1993, DIABETES CARE, V16, P310, DOI 10.2337/diacare.16.1.310; Rudolf M, 2006, ARCH DIS CHILD, V91, P736, DOI 10.1136/adc.2005.089896; Sabin MA, 2007, J EVAL CLIN PRACT, V13, P364, DOI 10.1111/j.1365-2753.2006.00706.x; SACHER PM, 2007, OBES REV S3, V8, P7; Schilling PL, 2008, J AM COLL SURGEONS, V206, P1, DOI 10.1016/j.jamcollsurg.2007.07.028; Shield JPH, 2008, ARCH DIS CHILD, V93, P369, DOI 10.1136/adc.2006.113316; Stice E, 2006, PSYCHOL BULL, V132, P667, DOI 10.1037/0033-2909.132.5.667; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; Westley H, 2007, BRIT MED J, V335, P1236, DOI 10.1136/bmj.39409.451678.AD; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Yajnik CS, 2002, J CLIN ENDOCR METAB, V87, P5575, DOI 10.1210/jc.2002-020434; Young KM, 2007, CLIN PSYCHOL REV, V27, P240, DOI 10.1016/j.cpr.2006.08.003	28	28	28	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2008	337	7676							a1848	10.1136/bmj.a1848	http://dx.doi.org/10.1136/bmj.a1848			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18945733				2022-12-28	WOS:000260298800037
J	Sterman, JD				Sterman, John D.			Economics - Risk communication on climate: Mental models and mass balance	SCIENCE			English	Editorial Material									[Sterman, John D.] MIT, Alfred P Sloan Sch Management, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT)	Sterman, JD (corresponding author), MIT, Alfred P Sloan Sch Management, 30 Wadsworth St, Cambridge, MA 02142 USA.	jsterman@mit.edu						Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; [Anonymous], 2000, BUSINESS DYNAMICS; CRONIN MA, 2008, ORGAN BEHAV HUM DEC, V21, DOI DOI 10.1016/J.OBHDP.2005.003; *GOOGL, MANH PROJ; Juan Williams, 1987, EYES PRIZE AM CIVIL, P1954; Kasemir B, 2000, GLOBAL ENVIRON CHANG, V10, P169, DOI 10.1016/S0959-3780(00)00022-4; Kempton W, 1997, ENVIRONMENT, V39, P12, DOI 10.1080/00139159709604765; Leiserowitz A., 2007, PUBLIC PERCEPTION OP; Meehl GA, 2005, SCIENCE, V307, P1769, DOI 10.1126/science.1106663; Morgan M. G., 2002, RISK COMMUNICATION M; Prins G, 2007, NATURE, V449, P973, DOI 10.1038/449973a; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Solomon S., 2007, PHYS SCI BASIS WORKI; STERMAN JD, 1994, SYST DYNAM REV, V10, P291, DOI 10.1002/sdr.4260100214; Sterman JD, 2007, CLIMATIC CHANGE, V80, P213, DOI 10.1007/s10584-006-9107-5; Sweeney LB, 2000, SYST DYNAM REV, V16, P249, DOI 10.1002/sdr.198; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wigley TML, 2005, SCIENCE, V307, P1766, DOI 10.1126/science.1103934; Yang CJ, 2007, CLIMATIC CHANGE, V80, P199, DOI 10.1007/s10584-006-9202-7	19	209	214	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					532	533		10.1126/science.1162574	http://dx.doi.org/10.1126/science.1162574			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	363WV	18948524				2022-12-28	WOS:000260299100022
J	Coles, AJ; Compston, DAS; Selmaj, KW; Lake, SL; Moran, S; Margolin, DH; Norris, K; Tandon, PK				Coles, Alasdair J.; Compston, D. Alastair S.; Selmaj, Krzysztof W.; Lake, Stephen L.; Moran, Susan; Margolin, David H.; Norris, Kim; Tandon, P. K.		CAMMS223 Trial Investigators	Alemtuzumab vs. Interferon beta-1a in early multiple sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOIMMUNE-DISEASES; GRAVES-DISEASE; DOUBLE-BLIND; THROMBOCYTOPENIA; MULTICENTER; PREVALENCE; DISABILITY; DEPLETION; PATIENT; RELAPSE	Background: Alemtuzumab, a humanized monoclonal antibody that targets CD52 on lymphocytes and monocytes, may be an effective treatment for early multiple sclerosis. Methods: In this phase 2, randomized, blinded trial involving previously untreated, early, relapsing-remitting multiple sclerosis, we assigned 334 patients with scores of 3.0 or less on the Expanded Disability Status Scale and a disease duration of 3 years or less to receive either subcutaneous interferon beta-1a (at a dose of 44 microg) three times per week or annual intravenous cycles of alemtuzumab (at a dose of either 12 mg or 24 mg per day) for 36 months. In September 2005, alemtuzumab therapy was suspended after immune thrombocytopenic purpura developed in three patients, one of whom died. Treatment with interferon beta-1a continued throughout the study. Results: Alemtuzumab significantly reduced the rate of sustained accumulation of disability, as compared with interferon beta-1a (9.0% vs. 26.2%; hazard ratio, 0.29; 95% confidence interval [CI], 0.16 to 0.54; P<0.001) and the annualized rate of relapse (0.10 vs. 0.36; hazard ratio, 0.26; 95% CI, 0.16 to 0.41; P<0.001). The mean disability score on a 10-point scale improved by 0.39 point in the alemtuzumab group and worsened by 0.38 point in the interferon beta-1a group (P<0.001). In the alemtuzumab group, the lesion burden (as seen on T(sub 2)-weighted magnetic resonance imaging) was reduced, as compared with that in the interferon beta-1a group (P=0.005). From month 12 to month 36, brain volume (as seen on T(sub 1)-weighted magnetic resonance imaging) increased in the alemtuzumab group but decreased in the interferon beta-1a group (P=0.02). Adverse events in the alemtuzumab group, as compared with the interferon beta-1a group, included autoimmunity (thyroid disorders [23% vs. 3%] and immune thrombocytopenic purpura [3% vs. 1%]) and infections (66% vs. 47%). There were no significant differences in outcomes between the 12-mg dose and the 24-mg dose of alemtuzumab. Conclusions: In patients with early, relapsing-remitting multiple sclerosis, alemtuzumab was more effective than interferon beta-1a but was associated with autoimmunity, most seriously manifesting as immune thrombocytopenic purpura. The study was not powered to identify uncommon adverse events. (ClinicalTrials.gov number, NCT00050778.).	[Coles, Alasdair J.; Compston, D. Alastair S.] Univ Cambridge, Sch Clin Med, Cambridge, England; [Selmaj, Krzysztof W.] Med Univ Lodz, Dept Neurol, Lodz, Poland; [Lake, Stephen L.; Moran, Susan; Margolin, David H.; Norris, Kim; Tandon, P. K.] Genzyme, Cambridge, MA USA	University of Cambridge; Medical University Lodz; Sanofi-Aventis; Genzyme Corporation	Coles, AJ (corresponding author), Addenbrookes Hosp, Dept Neurol, Box 165, Cambridge CB2 2QQ, England.	ajc1020@medschl.cam.ac.uk; compston@medschl.cam.ac.uk	Macedo, Ana/L-9912-2018	Macedo, Ana/0000-0002-6978-8989; Jones, Joanne/0000-0003-4974-1371; Kozubski, Wojciech/0000-0003-2777-261X; Moran, Susan/0000-0002-3735-5695; Yakhno, Nikolay/0000-0002-8255-5645; Boyko, Alexei/0000-0003-3306-9541; Selmaj, Krzysztof/0000-0003-1213-7218; Hale, Geoff/0000-0001-9473-423X	Genzyme; Bayer Schering Pharma; Medical Research Council [G7904009] Funding Source: researchfish; MRC [G7904009] Funding Source: UKRI	Genzyme(Sanofi-AventisGenzyme Corporation); Bayer Schering Pharma(Bayer AG); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by Genzyme and Bayer Schering Pharma. Dr. Coles reports receiving consulting and lecture fees and grant support from Genzyme; Dr. Compston, receiving consulting and lecture fees and grant support from Genzyme and lecture fees from Bayer Schering Pharma; Dr. Selmaj, receiving consulting fees from Genzyme, Biogen Idec, and Biopartners and lecture fees from Schering, Novartis, and Biogen Idec; and Drs. Lake, Moran, Margolin, and Tandon and Ms. Norris, being employees of Genzyme and having an equity interest in the company. No other potential conflict of interest relevant to this article was reported. We thank the following Genzyme employees for their assistance in study operations and data analysis: D. Boisvert, R. Clark, R. Dhanjal, J. Haas, O. Haider, A. Feleaga, K. Hoffman, G. Newgard, T. Rios, M. Rizzo, and Q. Yu.	COBBOLD SP, 1990, J IMMUNOL METHODS, V127, P19, DOI 10.1016/0022-1759(90)90335-S; Coles AJ, 2006, J NEUROL, V253, P98, DOI 10.1007/s00415-005-0934-5; Coles AJ, 1999, LANCET, V354, P1691, DOI 10.1016/S0140-6736(99)02429-0; COMPSTON A, MULTIPLE SC IN PRESS; DUQUETTE P, 1995, NEUROLOGY, V45, P1277; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Ebers GC, 1999, LANCET, V353, P678; Frohman EM, 2002, NEUROLOGY, V59, P480; Gilquin J, 1998, LANCET, V352, P1907, DOI 10.1016/S0140-6736(05)60398-4; Goodin DS, 2002, NEUROLOGY, V58, P169, DOI 10.1212/WNL.58.2.169; Granier H, 2001, REV MED INTERNE, V22, P1271, DOI 10.1016/S0248-8663(01)00502-1; Haider Imran, 2004, Hematology, V9, P409, DOI 10.1080/10245330400001942; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Hsiao LT, 2001, BONE MARROW TRANSPL, V28, P1151, DOI 10.1038/sj.bmt.1703291; Jacobs LD, 1996, ANN NEUROL, V40, P480; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Jones JL, 2004, J NEUROIMMUNOL, V154, P212; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kirby S, 2005, MULT SCLER, V11, pS29; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LACHIN JM, 1992, STAT MED, V11, P1151, DOI 10.1002/sim.4780110903; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Lin DY, 2000, J ROY STAT SOC B, V62, P711, DOI 10.1111/1467-9868.00259; Loh Y, 2007, BLOOD, V109, P2643, DOI 10.1182/blood-2006-07-035766; Losseff NA, 1996, BRAIN, V119, P2009, DOI 10.1093/brain/119.6.2009; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Moreau T, 1996, BRAIN, V119, P225, DOI 10.1093/brain/119.1.225; MOREAU T, 1994, LANCET, V344, P298, DOI 10.1016/S0140-6736(94)91339-0; MOREAU T, 1994, LANCET, V344, P486; Munteis E, 2006, MULT SCLER, V12, pS210; Otton SH, 1999, BRIT J HAEMATOL, V106, P261; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Segal JB, 2006, J THROMB HAEMOST, V4, P2377, DOI 10.1111/j.1538-7836.2006.02147.x; WEI LJ, 1984, J AM STAT ASSOC, V79, P653, DOI 10.2307/2288413	35	737	760	0	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2008	359	17					1786	1801		10.1056/nejmoa0802670	http://dx.doi.org/10.1056/nejmoa0802670			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363DJ	18946064	Bronze			2022-12-28	WOS:000260245800006
J	Maruyama, K; Sato, S; Ohira, T; Maeda, K; Noda, H; Kubota, Y; Nishimura, S; Kitamura, A; Kiyama, M; Okada, T; Imano, H; Nakamura, M; Ishikawa, Y; Kurokawa, M; Sasaki, S; Iso, H				Maruyama, Koutatsu; Sato, Shinichi; Ohira, Tetsuya; Maeda, Kenji; Noda, Hiroyuki; Kubota, Yoshimi; Nishimura, Setsuko; Kitamura, Akihiko; Kiyama, Masahiko; Okada, Takeo; Imano, Hironori; Nakamura, Masakazu; Ishikawa, Yoshinori; Kurokawa, Michinori; Sasaki, Satoshi; Iso, Hiroyasu			The joint impact on being overweight of self reported behaviours of eating quickly and eating until full : cross sectional survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AGED JAPANESE MEN; HEART-DISEASE; FAST LEADS; OBESITY; VALIDATION; FREQUENCY; STROKE; RISK	Objective To examine whether eating until full or eating quickly or combinations of these eating behaviours are associated with being overweight. Design and participants Cross sectional survey. Setting Two communities in Japan. Participants 3287 adults (1122 men, 2165 women) aged 30- 69 who participated in surveys on cardiovascular risk from 2003 to 2006. Main outcome measures Body mass index (overweight >= 25.0) and the dietary habits of eating until full ( lifestyle questionnaire) and speed of eating ( validated brief self administered questionnaire). Results 571 ( 50.9%) men and 1265 ( 58.4%) women self reported eating until full, and 523 ( 45.6%) men and 785 ( 36.3%) women self reported eating quickly. For both sexes the highest age adjusted mean values for height, weight, body mass index, and total energy intake were in the eating until full and eating quickly group compared with the not eating until full and not eating quickly group. The multivariable adjusted odds ratio of being overweight for eating until full was 2.00 ( 95% confidence interval 1.53 to 2.62) for men and 1.92 ( 1.53 to 2.40) for women and for eating quickly was 1.84 ( 1.42 to 2.38) for men and 2.09 ( 1.69 to 2.59) for women. The multivariable odds ratio of being overweight with both eating behaviours compared with neither was 3.13 ( 2.20 to 4.45) for men and 3.21 ( 2.41 to 4.29) for women. Conclusion Eating until full and eating quickly are associated with being overweight in Japanese men and women, and these eating behaviours combined may have a substantial impact on being overweight.	[Maruyama, Koutatsu; Ohira, Tetsuya; Noda, Hiroyuki; Kubota, Yoshimi; Iso, Hiroyasu] Osaka Univ, Dept Social & Environm Med, Grad Sch Med, Suita, Osaka 5650871, Japan; [Maruyama, Koutatsu; Sato, Shinichi; Ohira, Tetsuya; Maeda, Kenji; Kubota, Yoshimi; Nishimura, Setsuko; Kitamura, Akihiko; Kiyama, Masahiko; Okada, Takeo; Imano, Hironori; Nakamura, Masakazu; Ishikawa, Yoshinori] Osaka Med Ctr Hlth Sci & Promot, Osaka, Japan; [Sato, Shinichi] Chiba Prefectural Inst Publ Hlth, Chiba, Japan; [Noda, Hiroyuki] Harvard Univ, Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; [Kurokawa, Michinori] Div Hlth & Welf, Osaka, Japan; [Iso, Hiroyasu] Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Med, Tokyo, Japan	Osaka University; Harvard University; Harvard T.H. Chan School of Public Health; University of Tokyo	Iso, H (corresponding author), Osaka Univ, Dept Social & Environm Med, Grad Sch Med, Yamadaoka 2-2 Suita Shi, Suita, Osaka 5650871, Japan.	fvgh5640@mb.infoweb.ne.jp	Sriwisit, Sukhumaphorn/G-1405-2011; Noda, Hiroyuki/ABC-1692-2021	Noda, Hiroyuki/0000-0001-9086-3771				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Assmann SF, 1996, EPIDEMIOLOGY, V7, P286, DOI 10.1097/00001648-199605000-00012; Bellisle F, 1997, BRIT J NUTR, V77, pS57, DOI 10.1079/BJN19970104; Carnell S, 2007, APPETITE, V48, P104, DOI 10.1016/j.appet.2006.07.075; Das SK, 2007, AM J CLIN NUTR, V85, P1023, DOI 10.1093/ajcn/85.4.1023; de Zwaan M, 2001, INT J OBESITY, V25, pS51, DOI 10.1038/sj.ijo.0801699; Drummond SE, 1998, INT J OBESITY, V22, P105, DOI 10.1038/sj.ijo.0800552; Gerace TA, 1996, PREV MED, V25, P593, DOI 10.1006/pmed.1996.0094; Guertin TL, 1999, CLIN PSYCHOL REV, V19, P1, DOI 10.1016/S0272-7358(98)00017-8; Hill AJ, 2007, OBES REV, V8, P151, DOI 10.1111/j.1467-789X.2007.00335.x; Iso H, 2007, STROKE, V38, P1744, DOI 10.1161/STROKEAHA.106.469072; Kopelman P, 2007, OBES REV, V8, P13, DOI 10.1111/j.1467-789X.2007.00311.x; *MIN HTH LAB WELF, 2007, NUTR STAT BAS NAT NU; Otsuka R, 2008, PREV MED, V46, P154, DOI 10.1016/j.ypmed.2007.07.031; Otsuka R, 2006, J EPIDEMIOL, V16, P117, DOI 10.2188/jea.16.117; Raymond NC, 2003, OBES RES, V11, P869, DOI 10.1038/oby.2003.120; RICE JA, 1995, MATH STAT DATA ANAL, P149; Sakata T, 2003, EXP BIOL MED, V228, P1106, DOI 10.1177/153537020322801002; Sasaki S, 2000, J NUTR SCI VITAMINOL, V46, P285, DOI 10.3177/jnsv.46.285; Sasaki S, 1998, J Epidemiol, V8, P203; Sasaki S, 2003, INT J OBESITY, V27, P1405, DOI 10.1038/sj.ijo.0802425; Sasaki S., 2004, RES EVALUATION METHO, P10; SHIMAMOTO T, 1989, CIRCULATION, V79, P503, DOI 10.1161/01.CIR.79.3.503; Shiwaku K, 2004, INT J OBESITY, V28, P152, DOI 10.1038/sj.ijo.0802486	24	146	148	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2008	337								a2002	10.1136/bmj.a2002	http://dx.doi.org/10.1136/bmj.a2002			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374FO	18940848	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000261028800002
J	Alakeson, V				Alakeson, Vidhya			Rationing - Why Oregon went wrong	BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH PLAN		[Alakeson, Vidhya] Dept Hlth & Human Serv, Washington, DC USA		Alakeson, V (corresponding author), Dept Hlth & Human Serv, Washington, DC USA.	alakesonvidhya@yahoo.co.uk						COHEN R, 2008, STATE REGIONAL NATL; DiPrete B, 2007, BRIEF HIST HLTH SERV; Ham C, 1998, BRIT MED J, V316, P1965, DOI 10.1136/bmj.316.7149.1965; HRINDA S, 2007, OREGON HLTH PLAN; Oberlander J, 2007, HEALTH AFFAIR, V26, pW96, DOI 10.1377/hlthaff.26.1.w96; *OR HLTH FUND BOAR, 2008, AIM HIGH BUILD HLTH; Paterson N, 2007, PROF ENG, V20, P20	7	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 18	2008	337	7675							a2044	10.1136/bmj.a2044	http://dx.doi.org/10.1136/bmj.a2044			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360YE	18854361				2022-12-28	WOS:000260093900028
J	Chauhan, S; D'Cruz, S; Singh, R; Sachdev, A				Chauhan, Sandeep; D'Cruz, Sanjay; Singh, Ram; Sachdev, Atul			Mees' lines	LANCET			English	Editorial Material									[Chauhan, Sandeep; D'Cruz, Sanjay; Singh, Ram; Sachdev, Atul] Govt Med Coll & Hosp, Dept Med, Chandigarh, India		Chauhan, S (corresponding author), Govt Med Coll & Hosp, Dept Med, Sector 32, Chandigarh, India.	schauhan@doctors.org.uk	Sachdev, Atul/AAE-4831-2020; Franzeck, Fabian C/B-5055-2011						0	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 18	2008	372	9647					1410	1410		10.1016/S0140-6736(08)61587-1	http://dx.doi.org/10.1016/S0140-6736(08)61587-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362WP	18940464				2022-12-28	WOS:000260228200027
J	Keuchel, M; Hagenmuller, F				Keuchel, Martin; Hagenmueller, Friedrich			Commentary: Controversies in SIGN guidance on management of acute upper and lower gastrointestinal blood loss	BRITISH MEDICAL JOURNAL			English	Editorial Material							ENDOSCOPY; ENTEROSCOPY; GUIDELINES		[Keuchel, Martin; Hagenmueller, Friedrich] Asklepios Klin Altona, D-22763 Hamburg, Germany	Asklepios Klinik Altona	Keuchel, M (corresponding author), Asklepios Klin Altona, Paul Ehrlich Str 1, D-22763 Hamburg, Germany.	m.keuchel@asklepios.com						Adler DG, 2004, GASTROINTEST ENDOSC, V60, P497; JALAN R, 2000, GUT, V46, pS1; LEVACHER S, 1995, LANCET, V346, P865, DOI 10.1016/S0140-6736(95)92708-5; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Pohl J, 2008, ENDOSCOPY, V40, P609, DOI 10.1055/s-2008-1077371; Sidhu R, 2008, GUT, V57, P125, DOI 10.1136/gut.2007.129999	6	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 18	2008	337	7675							a1836	10.1136/bmj.a1836	http://dx.doi.org/10.1136/bmj.a1836			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360YE	18849312				2022-12-28	WOS:000260093900040
J	Messing, GL; Stevenson, AJ				Messing, Gary L.; Stevenson, Adam J.			Toward pore-free ceramics	SCIENCE			English	Editorial Material							ACOUSTIC MICROSCOPY		[Messing, Gary L.; Stevenson, Adam J.] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; [Messing, Gary L.; Stevenson, Adam J.] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Messing, GL (corresponding author), Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.	messing@matse.psu.edu; ajs515@psu.edu	Stevenson, Adam/A-4375-2014	Stevenson, Adam/0000-0002-5860-1293				BALK LJ, 1988, ADV ELECTRON EL PHYS, V71, P1; GUNTHER P, 1989, APPL PHYS B-PHOTO, V48, P89, DOI 10.1007/BF00694423; Ikesue A, 2006, ANNU REV MATER RES, V36, P397, DOI 10.1146/annurev.matsci.36.011205.152926; JOHNSTON RN, 1979, P NATL ACAD SCI USA, V76, P3325, DOI 10.1073/pnas.76.7.3325; Krell A, 2003, J AM CERAM SOC, V86, P12, DOI 10.1111/j.1151-2916.2003.tb03270.x; MIZUNO Y, 2007, J CERAM SOC JPN, V115, P181; OLEVSKY E, 2008, J AM CER SOC, V92; Polotai A, 2005, J AM CERAM SOC, V88, P3008, DOI 10.1111/j.1551-2916.2005.00552.x; Ramirez MO, 2008, OPT EXPRESS, V16, P5965, DOI 10.1364/OE.16.005965; Srdic VV, 2000, J AM CERAM SOC, V83, P729, DOI 10.1111/j.1151-2916.2000.tb01266.x; Yu ZL, 1995, REV MOD PHYS, V67, P863, DOI 10.1103/RevModPhys.67.863	11	158	161	7	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2008	322	5900					383	384		10.1126/science.1160903	http://dx.doi.org/10.1126/science.1160903			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927378				2022-12-28	WOS:000260094500028
J	Tjwa, E; Mattijssen, V				Tjwa, Eric; Mattijssen, Vera			Gingival hypertrophy and leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tjwa, Eric; Mattijssen, Vera] Rijnstate Hosp, NL-6800 TA Arnhem, Netherlands	Rijnstate Hospital	Tjwa, E (corresponding author), Rijnstate Hosp, NL-6800 TA Arnhem, Netherlands.		Tjwa, E.T./L-4694-2015						0	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2008	359	16					E21	E21		10.1056/NEJMicm064633	http://dx.doi.org/10.1056/NEJMicm064633			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360EY	18923168				2022-12-28	WOS:000260041400011
J	Kritchevsky, SB; Braun, BI; Bush, AJ; Bozikis, MR; Kusek, L; Burke, JP; Wong, ES; Jernigan, J; Davis, CC; Simmons, B				Kritchevsky, Stephen B.; Braun, Barbara I.; Bush, Andrew J.; Bozikis, Michele R.; Kusek, Linda; Burke, John P.; Wong, Edward S.; Jernigan, John; Davis, Cralen C.; Simmons, Bryan		TRAPE Study Grp	The effect of a quality improvement collaborative to improve antimicrobial prophylaxis in surgical patients - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							INFECTION PREVENTION PROJECT; OF-CARE; US HOSPITALS; SURGERY; FEEDBACK; OUTCOMES; LESSONS; BASE	Background: Quality improvement collaboratives are used to improve health care quality, but their efficacy remains controversial. Objective: To assess the effects of a quality improvement collaborative on preoperative antimicrobial prophylaxis. Design: Longitudinal cluster randomized trial, with the quality improvement collaborative as the intervention. Setting: United States. Participants: 44 acute care hospitals, each of which randomly sampled approximately 100 selected surgical cases (cardiac, hip or knee replacement, and hysterectomy) at both the baseline and remeasurement phases. Intervention: All hospitals received a comparative feedback report. Hospitals randomly assigned to the intervention group (n = 22) participated in a quality improvement collaborative comprising 2 in-person meetings led by experts, monthly teleconferences, and receipt of supplemental materials over 9 months. Measurements: Change in the proportion of patients receiving at least 1 antibiotic dose within 60 minutes of surgery (primary outcome) and change in the proportions of patients given any antibiotics, given antibiotics for 24 hours or less, given an appropriate drug, and given a single preoperative dose and receipt of any of the 5 measures (secondary outcome). Results: The groups did not differ in the change in proportion of patients who received a properly timed antimicrobial prophylaxis dose (-3.8 percentage points [95% CI, -13.9 to 6.2 percentage points]) after adjustment for region, hospital size, and surgery type. Similarly, the groups did not differ in individual measures of antibiotic duration; use of appropriate drug; receipt of a single preoperative dose; or an all-or-none measure combining timing, duration, and selection. Limitations: Hospitals volunteered for the effort, thereby resulting in selection for participants who were motivated to change. Implementation of the surgical infection prevention measure reporting requirements by the Centers for Medicare & Medicaid Services and The Joint Commission may have motivated improvement in prophylaxis performance. Conclusion: At a time of heightened national attention toward measures of antimicrobial prophylaxis performance, the trial did not demonstrate a benefit of participation in a quality improvement collaborative over performance feedback for improvement of these measures.	[Braun, Barbara I.] Int Joint Commiss, Div Qual Measurement & Res, Oak Brook Terrace, IL 60181 USA; Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; J Paul Sticht Ctr Aging, Winston Salem, NC USA; Univ Tennessee, Memphis, TN USA; LDS Hosp, Salt Lake City, UT USA; McGuire Vet Affairs Med Ctr, Richmond, VA USA; Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Methodist Hlth Syst, Memphis, TN USA	Wake Forest University; Wake Forest Baptist Medical Center; University of Tennessee System; University of Tennessee Health Science Center; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; Centers for Disease Control & Prevention - USA	Braun, BI (corresponding author), Int Joint Commiss, Div Qual Measurement & Res, 1 Renaissance Blvd, Oak Brook Terrace, IL 60181 USA.	bbraun@jointcommission.org		Jernigan, John/0000-0001-8163-925X; Woeltje, Keith/0000-0002-6385-3970; Kritchevsky, Stephen/0000-0003-3336-6781	Agency for Healthcare Research and Quality [R01 HS11331-01A1]; Centers for Disease Control and Prevention; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS011331] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By grant R01 HS11331-01A1 from the Agency for Healthcare Research and Quality and initial support from the Centers for Disease Control and Prevention.	[Anonymous], 2005, MMWR MORB MORTAL WKL; Beek CA, 2005, JAMA-J AM MED ASSOC, V294, P309, DOI 10.1001/jama.294.3.309; Bradley EH, 2004, QUAL SAF HEALTH CARE, V13, P26, DOI 10.1136/qhc.13.1.26; Bratzler DW, 2006, CLIN INFECT DIS, V43, P322, DOI 10.1086/505220; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; Bratzler DW, 2005, ARCH SURG-CHICAGO, V140, P174, DOI 10.1001/archsurg.140.2.174; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; CLASSEN DC, 1992, NEW ENGL J MED, V326, P281, DOI 10.1056/NEJM199201303260501; *CTR MED MED SERV, REP HOSP QUAL DAT AN; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; Dellinger EP, 2005, AM J SURG, V190, P9, DOI 10.1016/j.amjsurg.2004.12.001; Ferguson TB, 2003, JAMA-J AM MED ASSOC, V290, P49, DOI 10.1001/jama.290.1.49; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Goldberg H I, 1998, Jt Comm J Qual Improv, V24, P130; Grol R, 1999, Jt Comm J Qual Improv, V25, P503; *HOSP QUAL ALL, QUAL MEAS; Jamtvedt G, 2006, QUAL SAF HEALTH CARE, V15, P433, DOI 10.1136/qshc.2006.018549; Kilo C M, 1998, Qual Manag Health Care, V6, P1; KRITCHEVSKY SB, 1995, INFECT CONT HOSP EP, V16, P33; Landon BE, 2004, ANN INTERN MED, V140, P887, DOI 10.7326/0003-4819-140-11-200406010-00010; Landon BE, 2007, NEW ENGL J MED, V356, P921, DOI 10.1056/NEJMsa062860; Mittman BS, 2004, ANN INTERN MED, V140, P897, DOI 10.7326/0003-4819-140-11-200406010-00011; Murray DM, 1998, DESIGN ANAL GROUP RA; Nelson Eugene C, 2002, Jt Comm J Qual Improv, V28, P472; Ornstein S, 2004, ANN INTERN MED, V141, P523, DOI 10.7326/0003-4819-141-7-200410050-00008; Ovretveit J, 2002, QUAL SAF HEALTH CARE, V11, P345, DOI 10.1136/qhc.11.4.345; Render ML, 2006, JT COMM J QUAL PATIE, V32, P253, DOI 10.1016/S1553-7250(06)32033-8; Shojania KG, 2005, HEALTH AFFAIR, V24, P138, DOI 10.1377/hlthaff.24.1.138; Solberg LI, 2005, ANN FAM MED, V3, P198, DOI 10.1370/afm.304; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; Strom K L, 2001, J Healthc Qual, V23, P4; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778; Wilson Tim, 2003, Jt Comm J Qual Saf, V29, P85	33	39	39	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2008	149	7					472	W93		10.7326/0003-4819-149-7-200810070-00007	http://dx.doi.org/10.7326/0003-4819-149-7-200810070-00007			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QY	18838727				2022-12-28	WOS:000260004400004
J	Bhutta, ZA; Soofi, S				Bhutta, Zulfiqar A.; Soofi, Sajid			Community-based newborn care: are we there yet?	LANCET			English	Editorial Material							NEONATAL-MORTALITY; INFANT-MORTALITY; HEALTH; INTERVENTIONS; MANAGEMENT; SURVIVAL; IMPACT; INDIA		[Bhutta, Zulfiqar A.; Soofi, Sajid] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi 74800, Pakistan	Aga Khan University	Bhutta, ZA (corresponding author), Aga Khan Univ, Dept Paediat & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu						Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Bhandari N, 2002, J HEALTH POPUL NUTR, V20, P148; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Haws RA, 2007, HEALTH POLICY PLANN, V22, P193, DOI 10.1093/heapol/czm009; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; *PART MAT NEWB CHI, 2006, OPP AFR NEWB; Sloan NL, 2008, PEDIATRICS, V121, pE1047, DOI 10.1542/peds.2007-0076; Tlebere P, 2007, J MIDWIFERY WOM HEAL, V52, P342, DOI 10.1016/j.jmwh.2007.03.016	15	8	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2008	372	9644					1124	1126		10.1016/S0140-6736(08)61458-0	http://dx.doi.org/10.1016/S0140-6736(08)61458-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	355UN	18926260				2022-12-28	WOS:000259734700005
J	Walkup, JT; Albano, AM; Piacentini, J; Birmaher, B; Compton, SN; Sherrill, JT; Ginsburg, GS; Rynn, MA; McCracken, J; Waslick, B; Iyengar, S; March, JS; Kendall, PC				Walkup, John T.; Albano, Anne Marie; Piacentini, John; Birmaher, Boris; Compton, Scott N.; Sherrill, Joel T.; Ginsburg, Golda S.; Rynn, Moira A.; McCracken, James; Waslick, Bruce; Iyengar, Satish; March, John S.; Kendall, Philip C.			Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; CHILDREN; DISORDERS; ADOLESCENTS; YOUTH; FLUOXETINE; ADULTHOOD; RISK	Background: Anxiety disorders are common psychiatric conditions affecting children and adolescents. Although cognitive behavioral therapy and selective serotonin-reuptake inhibitors have shown efficacy in treating these disorders, little is known about their relative or combined efficacy. Methods: In this randomized, controlled trial, we assigned 488 children between the ages of 7 and 17 years who had a primary diagnosis of separation anxiety disorder, generalized anxiety disorder, or social phobia to receive 14 sessions of cognitive behavioral therapy, sertraline (at a dose of up to 200 mg per day), a combination of sertraline and cognitive behavioral therapy, or a placebo drug for 12 weeks in a 2:2:2:1 ratio. We administered categorical and dimensional ratings of anxiety severity and impairment at baseline and at weeks 4, 8, and 12. Results: The percentages of children who were rated as very much or much improved on the Clinician Global Impression-Improvement scale were 80.7% for combination therapy (P<0.001), 59.7% for cognitive behavioral therapy (P<0.001), and 54.9% for sertraline (P<0.001); all therapies were superior to placebo (23.7%). Combination therapy was superior to both monotherapies (P<0.001). Results on the Pediatric Anxiety Rating Scale documented a similar magnitude and pattern of response; combination therapy had a greater response than cognitive behavioral therapy, which was equivalent to sertraline, and all therapies were superior to placebo. Adverse events, including suicidal and homicidal ideation, were no more frequent in the sertraline group than in the placebo group. No child attempted suicide. There was less insomnia, fatigue, sedation, and restlessness associated with cognitive behavioral therapy than with sertraline. Conclusions: Both cognitive behavioral therapy and sertraline reduced the severity of anxiety in children with anxiety disorders; a combination of the two therapies had a superior response rate. (ClinicalTrials.gov number, NCT00052078.).	[Walkup, John T.; Ginsburg, Golda S.] Johns Hopkins Med Inst, Dept Psychiat & Behav Sci, Div Child & Adolescent Psychiat, Baltimore, MD 21287 USA; [Albano, Anne Marie; Rynn, Moira A.] Columbia Univ, Med Ctr, New York State Psychiat Inst, New York, NY USA; [Piacentini, John; McCracken, James] Univ Calif Los Angeles, Los Angeles, CA USA; [Birmaher, Boris; Iyengar, Satish] Univ Pittsburgh, Med Ctr, Western Psychiat Inst & Clin, Pittsburgh, PA USA; [Compton, Scott N.; March, John S.] Duke Univ, Med Ctr, Durham, NC USA; [Sherrill, Joel T.] NIMH, Div Serv & Intervent Res, Bethesda, MD 20892 USA; [Waslick, Bruce] Baystate Med Ctr, Springfield, MA USA; [Kendall, Philip C.] Temple Univ, Philadelphia, PA 19122 USA	Johns Hopkins University; Johns Hopkins Medicine; Columbia University; New York State Psychiatry Institute; University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Baystate Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Walkup, JT (corresponding author), Johns Hopkins Med Inst, Dept Psychiat & Behav Sci, Div Child & Adolescent Psychiat, 600 N Wolfe St, Baltimore, MD 21287 USA.		Compton, Scott/A-6656-2011; Piacentini, John/C-4645-2011		NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH064003, U01MH064089, U01MH063747, U01MH064107, U01MH064092, U01MH064088, K23MH075843] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ACHENBACH TM, 1995, J AM ACAD CHILD PSY, V34, P336, DOI 10.1097/00004583-199503000-00020; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Beidel DC, 2007, J AM ACAD CHILD PSY, V46, P1622, DOI 10.1097/chi.0b013e318154bb57; BENJAMIN RS, 1990, J ANXIETY DISORD, V4, P293, DOI 10.1016/0887-6185(90)90027-7; Birmaher B, 2003, J AM ACAD CHILD PSY, V42, P415, DOI 10.1097/01.CHI.0000037049.04952.9F; Birmaher B, 1998, PEDIATR CLIN N AM, V45, P1187, DOI 10.1016/S0031-3955(05)70069-9; Bridge JA, 2007, JAMA-J AM MED ASSOC, V297, P1683, DOI 10.1001/jama.297.15.1683; Chambless DL, 1998, J CONSULT CLIN PSYCH, V66, P7, DOI 10.1037/0022-006X.66.1.7; FERDINAND RF, 1995, AM J PSYCHIAT, V152, P1586; Gurley D, 1996, J AFFECT DISORDERS, V39, P191, DOI 10.1016/0165-0327(96)00020-1; GUY W, 1970, CGI CLIN GLOBAL IMPR; James A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004690.pub2; Kendall P.C., 2006, COPING CAT WORKBOOK, V2nd; KENDALL PC, 1994, J CONSULT CLIN PSYCH, V62, P100, DOI 10.1037/0022-006X.62.1.100; Kendall PC, 1997, J CONSULT CLIN PSYCH, V65, P366, DOI 10.1037/0022-006X.65.3.366; Kendall PC, 2006, COGNITIVE BEHAV THER, V3rd; Kendall PC, 2008, J AM ACAD CHILD PSY, V47, P987, DOI 10.1097/CHI.0b013e31817eed2f; Kendall PC, 2008, J CONSULT CLIN PSYCH, V76, P282, DOI 10.1037/0022-006X.76.2.282; KIESLER DJ, 1966, PSYCHOL BULL, V65, P110, DOI 10.1037/h0022911; KLEIN RG, 1995, CHILD ADOLESCENT PSY, P351; March JS, 2007, BIOL PSYCHIAT, V62, P1149, DOI 10.1016/j.biopsych.2007.02.025; Miller RG., 1966, SIMULTANEOUS STAT IN; PINE DS, 1994, J AM ACAD CHILD PSY, V33, P280, DOI 10.1097/00004583-199402000-00019; Pine DS, 1998, ARCH GEN PSYCHIAT, V55, P56, DOI 10.1001/archpsyc.55.1.56; Riddle MA, 2002, J AM ACAD CHILD PSY, V41, P1061, DOI 10.1097/01.CHI.0000020259.43550.F4; Rynn MA, 2001, AM J PSYCHIAT, V158, P2008, DOI 10.1176/appi.ajp.158.12.2008; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Shaffer D, 1996, J AM ACAD CHILD PSY, V35, P865, DOI 10.1097/00004583-199607000-00012; Silverman W, 1996, ANXIETY DISORDERS IN; Silverman WK, 2008, J CLIN CHILD ADOLESC, V37, P105, DOI 10.1080/15374410701817907; Wagner KD, 2004, ARCH GEN PSYCHIAT, V61, P1153, DOI 10.1001/archpsyc.61.11.1153; Walkup JT, 2001, NEW ENGL J MED, V344, P1279, DOI 10.1056/NEJM200104263441703	32	817	821	7	110	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2008	359	26					2753	2766		10.1056/NEJMoa0804633	http://dx.doi.org/10.1056/NEJMoa0804633			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	387KJ	18974308	Green Accepted			2022-12-28	WOS:000261950800003
J	Bredemeyer, AL; Helmink, BA; Innes, CL; Calderon, B; McGinnis, LM; Mahowald, GK; Gapud, EJ; Walker, LM; Collins, JB; Weaver, BK; Mandik-Nayak, L; Schreiber, RD; Allen, PM; May, MJ; Paules, RS; Bassing, CH; Sleckman, BP				Bredemeyer, Andrea L.; Helmink, Beth A.; Innes, Cynthia L.; Calderon, Boris; McGinnis, Lisa M.; Mahowald, Grace K.; Gapud, Eric J.; Walker, Laura M.; Collins, Jennifer B.; Weaver, Brian K.; Mandik-Nayak, Laura; Schreiber, Robert D.; Allen, Paul M.; May, Michael J.; Paules, Richard S.; Bassing, Craig H.; Sleckman, Barry P.			DNA double-strand breaks activate a multi-functional genetic program in developing lymphocytes	NATURE			English	Article							NF-KAPPA-B; LEAKY SCID PHENOTYPE; V(D)J RECOMBINATION; LYMPHOID ORGANS; IONIZING-RADIATION; BONE-MARROW; ATM; EXPRESSION; DAMAGE; DIFFERENTIATION	DNA double- strand breaks are generated by genotoxic agents and by cellular endonucleases as intermediates of several important physiological processes. The cellular response to genotoxic DNA breaks includes the activation of transcriptional programs known primarily to regulate cell- cycle checkpoints and cell survival(1-5). DNA double- strand breaks are generated in all developing lymphocytes during the assembly of antigen receptor genes, a process that is essential for normal lymphocyte development. Here we show that in murine lymphocytes these physiological DNA breaks activate a broad transcriptional program. This program transcends the canonical DNA double- strand break response and includes many genes that regulate diverse cellular processes important for lymphocyte development. Moreover, the expression of several of these genes is regulated similarly in response to genotoxic DNA damage. Thus, physiological DNA double- strand breaks provide cues that can regulate cell- type- specific processes not directly involved in maintaining the integrity of the genome, and genotoxic DNA breaks could disrupt normal cellular functions by corrupting these processes.	[Bredemeyer, Andrea L.; Helmink, Beth A.; Calderon, Boris; McGinnis, Lisa M.; Mahowald, Grace K.; Gapud, Eric J.; Walker, Laura M.; Weaver, Brian K.; Mandik-Nayak, Laura; Schreiber, Robert D.; Allen, Paul M.; Sleckman, Barry P.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Innes, Cynthia L.; Collins, Jennifer B.; Paules, Richard S.] NIEHS, Environm Stress & Canc Grp, Res Triangle Pk, NC 27709 USA; [Innes, Cynthia L.; Collins, Jennifer B.; Paules, Richard S.] NIEHS, Microarray Grp, Res Triangle Pk, NC 27709 USA; [May, Michael J.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Bassing, Craig H.] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Ctr Childhood Canc Res,Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Bassing, Craig H.] Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Sleckman, BP (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	Sleckman@immunology.wustl.edu	Schreiber, Robert D/A-1276-2013; Schreiber, Robert/Q-7550-2019	Schreiber, Robert D/0000-0001-6311-0432; Helmink, Beth/0000-0002-8206-0351; Bredemeyer, Andrea/0000-0003-2970-5998; May, Michael/0000-0002-2485-3716; Schreiber, Robert/0000-0003-1590-2341; Paules, Richard S/0000-0001-9106-7486; Calderon, Boris/0000-0003-1575-0739; Mahowald, Grace/0000-0003-4541-4920	National Institutes of Health [AI47829]; Washington University Department of Pathology and Immunology; Department of Pathology and Center for Childhood Cancer Research of the Children's Hospital of Philadelphia; Abramson Family Cancer Research Institute; National Institute of Environmental Health Sciences; Research Scholar Award from the American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA125195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Department of Pathology and Immunology; Department of Pathology and Center for Childhood Cancer Research of the Children's Hospital of Philadelphia; Abramson Family Cancer Research Institute; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Research Scholar Award from the American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Bednarski, B. Van Honten andM. Diaz for critical review of the manuscript, F. W. Alt for providing us with the Artemis 2/2 mice and D. Ballard for providing us with the I kappa B alpha-Delta N construct. This research is supported by the National Institutes of Health (NIH, grant AI47829) and the Washington University Department of Pathology and Immunology ( to B.P.S.); the Department of Pathology and Center for Childhood Cancer Research of the Children's Hospital of Philadelphia, and the Abramson Family Cancer Research Institute (to C.H.B.); and the intramural research program of the NIH, National Institute of Environmental Health Sciences (to R.S.P.). B.P.S. is a recipient of a Research Scholar Award from the American Cancer Society. C.H.B. is a Pew Scholar in the Biomedical Sciences. A.L.B. is supported by a post-doctoral training grant from the NIH.	Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Grawunder U, 1996, EUR J BIOCHEM, V241, P931, DOI 10.1111/j.1432-1033.1996.00931.x; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Innes CL, 2006, MOL CANCER RES, V4, P197, DOI 10.1158/1541-7786.MCR-05-0154; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Kashatus D, 2006, GENE DEV, V20, P225, DOI 10.1101/gad.1352206; Khor B, 2006, MOL CELL BIOL, V26, P2999, DOI 10.1128/MCB.26.8.2999-3007.2006; Ladi E, 2006, NAT IMMUNOL, V7, P338, DOI 10.1038/ni1323; Mandik-Nayak L, 2006, J EXP MED, V203, P1985, DOI 10.1084/jem.20060701; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Pearce G, 2006, NAT IMMUNOL, V7, P827, DOI 10.1038/ni1365; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; RAMSDEN DA, 1995, GENE DEV, V9, P2409, DOI 10.1101/gad.9.19.2409; Rashi-Elkeles S, 2006, ONCOGENE, V25, P1584, DOI 10.1038/sj.onc.1209189; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Rooney S, 2002, MOL CELL, V10, P1379, DOI 10.1016/S1097-2765(02)00755-4; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Weaver BK, 2007, MOL CELL BIOL, V27, P4603, DOI 10.1128/MCB.00223-07; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	38	109	114	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					819	U113		10.1038/nature07392	http://dx.doi.org/10.1038/nature07392			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18849970	Green Accepted			2022-12-28	WOS:000261559900055
J	Jones, BF; Wuchty, S; Uzzi, B				Jones, Benjamin F.; Wuchty, Stefan; Uzzi, Brian			Multi-University Research Teams: Shifting Impact, Geography, and Stratification in Science	SCIENCE			English	Article								This paper demonstrates that teamwork in science increasingly spans university boundaries, a dramatic shift in knowledge production that generalizes across virtually all fields of science, engineering, and social science. Moreover, elite universities play a dominant role in this shift. By examining 4.2 million papers published over three decades, we found that multi- university collaborations (i) are the fastest growing type of authorship structure, (ii) produce the highest- impact papers when they include a top-tier university, and ( iii) are increasingly stratified by in- group university rank. Despite the rising frequency of research that crosses university boundaries, the intensification of social stratification in multi- university collaborations suggests a concentration of the production of scientific knowledge in fewer rather than more centers of high- impact science.	[Jones, Benjamin F.; Uzzi, Brian] Northwestern Univ, JL Kellogg Grad Sch Management, Evanston, IL 60208 USA; [Jones, Benjamin F.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Wuchty, Stefan; Uzzi, Brian] Northwestern Univ, NW Inst Complex NICO, Evanston, IL 60208 USA; [Uzzi, Brian] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA	Northwestern University; National Bureau of Economic Research; Northwestern University; University of California System; University of California Berkeley	Uzzi, B (corresponding author), Northwestern Univ, JL Kellogg Grad Sch Management, Evanston, IL 60208 USA.	uzzi@northwestern.edu			Northwestern Institute on Complex Systems	Northwestern Institute on Complex Systems	We thank K. Murnighan, K. Williams Phillips, S. Stern, S. S. Sanchez, and two anonymous referees for helpful comments. The Northwestern Institute on Complex Systems provided financial support.	Agrawal A, 2008, AM ECON REV, V98, P1578, DOI 10.1257/aer.98.4.1578; Bradner E., 2002, P 2002 ACM C COMPUTE, P226, DOI [10.1145/587078.587110, DOI 10.1145/587078.587110]; Cairncross F., 1997, RSAI NEWSL NEW SER; CUMMINGS J, RES POLICY IN PRESS; Finholt TA, 1997, PSYCHOL SCI, V8, P28, DOI 10.1111/j.1467-9280.1997.tb00540.x; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; GURBAXANI V, 1990, COMMUN ACM, V33, P65, DOI 10.1145/96267.96283; Havemann Frank, 2006, J Biomed Discov Collab, V1, P6, DOI 10.1186/1747-5333-1-6; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Merton R. K., 1996, SOCIAL STRUCTURE SCI; Murmann Johann Peter, 2003, KNOWLEDGE COMPETITIV; Olson GM, 2000, HUM-COMPUT INTERACT, V15, P139, DOI 10.1207/S15327051HCI1523_4; Rosenblat TS, 2004, Q J ECON, V119, P971, DOI 10.1162/0033553041502199; Saxenian A, 1994, LOCAL GLOBAL NETWORK; Teasley S, 2001, SCIENCE, V292, P2254, DOI 10.1126/science.1061619; Wuchty S, 2007, SCIENCE, V317, P1497; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	17	414	423	16	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1259	1262		10.1126/science.1158357	http://dx.doi.org/10.1126/science.1158357			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	18845711				2022-12-28	WOS:000261033400046
J	Leaper, D; Burman-Roy, S; Palanca, A; Cullen, K; Worster, D; Gautam-Aitken, E; Whittle, M				Leaper, David; Burman-Roy, Shona; Palanca, Ana; Cullen, Katherine; Worster, Danielle; Gautam-Aitken, Eva; Whittle, Martin		Guideline Dev Grp	GUIDELINES Prevention and treatment of surgical site infection: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Leaper, David; Burman-Roy, Shona; Palanca, Ana; Cullen, Katherine; Worster, Danielle; Gautam-Aitken, Eva; Whittle, Martin] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England; [Leaper, David] Cardiff Univ, Dept Wound Healing, Cardiff, S Glam, Wales	Cardiff University	Leaper, D (corresponding author), Natl Collaborating Ctr Womens & Childrens Hlth, Kings Court,2-16 Goodge St, London W1T 2QA, England.	profdavidleaper@doctors.org.uk	Palanca, Ana/E-1541-2018	Palanca, Ana/0000-0003-3513-4458; Cullen, Katherine/0000-0002-3704-4598	National Institute for Health and Clinical Excellence	National Institute for Health and Clinical Excellence	The National Collaborating Centre for Women's and Children's Health was commissioned and funded by the National Institute for Health and Clinical Excellence to write this summary.	National Institute for Health and Clinical Excellence, 2008, SURG SIT INF; Smyth ETM, 2008, J HOSP INFECT, V69, P230, DOI 10.1016/j.jhin.2008.04.020	2	67	71	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 1	2008	337								a1924	10.1136/bmj.a1924	http://dx.doi.org/10.1136/bmj.a1924			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368AM	18957455				2022-12-28	WOS:000260593700032
J	Kendrick, T; Hegarty, K; Glasziou, P				Kendrick, Tony; Hegarty, Kelsey; Glasziou, Paul			Interpreting research findings to guide treatment in practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-CARE; TRICYCLIC ANTIDEPRESSANTS; DEPRESSION; PRACTITIONERS; INTERVENTIONS; TOLERABILITY; EFFICACY	When applying research findings to individual patients, practitioners can use the PICO approach, which considers characteristics of the patient or population, intervention, comparator or context, and outcome. Patient centred practitioners should however identify the outcomes which are important to individual patients.	[Kendrick, Tony] Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England; [Hegarty, Kelsey] Univ Melbourne, Dept Gen Practice, Carlton, Vic 3053, Australia; [Glasziou, Paul] Univ Oxford, Dept Primary Hlth Care, Ctr Evidence Based Med, Oxford OX3 7LF, England	University of Southampton; University of Melbourne; University of Oxford	Kendrick, T (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England.	A.R.Kendrick@soton.ac.uk	Kendrick, Tony/H-8558-2014; Glasziou, Paul/A-7832-2008	Kendrick, Tony/0000-0003-1618-9381; Glasziou, Paul/0000-0001-7564-073X; Hegarty, Kelsey/0000-0002-7532-5147				*AHCPR DEPR GUID P, 2000, DEPR PRIM CAR DET DI; Anderson L, 2005, BRIT J GEN PRACT, V55, P387; Arroll B, 2005, ANN FAM MED, V3, P449, DOI 10.1370/afm.349; Bower P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001025.pub2; Dowrick C., 2004, DEPRESSION NEW APPRO; Ellis PM, 2004, AUST NZ J PSYCHIAT, V38, P389, DOI 10.1080/j.1440-1614.2004.01377.x; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; Glasziou P, 2001, SYSTEMATIC REV HLTH, P9; GLASZIOU PP, 1995, BMJ-BRIT MED J, V311, P1356, DOI 10.1136/bmj.311.7016.1356; Griffin SJ, 2004, ANN FAM MED, V2, P595, DOI 10.1370/afm.142; Kendrick T, 2000, BMJ-BRIT MED J, V320, P200, DOI 10.1136/bmj.320.7229.200; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; MacGillivray S, 2003, BMJ-BRIT MED J, V326, P1014, DOI 10.1136/bmj.326.7397.1014; May C, 2004, SOCIOL HEALTH ILL, V26, P135, DOI 10.1111/j.1467-9566.2004.00384.x; National Collaborating Centre for Mental Health, 2004, DEPR MAN DEPR PRIM S; Parikh SV, 2001, CAN J PSYCHIAT, V46, p13S; Parker G, 2004, AUST NZ J PSYCHIAT, V38, P408, DOI 10.1111/j.1440-1614.2004.01386.x; Peveler R, 1999, BRIT MED J, V319, P612, DOI 10.1136/bmj.319.7210.612; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Ward E, 2000, BRIT MED J, V321, P1383, DOI 10.1136/bmj.321.7273.1383	20	19	19	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2008	337								a1499	10.1136/bmj.a1499	http://dx.doi.org/10.1136/bmj.a1499			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374FQ	18952681				2022-12-28	WOS:000261029000003
J	Williams, LE; Bargh, JA				Williams, Lawrence E.; Bargh, John A.			Experiencing physical warmth promotes interpersonal warmth	SCIENCE			English	Article							UNIVERSAL DIMENSIONS; SOCIAL-PERCEPTION; 1ST IMPRESSIONS	"Warmth" is the most powerful personality trait in social judgment, and attachment theorists have stressed the importance of warm physical contact with caregivers during infancy for healthy relationships in adulthood. Intriguingly, recent research in humans points to the involvement of the insula in the processing of both physical temperature and interpersonal warmth (trust) information. Accordingly, we hypothesized that experiences of physical warmth (or coldness) would increase feelings of interpersonal warmth (or coldness), without the person's awareness of this influence. In study 1, participants who briefly held a cup of hot (versus iced) coffee judged a target person as having a "warner" personality (generous, caring); in study 2, participants holding a hot (versus cold) therapeutic pad were more likely to choose a gift for a friend instead of for themselves.	[Williams, Lawrence E.] Univ Colorado, Leeds Sch Business, Boulder, CO 80309 USA; [Bargh, John A.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA	University of Colorado System; University of Colorado Boulder; Yale University	Williams, LE (corresponding author), Univ Colorado, Leeds Sch Business, UCB 419, Boulder, CO 80309 USA.	lawrence.williams@colorado.edu	Williams, Lawrence/AAE-1725-2021		National Institute of Mental Health [MH-R01-60767]; NSF Graduate Research Fellowship; Yale International Center for Finance Whitebox Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060767] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Yale International Center for Finance Whitebox Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Bloom, J. Gray, F. Keil, E. Morsella, A. Poehlman, P. Winkielman, S. Gottlieb, K Connolly, S. Hennessey, and funding from National Institute of Mental Health (grant MH-R01-60767), a NSF Graduate Research Fellowship, and a Yale International Center for Finance Whitebox Fellowship.	Asch S., 1958, PERSON PERCEPTION IN, P86; ASCH SE, 1946, J ABNORM SOC PSYCH, V41, P258, DOI 10.1037/h0055756; Balter M, 2007, SCIENCE, V315, P1208, DOI 10.1126/science.315.5816.1208; Bowlby J., 1969, ATTACHMENT AND LOSS; Clark H.H., 1973, COGNITIVE DEV ACQUIS, P27; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Cuddy AJC, 2008, ADV EXP SOC PSYCHOL, V40, P61, DOI 10.1016/S0065-2601(07)00002-0; Dijksterhuis A, 2001, ADV EXP SOC PSYCHOL, V33, P1, DOI 10.1016/S0065-2601(01)80003-4; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; HARLOW HF, 1958, AM PSYCHOL, V13, P673, DOI 10.1037/h0047884; Higgins ET., 1996, SOCIAL PSYCHOL HDB B, P133; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Johnson M., 1987, BODY MIND BODILY BAS; KELLEY HH, 1950, J PERS, V18, P431, DOI 10.1111/j.1467-6494.1950.tb01260.x; Kross E, 2007, J COGNITIVE NEUROSCI, V19, P945, DOI 10.1162/jocn.2007.19.6.945; Lorenz K., 1966, AGGRESSION; MANDLER JM, 1992, PSYCHOL REV, V99, P587, DOI 10.1037/0033-295X.99.4.587; Meyer-Lindenberg A, 2008, SCIENCE, V321, P778, DOI 10.1126/science.1162908; Niedenthal PM, 1999, PSYCHOL REV, V106, P337, DOI 10.1037/0033-295X.106.2.337; NISBETT RE, 1977, J PERS SOC PSYCHOL, V35, P250, DOI 10.1037//0022-3514.35.4.250; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sweetser E.E., 1990, ETYMOLOGY PRAGMATICS; TAIMY L, 1988, COGNITIVE SCI, V12, P49; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Wojciszke B, 1998, PERS SOC PSYCHOL B, V24, P1251, DOI 10.1177/01461672982412001	26	629	665	21	366	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					606	607		10.1126/science.1162548	http://dx.doi.org/10.1126/science.1162548			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948544	Green Accepted, Green Submitted			2022-12-28	WOS:000260299100048
J	Wiener, CM; Muse, VV; Mark, EJ; Tinsley, A; Harris, NL; Kanarek, DJ; Korzenik, J				Wiener, Charles M.; Muse, Victorine V.; Mark, Eugene J.; Tinsley, Andrew; Harris, Nancy Lee; Kanarek, David J.; Korzenik, Joshua			A woman with dyspnea on exertion - Interstitial lymphocytic pneumonitis and histiocytic pneumonia with eosinophils, findings that are consistent with drug or hypersensitivity reactions, possibly due to infliximab	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LUNG-DISEASE; BRONCHOALVEOLAR LAVAGE; INFECTIOUS-DISEASES; CT		[Wiener, Charles M.] Johns Hopkins Univ Hosp, Dept Med, Baltimore, MD 21287 USA; [Wiener, Charles M.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Muse, Victorine V.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Mark, Eugene J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Muse, Victorine V.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Mark, Eugene J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wiener, CM (corresponding author), Johns Hopkins Univ Hosp, Dept Med, Baltimore, MD 21287 USA.							Allen JN, 2004, CLIN CHEST MED, V25, P77, DOI 10.1016/S0272-5231(03)00141-2; Childs B, 2005, ANNU REV GENOM HUM G, V6, P313, DOI 10.1146/annurev.genom.6.080604.162345; Collins J, 2001, RADIOL CLIN N AM, V39, P1115, DOI 10.1016/S0033-8389(05)70334-1; Costabel U, 2004, CLIN CHEST MED, V25, P25, DOI 10.1016/S0272-5231(03)00143-6; Epler GR, 2004, CLIN CHEST MED, V25, P89, DOI 10.1016/S0272-5231(03)00140-0; Lawson MM, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD005112.PUB2; Mennink-Kersten MASH, 2006, INFECT DIS CLIN N AM, V20, P711, DOI 10.1016/j.idc.2006.06.009; Meyer KC, 2004, CLIN CHEST MED, V25, P637, DOI 10.1016/j.ccm.2004.08.001; Miller WT, 2005, AM J ROENTGENOL, V184, P613, DOI 10.2214/ajr.184.2.01840613; Muijsers RBR, 2002, DRUGS, V62, P1689, DOI 10.2165/00003495-200262110-00010; Muller NL, 2004, BRIT J CANCER, V91, pS24, DOI 10.1038/sj.bjc.6602064; Parry SD, 2002, EUR RESPIR J, V19, P756, DOI 10.1183/09031936.02.00267402; Saketkoo LA, 2006, INFECT DIS CLIN N AM, V20, P931, DOI 10.1016/j.idc.2006.09.001; Storch I, 2003, INFLAMM BOWEL DIS, V9, P104, DOI 10.1097/00054725-200303000-00004; Villeneuve E, 2006, J RHEUMATOL, V33, P1189; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317	16	13	14	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2008	359	17					1823	1832		10.1056/NEJMcpc0806979	http://dx.doi.org/10.1056/NEJMcpc0806979			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363DJ	18946068				2022-12-28	WOS:000260245800011
J	Kim, N; Stiegler, AL; Cameron, TO; Hallock, PT; Gomez, AM; Huang, JH; Hubbard, SR; Dustin, ML; Burden, SJ				Kim, Natalie; Stiegler, Amy L.; Cameron, Thomas O.; Hallock, Peter T.; Gomez, Andrea M.; Huang, Julie H.; Hubbard, Stevan R.; Dustin, Michael L.; Burden, Steven J.			Lrp4 Is a Receptor for Agrin and Forms a Complex with MuSK	CELL			English	Article							NEUROMUSCULAR-JUNCTION FORMATION; MUSCLE-SPECIFIC KINASE; ALPHA-DYSTROGLYCAN; SYNAPSE; PHOSPHORYLATION; AGGREGATION; PROTEIN-4; MEMBRANE; CALCIUM; PATHWAY	Neuromuscular synapse formation requires a complex exchange of signals between motor neurons and skeletal muscle fibers, leading to the accumulation of postsynaptic proteins, including acetylcholine receptors in the muscle membrane and specialized release sites, or active zones in the presynaptic nerve terminal. MuSK, a receptor tyrosine kinase that is expressed in skeletal muscle, and Agrin, a motor neuron-derived ligand that stimulates MuSK phosphorylation, play critical roles in synaptic differentiation, as synapses do not form in their absence, and mutations in MuSK or downstream effectors are a major cause of a group of neuromuscular disorders, termed congenital myasthenic syndromes (CMS). How Agrin activates MuSK and stimulates synaptic differentiation is not known and remains a fundamental gap in our understanding of signaling at neuromuscular synapses. Here, we report that Lrp4, a member of the LDLR family, is a receptor for Agrin, forms a complex with MuSK, and mediates MuSK activation by Agrin.	[Kim, Natalie; Stiegler, Amy L.; Hallock, Peter T.; Gomez, Andrea M.; Burden, Steven J.] NYU, Sch Med, Helen & Martin Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Mol Neurobiol Program, New York, NY 10016 USA; [Stiegler, Amy L.; Hubbard, Stevan R.] NYU, Sch Med, Helen & Martin Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Struct Biol Program, New York, NY 10016 USA; [Cameron, Thomas O.; Huang, Julie H.; Dustin, Michael L.] NYU, Sch Med, Helen & Martin Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Mol Pathogenesis Program, New York, NY 10016 USA	New York University; New York University; New York University	Burden, SJ (corresponding author), NYU, Sch Med, Helen & Martin Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Mol Neurobiol Program, 540 1st Ave, New York, NY 10016 USA.	burden@saturn.med.nyu.edu	Tuluc, Petronel/C-2527-2011; Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389; Gomez, Andrea/0000-0002-2923-6362; Hubbard, Stevan/0000-0002-2707-9383; Burden, Steven/0000-0002-3550-6891	National Cancer Institute Cancer Center Support [P30 CA016087]; National Institutes of Health [NS36193, R21 GM075180]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM075180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053414, R37NS036193, R01NS036193] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center Support(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Katherine Anderson, Lee Niswander, and Scott Weatherbee for providing us with lrp4 mutant mice and David Russell for the human LDLR plasmid. We are grateful to Jihua Fan for excellent technical assistance and Peter Lopez for help with the flow cytometry analysis. The flow cytometry core is supported by a National Cancer Institute Cancer Center Support Grant (P30 CA016087). This work was supported with funds from the National Institutes of Health (NS36193 to S. J. B., R21 GM075180 to M.	Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9; Beeson D, 2008, ANN NY ACAD SCI, V1132, P99, DOI 10.1196/annals.1405.049; Borges LS, 2002, J NEUROBIOL, V50, P69, DOI 10.1002/neu.10020; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Drogemuller C, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-5; Dustin ML, 2007, J BIOL CHEM, V282, P34748, DOI 10.1074/jbc.M705616200; Dustin ML, 1997, J BIOL CHEM, V272, P15782, DOI 10.1074/jbc.272.25.15782; Engel AG, 2005, CURR OPIN PHARMACOL, V5, P308, DOI 10.1016/j.coph.2004.12.007; Engel AG, 2008, ANN NY ACAD SCI, V1132, P104, DOI 10.1196/annals.1405.039; FAMBROUGH DM, 1973, SCIENCE, V182, P293, DOI 10.1126/science.182.4109.293; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; Garcia-Osta A, 2006, J NEUROSCI, V26, P7919, DOI 10.1523/JNEUROSCI.1674-06.2006; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Glass DJ, 1996, COLD SPRING HARB SYM, V61, P435; Glass DJ, 1997, CURR OPIN NEUROBIOL, V7, P379, DOI 10.1016/S0959-4388(97)80066-9; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1038/sj.emboj.7592228b; Hilgenberg LGW, 2006, CELL, V125, P359, DOI 10.1016/j.cell.2006.01.052; Hopf C, 1998, EUR J BIOCHEM, V253, P382, DOI 10.1046/j.1432-1327.1998.2530382.x; Jacobson C, 1998, J NEUROSCI, V18, P6340; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Kleiman RJ, 1996, CELL, V85, P461, DOI 10.1016/S0092-8674(00)81245-3; Ksiazek I, 2007, J NEUROSCI, V27, P7183, DOI 10.1523/JNEUROSCI.1609-07.2007; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Megeath LJ, 1998, J NEUROSCI, V18, P672; Meier T, 1996, EMBO J, V15, P2625, DOI 10.1002/j.1460-2075.1996.tb00622.x; Mittaud P, 2004, MOL CELL BIOL, V24, P7841, DOI 10.1128/MCB.24.18.7841-7854.2004; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; SEALOCK R, 1994, CELL, V77, P617, DOI 10.1016/0092-8674(94)90045-0; SIMON AM, 1993, MOL CELL BIOL, V13, P5133, DOI 10.1128/MCB.13.9.5133; Stiegler AL, 2006, J MOL BIOL, V364, P424, DOI 10.1016/j.jmb.2006.09.019; Tian QB, 2006, EUR J NEUROSCI, V23, P2864, DOI 10.1111/j.1460-9568.2006.04846.x; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; VERSCHUEREN H, 1985, J CELL SCI, V75, P279; Vincent A, 2005, CURR OPIN NEUROL, V18, P519, DOI 10.1097/01.wco.0000180660.57801.3f; Vincent Angela, 2002, Adv Neurol, V88, P159; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	47	460	479	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					334	342		10.1016/j.cell.2008.10.002	http://dx.doi.org/10.1016/j.cell.2008.10.002			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18848351	Bronze, Green Accepted			2022-12-28	WOS:000260130400022
J	Rodeheffer, MS; Birsoy, K; Friedman, JM				Rodeheffer, Matthew S.; Birsoy, Kivanc; Friedman, Jeffrey M.			Identification of White Adipocyte Progenitor Cells In Vivo	CELL			English	Article							MESENCHYMAL STEM-CELLS; HUMAN BONE-MARROW; ADIPOSE-TISSUE; HEMATOPOIETIC STEM; FAT PADS; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; MAMMARY-GLAND; CELLULARITY; OBESITY	The increased white adipose tissue (WAT) mass associated with obesity is the result of both hyperplasia and hypertrophy of adipocytes. However, the mechanisms controlling adipocyte number are unknown in part because the identity of the physiological adipocyte progenitor cells has not been defined in vivo. In this report, we employ a variety of approaches, including a noninvasive assay for following fat mass reconstitution in vivo, to identify a subpopulation of early adipocyte progenitor cells (Lin(-): CD29(+): CD34(+): Sca-1(+): CD24(+)) resident in adult WAT. When injected into the residual fat pads of A-Zip lipodystrophic mice, these cells reconstitute a normal WAT depot and rescue the diabetic phenotype that develops in these animals. This report provides the identification of an undifferentiated adipocyte precursor subpopulation resident within the adipose tissue stroma that is capable of proliferating and differentiating into an adipose depot in vivo.	[Rodeheffer, Matthew S.; Birsoy, Kivanc; Friedman, Jeffrey M.] Rockefeller Univ, Mol Genet Lab, New York, NY 10065 USA; [Rodeheffer, Matthew S.; Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Friedman, JM (corresponding author), Rockefeller Univ, Mol Genet Lab, 1230 York Ave, New York, NY 10065 USA.	friedj@rockefeller.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BERNLOHR DA, 1985, J BIOL CHEM, V260, P5563; Birsoy K, 2008, P NATL ACAD SCI USA, V105, P12985, DOI 10.1073/pnas.0805621105; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Boquest AC, 2005, MOL BIOL CELL, V16, P1131, DOI 10.1091/mbc.E04-10-0949; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Cinti S, 2000, METH MOL B, V155, P21; CINTI S, 1984, J SUBMICR CYTOL PATH, V16, P243; DEOME KB, 1959, CANCER RES, V19, P515; Fata JE, 2001, BIOL REPROD, V65, P680, DOI 10.1095/biolreprod65.3.680; FAUST IM, 1978, AM J PHYSIOL, V235, pE279, DOI 10.1152/ajpendo.1978.235.3.E279; Fischbach C, 2004, EXP CELL RES, V300, P54, DOI 10.1016/j.yexcr.2004.05.036; FORD CE, 1956, NATURE, V177, P452, DOI 10.1038/177452a0; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gonzalez FJ, 2005, CELL METAB, V1, P85, DOI 10.1016/j.cmet.2005.01.004; GREENWOOD MR, 1974, J LIPID RES, V15, P474; Hemmrich K, 2005, BIOMATERIALS, V26, P7025, DOI 10.1016/j.biomaterials.2005.04.065; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Hong L, 2006, CELLS TISSUES ORGANS, V183, P133, DOI 10.1159/000095987; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904; JOHNSON PR, 1971, J LIPID RES, V12, P706; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lane MD, 2005, BIRTH DEFECTS RES A, V73, P476, DOI 10.1002/bdra.20150; Lee JH, 2005, EXP CELL RES, V307, P174, DOI 10.1016/j.yexcr.2005.03.008; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; LEMONNIER D, 1970, EXPERIENTIA, V26, P974, DOI 10.1007/BF02114140; LEMONNIER D, 1972, J CLIN INVEST, V51, P2907, DOI 10.1172/JCI107115; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Patrick CW, 1999, TISSUE ENG, V5, P139, DOI 10.1089/ten.1999.5.139; RODBELL M, 1964, J BIOL CHEM, V239, P375; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sengenes C, 2005, J CELL PHYSIOL, V205, P114, DOI 10.1002/jcp.20381; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; SIMON G, 1965, HDB PHYSL 5; SMITH GH, 1988, J CELL SCI, V90, P173; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; TANG W, 2008, SCIENCE IN PRESS, DOI DOI 10.1126/SCIENCE.1156232; Thayer KA, 2001, HUM REPROD, V16, P988, DOI 10.1093/humrep/16.5.988; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; WASSERMANN F, 1926, Z ZELLFORSCH MIKROSK, V3, P325; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; WISE A, 1975, NUTR METAB, V19, P291; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Zheng B, 2006, TISSUE ENG, V12, P1891, DOI 10.1089/ten.2006.12.1891; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	54	660	680	5	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					240	249		10.1016/j.cell.2008.09.036	http://dx.doi.org/10.1016/j.cell.2008.09.036			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18835024	Bronze			2022-12-28	WOS:000260130400014
J	DeLisi, C				DeLisi, Charles			Santa Fe 1986: Human genome baby-steps	NATURE			English	Editorial Material									[DeLisi, Charles] Boston Univ, Boston, MA 02215 USA	Boston University	DeLisi, C (corresponding author), Boston Univ, Boston, MA 02215 USA.	delisi@bu.edu							0	19	22	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					876	877		10.1038/455876a	http://dx.doi.org/10.1038/455876a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923499	Bronze			2022-12-28	WOS:000260038300026
J	Ramocki, MB; Zoghbi, HY				Ramocki, Melissa B.; Zoghbi, Huda Y.			Failure of neuronal homeostasis results in common neuropsychiatric phenotypes	NATURE			English	Article							EXPRESSIVE-LANGUAGE DELAY; SEVERE MENTAL-RETARDATION; WILLIAMS-BEUREN-SYNDROME; FRAGILE-X-SYNDROME; GENE COPY-NUMBER; RETT-SYNDROME; MOUSE MODEL; MESSENGER-RNAS; HOMOLOGOUS RECOMBINATION; NEUROLOGICAL SYMPTOMS	Failure of normal brain development leads to mental retardation or autism in about 3% of children. Many genes integral to pathways by which synaptic modification and the remodelling of neuronal networks mediate cognitive and social development have been identified, usually through loss of function. Evidence is accumulating, however, that either loss or gain of molecular functions can be deleterious to the nervous system. Copy- number variation, regulation of gene expression by non- coding RNAs and epigenetic changes are all mechanisms by which altered gene dosage can cause the failure of neuronal homeostasis.	[Ramocki, Melissa B.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Sect Pediat Neurol & Dev Neurosci, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Sect Human & Mol Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Ramocki, MB (corresponding author), Baylor Coll Med, Dept Pediat, Sect Pediat Neurol & Dev Neurosci, 1 Baylor Plaza,MS 225,BCMT-T807, Houston, TX 77030 USA.	mramocki@bcm.tmc.edu; hzoghbi@bcm.tmc.edu		Zoghbi, Huda/0000-0002-0700-3349	Howard Hughes Medical Institute; National Institute of Neurological Disorders and Stroke [1R01 NS057819-01, T32 NS43124, 1K08 NS062711-01]; Simons Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS043124, R01NS057819, K08NS062711] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Simons Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	In memory of our mentor, Ralph D. Feigin. We are grateful to C. Rosenmund for careful reading of the manuscript, discussions and helping us to articulate our hypothesis. We are indebted to the Howard Hughes Medical Institute, the National Institute of Neurological Disorders and Stroke (grant number 1R01 NS057819-01 to H.Y.Z., and grant numbers T32 NS43124 and 1K08 NS062711-01 to M.B.R.) and the Simons Foundation for supporting our research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Battaglia A, 2005, BRAIN DEV-JPN, V27, P365, DOI 10.1016/j.braindev.2004.08.006; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berg JS, 2007, GENET MED, V9, P427, DOI 10.1097/GIM.0b013e3180986192; Bi WM, 2007, HUM MOL GENET, V16, P1802, DOI 10.1093/hmg/ddm128; Bi WM, 2005, HUM MOL GENET, V14, P983, DOI 10.1093/hmg/ddi085; Bi WM, 2004, HUM GENET, V115, P515, DOI 10.1007/s00439-004-1187-6; Bourgeron T, 2007, COLD SPRING HARB SYM, V72, P645, DOI 10.1101/sqb.2007.72.020; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Ding F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001709; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Elsea SH, 2008, EUR J HUM GENET, V16, P412, DOI 10.1038/sj.ejhg.5202009; Ensenauer RE, 2003, AM J HUM GENET, V73, P1027, DOI 10.1086/378818; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Friez MJ, 2006, PEDIATRICS, V118, pE1687, DOI 10.1542/peds.2006-0395; Gallagher RC, 2002, AM J HUM GENET, V71, P669, DOI 10.1086/342408; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Girirajan S, 2008, EUR J HUM GENET, V16, P941, DOI 10.1038/ejhg.2008.21; Gothelf D, 2007, AM J PSYCHIAT, V164, P663, DOI 10.1176/appi.ajp.164.4.663; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Heredia L, 2006, J NEUROSCI, V26, P6533, DOI 10.1523/JNEUROSCI.5567-05.2006; Hiroi N, 2005, P NATL ACAD SCI USA, V102, P19132, DOI 10.1073/pnas.0509635102; Hoogenraad CC, 2002, NAT GENET, V32, P116, DOI 10.1038/ng954; IMAI Y, 1995, MOL BRAIN RES, V31, P1, DOI 10.1016/0169-328X(95)00020-S; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; Lalande M, 2007, CELL MOL LIFE SCI, V64, P947, DOI 10.1007/s00018-007-6460-0; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lim MK, 2007, EXP CELL RES, V313, P2858, DOI 10.1016/j.yexcr.2007.04.016; Long JM, 2006, NEUROGENETICS, V7, P247, DOI 10.1007/s10048-006-0054-0; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Miura K, 2002, NEUROBIOL DIS, V9, P149, DOI 10.1006/nbdi.2001.0463; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Nakamoto M, 2007, P NATL ACAD SCI USA, V104, P15537, DOI 10.1073/pnas.0707484104; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; Paylor R, 2006, P NATL ACAD SCI USA, V103, P7729, DOI 10.1073/pnas.0600206103; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; Smyk M, 2008, AM J MED GENET B, V147B, P799, DOI 10.1002/ajmg.b.30683; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Tassabehji M, 2003, HUM MOL GENET, V12, pR229, DOI 10.1093/hmg/ddg299; Torniero C, 2007, EUR J HUM GENET, V15, P62, DOI 10.1038/sj.ejhg.5201730; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Walz K, 2006, J CLIN INVEST, V116, P3035, DOI 10.1172/JCI28953; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Yobb TM, 2005, AM J HUM GENET, V76, P865, DOI 10.1086/429841; Zhao CJ, 2005, DEVELOPMENT, V132, P2917, DOI 10.1242/dev.01871; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	69	283	288	0	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					912	918		10.1038/nature07457	http://dx.doi.org/10.1038/nature07457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923513	Green Accepted			2022-12-28	WOS:000260038300039
J	Yawar, A				Yawar, Athar			Can doctors think?	LANCET			English	Editorial Material									[Yawar, Athar] The Lancet, London NW1 7BY, England		Yawar, A (corresponding author), The Lancet, London NW1 7BY, England.							Borges Jorge Luis, 1970, ALEPH OTHER STORIES; DEIKMAN A, 1982, OBSERVING SELF; Evans-Pritchard E E, 1951, WITCHCRAFT ORACLES M; Illich I., 1995, LIMITS MED; Illich I., 1970, DESCHOOLING SOC; Kingsley P., 2003, REALITY INVERNESS; LESSING D, 1994, PRISONS WE CHOOSE LI; Littlewood R., 2000, CULTURAL PSYCHIAT ME; Micale Mark, 1995, APPROACHING HYSTERIA; Owen GS, 2007, BRIT J PSYCHIAT, V191, P453, DOI 10.1192/bjp.bp.107.037309; Polanyi M., 1962, PERSONAL KNOWLEDGE; RAHNEMA M, 1997, POST DEV READER; SHAH I, 1982, SEEKER TRUTH	13	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1285	1286		10.1016/S0140-6736(08)61533-0	http://dx.doi.org/10.1016/S0140-6736(08)61533-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18929891				2022-12-28	WOS:000260060500010
J	Murray, H; Errington, J				Murray, Heath; Errington, Jeff			Dynamic control of the DNA replication initiation protein DnaA by Soj/ParA	CELL			English	Article							BACTERIAL CHROMOSOME SEGREGATION; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; SPO0J PARB; SOJ PARA; PSEUDOMONAS-AERUGINOSA; PARTITIONING PROTEIN; CELL-DIVISION; SPORULATION; PLASMID	Regulation of DNA replication and segregation is essential for all cells. Orthologs of the plasmid partitioning genes parA, parB, and parS are present in bacterial genomes throughout the prokaryotic evolutionary tree and are required for accurate chromosome segregation. However, the mechanism(s) by which parABS genes ensure proper DNA segregation have remained unclear. Here we report that the ParA ortholog in B. subtilis (Soj) controls the activity of the DNA replication initiator protein DnaA. Subcellular localization of several Soj mutants indicates that Soj acts as a spatially regulated molecular switch, capable of either inhibiting or activating DnaA. We show that the classical effect of Soj inhibiting sporulation is an indirect consequence of its action on DnaA through activation of the Sda DNA replication checkpoint. These results suggest that the pleiotropy manifested by chromosomal parABS mutations could be the indirect effects of a primary activity regulating DNA replication initiation.	[Murray, Heath; Errington, Jeff] Univ Newcastle Upon Tyne, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Murray, H (corresponding author), Univ Newcastle Upon Tyne, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	heath.murray@ncl.ac.uk	Errington, Jeff/G-1832-2011	Errington, Jeff/0000-0002-6977-9388; Murray, Heath/0000-0002-6467-3656	BBSRC [43/G18654]; European Molecular Biology Organization (EMBO); Human Frontier Science Program (HFSP)	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP)(Human Frontier Science Program)	We thank Kenn Gerdes, Stephan Gruber, Leendert Hamoen, Christine Jacobs-Wagner, and Ling Juan Wu for critical reading of the manuscript. We thank Richard Daniel, Yoshikazu Kawai, and Ian Selmes for scientific and technical assistance. We are grateful to the Grossman Lab (MIT) for strains and Soj antibodies, to the Burkholder Lab (Stanford) for strains and communicating results prior to publication, and to the Spiegelman Lab for communicating results prior to publication. This work was supported by grant number 43/G18654 from the BBSRC to J.E. H.M. was supported by postdoctoral fellowships from the European Molecular Biology Organization (EMBO) and the Human Frontier Science Program (HFSP).	AUSTIN S, 1983, J MOL BIOL, V169, P373, DOI 10.1016/S0022-2836(83)80056-4; Autret S, 2003, MOL MICROBIOL, V47, P159, DOI 10.1046/j.1365-2958.2003.03264.x; Bartosik AA, 2004, J BACTERIOL, V186, P6983, DOI 10.1128/JB.186.20.6983-6998.2004; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; Burkholder WF, 2001, CELL, V104, P269, DOI 10.1016/S0092-8674(01)00211-2; Carr KM, 1996, MOL MICROBIOL, V20, P1307, DOI 10.1111/j.1365-2958.1996.tb02649.x; Cervin MA, 1998, MOL MICROBIOL, V29, P85, DOI 10.1046/j.1365-2958.1998.00905.x; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Errington J, 2005, PHILOS T R SOC B, V360, P497, DOI 10.1098/rstb.2004.1605; ERRINGTON J, 1983, J GEN MICROBIOL, V129, P2091; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; GERDES K, 1985, J BACTERIOL, V161, P292, DOI 10.1128/JB.161.1.292-298.1985; Glaser P, 1997, GENE DEV, V11, P1160, DOI 10.1101/gad.11.9.1160; Godfrin-Estevenon AM, 2002, MOL MICROBIOL, V43, P39, DOI 10.1046/j.1365-2958.2002.02735.x; Hassan AKM, 1997, J BACTERIOL, V179, P2494, DOI 10.1128/jb.179.8.2494-2502.1997; Hester CM, 2007, P NATL ACAD SCI USA, V104, P20326, DOI 10.1073/pnas.0705196105; HRANUELI D, 1974, J BACTERIOL, V119, P684, DOI 10.1128/JB.119.3.684-690.1974; Imai Y, 2000, MOL MICROBIOL, V36, P1037, DOI 10.1046/j.1365-2958.2000.01928.x; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; Ishikawa S, 2007, DNA RES, V14, P155, DOI 10.1093/dnares/dsm017; Ishikawa S, 2006, MOL MICROBIOL, V60, P1364, DOI 10.1111/j.1365-2958.2006.05184.x; Jakimowicz D, 2007, MICROBIOL-SGM, V153, P4050, DOI 10.1099/mic.0.2007/011619-0; Jakimowicz D, 2007, MOL MICROBIOL, V65, P625, DOI 10.1111/j.1365-2958.2007.05815.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kawai Y, 2003, MOL MICROBIOL, V47, P1113, DOI 10.1046/j.1365-2958.2003.03360.x; Kim HJ, 2000, J BACTERIOL, V182, P1313, DOI 10.1128/JB.182.5.1313-1320.2000; Kornberg A., 1992, DNA REPLICATION; Lasocki K, 2007, J BACTERIOL, V189, P5762, DOI 10.1128/JB.00371-07; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lee PS, 2006, MOL MICROBIOL, V60, P853, DOI 10.1111/j.1365-2958.2006.05140.x; Lee PS, 2003, J BACTERIOL, V185, P1326, DOI 10.1128/JB.185.4.1326-1337.2003; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Leonard TA, 2004, MOL MICROBIOL, V53, P419, DOI 10.1111/j.1365-2958.2004.04133.x; Lewis RA, 2002, MICROBIOL-SGM, V148, P537, DOI 10.1099/00221287-148-2-537; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Lin DCH, 1997, P NATL ACAD SCI USA, V94, P4721, DOI 10.1073/pnas.94.9.4721; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; LOVE PE, 1984, J BACTERIOL, V160, P910, DOI 10.1128/JB.160.3.910-920.1984; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; McLeod BN, 2005, J BACTERIOL, V187, P2532, DOI 10.1128/JB.187.7.2532-2536.2005; Messer W, 2001, BIOCHIMIE, V83, P5, DOI 10.1016/S0300-9084(00)01216-5; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Moriya S, 1997, DNA Res, V4, P115, DOI 10.1093/dnares/4.2.115; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3; Ogura Y, 2003, J BACTERIOL, V185, P6316, DOI 10.1128/JB.185.21.6316-6324.2003; Quisel JD, 2000, J BACTERIOL, V182, P3446, DOI 10.1128/JB.182.12.3446-3451.2000; Quisel JD, 1999, MOL CELL, V4, P665, DOI 10.1016/S1097-2765(00)80377-9; Saint-Dic D, 2006, J BACTERIOL, V188, P5626, DOI 10.1128/JB.00250-06; Sharpe ME, 1996, MOL MICROBIOL, V21, P501, DOI 10.1111/j.1365-2958.1996.tb02559.x; SKARSTAD K, 1988, J BACTERIOL, V170, P852, DOI 10.1128/jb.170.2.852-858.1988; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Wu LJ, 2003, MOL MICROBIOL, V49, P1463, DOI 10.1046/j.1365-2958.2003.03643.x	57	155	155	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 3	2008	135	1					74	84		10.1016/j.cell.2008.07.044	http://dx.doi.org/10.1016/j.cell.2008.07.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854156	Bronze			2022-12-28	WOS:000259728100010
J	Schunemann, HJ; Woodhead, M; Anzueto, A; Buist, S; MacNee, W; Rabe, KF; Heffner, J				Schuenemann, Holger J.; Woodhead, Mark; Anzueto, Antonio; Buist, Sonia; MacNee, William; Rabe, Klaus F.; Heffner, John			A vision statement on guideline development for respiratory disease: the example of COPD	LANCET			English	Editorial Material							RECOMMENDATIONS; STRENGTH; QUALITY		[Schuenemann, Holger J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Med Ctr 2C9, CLARITY Res Grp, Hamilton, ON L8N 3Z5, Canada; [Schuenemann, Holger J.] SUNY Buffalo, Dept Med, Buffalo, NY USA; [Woodhead, Mark] Manchester Royal Infirm, Manchester M13 9WL, Lancs, England; [Woodhead, Mark] Univ Manchester, Manchester, Lancs, England; [Anzueto, Antonio] Univ Texas Hlth Sci Ctr San Antonio, S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; [Buist, Sonia; Heffner, John] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [MacNee, William] Queens Med Res Inst, ELEGI Colt Res Labs, UoE MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Rabe, Klaus F.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands	McMaster University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Manchester; University of Manchester; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Oregon Health & Science University; University of Edinburgh; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Schunemann, HJ (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Med Ctr 2C9, CLARITY Res Grp, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	schuneh@mcmaster.ca	Rabe, Klaus F./AAW-6296-2021	Rabe, Klaus F./0000-0002-7020-1401; Schunemann, Holger/0000-0003-3211-8479; MacNee, William/0000-0002-3692-1448	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R13HL090485] Funding Source: NIH RePORTER; NHLBI NIH HHS [1R13HL 90485-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2008, COCHRANE HDB SYSTEMA; Bradbury J, 1999, LANCET, V353, P563, DOI 10.1016/S0140-6736(99)00028-8; Glasziou Paul, 2005, Evid Based Nurs, V8, P36, DOI 10.1136/ebn.8.2.36; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Horton R, 2002, LANCET, V359, P1605, DOI 10.1016/S0140-6736(02)08523-9; Oxman AD, 2007, LANCET, V369, P1883, DOI 10.1016/S0140-6736(07)60675-8; Oxman Andrew D, 2006, Health Res Policy Syst, V4, P12, DOI 10.1186/1478-4505-4-12; Schunemann HJ, 2006, AM J RESP CRIT CARE, V174, P605, DOI 10.1164/rccm.200602-197ST; Schunemann HJ, 2007, LANCET INFECT DIS, V7, P21, DOI 10.1016/S1473-3099(06)70684-3	11	49	53	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2009	373	9665					774	779		10.1016/S0140-6736(08)61347-1	http://dx.doi.org/10.1016/S0140-6736(08)61347-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	412LD	18835641				2022-12-28	WOS:000263725400037
J	Dimitrov, A; Quesnoit, M; Moutel, S; Cantaloube, I; Pous, C; Perez, F				Dimitrov, Ariane; Quesnoit, Melanie; Moutel, Sandrine; Cantaloube, Isabelle; Pous, Christian; Perez, Franck			Detection of GTP-Tubulin Conformation in Vivo Reveals a Role for GTP Remnants in Microtubule Rescues	SCIENCE			English	Article							STABILIZE MICROTUBULES; DYNAMIC INSTABILITY; P-I; CAP; POLYMERIZATION; HYDROLYSIS; TAXOL	Microtubules display dynamic instability, with alternating phases of growth and shrinkage separated by catastrophe and rescue events. The guanosine triphosphate (GTP) cap at the growing end of microtubules, whose presence is essential to prevent microtubule catastrophes in vitro, has been difficult to observe in vivo. We selected a recombinant antibody that specifically recognizes GTP- bound tubulin in microtubules and found that GTP- tubulin was indeed present at the plus end of growing microtubules. Unexpectedly, GTP- tubulin remnants were also present in older parts of microtubules, which suggests that GTP hydrolysis is sometimes incomplete during polymerization. Observations in living cells suggested that these GTP remnants may be responsible for the rescue events in which microtubules recover from catastrophe.	[Dimitrov, Ariane; Quesnoit, Melanie; Perez, Franck] Inst Curie, CNRS, UMR144, F-75248 Paris 05, France; [Dimitrov, Ariane; Quesnoit, Melanie; Moutel, Sandrine; Perez, Franck] Inst Curie, Ctr Rech, F-75248 Paris 05, France; [Quesnoit, Melanie; Cantaloube, Isabelle; Pous, Christian] Univ Paris 11, Fac Pharm, IFR141, F-92296 Chatenay Malabry, France; [Moutel, Sandrine] Inst Curie, Translat Res Dept, F-75248 Paris 05, France; [Pous, Christian] Hop Antoine Beclere, AP HP, F-92141 Clamart, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Perez, F (corresponding author), Inst Curie, CNRS, UMR144, 26 Rue Ulm, F-75248 Paris 05, France.	franck.perez@curie.fr	Perez, Franck/A-1558-2014; POÜS, Christian/R-5089-2018	Perez, Franck/0000-0002-9129-9401; Moutel, Sandrine/0000-0002-9585-4855; POUS, Christian/0000-0002-2502-7854	Institut de Recherches International Servier; Association pour la Recherche sur le Cancer; French Ministry of Research; Association Francaise contre les Myopathies; CNRS; Agence Nationale de la Recherche; Human Frontier Science Program Organization; ARC; French Ministry of Research [ACI-BCMS 338]	Institut de Recherches International Servier; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Human Frontier Science Program Organization(Human Frontier Science Program); ARC(Australian Research Council); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	We thank P. Benaroch for the selection of the TSB antibody, A. Khodjakov for the Ptk2 GFP-tubulin cell line, F. Severin and T. Hyman for help and advice, J. Sillibourne and D. Job for reading and commenting on the manuscript, and B. Goud for his constant support. Supported by the Institut de Recherches International Servier and the Association pour la Recherche sur le Cancer ( ARC) (M.Q.), by the French Ministry of Research and the Association Francaise contre les Myopathies ( A. D.), and by CNRS, the Agence Nationale de la Recherche (ANR non thematique), the Human Frontier Science Program Organization, ARC, and French Ministry of Research grant ACI-BCMS 338.	ARNAL I, 1995, CURR BIOL, V5, P900, DOI 10.1016/S0960-9822(95)00180-1; Caplow M, 1998, BIOCHEMISTRY-US, V37, P12994, DOI 10.1021/bi972602+; Caplow M, 1996, MOL BIOL CELL, V7, P663, DOI 10.1091/mbc.7.4.663; CARLIER MF, 1991, J BIOL CHEM, V266, P12361; CARLIER MF, 1989, BIOCHEMISTRY-US, V28, P1783, DOI 10.1021/bi00430a054; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Diamantopoulos GS, 1999, J CELL BIOL, V144, P99, DOI 10.1083/jcb.144.1.99; Dougherty CA, 1998, BIOCHEMISTRY-US, V37, P10861, DOI 10.1021/bi980677n; Draberova E, 2000, EUR J CELL BIOL, V79, P982, DOI 10.1078/0171-9335-00129; DRECHSEL DN, 1994, CURR BIOL, V4, P1053, DOI 10.1016/S0960-9822(00)00243-8; Elie-Caille C, 2007, CURR BIOL, V17, P1765, DOI 10.1016/j.cub.2007.08.063; MELKI R, 1990, BIOCHEMISTRY-US, V29, P8921, DOI 10.1021/bi00490a007; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Molodtsov MI, 2005, BIOPHYS J, V88, P3167, DOI 10.1529/biophysj.104.051789; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; Vandecandelaere A, 1999, BIOCHEMISTRY-US, V38, P8179, DOI 10.1021/bi9830765; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606	18	182	182	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1353	1356		10.1126/science.1165401	http://dx.doi.org/10.1126/science.1165401			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	18927356				2022-12-28	WOS:000261170600031
J	Grey, M; Haggart, JW; Smith, PL				Grey, Melissa; Haggart, James W.; Smith, Paul L.			Variation in Evolutionary Patterns Across the Geographic Range of a Fossil Bivalve	SCIENCE			English	Article							RANDOM-WALKS; MODE; RATES	The fossil record is the only direct source of data for studying modes ( patterns) and rates of morphological change over long periods of time. Determining modes and rates is important for understanding macroevolutionary processes, but just how modes and rates vary within a taxon, and why, remain largely unaddressed. We examined patterns of morphological change in the shell of the Mesozoic marine bivalve genus Buchia over its geographic and temporal range. Most modes conformed to either random walks or stasis, and both modes and rates showed variability between locations. For example, stasis was more common in deeper marine environments, whereas random walks occurred more often at the highest paleolatitudes studied. These results indicate that the environment can play an important role in shaping patterns of evolution.	[Grey, Melissa; Haggart, James W.; Smith, Paul L.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; [Haggart, James W.] Geol Survey Canada, Vancouver, BC V6B 5J3, Canada	University of British Columbia; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada	Grey, M (corresponding author), Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada.	mgrey@eos.ubc.ca			Natural Sciences and Engineering Research of Canada (NSERC); NSERC PGS-A scholarship	Natural Sciences and Engineering Research of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC PGS-A scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	Supported by a Natural Sciences and Engineering Research of Canada (NSERC) grant (to P.L.S.) and an NSERC PGS-A scholarship (to M.G.). We are grateful to P. Alsen, T. Bogdanova, A. Crame, J.S. Crampton, J. Dougherty, J. Grant-Mackie, D.A.T. Harper, D. Hikuroa, N. Hudson, E. Kalacheva, J. Rassmussen, J. Sha, I. Sey, and F. Surlyk for use of their collections and hospitality; to P. G. Lelievre for creating the MatLab morphometrics program (MorphLab 1.0); and to G. Hunt and P. Roopnarine for help and program codes for analyzing mode. This manuscript was substantially improved by the comments and suggestions of three reviewers.	BELL MA, 2006, PALEOBIOLOGY, V58, P814; GINGERICH PD, 1983, SCIENCE, V222, P159, DOI 10.1126/science.222.4620.159; Grey M, 2008, PALAEONTOLOGY, V51, P583, DOI 10.1111/j.1475-4983.2008.00765.x; Hannisdal B, 2007, PALEOBIOLOGY, V33, P98, DOI 10.1666/06038.1; Hunt G, 2007, P NATL ACAD SCI USA, V104, P18404, DOI 10.1073/pnas.0704088104; Hunt G, 2006, PALEOBIOLOGY, V32, P578, DOI 10.1666/05070.1; Jackson JBC, 1999, TRENDS ECOL EVOL, V14, P72, DOI 10.1016/S0169-5347(98)01504-3; JELETZKY JA, 1965, GEOL SURV CAN B, V103; LYNCH M, 1990, AM NAT, V136, P727, DOI 10.1086/285128; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Roopnarine PD, 2003, ANNU REV ECOL EVOL S, V34, P605, DOI 10.1146/annurev.ecolsys.34.011802.132407; Roopnarine PD, 2001, PALEOBIOLOGY, V27, P446, DOI 10.1666/0094-8373(2001)027<0446:TDACOE>2.0.CO;2; Sey LI, 1999, PALAEOGEOGR PALAEOCL, V150, P49, DOI 10.1016/S0031-0182(99)00007-3; Sha JG, 2003, CRETACEOUS RES, V24, P715, DOI 10.1016/j.cretres.2003.07.006; Sheets HD, 2001, GENETICA, V112, P105, DOI 10.1023/A:1013308409951; SURLYK F, 1982, PALAEONTOLOGY, V25, P727	16	8	8	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1238	1241		10.1126/science.1162046	http://dx.doi.org/10.1126/science.1162046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	18948502				2022-12-28	WOS:000261033400039
J	Haruyama, J; Ohtake, M; Matsunaga, T; Morota, T; Honda, C; Yokota, Y; Pieters, CM; Hara, S; Hioki, K; Saiki, K; Miyamoto, H; Iwasaki, A; Abe, M; Ogawa, Y; Takeda, H; Shirao, M; Yamaji, A; Josset, JL				Haruyama, Junichi; Ohtake, Makiko; Matsunaga, Tsuneo; Morota, Tomokatsu; Honda, Chikatoshi; Yokota, Yasuhiro; Pieters, Carle M.; Hara, Seiichi; Hioki, Kazuyuki; Saiki, Kazuto; Miyamoto, Hideaki; Iwasaki, Akira; Abe, Masanao; Ogawa, Yoshiko; Takeda, Hiroshi; Shirao, Motomaro; Yamaji, Atsushi; Josset, Jean-Luc			Lack of Exposed Ice Inside Lunar South Pole Shackleton Crater	SCIENCE			English	Article							WATER ICE; DEPOSITS; HYDROGEN; SURFACE; REGIONS; MOON	The inside of Shackleton Crater at the lunar south pole is permanently shadowed; it has been inferred to hold water- ice deposits. The Terrain Camera ( TC), a 10- meter- resolution stereo camera onboard the Selenological and Engineering Explorer ( SELENE) spacecraft, succeeded in imaging the inside of the crater, which was faintly lit by sunlight scattered from the upper inner wall near the rim. The estimated temperature of the crater floor, based on the crater shape model derived from the TC data, is less than similar to 90 kelvin, cold enough to hold water- ice. However, at the TC's spatial resolution, the derived albedo indicates that exposed relatively pure water- ice deposits are not on the crater floor. Water- ice may be disseminated and mixed with soil over a small percentage of the area or may not exist at all.	[Haruyama, Junichi; Ohtake, Makiko; Morota, Tomokatsu; Honda, Chikatoshi; Yokota, Yasuhiro; Abe, Masanao] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Matsunaga, Tsuneo; Ogawa, Yoshiko] Natl Inst Environm Studies, Ctr Global Environm Res, Tsukuba, Ibaraki 3058506, Japan; [Pieters, Carle M.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Hara, Seiichi; Hioki, Kazuyuki] NTT DATA CCS Corp, Koto Ku, Tokyo 1360071, Japan; [Saiki, Kazuto] Osaka Univ, Dept Earth & Space Sci, Grad Sch Sci, Osaka 5600043, Japan; [Miyamoto, Hideaki] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; [Iwasaki, Akira] Univ Tokyo, Dept Aerosp & Astronaut, Bunkyo Ku, Tokyo 1138656, Japan; [Takeda, Hiroshi] Chiba Inst Technol, Chiba 2750016, Japan; [Yamaji, Atsushi] Kyoto Univ, Div Earth & Planetary Sci, Sakyo Ku, Kyoto 6068502, Japan; [Josset, Jean-Luc] Space Explorat Inst, CH-2002 Neuchatel, Switzerland	Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); National Institute for Environmental Studies - Japan; Brown University; Osaka University; University of Tokyo; University of Tokyo; Chiba Institute of Technology	Haruyama, J (corresponding author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2298510, Japan.		Yamaji, Atsushi/ABB-2815-2021; Miyamoto, Hideaki/B-9666-2008; Miyamoto, Hideaki/E-3381-2012; Matsunaga, Tsuneo/H-3040-2018	Yamaji, Atsushi/0000-0001-8074-543X; Miyamoto, Hideaki/0000-0001-8013-6124; Matsunaga, Tsuneo/0000-0002-3380-5230	KAKENHI [20540416, 20.9211]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank all the contributors to the SELENE ( Kaguya) project, especially members of the project management group (Y. Takizawa, M. Kato, S. Sasaki, R. Nagashima, K. Tsuruda, and H. Mizutani) and the Lunar Imager/ Spectrometer (LISM) working group (H. Otake, H. Kawasaki, R. Nakamura, S. Kodama, S. Minami, S. Takechi, A. Akiyama, T. Yokota, T. Arai, T. Sugihara, Y. Yamaguchi, S. Sasaki, N. Asada, H. Demura, N. Hirata, J. Terazono, T. Hiroi, T. Hashimoto, T. Michikami, K. Kitazato, M. Higa, P. Pinet, T. Nimura, T. Yamamoto, N. Harada, K. Iseki, T. Hodokuma, S. Kikuchi, S. Kawabe, S. Okuno, and T. Takayama) for their efforts in the development, operation, and data processing of SELENE and LISM/TC. We thank the three anonymous reviewers for their helpful comments. This work was supported by KAKENHI (grants 20540416 to J. H. and C. H. and 20.9211 to T. Morota).	ARNOLD JR, 1979, J GEOPHYS RES, V84, P5659, DOI 10.1029/JB084iB10p05659; Campbell DB, 2006, NATURE, V443, P835, DOI 10.1038/nature05167; Crider DH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002030; Feldman WC, 2000, J GEOPHYS RES-PLANET, V105, P4175, DOI 10.1029/1999JE001129; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Hapke B., 1993, THEORY REFLECTANCE E; Haruyama J, 2008, EARTH PLANETS SPACE, V60, P243, DOI 10.1186/BF03352788; Mukai T, 1997, ADV SPACE RES-SERIES, V19, P1497, DOI 10.1016/S0273-1177(97)00348-7; *NASA, 1969, SP8023 NASA; Nozette S, 1996, SCIENCE, V274, P1495, DOI 10.1126/science.274.5292.1495; Nozette S, 2001, J GEOPHYS RES-PLANET, V106, P23253, DOI 10.1029/2000JE001417; Pike RJ., 1977, IMPACT EXPLOSION CRA, P489; Starukhina LV, 2000, ICARUS, V147, P585, DOI 10.1006/icar.2000.6476; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033	14	50	54	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					938	939		10.1126/science.1164020	http://dx.doi.org/10.1126/science.1164020			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18948501				2022-12-28	WOS:000260674100045
J	Nagai, S; Dubrana, K; Tsai-Pflugfelder, M; Davidson, MB; Roberts, TM; Brown, GW; Varela, E; Hediger, F; Gasser, SM; Krogan, NJ				Nagai, Shigeki; Dubrana, Karine; Tsai-Pflugfelder, Monika; Davidson, Marta B.; Roberts, Tania M.; Brown, Grant W.; Varela, Elisa; Hediger, Florence; Gasser, Susan M.; Krogan, Nevan J.			Functional targeting of DNA damage to a nuclear pore-associated SUMO-dependent ubiquitin ligase	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; PROTEIN COMPLEXES; YEAST; DYNAMICS; REPAIR; RECOMBINATION; ORGANIZATION; REPLICATION; SUMOYLATION; INSTABILITY	Recent findings suggest important roles for nuclear organization in gene expression. In contrast, little is known about how nuclear organization contributes to genome stability. Epistasis analysis (E-MAP) using DNA repair factors in yeast indicated a functional relationship between a nuclear pore subcomplex and Slx5/Slx8, a small ubiquitin-like modifier (SUMO)-dependent ubiquitin ligase, which we show physically interact. Real-time imaging and chromatin immunoprecipitation confirmed stable recruitment of damaged DNA to nuclear pores. Relocation required the Nup84 complex and Mec1/Tel1 kinases. Spontaneous gene conversion can be enhanced in a Slx8- and Nup84-dependent manner by tethering donor sites at the nuclear periphery. This suggests that strand breaks are shunted to nuclear pores for a repair pathway controlled by a conserved SUMO-dependent E3 ligase.	[Nagai, Shigeki; Tsai-Pflugfelder, Monika; Varela, Elisa; Gasser, Susan M.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Nagai, Shigeki; Dubrana, Karine; Hediger, Florence; Gasser, Susan M.] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Nagai, Shigeki; Dubrana, Karine; Hediger, Florence; Gasser, Susan M.] Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva, Switzerland; [Davidson, Marta B.; Roberts, Tania M.; Brown, Grant W.] Univ Toronto, Dept Biochem, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA	Friedrich Miescher Institute for Biomedical Research; University of Geneva; University of Geneva; University of Toronto; University of California System; University of California San Francisco	Gasser, SM (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	susan.gasser@fmi.ch	dubrana, karine/AAK-1447-2020	dubrana, karine/0000-0002-1269-2564; Roberts, Tania/0000-0001-9518-3011; Gasser, Susan/0000-0003-3610-9123; Brown, Grant/0000-0002-9002-5003	Novartis Research Foundation; Swiss Cancer League; Swiss National Science Foundation; Sandler Family Foundation; NIH; National Cancer Institute of Canada; Canadian Cancer Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084448] Funding Source: NIH RePORTER	Novartis Research Foundation; Swiss Cancer League; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sandler Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. E. Haber, M. Lisby, S. Jinks-Robertson, R. Kolodner, and R. Rothstein for generously providing strains; M. Shales for artwork; K. Saeturn and V. Kalck for technical help; and C. J. Ingles, J. E. Haber, and our laboratories for discussions. We acknowledge the Novartis Research Foundation, Swiss Cancer League, Swiss National Science Foundation, Sandler Family Foundation, NIH, National Cancer Institute of Canada, and Canadian Cancer Society for support.	Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Cobb JA, 2005, GENE DEV, V19, P3055, DOI 10.1101/gad.361805; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Dubrana K, 2007, J CELL SCI, V120, P4209, DOI 10.1242/jcs.018366; Enenkel C, 1999, MOL BIOL REP, V26, P131, DOI 10.1023/A:1006973803960; Freedman JA, 2002, GENETICS, V162, P15; Hediger F, 2004, METHOD ENZYMOL, V375, P345; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Loeillet S, 2005, DNA REPAIR, V4, P459, DOI 10.1016/j.dnarep.2004.11.010; Mullen JR, 2001, GENETICS, V157, P103; Palancade B, 2007, MOL BIOL CELL, V18, P2912, DOI 10.1091/mbc.E07-02-0123; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Soustelle C, 2004, MOL CELL BIOL, V24, P5130, DOI 10.1128/MCB.24.12.5130-5143.2004; Stade K, 2002, J BIOL CHEM, V277, P49554, DOI 10.1074/jbc.M207991200; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Therizols P, 2006, J CELL BIOL, V172, P189, DOI 10.1083/jcb.200505159; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Yang LT, 2006, NUCLEIC ACIDS RES, V34, P5541, DOI 10.1093/nar/gkl685; Zhang CY, 2006, DNA REPAIR, V5, P336, DOI 10.1016/j.dnarep.2005.10.010; Zhao XL, 2004, J CELL BIOL, V167, P605, DOI 10.1083/jcb.200405168	29	327	332	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					597	602		10.1126/science.1162790	http://dx.doi.org/10.1126/science.1162790			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948542	Green Accepted			2022-12-28	WOS:000260299100046
J	Shibata, N; Goto, A; Choi, SY; Mizoguchi, T; Findlay, SD; Yamamoto, T; Ikuhara, Y				Shibata, N.; Goto, A.; Choi, S. -Y.; Mizoguchi, T.; Findlay, S. D.; Yamamoto, T.; Ikuhara, Y.			Direct imaging of reconstructed atoms on TiO(2) (110) surfaces	SCIENCE			English	Article							ELECTRON-MICROSCOPY; RESOLUTION; RUTILE; DESORPTION; REDUCTION; TITANIA	Determining the atomic structures of oxide surfaces is critical for understanding their physical and chemical properties but also challenging because the breaking of atomic bonds in the formation of the surface termination can involve complex reconstructions. We used advanced transmission electron microscopy to directly observe the atomic structure of reduced titania (TiO(2)) (110) surfaces from directions parallel to the surface. In our direct atomic-resolution images, reconstructed titanium atoms at the top surface layer are clearly imaged and are found to occupy the interstitial sites of the TiO(2) structure. Combining observations from two orthogonal directions, the three-dimensional positioning of the Ti interstitials is identified at atomic dimensions and allows a resolution of two previous models that differ in their oxygen stoichiometries.	[Shibata, N.; Goto, A.; Choi, S. -Y.; Mizoguchi, T.; Findlay, S. D.; Yamamoto, T.; Ikuhara, Y.] Univ Tokyo, Inst Engn Innovat, Bunkyo Ku, Tokyo 1138656, Japan; [Shibata, N.] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan; [Yamamoto, T.; Ikuhara, Y.] Japan Fine Ceram Ctr, Nanostruct Res Lab, Atsuta Ku, Nagoya, Aichi 4568587, Japan; [Ikuhara, Y.] Tohoku Univ, World Premier Int Res Ctr, Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Japan Fine Ceramics Center; Tohoku University	Shibata, N (corresponding author), Univ Tokyo, Inst Engn Innovat, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1138656, Japan.	shibata@sigma.t.u-tokyo.ac.jp	Shibata, Naoya/E-5327-2013; Choi, Si-Young/X-8167-2019; Ikuhara, Yuichi/N-1001-2015; Mizoguchi, Teruyasu/B-8044-2008; Findlay, Scott D/C-9764-2013; Ikuhara, Yuichi/F-3066-2010	Choi, Si-Young/0000-0003-1648-142X; Ikuhara, Yuichi/0000-0003-3886-005X; Mizoguchi, Teruyasu/0000-0003-3712-7307; Findlay, Scott D/0000-0003-4862-4827; 	Grant-in-Aid for Scientific Research on Priority Areas Nano Materials Science for Atomic-scale Modification 474; Ministry of Education, Culture, Sports and Technology.; PRESTO, the Japan Science and Technology Agency; Industrial Technology Research Grant Program; New Energy and Industrial Technology Development Organization; Japanese Society for the Promotion of Science fellow	Grant-in-Aid for Scientific Research on Priority Areas Nano Materials Science for Atomic-scale Modification 474(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports and Technology.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO, the Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Industrial Technology Research Grant Program; New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Japanese Society for the Promotion of Science fellow(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank H. Tsunakawa for assistance with HVEM observations. This work was supported in part by the Grant-in-Aid for Scientific Research on Priority Areas Nano Materials Science for Atomic-scale Modification 474 from the Ministry of Education, Culture, Sports and Technology. N.S. acknowledges support from PRESTO, the Japan Science and Technology Agency, and the Industrial Technology Research Grant Program in 2007 from the New Energy and Industrial Technology Development Organization. S.D.F. is supported as a Japanese Society for the Promotion of Science fellow.	Blanco-Rey M, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.081402; Blanco-Rey M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.055502; Bowker M, 2006, CURR OPIN SOLID ST M, V10, P153, DOI 10.1016/j.cossms.2007.03.001; Chiaramonti AN, 2005, J MATER RES, V20, P1619, DOI 10.1557/JMR.2005.0211; COWLEY JM, 1986, PROG SURF SCI, V21, P209, DOI 10.1016/0079-6816(86)90006-7; Deak DS, 2007, MATER SCI TECH-LOND, V23, P127, DOI 10.1179/174328407X154383; Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0; Elliott SD, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.245415; Elliott SD, 2001, PHYS CHEM CHEM PHYS, V3, P1954, DOI 10.1039/b101804n; Henrich V. E., 1994, SURFACE SCI METAL OX; Ii S, 2005, APPL SURF SCI, V241, P68, DOI 10.1016/j.apsusc.2004.09.019; KNOTEK ML, 1978, PHYS REV LETT, V40, P964, DOI 10.1103/PhysRevLett.40.964; Lu Y, 2006, LANGMUIR, V22, P4472, DOI 10.1021/la053509m; Nakamura R, 2005, J PHYS CHEM B, V109, P1648, DOI 10.1021/jp044710t; Onishi H, 1996, PHYS REV LETT, V76, P791, DOI 10.1103/PhysRevLett.76.791; ONISHI H, 1994, SURF SCI, V313, pL783, DOI 10.1016/0039-6028(94)91146-0; Park KT, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.245415; Park K, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.226105; PENNYCOOK SJ, 1991, ULTRAMICROSCOPY, V37, P14, DOI 10.1016/0304-3991(91)90004-P; RAMSIER RD, 1991, SURF SCI REP, V12, P243, DOI 10.1016/0167-5729(91)90013-N; SMITH DJ, 1987, ULTRAMICROSCOPY, V23, P299, DOI 10.1016/0304-3991(87)90239-7; Wendt S, 2008, SCIENCE, V320, P1755, DOI 10.1126/science.1159846	22	109	113	1	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					570	573		10.1126/science.1165044	http://dx.doi.org/10.1126/science.1165044			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948536				2022-12-28	WOS:000260299100038
J	Strasser, BJ				Strasser, Bruno J.			Genetics - GenBank - Natural historyin the 21st century?	SCIENCE			English	Editorial Material							DATABASES		[Strasser, Bruno J.] Yale Univ, Sect Hist Med, New Haven, CT 06520 USA	Yale University	Strasser, BJ (corresponding author), Yale Univ, Sect Hist Med, New Haven, CT 06520 USA.	bruno.strasser@yale.edu	Strasser, Bruno J/E-9337-2012	Strasser, Bruno J./0000-0002-2773-6670				Bidartondo MI, 2008, SCIENCE, V319, P1616, DOI 10.1126/science.319.5870.1616a; COOKDEEGAN R, 1994, GENE WARS SCI POLITI, pCH8; DAYHOFF MO, ARCH NAT BIOM RES FD; Giles J, 2007, NATURE, V445, P691, DOI 10.1038/445691a; *GOAD WB, ARCHAM PHILOS SOC; *NIH, 2005, PUBL COLL DNA RNA SE; Pennisi E, 2008, SCIENCE, V319, P1598, DOI 10.1126/science.319.5870.1598; SANGER F, 1988, ANNU REV BIOCHEM, V57, P1, DOI 10.1146/annurev.bi.57.070188.000245; SMITH TF, 1990, GENOMICS, V6, P701, DOI 10.1016/0888-7543(90)90509-S	9	52	56	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					537	538		10.1126/science.1163399	http://dx.doi.org/10.1126/science.1163399			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948528	Green Published			2022-12-28	WOS:000260299100026
J	Wang, XG; Dong, WR; Xiao, CL; Che, L; Ren, ZF; Dai, DX; Wang, XY; Casavecchia, P; Yang, XM; Jiang, B; Xie, DQ; Sun, ZG; Lee, SY; Zhang, DH; Werner, HJ; Alexander, MH				Wang, Xingan; Dong, Wenrui; Xiao, Chunlei; Che, Li; Ren, Zefeng; Dai, Dongxu; Wang, Xiuyan; Casavecchia, Piergiorgio; Yang, Xueming; Jiang, Bin; Xie, Daiqian; Sun, Zhigang; Lee, Soo-Y.; Zhang, Dong H.; Werner, Hans-Joachim; Alexander, Millard H.			The extent of non-Born-Oppenheimer coupling in the reaction of Cl(P-2) with para-H-2	SCIENCE			English	Article							DIFFERENTIAL CROSS-SECTIONS; HYDROGEN-EXCHANGE REACTION; SPIN-ORBIT; REACTION DYNAMICS; F+H-2 REACTION; STATE; APPROXIMATION; SURFACE; SYSTEM; ATOM	Elementary triatomic reactions offer a compelling test of our understanding of the extent of electron-nuclear coupling in chemical reactions, which is neglected in the widely applied Born-Oppenheimer (BO) approximation. The BO approximation predicts that in reactions between chlorine (Cl) atoms and molecular hydrogen, the excited spin-orbit state (Cl*) should not participate to a notable extent. We report molecular beam experiments, based on hydrogen-atom Rydberg tagging detection, that reveal only a minor role of Cl*. These results are in excellent agreement with fully quantum-reactive scattering calculations based on two sets of ab initio potential energy surfaces. This study resolves a previous disagreement between theory and experiment and confirms our ability to simulate accurately chemical reactions on multiple potential energy surfaces.	[Wang, Xingan; Dong, Wenrui; Xiao, Chunlei; Che, Li; Ren, Zefeng; Dai, Dongxu; Wang, Xiuyan; Casavecchia, Piergiorgio; Yang, Xueming; Sun, Zhigang; Zhang, Dong H.] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Dalian 116023, Peoples R China; [Jiang, Bin; Xie, Daiqian] Nanjing Univ, Inst Theoret & Computat Chem, Key Lab Mesoscop Chem, Minist Educ,Sch Chem & Chem Engn, Nanjing 210093, Peoples R China; [Sun, Zhigang; Lee, Soo-Y.] Nanyang Technol Univ, Sch Phys & Math Sci, Singapore 637371, Singapore; [Werner, Hans-Joachim] Univ Stuttgart, Inst Theoret Chem, D-70569 Stuttgart, Germany; [Alexander, Millard H.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Alexander, Millard H.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Nanjing University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Stuttgart; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Yang, XM (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Dalian 116023, Peoples R China.	xmyang@dicp.ac.cn; dqxie@mail.nju.edu.cn; zhangdh@dicp.ac.cn; mha@umd.edu	Yang, Xueming/C-8764-2013; jiang, bin/F-2391-2014; xiao, chunlei/D-1019-2014; Casavecchia, Piergiorgio/F-4175-2014; Ren, Zefeng/B-1500-2009; Werner, Hans-Joachim/G-9509-2011; Sun, Zhigang/B-5757-2011; Ren, Zefeng/T-2259-2019	jiang, bin/0000-0003-2696-5436; xiao, chunlei/0000-0002-1549-5945; Casavecchia, Piergiorgio/0000-0003-1934-7891; Ren, Zefeng/0000-0002-5263-9346; Werner, Hans-Joachim/0000-0002-0435-539X; 	Chinese Academy of Sciences; National Natural Science Foundation of China [20533060, 20725312]; Ministry of Science and Technology of China; German Fonds der Chemischen Industrie	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); German Fonds der Chemischen Industrie(Fonds der Chemischen Industrie)	X.Y. and D.H.Z. were supported by the Chinese Academy of Sciences, the National Natural Science Foundation of China, and the Ministry of Science and Technology of China. DX was supported by the National Natural Science Foundation of China (20533060 and 20725312). P.C. is grateful to X.Y. and the Dalian Institute of Chemical Physics for a visiting professorship. H.J.W. is grateful to the German Fonds der Chemischen Industrie for financial support.	Alagia M, 1996, SCIENCE, V273, P1519, DOI 10.1126/science.273.5281.1519; Alexander MH, 2004, FARADAY DISCUSS, V127, P59, DOI 10.1039/b314189f; Alexander MH, 2002, SCIENCE, V296, P715, DOI 10.1126/science.1070472; Alexander MH, 2000, J CHEM PHYS, V113, P11084, DOI 10.1063/1.1326850; ALEXANDER MH, 2004, REACTION DYNAMICS, P45; Alexander MH, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2834690; Allison T. C., 1996, GAS PHASE REACTION S, P111; Althorpe SC, 2002, NATURE, V416, P67, DOI 10.1038/416067a; Aoiz FJ, 2005, INT REV PHYS CHEM, V24, P119, DOI 10.1080/01442350500195659; Balucani N, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.013201; Bian WS, 2000, J CHEM PHYS, V112, P220, DOI 10.1063/1.480574; Bowman JM, 2008, SCIENCE, V319, P40, DOI 10.1126/science.1152504; Casavecchia P, 2000, REP PROG PHYS, V63, P355, DOI 10.1088/0034-4885/63/3/203; Casavecchia P, 2005, J PHYS CHEM A, V109, P3527, DOI 10.1021/jp050627+; Che L, 2007, SCIENCE, V317, P1061, DOI 10.1126/science.1144984; DAGDIGIAN PJ, 1987, CHEM REV, V87, P1, DOI 10.1021/cr00077a001; Dong F, 2001, J CHEM PHYS, V115, P1197, DOI 10.1063/1.1378834; Garand E, 2008, SCIENCE, V319, P72, DOI 10.1126/science.1150602; Hu W, 2008, J PHYS CHEM A, V112, P2093, DOI 10.1021/jp076716z; LAIDLER KJ, 1987, CHEM KINETICS, P14; Lee SH, 1999, J CHEM PHYS, V110, P8229, DOI 10.1063/1.478735; Li GL, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2778421; MANOLOPOULOS DE, 1993, SCIENCE, V262, P1852, DOI 10.1126/science.262.5141.1852; Parsons BF, 2006, EUR PHYS J D, V38, P15, DOI 10.1140/epjd/e2006-00018-2; Qiu MH, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1960718; Qiu MH, 2006, SCIENCE, V311, P1440, DOI 10.1126/science.1123452; Schnieder L, 1997, J CHEM PHYS, V107, P6175, DOI 10.1063/1.474283; Skouteris D, 1999, SCIENCE, V286, P1713, DOI 10.1126/science.286.5445.1713; Skouteris D, 2001, J CHEM PHYS, V114, P10662, DOI 10.1063/1.1372764; Stark K, 1996, J CHEM PHYS, V104, P6515, DOI 10.1063/1.471372; Werner HJ, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2822905	31	92	93	9	215	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					573	576		10.1126/science.1163195	http://dx.doi.org/10.1126/science.1163195			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948537				2022-12-28	WOS:000260299100039
J	Chung, M; Raman, G; Trikalinos, T; Lau, J; Ip, S				Chung, Mei; Raman, Gowri; Trikalinos, Thomas; Lau, Joseph; Ip, Stanley			Interventions in Primary Care to Promote Breastfeeding: An Evidence Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED-CONTROLLED-TRIAL; EPITHELIAL OVARIAN-CANCER; LACTATION CONSULTANT INTERVENTION; ENVIRONMENTAL RISK-FACTORS; TO-SKIN CONTACT; REPRODUCTIVE FACTORS; DIABETES-MELLITUS; LATER LIFE; COGNITIVE-DEVELOPMENT; SUPPORT PROGRAM	Background: Evidence suggests that breastfeeding decreases the risk for many diseases in mothers and infants. It is therefore important to evaluate the effectiveness of breastfeeding interventions. Purpose: To systematically review evidence for the effectiveness of primary care-initiated interventions to promote breastfeeding with respect to breastfeeding and child and maternal health outcomes. Data Sources: Electronic searches of MEDLINE, the Cochrane Central Register of Controlled Trials, and CINAHL from September 2001 to February 2008 and references of selected articles, restricted to English-language publications. Study Selection: Randomized, controlled trials of primary care initiated interventions to promote breastfeeding, mainly in developed countries. Data Extraction: Characteristics of interventions and comparators, study setting, study design, population characteristics, the proportion of infants continuing breastfeeding by different durations, and infant or maternal health outcomes were recorded. Data Synthesis: Thirty-eight randomized, controlled trials ( 36 in developed countries) met eligibility criteria. In random-effects meta-analyses, breastfeeding promotion interventions in developed countries resulted in significantly increased rates of short- ( 1 to 3 months) and long-term ( 6 to 8 months) exclusive breastfeeding ( rate ratios, 1.28 [ 95% CI, 1.11 to 1.48] and 1.44 [ CI, 1.13 to 1.84], respectively). In subgroup analyses, combining pre- and postnatal breastfeeding interventions had a larger effect on increasing breastfeeding durations than either pre- or postnatal interventions alone. Furthermore, breastfeeding interventions with a component of lay support ( such as peer support or peer counseling) were more effective than usual care in increasing the short- term breastfeeding rate. Limitations: Meta-analyses were limited by clinical and methodological heterogeneity. Reliable estimates for the isolated effects of each component of multicomponent interventions could not be obtained. Conclusion: Evidence suggests that breastfeeding interventions are more effective than usual care in increasing short- and long-term breastfeeding rates. Combined pre- and postnatal interventions and inclusion of lay support in a multicomponent intervention may be beneficial.	Tufts Univ New England Med Ctr, Evidence Based Practice Ctr, Boston, MA USA	Tufts Medical Center	Chung, M (corresponding author), Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Clin Evidence Synth, 800 Washington St,Box 63, Boston, MA 02111 USA.	mchung1@tuftsmedicalcenter.org	Sandall, Jane/D-4146-2009; Trikalinos, Thomas A/A-1217-2009	Sandall, Jane/0000-0003-2000-743X; 	U. S. Department of Health and Human Services [290-02-0022]	U. S. Department of Health and Human Services	Grant Support: From the Agency for Healthcare Research and Quality, U. S. Department of Health and Human Services ( contract no. 290-02-0022).	Agostoni C, 2001, ADV EXP MED BIOL, V501, P137; ALDERMAN BW, 1986, AM J EPIDEMIOL, V124, P262, DOI 10.1093/oxfordjournals.aje.a114384; Alho OP, 1996, J CLIN EPIDEMIOL, V49, P9, DOI 10.1016/0895-4356(95)00538-2; *AM AC PED, 2004, PED NUTR HDB; Anderson AK, 2005, ARCH PEDIAT ADOL MED, V159, P836, DOI 10.1001/archpedi.159.9.836; Angelsen NK, 2001, ARCH DIS CHILD, V85, P183, DOI 10.1136/adc.85.3.183; Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; Bachrach VRG, 2003, ARCH PEDIAT ADOL MED, V157, P237, DOI 10.1001/archpedi.157.3.237; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; BERKEY CS, 1995, STAT MED, V14, P395, DOI 10.1002/sim.4780140406; Bernier MO, 2000, HUM REPROD UPDATE, V6, P374, DOI 10.1093/humupd/6.4.374; Bonuck KA, 2005, PEDIATRICS, V116, P1413, DOI 10.1542/peds.2005-0435; Bonuck KA, 2006, ARCH PEDIAT ADOL MED, V160, P953, DOI 10.1001/archpedi.160.9.953; Britton C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001141.pub3; Brooke H, 1997, BMJ-BRIT MED J, V314, P1516, DOI 10.1136/bmj.314.7093.1516; Burgess SW, 2006, PEDIATRICS, V117, pE787, DOI 10.1542/peds.2005-1753; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Carfoot S, 2005, MIDWIFERY, V21, P71, DOI 10.1016/j.midw.2004.09.002; Carfoot S, 2004, MIDWIFERY, V20, P188, DOI 10.1016/j.midw.2003.11.002; Chan HHL, 1996, OSTEOPOROSIS INT, V6, P228, DOI 10.1007/BF01622739; Chapman D, 2004, ADV EXP MED BIOL, V554, P303; Chaudron LH, 2001, J PSYCHOSOM OBST GYN, V22, P103, DOI 10.3109/01674820109049960; Chen AM, 2004, PEDIATRICS, V113, pE435, DOI 10.1542/peds.113.5.e435; Chiaffarino F, 2005, GYNECOL ONCOL, V98, P304, DOI 10.1016/j.ygyno.2005.05.006; Chien PFW, 2001, ADV NUTR RES, V10, P69; CHUNG M, 2008, AHRQ PUBLICATION; Cohen R, 1994, Am J Health Promot, V8, P436; COOPER PJ, 1993, J PSYCHOSOM RES, V37, P171, DOI 10.1016/0022-3999(93)90084-S; Coutinho SB, 2005, LANCET, V366, P1094, DOI 10.1016/S0140-6736(05)67421-1; CUMMING RG, 1993, INT J EPIDEMIOL, V22, P684, DOI 10.1093/ije/22.4.684; Dahlquist G, 2002, DIABETES CARE, V25, P1755; Dennis CL, 2002, CAN MED ASSOC J, V166, P21; Der G, 2006, BMJ-BRIT MED J, V333, P945, DOI 10.1136/bmj.38978.699583.55; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Napoli A, 2004, ACTA PAEDIATR, V93, P1108, DOI [10.1111/j.1651-2227.2004.tb02725.x, 10.1080/08035250410028525]; Duffy LC, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.4.e7; DUNCAN B, 1993, PEDIATRICS, V91, P867; Ekstrom A, 2006, PEDIATRICS, V118, pE309, DOI 10.1542/peds.2005-2064; Ekstrom A, 2006, BIRTH-ISS PERINAT C, V33, P123, DOI 10.1111/j.0730-7659.2006.00089.x; Finch C, 2002, J AM DIET ASSOC, V102, P981, DOI 10.1016/S0002-8223(02)90224-5; Fleming PJ, 1996, BMJ-BRIT MED J, V313, P191, DOI 10.1136/bmj.313.7051.191; Forster D, 2004, BIRTH-ISS PERINAT C, V31, P176, DOI 10.1111/j.0730-7659.2004.00302.x; Gagnon AJ, 2002, PEDIATRICS, V109, P1074, DOI 10.1542/peds.109.6.1074; Gammon MD, 2002, BREAST CANCER RES TR, V74, P235, DOI 10.1023/A:1016387020854; Gdalevich M, 2001, J PEDIATR-US, V139, P261, DOI 10.1067/mpd.2001.117006; Gdalevich M, 2001, J AM ACAD DERMATOL, V45, P520, DOI 10.1067/mjd.2001.114741; GERSTEIN HC, 1994, DIABETES CARE, V17, P13, DOI 10.2337/diacare.17.1.13; Graffy J, 2004, BRIT MED J, V328, P26, DOI 10.1136/bmj.328.7430.26; Greggi S, 2000, GYNECOL ONCOL, V79, P50, DOI 10.1006/gyno.2000.5909; Grummer-Strawn Laurence M, 2004, Pediatrics, V113, pe81, DOI 10.1542/peds.113.2.e81; Guise Jeanne-Marie, 2003, Ann Fam Med, V1, P70, DOI 10.1370/afm.56; HANNAH P, 1992, BRIT J PSYCHIAT, V160, P777, DOI 10.1192/bjp.160.6.777; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; HARTGE P, 1989, AM J OBSTET GYNECOL, V161, P10, DOI 10.1016/0002-9378(89)90221-4; Henderson A, 2001, BIRTH-ISS PERINAT C, V28, P236, DOI 10.1046/j.1523-536X.2001.00236.x; Henderson JJ, 2003, BIRTH-ISS PERINAT C, V30, P175, DOI 10.1046/j.1523-536X.2003.00242.x; Higgins JPT, 2001, STAT MED, V20, P2219, DOI 10.1002/sim.918; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOFFMAN S, 1993, OSTEOPOROSIS INT, V3, P171, DOI 10.1007/BF01623672; Howard CR, 2003, PEDIATRICS, V111, P511, DOI 10.1542/peds.111.3.511; Ip Stanley, 2007, Evid Rep Technol Assess (Full Rep), P1; Janney CA, 1997, AM J CLIN NUTR, V66, P1116, DOI 10.1093/ajcn/66.5.1116; Jernstrom H, 2004, JNCI-J NATL CANCER I, V96, P1094, DOI 10.1093/jnci/djh211; Jones ME, 1998, INT J EPIDEMIOL, V27, P444, DOI 10.1093/ije/27.3.444; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Kools EJ, 2005, PREV MED, V40, P60, DOI 10.1016/j.ypmed.2004.05.013; Kramer MS, 2001, JAMA-J AM MED ASSOC, V286, P322, DOI 10.1001/jama.286.3.322; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; KREIGER N, 1982, AM J EPIDEMIOL, V116, P141, DOI 10.1093/oxfordjournals.aje.a113388; Kronborg H, 2007, ACTA PAEDIATR, V96, P1064, DOI 10.1111/j.1651-2227.2007.00341.x; Kull I, 2004, J ALLERGY CLIN IMMUN, V114, P755, DOI 10.1016/j.jaci.2004.07.036; Kwan ML, 2004, PUBLIC HEALTH REP, V119, P521, DOI 10.1016/j.phr.2004.09.002; Labarere J, 2005, PEDIATRICS, V115, pE139, DOI 10.1542/peds.2004-1362; Labarere J, 2003, BJOG-INT J OBSTET GY, V110, P847, DOI 10.1111/j.1471-0528.2003.02539.x; Lavender T, 2005, BJOG-INT J OBSTET GY, V112, P1047, DOI 10.1111/j.1471-0528.2005.00644.x; Lawlor DA, 2006, PAEDIATR PERINAT EP, V20, P148, DOI 10.1111/j.1365-3016.2006.00704.x; Lee SY, 2003, INT J CANCER, V105, P390, DOI 10.1002/ijc.11078; Li RW, 2005, PEDIATRICS, V115, pE31, DOI 10.1542/peds.2004-0481; Martin RM, 2005, AM J EPIDEMIOL, V161, P15, DOI 10.1093/aje/kwh338; Martin RM, 2004, EUR HEART J, V25, P778, DOI 10.1016/j.ehj.2004.02.006; Mattar CN, 2007, OBSTET GYNECOL, V109, P73, DOI 10.1097/01.AOG.0000249613.15466.26; McKeever P, 2002, BIRTH-ISS PERINAT C, V29, P258, DOI 10.1046/j.1523-536X.2002.00200.x; McKinney PA, 1999, DIABETES CARE, V22, P928, DOI 10.2337/diacare.22.6.928; McLeod D, 2004, MIDWIFERY, V20, P37, DOI 10.1016/S0266-6138(03)00051-2; Meloni T, 1997, DIABETES CARE, V20, P340, DOI 10.2337/diacare.20.3.340; Michaelsson K, 2001, AM J EPIDEMIOL, V153, P1166, DOI 10.1093/aje/153.12.1166; MITCHELL EA, 1992, J PAEDIATR CHILD H, V28, pS3, DOI 10.1111/j.1440-1754.1992.tb02729.x; Mitchell EA, 1997, PEDIATRICS, V100, P835, DOI 10.1542/peds.100.5.835; Mizuno K, 2004, ACTA PAEDIATR, V93, P1640, DOI 10.1080/08035250410023115; Modugno F, 2001, ANN EPIDEMIOL, V11, P568, DOI 10.1016/S1047-2797(01)00213-7; Moore ER, 2007, J MIDWIFERY WOM HEAL, V52, P116, DOI 10.1016/j.jmwh.2006.12.002; Mortensen EL, 2002, JAMA-J AM MED ASSOC, V287, P2365, DOI 10.1001/jama.287.18.2365; Muirhead PE, 2006, BRIT J GEN PRACT, V56, P191; Ness RB, 2000, EPIDEMIOLOGY, V11, P111, DOI 10.1097/00001648-200003000-00006; Noel-Weiss J, 2006, JOGNN-J OBST GYN NEO, V35, P616, DOI 10.1111/J.1552-6909.2006.00077.x; Norris JM, 1996, EPIDEMIOLOGY, V7, P87, DOI 10.1097/00001648-199601000-00015; Oddy WH, 2003, PAEDIATR PERINAT EP, V17, P81, DOI 10.1046/j.1365-3016.2003.00464.x; Olson CM, 2003, INT J OBESITY, V27, P117, DOI 10.1038/sj.ijo.0802156; Owen CG, 2003, BMJ-BRIT MED J, V327, P1189, DOI 10.1136/bmj.327.7425.1189; Owen CG, 2006, AM J CLIN NUTR, V84, P1043, DOI 10.1093/ajcn/84.5.1043; Philipp BL, 2001, PEDIATRICS, V108, P677, DOI 10.1542/peds.108.3.677; Pugh LC, 2002, BIRTH-ISS PERINAT C, V29, P95, DOI 10.1046/j.1523-536X.2002.00169.x; Quinlivan JA, 2003, LANCET, V361, P893, DOI 10.1016/S0140-6736(03)12770-5; Quinn PJ, 2001, J PAEDIATR CHILD H, V37, P465, DOI 10.1046/j.1440-1754.2001.00702.x; Riman T, 2002, AM J EPIDEMIOL, V156, P363, DOI 10.1093/aje/kwf048; Ryser FG, 2004, J HUM LACT, V20, P300, DOI 10.1177/0890334404266985; Scariati PD, 1997, PEDIATRICS, V99, DOI 10.1542/peds.99.6.e5; Schlickau J, 2005, J PERINAT EDUC, V14, P24, DOI 10.1624/105812405X72302; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Seimyr L, 2004, J PSYCHOSOM OBST GYN, V25, P23, DOI 10.1080/01674820410001737414; SHEALY KR, 2005, CDC GUIDE BREASTFEED; Sichieri R, 2003, INT J OBESITY, V27, P815, DOI 10.1038/sj.ijo.0802285; Siskind V, 1997, EPIDEMIOLOGY, V8, P188, DOI 10.1097/00001648-199703000-00011; Stuebe AM, 2005, JAMA-J AM MED ASSOC, V294, P2601, DOI 10.1001/jama.294.20.2601; Su LL, 2007, BMJ-BRIT MED J, V335, P596, DOI 10.1136/bmj.39279.656343.55; Tai TY, 1998, DIABETES RES CLIN PR, V42, P197, DOI 10.1016/S0168-8227(98)00105-3; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Titus-Ernstoff L, 2001, BRIT J CANCER, V84, P714, DOI 10.1054/bjoc.2000.1596; Tung KH, 2003, AM J EPIDEMIOL, V158, P629, DOI 10.1093/aje/kwg177; U.S. Preventive Services Task Force, 2003, GUID CLIN PREV SERV; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; Vennemann MMT, 2005, ACTA PAEDIATR, V94, P655, DOI 10.1080/08035250410024231; Visalli N, 2003, ARCH DIS CHILD, V88, P695, DOI 10.1136/adc.88.8.695; Wallace LM, 2006, MIDWIFERY, V22, P262, DOI 10.1016/j.midw.2005.06.004; Warner R, 1996, BRIT J PSYCHIAT, V168, P607, DOI 10.1192/bjp.168.5.607; Wennergren G, 1997, ACTA PAEDIATR, V86, P963, DOI 10.1111/j.1651-2227.1997.tb15180.x; *WHO, 2004, BAB FRIENDL HOSP IN; Wilhelm SL, 2006, JOGNN-J OBST GYN NEO, V35, P340, DOI 10.1111/j.1552-6909.2006.00046.x; Winterburn S, 2003, J COMMUNITY NURSING, V17, P4; Wolfberg AJ, 2004, AM J OBSTET GYNECOL, V191, P708, DOI 10.1016/j.ajog.2004.05.019; Wright AL, 2001, THORAX, V56, P192, DOI 10.1136/thorax.56.3.192; Yen ML, 2003, GYNECOL ONCOL, V89, P318, DOI 10.1016/S0090-8258(03)00088-X	133	141	151	2	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2008	149	8					565	W111		10.7326/0003-4819-149-8-200810210-00009	http://dx.doi.org/10.7326/0003-4819-149-8-200810210-00009			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367XJ	18936504				2022-12-28	WOS:000260585600006
J	Kim, CS; Werner-Wasik, M				Kim, Catherine S.; Werner-Wasik, Maria			Lymphadenopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kim, Catherine S.; Werner-Wasik, Maria] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA	Jefferson University	Kim, CS (corresponding author), Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA.	cskim003@yahoo.com							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2008	359	15					1602	1602		10.1056/NEJMicm071065	http://dx.doi.org/10.1056/NEJMicm071065			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FS	18843124				2022-12-28	WOS:000259903100009
J	Korup, O; Montgomery, DR				Korup, Oliver; Montgomery, David R.			Tibetan plateau river incision inhibited by glacial stabilization of the Tsangpo gorge	NATURE			English	Article							LANDSLIDE; HIMALAYAS; EROSION; MORAINE; GROWTH; ICE	A considerable amount of research has focused on how and when the Tibetan plateau formed in the wake of tectonic convergence between India and Asia(1). Although far less enquiry has addressed the controls on river incision into the plateau itself(2), widely accepted theory(3) predicts that steep fluvial knick points ( river reaches with very steep gradients) in the eastern Himalayan syntaxis at the southeastern plateau margin should erode rapidly(4), driving a wave of incision back into the plateau. Preservation of the plateau edge thus presents something of a conundrum that may be resolved by invoking either differential rock uplift matching erosional decay(5-7), or other mechanisms for retarding bedrock river incision(8,9) in this region where high stream power excludes the potential for aridity as a simple limit to dissection of the plateau(10). Here we report morphologic evidence showing that Quaternary depression of the regional equilibrium line altitude, where long-term glacier mass gain equals mass loss, was sufficient to repeatedly form moraine dams on major rivers: such damming substantially impeded river incision into the southeastern edge of the Tibetan plateau through the coupled effects of upstream impoundment and interglacial aggradation. Such glacial stabilization of the resulting highly focused river incision centred on the Tsangpo gorge could further contribute to initiating and accentuating a locus of rapid exhumation, known as tectonic anaeurysm(6).	[Korup, Oliver] Swiss Fed Res Inst WSL SLF, CH-7260 Davos, Switzerland; [Montgomery, David R.] Univ Washington, Quaternary Res Ctr, Dept Earth & Space Sci, Seattle, WA 98195 USA	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Washington; University of Washington Seattle	Korup, O (corresponding author), Swiss Fed Res Inst WSL SLF, Fluelastr 11, CH-7260 Davos, Switzerland.	korup@slf.ch		Korup, Oliver/0000-0002-9084-1895	EU-FP6 [081412 IRASMOS]; Continental Dynamics Program of the US National Science Foundation [EAR-0003561]	EU-FP6(European Commission); Continental Dynamics Program of the US National Science Foundation	O.K. was partly supported by EU-FP6 contract 081412 IRASMOS. D.R.M. acknowledges support from the Continental Dynamics Program of the US National Science Foundation (EAR-0003561). We thank H. Greenberg for assistance in figure drafting. Reviews by D. Burbank and L. Owen helped improve an earlier manuscript.	Anders AM, 2006, GEOL SOC AM SPEC PAP, V398, P39, DOI 10.1130/2006.2398(03); Anderson RS, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000344; [Anonymous], 2001, GSA TODAY, DOI [10.1130/1052-5173(2001)0112.0.CO;2, DOI 10.1130/1052-5173(2001)011<0004:EHGATG>2.0.C0;2]; Bendick R, 2001, GEOLOGY, V29, P791, DOI 10.1130/0091-7613(2001)029<0791:HPITHA>2.0.CO;2; BENN DI, 2002, QUATERN INT, V65, P15; Brummer CJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR001981; Clague JJ, 2000, QUATERNARY SCI REV, V19, P1763, DOI 10.1016/S0277-3791(00)00090-1; Cruden D., 1996, LANDSLIDES INVESTIGA, P36; Finlayson DP, 2002, GEOLOGY, V30, P219, DOI 10.1130/0091-7613(2002)030<0219:SCORIE>2.0.CO;2; Finnegan NJ, 2008, GEOL SOC AM BULL, V120, P142, DOI 10.1130/B26224.1; Garzanti E, 2004, EARTH PLANET SC LETT, V220, P157, DOI 10.1016/S0012-821X(04)00035-4; Geng XY., 2005, J MT SCI-ENGL, V2, P155, DOI DOI 10.1007/BF02918331; Harkins N, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000570; HEWITT K, 1988, SCIENCE, V242, P64, DOI 10.1126/science.242.4875.64; Korup O, 2006, GEOLOGY, V34, P45, DOI 10.1130/G21959.1; Korup O, 2007, QUATERNARY SCI REV, V26, P3406, DOI 10.1016/j.quascirev.2007.10.012; Korup O, 2006, GEOMORPHOLOGY, V78, P3, DOI 10.1016/j.geomorph.2006.01.020; Lave J, 2001, J GEOPHYS RES-SOL EA, V106, P26561, DOI 10.1029/2001JB000359; Lliboutry L., 1977, J GLACIOL, V18, P239, DOI DOI 10.1017/S002214300002133X; Mitchell SG, 2006, QUATERNARY RES, V65, P96, DOI 10.1016/j.yqres.2005.08.018; Montgomery DR, 2004, QUATERNARY RES, V62, P201, DOI 10.1016/j.yqres.2004.06.008; Ouimet WB, 2007, GEOL SOC AM BULL, V119, P1462, DOI 10.1130/B26136.1; Owen LA, 2005, QUATERN INT, V138, P55, DOI 10.1016/j.quaint.2005.02.006; Seward D, 2008, TECTONOPHYSICS, V451, P282, DOI 10.1016/j.tecto.2007.11.057; Shang YJ, 2003, GEOMORPHOLOGY, V54, P225, DOI 10.1016/S0169-555X(02)00358-6; Shi B, 2002, J AM LEATHER CHEM AS, V97, P98; Sobel ER, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001883; Su Z, 2002, QUATERN INT, V97-8, P123, DOI 10.1016/S1040-6182(02)00057-5; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Whipple KX, 2004, ANNU REV EARTH PL SC, V32, P151, DOI 10.1146/annurev.earth.32.101802.120356; Yang B, 2008, GLOBAL PLANET CHANGE, V60, P126, DOI 10.1016/j.gloplacha.2006.07.035	32	152	181	6	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2008	455	7214					786	U4		10.1038/nature07322	http://dx.doi.org/10.1038/nature07322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18843366				2022-12-28	WOS:000259854900044
J	Konig, R; Zhou, YY; Elleder, D; Diamond, TL; Bonamy, GMC; Irelan, JT; Chiang, CY; Tu, BP; De Jesus, PD; Lilley, CE; Seidel, S; Opaluch, AM; Caldwell, JS; Weitzman, MD; Kuhen, KL; Bandyopadhyay, S; Ideker, T; Orth, AP; Miraglia, LJ; Bushman, FD; Young, JA; Chanda, SK				Konig, Renate; Zhou, Yingyao; Elleder, Daniel; Diamond, Tracy L.; Bonamy, Ghislain M. C.; Irelan, Jeffrey T.; Chiang, Chih-Yuan; Tu, Buu P.; De Jesus, Paul D.; Lilley, Caroline E.; Seidel, Shannon; Opaluch, Amanda M.; Caldwell, Jeremy S.; Weitzman, Matthew D.; Kuhen, Kelli L.; Bandyopadhyay, Sourav; Ideker, Trey; Orth, Anthony P.; Miraglia, Loren J.; Bushman, Frederic D.; Young, John A.; Chanda, Sumit K.			Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication	CELL			English	Article							DNA INTEGRATION; NUCLEAR IMPORT; VIRUS; TRANSCRIPTION; COMPLEX; CHROMATIN	Human Immunodeficiency Viruses (HIV-1 and HIV-2) rely upon host-encoded proteins to facilitate their replication. Here, we combined genome-wide siRNA analyses with interrogation of human interactome databases to assemble a host-pathogen biochemical network containing 213 confirmed host cellular factors and 11 HIV-1-encoded proteins. Protein complexes that regulate ubiquitin conjugation, proteolysis, DNA-damage response, and RNA splicing were identified as important modulators of early-stage HIV-1 infection. Additionally, over 40 new factors were shown to specifically influence the initiation and/or kinetics of HIV-1 DNA synthesis, including cytoskeletal regulatory proteins, modulators of post-translational modification, and nucleic acid-binding proteins. Finally, 15 proteins with diverse functional roles, including nuclear transport, prostaglandin synthesis, ubiquitination, and transcription, were found to influence nuclear import or viral DNA integration. Taken together, the multiscale approach described here has uncovered multiprotein virus-host interactions that likely act in concert to facilitate the early steps of HIV-1 infection.	[Elleder, Daniel; Seidel, Shannon; Young, John A.] Salk Inst Biol Studies, Infect Dis Lab, La Jolla, CA 92037 USA; [Konig, Renate; De Jesus, Paul D.; Opaluch, Amanda M.; Chanda, Sumit K.] Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Lilley, Caroline E.; Weitzman, Matthew D.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Bandyopadhyay, Sourav; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92037 USA; [Diamond, Tracy L.; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Zhou, Yingyao; Bonamy, Ghislain M. C.; Irelan, Jeffrey T.; Chiang, Chih-Yuan; Tu, Buu P.; Caldwell, Jeremy S.; Kuhen, Kelli L.; Orth, Anthony P.; Miraglia, Loren J.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Bonamy, Ghislain M. C.] Hudson Alpha Inst Biotechnol, Huntsville, AL 35801 USA	Salk Institute; Sanford Burnham Prebys Medical Discovery Institute; Salk Institute; University of California System; University of California San Diego; University of Pennsylvania; Novartis	Young, JA (corresponding author), Salk Inst Biol Studies, Infect Dis Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jyoung@salk.edu; schanda@burnham.org	Elleder, Daniel/G-3551-2014; König, Renate/AAB-8918-2019	König, Renate/0000-0003-4882-9179; Ideker, Trey/0000-0002-1708-8454; Bushman, Frederic/0000-0003-4740-4056; Bonamy, Ghislain/0000-0002-2826-5225	United States National Institutes of Health [1 RO1 AI072645-01, RO1 AI052845]; University of Pennsylvania Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072645, R01AI052845] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Tracy L. Diamond is a Leukemia and Lymphoma Society Fellow (Grant #5217-06). We thank U. O'Doherty and J.J. Yu for technical advice with the Alu-PCR assay and Zhang J. for excellent technical assistance; Walter Tian and Eric Lader (Qiagen GMBGH) for facilitating the acquisition of reagents used for this study; and John Hogenesch for critical feedback on the manuscript. This work was supported by a grant from the United States National Institutes of Health (1 RO1 AI072645-01 to J.A.Y. and RO1 AI052845 to F.D.B.) and the University of Pennsylvania Center for AIDS Research.	Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cartier C, 2003, J BIOL CHEM, V278, P35211, DOI 10.1074/jbc.M301257200; Ciuffi A, 2006, TRENDS GENET, V22, P388, DOI 10.1016/j.tig.2006.05.006; De Rijck J, 2007, BIOESSAYS, V29, P441, DOI 10.1002/bies.20561; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Gomez PF, 2005, J IMMUNOL, V175, P6924, DOI 10.4049/jimmunol.175.10.6924; Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.e03-10-0743; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Kuraoka I, 2008, J BIOL CHEM, V283, P940, DOI 10.1074/jbc.M706647200; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Luban J, 2007, J VIROL, V81, P1054, DOI 10.1128/JVI.01519-06; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; Mannioui A, 2004, VIROLOGY, V329, P77, DOI 10.1016/j.virol.2004.08.022; Mukherji M, 2006, P NATL ACAD SCI USA, V103, P14819, DOI 10.1073/pnas.0604320103; Naghavi MH, 2007, EMBO J, V26, P41, DOI 10.1038/sj.emboj.7601475; Nisole Sebastien, 2004, Retrovirology, V1, P9, DOI 10.1186/1742-4690-1-9; Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Schwartz O, 1998, J VIROL, V72, P3845, DOI 10.1128/JVI.72.5.3845-3850.1998; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Xu C, 2006, J BIOL CHEM, V281, P15900, DOI 10.1074/jbc.M511155200; Yueh A, 2006, J VIROL, V80, P342, DOI 10.1128/JVI.80.1.342-352.2006; Zar JH., 1999, BIOSTAT ANAL, V663rd	33	760	788	0	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					49	60		10.1016/j.cell.2008.07.032	http://dx.doi.org/10.1016/j.cell.2008.07.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854154	Bronze, Green Accepted			2022-12-28	WOS:000259728100008
J	Whitson, JA; Galinsky, AD				Whitson, Jennifer A.; Galinsky, Adam D.			Lacking control increases illusory pattern perception	SCIENCE			English	Article							SELF-AFFIRMATION; CAUSAL ATTRIBUTION; HELPLESSNESS; EVENTS; DESIRE	We present six experiments that tested whether lacking control increases illusory pattern perception, which we define as the identification of a coherent and meaningful interrelationship among a set of random or unrelated stimuli. Participants who lacked control were more likely to perceive a variety of illusory patterns, including seeing images in noise, forming illusory correlations in stock market information, perceiving conspiracies, and developing superstitions. Additionally, we demonstrated that increased pattern perception has a motivational basis by measuring the need for structure directly and showing that the causal link between lack of control and illusory pattern perception is reduced by affirming the self. Although these many disparate forms of pattern perception are typically discussed as separate phenomena, the current results suggest that there is a common motive underlying them.	[Whitson, Jennifer A.] Univ Texas Austin, Dept Management, Austin, TX 78712 USA; [Galinsky, Adam D.] Northwestern Univ, Dept Management & Org, Evanston, IL 60208 USA	University of Texas System; University of Texas Austin; Northwestern University	Whitson, JA (corresponding author), Univ Texas Austin, Dept Management, Austin, TX 78712 USA.	jennifer.whitson@mccombs.utexas.edu	sarinopoulos, isidoros/B-5453-2010		Kellogg School of Managemen	Kellogg School of Managemen	This work benefited from the generous financial support of the Dean's office of the Kellogg School of Management. We thank C. Appleton, K. Dover-Taylor, L. Howland, and A. Marfia for research help. The research was based in part on the doctoral dissertation submitted by J.W. to Northwestern University and has benefited from the comments of the committee members W. Gardner, V. Medvec, and K. Murnighan. We also thank L. Egan, Z. Kinias, G. Ku, K. Liljenquist, L. Nordgren, N. Sivanathan, C. Wang, and C. Zhong for their helpful comments.	Brehm J.W., 1966, THEORY PSYCHOL REACT; BRUNER JS, 1947, J ABNORM SOC PSYCH, V42, P33, DOI 10.1037/h0058484; BURGER JM, 1988, J PERS, V56, P531, DOI 10.1111/j.1467-6494.1988.tb00901.x; CLARY EG, 1983, PERS SOC PSYCHOL B, V9, P609, DOI 10.1177/0146167283094010; Cohen S., 1986, BEHAV HLTH ENV STRES; deCharms R., 1969, PERSONAL CAUSATION; Ekstrom R.B., 1976, MANUAL KIT FACTOR RE; GLASS DC, 1972, AM SCI, V60, P457; GLASS DC, 1973, J PERS, V41, P576, DOI 10.1111/j.1467-6494.1973.tb00112.x; GMELCH G, 1971, T ACTION, V9, P39; HASTIE R, 1984, J PERS SOC PSYCHOL, V46, P44, DOI 10.1037/0022-3514.46.1.44; KANAZAWA S, 1992, PERS SOC PSYCHOL B, V18, P659, DOI 10.1177/0146167292186001; Kelley HH., 1971, ATTRIBUTION SOCIAL I; KLEIN DC, 1976, J PERS SOC PSYCHOL, V33, P508, DOI 10.1037/0022-3514.33.5.508; Koole SL, 1999, J PERS SOC PSYCHOL, V77, P111, DOI 10.1037/0022-3514.77.1.111; KRAMER RM, 1994, MOTIV EMOTION, V18, P199, DOI 10.1007/BF02249399; Levine R, 1942, J PSYCHOL, V13, P283, DOI 10.1080/00223980.1942.9917096; LIU TJ, 1986, J PERS SOC PSYCHOL, V51, P531, DOI 10.1037/0022-3514.51.3.531; Luck A, 1999, LANCET, V354, P2032, DOI 10.1016/S0140-6736(98)10495-6; Malinowski Bronislaw, 1948, MAGIC SCI RELIG OTHE; NEUBERG SL, 1993, J PERS SOC PSYCHOL, V65, P113, DOI 10.1037/0022-3514.65.1.113; Pipes Daniel, 1997, CONSPIRACY PARANOID; PITTMAN NL, 1979, J PERS SOC PSYCHOL, V37, P39, DOI 10.1037/0022-3514.37.1.39; PITTMAN TS, 1980, J PERS SOC PSYCHOL, V39, P377, DOI 10.1037/0022-3514.39.3.377; PYSZCZYNSKI TA, 1981, J PERS SOC PSYCHOL, V40, P31, DOI 10.1037/0022-3514.40.1.31; Rosenthal R., 2008, ESSENTIALS BEHAV RES; SALES SM, 1973, J PERS SOC PSYCHOL, V28, P44, DOI 10.1037/h0035588; SIMONOV PV, 1977, AVIAT SPACE ENVIR MD, V48, P856; STEELE CM, 1983, J PERS SOC PSYCHOL, V45, P5, DOI 10.1037/0022-3514.45.1.5; WEINER B, 1985, PSYCHOL BULL, V97, P74, DOI 10.1037/0033-2909.97.1.74; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; WHITE RW, 1959, PSYCHOL REV, V66, P297, DOI 10.1037/h0040934	32	569	591	16	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2008	322	5898					115	117		10.1126/science.1159845	http://dx.doi.org/10.1126/science.1159845			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	355AE	18832647				2022-12-28	WOS:000259680200050
J	Aringer, M; Graessler, J				Aringer, Martin; Graessler, Juergen			Understanding deficient elimination of uric acid	LANCET			English	Editorial Material							SERUM URATE; GOUT; ASSOCIATION; EXCRETION		[Aringer, Martin; Graessler, Juergen] Tech Univ Dresden, Univ Clin Ctr Carl Gustav Carus, D-01307 Dresden, Germany	Technische Universitat Dresden	Aringer, M (corresponding author), Tech Univ Dresden, Univ Clin Ctr Carl Gustav Carus, D-01307 Dresden, Germany.	martin.aringer@uniklinikum-dresden.de	Aringer, Martin/AAJ-7641-2020	Aringer, Martin/0000-0003-4471-8375				Becker MA, 2005, ARTHRITIS RHEUM, V52, P916, DOI 10.1002/art.20935; DEHGHAN A, 2008, LANCET          1001, DOI DOI 10.1016/S0140-6736(08)61343-4; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Graessler J, 2006, ARTHRITIS RHEUM, V54, P292, DOI 10.1002/art.21499; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Pechey J., 1717, WHOLE WORKS EXCELLEN, P341; Sundy JS, 2007, ARTHRITIS RHEUM-US, V56, P1021, DOI 10.1002/art.22403; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269	11	7	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 6	2008	372	9654					1929	1930		10.1016/S0140-6736(08)61344-6	http://dx.doi.org/10.1016/S0140-6736(08)61344-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380NE	18834627				2022-12-28	WOS:000261471600004
J	Tang, JL; Liu, BY; Ma, KW				Tang, Jin-Ling; Liu, Bao-Yan; Ma, Kan-Wen			Traditional Chinese medicine	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS		[Tang, Jin-Ling] Chinese Univ Hong Kong, Hong Kong Cochrane Ctr, Sch Publ Hlth, Fac Med, Hong Kong, Peoples R China; [Liu, Bao-Yan] Chinese Acad Med Sci, Beijing 100037, Peoples R China; [Ma, Kan-Wen] UCL, Wellcome Trust Ctr Hist Med, London, England	Chinese University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; University of London; University College London	Tang, JL (corresponding author), Chinese Univ Hong Kong, Hong Kong Cochrane Ctr, Sch Publ Hlth, Fac Med, Hong Kong, Peoples R China.	jltang@cuhk.edu.hk	Tang, Jin-Ling/AAJ-4090-2021; Ran, Mao-Sheng/I-7957-2013; Tang, JL/G-1759-2013; Al-Bayati, Lubna Lubna al Bayati/E-5100-2019					*BEIJ U CHIN MED, 2006, CHIN STAT YB CHIN ME; BROWN AC, 2002, POTENTIALLY LIFE THR; European Medicines Agency, 2005, PUBL STAT RISK ASS U; Ezzo JM, 2006, COCHRANE DB SYST REV, V19, P2285, DOI DOI 10.1002/14651858.CD002285.PUB2; Fugh-Berman A, 2000, LANCET, V355, P134, DOI 10.1016/S0140-6736(99)06457-0; KAPTCHUK TJ, 2000, WEB THAT HAS NO WEAV; Keji C., 2003, EUR REV, V11, P225, DOI DOI 10.1017/S106279870300022X; Liang MX, 1998, PREDICAMENTS FUTURE, P1; MA KW, 1993, EW MED EXCHANGES THE, P154; *MED HEALTHC PROD, 2006, TOUGH ACT UK MED REG; Pittler MH, 1999, CLIN INFECT DIS, V28, P597, DOI 10.1086/515148; STRATHERN P, 2005, BRIEF HIST MED, P179; Tang JL, 2006, BMJ-BRIT MED J, V333, P391, DOI 10.1136/bmj.333.7564.391; Tang JL, 1999, BMJ-BRIT MED J, V319, P160, DOI 10.1136/bmj.319.7203.160; Tomlinson B, 2000, J CLIN PHARMACOL, V40, P451, DOI 10.1177/00912700022009206; Vickers A, 1998, CONTROL CLIN TRIALS, V19, P159, DOI 10.1016/S0197-2456(97)00150-5; Vines G, 2004, HERBAL HARVESTS FUTU; Wang G, 2007, CLIN THER, V29, P1456, DOI 10.1016/j.clinthera.2007.07.023; Zhang W, 2005, COCHRANE DB SYST REV, V2	19	305	314	8	91	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2008	372	9654					1938	1940		10.1016/S0140-6736(08)61354-9	http://dx.doi.org/10.1016/S0140-6736(08)61354-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380NE	18930523				2022-12-28	WOS:000261471600010
J	Kobayashi, YM; Rader, EP; Crawford, RW; Iyengar, NK; Thedens, DR; Faulkner, JA; Parikh, SV; Weiss, RM; Chamberlain, JS; Moore, SA; Campbell, KP				Kobayashi, Yvonne M.; Rader, Erik P.; Crawford, Robert W.; Iyengar, Nikhil K.; Thedens, Daniel R.; Faulkner, John A.; Parikh, Swapnesh V.; Weiss, Robert M.; Chamberlain, Jeffrey S.; Moore, Steven A.; Campbell, Kevin P.			Sarcolemma-localized nNOS is required to maintain activity after mild exercise	NATURE			English	Article							NITRIC-OXIDE SYNTHASE; DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; ALPHA-SARCOGLYCAN; NEUROMUSCULAR DISORDERS; MICE; DEFICIENT; FATIGUE; THERAPY; COMPLEX	Many neuromuscular conditions are characterized by an exaggerated exercise- induced fatigue response that is disproportionate to activity level. This fatigue is not necessarily correlated with greater central or peripheral fatigue in patients(1), and some patients experience severe fatigue without any demonstrable somatic disease(2). Except in myopathies that are due to specific metabolic defects, the mechanism underlying this type of fatigue remains unknown(2). With no treatment available, this form of inactivity is a major determinant of disability(3). Here we show, using mouse models, that this exaggerated fatigue response is distinct from a loss in specific force production by muscle, and that sarcolemma-localized signalling by neuronal nitric oxide synthase ( nNOS) in skeletal muscle is required to maintain activity after mild exercise. We show that nNOS- null mice do not have muscle pathology and have no loss of muscle- specific force after exercise but do display this exaggerated fatigue response to mild exercise. In mouse models of nNOS mislocalization from the sarcolemma, prolonged inactivity was only relieved by pharmacologically enhancing the cGMP signal that results from muscle nNOS activation during the nitric oxide signalling response to mild exercise. Our findings suggest that the mechanism underlying the exaggerated fatigue response to mild exercise is a lack of contraction- induced signalling from sarcolemma- localized nNOS, which decreases cGMP- mediated vasomodulation in the vessels that supply active muscle after mild exercise. Sarcolemmal nNOS staining was decreased in patient biopsies from a large number of distinct myopathies, suggesting a common mechanism of fatigue. Our results suggest that patients with an exaggerated fatigue response to mild exercise would show clinical improvement in response to treatment strategies aimed at improving exercise- induced signalling.	[Kobayashi, Yvonne M.; Rader, Erik P.; Crawford, Robert W.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; [Kobayashi, Yvonne M.; Rader, Erik P.; Crawford, Robert W.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Kobayashi, Yvonne M.; Rader, Erik P.; Crawford, Robert W.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; [Kobayashi, Yvonne M.; Rader, Erik P.; Crawford, Robert W.; Iyengar, Nikhil K.; Parikh, Swapnesh V.; Weiss, Robert M.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Thedens, Daniel R.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Radiol, Iowa City, IA 52242 USA; [Moore, Steven A.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Faulkner, John A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Chamberlain, Jeffrey S.] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle	Campbell, KP (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, 4283 Carver Biomed Res Bldg,285 Newton Rd, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu		Chamberlain, Jeffrey/0000-0001-5299-0059; Moore, Steven/0000-0002-6353-7900; Campbell, Kevin/0000-0003-2066-5889	Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant; University of Iowa Cardiovascular Interdisciplinary Research; National Research Service Award; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Senator Paul D. Wellstone Fellowship; Muscular Dystrophy Association Development Grant; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979, K26RR017369] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051199, F32AR048742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033610] Funding Source: NIH RePORTER	Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant; University of Iowa Cardiovascular Interdisciplinary Research; National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Senator Paul D. Wellstone Fellowship; Muscular Dystrophy Association Development Grant(Muscular Dystrophy Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Anderson and M. Henry for comments, and M. M. Kilburg, K. Uppal, B. J. Steinmann and S. Watkins and members of the Campbell laboratory for scientific contributions. This work was supported in part by a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant. Y.M.K. was supported by grants from the University of Iowa Cardiovascular Interdisciplinary Research/ National Research Service Award (NRSA) Fellowship, from an individual NRSA Fellowship from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, from the National Institutes of Health (NIH), and from a Senator Paul D. Wellstone Fellowship. E.P.R. was supported by a Muscular Dystrophy Association Development Grant. R.M.W. was supported by the NIH. K.P.C. is an investigator of the Howard Hughes Medical Institute.	Asai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000806; Bloom TJ, 2005, CAN J PHYSIOL PHARM, V83, P1055, DOI 10.1139/Y05-085; Bloom TJ, 2002, CAN J PHYSIOL PHARM, V80, P1132, DOI 10.1139/Y02-149; Chao DS, 1998, J NEUROCHEM, V71, P784; Consolino CM, 2005, PHYSIOL GENOMICS, V22, P244, DOI 10.1152/physiolgenomics.00311.2004; Crosbie RH, 1998, HUM MOL GENET, V7, P823, DOI 10.1093/hmg/7.5.823; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Imamura M, 2005, HUM MOL GENET, V14, P775, DOI 10.1093/hmg/ddi072; Judge LM, 2006, J CELL SCI, V119, P1537, DOI 10.1242/jcs.02857; Kalkman JS, 2007, J PSYCHOSOM RES, V62, P571, DOI 10.1016/j.jpsychores.2006.11.014; Kass DA, 2007, CIRC RES, V101, P1084, DOI 10.1161/CIRCRESAHA.107.162511; Marden FA, 2005, SKELETAL RADIOL, V34, P140, DOI 10.1007/s00256-004-0825-3; Ozawa E, 2005, MUSCLE NERVE, V32, P563, DOI 10.1002/mus.20349; Persson J, 2003, J VASC RES, V40, P538, DOI 10.1159/000075677; Phillips BA, 2000, CURR OPIN NEUROL, V13, P547, DOI 10.1097/00019052-200010000-00007; Radley HG, 2007, INT J BIOCHEM CELL B, V39, P469, DOI 10.1016/j.biocel.2006.09.009; Schillings ML, 2007, CLIN NEUROPHYSIOL, V118, P292, DOI 10.1016/j.clinph.2006.10.018; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Thomas GD, 2003, CIRC RES, V92, P554, DOI 10.1161/01.RES.0000061570.83105.52; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Torelli S, 2004, NEUROPATH APPL NEURO, V30, P540, DOI 10.1111/j.1365-2990.2004.00561.x; Yokoyama T, 2007, J PAIN, V8, P692, DOI 10.1016/j.jpain.2007.05.008; Zwarts MJ, 2008, CLIN NEUROPHYSIOL, V119, P2, DOI 10.1016/j.clinph.2007.09.126	25	210	219	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2008	456	7221					511	515		10.1038/nature07414	http://dx.doi.org/10.1038/nature07414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18953332	Green Published, Green Accepted			2022-12-28	WOS:000261170500040
J	Mistlberger, RE; Yamazaki, S; Pendergast, JS; Landry, GJ; Takumi, T; Nakamura, W				Mistlberger, Ralph E.; Yamazaki, Shin; Pendergast, Julie S.; Landry, Glenn J.; Takumi, Toru; Nakamura, Wataru			Comment on "Differential Rescue of Light- and Food-Entrainable Circadian Rhythms"	SCIENCE			English	Editorial Material							DORSOMEDIAL HYPOTHALAMIC NUCLEUS; EXPRESSION		[Mistlberger, Ralph E.; Landry, Glenn J.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Yamazaki, Shin; Pendergast, Julie S.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Takumi, Toru; Nakamura, Wataru] Osaka Biosci Inst, Osaka 5650874, Japan	Simon Fraser University; Vanderbilt University	Mistlberger, RE (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.	mistlber@sfu.ca	Landry, Glenn J/L-2133-2015	Landry, Glenn J/0000-0002-6946-3914; Yamazaki, Shin/0000-0002-6691-1531	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051278] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS051278-04, R01 NS051278, NS051278] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACOSTAGALVAN G, 2008, P SOC RES BIOL RHYTH, V11, P199; Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; Landry GJ, 2006, AM J PHYSIOL-REG I, V290, pR1527, DOI 10.1152/ajpregu.00874.2005; Landry GJ, 2007, J BIOL RHYTHM, V22, P484, DOI 10.1177/0748730407307811; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; MORIYA T, 2007, P 2 WORLD C CHRON, V2, P40; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; STORCH KF, 2008, P SOC RES BIOL RHYTH, V11, P202; STORCH KF, COMMUNICATION; TERMAN M, 1984, ANN NY ACAD SCI, V423, P470, DOI 10.1111/j.1749-6632.1984.tb23454.x; Verwey M, 2007, NEUROSCIENCE, V147, P277, DOI 10.1016/j.neuroscience.2007.04.044	16	41	43	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902								10.1126/science.1161284	http://dx.doi.org/10.1126/science.1161284			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974333	Green Accepted			2022-12-28	WOS:000260605200019
J	Beardsall, K; Vanhaesebrouck, S; Ogilvy-Stuart, AL; Vanhole, C; Palmer, CR; van Weissenbruch, M; Midgley, P; Thompson, M; Thio, M; Cornette, L; Ossuetta, I; Iglesias, I; Theyskens, C; de Jong, M; Ahluwalia, JS; de Zegher, F; Dunger, DB				Beardsall, Kathryn; Vanhaesebrouck, Sophie; Ogilvy-Stuart, Amanda L.; Vanhole, Christine; Palmer, Christopher R.; van Weissenbruch, Mirjam; Midgley, Paula; Thompson, Michael; Thio, Marta; Cornette, Luc; Ossuetta, Iviano; Iglesias, Isabel; Theyskens, Claire; de Jong, Miranda; Ahluwalia, Jag S.; de Zegher, Francis; Dunger, David B.			Early insulin therapy in very-low-birth-weight infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE-CARE UNITS; PARENTERAL-NUTRITION; HYPERGLYCEMIA; INFUSION; PROTEIN; PREMATURITY; RETINOPATHY; ASPART	Background: Studies involving adults and children being treated in intensive care units indicate that insulin therapy and glucose control may influence survival. Hyperglycemia in very-low-birth-weight infants is also associated with morbidity and mortality. This international randomized, controlled trial aimed to determine whether early insulin replacement reduced hyperglycemia and affected outcomes in such neonates. Methods: In this multicenter trial, we assigned 195 infants to continuous infusion of insulin at a dose of 0.05 U per kilogram of body weight per hour with 20% dextrose support and 194 to standard neonatal care on days 1 to 7. The efficacy of glucose control was assessed by continuous glucose monitoring. The primary outcome was mortality at the expected date of delivery. The study was discontinued early because of concerns about futility with regard to the primary outcome and potential harm. Results: As compared with infants in the control group, infants in the early-insulin group had lower mean (+/-SD) glucose levels (6.2+/-1.4 vs. 6.7+/-2.2 mmol per liter [112+/-25 vs. 121+/-40 mg per deciliter], P=0.007). Fewer infants in the early-insulin group had hyperglycemia for more than 10% of the first week of life (21% vs. 33%, P=0.008). The early-insulin group had significantly more carbohydrate infused (51+/-13 vs. 43+/-10 kcal per kilogram per day, P<0.001) and less weight loss in the first week (standard-deviation score for change in weight, -0.55+/-0.52 vs. -0.70+/-0.47; P=0.006). More infants in the early-insulin group had episodes of hypoglycemia (defined as a blood glucose level of <2.6 mmol per liter [47 mg per deciliter] for >1 hour) (29% in the early-insulin group vs. 17% in the control group, P=0.005), and the increase in hypoglycemia was significant in infants with birth weights of more than 1 kg. There were no differences in the intention-to-treat analyses for the primary outcome (mortality at the expected date of delivery) and the secondary outcome (morbidity). In the intention-to-treat analysis, mortality at 28 days was higher in the early-insulin group than in the control group (P=0.04). Conclusions: Early insulin therapy offers little clinical benefit in very-low-birth-weight infants. It reduces hyperglycemia but may increase hypoglycemia (Current Conrolled Trials number, ISRCTN78428828.).	[Beardsall, Kathryn; Palmer, Christopher R.; Dunger, David B.] Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Cambridge CB2 0QQ, England; [Beardsall, Kathryn; Ogilvy-Stuart, Amanda L.; Ahluwalia, Jag S.] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Cambridge, England; [Palmer, Christopher R.] Ctr Appl Med Stat, Cambridge, England; [Midgley, Paula] Royal Infirm Edinburgh NHS Trust, Simpson Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Thompson, Michael; Ossuetta, Iviano] Luton & Dunstable Hosp, Luton, Beds, England; [Cornette, Luc] Leeds Gen Infirm, Leeds, W Yorkshire, England; [Vanhaesebrouck, Sophie; Vanhole, Christine; de Zegher, Francis] Katholieke Univ Leuven, Louvain, Belgium; [Theyskens, Claire] Ziekenhuis Oost Limburg, Genk, Belgium; [van Weissenbruch, Mirjam; de Jong, Miranda] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Thio, Marta; Iglesias, Isabel] Hosp Univ Sant Joan Deu, Barcelona, Spain	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Royal Infirmary of Edinburgh; University of Edinburgh; Leeds General Infirmary; University of Leeds; KU Leuven; East Limburg Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Dunger, DB (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Box 116,Level 8,Hills Rd, Cambridge CB2 0QQ, England.	dbd25@cam.ac.uk	Iglesias-Platas, Isabel/AGY-9649-2022	Iglesias-Platas, Isabel/0000-0003-1960-7614; Dunger, Professor David/0000-0002-2566-9304; van Weissenbruch, Mirjam M/0000-0002-8086-9552	Cambridge University Hospitals National Health Service ( NHS) Foundation Trust; Novo Nordisk; Medtronic; Leeds General Infirmary Research Fund; University of Cambridge Department of Paediatrics; National Institute for Health Research; Cambridge Biomedical Research Institute; NHS Research and Development; UK Medicines for Children Research Network; Cow and Gate	Cambridge University Hospitals National Health Service ( NHS) Foundation Trust(University of Cambridge); Novo Nordisk(Novo Nordisk); Medtronic(Medtronic); Leeds General Infirmary Research Fund; University of Cambridge Department of Paediatrics(University of Cambridge); National Institute for Health Research(National Institute for Health Research (NIHR)); Cambridge Biomedical Research Institute; NHS Research and Development; UK Medicines for Children Research Network; Cow and Gate	Supported by the Cambridge University Hospitals National Health Service ( NHS) Foundation Trust; an unrestricted grant from Novo Nordisk; Medtronic; the Leeds General Infirmary Research Fund; the University of Cambridge Department of Paediatrics; the National Institute for Health Research, Cambridge Biomedical Research Institute; NHS Research and Development; and the UK Medicines for Children Research Network. Novo Nordisk provided the insulin aspart, and Medtronic provided the continuous glucose- monitoring system and sensors.; Dr. Dunger reports receiving an unrestricted grant to support this study and lecture fees from Novo Nordisk; Dr. van Weissenbruch, receiving a grant from Novo Nordisk for nursing support for this study; and Dr. Midgley, receiving a grant and lecture fees from Novo Nordisk and Cow and Gate. No other potential conflict of interest relevant to this article was reported.; We thank the trial steering committee for time and support: Professor Kate Costeloe, F. R. C. P., Peter Brocklehurst, F. R. C. O. G., Tim Cole, Sc. D., Robert Tasker, M. D., Alison Baillie, B. A., and Cheryl France, M. P. H.; the data and safety monitoring committee: Mike Preece, M. D., Diana Elbourne, Ph. D., and Edmund Hey, D. M.; the staff in the Clinical Trials Unit: Mark Wilson, Heather Withers, Diane Picton, Barry Widmer, research fellows Roy McDougal and Imran Ahmed, and research nurses Lynn Thomson, Yvonne Millar, Anneke Cranendonk, and Lisa Auty; and all the staff who cared for the infants and the families who agreed to participate.	Agus MSD, 2006, ANN SURG, V244, P536, DOI 10.1097/01.sla.0000237758.93186.c8; Beardsall K, 2005, ARCH DIS CHILD-FETAL, V90, pF307, DOI 10.1136/adc.2004.051979; Beardsall Kathryn, 2007, BMC Pediatr, V7, P29, DOI 10.1186/1471-2431-7-29; Beardsall K, 2007, J PEDIATR-US, V151, P611, DOI 10.1016/j.jpeds.2007.04.068; BINDER ND, 1989, J PEDIATR-US, V114, P273, DOI 10.1016/S0022-3476(89)80797-8; COCKBURN F, 1993, LANCET, V342, P193; COLLINS JW, 1991, J PEDIATR-US, V118, P921, DOI 10.1016/S0022-3476(05)82212-7; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; Cowett Richard M, 2004, Semin Neonatol, V9, P37, DOI 10.1016/S1084-2756(03)00113-1; Cryer PE, 2006, DIABETOLOGIA, V49, P1722, DOI 10.1007/s00125-006-0306-4; Grant AM, 2005, LANCET, V365, P711; Grover A, 2008, JPEN-PARENTER ENTER, V32, P140, DOI 10.1177/0148607108314373; Hall NJ, 2004, J PEDIATR SURG, V39, P898, DOI 10.1016/j.jpedsurg.2004.02.005; Hellstrom A, 2003, PEDIATRICS, V112, P1016, DOI 10.1542/peds.112.5.1016; Hey E, 2005, SEMIN FETAL NEONAT M, V10, P377, DOI 10.1016/j.siny.2005.04.008; Home PD, 1999, EUR J CLIN PHARMACOL, V55, P199, DOI 10.1007/s002280050618; International Conference on Harmonization, 1996, INT C HARM TECHN REQ; Kao LS, 2006, J PERINATOL, V26, P730, DOI 10.1038/sj.jp.7211593; KOH THHG, 1988, ARCH DIS CHILD, V63, P1353, DOI 10.1136/adc.63.11.1353; Leunissen RWJ, 2008, J CLIN ENDOCR METAB, V93, P445, DOI 10.1210/jc.2007-1543; Lofqvist C, 2006, PEDIATRICS, V117, P1930, DOI 10.1542/peds.2005-1926; LUCAS A, 1988, BRIT MED J, V297, P1304, DOI 10.1136/bmj.297.6659.1304; Meetze W, 1998, BIOL NEONATE, V74, P214, DOI 10.1159/000014027; Mortensen HB, 2000, EUR J PEDIATR, V159, P483, DOI 10.1007/s004310051315; OSTERTAG SG, 1986, PEDIATRICS, V78, P625; Platt MW, 2005, SEMIN FETAL NEONAT M, V10, P341, DOI 10.1016/j.siny.2005.04.001; Poindexter BB, 1998, J PEDIATR-US, V132, P948, DOI 10.1016/S0022-3476(98)70389-0; The International Neonatal Network, 1993, LANCET, V342, P626; Thureen P, 2005, PEDIATR RES, V57, p95R, DOI 10.1203/01.PDR.0000160434.69916.34; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Van den Berghe G, 2006, DIABETES, V55, P3151, DOI 10.2337/db06-0855	32	186	191	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2008	359	18					1873	1884		10.1056/NEJMoa0803725	http://dx.doi.org/10.1056/NEJMoa0803725			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366BL	18971490				2022-12-28	WOS:000260454500004
J	Michel, E; Baglin, A; Auvergne, M; Catala, C; Samadi, R; Baudin, F; Appourchaux, T; Barban, C; Weiss, WW; Berthomieu, G; Boumier, P; Dupret, MA; Garcia, RA; Fridlund, M; Garrido, R; Goupil, MJ; Kjeldsen, H; Lebreton, Y; Mosser, B; Grotsch-Noels, A; Janot-Pacheco, E; Provost, J; Roxburgh, IW; Thoul, A; Toutain, T; Tiphene, D; Turck-Chieze, S; Vauclair, SD; Vauclair, GP; Aerts, C; Alecian, G; Ballot, J; Charpinet, S; Hubert, AM; Lignieres, F; Mathias, P; Monteiro, MJPFG; Neiner, C; Poretti, E; de Medeiros, JR; Ribas, I; Rieutord, ML; Cortes, TR; Zwintz, K				Michel, Eric; Baglin, Annie; Auvergne, Michel; Catala, Claude; Samadi, Reza; Baudin, Frederic; Appourchaux, Thierry; Barban, Caroline; Weiss, Werner W.; Berthomieu, Gabrielle; Boumier, Patrick; Dupret, Marc-Antoine; Garcia, Rafael A.; Fridlund, Malcolm; Garrido, Rafael; Goupil, Marie-Jo; Kjeldsen, Hans; Lebreton, Yveline; Mosser, Benoit; Grotsch-Noels, Arlette; Janot-Pacheco, Eduardo; Provost, Janine; Roxburgh, Ian W.; Thoul, Anne; Toutain, Thierry; Tiphene, Didier; Turck-Chieze, Sylvaine; Vauclair, Sylvie D.; Vauclair, Gerard P.; Aerts, Conny; Alecian, Georges; Ballot, Jerome; Charpinet, Stephane; Hubert, Anne-Marie; Lignieres, Francois; Mathias, Philippe; Monteiro, Mario J. P. F. G.; Neiner, Coralie; Poretti, Ennio; de Medeiros, Jose Renan; Ribas, Ignasi; Rieutord, Michel L.; Roca Cortes, Teodoro; Zwintz, Konstanze			CoRoT measures solar-like oscillations and granulation in stars hotter than the Sun	SCIENCE			English	Article							HELIOSEISMOLOGY	Oscillations of the Sun have been used to understand its interior structure. The extension of similar studies to more distant stars has raised many difficulties despite the strong efforts of the international community over the past decades. The CoRoT (Convection Rotation and Planetary Transits) satellite, launched in December 2006, has now measured oscillations and the stellar granulation signature in three main sequence stars that are noticeably hotter than the sun. The oscillation amplitudes are about 1.5 times as large as those in the Sun; the stellar granulation is up to three times as high. The stellar amplitudes are about 25% below the theoretic values, providing a measurement of the nonadiabaticity of the process ruling the oscillations in the outer layers of the stars.	[Michel, Eric; Baglin, Annie; Auvergne, Michel; Catala, Claude; Samadi, Reza; Barban, Caroline; Dupret, Marc-Antoine; Goupil, Marie-Jo; Mosser, Benoit; Roxburgh, Ian W.; Tiphene, Didier] Univ Paris 06, LESIA, Observ Paris, CNRS,UMR 8109, F-92195 Meudon, France; [Michel, Eric; Baglin, Annie; Auvergne, Michel; Catala, Claude; Samadi, Reza; Barban, Caroline; Dupret, Marc-Antoine; Goupil, Marie-Jo; Mosser, Benoit; Roxburgh, Ian W.; Tiphene, Didier] Univ Paris 07, F-92195 Meudon, France; [Baudin, Frederic; Appourchaux, Thierry; Boumier, Patrick] Univ Paris 11, Inst Astrophys Spatiale, CNRS, UMR 8617, F-91405 Orsay, France; [Weiss, Werner W.; Zwintz, Konstanze] Univ Vienna, Inst Astron, A-1180 Vienna, Austria; [Berthomieu, Gabrielle; Provost, Janine] Observ Cote Azur, CNRS, Lab Cassiopee, CNRS,UMR 6202, F-06304 Nice 04, France; [Garcia, Rafael A.; Turck-Chieze, Sylvaine] Univ Paris 07, Lab Astrophys Interact Multiechelles AIM, Commisariat Energie Atom DSM, CNRS,CEA,IRFU,SAp, F-91191 Gif Sur Yvette, France; [Fridlund, Malcolm] European Space Agcy, European Space Res & Technol Ctr, Astrophys Miss Div, Res & Sci Support Dept,SCI SA, NL-2200 AG Noordwijk, Netherlands; [Garrido, Rafael] CSIC, Inst Astrofis Andalucia, E-18008 Granada, Spain; [Kjeldsen, Hans] Aarhus Univ, Danish Astroseismol Ctr DASC, Inst Fys Astron, DK-8000 Aarhus C, Denmark; [Lebreton, Yveline; Hubert, Anne-Marie; Neiner, Coralie] Observ Paris, CNRS, Lab Galaxies Etoiles Phys & Instrumentat GEPI, UMR 8111, F-92195 Meudon, France; [Grotsch-Noels, Arlette; Thoul, Anne] Univ Liege, Inst Astrophys & Geophys, B-4000 Liege, Belgium; [Janot-Pacheco, Eduardo] Inst Astron Geofis & Ciencias Atmosfer, BR-05508090 Sao Paulo, Brazil; [Roxburgh, Ian W.] Queen Mary Univ London, London E1 4NS, England; [Toutain, Thierry] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; [Vauclair, Sylvie D.; Vauclair, Gerard P.; Charpinet, Stephane; Lignieres, Francois; Rieutord, Michel L.] Univ Toulouse 1, CNRS, Lab Astrophys Toulouse Tarbes, UMR 5572, F-31400 Toulouse, France; [Aerts, Conny] Katholieke Univ Leuven, Inst Sterrenkunde, Dept Natuurkunde Sterrenkunde, B-3001 Heverlee, Belgium; [Alecian, Georges] Univ Paris 07, Lab Univers & Theories LUTH, Observ Paris, CNRS,UMR 8102, F-92190 Meudon, France; [Ballot, Jerome] Max Planck Inst Astrophys, D-85741 Garching, Germany; [Mathias, Philippe] Univ Nice, Lab Hippolyte Fizeau, Observ Cote Azur, CNRS UMR 6525, F-06108 Nice 2, France; [Monteiro, Mario J. P. F. G.] Univ Porto, Ctr Astrofis, P-4150762 Oporto, Portugal; [Poretti, Ennio] Ist Nazl Astrofis, Osservatorio Astron Brera, I-23807 Merate, LC, Italy; [de Medeiros, Jose Renan] Univ Fed Rio Grande do Norte, Dept Fis, BR-59072970 Natal, RN, Brazil; [Ribas, Ignasi] CSIC IEEC, Inst Ciencies Espai, Fac Ciencies, Bellaterra 08193, Spain; [Roca Cortes, Teodoro] Univ La Laguna, Inst Astrofis Canarias, Tenerife 38207, Spain; [Roca Cortes, Teodoro] Univ La Laguna, Dept Astrophys, Tenerife 38207, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Vienna; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; European Space Agency; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Aarhus University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; University of Liege; University of London; Queen Mary University London; University of Birmingham; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse 1 Capitole; KU Leuven; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; Max Planck Society; UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; Universidade do Porto; Istituto Nazionale Astrofisica (INAF); Universidade Federal do Rio Grande do Norte; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); Instituto de Astrofisica de Canarias; Universidad de la Laguna; Universidad de la Laguna	Michel, E (corresponding author), Univ Paris 06, LESIA, Observ Paris, CNRS,UMR 8109, Pl Jules Janssen, F-92195 Meudon, France.	Eric.Michel@obspm.fr	Haba, Rafael Garrido/M-6635-2017; Lebreton, Yveline/N-2268-2014; Monteiro, Mario J. P. F. G./B-4715-2008; Ribas, Ignasi/M-2134-2014; Poretti, Ennio/N-4730-2016; Cortés, Teodoro Roca/AAA-2659-2019; Ballot, Jérôme/G-1019-2010; de Medeiros, José/AAG-7839-2021; Zwintz, Konstanze/HIK-0566-2022	Haba, Rafael Garrido/0000-0001-5917-2884; Monteiro, Mario J. P. F. G./0000-0003-0513-8116; Ribas, Ignasi/0000-0002-6689-0312; Poretti, Ennio/0000-0003-1200-0473; Cortés, Teodoro Roca/0000-0003-2267-288X; Zwintz, Konstanze/0000-0001-9229-8315; Weiss, Werner/0000-0003-3977-4436; Aerts, Conny/0000-0003-1822-7126; Thoul, Anne/0000-0002-8107-118X; Appourchaux, Thierry/0000-0002-1790-1951; Neiner, Coralie/0000-0003-1978-9809; Janot-Pacheco, Eduardo/0000-0003-0079-3912; Charpinet, Stephane/0000-0002-6018-6180; Garcia, Rafael A./0000-0002-8854-3776; Ballot, Jerome/0000-0002-9649-1013; Mosser, Benoit/0000-0002-7547-1208; Baudin, Frederic/0000-0001-6213-6382	UK Space Agency [PP/E001793/1] Funding Source: researchfish	UK Space Agency		Baglin A., 2006, EUROPEAN SPACE AGENC, P33; BAUDIN F, 2006, ESA, P403; Bruntt H, 2005, ASTROPHYS J, V633, P440, DOI 10.1086/462401; CLAVERIE A, 1979, NATURE, V282, P591, DOI 10.1038/282591a0; FLETCHER ST, 2006, ESA; Frohlich C, 1997, SOL PHYS, V170, P1, DOI 10.1023/A:1004969622753; Gough DO, 1996, SCIENCE, V272, P1281, DOI 10.1126/science.272.5266.1281; Guenther DB, 2005, ASTROPHYS J, V635, P547, DOI 10.1086/497387; Guenther DB, 2007, COMMUN ASTEROSEIS, V151, P5, DOI [10.1553/cia151s5, DOI 10.1553/CIA151S5]; Harvey J., 1985, ESASP, V235, P199; KAROFF C, 2007, COAST, V150, P147; Kjeldsen H, 2005, ASTROPHYS J, V635, P1281, DOI 10.1086/497530; KJELDSEN H, 1995, ASTRON ASTROPHYS, V293, P87; Lebreton Y, 2008, ASTROPHYS SPACE SCI, V316, P167, DOI 10.1007/s10509-008-9781-z; Samadi R, 2007, ASTRON ASTROPHYS, V463, P297, DOI 10.1051/0004-6361:20041953; Schou J, 2001, ESA SP PUBL, V464, P391	16	185	185	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					558	560		10.1126/science.1163004	http://dx.doi.org/10.1126/science.1163004			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948534	Green Submitted			2022-12-28	WOS:000260299100034
J	Disney, MJ; Romano, JD; Garcia-Appadoo, DA; West, AA; Dalcanton, JJ; Cortese, L				Disney, M. J.; Romano, J. D.; Garcia-Appadoo, D. A.; West, A. A.; Dalcanton, J. J.; Cortese, L.			Galaxies appear simpler than expected	NATURE			English	Article							INTEGRAL PROPERTIES; HIPASS CATALOG; DENSITY	Galaxies are complex systems the evolution of which apparently results from the interplay of dynamics, star formation, chemical enrichment and feedback from supernova explosions and super-massive black holes(1). The hierarchical theory of galaxy formation holds that galaxies are assembled from smaller pieces, through numerous mergers of cold dark matter(2-4). The properties of an individual galaxy should be controlled by six independent parameters including mass, angular momentum, baryon fraction, age and size, as well as by the accidents of its recent haphazard merger history. Here we report that a sample of galaxies that were first detected through their neutral hydrogen radio- frequency emission, and are thus free from optical selection effects(5), shows five independent correlations among six independent observables, despite having a wide range of properties. This implies that the structure of these galaxies must be controlled by a single parameter, although we cannot identify this parameter from our data set. Such a degree of organization appears to be at odds with hierarchical galaxy formation, a central tenet of the cold dark matter model in cosmology(6).	[Disney, M. J.; Romano, J. D.; Garcia-Appadoo, D. A.; Cortese, L.] Cardiff Univ, Sch Phys & Astron, Cardiff CF24 3AA, Wales; [Romano, J. D.] Univ Texas Brownsville, Dept Phys & Astron, Brownsville, TX 78520 USA; [Garcia-Appadoo, D. A.] European So Observ, Santiago 19, Chile; [West, A. A.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [West, A. A.; Dalcanton, J. J.] Univ Washington, Dept Astron, Seattle, WA 98195 USA	Cardiff University; University of Texas System; University of Texas Rio Grande Valley; European Southern Observatory; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle	Disney, MJ (corresponding author), Cardiff Univ, Sch Phys & Astron, 5 Parade, Cardiff CF24 3AA, Wales.	mjd@astro.cf.ac.uk	Cortese, Luca/AAV-4926-2021; West, Andrew/H-3717-2014	Cortese, Luca/0000-0002-7422-9823; Dalcanton, Julianne/0000-0002-1264-2006				Adelman-McCarthy JK, 2007, ASTROPHYS J SUPPL S, V172, P634, DOI 10.1086/518864; BALKOWSKI C, 1973, ASTRON ASTROPHYS, V29, P43; Baugh CM, 2006, REP PROG PHYS, V69, P3101, DOI 10.1088/0034-4885/69/12/R02; Blanton MR, 2003, ASTROPHYS J, V592, P819, DOI 10.1086/375776; BLUMENTHAL GR, 1984, NATURE, V311, P517, DOI 10.1038/311517a0; BROSCHE P, 1973, ASTRON ASTROPHYS, V23, P259; BUJARRABAL V, 1981, ASTRON ASTROPHYS, V104, P1; Chatfield C., 1980, INTRO MULTIVARIATE A; Conselice CJ, 2006, MON NOT R ASTRON SOC, V373, P1389, DOI 10.1111/j.1365-2966.2006.11114.x; Dalcanton JJ, 1997, ASTROPHYS J, V482, P659, DOI 10.1086/304182; Dalcanton JJ, 1997, ASTRON J, V114, P635, DOI 10.1086/118499; DEJONG RS, 2007, ISLAND UNIVERSES STR; Disney MJ, 1999, ASTR SOC P, V170, P9; GARCIAAPPADOO DA, 2008, MON NOT R ASTR UNPUB; Gavazzi G, 1996, ASTRON ASTROPHYS, V312, P397; HAYNES MP, 1984, ASTRON J, V89, P758, DOI 10.1086/113573; Jolliffe IT., 2002, PRINCIPAL COMPONENT, DOI DOI 10.1007/B98835; Kormendy J, 2004, ANNU REV ASTRON ASTR, V42, P603, DOI 10.1146/annurev.astro.42.053102.134024; Kulkarni S.R., 1988, GALACTIC EXTRAGALACT, P95; Meyer MJ, 2004, MON NOT R ASTRON SOC, V350, P1195, DOI 10.1111/j.1365-2966.2004.07710.x; Mo HJ, 1998, MON NOT R ASTRON SOC, V295, P319, DOI 10.1046/j.1365-8711.1998.01227.x; Rosenberg JL, 2005, ASTRON J, V129, P1311, DOI 10.1086/427397; SHOSTAK GS, 1978, ASTRON ASTROPHYS, V68, P321; StaveleySmith L, 1996, PUBL ASTRON SOC AUST, V13, P243, DOI 10.1017/S1323358000020919; Strateva I, 2001, ASTRON J, V122, P1861, DOI 10.1086/323301; VANDERKRUIT PC, 1988, ASTRON ASTROPHYS, V192, P117; WHITMORE BC, 1984, ASTROPHYS J, V278, P61, DOI 10.1086/161768; Zibetti S, 2002, ASTROPHYS J, V579, P261, DOI 10.1086/342707; Zwaan MA, 2004, MON NOT R ASTRON SOC, V350, P1210, DOI 10.1111/j.1365-2966.2004.07782.x	29	84	86	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 23	2008	455	7216					1082	1084		10.1038/nature07366	http://dx.doi.org/10.1038/nature07366			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948949	Green Submitted			2022-12-28	WOS:000260252600038
J	Hand, E				Hand, Eric			Plumes of methane identified on Mars	NATURE			English	News Item																		Formisano V, 2004, SCIENCE, V306, P1758, DOI 10.1126/science.1101732	1	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1018	1018		10.1038/4551018a	http://dx.doi.org/10.1038/4551018a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948917	Bronze			2022-12-28	WOS:000260252600009
J	Jackevicius, CA; Tu, JV; Demers, V; Melo, M; Cox, J; Rinfret, S; Kalavrouziotis, D; Johansen, H; Behlouli, H; Newman, A; Pilote, L				Jackevicius, Cynthia A.; Tu, Jack V.; Demers, Virginie; Melo, Magda; Cox, Jafna; Rinfret, Stephane; Kalavrouziotis, Dimitri; Johansen, Helen; Behlouli, Hassan; Newman, Alice; Pilote, Louise			Cardiovascular outcomes after a change in prescription policy for clopidogrel	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; PRIOR-AUTHORIZATION PROGRAMS; ACUTE MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; TIME-SERIES; PREMATURE DISCONTINUATION; STENT IMPLANTATION; HEART-ASSOCIATION; AMERICAN-COLLEGE; PREVALENCE	Background: Drug-reimbursement policies may have an adverse effect on patient outcomes if they interfere with timely access to efficacious medications for acute medical conditions. Clopidogrel in combination with aspirin is the recommended standard of care for patients receiving coronary stents to prevent thrombosis. We examined the population-level effect of a change by a Canadian provincial government in a pharmacy-benefits program from a prior-authorization policy to a less restrictive, limited-use policy on access to clopidogrel among patients undergoing percutaneous coronary intervention (PCI) with stenting after acute myocardial infarction. Methods: We conducted a population-based, retrospective, time-series analysis from April 1, 2000, to March 31, 2005, of all patients 65 years of age or older with acute myocardial infarction who underwent PCI with stenting in Ontario, Canada. The primary outcome was the composite rate of death, recurrent acute myocardial infarction, PCI, and coronary-artery bypass grafting at 1 year, with adjustment for sex and age. The secondary outcome was major bleeding. Results: The rate of clopidogrel use within 30 days after hospital discharge following myocardial infarction increased from 35% in the prior-authorization period to 88% in the limited-use period. The median time to the first dispensing of a clopidogrel prescription decreased from 9 days in the first period to 0 days in the second period. The 1-year composite cardiovascular outcome significantly decreased from 15% in the prior-authorization group to 11% in the limited-use group (P=0.02). Rates of bleeding in the two groups did not change. Conclusions: The removal of a prior-authorization program led to improvement in timely access to clopidogrel for coronary stenting and improved cardiovascular outcomes.	[Jackevicius, Cynthia A.] Western Univ Hlth Sci, Coll Pharm, Pomona, CA 91766 USA; [Jackevicius, Cynthia A.; Tu, Jack V.] Univ Toronto, Toronto, ON, Canada; [Jackevicius, Cynthia A.] Univ Hlth Network, Toronto, ON, Canada; [Jackevicius, Cynthia A.; Tu, Jack V.; Melo, Magda; Newman, Alice] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Tu, Jack V.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Demers, Virginie; Behlouli, Hassan; Pilote, Louise] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Rinfret, Stephane] Univ Montreal, Montreal, PQ, Canada; [Cox, Jafna; Kalavrouziotis, Dimitri] Dalhousie Univ, Halifax, NS, Canada; [Johansen, Helen] STAT Canada, Ottawa, ON, Canada	Western University of Health Sciences; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McGill University; Universite de Montreal; Dalhousie University; Statistics Canada	Jackevicius, CA (corresponding author), Western Univ Hlth Sci, Coll Pharm, 309 E 2nd St, Pomona, CA 91766 USA.	cjackevicius@westernu.edu		Tu, Jack/0000-0003-0111-722X; Cox, Jafna/0000-0001-7908-5323; Pilote, Louise/0000-0002-6159-0628	Canadian Institutes for Health Research; Canada Research Chair in Health Services Research, Ottawa; Heart and Stroke Foundation of Ontario; Ontario Ministry of Health and Long-Term Care, Toronto; Fonds de la Recherche en Sant, du Quebec (FRSQ)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Health Services Research, Ottawa(Canada Research Chairs); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Ministry of Health and Long-Term Care, Toronto(Ministry of Health and Long-Term Care, Ontario); Fonds de la Recherche en Sant, du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	Supported by a Team Grant in Cardiovascular Outcomes Research to the Canadian Cardiovascular Outcomes Research Team (CCORT) from the Canadian Institutes for Health Research; by a Canada Research Chair in Health Services Research, Ottawa, and a Career Investigator Award from the Heart and Stroke Foundation of Ontario (to Dr. Tu); by an operating grant from the Ontario Ministry of Health and Long-Term Care, Toronto, to the Institute for Clinical Evaluative Sciences; by a CCORT Summer Student Award (to Dr. Demers); by the Fonds de la Recherche en Sant, du Quebec (FRSQ) (to Dr. Rinfret); by a CCORT master's student fellowship (to Dr. Kalavrouziotis); and by a James McGill chair and the FRSQ (to Dr. Pilote). Dr. Cox reports receiving consulting and lecture fees from Bristol-Myers Squibb, Merck, Pfizer, Sanofi-Aventis, and GlaxoSmithKline and research support from Merck and Pfizer and being a site investigator for a clinical trial sponsored by Sanofi-Aventis; and Dr. Rinfret, receiving consulting and lecture fees from Pfizer, Bristol-Myers Squibb, Sanofi-Aventis, and Abbott Vascular. No other potential conflict of interest relevant to this article was reported. We thank the Cardiac Care Network of Ontario for providing data regarding types of stents from its clinical registry.	Ackman ML, 2006, CAN J CARDIOL, V22, P1205, DOI 10.1016/S0828-282X(06)70960-6; *CAN I HLTH INF, 2007, DRUG EXP CAN 1985 20; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Fischer MA, 2004, NEW ENGL J MED, V351, P2187, DOI 10.1056/NEJMsa042770; Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944; Hamel MB, 2004, NEW ENGL J MED, V351, P2156, DOI 10.1056/NEJMp048294; JACKEVICIUS CA, 2006, CCORT CANADIAN CARDI, P180; Jackevicius CA, 2008, CIRCULATION, V117, P1028, DOI 10.1161/CIRCULATIONAHA.107.706820; Jackevicius CA, 2007, PHARMACOEPIDEM DR S, V16, P207, DOI 10.1002/pds.1289; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; McCombs JS, 2002, CLIN THER, V24, P1939, DOI 10.1016/S0149-2918(02)80090-X; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; PHILLIPS CR, 1997, J MANAGE CARE PHARM, V3, P699; Pindyck R.S., 2013, ECONOMETRIC MODELS E; Popma JJ, 2004, CHEST, V126, p576S, DOI 10.1378/chest.126.3_suppl.576S; Schneeweiss S, 2003, CLIN PHARMACOL THER, V74, P388, DOI 10.1016/S0009-9236(03)00227-3; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; Schneeweiss S, 2001, HEALTH POLICY, V55, P97, DOI 10.1016/S0168-8510(00)00120-2; Sheehy O, 2008, CAN MED ASSOC J, V178, P413, DOI 10.1503/cmaj.070586; SMALLEY WE, 1995, NEW ENGL J MED, V332, P1612, DOI 10.1056/NEJM199506153322406; Smith SC, 2006, J AM COLL CARDIOL, V47, P216, DOI 10.1016/j.jacc.2005.11.025; SOUMERAI SB, 1994, NEW ENGL J MED, V331, P650, DOI 10.1056/NEJM199409083311006; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Tran CTT, 2003, CAN J CARDIOL, V19, P38; Tricoci P, 2006, ARCH INTERN MED, V166, P806, DOI 10.1001/archinte.166.7.806; Tu JV, 2007, NEW ENGL J MED, V357, P1393, DOI 10.1056/NEJMoa071076; TU JV, 1999, CARDIOVASCULAR HLTH, P25; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Yaffee R.A., 2000, INTRO TIME SERIES AN	32	57	57	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2008	359	17					1802	1810		10.1056/NEJMsa0803410	http://dx.doi.org/10.1056/NEJMsa0803410			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363DJ	18946065	Bronze			2022-12-28	WOS:000260245800007
J	Mehta, RH; Liang, L; Karve, AM; Hernandez, AF; Rumsfeld, JS; Fonarow, GC; Peterson, ED				Mehta, Rajendra H.; Liang, Li; Karve, Amrita M.; Hernandez, Adrian F.; Rumsfeld, John S.; Fonarow, Gregg C.; Peterson, Eric D.			Association of patient case-mix adjustment, hospital process performance rankings, and eligibility for financial incentives	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROMES; COOPERATIVE CARDIOVASCULAR PROJECT; ACUTE MYOCARDIAL-INFARCTION; QUALITY-OF-CARE; ELDERLY-PATIENTS; UNSTABLE ANGINA; HEALTH-CARE; DISPARITIES; CRUSADE; PREVENTION	Context While most comparisons of hospital outcomes adjust for patient characteristics, process performance comparisons typically do not. Objective To evaluate the degree to which hospital process performance ratings and eligibility for financial incentives are altered after accounting for hospitals' patient demographics, clinical characteristics, and mix of treatment opportunities. Design, Setting, and Patients Using data from the American Heart Association's Get With the Guidelines program between January 2, 2000, and March 28, 2008, we analyzed hospital process performance based on the Centers for Medicare & Medicaid Services' defined core measures for acute myocardial infarction. Hospitals were initially ranked based on crude composite process performance and then ranked again after accounting for hospitals' patient demographics, clinical characteristics, and eligibility for measures using a hierarchical model. We then compared differences in hospital performance rankings and pay-for-performance financial incentive categories (top 20%, middle 60%, and bottom 20% institutions). Main Outcome Measures Hospital process performance ranking and pay-for-performance financial incentive categories. Results A total of 148 472 acute myocardial infarction patients met the study criteria from 449 centers. Hospitals for which crude composite acute myocardial infarction performance was in the bottom quintile (n=89) were smaller nonacademic institutions that treated a higher percentage of patients from racial or ethnic minority groups and also patients with greater comorbidities than hospitals ranked in the top quintile (n=90). Although there was overall agreement on hospital rankings based on observed vs adjusted composite scores (weighted kappa, 0.74), individual hospital ranking changed with adjustment (median, 22 ranks; range, 0-214; interquartile range, 9-40). Additionally, 16.5% of institutions (n=74) changed pay-for-performance financial status categories after accounting for patient and treatment opportunity mix. Conclusion Our findings suggest that accounting for hospital differences in patient characteristics and treatment opportunities is associated with modest changes in hospital performance rankings and eligibility for financial benefits in pay-for-performance programs for treatment of myocardial infarction.	[Mehta, Rajendra H.; Liang, Li; Karve, Amrita M.; Hernandez, Adrian F.; Peterson, Eric D.] Duke Clin Res Inst, Durham, NC 27715 USA; [Mehta, Rajendra H.; Liang, Li; Karve, Amrita M.; Hernandez, Adrian F.; Peterson, Eric D.] Duke Univ, Med Ctr, Durham, NC USA; [Rumsfeld, John S.] Denver Vet Affairs Med Ctr, Denver, CO USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA	Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Mehta, RH (corresponding author), Duke Clin Res Inst, Box 17969, Durham, NC 27715 USA.	mehta007@dcri.duke.edu	Fonarow, Gregg C/D-5988-2014; Hernandez, Adrian F/A-7818-2016; Peterson, Eric David/ABF-5033-2021	Fonarow, Gregg C/0000-0002-3192-8093; Hernandez, Adrian F/0000-0003-3387-9616; 	GlaxoSmithKline; Medtronic; Merck; Pfizer; National Institutes of Health; AHA; American Heart Association Pharmaceutical Roundtable [0675060N]; Elliot Corday (Los Angeles, California) Foundation; Ahmanson (Los Angeles, California) Foundation	GlaxoSmithKline(GlaxoSmithKline); Medtronic(Medtronic); Merck(Merck & Company); Pfizer(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); American Heart Association Pharmaceutical Roundtable(American Heart Association); Elliot Corday (Los Angeles, California) Foundation; Ahmanson (Los Angeles, California) Foundation	Dr Hernandez reports receiving research support from GlaxoSmithKline, Johnson & Johnson (Scios Inc), Medtronic, Novartis, and Roche Diagnostics; and honoraria from AstraZeneca, Novartis, Sanofi-Aventis, and Thoratec Corporation. Dr Peterson reports receiving research support from Schering Plough, BMS/Sanofi; and serving as the principal investigator for the American Heart Association's (AHA's) Get With the Guidelines Analytical Center. Drs Hernandez and Peterson report detailed listings of financial disclosures at http://www.dcri.duke.edu/research/coi.jsp. Dr Rumsfeld reports receiving an honorariun for participating on the scientific research advisory board of United Healthcare. Dr Fonarow reports receiving research grants from GlaxoSmithKline, Medtronic, Merck, Pfizer, and the National Institutes of Health; consulting for AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Medtronic, Merck, Novartis, Pfizer, Sanofi-Aventis, and Schering Plough; receiving honoraria from AstraZeneca, Abbott, Bristol-Myers Squibb, GlaxoSmithKline, Medtronic, Merck, Novartis, Pfizer, Sanofi-Aventis, and Schering Plough; and serving as chair of the AHA's Get With the Guidelines Steering Committee. Drs Mehta and Liang and Ms Karve report no disclosures. The Get With the Guidelines program is supported by the AHA in part through an unrestricted education grant from Merck-Schering Plough. Dr Hernandez reports receiving support from an American Heart Association Pharmaceutical Roundtable grant 0675060N. Dr Fonarow reports receiving support from the Elliot Corday (Los Angeles, California) and Ahmanson (Los Angeles, California) Foundations.	Alexander KP, 2005, J AM COLL CARDIOL, V46, P1479, DOI 10.1016/j.jacc.2005.05.084; Blomkalns AL, 2005, J AM COLL CARDIOL, V45, P832, DOI 10.1016/j.jacc.2004.11.055; Calvin JE, 2006, ANN INTERN MED, V145, P739, DOI 10.7326/0003-4819-145-10-200611210-00006; *CMS PREMIER HOSP, 2006, PROJ OV FIND YEAR 1; DeLong ER, 1997, STAT MED, V16, P2645, DOI 10.1002/(SICI)1097-0258(19971215)16:23<2645::AID-SIM696>3.0.CO;2-D; Eddy DM, 1998, HEALTH AFFAIR, V17, P7, DOI 10.1377/hlthaff.17.4.7; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Gaskin DJ, 1999, J URBAN HEALTH, V76, P351, DOI 10.1007/BF02345673; Institute of Medicine, 2002, LEAD EX COORD GOV RO; King ML, 2007, ARCH INTERN MED, V167, P1226, DOI 10.1001/archinte.167.12.1226; Krumholz HM, 1997, ARCH INTERN MED, V157, P2242, DOI 10.1001/archinte.157.19.2242; Krumholz HM, 2006, CIRCULATION, V113, P456, DOI 10.1161/CIRCULATIONAHA.105.170769; LaBresh KA, 2004, ARCH INTERN MED, V164, P203, DOI 10.1001/archinte.164.2.203; LaBresh Kenneth A, 2003, Jt Comm J Qual Saf, V29, P539; LaBresh Kenneth A, 2003, Qual Manag Health Care, V12, P20; Mannion R, 2005, J Health Organ Manag, V19, P431, DOI 10.1108/14777260510629689; Marshall M, 2002, BRIT J GEN PRACT, V52, P531; Mehta RH, 2006, ARCH INTERN MED, V166, P2027, DOI 10.1001/archinte.166.18.2027; Mehta RH, 2000, ARCH INTERN MED, V160, P1301, DOI 10.1001/archinte.160.9.1301; Meyer JA, 2004, HOSP QUALITY INGREDI; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; PEAR R, 2002, NY TIMES        1031, pA21; Rao S, 2003, J AM COLL CARDIOL, V41, P1948, DOI 10.1016/S0735-1097(03)00402-9; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Sonel AF, 2005, CIRCULATION, V111, P1225, DOI 10.1161/01.CIR.0000157732.03358.64; Stone PH, 1996, JAMA-J AM MED ASSOC, V275, P1104, DOI 10.1001/jama.275.14.1104; Thomas JW, 1999, MED CARE, V37, P83, DOI 10.1097/00005650-199901000-00012; THOMAS N, 1994, STAT MED, V13, P889, DOI 10.1002/sim.4780130902; *US DEP HHS, QUAL TOOL AD INCL PE; ZAMAN O, 2006, AM PUBLIC HOSP HLTH	30	59	59	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2008	300	16					1897	1903		10.1001/jama.300.16.1897	http://dx.doi.org/10.1001/jama.300.16.1897			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362UR	18940976				2022-12-28	WOS:000260223100019
J	Cook, EH; Scherer, SW				Cook, Edwin H., Jr.; Scherer, Stephen W.			Copy-number variations associated with neuropsychiatric conditions	NATURE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; FAMILIAL PARKINSONS-DISEASE; AUTISM SPECTRUM DISORDERS; STRUCTURAL VARIATION; MENTAL-RETARDATION; CHROMOSOMAL REARRANGEMENTS; MICRODELETION SYNDROME; TOURETTE-SYNDROME; GENE; DUPLICATION	Neuropsychiatric conditions such as autism and schizophrenia have long been attributed to genetic alterations, but identifying the genes responsible has proved challenging. Microarray experiments have now revealed abundant copy- number variation - a type of variation in which stretches of DNA are duplicated, deleted and sometimes rearranged - in the human population. Genes affected by copy- number variation are good candidates for research into disease susceptibility. The complexity of neuropsychiatric genetics, however, dictates that assessment of the biomedical relevance of copy- number variants and the genes that they affect needs to be considered in an integrated context.	[Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Toronto Med Discovery Tower MaRS Discovery Dist, Toronto, ON M5G 1L7, Canada; [Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Cook, Edwin H., Jr.] Univ Illinois, Inst Juvenile Res, Dept Psychiat, Chicago, IL 60608 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Scherer, SW (corresponding author), Hosp Sick Children, Ctr Appl Genom, Toronto Med Discovery Tower MaRS Discovery Dist, 14th Floor,101 Coll St, Toronto, ON M5G 1L7, Canada.	steve@genet.sickkids.on.ca	Scherer, Stephen W./B-3785-2013	Scherer, Stephen W./0000-0002-8326-1999; Cook, Edwin/0000-0002-5848-5114	The Centre for Applied Genomics; Genome Canada-Ontario Genomics Institute; Canadian Institutes for Health Research; Canadian Institute for Advanced Research; McLaughlin Centre for Molecular Medicine; Canadian Foundation for Innovation; Ontario Ministry of Research Innovation; National Institutes of Health [HD055751]; Children's Brain Research Foundation; Jean Young and Walden W. Shaw Foundation; Autism Speaks; SickKids Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055751] Funding Source: NIH RePORTER	The Centre for Applied Genomics; Genome Canada-Ontario Genomics Institute(Genome Canada); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); McLaughlin Centre for Molecular Medicine; Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Ministry of Research Innovation(Ministry of Research and Innovation, Ontario); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Brain Research Foundation; Jean Young and Walden W. Shaw Foundation; Autism Speaks; SickKids Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank P. Szatmari, R. Weksberg, C. Marshall, L. Feuk and D. Pinto for ideas. Research in our laboratories is supported by The Centre for Applied Genomics, Genome Canada-Ontario Genomics Institute, the Canadian Institutes for Health Research (CIHR), the Canadian Institute for Advanced Research, the McLaughlin Centre for Molecular Medicine, the Canadian Foundation for Innovation, the Ontario Ministry of Research & Innovation, the National Institutes of Health (grant number HD055751, to E.H.C.), Children's Brain Research Foundation, Jean Young and Walden W. Shaw Foundation, Autism Speaks, and the SickKids Foundation. S.W.S. holds the GlaxoSmithKline-CIHR Chair in Genetics and Genomics at the University of Toronto and the Hospital for Sick Children.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Beaudet AL, 2007, NAT MED, V13, P534, DOI 10.1038/nm0507-534; Berg JS, 2007, GENET MED, V9, P427, DOI 10.1097/GIM.0b013e3180986192; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Buchanan JA, 2008, GENET MED, V10, P639, DOI [10.1097/GIM.0b013e318183f848, 10.1097GIM.0b013e318183f848]; Burmeister M, 2008, NAT REV GENET, V9, P527, DOI 10.1038/nrg2381; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Christian SL, 2008, BIOL PSYCHIAT, V63, P1111, DOI 10.1016/j.biopsych.2008.01.009; Cook EH, 1997, AM J HUM GENET, V60, P928; Darilek S, 2008, GENET MED, V10, P13, DOI 10.1097/GIM.0b013e31815f1ddb; De Luca A, 2007, J MED GENET, V44, P800, DOI 10.1136/jmg.2007.053785; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Grisart B, 2008, EUR J HUM GENET, V16, P305, DOI 10.1038/sj.ejhg.5201978; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Inoue K, 2003, CURR OPIN GENET DEV, V13, P303, DOI 10.1016/S0959-437X(03)00057-1; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lachman HM, 2007, AM J MED GENET B, V144B, P259, DOI 10.1002/ajmg.b.30498; Lawson-Yuen A, 2008, EUR J HUM GENET, V16, P614, DOI 10.1038/sj.ejhg.5202006; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shelley BP, 2007, J INTELL DISABIL RES, V51, P620, DOI 10.1111/j.1365-2788.2006.00943.x; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabor HK, 2007, GENET MED, V9, P626, DOI 10.1097/GIM.0b013e3181485688; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; van Ommen GJB, 2005, NAT GENET, V37, P333, DOI 10.1038/ng0405-333; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	52	455	515	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					919	923		10.1038/nature07458	http://dx.doi.org/10.1038/nature07458			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923514				2022-12-28	WOS:000260038300040
J	Hyman, SE				Hyman, Steven E.			A glimmer of light for neuropsychiatric disorders	NATURE			English	Article							GENOME-WIDE ASSOCIATION; NATIONAL COMORBIDITY SURVEY; ALZHEIMERS-DISEASE; RETT-SYNDROME; COPY NUMBER; GENETICS; SCHIZOPHRENIA; GENES; LOCI; TRANSLOCATION		[Hyman, Steven E.] Harvard Univ, Sch Med, Off Provost, Dept Neurobiol, Cambridge, MA 02138 USA	Harvard University	Hyman, SE (corresponding author), Harvard Univ, Sch Med, Off Provost, Dept Neurobiol, Massachusetts Hall, Cambridge, MA 02138 USA.	seh@harvard.edu						American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Hennah W, 2009, MOL PSYCHIATR, V14, P865, DOI 10.1038/mp.2008.22; Hunter DJ, 2008, NEW ENGL J MED, V358, P2760, DOI 10.1056/NEJMp0804318; Hyman SE, 2007, NAT REV NEUROSCI, V8, P725, DOI 10.1038/nrn2218; Kendler KS, 2006, AM J PSYCHIAT, V163, P115, DOI 10.1176/appi.ajp.163.1.115; Kendler KS, 1997, BRIT J PSYCHIAT, V170, P541, DOI 10.1192/bjp.170.6.541; Kendler KS, 1998, AM J PSYCHIAT, V155, P172; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; Lewis JC, 2004, J MED GENET, V41, P203, DOI 10.1136/jmg.2003.012757; Merikangas KR, 2003, SCIENCE, V302, P599, DOI 10.1126/science.1091468; Merikangas KR, 2003, AM J PSYCHIAT, V160, P625, DOI 10.1176/appi.ajp.160.4.625; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Murray CJ, 1996, GLOBAL BURDEN DIS; Nestler E. J., 2008, MOL NEUROPHARMACOLOG; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Pacione LR, 2003, ANNU REV NEUROSCI, V26, P657, DOI 10.1146/annurev.neuro.26.041002.131416; Reddy Kavita S, 2005, BMC Med Genet, V6, P3, DOI 10.1186/1471-2350-6-3; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Valdmanis PN, 2008, NEUROLOGY, V70, P144, DOI 10.1212/01.wnl.0000296811.19811.db; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Waring SC, 2008, ARCH NEUROL-CHICAGO, V65, P329, DOI 10.1001/archneur.65.3.329; Watase K, 2003, NAT REV GENET, V4, P296, DOI 10.1038/nrg1045; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; WHO, 2001, WORLD HLTH REP MENT; Williams NM, 2006, INT REV NEUROBIOL, V73, P1, DOI 10.1016/S0074-7742(06)73001-X; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	48	81	84	1	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					890	893		10.1038/nature07454	http://dx.doi.org/10.1038/nature07454			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923510	Bronze			2022-12-28	WOS:000260038300036
J	Watts, G				Watts, Geoff			Research funding goes metric	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						*AC MED SCI, 2006, RESP DFES CONS REF R; HM Treasury, 2006, SCI INN INV FRAM 200; *HOUS COMM SCI TEC, 2002, 2 REP RES ASS EX; *MED SCH COUNC, 2008, MED SCH COUNC RESP C; ROBERTS G, 2003, JOINT FUNDING BODIES	5	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 13	2008	337								a1805	10.1136/bmj.a1805	http://dx.doi.org/10.1136/bmj.a1805			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374FH	18852165				2022-12-28	WOS:000261028100002
J	Rahman, S; Scobie, AI; Elkalaawy, M; Bidlake, LE; Fiennes, AG; Batterham, RL				Rahman, Suehana; Scobie, Antonia I.; Elkalaawy, Mohamed; Bidlake, Louise E.; Fiennes, Alberic G.; Batterham, Rachel L.			Can glucose make you faint?	LANCET			English	Editorial Material							WERNICKES ENCEPHALOPATHY		[Batterham, Rachel L.] UCL, Ctr Diabet & Endocrinol, Dept Med, London WC1E 6JJ, England; [Rahman, Suehana; Scobie, Antonia I.; Elkalaawy, Mohamed; Bidlake, Louise E.; Fiennes, Alberic G.; Batterham, Rachel L.] UCL Hosp, Div Surg, Bariatr Unit, London, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Batterham, RL (corresponding author), UCL, Ctr Diabet & Endocrinol, Dept Med, Rayne Bldg,5 Univ St, London WC1E 6JJ, England.	r.batterham@ucl.ac.uk		Batterham, Rachel/0000-0002-5477-8585	Medical Research Council [G108/551] Funding Source: Medline; MRC [G108/551] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Corcoran T B, 2002, Crit Care Resusc, V4, P31; Sechi G, 2007, LANCET NEUROL, V6, P442, DOI 10.1016/S1474-4422(07)70104-7; Singh S, 2007, NEUROLOGY, V68, P807, DOI 10.1212/01.wnl.0000256812.29648.86; Talwar D, 2000, CLIN CHEM, V46, P704; Wilson RK, 2006, NAT CLIN PRACT NEURO, V2, P54, DOI 10.1038/ncpneuro0094	5	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1358	1358		10.1016/S0140-6736(08)61557-3	http://dx.doi.org/10.1016/S0140-6736(08)61557-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18929908				2022-12-28	WOS:000260060500036
J	Schwalb, NK; Temps, F				Schwalb, Nina K.; Temps, Friedrich			Base sequence and higher-order structure induce the complex excited-state dynamics in DNA	SCIENCE			English	Article							MOLECULAR-SPECTROSCOPY; ENERGY-TRANSFER; FLUORESCENCE; CONVERSION; ADENINE; DELOCALIZATION; DEACTIVATION; SELECTIVITY; RELAXATION; EXCITATION	The high photostability of DNA is commonly attributed to efficient radiationless electronic relaxation processes. We used femtosecond time-resolved fluorescence spectroscopy to reveal that the ensuing dynamics are strongly dependent on base sequence and are also affected by higher-order structure. Excited electronic state lifetimes in dG-doped d(A)(20) single-stranded DNA and dG center dot dC-doped d(A)(20)center dot d(T)(20) double-stranded DNA decrease sharply with the substitution of only a few bases. In duplexes containing d(AGA) center dot d(TCT) or d(AG) center dot d(TC) repeats, deactivation of the fluorescing states occurs on the subpicosecond time scale, but the excited-state lifetimes increase again in extended d(G) runs. The results point at more complex and molecule-specific photodynamics in native DNA than may be evident in simpler model systems.	[Schwalb, Nina K.; Temps, Friedrich] Univ Kiel, Inst Chem Phys, D-24098 Kiel, Germany	University of Kiel	Schwalb, NK (corresponding author), Univ Kiel, Inst Chem Phys, Olshaussenstr 40, D-24098 Kiel, Germany.	schwalb@phc.uni-kiel.de; temps@phc.uni-kiel.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work has been supported by the Deutsche Forschungsgemeinschaft. Furthermore, the authors thank J. Grotzinger for letting us take the CD spectra.	Abo-Riziq A, 2005, P NATL ACAD SCI USA, V102, P20, DOI 10.1073/pnas.0408574102; Bloomfield V.A., 2000, NUCL ACIDS STRUCTURE, V1st ed.; Bouvier B, 2003, J PHYS CHEM B, V107, P13512, DOI 10.1021/jp036164u; Bouvier B, 2002, CHEM PHYS, V275, P75, DOI 10.1016/S0301-0104(01)00523-7; Buchvarov I, 2007, P NATL ACAD SCI USA, V104, P4794, DOI 10.1073/pnas.0606757104; Crespo-Hernandez CE, 2008, J AM CHEM SOC, V130, P10844, DOI 10.1021/ja802183s; Crespo-Hernandez CE, 2006, NATURE, V441, pE8, DOI 10.1038/nature04904; Crespo-Hernandez CE, 2004, CHEM REV, V104, P1977, DOI 10.1021/cr0206770; Crespo-Hernandez CE, 2005, NATURE, V436, P1141, DOI 10.1038/nature03933; Crespo-Hernandez CE, 2004, J PHYS CHEM B, V108, P11182, DOI 10.1021/jp0496046; Czader A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2821384; Elias B, 2008, J AM CHEM SOC, V130, P1152, DOI 10.1021/ja710358p; Emanuele E, 2005, CHEMPHYSCHEM, V6, P1387, DOI 10.1002/cphc.200500014; Groenhof G, 2007, J AM CHEM SOC, V129, P6812, DOI 10.1021/ja069176c; Gustavsson T, 2002, CHEM PHYS LETT, V351, P195, DOI 10.1016/S0009-2614(01)01375-6; Hyeon-Deuk K, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2894843; Kelley SO, 1999, SCIENCE, V283, P375, DOI 10.1126/science.283.5400.375; Kwok WM, 2006, J AM CHEM SOC, V128, P11894, DOI 10.1021/ja0622002; Markovitsi D, 2005, J AM CHEM SOC, V127, P17130, DOI 10.1021/ja054955z; Markovitsi D, 2003, CHEMPHYSCHEM, V4, P303, DOI 10.1002/cphc.200390050; Markovitsi D, 2006, NATURE, V441, pE7, DOI 10.1038/nature04903; Miannay FA, 2007, J AM CHEM SOC, V129, P14574, DOI 10.1021/ja077100q; Onidas D, 2002, J PHYS CHEM B, V106, P11367, DOI 10.1021/jp026063g; Onidas D, 2007, J PHYS CHEM B, V111, P9644, DOI 10.1021/jp072508v; Pancur T, 2005, CHEM PHYS, V313, P199, DOI 10.1016/j.chemphys.2004.12.019; Pecourt JML, 2001, J AM CHEM SOC, V123, P10370, DOI 10.1021/ja0161453; Peon J, 2001, CHEM PHYS LETT, V348, P255, DOI 10.1016/S0009-2614(01)01128-9; Schwalb NK, 2007, J AM CHEM SOC, V129, P9272, DOI 10.1021/ja073448+; Sobolewski AL, 2005, P NATL ACAD SCI USA, V102, P17903, DOI 10.1073/pnas.0504087102; Wan CZ, 2000, P NATL ACAD SCI USA, V97, P14052, DOI 10.1073/pnas.250483297	30	126	129	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					243	245		10.1126/science.1161651	http://dx.doi.org/10.1126/science.1161651			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845751				2022-12-28	WOS:000259902300043
J	Millett, GA; Flores, SA; Marks, G; Reed, JB; Herbst, JH				Millett, Gregorio A.; Flores, Stephen A.; Marks, Gary; Reed, J. Bailey; Herbst, Jeffrey H.			Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUAL-MEN; ANAL WARTS; PREVENTION; BEHAVIOR; HEALTH; AVAILABILITY; TRANSMISSION; REDUCTION; INCREASES	Context Randomized controlled trials and meta- analyses have demonstrated that male circumcision reduces men's risk of contracting human immunodeficiency virus ( HIV) infection during heterosexual intercourse. Less is known about whether male circumcision provides protection against HIV infection among men who have sex with men ( MSM). Objectives To quantitatively summarize the strength of the association between male circumcision and HIV infection and other sexually transmitted infections ( STIs) across observational studies of MSM. Data Sources Comprehensive search of databases, including MEDLINE, EMBASE, ERIC, Sociofile, PsycINFO, Web of Science, and Google Scholar, and correspondence with researchers, to find published articles, conference proceedings, and unpublished reports through February 2008. Study Selection Of 18 studies that quantitatively examined the association between male circumcision and HIV/ STI among MSM, 15 ( 83%) met the selection criteria for the meta- analysis. Data Extraction Independent abstraction was conducted by pairs of reviewers using a standardized abstraction form. Study quality was assessed using the Newcastle-ottawa Scale. Data Synthesis A total of 53 567 MSM participants ( 52% circumcised) were included in the meta- analysis. The odds of being HIV- positive were nonsignificantly lower among MSM who were circumcised than uncircumcised ( odds ratio, 0.86; 95% confidence interval, 0.65- 1.13; number of independent effect sizes [ k]= 15). Higher study quality was associated with a reduced odds of HIV infection among circumcised MSM ( beta, - 0.415; P=. 01). Among MSM who primarily engaged in insertive anal sex, the association between male circumcision and HIV was protective but not statistically significant ( odds ratio, 0.71; 95% confidence interval, 0.23- 2.22; k= 4). Male circumcision had a protective association with HIV in studies of MSM conducted before the introduction of highly active antiretroviral therapy ( odds ratio, 0.47; 95% confidence interval, 0.32- 0.69; k= 3). Neither the association between male circumcision and other STIs ( odds ratio, 1.02; 95% confidence interval, 0.83- 1.26; k= 8), nor its relationship with study quality was statistically significant ( beta, 0.265; P=. 47). Conclusions Pooled analyses of available observational studies of MSM revealed insufficient evidence that male circumcision protects against HIV infection or other STIs. However, the comparable protective effect of male circumcision in MSM studies conducted before the era of highly active antiretroviral therapy, as in the recent male circumcision trials of heterosexual African men, supports further investigation of male circumcision for HIV prevention among MSM.	[Millett, Gregorio A.; Flores, Stephen A.; Marks, Gary; Reed, J. Bailey; Herbst, Jeffrey H.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Millett, GA (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, 1600 Clifton Rd,Mail Stop E-37, Atlanta, GA 30333 USA.	gmillett@cdc.gov						Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P841; [Anonymous], HPV MEN CDC FACT SHE; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Aziz O, 2006, ANN SURG ONCOL, V13, P413, DOI 10.1245/ASO.2006.05.045; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bartholow BN, 2006, JAIDS-J ACQ IMM DEF, V43, P594; BEGLEY E, 2007, 14 C RETR OPP INF FE; BUCHBINDER S, 2007, HIV VACC TRIAL NETW; Buchbinder SP, 2005, JAIDS-J ACQ IMM DEF, V39, P82, DOI 10.1097/01.qai.0000134740.41585.f4; Calzavara L, 2002, AIDS, V16, P1655, DOI 10.1097/00002030-200208160-00011; Calzavara LM, 2007, 16 ANN CAN ASS HIV R; *CDCP, 2007, CONS MAL CIRC PREV H; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P69; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P773; Ciesielski Carol A., 2003, Curr Infect Dis Rep, V5, P145, DOI 10.1007/s11908-003-0051-5; Coplan PM, 1996, AM J EPIDEMIOL, V144, P817, DOI 10.1093/oxfordjournals.aje.a009016; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; DiClemente RJ, 2002, SOUTH MED J, V95, P421, DOI 10.1097/00007611-200204000-00009; Dukers NHTM, 2002, AIDS, V16, pF19, DOI 10.1097/00002030-200207050-00001; Dukers NHTM, 2001, AIDS, V15, P369, DOI 10.1097/00002030-200102160-00010; Fankem SL, 2008, INT J EPIDEMIOL, V37, P353, DOI 10.1093/ije/dym203; Fox KK, 2001, AM J PUBLIC HEALTH, V91, P959, DOI 10.2105/AJPH.91.6.959; GOLDEN MR, 2006, NAT STD PREV C MAY 8; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Grulich AE, 2001, AIDS, V15, P1188, DOI 10.1097/00002030-200106150-00020; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203; Herbst JH, 2007, AM J PREV MED, V32, pS38, DOI 10.1016/j.amepre.2006.12.006; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Jin F, 2007, SEX TRANSM DIS, V34, P488, DOI 10.1097/01.olq.0000245960.52668.e5; *KAIS FAM FDN DAIL, 2007, GLOB CHALL RISK SEX; KRIESS JK, 1993, J INFECT DIS, V168, P1404, DOI 10.1093/infdis/168.6.1404; KUMTA S, 14 INT AIDS C JUL 7; Lafferty WE, 1997, SEX TRANSM DIS, V24, P272, DOI 10.1097/00007435-199705000-00007; LAI SF, 2004, 15 INT AIDS C JUL 11; LIPSEY MW, 2001, PRACTICAL METALANALY; Macdonald N, 2004, SEX TRANSM INFECT, V80, P492, DOI 10.1136/sti.2004.011197; Marcus U, 2006, SEX TRANSM DIS, V33, P11, DOI 10.1097/01.olq.0000187224.10428.31; Millett GA, 2007, JAIDS-J ACQ IMM DEF, V46, P643, DOI 10.1097/QAI.0b013e31815b834d; Mor Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000861; Moses S, 1998, SEX TRANSM INFECT, V74, P368, DOI 10.1136/sti.74.5.368; Orwin R.G., 1994, HDB RES SYNTHESIS; Ostrow DE, 2002, AIDS, V16, P775, DOI 10.1097/00002030-200203290-00013; REID D, 2002, KNOW SCORE FINDINGS; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; SANCHEZ J, 2007, CTR HIV ID PREV TREA; Siegfried N, 2005, LANCET INFECT DIS, V5, P165, DOI 10.1016/S1473-3099(05)01309-5; Stolte IG, 2004, AIDS, V18, P303, DOI 10.1097/00002030-200401230-00021; Stram DO, 1996, BIOMETRICS, V52, P536, DOI 10.2307/2532893; Sullivan PS, 2007, PLOS MED, V4, P1162, DOI 10.1371/journal.pmed.0040223; Tabet S, 2002, AIDS, V16, P1271, DOI 10.1097/00002030-200206140-00010; TEMPLETON DJ, 2007, INT SOC SEX TRANSM D; Templeton DJ, 2007, 4 INT AIDS SOC C HIV; The Cochrane Collaborative Review Group on HIV infection and AIDS, ED POL INCL APPR EXP; Treat Asia, 2006, MSM HIV AIDS RISK AS; Van Der Snoek EM, 2005, SEX TRANSM DIS, V32, P170, DOI 10.1097/01.olq.0000149786.09706.66; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Wells G., NEWCASTLE OTTAWA SCA; *WHO, GLOB PREV MAL CIRC; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; World Bank, WORLD BANK DAT STAT; Xu F, 2007, SEX TRANSM DIS, V34, P479, DOI 10.1097/01.olq.0000253335.41841.04	65	163	166	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2008	300	14					1674	1684		10.1001/jama.300.14.1674	http://dx.doi.org/10.1001/jama.300.14.1674			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	356YF	18840841				2022-12-28	WOS:000259812800029
J	Guven-Ozkan, T; Nishi, Y; Robertson, SM; Lin, RL				Guven-Ozkan, Tugba; Nishi, Yuichi; Robertson, Scott M.; Lin, Rueyling			Global transcriptional repression in C-elegans germline precursors by regulated sequestration of TAF-4	CELL			English	Article							RNA-POLYMERASE-II; TO-EMBRYO TRANSITION; ZINC-FINGER PROTEINS; CAENORHABDITIS-ELEGANS; OOCYTE MATURATION; GENE-EXPRESSION; MATERNAL PROTEINS; PIE-1 PROTEIN; CHROMATIN; DEGRADATION	In C. elegans, four asymmetric divisions, beginning with the zygote (P0), generate transcriptionally repressed germline blastomeres (P1-P4) and somatic sisters that become transcriptionally active. The protein PIE-1 represses transcription in the later germline blastomeres but not in the earlier germline blastomeres P0 and P1. We show here that OMA-1 and OMA-2, previously shown to regulate oocyte maturation, repress transcription in P0 and P1 by binding to and sequestering in the cytoplasm TAF-4, a component critical for assembly of TFIID and the pol II pre-initiation complex. OMA-1/2 binding to TAF-4 is developmentally regulated, requiring phosphorylation by the DYRK kinase MBK-2, which is activated at meiosis II after fertilization. OMA-1/2 are normally degraded after the first mitosis, but ectopic expression of wild-type OMA-1 is sufficient to repress transcription in both somatic and later germline blastomeres. We propose that phosphorylation by MBK-2 serves as a developmental switch, converting OMA-1/2 from oocyte to embryo regulators.	[Guven-Ozkan, Tugba; Nishi, Yuichi; Robertson, Scott M.; Lin, Rueyling] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Lin, RL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	rueyling.lin@utsouthwestern.edu	Robertson, Scott/B-9018-2013		National Institutes of Health [HD37933]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank Lin lab members for discussions, Angela Collins for technical assistance in the initial isolation of taf-4 clones, Jim Priess for antibodies to MEX-5 and PIE-1, Judith Austin for AZ212, Ed Kipreos for ET113, Geraldine Seydoux for the vet-5 clone and pID3.01B, Andy Fire for vet-5 sequence information, Yuji Kohara for all yk cDNA clones, Zheng Zhou and Bob Horvitz for sharing the yeast two-hybrid library, Keith Blackwell and Amy Walker for anti-TAF-4 antibody, and Hiroyuki Kawahara for anti-OMA-1a antibody. All other strains used were provided by C. elegans Genome Center. This work was supported by a National Institutes of Health grant (HD37933) to R. L.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Batchelder C, 1999, GENE DEV, V13, P202, DOI 10.1101/gad.13.2.202; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; CHATTERJEE S, 1995, NATURE, V374, P820, DOI 10.1038/374820a0; Deshpande G, 2005, MECH DEVELOP, V122, P645, DOI 10.1016/j.mod.2004.12.009; Deshpande G, 2004, DEVELOPMENT, V131, P1247, DOI 10.1242/dev.01004; Detwiler MR, 2001, DEV CELL, V1, P187, DOI 10.1016/S1534-5807(01)00026-0; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Gangloff YG, 2000, MOL CELL BIOL, V20, P340, DOI 10.1128/MCB.20.1.340-351.2000; Gangloff YG, 2001, TRENDS BIOCHEM SCI, V26, P250, DOI 10.1016/S0968-0004(00)01741-2; Ghosh D, 2008, GENETICS, V178, P235, DOI 10.1534/genetics.107.083212; Giadrossi S, 2007, CURR OPIN GENET DEV, V17, P132, DOI 10.1016/j.gde.2007.02.012; Green MR, 2000, TRENDS BIOCHEM SCI, V25, P59, DOI 10.1016/S0968-0004(99)01527-3; Hanyu-Nakamura K, 2008, NATURE, V451, P730, DOI 10.1038/nature06498; Hao YS, 2006, DEV CELL, V10, P199, DOI 10.1016/j.devcel.2005.12.015; Hoffmann A, 1996, J BIOL CHEM, V271, P18194, DOI 10.1074/jbc.271.30.18194; Jadhav S, 2008, DEVELOPMENT, V135, P1803, DOI 10.1242/dev.013656; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; KLAGES N, 1995, NATURE, V374, P822, DOI 10.1038/374822a0; KOBAYASHI S, 1988, DEV GROWTH DIFFER, V30, P251; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Leatherman JL, 2002, CURR BIOL, V12, P1681, DOI 10.1016/S0960-9822(02)01182-X; Lin RL, 1998, CELL, V92, P229, DOI 10.1016/S0092-8674(00)80917-4; Lin RL, 2003, DEV BIOL, V258, P226, DOI 10.1016/S0012-1606(03)00119-2; Liu J, 2004, DEVELOPMENT, V131, P3513, DOI 10.1242/dev.01245; Martinho RG, 2004, CURR BIOL, V14, P159, DOI 10.1016/j.cub.2003.12.036; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Nishi Y, 2005, DEV BIOL, V288, P139, DOI 10.1016/j.ydbio.2005.09.053; Pagano JM, 2007, J BIOL CHEM, V282, P8883, DOI 10.1074/jbc.M700079200; Pellettieri J, 2003, DEV CELL, V5, P451, DOI 10.1016/S1534-5807(03)00231-4; Praitis V, 2001, GENETICS, V157, P1217; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Schaner CE, 2003, DEV CELL, V5, P747, DOI 10.1016/S1534-5807(03)00327-7; SCHAUER IE, 1990, DEVELOPMENT, V110, P1303; Seydoux G, 1997, DEVELOPMENT, V124, P2191; Seydoux G, 1996, NATURE, V382, P713, DOI 10.1038/382713a0; Seydoux G, 1995, METHOD CELL BIOL, V48, P323; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Shimada M, 2002, GENES CELLS, V7, P933, DOI 10.1046/j.1365-2443.2002.00570.x; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Shirayama M, 2006, CURR BIOL, V16, P47, DOI 10.1016/j.cub.2005.11.070; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stitzel ML, 2006, CURR BIOL, V16, P56, DOI 10.1016/j.cub.2005.11.063; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Surani MA, 2004, COLD SPRING HARB SYM, V69, P1, DOI 10.1101/sqb.2004.69.40; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Tenenhaus C, 1998, DEV BIOL, V200, P212, DOI 10.1006/dbio.1998.8940; Tenenhaus C, 2001, GENE DEV, V15, P1031, DOI 10.1101/gad.876201; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; VARNUM BC, 1989, ONCOGENE, V4, P119; Walker AK, 2004, J BIOL CHEM, V279, P15339, DOI 10.1074/jbc.M310731200; Walker AK, 2003, J BIOL CHEM, V278, P6181, DOI 10.1074/jbc.M211056200; Walker AK, 2001, EMBO J, V20, P5269, DOI 10.1093/emboj/20.18.5269; Walker AK, 2007, DEV BIOL, V304, P382, DOI 10.1016/j.ydbio.2006.12.039; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Zhang F, 2003, GENE DEV, V17, P748, DOI 10.1101/gad.1068203	61	78	92	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					149	160		10.1016/j.cell.2008.07.040	http://dx.doi.org/10.1016/j.cell.2008.07.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854162	Green Accepted, Bronze			2022-12-28	WOS:000259728100016
J	Lu, L; Jia, MH; Ma, YL; Yang, L; Chen, ZW; Ho, DD; Jiang, Y; Zhang, LQ				Lu, Lin; Jia, Manhong; Ma, Yanling; Yang, Li; Chen, Zhiwei; Ho, David D.; Jiang, Yan; Zhang, Linqi			The changing face of HIV in China	NATURE			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; CIRCULATING RECOMBINANT; INFECTION; HIV/AIDS; YUNNAN; DONORS; GENOME; STRAIN		[Lu, Lin; Jia, Manhong; Ma, Yanling; Yang, Li] Yunnan Ctr Dis Control & Prevent, Yunnan, Peoples R China; [Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Hong Kong, Peoples R China; [Ho, David D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Ho, David D.; Zhang, Linqi] Tsinghua Univ, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China; [Jiang, Yan] Chinese Ctr Dis Control & Prevent, Natl AIDS Reference Lab, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Zhang, Linqi] Chinese Acad Med Sci, AIDS Res Ctr, State Key Lab Mol Virol & Genet Engn, Inst Pathogen Biol, Beijing 100037, Peoples R China; [Zhang, Linqi] Peking Union Med Coll, Beijing 100021, Peoples R China	University of Hong Kong; Rockefeller University; Tsinghua University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Lu, L (corresponding author), Yunnan Ctr Dis Control & Prevent, Yunnan, Peoples R China.		Chen, Zhiwei/B-7793-2019; ZHANG, LIN/GYD-9123-2022; MA, YAN/HHN-2912-2022	Chen, Zhiwei/0000-0002-4511-2888; 	National Basic Research Program ( also called 973 Program) of Chinese Ministry of Science and Technology [2006CB504200]; Tenth Five-year Key Technologies R&D Programme of China [2004BA719A14-1, 2004BA719A14-2]	National Basic Research Program ( also called 973 Program) of Chinese Ministry of Science and Technology(National Basic Research Program of China); Tenth Five-year Key Technologies R&D Programme of China(National Key Technology R&D Program)	This work is supported by National Basic Research Program ( also called 973 Program) of Chinese Ministry of Science and Technology to L. Z. (2006CB504200) and by the Tenth Five-year Key Technologies R&D Programme of China: 2004BA719A14-1, 2004BA719A14-2. We also thank Mark Goldin for helpful suggestions.	CHENG HH, 1994, LANCET, V344, P953, DOI 10.1016/S0140-6736(94)92304-3; Chin KC, 2007, CHINESE CONNECTION C; Gill B, 2007, DEMOGRAPHY HIV AIDS; Graf M, 1998, AIDS RES HUM RETROV, V14, P285, DOI 10.1089/aid.1998.14.285; Kaufman J, 2002, SCIENCE, V296, P2339, DOI 10.1126/science.1074479; LUO CC, 1995, LANCET, V345, P1051, DOI 10.1016/S0140-6736(95)90792-0; Parekh BS, 2001, AIDS RES HUM RETROV, V17, P137, DOI 10.1089/08892220150217229; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; State Council AIDS Working Committee Office and UN Theme Group on AIDS in China, 2007, JOINT ASS HIV AIDS P; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; *US BUR INT NARC L, 2007, INT NARC CONTR STRAT, V1; WENIGER BG, 1994, AIDS, V8, pS13; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; WU ZY, 1995, LANCET, V346, P61, DOI 10.1016/S0140-6736(95)92698-4; Xiao Y, 2007, SOC SCI MED, V64, P665, DOI 10.1016/j.socscimed.2006.09.019; Yang RG, 2003, J VIROL, V77, P685, DOI 10.1128/JVI.77.1.685-695.2003; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; ZHENG XW, 1994, AIDS, V8, P1141, DOI 10.1097/00002030-199408000-00017	19	228	272	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					609	611		10.1038/455609a	http://dx.doi.org/10.1038/455609a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833270	Bronze			2022-12-28	WOS:000259639700035
J	Belogurov, GA; Vassylyeva, MN; Sevostyanova, A; Appleman, JR; Xiang, AX; Lira, R; Webber, SE; Klyuyev, S; Nudler, E; Artsimovitch, I; Vassylyev, DG				Belogurov, Georgiy A.; Vassylyeva, Marina N.; Sevostyanova, Anastasiya; Appleman, James R.; Xiang, Alan X.; Lira, Ricardo; Webber, Stephen E.; Klyuyev, Sergiy; Nudler, Evgeny; Artsimovitch, Irina; Vassylyev, Dmitry G.			Transcription inactivation through local refolding of the RNA polymerase structure	NATURE			English	Article							OPEN COMPLEX-FORMATION; ELECTRON-DENSITY MAPS; II ELONGATION COMPLEX; ANGSTROM RESOLUTION; START SITE; DNA; INHIBITION; HOLOENZYME; MOLSCRIPT	Structural studies of antibiotics not only provide a shortcut to medicine allowing for rational structure- based drug design, but may also capture snapshots of dynamic intermediates that become 'frozen' after inhibitor binding(1,2). Myxopyronin inhibits bacterial RNA polymerase ( RNAP) by an unknown mechanism(3). Here we report the structure of dMyx - a desmethyl derivative of myxopyronin B-4 - complexed with a Thermus thermophilus RNAP holoenzyme. The antibiotic binds to a pocket deep inside the RNAP clamp head domain, which interacts with the DNA template in the transcription bubble(5,6). Notably, binding of dMyx stabilizes refolding of the beta'-subunit switch- 2 segment, resulting in a configuration that might indirectly compromise binding to, or directly clash with, the melted template DNA strand. Consistently, footprinting data show that the antibiotic binding does not prevent nucleation of the promoter DNA melting but instead blocks its propagation towards the active site. Myxopyronins are thus, to our knowledge, a first structurally characterized class of antibiotics that target formation of the pre- catalytic transcription initiation complex the decisive step in gene expression control. Notably, mutations designed in switch- 2 mimic the dMyx effects on promoter complexes in the absence of antibiotic. Overall, our results indicate a plausible mechanism of the dMyx action and a stepwise pathway of open complex formation in which core enzyme mediates the final stage of DNA melting near the transcription start site, and that switch- 2 might act as a molecular checkpoint for DNA loading in response to regulatory signals or antibiotics. The universally conserved switch- 2 may have the same role in all multisubunit RNAPs.	[Belogurov, Georgiy A.; Sevostyanova, Anastasiya; Artsimovitch, Irina] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Vassylyeva, Marina N.; Klyuyev, Sergiy; Vassylyev, Dmitry G.] Univ Alabama, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Vassylyeva, Marina N.; Klyuyev, Sergiy; Vassylyev, Dmitry G.] Univ Alabama, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Appleman, James R.; Xiang, Alan X.; Lira, Ricardo; Webber, Stephen E.] Anadys Pharmaceut Inc, San Diego, CA 92121 USA; [Nudler, Evgeny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	University System of Ohio; Ohio State University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; New York University	Artsimovitch, I (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12Th Ave, Columbus, OH 43210 USA.	artsimovitch.1@osu.edu; dmitry@uab.edu	Artsimovitch, Irina/L-3467-2019; Vassylyev, Dmitry/A-9005-2008	Nudler, Evgeny/0000-0002-8811-3071; Belogurov, Georgiy/0000-0002-3070-6843	US Department of Energy, Office of Energy Research [W-31-109-Eng-38]; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074840, R01GM058750, R01GM074252] Funding Source: NIH RePORTER	US Department of Energy, Office of Energy Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	T. Townes for critical reading of the manuscript and R. Saecker for many stimulating discussions. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Energy Research under contract No. W-31-109-Eng-38. This work was supported by National Institutes of Health grants to I.A. and D.G.V.	Artsimovitch I, 2005, CELL, V122, P351, DOI 10.1016/j.cell.2005.07.014; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Artsimovitch I, 1996, P NATL ACAD SCI USA, V93, P9408, DOI 10.1073/pnas.93.18.9408; Belogurov GA, 2007, MOL CELL, V26, P117, DOI 10.1016/j.molcel.2007.02.021; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen YF, 1997, J MOL BIOL, V267, P47, DOI 10.1006/jmbi.1996.0853; Craig ML, 1998, J MOL BIOL, V283, P741, DOI 10.1006/jmbi.1998.2129; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Davis CA, 2007, P NATL ACAD SCI USA, V104, P7833, DOI 10.1073/pnas.0609888104; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; IRSCHIK H, 1983, J ANTIBIOT, V36, P1651, DOI 10.7164/antibiotics.36.1651; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuznedelov K, 2002, EMBO J, V21, P1369, DOI 10.1093/emboj/21.6.1369; Li XY, 1998, J BIOL CHEM, V273, P23558, DOI 10.1074/jbc.273.36.23558; Lira R, 2007, BIOORG MED CHEM LETT, V17, P6797, DOI 10.1016/j.bmcl.2007.10.017; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Severinov K, 1997, P NATL ACAD SCI USA, V94, P13481, DOI 10.1073/pnas.94.25.13481; SUH WC, 1993, SCIENCE, V259, P358, DOI 10.1126/science.8420002; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2005, NAT STRUCT MOL BIOL, V12, P1086, DOI 10.1038/nsmb1015; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Vassylyeva MN, 2002, ACTA CRYSTALLOGR D, V58, P1497, DOI 10.1107/S0907444902011770	31	106	113	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					332	U8		10.1038/nature07510	http://dx.doi.org/10.1038/nature07510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	18946472	Green Accepted			2022-12-28	WOS:000262440900043
J	Huang, JF; Mao, YL; Millis, JM				Huang, Jiefu; Mao, Yilei; Millis, J. Michael			Government policy and organ transplantation in China	LANCET			English	Editorial Material									[Huang, Jiefu; Mao, Yilei] Beijing Union Med Coll Hosp, Beijing 100730, Peoples R China; [Millis, J. Michael] Univ Chicago, Sect Transplantat, Chicago, IL 60637 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Chicago	Huang, JF (corresponding author), Beijing Union Med Coll Hosp, Beijing 100730, Peoples R China.	liuyong@moh.gov.cn	Millis, Michael/K-5346-2019					Abbud M, 2008, LANCET, V372, P5, DOI 10.1016/S0140-6736(08)60967-8; Cronin DC, 2001, NEW ENGL J MED, V344, P1633, DOI 10.1056/NEJM200105243442112; *HLTH CMO, 2008, REG HUM ORG TRANSPL; Huang Jie-fu, 2007, Zhonghua Wai Ke Za Zhi, V45, P292; Huang JF, 2007, LIVER TRANSPLANT, V13, P193, DOI 10.1002/lt.21081; Medicare Program, 2007, FED REGISTER, V72, P15198; Tibell A, 2007, TRANSPLANTATION, V84, P292, DOI 10.1097/01.tp.0000275181.33071.07; *UN ORG SHAR, 2007, DES TRANSPL PROGR CR; WENJUN C, 2008, ORGAN ACTION LIVER T	9	57	80	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2008	372	9654					1937	1938		10.1016/S0140-6736(08)61359-8	http://dx.doi.org/10.1016/S0140-6736(08)61359-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380NE	18930537				2022-12-28	WOS:000261471600009
J	Hu, XUJ; Cook, S; Salazar, MA				Hu, Xiaojiang; Cook, Sarah; Salazar, Miguel A.			Internal migration and health in China	LANCET			English	Editorial Material							TO-URBAN MIGRANTS		[Hu, Xiaojiang; Salazar, Miguel A.] Beijing Normal Univ, Inst Social Dev & Publ Policy, Beijing 100875, Peoples R China; [Cook, Sarah] Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England	Beijing Normal University; University of Sussex	Hu, XUJ (corresponding author), Beijing Normal Univ, Inst Social Dev & Publ Policy, Beijing 100875, Peoples R China.	Xhu@bnu.edu.cn		Cook, Sarah/0000-0002-2308-3967				Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; DENG HJ, 2004, SHANGHAI J PREVENTIV, V8, P375; Dummer TJB, 2007, HEALTH POLICY, V83, P1, DOI 10.1016/j.healthpol.2006.12.002; Escobar JI, 2000, HARVARD REV PSYCHIAT, V8, P64; FANG F, 2008, BEIJING DAILY   0507; GUO ZH, 2001, CHINA COMM MED, V7, P23; Hong Y, 2006, AIDS BEHAV, V10, P421, DOI 10.1007/s10461-005-9039-5; HUANG QL, 2001, J CHINESE ANTITUBERC, V23, P360; Li Xiaoming, 2006, World Health Popul, V8, P5; Li XM, 2004, AIDS EDUC PREV, V16, P538, DOI 10.1521/aeap.16.6.538.53787; LIU YL, 1995, SOC SCI MED, V41, P1085, DOI 10.1016/0277-9536(95)00428-A; Nansheng Bai, 2002, SHEHUIXUE YANJIU, V3, P64; Nielsen I, 2005, GLOB SOC POLICY, V5, P353, DOI 10.1177/1468018105057416; Pringle TE, 2003, INT J OCCUP ENV HEAL, V9, P309, DOI 10.1179/oeh.2003.9.4.309; THOMAS J, 1998, AIDS LINK, V49, P12; Wang Y, 2008, TROP MED INT HEALTH, V13, P927, DOI 10.1111/j.1365-3156.2008.02093.x; Yang Y.M., 2005, CHINESE PRIMARY HLTH, V6, P10; ZHANG Z, 2002, WSEAS T COMMUNICATIO, V1, P47; Zhang ZQ., 2007, STAT RES, V24, P9; Zhu L., 2007, CHIN HLTH RESOUR, V02, P89	20	251	259	1	61	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2008	372	9651					1717	1719		10.1016/S0140-6736(08)61360-4	http://dx.doi.org/10.1016/S0140-6736(08)61360-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	374XV	18930533	Bronze, Green Published			2022-12-28	WOS:000261077900009
J	Hernando, E				Hernando, Eva			CANCER Aneuploidy Advantages?	SCIENCE			English	Editorial Material									[Hernando, Eva] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University	Hernando, E (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	hernando@med.nyu.edu		Hernando, Eva/0000-0003-1023-0312				Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Cahill DP, 1999, TRENDS CELL BIOL, V9, pM57, DOI 10.1016/S0962-8924(99)01661-X; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Sussan TE, 2008, NATURE, V451, P73, DOI 10.1038/nature06446; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058	6	12	13	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					692	693		10.1126/science.1166151	http://dx.doi.org/10.1126/science.1166151			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974340				2022-12-28	WOS:000260605200033
J	Johnson, CH; Egli, M; Stewart, PL				Johnson, Carl Hirschie; Egli, Martin; Stewart, Phoebe L.			Structural Insights into a Circadian Oscillator	SCIENCE			English	Review							CLOCK PROTEINS KAIA; GENE-EXPRESSION; CRYSTAL-STRUCTURE; CELL-DIVISION; PHOSPHORYLATION; RHYTHMS; FEEDBACK; COMPLEX; SYSTEM	An endogenous circadian system in cyanobacteria exerts pervasive control over cellular processes, including global gene expression. Indeed, the entire chromosome undergoes daily cycles of topological changes and compaction. The biochemical machinery underlying a circadian oscillator can be reconstituted in vitro with just three cyanobacterial proteins, KaiA, KaiB, and KaiC. These proteins interact to promote conformational changes and phosphorylation events that determine the phase of the in vitro oscillation. The high- resolution structures of these proteins suggest a ratcheting mechanism by which the KaiABC oscillator ticks unidirectionally. This posttranslational oscillator may interact with transcriptional and translational feedback loops to generate the emergent circadian behavior in vivo. The conjunction of structural, biophysical, and biochemical approaches to this system reveals molecular mechanisms of biological timekeeping.	[Johnson, Carl Hirschie] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Egli, Martin] Vanderbilt Univ, Dept Biochem, Nashville, TN 37235 USA; [Stewart, Phoebe L.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Johnson, CH (corresponding author), Vanderbilt Univ, Dept Biol Sci, Box 35-1634, Nashville, TN 37235 USA.	carl.h.johnson@vanderbilt.edu	Johnson, Carl H/I-4655-2014		NIH [F32 GM71276]; National Institute of General Medical Sciences [GM067152, GM073845]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067152, F32GM071276, R37GM067152, R01GM073845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043836] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank our colleagues and coauthors at Vanderbilt University, especially M. Byrne, T. Mori, X. Qin, R. Pattanayek, S. Pattanayek, D. Williams, M. Woelfle, and Y. Xu. We also thank T. Kondo, S. Golden, M. Ishiura, and their laboratory members whose seminal contributions continue to make the study of cyanobacterial clocks fascinating. Supported by funds from the NIH, specifically the National Institute of General Medical Sciences ( grant GM067152 to C.H.J. and grant GM073845 to M.E.). Additional support from the NIH (grant F32 GM71276 to D. R. Williams in the Stewart laboratory) is gratefully acknowledged.	Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Egli M, 2008, MODELS, MYSTERIES AND MAGIC OF MOLECULES, P283, DOI 10.1007/978-1-4020-5941-4_13; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Garces RG, 2004, EMBO J, V23, P1688, DOI 10.1038/sj.emboj.7600190; Hayashi F, 2004, BIOCHEM BIOPH RES CO, V316, P195, DOI 10.1016/j.bbrc.2004.02.034; Hitomi K, 2005, J BIOL CHEM, V280, P19127, DOI 10.1074/jbc.M411284200; Huang GC, 2007, GENE DEV, V21, P3283, DOI 10.1101/gad.1610207; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Ito H, 2007, NAT STRUCT MOL BIOL, V14, P1084, DOI 10.1038/nsmb1312; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Johnson CH, 2005, METHOD ENZYMOL, V393, P818, DOI 10.1016/S0076-6879(05)93043-7; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Katayama M, 1999, J BACTERIOL, V181, P3516, DOI 10.1128/JB.181.11.3516-3524.1999; Kim YI, 2008, P NATL ACAD SCI USA, V105, P12825, DOI 10.1073/pnas.0800526105; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; Kitayama Y, 2008, GENE DEV, V22, P1513, DOI 10.1101/gad.1661808; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; Kondo T, 1997, SCIENCE, V275, P224, DOI 10.1126/science.275.5297.224; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; Mackey SR, 2007, TRENDS MICROBIOL, V15, P381, DOI 10.1016/j.tim.2007.08.005; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Mori T, 2001, J BACTERIOL, V183, P2439, DOI 10.1128/JB.183.8.2439-2444.2001; Mori T, 2007, PLOS BIOL, V5, P841, DOI 10.1371/journal.pbio.0050093; Nakahira Y, 2004, P NATL ACAD SCI USA, V101, P881, DOI 10.1073/pnas.0307411100; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; Pattanayek R, 2008, EMBO J, V27, P1767, DOI 10.1038/emboj.2008.104; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Smith RM, 2006, P NATL ACAD SCI USA, V103, P8564, DOI 10.1073/pnas.0508696103; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; Terauchi K, 2007, P NATL ACAD SCI USA, V104, P16377, DOI 10.1073/pnas.0706292104; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Vakonakis I, 2004, P NATL ACAD SCI USA, V101, P10925, DOI 10.1073/pnas.0403037101; Vakonakis L, 2004, P NATL ACAD SCI USA, V101, P1479, DOI 10.1073/pnas.0305516101; Woelfle MA, 2007, P NATL ACAD SCI USA, V104, P18819, DOI 10.1073/pnas.0706069104; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Ye S, 2004, J BIOL CHEM, V279, P20511, DOI 10.1074/jbc.M400077200	42	58	60	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					697	701		10.1126/science.1150451	http://dx.doi.org/10.1126/science.1150451			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974343	Green Accepted			2022-12-28	WOS:000260605200036
J	Lin, HH; Murray, M; Cohen, T; Colijn, C; Ezzati, M				Lin, Hsien-Ho; Murray, Megan; Cohen, Ted; Colijn, Caroline; Ezzati, Majid			Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study	LANCET			English	Article							AIR-POLLUTION; HEALTH SYSTEM; RURAL CHINA; MORTALITY; TOBACCO; BURDEN; INTERVENTIONS; CESSATION; DISEASE; IMPROVEMENT	Background Chronic obstructive pulmonary disease (COPD), lung cancer, and tuberculosis are three leading causes of death in China, where prevalences of smoking and solid-fuel use are also high. We aimed to predict the effects of risk-factor trends on COPD, lung cancer, and tuberculosis. Methods We used representative data sources to estimate past trends in smoking and household solid-fuel use and to construct a range of future scenarios. We obtained the aetiological effects of risk factors on diseases from meta-analyses of epidemiological studies and from large studies in China. We modelled future COPD and lung cancer mortality and tuberculosis incidence, taking into account the accumulation of hazardous effects of risk factors on COPD and lung cancer over time, and dependency of the risk of tuberculosis infection on the prevalence of disease. We quantified the sensitivity of our results to methods and data choices. Findings If smoking and solid-fuel use remain at current levels between 2003 and 2033, 65 million deaths from COPD and 18 million deaths from lung cancer are predicted in China; 82% of COPD deaths and 75% of lung cancer deaths will be attributable to the combined effects of smoking and solid-fuel use. Complete gradual cessation of smoking and solid-fuel use by 2033 could avoid 26 million deaths from COPD and 6.3 million deaths from lung cancer; interventions of intermediate magnitude would reduce deaths by 6-31% (COPD) and 8-26% (lung cancer). Complete cessation of smoking and solid-fuel use by 2033 would reduce the projected annual tuberculosis incidence in 2033 by 1.4-52% if 80% DOTS coverage is sustained, 27-62% if 50% coverage is sustained, or 33-71% if 20% coverage is sustained. Interpretation Reducing smoking and solid-fuel use can substantially lower predictions of COPD and lung cancer burden and would contribute to effective tuberculosis control in China. Funding International Union Against Tuberculosis and Lung Disease.	[Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA; [Lin, Hsien-Ho; Murray, Megan; Cohen, Ted] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Lin, Hsien-Ho] Mennonite Christian Hosp, Community Hlth Soc, Hualien, Taiwan; [Murray, Megan] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Murray, Megan; Cohen, Ted] Brigham & Womens Hosp, Div Social Med & Hlth Inequal, Boston, MA 02115 USA; [Colijn, Caroline] Univ Bristol, Dept Engn Math, Bristol, Avon, England; [Ezzati, Majid] Harvard Univ, Initiat Global Hlth, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; University of Bristol; Harvard University	Ezzati, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	majid_ezzati@harvard.edu	Tomescu, Cleopatra M/F-5197-2011; Cohen, Ted/G-8101-2011	LIN, HSIEN-HO/0000-0002-7481-6016; Green, Jonathan/0000-0002-0143-181X; Cohen, Ted/0000-0002-8091-7198	International Union Against Tuberculosis and Lung Disease; World Bank; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI055985] Funding Source: NIH RePORTER	International Union Against Tuberculosis and Lung Disease; World Bank(The World Bank India); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the International Union Against Tuberculosis and Lung Disease, through a grant from the World Bank. We thank Cheng-Yuan Chiang, Donald Enarson, Ems Baris, and Ziad Obermeyer for Valuable discussion on methods and models, Colin Mathers for mortality projections, Zheng Zhou for help with data on smoking and fuel use, Jonathan Sinton for discussions on fuels use trends in China, and the Chinese Ministry of Health for tuberculosis prevalence data. We thank the China Health and Nutrition Survey, Jill Boreham, Rachel Huxley, and Zhengming Chen for valuable information and data on risk factor exposure and effects.	Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; Alcaide J, 1996, TUBERCLE LUNG DIS, V77, P112, DOI 10.1016/S0962-8479(96)90024-6; [Anonymous], 2003, TOBACCO CONTROL POLI; Baris E, 2004, BMJ-BRIT MED J, V329, P1090, DOI 10.1136/bmj.329.7474.1090; Barnes DF, 2005, URBAN HOUSEHOLD ENER; Barroso Elizabeth Clara, 2003, J. Pneumologia, V29, P89, DOI 10.1590/S0102-35862003000200008; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Chapman RS, 2005, BMJ-BRIT MED J, V331, P1050, DOI 10.1136/bmj.38628.676088.55; Chapman Simon, 2003, N S W Public Health Bull, V14, P46, DOI 10.1071/NB03013; Chen XY, 2004, LANCET, V364, P417; *CHIN CDCP CAR POP, CHIN HLTH NUTR SURV; *CHIN DAT CTR, CHIN YEARL MACR STAT; Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5; Cohen T, 2006, P NATL ACAD SCI USA, V103, P7042, DOI 10.1073/pnas.0600349103; Colijn C, 2007, J THEOR BIOL, V247, P765, DOI 10.1016/j.jtbi.2007.04.015; *DEP AGR, 1997, CHIN RUR EN YB 1991; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; El Sony A, 2007, INT J TUBERC LUNG D, V11, P150; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2004, ANNU REV ENV RESOUR, V29, P383, DOI 10.1146/annurev.energy.29.062103.121246; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Ezzati M, 2004, COMP QUANTIFICATION; FERNANDEZ GO, 2006, ENCUESTA NACL SALUD; Florig HK, 1997, ENVIRON SCI TECHNOL, V31, pA274, DOI 10.1021/es972315t; Gakidou E, 2007, JAMA-J AM MED ASSOC, V298, P1876, DOI 10.1001/jama.298.16.1876; GILMORE J, 2002, REPORT SMOKING CANAD; Grimard Franque, IMPACT TUBERCULOSIS; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; Harries AD, 2008, PLOS MED, V5, P859, DOI 10.1371/journal.pmed.0050124; Hedley AJ, 2002, LANCET, V360, P1646, DOI 10.1016/S0140-6736(02)11612-6; Huxley R, 2007, AM J EPIDEMIOL, V165, P1280, DOI 10.1093/aje/kwm002; International Energy Agency, 2002, WORLD EN OUTL 2002; Jha P., 2000, TOBACCO CONTROL DEV; Jha P, 2006, DRUG ALCOHOL REV, V25, P597, DOI 10.1080/09595230600944511; Jiang L., 2004, INT J GLOBAL ENERGY, V21, P2, DOI DOI 10.1504/IJGEI.2004.004691; KOH H, 2002, TOBACCO CONTROL S11, V11, P1; Lan Q, 2002, J NATL CANCER I, V94, P826, DOI 10.1093/jnci/94.11.826; Laxminarayan R, 2007, EC BENEFIT TUBERCULO; Leung CC, 2004, AM J RESP CRIT CARE, V170, P1027, DOI 10.1164/rccm.200404-512oc; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Masera, 2005, ENERGY SUSTAIN DEV, V9, P25, DOI [10.1016/S0973-0826(08)60480-9, DOI 10.1016/S0973-0826(08)60480-9]; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; *MIN HLTH, 1994, RES NAT HLTH SERV AN; *MIN HLTH, 1999, RES NAT HLTH SERV AN; *MIN PUBL HLTH PEO, 1985, NAT RAND SURV EP TUB; *MIN PUBL HLTH PEO, 2000, NAT RAND SURV EP TUB; *MIN PUBL HLTH PEO, 1979, NAT RAND SURV EP TUB; *MIN PUBL HLTH PEO, 1990, NAT RAND SURV EP TUB; Ministry of Health, 2004, RES NAT HLTH SERV AN; Onyebujoh PC, 1999, LANCET, V354, P116, DOI 10.1016/S0140-6736(98)10448-8; *POP CENS OFF, 2002, TAB 2000 POP CENS PR; Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922; Sassi F., 2008, PREVENTION LIFESTYLE; Schneider NK, 2007, B WORLD HEALTH ORGAN, V85, P820, DOI 10.2471/BLT.07.034797; Shafey O, 2003, TOBACCO CONTROL COUN; Sinton JE, 2004, ENERGY SUSTAIN DEV, V8, P33, DOI [10.1016/S0973-0826(08)60465-2, DOI 10.1016/S0973-0826(08)60465-2]; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Smith K.R., 2004, COMP QUANTIFICATION, V18, P1435; SMITH KR, 1993, WORLD DEV, V21, P941, DOI 10.1016/0305-750X(93)90053-C; SPRINGETT V H, 1971, Tubercle, V52, P73, DOI 10.1016/0041-3879(71)90015-8; Squire SB, 2004, LANCET, V364, P391, DOI 10.1016/S0140-6736(04)16777-9; Suhrcke M., 2006, CHRONIC DIS EC PERSP; Tang SL, 2005, HEALTH POLICY, V72, P93, DOI 10.1016/j.healthpol.2004.06.009; Thun MJ, 1997, NATL CANCER I MONOGR, P305; United Nations Population Division, WORLD POP PROSP 2006; *US DEP HHS, 1990, DHHS PUBL CDC; Vynnycky E, 1999, INT J EPIDEMIOL, V28, P327, DOI 10.1093/ije/28.2.327; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268; Wang Jun, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P837; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; World Bank, 2007, COST POLLUTION CHINA; Yan F, 2007, HEALTH POLICY, V82, P186, DOI 10.1016/j.healthpol.2006.08.001; [杨功焕 Yang Gonghuan], 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P77; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479; Zhang TH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-19	79	184	210	2	57	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2008	372	9648					1473	1483		10.1016/S0140-6736(08)61345-8	http://dx.doi.org/10.1016/S0140-6736(08)61345-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370ZJ	18835640	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000260801300024
J	Montgomery, MH				Montgomery, M. H.			Astronomy - The pulse of distant stars	SCIENCE			English	Editorial Material							WHOLE EARTH TELESCOPE		[Montgomery, M. H.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Montgomery, M. H.] Mt Cuba Observ, Delaware Asteroseism Res Ctr, Greenville, DE USA	University of Texas System; University of Texas Austin	Montgomery, MH (corresponding author), Univ Texas Austin, Dept Astron, RLM 15308, Austin, TX 78712 USA.	mikemon@astro.as.utexas.edu		Montgomery, Michael/0000-0002-6748-1748				Ahmad QR, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.011301; Gough DO, 1996, SCIENCE, V272, P1281, DOI 10.1126/science.272.5266.1281; Michel E, 2008, SCIENCE, V322, P558, DOI 10.1126/science.1163004; SANDAGE A, 1968, ASTROPHYS J, V151, P531, DOI 10.1086/149454; WINGET DE, 1991, ASTROPHYS J, V378, P326, DOI 10.1086/170434; WINGET DE, 1994, ASTROPHYS J, V430, P839, DOI 10.1086/174455	6	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					536	537		10.1126/science.1164633	http://dx.doi.org/10.1126/science.1164633			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948527				2022-12-28	WOS:000260299100025
J	Kim, HJ; Oh, SA; Brownfield, L; Hong, SH; Ryu, H; Hwang, I; Twell, D; Nam, HG				Kim, Hyo Jung; Oh, Sung Aeong; Brownfield, Lynette; Hong, Sung Hyun; Ryu, Hojin; Hwang, Ildoo; Twell, David; Nam, Hong Gil			Control of plant germline proliferation by SCFFBL17 degradation of cell cycle inhibitors	NATURE			English	Article							F-BOX PROTEINS; FUNCTIONAL-ANALYSIS; ARABIDOPSIS; EXPRESSION; SIGNAL; GENE; INSIGHTS; MUTANTS; COMPLEX; TOBACCO	Flowering plants possess a unique reproductive strategy, involving double fertilization by twin sperm cells(1). Unlike animal germ lines, the male germ cell lineage in plants only forms after meiosis and involves asymmetric division of haploid microspores, to produce a large, non- germline vegetative cell and a germ cell that undergoes one further division to produce the twin sperm cells(2). Although this switch in cell cycle control is critical for sperm cell production and delivery, the underlying molecular mechanisms are unknown. Here we identify a novel F- box protein of Arabidopsis thaliana, designated FBL17 ( F- box- like 17), that enables this switch by targeting the degradation of cyclin- dependent kinase A; 1 inhibitors specifically in male germ cells. We show that FBL17 is transiently expressed in the male germ line after asymmetric division and forms an SKP1 -Cullin1 - F- box protein ( SCF) E3 ubiquitin ligase complex (SCFFBL17) that targets the cyclin- dependent kinase inhibitors KRP6 and KRP7 for proteasome- dependent degradation. Accordingly, the loss of FBL17 function leads to the stabilization of KRP6 and inhibition of germ cell cycle progression. Our results identify SCFFBL17 as an essential male germ cell proliferation complex that promotes twin sperm cell production and double fertilization in flowering plants.	[Oh, Sung Aeong; Brownfield, Lynette; Twell, David] Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England; [Kim, Hyo Jung; Hong, Sung Hyun; Ryu, Hojin; Hwang, Ildoo; Nam, Hong Gil] Pohang Univ Sci & Technol, Div Mol Life Sci, Pohang 790784, South Korea; [Nam, Hong Gil] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, South Korea	University of Leicester; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Twell, D (corresponding author), Univ Leicester, Dept Biol, Univ Rd, Leicester LE1 7RH, Leics, England.	twe@le.ac.uk; nam@postech.ac.kr	Twell, David/D-8043-2011	Twell, David/0000-0003-0483-1461	MOST ( KOSEF) through the National Core Research Center for Systems Bio-Dynamics; Crop Functional Genomics Research Program; Biotechnology and Biological Sciences Research Council; BK21 research fellowship for Life Science, Kyungpook National University; KRF grant; MOHERD; BBSRC [BB/E001017/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E001017/1, BB/C004205/1] Funding Source: researchfish	MOST ( KOSEF) through the National Core Research Center for Systems Bio-Dynamics(Korea Science and Engineering Foundation); Crop Functional Genomics Research Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BK21 research fellowship for Life Science, Kyungpook National University; KRF grant(National Research Foundation of Korea); MOHERD; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank K.H. Suh, Y.S. Park and B.H. Kim for technical assistance. This work was supported by MOST (KOSEF) through the National Core Research Center for Systems Bio-Dynamics (to H.G.N.) and the Crop Functional Genomics Research Program (to H.G.N.), by the Biotechnology and Biological Sciences Research Council (to D.T.), by the BK21 research fellowship for Life Science, Kyungpook National University ( to S.A.O.), and by a KRF grant from MOHERD (to I.H.).	Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Veylder L, 2001, PLANT CELL, V13, P1653, DOI 10.2307/3871392; Duplakova N, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-39; Durbarry A, 2005, PLANT PHYSIOL, V137, P297, DOI 10.1104/pp.104.053165; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Howden R, 1998, GENETICS, V149, P621; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Iwakawa H, 2006, PLANT J, V45, P819, DOI 10.1111/j.1365-313X.2005.02643.x; Kiba T, 2007, PLANT CELL, V19, P2516, DOI 10.1105/tpc.107.053033; Koo JC, 2004, PLANT J, V37, P439, DOI 10.1046/j.1365-313X.2003.01869.x; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Nowack MK, 2006, NAT GENET, V38, P63, DOI 10.1038/ng1694; Padidam M, 2003, TRANSGENIC RES, V12, P101, DOI 10.1023/A:1022113817892; Park SK, 2004, SEX PLANT REPROD, V17, P63, DOI 10.1007/s00497-004-0216-x; Park SK, 1998, DEVELOPMENT, V125, P3789; Park SK, 2001, PLANT PHYSIOL, V126, P899, DOI 10.1104/pp.126.2.899; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rotman N, 2005, CURR BIOL, V15, P244, DOI 10.1016/j.cub.2005.01.013; Ryu JS, 2005, CELL, V120, P395, DOI 10.1016/j.cell.2004.12.019; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Toda T, 1999, PHILOS T ROY SOC B, V354, P1551, DOI 10.1098/rstb.1999.0498; Verdaguer B, 1996, PLANT MOL BIOL, V31, P1129, DOI 10.1007/BF00040830; Verkest A, 2005, PLANT PHYSIOL, V139, P1099, DOI 10.1104/pp.105.069906; Xiao WY, 2000, TRENDS PLANT SCI, V5, P454, DOI 10.1016/S1360-1385(00)01769-6; Yadegari R, 2004, PLANT CELL, V16, pS133, DOI 10.1105/tpc.018192	36	147	152	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2008	455	7216					1134	U14		10.1038/nature07289	http://dx.doi.org/10.1038/nature07289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948957				2022-12-28	WOS:000260252600050
J	Daniels, N; Sabin, JE				Daniels, Norman; Sabin, James E.			Accountability for reasonableness - an update	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Daniels, Norman] Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA; [Sabin, James E.] Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Daniels, N (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	ndaniels@hsph.harvard.edu						Daniels N, 2000, BMJ-BRIT MED J, V321, P1300, DOI 10.1136/bmj.321.7272.1300; Daniels N, 1997, PHILOS PUBLIC AFF, V26, P303, DOI 10.1111/j.1088-4963.1997.tb00082.x; Daniels N, 2002, SETTING LIMITS FAIRL; Daniels Norman, 2008, JUST HLTH M HLTH NEE; Gonzalez-Pier E, 2006, LANCET, V368, P1608, DOI 10.1016/S0140-6736(06)69567-6; Gruskin S, 2008, AM J PUBLIC HEALTH, V98, P1573, DOI 10.2105/AJPH.2007.123182; *NAT I HLTH CLIN E, 2005, SOC VAL JUDGM PRINC; *OR HLTH FUND BOAR, 2008, AIM HIGH BUILD HLTH; *OR HLTH POL RES, 2008, OR HLTH FUND BOARD; Rawlins MD, 2005, CLIN MED, V5, P471, DOI 10.7861/clinmedicine.5-5-471; Sabin JE., 2008, SETTING LIMITS FAIRL	11	118	118	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2008	337	7675							a1850	10.1136/bmj.a1850	http://dx.doi.org/10.1136/bmj.a1850			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	360YE	18845595				2022-12-28	WOS:000260093900031
J	Janes, KA; Reinhardt, HC; Yaffe, MB				Janes, Kevin A.; Reinhardt, H. Christian; Yaffe, Michael B.			Cytokine-Induced Signaling Networks Prioritize Dynamic Range over Signal Strength	CELL			English	Article							NF-KAPPA-B; INDUCED APOPTOSIS; GENE-EXPRESSION; ERK ACTIVATION; MESSENGER-RNA; MAP KINASE; CANCER; IDENTIFICATION; MIGRATION; TNF	Signaling networks respond to diverse stimuli, but how the state of the signaling network is relayed to downstream cellular responses is unclear. We modeled how incremental activation of signaling molecules is transmitted to control apoptosis as a function of signal strength and dynamic range. A linear relationship between signal input and response output, with the dynamic range of signaling molecules uniformly distributed across activation states, most accurately predicted cellular responses. When nonlinearized signals with compressed dynamic range relay network activation to apoptosis, we observe catastrophic, stimulus-specific prediction failures. We develop a general computational technique, "model-breakpoint analysis,'' to analyze the mechanism of these failures, identifying new time- and stimulus-specific roles for Akt, ERK, and MK2 kinase activity in apoptosis, which were experimentally verified. Dynamic range is rarely measured in signal-transduction studies, but our experiments using model-break-point analysis suggest it may be a greater determinant of cell fate than measured signal strength.	[Janes, Kevin A.; Reinhardt, H. Christian; Yaffe, Michael B.] MIT, Dept Biol, Koch Inst Integrat Canc Res, Ctr Cell Decis Proc, Cambridge, MA 02139 USA; [Janes, Kevin A.; Reinhardt, H. Christian; Yaffe, Michael B.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Janes, Kevin A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Yaffe, MB (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, Ctr Cell Decis Proc, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	myaffe@mit.edu			National Institute of Health [GM68762, CA112967, ES015339]; Deutsche Forschungsgemeinschaft [RE2246/1-1]; David H. Koch Fund; Edgerly Science Innovation Fund; American Cancer Society [PF-05-224-01-MGO]; NATIONAL CANCER INSTITUTE [U54CA112967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762, R01GM060594] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); David H. Koch Fund; Edgerly Science Innovation Fund; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Neil Kumar for providing the phosphoproteomic model and Suzanne Gaudet, Greg Hoffman, and Stephanie Walker for critically reading this manuscript. This work was supported by the National Institute of Health (GM68762, CA112967, ES015339 to M.B.Y.), the Deutsche Forschungsgemeinschaft (RE2246/1-1 to H. C. R.), the David H. Koch Fund, the Edgerly Science Innovation Fund, and the American Cancer Society ( New England Division-SpinOdyssey 2005, PF-05-224-01-MGO to K.A.J.).	Albeck JG, 2006, NAT REV MOL CELL BIO, V7, P803, DOI 10.1038/nrm2042; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Efron B., 1994, MONOGRAPHS STAT APPL; Gaudet S, 2005, MOL CELL PROTEOMICS, V4, P1569, DOI 10.1074/mcp.M500158-MCP200; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/1066527041887258; Janes KA, 2003, MOL CELL PROTEOMICS, V2, P463, DOI 10.1074/mcp.M300045-MCP200; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kumar N, 2007, PLOS COMPUT BIOL, V3, P35, DOI 10.1371/journal.pcbi.0030004; LAGNADO CA, 1994, MOL CELL BIOL, V14, P7984, DOI 10.1128/MCB.14.12.7984; Martens H., 2001, MULTIVARIATE ANAL QU; Matsubayashi Y, 2004, CURR BIOL, V14, P731, DOI 10.1016/j.cub.2004.03.060; Miller-Jensen K, 2007, NATURE, V448, P604, DOI 10.1038/nature06001; Miller-Jensen K, 2006, J CELL SCI, V119, P3788, DOI 10.1242/jcs.03102; Mori N, 1996, BLOOD, V87, P3410, DOI 10.1182/blood.V87.8.3410.bloodjournal8783410; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pradervand S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r11; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Spencer KSR, 2000, J CELL BIOL, V148, P385, DOI 10.1083/jcb.148.2.385; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Torii S, 2006, CANCER SCI, V97, P697, DOI 10.1111/j.1349-7006.2006.00244.x; Tufte E., 2006, BEAUTIFUL EVIDENCE; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; WOLD S, 1994, CHEMOMETR INTELL LAB, V23, P149, DOI 10.1016/0169-7439(93)E0075-F; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094	38	75	77	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 17	2008	135	2					343	354		10.1016/j.cell.2008.08.034	http://dx.doi.org/10.1016/j.cell.2008.08.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957207	Bronze, Green Accepted			2022-12-28	WOS:000260130400023
J	Kriegenburg, F; Seeger, M; Saeki, Y; Tanaka, K; Lauridsen, AMB; Hartmann-Petersen, R; Hendil, KB				Kriegenburg, Franziska; Seeger, Michael; Saeki, Yasushi; Tanaka, Keiji; Lauridsen, Anne-Marie B.; Hartmann-Petersen, Rasmus; Hendil, Klavs B.			Mammalian 26S Proteasomes Remain Intact during Protein Degradation	CELL			English	Article							ATP-DEPENDENT PROTEASES; MULTIUBIQUITIN-CHAIN; DEUBIQUITINATING ENZYME; PROTEOLYTIC PATHWAY; REGULATORY COMPLEX; SUBSTRATE ENTRY; 20S PROTEASOME; FISSION YEAST; HELA-CELLS; UBIQUITIN	It has been suggested that degradation of polyubiquitylated proteins is coupled to dissociation of 26S proteasomes. In contrast, using several independent types of experiments, we find that mammalian proteasomes can degrade polyubiquitylated proteins without disassembling. Thus, immobilized, 35 S-labeled 26S proteasomes degraded polyubiquitylated Sic1 and c-IAP1 without releasing any subunits. In addition, it is predicted that if 26S proteasomes dissociate into 20S proteasomes and regulatory complexes during a degradation cycle, the reassembly rate would be limiting at low proteasome concentrations. However, the rate with which each proteasome degraded polyubiquitylated Sic1 was independent of the proteasome concentration. Likewise, substrate-dependent dissociation of 26S proteasomes could not be detected by nondenaturing electrophoresis. Lastly, epoxomicin-inhibited 20S proteasomes can trap released regulatory complexes, forming inactive 26S proteasomes, but addition of epoxomicin-inhibited 20S proteasomes had no effect on the degradation of either polyubiquitylated Sic1 or UbcH10 by 26S proteasomes or of endogenous substrates in cell extracts.	[Kriegenburg, Franziska; Lauridsen, Anne-Marie B.; Hartmann-Petersen, Rasmus; Hendil, Klavs B.] Dept Biol, DK-2100 Copenhagen O, Denmark; [Seeger, Michael] Charite Univ Med Berlin, Inst Biochem, D-10117 Berlin, Germany; [Saeki, Yasushi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Tokyo Metropolitan Institute of Medical Science	Hartmann-Petersen, R (corresponding author), Dept Biol, August Krogh Bldg,Univ Pk 13, DK-2100 Copenhagen O, Denmark.	rhpetersen@bio.ku.dk; kbhendil@bio.ku.dk	Hartmann-Petersen, Rasmus/K-4434-2014; Saeki, Yasushi/AAR-8198-2021	Hartmann-Petersen, Rasmus/0000-0002-4155-7791; Saeki, Yasushi/0000-0002-9202-5453				Adams GM, 1998, BIOCHEMISTRY-US, V37, P12927, DOI 10.1017/S1431927600024880; Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028; Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GREGORI L, 1990, J BIOL CHEM, V265, P8354; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guterman A, 2004, CURR PROTEIN PEPT SC, V5, P201, DOI 10.2174/1389203043379756; Hartmann-Petersen R, 2003, TRENDS BIOCHEM SCI, V28, P26, DOI 10.1016/S0968-0004(02)00002-6; Hartmann-Petersen R, 2001, ARCH BIOCHEM BIOPHYS, V386, P89, DOI 10.1006/abbi.2000.2178; HENDIL KB, 1988, BIOCHEM INT, V17, P471; Hendil KB, 2002, J MOL BIOL, V315, P627, DOI 10.1006/jmbi.2001.5285; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Horwitz AA, 2007, J BIOL CHEM, V282, P22921, DOI 10.1074/jbc.M702846200; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Klare N, 2007, J MOL BIOL, V373, P1, DOI 10.1016/j.jmb.2007.07.038; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kominami K, 1997, MOL BIOL CELL, V8, P171, DOI 10.1091/mbc.8.1.171; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Liu CW, 2002, J BIOL CHEM, V277, P26815, DOI 10.1074/jbc.M201782200; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MA CP, 1994, J BIOL CHEM, V269, P3539; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; ORINO E, 1991, FEBS LETT, V284, P206, DOI 10.1016/0014-5793(91)80686-W; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Singh SK, 1999, BIOCHEMISTRY-US, V38, P14906, DOI 10.1021/bi991615f; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith SE, 2005, WOMAN ART J, V26, P20, DOI 10.2307/3566530; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Stone M, 2004, J MOL BIOL, V344, P697, DOI 10.1016/j.jmb.2004.09.057; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wilkinson CRM, 2000, J BIOL CHEM, V275, P15182, DOI 10.1074/jbc.275.20.15182; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874	64	32	34	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					355	365		10.1016/j.cell.2008.08.032	http://dx.doi.org/10.1016/j.cell.2008.08.032			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957208	Bronze			2022-12-28	WOS:000260130400024
J	Sugimoto, Y; Pou, P; Custance, O; Jelinek, P; Abe, M; Perez, R; Morita, S				Sugimoto, Yoshiaki; Pou, Pablo; Custance, Oscar; Jelinek, Pavel; Abe, Masayuki; Perez, Ruben; Morita, Seizo			Complex patterning by vertical interchange atom manipulation using atomic force microscopy	SCIENCE			English	Article							SCANNING TUNNELING MICROSCOPE; SURFACE; QUANTUM; ENERGY	The ability to incorporate individual atoms in a surface following predetermined arrangements may bring future atom-based technological enterprises closer to reality. Here, we report the assembling of complex atomic patterns at room temperature by the vertical interchange of atoms between the tip apex of an atomic force microscope and a semiconductor surface. At variance with previous methods, these manipulations were produced by exploring the repulsive part of the short-range chemical interaction between the closest tip-surface atoms. By using first-principles calculations, we clarified the basic mechanisms behind the vertical interchange of atoms, characterizing the key atomistic processes involved and estimating the magnitude of the energy barriers between the relevant atomic configurations that leads to these manipulations.	[Custance, Oscar] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Jelinek, Pavel] Acad Sci Czech Republic, Inst Phys, Prague 186253, Czech Republic; [Abe, Masayuki] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Sugimoto, Yoshiaki; Abe, Masayuki; Morita, Seizo] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Pou, Pablo; Perez, Ruben] Univ Autonoma Madrid, Dept Fis Teor Mat Condensada, E-28049 Madrid, Spain	National Institute for Materials Science; Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; Japan Science & Technology Agency (JST); Osaka University; Autonomous University of Madrid	Custance, O (corresponding author), Natl Inst Mat Sci, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	custance.oscar@nims.go.jp	Pou, Pablo/C-3888-2012; Jelínek, Pavel/ABE-8589-2020; Abe, Masayuki/I-9274-2018; CUSTANCE, Oscar/H-2924-2011; Jelinek, Pavel/G-1542-2010; Perez, Ruben/F-1849-2010; Abe, Masayuki/X-3707-2019; 清三, 森田/W-1919-2019; Sugimoto, Yoshiaki/K-1691-2013	Pou, Pablo/0000-0002-5854-8218; Jelínek, Pavel/0000-0002-5645-8542; Jelinek, Pavel/0000-0002-5645-8542; Perez, Ruben/0000-0001-5896-541X; Abe, Masayuki/0000-0001-5619-3911; Sugimoto, Yoshiaki/0000-0003-3346-1586; Custance, Oscar/0000-0001-7931-603X	Ministry of Education, Culture, Sports, Science and Technology (MEXT); JST; Handai Frontier Research Center; Global Center of Excellence program "Center for Electronic Devices Innovation; Air Force Office of Scientific Research-Asian Office of Aerospace Research and Development; Frontier Research Base for Global Young Researchers; Ministerio de Educacion y Ciencia (Spain); Grantova Agentura Akademie Ved (Czech Republic)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST)); Handai Frontier Research Center; Global Center of Excellence program "Center for Electronic Devices Innovation(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Air Force Office of Scientific Research-Asian Office of Aerospace Research and Development(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Frontier Research Base for Global Young Researchers; Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Grantova Agentura Akademie Ved (Czech Republic)(Czech Republic Government)	S.Y., O.C., M.A., and S.M. acknowledge support from grants in aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), JST, Handai Frontier Research Center, the Project Atomic Technology funded by MEXT, and Global Center of Excellence program "Center for Electronic Devices Innovation." O.C. also acknowledges support from the Air Force Office of Scientific Research-Asian Office of Aerospace Research and Development. The work of Y.S. is supported by the Frontier Research Base for Global Young Researchers funded by MEXT. P.P. and R.P. acknowledge the support of Ministerio de Educacion y Ciencia (Spain) and computer time provided by Red Espanola de Supercomputacion at the Barcelona Supercomputing Center. P. J. acknowledges the support of Grantova Agentura Akademie Ved (Czech Republic)	Abe M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2108112; ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; Durig U, 1999, APPL PHYS LETT, V75, P433, DOI 10.1063/1.124399; EIGLER DM, 1991, NATURE, V352, P600, DOI 10.1038/352600a0; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Giessibl FJ, 1997, PHYS REV B, V56, P16010, DOI 10.1103/PhysRevB.56.16010; Heinrich AJ, 2002, SCIENCE, V298, P1381, DOI 10.1126/science.1076768; Holscher H, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.075402; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Jelinek P, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.235101; Jemander ST, 2001, SURF SCI, V475, P181, DOI 10.1016/S0039-6028(00)01100-6; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Kantorovich LN, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.236102; Kitchen D, 2006, NATURE, V442, P436, DOI 10.1038/nature04971; Lantz MA, 2001, SCIENCE, V291, P2580, DOI 10.1126/science.1057824; MILLS G, 1994, PHYS REV LETT, V72, P1124, DOI 10.1103/PhysRevLett.72.1124; Oyabu N, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106101; Paz O, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.056103; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Sader JE, 2004, APPL PHYS LETT, V84, P1801, DOI 10.1063/1.1667267; Sasaki N, 2000, JPN J APPL PHYS 2, V39, pL1334, DOI 10.1143/JJAP.39.L1334; Shinada T, 2005, NATURE, V437, P1128, DOI 10.1038/nature04086; Sugimoto Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106104; Sugimoto Y, 2007, NATURE, V446, P64, DOI 10.1038/nature05530; Sugimoto Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.205329; Ternes M, 2008, SCIENCE, V319, P1066, DOI 10.1126/science.1150288	27	194	208	6	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					413	417		10.1126/science.1160601	http://dx.doi.org/10.1126/science.1160601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927388				2022-12-28	WOS:000260094500039
J	Bshary, R; Grutter, AS; Willener, AST; Leimar, O				Bshary, Redouan; Grutter, Alexandra S.; Willener, Astrid S. T.; Leimar, Olof			Pairs of cooperating cleaner fish provide better service quality than singletons	NATURE			English	Article							TIT-FOR-TAT; PARTNER CONTROL; LABROIDES DIMIDIATUS; ANIMAL SOCIETIES; REEF FISH; MUTUALISM; EVOLUTION; PUNISHMENT; ECOLOGY; RATES	Service providers may vary service quality depending on whether they work alone or provide the service simultaneously with a partner. The latter case resembles a prisoner's dilemma(1-4), in which one provider may try to reap the benefits of the interaction without providing the service. Here we present a game- theory model based on the marginal value theorem(5), which predicts that as long as the client determines the duration, and the providers cooperate towards mutual gain, service quality will increase in the pair situation. This prediction is consistent with field observations and with an experiment on cleaning mutualism, in which stable male - female pairs of the cleaner wrasse Labroides dimidiatus repeatedly inspect client fish jointly. Cleaners cooperate by eating ectoparasites(6) off clients but actually prefer to cheat and eat client mucus(7). Because clients often leave in response to such cheating, the benefits of cheating can be gained by only one cleaner during a pair inspection. In both data sets, the increased service quality during pair inspection was mainly due to the smaller females behaving significantly more cooperatively than their larger male partners. In contrast, during solitary inspections, cleaning behaviour was very similar between the sexes. Our study highlights the importance of incorporating interactions between service providers to make more quantitative predictions about cooperation between species.	[Bshary, Redouan; Willener, Astrid S. T.] Univ Neuchatel, Dept Zool, CH-2009 Neuchatel, Switzerland; [Grutter, Alexandra S.] Univ Queensland, Sch Integrat Biol, St Lucia, Qld 4072, Australia; [Leimar, Olof] Stockholm Univ, Dept Zool, SE-10691 Stockholm, Sweden	University of Neuchatel; University of Queensland; Stockholm University	Bshary, R (corresponding author), Univ Neuchatel, Dept Zool, Rue Emile Argand 11 Case Postale 158, CH-2009 Neuchatel, Switzerland.	redouan.bshary@unine.ch	Grutter, Alexandra S/J-2737-2013; Leimar, Olof/L-3781-2014	Grutter, Alexandra S/0000-0003-1688-2821; Leimar, Olof/0000-0001-8621-6977; Bshary, Redouan/0000-0001-7198-8472	Natural Environment Research Council; Swiss Science Foundation; Australian Research Council	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Australian Research Council(Australian Research Council)	We thank the Egyptian Environmental Affairs Agency for permission to work at Ras Mohammed National Park, the Park Rangers and I. Riepl for local support, and M. Wurth and A. Hubl for field assistance. We further thank the Lizard Island Research Station for their support concerning the experiments. R.B. was funded by the Natural Environment Research Council and by the Swiss Science Foundation. A.S.T.W. was funded by the Swiss Science Foundation. A.S.G. was funded by the Australian Research Council. O.L. was funded by the Swedish	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bowles S, 2003, DAHL WS ENV, P153; Bshary R, 2005, BIOL LETTERS, V1, P396, DOI 10.1098/rsbl.2005.0344; Bshary R, 2002, ANIM BEHAV, V63, P557, DOI 10.1006/anbe.2001.1923; Bshary R, 2002, ANIM BEHAV, V63, P547, DOI 10.1006/anbe.2001.1937; Bshary R, 2001, P ROY SOC B-BIOL SCI, V268, P1495, DOI 10.1098/rspb.2001.1495; Bshary R, 2006, NATURE, V441, P975, DOI 10.1038/nature04755; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Cote IM, 2000, OCEANOGR MAR BIOL, V38, P311; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Dugatkin L.A., 1997, COOPERATION ANIMALS; DUGATKIN LA, 1988, BEHAV ECOL SOCIOBIOL, V23, P395, DOI 10.1007/BF00303714; Grutter A, 1996, MAR ECOL PROG SER, V130, P61, DOI 10.3354/meps130061; GRUTTER AS, 1995, MAR ECOL PROG SER, V118, P51, DOI 10.3354/meps118051; Grutter AS, 2003, P ROY SOC B-BIOL SCI, V270, pS242, DOI 10.1098/rsbl.2003.0077; HAMMERSTEIN P, 2003, WHY IS RECIPROCITY S, P83; HEINSOHN R, 1995, SCIENCE, V269, P1260, DOI 10.1126/science.7652573; Johnstone RA, 2002, ECOL LETT, V5, P634, DOI 10.1046/j.1461-0248.2002.00358.x; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; NOE R, 1991, ETHOLOGY, V87, P97; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; ROBERTSON DR, 1972, SCIENCE, V177, P1007, DOI 10.1126/science.177.4053.1007	28	88	89	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					964	U46		10.1038/nature07184	http://dx.doi.org/10.1038/nature07184			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923522	Green Submitted			2022-12-28	WOS:000260038300049
J	Kahrilas, PJ				Kahrilas, Peter J.			Gastroesophageal reflux disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROTON PUMP INHIBITORS; BODY-MASS INDEX; BARRETTS-ESOPHAGUS; ANTIREFLUX SURGERY; UNITED-STATES; GASTRIC-ACID; RISK-FACTORS; FOLLOW-UP; SYMPTOMS; THERAPY		[Kahrilas, Peter J.] Feinberg Sch Med, Div Gastroenterol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Kahrilas, PJ (corresponding author), Feinberg Sch Med, Div Gastroenterol, 676 St Clair St,Suite 1400, Chicago, IL 60611 USA.	p-kahrilas@northwestern.edu			Public Health Service [R01 DC00646]; AstraZeneca; Procter Gamble; Xenoport; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000646] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); AstraZeneca(AstraZeneca); Procter Gamble(Procter & Gamble); Xenoport; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by a grant (R01 DC00646) from the Public Health Service.; Dr. Kahrilas reports receiving consulting fees from AstraZeneca, Procter & Gamble, and Xenoport. No other potential conflict of interest relevant to this article was reported.	Armstrong D, 2005, CAN J GASTROENTEROL, V19, P15, DOI 10.1155/2005/836030; Bais JE, 2000, LANCET, V355, P170, DOI 10.1016/S0140-6736(99)03097-4; Camilleri M, 2005, CLIN GASTROENTEROL H, V3, P543, DOI 10.1016/S1542-3565(05)00153-9; Chiba N, 1997, GASTROENTEROLOGY, V112, P1798, DOI 10.1053/gast.1997.v112.pm9178669; Conio M, 2003, AM J GASTROENTEROL, V98, P1931, DOI 10.1016/S0002-9270(03)00629-4; Corley DA, 2002, GASTROENTEROLOGY, V122, P633, DOI 10.1053/gast.2002.31879; Corley DA, 2007, GASTROENTEROLOGY, V133, P34, DOI 10.1053/j.gastro.2007.04.046; de Vries DR, 2008, AM J GASTROENTEROL, V103, P1349, DOI 10.1111/j.1572-0241.2008.01909.x; Dean BB, 2004, CLIN GASTROENTEROL H, V2, P656, DOI 10.1016/S1542-3565(04)00288-5; Dellon ES, 2005, J CLIN ONCOL, V23, P4478, DOI 10.1200/JCO.2005.19.059; Dent J, 2006, ALIMENT PHARM THER, V24, P1269, DOI 10.1111/j.1365-2036.2006.03122.x; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; DeVault KR, 2005, AM J GASTROENTEROL, V100, P190, DOI 10.1111/j.1572-0241.2005.41217.x; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; Diav-Citrin O, 2005, ALIMENT PHARM THER, V21, P269, DOI 10.1111/j.1365-2036.2005.02306.x; Dominitz JA, 2006, CLIN GASTROENTEROL H, V4, P299, DOI 10.1016/j.cgh.2005.12.019; El-Serag HB, 1998, GUT, V43, P327, DOI 10.1136/gut.43.3.327; Eloubeidi MA, 2003, AM J GASTROENTEROL, V98, P1627, DOI 10.1016/S0002-9270(03)00228-4; Finks JF, 2006, SURG ENDOSC, V20, P1698, DOI 10.1007/s00464-006-0042-3; Forman D, 2005, J NATL CANCER I, V97, P1013, DOI 10.1093/jnci/dji180; Hirschowitz BI, 2004, CLIN GASTROENTEROL H, V2, P220, DOI 10.1016/S1542-3565(04)00009-6; Jacobson BC, 2006, NEW ENGL J MED, V354, P2340, DOI 10.1056/NEJMoa054391; Johnson DA, 2001, AM J GASTROENTEROL, V96, P27; Kahrilas PJ, 2008, GASTROENTEROLOGY, V135, P1392, DOI 10.1053/j.gastro.2008.08.044; Kahrilas PJ, 1999, AM J GASTROENTEROL, V94, P92; Kahrilas PJ, 2000, GASTROENTEROLOGY, V118, P688, DOI 10.1016/S0016-5085(00)70138-7; Kaltenbach T, 2006, ARCH INTERN MED, V166, P965, DOI 10.1001/archinte.166.9.965; Khan M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003244.pub2; Klaus A, 2003, AM J MED, V114, P6, DOI 10.1016/S0002-9343(02)01301-3; Klinkenberg-Knol EC, 2000, GASTROENTEROLOGY, V118, P661, DOI 10.1016/S0016-5085(00)70135-1; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Laine L, 2000, ALIMENT PHARM THER, V14, P651; Lundell L, 2007, BRIT J SURG, V94, P198, DOI 10.1002/bjs.5492; Pandolfino JE, 2003, GASTROENTEROLOGY, V125, P1018, DOI 10.1016/S0016-5085(03)01210-1; Peghini PL, 1998, GASTROENTEROLOGY, V115, P1335, DOI 10.1016/S0016-5085(98)70010-1; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Rantanen TK, 1999, AM J GASTROENTEROL, V94, P1777; Rodriguez LAG, 1997, EPIDEMIOLOGY, V8, P571; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; SABESIN SM, 1991, ARCH INTERN MED, V151, P2394, DOI 10.1001/archinte.151.12.2394; Shaheen N, 2002, JAMA-J AM MED ASSOC, V287, P1972, DOI 10.1001/jama.287.15.1972; Shaheen NJ, 2006, AM J GASTROENTEROL, V101, P2128, DOI 10.1111/j.1572-0241.2006.00723.x; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; Sharma P, 2004, GASTROENTEROLOGY, V127, P310, DOI 10.1053/j.gastro.2004.04.010; Spechler SJ, 2001, JAMA-J AM MED ASSOC, V285, P2331, DOI 10.1001/jama.285.18.2331; Tran T, 2005, AM J GASTROENTEROL, V100, P1002, DOI 10.1111/j.1572-0241.2005.41007.x; Vakil N, 2003, AM J MED, V114, P1, DOI 10.1016/S0002-9343(02)01390-6; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; van Pinxteren B, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002095.pub3; vanderBurgh A, 1996, GUT, V39, P5, DOI 10.1136/gut.39.1.5; Venables TL, 1997, SCAND J GASTROENTERO, V32, P965, DOI 10.3109/00365529709011211; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947; Ye WM, 2001, GASTROENTEROLOGY, V121, P1286, DOI 10.1053/gast.2001.29569	53	197	209	2	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2008	359	16					1700	1707		10.1056/NEJMcp0804684	http://dx.doi.org/10.1056/NEJMcp0804684			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360EY	18923172	Green Accepted			2022-12-28	WOS:000260041400008
J	Sudhof, TC				Sudhof, Thomas C.			Neuroligins and neurexins link synaptic function to cognitive disease	NATURE			English	Article							ALPHA-NEUREXINS; CELL-ADHESION; TRANSMITTER RELEASE; STRUCTURAL VARIANTS; VARIABLE PHENOTYPE; DELETION SYNDROME; AUTISM; PROTEIN; GENES; COMPLEX	The brain processes information by transmitting signals at synapses, which connect neurons into vast networks of communicating cells. In these networks, synapses not only transmit signals but also transform and refine them. Neurexins and neuroligins are synaptic cell- adhesion molecules that connect presynaptic and postsynaptic neurons at synapses, mediate signalling across the synapse, and shape the properties of neural networks by specifying synaptic functions. In humans, alterations in genes encoding neurexins or neuroligins have recently been implicated in autism and other cognitive diseases, linking synaptic cell adhesion to cognition and its disorders.	[Sudhof, Thomas C.] Stanford Univ, Inst Neurosci, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; [Sudhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Sudhof, TC (corresponding author), Stanford Univ, Inst Neurosci, Dept Mol & Cellular Physiol, 1050 Arastradero Rd B249, Palo Alto, CA 94304 USA.	tcs1@stanford.edu			National Institute of Mental Health; Simon Foundation	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simon Foundation	I thank D. Arac, A. Brunger, X. Liu, J. Gibson and K. Huber for advice and help with figures. Work in my laboratory on NRXNs and NLGNs is supported by the National Institute of Mental Health and the Simon Foundation.	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Berninghausen O, 2007, J NEUROCHEM, V103, P1855, DOI 10.1111/j.1471-4159.2007.04918.x; Biederer T, 2001, J BIOL CHEM, V276, P47869, DOI 10.1074/jbc.M105287200; Bolliger MF, 2008, P NATL ACAD SCI USA, V105, P6421, DOI 10.1073/pnas.0801383105; Borg JP, 1999, J NEUROSCI, V19, P1307; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Chen X, 2008, NAT STRUCT MOL BIOL, V15, P50, DOI 10.1038/nsmb1350; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chocholska S, 2006, AM J MED GENET A, V140A, P604, DOI 10.1002/ajmg.a.31145; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Dityatev A., 2006, MOL MECH SYNAPTOGENE; Dudanova I, 2006, J NEUROSCI, V26, P10599, DOI 10.1523/JNEUROSCI.1913-06.2006; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hata Y, 1996, J NEUROSCI, V16, P2488; Hishimoto A, 2007, HUM MOL GENET, V16, P2880, DOI 10.1093/hmg/ddm247; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Jeffries AR, 2005, AM J MED GENET A, V137A, P139, DOI 10.1002/ajmg.a.30780; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Koehnke J, 2008, STRUCTURE, V16, P410, DOI 10.1016/j.str.2007.12.024; Lachman HM, 2007, HUM MOL GENET, V16, P1327, DOI 10.1093/hmg/ddm081; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Lawson-Yuen A, 2008, EUR J HUM GENET, V16, P614, DOI 10.1038/sj.ejhg.5202006; Linkenhoker BA, 2005, NAT NEUROSCI, V8, P93, DOI 10.1038/nn1367; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; Macarov M, 2007, J INTELL DISABIL RES, V51, P329, DOI 10.1111/j.1365-2788.2006.00880.x; Manning MA, 2004, PEDIATRICS, V114, P451, DOI 10.1542/peds.114.2.451; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Maxwell Cowan W., 2000, SYNAPSES; Meinrenken CJ, 2003, J PHYSIOL-LONDON, V547, P665, DOI 10.1113/jphsiol.2002.032714; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Okamoto N, 2007, AM J MED GENET A, V143A, P2804, DOI 10.1002/ajmg.a.31771; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Peles E, 2000, CURR OPIN NEUROBIOL, V10, P558, DOI 10.1016/S0959-4388(00)00122-7; Petrenko AG, 1996, J NEUROSCI, V16, P4360; Rissone A, 2007, MOL BIOL EVOL, V24, P236, DOI 10.1093/molbev/msl147; Rozic-Kotliroff G, 2007, BIOCHEM BIOPH RES CO, V352, P226, DOI 10.1016/j.bbrc.2006.11.008; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schmitz C, 2008, NEUROPATH APPL NEURO, V34, P4, DOI 10.1111/j.1365-2990.2007.00872.x; Shen KC, 2008, STRUCTURE, V16, P422, DOI 10.1016/j.str.2008.01.005; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Sugita S, 1999, NEURON, V22, P489, DOI 10.1016/S0896-6273(00)80704-7; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Talebizadeh Z, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036897; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; Tobaben S, 2000, J BIOL CHEM, V275, P36204, DOI 10.1074/jbc.M006448200; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Ushkaryov Yuri A., 2008, V184, P171; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629; Yan J, 2008, NEUROSCI LETT, V438, P368, DOI 10.1016/j.neulet.2008.04.074; Zahir FR, 2008, J MED GENET, V45, P239, DOI 10.1136/jmg.2007.054437; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005	91	1203	1244	0	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					903	911		10.1038/nature07456	http://dx.doi.org/10.1038/nature07456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923512	Green Accepted			2022-12-28	WOS:000260038300038
J	Winzeler, EA				Winzeler, Elizabeth Ann			Malaria research in the post-genomic era	NATURE			English	Review							PARASITE PLASMODIUM-FALCIPARUM; LIFE-CYCLE; CIRCUMSPOROZOITE PROTEIN; ANTIMALARIAL-DRUGS; ANOPHELES-GAMBIAE; VIRULENCE GENES; LIVER STAGES; EXPRESSION; MOSQUITO; STAGE	For many pathogens the availability of genome sequence, permitting genome- dependent methods of research, can partially substitute for powerful forward genetic methods ( genome- independent) that have advanced model organism research for decades. In 2002 the genome sequence of Plasmodium falciparum, the parasite causing the most severe type of human malaria, was completed, eliminating many of the barriers to performing state- of- the- art molecular biological research on malaria parasites. Although new, licensed therapies may not yet have resulted from genome- dependent experiments, they have produced a wealth of new observations about the basic biology of malaria parasites, and it is likely that these will eventually lead to new therapeutic approaches. This review will focus on the basic research discoveries that have depended, in part, on the availability of the Plasmodium genome sequences.	[Winzeler, Elizabeth Ann] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Winzeler, Elizabeth Ann] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Novartis; Scripps Research Institute	Winzeler, EA (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA USA.	winzeler@scripps.edu	Winzeler, Elizabeth/AAP-6752-2020	Winzeler, Elizabeth/0000-0002-4049-2113	Keck Foundation; Wellcome Trust; Novartis; NIH [RO1 AI059742]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059472, R01AI059742] Funding Source: NIH RePORTER	Keck Foundation(W.M. Keck Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Novartis(Novartis); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	E. A. W. is grateful for support from the Keck Foundation, the Wellcome Trust, Novartis and NIH RO1 AI059742.	Afonso A, 2006, ANTIMICROB AGENTS CH, V50, P480, DOI 10.1128/AAC.50.2.480-489.2006; Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Baird JK, 2005, NEW ENGL J MED, V352, P1565, DOI 10.1056/NEJMra043207; Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Baniecki ML, 2007, ANTIMICROB AGENTS CH, V51, P716, DOI 10.1128/AAC.01144-06; Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Boivin MJ, 2007, PEDIATRICS, V119, pE360, DOI 10.1542/peds.2006-2027; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Carret CK, 2005, MOL BIOCHEM PARASIT, V144, P177, DOI 10.1016/j.molbiopara.2005.08.010; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Dzikowski R, 2006, PLOS PATHOG, V2, P184, DOI 10.1371/journal.ppat.0020022; Epstein JE, 2007, J INFECT DIS, V196, P145, DOI 10.1086/518510; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Kariu T, 2006, MOL MICROBIOL, V59, P1369, DOI 10.1111/j.1365-2958.2005.05024.x; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; Kidgell C, 2006, PLOS PATHOG, V2, P562, DOI 10.1371/journal.ppat.0020057; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Kyes SA, 2007, EUKARYOT CELL, V6, P1511, DOI 10.1128/EC.00173-07; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Matuschewski K, 2002, J BIOL CHEM, V277, P41948, DOI 10.1074/jbc.M207315200; Mehlin C, 2006, MOL BIOCHEM PARASIT, V148, P144, DOI 10.1016/j.molbiopara.2006.03.011; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Moran M., 2007, MALARIA PRODUCT PIPE; Mourier T, 2008, GENOME RES, V18, P281, DOI 10.1101/gr.6836108; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Saul A, 2007, CURR OPIN INFECT DIS, V20, P476, DOI 10.1097/QCO.0b013e3282a95e12; Siau A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000121; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Todryk SM, 2007, NAT REV MICROBIOL, V5, P487, DOI 10.1038/nrmicro1712; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Vennerstrom JL, 2004, NATURE, V430, P900, DOI 10.1038/nature02779; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Volkman SK, 2002, SCIENCE, V298, P216, DOI 10.1126/science.1075642; Voss TS, 2006, NATURE, V439, P1004, DOI 10.1038/nature04407; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Zhou YY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001570	80	109	116	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 9	2008	455	7214					751	756		10.1038/nature07361	http://dx.doi.org/10.1038/nature07361			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18843360	Green Accepted			2022-12-28	WOS:000259854900037
J	Ahlquist, DA; Sargent, DJ; Loprinzi, CL; Levin, TR; Rex, DK; Ahnen, DJ; Knigge, K; Lance, P; Burgart, LJ; Hamilton, SR; Allison, JE; Lawson, MJ; Devens, ME; Harrington, JJ; Hillman, SL				Ahlquist, David A.; Sargent, Daniel J.; Loprinzi, Charles L.; Levin, Theodore R.; Rex, Douglas K.; Ahnen, Dennis J.; Knigge, Kandice; Lance, Peter; Burgart, Lawrence J.; Hamilton, Stanley R.; Allison, James E.; Lawson, Michael J.; Devens, Mary E.; Harrington, Jonathan J.; Hillman, Shauna L.			Stool DNA and occult blood testing for screen detection of colorectal neoplasia	ANNALS OF INTERNAL MEDICINE			English	Article							RAS CODON-12 MUTATIONS; ABERRANT CRYPT FOCI; FECAL DNA; APC MUTATIONS; CANCER; COLONOSCOPY; PERFORMANCE; POLYPS; COLON; RISK	Background: Stool DNA testing is a new approach to colorectal cancer detection. Few data are available from the screening setting. Objective: To compare stool DNA and fecal blood testing for detection of screen-relevant neoplasia (curable-stage cancer, high-grade dysplasia, or adenomas > 1 cm). Design: Blinded, multicenter, cross-sectional study. Setting: Communities surrounding 22 participating academic and regional health care systems in the United States. Participants: 4482 average-risk adults. Measurements: Fecal blood and DNA markers. Participants collected 3 stools, smeared fecal blood test cards and used same-day shipment to a central facility. Fecal blood cards (Hemoccult and HemoccultSensa, Beckman Coulter, Fullerton, California) were tested on 3 stools and DNA assays on 1 stool per patient. Stool DNA test 1 (SDT-1) was a precommercial 23-marker assay, and a novel test (SDT-2) targeted 3 broadly informative markers. The criterion standard was colonoscopy. Results: Sensitivity for screen-relevant neoplasms was 20% by SDT-1, 11% by Hemoccult (P = 0.020), 21% by HemoccultSensa (P = 0.80); sensitivity for cancer plus high-grade dysplasia did not differ among tests. Specificity was 96% by SDT-1, compared with 98% by Hemoccult (P < 0.001) and 97% by HemoccultSensa (P = 0.20). Stool DNA test 2 detected 46% of screen-relevant neoplasms, compared with 16% by Hemoccult (P < 0.001) and 24% by HemoccultSensa (P < 0.001). Stool DNA test 2 detected 46% of adenomas 1 cm or larger, compared with 10% by Hemoccult (P < 0.001) and 17% by HemoccultSensa (P < 0.001). Among colonoscopically normal patients, the positivity rate was 16% with SDT-2, compared with 4% with Hemoccult (P = 0.010) and 5% with HemoccultSensa (P = 0.030). Limitations: Stool DNA test 2 was not performed on all subsets of patients without screen-relevant neoplasms. Stools were collected without preservative, which reduced detection of some DNA markers. Conclusion: Stool DNA test 1 provides no improvement over HemoccultSensa for detection of screen-relevant neoplasms. Stool DNA test 2 detects significantly more neoplasms than does Hemoccult or HemoccultSensa, but with more positive results in colonoscopically normal patients. Higher sensitivity of SDT-2 was particularly apparent for adenomas.	[Ahlquist, David A.] Mayo Clin, Rochester, MN 55905 USA; Kaiser Permanente, Oakland, CA USA; Kaiser Permanente, Sacramento, CA USA; Indiana Univ, Indianapolis, IN 46204 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Univ Portland, Portland, OR 97203 USA; Univ Arizona, Hlth Sci Ctr, Tucson, AZ USA; Abbott NW Hosp, Minneapolis, MN 55407 USA; Univ Texas Houston, Houston, TX USA	Mayo Clinic; Kaiser Permanente; Kaiser Permanente; Indiana University System; Indiana University-Purdue University Indianapolis; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Portland; University of Arizona; University of Arizona Health Sciences; University of Texas System; University of Texas Health Science Center Houston	Ahlquist, DA (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	ahlquist.david@mayo.edu	Lance, Peter/I-2196-2014	Lance, Peter/0000-0003-2944-1881; Sargent, Daniel/0000-0002-2684-4741	National Institutes of Health [UO1 CA 89389, UO1 CA 37404]; NATIONAL CANCER INSTITUTE [U01CA089389, U10CA037404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By grants UO1 CA 89389 and UO1 CA 37404 from the National Institutes of Health.	AHLQUIST D, 2003, TXB GASTROENTEROLOGY, P724; Ahlquist DA, 2000, BMJ-BRIT MED J, V321, P254, DOI 10.1136/bmj.321.7256.254; Ahlquist DA, 2000, GASTROENTEROLOGY, V119, P1219, DOI 10.1053/gast.2000.19580; AHLQUIST DA, 1993, JAMA-J AM MED ASSOC, V269, P1262, DOI 10.1001/jama.269.10.1262; AHLQUIST DA, 1989, CANCER, V63, P1826; Allison JE, 2007, JNCI-J NATL CANCER I, V99, P1462, DOI 10.1093/jnci/djm150; Calistri D, 2003, CLIN GASTROENTEROL H, V1, P377, DOI 10.1053/S1542-3565(03)00186-1; Chen WD, 2005, JNCI-J NATL CANCER I, V97, P1124, DOI 10.1093/jnci/dji204; Chien CC, 2007, TRANSL RES, V149, P96, DOI 10.1016/j.trsl.2006.09.006; Collins JF, 2005, ANN INTERN MED, V142, P81, DOI 10.7326/0003-4819-142-2-200501180-00006; Davies RJ, 2005, NAT REV CANCER, V5, P199, DOI 10.1038/nrc1569; Derks S, 2006, CELL ONCOL, V28, P247; Dong SM, 2001, J NATL CANCER I, V93, P858, DOI 10.1093/jnci/93.11.858; Heresbach D, 2006, EUR J GASTROEN HEPAT, V18, P427, DOI 10.1097/00042737-200604000-00018; HERZOG P, 1982, GASTROENTEROLOGY, V83, P957; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Itzkowitz SH, 2007, CLIN GASTROENTEROL H, V5, P111, DOI 10.1016/j.cgh.2006.10.006; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kann L, 2006, CLIN CHEM, V52, P2299, DOI 10.1373/clinchem.2007.070896; Koshiji M, 2002, J SURG ONCOL, V80, P34, DOI 10.1002/jso.10096; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Kronborg O, 2004, SCAND J GASTROENTERO, V39, P846, DOI 10.1080/00365520410003182; Leung WK, 2007, AM J GASTROENTEROL, V102, P1070, DOI 10.1111/j.1572-0241.2007.01108.x; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Meissner HI, 2006, CANCER EPIDEM BIOMAR, V15, P389, DOI 10.1158/1055-9965.EPI-05-0678; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Nakama H, 2001, DIS COLON RECTUM, V44, P871, DOI 10.1007/BF02234712; Olson J, 2005, DIAGN MOL PATHOL, V14, P183, DOI 10.1097/01.pas.0000176768.18423.7e; Osborn NK, 2005, GASTROENTEROLOGY, V128, P192, DOI 10.1053/j.gastro.2004.10.041; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Rengucci C, 2001, CLIN CANCER RES, V7, P590; ROBINSON MHE, 1995, BRIT J SURG, V82, P318, DOI 10.1002/bjs.1800820310; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; SMITH AJ, 1994, CANCER RES, V54, P5527; Smith A, 2006, CANCER, V107, P2152, DOI 10.1002/cncr.22230; Tagore Kuldeep S, 2003, Clin Colorectal Cancer, V3, P47, DOI 10.3816/CCC.2003.n.011; Takayama T, 1998, NEW ENGL J MED, V339, P1277, DOI 10.1056/NEJM199810293391803; Traverso G, 2002, NEW ENGL J MED, V346, P311, DOI 10.1056/NEJMoa012294; Whitney D, 2004, J MOL DIAGN, V6, P386, DOI 10.1016/S1525-1578(10)60536-3; WINAWER SJ, 1993, J NATL CANCER I, V85, P1311, DOI 10.1093/jnci/85.16.1311; Zou HZ, 2008, GASTROENTEROLOGY, V134, pA109; Zou HZ, 2006, CANCER EPIDEM BIOMAR, V15, P1115, DOI 10.1158/1055-9965.EPI-05-0992	46	207	237	2	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2008	149	7					441	W81		10.7326/0003-4819-149-7-200810070-00004	http://dx.doi.org/10.7326/0003-4819-149-7-200810070-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QY	18838724	Green Accepted			2022-12-28	WOS:000260004400001
J	DeConto, RM; Pollard, D; Wilson, PA; Palike, H; Lear, CH; Pagani, M				DeConto, Robert M.; Pollard, David; Wilson, Paul A.; Palike, Heiko; Lear, Caroline H.; Pagani, Mark			Thresholds for Cenozoic bipolar glaciation	NATURE			English	Article							CARBON-DIOXIDE CONCENTRATIONS; ANTARCTIC GLACIATION; ICE-SHEET; EARLY MIOCENE; OLIGOCENE; CLIMATE; TRANSITION; GREENLAND; ONSET; OCEAN	The long-standing view of Earth's Cenozoic glacial history calls for the first continental-scale glaciation of Antarctica in the earliest Oligocene epoch (similar to 33.6 million years ago(1)), followed by the onset of northern- hemispheric glacial cycles in the late Pliocene epoch, about 31 million years later(2). The pivotal early Oligocene event is characterized by a rapid shift of 1.5 parts per thousand in deep- sea benthic oxygen- isotope values(3) ( Oi- 1) within a few hundred thousand years(4), reflecting a combination of terrestrial ice growth and deep- sea cooling. The apparent absence of contemporaneous cooling in deep- sea Mg/Ca records(4-6), however, has been argued to reflect the growth of more ice than can be accommodated on Antarctica; this, combined with new evidence of continental cooling(7) and ice- rafted debris(8,9) in the Northern Hemisphere during this period, raises the possibility that Oi- 1 represents a precursory bipolar glaciation. Here we test this hypothesis using an isotope-capable global climate/ ice- sheet model that accommodates both the long- term decline of Cenozoic atmospheric CO2 levels(10,11) and the effects of orbital forcing(12). We show that the CO2 threshold below which glaciation occurs in the Northern Hemisphere (similar to 280 p.p.m.v.) is much lower than that for Antarctica (similar to 750 p.p.m.v.). Therefore, the growth of ice sheets in the Northern Hemisphere immediately following Antarctic glaciation would have required rapid CO2 drawdown within the Oi- 1 time-frame, to levels lower than those estimated by geochemical proxies(10,11) and carbon- cycle models(13,14). Instead of bipolar glaciation, we find that Oi- 1 is best explained by Antarctic glaciation alone, combined with deep- sea cooling of up to 4 degrees C and Antarctic ice that is less isotopically depleted (-30 to -35 parts per thousand) than previously suggested(15,16). Proxy CO2 estimates remain above our model's northern- hemispheric glaciation threshold of similar to 280 p.p.m.v. until similar to 25 Myr ago, but have been near or below that level ever since(10,11). This implies that episodic northern- hemispheric ice sheets have been possible some 20 million years earlier than currently assumed ( although still much later than Oi- 1) and could explain some of the variability in Miocene sea- level records(17,18).	[DeConto, Robert M.] Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA; [Pollard, David] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Wilson, Paul A.; Palike, Heiko] Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; [Lear, Caroline H.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3YE, Wales; [Pagani, Mark] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA	University of Massachusetts System; University of Massachusetts Amherst; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; NERC National Oceanography Centre; University of Southampton; Cardiff University; Yale University	DeConto, RM (corresponding author), Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA.	deconto@geo.umass.edu	Palike, Heiko/A-6560-2008; Lear, Caroline/D-2582-2009; Pagani, Mark/B-3233-2008	Palike, Heiko/0000-0003-3386-0923; Wilson, Paul/0000-0001-6425-8906; Lear, Caroline/0000-0002-7533-4430	National Science Foundation.; NERC [NE/D000343/1] Funding Source: UKRI; STFC [PP/D002176/1] Funding Source: UKRI; Natural Environment Research Council [NE/D000343/1] Funding Source: researchfish; Science and Technology Facilities Council [PP/D002176/1] Funding Source: researchfish	National Science Foundation.(National Science Foundation (NSF)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This material is based on work supported by the National Science Foundation.	Bamber JL, 1997, ANN GLACIOL, V25, P439, DOI 10.3189/S0260305500014427; Barrett P.J, 1996, TERRA ANTARCTICA, V3, P103; Billups K, 2003, EARTH PLANET SC LETT, V209, P181, DOI 10.1016/S0012-821X(03)00067-0; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DeConto R, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001350; Edgar KM, 2007, NATURE, V448, P908, DOI 10.1038/nature06053; EDRETT JS, 2007, NATURE, V466, P176; Huybrechts P, 2002, QUATERNARY SCI REV, V21, P203, DOI 10.1016/S0277-3791(01)00082-8; Katz ME, 2008, NAT GEOSCI, V1, P329, DOI 10.1038/ngeo179; KENNETT JP, 1977, J GEOPHYS RES-OC ATM, V82, P3843, DOI 10.1029/JC082i027p03843; Kominz MA, 2001, GEOL SOC AM BULL, V113, P291, DOI 10.1130/0016-7606(2001)113<0291:OEFTDS>2.0.CO;2; LARSEN HC, 1994, SCIENCE, V264, P952, DOI 10.1126/science.264.5161.952; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lear CH, 2008, GEOLOGY, V36, P251, DOI 10.1130/G24584A.1; Lear CH, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001039; Lhomme N, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023774; Mathieu R, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD900255; Merico A, 2008, NATURE, V452, P979, DOI 10.1038/nature06853; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Pekar SF, 2006, PALAEOGEOGR PALAEOCL, V231, P101, DOI 10.1016/j.palaeo.2005.07.027; Pekar SF, 2008, PALAEOGEOGR PALAEOCL, V260, P41, DOI 10.1016/j.palaeo.2007.08.019; Pollard D, 2005, GLOBAL PLANET CHANGE, V45, P9, DOI 10.1016/j.gloplacha.2004.09.011; POLLARD D, 2007, INT ASS SEDIMENTOLOG, V39, P37; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; SHACKLETON NJ, 1984, NATURE, V307, P620, DOI 10.1038/307620a0; Sorlien CC, 2007, GEOLOGY, V35, P467, DOI 10.1130/G23387A.1; St John K, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001483; Tripati AK, 2008, EARTH PLANET SC LETT, V265, P112, DOI 10.1016/j.epsl.2007.09.045; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2005, GLOBAL PLANET CHANGE, V47, P51, DOI 10.1016/j.gloplacha.2005.01.001; Zanazzi A, 2007, NATURE, V445, P639, DOI 10.1038/nature05551	34	266	273	4	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					652	U52		10.1038/nature07337	http://dx.doi.org/10.1038/nature07337			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833277				2022-12-28	WOS:000259639700044
J	Kumar, V; Mohanty, S; Kumar, A; Misra, RP; Santosham, M; Awasthi, S; Baqui, AH; Singh, P; Singh, V; Ahuja, RC; Singh, JV; Malik, GK; Ahmed, S; Black, RE; Bhandari, M; Darmstadt, GL				Kumar, Vishwajeet; Mohanty, Saroj; Kumar, Aarti; Misra, Rajendra P.; Santosham, Mathuram; Awasthi, Shally; Baqui, Abdullah H.; Singh, Pramod; Singh, Vivek; Ahuja, Ramesh C.; Singh, Jai Vir; Malik, Gyanendra Kumar; Ahmed, Saifuddin; Black, Robert E.; Bhandari, Mahendra; Darmstadt, Gary L.		Saksham Study Grp	Effect of community-based behaviour change management on neonatal mortality in Shivgarh, Uttar Pradesh, India: a cluster-randomised controlled trial	LANCET			English	Article							BIRTH ATTENDANTS; HEALTH-EDUCATION; SYLHET DISTRICT; SOUTHERN NEPAL; INTERVENTION; CARE; CHLORHEXIDINE; BANGLADESH; STRATEGIES; PAKISTAN	Background In rural India, most births take place in the home, where high-risk care practices are common. We developed an intervention of behaviour change management, with a focus on prevention of hypothermia, aimed at modifying practices and reducing neonatal mortality. Methods We did a cluster-randomised controlled efficacy trial in Shivgarh, a rural area in Uttar Pradesh. 39 village administrative units (population 104123) were allocated to one of three groups: a control group, which received the usual services of governmental and non-governmental organisations in the area; an intervention group, which received a preventive package of interventions for essential newborn care (birth preparedness, clean delivery and cord care, thermal care [including skin-to-skin care], breastfeeding promotion, and danger sign recognition); or another intervention group, which received the package of essential newborn care plus use of a liquid crystal hypothermia indicator (ThermoSpot). In the intervention clusters, community health workers delivered the packages via collective meetings and two antenatal and two postnatal household visitations. Outcome measures included changes in newborn-care practices and neonatal mortality rate compared with the control group. Analysis was by intention to treat. This study is registered as International Standard Randomised Control Trial, number NCT00198653. Findings Improvements in birth preparedness, hygienic delivery, thermal care (including skin-to-skin care), umbilical cord care, skin care, and breastfeeding were seen in intervention arms. There was little change in care-seeking. Compared with controls, neonatal mortality rate was reduced by 54% in the essential newborn-care intervention (rate ratio 0 . 46 [95% CI 0 . 35-0.60], p<0 . 0001) and by 52% in the essential newborn care plus ThermoSpot arm (0.48 [95% Cl 0 . 35-0.66], p<0 . 0001). Interpretation A socioculturally contextualised, community-based intervention, targeted at high-risk newborn-care practices, can lead to substantial behavioural modification and reduction in neonatal mortality. This approach can be applied to behaviour change along the continuum of care, harmonise vertical interventions, and build community capacity for sustained development. Funding USAID and Save the Children-US through a grant from the Bill & Melinda Gates Foundation.	Johns Hopkins Univ, ICANH, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Kumar, Vishwajeet; Santosham, Mathuram; Baqui, Abdullah H.; Ahmed, Saifuddin; Black, Robert E.; Darmstadt, Gary L.] Bill & Melinda Gates Fdn, Integrated Hlth Solut Dev, Global Hlth Program, Seattle, WA 98102 USA; [Kumar, Vishwajeet; Mohanty, Saroj; Kumar, Aarti; Misra, Rajendra P.; Awasthi, Shally; Singh, Pramod; Singh, Vivek; Ahuja, Ramesh C.; Singh, Jai Vir; Malik, Gyanendra Kumar] CSM Med Univ, Clin Epidemiol Unit, Lucknow, Uttar Pradesh, India; [Awasthi, Shally; Malik, Gyanendra Kumar] CSM Med Univ, Dept Pediat, Lucknow, Uttar Pradesh, India; [Singh, Jai Vir] CSM Med Univ, Dept Social & Prevent Med, Lucknow, Uttar Pradesh, India; [Bhandari, Mahendra] Henry Ford Hlth Syst, Vattikuti Urol Inst, Detroit, MI USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Bill & Melinda Gates Foundation; King George's Medical University; King George's Medical University; King George's Medical University; Henry Ford Health System; Henry Ford Hospital	Darmstadt, GL (corresponding author), Bill & Melinda Gates Fdn, Integrated Hlth Solut Dev, Global Hlth Program, POB 23350, Seattle, WA 98102 USA.	gdarmsta@jhsph.edu	Darmstadt, Gary/AAU-7488-2020	Darmstadt, Gary/0000-0002-7522-5824; Black, Robert/0000-0001-9926-7984	United States Agency for International Development; Delhi Mission; Saving Newborn Lives programme of Save the Children-US; Bill & Melinda Gates Foundation	United States Agency for International Development(United States Agency for International Development (USAID)); Delhi Mission; Saving Newborn Lives programme of Save the Children-US; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by the United States Agency for International Development, Delhi Mission and the Saving Newborn Lives programme of Save the Children-US through a grant from the Bill & Melinda Gates Foundation. We thank Massee Bateman for his extraordinary support throughout the study; Rajiv Tandon (USAID, New Delhi Mission), Neal Brandes, Lily Kak, and Heather Haberle (USAID, Washington, DC), and Anne Tinker, Stephen Wall, and Shyam Thapa (Saving Newborn Lives, Washington DC) for their support. We drew inspiration for our model ofcommunity empowerment from the work of Shri Dilip Kumar. We thank Raja Rakesh Pratap Singh and all members of the community of Shivgarh for their active involvement, encouragement, and support; all our community volunteers, community stakeholders, and newborn-care stakeholders, in particular, Jamunaji, Baisain buaji, Shakuntala mammiji, Virendra Chauhan, Gokaran Yadav, Sheshpal Singh, Kannuddin chachaji, Hiralal, Mata Prasad, Prema Devi, Ausaan Das, Kunti, Rajkumari, Premawati, Gangadei, Chauhanin bua, Munni Devi, Krishnavati for enthusiastically volunteering their time and effort; all our Saksharn Sahayaks, in particular, Nita Dwivedi, Alok Awasthi, Krishna Singh, Poonam Singh, Anoop Shukla, Chandra Kishore, Sankat Mochan, Raj Kumar Maurya, Amarkant Awasthi, Pavan, Devendra Awasthi, Narendra, Ram Prakash, Mamta; Virendra Kumar for his support and our implementation team for their dedication and commitment towards the successful completion of the trial: Ramesh Srivastava, Sujeet Verma, Nalin Singh Negi, Adil Hussain Khan, Satyavrat Tripathi, Ablushek Singh, Vishnu Pratap Yadav, Padmaja Pancley, Sanjay Tiwari, Jagdish Kumar, Tashfeen Usmani, Satyaprakash Shukla and Sharad Yadav. We also thank Keya Pandey for her key contributions during the formative phase; John Zeal for instruction in temperature measurement using thermometers and the ThermSpot device; the members of the data safety and monitoring board: P S S Sundar Rao (Emeritus, Christian Medical College, Vellore, India), Ashok Deorari (All India Institute ofMedical Sciences, Delhi, India), Jorge Tolosa (Oregon Health Sciences University, Portland, Oregon, USA), and Atarm Kumar Jana (Christian Medical Center, Vellore, India); Narendra K Arora, Vinod Paul, Jose Martines, Rajiv Bahl, Prasanna K Hota, and Bernadette Kumar for their guidance, encouragement, and expert advice; Arvind Saili, V K Srivastava, A Niswade, C M Pandey, Raja Shalender Singh, Teresa Wakeen, and the Lucknow Management Association for their support and encouragement; and the Department of Health and Family Welfare, Government of Uttar Pradesh, for its contributions in evolving and integrating the behaviour change management approach from the Shivgarh trial into the Uttar Pradesh Comprehensive Child Survival Programme.	Armitage P., 2001, STAT METHODS MED RES; Aronson E, 1997, AM J PSYCHOL, V110, P127, DOI 10.2307/1423706; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS92, DOI 10.1038/sj.jp.7211277; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Bennett S, 2002, INT J EPIDEMIOL, V31, P839, DOI 10.1093/ije/31.4.839; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Bolam A, 1998, BRIT MED J, V316, P805, DOI 10.1136/bmj.316.7134.805; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Darmstadt GL, 2006, J PERINATOL, V26, P597, DOI 10.1038/sj.jp.7211569; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; DONNER A, 1994, AM J EPIDEMIOL, V140, P279, DOI 10.1093/oxfordjournals.aje.a117247; Donner A, 1996, J CLIN EPIDEMIOL, V49, P435, DOI 10.1016/0895-4356(95)00511-0; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Hahn Seokyung, 2005, BMC Med Res Methodol, V5, P10, DOI 10.1186/1471-2288-5-10; Haws RA, 2007, HEALTH POLICY PLANN, V22, P193, DOI 10.1093/heapol/czm009; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; International Institute for Population Sciences (IIPS) and ORC Macro, 2000, NAT FAM HLTH SURV NF; Jalil F, 2004, ACTA PAEDIATR, V93, P1273, DOI 10.1080/08035250410017022; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lewis SC, 2004, J NEUROL NEUROSUR PS, V75, P181, DOI 10.1136/jnnp.2003.025833; Maibach EW, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-88; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; McClure EM, 2007, INT J GYNECOL OBSTET, V97, P89, DOI 10.1016/j.ijgo.2007.01.014; McKinlay JB, 2000, INT J HEALTH SERV, V30, P49, DOI 10.2190/2V5H-RHBR-FTM1-KGCF; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Mullany BC, 2007, HEALTH EDUC RES, V22, P166, DOI 10.1093/her/cyl060; Mullany LC, 2006, LANCET, V367, P910, DOI 10.1016/S0140-6736(06)68381-5; Paul BK, 2002, SOC SCI MED, V54, P1755, DOI 10.1016/S0277-9536(01)00148-4; Puffer S, 2005, J EVAL CLIN PRACT, V11, P479, DOI 10.1111/j.1365-2753.2005.00568.x; Sheps DS, 2003, PSYCHOSOM MED, V65, P1; THOMAS A, IN PRESS INT J HLTH; Tielsch JM, 2007, PEDIATRICS, V119, pE330, DOI 10.1542/peds.2006-1192; Wade Angie, 2006, BMC Pregnancy Childbirth, V6, P20, DOI 10.1186/1471-2393-6-20; WILLIS JR, IN PRESS J HLTH POP; WILLIS JR, 2006, THESIS J HOPKINS U; Winch PJ, 2005, LANCET, V366, P478, DOI 10.1016/S0140-6736(05)66836-5; 2002, STUD FAM PLANN, V54, P1755	42	337	340	0	37	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2008	372	9644					1151	1162		10.1016/S0140-6736(08)61483-X	http://dx.doi.org/10.1016/S0140-6736(08)61483-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	355UN	18926277				2022-12-28	WOS:000259734700030
J	Francois, M; Caprini, A; Hosking, B; Orsenigo, F; Wilhelm, D; Browne, C; Paavonen, K; Karnezis, T; Shayan, R; Downes, M; Davidson, T; Tutt, D; Cheah, KSE; Stacker, SA; Muscat, GEO; Achen, MG; Dejana, E; Koopman, P				Francois, Mathias; Caprini, Andrea; Hosking, Brett; Orsenigo, Fabrizio; Wilhelm, Dagmar; Browne, Catherine; Paavonen, Karri; Karnezis, Tara; Shayan, Ramin; Downes, Meredith; Davidson, Tara; Tutt, Desmond; Cheah, Kathryn S. E.; Stacker, Steven A.; Muscat, George E. O.; Achen, Marc G.; Dejana, Elisabetta; Koopman, Peter			Sox18 induces development of the lymphatic vasculature in mice	NATURE			English	Article							ENDOTHELIAL-CELLS; BOX GENE; SYSTEM; MOUSE; EXPRESSION; MUTATIONS; PROX1; LYMPHANGIOGENESIS; DIFFERENTIATION; ANGIOGENESIS	The lymphatic system plays a key role in tissue fluid regulation and tumour metastasis, and lymphatic defects underlie many pathological states including lymphoedema, lymphangiectasia, lymphangioma and lymphatic dysplasia(1-3). However, the origins of the lymphatic system in the embryo, and the mechanisms that direct growth of the network of lymphatic vessels, remain unclear. Lymphatic vessels are thought to arise from endothelial precursor cells budding from the cardinal vein under the influence of the lymphatic hallmark gene Prox1 ( prospero homeobox 1; ref. 4). Defects in the transcription factor gene SOX18 ( SRY ( sex determining region Y) box 18) cause lymphatic dysfunction in the human syndrome hypotrichosis- lymphoedema- telangiectasia(5), suggesting that Sox18 may also play a role in lymphatic development or function. Here we use molecular, cellular and genetic assays in mice to show that Sox18 acts as a molecular switch to induce differentiation of lymphatic endothelial cells. Sox18 is expressed in a subset of cardinal vein cells that later co- express Prox1 and migrate to form lymphatic vessels. Sox18 directly activates Prox1 transcription by binding to its proximal promoter. Overexpression of Sox18 in blood vascular endothelial cells induces them to express Prox1 and other lymphatic endothelial markers, while Sox18- null embryos show a complete blockade of lymphatic endothelial cell differentiation from the cardinal vein. Our findings demonstrate a critical role for Sox18 in developmental lymphangiogenesis, and suggest new avenues to investigate for therapeutic management of human lymphangiopathies.	[Francois, Mathias; Hosking, Brett; Wilhelm, Dagmar; Browne, Catherine; Downes, Meredith; Davidson, Tara; Tutt, Desmond; Muscat, George E. O.; Koopman, Peter] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Caprini, Andrea; Orsenigo, Fabrizio; Dejana, Elisabetta] FIRC Inst Mol Oncol, IFOM, I-20139 Milan, Italy; [Paavonen, Karri; Karnezis, Tara; Shayan, Ramin; Stacker, Steven A.; Achen, Marc G.] Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia; [Shayan, Ramin] Univ Melbourne, Dept Surg, Parkville, Vic 3052, Australia; [Cheah, Kathryn S. E.] Univ Hong Kong, Dept Biochem, Hong Kong, Peoples R China; [Cheah, Kathryn S. E.] Univ Hong Kong, Ctr Reprod Dev & Growth, Hong Kong, Peoples R China; [Dejana, Elisabetta] Univ Milan, Dept Biomol Sci & Biotechnol, I-20129 Milan, Italy	University of Queensland; IFOM - FIRC Institute of Molecular Oncology; Ludwig Institute for Cancer Research; Royal Melbourne Hospital; University of Melbourne; University of Hong Kong; University of Hong Kong; University of Milan	Koopman, P (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	elisabetta.dejana@ifom-ieo-campus.it; p.koopman@imb.uq.edu.au	Downes, Meredith/B-7370-2013; Wilhelm, Dagmar/B-6915-2009; Stacker, Steven A/J-2205-2012; Koopman, Peter A/C-9416-2009; francois, mathias/A-9604-2014; Downes, Meredith/P-8203-2018; Muscat, George/A-6401-2017	Wilhelm, Dagmar/0000-0002-7757-4075; Stacker, Steven A/0000-0003-4096-9273; Koopman, Peter A/0000-0001-6939-0914; francois, mathias/0000-0002-9846-6882; DEJANA, ELISABETTA/0000-0002-0007-0426; Achen, Marc/0000-0002-3791-803X; Downes, Meredith/0000-0002-6517-1834; Orsenigo, Fabrizio/0000-0001-9135-8478; Muscat, George/0000-0002-5829-5695	National Health and Medical Research Council (Australia); INSERM ( France); Associazione Italiana per la Ricerca sul Cancro (Italy); European Community [LSHG-CT-2004-503573]; Pfizer Foundation (Australia); Australia), the Research Grants Council ( Hong Kong); Research Grants Council (Hong Kong); Raelene Boyle Sporting Chance Foundation (Australia); Royal Australasian College of Surgeons; Heart Foundation of Australia; Australian Research Council	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); INSERM ( France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Associazione Italiana per la Ricerca sul Cancro (Italy)(Fondazione AIRC per la ricerca sul cancro); European Community(European Commission); Pfizer Foundation (Australia); Australia), the Research Grants Council ( Hong Kong); Research Grants Council (Hong Kong)(Hong Kong Research Grants Council); Raelene Boyle Sporting Chance Foundation (Australia); Royal Australasian College of Surgeons; Heart Foundation of Australia(National Heart Foundation of Australia); Australian Research Council(Australian Research Council)	We thank A. Nagy, W. Abramow-Newerly, L. Naldini, P. Berta, A. Yap and J. Gamble for gifts of reagents. We also thank L. Bernard, L. Tizzoni and V. Dall'Olio for quantitative real- time PCR analysis, M. Chan and A. Pelling for antibody characterization, and S. Pizzi for technical assistance. Confocal microscopy was performed at the Australian Cancer Research Foundation Dynamic Imaging Centre for Cancer Biology. This work was supported by the National Health and Medical Research Council ( Australia), INSERM ( France), the Associazione Italiana per la Ricerca sul Cancro ( Italy), the European Community (LSHG-CT-2004-503573, Eustroke and Optistem networks), the Pfizer Foundation (Australia), the Research Grants Council (Hong Kong), the Raelene Boyle Sporting Chance Foundation ( Australia), the Royal Australasian College of Surgeons, the Heart Foundation of Australia, and the Australian Research Council.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Balconi G, 2000, ARTERIOSCL THROM VAS, V20, P1443, DOI 10.1161/01.ATV.20.6.1443; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; CARTER TC, 1954, J HERED, V45, P151; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291; Garlanda C, 1997, EUR J CELL BIOL, V73, P368; GREEN EL, 1961, J HERED, V52, P223, DOI 10.1093/oxfordjournals.jhered.a107077; Hosking BM, 2004, J BIOL CHEM, V279, P5314, DOI 10.1074/jbc.M308512200; Hosking BM, 2001, BIOCHEM BIOPH RES CO, V287, P493, DOI 10.1006/bbrc.2001.5589; Hosking BM, 2001, GENE, V262, P239, DOI 10.1016/S0378-1119(00)00525-4; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; James K, 2003, GENESIS, V36, P1, DOI 10.1002/gene.10190; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Leung KKH, 1998, J CELL BIOL, V141, P1291, DOI 10.1083/jcb.141.6.1291; Liersch R, 2006, BLOOD, V107, P1214, DOI 10.1182/blood-2005-08-3400; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Pennisi D, 2000, MOL CELL BIOL, V20, P9331, DOI 10.1128/MCB.20.24.9331-9336.2000; Rodriguez-Niedenfuhr M, 2001, ANAT EMBRYOL, V204, P399, DOI 10.1007/s00429-001-0214-9; Shayan R, 2007, GROWTH FACTORS, V25, P417, DOI 10.1080/08977190801932550; SLEE JOHN, 1957, JOUR GENETICS, V55, P570, DOI 10.1007/BF02984073; SOROKIN L, 1994, EUR J BIOCHEM, V223, P603, DOI 10.1111/j.1432-1033.1994.tb19031.x; Spagnuolo R, 2004, BLOOD, V103, P3005, DOI 10.1182/blood-2003-07-2459; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Wilhelm D, 2005, DEV BIOL, V287, P111, DOI 10.1016/j.ydbio.2005.08.039; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4	33	377	386	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					643	669		10.1038/nature07391	http://dx.doi.org/10.1038/nature07391			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18931657				2022-12-28	WOS:000261340000042
J	Zhe, D; Phillips, MR				Zhe, Dong; Phillips, Michael R.			Evolution of China's health-care system	LANCET			English	Editorial Material									[Zhe, Dong] Peking Univ, Ctr Hlth Sci, Beijing, Peoples R China; [Zhe, Dong] Peking Univ, Inst Global Hlth, Beijing, Peoples R China; [Phillips, Michael R.] Beijing Hui Long Guan Hosp, Beijing Suicide Res & Prevent Ctr, WHO Coordinating Ctr Res & Training Suicide Preve, Beijing 100096, Peoples R China; [Phillips, Michael R.] Columbia Univ, Dept Psychiat, New York, NY USA; [Phillips, Michael R.] Columbia Univ, Dept Epidemiol, New York, NY USA	Peking University; Peking University; Columbia University; Columbia University	Zhe, D (corresponding author), Peking Univ, Ctr Hlth Sci, Beijing, Peoples R China.	dougzhe@bjmu.edu.cn	Phillips, Michael Robert/AAE-7585-2021	Phillips, Michael Robert/0000-0002-5973-2439				Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Chan EYY, 2008, LANCET, V372, P359, DOI 10.1016/S0140-6736(08)61141-1; Dib HH, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-17; Eggleston K, 2008, HEALTH ECON, V17, P149, DOI 10.1002/hec.1306; Hesketh T, 1997, BRIT MED J, V314, P1543, DOI 10.1136/bmj.314.7093.1543; HOUGAARD J. L., 2008, CHINESE HLTH CARE SY; Ma S., 2008, COMP HLTH SYSTEMS CH; Phillips MR, 1998, CHINA J, V39, P1, DOI 10.2307/2667691; Shaw K, 2006, PUBLIC HEALTH, V120, P8, DOI 10.1016/j.puhe.2005.10.002; Sidel Victor W., 1982, HLTH CHINA; Wang HL, 2007, JAMA-J AM MED ASSOC, V298, P1928, DOI 10.1001/jama.298.16.1928; Yip W, 2008, HEALTH AFFAIR, V27, P460, DOI 10.1377/hlthaff.27.2.460	12	40	40	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 15	2008	372	9651					1715	1716		10.1016/S0140-6736(08)61351-3	http://dx.doi.org/10.1016/S0140-6736(08)61351-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	374XV	18930524				2022-12-28	WOS:000261077900008
J	Verpy, E; Weil, D; Leibovici, M; Goodyear, RJ; Hamard, G; Houdon, C; Lefevre, GM; Hardelin, JP; Richardson, GP; Avan, P; Petit, C				Verpy, Elisabeth; Weil, Dominique; Leibovici, Michel; Goodyear, Richard J.; Hamard, Ghislaine; Houdon, Carine; Lefevre, Gaelle M.; Hardelin, Jean-Pierre; Richardson, Guy P.; Avan, Paul; Petit, Christine			Stereocilin-deficient mice reveal the origin of cochlear waveform distortions	NATURE			English	Article							OUTER HAIR-CELLS; TECTORIAL MEMBRANE; CHINCHILLA COCHLEA; BASILAR-MEMBRANE; TUNING CURVES; MECHANICS; RESPONSES; LINKS; MUTATIONS; EMISSIONS	Although the cochlea is an amplifier and a remarkably sensitive and finely tuned detector of sounds, it also produces conspicuous mechanical and electrical waveform distortions(1). These distortions reflect nonlinear mechanical interactions within the cochlea. By allowing one tone to suppress another ( masking effect), they contribute to speech intelligibility(2). Tones can also combine to produce sounds with frequencies not present in the acoustic stimulus(3). These sounds compose the otoacoustic emissions that are extensively used to screen hearing in newborns. Because both cochlear amplification and distortion originate from the outer hair cells - one of the two types of sensory receptor cells - it has been speculated that they stem from a common mechanism. Here we show that the nonlinearity underlying cochlear waveform distortions relies on the presence of stereocilin, a protein defective in a recessive form of human deafness(4). Stereocilin was detected in association with horizontal top connectors(5-7), lateral links that join adjacent stereocilia within the outer hair cell's hair bundle. These links were absent in stereocilin- null mutant mice, which became progressively deaf. At the onset of hearing, however, their cochlear sensitivity and frequency tuning were almost normal, although masking was much reduced and both acoustic and electrical waveform distortions were completely lacking. From this unique functional situation, we conclude that the main source of cochlear waveform distortions is a deflection- dependent hair bundle stiffness resulting from constraints imposed by the horizontal top connectors, and not from the intrinsic nonlinear behaviour of the mechanoelectrical transducer channel.	[Verpy, Elisabeth; Weil, Dominique; Leibovici, Michel; Houdon, Carine; Lefevre, Gaelle M.; Hardelin, Jean-Pierre; Petit, Christine] Inst Pasteur, Unite Genet & Physiol Audit, F-75015 Paris, France; [Verpy, Elisabeth; Weil, Dominique; Leibovici, Michel; Houdon, Carine; Lefevre, Gaelle M.; Hardelin, Jean-Pierre; Petit, Christine] INSERM, UMRS 587, F-75015 Paris, France; [Verpy, Elisabeth; Weil, Dominique; Leibovici, Michel; Houdon, Carine; Lefevre, Gaelle M.; Hardelin, Jean-Pierre; Petit, Christine] Coll France, F-75015 Paris, France; [Verpy, Elisabeth; Weil, Dominique; Leibovici, Michel; Houdon, Carine; Lefevre, Gaelle M.; Hardelin, Jean-Pierre; Petit, Christine] Univ Paris 06, F-75015 Paris, France; [Goodyear, Richard J.; Richardson, Guy P.] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Hamard, Ghislaine] Inst Cochin Genet Mol, F-75014 Paris, France; [Avan, Paul] Univ Auvergne, Lab Biophys Sensorielle, F-63001 Clermont Ferrand, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; Sorbonne Universite; University of Sussex; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Clermont Auvergne (UCA)	Petit, C (corresponding author), Inst Pasteur, Unite Genet & Physiol Audit, F-75015 Paris, France.	everpy@pasteur.fr; cpetit@pasteur.fr	AVAN, Paul/J-6878-2015; Leibovici, Michel/ABB-6745-2020	AVAN, Paul/0000-0003-1054-1479; Petit, Christine/0000-0002-9069-002X	European Commission FP6 Integrated Project EuroHear,; Fondation Raymonde et Guy Strittmatter; Region Ile-de-France (Programme Sesame); Wellcome Trust	European Commission FP6 Integrated Project EuroHear,(European CommissionEuropean Commission Joint Research Centre); Fondation Raymonde et Guy Strittmatter; Region Ile-de-France (Programme Sesame)(Region Ile-de-France); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank M. Lenoir, S. Guadagnini and M.-C. Prevost for advice on SEM; E. Perret and P. Roux for advice on confocal microscopy, S. Chardenoux, S. Nouaille and A. Mallet for technical help, Y. Lallemand for providing us with PGK- Cre m mice, N. Michalski for help with figure drawing and J. Boutet de Monvel for critical reading of the manuscript. This work was supported by the European Commission FP6 Integrated Project EuroHear, Fondation Raymonde et Guy Strittmatter, Region Ile-de-France (Programme Sesame), and the Wellcome Trust.	ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; DALLOS P, 1978, J NEUROPHYSIOL, V41, P365, DOI 10.1152/jn.1978.41.2.365; DALLOS P, 1976, J ACOUST SOC AM, V59, P591, DOI 10.1121/1.380903; Delgutte B., 1996, AUDITORY COMPUTATION, P157, DOI DOI 10.1007/978-1-4612-4070-9_5; Delmaghani S, 2006, NAT GENET, V38, P770, DOI 10.1038/ng1829; Fettiplace R, 2006, J PHYSIOL-LONDON, V576, P29, DOI 10.1113/jphysiol.2006.115949; FLOCK A, 1984, NATURE, V310, P597, DOI 10.1038/310597a0; FURNESS DN, 1985, HEARING RES, V18, P177, DOI 10.1016/0378-5955(85)90010-3; GOLDSTEIN JL, 1967, J ACOUST SOC AM, V41, P676, DOI 10.1121/1.1910396; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; He DZZ, 1999, P NATL ACAD SCI USA, V96, P8223, DOI 10.1073/pnas.96.14.8223; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; KIM DO, 1980, J ACOUST SOC AM, V67, P1704, DOI 10.1121/1.384297; Kimura R S, 1966, Acta Otolaryngol, V61, P55, DOI 10.3109/00016486609127043; Kress C, 1998, MAMM GENOME, V9, P998, DOI 10.1007/s003359900914; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; LIBERMAN MC, 1984, HEARING RES, V16, P55, DOI 10.1016/0378-5955(84)90025-X; Lukashkin AN, 2004, J NEUROPHYSIOL, V91, P163, DOI 10.1152/jn.00680.2003; Michel V, 2005, DEV BIOL, V280, P281, DOI 10.1016/j.ydbio.2005.01.014; Moore B. C. J., 1998, COCHLEAR HEARING LOS; Patuzzi R., 1996, COCHLEA, P186; PATUZZI RB, 1989, HEARING RES, V42, P47, DOI 10.1016/0378-5955(89)90117-2; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Robles L, 1997, J NEUROPHYSIOL, V77, P2385, DOI 10.1152/jn.1997.77.5.2385; RUGGERO MA, 1992, J NEUROPHYSIOL, V68, P1087, DOI 10.1152/jn.1992.68.4.1087; Tsuprun V, 2002, J HISTOCHEM CYTOCHEM, V50, P493, DOI 10.1177/002215540205000406; van Netten SM, 2000, P ROY SOC B-BIOL SCI, V267, P1915, DOI 10.1098/rspb.2000.1230; Verpy E, 2001, NAT GENET, V29, P345, DOI 10.1038/ng726	34	96	98	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2008	456	7219					255	U56		10.1038/nature07380	http://dx.doi.org/10.1038/nature07380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	18849963	Green Accepted			2022-12-28	WOS:000261039300043
J	Appleby, J				Appleby, John			The credit crisis and health care	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Appleby, John] Kings Fund Inst, London W1G 0AN, England		Appleby, J (corresponding author), Kings Fund Inst, London W1G 0AN, England.	j.appleby@kingsfund.org.uk						*BANK ENGL, LETT GOV BANK ENGL B; Chancellor of the Exchequer, 2007, M ASP BRIT PEOPL 200; Department of Health, 2005, RES ALL WEIGHT CAP F; FLORY D, 2008, QUARTER QUARTER 1 20; *HM TREAS, GDP DEFL; *HM TREAS, PUBL EXP STAT AN 198; *HOUS COMM HLTH SE, PUBL EXP HLTH PERS S; *NHS EMPL, 2008 9 PAY AW; *OFF NAT STAT, 2008, RPI PERC CHANG 12 MO; *OFF NAT STAT, 2008, CPI ANN RAT; *OFF NAT STAT, 2008, PUBL SECT FIN NET DE; 2005, MANAGING OPERATING C	12	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 1	2008	337								a2259	10.1136/bmj.a2259	http://dx.doi.org/10.1136/bmj.a2259			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368AM	18957699				2022-12-28	WOS:000260593700023
J	Schekman, RW				Schekman, Randy W.			George E. Palade (1912-2008) RETROSPECTIVE	SCIENCE			English	Biographical-Item									[Schekman, Randy W.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Schekman, RW (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	schekman@berkeley.edu							0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					695	695		10.1126/science.1167174	http://dx.doi.org/10.1126/science.1167174			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974342				2022-12-28	WOS:000260605200035
J	Teng, CC				Teng, Christopher C.			Corneal dendritic ulcer from herpes simplex virus infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Teng, Christopher C.] NYU, Langone Med Ctr, New York, NY 10016 USA	New York University; NYU Langone Medical Center	Teng, CC (corresponding author), NYU, Langone Med Ctr, New York, NY 10016 USA.			Teng, Christopher/0000-0002-9484-3572					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2008	359	17					E22	E22		10.1056/NEJMicm070168	http://dx.doi.org/10.1056/NEJMicm070168			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363DJ	18946058				2022-12-28	WOS:000260245800010
J	Mokotoff, DM				Mokotoff, David M.			Remembering Earl	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												dmok@tampabay.rr.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2008	300	16					1853	1854		10.1001/jama.300.16.1853	http://dx.doi.org/10.1001/jama.300.16.1853			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362UR	18940964				2022-12-28	WOS:000260223100001
J	Hebert, PL; Sisk, JE; Wang, JJ; Tuzzio, L; Casabianca, JM; Chassin, MR; Horowitz, C; McLaughlin, MA				Hebert, Paul L.; Sisk, Jane E.; Wang, Jason J.; Tuzzio, Leah; Casabianca, Jodi M.; Chassin, Mark R.; Horowitz, Carol; McLaughlin, Mary Ann			Cost-Effectiveness of Nurse-Led Disease Management for Heart Failure in an Ethnically Diverse Urban Community	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED-TRIAL; SF-12; CARE; QUALITY; HEALTH; POPULATION; UTILITY; TRENDS; RISK	Background: Randomized, controlled trials have shown that nurse-led disease management for patients with heart failure can reduce hospitalizations. Less is known about the cost-effectiveness of these interventions. Objective: To estimate the cost-effectiveness of a nurse-led disease management intervention over 12 months, implemented in a randomized, controlled effectiveness trial. Design: Cost-effectiveness analysis conducted alongside a randomized trial. Data Sources: Medical costs from administrative records, and self-reported quality of life and nonmedical costs from patient surveys. Participants: Patients with systolic dysfunction recruited from ambulatory clinics in Harlem, New York. Time Horizon: 12 months. Perspective: Societal and payer. Intervention: 12-month program that involved 1 face-to-face encounter with a nurse and regular telephone follow- up. Outcome Measures: Quality of life as measured by the Health Utilities Index Mark 3 and EuroQol-5D and cost-effectiveness as measured by the incremental cost-effectiveness ratio ( ICER). Results of Base-Case Analysis: Costs and quality of life were higher in the nurse-managed group than the usual care group. The ICERs over 12 months were $17 543 per EuroQol-5D-based quality-adjusted life-year ( QALY) and $15 169 per Health Utilities Index Mark 3-based QALY ( in 2001 U. S. dollars). Results of Sensitivity Analysis: From a payer perspective, the ICER ranged from $3673 to $4495 per QALY. Applying national prices in place of New York City prices yielded a societal ICER of $13 460 to $ 15 556 per QALY. Cost-effectiveness acceptability curves suggest that the intervention was most likely cost-effective for patients with less severe ( New York Heart Association classes I to II) heart failure. Limitation: The trial was conducted in an ethnically diverse, inner-city neighborhood; thus, results may not be generalizable to other communities. Conclusion: Over 12 months, the nurse-led disease management program was a reasonably cost-effective way to reduce the burden of heart failure in this community.	Univ Washington, Sch Publ Hlth & Community Med, Vet Adm Puget Sound Hlth Care Syst, Seattle, WA 98195 USA; Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; Mt Sinai Sch Med, New York, NY USA; Fordham Univ, Bronx, NY 10458 USA; Joint Commiss, Oak Brook Terrace, IL USA	University of Washington; University of Washington Seattle; Group Health Cooperative; Icahn School of Medicine at Mount Sinai; Fordham University	Hebert, PL (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Hlth Serv Res & Dev, 1100 Olive Way,Suite 1400, Seattle, WA 98101 USA.	Paul.Hebert2@va.gov	Wang, Jason/AAG-8248-2019		Agency for Healthcare Research and Quality [R01 HS10402-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010402] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P60MD000270] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Grant Support: Dr. Sisk was supported by a grant from the Agency for Healthcare Research and Quality (R01 HS10402-01).	[Anonymous], ANN PHYS FEE SCHED P; Baker DW, 1999, PATIENT EDUC COUNS, V38, P33, DOI 10.1016/S0738-3991(98)00116-5; Benatar D, 2003, ARCH INTERN MED, V163, P347, DOI 10.1001/archinte.163.3.347; Blough DK, 1999, J HEALTH ECON, V18, P153, DOI 10.1016/S0167-6296(98)00032-0; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Chapman RH, 2000, MED DECIS MAKING, V20, P451, DOI 10.1177/0272989X0002000409; CHEN A, 2008, 8914762 MATH POL RES; *CTR MED MED SERV, PAYM IMP FIL; *CTR MED MED SERV, UPD CAL YEAR 2001 HO; *CTR MED MED SERV, 2001, HLTH CAR PROC COD SY; *CTR MED MED SERV, MED FED UPP LIM DAT; Davis SK, 2003, AM J PUBLIC HEALTH, V93, P447, DOI 10.2105/AJPH.93.3.447; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Franks P, 2003, MED CARE, V41, P1277, DOI 10.1097/01.MLR.0000093480.58308.D8; GABREL CS, 2000, OVERVIEW NURSING HOM, P1; GHALI JK, 1988, ARCH INTERN MED, V148, P2013, DOI 10.1001/archinte.148.9.2013; GLICK HA, 2007, EC EVALUATIONS CLIN, P181; Gold MR, 1996, COST EFFECTIVENESS H; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; Horowitz CR, 2004, SOC SCI MED, V58, P631, DOI 10.1016/S0277-9536(03)00232-6; Kasper EK, 2002, J AM COLL CARDIOL, V39, P471, DOI 10.1016/S0735-1097(01)01761-2; Kozak LJ, 2001, HEALTH AFFAIR, V20, P225, DOI 10.1377/hlthaff.20.2.225; Lawrence WF, 2004, MED DECIS MAKING, V24, P160, DOI 10.1177/0272989X04264015; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Pugh LC., 2001, MEDSURG NURS, V10, P71; Rich MW, 1999, ARCH INTERN MED, V159, P1690, DOI 10.1001/archinte.159.15.1690; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Sengupta N, 2004, MED CARE, V42, P927, DOI 10.1097/01.mlr.0000135812.52570.42; Sisk JE, 2006, ANN INTERN MED, V145, P273, DOI 10.7326/0003-4819-145-4-200608150-00007; Smith B, 2005, AM J MANAG CARE, V11, P701; Smith B, 2008, AM J MANAG CARE, V14, P106; StataCorp, 2005, STAT STAT SOFTW REL; *US BUR LAB STAT, 2001, PROD PRIN IND IND DA; *US BUR LAB STAT, 2001, CURR POP SURV; *US BUR LAB STAT, 2000 METR AR OCC EMP; US Bureau of Labor Statistics, CONS PRIC IND DET RE	39	79	82	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2008	149	8					540	W105		10.7326/0003-4819-149-8-200810210-00006	http://dx.doi.org/10.7326/0003-4819-149-8-200810210-00006			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367XJ	18936502	Green Accepted			2022-12-28	WOS:000260585600003
J	Wilson, JF				Wilson, Jennifer Fisher			Primary Care Delivery Changes as Nonphysician Clinicians Gain Independence	ANNALS OF INTERNAL MEDICINE			English	News Item							NURSE-PRACTITIONERS; PHYSICIAN ASSISTANTS; OUTCOMES					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Cipher Daisha J, 2006, JAAPA, V19, P39; Cipher DJ, 2006, JAAPA-J AM ACAD PHYS, V19, P42; Cipher DJ, 2006, JAAPA-J AM ACAD PHYS, V19, P39; Cooper Richard, 2004, J Health Serv Res Policy, V9 Suppl 1, P39, DOI 10.1258/135581904322724121; Cooper RA, 2007, ACAD MED, V82, P827, DOI 10.1097/ACM.0b013e31812f7939; Hooker RS, 2006, MED J AUSTRALIA, V185, P4, DOI 10.5694/j.1326-5377.2006.tb00438.x; HOOKER RS, 2003, PHYS ASSISTANTS AM M; Larson Eric H, 2007, J Allied Health, V36, P121; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Lenz ER, 2004, MED CARE RES REV, V61, P332, DOI 10.1177/1077558704266821; *MASS MED SOC, MASS MED SOC 2007 WO; Mundinger MO, 2000, JAMA-J AM MED ASSOC, V283, P59, DOI 10.1001/jama.283.1.59; *NAT ASS COMM HLTH, ACC DEN LOOK AM MED; Sox HC, 2000, JAMA-J AM MED ASSOC, V283, P106, DOI 10.1001/jama.283.1.106; US Department of Health and Human Services, REG NURS POP FIND 20	15	10	10	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2008	149	8					597	600		10.7326/0003-4819-149-8-200810210-00025	http://dx.doi.org/10.7326/0003-4819-149-8-200810210-00025			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367XJ	18936515				2022-12-28	WOS:000260585600020
J	Sousa, R				Sousa, Rui			Tie Me Up, Tie Me Down: Inhibiting RNA Polymerase	CELL			English	Editorial Material							STRUCTURAL BASIS; ALPHA-AMANITIN; TRANSCRIPTION; MECHANISM		Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Sousa, R (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	sousa@biochem.uthscsa.edu		Sousa, Rui/0000-0003-4314-121X	NIGMS NIH HHS [R01 GM052522] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052522] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Chopra I, 2007, CURR OPIN INVEST DR, V8, P600; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; IRSCHIK H, 1983, J ANTIBIOT, V36, P1651, DOI 10.7164/antibiotics.36.1651; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; Shinnick T. M., 1996, CURR TOP MICROBIOL; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017	9	7	9	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 17	2008	135	2					205	207		10.1016/j.cell.2008.09.052	http://dx.doi.org/10.1016/j.cell.2008.09.052			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957193	Bronze, Green Accepted			2022-12-28	WOS:000260130400007
J	Dinulos, JGH; Zembowicz, A; Burnett, MM; Harris, NL				Dinulos, James G. H.; Zembowicz, Artur; Burnett, Melissa M.; Harris, Nancy Lee			A girl with recurrent oral lesions and cutaneous bullae - Dermatitis due to zinc deficiency (acrodermatitis enteropathica-like syndrome)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPIDERMOLYSIS-BULLOSA; ERYTHEMA MULTIFORME		[Dinulos, James G. H.] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA; [Dinulos, James G. H.] Dartmouth Hitchcock Med Ctr, Dept Pediat, Lebanon, NH 03766 USA; [Dinulos, James G. H.] Dartmouth Med Sch, Dept Med, Hanover, NH USA; [Dinulos, James G. H.] Dartmouth Med Sch, Dept Pediat, Hanover, NH USA; [Zembowicz, Artur] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Zembowicz, Artur] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Dinulos, JGH (corresponding author), Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA.				SkinMedica; Barrier Pharmaceuticals; Connetics; Novartis; Merck	SkinMedica; Barrier Pharmaceuticals; Connetics; Novartis(Novartis); Merck(Merck & Company)	Dr. Dinulos reports receiving consulting fees from SkinMedica, Barrier Pharmaceuticals, and Connetics and lecture fees from Novartis. Dr. Zembowicz reports receiving consulting fees from Merck. No other potential conflict of interest relevant to this article was reported.	Ayangco L, 2003, DERMATOL CLIN, V21, P195, DOI 10.1016/S0733-8635(02)00062-1; Borlu M, 2006, INT J DERMATOL, V45, P713, DOI 10.1111/j.1365-4632.2006.02754.x; BORRONI G, 1992, AM J DERMATOPATH, V14, P304, DOI 10.1097/00000372-199208000-00003; Galbraith SS, 2005, PEDIATRICS, V116, pE439, DOI 10.1542/peds.2004-2281; GELMETTI C, 2000, TXB PEDIAT DERMATOLO, V1, P265; GONZALEZ JR, 1982, AM J DERMATOPATH, V4, P303, DOI 10.1097/00000372-198208000-00003; JENSEN SL, 2008, J CUTAN PATHOL   JUN; Kienast A, 2007, EUR J PEDIATR, V166, P189, DOI 10.1007/s00431-006-0218-9; Krasovec M, 1996, DERMATOLOGY, V193, P361, DOI 10.1159/000246296; Leaute-Labreze C, 2000, ARCH DIS CHILD, V83, P347, DOI 10.1136/adc.83.4.347; Lofgren SM, 2006, DERMATITIS, V17, P165, DOI 10.2310/6620.2006.05021; Maverakis E, 2007, J AM ACAD DERMATOL, V56, P116, DOI 10.1016/j.jaad.2006.08.015; Nadiminti H, 2005, CONTACT DERMATITIS, V52, P46, DOI 10.1111/j.0105-1873.2005.0483c.x; Nakano A, 2002, HUM GENET, V110, P41, DOI 10.1007/s00439-001-0630-1; Ng PPL, 2003, DERMATOLOGY, V207, P349, DOI 10.1159/000074112; Pope E, 2005, J AM ACAD DERMATOL, V52, P171, DOI 10.1016/j.jaad.2004.06.048; Sun YJ, 2003, J MED VIROL, V71, P423, DOI 10.1002/jmv.10502; Torgerson RR, 2007, J AM ACAD DERMATOL, V57, P315, DOI 10.1016/j.jaad.2007.04.017; Uitto J, 2005, CLIN DERMATOL, V23, P33, DOI 10.1016/j.clindermatol.2004.09.015; Varki R, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039685	20	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2008	359	16					1718	1724		10.1056/NEJMcpc0805312	http://dx.doi.org/10.1056/NEJMcpc0805312			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360EY	18923175				2022-12-28	WOS:000260041400012
J	Rosenbaum, L				Rosenbaum, Lisa			Becoming a physician: Living unlabeled - Diagnosis and disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenbaum, Lisa] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Rosenbaum, L (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.								0	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2008	359	16					1650	1653		10.1056/NEJMp0804984	http://dx.doi.org/10.1056/NEJMp0804984			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360EY	18923169				2022-12-28	WOS:000260041400003
J	Aisen, PS; Schneider, LS; Sano, M; Diaz-Arrastia, R; van Dyck, CH; Weiner, MF; Bottiglieri, T; Jin, S; Stokes, KT; Thomas, RG; Thal, LJ				Aisen, Paul S.; Schneider, Lon S.; Sano, Mary; Diaz-Arrastia, Ramon; van Dyck, Christopher H.; Weiner, Myron F.; Bottiglieri, Teodoro; Jin, Shelia; Stokes, Karen T.; Thomas, Ronald G.; Thal, Leon J.		Alzheimer Dis Cooperat Study	High-dose B vitamin supplementation and cognitive decline in Alzheimer disease - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOLIC-ACID SUPPLEMENTATION; ELEVATED PLASMA HOMOCYSTEINE; DOUBLE-BLIND; RISK-FACTOR; DEMENTIA; PLACEBO; FOLATE; PERFORMANCE; INHIBITORS; INVENTORY	Context Blood levels of homocysteine may be increased in Alzheimer disease ( AD) and hyperhomocysteinemia may contribute to disease pathophysiology by vascular and direct neurotoxic mechanisms. Even in the absence of vitamin deficiency, homocysteine levels can be reduced by administration of high- dose supplements of folic acid and vitamins B-6 and B-12. Prior studies of B vitamins to reduce homocysteine in AD have not had sufficient size or duration to assess their effect on cognitive decline. Objective To determine the efficacy and safety of B vitamin supplementation in the treatment of AD. Design, Setting, and Patients A multicenter, randomized, double- blind controlled clinical trial of high- dose folate, vitamin B-6, and vitamin B-12 supplementation in 409 ( of 601 screened) individuals with mild to moderate AD ( Mini- Mental State Examination scores between 14 and 26, inclusive) and normal folic acid, vitamin B-12, and homocysteine levels. The study was conducted between February 20, 2003, and December 15, 2006, at clinical research sites of the Alzheimer Disease Cooperative Study located throughout the United States. Intervention Participants were randomly assigned to 2 groups of unequal size to increase enrollment ( 60% treated with high- dose supplements [ 5 mg/ d of folate, 25 mg/ d of vitamin B-6, 1 mg/ d of vitamin B-12] and 40% treated with identical placebo); duration of treatment was 18 months. Main Outcome Measure Change in the cognitive subscale of the Alzheimer Disease Assessment Scale ( ADAS- cog). Results A total of 340 participants ( 202 in active treatment group and 138 in placebo group) completed the trial while taking study medication. Although the vitamin supplement regimen was effective in reducing homocysteine levels ( mean [ SD], - 2.42 [ 3.35] in active treatment group vs - 0.86 [ 2.59] in placebo group; P <. 001), it had no beneficial effect on the primary cognitive measure, rate of change in ADAS- cog score during 18 months ( 0.372 points per month for placebo group vs 0.401 points per month for active treatment group, P=. 52; 95% confidence interval of rate difference, - 0.06 to 0.12; based on the intention- to- treat generalized estimating equations model), or on any secondary measures. A higher quantity of adverse events involving depression was observed in the group treated with vitamin supplements. Conclusion This regimen of high- dose B vitamin supplements does not slow cognitive decline in individuals with mild to moderate AD. Trial Registration clinicaltrials. gov Identifier: NCT00056225.	[Aisen, Paul S.; Stokes, Karen T.; Thomas, Ronald G.; Thal, Leon J.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Jin, Shelia; Thomas, Ronald G.; Thal, Leon J.] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Schneider, Lon S.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Sano, Mary] Mt Sinai Sch Med, Bronx, NY USA; [Diaz-Arrastia, Ramon; Weiner, Myron F.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [van Dyck, Christopher H.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Bottiglieri, Teodoro] Baylor Univ, Med Ctr, Inst Metab Dis, Dallas, TX USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Southern California; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University; Baylor University; Baylor University Medical Center	Aisen, PS (corresponding author), Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr,M-C 0949, La Jolla, CA 92093 USA.	paisen@ucsd.edu	Obisesan, Thomas O/D-4184-2011	DeKosky, Steven/0000-0003-3743-2758; Weiner, Myron/0000-0001-5682-4410; Diaz-Arrastia, Ramon/0000-0001-6051-3594	National Institute on Aging [U01-AG10483]; General Clinical Research Center Program of the National Center for Research Resources; National Institutes of Health; NATIONAL INSTITUTE ON AGING [U19AG010483, U01AG010483] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); General Clinical Research Center Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grant U01-AG10483 from the National Institute on Aging (NIA), as well as grants from the General Clinical Research Center Program of the National Center for Research Resources, National Institutes of Health. Folic acid and vitamins B<INF>6</INF> and B<INF>12</INF> were donated by Roche Inc.	Aisen PS, 2005, CNS DRUGS, V19, P989, DOI 10.2165/00023210-200519120-00002; Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Aisen PS, 2000, NEUROLOGY, V54, P588, DOI 10.1212/WNL.54.3.588; Aisen PS, 2003, AM J GERIAT PSYCHIAT, V11, P246, DOI 10.1176/appi.ajgp.11.2.246; Balk EM, 2007, ARCH INTERN MED, V167, P21, DOI 10.1001/archinte.167.1.21; Bisp MR, 2002, ANAL BIOCHEM, V305, P82, DOI 10.1006/abio.2002.5638; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; Connelly PJ, 2008, INT J GERIATR PSYCH, V23, P155, DOI 10.1002/gps.1856; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; Durga J, 2007, LANCET, V369, P208, DOI 10.1016/S0140-6736(07)60109-3; Fava M, 2007, J CLIN PSYCHIAT, V68, P4; Fillit HM, 2002, J MOL NEUROSCI, V19, P249, DOI 10.1007/s12031-002-0001-y; Flicker L, 2008, NEUROBIOL AGING, V29, P303, DOI 10.1016/j.neurobiolaging.2006.10.007; Folstein M, 2007, AM J PSYCHIAT, V164, P861, DOI 10.1176/appi.ajp.164.6.861; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; Irizarry MC, 2005, NEUROLOGY, V65, P1402, DOI 10.1212/01.wnl.0000183063.99107.5c; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Logsdon R.G., 1999, J MENTAL HLTH AGING, V5, P21, DOI DOI 10.1037/T03352-000; Longo Frank M, 2004, NeuroRx, V1, P117, DOI 10.1602/neurorx.1.1.117; Luchsinger JA, 2007, NEUROCHEM RES, V32, P775, DOI 10.1007/s11064-006-9207-7; MALOUF M, 2003, COCHRANE DB SYST REV; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McMahon JA, 2006, NEW ENGL J MED, V354, P2764, DOI 10.1056/NEJMoa054025; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nilsson K, 2001, INT J GERIATR PSYCH, V16, P609, DOI 10.1002/gps.388; O'Suilleabhain PE, 2004, ARCH NEUROL-CHICAGO, V61, P865, DOI 10.1001/archneur.61.6.865; Reynolds E, 2006, LANCET NEUROL, V5, P949, DOI 10.1016/S1474-4422(06)70598-1; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; SCHAUMBURG H, 1983, NEW ENGL J MED, V309, P445, DOI 10.1056/NEJM198308253090801; Selhub J, 2006, J NUTR, V136, p1726S, DOI 10.1093/jn/136.6.1726S; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Sun Y, 2007, CLIN THER, V29, P2204, DOI 10.1016/j.clinthera.2007.10.012; UBBINK JB, 1991, KLIN WOCHENSCHR, V69, P527, DOI 10.1007/BF01649290; Wright CB, 2005, STROKE, V36, P1207, DOI 10.1161/01.STR.0000165923.02318.22; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	40	360	377	1	61	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2008	300	15					1774	1783		10.1001/jama.300.15.1774	http://dx.doi.org/10.1001/jama.300.15.1774			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QA	18854539	Green Accepted, Bronze			2022-12-28	WOS:000260002000029
J	Sokol, DK				Sokol, Daniel K.			The harms of medicoplasty	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sokol, Daniel K.] Univ London St Georges Hosp, London, England	St Georges University London	Sokol, DK (corresponding author), Univ London St Georges Hosp, London, England.	daniel.sokol@talk21.com						Liao LM, 2007, BMJ-BRIT MED J, V334, P1090, DOI 10.1136/bmj.39206.422269.BE; 2008, BMJ, V337, pA1684	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2008	337	7674							a1983	10.1136/bmj.a1983	http://dx.doi.org/10.1136/bmj.a1983			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FU	18840633				2022-12-28	WOS:000259903300030
J	Hammond, SP; Baden, LR				Hammond, Sarah P.; Baden, Lindsey R.			Management of skin and soft-tissue infection - Polling results	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RESISTANT STAPHYLOCOCCUS-AUREUS		[Hammond, Sarah P.; Baden, Lindsey R.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Hammond, SP (corresponding author), Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA.			Hammond, Sarah/0000-0002-4271-7443				Chambers HF, 2008, NEW ENGL J MED, V359, P1063, DOI 10.1056/NEJMclde0708359; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Rajendran PM, 2007, ANTIMICROB AGENTS CH, V51, P4044, DOI 10.1128/AAC.00377-07	4	25	25	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2008	359	15					E20	U10		10.1056/NEJMclde0806337	http://dx.doi.org/10.1056/NEJMclde0806337			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FS	18843122				2022-12-28	WOS:000259903100014
J	Henney, A; Superti-Furga, G				Henney, Adriano; Superti-Furga, Giulio			A network solution	NATURE			English	Editorial Material							LATE SODIUM CURRENT; INHIBITORS; SYSTEMS; KINASE		[Henney, Adriano] AstraZeneca, Global Discovery Enabling Capabil & Sci, Alderley Pk, England; [Superti-Furga, Giulio] Austrian Acad Sci, Ctr Mol Med, A-1010 Vienna, Austria	AstraZeneca; Austrian Academy of Sciences	Henney, A (corresponding author), AstraZeneca, Global Discovery Enabling Capabil & Sci, Alderley Pk, England.	adriano.henney@btinternet.com; gsuperti@cemm.oeaw.ac.at	Superti-Furga, Giulio/AAE-5681-2019; Superti-Furga, Giulio/F-4755-2015	Superti-Furga, Giulio/0000-0002-0570-1768				*ASTRAZENECA, 2008, HYP PUTT SYST BIOL W; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Belardinelli L, 2006, HEART, V92, P6, DOI 10.1136/hrt.2005.078790; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Mo ML, 2007, MOL BIOSYST, V3, P598, DOI 10.1039/b705597h; Noble D, 2006, HEART, V92, P1, DOI 10.1136/hrt.2005.078782; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061	8	29	30	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2008	455	7214					730	731		10.1038/455730a	http://dx.doi.org/10.1038/455730a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18843342				2022-12-28	WOS:000259854900020
J	Uchida, K; Takahashi, S; Harii, K; Ieda, J; Koshibae, W; Ando, K; Maekawa, S; Saitoh, E				Uchida, K.; Takahashi, S.; Harii, K.; Ieda, J.; Koshibae, W.; Ando, K.; Maekawa, S.; Saitoh, E.			Observation of the spin Seebeck effect	NATURE			English	Article							ROOM-TEMPERATURE; SEMICONDUCTORS; SPINTRONICS; ELECTRONICS	The generation of electric voltage by placing a conductor in a temperature gradient is called the Seebeck effect(1,2). Its efficiency is represented by the Seebeck coefficient, S, which is defined as the ratio of the generated electric voltage to the temperature difference, and is determined by the scattering rate and the density of the conduction electrons. The effect can be exploited, for example, in thermal electric- power generators and for temperature sensing, by connecting two conductors with different Seebeck coefficients, a device called a thermocouple(1,2). Here we report the observation of the thermal generation of driving power, or voltage, for electron spin: the spin Seebeck effect. Using a recently developed spin-detection technique that involves the spin Hall effect(3-14), we measure the spin voltage generated from a temperature gradient in a metallic magnet. This thermally induced spin voltage persists even at distances far from the sample ends, and spins can be extracted from every position on the magnet simply by attaching a metal. The spin Seebeck effect observed here is directly applicable to the production of spin- voltage generators, which are crucial for driving spintronic(15-18) devices. The spin Seebeck effect allows us to pass a pure spin current(19), a flow of electron spins without electric currents, over a long distance. These innovative capabilities will invigorate spintronics research.	[Uchida, K.; Harii, K.; Ando, K.; Saitoh, E.] Keio Univ, Dept Appl Phys & Physicoinformat, Yokohama, Kanagawa 2238522, Japan; [Takahashi, S.; Ieda, J.; Maekawa, S.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Takahashi, S.; Ieda, J.; Maekawa, S.] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan; [Koshibae, W.] RIKEN, Cross Correlated Mat Res Grp, Wako, Saitama 3510198, Japan; [Saitoh, E.] Japan Sci & Technol Agcy, PRESTO, Tokyo 1020075, Japan	Keio University; Tohoku University; Japan Science & Technology Agency (JST); RIKEN; Japan Science & Technology Agency (JST)	Saitoh, E (corresponding author), Keio Univ, Dept Appl Phys & Physicoinformat, Yokohama, Kanagawa 2238522, Japan.	saitoheiji@appi.keio.ac.jp	Saitoh, Eiji/C-1004-2011; Koshibae, Wataru/B-2838-2013; Maekawa, Sadamichi/J-6194-2018; Ando, Kazuya/A-8521-2011; Ieda, Jun'ichi/A-3345-2009; Takahashi, Saburo/A-8472-2011; Uchida, Ken-ichi/H-3098-2011	Saitoh, Eiji/0000-0003-2675-0718; Maekawa, Sadamichi/0000-0002-4237-7741; Ieda, Jun'ichi/0000-0001-6069-8533; Uchida, Ken-ichi/0000-0001-7680-3051	MEXT, Japan [19048028]; MIC, Japan; IMS, Japan	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MIC, Japan; IMS, Japan	The authors thank Y. Suzuki, S. E. Barnes, Y. Fujitani, G. Tatara, K. M. Itoh, H. Kuwahara and M. Matoba for discussions. This work was supported by a Grant-in-Aid for Scientific Research in Priority Area 'Creation and control of spin current' (19048028) from MEXT, Japan, a Grant-in-Aid for Encouragement of Young Scientists (A) from MEXT, Japan, the global COE for the 'High- level global cooperation for leading- edge platform on access spaces' from MEXT, Japan, a Strategic Information and Communications R&D Promotion Programme from MIC, Japan, and the Next Generation Supercomputing Project of Nanoscience Program from IMS, Japan.	Ashcroft N. W., 1976, SOLID STATE PHYS, P253; CADEVILLE MC, 1971, J PHYS F MET PHYS, V1, P686, DOI 10.1088/0305-4608/1/5/323; Callen H. B., 1960, THERMODYNAMICS, V17; Chappert C, 2007, NAT MATER, V6, P813, DOI 10.1038/nmat2024; DYAKONOV MI, 1971, PHYS LETT A, VA 35, P459, DOI 10.1016/0375-9601(71)90196-4; Gravier L, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.024419; Hatami M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.066603; Hirohata A, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.104425; Hirsch JE, 1999, PHYS REV LETT, V83, P1834, DOI 10.1103/PhysRevLett.83.1834; Jedema FJ, 2001, NATURE, V410, P345, DOI 10.1038/35066533; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; Kimura T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.156601; MAEKAWA S, 2004, PHYS TRANSITION META, P323; Maekawa S., 2006, CONCEPTS SPIN ELECT; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; Saitoh E, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2199473; Seki T, 2008, NAT MATER, V7, P125, DOI 10.1038/nmat2098; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; SLONCZEWSKI JC, 1989, PHYS REV B, V39, P6995, DOI 10.1103/PhysRevB.39.6995; Takahashi S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.116601; Takahashi S, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.031009; Tsyplyatyev O, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.132403; Valenzuela SO, 2006, NATURE, V442, P176, DOI 10.1038/nature04937; VALET T, 1993, PHYS REV B, V48, P7099, DOI 10.1103/PhysRevB.48.7099; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Wunderlich J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047204; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323	28	1603	1625	29	758	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 9	2008	455	7214					778	781		10.1038/nature07321	http://dx.doi.org/10.1038/nature07321			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18843364				2022-12-28	WOS:000259854900042
J	Bernardi, E; Camporese, G; Buller, HR; Siragusa, S; Imberti, D; Berchio, A; Ghirarduzzi, A; Verlato, F; Anastasio, R; Prati, C; Piccioli, A; Pesavento, R; Bova, C; Maltempi, P; Zanatta, N; Cogo, A; Cappelli, R; Bucherini, E; Cuppini, S; Noventa, F; Prandoni, P				Bernardi, Enrico; Camporese, Giuseppe; Buller, Harry R.; Siragusa, Sergio; Imberti, Davide; Berchio, Arrigo; Ghirarduzzi, Angelo; Verlato, Fabio; Anastasio, Raffaela; Prati, Carolina; Piccioli, Andrea; Pesavento, Raffaele; Bova, Carlo; Maltempi, Patrizia; Zanatta, Nello; Cogo, Alberto; Cappelli, Roberto; Bucherini, Eugenio; Cuppini, Stefano; Noventa, Franco; Prandoni, Paolo		Erasmus Study Grp	Serial 2-point ultrasonography plus D-Dimer vs whole-leg color-coded doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	21st Congress of the International-Society-on-Thrombosis-and-Haemostasis	JUL 06-12, 2007	Geneva, SWITZERLAND	Int Soc Thrombosis & Haemostasis (ISTH)			COMPLETE COMPRESSION ULTRASONOGRAPHY; VENOUS THROMBOSIS; PROSPECTIVE COHORT; ULTRASOUND; MANAGEMENT; OUTPATIENTS; NEED	Context Patients with suspected deep vein thrombosis ( DVT) of the lower extremities are usually investigated with ultrasonography either by the proximal veins ( 2-point ultrasonography) or the entire deep vein system ( whole- leg ultrasonography). The latter approach is thought to be better based on its ability to detect isolated calf vein thrombosis; however, it requires skilled operators and is mainly available only during working hours. No randomized comparisons are yet available evaluating the relative values of these 2 strategies. Objective To assess if the 2 diagnostic strategies are equivalent for the management of symptomatic outpatients with suspected DVT of the lower extremities. Design, Setting, and Patients A prospective, randomized, multicenter study of consecutive symptomatic outpatients ( n= 2465) with a first episode of suspected DVT of the lower extremities who were randomized to undergo 2- point or whole- leg ultrasonography. Data were taken from ultrasound laboratories of 14 Italian universities or civic hospitals between January 1, 2003, and December 21, 2006. Patients with normal ultrasound findings were followed up for 3 months, with study completion on March 20, 2007. Main Outcome Measure Objectively confirmed 3- month incidence of symptomatic venous thromboembolism in patients with an initially normal diagnostic workup. Results Of 2465 eligible patients, 345 met 1 or more exclusion criteria and 22 refused to participate; therefore, 2098 patients were randomized to either 2- point ( n= 1045) or whole- leg ( n= 1053) ultrasonography. Symptomatic venous thromboembolism occurred in 7 of 801 patients ( incidence, 0.9%; 95% confidence interval [ CI], 0.3%1.8%) in the 2- point strategy group and in 9 of 763 patients ( incidence, 1.2%; 95% CI, 0.5%- 2.2%) in the whole- leg strategy group. This met the established equivalence criterion ( observed difference, 0.3%; 95% CI, - 1.4% to 0.8%). Conclusion The 2 diagnostic strategies are equivalent when used for the management of symptomatic outpatients with suspected DVT of the lower extremities. Trial Registration clinicaltrials. gov Identifier: NCT00353093.	[Bernardi, Enrico] Civ Hosp, Dept Emergency & Accid Med, Conegliano, Italy; [Camporese, Giuseppe; Verlato, Fabio] Univ Hosp Padua, Angiol Unit, Padua, Italy; [Piccioli, Andrea; Prandoni, Paolo] Univ Hosp Padua, Dept Med & Surg Sci, Padua, Italy; [Noventa, Franco] Univ Hosp Padua, Dept Clin & Expt Med, Grp Clin Epidemiol, Padua, Italy; [Buller, Harry R.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Siragusa, Sergio; Anastasio, Raffaela] Univ Hosp Palermo, Serv Haemostasis & Thrombosis, Palermo, Italy; [Imberti, Davide; Prati, Carolina] Civ Hosp, Ctr Haemostasis & Thrombosis, Dept Emergency & Accid Med, Piacenza, Italy; [Berchio, Arrigo] S Giovanni Battista Hosp, Dept Emergency & Accid Med, Turin, Italy; [Ghirarduzzi, Angelo] S Maria Nuovo Hosp, Angiol Unit, Dept Internal Med, Reggio Emilia, Italy; [Pesavento, Raffaele] Civ Hosp, Dept Angiol, Castelfranco Veneto, Italy; [Zanatta, Nello] Civ Hosp, Dept Internal Med, Cosenza, Italy; [Cogo, Alberto] Villa Berica Hosp, Dept Vasc Med, Vicenza, Italy; [Cappelli, Roberto] Policlin Scotte, Dept Internal Cardiovasc & Geriatr Med, Siena, Italy; [Bucherini, Eugenio] Civ Hosp, Angiol Unit, Faenza, Italy; [Cuppini, Stefano] Civ Hosp, Dept Internal Med, Rovigo, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Amsterdam; Academic Medical Center Amsterdam; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Siena	Bernardi, E (corresponding author), Osped Conegliano, Dipartimento Sci Chirurg, Via Brigata Bisagno 4, I-31015 Conegliano, Italy.	enrico.bernardi@ulss7.it	Imberti, Davide/AGB-5049-2022; Bova, Carlo/AAO-7422-2021; Noventa, Franco/C-1202-2008; Pesavento, Raffaele/E-1095-2012; Pesavento, Raffaele/J-1643-2014; Zanatta, Nilo/P-7137-2017	Imberti, Davide/0000-0002-9284-6227; Noventa, Franco/0000-0003-4622-5523; Pesavento, Raffaele/0000-0001-9578-3455; Pesavento, Raffaele/0000-0001-9578-3455; Zanatta, Nilo/0000-0002-0959-9043				Anderson DR, 1999, ARCH INTERN MED, V159, P477, DOI 10.1001/archinte.159.5.477; BAXTER GM, 1992, CLIN RADIOL, V46, P198, DOI 10.1016/S0009-9260(05)80445-3; Bernardi E, 1998, BRIT MED J, V317, P1037; Birdwell BG, 2000, ARCH INTERN MED, V160, P309, DOI 10.1001/archinte.160.3.309; Blaivas M, 2007, CRIT CARE MED, V35, pS224, DOI 10.1097/01.CCM.0000260672.13913.FD; Bounameaux H, 2004, J THROMB HAEMOST, V2, P2260, DOI 10.1111/j.1538-7836.2004.01030.x; Cogo A, 1998, BRIT MED J, V316, P17, DOI 10.1136/bmj.316.7124.17; COGO A, 1993, ARCH INTERN MED, V153, P2777, DOI 10.1001/archinte.153.24.2777; El Kheir D, 2004, ANN INTERN MED, V140, P1052, DOI 10.7326/0003-4819-140-12-200406150-00016; Elias A, 2003, THROMB HAEMOSTASIS, V89, P221; Gaitini D, 2006, J CLIN ULTRASOUND, V34, P289, DOI 10.1002/jcu.20236; HEIJBOER H, 1993, NEW ENGL J MED, V329, P1365, DOI 10.1056/NEJM199311043291901; Hull RD, 2005, ANN INTERN MED, V142, P583, DOI 10.7326/0003-4819-142-7-200504050-00015; Imberti D, 2006, J THROMB HAEMOST, V4, P1037, DOI 10.1111/j.1538-7836.2006.01940.x; Jacoby J, 2007, J EMERG MED, V32, P197, DOI 10.1016/j.jemermed.2006.06.008; Kearon C, 2005, ANN INTERN MED, V142, P490, DOI 10.7326/0003-4819-142-7-200504050-00007; Kearon C, 2001, ANN INTERN MED, V135, P108, DOI 10.7326/0003-4819-135-2-200107170-00011; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Kraaijenhagen R A, 1997, Curr Opin Pulm Med, V3, P268, DOI 10.1097/00063198-199707000-00006; Kraaijenhagen RA, 2002, ARCH INTERN MED, V162, P907, DOI 10.1001/archinte.162.8.907; LAGERSTEDT CI, 1985, LANCET, V2, P515; LENSING AWA, 1989, NEW ENGL J MED, V320, P342, DOI 10.1056/NEJM198902093200602; LEWIS BD, 1994, RADIOLOGY, V192, P651, DOI 10.1148/radiology.192.3.8058929; MANTONI M, 1989, ACTA RADIOL, V30, P575; McIlrath ST, 2006, AM J EMERG MED, V24, P325, DOI 10.1016/j.ajem.2005.11.020; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Righini M, 2006, THROMB HAEMOSTASIS, V95, P56, DOI 10.1160/TH05-08-0588; Righini M, 2004, ANN INTERN MED, V141, P888, DOI 10.7326/0003-4819-141-11-200412070-00017; Schellong SM, 2003, THROMB HAEMOSTASIS, V89, P228; Stevens SM, 2004, ANN INTERN MED, V140, P985, DOI 10.7326/0003-4819-140-12-200406150-00007; Tick LW, 2002, AM J MED, V113, P630, DOI 10.1016/S0002-9343(02)01347-5; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; WELLS PS, 1995, CIRCULATION, V91, P2184, DOI 10.1161/01.CIR.91.8.2184; ZIERLER BK, 2004, CIRCULATION S1, V109, P9	34	180	185	1	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2008	300	14					1653	1659		10.1001/jama.300.14.1653	http://dx.doi.org/10.1001/jama.300.14.1653			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	356YF	18840838	Bronze			2022-12-28	WOS:000259812800026
J	Teklehaimanot, A; Teklehaimanot, HD				Teklehaimanot, Awash; Teklehaimanot, Hailay Desta			Alternative form of artemether-lumefantrine for infants	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM MALARIA; INDIVIDUAL PATIENT DATA; POOLED ANALYSIS; 6-DOSE REGIMEN; EFFICACY; SAFETY		[Teklehaimanot, Awash] Columbia Univ, Earth Inst, New York, NY 10025 USA; [Teklehaimanot, Hailay Desta] Ctr Natl Hlth Dev Ethiopia, Addis Ababa, Ethiopia	Columbia University	Teklehaimanot, A (corresponding author), Columbia Univ, Earth Inst, New York, NY 10025 USA.	at2076@columbia.edu						ABDULLA S, 2008, LANCET          1015, DOI DOI 10.1016/S0140-6736(08)61492-0; [Anonymous], 2004, SCAL HOM BAS MAN MAL; Barnes KI, 2008, TRENDS PARASITOL, V24, P127, DOI 10.1016/j.pt.2007.11.008; Makanga M, 2006, AM J TROP MED HYG, V74, P991, DOI 10.4269/ajtmh.2006.74.991; Mueller EA, 2006, ACTA TROP, V100, P41, DOI 10.1016/j.actatropica.2006.09.007; Omari AA, 2005, COCHRANE DB SYST REV, V4; Ramharter M, 2007, J ANTIMICROB CHEMOTH, V60, P1091, DOI 10.1093/jac/dkm355; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; White NJ, 2002, TRENDS PARASITOL, V18, P458, DOI 10.1016/S1471-4922(02)02373-5; Yeung S, 2005, TROP MED INT HEALTH, V10, P121, DOI 10.1111/j.1365-3156.2004.01364.x	10	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2008	372	9652					1786	1787		10.1016/S0140-6736(08)61493-2	http://dx.doi.org/10.1016/S0140-6736(08)61493-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	18926568				2022-12-28	WOS:000261112000005
J	Hart, R				Hart, Roger			Preservation of fertility in adults and children diagnosed with cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CRYOPRESERVED OVARIAN TISSUE; BREAST-CANCER; OOCYTE CRYOPRESERVATION; CHILDHOOD-CANCER; YOUNG-WOMEN; FOLLOW-UP; CHEMOTHERAPY; TRANSPLANTATION; STIMULATION; LETROZOLE		[Hart, Roger] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6008, Australia; [Hart, Roger] Fertil Specialists Western Australia, Perth, WA 6010, Australia	University of Western Australia	Hart, R (corresponding author), Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6008, Australia.	roger.hart@uwa.edu.au						Ahmad G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006583.pub2; [Anonymous], 2004, FERT ASS TREATM PEOP; Azim AA, 2008, J CLIN ONCOL, V26, P2630, DOI 10.1200/JCO.2007.14.8700; BADAWY A, 2008, FERTIL STERIL   0801; Bahadur G, 2002, HUM REPROD, V17, P2654, DOI 10.1093/humrep/17.10.2654; Blumenfeld Z, 2008, FERTIL STERIL, V89, P166, DOI 10.1016/j.fertnstert.2007.02.010; *CAN RES UK, 2008, CANCERSTATS KEY FACT; Critchley Hilary O D, 2005, J Natl Cancer Inst Monogr, P64; Deepinder F, 2008, REPROD BIOMED ONLINE, V16, P784, DOI 10.1016/S1472-6483(10)60143-5; Demeestere I, 2007, ONCOLOGIST, V12, P1437, DOI 10.1634/theoncologist.12-12-1437; Donnez J, 2004, LANCET, V364, P1405, DOI 10.1016/S0140-6736(04)17222-X; Duffy CM, 2005, J CLIN ONCOL, V23, P766, DOI 10.1200/JCO.2005.01.134; Golombok S, 2005, HUM REPROD, V20, P286, DOI 10.1093/humrep/deh585; Gook DA, 2007, HUM REPROD UPDATE, V13, P591, DOI 10.1093/humupd/dmm028; GREEN DM, 1982, CANCER, V49, P2285, DOI 10.1002/1097-0142(19820601)49:11<2285::AID-CNCR2820491114>3.0.CO;2-N; Hart R, 1999, GYNAECOL ENDOSC, V8, P51, DOI 10.1046/j.1365-2508.1999.00219.x; Hart R, 2001, GYNAECOL ENDOSC, V10, P289, DOI 10.1046/j.1365-2508.2001.00466.x; Holm K, 1999, BONE MARROW TRANSPL, V23, P259, DOI 10.1038/sj.bmt.1701569; Hoy J, 1999, HUM REPROD, V14, P1760, DOI 10.1093/humrep/14.7.1760; Ives A, 2007, BMJ-BRIT MED J, V334, P194, DOI 10.1136/bmj.39035.667176.55; Kelleher S, 2001, HUM REPROD, V16, P2632, DOI 10.1093/humrep/16.12.2632; Lansac J, 2001, HUM REPROD UPDATE, V7, P33, DOI 10.1093/humupd/7.1.33; Larsen EC, 2004, ACTA OBSTET GYN SCAN, V83, P96, DOI 10.1111/j.1600-0412.2004.00332.x; Lass A, 2001, HUM REPROD UPDATE, V7, P370, DOI 10.1093/humupd/7.4.370; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; Meirow D, 2008, HUM REPROD, V23, P1007, DOI 10.1093/humrep/den055; Newton H, 1996, HUM REPROD, V11, P1487; O'Flaherty C, 2008, HUM REPROD, V23, P1044, DOI 10.1093/humrep/den081; *OFF CANC SURV, 2005, FACTS CANC SURV; Oktay K, 2005, J CLIN ONCOL, V23, P4347, DOI 10.1200/JCO.2005.05.037; Oktay K, 2007, ONCOLOGIST, V12, P1055, DOI 10.1634/theoncologist.12-9-1055; Oktay K, 2006, J CLIN ENDOCR METAB, V91, P3885, DOI 10.1210/jc.2006-0962; Oktay K, 2006, FERTIL STERIL, V86, P70, DOI 10.1016/j.fertnstert.2006.03.017; Partridge AH, 2007, BREAST, V16, pS175, DOI 10.1016/j.breast.2007.07.029; Quinn GP, 2008, SOC SCI MED, V66, P784, DOI 10.1016/j.socscimed.2007.09.013; Reinblatt SL, 2008, SEMIN REPROD MED, V26, P121, DOI 10.1055/s-2007-992932; Revel A, 2008, MOL CELL ENDOCRINOL, V282, P143, DOI 10.1016/j.mce.2007.11.003; Royal Colleges of Physicians Radiologists and Obstetricians and Gynaecologists, 2007, EFF CANC TREATM REPR; SANGER WG, 1992, FERTIL STERIL, V58, P1024; Wallace WHB, 2005, INT J RADIAT ONCOL, V62, P738, DOI 10.1016/j.ijrobp.2004.11.038; WANG YA, 2007, ASSISTED REPROD TECH, V11; Zebrack BJ, 2004, PSYCHO-ONCOL, V13, P689, DOI 10.1002/pon.784	42	20	23	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2008	337								a2045	10.1136/bmj.a2045	http://dx.doi.org/10.1136/bmj.a2045			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368AM	18955375				2022-12-28	WOS:000260593700031
J	Falkowski, PG; Isozaki, Y				Falkowski, Paul G.; Isozaki, Yukio			Geology - The story of O(2)	SCIENCE			English	Editorial Material							ATMOSPHERIC OXYGEN; CARBON-CYCLE; EVOLUTION; WATER; NITROGEN; ORIGIN; EARTH; MODEL; TIME; RISE		[Falkowski, Paul G.] Rutgers State Univ, Dept Earth & Planetary Sci, New Brunswick, NJ 08901 USA; [Falkowski, Paul G.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Isozaki, Yukio] Univ Tokyo, Dept Earth Sci & Astron, Tokyo 1538902, Japan	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Tokyo	Falkowski, PG (corresponding author), Rutgers State Univ, Dept Earth & Planetary Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	falko@imcs.rutgers.edu; isozaki@ea.c.u-tokyo.ac.jp	Isozaki, Yukio/A-1806-2009	Isozaki, Yukio/0000-0002-3596-581X	Grants-in-Aid for Scientific Research [20224012] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Barber J, 2008, PHILOS T R SOC B, V363, P1125, DOI 10.1098/rstb.2007.2227; Berner R.A., 2004, PHANEROZOIC CARBON C; Berner RA, 2006, GEOLOGY, V34, P413, DOI 10.1130/G22470.1; BLANKENSHIP RE, 1992, PHOTOSYNTH RES, V33, P91, DOI 10.1007/BF00039173; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Catling DC, 2005, EARTH PLANET SC LETT, V237, P1, DOI 10.1016/j.epsl.2005.06.013; Falkowski P, 2007, EVOLUTION PRIMARY PR; Falkowski PG, 2008, PHILOS T R SOC B, V363, P2705, DOI 10.1098/rstb.2008.0054; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; Hayes JM, 2006, PHILOS T R SOC B, V361, P931, DOI 10.1098/rstb.2006.1840; Holland HD., 1984, CHEM EVOLUTION ATMOS; Isozaki Y, 1997, SCIENCE, V276, P235, DOI 10.1126/science.276.5310.235; Jaffres JBD, 2007, EARTH-SCI REV, V83, P83, DOI 10.1016/j.earscirev.2007.04.002; KASTING JF, 1981, J GEOPHYS RES-OCEANS, V86, P1147, DOI 10.1029/JC086iC02p01147; KEELING RF, 1993, GLOBAL BIOGEOCHEM CY, V7, P37, DOI 10.1029/92GB02733; KNOLL AH, 1999, SCIENCE, V284, P2129, DOI DOI 10.1126/SCIENCE.284.5423.2129; Kump LR, 2008, NATURE, V451, P277, DOI 10.1038/nature06587; Maruyama S, 2005, INT GEOL REV, V47, P775, DOI 10.2747/0020-6814.47.8.775; Mojzsis SJ, 2001, NATURE, V409, P178, DOI 10.1038/35051557; Robert F, 2001, SCIENCE, V293, P1056, DOI 10.1126/science.1064051; Tappert R, 2005, GEOLOGY, V33, P565, DOI 10.1130/G21637.1	22	45	49	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					540	542		10.1126/science.1162641	http://dx.doi.org/10.1126/science.1162641			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948530				2022-12-28	WOS:000260299100028
J	Karapetis, CS; Khambata-Ford, S; Jonker, DJ; O'Callaghan, CJ; Tu, D; Tebbutt, NC; Simes, RJ; Chalchal, H; Shapiro, JD; Robitaille, S; Price, TJ; Shepherd, L; Au, HJ; Langer, C; Moore, MJ; Zalcberg, JR				Karapetis, Christos S.; Khambata-Ford, Shirin; Jonker, Derek J.; O'Callaghan, Chris J.; Tu, Dongsheng; Tebbutt, Niall C.; Simes, R. John; Chalchal, Haji; Shapiro, Jeremy D.; Robitaille, Sonia; Price, Timothy J.; Shepherd, Lois; Au, Heather-Jane; Langer, Christiane; Moore, Malcolm J.; Zalcberg, John R.			K-ras mutations and benefit from cetuximab in advanced colorectal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	10th World Congress on Gastrointestinal Cancer	JUN 25-28, 2008	Barcelona, SPAIN	ESMO			GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; KRAS MUTATION; PHASE-II; SURVIVAL; THERAPY; EGFR; EXPRESSION; PLUS; ADENOCARCINOMAS	Background: Treatment with cetuximab, a monoclonal antibody directed against the epidermal growth factor receptor, improves overall and progression-free survival and preserves the quality of life in patients with colorectal cancer that has not responded to chemotherapy. The mutation status of the K-ras gene in the tumor may affect the response to cetuximab and have treatment-independent prognostic value. Methods: We analyzed tumor samples, obtained from 394 of 572 patients (68.9%) with colorectal cancer who were randomly assigned to receive cetuximab plus best supportive care or best supportive care alone, to look for activating mutations in exon 2 of the K-ras gene. We assessed whether the mutation status of the K-ras gene was associated with survival in the cetuximab and supportive-care groups. Results: Of the tumors evaluated for K-ras mutations, 42.3% had at least one mutation in exon 2 of the gene. The effectiveness of cetuximab was significantly associated with K-ras mutation status (P=0.01 and P<0.001 for the interaction of K-ras mutation status with overall survival and progression-free survival, respectively). In patients with wild-type K-ras tumors, treatment with cetuximab as compared with supportive care alone significantly improved overall survival (median, 9.5 vs. 4.8 months; hazard ratio for death, 0.55; 95% confidence interval [CI], 0.41 to 0.74; P<0.001) and progression-free survival (median, 3.7 months vs. 1.9 months; hazard ratio for progression or death, 0.40; 95% CI, 0.30 to 0.54; P<0.001). Among patients with mutated K-ras tumors, there was no significant difference between those who were treated with cetuximab and those who received supportive care alone with respect to overall survival (hazard ratio, 0.98; P=0.89) or progression-free survival (hazard ratio, 0.99; P=0.96). In the group of patients receiving best supportive care alone, the mutation status of the K-ras gene was not significantly associated with overall survival (hazard ratio for death, 1.01; P=0.97). Conclusions: Patients with a colorectal tumor bearing mutated K-ras did not benefit from cetuximab, whereas patients with a tumor bearing wild-type K-ras did benefit from cetuximab. The mutation status of the K-ras gene had no influence on survival among patients treated with best supportive care alone. (ClinicalTrials.gov number, NCT00079066.).	[Karapetis, Christos S.] Flinders Med Ctr, Adelaide, SA, Australia; [Karapetis, Christos S.] Flinders Univ S Australia, Adelaide, SA, Australia; [Khambata-Ford, Shirin] Bristol Myers Squibb Co, Res & Dev, Princeton, NJ USA; [Jonker, Derek J.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [O'Callaghan, Chris J.; Tu, Dongsheng; Robitaille, Sonia; Shepherd, Lois] Natl Canc Inst Canada Clin Trials Grp, Kingston, ON, Canada; [Tebbutt, Niall C.] Austin Hlth, Melbourne, Vic, Australia; [Simes, R. John] Univ Sydney, Natl Hlth & Med Res Council Clin Trials Ctr, Sydney, NSW 2006, Australia; [Chalchal, Haji] Allan Blair Canc Ctr, Regina, SK, Canada; [Shapiro, Jeremy D.] Cabrini Hosp, Melbourne, Vic, Australia; [Shapiro, Jeremy D.] Alfred Hosp, Melbourne, Vic, Australia; [Price, Timothy J.] Univ Adelaide, Queen Elizabeth Hosp, Adelaide, SA, Australia; [Au, Heather-Jane] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Langer, Christiane] Bristol Myers Squibb Co, Wallingford, CT 06492 USA; [Moore, Malcolm J.] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; [Zalcberg, John R.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Zalcberg, John R.] Univ Melbourne, Melbourne, Vic, Australia	Flinders Medical Centre; Flinders University South Australia; Bristol-Myers Squibb; University of Ottawa; Ottawa Hospital Research Institute; Queens University - Canada; Canadian Cancer Trials Group; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Sydney; Cabrini Health; Florey Institute of Neuroscience & Mental Health; University of Adelaide; University of Alberta; Bristol-Myers Squibb; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Peter Maccallum Cancer Center; University of Melbourne	Karapetis, CS (corresponding author), Flinders Med Ctr, Dept Med Oncol, Flinders Dr, Bedford Pk, SA 5042, Australia.	c.karapetis@flinders.edu.au	Simes, Robert John/P-1497-2014; Price, Timothy J/G-1404-2012	Price, Timothy J/0000-0002-3922-2693; Zalcberg, John/0000-0002-6624-0782; Karapetis, Christos/0000-0003-1741-996X				Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Andreyev HJN, 1998, J NATL CANCER I, V90, P675, DOI 10.1093/jnci/90.9.675; Andreyev HJN, 2001, GUT, V48, P230, DOI 10.1136/gut.48.2.230; Barault L, 2008, INT J CANCER, V122, P2255, DOI 10.1002/ijc.23388; Baselga J, 2001, EUR J CANCER, V37, pS16; Bazan V, 2005, ANN ONCOL, V16, P50, DOI 10.1093/annonc/mdi908; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bleeker WA, 2000, AM J GASTROENTEROL, V95, P2953, DOI 10.1016/S0002-9270(00)01119-9; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Esteller M, 2001, J CLIN ONCOL, V19, P299, DOI 10.1200/JCO.2001.19.2.299; Francoual M, 2006, ANN ONCOL, V17, P962, DOI 10.1093/annonc/mdl037; Fransen K, 2004, CARCINOGENESIS, V25, P527, DOI 10.1093/carcin/bgh049; Frattini M, 2007, BRIT J CANCER, V97, P1139, DOI 10.1038/sj.bjc.6604009; Hebbar M, 2006, ANTI-CANCER DRUG, V17, P855, DOI 10.1097/01.cad.0000217425.44584.9f; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Lenz HJ, 2006, J CLIN ONCOL, V24, P4914, DOI 10.1200/JCO.2006.06.7595; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Massarelli E, 2007, CLIN CANCER RES, V13, P2890, DOI 10.1158/1078-0432.CCR-06-3043; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Penault-Llorca F, 2006, ONCOL REP, V16, P1173; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; van Zandwijk N, 2007, ANN ONCOL, V18, P99, DOI 10.1093/annonc/mdl323; WIERZBICKI RD, 2008, J CLIN OINCOL S, V26, pS15; Zhang W, 2006, PHARMACOGENET GENOM, V16, P475, DOI 10.1097/01.fpc.0000220562.67595.a5	32	2838	2974	11	264	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2008	359	17					1757	1765		10.1056/NEJMoa0804385	http://dx.doi.org/10.1056/NEJMoa0804385			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	363DJ	18946061				2022-12-28	WOS:000260245800003
J	Tottey, S; Waldron, KJ; Firbank, SJ; Reale, B; Bessant, C; Sato, K; Cheek, TR; Gray, J; Banfield, MJ; Dennison, C; Robinson, NJ				Tottey, Steve; Waldron, Kevin J.; Firbank, Susan J.; Reale, Brian; Bessant, Conrad; Sato, Katsuko; Cheek, Timothy R.; Gray, Joe; Banfield, Mark J.; Dennison, Christopher; Robinson, Nigel J.			Protein-folding location can regulate manganese-binding versus copper- or zinc-binding	NATURE			English	Article							OXALATE DECARBOXYLASE; QUERCETIN 2,3-DIOXYGENASE; BACILLUS-SUBTILIS; SENSITIVITY; EXPRESSION; CHAPERONE; PATHWAY; YEAST; EPR	Metals are needed by at least one-quarter of all proteins(1,2). Although metallochaperones(3-8) insert the correct metal into some proteins, they have not been found for the vast majority, and the view is that most metalloproteins acquire their metals directly from cellular pools. However, some metals form more stable complexes with proteins than do others. For instance, as described in the Irving Williams series(9), Cu2+ and Zn2+ typically form more stable complexes than Mn2+. Thus it is unclear what cellular mechanisms manage metal acquisition by most nascent proteins. To investigate this question, we identified the most abundant Cu2+-protein, CucA (Cu2+- cupin A), and the most abundant Mn2+- protein, MncA (Mn2+- cupin A), in the periplasm of the cyanobacterium Synechocystis PCC 6803. Each of these newly identified proteins binds its respective metal via identical ligands within a cupin fold. Consistent with the Irving - Williams series, MncA only binds Mn2+ after folding in solutions containing at least a 10(4) times molar excess of Mn2+ over Cu2+ or Zn2+. However once MncA has bound Mn2+, the metal does not exchange with Cu2+. MncA and CucA have signal peptides for different export pathways into the periplasm, Tat and Sec respectively. Export by the Tat pathway allows MncA to fold in the cytoplasm, which contains only tightly bound copper or Zn2+ ( refs 10-12) but micromolar Mn2+ ( ref. 13). In contrast, CucA folds in the periplasm to acquire Cu2+. These results reveal a mechanism whereby the compartment in which a protein folds overrides its binding preference to control its metal content. They explain why the cytoplasm must contain only tightly bound and buffered copper and Zn2+.	[Tottey, Steve; Waldron, Kevin J.; Firbank, Susan J.; Reale, Brian; Sato, Katsuko; Cheek, Timothy R.; Gray, Joe; Banfield, Mark J.; Dennison, Christopher; Robinson, Nigel J.] Univ Newcastle, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Bessant, Conrad] Cranfield Univ, Cranfield Bioinformat Grp, Cranfield MK43 0AL, Beds, England	Newcastle University - UK; Cranfield University	Robinson, NJ (corresponding author), Univ Newcastle, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	n.j.robinson@ncl.ac.uk	Waldron, Kevin/J-2368-2016; Waldron, Kevin John/HHM-8983-2022; Robinson, Nigel J/J-6363-2012; Bessant, Conrad/E-7620-2010; Banfield, Mark/C-7453-2013; Johnson, Michael D. L./B-4352-2012	Waldron, Kevin/0000-0002-5577-7357; Waldron, Kevin John/0000-0002-5577-7357; Robinson, Nigel J/0000-0001-5586-1092; Banfield, Mark/0000-0001-8921-3835; Gray, Joseph/0000-0003-2338-0301; Bessant, Conrad/0000-0002-7983-1020; Dennison, Christopher/0000-0001-8665-052X	BBSRC PMS committee [BBS/B/02576, BB/E001688/1]; J. Gitlin and the Children's Discovery Institute; Royal Society University Research Fellow; BBSRC [BB/E001688/1] Funding Source: UKRI; MRC [G0500367, G0600759] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/02576, BB/E001688/1] Funding Source: researchfish; Medical Research Council [G0600759, G0500367] Funding Source: researchfish	BBSRC PMS committee(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); J. Gitlin and the Children's Discovery Institute; Royal Society University Research Fellow(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the BBSRC PMS committee (BBS/B/02576 and BB/E001688/1). B. R. was supported by J. Gitlin and the Children's Discovery Institute. M. J. B. is a Royal Society University Research Fellow. J. Kotz provided advice on the draft manuscript. We thank T. Palmer, B. Ize and G. Buchanan for donating E. coli BL21 tat deletion strains and for advice.	Anand R, 2002, BIOCHEMISTRY-US, V41, P7659, DOI 10.1021/bi0200965; Angerhofer A, 2007, J PHYS CHEM B, V111, P5043, DOI 10.1021/jp0715326; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Beers J, 1997, J BIOL CHEM, V272, P33191, DOI 10.1074/jbc.272.52.33191; Bellingham SA, 2004, J BIOL CHEM, V279, P20378, DOI 10.1074/jbc.M400805200; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; DeLano W.L, PYMOL MOL GRAPHICS S; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer M, 2007, NATURE, V445, P91, DOI 10.1038/nature05362; Fulda S, 2000, EUR J BIOCHEM, V267, P5900, DOI 10.1046/j.1432-1327.2000.01642.x; Fusetti F, 2002, STRUCTURE, V10, P259, DOI 10.1016/S0969-2126(02)00704-9; Helmann JD, 2007, MOL CELL, V27, P859, DOI 10.1016/j.molcel.2007.09.002; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; Kooter IM, 2002, EUR J BIOCHEM, V269, P2971, DOI 10.1046/j.1432-1033.2002.02973.x; Leslie AGW, 1992, RECENT CHANGES MOSFL; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; ODERMATT A, 1995, J BIOL CHEM, V270, P4349, DOI 10.1074/jbc.270.9.4349; Orriss GL, 2007, FEBS LETT, V581, P4091, DOI 10.1016/j.febslet.2007.07.044; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Palmer T, 2003, MICROBIOL-SGM, V149, P547, DOI 10.1099/mic.0.25900-0; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Ranquet C, 2007, J BIOL CHEM, V282, P30442, DOI 10.1074/jbc.M702519200; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Rosenzweig AC, 2002, CHEM BIOL, V9, P673, DOI 10.1016/S1074-5521(02)00156-4; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Svedruzic D, 2007, ARCH BIOCHEM BIOPHYS, V464, P36, DOI 10.1016/j.abb.2007.03.016; Tanner A, 2001, J BIOL CHEM, V276, P43627, DOI 10.1074/jbc.M107202200; Tottey S, 2002, J BIOL CHEM, V277, P5490, DOI 10.1074/jbc.M105857200; Tottey Stephen, 2007, V6, P3, DOI 10.1007/7171_2006_072; Valentine JS, 1997, SCIENCE, V278, P817, DOI 10.1126/science.278.5339.817; Waldron KJ, 2007, J BIOL CHEM, V282, P3837, DOI 10.1074/jbc.M609916200; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9	42	236	243	3	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2008	455	7216					1138	U17		10.1038/nature07340	http://dx.doi.org/10.1038/nature07340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948958				2022-12-28	WOS:000260252600051
J	Kipping, RR; Jago, R; Lawlor, DA				Kipping, Ruth R.; Jago, Russell; Lawlor, Debbie A.			Obesity in children. Part 1: Epidemiology, measurement, risk factors, and screening	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BODY-MASS INDEX; CHILDHOOD OBESITY; PEDIATRIC OBESITY; PHYSICAL-ACTIVITY; ADOLESCENTS; OVERWEIGHT; ADULTHOOD; WORLDWIDE; FATNESS; DISEASE		[Kipping, Ruth R.; Lawlor, Debbie A.] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Jago, Russell] Univ Bristol, Dept Exercise Nutr & Hlth Sci, Bristol BS8 1TP, Avon, England; [Lawlor, Debbie A.] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol BS8 2BN, Avon, England	University of Bristol; University of Bristol; University of Bristol	Kipping, RR (corresponding author), Univ Bristol, Dept Social Med, Bristol, Avon, England.	ruth.kipping@bristol.ac.uk	Jago, Russell/ABD-6271-2021	Jago, Russell/0000-0002-3394-0176; Kipping, Ruth/0000-0002-5446-8077; Lawlor, Debbie A/0000-0002-6793-2262				Andersen LB, 2008, INT J PEDIATR OBES, V3, P58, DOI 10.1080/17477160801896366; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; *DEP HLTH, 2007, RES PAR ATT ROUT MEA; Dietz WH, 1999, AM J CLIN NUTR, V70, p123S; Flodmark CE, 2005, INT J OBESITY, V29, pS31, DOI 10.1038/sj.ijo.0803060; Fraser A, 2007, GASTROENTEROLOGY, V133, P1814, DOI 10.1053/j.gastro.2007.08.077; FRENCH SA, 1995, OBES RES, V3, P479, DOI 10.1002/j.1550-8528.1995.tb00179.x; Goran MI, 2003, J CLIN ENDOCR METAB, V88, P1417, DOI 10.1210/jc.2002-021442; Goran MI, 1998, PEDIATRICS, V101, P505; *INF CTR, 2008, NAT CHILD MEAS PROGR; Justus MB, 2007, J SCHOOL HEALTH, V77, P706, DOI 10.1111/j.1746-1561.2007.00255.x; Kipping RR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1848; Lawlor DA, 2005, DIABETIC MED, V22, P921, DOI 10.1111/j.1464-5491.2005.01551.x; Lobstein T, 2006, INT J PEDIATR OBES, V1, P33, DOI 10.1080/17477160600586689; Ma GS, 2004, AM J CLIN NUTR, V79, P653; McCarthy HD, 2001, EUR J CLIN NUTR, V55, P902, DOI 10.1038/sj.ejcn.1601240; *NAT CTR HLTH STAT, 2006, PREV OV CHILDR AD US; National Health Medical Research Council (Australia), 2003, CLIN PRACT GUID MAN; National Institute for HealthandClinical Excellence, 2006, OB PREV ID ASS MAN O; Nooyens ACJ, 2007, AM J CLIN NUTR, V85, P1533, DOI 10.1093/ajcn/85.6.1533; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Power C, 1997, AM J CLIN NUTR, V66, P1094, DOI 10.1093/ajcn/66.5.1094; Reilly JJ, 2007, PEDIATR RES, V61, P646, DOI 10.1203/pdr.0b013e3180536667; *SCI ADV COMM NUTR, 2007, APPL WHO GROWTH STAN; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wareham N, 2007, OBES REV, V8, P109, DOI 10.1111/j.1467-789X.2007.00328.x; Westwood M, 2007, ARCH DIS CHILD, V92, P416, DOI 10.1136/adc.2006.113589; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; *WHO, CHILDH OV OB 2008; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1	34	93	95	2	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2008	337	7675							a1824	10.1136/bmj.a1824	http://dx.doi.org/10.1136/bmj.a1824			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360YE	18922835				2022-12-28	WOS:000260093900038
J	Nishino, J; Kim, I; Chada, K; Morrison, SJ				Nishino, Jinsuke; Kim, Injune; Chada, Kiran; Morrison, Sean J.			Hmga2 Promotes Neural Stem Cell Self-Renewal in Young but Not Old Mice by Reducing p16(Ink4a) and p19(Arf) Expression	CELL			English	Article							TUMOR SUPPRESSION; DEPENDENCE DISTINGUISHES; TRANSGENIC MICE; INK4A LOCUS; BMI-1; MOUSE; PROTEINS; PROLIFERATION; SENESCENCE; GENE	Stem cells persist throughout life in diverse tissues by undergoing self-renewing divisions. Self-renewal capacity declines with age, partly because of increasing expression of the tumor suppressor p16(Ink4a). We discovered that the Hmga2 transcriptional regulator is highly expressed in fetal neural stem cells but that expression declines with age. This decrease is partly caused by the increasing expression of let-7b microRNA, which is known to target HMGA2. Hmga2-deficient mice show reduced stem cell numbers and self-renewal throughout the central and peripheral nervous systems of fetal and young-adult mice but not old-adult mice. Furthermore, p16(Ink4a) and p19(Arf) expression were increased in Hmga2-deficient fetal and young-adult stem cells, and deletion of p16(Ink4a) and/or p19(Arf) partially restored self-renewal capacity. let-7b overexpression reduced Hmga2 and increased p16(Ink4a)/p19(Arf) expression. Hmga2 thus promotes fetal and young-adult stem cell self-renewal by decreasing p16(Ink4a)/p19(Arf) expression. Changes in let-7 and Hmga2 expression during aging contribute to the decline in neural stem cell function.	[Nishino, Jinsuke; Kim, Injune; Morrison, Sean J.] Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA; [Nishino, Jinsuke; Kim, Injune; Morrison, Sean J.] Univ Michigan, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Chada, Kiran] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08554 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Rutgers State University New Brunswick; Rutgers State University Medical Center	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021; Kim, Injune/C-1710-2011	Kim, Injune/0000-0001-9244-815X; Morrison, Sean/0000-0003-1587-8329	Howard Hughes Medical Institute; National Institute of Neurological Disorder and Stroke [R01 NS040750]; National Institute on Aging [R01 AG024945-01]; University of Michigan (UM) Comprehensive Cancer National Institutes of Health (NIH) [CA46592]; National Institute of Diabetes, Digestive, and Kidney Diseases [NIH5P60-DK20572]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024945] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Neurological Disorder and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Michigan (UM) Comprehensive Cancer National Institutes of Health (NIH)(University of Michigan SystemUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes, Digestive, and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Howard Hughes Medical Institute, the National Institute of Neurological Disorder and Stroke (R01 NS040750), and the National Institute on Aging (R01 AG024945-01). Flow cytometry was partially supported by the University of Michigan (UM) Comprehensive Cancer National Institutes of Health (NIH) CA46592. Antibody production was supported in part by National Institute of Diabetes, Digestive, and Kidney Diseases grant NIH5P60-DK20572 to the Michigan Diabetes Research and Training Center. J.N. was supported by a postdoctoral fellowship from the Japan Society for the Promotion of Science. Thanks to David Adams and Martin White for flow cytometry and to Elizabeth Smith (UM Hybridoma Core) for antibody production. Thanks to Charles Sherr for providing p19<SUP>Arf-/-</SUP> mice and to Ron DePinho for providing p16<SUP>Ink4a</SUP>/p19Arf<SUP>-/-</SUP> and p16<SUP>Ink4a-/-</SUP> mice. Thanks to Scott Lowe and to Masashi Narita for providing anti-Hmga2 antibody and to Tom Lanigan in the UM Vector Core for generating	Arlotta P, 2000, J BIOL CHEM, V275, P14394, DOI 10.1074/jbc.M000564200; BENSON KF, 1994, GENET RES, V64, P27, DOI 10.1017/S0016672300032511; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Fedele M, 2006, CANCER CELL, V9, P459, DOI 10.1016/j.ccr.2006.04.024; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Hirning-Folz U, 1998, GENE CHROMOSOME CANC, V23, P350, DOI 10.1002/(SICI)1098-2264(199812)23:4<350::AID-GCC10>3.0.CO;2-E; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kiel MJ, 2005, DEV BIOL, V283, P29, DOI 10.1016/j.ydbio.2005.03.037; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	39	471	480	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					227	239		10.1016/j.cell.2008.09.017	http://dx.doi.org/10.1016/j.cell.2008.09.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957199	Bronze, Green Accepted			2022-12-28	WOS:000260130400013
J	Krishnan, V; Nestler, EJ				Krishnan, Vaishnav; Nestler, Eric J.			The molecular neurobiology of depression	NATURE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; NEUROTROPHIC FACTOR VAL66MET; DEEP BRAIN-STIMULATION; MAJOR DEPRESSION; MOOD DISORDERS; PSYCHIATRIC-DISORDERS; ESSENTIAL MEDIATOR; NUCLEUS-ACCUMBENS; RAT HIPPOCAMPUS; KNOCKOUT MICE		[Krishnan, Vaishnav; Nestler, Eric J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Krishnan, Vaishnav; Nestler, Eric J.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Icahn School of Medicine at Mount Sinai	Nestler, EJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	eric.nestler@mssm.edu	Yan, Shuo/B-8381-2009	Krishnan, Vaishnav/0000-0002-2847-0069	National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066172, R01MH051399] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Work in E.J.N.'s laboratory was supported by grants from the National Institute of Mental Health.	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Ansorge MS, 2007, CURR OPIN PHARMACOL, V7, P8, DOI 10.1016/j.coph.2006.11.006; Bergstrom A, 2007, J MOL NEUROSCI, V33, P201, DOI 10.1007/s12031-007-0065-9; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Berton O, 2007, NEURON, V55, P289, DOI 10.1016/j.neuron.2007.06.033; Brouwer JP, 2005, EUR J ENDOCRINOL, V152, P185, DOI 10.1530/eje.1.01828; Brown ES, 2004, BIOL PSYCHIAT, V55, P1, DOI 10.1016/S0006-3223(03)00473-6; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chourbaji S, 2006, NEUROBIOL DIS, V23, P587, DOI 10.1016/j.nbd.2006.05.001; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Dunn AJ, 2005, NEUROSCI BIOBEHAV R, V29, P891, DOI 10.1016/j.neubiorev.2005.03.023; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Eisch AJ, 2003, BIOL PSYCHIAT, V54, P994, DOI 10.1016/j.biopsych.2003.08.003; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; Garcia LSB, 2008, PROG NEURO-PSYCHOPH, V32, P140, DOI 10.1016/j.pnpbp.2007.07.027; Georgescu D, 2005, J NEUROSCI, V25, P2933, DOI 10.1523/JNEUROSCI.1714-04.2005; Gildengers AG, 2008, AM J GERIAT PSYCHIAT, V16, P194, DOI 10.1097/JGP.0b013e318157c5b1; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Gourley SL, 2008, BIOL PSYCHIAT, V63, P353, DOI 10.1016/j.biopsych.2007.07.016; Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Harrison PJ, 2002, BRAIN, V125, P1428, DOI 10.1093/brain/awf149; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; Holsboer F, 2008, NAT REV NEUROSCI, V9, P638, DOI 10.1038/nrn2453; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Hunsberger JG, 2007, NAT MED, V13, P1476, DOI 10.1038/nm1669; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Kaufman J, 2006, BIOL PSYCHIAT, V59, P673, DOI 10.1016/j.biopsych.2005.10.026; Kempermann G, 2008, TRENDS NEUROSCI, V31, P163, DOI 10.1016/j.tins.2008.01.002; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim JM, 2007, BIOL PSYCHIAT, V62, P423, DOI 10.1016/j.biopsych.2006.11.020; Kishi T, 2005, MOL PSYCHIATR, V10, P132, DOI 10.1038/sj.mp.4001638; Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Loftis JM, 2004, J AFFECT DISORDERS, V82, P175, DOI 10.1016/j.jad.2004.04.002; Lopez-Leon S, 2008, MOL PSYCHIATR, V13, P772, DOI 10.1038/sj.mp.4002088; Lu XY, 2006, P NATL ACAD SCI USA, V103, P1593, DOI 10.1073/pnas.0508901103; Lucas G, 2007, NEURON, V55, P712, DOI 10.1016/j.neuron.2007.07.041; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; Maeng Sungho, 2007, Curr Psychiatry Rep, V9, P467, DOI 10.1007/s11920-007-0063-1; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Mathew SJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2080, DOI 10.1038/sj.npp.1301652; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Mill J, 2007, MOL PSYCHIATR, V12, P799, DOI 10.1038/sj.mp.4001992; Monteggia LM, 2007, BIOL PSYCHIAT, V61, P187, DOI 10.1016/j.biopsych.2006.03.021; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Nemeroff CB, 2002, NAT NEUROSCI, V5, P1068, DOI 10.1038/nn943; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Parker KJ, 2003, HORM BEHAV, V43, P60, DOI 10.1016/S0018-506X(02)00016-8; Peaston AE, 2006, MAMM GENOME, V17, P365, DOI 10.1007/s00335-005-0180-2; Pezawas L, 2008, MOL PSYCHIATR, V13, P709, DOI 10.1038/mp.2008.32; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Roy M, 2007, BIOL PSYCHIAT, V61, P174, DOI 10.1016/j.biopsych.2006.03.076; Ruhe HG, 2007, MOL PSYCHIATR, V12, P331, DOI 10.1038/sj.mp.4001949; Rush AJ, 2007, J CLIN PSYCHIAT, V68, P8; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Sajdyk TJ, 2008, J NEUROSCI, V28, P893, DOI 10.1523/JNEUROSCI.0659-07.2008; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schatzberg AF, 2008, EUR J PHARMACOL, V583, P358, DOI 10.1016/j.ejphar.2008.01.001; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Schroeder FA, 2007, BIOL PSYCHIAT, V62, P55, DOI 10.1016/j.biopsych.2006.06.036; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Simen BB, 2006, BIOL PSYCHIAT, V59, P775, DOI 10.1016/j.biopsych.2005.10.013; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; Szeszko PR, 2005, MOL PSYCHIATR, V10, P631, DOI 10.1038/sj.mp.4001656; Szyf M, 2007, REPROD TOXICOL, V24, P9, DOI 10.1016/j.reprotox.2007.05.001; Thakker-Varia S, 2007, J NEUROSCI, V27, P12156, DOI 10.1523/JNEUROSCI.1898-07.2007; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Uhr M, 2008, NEURON, V57, P203, DOI 10.1016/j.neuron.2007.11.017; Warner-Schmidt JL, 2007, P NATL ACAD SCI USA, V104, P4647, DOI 10.1073/pnas.0610282104; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Yehuda R, 2004, J CLIN PSYCHIAT, V65, P29; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zorner B, 2003, BIOL PSYCHIAT, V54, P972, DOI 10.1016/S0006-3223(03)00418-9	99	1874	1997	21	652	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					894	902		10.1038/nature07455	http://dx.doi.org/10.1038/nature07455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923511	Green Accepted			2022-12-28	WOS:000260038300037
J	Karelis, AD				Karelis, Antony D.			Metabolically healthy but obese individuals	LANCET			English	Editorial Material							NORMAL-WEIGHT; WOMEN; IDENTIFICATION; POPULATION; PREVALENCE; PROFILE; RISK		[Karelis, Antony D.] Univ Quebec, Dept Kinesiol, Montreal, PQ H2X 3R9, Canada	University of Quebec; University of Quebec Montreal	Karelis, AD (corresponding author), Univ Quebec, Dept Kinesiol, Montreal, PQ H2X 3R9, Canada.	karelis.antony@uqam.ca						AGUILARSALINAS CA, 2008, J CLIN ENDOCRIN 0805; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Dvorak RV, 1999, DIABETES, V48, P2210, DOI 10.2337/diabetes.48.11.2210; Iacobellis G, 2005, OBES RES, V13, P1116, DOI 10.1038/oby.2005.130; Karelis AD, 2008, DIABETOLOGIA, V51, P1752, DOI 10.1007/s00125-008-1038-4; Karelis AD, 2008, DIABETES METAB, V34, P183, DOI 10.1016/j.diabet.2007.11.004; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Perseghin G, 2008, DIABETOLOGIA, V51, P1567, DOI 10.1007/s00125-008-1077-x; Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617	13	191	196	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1281	1283		10.1016/S0140-6736(08)61531-7	http://dx.doi.org/10.1016/S0140-6736(08)61531-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18929889				2022-12-28	WOS:000260060500008
J	Shevach, EM				Shevach, Ethan M.			Regulating suppression	SCIENCE			English	Editorial Material							DENDRITIC CELLS; ANTIGEN 4; CTLA-4; INHIBITION; BLOCKADE; CD28		[Shevach, Ethan M.] NIAID, Immunol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shevach, EM (corresponding author), NIAID, Immunol Lab, Bldg 10, Bethesda, MD 20892 USA.	eshevach@niaid.nih.gov						Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; FIFE BT, 2006, IMMUNOL REV, V212, P166; Kremer JM, 2003, NEW ENGL J MED, V349, P1907, DOI 10.1056/NEJMoa035075; Oderup C, 2006, IMMUNOLOGY, V118, P240, DOI 10.1111/j.1365-2567.2006.02362.x; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	15	15	18	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					202	203		10.1126/science.1164872	http://dx.doi.org/10.1126/science.1164872			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845735				2022-12-28	WOS:000259902300026
J	Merkel, PA; McCarty, D; Sharma, A; Stone, JR; Rosenberg, ES; Seton, M				Merkel, Peter A.; McCarty, David; Sharma, Amita; Stone, James R.; Rosenberg, Eric S.; Seton, Margaret			A man with chest pain, arthralgias, and a mediastinal mass - Wegener's granulomatosis involving the mediastinum, heart, and pulmonary artery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; ANTIMYELOPEROXIDASE ANTIBODIES; VASCULITIS; PREVALENCE; COHORT		[Merkel, Peter A.] Boston Univ, Sch Med, Ctr Arthritis, Boston Med Ctr, Boston, MA 02118 USA; [Merkel, Peter A.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [McCarty, David] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Sharma, Amita] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Stone, James R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [McCarty, David] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Sharma, Amita] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Stone, James R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Boston Medical Center; Boston University; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Merkel, PA (corresponding author), Boston Univ, Sch Med, Ctr Arthritis, Boston Med Ctr, Boston, MA 02118 USA.		McCarty, David/G-3330-2011		Merck; Muscle Tech; GlaxoSmithKline; Proteon Therapeutics; Genzyme; Bristol-Myers Squibb; Genentech	Merck(Merck & Company); Muscle Tech; GlaxoSmithKline(GlaxoSmithKline); Proteon Therapeutics; Genzyme(Sanofi-AventisGenzyme Corporation); Bristol-Myers Squibb(Bristol-Myers Squibb); Genentech(Roche HoldingGenentech)	Dr. Stone reports receiving consulting fees from Merck, Muscle Tech, GlaxoSmithKline, and Proteon Therapeutics. Dr. Merkel reports receiving research support from Genzyme (to Boston University) and from Bristol-Myers Squibb and Genentech (for research also sponsored by the National Institutes of Health).	ANDERSON G, 1992, Q J MED, V83, P427; Choi HK, 2000, ARTHRITIS RHEUM, V43, P405, DOI 10.1002/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5; Choi HK, 2000, ARTHRITIS RHEUM, V43, P226, DOI 10.1002/1529-0131(200001)43:1<226::AID-ANR27>3.0.CO;2-Q; Choi HK, 2001, J RHEUMATOL, V28, P1584; Davies DJ, 2005, CARDIOVASC PATHOL, V14, P335, DOI 10.1016/j.carpath.2005.08.001; Fidder HH, 1999, CHEST, V115, P1473, DOI 10.1378/chest.115.5.1473; George TM, 1997, ARTHRITIS RHEUM, V40, P1992, DOI 10.1002/art.1780401111; Hagen EC, 1998, KIDNEY INT, V53, P743, DOI 10.1046/j.1523-1755.1998.00807.x; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; Hoffman GS, 1998, ARTHRITIS RHEUM-US, V41, P1521, DOI 10.1002/1529-0131(199809)41:9<1521::AID-ART2>3.0.CO;2-A; Hopkins J, 2003, ARTHRITIS RHEUM-US, V48, P2299, DOI 10.1002/art.11075; Matteson EL, 1996, AM J MED, V101, P129, DOI 10.1016/S0002-9343(96)80066-0; Merkel PA, 1997, ANN INTERN MED, V126, P866, DOI 10.7326/0003-4819-126-11-199706010-00003; Reinhold-Keller E, 2000, ARTHRITIS RHEUM, V43, P1021, DOI 10.1002/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J; ReinholdKeller E, 2000, ARTHRITIS RHEUM, V43, P2379; Yi ES, 2001, SEMIN DIAGN PATHOL, V18, P34, DOI 10.1053/sdia.2001.22139	16	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2008	359	15					1603	1614		10.1056/NEJMcpc0805310	http://dx.doi.org/10.1056/NEJMcpc0805310			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FS	18843125				2022-12-28	WOS:000259903100011
J	Stark, DP; Swinbank, AM; Ellis, RS; Dye, S; Smail, IR; Richard, J				Stark, Daniel P.; Swinbank, A. Mark; Ellis, Richard S.; Dye, Simon; Smail, Ian R.; Richard, Johan			The formation and assembly of a typical star-forming galaxy at redshift z approximate to 3	NATURE			English	Article							GAS; Z-SIMILAR-TO-2; CONSTRAINTS	Recent studies of galaxies similar to 2-3 Gyr after the Big Bang have revealed large, rotating disks, similar to those of galaxies today(1,2). The existence of well- ordered rotation in galaxies during this peak epoch of cosmic star formation indicates that gas accretion is likely to be the dominant mode by which galaxies grow, because major mergers of galaxies would completely disrupt the observed velocity fields. But poor spatial resolution and sensitivity have hampered this interpretation; such studies have been limited to the largest and most luminous galaxies, which may have fundamentally different modes of assembly from those of more typical galaxies ( which are thought to grow into the spheroidal components at the centres of galaxies similar to the Milky Way). Here we report observations of a typical star- forming galaxy at z = 3.07, with a linear resolution of similar to 100 parsecs. We find a well- ordered compact source in which molecular gas is being converted efficiently into stars, likely to be assembling a spheroidal bulge similar to those seen in spiral galaxies at the present day. The presence of undisrupted rotation may indicate that galaxies such as the Milky Way gain much of their mass by accretion rather than major mergers.	[Stark, Daniel P.; Ellis, Richard S.; Richard, Johan] CALTECH, Dept Astron, Pasadena, CA 91125 USA; [Swinbank, A. Mark; Smail, Ian R.] Univ Durham, Inst Computat Cosmol, Durham DH1 3LE, England; [Dye, Simon] Cardiff Univ, Sch Phys & Astron, Cardiff CF24 3AA, Wales	California Institute of Technology; Durham University; Cardiff University	Stark, DP (corresponding author), CALTECH, Dept Astron, Pasadena, CA 91125 USA.	dps@astro.caltech.edu	Smail, Ian/M-5161-2013; Smail, Ian/AAL-9018-2020	Smail, Ian/0000-0003-3037-257X; Smail, Ian/0000-0003-3037-257X; swinbank, mark/0000-0003-1192-5837; Dye, Simon/0000-0002-1318-8343; Richard, Johan/0000-0001-5492-1049	W. M. Keck Foundation; STFC; Royal Society; Science and Technology Facilities Council [ST/F002963/1] Funding Source: researchfish; STFC [ST/F002963/1] Funding Source: UKRI	W. M. Keck Foundation(W.M. Keck Foundation); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Royal Society(Royal Society of London); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank J. Lyke for assistance with the Keck observations, and R. Bower, K. Coppin, M. Lehnert, R. Genzel, D. Erb, D. Law, A. Shapley, A. Jenkins, P. Salucci and T. Theuns for discussions. The OSIRIS data were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership between the California Institute of Technology, the University of California and NASA. The observatory was made possible by the financial support of the W. M. Keck Foundation. The SINFONI data are based on observations made with the ESO Telescopes at the Paranal Observatories. A. M. S. acknowledges financial support from STFC, and I. R. S. and R. S. E. acknowledge financial support from the Royal Society.	Bouwens RJ, 2004, ASTROPHYS J, V611, DOI 10.1086/423786; Coppin KEK, 2007, ASTROPHYS J, V665, P936, DOI 10.1086/519789; Dye S, 2007, MON NOT R ASTRON SOC, V379, P308, DOI 10.1111/j. 1365-2966.2007.11960.x; Ellis R, 2001, ASTROPHYS J, V560, pL119, DOI 10.1086/324423; Erb DK, 2006, ASTROPHYS J, V646, P107, DOI 10.1086/504891; Erb DK, 2006, ASTROPHYS J, V647, P128, DOI 10.1086/505341; Genzel R, 2006, NATURE, V442, P786, DOI 10.1038/nature05052; Heckman TM, 2002, ASTR SOC P, V254, P292; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Kneib JP, 2004, ASTROPHYS J, V607, P697, DOI 10.1086/386281; Larkin J, 2006, NEW ASTRON REV, V50, P362, DOI 10.1016/j.newar.2006.02.005; Law DR, 2007, ASTROPHYS J, V669, P929, DOI 10.1086/521786; Nesvadba NPH, 2006, ASTROPHYS J, V650, P661, DOI 10.1086/507090; Pettini M, 2004, MON NOT R ASTRON SOC, V348, pL59, DOI 10.1111/j.1365-2966.2004.07591.x; Pilyugin LS, 2005, ASTROPHYS J, V631, P231, DOI 10.1086/432408; Schreiber NMF, 2006, ASTROPHYS J, V645, P1062, DOI 10.1086/504403; Shapley AE, 2001, ASTROPHYS J, V562, P95, DOI 10.1086/323432; Smail I, 2007, ASTROPHYS J, V654, pL33, DOI 10.1086/510902; Solomon PM, 2005, ANNU REV ASTRON ASTR, V43, P677, DOI 10.1146/annurev.astro.43.051804.102221; Solomon PM, 1997, ASTROPHYS J, V478, P144, DOI 10.1086/303765; Swinbank AM, 2007, MON NOT R ASTRON SOC, V376, P479, DOI 10.1111/j.1365-2966.2007.11454.x; Tacconi LJ, 2008, ASTROPHYS J, V680, P246, DOI 10.1086/587168	23	136	136	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2008	455	7214					775	777		10.1038/nature07294	http://dx.doi.org/10.1038/nature07294			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18843363	Green Submitted			2022-12-28	WOS:000259854900041
J	Roddam, AW; Allen, NE; Appleby, P; Key, TJ; Ferrucci, L; Carter, HB; Metter, EJ; Chen, C; Weiss, NS; Fitzpatrick, A; Hsing, AW; Lacey, JV; Helzlsouer, K; Rinaldi, S; Riboli, E; Kaaks, R; Janssen, JAMJL; Wildhagen, MF; Schroder, FH; Platz, EA; Pollak, M; Giovannucci, E; Schaefer, C; Quesenberry, CP; Vogelman, JH; Severi, G; English, DR; Giles, GG; Stattin, P; Hallmans, G; Johansson, M; Chan, JM; Gann, P; Oliver, SE; Holly, JM; Donovan, J; Meyer, F; Bairati, I; Galan, P				Roddam, Andrew W.; Allen, Naomi E.; Appleby, Paul; Key, Timothy J.; Ferrucci, Luigi; Carter, H. Ballentine; Metter, E. Jeffrey; Chen, Chu; Weiss, Noel S.; Fitzpatrick, Annette; Hsing, Ann W.; Lacey, James V., Jr.; Helzlsouer, Kathy; Rinaldi, Sabina; Riboli, Elio; Kaaks, Rudolf; Janssen, Joop A. M. J. L.; Wildhagen, Mark F.; Schroeder, Fritz H.; Platz, Elizabeth A.; Pollak, Michael; Giovannucci, Edward; Schaefer, Catherine; Quesenberry, Charles P., Jr.; Vogelman, Joseph H.; Severi, Gianluca; English, Dallas R.; Giles, Graham G.; Stattin, Paer; Hallmans, Goeran; Johansson, Mattias; Chan, June M.; Gann, Peter; Oliver, Steven E.; Holly, Jeff M.; Donovan, Jenny; Meyer, Francois; Bairati, Isabelle; Galan, Pilar			Insulin-like growth factors, their binding proteins, and prostate cancer risk: Analysis of individual patient data from 12 prospective studies	ANNALS OF INTERNAL MEDICINE			English	Article							I IGF-I; FACTOR (IGF)-I; FACTOR AXIS; PSA ERA; MEN; PREDICTORS; METAANALYSIS; ASSOCIATION; ANDROGENS; ANTIGEN	Background: Some, but not all, published results have shown an association between circulating blood levels of some insulin-like growth factors (IGFs) and their binding proteins (IGFBPs) and the subsequent risk for prostate cancer. Purpose: To assess the association between levels of IGFs and IGFBPs and the subsequent risk for prostate cancer. Data Sources: Studies identified in PubMed, Web of Science, and CancerLit. Study Selection: The principal investigators of all studies that published data on circulating concentrations of sex steroids, IGFs, or IGFBPs and prostate cancer risk using prospectively collected blood samples were invited to collaborate. Data Extraction: Investigators provided individual participant data on circulating concentrations of IGF-I, IGF-II, IGFBP-II, and IGFBP-III and participant characteristics to a central data set in Oxford, United Kingdom. Data Synthesis: The study included data on 3700 men with prostate cancer and 5200 control participants. On average, case patients were 61.5 years of age at blood collection and received a diagnosis of prostate cancer 5 years after blood collection. The greater the serum IGF-I concentration, the greater the subsequent risk for prostate cancer (odds ratio [OR] in the highest vs. lowest quintile, 1.38 [95% CI, 1.19 to 1.60]; P < 0.001 for trend). Neither IGF-II nor IGFBP-II concentrations were associated with prostate cancer risk, but statistical power was limited. Insulin-like growth factor I and IGFBP-III were correlated (r = 0.58), and although IGFBP-III concentration seemed to be associated with prostate cancer risk, this was secondary to its association with IGF-I levels. Insulin-like growth factor I concentrations seemed to be more positively associated with low-grade than high-grade disease; otherwise, the association between IGFs and IGFBPs and prostate cancer risk had no statistically significant heterogeneity related to stage or grade of disease, time between blood collection and diagnosis, age and year of diagnosis, prostate-specific antigen level at recruitment, body mass index, smoking, or alcohol intake. Limitations: Insulin-like growth factor concentrations were measured in only 1 sample for each participant, and the laboratory methods to measure IGFs differed in each study. Not all patients had disease stage or grade information, and the diagnosis of prostate cancer may differ among the studies. Conclusion: High circulating IGF-I concentrations are associated with a moderately increased risk for prostate cancer.	[Roddam, Andrew W.] Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England; Johns Hopkins Univ, NIA, Harbor Hosp, Baltimore, MD USA; St Johns Mercy Med Ctr, Baltimore, MD USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Collaborat Hlth Studies Coordinating Ctr, Seattle, WA USA; NCI, Bethesda, MD 20892 USA; Int Agcy Res Canc, F-69372 Lyon, France; German Natl Canc Ctr, Heidelberg, Germany; Univ London Imperial Coll Sci Technol & Med, London, England; Erasmus MC, Rotterdam, Netherlands; McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Canc Prevent Res Unit, Montreal, PQ H3T 1E2, Canada; Univ Laval, Ctr Rech Cancerol, Quebec City, PQ, Canada; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Kaiser Div Res, Oakland, CA USA; Orentreich Fdn Advancement Sci, Cold Spring on Hudson, NY USA; Canc Epidemiol Ctr, Canc Council Victoria, Carlton, Vic, Australia; Umea Univ, Umea, Sweden; Univ Calif San Francisco, San Francisco, CA 94143 USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; Univ Bristol, Paul OGorman Lifeline Ctr, Southmead Hosp, Bristol, Avon, England; UMR SMBH Univ, Bobigny, France	University of Oxford; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Mercy Medical Center - Maryland; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); World Health Organization; International Agency for Research on Cancer (IARC); Imperial College London; Erasmus University Rotterdam; Erasmus MC; Lady Davis Institute; McGill University; Laval University; Harvard University; Harvard T.H. Chan School of Public Health; Kaiser Permanente; Cancer Council Victoria; Umea University; University of California System; University of California San Francisco; Northwestern University; Feinberg School of Medicine; University of Hull; University of York - UK; Southmead Hospital; University of Bristol	Roddam, AW (corresponding author), Univ Oxford, Canc Epidemiol Unit, Richard Doll Bldg,Roosevelt Dr, Oxford OX3 7LF, England.	andrew.roddam@ceu.ox.ac.uk	Pilar, Galan/F-2908-2017; Johansson, Mattias/ABF-3365-2020; English, Dallas/AAH-5005-2019; Severi, Gianluca/Q-1824-2019; Janssen, Joseph A.M.J.L./AAU-5133-2021; Severi, Gianluca/H-3774-2018; Pollak, Michael/G-9094-2011	Pilar, Galan/0000-0003-1706-3107; English, Dallas/0000-0001-7828-8188; Severi, Gianluca/0000-0001-7157-419X; Janssen, Joseph A.M.J.L./0000-0002-9363-6408; Severi, Gianluca/0000-0001-7157-419X; Pollak, Michael/0000-0003-3047-0604; Riboli, Elio/0000-0001-6795-6080; Johansson, Mattias/0000-0002-3116-5081; Chan, June/0000-0002-7620-569X; Giles, Graham/0000-0003-4946-9099	Cancer Research UK, London, United Kingdom; NATIONAL INSTITUTE ON AGING [ZIAAG000015, ZIAAG000633] Funding Source: NIH RePORTER; Medical Research Council [G0500966, G0501019] Funding Source: researchfish; MRC [G0501019, G0500966] Funding Source: UKRI	Cancer Research UK, London, United Kingdom(Cancer Research UK); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The central pooling and analysis of these data were supported by Cancer Research UK, London, United Kingdom.	Albertsen PC, 2005, J NATL CANCER I, V97, P1248, DOI 10.1093/jnci/dji248; Allen NE, 2007, CANCER EPIDEM BIOMAR, V16, P1121, DOI 10.1158/1055-9965.EPI-06-1062; Allen NE, 2000, BRIT J CANCER, V83, P95, DOI 10.1054/bjoc.2000.1509; Borugian MJ, 2008, CANCER EPIDEM BIOMAR, V17, P252, DOI 10.1158/1055-9965.EPI-07-2694; Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; Carpenter WR, 2008, JNCI-J NATL CANCER I, V100, P158, DOI 10.1093/jnci/djm329; Chan JM, 2002, J NATL CANCER I, V94, P1099; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Chen C, 2005, CANCER, V103, P76, DOI 10.1002/cncr.20727; DeLellis K, 2004, CANCER EPIDEM BIOMAR, V13, P1444; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; *EARL BREAST CANC, 1990, INTR METH SECT REPR; Ferlay J, 2004, IARC CANC BASE; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gapstur SM, 2004, CANCER EPIDEM BIOMAR, V13, P2208; Giovannucci E, 2003, CANCER EPIDEM BIOMAR, V12, P84; Grimberg A, 2000, J CELL PHYSIOL, V183, P1, DOI 10.1002/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J; Hankey BF, 1999, JNCI-J NATL CANCER I, V91, P1017, DOI 10.1093/jnci/91.12.1017; Harman SM, 2000, J CLIN ENDOCR METAB, V85, P4258, DOI 10.1210/jc.85.11.4258; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Janssen JAMJL, 2004, J CLIN ENDOCR METAB, V89, P4391, DOI 10.1210/jc.2004-0232; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; JUUL A, 1994, J CLIN ENDOCR METAB, V78, P744, DOI 10.1210/jc.78.3.744; Kaaks R, 2000, PROSTATE CANCER P D, V3, P157, DOI 10.1038/sj.pcan.4500421; Lacey JV, 2001, CANCER EPIDEM BIOMAR, V10, P1101; Meyer F, 2005, CANCER EPIDEM BIOMAR, V14, P2269, DOI 10.1158/1055-9965.EPI-05-0303; Morris JK, 2006, BRIT J CANCER, V95, P112, DOI 10.1038/sj.bjc.6603200; Oliver SE, 2004, INT J CANCER, V108, P887, DOI 10.1002/ijc.11631; Platz EA, 2005, CANCER CAUSE CONTROL, V16, P255, DOI 10.1007/s10552-004-3484-8; Platz EA, 2004, J CELL BIOCHEM, V91, P553, DOI 10.1002/jcb.10700; Pollak M, 2001, EPIDEMIOL REV, V23, P59, DOI 10.1093/oxfordjournals.epirev.a000796; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Rinaldi S, 2005, CANCER EPIDEM BIOMAR, V14, P48; Roddam AW, 2008, J NATL CANCER I, V100, P170, DOI 10.1093/jnci/djm323; Schaefer C, 1998, SCIENCE, V282, P199; Severi G, 2006, CANCER EPIDEM BIOMAR, V15, P1137, DOI 10.1158/1055-9965.EPI-05-0823; Stattin P, 2004, J CLIN ONCOL, V22, P3104, DOI 10.1200/JCO.2004.10.105; Stattin P, 2000, J NATL CANCER I, V92, P1910, DOI 10.1093/jnci/92.23.1910; Weiss JM, 2007, INT J CANCER, V121, P2267, DOI 10.1002/ijc.22921; Woodson K, 2003, CANCER RES, V63, P3991	40	243	253	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2008	149	7					461	W88		10.7326/0003-4819-149-7-200810070-00006	http://dx.doi.org/10.7326/0003-4819-149-7-200810070-00006			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QY	18838726	Green Accepted			2022-12-28	WOS:000260004400003
J	Goodier, JL; Kazazian, HH				Goodier, John L.; Kazazian, Haig H., Jr.			Retrotransposons revisited: The restraint and rehabilitation of parasites	CELL			English	Review							HUMAN L1 RETROTRANSPOSITION; SMALL INTERFERING RNAS; MALE GERM-CELLS; TRANSPOSABLE ELEMENTS; ALU REPEATS; LINE-1 RETROTRANSPOSITION; PROCESSED PSEUDOGENES; GENE-EXPRESSION; SVA ELEMENTS; DNA-DAMAGE	Retrotransposons, mainly LINEs, SINEs, and endogenous retroviruses, make up roughly 40% of the mammalian genome and have played an important role in genome evolution. Their prevalence in genomes reflects a delicate balance between their further expansion and the restraint imposed by the host. In any human genome only a small number of LINE1s (L1s) are active, moving their own and SINE sequences into new genomic locations and occasionally causing disease. Recent insights and new technologies promise answers to fundamental questions about the biology of transposable elements.	[Goodier, John L.; Kazazian, Haig H., Jr.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania	Goodier, JL (corresponding author), Univ Penn, Sch Med, Dept Genet, 415 Curie Blvd, Philadelphia, PA 19104 USA.	jgoodier@mail.med.upenn.edu			NIH/NIGMS; DOD/CDMRP [BC051386]	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOD/CDMRP(United States Department of Defense)	We thank J. Garcia-Perez, J. Meyer, and S. Rangwala for critical review of the manuscript and S. Robinson for assistance with its preparation. This work was supported by NIH/NIGMS grants to H.H.K. and DOD/CDMRP grant BC051386 to J.L.G.	Akagi K, 2008, GENOME RES, V18, P869, DOI 10.1101/gr.075770.107; Alisch RS, 2006, GENE DEV, V20, P210, DOI 10.1101/gad.1380406; An WF, 2006, P NATL ACAD SCI USA, V103, P18662, DOI 10.1073/pnas.0605300103; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; ARCOT SS, 1995, GENOMICS, V29, P136, DOI 10.1006/geno.1995.1224; Arnaud P, 2000, MOL CELL BIOL, V20, P3434, DOI 10.1128/MCB.20.10.3434-3441.2000; Babushok DV, 2007, GENOME RES, V17, P1129, DOI 10.1101/gr.6252107; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Badge RM, 2003, AM J HUM GENET, V72, P823, DOI 10.1086/373939; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Belancio VP, 2008, GENOME RES, V18, P343, DOI 10.1101/gr.5558208; Belgnaoui SM, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-13; Bennettt EA, 2004, GENETICS, V168, P933, DOI 10.1534/genetics.104.031757; Bohne A, 2008, CHROMOSOME RES, V16, P203, DOI 10.1007/s10577-007-1202-6; Boissinot SP, 2001, MOL BIOL EVOL, V18, P2186, DOI 10.1093/oxfordjournals.molbev.a003765; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Bradley J, 2004, NAT GENET, V36, P872, DOI 10.1038/ng1390; BRITTEN RJ, 1971, S QUANT BIOL, V21, P197; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Brouha B, 2002, AM J HUM GENET, V71, P327, DOI 10.1086/341722; Buzdin A, 2007, FEBS LETT, V581, P2877, DOI 10.1016/j.febslet.2007.05.034; Cantrell MA, 2008, GENETICS, V178, P393, DOI 10.1534/genetics.107.080275; Capy P, 2000, HEREDITY, V85, P101, DOI 10.1046/j.1365-2540.2000.00751.x; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Conley AB, 2008, TRENDS GENET, V24, P53, DOI 10.1016/j.tig.2007.11.008; Cordaux R, 2006, GENE, V373, P134, DOI 10.1016/j.gene.2006.01.019; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Crowell RC, 2007, BIOCHEM SOC T, V35, P629, DOI 10.1042/BST0350629; De la Fuente R, 2006, NAT CELL BIOL, V8, P1448, DOI 10.1038/ncb1513; Devor EJ, 2003, HUM BIOL, V75, P661, DOI 10.1353/hub.2003.0075; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Donnelly SR, 1999, HUM MOL GENET, V8, P1723, DOI 10.1093/hmg/8.9.1723; Eickbush TH, 2008, VIRUS RES, V134, P221, DOI 10.1016/j.virusres.2007.12.010; Ergun S, 2004, J BIOL CHEM, V279, P27753, DOI 10.1074/jbc.M312985200; Evsikov AV, 2004, CYTOGENET GENOME RES, V105, P240, DOI 10.1159/000078195; Farkash EA, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/37285; Garcia-Perez JL, 2007, GENOME RES, V17, P602, DOI 10.1101/gr.5870107; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Gentles AJ, 2007, GENOME RES, V17, P992, DOI 10.1101/gr.6070707; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; Gladyshev EA, 2007, P NATL ACAD SCI USA, V104, P9352, DOI 10.1073/pnas.0702741104; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; Goodier JL, 2007, MOL CELL BIOL, V27, P6469, DOI 10.1128/MCB.00332-07; Gotea V, 2006, TRENDS GENET, V22, P260, DOI 10.1016/j.tig.2006.03.006; Graff JR, 1997, J BIOL CHEM, V272, P22322, DOI 10.1074/jbc.272.35.22322; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P5491, DOI 10.1093/nar/gkl706; Han JS, 2005, BIOESSAYS, V27, P775, DOI 10.1002/bies.20257; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hasler J, 2007, CELL MOL LIFE SCI, V64, P1793, DOI 10.1007/s00018-007-7084-0; Hauptmann S, 2006, MED HYPOTHESES, V66, P580, DOI 10.1016/j.mehy.2005.08.051; Jones RB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001547; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kajikawa M, 2002, CELL, V111, P433, DOI 10.1016/S0092-8674(02)01041-3; Kale Shubha P, 2006, Int J Environ Res Public Health, V3, P121, DOI 10.3390/ijerph2006030015; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Kondo Y, 2003, J BIOL CHEM, V278, P27658, DOI 10.1074/jbc.M304072200; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kramerov DA, 2005, INT REV CYTOL, V247, P165, DOI 10.1016/S0074-7696(05)47004-7; Kubo S, 2006, P NATL ACAD SCI USA, V103, P8036, DOI 10.1073/pnas.0601954103; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lee Y, 2006, P NATL ACAD SCI USA, V103, P17885, DOI 10.1073/pnas.0608344103; Li TH, 1999, GENE, V239, P367, DOI 10.1016/S0378-1119(99)00384-4; Lin D, 2008, MOL CELL BIOL, V28, P3008, DOI 10.1128/MCB.01800-07; Liu J, 1997, GENE CHROMOSOME CANC, V18, P232, DOI 10.1002/(SICI)1098-2264(199703)18:3<232::AID-GCC10>3.0.CO;2-K; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Lyon MF, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/59746; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Martin SL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/45621; Matlik K, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/71753; Medstrand P, 2005, CYTOGENET GENOME RES, V110, P342, DOI 10.1159/000084966; MIKI Y, 1992, CANCER RES, V52, P643; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Mine M, 2007, HUM MUTAT, V28, P137, DOI 10.1002/humu.20449; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; MORAN JV, 2002, MOBILE DNA, V2; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Morrish TA, 2007, NATURE, V446, P208, DOI 10.1038/nature05560; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nakamura TM, 1998, CELL, V92, P587, DOI 10.1016/S0092-8674(00)81123-X; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; Nishihara H, 2006, GENOME RES, V16, P864, DOI 10.1101/gr.5255506; Nishikura K, 2007, NAT GENET, V7, P919; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; Ohshima K, 2005, CYTOGENET GENOME RES, V110, P475, DOI 10.1159/000084981; Ohshima K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r74; Ostertag EM, 2003, AM J HUM GENET, V73, P1444, DOI 10.1086/380207; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Pardue ML, 2005, CHROMOSOME RES, V13, P443, DOI 10.1007/s10577-005-0993-6; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Piriyapongsa J, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-31; Prak ETL, 2003, P NATL ACAD SCI USA, V100, P1832, DOI 10.1073/pnas.0337627100; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Roman AC, 2008, P NATL ACAD SCI USA, V105, P1632, DOI 10.1073/pnas.0708366105; Santangelo AM, 2007, PLOS GENET, V3, P1813, DOI 10.1371/journal.pgen.0030166; Sasaki T, 2008, P NATL ACAD SCI USA, V105, P4220, DOI 10.1073/pnas.0709398105; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Schmitz J, 2008, GENOME RES, V18, P1005, DOI 10.1101/gr.7177908; Schulz WA, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/83672; Schumann GG, 2007, BIOCHEM SOC T, V35, P637, DOI 10.1042/BST0350637; Seleme MDC, 2006, P NATL ACAD SCI USA, V103, P6611, DOI 10.1073/pnas.0601324103; Sen SK, 2007, NUCLEIC ACIDS RES, V35, P3741, DOI 10.1093/nar/gkm317; She XW, 2008, NAT GENET, V40, P909, DOI 10.1038/ng.172; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smalheiser NR, 2006, TRENDS GENET, V22, P532, DOI 10.1016/j.tig.2006.08.007; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Soifer HS, 2005, NUCLEIC ACIDS RES, V33, P846, DOI 10.1093/nar/gki223; Soper SFC, 2008, DEV CELL, V15, P285, DOI 10.1016/j.devcel.2008.05.015; Sorek R, 2007, RNA, V13, P1603, DOI 10.1261/rna.682507; Spadafora C, 2008, SYST BIOL REPROD MED, V54, P11, DOI 10.1080/19396360701876815; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Takasu M, 2007, TISSUE ANTIGENS, V70, P144, DOI 10.1111/j.1399-0039.2007.00870.x; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; Volff J. -N., 2007, V3, P175, DOI 10.1159/000107611; Wallace NA, 2008, GENE, V419, P75, DOI 10.1016/j.gene.2008.04.013; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850; Xing J, 2006, P NATL ACAD SCI USA, V103, P17608, DOI 10.1073/pnas.0603224103; Xing J, 2007, YEARB PHYS ANTHROPOL, V50, P2, DOI 10.1002/ajpa.20722; Xu MG, 2008, BIOL REPROD, V79, P51, DOI 10.1095/biolreprod.108.068072; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zemojtel T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-392; Zhang XHF, 2006, P NATL ACAD SCI USA, V103, P13427, DOI 10.1073/pnas.0603042103; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003	149	432	454	3	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					23	35		10.1016/j.cell.2008.09.022	http://dx.doi.org/10.1016/j.cell.2008.09.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854152	Bronze			2022-12-28	WOS:000259728100006
J	Lakhal, K; Paubelle, E				Lakhal, Karim; Paubelle, Etienne			Emphysematous cystitis	LANCET			English	Editorial Material									[Lakhal, Karim; Paubelle, Etienne] Hop Bichat Claude Bernard, Med & Infect Dis Intens Care Unit, F-75018 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Lakhal, K (corresponding author), Hop Bichat Claude Bernard, Med & Infect Dis Intens Care Unit, 46 Rue H Huchard, F-75018 Paris, France.	lakhal_karim@yahoo.fr							0	6	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP-OCT	2008	372	9644					1184	1184		10.1016/S0140-6736(08)61484-1	http://dx.doi.org/10.1016/S0140-6736(08)61484-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	355UN	18926278				2022-12-28	WOS:000259734700033
J	Dhonukshe, P; Tanaka, H; Goh, T; Ebine, K; Mahonen, AP; Prasad, K; Blilou, I; Geldner, N; Xu, J; Uemura, T; Chory, J; Ueda, T; Nakano, A; Scheres, B; Friml, J				Dhonukshe, Pankaj; Tanaka, Hirokazu; Goh, Tatsuaki; Ebine, Kazuo; Mahonen, Ari Pekka; Prasad, Kalika; Blilou, Ikram; Geldner, Niko; Xu, Jian; Uemura, Tomohiro; Chory, Joanne; Ueda, Takashi; Nakano, Akihiko; Scheres, Ben; Friml, Jiri			Generation of cell polarity in plants links endocytosis, auxin distribution and cell fate decisions	NATURE			English	Article							ARABIDOPSIS-THALIANA; H+-ATPASE; EFFLUX; TRANSPORT; ROOT; TRAFFICKING; GRADIENTS; DISTINCT; STEM; BIOSYNTHESIS	Dynamically polarized membrane proteins define different cell boundaries and have an important role in intercellular communication - a vital feature of multicellular development. Efflux carriers for the signalling molecule auxin from the PIN family(1) are landmarks of cell polarity in plants and have a crucial involvement in auxin distribution- dependent development including embryo patterning, organogenesis and tropisms(2-7). Polar PIN localization determines the direction of intercellular auxin flow(8), yet the mechanisms generating PIN polarity remain unclear. Here we identify an endocytosis- dependent mechanism of PIN polarity generation and analyse its developmental implications. Real- time PIN tracking showed that after synthesis, PINs are initially delivered to the plasma membrane in a non- polar manner and their polarity is established by subsequent endocytic recycling. Interference with PIN endocytosis either by auxin or by manipulation of the Arabidopsis Rab5 GTPase pathway prevents PIN polarization. Failure of PIN polarization transiently alters asymmetric auxin distribution during embryogenesis and increases the local auxin response in apical embryo regions. This results in ectopic expression of auxin pathway- associated root- forming master regulators in embryonic leaves and promotes homeotic transformation of leaves to roots. Our results indicate a two- step mechanism for the generation of PIN polar localization and the essential role of endocytosis in this process. It also highlights the link between endocytosis- dependent polarity of individual cells and auxin distribution- dependent cell fate establishment for multicellular patterning.	[Dhonukshe, Pankaj; Mahonen, Ari Pekka; Prasad, Kalika; Blilou, Ikram; Xu, Jian; Scheres, Ben] Univ Utrecht, Dept Biol, Fac Sci, NL-3584 CH Utrecht, Netherlands; [Tanaka, Hirokazu; Friml, Jiri] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Tanaka, Hirokazu; Friml, Jiri] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Goh, Tatsuaki; Ebine, Kazuo; Uemura, Tomohiro; Ueda, Takashi; Nakano, Akihiko] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Geldner, Niko] Univ Lausanne, Dept Plant Mol Biol DBMV, UNIL Sorge, CH-1015 Lausanne, Switzerland; [Geldner, Niko; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Nakano, Akihiko] RIKEN Adv Sci Inst, Mol Membrane Biol Lab, Wako, Saitama 3510198, Japan	Utrecht University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of Tokyo; University of Lausanne; Salk Institute; RIKEN	Dhonukshe, P (corresponding author), Univ Utrecht, Dept Biol, Fac Sci, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	P.B.Dhonukshe@uu.nl; jiri.friml@psb.ugent.be	Friml, Jiri/D-9511-2012; Nakano, Akihiko/C-6185-2009; Geldner, Niko/Y-2481-2019; Mähönen, Ari Pekka/B-9764-2015; UEDA, TAKASHI/G-4939-2014; Uemura, Tomohiro/ABD-4888-2021; Nakano, Akihiko/A-6420-2016; Ueda, Takashi/G-6984-2011	Friml, Jiri/0000-0002-8302-7596; Mähönen, Ari Pekka/0000-0001-6051-866X; Nakano, Akihiko/0000-0003-3635-548X; Ueda, Takashi/0000-0002-5190-892X; Geldner, Niko/0000-0002-2300-9644; Scheres, Ben/0000-0001-5400-9578; prasad, kalika/0000-0001-8666-856X; ebine, kazuo/0000-0003-3020-7208	VolkswagenStiftung; EMBO Long Term Fellowship; Netherlands Organization for Scientific Research (NWO)-VENI; EMBO Young Investigator Program; Odysseus program; HFSP fellowship; NWO-VIDI; Swiss National Science Foundation; HHMI; USDA; NIH; NWO-Spinoza; Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052413] Funding Source: NIH RePORTER	VolkswagenStiftung(Volkswagen); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Netherlands Organization for Scientific Research (NWO)-VENI(Netherlands Organization for Scientific Research (NWO)); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); Odysseus program; HFSP fellowship; NWO-VIDI(Netherlands Organization for Scientific Research (NWO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); HHMI(Howard Hughes Medical Institute); USDA(United States Department of Agriculture (USDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NWO-Spinoza(Netherlands Organization for Scientific Research (NWO)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Bennett, T. Gaude, L. Jiang, G. Jurgens, C. Luschnig, E. Meywerowitz, W. Michalke, R. Offringa, D. Robinson, K. Schumacher, J. Wiedenmann and D. Weijers for sharing published material and RIKEN, SALK and NASC Arabidopsis stock centres for providing mutant lines and the RNAi construct. We thank W. Muller for assistance with SEM and F. Kindt and R. Leito for photography. We acknowledge the Center for Plant Molecular Biology (ZMBP), University of Tubingen, Germany for the facilities during the initial phase of the project. This work was supported by VolkswagenStiftung (P.D. and J.F.), EMBO Long Term Fellowship and Netherlands Organization for Scientific Research (NWO)- VENI grant (P.D.), EMBO Young Investigator Program and Odysseus program of FWO (J.F.), HFSP fellowship (H.T.), EMBO Long Term Fellowship and HFSP fellowship (A.P.M.), EMBO Long Term Fellowship (K.P.), NWO-VIDI grant (I.B.), HFSP fellowship and Swiss National Science Foundation (N.G.), HHMI, USDA and NIH (J.C.), NWO-Spinoza award ( B. S.) and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (T.U. and A.N.).	Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Dhonukshe P, 2006, DEV CELL, V10, P137, DOI 10.1016/j.devcel.2005.11.015; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Goh T, 2007, PLANT CELL, V19, P3504, DOI 10.1105/tpc.107.053876; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Jaillais Y, 2007, CELL, V130, P1057, DOI 10.1016/j.cell.2007.08.040; Kleine-Vehn J, 2008, CURR BIOL, V18, P526, DOI 10.1016/j.cub.2008.03.021; Kleine-Vehn J, 2006, PLANT CELL, V18, P3171, DOI 10.1105/tpc.106.042770; Lam SK, 2007, PLANT CELL, V19, P296, DOI 10.1105/tpc.106.045708; Langhans M, 2001, PLANTA, V213, P11, DOI 10.1007/s004250000475; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Men SZ, 2008, NAT CELL BIOL, V10, P237, DOI 10.1038/ncb1686; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Movafeghi A, 1999, PLANT PHYSIOL, V119, P1437, DOI 10.1104/pp.119.4.1437; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Richter S, 2007, NATURE, V448, P488, DOI 10.1038/nature05967; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Tanaka H, 2006, CELL MOL LIFE SCI, V63, P2738, DOI 10.1007/s00018-006-6116-5; Ueda T, 2004, PLANT J, V40, P783, DOI 10.1111/j.1365-313X.2004.02249.x; Weijers D, 2001, DEVELOPMENT, V128, P4289; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790; Zhao YD, 2008, CURR OPIN PLANT BIOL, V11, P16, DOI 10.1016/j.pbi.2007.10.008	44	186	193	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					962	U75		10.1038/nature07409	http://dx.doi.org/10.1038/nature07409			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	18953331	Green Accepted			2022-12-28	WOS:000261768300048
J	McFarland, BK; Farrell, JP; Bucksbaum, PH; Guhr, M				McFarland, Brian K.; Farrell, Joseph P.; Bucksbaum, Philip H.; Guhr, Markus			High Harmonic Generation from Multiple Orbitals in N-2	SCIENCE			English	Article							FIELD; MOLECULES; IONIZATION	Molecular electronic states energetically below the highest occupied molecular orbital ( HOMO) should contribute to laser- driven high harmonic generation (HHG), but this behavior has not been observed previously. Our measurements of the HHG spectrum of N-2 molecules aligned perpendicular to the laser polarization showed a maximum at the rotational half- revival. This feature indicates the influence of electrons occupying the orbital just below the N-2 HOMO, referred to as the HOMO-1. Such observations of lower- lying orbitals are essential to understanding subfemtosecond/subangstrom electronic motion in laser- excited molecules.	[McFarland, Brian K.; Farrell, Joseph P.; Bucksbaum, Philip H.; Guhr, Markus] SLAC, PULSE Inst, Menlo Pk, CA 94025 USA; [McFarland, Brian K.; Farrell, Joseph P.; Bucksbaum, Philip H.; Guhr, Markus] Stanford Univ, Dept Phys & Appl Phys, Stanford, CA 94305 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University	Guhr, M (corresponding author), SLAC, PULSE Inst, Menlo Pk, CA 94025 USA.	mguehr@stanford.edu	Guehr, Markus/X-2744-2019; Guehr, Markus MG/B-7446-2015	Guehr, Markus MG/0000-0002-9111-8981; Bucksbaum, Philip/0000-0003-1258-5571	U.S. Department of Energy Division of Basic Energy Sciences; Stanford Linear Accelerator Center; Humboldt Foundation fellowship	U.S. Department of Energy Division of Basic Energy Sciences(United States Department of Energy (DOE)); Stanford Linear Accelerator Center; Humboldt Foundation fellowship	We thank H. Merdji and O. Smirnova for insightful discussions. Supported by the U.S. Department of Energy Division of Basic Energy Sciences through the Stanford Linear Accelerator Center, and by a Humboldt Foundation fellowship (M.G.)	Balcou P, 1997, PHYS REV A, V55, P3204, DOI 10.1103/PhysRevA.55.3204; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Gallagher T. F., 1994, RYDBERG ATOMS; Guhr M, 2007, J PHYS B-AT MOL OPT, V40, P3745, DOI 10.1088/0953-4075/40/18/013; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; Kanai T, 2005, NATURE, V435, P470, DOI 10.1038/nature03577; Kulander KC, 1993, LASER PHYS, V3, P359; Le AT, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.041402; Lein M, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.023805; Levesque J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.183903; Levesque J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.243001; Liu P, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.015802; MAIRESSE Y, 2008, 11 INT C MULT PROC M, pFR62; Ortigoso J, 1999, J CHEM PHYS, V110, P3870, DOI 10.1063/1.478824; Pavicic D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.243001; Perez P, 2003, TETRAHEDRON, V59, P3117, DOI 10.1016/S0040-4020(03)00374-0; Ramakrishna S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.113901; SALIERES P, 1995, PHYS REV LETT, V74, P3776, DOI 10.1103/PhysRevLett.74.3776; SMIRNOVA O, 2008, 11 INT C MULT PROC M, P7; Spanner M, 2004, J PHYS B-AT MOL OPT, V37, pL243, DOI 10.1088/0953-4075/37/12/L02; Stapelfeldt H, 2003, REV MOD PHYS, V75, P543, DOI 10.1103/RevModPhys.75.543; Tong XM, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.033402; Usachenko VI, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.063410; Vozzi C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.153902; Zhou XB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.073902	25	387	394	3	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1232	1235		10.1126/science.1162780	http://dx.doi.org/10.1126/science.1162780			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	18974318	Green Submitted			2022-12-28	WOS:000261033400037
J	Tao, F; Grass, ME; Zhang, YW; Butcher, DR; Renzas, JR; Liu, Z; Chung, JY; Mun, BS; Salmeron, M; Somorjai, GA				Tao, Feng; Grass, Michael E.; Zhang, Yawen; Butcher, Derek R.; Renzas, James R.; Liu, Zhi; Chung, Jen Y.; Mun, Bongjin S.; Salmeron, Miquel; Somorjai, Gabor A.			Reaction-Driven Restructuring of Rh-Pd and Pt-Pd Core-Shell Nanoparticles	SCIENCE			English	Article							SURFACE; CATALYSTS; CHEMISTRY; METALS	Heterogeneous catalysts that contain bimetallic nanoparticles may undergo segregation of the metals, driven by oxidizing and reducing environments. The structure and composition of core- shell Rh0.5Pd0.5 and Pt0.5Pd0.5 nanoparticle catalysts were studied in situ, during oxidizing, reducing, and catalytic reactions involving NO, O-2, CO, and H-2 by x- ray photoelectron spectroscopy at near-ambient pressure. The Rh0.5Pd0.5 nanoparticles underwent dramatic and reversible changes in composition and chemical state in response to oxidizing or reducing conditions. In contrast, no substantial segregation of Pd or Pt atoms was found in Pt0.5Pd0.5 nanoparticles. The different behaviors in restructuring and chemical response of Rh0.5Pd0.5 and Pt0.5Pd0.5 nanoparticle catalysts under the same reaction conditions illustrates the flexibility and tunability of the structure of bimetallic nanoparticle catalysts during catalytic reactions.	[Tao, Feng; Grass, Michael E.; Zhang, Yawen; Butcher, Derek R.; Renzas, James R.; Liu, Zhi; Salmeron, Miquel; Somorjai, Gabor A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Mat Sci & Chem Sci Div, Berkeley, CA 94720 USA; [Tao, Feng; Grass, Michael E.; Zhang, Yawen; Butcher, Derek R.; Renzas, James R.; Somorjai, Gabor A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Liu, Zhi; Chung, Jen Y.; Mun, Bongjin S.] Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; [Salmeron, Miquel] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Zhang, Yawen] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Peking University	Salmeron, M (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Mat Sci & Chem Sci Div, Berkeley, CA 94720 USA.	somorjai@berkeley.edu; mbsalmeron@lbl.gov	Liu, Zhi/B-3642-2009; Mun, Bongjin/G-1701-2013	Liu, Zhi/0000-0002-8973-6561; Renzas, James/0000-0001-9117-7546	Office of Science; Office of Advanced Scientific Computing Research; Office of Basic Energy Sciences; Materials Sciences and Engineering; Chemical Sciences; Geosciences; Biosciences Division of the U. S. Department of Energy [DE-AC-02-05CH11231]	Office of Science(United States Department of Energy (DOE)); Office of Advanced Scientific Computing Research; Office of Basic Energy Sciences(United States Department of Energy (DOE)); Materials Sciences and Engineering(United States Department of Energy (DOE)); Chemical Sciences; Geosciences; Biosciences Division of the U. S. Department of Energy(United States Department of Energy (DOE))	Supported by the director of the Office of Science; Office of Advanced Scientific Computing Research; Office of Basic Energy Sciences, Materials Sciences and Engineering; and Chemical Sciences, Geosciences, and Biosciences Division of the U. S. Department of Energy under contract DE-AC02-05CH11231.	Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a; CAMPBELL CT, 1990, ANNU REV PHYS CHEM, V41, P775; CHRISTENSEN A, 1995, J PHYS-CONDENS MAT, V7, P1047, DOI 10.1088/0953-8984/7/6/008; Enache DI, 2006, SCIENCE, V311, P362, DOI 10.1126/science.1120560; Huber GW, 2003, SCIENCE, V300, P2075, DOI 10.1126/science.1085597; Maillet T, 2001, J CATAL, V202, P367, DOI 10.1006/jcat.2001.3268; Maroun F, 2001, SCIENCE, V293, P1811, DOI 10.1126/science.1061696; Ogletree DF, 2002, REV SCI INSTRUM, V73, P3872, DOI 10.1063/1.1512336; Powell C. J., 2000, NIST ELECT INELASTIC; RODRIGUEZ JA, 1992, SCIENCE, V257, P897, DOI 10.1126/science.257.5072.897; Ruban AV, 1999, PHYS REV B, V59, P15990, DOI 10.1103/PhysRevB.59.15990; Salmeron M, 2008, SURF SCI REP, V63, P169, DOI 10.1016/j.surfrep.2008.01.001; SALMERON M, 1981, SURF SCI, V112, P207, DOI 10.1016/0039-6028(81)90370-8; SKRIVER HL, 1992, PHYS REV B, V46, P7157, DOI 10.1103/PhysRevB.46.7157; Somorjai G. A., 1994, INTRO SURFACE CHEM C, P500	15	993	1013	34	1147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					932	934		10.1126/science.1164170	http://dx.doi.org/10.1126/science.1164170			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18845713	Green Submitted			2022-12-28	WOS:000260674100043
J	Reichenbach, A; Pannicke, T				Reichenbach, Andreas; Pannicke, Thomas			NEUROSCIENCE A New Glance at Glia	SCIENCE			English	Editorial Material							ROLES		[Reichenbach, Andreas; Pannicke, Thomas] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany	Leipzig University	Reichenbach, A (corresponding author), Univ Leipzig, Paul Flechsig Inst Brain Res, Jahnallee 59, D-04109 Leipzig, Germany.	reia@medizin.uni-leipzig.de	Pannicke, Thomas/A-5078-2017; Reichenbach, Andreas/B-2510-2017	Pannicke, Thomas/0000-0001-7435-9540; 				Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bacaj T, 2008, SCIENCE, V322, P744, DOI [10.1126/science.1163074, 10.1126/science.1161473]; Dubois-Dauphin M, 2000, NEUROSCIENCE, V95, P9; Franze K, 2007, P NATL ACAD SCI USA, V104, P8287, DOI 10.1073/pnas.0611180104; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Heiman MG, 2007, NEURON GLIA BIOL, V3, P55, DOI 10.1017/S1740925X07000609; Martin VJ, 2002, CAN J ZOOL, V80, P1703, DOI 10.1139/Z02-136; NORENBERG MD, 1992, PROG BRAIN RES, V94, P261; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Parker RJ, 2006, SEMIN CELL DEV BIOL, V17, P66, DOI 10.1016/j.semcdb.2005.11.012; Reichenbach A, 2004, GLIAL NEURONAL SIGNALING, P53; REICHENBACH A, 1989, GLIA, V2, P71, DOI 10.1002/glia.440020202; Wolburg H, 2009, CELL TISSUE RES, V335, P75, DOI 10.1007/s00441-008-0658-9; Yoshimura S, 2008, DEVELOPMENT, V135, P2263, DOI 10.1242/dev.019547	14	22	22	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					693	694		10.1126/science.1166197	http://dx.doi.org/10.1126/science.1166197			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974341				2022-12-28	WOS:000260605200034
J	Williams, BR; Prabhu, VR; Hunter, KE; Glazier, CM; Whittaker, CA; Housman, DE; Amon, A				Williams, Bret R.; Prabhu, Vineet R.; Hunter, Karen E.; Glazier, Christina M.; Whittaker, Charles A.; Housman, David E.; Amon, Angelika			Aneuploidy Affects Proliferation and Spontaneous Immortalization in Mammalian Cells	SCIENCE			English	Article							DOWNS-SYNDROME; COLORECTAL ADENOMAS; SOLID TUMORS; TRISOMY; MOUSE; METABOLISM; EXPRESSION; STRESS; YEAST; MICE	Aneuploidy, an incorrect number of chromosomes, is the leading cause of miscarriages and mental retardation in humans and is a hallmark of cancer. We examined the effects of aneuploidy on primary mouse cells by generating a series of cell lines that carry an extra copy of one of four mouse chromosomes. In all four trisomic lines, proliferation was impaired and metabolic properties were altered. Immortalization, the acquisition of the ability to proliferate indefinitely, was also affected by the presence of an additional copy of certain chromosomes. Our data indicate that aneuploidy decreases not only organismal but also cellular fitness and elicits traits that are shared between different aneuploid cells.	[Williams, Bret R.; Prabhu, Vineet R.; Hunter, Karen E.; Glazier, Christina M.; Whittaker, Charles A.; Housman, David E.; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Williams, Bret R.; Hunter, Karen E.; Glazier, Christina M.; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu		Whittaker, Charles/0000-0002-2400-0094; Amon, Angelika/0000-0001-9837-0314	Howard Hughes Medical Institute; David Koch Research Award; Curt W. and Kathy Marble Cancer Research Fund; David Koch Graduate Fellowship	Howard Hughes Medical Institute(Howard Hughes Medical Institute); David Koch Research Award; Curt W. and Kathy Marble Cancer Research Fund; David Koch Graduate Fellowship	We thank E. Vazile in the Koch Institute Microscopy and Imaging Facility for help with SKY analysis; M. Luo in the MIT BioMicro Center for help with microarray analysis; L. Chan for assistance with the double linear fit models for immortalization kinetics; A. Regev and M. Guttman for advice and assistance with statistical analysis; and M. Dunham, M. Hemann, J. Lees, F. Solomon, and members of the Amon lab for critical reading of this manuscript. This work was supported by the Howard Hughes Medical Institute, a David Koch Research Award, a grant from the Curt W. and Kathy Marble Cancer Research Fund, and a David Koch Graduate Fellowship (V.R.P.). All microarray data are provided in final processed form in table S1 and as raw data through the Gene Expression Omnibus (www.ncbi.nlm.nih. gov/geo) under accession number GSE12501.	ABERCROMBIE M., 1961, EXPTL CELL RES SUPPL, V8, P188, DOI 10.1016/0014-4827(61)90348-2; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Bomme L, 1998, CANCER GENET CYTOGEN, V106, P66, DOI 10.1016/S0165-4608(98)00047-8; Bomme L, 2001, INT J CANCER, V92, P816, DOI 10.1002/ijc.1275; Boveri T., 1902, Verb Ges Wurzburg, Vxxxv, P67; Dyban A.P., 1987, CYTOGENETICS MAMMALI; EDLUND T, 1981, NATURE, V292, P269, DOI 10.1038/292269a0; FARBER E, 1990, BIOCHEM PHARMACOL, V39, P1837, DOI 10.1016/0006-2952(90)90599-G; GROPP A, 1983, J EXP ZOOL, V228, P253, DOI 10.1002/jez.1402280210; GROPP A, 1975, CYTOGENET CELL GENET, V14, P42, DOI 10.1159/000130318; Haddow A., 1938, ACTA UNION INT CONTR, V3, P342; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Larson PS, 2006, J PATHOL, V209, P307, DOI 10.1002/path.1973; LINDSLEY DL, 1972, GENETICS, V71, P157; Mao R, 2003, GENOMICS, V81, P457, DOI 10.1016/S0888-7543(03)00035-1; McClintock B, 1929, GENETICS, V14, P180; Mihaylova VT, 2003, MOL CELL BIOL, V23, P3265, DOI 10.1128/MCB.23.9.3265-3273.2003; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; NIELSEN K, 1985, HEREDITAS, V102, P77, DOI 10.1111/j.1601-5223.1985.tb00468.x; NIWA O, 1985, CURR GENET, V9, P463, DOI 10.1007/BF00434051; Niwa O, 2006, YEAST, V23, P937, DOI 10.1002/yea.1411; Pai GS., 2003, HDB CHROMOSOMAL SYND; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; Rosner M, 2003, J NEURAL TRANSM-SUPP, P51; Satge D, 2003, INT J CANCER, V106, P297, DOI 10.1002/ijc.11212; Satge D, 1998, AM J MED GENET, V78, P207, DOI 10.1002/(SICI)1096-8628(19980707)78:3<207::AID-AJMG1>3.3.CO;2-Q; SEGAL DJ, 1974, J CELL PHYSIOL, V83, P85, DOI 10.1002/jcp.1040830112; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Singh K, 1996, GENETICS, V143, P517; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Sung HM, 2003, J BACTERIOL, V185, P2153, DOI 10.1128/JB.185.7.2153-2160.2003; Sussan TE, 2008, NATURE, V451, P73, DOI 10.1038/nature06446; Tannock I., 2013, BASIC SCI ONCOLOGY; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Warburg O, 1924, BIOCHEM Z, V152, P309; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003	37	419	427	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					703	709		10.1126/science.1160058	http://dx.doi.org/10.1126/science.1160058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974345	Green Accepted			2022-12-28	WOS:000260605200038
J	Han, QD; Chen, L; Evans, T; Horton, R				Han, Qide; Chen, Lincoln; Evans, Tim; Horton, Richard			China and global health	LANCET			English	Editorial Material									[Chen, Lincoln] China Med Board, Cambridge, MA 02138 USA; [Han, Qide] Natl Peoples Congress, Beijing, Peoples R China; [Han, Qide] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Evans, Tim] WHO, Div Informat Evidence & Policy, CH-1211 Geneva, Switzerland; [Horton, Richard] The Lancet, London NW1 7BY, England	Peking University; World Health Organization	Chen, L (corresponding author), China Med Board, Cambridge, MA 02138 USA.	lchen@cmbfound.org						ANAND S, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61363-X; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; CHEN Z, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61352-5; DONG Z, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61351-3; FANG J, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61361-6; HU S, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61368-9; HU X, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61360-4; HUANG J, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61359-8; LIU Y, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61362-8; TANG JL, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61354-9; TANG S, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61364-1; WANG L, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61357-4; WANG L, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61365-3; WANG R, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61353-7; WANG SY, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61367-7; XIAO S, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61361-6; YANG G, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61366-5; ZHANG D, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61355-0; ZHANG KL, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61357-4	19	26	30	1	36	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 25	2008	372	9648					1439	1441		10.1016/S0140-6736(08)61350-1	http://dx.doi.org/10.1016/S0140-6736(08)61350-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	370ZJ	18930535	Green Published, Bronze			2022-12-28	WOS:000260801300004
J	Beddington, J; Cooper, CL; Field, J; Goswami, U; Huppert, FA; Jenkins, R; Jones, HS; Kirkwood, TBL; Sahakian, BJ; Thomas, SM				Beddington, John; Cooper, Cary L.; Field, John; Goswami, Usha; Huppert, Felicia A.; Jenkins, Rachel; Jones, Hannah S.; Kirkwood, Tom B. L.; Sahakian, Barbara J.; Thomas, Sandy M.			The mental wealth of nations	NATURE			English	Editorial Material							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; DEPRESSION; DISORDERS; ALLELES		[Beddington, John] Govt Off Sci, London, England; [Cooper, Cary L.] Univ Lancaster, Lancaster LA1 4YW, England; [Field, John] Univ Stirling, Ctr Res Lifelong Learning, Stirling Inst Educ, Stirling FK9 4LA, Scotland; [Goswami, Usha; Sahakian, Barbara J.] Univ Cambridge, Ctr Neurosci Educ, Cambridge CB2 1TN, England; [Huppert, Felicia A.] Univ Cambridge, Dept Psychiat, Cambridge CB2 1TN, England; [Huppert, Felicia A.] Univ Cambridge, Well Being Inst, Cambridge CB2 1TN, England; [Jenkins, Rachel] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Jones, Hannah S.] Govt Off Sci, Foresight Project Team, London, England; [Kirkwood, Tom B. L.] Univ Newcastle, Inst Ageing & Hlth, Newcastle Upon Tyne, Tyne & Wear, England; [Thomas, Sandy M.] Govt Off Sci, Foresight Programme, London, England	Lancaster University; University of Stirling; University of Cambridge; University of Cambridge; University of Cambridge; University of London; King's College London; Newcastle University - UK	Beddington, J (corresponding author), Govt Off Sci, London, England.		Sahakian, Barbara/AAW-1198-2020; Jenkins, Rachel/E-4287-2010; Jenkins, Rachel/H-2953-2019	Sahakian, Barbara/0000-0001-7352-1745; Jenkins, Rachel/0000-0002-2958-0331; Jenkins, Rachel/0000-0002-2958-0331; Cooper, Cary/0000-0002-0360-8498; Huppert, Felicia/0000-0003-2696-2286	MRC [G0400574] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C008200/1] Funding Source: Medline; Medical Research Council [G0001354, G0400574] Funding Source: Medline; Medical Research Council [G0001354B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Albert MS, 2006, ANNU REV CLIN PSYCHO, V2, P379, DOI 10.1146/annurev.clinpsy.1.102803.144039; BEBBINGTON PE, BR J PSYCHI IN PRESS; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; CHALLEN A, 2008, FORESIGHT MENTAL CAP; Chen CH, 2008, NEUROPSYCHOPHARMACOL, V33, P1909, DOI 10.1038/sj.npp.1301593; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Cooper C, 2008, PSYCHOL MED, V38, P335, DOI 10.1017/S0033291707001493; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Goswami U, 2008, FORESIGHT MENTAL CAP; Jenkins R, 2008, PSYCHOL MED, V38, P1485, DOI 10.1017/S0033291707002516; Jenkins R, 2008, FORESIGHT MENTAL CAP; Kirkwood TB., 2008, FORESIGHT MENTAL CAP; Knapp M, 2007, DEMENTIA UK; LLEWELLYN DJ, AGE AGEING IN PRESS; Mayberg HS, 1997, NEUROREPORT, V8, P1057, DOI 10.1097/00001756-199703030-00048; *OFF NAT STAT, 2008, NAT POP PROJ 2006 BA; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Phillips ML, 2007, SCHIZOPHRENIA BULL, V33, P893, DOI 10.1093/schbul/sbm060; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; *SAINSB CTR MENT H, 2003, EC SOC COSTS MENT IL; Schott JM, 2005, NEUROLOGY, V65, P119, DOI 10.1212/01.wnl.0000167542.89697.0f	21	310	314	4	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1057	1060		10.1038/4551057a	http://dx.doi.org/10.1038/4551057a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	363FG	18948946	Green Accepted			2022-12-28	WOS:000260252600030
J	Feig, DI; Kang, DH; Johnson, RJ				Feig, Daniel I.; Kang, Duk-Hee; Johnson, Richard J.			Uric acid and cardiovascular risk	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CORONARY-HEART-DISEASE; MUSCLE-CELL-PROLIFERATION; SALT-SENSITIVE HYPERTENSION; BLOOD-PRESSURE; ENDOTHELIAL FUNCTION; OXIDATIVE STRESS; METABOLIC SYNDROME; ATHEROSCLEROSIS RISK; RENAL-FUNCTION; SERUM URATE		[Feig, Daniel I.] Baylor Coll Med, Dept Pediat, Coll Med, Renal Sect, Houston, TX 77030 USA; [Kang, Duk-Hee] Ewha Womans Univ, Sch Med, Seoul, South Korea; [Johnson, Richard J.] Univ Colorado, Hlth Sci Ctr, Denver, CO USA	Baylor College of Medicine; Ewha Womans University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Feig, DI (corresponding author), Baylor Coll Med, Dept Pediat, Coll Med, Renal Sect, Houston, TX 77030 USA.	dfeig@bcm.tmc.edu		Johnson, Richard/0000-0003-3312-8193; Feig, Daniel/0000-0002-0017-6335	U.S. Public Health Service [HL-68607, DK-52121, DK064587]; Korea Science and Engineering Foundation through the government of Korea, Ministry of Education, Science, and Technology [R01-2008-000-10845-0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK064587, R01DK052121] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Korea Science and Engineering Foundation through the government of Korea, Ministry of Education, Science, and Technology(Korea Science and Engineering Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the U.S. Public Health Service (HL-68607 and DK-52121, to Dr. Johnson; and DK064587, to Dr. Feig) and from the Korea Science and Engineering Foundation through the government of Korea, Ministry of Education, Science, and Technology (R01-2008-000-10845-0, to Dr. Kang). Dr. Johnson reports being listed as an inventor on several patent applications related to the role of uric acid in hypertension and the metabolic syndrome and being an author of The Sugar Fix, a book for the lay public on fructose and uric acid published by Rodale in 2008. No other potential conflict of interest relevant to this article was reported.	ADAMOPOULOS D, 1977, ACTA ENDOCRINOL-COP, V85, P198; Alderman MH, 1999, HYPERTENSION, V34, P144, DOI 10.1161/01.HYP.34.1.144; Alper AB, 2005, HYPERTENSION, V45, P34, DOI 10.1161/01.HYP.0000150783.79172.bb; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Athyros VG, 2004, AM J KIDNEY DIS, V43, P589, DOI 10.1053/j.ajkd.2003.12.023; Baker JF, 2005, AM J MED, V118, P816, DOI 10.1016/j.amjmed.2005.03.043; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; BRAND FN, 1985, AM J EPIDEMIOL, V121, P11, DOI 10.1093/oxfordjournals.aje.a113972; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; Brown CM, 2008, AM J PHYSIOL-REG I, V294, pR730, DOI 10.1152/ajpregu.00680.2007; BULPITT CJ, 1975, BRIT HEART J, V37, P1210; CANNON PJ, 1966, NEW ENGL J MED, V275, P457, DOI 10.1056/NEJM196609012750902; CAPPUCCIO FP, 1993, JAMA-J AM MED ASSOC, V270, P354, DOI 10.1001/jama.270.3.354; Carnethon MR, 2003, AM J EPIDEMIOL, V158, P1058, DOI 10.1093/aje/kwg260; CHANG FM, 1987, BIOL RES PREG PERIN, V8, P35; Chaves FJ, 2007, PHARMACOGENET GENOM, V17, P589, DOI 10.1097/01.fpc.0000239970.23723.38; Cheung KJ, 2007, CELL METAB, V5, P115, DOI 10.1016/j.cmet.2007.01.005; Chien KL, 2008, CLIN CHEM, V54, P310, DOI 10.1373/clinchem.2007.095190; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choi HK, 2007, AM J MED, V120, P442, DOI 10.1016/j.amjmed.2006.06.040; Choi JWJ, 2008, ARTHRIT RHEUM-ARTHR, V59, P109, DOI 10.1002/art.23245; Cook S, 2003, SWISS MED WKLY, V133, P360; Coombs FS, 1940, J CLIN INVEST, V19, P525, DOI 10.1172/JCI101156; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Cuspidi C, 2007, AM J HYPERTENS, V20, P678, DOI 10.1016/j.amjhyper.2007.01.013; Davis Jr NS ., 1897, JAMA-J AM MED ASSOC, VXXIX, P261, DOI [10.1001/jama.1897.02440320005001a, DOI 10.1001/JAMA.1897.02440320005001A]; Davy KP, 2004, AM J PHYSIOL-REG I, V286, pR803, DOI 10.1152/ajpregu.00707.2003; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Doehner W, 2002, CIRCULATION, V105, P2619, DOI 10.1161/01.CIR.0000017502.58595.ED; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Dyer AR, 1999, J HUM HYPERTENS, V13, P13, DOI 10.1038/sj.jhh.1000740; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Farquharson CA, 2002, CIRCULATION, V106, P221, DOI 10.1161/01.CIR.0000022140.61460.1D; Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924; Feig DI, 2003, HYPERTENSION, V42, P247, DOI 10.1161/01.HYP.0000085858.66548.59; Feig DI, 2004, KIDNEY INT, V66, P281, DOI 10.1111/j.1523-1755.2004.00729.x; Fishberg AM, 1924, ARCH INTERN MED, V34, P503, DOI 10.1001/archinte.1924.00120040089007; Ford ES, 2007, CIRCULATION, V115, P2526, DOI 10.1161/CIRCULATIONAHA.106.657627; Forman JP, 2007, J AM SOC NEPHROL, V18, P287, DOI 10.1681/ASN.2006080865; Franco M, 2001, J AM SOC NEPHROL, V12, P2263, DOI 10.1681/ASN.V12112263; Franco MCP, 2006, HYPERTENSION, V48, P45, DOI 10.1161/01.HYP.0000223446.49596.3a; FREEDMAN DS, 1995, AM J EPIDEMIOL, V141, P637, DOI 10.1093/oxfordjournals.aje.a117479; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; GALVAN AQ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1, DOI 10.1152/ajpendo.1995.268.1.E1; Gao XA, 2007, HYPERTENSION, V50, P306, DOI 10.1161/HYPERTENSIONAHA.107.091041; George J, 2006, CIRCULATION, V114, P2508, DOI 10.1161/CIRCULATIONAHA.106.651117; GERTLER MM, 1951, ANN INTERN MED, V34, P1421, DOI 10.7326/0003-4819-34-6-1421; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; HALL AP, 1967, AM J MED, V42, P27, DOI 10.1016/0002-9343(67)90004-6; HALLFRISCH J, 1990, FASEB J, V4, P2652, DOI 10.1096/fasebj.4.9.2189777; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; Hoieggen A, 2004, KIDNEY INT, V65, P1041, DOI 10.1111/j.1523-1755.2004.00484.x; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; HUNT SC, 1991, HYPERTENSION, V17, P969, DOI 10.1161/01.HYP.17.6.969; Imazu M, 2001, HYPERTENS RES, V24, P531, DOI 10.1291/hypres.24.531; Iseki K, 2004, AM J KIDNEY DIS, V44, P642, DOI 10.1016/S0272-6386(04)00934-5; Iseki K, 2001, HYPERTENS RES, V24, P691, DOI 10.1291/hypres.24.691; Jacobson BM, 1938, ANN INTERN MED, V11, P1277, DOI 10.7326/0003-4819-11-7-1277; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Johnson RJ, 2005, SEMIN NEPHROL, V25, P3, DOI 10.1016/j.semnephrol.2004.09.002; Johnson RJ, 2002, NEW ENGL J MED, V346, P913, DOI 10.1056/NEJMra011078; JOSSA F, 1994, J HUM HYPERTENS, V8, P677; Kanbay M, 2007, INT UROL NEPHROL, V39, P1227, DOI 10.1007/s11255-007-9253-3; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; Kang DH, 2005, AM J NEPHROL, V25, P425, DOI 10.1159/000087713; Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; KINSEY D, 1961, CIRCULATION, V24, P972; Krishnan E, 2007, HYPERTENSION, V49, P298, DOI 10.1161/01.HYP.0000254480.64564.b6; Lee JE, 2006, HYPERTENSION, V47, P962, DOI 10.1161/01.HYP.0000210550.97398.c2; Lehto S, 1998, STROKE, V29, P635, DOI 10.1161/01.STR.29.3.635; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Mellen PB, 2006, HYPERTENSION, V48, P1037, DOI 10.1161/01.HYP.0000249768.26560.66; Mercuro G, 2004, AM J CARDIOL, V94, P932, DOI 10.1016/j.amjcard.2004.06.032; MESSERLI FH, 1980, ANN INTERN MED, V93, P817, DOI 10.7326/0003-4819-93-6-817; Moriarity JT, 2000, ANN EPIDEMIOL, V10, P136, DOI 10.1016/S1047-2797(99)00037-X; Nagahama K, 2004, HYPERTENS RES, V27, P835, DOI 10.1291/hypres.27.835; Nakagawa T, 2005, NAT CLIN PRACT NEPHR, V1, P80, DOI 10.1038/ncpneph0019; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Nieto FJ, 2000, ATHEROSCLEROSIS, V148, P131, DOI 10.1016/S0021-9150(99)00214-2; Niskanen L, 2006, DIABETES CARE, V29, P709, DOI 10.2337/diacare.29.03.06.dc05-1465; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Perlstein TS, 2006, HYPERTENSION, V48, P1031, DOI 10.1161/01.HYP.0000248752.08807.4c; Quiroz Y, 2001, AM J PHYSIOL-RENAL, V281, pF38, DOI 10.1152/ajprenal.2001.281.1.F38; RAO GN, 1991, J BIOL CHEM, V266, P8604; Reungjui S, 2007, J AM SOC NEPHROL, V18, P2724, DOI 10.1681/ASN.2007040416; Roberts JM, 2005, HYPERTENSION, V46, P1263, DOI 10.1161/01.HYP.0000188703.27002.14; Rosolowsky ET, 2008, CLIN J AM SOC NEPHRO, V3, P706, DOI 10.2215/CJN.04271007; SAITO I, 1978, J AM GERIATR SOC, V26, P241, DOI 10.1111/j.1532-5415.1978.tb02396.x; Sanchez-Lozada LG, 2008, AM J PHYSIOL-RENAL, V294, pF710, DOI 10.1152/ajprenal.00454.2007; Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, pF1238, DOI 10.1152/ajprenal.00164.2006; Sanchez-Lozada LG, 2005, KIDNEY INT, V67, P237, DOI 10.1111/j.1523-1755.2005.00074.x; Santos CXC, 1999, ARCH BIOCHEM BIOPHYS, V372, P285, DOI 10.1006/abbi.1999.1491; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Schretlen DJ, 2007, NEUROLOGY, V69, P1418, DOI 10.1212/01.wnl.0000277468.10236.f1; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Segal MS, 2007, EUR J NUTR, V46, P406, DOI 10.1007/s00394-007-0680-9; SELBY JV, 1990, AM J EPIDEMIOL, V131, P1017, DOI 10.1093/oxfordjournals.aje.a115593; SELBY JV, 1990, AM J EPIDEMIOL, V132, P589; Shankar A, 2006, J HUM HYPERTENS, V20, P937, DOI 10.1038/sj.jhh.1002095; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shi Y, 2006, J IMMUNOL, V176, P3905, DOI 10.4049/jimmunol.176.7.3905; Simsolo RB, 1999, AM J HYPERTENS, V12, P260, DOI 10.1016/S0895-7061(98)00253-2; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; Syamala S, 2007, J HYPERTENS, V25, P1583, DOI 10.1097/HJH.0b013e32813aeb6c; Talaat KM, 2007, AM J NEPHROL, V27, P435, DOI 10.1159/000105142; TALBOTT JH, 1960, MEDICINE, V39, P405; Taniguchi Y, 2001, J HYPERTENS, V19, P1209, DOI 10.1097/00004872-200107000-00005; Tomita M, 2000, J Epidemiol, V10, P403; Tuttle KR, 2001, AM J CARDIOL, V87, P1411, DOI 10.1016/S0002-9149(01)01566-1; UENO M, 1988, J HYPERTENS, V6, pS50, DOI 10.1097/00004872-198812040-00011; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wannamethee SG, 1997, HEART, V78, P147, DOI 10.1136/hrt.78.2.147; Waring WS, 2007, DIABETOLOGIA, V50, P2572, DOI 10.1007/s00125-007-0817-7; Waring WS, 2006, DIABETES, V55, P3127, DOI 10.2337/db06-0283; Waring WS, 2003, CLIN SCI, V105, P425, DOI 10.1042/CS20030149; Watanabe S, 2002, HYPERTENSION, V40, P355, DOI 10.1161/01.HYP.0000028589.66335.AA; Wheeler JG, 2005, PLOS MED, V2, P236, DOI 10.1371/journal.pmed.0020076; YU TF, 1979, AM J MED, V67, P766, DOI 10.1016/0002-9343(79)90732-0; YU TF, 1982, AM J MED, V72, P95, DOI 10.1016/0002-9343(82)90593-9	130	1630	1765	4	199	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2008	359	17					1811	1821		10.1056/NEJMra0800885	http://dx.doi.org/10.1056/NEJMra0800885			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363DJ	18946066	Green Accepted			2022-12-28	WOS:000260245800008
J	Fan, T; Wang, G; Mao, B; Xiong, ZY; Zhang, Y; Liu, XM; Wang, L; Yang, S				Fan, Tao; Wang, Gang; Mao, Bing; Xiong, Zeyu; Zhang, Yu; Liu, Xuemei; Wang, Lei; Yang, Sai			Prophylactic administration of parenteral steroids for preventing airway complications after extubation in adults: meta-analysis of randomised placebo controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ENDOTRACHEAL INTUBATION; LARYNGEAL EDEMA; POSTEXTUBATION STRIDOR; CORTICOSTEROIDS; VOLUME; RISK	Objective To determine whether steroids are effective in preventing laryngeal oedema after extubation and reducing the need for subsequent reintubation in critically ill adults. Design Meta- analysis. Data sources PubMed, Cochrane Controlled Trials Register, Web of Science, and Embase with no limitation on language, study year, or publication status. Selection criteria Randomised placebo controlled trials in which parenteral steroids were compared with placebo for preventing complications after extubation in adults. Review methods Search, application of inclusion and exclusion criteria, data extraction, and assessment of methodological quality, independently performed in duplicate. Odds ratios with 95% confidence intervals, risk difference, and number needed to treat were calculated and pooled. Main outcome measures Primary outcome: laryngeal oedema after extubation. Secondary outcome: subsequent reintubation because of laryngeal oedema. Results Six trials ( n= 1923) were identified. Comparedwith placebo, steroids given before planned extubation decreased the odds ratio for laryngeal oedema (0.38, 95% confidence interval 0.17 to 0.85) and subsequent reintubation ( 0.29, 0.15 to 0.58), corresponding with a risk difference of - 0.10 (- 0.12 to - 0.07; number needed to treat 10) and - 0.02 (- 0.04 to - 0.01; 50), respectively. Subgroup analyses indicated that a multidose regimen of steroids had marked positive effects on the occurrence of laryngeal oedema ( 0.14; 0.08 to 0.23) and on the rate of subsequent reintubation ( 0.19; 0.07 to 0.50), with a risk difference of - 0.19 (- 0.24 to - 0.15; 5) and- 0.04 (- 0.07 to - 0.02; 25). In single doses there was only a trend towards benefit, with the confidence interval including 1. Side effects related to steroids were not found. Conclusion Prophylactic administration of steroids in multidose regimens before planned extubation reduces the incidence of laryngeal oedema after extubation and the consequent reintubation rate in adults, with few adverse events.	[Fan, Tao; Wang, Gang; Mao, Bing; Wang, Lei] Sichuan Univ, W China Hosp, Pneumol Grp, Dept Integrated Tradit Chinese & Western Med, Chengdu 610041, Peoples R China; [Xiong, Zeyu] Univ Pittsburgh, Med Ctr, Div Pulm Allergy & Crit Care Med, Dept Med, Pittsburgh, PA 15213 USA; [Zhang, Yu] First Peoples Hosp Chengdu City, Dept Intens Care Med, Chengdu 610041, Peoples R China; [Liu, Xuemei] Sichuan Univ, Chinese Cochrane Ctr, W China Hosp, Chengdu 610064, Peoples R China; [Yang, Sai] Sichuan Univ, Dept Resp & Crit Care Med, W China Hosp, Chengdu 610064, Peoples R China	Sichuan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Sichuan University; Sichuan University	Wang, G (corresponding author), Sichuan Univ, W China Hosp, Pneumol Grp, Dept Integrated Tradit Chinese & Western Med, Chengdu 610041, Peoples R China.	wcums-respiration@hotmail.com			West China Hospital, Sichuan University [141070062]	West China Hospital, Sichuan University(Sichuan University)	This work was supported by West China Hospital, Sichuan University, grant No 141070062.	Chung YH, 2006, CRIT CARE MED, V34, P409, DOI 10.1097/01.CCM.0000198105.65413.85; Davis PG, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000308; Ding LW, 2006, EUR RESPIR J, V27, P384, DOI 10.1183/09031936.06.00029605; Epstein SK, 1998, AM J RESP CRIT CARE, V158, P489, DOI 10.1164/ajrccm.158.2.9711045; Epstein SK, 2006, CRIT CARE MED, V34, P1547, DOI 10.1097/01.CCM.0000208325.85450.2F; HAWKINS DB, 1983, OTOLARYNG HEAD NECK, V91, P593, DOI 10.1177/019459988309100601; Holst B, 2007, ANAESTHESIA, V62, P199, DOI 10.1111/j.1365-2044.2007.04968.x; Jaber S, 2003, INTENS CARE MED, V29, P69, DOI 10.1007/s00134-002-1563-4; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; KASTANOS N, 1983, CRIT CARE MED, V11, P362, DOI 10.1097/00003246-198305000-00009; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; MACKENZIE CF, 1979, ANESTHESIOLOGY, V50, P235, DOI 10.1097/00000542-197903000-00015; Markovitz BP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001000.pub2; Markovitz Barry P., 2002, Pediatr Crit Care Med, V3, P223, DOI 10.1097/00130478-200207000-00003; MARKOVITZ BP, 2000, COCHRANE DB SYST REV; Meade MO, 2001, CHEST, V120, p464S, DOI 10.1378/chest.120.6_suppl.464S; Miller RL, 1996, CHEST, V110, P1035, DOI 10.1378/chest.110.4.1035; Roberts RJ, 2008, ANN PHARMACOTHER, V42, P686, DOI 10.1345/aph.1K655; STAUFFER JL, 1981, AM J MED, V70, P65, DOI 10.1016/0002-9343(81)90413-7; Suominen P, 2006, PEDIATR ANESTH, V16, P641, DOI 10.1111/j.1460-9592.2005.01832.x; TORRES A, 1995, AM J RESP CRIT CARE, V152, P137, DOI 10.1164/ajrccm.152.1.7599812; Wang G, 2006, ACTA PHARMACOL SIN, V27, P1206, DOI 10.1111/j.1745-7254.2006.00418.x	22	33	36	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2008	337								a1841	10.1136/bmj.a1841	http://dx.doi.org/10.1136/bmj.a1841			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374FL	18936064	Green Published			2022-12-28	WOS:000261028500002
J	McMichael, RD; Stiles, MD				McMichael, R. D.; Stiles, M. D.			A new spin on the Doppler effect	SCIENCE			English	Editorial Material							TRANSFER TORQUES; DOMAIN DRAG; MAGNETORESISTANCE; FIELD		[McMichael, R. D.; Stiles, M. D.] Natl Inst Stand & Technol, Ctr Nanoscale Sci & Technol, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA	McMichael, RD (corresponding author), Natl Inst Stand & Technol, Ctr Nanoscale Sci & Technol, Gaithersburg, MD 20899 USA.	robert.mcmichael@nist.gov; mark.stiles@nist.gov	McMichael, Robert/J-8688-2012; Stiles, Mark/K-2426-2012	Stiles, Mark/0000-0001-8238-4156; McMichael, Robert/0000-0002-1372-664X				BAIBICH MN, 1988, PHYS REV LETT, V61, P2472, DOI 10.1103/PhysRevLett.61.2472; Beach GSD, 2008, J MAGN MAGN MATER, V320, P1272, DOI 10.1016/j.jmmm.2007.12.021; BERGER L, 1979, J APPL PHYS, V50, P2137, DOI 10.1063/1.327083; BERGER L, 1978, J APPL PHYS, V49, P2156, DOI 10.1063/1.324716; BINASCH G, 1989, PHYS REV B, V39, P4828, DOI 10.1103/PhysRevB.39.4828; Hayashi M, 2008, SCIENCE, V320, P209, DOI 10.1126/science.1154587; Katine JA, 2008, J MAGN MAGN MATER, V320, P1217, DOI 10.1016/j.jmmm.2007.12.013; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Ralph DC, 2008, J MAGN MAGN MATER, V320, P1190, DOI 10.1016/j.jmmm.2007.12.019; Vlaminck V, 2008, SCIENCE, V322, P410, DOI 10.1126/science.1162843; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323	11	9	9	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					386	387		10.1126/science.1165717	http://dx.doi.org/10.1126/science.1165717			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927380				2022-12-28	WOS:000260094500030
J	Hill, DR; Ryan, ET				Hill, David R.; Ryan, Edward T.			Management of travellers' diarrhoea	BMJ-BRITISH MEDICAL JOURNAL			English	Review							NORTH-AMERICAN TRAVELERS; IRRITABLE-BOWEL-SYNDROME; DOUBLE-BLIND; ESCHERICHIA-COLI; PLUS LOPERAMIDE; RIFAXIMIN; PLACEBO; AZITHROMYCIN; TRIAL; CIPROFLOXACIN		[Hill, David R.] Hosp Trop Dis, Natl Travel Hlth Network & Ctr, London WC1E 6JB, England; [Hill, David R.] Hosp Trop Dis, London Sch Hyg & Trop Med, London WC1E 6JB, England; [Ryan, Edward T.] Massachusetts Gen Hosp, Travelers Advice & Immunizat Ctr, Boston, MA 02114 USA; [Ryan, Edward T.] Massachusetts Gen Hosp, Trop & Geog Med Ctr, Boston, MA 02114 USA	University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Hill, DR (corresponding author), Hosp Trop Dis, Natl Travel Hlth Network & Ctr, London WC1E 6JB, England.	david.hill@uclh.org						Adachi JA, 2003, CLIN INFECT DIS, V37, P1165, DOI 10.1086/378746; Adachi JA, 2001, CLIN INFECT DIS, V32, P1706, DOI 10.1086/320756; Caeiro JP, 1999, CLIN INFECT DIS, V28, P1286, DOI 10.1086/514786; Cartwright RY, 2003, J APPL MICROBIOL, V94, p12S, DOI 10.1046/j.1365-2672.94.s1.2.x; DEBRUYN G, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002242; DuPont HL, 2007, CLIN GASTROENTEROL H, V5, P451, DOI 10.1016/j.cgh.2007.02.004; DuPont HL, 2005, ANN INTERN MED, V142, P805, DOI 10.7326/0003-4819-142-10-200505170-00005; DuPont HL, 2001, CLIN INFECT DIS, V33, P1807, DOI 10.1086/323814; DUPONT HL, 1977, GASTROENTEROLOGY, V73, P715; DUPONT HL, 1987, JAMA-J AM MED ASSOC, V257, P1347, DOI 10.1001/jama.257.10.1347; Ekdahl K, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-54; Ericsson CD, 2007, J TRAVEL MED, V14, P312, DOI 10.1111/j.1708-8305.2007.00144.x; Frech SA, 2008, LANCET, V371, P2019, DOI 10.1016/S0140-6736(08)60839-9; Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331; Greenwood Z, 2008, J TRAVEL MED, V15, P221, DOI 10.1111/j.1708-8305.2008.00203.x; Hill DR, 2006, CLIN INFECT DIS, V43, P1499, DOI 10.1086/508782; Hill DR, 2006, LANCET INFECT DIS, V6, P361, DOI 10.1016/S1473-3099(06)70494-7; Hill DR, 2000, AM J TROP MED HYG, V62, P585, DOI 10.4269/ajtmh.2000.62.585; HILL DR, 2008, TRAVELERS DIARRHEA, P180; Huang DB, 2004, CLIN INFECT DIS, V39, P468, DOI 10.1086/422322; Jian Zhang, 2008, TENCON 2008 - 2008 IEEE Region 10 Conference, DOI 10.1109/TENCON.2008.4766399; Jiang ZD, 2002, J INFECT DIS, V185, P497, DOI 10.1086/338834; JOHNSON PC, 1986, JAMA-J AM MED ASSOC, V255, P757, DOI 10.1001/jama.255.6.757; Ko GP, 2005, J CLIN MICROBIOL, V43, P6126, DOI 10.1128/JCM.43.12.6126-6129.2005; Nair P, 2008, AM J TROP MED HYG, V79, P210, DOI 10.4269/ajtmh.2008.79.210; Norman FF, 2008, CLIN INFECT DIS, V46, P1060, DOI 10.1086/529380; Okhuysen PC, 2004, AM J GASTROENTEROL, V99, P1774, DOI 10.1111/j.1572-0241.2004.30435.x; Riddle MS, 2006, AM J TROP MED HYG, V74, P891, DOI 10.4269/ajtmh.2006.74.891; Sazawal S, 2006, LANCET INFECT DIS, V6, P374, DOI 10.1016/S1473-3099(06)70495-9; Shlim DR, 2005, CLIN INFECT DIS, V41, pS531, DOI 10.1086/432947; Steffen R, 1999, JAMA-J AM MED ASSOC, V281, P811, DOI 10.1001/jama.281.9.811; Stermer E, 2006, CLIN INFECT DIS, V43, P898, DOI 10.1086/507540; Taylor DN, 2006, AM J TROP MED HYG, V74, P1060, DOI 10.4269/ajtmh.2006.74.1060; Tribble DR, 2007, CLIN INFECT DIS, V44, P338, DOI 10.1086/510589	34	16	17	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 11	2008	337	7674							a1746	10.1136/bmj.a1746	http://dx.doi.org/10.1136/bmj.a1746			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FU	18838421	Green Accepted			2022-12-28	WOS:000259903300036
J	Carlton, JM; Adams, JH; Silva, JC; Bidwell, SL; Lorenzi, H; Caler, E; Crabtree, J; Angiuoli, SV; Merino, EF; Amedeo, P; Cheng, Q; Coulson, RMR; Crabb, BS; del Portillo, HA; Essien, K; Feldblyum, TV; Fernandez-Becerra, C; Gilson, PR; Gueye, AH; Guo, X; Kang'a, S; Kooij, TWA; Korsinczky, M; Meyer, EVS; Nene, V; Paulsen, I; White, O; Ralph, SA; Ren, QH; Sargeant, TJ; Salzberg, SL; Stoeckert, CJ; Sullivan, SA; Yamamoto, MM; Hoffman, SL; Wortman, JR; Gardner, MJ; Galinski, MR; Barnwell, JW; Fraser-Liggett, CM				Carlton, Jane M.; Adams, John H.; Silva, Joana C.; Bidwell, Shelby L.; Lorenzi, Hernan; Caler, Elisabet; Crabtree, Jonathan; Angiuoli, Samuel V.; Merino, Emilio F.; Amedeo, Paolo; Cheng, Qin; Coulson, Richard M. R.; Crabb, Brendan S.; del Portillo, Hernando A.; Essien, Kobby; Feldblyum, Tamara V.; Fernandez-Becerra, Carmen; Gilson, Paul R.; Gueye, Amy H.; Guo, Xiang; Kang'a, Simon; Kooij, Taco W. A.; Korsinczky, Michael; Meyer, Esmeralda V. -S.; Nene, Vish; Paulsen, Ian; White, Owen; Ralph, Stuart A.; Ren, Qinghu; Sargeant, Tobias J.; Salzberg, Steven L.; Stoeckert, Christian J.; Sullivan, Steven A.; Yamamoto, Marcio M.; Hoffman, Stephen L.; Wortman, Jennifer R.; Gardner, Malcolm J.; Galinski, Mary R.; Barnwell, John W.; Fraser-Liggett, Claire M.			Comparative genomics of the neglected human malaria parasite Plasmodium vivax	NATURE			English	Article							RED-BLOOD-CELLS; PHENOTYPIC VARIATION; RODENT MALARIA; FALCIPARUM; PROTEINS; BINDING; IDENTIFICATION; SUPERFAMILY; EXPRESSION; RESISTANCE	The human malaria parasite Plasmodium vivax is responsible for 25 - 40% of the similar to 515 million annual cases of malaria worldwide. Although seldom fatal, the parasite elicits severe and incapacitating clinical symptoms and often causes relapses months after a primary infection has cleared. Despite its importance as a major human pathogen, P. vivax is little studied because it cannot be propagated continuously in the laboratory except in non- human primates. We sequenced the genome of P. vivax to shed light on its distinctive biological features, and as a means to drive development of new drugs and vaccines. Here we describe the synteny and isochore structure of P. vivax chromosomes, and show that the parasite resembles other malaria parasites in gene content and metabolic potential, but possesses novel gene families and potential alternative invasion pathways not recognized previously. Completion of the P. vivax genome provides the scientific community with a valuable resource that can be used to advance investigation into this neglected species.	[Carlton, Jane M.; Bidwell, Shelby L.; Lorenzi, Hernan; Caler, Elisabet; Crabtree, Jonathan; Amedeo, Paolo; Guo, Xiang; Paulsen, Ian; Ren, Qinghu; Gardner, Malcolm J.] J Craig Venter Inst, Inst Genom Res, Rockville, MD 20850 USA; [Carlton, Jane M.; Merino, Emilio F.; Kang'a, Simon; Sullivan, Steven A.] NYU, Langone Med Ctr, Dept Med Parasitol, New York, NY 10010 USA; [Adams, John H.] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33612 USA; [Silva, Joana C.; Nene, Vish] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Silva, Joana C.; Crabtree, Jonathan; Angiuoli, Samuel V.; Feldblyum, Tamara V.; Nene, Vish; White, Owen; Wortman, Jennifer R.; Fraser-Liggett, Claire M.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [White, Owen] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; [Wortman, Jennifer R.; Fraser-Liggett, Claire M.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Angiuoli, Samuel V.; Salzberg, Steven L.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Cheng, Qin; Korsinczky, Michael] Australian Army Malaria Inst, Enoggera, Qld 4051, Australia; [Coulson, Richard M. R.] European Bioinformat Inst, Microarray Grp, Cambridge CB10 1SD, England; [Crabb, Brendan S.; Gilson, Paul R.; Sargeant, Tobias J.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Crabb, Brendan S.] Burnet Inst, Melbourne, Vic 3004, Australia; [del Portillo, Hernando A.; Fernandez-Becerra, Carmen] Univ Barcelona, Barcelona Ctr Int Hlth Res, Hosp Clin IDIBAPS, E-08036 Barcelona, Spain; [del Portillo, Hernando A.] Passeig Lluis Co, Inst Catalana Recerca & Estud Avancats, Barcelona 08010, Spain; [Essien, Kobby; Stoeckert, Christian J.] Univ Penn, Sch Med, Ctr Bioinformat, Philadelphia, PA 19104 USA; [Essien, Kobby; Stoeckert, Christian J.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Essien, Kobby] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Gueye, Amy H.] Hood Coll, Frederick, MD 21701 USA; [Kooij, Taco W. A.] Heidelberg Univ, Sch Med, Dept Parasitol, D-69120 Heidelberg, Germany; [Korsinczky, Michael; Galinski, Mary R.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Meyer, Esmeralda V. -S.] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Meyer, Esmeralda V. -S.] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30329 USA; [Paulsen, Ian] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Ralph, Stuart A.] Univ Melbourne, Dept Biochem & Mol Biol, Bio21 Mol Sci & Biotechnol Inst, Melbourne, Vic 3010, Australia; [Sargeant, Tobias J.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Yamamoto, Marcio M.] Univ Sao Paulo, Dept Parasitol, Inst Ciencias Biomed, BR-05508900 Sao Paulo, Brazil; [Hoffman, Stephen L.] Sanaria Inc, Rockville, MD 20850 USA; [Barnwell, John W.] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis, Natl Ctr Zoonot Vectorborne & Enter Dis, Atlanta, GA 30341 USA	J. Craig Venter Institute; New York University; NYU Langone Medical Center; State University System of Florida; University of South Florida; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park; QIMR Berghofer Medical Research Institute; European Molecular Biology Laboratory (EMBL); Walter & Eliza Hall Institute; Burnet Institute; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ICREA; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Queensland; Emory University; Emory University; Macquarie University; University of Melbourne; University of Melbourne; Universidade de Sao Paulo; Sanaria Inc.; Centers for Disease Control & Prevention - USA	Carlton, JM (corresponding author), J Craig Venter Inst, Inst Genom Res, 9704 Med Res Dr, Rockville, MD 20850 USA.	jane.carlton@nyumc.org	Salzberg, Steven/Q-6514-2019; Salzberg, Steven L/F-6162-2011; Adams, John H./ABB-8458-2020; Silva, Joana/GVT-6441-2022; Angiuoli, Samuel V/H-7340-2014; Fernandez Becerra, Carmen/L-2069-2014; Cheng, Qin/AAO-2198-2020; del Portillo, Hernando A/L-2131-2014; Paulsen, Ian T/K-3832-2012; Crabb, Brendan/F-5287-2013; Adams, John/G-1800-2015; Silva, Joana/GYQ-9526-2022; Kooij, Taco W.A./L-5623-2015; Ralph, Stuart/C-8590-2014	Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432; Adams, John H./0000-0003-3707-7979; Fernandez Becerra, Carmen/0000-0001-5154-0013; Cheng, Qin/0000-0001-7776-4437; del Portillo, Hernando A/0000-0002-5278-3452; Paulsen, Ian T/0000-0001-9015-9418; Adams, John/0000-0003-3707-7979; Kooij, Taco W.A./0000-0002-8547-7523; Fraser, Claire/0000-0003-1462-2428; Sargeant, Tobias/0000-0002-0909-7182; Ralph, Stuart/0000-0003-0114-7808; Nene, Vishvanath/0000-0001-7066-4169; Wortman, Jennifer/0000-0002-8713-1227; Angiuoli, Samuel/0000-0001-9525-4350; Lorenzi, Hernan/0000-0003-0910-7894	US Department of Defense and National Institute of Allergy and Infectious Diseases; BurroughsWellcome Fund; National Institute of General Medical Sciences; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070793, R01GM083873] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	US Department of Defense and National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)United States Department of Defense); BurroughsWellcome Fund(Burroughs Wellcome Fund); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank the P. vivax research community for their support, and in particular M. Gottlieb and V. McGovern for facilitating financial support. Funding came from the following sources: P. vivax sequencing, assembly and closure, US Department of Defense and National Institute of Allergy and Infectious Diseases; genome mapping, BurroughsWellcome Fund; and selective constraint analysis, National Institute of General Medical Sciences. We wish to thank TIGR's SeqCore, Closure and IFX core facilities, E. Lee, J. Sundaram, J. Orvis, B. Haas and T. Creasy for engineering support, R. K. Smith Jr for annotation support, E. Lyons and H. Zhang for technical assistance, H. Potts for statistical analysis, T. McCutchan for rDNA sequence annotation, and S. Perkins for the Plasmodium phylogeny.	Akoachere M, 2005, BIOL CHEM, V386, P41, DOI 10.1515/BC.2005.006; ANDERS RF, 1986, PARASITE IMMUNOL, V8, P529, DOI 10.1111/j.1365-3024.1986.tb00867.x; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Carraz M, 2006, PLOS MED, V3, P2392, DOI 10.1371/journal.pmed.0030513; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; del Portillo HA, 2001, NATURE, V410, P839, DOI 10.1038/35071118; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Dzikowski R, 2006, CELL MICROBIOL, V8, P1371, DOI 10.1111/j.1462-5822.2006.00760.x; FANG XD, 1991, MOL BIOCHEM PARASIT, V44, P125, DOI 10.1016/0166-6851(91)90228-X; Feng XR, 2003, P NATL ACAD SCI USA, V100, P8502, DOI 10.1073/pnas.1232502100; Ferdig MT, 2000, PARASITOL TODAY, V16, P307, DOI 10.1016/S0169-4758(00)01676-8; Fernandez-Becerra C, 2005, MOL MICROBIOL, V58, P648, DOI 10.1111/j.1365-2958.2005.04850.x; Frank M, 2006, J BIOL CHEM, V281, P9942, DOI 10.1074/jbc.M513067200; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Gruner AC, 2004, MICROBES INFECT, V6, P864, DOI 10.1016/j.micinf.2004.04.004; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hughes AL, 2004, J MOL EVOL, V59, P528, DOI 10.1007/s00239-004-2645-4; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Jalah R, 2005, MOL BIOCHEM PARASIT, V142, P158, DOI 10.1016/j.molbiopara.2005.01.020; Joy DA, 2008, MOL BIOL EVOL, V25, P1245, DOI 10.1093/molbev/msn073; Kooij TWA, 2005, PLOS PATHOG, V1, P349, DOI 10.1371/journal.ppat.0010044; Korsinczky M, 2000, ANTIMICROB AGENTS CH, V44, P2100, DOI 10.1128/AAC.44.8.2100-2108.2000; Krotoski W A, 1989, Prog Clin Parasitol, V1, P1; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; MCCUTCHAN TF, 1984, SCIENCE, V225, P808, DOI 10.1126/science.6382604; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Merino EF, 2006, MOL BIOCHEM PARASIT, V149, P10, DOI 10.1016/j.molbiopara.2006.04.002; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Preiser PR, 1999, NATURE, V398, P618, DOI 10.1038/19309; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Russell B, 2008, ANTIMICROB AGENTS CH, V52, P1040, DOI 10.1128/AAC.01334-07; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Sato S, 2005, CURR TOP MICROBIOL, V295, P251; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; SCHERF A, 2004, GENOMES MOL CELL BIO; Suwanarusk R, 2004, J INFECT DIS, V189, P190, DOI 10.1086/380468; Udomsangpetch R, 2008, TRENDS PARASITOL, V24, P85, DOI 10.1016/j.pt.2007.09.010; Uhlemann AC, 2005, NAT STRUCT MOL BIOL, V12, P628, DOI 10.1038/nsmb947; van Noort V, 2006, TRENDS GENET, V22, P73, DOI 10.1016/j.tig.2005.12.002; Young JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-70	49	611	663	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2008	455	7214					757	763		10.1038/nature07327	http://dx.doi.org/10.1038/nature07327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18843361	Green Accepted, hybrid			2022-12-28	WOS:000259854900038
J	Needham, DM				Needham, Dale M.			Mobilizing patients in the intensive care unit - Improving neuromuscular weakness and physical function	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	1st International Meeting of Physical Rehabilitation in the Critically Ill	MAY 17, 2008	Toronto, CANADA				QUALITY-OF-LIFE; RESPIRATORY-DISTRESS-SYNDROME; CRITICALLY-ILL PATIENTS; ACUTE LUNG INJURY; MECHANICALLY VENTILATED PATIENTS; BED REST; CRITICAL ILLNESS; SKELETAL-MUSCLE; PULMONARY-FUNCTION; SURVIVORS	Early mobilization of patients in the hospital and the intensive care unit has a strong historical precedent. However, in more recent times, deep sedation and bed rest have been part of routine medical care for many mechanically ventilated patients. A growing body of literature demonstrates that survivors of severe critical illness commonly have significant and prolonged neuromuscular complications that impair their physical function and quality of life after hospital discharge. Bed rest, and its associated mechanisms, may play an important role in the pathogenesis of neuromuscular weakness in critically ill patients. A new approach for managing mechanically ventilated patients includes reducing deep sedation and increasing rehabilitation therapy and mobilization soon after admission to the intensive care unit. Emerging research in this field provides preliminary evidence supporting the safety, feasibility, and potential benefits of early mobilization in critical care medicine.	[Needham, Dale M.] Johns Hopkins Univ, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; [Needham, Dale M.] Johns Hopkins Univ, Dept Phys Med & Rehabil, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Needham, DM (corresponding author), Johns Hopkins Univ, Div Pulm & Crit Care Med, 1830 E Monument St,5th Floor, Baltimore, MD 21205 USA.	dale.needham@jhmi.edu						[Anonymous], 1948, BRIT MED J, V2, P1026; Bailey P, 2007, CRIT CARE MED, V35, P139, DOI 10.1097/01.CCM.0000251130.69568.87; Berg HE, 1997, J APPL PHYSIOL, V82, P182, DOI 10.1152/jappl.1997.82.1.182; BERGEL RR, 1990, RHEUM DIS CLIN N AM, V16, P791; Bolton CF, 2007, CHEST, V131, P1273, DOI 10.1378/chest.07-0367; BURNS JR, 1975, CHEST, V68, P608; Chiang LL, 2006, PHYS THER, V86, P1271, DOI 10.2522/ptj.20050036; Convertino VA, 1997, MED SCI SPORT EXER, V29, P187, DOI 10.1097/00005768-199702000-00004; Davidson TA, 1999, JAMA-J AM MED ASSOC, V281, P354, DOI 10.1001/jama.281.4.354; De Jonghe B, 2005, CRIT CARE MED, V33, P120, DOI 10.1097/01.CCM.0000150268.04228.68; De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; de Letter MACJ, 2001, CRIT CARE MED, V29, P2281, DOI 10.1097/00003246-200112000-00008; Dock W., 1944, JAMA-J AM MED ASSOC, V125, P1085; Dowdy DW, 2006, INTENS CARE MED, V32, P1115, DOI 10.1007/s00134-006-0217-3; Dowdy DW, 2005, INTENS CARE MED, V31, P611, DOI 10.1007/s00134-005-2592-6; Ferrando AA, 1996, AM J PHYSIOL-ENDOC M, V270, pE627, DOI 10.1152/ajpendo.1996.270.4.E627; Fink H, 2008, CRIT CARE MED, V36, P910, DOI 10.1097/CCM.0B013E3181659669; Fortney S.M., 1996, HDB PHYSL, P889, DOI DOI 10.1002/CPHY.CP040239; Gosselink R, 2008, INTENS CARE MED, V34, P1188, DOI 10.1007/s00134-008-1026-7; Hamburg NM, 2007, ARTERIOSCL THROM VAS, V27, P2650, DOI 10.1161/ATVBAHA.107.153288; Hermans G, 2007, AM J RESP CRIT CARE, V175, P480, DOI 10.1164/rccm.200605-665OC; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Hopkins RO, 2007, CRIT CARE CLIN, V23, P81, DOI 10.1016/j.ccc.2006.11.004; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Hough CL, 2007, CURR OPIN CRIT CARE, V13, P489, DOI 10.1097/MCC.0b013e3282efea3a; Hough CL, 2006, CLIN CHEST MED, V27, P691, DOI 10.1016/j.ccm.2006.07.002; HUNG J, 1983, AM J CARDIOL, V51, P344, DOI 10.1016/S0002-9149(83)80063-0; Keys A., 1944, FED PROC, V3, P189; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Kress JP, 2003, AM J RESP CRIT CARE, V168, P1457, DOI 10.1164/rccm.200303-455OC; Leijten FSS, 1997, EUR J NEUROL, V4, P124, DOI 10.1111/j.1468-1331.1997.tb00317.x; Maramattom BV, 2006, CRIT CARE MED, V34, P2835, DOI 10.1097/01.CCM.0000239436.63452.81; Martin UJ, 2005, CRIT CARE MED, V33, P2259, DOI 10.1097/01.CCM.0000181730.02238.9B; Morris PE, 2008, CRIT CARE MED, V36, P2238, DOI 10.1097/CCM.0b013e318180b90e; Nava S, 1998, ARCH PHYS MED REHAB, V79, P849, DOI 10.1016/S0003-9993(98)90369-0; Needham DM, 2007, J CRIT CARE, V22, P275, DOI 10.1016/j.jcrc.2007.02.001; Orme J, 2003, AM J RESP CRIT CARE, V167, P690, DOI 10.1164/rccm.200206-542OC; Petty TL, 1998, CHEST, V114, P360, DOI 10.1378/chest.114.2.360; Ross G, 1972, Phys Ther, V52, P519; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schelling G, 2000, INTENS CARE MED, V26, P1304, DOI 10.1007/s001340051342; SCIAKY AJ, 1994, PHYS THER PRACT, V3, P69; Stein TP, 2005, J NUTR, V135, p1824S, DOI 10.1093/jn/135.7.1824S; Stevens RD, 2007, INTENS CARE MED, V33, P1876, DOI 10.1007/s00134-007-0772-2; Stiller Kathy, 2004, Physiotherapy Theory and Practice, V20, P175, DOI 10.1080/09593980490487474; Thomsen GE, 2008, CRIT CARE MED, V36, P1119, DOI 10.1097/CCM.0b013e318168f986; Weinert CR, 1997, AM J RESP CRIT CARE, V156, P1120, DOI 10.1164/ajrccm.156.4.9611047; Weinert CR, 2007, CRIT CARE MED, V35, P393, DOI 10.1097/01.CCM.0000254339.18639.1D; Winkelman C, 2007, CRIT CARE CLIN, V23, P21, DOI 10.1016/j.ccc.2006.11.002; Winkelman C, 2005, DIMENS CRIT CARE NUR, V24, P281, DOI 10.1097/00003465-200511000-00011	50	309	338	1	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2008	300	14					1685	1690		10.1001/jama.300.14.1685	http://dx.doi.org/10.1001/jama.300.14.1685			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	356YF	18840842				2022-12-28	WOS:000259812800030
J	Blackwell, TK; Walker, AK				Blackwell, T. Keith; Walker, Amy K.			OMA-gosh, where's that TAF?	CELL			English	Editorial Material							OOCYTE MATURATION; C-ELEGANS; TRANSCRIPTION; ELONGATION; PROTEINS; PIE-1	How transcription is silenced in early embryos has long been a mystery. In this issue, Guven-Ozkan et al. (2008) report that transcriptional repression during worm embryogenesis is mediated through sequestration of the general transcription factor TAF-4 and is regulated by mechanisms that orchestrate the transition between maternal and zygotic gene expression.	[Blackwell, T. Keith] Harvard Univ, Sch Med,Harvard Stem Cell Inst, Sect Dev & Stem Cell Biol, Joslin Diabet Ctr,Dept Pathol, Boston, MA 02215 USA; [Walker, Amy K.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Massachusetts General Hospital	Blackwell, TK (corresponding author), Harvard Univ, Sch Med,Harvard Stem Cell Inst, Sect Dev & Stem Cell Biol, Joslin Diabet Ctr,Dept Pathol, Boston, MA 02215 USA.	keith.blackwell@joslin.harvard.edu; awalker6@partners.org						Detwiler MR, 2001, DEV CELL, V1, P187, DOI 10.1016/S1534-5807(01)00026-0; Ghosh D, 2008, GENETICS, V178, P235, DOI 10.1534/genetics.107.083212; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Stitzel ML, 2006, CURR BIOL, V16, P56, DOI 10.1016/j.cub.2005.11.063; Walker AK, 2007, DEV BIOL, V304, P382, DOI 10.1016/j.ydbio.2006.12.039; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Zhang F, 2003, GENE DEV, V17, P748, DOI 10.1101/gad.1068203	8	1	2	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 3	2008	135	1					18	20		10.1016/j.cell.2008.09.021	http://dx.doi.org/10.1016/j.cell.2008.09.021			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854150	Bronze			2022-12-28	WOS:000259728100004
J	Brown, NH				Brown, Nicholas H.			Spectraplakins: The cytoskeleton's swiss army knife	CELL			English	Editorial Material							FOCAL ADHESIONS; ACTIN; MICROTUBULES; INVOLVEMENT; PLAKIN	Spectraplakins are multifunctional proteins that interact with all three types of cytoskeletal filaments. In this issue, Wu et al. (2008) demonstrate a new actin-dependent ATPase activity for the spectraplakin ACF7 that allows it to guide microtubule ends along actin stress fibers to focal adhesions, promoting disassembly of adhesion contacts and hence cell movement.	[Brown, Nicholas H.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Brown, Nicholas H.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Brown, NH (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	nb117@cam.ac.uk		Brown, Nicholas/0000-0002-8958-7017				Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Enomoto T, 1996, CELL STRUCT FUNCT, V21, P317, DOI 10.1247/csf.21.317; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Roper K, 2002, J CELL SCI, V115, P4215, DOI 10.1242/jcs.00157; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039	9	8	8	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					16	18		10.1016/j.cell.2008.09.023	http://dx.doi.org/10.1016/j.cell.2008.09.023			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854149	Bronze			2022-12-28	WOS:000259728100003
J	Wirtz-Peitz, F; Nishimura, T; Knoblich, JA				Wirtz-Peitz, Frederik; Nishimura, Takashi; Knoblich, Juergen A.			Linking cell cycle to asymmetric division: Aurora-A phosphorylates the par complex to regulate Numb localization	CELL			English	Article							LETHAL-GIANT-LARVAE; NEUROBLAST SELF-RENEWAL; NEURAL STEM-CELLS; TUMOR-SUPPRESSOR; DROSOPHILA NEUROBLASTS; MEMBRANE LOCALIZATION; FATE DETERMINANTS; PROTEIN; POLARITY; APKC	Drosophila neural precursor cells divide asymmetrically by segregating the Numb protein into one of the two daughter cells. Numb is uniformly cortical in interphase but assumes a polarized localization in mitosis. Here, we show that a phosphorylation cascade triggered by the activation of Aurora-A is responsible for the asymmetric localization of Numb in mitosis. Aurora-A phosphorylates Par-6, a regulatory subunit of atypical protein kinase C (aPKC). This activates aPKC, which initially phosphorylates Lethal (2) giant larvae (Lgl), a cytoskeletal protein that binds and inhibits aPKC during interphase. Phosphorylated Lgl is released from aPKC and thereby allows the PDZ domain protein Bazooka to enter the complex. This changes substrate specificity and allows aPKC to phosphorylate Numb and release the protein from one side of the cell cortex. Our data reveal a molecular mechanism for the asymmetric localization of Numb and show how cell polarity can be coupled to cell-cycle progression.	[Wirtz-Peitz, Frederik; Nishimura, Takashi; Knoblich, Juergen A.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Nishimura, Takashi/AAQ-9299-2020; Nishimura, Takashi/D-7672-2017; Knoblich, Juergen A/C-2974-2015	Nishimura, Takashi/0000-0002-6773-0302; Nishimura, Takashi/0000-0002-6773-0302; Knoblich, Juergen A/0000-0002-6751-3404	Boehringer Ingelheim Fonds; Human Frontiers Science Program; Austrian Academy of Sciences; Austrian Science Fund; Vienna Science and Technology Fund; European Union EUROSYSTEMS; ONCASYM	Boehringer Ingelheim Fonds(Boehringer Ingelheim); Human Frontiers Science Program(Human Frontier Science Program); Austrian Academy of Sciences; Austrian Science Fund(Austrian Science Fund (FWF)); Vienna Science and Technology Fund; European Union EUROSYSTEMS(European Commission); ONCASYM	We thank C. Juschke and S.K. Bowman for comments on the manuscript; Y. Bellaiche, T. Hirota, Y.N. Jan, D. St Johnston, K. Kaibuchi, F. Matsuzaki, T. Murphy, S. Ohno, H. Saya, F. Schweisguth, and the Developmental Studies Hybridoma Bank for constructs, antibodies, and fly stocks; J. Betschinger, D. Berdnik, and A. Hutterer for generating transgenic fly lines and constructs; N. Nishimura and S. Farina Lopez for technical assistance; and M.P. Posti-glione, S. Goulas, and other members of our lab for discussion. F.W.P. was supported by a PhD fellowship of the Boehringer Ingelheim Fonds; T.N. is supported by a long-term fellowship of the Human Frontiers Science Program; and work in J.A.K.'s lab is supported by the Austrian Academy of Sciences, the Austrian Science Fund, the Vienna Science and Technology Fund, the European Union EUROSYSTEMS, and ONCASYM.	Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bhalerao S, 2005, CURR BIOL, V15, P1583, DOI 10.1016/j.cub.2005.07.061; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Dornan S, 1997, MOL BIOL CELL, V8, P1391, DOI 10.1091/mbc.8.8.1391; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Langevin J, 2005, CURR BIOL, V15, P955, DOI 10.1016/j.cub.2005.04.054; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Noda Y, 2003, J BIOL CHEM, V278, P43516, DOI 10.1074/jbc.M306330200; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Phair RD, 2004, METHOD ENZYMOL, V375, P393; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Roegiers F, 2005, MOL BIOL CELL, V16, P3480, DOI 10.1091/mbc.E05-03-0177; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Wirtz-Peitz F, 2006, TRENDS CELL BIOL, V16, P234, DOI 10.1016/j.tcb.2006.03.006; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x; Yamanaka T, 2006, J CELL SCI, V119, P2107, DOI 10.1242/jcs.02938	40	272	275	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 3	2008	135	1					161	173		10.1016/j.cell.2008.07.049	http://dx.doi.org/10.1016/j.cell.2008.07.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854163	Green Accepted, Bronze			2022-12-28	WOS:000259728100017
J	Shiraishi, R; Ohtani, E; Kanagawa, K; Shimojuku, A; Zhao, DP				Shiraishi, Rei; Ohtani, Eiji; Kanagawa, Kyuichi; Shimojuku, Akira; Zhao, Dapeng			Crystallographic preferred orientation of akimotoite and seismic anisotropy of Tonga slab	NATURE			English	Article							FABRIC TRANSITIONS; HIGH-PRESSURES; BENEATH FIJI; MANTLE; TEMPERATURE; ILMENITE; WATER; DEFORMATION; MINERALS; OLIVINE	The mineral akimotoite, ilmenite- structured MgSiO3, exists at the bottom of the Earth's mantle transition zone and within the uppermost lower mantle, especially under low- temperature conditions(1). Akimotoite is thought to be a major constituent of the harzburgite layer of subducting slabs, and the most anisotropic mineral in the mantle transition zone(2-4). It has been predicted that if akimotoite crystals are preferentially oriented by plastic deformation, a cold subducted slab would be extremely anisotropic(5). However, there have been no studies of crystallographic preferred orientations and very few reports of plastic deformation experiments for MgSiO3 ilmenite. Here we present plastic deformation experiments on polycrystalline akimotoite, which were conducted at confining pressures of 20-22 GPa and temperatures of 1,000-1,300 degrees C. We found a change in crystallographic preferred orientation pattern of akimotoite with temperature, where the c-axis maximum parallel to the compression direction develops at high temperature, whereas the c axes are preferentially oriented parallel to the shear direction or perpendicular to the compression direction at lower temperature. The previously reported difference in compressional- wave seismic anisotropy between the northern and southern segments of the Tonga slab at depths of the mantle transition zone(6) can conceivably be attributed to the difference in the crystallographic preferred orientation pattern of akimotoite at varying temperature within the slab.	[Shiraishi, Rei; Ohtani, Eiji; Shimojuku, Akira] Tohoku Univ, Inst Mineral Petrol & Econ Geol, Sendai, Miyagi 9808578, Japan; [Zhao, Dapeng] Tohoku Univ, Dept Geophys, Sendai, Miyagi 9808578, Japan; [Kanagawa, Kyuichi] Chiba Univ, Dept Earth Sci, Chiba 2638522, Japan; [Shimojuku, Akira] Kyushu Univ, Dept Earth & Planetary Sci, Fac Sci, Fukuoka 8128581, Japan	Tohoku University; Tohoku University; Chiba University; Kyushu University	Shiraishi, R (corresponding author), Tohoku Univ, Inst Mineral Petrol & Econ Geol, Sendai, Miyagi 9808578, Japan.	siraisir@ganko.tohoku.ac.jp	Ohtani, Eiji/AAD-8011-2019	Zhao, Dapeng/0000-0003-2096-5195; Ohtani, Eiji/0000-0001-8631-0736; Shiraishi, Rei/0000-0002-5855-5768	Grant-in-Aid for Scientific Research; Ministry of Education, Culture, Science, Sport, and Technology of the Japanese Government.	Grant-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Science, Sport, and Technology of the Japanese Government.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Science, Sport, and Technology of the Japanese Government.	Akaogi M, 2002, PHYS EARTH PLANET IN, V132, P303, DOI 10.1016/S0031-9201(02)00075-4; ANDERSON DL, 1989, THEORY EARTH; Bascou J, 2002, EARTH PLANET SC LETT, V198, P77, DOI 10.1016/S0012-821X(02)00475-2; BLACIC JD, 1975, TECTONOPHYSICS, V27, P271, DOI 10.1016/0040-1951(75)90021-9; Bolfan-Casanova N, 2000, EARTH PLANET SC LETT, V182, P209, DOI 10.1016/S0012-821X(00)00244-2; Brudzinski MR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002012; CARTER NL, 1970, GEOL SOC AM BULL, V81, P2181, DOI 10.1130/0016-7606(1970)81[2181:HTFODA]2.0.CO;2; Chen WP, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016330; Chen WP, 2001, SCIENCE, V292, P2475, DOI 10.1126/science.292.5526.2475; Cordier P, 2002, REV MINERAL GEOCHEM, V51, P137, DOI 10.2138/gsrmg.51.1.137; Da Silva CRS, 1999, GEOPHYS RES LETT, V26, P943, DOI 10.1029/1999GL900149; Gudmundsson O, 1998, J GEOPHYS RES-SOL EA, V103, P7121, DOI 10.1029/97JB02488; Jung H, 2001, SCIENCE, V293, P1460, DOI 10.1126/science.1062235; Karato S, 1997, J GEOPHYS RES-SOL EA, V102, P20111, DOI 10.1029/97JB01732; Katayama I, 2006, PHYS EARTH PLANET IN, V157, P33, DOI 10.1016/j.pepi.2006.03.005; LISTER GS, 1979, B MINERAL, V102, P232, DOI 10.3406/bulmi.1979.7284; MAINPRICE D, 1986, GEOLOGY, V14, P819, DOI 10.1130/0091-7613(1986)14<819:DCSIND>2.0.CO;2; MAINPRICE D, 1990, COMPUT GEOSCI, V16, P385, DOI 10.1016/0098-3004(90)90072-2; PATERSON MS, 1982, B MINERAL, V105, P20; Randle V., 2003, MICROTEXTURE DETERMI, V2nd; SCHMID SM, 1986, AM GEOPHYS UNION GEO, V36, P263, DOI DOI 10.1016/J.GR.2007.09.003; Tommasi A, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB004168; Vavrycuk V, 2006, PHYS EARTH PLANET IN, V155, P63, DOI 10.1016/j.pepi.2005.10.005; WEIDNER DJ, 1985, PHYS EARTH PLANET IN, V40, P65, DOI 10.1016/0031-9201(85)90006-8; Zhang YG, 2005, PHYS EARTH PLANET IN, V151, P309, DOI 10.1016/j.pepi.2005.04.003; Zhao DP, 1997, SCIENCE, V278, P254, DOI 10.1126/science.278.5336.254	26	19	19	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					657	660		10.1038/nature07301	http://dx.doi.org/10.1038/nature07301			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833278				2022-12-28	WOS:000259639700045
J	Worobey, M; Gemmel, M; Teuwen, DE; Haselkorn, T; Kunstman, K; Bunce, M; Muyembe, JJ; Kabongo, JMM; Kalengayi, RM; Van Marck, E; Gilbert, MTP; Wolinsky, SM				Worobey, Michael; Gemmel, Marlea; Teuwen, Dirk E.; Haselkorn, Tamara; Kunstman, Kevin; Bunce, Michael; Muyembe, Jean-Jacques; Kabongo, Jean-Marie M.; Kalengayi, Raphael M.; Van Marck, Eric; Gilbert, M. Thomas P.; Wolinsky, Steven M.			Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ORIGIN; INFERENCE; TYPE-1; RESERVOIRS; ANCESTOR; SUBTYPES	Human immunodeficiency virus type 1 ( HIV- 1) sequences that pre- date the recognition of AIDS are critical to defining the time of origin and the timescale of virus evolution(1,2). A viral sequence from 1959 ( ZR59) is the oldest known HIV- 1 infection(1). Other historically documented sequences, important calibration points to convert evolutionary distance into time, are lacking, however; ZR59 is the only one sampled before 1976. Here we report the amplification and characterization of viral sequences from a Bouin's- fixed paraffin- embedded lymph node biopsy specimen obtained in 1960 from an adult female in Leopoldville, Belgian Congo ( now Kinshasa, Democratic Republic of the Congo ( DRC)), and we use them to conduct the first comparative evolutionary genetic study of early pre- AIDS epidemic HIV- 1 group M viruses. Phylogenetic analyses position this viral sequence ( DRC60) closest to the ancestral node of subtype A ( excluding A2). Relaxed molecular clock analyses incorporating DRC60 and ZR59 date the most recent common ancestor of the M group to near the beginning of the twentieth century. The sizeable genetic distance between DRC60 and ZR59 directly demonstrates that diversification of HIV- 1 in west- central Africa occurred long before the recognized AIDS pandemic. The recovery of viral gene sequences from decades- old paraffin- embedded tissues opens the door to a detailed palaeovirological investigation of the evolutionary history of HIV- 1 that is not accessible by other methods.	[Worobey, Michael; Gemmel, Marlea; Haselkorn, Tamara; Gilbert, M. Thomas P.] Univ Arizona, Tucson, AZ 85721 USA; [Teuwen, Dirk E.] Sanofi Pasteur, F-69367 Lyon 07, France; [Teuwen, Dirk E.] UCB SA Pharma, BE-1420 Braine Lalleud, Belgium; [Kunstman, Kevin; Wolinsky, Steven M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Bunce, Michael] Murdoch Univ, Sch Biol Sci & Biotechnol, Ancient DNA Lab, Perth, WA 6150, Australia; [Muyembe, Jean-Jacques; Kabongo, Jean-Marie M.; Kalengayi, Raphael M.] Univ Kinshasa, Dept Anat & Pathol, Kinshasa, DEM REP CONGO; [Muyembe, Jean-Jacques] Natl Lab Publ Hlth, Natl Inst Biomed Res, Kinshasa, DEM REP CONGO; [Van Marck, Eric] Univ Antwerp, Univ Hosp, Dept Pathol, B-2610 Antwerp, Belgium	University of Arizona; UCB Pharma SA; Northwestern University; Feinberg School of Medicine; Murdoch University; Universite de Kinshasa; Institute Nacional de Recherche Biomedical; University of Antwerp	Worobey, M (corresponding author), Univ Arizona, Tucson, AZ 85721 USA.	worobey@email.arizona.edu	Gilbert, Marcus TP/A-8936-2013; Wolinsky, Steven/B-2893-2012	Gilbert, Marcus TP/0000-0002-5805-7195; Bunce, Michael/0000-0002-0302-4206; Wolinsky, Steven/0000-0002-9625-6697; Teuwen, Dirk/0000-0003-0668-600X	NIH/NIAID; David and Lucile Packard Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065371] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Wertheim and M. Sanderson for computational assistance, and L. Jewel for providing the Canadian control specimen. The NIH/NIAID and the David and Lucile Packard Foundation funded the research.	Chitnis A, 2000, AIDS RES HUM RETROV, V16, P5, DOI 10.1089/088922200309548; Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; HANCE WA, 1970, POPULATION MIGRATION, P209; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; LEITNER T, 2005, HIV SEQUENCE COMPEND; Lemey P, 2004, GENETICS, V167, P1059, DOI 10.1534/genetics.104.026666; Rambaut A, 2001, NATURE, V410, P1047, DOI 10.1038/35074179; Salemi M, 2001, FASEB J, V15, P276, DOI 10.1096/fj.00-0449fje; Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390; Sharp PM, 2001, PHILOS T R SOC B, V356, P867, DOI 10.1098/rstb.2001.0863; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000; Worobey M, 2001, MOL BIOL EVOL, V18, P1425, DOI 10.1093/oxfordjournals.molbev.a003928; WOROBEY M, 2008, GLOBAL HIV AIDS MED, P13; Worobey M, 2008, J VIROL, V82, P3769, DOI 10.1128/JVI.02207-07; Yusim K, 2001, PHILOS T R SOC B, V356, P855, DOI 10.1098/rstb.2001.0859; Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400	27	352	369	1	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					661	U57		10.1038/nature07390	http://dx.doi.org/10.1038/nature07390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833279	Green Published, Green Accepted			2022-12-28	WOS:000259639700046
J	Green, MH				Green, Monica H.			Midwives and obstetric catastrophe: retrieving the past	LANCET			English	Editorial Material									[Green, Monica H.] Arizona State Univ, Dept Hist, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Green, MH (corresponding author), Arizona State Univ, Dept Hist, Tempe, AZ 85287 USA.	Monica.Green@asu.edu	Green, Monica/AAB-6124-2022	Green, Monica/0000-0001-8978-9631				Green M., 2008, MAKING WOMENS MED MA; Green MH, 2008, J MEDIEVAL HIST, V34, P185, DOI 10.1016/j.jmedhist.2008.03.001; Huisman Frank, 2004, LOCATING MED HIST ST; Kleinman A, 2008, LANCET, V371, P22, DOI 10.1016/S0140-6736(08)60057-4	4	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP-OCT	2008	372	9644					1142	1143		10.1016/S0140-6736(08)61467-1	http://dx.doi.org/10.1016/S0140-6736(08)61467-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	355UN	18942196				2022-12-28	WOS:000259734700014
J	Bohannon, J				Bohannon, John			Video games - 'Spore' documentary spawns protest by scientists who starred in it	SCIENCE			English	News Item								video											0	14	14	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					517	517						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948523				2022-12-28	WOS:000260299100007
